data_2mok_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mok _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.446 0 N-CA-C 110.634 -0.135 . . . . 0.0 110.634 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.1 pt -102.1 -16.85 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 123.962 0.905 . . . . 0.0 111.718 -179.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 16.4 m -114.58 126.89 55.43 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.682 1.593 . . . . 0.0 108.671 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -102.52 119.93 6.63 Favored Glycine 0 CA--C 1.52 0.348 0 N-CA-C 107.816 -2.114 . . . . 0.0 107.816 169.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 43.5 mt -96.22 124.54 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 104.405 -2.443 . . . . 0.0 104.405 172.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -122.84 130.18 52.57 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 176.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -129.47 130.78 46.32 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 119.615 1.098 . . . . 0.0 112.551 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -81.78 152.76 32.13 Favored Glycine 0 C--N 1.339 0.697 0 N-CA-C 108.102 -1.999 . . . . 0.0 108.102 168.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 16.8 p -153.27 166.04 33.84 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 120.128 1.964 . . . . 0.0 111.413 -176.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -144.49 -58.4 0.37 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.588 0.755 . . . . 0.0 109.745 168.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.2 p -83.36 -12.42 56.55 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.691 1.197 . . . . 0.0 111.875 175.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.06 7.84 59.39 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 124.714 1.15 . . . . 0.0 113.059 175.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -65.9 -37.74 86.89 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 118.459 1.129 . . . . 0.0 110.929 -176.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.82 -24.5 66.17 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.437 0.695 . . . . 0.0 111.914 -175.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -62.21 -40.97 97.88 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 119.114 0.87 . . . . 0.0 109.733 177.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -66.28 -37.79 86.27 Favored 'General case' 0 CA--C 1.529 0.141 0 O-C-N 122.13 -0.356 . . . . 0.0 110.123 178.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 27.1 mm -62.77 -48.9 85.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 175.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.1 -39.41 86.06 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.331 0.514 . . . . 0.0 111.156 -178.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 57.8 mttm -67.99 -42.93 80.01 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 118.52 -0.752 . . . . 0.0 111.223 175.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 75.1 mtm -64.78 -28.09 69.34 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 119.938 1.245 . . . . 0.0 111.506 178.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 83.6 mt -68.63 -57.73 8.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 169.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -59.16 -39.9 83.92 Favored 'General case' 0 C--O 1.226 -0.152 0 C-N-CA 122.938 0.495 . . . . 0.0 111.601 -171.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -64.54 -34.08 77.4 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 118.616 0.644 . . . . 0.0 111.435 -176.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -73.0 -47.58 43.9 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 118.159 0.436 . . . . 0.0 110.332 177.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 54.2 mt -67.18 -34.05 76.69 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 122.698 0.399 . . . . 0.0 111.594 -178.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.59 145.95 17.73 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 125.587 1.565 . . . . 0.0 110.762 -173.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -63.52 -28.72 70.14 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.765 0.826 . . . . 0.0 111.81 -176.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -66.88 -23.91 66.06 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.092 0.557 . . . . 0.0 111.349 176.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 53.1 t -101.3 -39.11 6.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 124.592 1.157 . . . . 0.0 110.441 -175.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -132.68 145.03 50.72 Favored 'General case' 0 C--N 1.342 0.245 0 CA-C-N 119.539 1.063 . . . . 0.0 112.111 -173.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -127.01 158.68 36.29 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.754 1.222 . . . . 0.0 109.757 172.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 71.0 t -119.27 138.08 51.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 125.021 1.328 . . . . 0.0 110.257 -169.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -146.35 166.54 26.01 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.847 1.659 . . . . 0.0 111.815 -170.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -126.82 135.53 51.14 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 105.357 -2.09 . . . . 0.0 105.357 168.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.9 tp -61.97 -17.2 17.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-N 118.88 0.763 . . . . 0.0 112.99 -170.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -52.32 -37.24 55.38 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.172 0.989 . . . . 0.0 112.339 179.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.15 1.43 57.15 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.632 0.773 . . . . 0.0 112.664 -177.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 52.5 m -87.89 157.68 18.91 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 122.374 1.083 . . . . 0.0 112.204 -174.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 23.7 m -129.23 172.51 11.38 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 127.971 2.509 . . . . 0.0 104.894 167.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.5 ptmm? -58.41 -38.69 77.91 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 120.059 1.299 . . . . 0.0 111.264 -173.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -71.51 -17.12 62.35 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.87 -0.519 . . . . 0.0 111.884 -176.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -68.23 -27.05 66.03 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.69 0.796 . . . . 0.0 111.039 -175.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.3 mp -86.97 -40.19 15.01 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 123.445 0.698 . . . . 0.0 109.845 171.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -63.74 -20.93 66.14 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.275 0.63 . . . . 0.0 111.921 -175.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.36 -29.96 70.23 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.278 1.031 . . . . 0.0 112.456 174.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -96.88 151.46 19.65 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.438 1.095 . . . . 0.0 110.669 -177.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -87.25 -37.95 16.76 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.556 170.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 22.2 mt -110.54 136.44 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -177.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 74.8 mt -132.42 120.84 22.53 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 124.139 0.976 . . . . 0.0 108.558 -176.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 8.9 mp -109.67 107.39 17.42 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 105.534 -2.024 . . . . 0.0 105.534 177.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 68.0 mt -110.17 100.85 9.68 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -170.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.97 131.73 10.8 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 124.726 1.155 . . . . 0.0 110.247 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.1 tt -142.26 122.32 8.15 Favored Pre-proline 0 CA--C 1.54 0.595 0 CA-C-N 118.358 1.079 . . . . 0.0 110.215 -179.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -81.07 161.51 20.63 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 123.07 2.513 . . . . 0.0 109.33 169.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 62.2 m -118.46 141.52 48.48 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 173.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 64.9 m95 -134.6 173.84 11.21 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 124.913 1.285 . . . . 0.0 109.442 -177.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 28.73 64.2 0.11 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 127.546 2.338 . . . . 0.0 114.479 169.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 56.73 62.84 2.13 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.445 1.098 . . . . 0.0 111.66 175.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.53 14.87 72.52 Favored Glycine 0 CA--C 1.532 1.138 0 CA-C-N 115.952 -0.567 . . . . 0.0 114.274 171.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -78.07 143.55 37.3 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 124.869 1.268 . . . . 0.0 110.117 176.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -93.89 143.94 25.89 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.342 1.057 . . . . 0.0 109.027 169.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -58.9 146.41 37.74 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.979 0.419 . . . . 0.0 110.592 177.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 60.8 m -59.25 -33.04 70.55 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.169 0.988 . . . . 0.0 112.97 -168.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -66.44 -43.7 84.89 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.247 0.476 . . . . 0.0 109.901 -178.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -71.81 -43.16 66.1 Favored 'General case' 0 C--N 1.341 0.204 0 C-N-CA 123.02 0.528 . . . . 0.0 110.029 176.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -59.15 -41.56 88.61 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 118.358 0.526 . . . . 0.0 111.858 -178.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -69.3 -23.32 63.8 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.76 0.824 . . . . 0.0 112.095 176.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -90.09 -20.76 22.78 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 118.277 -0.868 . . . . 0.0 112.302 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -51.96 -41.49 79.79 Favored Pre-proline 0 CA--C 1.544 0.72 0 CA-C-O 116.706 -1.616 . . . . 0.0 114.577 178.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -65.21 -13.89 42.17 Favored 'Trans proline' 0 CA--C 1.544 0.983 0 CA-C-N 122.809 2.039 . . . . 0.0 114.073 174.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 30.5 m -93.42 -36.15 12.64 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.46 1.104 . . . . 0.0 109.803 169.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 25.9 tp -56.1 -40.14 73.23 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 124.225 1.01 . . . . 0.0 110.501 178.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -72.78 1.11 9.13 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 178.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -112.55 -7.27 13.9 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.455 1.025 . . . . 0.0 111.52 174.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 62.7 mt -75.18 139.86 18.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -177.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -75.4 117.33 17.08 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 171.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -109.95 6.38 23.12 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 118.191 -0.909 . . . . 0.0 111.183 173.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 -60.62 116.91 4.72 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 120.754 1.616 . . . . 0.0 109.281 -175.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 74.61 -1.29 52.94 Favored Glycine 0 CA--C 1.535 1.315 0 CA-C-O 118.307 -1.274 . . . . 0.0 113.935 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -67.68 137.25 55.4 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 120.039 1.919 . . . . 0.0 107.428 172.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 17.8 mt -89.24 129.33 35.83 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 172.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.1 t -129.64 136.24 59.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -175.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -129.81 147.47 51.58 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 125.115 1.366 . . . . 0.0 107.326 175.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 69.2 mt -120.34 148.51 43.65 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -176.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -143.5 157.53 44.36 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.229 0.612 . . . . 0.0 110.654 175.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -175.47 172.34 45.37 Favored Glycine 0 CA--C 1.525 0.714 0 CA-C-O 122.634 1.13 . . . . 0.0 112.3 -178.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 4.3 m -142.76 158.65 43.43 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.369 1.868 . . . . 0.0 106.749 -173.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -169.76 -174.5 38.09 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 120.072 -1.061 . . . . 0.0 114.961 -177.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -144.29 140.38 29.14 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 129.834 3.254 . . . . 0.0 104.473 177.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.15 16.49 1.19 Allowed 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.739 1.216 . . . . 0.0 112.104 -171.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -63.82 -48.62 76.08 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.653 0.66 . . . . 0.0 109.316 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -98.78 -30.4 12.44 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.035 0.534 . . . . 0.0 111.136 171.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -83.91 42.59 0.87 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.711 1.605 . . . . 0.0 110.298 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.46 -17.32 59.2 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 -167.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -108.88 5.46 24.49 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.801 0.841 . . . . 0.0 112.594 176.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -126.14 15.31 7.86 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.683 1.193 . . . . 0.0 113.015 -169.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -62.9 121.94 14.75 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 119.588 1.086 . . . . 0.0 109.528 -177.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 82.4 m 47.12 35.98 3.98 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.709 1.604 . . . . 0.0 112.303 -177.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -50.19 -42.69 51.74 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.026 1.33 . . . . 0.0 111.655 -173.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.78 -12.02 61.02 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -170.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 82.2 mt -56.94 -42.17 79.56 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 119.143 0.883 . . . . 0.0 109.614 169.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.0 -34.28 88.38 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 111.246 -0.742 . . . . 0.0 111.246 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 4.7 m -64.18 -41.84 96.94 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 117.95 0.875 . . . . 0.0 110.578 -178.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 8.5 mt -72.16 -47.09 55.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 176.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 50.5 tpt85 -57.62 -33.02 67.82 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.488 0.715 . . . . 0.0 112.119 -175.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -70.42 -29.68 66.35 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 123.432 0.693 . . . . 0.0 112.29 179.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 94.6 mt -90.68 -40.33 12.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 123.52 0.728 . . . . 0.0 110.142 -173.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 15.4 pt -74.32 -32.39 31.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 118.853 0.751 . . . . 0.0 111.991 -169.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -63.37 -53.89 48.97 Favored Pre-proline 0 CA--C 1.541 0.596 0 CA-C-O 117.363 -1.303 . . . . 0.0 112.26 -178.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -66.22 -24.6 51.0 Favored 'Trans proline' 0 C--N 1.352 0.739 0 CA-C-N 121.942 1.729 . . . . 0.0 112.223 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -77.69 0.92 21.58 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 118.718 0.69 . . . . 0.0 112.205 171.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 100.25 11.17 43.01 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-O 118.208 -1.329 . . . . 0.0 115.469 168.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.33 150.11 40.34 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 119.292 1.546 . . . . 0.0 111.475 178.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 62.0 m -104.99 123.91 48.61 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 105.482 -2.044 . . . . 0.0 105.482 167.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 12.3 mm -91.79 138.87 18.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 -171.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 27.1 m -136.86 173.33 13.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 124.751 1.22 . . . . 0.0 109.114 170.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 81.95 43.42 8.23 Favored Glycine 0 C--N 1.337 0.628 0 CA-C-O 119.229 -0.761 . . . . 0.0 114.719 169.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 20.4 p80 -62.57 158.2 18.68 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 118.265 1.032 . . . . 0.0 109.716 168.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 77.5 t-105 -141.33 131.35 12.95 Favored Pre-proline 0 CA--C 1.534 0.331 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -68.4 145.19 64.39 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 121.912 1.741 . . . . 0.0 112.117 -173.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 57.1 p . . . . . 0 CA--C 1.532 0.283 0 C-N-CA 123.119 0.568 . . . . 0.0 110.926 171.988 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.473 0.695 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -77.82 -2.72 82.43 Favored Glycine 0 CA--C 1.531 1.065 0 CA-C-O 118.573 -1.126 . . . . 0.0 112.969 172.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 96.5 mt -66.51 133.29 50.06 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 120.171 1.986 . . . . 0.0 110.019 178.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -97.17 -33.82 11.35 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 166.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -145.58 162.77 36.69 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 127.378 2.271 . . . . 0.0 106.704 169.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -55.01 -28.01 48.76 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 118.942 0.792 . . . . 0.0 112.04 174.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -84.64 -19.68 32.54 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.468 1.107 . . . . 0.0 113.671 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 32.2 p-80 -153.31 137.63 16.62 Favored 'General case' 0 C--N 1.345 0.4 0 CA-C-O 123.064 1.411 . . . . 0.0 114.257 -176.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -73.05 154.09 40.59 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 125.436 1.494 . . . . 0.0 109.245 168.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 4.9 p -76.32 -18.07 15.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 124.546 1.138 . . . . 0.0 111.745 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -141.9 171.66 24.39 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 125.634 1.587 . . . . 0.0 109.373 177.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -59.03 130.15 45.61 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 172.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.19 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 178.717 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 18.1 mt . . . . . 0 CA--C 1.54 0.581 0 CA-C-O 122.41 1.1 . . . . 0.0 109.032 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 44.6 m -69.8 -48.18 60.06 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 126.118 1.767 . . . . 0.0 112.388 -168.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -60.85 -42.91 98.74 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -166.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -64.49 -37.87 89.04 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 118.319 0.509 . . . . 0.0 110.434 178.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 53.5 mtt85 -70.54 -44.48 67.41 Favored 'General case' 0 C--N 1.339 0.119 0 O-C-N 121.622 -0.674 . . . . 0.0 110.68 -178.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 22.5 m -73.79 -26.81 21.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 CA-C-O 118.523 -0.751 . . . . 0.0 110.613 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -62.0 -51.12 69.3 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 120.247 1.385 . . . . 0.0 109.13 170.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -58.43 -43.95 88.92 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 118.179 0.445 . . . . 0.0 110.542 179.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 73.2 t90 -67.02 -44.34 80.52 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 118.934 0.788 . . . . 0.0 110.689 -177.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 54.7 t -62.48 -38.95 82.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 55.8 mttm -66.7 -38.81 87.5 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.176 -0.952 . . . . 0.0 110.091 179.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 42.0 mm-40 -62.61 -50.94 69.25 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-N 118.538 0.608 . . . . 0.0 110.9 175.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 29.4 pt -64.7 -33.92 66.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-N 119.341 0.973 . . . . 0.0 109.973 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 57.6 m -61.76 -24.46 66.84 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 117.766 -1.111 . . . . 0.0 112.597 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -95.15 -11.32 28.35 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 120.317 1.417 . . . . 0.0 112.677 175.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -85.44 -40.03 16.87 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 119.183 0.901 . . . . 0.0 110.082 169.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 64.1 mt -84.64 -12.91 53.02 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.668 1.987 . . . . 0.0 111.609 -179.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 56.85 32.12 20.83 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.762 1.625 . . . . 0.0 112.419 -170.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 58.3 mt . . . . . 0 C--N 1.342 0.258 0 O-C-N 121.752 -0.592 . . . . 0.0 110.733 169.143 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.349 0 N-CA-C 110.516 -0.179 . . . . 0.0 110.516 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.0 pt -85.91 -27.09 6.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 123.087 0.555 . . . . 0.0 111.145 178.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 49.3 m -111.92 120.59 42.44 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.295 1.038 . . . . 0.0 109.318 -178.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -94.51 116.06 5.2 Favored Glycine 0 CA--C 1.52 0.376 0 N-CA-C 107.048 -2.421 . . . . 0.0 107.048 169.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 72.7 mt -95.21 97.1 6.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 104.852 -2.277 . . . . 0.0 104.852 176.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -91.71 137.83 32.05 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 176.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -136.93 159.48 41.74 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 123.592 0.757 . . . . 0.0 110.644 -176.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -131.31 147.47 18.55 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 107.739 -2.144 . . . . 0.0 107.739 167.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 29.6 m -168.44 143.02 3.36 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.375 1.588 . . . . 0.0 109.589 -179.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -91.07 -45.15 8.86 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 122.53 0.332 . . . . 0.0 111.001 170.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 82.5 p -107.47 9.13 29.7 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.014 0.926 . . . . 0.0 112.563 -175.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 79.72 13.34 82.51 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 124.128 0.87 . . . . 0.0 114.452 178.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -72.42 -46.17 56.31 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 119.515 1.658 . . . . 0.0 111.582 -177.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.5 m -74.32 -25.17 59.39 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 119.471 1.032 . . . . 0.0 109.896 179.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -58.64 -40.89 84.66 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.214 -0.929 . . . . 0.0 110.3 169.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -64.0 -36.6 84.52 Favored 'General case' 0 CA--C 1.532 0.282 0 O-C-N 121.48 -0.762 . . . . 0.0 110.905 178.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 29.6 mm -64.29 -45.99 94.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 174.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.21 -41.53 79.61 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.475 0.58 . . . . 0.0 111.215 178.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -67.86 -42.88 80.66 Favored 'General case' 0 N--CA 1.463 0.212 0 O-C-N 121.738 -0.601 . . . . 0.0 110.994 178.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.38 -23.37 64.66 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 119.248 0.931 . . . . 0.0 112.008 178.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 59.1 mt -71.22 -54.98 15.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 169.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -59.98 -38.16 81.72 Favored 'General case' 0 C--O 1.225 -0.234 0 CA-C-O 118.928 -0.558 . . . . 0.0 111.6 -173.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -59.13 -37.99 78.54 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 118.925 0.784 . . . . 0.0 110.885 -176.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -72.52 -39.93 67.2 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.101 0.561 . . . . 0.0 111.316 178.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.3 mp -75.17 -33.59 61.48 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.031 0.378 . . . . 0.0 111.131 -176.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.64 149.42 14.32 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.878 1.228 . . . . 0.0 110.93 -172.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -64.32 -28.47 69.73 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.884 0.873 . . . . 0.0 111.911 -173.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -66.87 -25.93 66.64 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.081 0.552 . . . . 0.0 111.426 178.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 39.3 t -100.75 -42.15 9.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 124.357 1.063 . . . . 0.0 109.999 -175.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -131.7 145.63 51.74 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 119.124 0.874 . . . . 0.0 111.584 -174.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -135.67 139.11 43.47 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 123.616 0.766 . . . . 0.0 109.777 178.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 92.9 t -101.99 135.07 40.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 C-N-CA 124.373 1.069 . . . . 0.0 109.523 -170.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 79.2 m-70 -141.31 137.08 32.17 Favored 'General case' 0 C--N 1.339 0.138 0 C-N-CA 124.62 1.168 . . . . 0.0 111.112 -173.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.31 131.6 43.67 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 168.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.6 tp -68.56 -33.52 60.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 O-C-N 121.551 -0.718 . . . . 0.0 111.402 -179.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.87 -40.24 94.82 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.98 0.809 . . . . 0.0 112.108 -169.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -75.27 -17.69 60.24 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 118.149 0.431 . . . . 0.0 112.038 178.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 53.1 m -75.84 163.63 27.04 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.444 0.64 . . . . 0.0 111.108 -169.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 47.1 m -127.33 168.45 14.78 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.159 1.383 . . . . 0.0 109.587 -175.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -52.05 -46.15 64.98 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.545 1.138 . . . . 0.0 111.756 -173.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -74.15 -14.4 60.95 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 122.823 0.449 . . . . 0.0 111.827 -173.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -78.82 -30.58 45.42 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 121.393 -0.817 . . . . 0.0 111.248 -170.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.2 mp -79.45 -39.18 32.89 Favored 'General case' 0 C--N 1.345 0.391 0 O-C-N 122.109 -0.37 . . . . 0.0 110.195 171.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -55.35 -28.52 54.39 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.266 1.027 . . . . 0.0 112.274 -176.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.44 -29.39 69.52 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.195 0.998 . . . . 0.0 113.438 -178.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -88.12 156.6 19.17 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.068 0.947 . . . . 0.0 110.591 -175.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -99.94 -32.32 11.03 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 123.056 0.542 . . . . 0.0 111.393 170.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.1 mp -108.77 128.16 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 172.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -114.7 128.23 56.2 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 170.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.2 mp -109.63 126.84 54.06 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 169.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 67.2 mt -123.18 118.23 27.16 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -169.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -111.66 102.66 1.44 Allowed Glycine 0 C--N 1.336 0.528 0 C-N-CA 125.464 1.507 . . . . 0.0 111.881 -170.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 17.3 tt -127.34 117.17 21.53 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 123.406 0.682 . . . . 0.0 112.165 -169.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -82.6 150.71 14.83 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 122.883 2.389 . . . . 0.0 110.321 168.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.8 m -96.83 137.98 35.08 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 178.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 19.9 m95 -133.15 175.27 9.53 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.166 1.386 . . . . 0.0 111.129 -171.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 51.06 -91.79 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 128.268 2.627 . . . . 0.0 113.445 -178.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -152.57 81.61 1.23 Allowed 'General case' 0 C--O 1.235 0.318 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 176.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 63.22 50.82 59.77 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 -175.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -121.28 154.15 36.75 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 124.583 1.153 . . . . 0.0 108.326 175.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -73.2 147.93 44.25 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.068 0.461 . . . . 0.0 110.387 169.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 16.2 tp60 -56.22 142.66 36.47 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 167.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 56.8 m -56.2 -32.05 64.03 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.05 0.94 . . . . 0.0 112.41 -170.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -57.08 -43.72 82.4 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 123.919 0.887 . . . . 0.0 110.491 178.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -81.94 -41.25 21.11 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 123.664 0.786 . . . . 0.0 110.579 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -58.01 -39.18 77.67 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.154 0.433 . . . . 0.0 111.325 -178.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -70.36 -25.85 63.46 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.466 0.706 . . . . 0.0 112.033 176.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -90.88 -23.28 20.57 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 118.613 -0.708 . . . . 0.0 112.567 -177.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 20.7 m-30 -49.36 -42.06 61.76 Favored Pre-proline 0 CA--C 1.542 0.652 0 CA-C-O 116.457 -1.735 . . . . 0.0 115.114 -178.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -64.32 -18.11 62.04 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 CA-C-N 122.934 2.084 . . . . 0.0 113.474 176.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 25.0 m -88.45 -42.4 12.16 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.095 0.958 . . . . 0.0 109.591 169.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 27.3 tp -55.8 -38.82 70.45 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.308 1.043 . . . . 0.0 111.284 -177.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -70.82 -7.75 47.59 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -178.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -95.2 -17.64 21.57 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 119.712 1.142 . . . . 0.0 111.739 171.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 97.6 mt -77.04 133.82 30.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 -173.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -82.35 140.01 33.76 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.023 0.929 . . . . 0.0 109.496 175.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -129.58 11.01 5.71 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 118.368 -0.825 . . . . 0.0 111.469 174.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -66.6 123.59 20.49 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 120.742 1.61 . . . . 0.0 109.621 -172.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.72 2.45 50.9 Favored Glycine 0 CA--C 1.537 1.443 0 CA-C-O 117.965 -1.464 . . . . 0.0 114.088 -174.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -79.81 150.25 30.77 Favored 'General case' 0 C--N 1.345 0.385 0 CA-C-N 120.222 2.011 . . . . 0.0 107.722 170.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 19.9 mt -91.71 137.45 32.36 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 171.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 16.0 t -133.73 142.73 40.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 177.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -134.3 151.0 51.02 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 170.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -113.54 145.71 40.79 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 124.367 1.067 . . . . 0.0 109.022 -174.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -143.42 159.03 43.14 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 166.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 179.31 177.4 47.69 Favored Glycine 0 N--CA 1.447 -0.598 0 O-C-N 121.184 -0.947 . . . . 0.0 113.282 -177.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 20.1 m -134.95 155.31 50.95 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.362 1.065 . . . . 0.0 109.533 -169.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -168.03 -176.09 38.26 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -177.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -132.15 110.85 10.96 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 172.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -75.22 -9.79 58.88 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 117.831 -1.081 . . . . 0.0 113.481 -168.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -110.44 -47.07 3.32 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 120.347 1.43 . . . . 0.0 110.673 -177.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -81.19 -22.27 39.02 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.993 -0.442 . . . . 0.0 111.619 -173.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -126.23 44.36 2.88 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.377 1.471 . . . . 0.0 109.047 172.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.34 -21.93 64.46 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.683 1.193 . . . . 0.0 113.829 -173.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -86.83 -2.47 58.6 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.791 0.836 . . . . 0.0 111.911 178.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -141.06 23.79 2.19 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.802 1.241 . . . . 0.0 110.968 -169.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -65.05 123.92 20.73 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 118.86 0.754 . . . . 0.0 110.713 -168.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 69.1 m 52.01 31.54 8.86 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.355 1.462 . . . . 0.0 112.981 178.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -57.51 -37.72 73.46 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.638 -0.663 . . . . 0.0 112.279 -178.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.35 -26.49 67.31 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -169.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.8 mp -62.38 -36.16 81.43 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.48 -0.763 . . . . 0.0 109.268 176.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -67.78 -29.21 73.58 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 123.651 0.643 . . . . 0.0 111.853 175.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.1 m -65.97 -36.71 84.07 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 118.801 1.301 . . . . 0.0 110.353 176.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 5.1 mt -68.69 -47.83 74.59 Favored 'Isoleucine or valine' 0 C--N 1.343 0.283 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 173.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 40.4 ttt-85 -49.89 -45.96 51.3 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 119.03 0.832 . . . . 0.0 111.037 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -60.36 -22.27 63.08 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.013 0.925 . . . . 0.0 112.759 -177.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 86.1 mt -96.2 -47.84 12.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 124.359 1.064 . . . . 0.0 109.681 178.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 30.4 pt -75.05 -31.44 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 119.464 1.029 . . . . 0.0 111.698 -170.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -66.81 -50.85 42.07 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-O 117.584 -1.198 . . . . 0.0 111.722 -176.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -67.6 -24.56 41.64 Favored 'Trans proline' 0 C--N 1.353 0.767 0 CA-C-N 122.079 1.778 . . . . 0.0 112.276 176.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 81.1 mmt-85 -75.23 6.33 4.51 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.619 0.768 . . . . 0.0 113.043 170.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 85.22 11.81 74.92 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-O 118.147 -1.363 . . . . 0.0 114.686 168.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -56.17 138.04 50.67 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 119.293 1.547 . . . . 0.0 110.433 174.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 61.7 m -90.13 118.99 30.09 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 104.392 -2.447 . . . . 0.0 104.392 167.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 47.5 mt -101.47 130.75 50.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 -170.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 34.6 m -133.03 173.89 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 125.093 1.357 . . . . 0.0 109.245 177.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 81.32 28.47 44.27 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-O 119.507 -0.607 . . . . 0.0 112.948 176.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 67.0 m80 -58.39 146.13 35.86 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 118.06 0.93 . . . . 0.0 109.593 170.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 59.2 t-105 -131.4 135.97 27.88 Favored Pre-proline 0 CA--C 1.534 0.343 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 -177.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -67.14 139.89 52.06 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.003 1.802 . . . . 0.0 110.859 -174.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.4 t . . . . . 0 CA--C 1.543 0.687 0 C-N-CA 123.459 0.704 . . . . 0.0 110.748 176.88 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 88.8 mttt . . . . . 0 N--CA 1.469 0.508 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -81.99 6.7 65.68 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-N 118.62 0.646 . . . . 0.0 112.719 169.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 79.5 mt -64.83 142.16 58.53 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 118.586 1.193 . . . . 0.0 111.345 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -116.77 -16.89 10.61 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.999 1.32 . . . . 0.0 110.385 168.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -143.08 156.57 44.84 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 127.191 2.196 . . . . 0.0 106.126 173.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -54.76 -23.69 19.05 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.572 1.149 . . . . 0.0 113.707 -173.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -124.33 11.29 8.7 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.884 0.873 . . . . 0.0 113.334 177.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -138.42 129.36 26.83 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 120.52 -1.363 . . . . 0.0 112.096 -176.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -70.01 153.11 43.63 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.445 1.098 . . . . 0.0 109.048 168.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 9.7 p -62.44 -24.78 36.13 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 123.604 0.762 . . . . 0.0 111.244 173.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -157.9 179.4 33.65 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 123.557 0.599 . . . . 0.0 112.171 -169.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -70.92 110.01 5.4 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 123.56 0.744 . . . . 0.0 109.478 -178.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.375 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 167.999 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 11.4 mt . . . . . 0 CA--C 1.539 0.556 0 N-CA-C 111.622 0.23 . . . . 0.0 111.622 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 35.9 m -43.18 -61.13 1.41 Allowed 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 126.499 1.919 . . . . 0.0 112.737 -167.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -70.97 -35.84 72.3 Favored 'General case' 0 N--CA 1.452 -0.346 0 O-C-N 121.845 -0.535 . . . . 0.0 111.032 -169.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -72.72 -30.22 64.01 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.873 0.761 . . . . 0.0 111.278 178.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 74.1 mtp85 -63.3 -43.41 97.95 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 119.703 1.138 . . . . 0.0 109.515 172.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 66.2 t -66.03 -41.61 90.0 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.246 0 CA-C-O 118.325 -0.845 . . . . 0.0 109.023 178.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -59.94 -49.53 77.31 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 120.483 1.492 . . . . 0.0 110.487 176.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -61.84 -39.78 93.01 Favored 'General case' 0 N--CA 1.462 0.144 0 O-C-N 122.014 -0.428 . . . . 0.0 110.47 -176.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 60.9 t90 -70.73 -48.72 53.05 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 118.344 0.52 . . . . 0.0 110.642 178.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 55.6 t -60.77 -39.63 82.35 Favored 'Isoleucine or valine' 0 C--O 1.231 0.108 0 C-N-CA 123.041 0.536 . . . . 0.0 110.339 -175.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -68.0 -36.34 79.82 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 121.632 -0.668 . . . . 0.0 109.919 -177.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 46.8 mm-40 -67.73 -50.38 57.66 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 122.911 0.484 . . . . 0.0 110.677 174.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 6.3 pt -66.77 -31.87 55.47 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.313 0 CA-C-N 119.151 0.887 . . . . 0.0 110.937 -176.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 66.1 m -59.03 -37.39 76.83 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.316 0.962 . . . . 0.0 111.716 -179.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -83.69 -31.02 26.32 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 119.339 0.972 . . . . 0.0 111.788 178.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -68.4 -36.46 79.16 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 118.733 0.697 . . . . 0.0 110.783 176.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 76.9 mt -81.63 -3.3 53.1 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.881 1.673 . . . . 0.0 111.612 174.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . 0.324 1.3 p-80 50.12 19.11 0.45 Allowed 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 129.88 3.272 . . . . 0.0 114.719 -174.002 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 4.6 pp . . . . . 0 N--CA 1.462 0.164 0 C-N-CA 123.103 0.561 . . . . 0.0 111.505 176.828 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.261 0 CA-C-O 121.093 0.473 . . . . 0.0 111.723 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.4 pt -119.65 -12.63 9.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 125.37 1.468 . . . . 0.0 111.537 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.1 m -114.58 127.03 55.57 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 125.35 1.46 . . . . 0.0 107.934 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -99.38 116.35 5.56 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 108.114 -1.994 . . . . 0.0 108.114 169.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 60.2 mt -92.55 119.96 41.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 N-CA-C 104.899 -2.259 . . . . 0.0 104.899 171.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -116.82 133.47 55.97 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 176.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -134.14 163.71 28.98 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 122.833 0.453 . . . . 0.0 111.591 -173.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -131.23 144.38 15.92 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 107.92 -2.072 . . . . 0.0 107.92 166.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 9.1 m -166.65 155.18 10.37 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-N 119.356 1.578 . . . . 0.0 110.127 176.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -115.61 -50.4 2.71 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.964 0.906 . . . . 0.0 109.841 167.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.6 p -86.92 8.43 23.15 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.819 1.248 . . . . 0.0 112.802 177.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 80.31 2.91 89.69 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 124.687 1.137 . . . . 0.0 115.609 169.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -70.2 -49.05 54.15 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 119.593 1.696 . . . . 0.0 112.375 -174.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 10.2 m -74.08 -26.62 60.48 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 120.546 1.521 . . . . 0.0 109.614 -178.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -60.48 -43.49 96.91 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.82 0.848 . . . . 0.0 110.157 169.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -64.69 -41.81 95.78 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 121.467 -0.771 . . . . 0.0 110.72 176.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 46.2 mm -59.29 -45.76 92.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-N 118.561 0.619 . . . . 0.0 109.332 175.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.65 -44.57 85.75 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.483 0.713 . . . . 0.0 110.952 178.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -66.52 -41.45 88.76 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 118.691 -0.671 . . . . 0.0 110.719 179.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 94.4 mtp -62.33 -40.3 95.89 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 119.531 1.059 . . . . 0.0 110.623 177.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 34.5 mt -63.33 -42.75 97.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 119.028 0.831 . . . . 0.0 109.152 175.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -59.71 -41.32 90.54 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 119.204 0.911 . . . . 0.0 110.921 177.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -64.53 -35.41 80.88 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 118.839 0.745 . . . . 0.0 110.463 178.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -67.72 -46.93 70.79 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.039 0.536 . . . . 0.0 110.697 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -76.77 -31.97 57.39 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 118.724 0.693 . . . . 0.0 111.523 -178.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.79 146.27 20.67 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 125.389 1.471 . . . . 0.0 110.798 -173.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -64.14 -28.78 70.0 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.949 0.9 . . . . 0.0 111.807 -174.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -78.58 -3.78 45.52 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 178.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 48.3 t -113.8 -38.13 2.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 124.791 1.236 . . . . 0.0 109.708 178.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -129.74 142.37 50.71 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 119.307 0.958 . . . . 0.0 111.741 -176.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -119.47 159.53 24.1 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.01 1.724 . . . . 0.0 108.493 172.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 48.4 t -133.46 130.22 56.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 C-N-CA 124.601 1.161 . . . . 0.0 109.515 -169.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -144.99 150.36 36.78 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.168 0.987 . . . . 0.0 111.625 174.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -72.45 134.84 45.55 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 166.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.2 tp -56.81 -32.33 38.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 118.697 0.68 . . . . 0.0 111.621 -173.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.65 -28.51 69.97 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.9 0.773 . . . . 0.0 112.243 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -82.06 -17.31 47.11 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.299 0.64 . . . . 0.0 110.597 178.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.9 t -75.52 174.17 10.03 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 122.117 0.961 . . . . 0.0 110.377 174.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 21.3 m -145.53 167.09 23.87 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 127.726 2.41 . . . . 0.0 107.676 -177.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -52.68 -49.79 64.57 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.294 0.638 . . . . 0.0 110.843 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -76.0 -15.78 60.08 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 122.735 0.414 . . . . 0.0 111.701 -175.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -81.62 -37.05 28.19 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 121.685 -0.635 . . . . 0.0 110.233 -178.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.78 -43.65 88.14 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-N 118.345 0.52 . . . . 0.0 109.894 168.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -62.42 -20.98 65.05 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.4 0.68 . . . . 0.0 112.321 -177.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.25 -28.08 69.49 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.449 0.7 . . . . 0.0 112.009 177.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -103.47 138.45 40.17 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.559 1.144 . . . . 0.0 110.541 -176.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -88.39 -29.85 19.95 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.0 171.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.5 mm -106.4 128.76 60.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 178.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 88.6 mt -129.22 140.58 51.42 Favored 'General case' 0 CA--C 1.52 -0.208 0 C-N-CA 123.034 0.534 . . . . 0.0 109.809 -175.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -122.36 126.87 48.95 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 172.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 67.3 mt -121.07 122.02 39.16 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -173.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -117.75 103.92 1.11 Allowed Glycine 0 CA--C 1.524 0.609 0 C-N-CA 125.349 1.452 . . . . 0.0 112.45 -169.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 16.9 tt -127.17 111.98 21.56 Favored Pre-proline 0 CA--C 1.542 0.657 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -169.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -75.76 147.84 31.68 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 122.287 1.991 . . . . 0.0 108.983 167.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 44.3 m -95.62 137.18 35.05 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 176.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 23.9 m95 -134.49 172.04 13.47 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.655 1.182 . . . . 0.0 111.43 -173.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 58.55 -79.53 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 128.565 2.746 . . . . 0.0 113.663 172.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -152.18 51.41 0.79 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.843 2.057 . . . . 0.0 108.923 -171.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.42 37.87 62.47 Favored Glycine 0 CA--C 1.525 0.661 0 O-C-N 121.56 -0.713 . . . . 0.0 111.63 -174.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -115.5 160.0 20.49 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.506 1.123 . . . . 0.0 109.791 -175.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.7 160.54 29.26 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.471 169.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -75.52 155.98 35.57 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 168.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 59.7 m -55.41 -29.79 59.22 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.84 0.856 . . . . 0.0 112.381 -177.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -65.8 -42.37 90.76 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.094 0.558 . . . . 0.0 110.691 -177.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 80.1 m95 -76.25 -44.35 37.76 Favored 'General case' 0 C--N 1.341 0.226 0 C-N-CA 122.813 0.445 . . . . 0.0 110.094 174.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -62.41 -37.11 84.53 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.792 0.437 . . . . 0.0 111.939 -172.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -71.23 -21.69 62.09 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.542 0.737 . . . . 0.0 112.018 175.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -90.16 -23.86 21.21 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.459 0.703 . . . . 0.0 111.385 179.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -51.02 -42.43 79.96 Favored Pre-proline 0 CA--C 1.544 0.714 0 CA-C-O 116.627 -1.654 . . . . 0.0 114.784 178.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -64.24 -22.94 66.55 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 CA-C-N 122.954 2.091 . . . . 0.0 113.194 174.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.3 m -81.04 -38.0 28.16 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.049 0.94 . . . . 0.0 109.738 170.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 13.4 tp -59.84 -35.23 74.32 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.79 1.236 . . . . 0.0 110.928 -175.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -79.63 -4.46 51.72 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.053 0.941 . . . . 0.0 113.035 177.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -93.73 -24.95 17.64 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 119.612 1.097 . . . . 0.0 111.176 169.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 95.7 mt -67.92 137.6 24.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 -176.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -86.83 81.03 8.3 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -177.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -70.0 -5.42 26.28 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 118.381 -0.819 . . . . 0.0 112.843 -176.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 57.1 m-80 -53.44 117.94 3.47 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 119.609 1.095 . . . . 0.0 109.513 -179.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 82.44 -4.8 76.21 Favored Glycine 0 CA--C 1.533 1.165 0 CA-C-O 117.849 -1.528 . . . . 0.0 114.47 175.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -64.56 139.68 58.79 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 120.527 2.164 . . . . 0.0 107.894 169.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.7 mt -95.96 124.97 40.2 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 106.487 -1.672 . . . . 0.0 106.487 169.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.2 t -131.07 146.49 33.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -169.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -131.41 146.49 52.29 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 169.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.2 mt -112.59 142.53 45.06 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 124.211 1.005 . . . . 0.0 109.437 -177.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 24.8 p90 -138.51 155.97 47.93 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 168.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -168.77 169.15 41.58 Favored Glycine 0 N--CA 1.447 -0.586 0 O-C-N 121.469 -0.769 . . . . 0.0 111.654 -176.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 56.5 m -136.27 156.01 49.28 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.242 1.017 . . . . 0.0 109.192 -171.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -170.89 -167.26 30.99 Favored Glycine 0 CA--C 1.526 0.777 0 O-C-N 123.256 0.348 . . . . 0.0 112.601 -173.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -138.56 141.69 39.25 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 126.509 1.924 . . . . 0.0 109.176 177.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -110.89 -11.8 14.32 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.981 1.312 . . . . 0.0 111.889 -177.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -84.95 -31.68 23.46 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 118.416 0.553 . . . . 0.0 111.245 -168.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -128.33 -39.34 1.7 Allowed 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.348 0.659 . . . . 0.0 111.714 173.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -83.15 32.97 0.44 Allowed 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 118.419 0.554 . . . . 0.0 112.149 -177.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.27 -27.68 69.21 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.654 1.182 . . . . 0.0 113.259 -172.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -79.43 -0.2 31.98 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.023 0.929 . . . . 0.0 111.602 176.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -140.91 16.56 2.3 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 125.481 1.512 . . . . 0.0 110.621 -172.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -65.43 115.05 5.28 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 119.561 1.073 . . . . 0.0 108.788 -169.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 75.9 m 53.47 34.3 17.97 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.567 1.547 . . . . 0.0 113.178 -174.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -51.01 -43.66 60.87 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.75 1.22 . . . . 0.0 111.741 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.53 -14.93 63.37 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -169.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 67.5 mt -58.09 -41.62 83.88 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 118.866 0.757 . . . . 0.0 110.055 169.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -65.38 -32.97 85.29 Favored Glycine 0 C--N 1.339 0.744 0 N-CA-C 111.245 -0.742 . . . . 0.0 111.245 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.3 m -65.37 -37.23 86.4 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 118.229 1.015 . . . . 0.0 110.704 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 5.0 mt -73.56 -44.87 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 118.952 0.796 . . . . 0.0 108.97 174.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 35.9 ttt180 -53.28 -44.14 68.01 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 119.297 0.953 . . . . 0.0 110.608 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -61.92 -16.14 48.59 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.691 1.196 . . . . 0.0 113.035 -178.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 86.8 mt -101.0 -58.35 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 124.252 1.021 . . . . 0.0 109.095 173.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 20.1 pt -68.75 -32.98 57.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 O-C-N 121.144 -0.972 . . . . 0.0 112.142 -167.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -67.99 -53.4 20.16 Favored Pre-proline 0 CA--C 1.541 0.627 0 CA-C-O 117.671 -1.157 . . . . 0.0 111.242 -176.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -68.45 -23.45 37.67 Favored 'Trans proline' 0 C--N 1.353 0.786 0 CA-C-N 121.708 1.646 . . . . 0.0 112.83 175.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 30.9 mmm180 -74.41 -0.56 17.73 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 119.343 0.974 . . . . 0.0 112.17 170.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 94.0 14.69 51.26 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-O 118.558 -1.134 . . . . 0.0 114.999 168.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.26 144.34 57.02 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 119.183 1.492 . . . . 0.0 109.411 170.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 47.0 m -93.59 119.52 32.72 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 104.163 -2.532 . . . . 0.0 104.163 167.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 21.4 mt -100.56 130.75 49.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 107.016 -1.475 . . . . 0.0 107.016 -176.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.7 m -133.05 -172.88 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 125.549 1.539 . . . . 0.0 107.948 169.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 70.57 21.3 77.66 Favored Glycine 0 CA--C 1.529 0.963 0 O-C-N 120.979 -1.075 . . . . 0.0 111.572 -171.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 21.3 p-80 -59.19 133.12 55.81 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 168.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 70.7 t-105 -115.73 130.04 24.67 Favored Pre-proline 0 C--O 1.237 0.401 0 C-N-CA 124.573 1.149 . . . . 0.0 108.827 -167.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -67.37 139.58 50.09 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 121.51 1.473 . . . . 0.0 111.034 -175.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 2.1 t . . . . . 0 CA--C 1.545 0.764 0 C-N-CA 123.763 0.825 . . . . 0.0 111.917 -174.879 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.538 0.484 0 CA-C-O 120.052 -0.023 . . . . 0.0 110.955 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -78.28 -1.65 81.55 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-O 118.215 -1.325 . . . . 0.0 114.024 169.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 59.8 mt -63.05 122.49 16.2 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 120.96 2.38 . . . . 0.0 108.21 170.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -97.92 -26.91 14.5 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.248 1.019 . . . . 0.0 110.352 177.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -144.62 160.03 41.83 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.819 2.047 . . . . 0.0 106.769 175.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -55.18 -25.94 35.73 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.931 0.892 . . . . 0.0 112.822 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -111.08 -0.65 16.53 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.471 1.108 . . . . 0.0 113.701 179.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 -141.39 133.55 27.86 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 120.206 1.366 . . . . 0.0 113.426 -175.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -77.7 152.76 33.55 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 166.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 12.5 p -58.92 -28.58 38.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 123.913 0.885 . . . . 0.0 111.323 174.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -155.51 170.53 33.49 Favored Glycine 0 C--N 1.338 0.673 0 C-N-CA 123.957 0.789 . . . . 0.0 111.418 -170.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -60.93 126.48 27.51 Favored 'General case' 0 C--N 1.334 -0.073 0 C-N-CA 124.314 1.046 . . . . 0.0 109.176 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.301 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 172.24 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 88.5 mt . . . . . 0 N--CA 1.471 0.61 0 N-CA-C 110.639 -0.134 . . . . 0.0 110.639 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 93.2 m -45.49 -53.74 8.46 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 125.892 1.677 . . . . 0.0 112.165 -169.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -68.45 -38.67 81.32 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 119.226 -0.416 . . . . 0.0 111.36 -169.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -73.74 -32.87 64.08 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 118.64 0.655 . . . . 0.0 110.805 178.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 51.9 mtp85 -67.17 -45.77 75.99 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-N 118.791 0.723 . . . . 0.0 109.603 178.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 23.7 m -71.5 -31.68 43.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-O 118.083 -0.96 . . . . 0.0 110.564 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -58.8 -56.83 17.15 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 120.378 1.445 . . . . 0.0 109.59 172.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -60.54 -34.39 74.06 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 122.992 0.517 . . . . 0.0 110.798 -175.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 33.1 t90 -77.86 -50.0 13.13 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 117.975 0.352 . . . . 0.0 110.796 -178.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 66.5 t -63.87 -32.41 56.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 O-C-N 120.782 -1.199 . . . . 0.0 110.151 -176.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -59.95 -35.91 75.95 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 117.981 -1.009 . . . . 0.0 111.566 175.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . 0.251 13.2 pt20 -75.71 -50.71 14.57 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 119.552 1.069 . . . . 0.0 111.012 171.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 1.4 pt -64.51 -32.07 56.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-N 120.096 1.316 . . . . 0.0 111.552 -169.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 6.3 p -61.43 -38.47 87.27 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 118.468 -0.777 . . . . 0.0 110.858 -178.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -82.7 -36.83 25.52 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 119.724 1.147 . . . . 0.0 111.38 175.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 63.1 mt-10 -70.59 -34.02 71.71 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 118.606 0.639 . . . . 0.0 111.749 -175.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 64.1 mt -86.71 1.23 52.8 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.008 1.323 . . . . 0.0 110.971 175.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 56.17 32.35 20.03 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.856 1.662 . . . . 0.0 112.984 -176.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 90.6 mt . . . . . 0 N--CA 1.465 0.304 0 C-N-CA 123.364 0.666 . . . . 0.0 109.584 173.428 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.359 0 N-CA-C 110.305 -0.257 . . . . 0.0 110.305 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.8 pt -82.71 -19.33 10.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -174.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.8 m -115.09 127.39 55.58 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.203 1.401 . . . . 0.0 108.416 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -102.63 117.4 5.78 Favored Glycine 0 CA--C 1.52 0.394 0 N-CA-C 107.914 -2.074 . . . . 0.0 107.914 170.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 64.9 mt -96.29 93.83 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 176.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -88.37 132.83 34.28 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 177.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -130.64 128.62 41.34 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 119.207 0.912 . . . . 0.0 112.167 179.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -93.53 142.85 16.18 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 107.54 -2.224 . . . . 0.0 107.54 166.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.4 t -156.14 175.18 14.31 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 119.279 1.539 . . . . 0.0 109.285 172.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -122.09 -54.78 1.9 Allowed 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.041 0.537 . . . . 0.0 110.226 169.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.1 p -94.9 -0.37 54.04 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.144 0.978 . . . . 0.0 112.597 175.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 90.15 15.36 57.63 Favored Glycine 0 C--N 1.343 0.949 0 CA-C-O 118.963 -0.91 . . . . 0.0 114.256 169.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -68.28 -39.9 82.01 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 119.787 1.794 . . . . 0.0 110.526 175.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.79 -29.52 68.27 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 119.131 0.878 . . . . 0.0 111.346 175.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -64.41 -40.34 95.58 Favored 'General case' 0 C--N 1.343 0.285 0 CA-C-N 118.819 0.736 . . . . 0.0 109.604 176.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -65.31 -41.95 93.53 Favored 'General case' 0 CA--C 1.529 0.146 0 O-C-N 121.976 -0.453 . . . . 0.0 110.335 178.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 48.1 mm -60.17 -48.6 87.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 174.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.48 -43.37 98.98 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.42 0.688 . . . . 0.0 111.538 -178.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 54.7 mttm -63.69 -44.03 94.87 Favored 'General case' 0 C--N 1.338 0.106 0 CA-C-O 118.331 -0.842 . . . . 0.0 110.386 178.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 69.6 mtm -59.39 -47.64 84.69 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-N 119.2 0.909 . . . . 0.0 109.76 177.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 62.6 mt -57.19 -46.76 84.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -62.71 -40.57 97.56 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 119.503 1.047 . . . . 0.0 111.024 -179.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -63.25 -38.34 90.76 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 119.424 1.011 . . . . 0.0 110.723 177.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -69.51 -39.44 77.55 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.187 0.595 . . . . 0.0 110.813 178.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.1 mp -79.0 -35.43 42.89 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.921 0.889 . . . . 0.0 111.655 -176.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 94.43 145.3 17.95 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 125.236 1.398 . . . . 0.0 110.903 -171.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.1 ptpt -65.32 -28.71 69.5 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -172.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -68.22 -29.52 68.37 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 122.863 0.465 . . . . 0.0 111.011 176.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 49.1 t -91.21 -37.44 9.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 C-N-CA 124.186 0.994 . . . . 0.0 110.161 -175.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -135.78 146.33 47.49 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-N 119.285 0.948 . . . . 0.0 113.222 -174.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -130.66 144.9 51.74 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.713 1.205 . . . . 0.0 109.295 171.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 80.1 t -98.14 140.49 17.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.442 0 C-N-CA 124.078 0.951 . . . . 0.0 109.051 -174.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -149.22 172.82 14.22 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.677 1.191 . . . . 0.0 111.255 -169.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -141.64 127.05 18.77 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 126.973 2.109 . . . . 0.0 107.117 -173.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.6 tp -58.91 -31.41 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-O 118.831 -0.604 . . . . 0.0 111.231 -172.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.61 -26.47 68.41 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 118.698 0.681 . . . . 0.0 111.488 -177.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -89.56 -15.35 33.06 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.48 1.112 . . . . 0.0 111.516 177.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 53.0 p -84.38 175.88 9.06 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 118.76 0.709 . . . . 0.0 111.597 -174.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.2 m -137.55 167.44 21.66 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.651 1.58 . . . . 0.0 108.361 176.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -51.41 -48.48 62.64 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.884 0.874 . . . . 0.0 111.794 -177.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -81.55 -11.69 59.07 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 122.707 0.403 . . . . 0.0 111.608 -175.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -77.56 -31.15 53.0 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 121.399 -0.813 . . . . 0.0 111.457 -172.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.6 mp -68.34 -36.7 79.65 Favored 'General case' 0 C--N 1.344 0.348 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 172.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -69.88 -14.05 62.55 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.656 0.782 . . . . 0.0 111.988 -173.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.1 -30.13 68.36 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.738 0.815 . . . . 0.0 111.709 175.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -82.81 152.17 25.78 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 123.92 0.888 . . . . 0.0 110.211 178.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -92.0 -41.6 10.45 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.208 169.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 21.7 mt -108.25 130.74 60.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 92.3 mt -113.84 130.28 56.49 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 171.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.2 mp -111.64 115.87 29.85 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 104.52 -2.4 . . . . 0.0 104.52 169.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 64.6 mt -116.27 110.48 18.8 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -171.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -93.74 125.89 8.42 Favored Glycine 0 CA--C 1.521 0.427 0 N-CA-C 109.18 -1.568 . . . . 0.0 109.18 176.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 16.5 tt -139.28 133.07 15.89 Favored Pre-proline 0 CA--C 1.537 0.48 0 CA-C-N 118.842 1.321 . . . . 0.0 111.346 -177.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -92.41 153.86 3.03 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 122.408 2.072 . . . . 0.0 110.327 176.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.7 m -108.95 126.5 53.16 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 171.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 61.9 m95 -130.57 170.9 13.65 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 125.368 1.467 . . . . 0.0 109.063 178.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 44.23 49.12 7.82 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.351 1.861 . . . . 0.0 114.279 168.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 55.08 65.02 1.61 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.379 1.071 . . . . 0.0 111.06 176.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.85 47.68 5.5 Favored Glycine 0 CA--C 1.532 1.124 0 CA-C-N 115.854 -0.612 . . . . 0.0 113.219 171.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -128.48 157.74 40.3 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.177 1.391 . . . . 0.0 108.544 168.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -90.88 175.38 7.0 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.507 0.723 . . . . 0.0 109.925 170.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -62.39 146.84 50.25 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 107.942 -1.132 . . . . 0.0 107.942 169.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 62.3 m -56.77 -41.27 77.34 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -168.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -71.01 -40.31 71.88 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.238 0.926 . . . . 0.0 110.691 -178.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -62.38 -43.86 97.83 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.328 0.651 . . . . 0.0 110.135 175.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -61.9 -42.2 98.81 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 123.513 0.725 . . . . 0.0 110.79 178.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -68.63 -18.77 64.36 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.907 0.883 . . . . 0.0 112.309 176.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 29.7 t80 -86.04 -18.76 31.61 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 121.604 -0.685 . . . . 0.0 112.343 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -54.09 -43.03 96.41 Favored Pre-proline 0 CA--C 1.543 0.706 0 CA-C-O 116.807 -1.568 . . . . 0.0 114.138 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -63.75 -21.93 69.59 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 CA-C-N 122.475 1.92 . . . . 0.0 113.554 174.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.9 m -79.47 -40.28 30.18 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 119.57 1.077 . . . . 0.0 109.357 170.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 14.5 tp -59.63 -38.65 81.91 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.18 0.992 . . . . 0.0 110.955 -174.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -76.79 -4.77 45.21 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.698 0.799 . . . . 0.0 112.981 178.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 48.3 mm-40 -98.13 -18.6 18.41 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.188 0.995 . . . . 0.0 110.535 171.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 77.5 mt -77.68 148.93 6.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 172.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -115.97 133.13 56.35 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -117.12 15.79 15.0 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.632 0.773 . . . . 0.0 111.688 -172.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 33.2 m-80 -56.36 119.28 5.75 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 120.049 1.295 . . . . 0.0 109.319 177.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 79.83 -2.84 72.42 Favored Glycine 0 CA--C 1.535 1.327 0 CA-C-O 118.493 -1.171 . . . . 0.0 114.573 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -78.06 143.73 37.17 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 119.995 1.897 . . . . 0.0 107.209 173.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 14.5 mt -92.55 135.82 33.74 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 171.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 16.8 t -133.61 134.64 56.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -124.49 146.6 48.87 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 171.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 69.0 mt -118.92 147.48 43.96 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -174.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -142.26 159.71 41.69 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 168.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -171.41 159.47 31.2 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 119.343 -1.408 . . . . 0.0 115.347 -174.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 6.9 m -107.67 142.45 37.61 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 113.405 -1.397 . . . . 0.0 108.798 -170.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -170.89 174.88 44.74 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -178.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -144.71 122.87 12.17 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.774 0.83 . . . . 0.0 110.203 177.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -78.76 71.27 5.21 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.111 1.364 . . . . 0.0 109.234 174.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -131.06 -112.32 0.25 Allowed 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 173.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -72.93 -22.66 60.69 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 119.379 0.991 . . . . 0.0 111.94 -174.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -82.98 34.06 0.45 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.107 1.763 . . . . 0.0 111.163 -177.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.39 -23.2 65.62 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 -167.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -97.91 -1.66 42.41 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 118.937 0.789 . . . . 0.0 112.142 177.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -126.39 16.29 7.69 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.306 1.442 . . . . 0.0 111.354 -169.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -63.89 125.34 24.09 Favored 'General case' 0 C--O 1.236 0.358 0 O-C-N 121.593 -0.692 . . . . 0.0 110.172 -170.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 71.1 m 48.12 32.63 3.09 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.655 1.982 . . . . 0.0 113.723 -178.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -54.75 -34.72 62.92 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.587 0.755 . . . . 0.0 112.755 -178.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -62.87 -24.99 68.07 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -174.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 69.9 mt -58.69 -45.26 89.87 Favored 'General case' 0 C--N 1.344 0.337 0 O-C-N 121.497 -0.752 . . . . 0.0 109.965 173.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -65.01 -32.7 85.07 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.7 m -64.99 -36.01 83.02 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.25 1.025 . . . . 0.0 110.72 178.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 17.8 mt -69.54 -52.85 28.44 Favored 'Isoleucine or valine' 0 C--N 1.347 0.476 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 171.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 50.5 ttt180 -51.01 -47.13 61.67 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.341 0.656 . . . . 0.0 111.16 -172.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -61.91 -16.03 47.61 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.649 1.18 . . . . 0.0 112.806 -175.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 97.9 mt -100.83 -55.82 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 C-N-CA 124.268 1.027 . . . . 0.0 109.28 173.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 48.2 pt -67.56 -34.45 68.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 119.946 1.248 . . . . 0.0 112.284 -167.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -67.65 -53.21 22.98 Favored Pre-proline 0 CA--C 1.546 0.794 0 CA-C-O 117.71 -1.138 . . . . 0.0 110.701 -175.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -68.93 -23.33 34.84 Favored 'Trans proline' 0 C--N 1.353 0.801 0 CA-C-N 121.652 1.626 . . . . 0.0 112.928 174.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 31.3 mmm180 -77.39 8.94 3.59 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 119.482 1.037 . . . . 0.0 112.274 171.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 94.73 3.33 62.52 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-O 118.194 -1.337 . . . . 0.0 116.218 167.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.1 142.87 56.36 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 119.622 1.711 . . . . 0.0 110.075 177.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 57.8 m -88.61 119.5 29.12 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 104.798 -2.297 . . . . 0.0 104.798 168.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 19.7 mm -95.19 132.86 38.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 -171.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 19.3 m -137.93 171.53 15.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 124.979 1.312 . . . . 0.0 109.039 176.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 79.51 23.21 63.1 Favored Glycine 0 CA--C 1.526 0.775 0 CA-C-O 119.048 -0.862 . . . . 0.0 113.367 175.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 28.3 p-80 -61.23 135.99 57.91 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 168.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 39.0 t-105 -122.84 135.29 25.63 Favored Pre-proline 0 CA--C 1.533 0.315 0 C-N-CA 124.759 1.224 . . . . 0.0 108.249 -169.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -66.85 139.6 52.49 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 121.83 1.687 . . . . 0.0 111.316 -174.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 65.0 p . . . . . 0 CA--C 1.535 0.389 0 C-N-CA 123.018 0.527 . . . . 0.0 111.16 -178.594 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 67.6 mttm . . . . . 0 N--CA 1.472 0.631 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -88.09 5.53 84.7 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 124.13 0.872 . . . . 0.0 112.419 168.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 96.1 mt -67.52 134.26 50.97 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 118.982 1.391 . . . . 0.0 110.253 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -96.21 -34.45 11.65 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 166.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -145.88 161.28 40.38 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 128.152 2.581 . . . . 0.0 105.81 168.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -58.67 -25.19 62.54 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 120.627 -1.295 . . . . 0.0 112.112 178.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -92.04 -9.6 42.18 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.201 1.0 . . . . 0.0 113.347 176.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 63.1 m80 -143.39 123.63 13.78 Favored 'General case' 0 C--N 1.346 0.426 0 CA-C-N 120.216 1.371 . . . . 0.0 112.398 -175.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -73.34 152.16 41.0 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 166.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 9.3 p -64.29 -21.71 29.61 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 O-C-N 121.811 -0.556 . . . . 0.0 111.228 175.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -155.66 175.14 33.6 Favored Glycine 0 C--N 1.339 0.705 0 C-N-CA 123.792 0.71 . . . . 0.0 111.776 -172.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -71.94 104.02 3.38 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.809 0.844 . . . . 0.0 109.12 -177.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.297 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 169.227 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 75.2 mt . . . . . 0 N--CA 1.468 0.447 0 N-CA-C 110.353 -0.24 . . . . 0.0 110.353 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 58.4 m -41.02 -54.44 2.78 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 127.516 2.326 . . . . 0.0 112.982 -169.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -76.8 -32.07 57.39 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -173.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -71.75 -38.84 70.33 Favored 'General case' 0 CA--C 1.529 0.157 0 O-C-N 121.913 -0.492 . . . . 0.0 109.939 178.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 74.1 mtp85 -66.49 -41.81 88.36 Favored 'General case' 0 N--CA 1.462 0.173 0 O-C-N 121.682 -0.637 . . . . 0.0 110.445 -178.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 34.4 m -70.39 -27.8 32.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 119.077 0.853 . . . . 0.0 111.195 177.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -65.49 -53.74 38.25 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 120.647 1.567 . . . . 0.0 109.583 172.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -61.63 -36.45 80.79 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 117.795 0.27 . . . . 0.0 110.888 -177.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 35.3 t90 -75.43 -46.64 31.46 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 118.178 0.445 . . . . 0.0 111.077 -178.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 42.5 t -59.89 -36.5 67.07 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.094 0 CA-C-N 118.581 0.628 . . . . 0.0 110.084 177.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -64.08 -40.84 97.14 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 117.937 -1.03 . . . . 0.0 110.654 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -69.27 -48.03 62.88 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 119.556 1.071 . . . . 0.0 110.659 175.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 7.5 pt -66.8 -29.82 47.64 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.333 0 CA-C-N 119.705 1.139 . . . . 0.0 110.759 -173.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 51.1 m -61.81 -29.29 70.06 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 117.877 -1.058 . . . . 0.0 112.459 176.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -92.16 -24.16 19.17 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 120.52 1.509 . . . . 0.0 111.641 175.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -73.02 -36.29 66.94 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 118.674 0.67 . . . . 0.0 110.794 174.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 66.1 mt -93.45 -9.16 39.48 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.349 1.86 . . . . 0.0 111.794 -179.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 39.2 m80 56.25 29.94 15.76 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.615 1.566 . . . . 0.0 112.911 -169.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 73.3 mt . . . . . 0 N--CA 1.468 0.427 0 O-C-N 121.457 -0.777 . . . . 0.0 110.909 169.874 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.399 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 31.0 pt -85.78 -22.69 7.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 123.393 0.677 . . . . 0.0 111.444 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 26.3 m -114.63 134.73 54.84 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.738 1.615 . . . . 0.0 109.09 -177.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -107.19 122.32 6.85 Favored Glycine 0 CA--C 1.52 0.401 0 N-CA-C 107.442 -2.263 . . . . 0.0 107.442 168.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 54.4 mt -100.62 91.69 2.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.14 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 176.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -88.16 130.33 35.08 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 -179.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 16.1 p90 -130.74 132.07 45.12 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 119.435 1.016 . . . . 0.0 112.338 179.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -86.54 149.76 22.87 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 168.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.8 m -167.9 157.78 10.17 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.936 1.368 . . . . 0.0 110.643 173.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -121.68 -52.89 2.0 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.953 0.901 . . . . 0.0 109.948 168.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.0 p -88.53 7.72 31.71 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.551 1.14 . . . . 0.0 112.733 174.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 84.92 -4.73 84.73 Favored Glycine 0 CA--C 1.533 1.174 0 N-CA-C 116.621 1.408 . . . . 0.0 116.621 168.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.88 -35.47 78.42 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 120.243 2.022 . . . . 0.0 113.696 -169.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 12.8 m -70.82 -17.29 62.76 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 119.524 1.056 . . . . 0.0 110.665 -175.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -60.19 -41.87 93.83 Favored 'General case' 0 C--N 1.342 0.278 0 O-C-N 121.118 -0.989 . . . . 0.0 110.338 175.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -64.42 -39.0 92.98 Favored 'General case' 0 C--N 1.339 0.127 0 O-C-N 122.072 -0.393 . . . . 0.0 110.306 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.0 mm -64.37 -46.37 93.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.72 -42.45 98.97 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.296 0.639 . . . . 0.0 111.531 178.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 54.8 mttm -64.57 -43.39 94.03 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 118.88 -0.581 . . . . 0.0 110.858 178.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 72.6 mtm -62.5 -39.64 94.15 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 119.169 0.895 . . . . 0.0 110.733 178.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 62.9 mt -60.11 -48.49 87.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 175.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -59.21 -39.61 83.2 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.803 0.729 . . . . 0.0 111.058 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -68.11 -36.43 79.75 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 119.432 1.014 . . . . 0.0 111.026 178.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 19.4 mm100 -65.78 -49.6 67.73 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.574 0.625 . . . . 0.0 111.529 -178.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.97 -8.22 34.34 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -175.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.42 143.3 12.22 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 125.119 1.342 . . . . 0.0 112.122 175.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.2 pttp -70.09 -23.64 63.09 Favored 'General case' 0 N--CA 1.469 0.489 0 O-C-N 121.584 -0.95 . . . . 0.0 113.082 -178.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -60.37 -34.74 74.3 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 122.985 0.514 . . . . 0.0 110.763 171.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 62.1 t -83.69 -42.48 17.42 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-O 118.001 -0.999 . . . . 0.0 110.136 178.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -132.77 147.08 52.31 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-N 119.838 1.199 . . . . 0.0 114.182 -170.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -120.97 140.87 51.29 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 123.831 0.852 . . . . 0.0 109.696 169.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 94.6 t -85.97 139.26 17.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -147.01 170.65 16.67 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.29 1.036 . . . . 0.0 111.881 -168.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -145.65 125.19 13.2 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 125.79 1.636 . . . . 0.0 108.641 -170.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.4 tp -63.08 -29.14 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-O 118.967 -0.54 . . . . 0.0 111.747 -171.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.03 -28.44 69.49 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 118.945 0.793 . . . . 0.0 111.692 -176.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -101.27 -7.21 23.24 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.674 0.79 . . . . 0.0 112.299 175.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 42.5 m -75.43 171.48 14.18 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 123.649 0.78 . . . . 0.0 110.547 177.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 14.1 m -139.26 160.53 39.6 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.819 1.248 . . . . 0.0 108.875 178.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -53.79 -46.85 71.15 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.073 0.949 . . . . 0.0 111.455 -174.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -80.92 -15.26 56.77 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 122.571 0.349 . . . . 0.0 111.551 -176.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -77.95 -29.71 50.02 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 121.439 -0.788 . . . . 0.0 111.213 -175.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -59.41 -41.5 89.6 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.111 0.564 . . . . 0.0 109.709 169.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -72.96 -13.17 61.19 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.637 0.775 . . . . 0.0 112.315 -170.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.71 -30.56 70.1 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.446 0.698 . . . . 0.0 111.91 176.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -82.37 155.96 24.45 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.99 0.916 . . . . 0.0 110.284 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -104.49 -24.3 13.04 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.821 169.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.3 mp -118.37 127.93 75.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 176.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -114.63 119.71 37.66 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 175.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.9 mp -105.98 117.95 35.34 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 105.282 -2.118 . . . . 0.0 105.282 169.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 66.9 mt -119.99 108.38 14.23 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 -169.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.81 120.32 6.52 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 125.679 1.609 . . . . 0.0 109.708 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.0 tt -134.24 112.29 12.07 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 118.104 0.952 . . . . 0.0 110.466 -176.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -74.83 143.69 29.98 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.391 2.061 . . . . 0.0 109.202 169.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 30.3 m -96.41 136.65 36.62 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 174.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 63.7 m95 -134.45 171.91 13.64 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 124.754 1.222 . . . . 0.0 109.992 -178.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 42.7 46.42 4.38 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 127.016 2.127 . . . . 0.0 114.285 167.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 57.46 69.43 0.74 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.509 1.124 . . . . 0.0 111.323 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.52 33.33 22.6 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 115.629 -0.714 . . . . 0.0 113.94 169.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -119.53 164.5 15.72 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 125.399 1.48 . . . . 0.0 109.632 175.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -96.53 170.88 8.91 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 123.983 0.913 . . . . 0.0 108.791 168.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 47.1 mm-40 -70.02 148.85 48.34 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 169.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 58.6 m -59.47 -35.18 73.59 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -168.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -72.29 -29.14 63.6 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.249 0.619 . . . . 0.0 111.469 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -78.84 -44.92 21.92 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.963 0.905 . . . . 0.0 109.349 175.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -60.42 -41.35 93.77 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.33 1.052 . . . . 0.0 111.228 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -62.66 -21.77 65.96 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.087 0.955 . . . . 0.0 112.269 178.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -85.01 -18.93 32.91 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 117.875 -1.06 . . . . 0.0 112.227 178.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -55.65 -42.75 97.65 Favored Pre-proline 0 CA--C 1.541 0.615 0 CA-C-N 121.243 1.838 . . . . 0.0 114.116 -179.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.28 -14.28 44.24 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 CA-C-N 122.603 1.965 . . . . 0.0 113.714 174.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.1 m -88.72 -42.62 11.84 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 119.195 0.907 . . . . 0.0 109.227 169.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 18.3 tp -56.62 -38.22 71.79 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 124.998 1.319 . . . . 0.0 110.841 -177.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -71.78 -1.18 13.13 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -105.97 -11.95 15.99 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.497 1.044 . . . . 0.0 111.872 172.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 98.5 mt -81.63 140.97 15.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -175.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -87.44 133.63 33.72 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 123.464 0.706 . . . . 0.0 110.133 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -126.57 15.03 7.62 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.962 0.905 . . . . 0.0 111.612 174.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 17.0 m-80 -58.73 116.12 3.51 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 119.987 1.267 . . . . 0.0 109.886 -174.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.78 1.19 58.21 Favored Glycine 0 CA--C 1.533 1.175 0 CA-C-O 118.567 -1.13 . . . . 0.0 113.803 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -74.86 147.61 40.94 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 119.628 1.714 . . . . 0.0 107.835 172.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 14.9 mt -88.77 136.04 33.21 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 174.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.2 t -132.44 139.97 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -136.71 141.56 43.08 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 175.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 62.1 mt -112.62 148.16 35.17 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -173.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -144.42 168.15 20.8 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 169.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -179.53 176.09 47.42 Favored Glycine 0 N--CA 1.447 -0.577 0 CA-C-O 122.174 0.875 . . . . 0.0 113.0 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 24.4 m -129.53 152.58 48.91 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 125.727 1.611 . . . . 0.0 107.737 -171.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -169.8 -173.79 37.55 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -177.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -147.56 166.89 25.95 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 168.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -111.47 -6.39 14.45 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.725 1.61 . . . . 0.0 111.996 -171.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -59.45 -48.25 82.35 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 123.626 0.77 . . . . 0.0 111.787 -169.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -138.18 1.99 2.27 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -173.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -111.38 27.83 9.31 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.39 1.076 . . . . 0.0 111.396 -169.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.13 -17.38 64.67 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 -169.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -94.64 -0.61 54.29 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.62 1.168 . . . . 0.0 111.995 174.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -139.08 22.61 2.6 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 125.762 1.625 . . . . 0.0 110.283 -170.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -70.76 121.03 17.24 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -169.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 74.0 m 48.3 38.92 11.22 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.617 1.167 . . . . 0.0 111.679 -177.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -61.95 -38.81 89.89 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.466 1.106 . . . . 0.0 112.061 -172.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.15 -21.34 66.33 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 114.136 1.162 . . . . 0.0 114.136 -168.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 7.1 mp -61.28 -35.22 76.72 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 119.766 1.166 . . . . 0.0 110.22 175.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.37 -33.48 86.35 Favored Glycine 0 CA--C 1.531 1.039 0 N-CA-C 111.318 -0.713 . . . . 0.0 111.318 177.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.2 m -65.05 -37.3 87.13 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 117.774 0.787 . . . . 0.0 110.361 177.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 6.0 mt -70.31 -49.15 56.34 Favored 'Isoleucine or valine' 0 C--N 1.343 0.319 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 173.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 55.8 ttt-85 -51.31 -47.21 62.68 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 118.617 0.644 . . . . 0.0 110.563 -176.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -63.23 -22.92 67.18 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.114 0.966 . . . . 0.0 112.914 -175.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 96.9 mt -91.63 -44.6 14.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 123.666 0.786 . . . . 0.0 109.379 177.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 22.4 pt -74.78 -29.43 22.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-N 118.999 0.818 . . . . 0.0 111.617 -171.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -62.03 -56.22 33.63 Favored Pre-proline 0 CA--C 1.543 0.685 0 CA-C-O 117.74 -1.124 . . . . 0.0 112.063 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -66.16 -21.79 54.96 Favored 'Trans proline' 0 C--N 1.351 0.701 0 CA-C-N 121.769 1.668 . . . . 0.0 112.612 178.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 73.0 mmt-85 -82.07 9.46 8.44 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.99 0.916 . . . . 0.0 112.841 172.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 77.51 16.16 80.62 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-O 118.367 -1.24 . . . . 0.0 114.877 168.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -59.63 144.66 47.14 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 119.036 1.418 . . . . 0.0 110.355 170.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 44.6 m -95.29 119.94 34.66 Favored 'General case' 0 C--N 1.333 -0.123 0 N-CA-C 104.663 -2.347 . . . . 0.0 104.663 167.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 15.8 mt -100.86 127.54 53.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 -171.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 31.8 m -137.44 178.23 4.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 124.983 1.313 . . . . 0.0 109.285 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 78.83 36.51 28.56 Favored Glycine 0 CA--C 1.527 0.835 0 O-C-N 121.912 -0.493 . . . . 0.0 111.976 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 68.3 m80 -63.22 142.6 58.33 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 117.615 0.707 . . . . 0.0 109.153 172.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 75.2 t-105 -123.58 129.49 24.83 Favored Pre-proline 0 CA--C 1.534 0.357 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 -174.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -67.74 144.23 64.76 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 121.437 1.425 . . . . 0.0 112.129 -170.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 71.6 p . . . . . 0 CA--C 1.537 0.454 0 C-N-CA 123.614 0.766 . . . . 0.0 111.136 177.923 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.837 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -74.63 -0.56 59.16 Favored Glycine 0 CA--C 1.535 1.319 0 CA-C-O 118.637 -1.091 . . . . 0.0 113.412 169.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 43.7 mt -63.41 131.49 48.4 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 120.583 2.192 . . . . 0.0 109.503 174.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -100.77 -32.79 10.53 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.176 0.99 . . . . 0.0 109.323 169.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -149.49 161.78 41.44 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 127.313 2.245 . . . . 0.0 107.103 174.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -53.06 -31.78 43.4 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.328 0.651 . . . . 0.0 112.389 176.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -93.38 -11.33 32.52 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.284 1.034 . . . . 0.0 113.335 -178.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 10.9 m-70 -146.92 128.98 15.54 Favored 'General case' 0 C--N 1.346 0.431 0 CA-C-N 119.76 1.163 . . . . 0.0 113.729 -170.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -77.49 155.57 31.59 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 166.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.4 p -66.12 -22.86 30.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 C-N-CA 123.972 0.909 . . . . 0.0 111.642 178.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -158.93 169.99 35.29 Favored Glycine 0 C--N 1.338 0.659 0 CA-C-N 118.471 0.578 . . . . 0.0 112.314 -169.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -69.35 111.97 5.6 Favored 'General case' 0 CA--C 1.521 -0.144 0 C-N-CA 124.452 1.101 . . . . 0.0 109.496 -175.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.332 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 169.606 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 20.7 mt . . . . . 0 CA--C 1.541 0.623 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 38.8 m -46.31 -53.08 11.46 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 127.163 2.185 . . . . 0.0 112.913 -167.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -82.07 -40.54 21.83 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 119.395 -0.336 . . . . 0.0 111.038 -174.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -67.65 -28.15 67.47 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.026 0.83 . . . . 0.0 111.856 -173.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 59.6 mtp85 -62.77 -45.46 92.58 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 118.718 0.69 . . . . 0.0 110.021 175.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 17.3 m -74.34 -31.03 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-O 117.706 -1.14 . . . . 0.0 111.274 177.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -58.33 -52.07 67.14 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 120.99 1.723 . . . . 0.0 109.406 173.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -62.49 -37.79 87.37 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 122.724 0.41 . . . . 0.0 110.654 -179.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 59.2 t90 -74.91 -44.49 48.4 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 118.278 0.49 . . . . 0.0 111.644 -175.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 77.8 t -64.22 -34.0 66.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -61.25 -35.85 78.4 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 121.261 -0.899 . . . . 0.0 111.4 175.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -63.44 -55.99 19.8 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 119.177 0.899 . . . . 0.0 110.294 175.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 9.8 pt -67.08 -28.59 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 O-C-N 122.12 -0.363 . . . . 0.0 110.351 -173.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 64.2 m -60.77 -23.74 65.23 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 118.377 -0.821 . . . . 0.0 112.489 177.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -82.96 -31.9 27.37 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 119.927 1.24 . . . . 0.0 111.055 175.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -80.07 -38.31 32.03 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.713 0.805 . . . . 0.0 110.621 -178.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 5.4 mp -88.9 -3.7 58.67 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.448 1.899 . . . . 0.0 110.886 -179.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 55.63 32.85 20.06 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.847 1.659 . . . . 0.0 112.689 -174.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 47.1 mt . . . . . 0 N--CA 1.467 0.389 0 O-C-N 121.787 -0.57 . . . . 0.0 110.519 172.308 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.268 0 CA-C-O 120.722 0.296 . . . . 0.0 111.282 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 32.4 pt -109.94 -20.53 6.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 125.189 1.396 . . . . 0.0 111.239 178.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 44.5 m -105.85 128.16 53.58 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.736 1.214 . . . . 0.0 108.146 174.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -99.82 116.19 5.51 Favored Glycine 0 CA--C 1.519 0.313 0 N-CA-C 107.198 -2.361 . . . . 0.0 107.198 169.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 46.6 mt -90.63 122.59 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 104.135 -2.543 . . . . 0.0 104.135 171.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -118.19 132.8 56.3 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 174.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -132.9 158.42 42.63 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 118.345 0.521 . . . . 0.0 111.187 -174.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -132.73 154.36 21.08 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 108.091 -2.003 . . . . 0.0 108.091 167.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 16.3 m -163.7 163.51 24.17 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 119.212 1.506 . . . . 0.0 109.491 -175.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -137.98 -52.53 0.62 Allowed 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.667 0.787 . . . . 0.0 110.379 171.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.9 p -77.52 -14.73 59.6 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.237 0.615 . . . . 0.0 111.753 170.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 104.98 8.21 36.93 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.014 1.292 . . . . 0.0 113.961 169.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -66.55 -54.29 25.26 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 119.02 1.41 . . . . 0.0 111.927 -173.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.3 m -75.78 -18.38 59.55 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 122.027 -0.421 . . . . 0.0 111.515 -166.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -59.72 -46.78 88.08 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 167.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 33.2 t30 -68.3 -39.67 81.98 Favored 'General case' 0 C--N 1.339 0.122 0 O-C-N 121.864 -0.523 . . . . 0.0 110.305 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 49.8 mm -59.48 -45.16 94.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 118.738 0.699 . . . . 0.0 109.265 175.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.73 -40.61 95.69 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.753 0.706 . . . . 0.0 111.174 178.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -64.18 -42.49 96.67 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-O 118.823 -0.608 . . . . 0.0 110.826 176.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 98.8 mtp -63.82 -44.37 93.43 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 119.35 0.977 . . . . 0.0 110.464 177.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 69.9 mt -57.26 -47.57 84.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 176.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -58.29 -42.97 87.78 Favored 'General case' 0 CA--C 1.53 0.2 0 O-C-N 121.467 -0.771 . . . . 0.0 111.157 176.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -64.0 -35.93 82.32 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 119.416 1.007 . . . . 0.0 110.683 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -69.21 -45.52 69.67 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.286 0.635 . . . . 0.0 110.936 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -79.88 -30.09 40.12 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.031 0.832 . . . . 0.0 112.101 -178.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.73 145.26 16.13 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 125.008 1.29 . . . . 0.0 110.699 -170.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.9 tttm -65.04 -31.01 72.02 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 121.889 -0.771 . . . . 0.0 111.799 -170.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -77.6 -7.06 55.8 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.063 0.545 . . . . 0.0 112.069 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 49.0 t -104.67 -43.21 7.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 124.254 1.022 . . . . 0.0 109.258 174.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -134.46 134.11 41.18 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 119.478 1.036 . . . . 0.0 111.491 -175.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -123.94 148.55 46.8 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 175.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 59.5 t -106.42 140.07 25.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 124.477 1.111 . . . . 0.0 111.158 -168.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -139.64 144.18 37.55 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.811 1.644 . . . . 0.0 109.847 177.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -83.92 126.25 32.82 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 169.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 11.0 tp -58.54 -31.23 43.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -171.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.72 -29.83 67.31 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.985 0.811 . . . . 0.0 112.024 -177.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 47.4 mtmt -76.54 -33.3 58.56 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 118.206 0.457 . . . . 0.0 110.835 177.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 57.7 m -70.77 165.01 23.98 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.678 1.191 . . . . 0.0 112.248 -174.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.5 m -133.04 174.59 10.2 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.225 1.81 . . . . 0.0 109.146 -176.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -49.05 -54.26 16.7 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.288 1.035 . . . . 0.0 111.655 -173.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -76.27 -11.83 59.98 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 122.473 0.309 . . . . 0.0 111.758 -170.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -71.22 -33.85 70.29 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 121.882 -0.512 . . . . 0.0 110.766 -174.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 8.4 mp -74.3 -38.75 63.26 Favored 'General case' 0 C--N 1.342 0.279 0 C-N-CA 122.594 0.358 . . . . 0.0 110.109 171.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -67.06 -18.14 65.21 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 122.898 0.479 . . . . 0.0 112.126 -169.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.92 -28.98 69.91 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.482 1.113 . . . . 0.0 112.527 173.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -96.16 156.94 16.12 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.147 0.979 . . . . 0.0 111.048 -175.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -99.5 -29.39 12.75 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.31 0.644 . . . . 0.0 111.514 170.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.0 mp -110.76 127.69 67.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 174.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -115.52 135.16 54.37 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 174.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.5 mp -118.74 114.13 22.23 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 172.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 51.6 mt -112.47 112.4 23.92 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 -169.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -102.58 103.4 2.43 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 125.404 1.478 . . . . 0.0 111.075 -173.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 14.6 tt -127.72 119.39 21.42 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 124.123 0.969 . . . . 0.0 111.077 -169.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -76.29 150.31 32.62 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 121.909 1.739 . . . . 0.0 110.501 170.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 19.1 m -98.3 140.78 32.07 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 169.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 42.4 m95 -136.2 174.38 10.67 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.718 1.607 . . . . 0.0 109.479 -178.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 21.52 82.27 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 128.476 2.71 . . . . 0.0 114.702 169.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 57.49 49.52 12.69 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.937 0.895 . . . . 0.0 111.927 172.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 81.03 19.0 68.27 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 123.743 0.687 . . . . 0.0 113.541 170.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -88.48 156.13 19.28 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 124.316 1.046 . . . . 0.0 110.162 178.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.97 144.5 34.69 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 169.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -59.93 149.28 32.24 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 169.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 75.4 m -61.04 -25.84 67.21 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -168.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 39.4 p30 -68.45 -36.39 78.93 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.474 0.71 . . . . 0.0 111.848 178.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -80.36 -41.43 24.72 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 118.695 0.68 . . . . 0.0 111.091 171.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -60.98 -39.34 89.25 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.505 0.593 . . . . 0.0 111.533 -176.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -67.4 -20.82 65.59 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.358 0.663 . . . . 0.0 112.168 175.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -94.43 -20.9 19.29 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.043 0.937 . . . . 0.0 111.825 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 21.6 m-30 -52.49 -40.32 74.48 Favored Pre-proline 0 CA--C 1.545 0.758 0 CA-C-O 116.67 -1.633 . . . . 0.0 114.544 178.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -64.41 -23.83 64.78 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 CA-C-N 123.103 2.144 . . . . 0.0 113.036 174.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.6 m -79.79 -38.34 33.28 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 119.239 0.927 . . . . 0.0 109.168 170.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 19.4 tp -60.64 -33.32 72.62 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.016 -1.052 . . . . 0.0 111.84 -174.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -81.97 -4.3 56.37 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.65 0.78 . . . . 0.0 112.863 176.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -96.15 -28.33 14.62 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 119.112 0.869 . . . . 0.0 109.947 170.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 88.7 mt -64.26 136.22 26.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 176.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -86.67 130.89 34.31 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 123.421 0.688 . . . . 0.0 109.548 172.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -118.03 6.7 12.13 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.17 0.988 . . . . 0.0 112.005 176.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 21.9 m-80 -56.55 115.49 2.55 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 120.463 1.483 . . . . 0.0 110.478 -173.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.71 0.37 63.55 Favored Glycine 0 CA--C 1.535 1.321 0 CA-C-O 118.548 -1.14 . . . . 0.0 114.285 178.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -75.24 147.5 40.26 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 119.679 1.739 . . . . 0.0 108.202 174.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 69.3 mt -91.24 135.86 33.5 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 175.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.8 t -135.27 130.43 51.08 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -116.3 150.23 37.97 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 169.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 79.7 mt -117.55 150.71 38.53 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 -178.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -149.03 162.07 40.66 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 170.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 171.91 150.03 6.96 Favored Glycine 0 N--CA 1.448 -0.51 0 CA-C-O 121.88 0.711 . . . . 0.0 112.789 174.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 4.5 p -78.01 164.18 25.29 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 121.321 0.581 . . . . 0.0 109.837 169.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -160.58 -162.51 12.57 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 173.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -145.63 122.58 11.34 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 127.08 2.152 . . . . 0.0 105.473 177.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -110.51 1.95 18.51 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.228 1.411 . . . . 0.0 111.474 -173.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -108.8 -45.12 3.88 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.369 1.068 . . . . 0.0 110.827 -168.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -104.3 -35.45 7.97 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.804 1.242 . . . . 0.0 109.975 178.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -98.19 40.46 1.18 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.376 1.071 . . . . 0.0 110.279 169.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.03 -21.78 65.17 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.174 1.39 . . . . 0.0 113.787 -173.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -95.96 5.95 50.01 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.986 0.914 . . . . 0.0 111.691 177.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -138.56 18.7 2.71 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.983 1.313 . . . . 0.0 110.907 -172.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 30.8 t80 -64.93 132.5 49.49 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -173.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . 0.282 28.6 p 54.95 24.41 5.86 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.675 1.99 . . . . 0.0 114.454 171.043 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -61.56 -32.49 72.57 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.146 1.378 . . . . 0.0 111.867 -174.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.24 -32.57 71.88 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 120.903 -1.123 . . . . 0.0 111.427 -178.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 7.0 mp -63.82 -43.88 94.91 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 119.658 1.117 . . . . 0.0 108.849 173.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -60.51 -34.77 87.04 Favored Glycine 0 CA--C 1.533 1.185 0 N-CA-C 111.436 -0.666 . . . . 0.0 111.436 174.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 17.0 m -65.02 -37.38 87.44 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 121.716 -0.873 . . . . 0.0 110.6 176.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 5.1 mt -67.32 -47.45 81.14 Favored 'Isoleucine or valine' 0 C--N 1.345 0.382 0 CA-C-O 117.643 -1.17 . . . . 0.0 108.967 173.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -56.92 -38.22 72.57 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 120.38 1.445 . . . . 0.0 110.928 -174.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -60.69 -25.08 66.12 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.206 1.002 . . . . 0.0 112.457 178.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 75.8 mt -94.02 -49.36 12.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 124.419 1.087 . . . . 0.0 110.041 177.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 36.5 pt -75.58 -28.37 19.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-N 120.002 1.274 . . . . 0.0 111.9 -168.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -63.13 -53.95 50.0 Favored Pre-proline 0 CA--C 1.542 0.663 0 CA-C-O 117.447 -1.263 . . . . 0.0 111.836 178.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -68.08 -20.87 43.62 Favored 'Trans proline' 0 C--N 1.351 0.707 0 CA-C-N 122.064 1.773 . . . . 0.0 112.719 176.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 31.4 mmm180 -78.58 1.98 20.8 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 119.163 0.892 . . . . 0.0 112.144 170.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 93.26 10.43 59.53 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 125.048 1.309 . . . . 0.0 115.204 168.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.94 146.79 45.55 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 119.205 1.502 . . . . 0.0 110.757 174.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 86.1 m -101.93 124.16 47.08 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 105.206 -2.146 . . . . 0.0 105.206 167.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 19.4 mm -90.76 133.28 33.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 -171.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 18.7 m -131.76 168.51 23.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.395 0 C-N-CA 125.99 1.716 . . . . 0.0 108.81 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 70.07 39.66 73.25 Favored Glycine 0 CA--C 1.527 0.792 0 O-C-N 121.691 -0.631 . . . . 0.0 113.05 177.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -64.55 134.83 55.2 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 171.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 57.6 t-105 -114.76 127.26 26.99 Favored Pre-proline 0 CA--C 1.535 0.398 0 C-N-CA 124.752 1.221 . . . . 0.0 108.494 -169.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -61.98 141.93 90.98 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 CA-C-N 121.02 1.4 . . . . 0.0 112.831 -173.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 56.7 p . . . . . 0 CA--C 1.534 0.335 0 C-N-CA 123.037 0.535 . . . . 0.0 110.991 174.409 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.47 0.535 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -79.6 7.88 51.63 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-O 119.184 -0.787 . . . . 0.0 113.113 169.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 97.5 mt -64.75 138.56 58.46 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 120.178 1.989 . . . . 0.0 109.942 174.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -106.21 -31.04 8.84 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.982 1.313 . . . . 0.0 108.925 167.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -149.16 162.98 38.89 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 127.466 2.306 . . . . 0.0 106.929 171.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -54.68 -30.84 56.71 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 121.371 -0.831 . . . . 0.0 112.162 176.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -91.98 -9.77 41.74 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.322 1.049 . . . . 0.0 113.325 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 11.9 m-70 -146.71 126.34 13.35 Favored 'General case' 0 C--N 1.346 0.415 0 CA-C-N 119.569 1.077 . . . . 0.0 113.376 -170.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -75.3 153.38 37.95 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 166.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 8.9 p -65.86 -18.88 24.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 124.288 1.035 . . . . 0.0 112.395 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -166.68 179.86 40.3 Favored Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -173.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -71.07 87.86 0.77 Allowed 'General case' 0 CA--C 1.522 -0.101 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 -178.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.475 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 169.319 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 23.7 mt . . . . . 0 N--CA 1.474 0.731 0 CA-C-O 121.474 0.654 . . . . 0.0 110.973 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 75.0 m -56.77 -51.46 68.82 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.37 1.468 . . . . 0.0 111.563 -169.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.32 -41.22 89.96 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -167.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -70.46 -35.03 73.09 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 118.219 0.463 . . . . 0.0 110.732 177.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 58.9 mtt180 -69.21 -43.86 73.28 Favored 'General case' 0 C--O 1.233 0.208 0 O-C-N 121.555 -0.716 . . . . 0.0 110.493 -178.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 26.6 m -70.42 -29.05 37.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 119.3 0.955 . . . . 0.0 110.544 177.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -64.21 -53.9 41.9 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 120.4 1.455 . . . . 0.0 109.755 171.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -58.2 -36.79 73.64 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 118.863 -0.589 . . . . 0.0 110.641 -178.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 46.1 t90 -77.14 -50.1 13.76 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 118.469 0.577 . . . . 0.0 111.426 -177.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 45.8 t -62.02 -33.58 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 O-C-N 121.458 -0.776 . . . . 0.0 109.992 -177.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -60.16 -38.32 82.79 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-O 118.343 -0.837 . . . . 0.0 111.17 177.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -59.07 -55.01 40.62 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 118.954 0.797 . . . . 0.0 109.802 176.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 19.0 pt -68.53 -29.74 45.0 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.235 0 O-C-N 122.133 -0.354 . . . . 0.0 110.248 -174.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 35.6 m -65.34 -25.41 67.59 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 118.705 -0.664 . . . . 0.0 111.74 175.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -86.03 -39.1 17.18 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 119.547 1.067 . . . . 0.0 110.253 174.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -64.51 -40.09 94.98 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 122.933 0.493 . . . . 0.0 110.92 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.7 mp -100.02 2.33 43.31 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.686 1.594 . . . . 0.0 111.005 -175.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . 0.291 31.7 p80 50.94 26.71 2.81 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 127.022 2.129 . . . . 0.0 113.948 -174.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 55.9 mt . . . . . 0 C--N 1.344 0.33 0 O-C-N 121.505 -0.747 . . . . 0.0 110.275 172.851 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.389 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 27.4 pt -83.5 -23.02 8.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 -178.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.1 m -112.2 127.37 55.93 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.955 1.302 . . . . 0.0 108.391 -178.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -101.67 118.96 6.31 Favored Glycine 0 CA--C 1.519 0.331 0 N-CA-C 107.846 -2.101 . . . . 0.0 107.846 169.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 44.7 mt -95.05 118.3 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 104.37 -2.456 . . . . 0.0 104.37 171.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -114.32 127.1 55.7 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 177.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -127.81 125.06 39.1 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 118.702 0.683 . . . . 0.0 112.017 -175.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -82.12 145.43 24.45 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 168.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.4 m -159.91 161.47 34.31 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 119.083 1.442 . . . . 0.0 109.844 175.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -138.74 -48.05 0.51 Allowed 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.037 0.935 . . . . 0.0 109.817 168.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.2 p -79.29 -13.52 59.6 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.486 0.714 . . . . 0.0 111.689 169.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.03 6.53 53.84 Favored Glycine 0 C--N 1.343 0.965 0 C-N-CA 124.767 1.175 . . . . 0.0 113.813 170.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -70.16 -38.4 75.43 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 118.769 1.284 . . . . 0.0 112.553 -169.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -69.83 -17.77 63.41 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 119.548 1.067 . . . . 0.0 111.383 -174.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -60.14 -41.21 92.22 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.185 0.902 . . . . 0.0 110.179 175.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -65.96 -39.89 90.81 Favored 'General case' 0 N--CA 1.463 0.195 0 O-C-N 121.924 -0.485 . . . . 0.0 110.106 178.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 27.2 mm -60.61 -49.05 85.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 176.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.16 -41.18 92.26 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.386 0.674 . . . . 0.0 111.702 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.9 mttm -67.11 -40.25 86.84 Favored 'General case' 0 N--CA 1.461 0.119 0 O-C-N 121.661 -0.65 . . . . 0.0 111.113 177.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 70.2 mtm -66.37 -31.95 73.04 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 119.504 1.047 . . . . 0.0 111.447 177.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 76.7 mt -65.81 -54.6 25.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 171.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -62.1 -37.03 83.54 Favored 'General case' 0 C--O 1.224 -0.251 0 CA-C-O 118.952 -0.546 . . . . 0.0 111.366 -173.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -63.68 -36.06 82.6 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 119.325 0.966 . . . . 0.0 110.91 -178.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -74.86 -41.36 59.96 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.131 0.573 . . . . 0.0 110.74 177.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.3 mp -73.99 -33.27 63.76 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 118.081 0.4 . . . . 0.0 111.23 -176.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 88.13 146.47 11.96 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 124.861 1.219 . . . . 0.0 110.763 -172.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -64.79 -29.61 70.59 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.875 0.87 . . . . 0.0 111.984 -172.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -67.53 -29.71 69.18 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 122.674 0.39 . . . . 0.0 111.07 177.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 22.8 t -93.47 -37.77 8.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 C-N-CA 123.921 0.888 . . . . 0.0 110.119 -175.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -135.58 144.05 45.97 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-N 119.3 0.955 . . . . 0.0 112.82 -176.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -128.53 153.18 47.46 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.565 1.146 . . . . 0.0 109.578 173.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 77.5 t -114.25 131.62 65.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 124.655 1.182 . . . . 0.0 110.263 -168.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 -144.63 166.5 25.01 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.645 1.578 . . . . 0.0 112.219 -169.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -130.63 129.42 42.67 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 127.088 2.155 . . . . 0.0 106.332 -178.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.4 tp -61.87 -19.62 21.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 123.64 0.776 . . . . 0.0 112.299 -171.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -58.39 -30.27 66.69 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 118.676 0.671 . . . . 0.0 112.461 -175.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 60.9 pttt -98.09 -6.42 31.71 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.755 0.822 . . . . 0.0 112.619 177.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 67.2 m -76.26 158.96 31.06 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.705 0.764 . . . . 0.0 111.444 -175.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 21.8 m -130.43 175.47 8.94 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.723 2.009 . . . . 0.0 107.145 172.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -51.61 -48.83 63.1 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 118.497 0.59 . . . . 0.0 111.654 -174.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -77.67 -12.62 59.99 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -172.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -68.47 -32.92 73.25 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 118.74 0.7 . . . . 0.0 110.824 -177.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -74.91 -42.46 57.75 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 123.603 0.761 . . . . 0.0 109.502 172.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -68.94 -19.54 64.18 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.633 0.773 . . . . 0.0 111.954 -170.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.57 -29.78 70.43 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.011 0.925 . . . . 0.0 112.433 176.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -86.21 160.46 19.19 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 124.292 1.037 . . . . 0.0 110.316 178.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -111.2 -24.26 10.38 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.596 0.758 . . . . 0.0 111.802 169.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.0 mp -117.02 131.92 68.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 174.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 79.8 mt -130.56 123.7 30.17 Favored 'General case' 0 CA--C 1.523 -0.08 0 C-N-CA 123.965 0.906 . . . . 0.0 109.363 -177.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 8.1 mp -109.6 107.74 17.93 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 176.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.9 mt -108.27 108.96 20.19 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -168.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -100.42 117.39 5.86 Favored Glycine 0 CA--C 1.518 0.245 0 C-N-CA 125.516 1.531 . . . . 0.0 109.709 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 15.5 tt -129.74 118.9 18.9 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 118.43 1.115 . . . . 0.0 110.627 -176.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -79.36 150.95 22.7 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.403 2.069 . . . . 0.0 110.289 173.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 17.3 m -100.68 137.07 39.57 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 175.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 66.8 m95 -137.25 173.8 11.3 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.782 1.633 . . . . 0.0 110.599 -173.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 54.49 -89.17 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 127.976 2.51 . . . . 0.0 113.246 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -151.02 62.12 0.91 Allowed 'General case' 0 C--O 1.237 0.417 0 C-N-CA 126.168 1.787 . . . . 0.0 107.89 -173.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 67.67 54.85 16.78 Favored Glycine 0 CA--C 1.53 1.003 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 -174.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -129.24 164.6 23.1 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.104 1.362 . . . . 0.0 108.642 175.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.36 164.29 22.24 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 121.221 0.534 . . . . 0.0 110.027 170.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -70.33 150.7 46.05 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 169.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 84.0 m -56.84 -33.35 66.7 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -168.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -69.26 -40.47 77.82 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 119.092 0.86 . . . . 0.0 110.687 -177.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -72.21 -41.49 66.86 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 174.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -60.0 -40.98 91.11 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 122.697 0.399 . . . . 0.0 111.39 -178.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -70.05 -21.07 63.21 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.092 0.957 . . . . 0.0 112.018 177.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -90.91 -19.16 23.63 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 118.7 -0.666 . . . . 0.0 112.316 -178.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -51.7 -41.72 79.61 Favored Pre-proline 0 CA--C 1.543 0.709 0 CA-C-O 116.389 -1.767 . . . . 0.0 114.666 178.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -62.4 -21.18 72.36 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 CA-C-N 122.909 2.075 . . . . 0.0 113.632 175.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.2 m -84.88 -41.97 15.49 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.454 1.025 . . . . 0.0 109.124 169.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.2 tp -56.47 -38.39 71.62 Favored 'General case' 0 C--N 1.341 0.219 0 C-N-CA 124.054 0.942 . . . . 0.0 111.177 -177.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -72.66 -2.8 21.52 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -109.86 -14.81 14.22 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.325 1.05 . . . . 0.0 111.622 173.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 74.5 mt -71.8 139.63 19.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -178.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -81.21 128.38 33.71 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.905 176.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -125.58 12.31 8.02 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.829 0.851 . . . . 0.0 111.737 172.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 42.8 m-80 -62.42 116.3 4.96 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 119.647 1.112 . . . . 0.0 109.385 -171.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.66 2.18 60.0 Favored Glycine 0 CA--C 1.534 1.239 0 CA-C-O 118.671 -1.072 . . . . 0.0 113.782 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 62.1 mttm -73.31 148.27 43.7 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 119.533 1.666 . . . . 0.0 107.714 171.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 60.9 mt -90.5 137.81 32.06 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 174.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.6 t -136.01 147.96 27.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 -178.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -140.18 144.23 36.51 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 169.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.9 mp -113.48 151.27 31.7 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 123.677 0.791 . . . . 0.0 109.512 -172.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 25.9 p90 -149.2 168.46 23.21 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 168.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 177.93 157.99 19.88 Favored Glycine 0 N--CA 1.449 -0.498 0 O-C-N 121.144 -0.973 . . . . 0.0 113.445 178.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 14.2 m -110.64 153.42 25.24 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 124.805 1.242 . . . . 0.0 109.268 -169.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -163.46 -166.54 22.45 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 178.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -152.61 118.69 5.49 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 124.898 1.279 . . . . 0.0 107.699 176.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -82.67 -34.15 27.5 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -169.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -56.33 -46.67 79.8 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 123.867 0.867 . . . . 0.0 111.648 -169.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -97.17 -42.6 7.76 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 118.601 0.637 . . . . 0.0 112.245 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 -91.94 44.72 1.18 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.958 0.903 . . . . 0.0 110.357 -172.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.33 -24.66 66.6 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.258 1.423 . . . . 0.0 113.421 -169.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -104.62 10.37 34.91 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.267 1.027 . . . . 0.0 112.75 178.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -135.62 16.86 3.35 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 124.939 1.296 . . . . 0.0 111.177 -178.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -66.41 124.45 22.77 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 121.159 -0.963 . . . . 0.0 110.518 -168.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 92.6 m 49.97 36.78 12.42 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.684 1.593 . . . . 0.0 113.058 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -59.93 -36.35 76.86 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.464 -0.772 . . . . 0.0 112.549 179.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.44 -24.81 67.75 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 -167.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.8 mp -61.57 -36.35 80.41 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 120.967 -1.083 . . . . 0.0 109.902 175.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.32 -31.22 78.51 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 123.706 0.669 . . . . 0.0 111.455 177.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.9 m -66.89 -36.67 82.82 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 121.858 -0.789 . . . . 0.0 110.533 179.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 15.7 mt -71.46 -49.16 49.0 Favored 'Isoleucine or valine' 0 C--N 1.343 0.318 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 174.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 18.3 tpt180 -50.15 -44.4 52.51 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.16 0.984 . . . . 0.0 111.052 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -60.87 -28.1 68.61 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.88 0.872 . . . . 0.0 112.643 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 97.0 mt -92.9 -46.09 14.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 124.351 1.06 . . . . 0.0 109.923 -178.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 32.6 pt -78.22 -23.09 13.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 O-C-N 121.23 -0.918 . . . . 0.0 111.931 -169.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -62.91 -58.06 18.38 Favored Pre-proline 0 CA--C 1.544 0.712 0 CA-C-O 117.412 -1.28 . . . . 0.0 111.629 177.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -65.8 -23.52 55.4 Favored 'Trans proline' 0 C--N 1.352 0.761 0 CA-C-N 121.708 1.646 . . . . 0.0 112.39 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 76.6 mmt-85 -79.66 6.26 11.13 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.211 1.004 . . . . 0.0 112.807 173.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 77.73 19.2 76.13 Favored Glycine 0 CA--C 1.528 0.876 0 CA-C-O 118.271 -1.294 . . . . 0.0 114.988 168.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.03 144.36 53.57 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 119.318 1.559 . . . . 0.0 110.09 169.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 42.2 m -97.45 124.99 41.84 Favored 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 105.01 -2.218 . . . . 0.0 105.01 167.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 20.8 mt -113.44 125.8 70.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -169.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 33.3 m -127.76 178.72 4.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 124.69 1.196 . . . . 0.0 109.21 174.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 79.77 27.64 53.29 Favored Glycine 0 CA--C 1.528 0.898 0 O-C-N 121.851 -0.531 . . . . 0.0 112.57 179.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 80.8 m-70 -62.0 141.58 57.98 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 170.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 71.5 t-105 -131.12 138.03 32.01 Favored Pre-proline 0 CA--C 1.537 0.446 0 C-N-CA 124.125 0.97 . . . . 0.0 109.5 -170.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -62.93 151.29 85.27 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 121.818 1.679 . . . . 0.0 112.985 -176.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 35.5 p . . . . . 0 CA--C 1.536 0.435 0 O-C-N 121.852 -0.53 . . . . 0.0 111.515 171.511 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 90.0 mttt . . . . . 0 N--CA 1.471 0.589 0 N-CA-C 113.928 1.084 . . . . 0.0 113.928 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -83.95 4.98 81.36 Favored Glycine 0 CA--C 1.534 1.269 0 CA-C-O 119.518 -0.601 . . . . 0.0 112.207 169.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 9.0 mp -62.23 135.26 57.4 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 118.969 1.385 . . . . 0.0 111.71 -177.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -97.05 -29.59 13.54 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.484 1.514 . . . . 0.0 109.313 167.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -146.82 167.68 23.29 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.149 1.78 . . . . 0.0 107.327 174.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -55.64 -25.89 41.44 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.12 1.368 . . . . 0.0 113.947 -169.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -122.45 11.71 9.99 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.85 1.26 . . . . 0.0 113.574 -178.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -141.14 125.72 17.81 Favored 'General case' 0 C--N 1.343 0.304 0 CA-C-N 119.362 0.983 . . . . 0.0 111.587 -176.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -71.54 150.17 45.04 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.333 1.053 . . . . 0.0 108.31 166.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 6.1 p -67.74 -8.6 8.98 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 123.98 0.912 . . . . 0.0 112.099 175.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -168.66 176.22 43.0 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 -172.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -70.73 103.12 2.48 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 -179.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.365 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 169.0 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 66.7 mt . . . . . 0 CA--C 1.531 0.248 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 50.5 m -41.03 -53.41 3.01 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 128.175 2.59 . . . . 0.0 111.766 -177.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -76.62 -40.74 48.39 Favored 'General case' 0 N--CA 1.452 -0.357 0 O-C-N 122.264 -0.272 . . . . 0.0 111.001 -172.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -62.9 -47.28 84.0 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 117.993 0.36 . . . . 0.0 110.377 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 47.6 mtp180 -65.71 -39.54 91.3 Favored 'General case' 0 N--CA 1.464 0.249 0 O-C-N 121.932 -0.48 . . . . 0.0 110.325 -175.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 86.4 t -72.68 -37.47 55.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-O 118.226 -0.893 . . . . 0.0 109.899 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -62.05 -49.83 74.4 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 120.722 1.601 . . . . 0.0 110.245 174.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -62.72 -34.56 77.43 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 118.898 -0.572 . . . . 0.0 110.746 -176.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 40.2 t90 -71.79 -51.63 21.64 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 118.531 0.605 . . . . 0.0 110.384 176.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 68.9 t -64.44 -35.07 73.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 O-C-N 121.533 -0.729 . . . . 0.0 110.835 -172.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -63.45 -35.53 80.74 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.404 -0.81 . . . . 0.0 110.324 177.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 53.7 mm-40 -71.63 -48.39 48.23 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.552 0.741 . . . . 0.0 111.178 174.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 3.8 pt -63.72 -32.51 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-N 119.771 1.169 . . . . 0.0 110.362 -177.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 50.2 m -61.85 -33.68 74.61 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 118.309 -0.853 . . . . 0.0 111.505 -179.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -86.41 -24.66 25.64 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 120.227 1.376 . . . . 0.0 111.954 177.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -73.74 -37.61 65.01 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 118.683 0.674 . . . . 0.0 110.701 174.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 77.7 mt -89.97 -4.79 57.26 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.058 1.743 . . . . 0.0 111.484 -178.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 82.7 m-70 56.6 25.29 9.76 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.952 1.701 . . . . 0.0 113.195 -172.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 79.8 mt . . . . . 0 N--CA 1.464 0.246 0 O-C-N 121.456 -0.778 . . . . 0.0 110.381 172.006 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.224 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 28.6 pt -80.68 -24.73 11.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 O-C-N 122.143 -0.348 . . . . 0.0 111.351 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.1 m -113.19 130.16 56.3 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.002 1.321 . . . . 0.0 108.771 178.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -102.76 124.68 8.24 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 107.974 -2.051 . . . . 0.0 107.974 169.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 27.3 mt -103.32 94.72 3.35 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 105.248 -2.131 . . . . 0.0 105.248 177.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -90.27 129.44 36.5 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 -177.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -122.43 123.47 41.4 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 119.806 1.185 . . . . 0.0 112.637 -176.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -82.51 141.72 21.42 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 106.391 -2.684 . . . . 0.0 106.391 165.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.1 m -161.85 171.33 17.93 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 119.939 1.87 . . . . 0.0 110.452 177.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -133.93 -50.67 0.83 Allowed 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.027 0.931 . . . . 0.0 109.817 169.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 81.9 p -92.41 5.0 52.31 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.021 0.928 . . . . 0.0 112.31 177.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 76.13 18.15 79.56 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 124.032 0.825 . . . . 0.0 113.317 -175.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -76.85 -47.19 22.07 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 119.263 1.532 . . . . 0.0 111.235 -176.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 72.8 m -74.06 -23.57 59.38 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 118.968 0.804 . . . . 0.0 109.974 178.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -56.09 -46.27 79.12 Favored 'General case' 0 C--N 1.342 0.248 0 O-C-N 121.385 -0.822 . . . . 0.0 109.616 169.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -64.95 -34.28 78.05 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 121.781 -0.574 . . . . 0.0 111.033 -177.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 45.4 mm -60.43 -44.1 95.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 172.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.61 -41.51 97.57 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.702 -0.624 . . . . 0.0 111.576 177.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 29.2 mmtp -64.14 -41.87 97.03 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 121.45 -0.782 . . . . 0.0 110.276 176.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 78.7 mtp -62.24 -40.6 96.72 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.399 1.0 . . . . 0.0 110.473 178.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 55.5 mt -60.62 -49.59 83.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 174.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -58.59 -38.15 77.32 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 121.233 -0.917 . . . . 0.0 111.417 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -63.63 -34.56 78.1 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 120.077 1.308 . . . . 0.0 111.246 -178.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -72.27 -40.6 67.5 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 118.371 0.532 . . . . 0.0 110.758 174.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -80.58 -34.22 35.47 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -171.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 84.3 144.61 6.48 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 -168.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 54.0 tttp -63.41 -30.93 71.97 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 121.912 -0.758 . . . . 0.0 111.975 -171.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -64.47 -30.98 72.01 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 122.85 0.46 . . . . 0.0 111.26 178.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.1 t -92.97 -39.96 11.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 123.502 0.721 . . . . 0.0 109.927 -176.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.22 137.44 32.59 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 118.92 0.782 . . . . 0.0 112.045 -178.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -129.23 144.71 51.32 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 176.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 59.7 t -90.32 134.78 28.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 123.871 0.868 . . . . 0.0 108.777 -170.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -147.12 169.19 19.81 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.886 1.274 . . . . 0.0 111.201 -168.117 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -138.31 128.33 25.56 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 125.173 1.389 . . . . 0.0 109.036 -169.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.3 tp -63.44 -29.84 48.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 CA-C-O 118.832 -0.604 . . . . 0.0 111.708 -173.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.52 -28.53 68.62 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 119.105 0.866 . . . . 0.0 110.318 -178.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -89.23 -27.14 20.81 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.172 1.389 . . . . 0.0 110.511 177.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 21.3 m -68.64 167.05 15.95 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 124.433 1.093 . . . . 0.0 111.801 -177.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.6 m -135.12 164.56 27.38 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.481 1.512 . . . . 0.0 108.932 178.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -53.17 -54.8 30.53 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.326 1.05 . . . . 0.0 111.45 -175.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -78.28 -15.96 58.24 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 122.312 0.245 . . . . 0.0 111.195 -175.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -74.32 -30.22 61.95 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 121.772 -0.58 . . . . 0.0 110.966 -179.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.7 mp -69.17 -43.51 74.12 Favored 'General case' 0 C--N 1.343 0.305 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 169.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -62.86 -17.41 61.44 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -177.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.15 -29.08 67.88 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.654 0.782 . . . . 0.0 112.289 176.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -82.29 155.99 24.53 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.195 0.998 . . . . 0.0 110.023 177.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -108.86 -26.48 10.24 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.111 0.564 . . . . 0.0 111.673 169.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.0 mp -113.81 127.89 70.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 174.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 96.3 mt -118.05 127.5 53.86 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 124.192 0.997 . . . . 0.0 108.436 177.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.2 mp -111.85 116.31 30.46 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 104.411 -2.44 . . . . 0.0 104.411 168.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 91.1 mt -115.23 109.08 17.44 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 -169.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.69 117.6 5.61 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 108.848 -1.701 . . . . 0.0 108.848 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 15.3 tt -135.91 105.29 9.7 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-N 118.731 1.266 . . . . 0.0 109.617 178.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -71.58 150.95 58.05 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 121.91 1.74 . . . . 0.0 109.635 170.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 29.3 m -99.19 139.27 35.08 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -179.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 47.5 m95 -135.7 172.79 12.5 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.86 1.264 . . . . 0.0 111.245 -170.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 53.87 -87.27 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 127.511 2.324 . . . . 0.0 112.958 176.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -149.69 80.01 1.38 Allowed 'General case' 0 C--O 1.235 0.31 0 C-N-CA 126.379 1.872 . . . . 0.0 106.847 174.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.71 16.96 76.32 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-O 119.575 -0.57 . . . . 0.0 113.306 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -91.99 161.8 14.65 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 118.54 1.17 . . . . 0.0 110.584 -175.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.27 161.56 28.65 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 123.915 0.886 . . . . 0.0 111.284 173.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 12.8 tm0? -64.57 146.4 54.69 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 168.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 56.3 m -56.45 -39.96 74.02 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 -167.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -77.33 -39.03 49.13 Favored 'General case' 0 C--N 1.333 -0.109 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -174.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -62.74 -44.95 94.88 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 172.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -58.98 -42.04 89.01 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.319 0.648 . . . . 0.0 111.358 178.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -69.33 -27.5 65.42 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.335 0.654 . . . . 0.0 112.336 176.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -88.32 -17.8 29.87 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.627 0.771 . . . . 0.0 112.629 -177.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -51.8 -40.45 70.97 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-O 116.426 -1.75 . . . . 0.0 115.349 -179.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -61.26 -30.21 87.71 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 CA-C-N 123.197 2.178 . . . . 0.0 112.701 173.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.7 m -75.23 -42.28 55.74 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.923 0.783 . . . . 0.0 109.446 172.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 12.3 tp -58.24 -37.62 75.25 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.126 0.97 . . . . 0.0 110.387 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -67.71 -11.64 58.77 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.55 1.14 . . . . 0.0 113.202 177.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -95.91 -17.91 20.71 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 119.803 1.183 . . . . 0.0 112.179 173.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 95.7 mt -76.38 143.59 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 -172.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -89.49 132.26 35.13 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 123.507 0.723 . . . . 0.0 109.691 175.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -124.62 6.08 8.21 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.913 0.885 . . . . 0.0 112.067 177.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -66.48 124.48 22.88 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 120.358 1.435 . . . . 0.0 110.378 -169.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.26 -0.94 58.26 Favored Glycine 0 CA--C 1.537 1.424 0 CA-C-O 118.433 -1.204 . . . . 0.0 114.277 -175.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -76.67 150.45 36.36 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 119.698 1.749 . . . . 0.0 108.408 173.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 66.9 mt -95.38 138.2 33.39 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 175.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 15.2 t -136.38 147.93 27.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -178.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -138.04 147.81 44.47 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 169.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -110.2 147.3 34.02 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 124.607 1.163 . . . . 0.0 108.607 -175.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -149.04 163.9 36.19 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 167.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 174.55 143.6 4.5 Favored Glycine 0 C--N 1.33 0.215 0 O-C-N 121.251 -0.906 . . . . 0.0 111.406 173.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 53.7 m -81.44 159.7 24.2 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 175.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.9 -167.63 27.89 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.403 -0.679 . . . . 0.0 111.403 -177.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -147.64 126.41 12.64 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 126.034 1.734 . . . . 0.0 107.994 176.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -106.89 2.38 25.32 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.328 1.051 . . . . 0.0 112.214 176.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -91.22 -46.32 8.14 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 119.24 0.927 . . . . 0.0 110.05 -173.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -105.58 -44.52 4.66 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.172 0.589 . . . . 0.0 110.493 178.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -82.75 40.91 0.7 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.551 1.141 . . . . 0.0 110.482 171.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.73 -21.86 64.87 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 127.002 2.121 . . . . 0.0 114.219 -170.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -103.26 7.81 38.39 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.173 1.389 . . . . 0.0 111.699 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -137.15 17.46 2.99 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.605 1.162 . . . . 0.0 111.387 -174.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -63.54 132.63 51.89 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 119.078 0.854 . . . . 0.0 109.363 -170.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . 0.258 23.0 p 52.05 22.98 2.03 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 127.357 2.263 . . . . 0.0 114.772 173.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -52.16 -41.54 62.67 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.851 1.261 . . . . 0.0 111.401 -175.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.35 -23.08 67.26 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -172.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 63.5 mt -61.39 -40.24 93.64 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 119.1 0.864 . . . . 0.0 109.621 175.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -68.19 -28.08 73.47 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 124.037 0.827 . . . . 0.0 111.591 -179.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.3 m -65.25 -37.12 86.22 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 118.243 1.021 . . . . 0.0 110.356 178.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 8.0 mt -71.25 -46.12 67.09 Favored 'Isoleucine or valine' 0 C--N 1.343 0.304 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 173.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 40.2 ttt180 -50.54 -46.11 57.29 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 118.858 0.754 . . . . 0.0 110.754 -177.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -61.87 -23.02 66.03 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.822 0.849 . . . . 0.0 113.025 -177.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 93.6 mt -92.21 -47.78 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 124.278 1.031 . . . . 0.0 109.268 178.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 30.0 pt -82.0 -36.77 14.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 118.989 0.813 . . . . 0.0 112.59 -168.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -68.19 -47.53 39.02 Favored Pre-proline 0 CA--C 1.54 0.575 0 CA-C-O 117.902 -1.047 . . . . 0.0 112.28 -170.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -68.66 -16.37 42.16 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 CA-C-N 121.532 1.583 . . . . 0.0 112.382 175.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 90.0 mtt-85 -91.51 20.29 5.48 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.736 1.214 . . . . 0.0 111.719 176.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 79.44 10.88 85.47 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 125.906 1.717 . . . . 0.0 115.023 168.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.45 137.76 58.1 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 119.649 1.724 . . . . 0.0 109.057 170.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 35.7 m -94.42 120.63 34.96 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 105.179 -2.156 . . . . 0.0 105.179 168.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 29.6 mt -99.2 132.62 44.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 -177.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 34.4 m -130.08 178.73 4.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 125.259 1.423 . . . . 0.0 108.812 172.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 77.14 28.11 58.9 Favored Glycine 0 C--N 1.335 0.523 0 CA-C-O 119.365 -0.686 . . . . 0.0 113.76 178.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 65.3 m80 -57.17 133.45 55.05 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 169.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 57.4 t-105 -115.61 135.78 22.7 Favored Pre-proline 0 CA--C 1.535 0.374 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -177.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.7 145.56 52.05 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 121.823 1.682 . . . . 0.0 111.754 -170.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 34.9 p . . . . . 0 CA--C 1.534 0.343 0 C-N-CA 122.963 0.505 . . . . 0.0 110.784 169.819 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 83.5 mttt . . . . . 0 N--CA 1.468 0.431 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -86.65 9.34 71.67 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 123.774 0.702 . . . . 0.0 111.815 167.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 95.3 mt -60.59 141.35 56.76 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 118.636 1.218 . . . . 0.0 110.889 177.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -108.74 -31.04 7.87 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.159 1.384 . . . . 0.0 108.89 167.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -146.4 162.48 38.13 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 127.869 2.468 . . . . 0.0 106.389 169.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -55.91 -29.05 59.44 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 119.27 0.941 . . . . 0.0 112.167 176.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -89.98 -11.5 41.45 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.295 1.038 . . . . 0.0 113.406 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 7.4 m-70 -149.48 131.52 15.32 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 119.742 1.155 . . . . 0.0 113.14 -169.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -75.02 158.98 32.32 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 167.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 12.4 p -61.69 -22.83 29.24 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 C-N-CA 123.227 0.611 . . . . 0.0 111.364 173.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -161.97 -172.26 29.15 Favored Glycine 0 C--N 1.337 0.636 0 O-C-N 121.514 -0.742 . . . . 0.0 111.798 -171.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.35 86.96 1.13 Allowed 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 124.755 1.222 . . . . 0.0 109.082 179.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.419 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 168.949 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 88.8 mt . . . . . 0 N--CA 1.465 0.308 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 83.2 m -43.14 -52.18 5.6 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 127.409 2.284 . . . . 0.0 111.696 -174.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -72.89 -33.7 66.2 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 118.888 -0.577 . . . . 0.0 110.731 -170.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -65.74 -43.47 88.89 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 118.552 0.615 . . . . 0.0 110.223 174.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -59.64 -49.6 77.13 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 178.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 98.2 t -67.33 -45.7 85.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-O 118.179 -0.915 . . . . 0.0 109.434 -176.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -53.77 -51.63 62.81 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 119.306 0.957 . . . . 0.0 110.1 -178.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 42.0 mttp -70.44 -42.17 71.9 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-O 118.838 -0.601 . . . . 0.0 110.697 -175.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 69.2 t90 -63.89 -44.5 92.83 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-N 118.943 0.792 . . . . 0.0 109.727 -178.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 54.3 t -61.96 -40.15 86.2 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 O-C-N 122.075 -0.391 . . . . 0.0 110.015 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -64.39 -40.24 95.42 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 121.369 -0.832 . . . . 0.0 110.232 178.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 20.6 mm100 -64.5 -51.46 62.83 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.321 0.51 . . . . 0.0 110.903 177.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 14.4 pt -66.01 -32.41 58.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 119.476 1.035 . . . . 0.0 110.704 -176.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 58.4 m -62.78 -26.63 68.81 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 118.139 -0.934 . . . . 0.0 112.127 -177.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -90.55 -17.69 26.57 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 120.259 1.39 . . . . 0.0 112.477 174.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -80.61 -35.71 33.72 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.25 0.932 . . . . 0.0 110.454 171.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 75.2 mt -91.63 -7.29 50.48 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.613 1.965 . . . . 0.0 111.598 -178.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 30.6 m80 56.26 24.68 8.44 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 126.076 1.75 . . . . 0.0 113.359 -172.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 86.9 mt . . . . . 0 N--CA 1.465 0.281 0 O-C-N 121.771 -0.581 . . . . 0.0 110.387 172.555 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.38 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.5 pt -83.81 -24.77 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 O-C-N 121.958 -0.464 . . . . 0.0 111.476 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 17.3 m -112.08 131.48 55.41 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.216 1.406 . . . . 0.0 108.732 177.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -107.0 121.87 6.71 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 108.374 -1.891 . . . . 0.0 108.374 170.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 52.5 mt -99.85 100.66 10.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 177.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -97.55 124.36 41.77 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 17.8 p90 -124.41 127.6 47.78 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 119.111 0.869 . . . . 0.0 112.131 -177.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -84.14 143.52 21.23 Favored Glycine 0 C--N 1.341 0.819 0 N-CA-C 110.316 -1.114 . . . . 0.0 110.316 168.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.6 m -160.38 159.26 30.87 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 118.895 1.348 . . . . 0.0 110.739 173.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -135.6 -47.64 0.69 Allowed 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.288 1.035 . . . . 0.0 109.851 169.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.4 p -80.12 -12.38 59.67 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.555 0.742 . . . . 0.0 111.954 170.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.9 7.96 54.71 Favored Glycine 0 C--N 1.342 0.869 0 C-N-CA 124.732 1.158 . . . . 0.0 113.449 170.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -69.76 -41.79 74.71 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 118.82 1.31 . . . . 0.0 112.442 -169.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.4 m -70.02 -18.01 63.29 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 119.408 1.004 . . . . 0.0 111.27 -172.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -58.23 -42.84 87.2 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 119.116 0.871 . . . . 0.0 110.166 174.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -65.8 -38.41 88.91 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 121.915 -0.491 . . . . 0.0 110.485 -178.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 36.9 mm -65.1 -47.52 87.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 176.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.0 -38.27 85.45 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.183 0.593 . . . . 0.0 111.575 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.0 mtpt -68.22 -44.69 75.18 Favored 'General case' 0 N--CA 1.463 0.188 0 O-C-N 121.643 -0.661 . . . . 0.0 110.594 176.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 75.5 mtm -66.85 -22.72 65.98 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.352 0.978 . . . . 0.0 111.946 178.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 68.3 mt -71.31 -59.07 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 168.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -55.16 -42.19 72.81 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 118.382 -0.818 . . . . 0.0 112.349 -174.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -58.94 -32.04 69.23 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 119.65 1.114 . . . . 0.0 111.903 -175.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -75.27 -39.6 59.58 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.062 0.545 . . . . 0.0 111.538 178.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -79.39 -35.4 40.76 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 118.652 0.66 . . . . 0.0 111.508 -177.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 88.09 146.1 11.43 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 124.778 1.18 . . . . 0.0 110.353 -169.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 55.5 tttp -63.37 -31.95 73.24 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 121.953 -0.733 . . . . 0.0 112.117 -169.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -66.24 -29.14 69.33 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 122.955 0.502 . . . . 0.0 111.397 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 39.0 t -92.56 -39.67 11.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 123.878 0.871 . . . . 0.0 109.582 -177.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -140.15 132.85 28.93 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 119.241 0.928 . . . . 0.0 111.513 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -125.05 149.7 47.52 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 175.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 60.5 t -97.83 138.98 21.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 124.595 1.158 . . . . 0.0 110.101 -168.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -149.63 172.39 15.13 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.948 1.299 . . . . 0.0 111.512 -173.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -137.74 132.17 32.39 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 125.647 1.579 . . . . 0.0 108.032 -174.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.5 tp -65.8 -27.03 40.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-O 118.581 -0.723 . . . . 0.0 112.927 -168.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.11 -30.44 68.72 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 119.221 0.919 . . . . 0.0 110.297 178.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 43.8 mtmt -81.03 -31.36 34.6 Favored 'General case' 0 C--N 1.342 0.244 0 C-N-CA 123.252 0.621 . . . . 0.0 110.421 174.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.7 m -70.43 169.51 13.88 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.522 1.129 . . . . 0.0 111.654 -172.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 14.8 m -135.3 160.96 36.77 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.146 1.379 . . . . 0.0 108.733 178.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 45.2 tttm -53.6 -51.75 62.02 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.78 0.832 . . . . 0.0 111.042 -174.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.2 mp0 -73.82 -14.32 61.08 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 119.343 -0.361 . . . . 0.0 111.683 -175.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -71.71 -39.39 70.19 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 119.487 1.04 . . . . 0.0 110.675 -178.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 8.3 mp -66.22 -31.83 72.89 Favored 'General case' 0 C--N 1.343 0.315 0 C-N-CA 122.375 0.27 . . . . 0.0 110.361 173.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -70.15 -20.93 63.12 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 119.178 -0.439 . . . . 0.0 111.612 -176.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.61 -30.3 61.62 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.622 0.769 . . . . 0.0 112.559 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -76.36 151.78 36.53 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 123.681 0.792 . . . . 0.0 109.928 177.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -100.12 -31.43 11.42 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 122.709 0.404 . . . . 0.0 111.338 170.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.1 mp -110.52 128.77 66.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 175.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 96.2 mt -114.17 128.33 56.32 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 172.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.2 mp -110.27 115.81 30.36 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 105.345 -2.095 . . . . 0.0 105.345 169.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 85.8 mt -115.92 109.7 17.95 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 -169.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -100.26 119.15 6.41 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 125.966 1.746 . . . . 0.0 109.85 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.6 tt -132.74 123.85 18.5 Favored Pre-proline 0 CA--C 1.541 0.605 0 CA-C-N 118.906 1.353 . . . . 0.0 112.15 -173.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -85.59 157.09 10.6 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 123.042 2.495 . . . . 0.0 110.658 170.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.0 m -112.32 142.08 45.26 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 175.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 75.2 m95 -140.95 171.29 14.28 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.11 1.764 . . . . 0.0 111.074 -169.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 36.2 t80 50.83 -89.59 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 127.648 2.379 . . . . 0.0 112.569 -177.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -149.7 84.15 1.41 Allowed 'General case' 0 C--O 1.235 0.303 0 C-N-CA 126.652 1.981 . . . . 0.0 106.215 173.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 73.58 13.44 80.22 Favored Glycine 0 CA--C 1.534 1.235 0 CA-C-O 119.203 -0.776 . . . . 0.0 114.088 177.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -84.59 161.99 19.95 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.625 1.212 . . . . 0.0 108.915 174.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -84.95 175.1 9.28 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 166.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.4 142.44 56.95 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 168.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 58.6 m -57.61 -36.47 71.82 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 119.311 0.959 . . . . 0.0 112.998 -169.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -72.53 -28.51 62.9 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.133 0.573 . . . . 0.0 111.908 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -79.91 -41.83 25.35 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.649 1.179 . . . . 0.0 109.468 176.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -59.7 -42.21 92.47 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.564 1.146 . . . . 0.0 110.689 176.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -62.22 -19.63 63.37 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.0 0.92 . . . . 0.0 112.525 177.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -90.4 -15.31 31.24 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 118.252 -0.88 . . . . 0.0 112.294 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -54.15 -42.87 95.87 Favored Pre-proline 0 CA--C 1.541 0.632 0 CA-C-N 120.992 1.724 . . . . 0.0 113.963 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -63.14 -21.96 72.77 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 CA-C-N 122.523 1.937 . . . . 0.0 113.397 174.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.2 m -82.25 -38.8 23.91 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.462 1.028 . . . . 0.0 109.702 171.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 14.0 tp -59.02 -40.69 85.76 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.312 1.045 . . . . 0.0 109.941 -176.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -75.63 4.15 8.26 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 178.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -105.38 -16.42 14.75 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.288 1.035 . . . . 0.0 111.111 169.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 96.7 mt -75.28 140.53 17.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 179.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -88.92 131.42 35.14 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 123.543 0.737 . . . . 0.0 109.524 174.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -121.51 8.01 10.12 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.86 0.864 . . . . 0.0 111.952 177.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 29.6 m-80 -58.72 116.45 3.73 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 119.814 1.188 . . . . 0.0 109.835 -172.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.58 1.92 67.48 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-O 118.571 -1.127 . . . . 0.0 114.283 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -74.25 150.84 40.07 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 119.674 1.737 . . . . 0.0 108.581 172.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 23.8 mt -92.04 137.59 32.24 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 172.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 19.7 t -134.28 144.07 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 177.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -137.65 145.94 43.28 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 171.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.2 mp -116.34 150.23 38.02 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 123.102 0.561 . . . . 0.0 109.646 -171.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -144.27 162.86 35.33 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 167.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -171.32 168.02 41.14 Favored Glycine 0 N--CA 1.452 -0.299 0 O-C-N 120.773 -1.204 . . . . 0.0 112.778 -176.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 21.3 m -133.28 151.6 51.9 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.569 1.148 . . . . 0.0 109.223 -168.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -178.35 -174.41 44.59 Favored Glycine 0 CA--C 1.528 0.857 0 CA-C-O 121.022 0.235 . . . . 0.0 112.57 -177.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -145.4 153.2 40.95 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 128.247 2.619 . . . . 0.0 106.952 175.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.9 12.8 3.38 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.182 1.393 . . . . 0.0 111.79 -173.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -68.47 -47.5 66.94 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 177.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -106.33 -38.72 6.13 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 123.395 0.678 . . . . 0.0 111.341 175.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -84.45 39.99 0.76 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.548 1.139 . . . . 0.0 111.404 -172.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.45 -19.83 65.8 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.266 1.027 . . . . 0.0 113.126 -171.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -93.11 0.31 57.22 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.476 1.11 . . . . 0.0 111.921 175.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -139.04 20.72 2.63 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.657 1.183 . . . . 0.0 111.573 -169.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -66.24 119.66 11.9 Favored 'General case' 0 C--O 1.235 0.32 0 O-C-N 121.122 -0.986 . . . . 0.0 108.925 -172.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 67.3 m 49.01 35.03 6.17 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.848 1.659 . . . . 0.0 112.581 -174.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -52.22 -41.21 62.54 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.815 1.246 . . . . 0.0 112.061 -171.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.53 -18.09 64.51 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -169.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 39.5 mt -54.58 -42.78 71.47 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.718 0.807 . . . . 0.0 110.137 171.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.69 -34.17 89.2 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 -179.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.2 m -64.91 -36.37 84.14 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 117.959 0.88 . . . . 0.0 110.864 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 8.1 mt -67.97 -51.18 52.08 Favored 'Isoleucine or valine' 0 C--N 1.345 0.392 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 173.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 60.3 ttp85 -55.17 -44.3 75.1 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 119.514 1.052 . . . . 0.0 110.488 -175.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -58.81 -21.46 56.37 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.793 0.837 . . . . 0.0 112.683 -177.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 96.7 mt -96.34 -51.38 10.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 124.325 1.05 . . . . 0.0 109.728 176.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 31.9 pt -74.64 -32.49 29.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-N 119.674 1.124 . . . . 0.0 111.762 -169.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -67.46 -54.2 19.63 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-O 117.61 -1.186 . . . . 0.0 112.069 -174.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -66.28 -23.23 52.19 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 CA-C-N 121.483 1.565 . . . . 0.0 112.024 176.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 60.5 mtp85 -85.62 16.67 3.73 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.014 0.926 . . . . 0.0 112.319 177.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 82.19 14.4 76.91 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-O 118.157 -1.357 . . . . 0.0 116.146 166.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.68 144.45 57.02 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 119.59 1.695 . . . . 0.0 109.807 170.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 74.9 m -96.87 121.36 38.65 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 167.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 34.9 mt -102.04 128.37 54.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 -173.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 32.7 m -128.79 178.09 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 125.658 1.583 . . . . 0.0 108.72 175.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 74.57 28.91 62.46 Favored Glycine 0 CA--C 1.525 0.7 0 O-C-N 121.426 -0.796 . . . . 0.0 113.213 -179.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 80.2 m-70 -61.98 140.92 58.3 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 169.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 68.3 t-105 -129.47 135.29 27.33 Favored Pre-proline 0 CA--C 1.535 0.382 0 C-N-CA 124.042 0.937 . . . . 0.0 108.866 -173.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -65.72 143.87 75.84 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 121.974 1.783 . . . . 0.0 112.182 -170.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 57.5 p . . . . . 0 CA--C 1.536 0.424 0 C-N-CA 123.679 0.792 . . . . 0.0 111.199 177.637 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.716 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -77.56 6.21 47.18 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.158 0.885 . . . . 0.0 113.433 173.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 93.5 mt -65.35 139.47 58.58 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 119.754 1.777 . . . . 0.0 109.864 176.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -106.14 -32.21 8.34 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.376 1.47 . . . . 0.0 108.184 167.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -146.45 161.78 39.68 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 128.143 2.577 . . . . 0.0 106.063 169.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -56.36 -29.44 61.4 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 121.108 -0.995 . . . . 0.0 112.276 176.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -90.29 -10.74 43.05 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.091 0.956 . . . . 0.0 113.448 179.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -144.81 124.74 13.49 Favored 'General case' 0 C--N 1.345 0.408 0 CA-C-N 119.862 1.21 . . . . 0.0 112.985 -171.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -73.17 153.24 40.8 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 166.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 8.4 p -64.84 -18.83 24.31 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 124.206 1.002 . . . . 0.0 112.081 178.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -161.36 176.02 37.93 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 -169.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -74.15 92.8 2.23 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.529 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 169.48 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 72.5 mt . . . . . 0 N--CA 1.467 0.417 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 41.2 m -46.57 -57.53 4.66 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 125.561 1.544 . . . . 0.0 111.999 -170.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -71.03 -30.32 66.48 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 122.529 0.332 . . . . 0.0 111.237 -169.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -68.26 -46.68 69.76 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 173.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -66.98 -39.2 87.11 Favored 'General case' 0 N--CA 1.463 0.18 0 O-C-N 121.738 -0.601 . . . . 0.0 111.576 -174.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 29.0 m -71.2 -23.18 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 119.127 0.876 . . . . 0.0 111.378 177.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -74.24 -52.84 11.15 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 120.14 1.336 . . . . 0.0 109.16 170.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -58.24 -43.53 87.82 Favored 'General case' 0 N--CA 1.462 0.169 0 O-C-N 122.17 -0.331 . . . . 0.0 110.934 -175.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 58.5 t90 -67.62 -46.71 71.72 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 118.199 0.454 . . . . 0.0 110.039 -176.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 67.9 t -63.49 -38.57 82.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 O-C-N 122.015 -0.428 . . . . 0.0 110.044 -178.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -66.53 -37.02 84.1 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.368 -0.833 . . . . 0.0 110.266 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 17.8 mm100 -66.53 -51.8 52.66 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.371 0.532 . . . . 0.0 110.917 175.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 15.5 pt -65.85 -29.24 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-N 119.469 1.032 . . . . 0.0 110.8 -176.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 70.6 m -58.9 -26.62 64.47 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 117.79 -1.1 . . . . 0.0 112.386 178.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -96.31 -9.57 29.87 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 120.341 1.428 . . . . 0.0 112.769 175.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -85.16 -39.72 17.55 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 119.138 0.881 . . . . 0.0 110.0 169.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 80.5 mt -87.28 -10.98 50.95 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.836 2.054 . . . . 0.0 111.531 -179.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 55.67 32.66 19.76 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.955 1.702 . . . . 0.0 112.535 -171.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 81.2 mt . . . . . 0 N--CA 1.466 0.366 0 O-C-N 121.804 -0.56 . . . . 0.0 110.069 169.26 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.361 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 31.6 pt -85.73 -23.64 7.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 122.413 0.285 . . . . 0.0 111.592 -177.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 11.7 m -109.36 128.11 54.85 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 125.235 1.414 . . . . 0.0 108.858 179.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -103.55 122.02 7.29 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 106.927 -2.469 . . . . 0.0 106.927 168.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 57.6 mt -100.99 92.35 2.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 N-CA-C 105.144 -2.169 . . . . 0.0 105.144 177.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -88.6 132.17 34.65 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 -178.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -130.06 133.28 46.6 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 119.521 1.055 . . . . 0.0 111.617 176.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -88.02 145.5 19.27 Favored Glycine 0 C--N 1.339 0.726 0 N-CA-C 108.384 -1.886 . . . . 0.0 108.384 171.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -159.47 176.35 12.2 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 119.446 1.623 . . . . 0.0 112.903 179.139 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -146.8 -47.22 0.18 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.944 2.098 . . . . 0.0 108.802 168.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 35.8 p -84.01 -15.86 46.07 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.14 0.976 . . . . 0.0 112.606 177.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 79.62 18.9 72.23 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-O 118.823 -0.987 . . . . 0.0 112.61 -174.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -74.16 -40.52 62.53 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.628 1.714 . . . . 0.0 110.182 178.343 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -62.27 -25.78 68.03 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.457 1.103 . . . . 0.0 111.827 177.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -59.53 -42.61 92.7 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 118.729 0.695 . . . . 0.0 110.222 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -67.7 -34.39 76.79 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 121.828 -0.545 . . . . 0.0 110.459 -179.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.6 mm -64.5 -46.92 91.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 175.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.77 -41.91 92.12 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 122.982 0.513 . . . . 0.0 111.042 178.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -63.38 -42.74 98.84 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 119.03 -0.51 . . . . 0.0 110.891 176.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 72.6 mtm -68.65 -27.78 66.3 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 119.175 0.898 . . . . 0.0 111.695 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 54.2 mt -69.8 -51.23 42.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 170.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -60.54 -41.41 94.4 Favored 'General case' 0 C--O 1.225 -0.22 0 O-C-N 121.688 -0.633 . . . . 0.0 111.404 -175.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.37 -38.27 86.37 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 118.86 0.755 . . . . 0.0 110.699 -177.098 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -74.52 -37.3 63.12 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 122.879 0.472 . . . . 0.0 111.091 178.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.7 mp -74.29 -34.62 63.58 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.311 0.505 . . . . 0.0 111.198 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.59 145.08 16.61 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 125.157 1.36 . . . . 0.0 110.511 -173.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -65.59 -30.16 70.86 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.679 0.792 . . . . 0.0 112.155 -172.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -68.05 -29.47 68.45 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 122.1 -0.375 . . . . 0.0 110.887 177.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 38.9 t -91.69 -36.72 8.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 C-N-CA 124.413 1.085 . . . . 0.0 110.096 -175.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -136.55 145.78 45.41 Favored 'General case' 0 C--N 1.34 0.183 0 CA-C-N 119.366 0.985 . . . . 0.0 113.283 -172.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -131.49 141.58 49.79 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.61 1.164 . . . . 0.0 109.889 174.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 83.3 t -89.24 139.44 17.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 124.002 0.921 . . . . 0.0 109.107 -178.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -149.45 173.35 13.66 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.449 1.1 . . . . 0.0 111.425 -168.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -147.96 121.43 9.09 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 125.926 1.691 . . . . 0.0 108.081 -172.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.2 tp -60.14 -22.24 24.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 123.819 0.848 . . . . 0.0 112.267 -171.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.84 -27.91 67.04 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 118.848 0.749 . . . . 0.0 111.251 178.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt -87.69 -21.25 25.33 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.244 1.018 . . . . 0.0 111.481 178.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 70.8 m -74.91 168.79 19.24 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.6 1.16 . . . . 0.0 112.359 -169.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 68.9 m -156.58 178.33 10.45 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.32 2.248 . . . . 0.0 106.995 177.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 27.4 tptp -50.42 -46.79 56.61 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.814 0.845 . . . . 0.0 111.997 -175.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -80.19 -11.6 59.72 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -173.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -76.76 -43.03 38.67 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 121.531 -0.731 . . . . 0.0 111.464 -172.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.7 mp -75.72 -28.74 58.68 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 118.033 0.379 . . . . 0.0 111.121 178.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -63.48 -18.1 63.43 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.91 0.884 . . . . 0.0 111.422 -177.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.21 -29.59 65.33 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.316 1.046 . . . . 0.0 112.728 177.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -89.18 156.84 18.54 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.346 1.058 . . . . 0.0 110.472 -175.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -107.64 -27.12 10.52 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.621 171.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.0 mp -116.76 130.37 71.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 175.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -113.88 116.55 29.48 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 177.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -103.16 112.45 25.32 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 104.623 -2.362 . . . . 0.0 104.623 171.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.4 mt -117.18 107.68 14.76 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -170.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -90.78 105.11 3.23 Favored Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 178.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.9 tp -115.87 102.59 53.99 Favored Pre-proline 0 CA--C 1.536 0.405 0 C-N-CA 125.024 1.33 . . . . 0.0 108.86 -174.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -72.85 143.14 36.42 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 121.289 1.326 . . . . 0.0 108.675 169.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 50.0 m -90.95 137.37 32.42 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 173.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 45.2 m95 -132.98 175.87 8.99 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 125.948 1.699 . . . . 0.0 108.896 -177.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 42.54 48.18 4.57 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.844 2.058 . . . . 0.0 114.092 168.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.3 p90 48.3 66.7 0.99 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.221 1.408 . . . . 0.0 111.963 176.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 87.89 52.54 2.92 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 124.303 0.954 . . . . 0.0 111.701 175.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -143.55 164.27 30.85 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.032 1.333 . . . . 0.0 108.777 174.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -82.84 161.38 21.95 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 167.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -62.42 149.21 43.17 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 168.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 65.9 m -56.74 -36.13 69.41 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.007 0.923 . . . . 0.0 113.144 -168.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -68.85 -38.05 79.52 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 118.894 0.77 . . . . 0.0 110.756 -177.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -69.82 -46.5 65.51 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 175.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -58.52 -39.93 81.5 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 122.717 0.407 . . . . 0.0 111.65 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -68.77 -23.44 64.31 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 123.924 0.889 . . . . 0.0 112.169 177.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -95.35 -20.12 19.39 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.452 0.701 . . . . 0.0 112.328 -178.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 21.5 m-30 -49.94 -40.47 54.76 Favored Pre-proline 0 CA--C 1.544 0.746 0 CA-C-O 116.656 -1.64 . . . . 0.0 114.47 176.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -63.78 -26.83 67.85 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 CA-C-N 123.032 2.119 . . . . 0.0 113.094 174.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.4 m -78.32 -35.11 48.15 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 119.576 1.08 . . . . 0.0 109.661 171.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 16.8 tp -63.36 -27.46 69.33 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 121.185 -0.947 . . . . 0.0 111.495 -176.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -87.67 -0.12 56.46 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.974 0.91 . . . . 0.0 112.964 174.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -96.33 -36.07 11.0 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 119.384 0.993 . . . . 0.0 108.469 169.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 68.0 mt -61.34 133.66 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -85.31 136.87 33.3 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 123.387 0.675 . . . . 0.0 109.545 176.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -129.14 18.32 6.01 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.97 0.908 . . . . 0.0 110.818 175.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -58.55 112.42 1.59 Allowed 'General case' 0 C--N 1.341 0.196 0 CA-C-N 120.373 1.442 . . . . 0.0 109.925 -176.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.37 1.57 57.67 Favored Glycine 0 CA--C 1.535 1.309 0 CA-C-O 118.599 -1.111 . . . . 0.0 114.207 -178.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -75.0 154.9 37.85 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 119.971 1.886 . . . . 0.0 107.689 170.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 27.2 mt -95.63 141.88 28.6 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.0 t -135.52 144.03 35.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 176.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -141.33 146.19 36.4 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 125.105 1.362 . . . . 0.0 107.343 172.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 68.8 mt -119.59 144.98 46.8 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 -170.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -143.54 165.89 26.32 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 123.608 0.763 . . . . 0.0 109.161 170.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -175.26 164.62 35.19 Favored Glycine 0 CA--C 1.521 0.418 0 CA-C-O 122.342 0.968 . . . . 0.0 112.623 179.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 38.1 m -115.89 159.25 21.8 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 125.725 1.61 . . . . 0.0 107.765 175.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -149.17 -164.18 11.44 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 175.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -148.81 153.05 37.57 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 117.639 0.719 . . . . 0.0 110.463 174.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -113.88 -1.86 13.76 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -168.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -70.79 -42.84 69.8 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 119.577 1.08 . . . . 0.0 110.669 -177.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -136.48 -32.77 0.83 Allowed 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -177.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -85.25 18.24 2.71 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -174.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.75 -14.29 62.83 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -174.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -89.93 0.13 57.25 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.074 0.95 . . . . 0.0 111.456 173.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -132.44 26.05 4.45 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 126.237 1.815 . . . . 0.0 109.303 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -64.92 121.09 13.82 Favored 'General case' 0 N--CA 1.452 -0.356 0 O-C-N 121.671 -0.643 . . . . 0.0 110.271 -168.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 74.5 m 48.42 34.29 4.63 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.363 1.865 . . . . 0.0 113.608 -177.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -54.42 -38.6 66.45 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.136 0.974 . . . . 0.0 113.132 -177.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.27 -12.53 61.65 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -170.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 52.2 mt -57.32 -40.64 78.34 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 118.67 0.668 . . . . 0.0 109.691 169.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -63.78 -31.62 81.4 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 123.591 0.615 . . . . 0.0 111.707 -179.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.6 m -65.77 -44.62 85.26 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 117.97 0.885 . . . . 0.0 109.905 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 4.3 mt -69.95 -40.9 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 119.029 0.832 . . . . 0.0 109.207 178.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 51.9 tpt85 -56.85 -33.24 66.6 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 118.469 0.577 . . . . 0.0 111.729 177.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -74.23 -33.76 63.46 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.242 0.617 . . . . 0.0 111.852 176.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 75.8 mt -79.34 -43.57 23.79 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 123.567 0.747 . . . . 0.0 110.629 -175.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 6.1 pt -76.8 -21.06 14.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 118.773 0.715 . . . . 0.0 112.923 -168.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -62.39 -56.66 28.43 Favored Pre-proline 0 CA--C 1.544 0.718 0 CA-C-O 117.604 -1.189 . . . . 0.0 112.273 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -66.71 -16.48 50.52 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 122.339 2.026 . . . . 0.0 112.915 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 19.4 mmm180 -84.6 4.04 34.08 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.409 0.684 . . . . 0.0 112.018 172.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 79.46 16.45 77.94 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 124.583 1.087 . . . . 0.0 113.953 170.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.32 146.68 47.22 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 118.551 1.175 . . . . 0.0 111.423 177.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 67.8 m -96.92 126.84 42.35 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 104.583 -2.377 . . . . 0.0 104.583 167.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 19.9 mt -113.18 131.6 64.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 -168.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 31.0 m -136.49 -177.87 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 124.725 1.21 . . . . 0.0 109.501 177.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 81.75 39.5 11.92 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-O 119.48 -0.622 . . . . 0.0 113.577 172.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 25.5 m170 -64.52 158.11 24.99 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.438 1.119 . . . . 0.0 109.718 169.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 43.8 t-105 -135.81 135.07 21.13 Favored Pre-proline 0 CA--C 1.536 0.433 0 CA-C-O 117.955 -1.021 . . . . 0.0 108.923 173.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_exo -65.68 145.93 82.75 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 121.781 1.654 . . . . 0.0 113.366 -175.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 36.2 p . . . . . 0 CA--C 1.534 0.361 0 O-C-N 121.684 -0.635 . . . . 0.0 109.819 169.821 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? . . . . . 0 N--CA 1.47 0.531 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -77.35 -2.21 78.53 Favored Glycine 0 CA--C 1.537 1.435 0 CA-C-N 118.763 0.71 . . . . 0.0 113.529 173.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 8.5 mp -58.31 133.14 55.43 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 119.027 1.413 . . . . 0.0 110.558 174.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -95.64 -31.41 13.27 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.067 0.947 . . . . 0.0 108.595 167.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -144.32 162.86 35.34 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 127.14 2.176 . . . . 0.0 106.764 170.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -52.64 -30.14 29.99 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.368 0.667 . . . . 0.0 112.305 175.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -86.03 -17.81 34.2 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -178.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 30.0 p-80 -154.31 141.12 19.11 Favored 'General case' 0 C--N 1.347 0.469 0 CA-C-N 120.577 1.535 . . . . 0.0 114.684 -176.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -72.14 150.67 43.6 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.356 1.463 . . . . 0.0 108.555 167.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 8.8 p -69.41 -20.61 24.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 123.373 0.669 . . . . 0.0 111.515 175.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -148.22 171.05 28.73 Favored Glycine 0 C--N 1.337 0.589 0 C-N-CA 124.72 1.152 . . . . 0.0 110.264 -177.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -67.37 112.99 4.89 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 175.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.282 0 C-N-CA 124.875 1.27 . . . . 0.0 108.048 -174.498 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 79.4 mt . . . . . 0 CA--C 1.535 0.402 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 26.0 m -46.9 -57.35 5.04 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 126.688 1.995 . . . . 0.0 111.187 -170.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -75.43 -33.88 60.95 Favored 'General case' 0 N--CA 1.452 -0.373 0 O-C-N 122.233 -0.292 . . . . 0.0 110.557 -171.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 25.1 mp0 -64.71 -45.46 86.48 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.307 1.043 . . . . 0.0 109.444 178.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -66.03 -40.5 91.09 Favored 'General case' 0 N--CA 1.463 0.206 0 O-C-N 121.535 -0.728 . . . . 0.0 110.246 178.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 69.8 t -68.04 -33.47 61.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 118.916 0.78 . . . . 0.0 110.087 179.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -65.31 -51.92 57.46 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 120.416 1.462 . . . . 0.0 109.621 171.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -61.32 -27.89 68.81 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 118.74 -0.648 . . . . 0.0 111.501 -177.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 36.1 t90 -81.47 -51.99 7.71 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 119.174 0.897 . . . . 0.0 110.456 177.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 77.8 t -67.2 -31.09 51.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 O-C-N 121.376 -0.828 . . . . 0.0 110.584 -170.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -61.9 -35.0 77.08 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 121.2 -0.937 . . . . 0.0 110.856 174.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 63.0 mt-30 -69.91 -49.26 53.8 Favored 'General case' 0 C--N 1.341 0.219 0 C-N-CA 123.353 0.661 . . . . 0.0 110.664 173.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 2.7 pt -62.76 -33.19 58.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-N 119.266 0.939 . . . . 0.0 109.872 -175.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 48.2 m -61.31 -30.45 70.5 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 118.478 -0.772 . . . . 0.0 111.887 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -90.44 -26.0 20.06 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.877 1.217 . . . . 0.0 112.024 176.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -72.28 -38.46 68.78 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.057 0.844 . . . . 0.0 110.758 174.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 78.3 mt -83.49 -9.36 59.03 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.804 1.642 . . . . 0.0 111.544 179.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 55.33 32.53 18.9 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.621 1.568 . . . . 0.0 112.544 -170.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 80.3 mt . . . . . 0 N--CA 1.465 0.278 0 O-C-N 121.571 -0.706 . . . . 0.0 110.37 170.019 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.315 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 17.6 pt -88.11 -22.34 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 122.397 0.279 . . . . 0.0 111.309 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.9 m -112.43 127.19 55.96 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.725 1.21 . . . . 0.0 109.294 -174.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -100.46 115.13 5.22 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 106.88 -2.488 . . . . 0.0 106.88 167.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 84.8 mt -88.66 116.12 29.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 104.068 -2.567 . . . . 0.0 104.068 169.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -112.13 127.6 55.97 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 173.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -132.88 136.86 46.45 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 119.478 1.036 . . . . 0.0 112.234 -178.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -85.43 158.59 32.73 Favored Glycine 0 CA--C 1.533 1.197 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 167.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 17.0 m -159.53 167.63 28.12 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 119.406 1.603 . . . . 0.0 110.526 176.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -144.81 -55.89 0.33 Allowed 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.419 0.688 . . . . 0.0 110.711 169.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 39.0 p -81.73 -6.38 58.98 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.731 0.812 . . . . 0.0 112.287 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 78.5 27.68 56.86 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-O 119.501 -0.611 . . . . 0.0 111.734 -172.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -87.64 -49.73 6.96 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-N 118.193 0.996 . . . . 0.0 110.115 173.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 26.9 m -70.09 -24.0 63.15 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 118.494 0.588 . . . . 0.0 111.517 -170.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -59.31 -34.46 72.35 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 121.388 -0.82 . . . . 0.0 111.26 174.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -70.96 -31.46 68.03 Favored 'General case' 0 C--O 1.226 -0.164 0 O-C-N 121.34 -0.85 . . . . 0.0 110.053 -179.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 23.1 mm -66.59 -47.73 82.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 176.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.71 -43.13 90.01 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 122.731 0.412 . . . . 0.0 111.389 176.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -69.42 -40.0 77.53 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-O 118.787 -0.625 . . . . 0.0 111.346 -178.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 68.1 mtm -61.81 -46.29 90.13 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 119.266 0.939 . . . . 0.0 109.755 174.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 75.2 mt -58.28 -47.16 88.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 177.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -59.5 -40.31 86.62 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 119.551 1.069 . . . . 0.0 111.456 178.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 59.0 tptt -64.23 -39.36 93.8 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 119.376 0.989 . . . . 0.0 110.222 178.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -69.43 -41.12 76.77 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.729 0.811 . . . . 0.0 110.959 179.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -73.89 -38.47 64.36 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.641 1.176 . . . . 0.0 110.56 -178.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.32 145.55 17.51 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 125.598 1.571 . . . . 0.0 110.759 -171.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.6 tptp -62.54 -30.2 71.13 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.449 1.1 . . . . 0.0 111.692 -175.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -68.92 -25.1 64.41 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.293 0.637 . . . . 0.0 111.412 178.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.2 t -99.82 -36.84 5.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 C-N-CA 124.106 0.962 . . . . 0.0 110.339 -175.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -133.5 139.57 46.73 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 119.32 0.964 . . . . 0.0 113.517 -175.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -122.22 150.25 42.54 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.484 1.114 . . . . 0.0 109.486 172.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 53.1 t -111.79 139.09 37.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 123.804 0.842 . . . . 0.0 110.93 -168.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -147.33 166.45 27.07 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.72 2.008 . . . . 0.0 111.101 -171.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -124.73 134.97 52.64 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 105.73 -1.952 . . . . 0.0 105.73 169.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.8 tp -60.14 -18.91 16.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 119.271 0.941 . . . . 0.0 112.556 -173.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -51.49 -37.71 50.42 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.442 1.097 . . . . 0.0 112.223 177.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.8 -1.42 56.8 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.346 0.658 . . . . 0.0 112.52 -178.295 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 64.4 m -79.81 156.39 27.42 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 122.287 1.042 . . . . 0.0 111.474 -177.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 33.6 p -127.41 176.64 7.3 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 127.371 2.268 . . . . 0.0 106.656 169.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -56.08 -36.33 67.99 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.776 -0.578 . . . . 0.0 111.837 -177.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -86.44 -11.72 51.08 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.014 0.526 . . . . 0.0 112.325 -176.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -69.52 -33.39 72.75 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 121.346 -0.846 . . . . 0.0 112.153 -169.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.7 mp -80.95 -31.86 34.73 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 122.936 0.494 . . . . 0.0 110.437 176.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -67.93 -18.46 64.77 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 123.279 0.632 . . . . 0.0 111.884 -172.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.12 -28.31 69.55 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.761 1.224 . . . . 0.0 112.157 175.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -96.79 157.65 15.8 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.436 1.094 . . . . 0.0 110.598 -179.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -104.82 -30.48 9.85 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.219 171.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.1 mm -106.7 138.63 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 174.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 86.0 mt -132.05 129.69 40.35 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 177.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.6 mp -114.22 113.84 25.19 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 172.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 61.2 mt -110.59 109.67 20.07 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 -170.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.68 118.61 5.63 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 125.726 1.632 . . . . 0.0 109.575 178.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.7 tp -135.03 108.91 10.59 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 117.994 0.897 . . . . 0.0 109.358 -170.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -76.19 146.03 28.12 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 121.762 1.641 . . . . 0.0 110.355 170.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 42.9 m -99.19 131.7 45.03 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 175.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 8.4 m95 -137.19 174.83 10.19 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 123.916 0.886 . . . . 0.0 111.63 -170.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 60.85 -76.69 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 128.557 2.743 . . . . 0.0 113.957 171.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -149.23 39.24 0.82 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.82 1.648 . . . . 0.0 109.841 -170.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.74 56.28 6.73 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 -170.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -131.18 164.54 25.29 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.264 1.426 . . . . 0.0 108.984 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.87 161.83 28.65 Favored 'General case' 0 C--O 1.236 0.354 0 O-C-N 121.848 -0.533 . . . . 0.0 110.09 169.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -71.1 154.85 41.42 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 170.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 58.6 m -59.16 -36.92 76.12 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.858 0.863 . . . . 0.0 112.885 -169.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -65.73 -43.14 89.9 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 118.505 0.593 . . . . 0.0 110.056 -178.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -69.39 -47.42 64.27 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.381 0.672 . . . . 0.0 109.81 177.427 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -60.09 -35.87 76.16 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.425 0.69 . . . . 0.0 111.818 -177.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -70.45 -25.83 63.37 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.861 0.864 . . . . 0.0 112.248 176.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -92.76 -21.4 19.96 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.312 0.645 . . . . 0.0 112.076 -179.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 17.0 m-30 -48.66 -42.99 61.28 Favored Pre-proline 0 CA--C 1.547 0.865 0 CA-C-O 116.86 -1.543 . . . . 0.0 114.52 177.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -64.52 -23.38 64.46 Favored 'Trans proline' 0 CA--C 1.544 1.019 0 CA-C-N 122.972 2.097 . . . . 0.0 113.462 175.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.1 m -79.63 -40.28 29.6 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 119.302 0.955 . . . . 0.0 109.001 170.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 16.7 tp -60.85 -32.16 71.57 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.726 1.21 . . . . 0.0 111.798 -172.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -78.53 -11.14 59.94 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.999 0.92 . . . . 0.0 112.361 177.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -87.18 -32.92 19.56 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 119.818 1.19 . . . . 0.0 110.035 170.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 86.7 mt -63.93 143.13 15.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 -178.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -98.18 133.8 42.12 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.121 0.968 . . . . 0.0 108.865 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -124.2 14.6 9.05 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 118.306 -0.854 . . . . 0.0 111.032 178.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -56.71 115.46 2.57 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-N 119.963 1.256 . . . . 0.0 109.345 -178.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.76 2.91 62.03 Favored Glycine 0 CA--C 1.535 1.291 0 CA-C-O 118.368 -1.24 . . . . 0.0 114.174 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -79.18 147.25 32.71 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 119.675 1.737 . . . . 0.0 107.287 170.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 8.4 mt -95.09 134.27 37.99 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 178.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 15.2 t -130.86 145.28 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 178.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -136.2 151.13 49.38 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 170.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 81.5 mt -120.63 148.1 44.35 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -171.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -145.81 166.26 26.44 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 169.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 178.33 172.16 42.43 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-O 122.692 1.162 . . . . 0.0 114.566 177.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 68.7 m -123.02 151.19 42.15 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 112.936 -1.632 . . . . 0.0 109.526 -169.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -169.49 176.92 43.31 Favored Glycine 0 N--CA 1.442 -0.957 0 N-CA-C 109.634 -1.387 . . . . 0.0 109.634 -172.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -127.03 110.23 12.74 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 177.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -78.93 -6.69 56.85 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 118.692 -0.671 . . . . 0.0 112.381 -169.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -111.72 -41.71 3.99 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.49 1.041 . . . . 0.0 110.639 -176.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -82.63 -29.0 30.4 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 121.76 -0.587 . . . . 0.0 111.999 -175.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -122.65 50.64 1.48 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.298 1.439 . . . . 0.0 108.974 172.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.57 -19.76 50.92 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 126.175 1.79 . . . . 0.0 115.401 -170.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -108.44 4.08 23.92 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.207 1.003 . . . . 0.0 112.929 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -127.98 19.96 6.49 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.046 1.338 . . . . 0.0 110.689 -178.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -65.96 128.52 36.36 Favored 'General case' 0 C--O 1.234 0.285 0 O-C-N 121.458 -0.777 . . . . 0.0 110.93 -168.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 95.5 m 52.25 31.39 9.19 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.918 1.687 . . . . 0.0 113.937 176.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -56.02 -41.3 74.72 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.02 -21.12 64.14 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 -168.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 7.7 mp -60.29 -40.04 89.07 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 119.113 0.87 . . . . 0.0 109.798 172.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.12 -33.81 88.25 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 177.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 5.8 m -64.11 -38.45 91.1 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.26 1.03 . . . . 0.0 110.177 177.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 4.0 mt -66.66 -44.58 89.62 Favored 'Isoleucine or valine' 0 C--N 1.344 0.366 0 CA-C-O 117.632 -1.175 . . . . 0.0 109.075 175.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 60.3 ttp85 -55.75 -45.62 78.0 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 120.174 1.352 . . . . 0.0 110.136 178.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -60.44 -25.2 65.81 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -178.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 78.6 mt -87.27 -45.44 16.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 123.989 0.916 . . . . 0.0 110.667 176.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.6 pt -86.43 -22.86 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 120.114 1.325 . . . . 0.0 112.779 -169.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -67.34 -46.12 49.45 Favored Pre-proline 0 CA--C 1.545 0.751 0 CA-C-O 117.436 -1.268 . . . . 0.0 111.661 -177.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -60.68 -28.1 85.95 Favored 'Trans proline' 0 C--N 1.356 0.934 0 C-N-CA 122.061 1.841 . . . . 0.0 112.969 172.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 15.4 mmm180 -86.37 10.57 14.58 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.877 1.271 . . . . 0.0 111.764 -177.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 77.81 15.67 80.95 Favored Glycine 0 CA--C 1.529 0.91 0 CA-C-O 118.494 -1.17 . . . . 0.0 114.721 169.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.31 141.01 56.79 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 119.072 1.436 . . . . 0.0 109.834 173.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 55.5 m -92.73 121.96 34.66 Favored 'General case' 0 C--O 1.232 0.133 0 N-CA-C 105.337 -2.098 . . . . 0.0 105.337 168.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 43.6 mt -105.12 123.39 59.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 -171.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 26.8 m -126.15 174.77 9.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 125.149 1.379 . . . . 0.0 109.011 178.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 78.24 33.28 40.51 Favored Glycine 0 CA--C 1.527 0.796 0 O-C-N 121.844 -0.535 . . . . 0.0 112.333 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -63.86 143.88 57.5 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 169.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 72.8 t-105 -135.74 133.88 20.36 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 118.199 -0.905 . . . . 0.0 108.936 -167.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -68.32 141.77 52.71 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 121.496 1.464 . . . . 0.0 112.442 -170.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 12.6 p . . . . . 0 CA--C 1.536 0.442 0 C-N-CA 122.732 0.413 . . . . 0.0 110.041 169.202 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? . . . . . 0 N--CA 1.47 0.572 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -78.1 1.21 70.45 Favored Glycine 0 CA--C 1.532 1.143 0 CA-C-N 118.871 0.759 . . . . 0.0 113.078 171.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 7.9 mp -62.88 132.69 52.98 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 118.872 1.336 . . . . 0.0 110.869 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -96.01 -29.64 14.03 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.384 1.474 . . . . 0.0 108.584 166.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -145.28 161.77 38.8 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 127.511 2.325 . . . . 0.0 106.558 170.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -53.5 -33.28 53.84 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 119.438 1.017 . . . . 0.0 112.355 176.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -89.08 -7.52 55.67 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.831 0.853 . . . . 0.0 113.245 -178.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 64.6 m80 -146.8 125.19 12.32 Favored 'General case' 0 C--N 1.347 0.491 0 CA-C-N 119.759 1.163 . . . . 0.0 113.95 -170.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -69.79 151.84 45.3 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 164.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 9.0 p -69.74 -12.61 16.26 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 123.881 0.873 . . . . 0.0 111.946 175.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -164.48 171.02 39.86 Favored Glycine 0 CA--C 1.523 0.562 0 O-C-N 121.29 -0.881 . . . . 0.0 111.187 -172.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -67.22 114.74 6.19 Favored 'General case' 0 C--N 1.334 -0.09 0 C-N-CA 123.755 0.822 . . . . 0.0 108.975 -178.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.206 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 170.638 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 82.2 mt . . . . . 0 N--CA 1.463 0.196 0 N-CA-C 111.438 0.162 . . . . 0.0 111.438 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 52.9 m -41.76 -44.98 3.42 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.563 1.945 . . . . 0.0 113.299 -175.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -70.44 -31.5 68.7 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 119.155 0.888 . . . . 0.0 111.914 -173.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -71.98 -40.26 68.7 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 169.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 72.0 mtp85 -66.67 -38.26 86.46 Favored 'General case' 0 C--O 1.225 -0.186 0 CA-C-O 118.551 -0.737 . . . . 0.0 110.974 -174.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 26.8 m -69.3 -31.29 49.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-N 119.928 1.24 . . . . 0.0 111.179 177.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -65.49 -52.63 51.47 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 120.255 1.389 . . . . 0.0 109.501 171.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 39.3 mttp -61.15 -31.08 70.8 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 118.892 -0.575 . . . . 0.0 111.448 -177.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 61.5 t90 -78.92 -51.97 8.93 Favored 'General case' 0 N--CA 1.457 -0.094 0 CA-C-N 118.845 0.748 . . . . 0.0 111.19 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 56.8 t -63.72 -31.29 52.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 O-C-N 121.563 -0.711 . . . . 0.0 110.26 -175.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -59.48 -35.44 74.11 Favored 'General case' 0 CA--C 1.532 0.26 0 O-C-N 121.283 -0.886 . . . . 0.0 111.368 174.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -63.95 -53.57 48.16 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 118.711 0.687 . . . . 0.0 109.956 172.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 2.2 pt -69.0 -26.86 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 O-C-N 121.89 -0.507 . . . . 0.0 110.373 -170.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 46.1 m -58.97 -32.5 69.7 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 119.118 -0.468 . . . . 0.0 111.199 174.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -77.98 -43.75 28.7 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.553 1.07 . . . . 0.0 110.043 175.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -67.7 -34.06 76.13 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.587 0.755 . . . . 0.0 111.629 -174.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 83.7 mt -87.16 3.88 44.58 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.576 1.551 . . . . 0.0 111.108 177.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 25.9 m80 56.18 31.61 18.66 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.182 1.793 . . . . 0.0 113.001 -177.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 92.1 mt . . . . . 0 N--CA 1.464 0.255 0 C-N-CA 123.623 0.769 . . . . 0.0 110.304 173.714 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.248 0 CA-C-O 120.836 0.351 . . . . 0.0 111.385 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.9 pt -105.9 -14.98 8.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 125.248 1.419 . . . . 0.0 111.13 178.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 88.2 m -119.43 127.91 53.54 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.989 1.316 . . . . 0.0 108.826 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -91.28 129.34 9.75 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 107.856 -2.098 . . . . 0.0 107.856 169.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 33.0 mt -103.83 95.75 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 103.368 -2.827 . . . . 0.0 103.368 171.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 19.6 m-30 -100.16 129.65 46.21 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 -177.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 26.1 p90 -132.93 163.99 27.94 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 118.424 0.556 . . . . 0.0 110.99 -172.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -140.03 139.2 9.67 Favored Glycine 0 C--N 1.336 0.554 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 168.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.8 m -141.29 167.52 21.98 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.932 1.366 . . . . 0.0 110.696 -174.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -136.83 -50.8 0.66 Allowed 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.509 0.724 . . . . 0.0 110.157 168.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.3 p -82.48 -11.63 58.36 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.607 0.763 . . . . 0.0 112.084 171.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.92 6.59 51.93 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 124.961 1.267 . . . . 0.0 113.747 170.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -70.69 -44.05 67.77 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 118.757 1.279 . . . . 0.0 111.731 -173.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.01 -27.33 67.33 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 120.97 -1.081 . . . . 0.0 111.146 -175.175 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -62.57 -42.11 99.34 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 118.719 0.691 . . . . 0.0 109.85 172.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -63.5 -42.25 98.51 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 121.8 -0.562 . . . . 0.0 110.377 178.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 21.0 mm -62.06 -46.34 96.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 176.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.6 -41.38 94.65 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 121.929 -0.482 . . . . 0.0 111.426 -179.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.2 mtpt -65.66 -40.91 92.93 Favored 'General case' 0 C--O 1.227 -0.098 0 CA-C-O 118.49 -0.767 . . . . 0.0 110.676 177.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 61.8 mtm -62.38 -40.98 98.23 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 119.73 1.15 . . . . 0.0 110.759 176.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 70.2 mt -59.96 -47.04 93.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 176.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -63.53 -37.84 88.87 Favored 'General case' 0 CA--C 1.53 0.181 0 O-C-N 121.017 -1.052 . . . . 0.0 111.685 178.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -65.05 -34.04 77.48 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 120.115 1.325 . . . . 0.0 111.088 178.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 12.9 mm100 -70.1 -43.66 70.6 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 118.184 0.447 . . . . 0.0 110.744 175.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -82.93 -32.5 27.18 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.461 0.704 . . . . 0.0 112.434 -170.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 90.45 144.42 11.97 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 124.852 1.215 . . . . 0.0 111.117 -169.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 56.5 tptt -57.36 -35.77 70.36 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 125.281 1.432 . . . . 0.0 111.864 -175.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -82.95 -1.94 53.74 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.009 0.523 . . . . 0.0 112.351 -176.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.5 t -110.01 -46.93 6.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 123.769 0.828 . . . . 0.0 109.186 176.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -131.65 139.55 49.13 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 119.242 0.928 . . . . 0.0 110.458 -177.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -130.5 141.77 50.49 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 99.2 t -100.77 129.99 50.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 C-N-CA 124.813 1.245 . . . . 0.0 110.718 -167.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -143.97 145.37 32.19 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.945 0.898 . . . . 0.0 110.136 175.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -74.98 134.29 41.52 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 169.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.4 tp -56.53 -31.3 33.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 123.387 0.675 . . . . 0.0 112.057 -174.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.29 -32.53 70.11 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -170.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -92.07 -10.38 39.27 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -178.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 36.9 m -70.2 126.09 28.66 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 119.214 0.915 . . . . 0.0 108.73 177.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 14.5 m -73.43 168.2 19.72 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.597 0.759 . . . . 0.0 109.742 173.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -53.39 -41.11 65.59 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.585 0.754 . . . . 0.0 110.865 174.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -77.44 -15.92 59.07 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.099 0.56 . . . . 0.0 112.178 -178.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -75.27 -28.3 59.74 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 121.141 -0.974 . . . . 0.0 111.109 -176.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -68.66 -43.71 75.64 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.596 0.758 . . . . 0.0 109.024 169.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -65.65 -25.79 67.51 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.161 0.584 . . . . 0.0 112.137 -179.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.3 -30.32 70.14 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.681 0.793 . . . . 0.0 112.709 -174.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -92.57 154.85 18.16 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.35 1.06 . . . . 0.0 110.112 178.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -104.01 -21.87 13.54 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.353 0.661 . . . . 0.0 111.775 169.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.8 mp -121.65 132.74 70.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 176.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 80.0 mt -133.25 135.81 45.18 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 123.42 0.688 . . . . 0.0 109.991 178.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 7.3 mp -114.42 118.62 34.35 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 104.469 -2.419 . . . . 0.0 104.469 170.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 73.9 mt -112.48 117.72 33.17 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 123.32 0.648 . . . . 0.0 109.733 -169.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -101.4 98.82 1.84 Allowed Glycine 0 C--N 1.335 0.494 0 C-N-CA 125.713 1.625 . . . . 0.0 111.273 -173.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 2.1 tp -120.86 109.61 35.7 Favored Pre-proline 0 CA--C 1.538 0.487 0 C-N-CA 125.466 1.506 . . . . 0.0 109.476 -169.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -81.48 155.38 18.7 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.854 2.37 . . . . 0.0 110.418 173.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.7 m -101.06 136.22 41.26 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 172.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 60.7 m95 -135.51 173.53 11.62 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 125.647 1.579 . . . . 0.0 109.864 -178.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 13.4 t80 38.98 56.03 2.03 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.095 2.158 . . . . 0.0 113.443 168.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 26.2 p90 46.3 66.05 1.05 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.086 1.355 . . . . 0.0 112.088 176.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.55 52.36 3.38 Favored Glycine 0 CA--C 1.525 0.67 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.818 172.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -136.23 154.26 50.97 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 124.513 1.125 . . . . 0.0 109.116 174.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -79.28 146.08 33.18 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 169.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -59.47 147.43 36.67 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 171.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 74.5 m -58.13 -29.73 65.76 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.212 1.005 . . . . 0.0 113.546 -168.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -68.47 -32.73 72.93 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 118.891 0.769 . . . . 0.0 111.213 -178.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 92.1 m95 -79.44 -45.52 19.28 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-N 118.121 0.418 . . . . 0.0 110.085 171.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -60.54 -38.26 83.87 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.021 0.373 . . . . 0.0 111.926 -175.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -68.09 -24.75 65.08 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.581 0.753 . . . . 0.0 112.11 176.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -88.85 -25.4 22.19 Favored 'General case' 0 C--N 1.341 0.225 0 CA-C-O 118.738 -0.649 . . . . 0.0 111.914 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -49.57 -43.15 71.29 Favored Pre-proline 0 CA--C 1.546 0.819 0 CA-C-O 116.704 -1.617 . . . . 0.0 114.729 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -66.61 -15.19 46.83 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 CA-C-N 122.784 2.03 . . . . 0.0 113.774 176.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.1 m -89.78 -40.67 12.33 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.85 0.86 . . . . 0.0 109.013 169.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 31.3 tp -56.62 -38.32 71.93 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 125.017 1.327 . . . . 0.0 111.567 -176.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -68.74 -10.19 55.07 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -96.22 -7.19 36.3 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 119.646 1.112 . . . . 0.0 112.001 177.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 95.8 mt -91.57 146.39 6.32 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 -169.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -91.58 130.47 37.39 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 178.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -125.35 10.59 8.0 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 123.778 0.831 . . . . 0.0 111.768 176.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -63.89 126.55 28.01 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 120.231 1.378 . . . . 0.0 110.133 -175.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 74.84 -3.05 46.62 Favored Glycine 0 CA--C 1.538 1.474 0 CA-C-O 118.102 -1.388 . . . . 0.0 114.152 -175.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 63.1 mttm -79.61 146.16 32.69 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 120.226 2.013 . . . . 0.0 108.045 175.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 20.0 mt -95.38 131.6 41.33 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 176.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.9 t -132.25 143.14 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 178.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -129.63 156.16 44.67 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.893 1.277 . . . . 0.0 107.832 170.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 14.3 mt -122.27 145.87 47.83 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 124.324 1.05 . . . . 0.0 108.335 -175.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -141.36 156.15 45.85 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 123.851 0.86 . . . . 0.0 109.08 170.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -179.94 -169.25 39.89 Favored Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 111.394 -0.682 . . . . 0.0 111.394 -178.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 21.9 p -135.59 171.88 13.81 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 126.379 1.872 . . . . 0.0 109.196 -169.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -169.69 178.23 42.78 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 112.423 -0.271 . . . . 0.0 112.423 170.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -127.77 138.98 52.93 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 125.712 1.605 . . . . 0.0 108.201 169.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -121.28 24.99 9.74 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.274 1.029 . . . . 0.0 111.012 -172.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -119.02 -48.63 2.44 Favored 'General case' 0 C--O 1.234 0.263 0 O-C-N 121.444 -0.785 . . . . 0.0 109.903 -177.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -107.68 -33.78 7.18 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.936 0.894 . . . . 0.0 110.617 176.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -98.13 25.48 6.09 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.994 0.918 . . . . 0.0 111.925 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.17 -21.15 66.45 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -173.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -84.33 -3.01 58.0 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.905 0.882 . . . . 0.0 112.001 174.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -135.69 17.96 3.31 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.876 1.671 . . . . 0.0 109.614 -173.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -65.07 118.76 9.64 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -168.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 56.3 m 53.35 27.56 6.4 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.394 1.478 . . . . 0.0 113.2 -177.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -54.03 -38.17 64.9 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.06 1.344 . . . . 0.0 112.281 -173.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.25 -13.29 61.48 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -171.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 82.0 mt -58.97 -43.51 91.39 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 119.022 0.828 . . . . 0.0 109.759 175.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -69.98 -29.36 70.81 Favored Glycine 0 CA--C 1.529 0.91 0 N-CA-C 111.923 -0.471 . . . . 0.0 111.923 -177.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 8.3 m -63.21 -37.15 86.1 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 117.873 0.837 . . . . 0.0 111.133 -174.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.4 mt -73.82 -45.36 50.02 Favored 'Isoleucine or valine' 0 C--N 1.344 0.339 0 CA-C-O 118.452 -0.785 . . . . 0.0 108.938 176.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 37.4 ttt180 -53.33 -42.4 66.71 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 119.081 0.855 . . . . 0.0 110.738 -178.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -61.27 -17.61 54.34 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.104 0.962 . . . . 0.0 112.847 -179.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 69.7 mt -99.2 -48.33 11.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 124.66 1.184 . . . . 0.0 109.627 175.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 40.8 pt -79.9 -34.25 15.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 119.459 1.027 . . . . 0.0 112.117 -168.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -70.6 -41.67 13.01 Favored Pre-proline 0 CA--C 1.543 0.687 0 CA-C-O 117.576 -1.202 . . . . 0.0 110.88 -175.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -63.47 -30.33 71.75 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.032 1.821 . . . . 0.0 113.322 171.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -76.67 7.61 4.44 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.101 0.96 . . . . 0.0 112.328 171.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 93.33 6.64 62.68 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 125.882 1.706 . . . . 0.0 114.976 168.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.62 137.37 57.56 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 119.652 1.726 . . . . 0.0 109.424 175.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 87.3 m -90.83 122.77 33.84 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 169.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 23.1 mm -100.15 126.85 53.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 -171.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 27.6 m -130.91 179.72 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 125.024 1.329 . . . . 0.0 108.612 175.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 74.44 32.61 57.58 Favored Glycine 0 C--N 1.338 0.659 0 O-C-N 121.528 -0.733 . . . . 0.0 112.082 179.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 83.8 m-70 -64.24 143.03 58.19 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 169.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 55.1 t-105 -130.19 140.67 39.34 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-O 117.866 -1.064 . . . . 0.0 108.963 -178.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -61.31 148.42 92.97 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 CA-C-N 121.063 1.415 . . . . 0.0 114.772 -170.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 41.4 p . . . . . 0 CA--C 1.537 0.469 0 C-N-CA 123.485 0.714 . . . . 0.0 110.629 167.958 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.471 0.595 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -82.2 5.77 70.69 Favored Glycine 0 CA--C 1.527 0.843 0 CA-C-O 118.633 -1.093 . . . . 0.0 113.153 177.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 8.5 mp -63.16 128.15 34.54 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 119.909 1.854 . . . . 0.0 110.238 178.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.26 -37.63 25.64 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.587 1.555 . . . . 0.0 107.746 167.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -153.94 165.75 35.12 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 129.481 3.112 . . . . 0.0 106.227 -177.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -51.03 -35.92 36.88 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.275 0.943 . . . . 0.0 112.41 175.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -96.18 -3.4 44.44 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -175.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -146.54 139.42 25.4 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 120.542 1.519 . . . . 0.0 112.455 -172.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -84.91 155.54 21.63 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.613 1.565 . . . . 0.0 108.706 167.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 24.4 m -70.03 -8.65 11.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 125.127 1.371 . . . . 0.0 112.735 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -158.23 173.62 35.4 Favored Glycine 0 C--N 1.337 0.622 0 C-N-CA 124.964 1.269 . . . . 0.0 110.564 -178.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -64.94 132.02 48.2 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 124.556 1.142 . . . . 0.0 109.007 176.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.309 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 169.286 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 83.1 mt . . . . . 0 N--CA 1.464 0.246 0 N-CA-C 110.682 -0.118 . . . . 0.0 110.682 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 5.0 m -48.7 -50.06 35.08 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.418 1.087 . . . . 0.0 110.892 -179.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.88 -41.81 86.62 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.641 0.655 . . . . 0.0 110.714 -171.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -61.89 -48.42 80.56 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 123.023 0.529 . . . . 0.0 109.855 177.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 75.8 mtt180 -62.54 -45.74 91.57 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 122.933 0.493 . . . . 0.0 110.114 -176.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 83.3 t -68.75 -43.72 82.71 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.118 0 CA-C-O 118.274 -0.869 . . . . 0.0 109.84 -178.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -62.38 -45.07 94.82 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 120.556 1.525 . . . . 0.0 110.124 -178.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -65.6 -39.7 91.85 Favored 'General case' 0 C--N 1.333 -0.137 0 O-C-N 121.924 -0.485 . . . . 0.0 110.239 -179.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 75.9 t90 -66.67 -45.96 77.22 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-N 118.452 0.569 . . . . 0.0 110.356 178.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 55.9 t -59.07 -41.53 83.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 45.5 mttm -62.46 -44.97 95.12 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 118.678 0.672 . . . . 0.0 109.881 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 19.8 mm100 -62.1 -52.83 62.31 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 122.852 0.461 . . . . 0.0 110.569 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 22.8 pt -68.24 -32.2 54.8 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 CA-C-O 118.811 -0.614 . . . . 0.0 110.825 -174.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 48.8 m -62.92 -30.67 71.73 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 119.188 0.904 . . . . 0.0 111.082 -178.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -77.67 -41.99 36.2 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 119.327 0.967 . . . . 0.0 110.578 175.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -68.18 -33.96 75.41 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.505 0.722 . . . . 0.0 111.708 -177.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 81.1 mt -90.62 -2.38 57.86 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.202 1.801 . . . . 0.0 111.327 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 25.2 m80 56.82 22.36 6.93 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.9 1.68 . . . . 0.0 113.478 -174.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 78.8 mt . . . . . 0 N--CA 1.464 0.226 0 C-N-CA 124.275 1.03 . . . . 0.0 110.536 175.96 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.347 0 N-CA-C 110.517 -0.179 . . . . 0.0 110.517 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 31.0 pt -87.27 -22.48 6.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 123.107 0.563 . . . . 0.0 111.375 -179.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 15.4 m -110.63 126.51 54.55 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 125.612 1.565 . . . . 0.0 108.531 178.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -102.77 123.79 7.96 Favored Glycine 0 CA--C 1.521 0.419 0 N-CA-C 107.056 -2.418 . . . . 0.0 107.056 169.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 62.3 mt -105.26 92.28 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 N-CA-C 105.338 -2.097 . . . . 0.0 105.338 178.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -88.64 135.26 33.59 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 -177.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -132.58 133.37 43.6 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 119.943 1.247 . . . . 0.0 112.596 176.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -87.97 148.14 20.74 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 108.283 -1.927 . . . . 0.0 108.283 167.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.9 m -168.35 160.46 11.36 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 119.069 1.435 . . . . 0.0 110.624 174.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -125.3 -53.36 1.61 Allowed 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.821 0.848 . . . . 0.0 109.493 167.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.8 p -85.92 6.01 30.41 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 124.944 1.298 . . . . 0.0 113.219 174.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 85.25 -7.18 76.84 Favored Glycine 0 CA--C 1.532 1.107 0 N-CA-C 117.302 1.681 . . . . 0.0 117.302 167.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.55 -36.08 77.58 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 120.51 2.155 . . . . 0.0 113.461 -170.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 11.4 m -73.02 -16.2 61.51 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 119.408 1.004 . . . . 0.0 110.791 -175.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -60.77 -42.5 97.58 Favored 'General case' 0 C--N 1.342 0.264 0 O-C-N 121.101 -0.999 . . . . 0.0 109.879 173.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -65.94 -39.04 90.14 Favored 'General case' 0 C--N 1.339 0.142 0 O-C-N 121.984 -0.448 . . . . 0.0 110.086 -178.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 41.0 mm -62.33 -47.69 91.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 176.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.34 -43.9 96.02 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 122.843 0.457 . . . . 0.0 111.345 179.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 54.9 mttm -63.85 -43.72 95.28 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 118.811 -0.614 . . . . 0.0 110.848 178.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 75.6 mtm -63.5 -37.06 85.86 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 119.328 0.967 . . . . 0.0 110.965 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 34.0 mt -65.22 -44.6 95.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 174.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -60.12 -40.13 88.64 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 119.291 0.951 . . . . 0.0 110.741 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -64.45 -34.17 77.58 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 119.007 0.821 . . . . 0.0 111.172 179.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -68.2 -51.13 49.03 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 118.689 0.677 . . . . 0.0 110.431 175.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 42.5 mt -71.16 -31.92 68.29 Favored 'General case' 0 C--N 1.341 0.227 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -174.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.63 147.21 20.86 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 125.31 1.433 . . . . 0.0 110.983 -174.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -65.05 -29.71 70.63 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.764 0.826 . . . . 0.0 112.172 -172.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -67.51 -29.37 68.77 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 122.63 0.372 . . . . 0.0 111.117 177.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 33.3 t -93.69 -36.9 7.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 C-N-CA 124.585 1.154 . . . . 0.0 110.256 -175.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -134.93 144.54 47.52 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 119.067 0.849 . . . . 0.0 112.838 -171.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -131.09 141.69 50.18 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.376 1.07 . . . . 0.0 110.058 172.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 87.9 t -88.88 141.32 14.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 123.728 0.811 . . . . 0.0 108.911 -178.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.545 ' CE1' ' HG ' ' A' ' 39' ' ' SER . 0.6 OUTLIER -145.28 169.57 17.99 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.442 1.097 . . . . 0.0 111.444 -169.026 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -144.95 121.17 10.85 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.275 1.43 . . . . 0.0 107.474 -177.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.4 tp -59.09 -21.76 20.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 123.474 0.71 . . . . 0.0 112.242 -171.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.82 -29.16 69.98 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.05 0.54 . . . . 0.0 111.725 176.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 57.8 pttt -108.49 -19.53 13.42 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.302 1.041 . . . . 0.0 112.408 178.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.545 ' HG ' ' CE1' ' A' ' 34' ' ' HIS . 1.4 m -63.88 165.32 8.84 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 119.262 0.937 . . . . 0.0 110.53 170.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 24.4 p -143.95 166.89 23.7 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.163 0.985 . . . . 0.0 110.095 -179.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -52.93 -49.19 66.49 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.369 1.067 . . . . 0.0 111.32 -172.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -80.02 -24.02 41.09 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 122.134 0.174 . . . . 0.0 111.02 -175.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -73.35 -32.77 64.73 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.068 0.547 . . . . 0.0 111.091 -179.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -59.23 -37.77 78.33 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.405 0.682 . . . . 0.0 110.966 171.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -72.17 -16.59 61.97 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 122.884 0.473 . . . . 0.0 112.257 -173.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.18 -29.01 65.77 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.473 0.709 . . . . 0.0 111.871 -178.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -79.8 157.29 27.09 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.253 1.021 . . . . 0.0 110.169 179.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -109.77 -28.8 8.62 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.107 169.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.2 mp -112.04 126.91 69.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 173.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -112.58 122.22 47.06 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 175.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.2 mp -109.71 118.27 36.09 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 171.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 60.0 mt -119.46 109.16 15.42 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -171.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.5 122.57 7.19 Favored Glycine 0 CA--C 1.521 0.407 0 C-N-CA 125.629 1.585 . . . . 0.0 110.162 -179.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 18.4 tt -136.71 109.19 9.29 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-N 118.121 0.961 . . . . 0.0 111.648 -176.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.1 140.54 31.33 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 N-CA-C 107.32 -1.839 . . . . 0.0 107.32 166.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 90.5 m -91.97 136.17 33.37 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 177.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 30.1 m95 -129.62 173.97 10.11 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.518 1.127 . . . . 0.0 111.405 -172.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 55.07 -89.88 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 127.909 2.484 . . . . 0.0 112.397 179.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -153.58 78.66 1.14 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 126.271 1.829 . . . . 0.0 106.754 175.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 65.75 51.84 43.43 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 -177.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -127.79 155.85 43.41 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.1 0.96 . . . . 0.0 109.631 176.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -79.23 166.35 22.27 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.751 0.82 . . . . 0.0 109.968 170.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 18.1 mm-40 -72.57 153.75 41.13 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 169.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 60.8 m -58.98 -37.01 75.84 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.598 0.759 . . . . 0.0 112.739 -169.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -72.14 -38.38 69.24 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 118.712 0.687 . . . . 0.0 110.579 -177.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -66.42 -46.78 75.38 Favored 'General case' 0 C--N 1.342 0.241 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 173.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -60.53 -38.75 85.44 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.331 0.652 . . . . 0.0 111.557 -178.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -70.01 -25.72 63.72 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.996 0.918 . . . . 0.0 112.189 176.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -90.71 -20.55 22.33 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.445 0.698 . . . . 0.0 112.293 -179.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 19.3 m-30 -51.02 -42.24 78.85 Favored Pre-proline 0 CA--C 1.546 0.822 0 CA-C-O 116.762 -1.589 . . . . 0.0 114.253 177.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -65.5 -21.21 60.4 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 CA-C-N 122.966 2.095 . . . . 0.0 113.402 174.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.8 m -81.95 -36.33 28.08 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 119.371 0.987 . . . . 0.0 109.604 170.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 21.7 tp -61.91 -30.8 71.13 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.059 -1.026 . . . . 0.0 111.37 -175.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -82.96 -2.36 54.91 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.163 0.985 . . . . 0.0 113.134 175.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 39.4 mm-40 -100.36 -26.03 14.02 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.331 1.052 . . . . 0.0 110.425 172.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 80.9 mt -70.69 152.76 8.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 174.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -106.99 134.83 49.56 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.533 1.133 . . . . 0.0 109.465 178.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -124.98 15.55 8.53 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.499 1.119 . . . . 0.0 111.53 177.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -56.07 115.04 2.2 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 119.646 1.112 . . . . 0.0 109.79 -178.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 74.44 3.08 65.13 Favored Glycine 0 CA--C 1.536 1.358 0 CA-C-O 118.531 -1.149 . . . . 0.0 114.294 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -80.02 148.67 31.02 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 119.385 1.593 . . . . 0.0 107.742 171.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 19.1 mt -91.44 134.33 34.72 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 178.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 19.0 t -130.96 132.78 63.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 178.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -128.32 143.32 51.0 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 176.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 77.8 mt -115.99 146.23 42.3 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -173.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -141.55 160.35 40.33 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 169.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -170.9 170.06 42.91 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-O 122.419 1.01 . . . . 0.0 113.059 -171.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 15.5 m -136.7 148.8 47.54 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 125.739 1.616 . . . . 0.0 107.367 -169.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.6 -167.29 28.05 Favored Glycine 0 CA--C 1.528 0.859 0 O-C-N 123.233 0.333 . . . . 0.0 112.604 -174.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -139.78 143.57 36.97 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.721 1.608 . . . . 0.0 109.896 -179.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -118.66 3.85 11.68 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.053 1.741 . . . . 0.0 112.268 -178.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -85.81 -47.59 9.58 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 119.699 1.136 . . . . 0.0 110.572 176.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -129.68 -37.97 1.53 Allowed 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.248 0.619 . . . . 0.0 111.825 -170.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -87.26 18.82 3.49 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.218 0.607 . . . . 0.0 112.133 174.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.67 -39.72 71.33 Favored 'General case' 0 C--N 1.342 0.247 0 C-N-CA 124.729 1.212 . . . . 0.0 112.365 -173.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -65.93 -13.96 60.68 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 118.577 0.626 . . . . 0.0 111.938 -177.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -120.83 21.57 11.39 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 126.546 1.939 . . . . 0.0 110.112 -177.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -60.34 119.32 7.73 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 118.832 0.742 . . . . 0.0 110.729 -169.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 72.2 m 47.63 32.03 2.34 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.021 1.729 . . . . 0.0 112.749 -177.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -54.87 -37.5 66.34 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.055 0.942 . . . . 0.0 112.087 -173.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.87 -14.07 62.81 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -171.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 84.9 mt -56.07 -42.98 77.52 Favored 'General case' 0 C--N 1.345 0.371 0 CA-C-N 118.961 0.801 . . . . 0.0 109.609 169.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.97 -33.15 86.47 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 -178.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.2 m -64.33 -41.37 96.82 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 118.18 0.99 . . . . 0.0 110.194 178.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 6.2 mt -68.22 -45.21 83.31 Favored 'Isoleucine or valine' 0 C--N 1.343 0.312 0 CA-C-N 119.198 0.908 . . . . 0.0 108.8 176.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 52.3 ttt-85 -52.95 -47.82 67.83 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 119.236 0.925 . . . . 0.0 110.157 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -64.98 -23.24 67.16 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 123.87 0.868 . . . . 0.0 112.381 -175.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 76.2 mt -86.2 -46.42 16.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 118.844 0.747 . . . . 0.0 109.381 175.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.0 pt -76.47 -26.27 16.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 119.363 0.983 . . . . 0.0 112.811 -169.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -64.06 -50.23 70.08 Favored Pre-proline 0 CA--C 1.547 0.832 0 CA-C-O 117.654 -1.165 . . . . 0.0 111.846 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -54.54 -29.75 61.58 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.858 2.372 . . . . 0.0 114.038 172.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 28.5 mmm180 -88.11 9.85 21.25 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.888 0.875 . . . . 0.0 111.799 -177.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 79.27 12.62 83.73 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-O 118.645 -1.086 . . . . 0.0 114.132 169.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.42 143.33 45.73 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 118.846 1.323 . . . . 0.0 110.287 173.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 48.7 m -93.15 121.11 34.17 Favored 'General case' 0 CA--C 1.528 0.108 0 N-CA-C 104.821 -2.288 . . . . 0.0 104.821 168.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 14.9 mt -102.23 126.06 56.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -168.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 6.1 m -140.98 174.28 7.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 125.928 1.691 . . . . 0.0 108.979 -170.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 74.56 37.11 47.2 Favored Glycine 0 CA--C 1.529 0.934 0 O-C-N 121.479 -0.763 . . . . 0.0 112.228 -175.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -66.56 138.88 57.8 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 173.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 70.9 t-105 -124.61 126.24 25.42 Favored Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 124.782 1.233 . . . . 0.0 108.423 -169.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -68.47 145.02 63.41 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 121.483 1.455 . . . . 0.0 112.358 -169.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 4.1 p . . . . . 0 CA--C 1.534 0.344 0 CA-C-O 119.234 -0.413 . . . . 0.0 110.674 169.988 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt . . . . . 0 N--CA 1.469 0.486 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -82.69 10.0 57.64 Favored Glycine 0 CA--C 1.534 1.268 0 CA-C-N 118.773 0.715 . . . . 0.0 112.743 169.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 82.0 mt -64.67 135.73 56.21 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 118.947 1.374 . . . . 0.0 111.162 -178.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -98.21 -31.57 12.01 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.927 1.291 . . . . 0.0 108.318 166.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -149.54 163.15 38.62 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 127.756 2.422 . . . . 0.0 106.797 172.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -55.71 -30.21 60.75 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.182 -0.949 . . . . 0.0 112.088 176.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -88.07 -10.49 50.02 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 10.9 m-70 -150.94 127.58 10.84 Favored 'General case' 0 C--N 1.347 0.476 0 CA-C-N 119.843 1.201 . . . . 0.0 113.684 -169.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -73.0 151.93 41.55 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 164.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 8.0 p -66.12 -19.05 25.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 O-C-N 121.98 -0.45 . . . . 0.0 112.016 176.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -154.77 163.17 31.17 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 123.791 0.71 . . . . 0.0 111.349 -171.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -56.71 127.82 33.4 Favored 'General case' 0 CA--C 1.522 -0.121 0 C-N-CA 124.22 1.008 . . . . 0.0 108.487 177.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.355 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 176.478 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 62.0 mt . . . . . 0 N--CA 1.471 0.607 0 N-CA-C 111.694 0.257 . . . . 0.0 111.694 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 87.7 m -53.83 -52.43 60.39 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 125.099 1.36 . . . . 0.0 111.012 -169.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -71.44 -32.3 68.2 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 122.178 0.191 . . . . 0.0 110.786 -171.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -67.16 -44.03 80.75 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 122.995 0.518 . . . . 0.0 109.64 173.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 38.5 mtt180 -66.2 -42.83 88.27 Favored 'General case' 0 C--O 1.232 0.184 0 O-C-N 121.606 -0.684 . . . . 0.0 110.964 -177.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 28.3 m -69.09 -35.52 68.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-O 118.148 -0.929 . . . . 0.0 109.809 178.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -60.07 -49.96 75.61 Favored 'General case' 0 C--N 1.342 0.279 0 CA-C-N 120.469 1.486 . . . . 0.0 110.233 174.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 59.6 mttm -57.83 -40.01 79.04 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 118.132 0.424 . . . . 0.0 110.554 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 61.8 t90 -72.09 -45.35 61.02 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 117.872 0.305 . . . . 0.0 110.745 -177.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 75.7 t -63.68 -34.81 70.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 O-C-N 121.489 -0.757 . . . . 0.0 109.716 -179.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -62.75 -34.61 77.56 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 118.455 -0.783 . . . . 0.0 110.714 177.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -62.67 -57.19 11.88 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.992 0.814 . . . . 0.0 110.053 171.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 6.9 pt -65.61 -30.27 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 118.828 0.74 . . . . 0.0 110.369 -171.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 49.4 m -58.74 -29.09 66.46 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 117.711 -1.138 . . . . 0.0 112.151 178.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -96.86 -13.32 22.6 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 120.456 1.48 . . . . 0.0 113.118 175.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -82.82 -39.67 21.39 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 118.972 0.806 . . . . 0.0 110.34 173.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 1.9 mp -90.24 -12.61 37.47 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.556 1.942 . . . . 0.0 110.719 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 57.19 30.52 18.5 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.731 1.612 . . . . 0.0 112.703 -169.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 55.2 mt . . . . . 0 N--CA 1.467 0.403 0 O-C-N 121.434 -0.791 . . . . 0.0 110.476 169.485 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.301 0 N-CA-C 110.597 -0.149 . . . . 0.0 110.597 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.0 pt -74.51 -29.93 24.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 O-C-N 122.144 -0.347 . . . . 0.0 110.987 178.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.3 m -110.25 136.01 50.12 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 124.637 1.175 . . . . 0.0 109.338 -179.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -108.21 118.96 5.55 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 107.299 -2.32 . . . . 0.0 107.299 168.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 39.8 mt -92.83 127.49 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 104.573 -2.38 . . . . 0.0 104.573 169.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -122.87 128.94 51.03 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 176.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -123.53 127.11 47.87 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 118.979 0.809 . . . . 0.0 112.376 -177.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -87.28 141.54 17.56 Favored Glycine 0 C--N 1.338 0.692 0 N-CA-C 108.35 -1.9 . . . . 0.0 108.35 167.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 37.8 m -153.15 166.44 32.49 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.716 1.758 . . . . 0.0 110.534 176.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -145.76 -51.65 0.25 Allowed 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.283 1.033 . . . . 0.0 109.794 169.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.9 p -80.77 -15.14 57.23 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.815 0.846 . . . . 0.0 112.058 172.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.22 32.09 6.9 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 124.491 1.043 . . . . 0.0 113.058 172.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -82.58 -52.73 6.55 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 118.423 1.112 . . . . 0.0 111.772 176.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -67.58 -23.62 65.42 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 121.588 -0.695 . . . . 0.0 112.441 -167.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -60.67 -35.65 76.77 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.283 0.947 . . . . 0.0 111.032 175.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -70.09 -42.79 72.26 Favored 'General case' 0 C--N 1.34 0.16 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 26.5 mm -61.77 -42.14 93.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 178.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.13 -41.88 93.62 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 121.517 -0.739 . . . . 0.0 111.017 178.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -67.72 -39.26 84.31 Favored 'General case' 0 CA--C 1.53 0.198 0 O-C-N 121.77 -0.581 . . . . 0.0 110.77 176.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 75.2 mtp -64.62 -30.01 71.03 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 119.283 0.947 . . . . 0.0 111.653 177.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 58.9 mt -70.4 -55.99 12.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 170.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -59.13 -32.97 70.33 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 121.323 -0.861 . . . . 0.0 112.386 -173.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -66.65 -34.85 78.78 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 120.039 1.29 . . . . 0.0 111.487 179.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -75.57 -39.65 57.81 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.015 0.526 . . . . 0.0 110.663 175.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -75.26 -39.79 59.44 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.807 0.843 . . . . 0.0 111.383 -174.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.53 141.57 5.87 Favored Glycine 0 CA--C 1.531 1.034 0 N-CA-C 108.818 -1.713 . . . . 0.0 108.818 -167.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 58.3 tttp -62.1 -31.08 71.48 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 121.643 -0.916 . . . . 0.0 111.722 -172.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -65.06 -29.53 70.43 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 123.071 0.548 . . . . 0.0 111.74 178.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.2 t -92.7 -38.24 9.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 123.755 0.822 . . . . 0.0 109.68 -178.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -139.04 125.71 20.72 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 119.411 1.005 . . . . 0.0 112.028 178.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -103.31 159.58 15.43 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.408 0.683 . . . . 0.0 110.191 173.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 51.1 t -121.7 129.35 75.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 124.234 1.013 . . . . 0.0 109.971 -169.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -144.9 172.43 13.04 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.887 1.675 . . . . 0.0 111.736 -173.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -125.88 136.81 53.49 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 175.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.5 tp -60.86 -25.99 37.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 O-C-N 121.435 -0.791 . . . . 0.0 111.633 -174.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -55.03 -36.36 65.44 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.578 1.151 . . . . 0.0 112.05 178.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -105.31 0.78 27.39 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.885 1.274 . . . . 0.0 111.912 -178.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 18.4 m -88.14 175.0 7.91 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.941 0.896 . . . . 0.0 109.654 177.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 70.7 m -153.85 162.4 41.26 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 120.888 -1.132 . . . . 0.0 109.483 179.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -51.0 -47.85 61.52 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.849 1.26 . . . . 0.0 111.178 -176.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -73.67 -24.39 59.97 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.459 -174.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -77.74 -35.58 51.67 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 122.818 0.447 . . . . 0.0 110.513 176.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -64.28 -50.46 67.82 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.498 0.719 . . . . 0.0 110.34 178.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -67.74 -19.27 65.11 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -172.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.51 -29.93 69.47 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.153 0.981 . . . . 0.0 112.667 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -75.25 159.57 31.38 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 123.827 0.851 . . . . 0.0 109.861 175.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -110.21 -22.23 11.86 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.309 0.644 . . . . 0.0 112.218 170.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.0 mp -120.71 132.56 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 175.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 97.4 mt -126.87 125.66 41.99 Favored 'General case' 0 CA--C 1.519 -0.232 0 C-N-CA 124.081 0.953 . . . . 0.0 108.865 -178.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 7.4 mp -114.11 107.92 16.29 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 176.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 66.7 mt -110.54 107.71 17.43 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 -170.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.43 117.94 5.44 Favored Glycine 0 C--N 1.331 0.285 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 17.5 tt -131.61 118.22 16.75 Favored Pre-proline 0 CA--C 1.539 0.523 0 CA-C-N 118.034 0.917 . . . . 0.0 110.408 -177.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -83.33 147.19 12.66 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.754 2.302 . . . . 0.0 108.427 168.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 54.5 m -99.29 143.52 29.45 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 177.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 68.2 m95 -136.13 171.15 14.9 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 125.731 1.612 . . . . 0.0 110.242 -174.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 25.83 72.17 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 128.062 2.545 . . . . 0.0 114.394 169.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 56.69 54.6 7.13 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.128 0.971 . . . . 0.0 111.81 174.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 82.8 13.3 78.19 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-O 119.388 -0.673 . . . . 0.0 114.326 171.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -74.39 154.08 38.97 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.511 1.156 . . . . 0.0 109.873 169.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.56 165.9 23.18 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 123.508 0.723 . . . . 0.0 110.571 170.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 14.9 tm0? -61.91 145.18 53.62 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 169.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 52.4 m -60.12 -37.2 79.32 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 114.959 1.466 . . . . 0.0 114.959 -167.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -76.09 -38.21 57.25 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 118.632 0.651 . . . . 0.0 109.281 -177.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -62.77 -47.26 84.29 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.185 0.594 . . . . 0.0 109.543 173.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -59.0 -40.36 84.66 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.598 0.759 . . . . 0.0 111.431 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -69.01 -31.76 70.81 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.245 0.618 . . . . 0.0 112.098 176.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -84.84 -21.84 29.68 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 117.889 -1.053 . . . . 0.0 112.647 -177.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 18.2 m-30 -48.37 -44.65 65.06 Favored Pre-proline 0 CA--C 1.544 0.735 0 CA-C-N 121.005 1.729 . . . . 0.0 115.114 -178.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.07 -16.36 54.85 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 CA-C-N 122.731 2.011 . . . . 0.0 113.897 176.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 31.5 m -91.46 -35.14 14.51 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.185 0.994 . . . . 0.0 109.643 169.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 17.0 tp -59.39 -39.17 82.52 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.222 1.009 . . . . 0.0 110.491 -178.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -73.66 -7.99 54.19 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -93.51 -1.55 55.46 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 119.619 1.1 . . . . 0.0 111.344 178.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 66.7 mt -92.37 146.03 6.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 -175.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -86.13 121.22 28.42 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 172.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -114.08 10.54 17.45 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 118.3 -0.857 . . . . 0.0 111.715 175.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 31.6 m-80 -59.32 117.36 4.71 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 120.269 1.395 . . . . 0.0 109.791 -172.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 72.84 -1.04 41.19 Favored Glycine 0 CA--C 1.534 1.28 0 CA-C-O 118.689 -1.062 . . . . 0.0 114.212 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -72.27 144.96 48.21 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 119.602 1.701 . . . . 0.0 108.024 172.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 35.7 mt -85.17 133.51 34.19 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 177.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.1 t -132.1 135.86 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 176.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -129.35 143.9 51.03 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 175.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 67.1 mt -118.94 148.19 43.22 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -175.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -145.65 153.69 41.3 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 123.205 0.602 . . . . 0.0 110.614 175.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -174.64 164.56 35.5 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-O 121.701 0.612 . . . . 0.0 112.683 179.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 24.9 p -121.27 167.67 12.47 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 125.418 1.487 . . . . 0.0 109.253 175.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -163.74 -160.18 11.45 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 114.271 0.468 . . . . 0.0 114.271 -177.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -143.42 153.67 42.9 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 126.622 1.969 . . . . 0.0 109.991 -175.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -138.28 7.66 2.64 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.865 0.866 . . . . 0.0 112.519 168.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -69.11 -33.28 73.24 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.58 1.082 . . . . 0.0 109.285 173.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -135.22 -36.7 0.8 Allowed 'General case' 0 C--O 1.234 0.285 0 C-N-CA 123.002 0.521 . . . . 0.0 112.17 171.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -89.78 29.98 1.1 Allowed 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 118.562 0.619 . . . . 0.0 112.604 -173.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.32 -31.8 71.66 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.189 0.996 . . . . 0.0 112.801 -174.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -79.92 1.16 28.35 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.266 1.026 . . . . 0.0 112.071 178.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -134.95 19.8 3.48 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.597 1.559 . . . . 0.0 109.896 -176.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -65.59 114.82 5.2 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -171.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 72.6 m 51.27 34.99 12.55 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.54 1.536 . . . . 0.0 113.203 -173.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -50.6 -44.54 57.06 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.672 1.189 . . . . 0.0 111.489 -179.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.84 -12.88 62.01 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 -169.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 90.0 mt -58.55 -39.68 80.93 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 118.893 0.77 . . . . 0.0 109.707 169.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.9 -32.08 83.04 Favored Glycine 0 CA--C 1.528 0.848 0 N-CA-C 111.412 -0.675 . . . . 0.0 111.412 178.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.6 m -65.85 -38.58 89.24 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.358 1.079 . . . . 0.0 110.334 178.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 7.0 mt -71.82 -42.49 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 119.105 0.866 . . . . 0.0 109.004 175.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 47.5 ttt180 -53.46 -45.43 69.55 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 119.408 1.003 . . . . 0.0 110.334 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -63.85 -20.07 65.53 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.026 0.93 . . . . 0.0 112.81 -177.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 96.4 mt -92.09 -48.77 13.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 123.974 0.91 . . . . 0.0 109.661 176.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.5 pt -78.07 -33.85 18.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-N 118.921 0.782 . . . . 0.0 111.979 -168.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -70.76 -43.91 15.43 Favored Pre-proline 0 CA--C 1.544 0.715 0 CA-C-O 117.962 -1.018 . . . . 0.0 111.269 -172.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -64.6 -31.42 59.92 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.032 1.821 . . . . 0.0 113.132 173.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? -75.81 6.51 4.92 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.019 0.928 . . . . 0.0 112.259 172.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 78.52 20.16 72.24 Favored Glycine 0 CA--C 1.527 0.828 0 CA-C-O 118.686 -1.064 . . . . 0.0 114.082 169.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -59.75 142.42 53.25 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 118.725 1.263 . . . . 0.0 109.857 170.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 37.6 m -89.1 116.45 27.37 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 104.461 -2.422 . . . . 0.0 104.461 168.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 38.9 mt -90.92 130.53 39.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 -176.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 3.7 m -137.44 165.86 26.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 126.103 1.761 . . . . 0.0 108.487 -177.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 74.49 31.44 58.87 Favored Glycine 0 CA--C 1.524 0.616 0 CA-C-O 119.141 -0.811 . . . . 0.0 112.293 -175.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 83.9 m-70 -58.48 134.08 56.36 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 169.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 70.8 t-105 -113.38 124.96 30.36 Favored Pre-proline 0 C--O 1.235 0.296 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -169.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -67.95 140.31 49.87 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 121.254 1.303 . . . . 0.0 110.632 -173.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 81.1 p . . . . . 0 CA--C 1.535 0.391 0 C-N-CA 123.186 0.594 . . . . 0.0 110.876 176.472 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.537 0.47 0 N-CA-C 110.882 -0.044 . . . . 0.0 110.882 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -78.46 0.19 76.54 Favored Glycine 0 CA--C 1.533 1.164 0 CA-C-O 118.404 -1.22 . . . . 0.0 113.798 169.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 65.0 mt -62.31 125.73 24.89 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 120.869 2.335 . . . . 0.0 108.618 171.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -91.82 -32.55 15.31 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.714 0.806 . . . . 0.0 109.541 170.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -149.78 163.02 39.1 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 127.227 2.211 . . . . 0.0 106.848 172.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -55.29 -29.55 58.41 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.392 -0.817 . . . . 0.0 112.243 175.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -90.49 -12.39 37.42 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.216 1.007 . . . . 0.0 113.486 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -147.58 128.23 14.22 Favored 'General case' 0 C--N 1.346 0.434 0 CA-C-N 119.991 1.269 . . . . 0.0 113.399 -170.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -78.45 152.32 32.19 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 166.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 10.7 p -58.15 -28.68 35.13 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 C-N-CA 124.824 1.249 . . . . 0.0 111.49 175.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -157.8 175.83 35.0 Favored Glycine 0 C--N 1.336 0.56 0 C-N-CA 125.048 1.309 . . . . 0.0 110.219 -174.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -56.96 126.6 27.87 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 124.101 0.96 . . . . 0.0 108.611 178.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.377 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 -179.674 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 23.5 mt . . . . . 0 N--CA 1.473 0.7 0 CA-C-O 120.709 0.29 . . . . 0.0 111.192 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 99.1 m -53.81 -50.66 65.65 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 125.697 1.599 . . . . 0.0 110.861 -169.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -71.64 -34.52 69.84 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 119.075 -0.488 . . . . 0.0 111.063 -171.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -67.53 -43.96 79.51 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 118.507 0.594 . . . . 0.0 109.687 175.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 52.1 mtt180 -64.61 -43.2 94.53 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 121.933 -0.48 . . . . 0.0 110.633 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 58.1 t -67.82 -40.18 83.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-O 118.247 -0.883 . . . . 0.0 109.8 178.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -60.69 -47.48 86.07 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 120.612 1.551 . . . . 0.0 109.909 176.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 59.3 mttm -57.98 -45.89 86.06 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 118.331 0.514 . . . . 0.0 110.184 178.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 55.1 t90 -65.62 -45.78 81.79 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 118.109 0.413 . . . . 0.0 110.513 -177.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 55.6 t -62.56 -38.64 81.98 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 C-N-CA 123.046 0.538 . . . . 0.0 110.202 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -69.8 -36.05 75.36 Favored 'General case' 0 CA--C 1.532 0.265 0 O-C-N 121.224 -0.923 . . . . 0.0 110.256 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 20.5 mm100 -64.61 -52.09 59.25 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.652 0.66 . . . . 0.0 110.634 174.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 12.3 pt -64.22 -32.69 58.46 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 CA-C-N 119.51 1.05 . . . . 0.0 110.787 -178.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 57.2 m -56.05 -36.07 67.63 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.287 0.949 . . . . 0.0 112.172 176.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -87.62 -27.17 22.67 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.9 1.227 . . . . 0.0 112.24 177.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -68.55 -32.02 71.65 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 119.357 0.981 . . . . 0.0 110.73 173.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 1.8 mp -82.69 -3.68 56.73 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.458 1.903 . . . . 0.0 110.89 174.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 54.8 35.12 23.41 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 126.126 1.771 . . . . 0.0 112.379 -177.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 70.1 mt . . . . . 0 N--CA 1.464 0.273 0 O-C-N 121.314 -0.866 . . . . 0.0 111.301 -177.776 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.29 0 CA-C-O 121.025 0.441 . . . . 0.0 111.372 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.5 pt -104.45 -24.84 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 126.051 1.741 . . . . 0.0 110.587 178.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 51.6 m -105.79 125.9 51.54 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.142 1.377 . . . . 0.0 108.547 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -100.36 116.02 5.46 Favored Glycine 0 C--N 1.331 0.295 0 N-CA-C 107.082 -2.407 . . . . 0.0 107.082 168.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 35.0 mt -92.57 122.27 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 104.304 -2.48 . . . . 0.0 104.304 172.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -118.21 128.11 54.39 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 106.633 -1.618 . . . . 0.0 106.633 176.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -123.81 132.66 53.82 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 118.574 0.625 . . . . 0.0 111.247 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -86.36 142.32 18.75 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 108.205 -1.958 . . . . 0.0 108.205 168.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.9 m -160.62 160.41 31.63 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 119.233 1.517 . . . . 0.0 110.815 173.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -137.31 -47.14 0.57 Allowed 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.89 1.276 . . . . 0.0 109.525 169.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.2 p -80.99 -12.58 59.35 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.323 1.049 . . . . 0.0 112.162 170.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.41 10.86 53.21 Favored Glycine 0 C--N 1.343 0.946 0 C-N-CA 124.799 1.19 . . . . 0.0 113.884 170.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -66.28 -47.76 72.62 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 118.835 1.318 . . . . 0.0 112.158 -172.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.1 m -74.52 -14.93 60.87 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -168.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -56.15 -43.38 78.24 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.683 0.674 . . . . 0.0 109.755 171.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -68.78 -37.63 79.44 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 121.772 -0.58 . . . . 0.0 109.906 -177.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 29.7 mm -63.83 -43.33 97.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 176.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.36 -38.92 85.39 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.58 -0.7 . . . . 0.0 110.942 177.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -68.28 -40.62 81.75 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 118.177 -0.916 . . . . 0.0 111.342 175.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 63.9 mtt -58.98 -34.26 71.63 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 120.027 1.285 . . . . 0.0 111.051 175.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 55.6 mt -71.45 -53.96 18.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 175.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -61.49 -37.03 82.19 Favored 'General case' 0 N--CA 1.462 0.161 0 O-C-N 121.364 -0.835 . . . . 0.0 111.827 -173.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -63.55 -35.72 81.41 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 119.202 0.91 . . . . 0.0 111.088 -178.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -75.33 -41.79 55.88 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 122.902 0.481 . . . . 0.0 111.05 177.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -72.47 -34.24 67.58 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 122.73 0.412 . . . . 0.0 111.083 -177.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.43 145.07 8.52 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 -169.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -58.78 -33.98 70.93 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 122.015 -0.697 . . . . 0.0 112.078 -175.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -74.64 -11.75 60.27 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.26 -174.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.2 t -106.65 -42.09 6.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 124.337 1.055 . . . . 0.0 109.586 178.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -129.4 140.25 51.4 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 119.473 1.033 . . . . 0.0 111.482 -178.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -122.58 155.29 36.6 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.556 1.142 . . . . 0.0 109.473 177.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 77.6 t -119.7 130.33 74.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 124.234 1.014 . . . . 0.0 110.071 -169.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -146.79 177.61 8.97 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.857 1.663 . . . . 0.0 111.551 -172.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -133.81 130.22 37.64 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 126.884 2.074 . . . . 0.0 105.764 178.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.2 tp -60.56 -21.35 23.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 C-N-CA 123.496 0.719 . . . . 0.0 112.137 -172.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.6 -29.52 68.03 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 118.893 0.77 . . . . 0.0 111.322 177.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -81.08 -26.75 36.04 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.097 0.559 . . . . 0.0 111.438 177.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 62.7 m -71.89 159.48 34.2 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 122.129 0.966 . . . . 0.0 112.427 -168.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 23.5 m -130.07 175.34 8.97 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.849 2.059 . . . . 0.0 107.054 173.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -53.01 -45.63 68.01 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.236 0.615 . . . . 0.0 112.002 -172.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -81.6 -11.8 58.99 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 -175.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -70.8 -32.6 69.74 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 118.98 0.809 . . . . 0.0 111.304 -176.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -69.33 -43.71 73.16 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 123.429 0.692 . . . . 0.0 109.392 173.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 77.9 mt-10 -70.79 -11.66 61.08 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.932 0.893 . . . . 0.0 112.049 -171.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.88 -29.26 69.68 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.08 0.952 . . . . 0.0 111.907 173.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -98.34 153.6 18.43 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.854 1.262 . . . . 0.0 110.348 -178.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -99.54 -27.91 13.48 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.567 174.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.2 mp -113.84 129.79 69.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 174.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -114.15 125.71 54.25 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 107.086 -1.449 . . . . 0.0 107.086 175.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.3 mp -111.89 112.35 23.94 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 173.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.1 mt -112.9 112.28 23.64 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -169.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -100.82 115.15 5.21 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 125.602 1.572 . . . . 0.0 110.126 -178.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 16.2 tt -123.02 118.17 28.2 Favored Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 118.442 1.121 . . . . 0.0 111.71 -173.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -79.63 138.19 13.37 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 121.731 1.621 . . . . 0.0 108.039 167.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 79.7 m -94.39 143.71 26.17 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 174.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 66.2 m95 -134.25 173.74 11.27 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 126.082 1.753 . . . . 0.0 109.414 -177.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 24.4 t80 32.26 64.69 0.23 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 127.902 2.481 . . . . 0.0 114.364 169.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 54.58 53.69 10.33 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.816 0.847 . . . . 0.0 111.738 171.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 82.79 55.78 2.9 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 123.551 0.596 . . . . 0.0 112.085 174.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -128.99 155.87 44.7 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 125.846 1.658 . . . . 0.0 108.355 170.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.13 161.83 27.09 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 123.133 0.573 . . . . 0.0 110.252 172.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 34.1 tp60 -67.33 143.94 56.11 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 169.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 58.4 m -55.62 -35.23 65.65 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.815 0.846 . . . . 0.0 112.51 -172.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -64.76 -41.06 96.17 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.291 0.637 . . . . 0.0 110.444 -178.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -73.31 -46.75 47.72 Favored 'General case' 0 C--N 1.34 0.185 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 177.082 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -58.26 -36.24 72.94 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.582 0.753 . . . . 0.0 112.155 -177.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -69.9 -23.58 63.26 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.736 0.815 . . . . 0.0 112.552 177.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -100.39 -15.64 17.89 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.219 1.007 . . . . 0.0 112.025 -177.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 12.8 m-30 -48.4 -45.94 68.18 Favored Pre-proline 0 CA--C 1.542 0.668 0 CA-C-O 117.09 -1.433 . . . . 0.0 113.119 171.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -65.04 -20.93 63.83 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 CA-C-N 122.577 1.956 . . . . 0.0 113.116 176.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.8 m -82.75 -35.6 26.47 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 119.589 1.086 . . . . 0.0 110.047 174.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 71.8 mt -56.91 -34.0 67.51 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 119.856 1.207 . . . . 0.0 111.205 178.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -82.53 -1.23 49.9 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 178.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -99.95 -29.58 12.49 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.122 0.969 . . . . 0.0 109.629 169.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 92.9 mt -66.4 142.91 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 C-N-CA 125.69 1.596 . . . . 0.0 107.93 177.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -88.14 130.53 35.01 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 123.547 0.739 . . . . 0.0 109.537 173.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -124.37 18.48 8.97 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.513 0.725 . . . . 0.0 111.741 172.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 23.1 m-80 -61.95 116.79 5.18 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 119.95 1.25 . . . . 0.0 109.554 -175.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.0 5.92 66.56 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-O 118.881 -0.955 . . . . 0.0 113.189 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 9.8 mmpt? -76.88 153.13 35.06 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 119.216 1.508 . . . . 0.0 107.26 172.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -95.05 141.02 29.17 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 173.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 15.5 t -134.89 146.38 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 175.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -137.59 146.88 44.55 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 170.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 75.5 mt -116.78 142.36 47.02 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -172.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -138.85 157.3 46.3 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 169.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -162.72 153.41 23.99 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-O 122.455 1.03 . . . . 0.0 112.835 -171.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 51.8 m -126.12 150.93 47.88 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 113.017 -1.592 . . . . 0.0 108.821 -168.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -177.46 175.99 47.84 Favored Glycine 0 CA--C 1.523 0.534 0 C-N-CA 121.035 -0.602 . . . . 0.0 113.544 -172.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -100.54 140.68 34.46 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 125.391 1.476 . . . . 0.0 109.007 171.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -130.15 37.85 3.85 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.219 1.007 . . . . 0.0 109.532 -179.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -113.07 -55.55 2.51 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 124.44 1.096 . . . . 0.0 108.443 172.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -113.75 -33.3 5.85 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.551 1.14 . . . . 0.0 111.198 -175.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -92.02 22.57 4.23 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.703 0.801 . . . . 0.0 112.357 -178.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.61 -33.61 74.2 Favored 'General case' 0 C--N 1.343 0.302 0 CA-C-N 120.023 1.283 . . . . 0.0 113.515 -169.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -65.03 -31.01 72.03 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 119.934 1.243 . . . . 0.0 110.284 175.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -100.18 9.17 43.19 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.745 1.618 . . . . 0.0 111.218 -177.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -65.97 118.76 10.23 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 119.114 0.87 . . . . 0.0 108.884 -169.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 60.6 m 53.24 28.71 7.45 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.967 1.307 . . . . 0.0 112.789 -175.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -53.71 -36.48 62.29 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.73 1.212 . . . . 0.0 111.731 -176.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.72 -11.78 61.15 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -174.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 32.1 mt -54.38 -47.86 72.18 Favored 'General case' 0 C--N 1.344 0.353 0 CA-C-N 119.148 0.885 . . . . 0.0 110.47 173.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.0 -29.23 74.29 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 111.745 -0.542 . . . . 0.0 111.745 -176.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.8 m -63.63 -37.63 88.06 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 117.76 0.78 . . . . 0.0 110.049 177.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 5.8 mt -67.87 -44.17 85.5 Favored 'Isoleucine or valine' 0 C--N 1.344 0.346 0 CA-C-O 117.781 -1.104 . . . . 0.0 108.938 177.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 57.7 ttp85 -56.27 -46.74 79.58 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 120.032 1.287 . . . . 0.0 110.041 177.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -59.82 -28.18 67.24 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -178.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 80.0 mt -84.28 -45.67 18.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 124.38 1.072 . . . . 0.0 110.688 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 10.5 pt -85.83 -28.1 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 119.508 1.049 . . . . 0.0 112.584 -169.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -63.56 -42.12 70.85 Favored Pre-proline 0 CA--C 1.548 0.868 0 CA-C-O 117.814 -1.089 . . . . 0.0 111.434 -174.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -61.54 -20.02 67.01 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 122.727 2.285 . . . . 0.0 114.19 172.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 23.9 mmm180 -86.9 5.01 39.09 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.065 0.946 . . . . 0.0 111.44 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 75.73 17.53 80.06 Favored Glycine 0 CA--C 1.529 0.945 0 CA-C-O 118.51 -1.161 . . . . 0.0 113.03 178.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -59.1 137.76 57.82 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 118.809 1.305 . . . . 0.0 109.482 169.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 36.6 m -94.18 126.57 39.5 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 169.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 57.1 mt -105.22 132.6 51.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -174.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 27.1 m -129.01 176.35 8.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 125.737 1.615 . . . . 0.0 108.523 172.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 80.78 26.58 53.37 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-O 119.043 -0.865 . . . . 0.0 114.023 175.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 65.1 m80 -62.3 130.45 45.38 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 168.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 65.2 t-105 -107.64 124.56 34.59 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-O 118.258 -0.877 . . . . 0.0 108.787 -169.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -71.29 146.86 51.98 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 121.501 1.468 . . . . 0.0 112.144 -172.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 33.2 p . . . . . 0 CA--C 1.531 0.227 0 C-N-CA 123.874 0.87 . . . . 0.0 111.242 179.158 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.789 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -64.75 -18.73 64.38 Favored Glycine 0 CA--C 1.536 1.404 0 CA-C-N 119.407 1.003 . . . . 0.0 112.295 169.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 91.7 mt -64.44 130.29 43.17 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.809 1.304 . . . . 0.0 109.237 175.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -93.7 -33.44 13.64 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.472 0.709 . . . . 0.0 109.386 168.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -149.87 165.78 31.53 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 126.717 2.007 . . . . 0.0 107.638 177.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -55.67 -26.79 46.54 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 121.717 -0.614 . . . . 0.0 112.108 172.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -90.55 -19.3 23.92 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.891 1.276 . . . . 0.0 114.216 -179.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 24.0 p80 -156.74 147.34 21.56 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 120.481 1.491 . . . . 0.0 114.311 -176.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -82.72 151.17 26.31 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 126.215 1.806 . . . . 0.0 108.607 168.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 5.8 p -69.19 -16.96 21.33 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 122.856 0.462 . . . . 0.0 111.612 179.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -157.45 174.06 34.91 Favored Glycine 0 C--N 1.339 0.742 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 178.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -67.08 105.63 1.73 Allowed 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 123.542 0.737 . . . . 0.0 109.219 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.366 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 168.195 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 47.5 mt . . . . . 0 N--CA 1.474 0.744 0 CA-C-O 121.57 0.7 . . . . 0.0 112.002 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 87.4 m -59.42 -51.35 70.26 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 125.159 1.384 . . . . 0.0 111.118 -176.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -67.53 -31.92 72.35 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 119.398 -0.334 . . . . 0.0 111.01 -169.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 24.8 mp0 -60.81 -43.72 97.83 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.513 1.125 . . . . 0.0 109.813 174.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 68.4 mtt85 -62.8 -42.69 99.82 Favored 'General case' 0 N--CA 1.466 0.347 0 O-C-N 121.573 -0.705 . . . . 0.0 110.506 175.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 58.1 t -66.64 -37.88 80.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-O 118.753 -0.641 . . . . 0.0 109.494 -179.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -62.03 -51.04 69.59 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 120.215 1.37 . . . . 0.0 110.012 175.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 61.1 mttm -58.51 -42.63 88.14 Favored 'General case' 0 CA--C 1.529 0.153 0 O-C-N 122.119 -0.363 . . . . 0.0 110.43 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 58.0 t90 -67.85 -47.51 68.77 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 118.131 0.423 . . . . 0.0 110.641 -177.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 50.9 t -60.64 -37.91 76.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 118.365 0.53 . . . . 0.0 110.104 -178.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 56.0 mttm -64.99 -46.8 79.92 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 121.637 -0.665 . . . . 0.0 109.275 176.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 6.1 mm-40 -59.86 -46.95 87.66 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 118.695 0.679 . . . . 0.0 111.819 179.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 18.5 pt -68.74 -32.11 53.57 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.19 0 CA-C-N 119.329 0.968 . . . . 0.0 110.212 -178.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 36.0 m -61.69 -32.16 72.34 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 119.033 0.833 . . . . 0.0 110.927 172.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -72.12 -44.42 63.2 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.442 1.019 . . . . 0.0 110.192 174.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -66.75 -35.62 80.52 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.168 0.587 . . . . 0.0 111.466 -178.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 86.3 mt -84.28 -3.12 58.03 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.533 1.533 . . . . 0.0 111.452 178.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 54.53 28.24 9.48 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.837 1.655 . . . . 0.0 112.811 -173.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 85.8 mt . . . . . 0 N--CA 1.464 0.231 0 C-N-CA 123.233 0.613 . . . . 0.0 109.846 170.077 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.323 0 CA-C-O 121.006 0.431 . . . . 0.0 111.487 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.1 pt -113.45 -18.24 7.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 126.317 1.847 . . . . 0.0 111.045 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 40.9 m -109.92 124.29 51.11 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.565 1.546 . . . . 0.0 108.845 178.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -99.43 120.24 6.79 Favored Glycine 0 CA--C 1.522 0.469 0 N-CA-C 108.437 -1.865 . . . . 0.0 108.437 169.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 55.1 mt -97.67 94.21 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 104.773 -2.306 . . . . 0.0 104.773 177.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -97.1 108.53 21.29 Favored 'General case' 0 CA--C 1.52 -0.177 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 178.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -128.25 118.45 23.31 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 118.961 0.8 . . . . 0.0 109.755 -168.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -83.8 132.98 11.46 Favored Glycine 0 C--N 1.338 0.688 0 N-CA-C 110.376 -1.089 . . . . 0.0 110.376 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.1 m -137.78 161.22 37.14 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.292 1.437 . . . . 0.0 107.959 174.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -136.13 -50.92 0.7 Allowed 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.088 0.555 . . . . 0.0 110.008 169.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -81.74 -6.4 59.01 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.424 0.689 . . . . 0.0 111.778 170.484 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.33 11.65 51.13 Favored Glycine 0 C--N 1.345 1.034 0 C-N-CA 124.615 1.102 . . . . 0.0 115.138 167.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -73.47 -46.22 49.48 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 119.324 1.562 . . . . 0.0 111.822 -177.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.76 -39.08 93.02 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 118.8 0.727 . . . . 0.0 110.601 -168.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -64.13 -27.58 69.18 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.232 -0.918 . . . . 0.0 112.096 -178.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -66.72 -37.04 83.87 Favored 'General case' 0 N--CA 1.465 0.276 0 O-C-N 121.49 -0.756 . . . . 0.0 109.984 174.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.3 mm -67.61 -43.26 87.06 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.153 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 174.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.39 -38.5 71.57 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.912 0.778 . . . . 0.0 111.059 -179.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 68.6 mttt -67.19 -42.34 84.34 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 122.955 0.502 . . . . 0.0 110.833 175.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 77.3 mtm -67.15 -29.78 69.58 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 119.281 0.946 . . . . 0.0 111.883 177.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 70.6 mt -68.73 -53.92 24.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 173.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -59.33 -37.9 78.96 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.765 -0.584 . . . . 0.0 111.193 -176.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -63.44 -39.18 93.8 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 119.116 0.871 . . . . 0.0 110.952 -179.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -71.97 -41.62 67.5 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 122.697 0.399 . . . . 0.0 110.978 177.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.9 mp -73.82 -33.44 64.17 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 118.096 0.407 . . . . 0.0 111.174 -176.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.16 143.34 12.88 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 125.26 1.409 . . . . 0.0 110.58 -171.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -65.37 -29.0 69.67 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.735 -0.862 . . . . 0.0 111.794 -174.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -77.47 -7.57 56.4 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 122.942 0.497 . . . . 0.0 112.006 177.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.0 t -108.04 -41.03 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 C-N-CA 124.421 1.088 . . . . 0.0 109.569 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -132.82 147.53 52.31 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 119.512 1.051 . . . . 0.0 112.144 -175.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.3 t0 -132.71 151.31 52.01 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.515 0.726 . . . . 0.0 110.773 173.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 97.5 t -106.9 137.48 37.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 C-N-CA 124.87 1.268 . . . . 0.0 109.648 -169.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -145.11 164.78 30.22 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.615 1.566 . . . . 0.0 110.598 -171.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -131.02 134.38 46.63 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 175.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.3 tp -65.72 -26.36 38.69 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-O 118.514 -0.755 . . . . 0.0 113.003 -168.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.99 -29.58 68.64 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 119.287 0.949 . . . . 0.0 110.479 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -84.22 -28.75 27.06 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.417 0.687 . . . . 0.0 111.325 175.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.4 m -77.32 168.4 20.09 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.137 0.975 . . . . 0.0 111.621 -169.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.3 m -131.3 159.67 37.19 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.887 1.275 . . . . 0.0 110.138 -174.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -53.25 -47.58 68.94 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.676 1.19 . . . . 0.0 111.811 -175.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -80.81 -13.42 58.97 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 122.245 -0.284 . . . . 0.0 111.63 -174.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -76.68 -31.16 57.08 Favored 'General case' 0 C--O 1.234 0.267 0 O-C-N 121.534 -0.729 . . . . 0.0 111.566 -172.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.9 mp -66.22 -35.69 81.08 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 175.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -68.83 -13.43 62.41 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.348 0.659 . . . . 0.0 112.38 -174.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.15 -29.12 68.73 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.531 0.732 . . . . 0.0 111.484 174.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -94.22 147.61 23.01 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.162 0.985 . . . . 0.0 110.381 -177.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -91.38 -33.65 15.18 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.895 173.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.2 mp -107.82 134.52 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 176.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 96.8 mt -122.07 124.36 43.76 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 174.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.3 mp -105.79 110.08 22.25 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 104.956 -2.239 . . . . 0.0 104.956 169.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 73.9 mt -109.55 111.15 22.48 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 -173.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -96.25 123.31 7.66 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 -179.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 2.1 tp -137.12 100.87 9.45 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 125.067 1.347 . . . . 0.0 109.32 -171.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.25 142.52 30.51 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.204 1.936 . . . . 0.0 109.091 168.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 59.1 m -91.84 136.84 32.85 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 177.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 24.5 m95 -135.51 168.17 19.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 120.58 1.536 . . . . 0.0 112.605 -169.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 58.66 -61.69 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 130.707 3.603 . . . . 0.0 116.32 169.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -150.98 30.08 0.64 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.448 1.899 . . . . 0.0 110.44 -169.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 73.23 48.39 19.58 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 -171.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -123.98 175.75 6.76 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.58 1.552 . . . . 0.0 108.43 177.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -79.24 158.35 27.62 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.138 -0.976 . . . . 0.0 109.54 169.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -58.95 138.11 57.58 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 172.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 99.5 m -55.78 -40.21 72.34 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -167.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -73.73 -27.1 61.01 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.366 0.667 . . . . 0.0 111.705 -177.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -77.79 -44.49 27.38 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.172 0.989 . . . . 0.0 109.541 174.194 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -58.65 -42.12 87.63 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.399 1.079 . . . . 0.0 111.06 176.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -61.8 -22.29 65.32 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.16 0.984 . . . . 0.0 112.2 177.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -90.85 -17.12 27.06 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 118.348 -0.834 . . . . 0.0 112.067 178.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 21.2 m-30 -54.98 -40.66 85.83 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-O 116.445 -1.741 . . . . 0.0 114.408 179.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -63.49 -20.27 69.43 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 CA-C-N 122.912 2.076 . . . . 0.0 113.24 173.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.4 m -82.44 -45.16 15.13 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.262 0.937 . . . . 0.0 109.14 170.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 12.9 tp -56.22 -40.16 73.63 Favored 'General case' 0 C--N 1.342 0.241 0 C-N-CA 125.077 1.351 . . . . 0.0 110.523 -175.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -72.39 -1.02 14.02 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -178.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -104.94 -12.0 16.42 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 119.647 1.112 . . . . 0.0 112.124 172.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 80.8 mt -78.23 142.04 14.67 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 -179.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -82.63 130.05 35.05 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 178.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -122.06 13.01 10.46 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 118.682 -0.675 . . . . 0.0 111.849 173.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -62.3 115.79 4.48 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-N 120.035 1.289 . . . . 0.0 108.754 -176.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 74.69 -0.72 55.7 Favored Glycine 0 CA--C 1.535 1.296 0 CA-C-O 118.459 -1.189 . . . . 0.0 114.095 -179.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -69.33 146.47 52.15 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 119.738 1.769 . . . . 0.0 107.288 169.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -90.03 137.34 32.42 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 170.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.0 t -131.97 142.35 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 177.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -131.27 141.45 49.98 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 170.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 73.3 mt -110.66 149.98 29.67 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -176.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -141.53 147.49 37.84 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 -179.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -164.96 137.58 4.79 Favored Glycine 0 CA--C 1.522 0.5 0 CA-C-N 119.216 0.916 . . . . 0.0 110.936 169.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 4.5 p -95.11 152.81 18.02 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 168.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -145.33 -158.36 7.63 Favored Glycine 0 CA--C 1.525 0.702 0 CA-C-O 121.048 0.249 . . . . 0.0 113.019 -173.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -146.9 145.38 29.8 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 127.504 2.322 . . . . 0.0 107.85 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -133.14 12.39 4.24 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.37 1.468 . . . . 0.0 109.931 177.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -81.9 -47.05 13.24 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 177.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -126.72 -33.2 2.53 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 123.949 0.9 . . . . 0.0 111.126 -175.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -91.33 33.89 0.97 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.211 1.004 . . . . 0.0 111.421 176.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.45 -20.02 62.65 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.278 1.431 . . . . 0.0 113.116 -178.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -97.62 6.6 47.79 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.912 0.885 . . . . 0.0 111.948 176.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -138.53 24.47 2.67 Favored 'General case' 0 C--O 1.237 0.411 0 O-C-N 120.854 -1.154 . . . . 0.0 110.858 -174.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -65.97 118.57 9.95 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -169.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 86.3 m 48.28 35.23 5.3 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.648 1.979 . . . . 0.0 113.636 -175.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -53.38 -41.17 65.62 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.364 0.666 . . . . 0.0 112.342 -178.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.99 -12.06 60.06 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -170.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 53.9 mt -56.22 -42.21 76.88 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 118.719 0.691 . . . . 0.0 109.647 169.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -65.0 -30.66 78.6 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.811 -0.515 . . . . 0.0 111.811 -178.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 4.3 m -64.93 -40.13 94.57 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 117.985 0.893 . . . . 0.0 110.098 179.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.7 mt -73.86 -39.85 52.43 Favored 'Isoleucine or valine' 0 C--N 1.344 0.363 0 CA-C-N 118.908 0.777 . . . . 0.0 109.271 176.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 57.7 ttt-85 -52.67 -46.64 67.29 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 119.583 1.083 . . . . 0.0 110.331 177.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -64.73 -21.59 66.79 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.596 0.758 . . . . 0.0 112.455 -176.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 95.8 mt -87.98 -46.01 15.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 123.454 0.702 . . . . 0.0 109.474 175.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 7.0 pt -77.79 -28.69 15.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-N 118.926 0.785 . . . . 0.0 112.045 -169.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -62.12 -56.86 27.35 Favored Pre-proline 0 CA--C 1.544 0.724 0 CA-C-O 117.568 -1.206 . . . . 0.0 112.167 179.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -66.23 -24.06 51.53 Favored 'Trans proline' 0 C--N 1.353 0.781 0 CA-C-N 121.96 1.736 . . . . 0.0 112.208 -179.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 79.5 mmt-85 -78.28 5.11 11.08 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.856 0.862 . . . . 0.0 112.774 172.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 77.22 20.92 74.52 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-N 119.604 1.093 . . . . 0.0 113.993 169.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.9 148.91 48.31 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 118.56 1.18 . . . . 0.0 110.589 170.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 60.2 m -97.47 124.36 41.65 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 105.01 -2.218 . . . . 0.0 105.01 167.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 48.9 mt -98.43 134.13 38.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 -175.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 29.1 m -133.14 176.63 8.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 125.582 1.553 . . . . 0.0 108.854 172.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 78.04 23.38 66.45 Favored Glycine 0 CA--C 1.529 0.926 0 CA-C-O 119.065 -0.853 . . . . 0.0 113.906 175.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 15.4 p-80 -60.3 140.85 56.87 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 118.327 1.063 . . . . 0.0 108.809 168.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 75.4 t-105 -131.19 136.48 28.84 Favored Pre-proline 0 CA--C 1.536 0.43 0 C-N-CA 124.26 1.024 . . . . 0.0 110.244 -168.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -70.36 152.3 66.13 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.466 2.111 . . . . 0.0 111.912 -176.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 22.2 p . . . . . 0 CA--C 1.537 0.48 0 C-N-CA 123.867 0.867 . . . . 0.0 112.613 174.283 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 84.3 mttt . . . . . 0 N--CA 1.473 0.69 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -83.04 8.59 62.88 Favored Glycine 0 CA--C 1.535 1.324 0 CA-C-N 118.619 0.645 . . . . 0.0 112.775 168.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 74.9 mt -62.29 138.77 58.49 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.564 1.145 . . . . 0.0 111.204 -179.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -104.56 -26.22 12.44 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.629 1.572 . . . . 0.0 109.792 168.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -143.66 165.71 26.88 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.01 1.724 . . . . 0.0 107.219 172.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -53.61 -27.2 25.54 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.197 1.399 . . . . 0.0 114.186 -169.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -123.49 9.98 9.1 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.781 1.232 . . . . 0.0 113.58 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -137.91 130.39 29.4 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 119.788 1.176 . . . . 0.0 111.143 -172.187 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -81.39 151.44 27.93 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 124.935 1.294 . . . . 0.0 110.165 173.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 14.5 p -61.89 -29.89 47.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 123.0 0.52 . . . . 0.0 111.528 175.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -141.28 -176.36 15.57 Favored Glycine 0 CA--C 1.521 0.445 0 C-N-CA 125.305 1.431 . . . . 0.0 109.606 -175.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -60.9 125.99 25.75 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 169.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.355 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 171.243 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 74.3 mt . . . . . 0 CA--C 1.539 0.539 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 97.1 m -51.09 -53.44 34.12 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 126.988 2.115 . . . . 0.0 111.85 -174.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.59 -43.86 95.71 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 119.083 -0.484 . . . . 0.0 111.884 -166.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -67.12 -36.1 81.2 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 118.794 0.725 . . . . 0.0 111.091 -177.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 77.3 mtt85 -67.12 -47.55 70.79 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 118.825 0.738 . . . . 0.0 109.883 -179.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 16.8 m -72.41 -31.67 39.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-O 118.77 -0.633 . . . . 0.0 110.481 -176.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -63.35 -49.63 73.12 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 119.659 1.118 . . . . 0.0 109.948 171.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -58.61 -42.26 87.76 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 118.477 0.58 . . . . 0.0 109.972 178.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 66.8 t90 -64.32 -46.77 82.09 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 118.822 0.737 . . . . 0.0 110.589 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 28.5 t -56.89 -42.71 78.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 118.24 0.473 . . . . 0.0 109.863 176.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 54.7 mttm -69.01 -38.32 79.16 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 118.567 -0.73 . . . . 0.0 109.825 -176.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 19.1 mm100 -59.89 -55.45 34.04 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 118.611 0.641 . . . . 0.0 110.304 172.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 16.1 pt -65.32 -30.53 50.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 118.924 0.784 . . . . 0.0 110.642 -174.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 50.8 m -61.82 -25.74 67.69 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.747 0.703 . . . . 0.0 111.692 177.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -89.33 -28.88 19.54 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 119.599 1.091 . . . . 0.0 111.023 176.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -72.19 -37.82 69.21 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 118.663 0.665 . . . . 0.0 110.67 175.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 76.8 mt -90.83 -9.32 46.84 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.186 1.794 . . . . 0.0 111.848 -177.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 55.57 29.44 13.48 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.534 1.534 . . . . 0.0 112.759 -170.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 86.5 mt . . . . . 0 N--CA 1.466 0.366 0 O-C-N 121.349 -0.845 . . . . 0.0 110.286 169.362 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.297 0 CA-C-O 120.769 0.319 . . . . 0.0 111.408 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.1 pt -109.89 -15.96 9.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 125.363 1.465 . . . . 0.0 111.3 178.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 28.9 m -111.77 123.69 50.77 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.201 1.4 . . . . 0.0 108.317 177.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -96.49 119.29 6.26 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 107.434 -2.267 . . . . 0.0 107.434 169.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 56.8 mt -98.07 91.88 2.64 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 105.23 -2.137 . . . . 0.0 105.23 176.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -88.48 129.08 35.53 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 178.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -128.54 133.48 48.41 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 120.011 1.278 . . . . 0.0 111.88 179.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -89.92 145.24 18.12 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 169.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 9.3 m -164.23 158.34 18.85 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.679 1.24 . . . . 0.0 109.743 172.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -125.18 -51.13 1.66 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.614 0.765 . . . . 0.0 109.432 168.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.2 p -86.35 8.11 22.84 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.097 1.359 . . . . 0.0 112.976 173.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 84.19 -9.02 64.99 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 116.963 1.545 . . . . 0.0 116.963 168.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -60.78 -37.45 81.92 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 120.23 2.015 . . . . 0.0 113.825 -169.457 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.7 m -73.55 -15.09 61.3 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 120.01 1.277 . . . . 0.0 110.799 -175.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -60.19 -41.95 94.04 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 119.643 1.111 . . . . 0.0 109.676 172.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -63.04 -41.29 99.46 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -178.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 25.7 mm -64.8 -45.06 96.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 177.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.88 -40.25 88.09 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.589 0.631 . . . . 0.0 111.04 178.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.2 mtpt -67.47 -42.09 83.56 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 118.022 -0.99 . . . . 0.0 110.72 177.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 63.4 mtt -55.66 -47.62 76.4 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 119.851 1.205 . . . . 0.0 109.721 175.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 62.1 mt -60.37 -52.69 58.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -179.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -61.79 -38.64 88.81 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.958 0.799 . . . . 0.0 111.212 -175.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -65.02 -35.86 82.53 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 118.908 0.776 . . . . 0.0 111.023 -179.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -70.64 -49.38 48.13 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.322 0.51 . . . . 0.0 110.838 175.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 54.5 mt -67.8 -32.6 73.27 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.329 0.513 . . . . 0.0 111.783 -177.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.0 145.09 14.79 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 125.407 1.48 . . . . 0.0 110.792 -173.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 22.8 ptmt -63.72 -29.53 70.74 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 121.728 -0.866 . . . . 0.0 113.184 -172.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -77.68 -11.49 59.88 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.591 179.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 22.4 t -103.57 -39.33 5.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 C-N-CA 124.283 1.033 . . . . 0.0 109.711 177.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -133.24 146.55 51.56 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 119.234 0.924 . . . . 0.0 111.94 -176.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -130.71 139.58 50.3 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.104 0.962 . . . . 0.0 109.853 175.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 98.3 t -90.4 139.27 17.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 123.655 0.782 . . . . 0.0 109.15 -177.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -148.27 172.95 13.54 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.925 1.29 . . . . 0.0 111.133 -168.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -143.79 125.63 15.2 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 125.856 1.662 . . . . 0.0 108.629 -172.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.4 tp -62.35 -28.43 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-O 118.855 -0.593 . . . . 0.0 111.723 -172.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.09 -27.89 69.7 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 118.77 0.714 . . . . 0.0 111.537 -175.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 61.9 pttt -105.45 -3.95 21.93 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.627 1.171 . . . . 0.0 112.359 176.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 50.9 m -79.25 166.85 21.71 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.398 0.679 . . . . 0.0 110.953 -179.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.4 m -134.43 163.58 29.36 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.189 1.396 . . . . 0.0 109.021 179.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 53.5 tttm -52.81 -57.25 10.8 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.024 0.93 . . . . 0.0 110.985 -174.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -75.34 -16.07 60.43 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 122.354 0.262 . . . . 0.0 111.329 -173.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -74.31 -29.29 61.56 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 122.889 0.476 . . . . 0.0 110.928 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.8 mp -71.43 -41.98 68.81 Favored 'General case' 0 C--N 1.344 0.336 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 168.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.3 -15.73 63.46 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.234 0.614 . . . . 0.0 112.264 -174.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.88 -30.06 70.12 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.324 1.05 . . . . 0.0 112.277 174.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -84.58 155.22 22.16 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 123.845 0.858 . . . . 0.0 110.059 178.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -102.45 -26.73 13.15 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.236 0.614 . . . . 0.0 111.129 169.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.9 mp -113.74 123.43 69.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 174.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -109.85 123.14 49.05 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 173.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.1 mp -109.2 120.68 43.24 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 105.43 -2.063 . . . . 0.0 105.43 169.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 59.6 mt -118.38 109.42 16.25 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 -173.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -90.05 121.24 6.09 Favored Glycine 0 N--CA 1.451 -0.323 0 N-CA-C 108.568 -1.813 . . . . 0.0 108.568 176.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 3.0 tp -141.65 103.84 5.88 Favored Pre-proline 0 CA--C 1.541 0.611 0 CA-C-N 117.741 0.771 . . . . 0.0 110.039 -169.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -76.47 147.14 28.31 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.463 2.109 . . . . 0.0 109.564 169.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 33.5 m -95.5 140.93 29.65 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 177.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 38.7 m95 -134.16 171.29 14.43 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 125.208 1.403 . . . . 0.0 111.24 -170.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 51.85 -87.59 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 127.8 2.44 . . . . 0.0 113.114 178.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -150.0 78.23 1.34 Allowed 'General case' 0 C--O 1.234 0.289 0 C-N-CA 126.682 1.993 . . . . 0.0 106.813 179.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 70.99 19.6 77.21 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 123.68 0.657 . . . . 0.0 113.337 179.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -93.12 161.33 14.47 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.582 1.153 . . . . 0.0 109.357 -176.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -79.31 159.41 27.22 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 167.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -58.18 143.88 42.59 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 168.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 60.4 m -51.74 -38.89 57.23 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.566 1.146 . . . . 0.0 113.645 -169.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -70.78 -35.63 72.66 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 118.548 0.613 . . . . 0.0 110.694 -175.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -71.5 -45.51 62.29 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 175.018 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -57.92 -41.29 82.36 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 122.738 0.415 . . . . 0.0 111.379 179.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -68.2 -25.53 65.27 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.729 0.812 . . . . 0.0 112.268 177.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -92.69 -18.65 22.72 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.55 0.74 . . . . 0.0 112.506 -178.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 19.4 m-30 -50.73 -40.61 64.46 Favored Pre-proline 0 CA--C 1.545 0.78 0 CA-C-O 116.469 -1.729 . . . . 0.0 114.633 178.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -63.2 -20.86 71.8 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 CA-C-N 123.033 2.119 . . . . 0.0 113.912 173.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.2 m -85.7 -39.05 17.64 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 119.381 0.991 . . . . 0.0 109.441 169.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 13.6 tp -58.24 -38.05 76.11 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.031 0.932 . . . . 0.0 110.697 -177.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -72.51 -3.98 27.72 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 179.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -103.13 -12.46 17.35 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.134 0.879 . . . . 0.0 111.357 173.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 79.4 mt -77.23 138.39 20.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -176.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -78.18 124.23 27.83 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.592 176.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -122.06 11.03 10.18 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.769 0.827 . . . . 0.0 111.6 172.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -63.08 114.09 3.51 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 120.012 1.278 . . . . 0.0 109.143 -171.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.17 3.65 61.54 Favored Glycine 0 CA--C 1.536 1.392 0 CA-C-O 118.546 -1.141 . . . . 0.0 113.866 -178.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -75.21 152.03 38.4 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 119.544 1.672 . . . . 0.0 108.182 170.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 20.8 mt -91.6 136.59 33.02 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 175.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 18.5 t -133.81 141.69 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -134.32 143.26 47.6 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 171.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 64.7 mt -111.86 144.42 41.2 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -177.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -140.53 154.46 46.55 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 170.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -173.54 155.66 22.65 Favored Glycine 0 N--CA 1.449 -0.476 0 CA-C-O 122.416 1.009 . . . . 0.0 112.705 176.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 64.1 m -101.96 149.87 23.78 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 169.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -145.51 -159.32 8.08 Favored Glycine 0 CA--C 1.521 0.409 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 176.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -144.79 139.51 27.85 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 124.968 1.307 . . . . 0.0 108.546 170.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -109.09 -14.7 14.48 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 123.962 0.905 . . . . 0.0 111.419 177.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -75.11 -43.62 51.79 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 119.843 1.201 . . . . 0.0 110.796 -170.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -112.87 -40.22 4.05 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 123.495 0.718 . . . . 0.0 110.755 179.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -83.89 37.86 0.62 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.533 0.733 . . . . 0.0 111.018 176.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.06 -23.64 63.92 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 126.805 2.042 . . . . 0.0 114.019 -170.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -99.34 0.26 42.52 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.321 1.448 . . . . 0.0 111.918 -179.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -131.98 16.99 4.65 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.258 1.023 . . . . 0.0 111.925 -169.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -65.15 125.88 26.35 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 121.247 -0.908 . . . . 0.0 110.27 -169.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 88.1 m 53.24 29.45 8.48 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.842 1.657 . . . . 0.0 114.349 176.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -61.43 -31.51 71.46 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.755 0.822 . . . . 0.0 111.339 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.56 -33.58 76.25 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 120.754 -1.216 . . . . 0.0 111.687 179.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 7.5 mp -63.29 -43.89 96.6 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-N 119.691 1.132 . . . . 0.0 109.633 175.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.71 -31.99 82.01 Favored Glycine 0 CA--C 1.532 1.114 0 N-CA-C 111.337 -0.705 . . . . 0.0 111.337 174.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 14.7 m -66.56 -41.42 88.65 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 117.76 0.78 . . . . 0.0 110.113 176.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 5.4 mt -65.75 -43.83 93.38 Favored 'Isoleucine or valine' 0 C--N 1.345 0.401 0 CA-C-N 119.425 1.012 . . . . 0.0 109.509 173.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 41.3 ttt180 -52.32 -45.93 65.81 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 119.381 0.991 . . . . 0.0 110.435 -178.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -62.0 -17.98 58.96 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.96 0.904 . . . . 0.0 113.035 -178.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 82.8 mt -95.4 -54.72 6.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 124.397 1.079 . . . . 0.0 109.216 175.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 23.2 pt -71.56 -33.46 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 O-C-N 121.251 -0.906 . . . . 0.0 112.195 -168.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -66.53 -50.37 47.22 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-O 117.694 -1.146 . . . . 0.0 111.486 -174.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -68.36 -24.67 36.83 Favored 'Trans proline' 0 C--N 1.354 0.836 0 CA-C-N 121.731 1.654 . . . . 0.0 112.769 174.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 7.7 mpt_? -74.76 6.76 3.63 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 119.42 1.009 . . . . 0.0 112.523 169.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 81.38 16.66 73.29 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-O 118.435 -1.203 . . . . 0.0 114.007 169.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.13 141.9 55.11 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 118.882 1.341 . . . . 0.0 109.998 170.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 88.1 m -93.13 119.34 32.24 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 104.641 -2.355 . . . . 0.0 104.641 167.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 33.6 mt -96.61 132.79 40.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 -173.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 29.9 m -129.44 172.62 15.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 C-N-CA 124.869 1.268 . . . . 0.0 109.033 175.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 77.35 27.74 59.09 Favored Glycine 0 CA--C 1.526 0.722 0 CA-C-O 119.105 -0.83 . . . . 0.0 113.542 177.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 28.9 p-80 -60.84 139.69 57.88 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 118.815 1.307 . . . . 0.0 108.678 168.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 75.6 t-105 -127.78 137.88 31.7 Favored Pre-proline 0 CA--C 1.533 0.321 0 C-N-CA 124.453 1.101 . . . . 0.0 108.245 -169.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -70.89 144.65 48.6 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 121.762 1.642 . . . . 0.0 112.347 -170.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 63.0 p . . . . . 0 CA--C 1.536 0.419 0 C-N-CA 123.471 0.708 . . . . 0.0 110.055 169.367 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.836 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -75.76 0.79 60.59 Favored Glycine 0 CA--C 1.535 1.295 0 CA-C-O 119.216 -0.769 . . . . 0.0 112.867 169.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 96.7 mt -64.32 139.19 58.74 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 119.468 1.634 . . . . 0.0 111.083 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -108.53 -31.07 7.93 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.456 1.503 . . . . 0.0 108.778 167.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -145.23 162.54 36.89 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 127.86 2.464 . . . . 0.0 106.181 169.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -55.65 -30.52 61.14 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 121.17 -0.956 . . . . 0.0 112.084 176.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -91.0 -9.41 46.06 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.241 1.016 . . . . 0.0 113.448 -179.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 58.7 m80 -147.36 130.94 16.81 Favored 'General case' 0 C--N 1.348 0.509 0 CA-C-N 119.93 1.241 . . . . 0.0 113.229 -171.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -76.22 155.58 34.31 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.008 0.923 . . . . 0.0 108.767 167.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 14.2 p -60.56 -32.19 50.85 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 124.144 0.978 . . . . 0.0 111.419 176.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -146.41 -177.25 20.9 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 124.905 1.241 . . . . 0.0 110.32 -172.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -62.55 123.39 18.21 Favored 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 171.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.374 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 -176.654 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 90.0 mt . . . . . 0 N--CA 1.468 0.458 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 93.9 m -53.66 -58.21 8.02 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.424 1.09 . . . . 0.0 110.614 -175.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -68.91 -32.67 72.46 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 122.278 -0.264 . . . . 0.0 110.517 -169.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 25.3 mp0 -63.97 -48.47 76.33 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.234 1.014 . . . . 0.0 109.292 176.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 74.3 mtt85 -65.53 -37.18 86.0 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 118.912 0.778 . . . . 0.0 110.635 -179.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 96.3 t -64.41 -42.26 94.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-O 118.358 -0.829 . . . . 0.0 109.093 174.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -59.41 -48.71 80.59 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-N 119.832 1.196 . . . . 0.0 110.359 177.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -58.94 -44.62 91.44 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 118.088 0.403 . . . . 0.0 110.094 179.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 68.0 t90 -66.06 -44.44 84.52 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 118.363 0.529 . . . . 0.0 110.02 -175.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 79.1 t -62.77 -39.64 85.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -65.17 -38.67 91.27 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 121.389 -0.819 . . . . 0.0 110.138 178.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 43.4 mm-40 -64.35 -52.19 59.61 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 118.586 0.63 . . . . 0.0 110.964 176.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 21.0 pt -64.59 -31.72 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 119.568 1.077 . . . . 0.0 110.326 -178.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 65.6 m -60.79 -26.14 67.06 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 118.062 -0.97 . . . . 0.0 112.538 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -95.22 -10.39 30.54 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 120.117 1.326 . . . . 0.0 112.699 175.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -88.0 -39.5 14.62 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 118.981 0.809 . . . . 0.0 110.304 171.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 88.0 mt -84.51 -12.32 54.44 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.677 1.991 . . . . 0.0 111.421 178.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 30.4 m80 56.58 30.16 16.82 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.556 1.543 . . . . 0.0 112.885 -170.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 67.6 mt . . . . . 0 N--CA 1.466 0.366 0 O-C-N 121.477 -0.764 . . . . 0.0 110.38 169.532 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.33 0 N-CA-C 110.536 -0.172 . . . . 0.0 110.536 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.7 pt -86.78 -23.9 6.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 122.269 0.228 . . . . 0.0 111.581 -178.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.9 m -112.01 130.15 55.96 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.825 1.25 . . . . 0.0 108.646 -178.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -103.95 116.35 5.35 Favored Glycine 0 CA--C 1.521 0.417 0 N-CA-C 108.241 -1.944 . . . . 0.0 108.241 169.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 74.6 mt -90.81 126.14 43.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 104.847 -2.279 . . . . 0.0 104.847 171.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -122.38 126.94 49.06 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 174.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -125.28 136.59 53.67 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 118.311 0.505 . . . . 0.0 111.027 178.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -85.93 136.86 14.63 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 108.632 -1.787 . . . . 0.0 108.632 168.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 22.6 m -157.35 158.12 35.39 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 119.395 1.598 . . . . 0.0 110.908 169.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -142.67 -42.79 0.32 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.878 1.271 . . . . 0.0 110.062 170.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.5 p -77.54 -13.28 59.95 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 122.977 0.511 . . . . 0.0 111.506 169.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 88.71 34.58 9.03 Favored Glycine 0 C--N 1.342 0.895 0 C-N-CA 124.079 0.847 . . . . 0.0 112.373 172.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -86.02 -54.12 4.67 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 117.493 0.647 . . . . 0.0 111.759 179.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.4 m -74.74 -16.62 60.73 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 118.511 -0.757 . . . . 0.0 112.21 -168.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -58.19 -35.97 72.41 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 119.605 1.093 . . . . 0.0 110.514 172.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -71.43 -40.85 70.14 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -179.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 34.4 mm -63.55 -43.5 98.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 177.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.03 -42.65 90.7 Favored 'General case' 0 CA--C 1.53 0.184 0 O-C-N 121.661 -0.65 . . . . 0.0 110.628 177.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -66.88 -39.77 87.59 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 118.434 -0.793 . . . . 0.0 111.087 176.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 63.0 mtt -61.77 -33.48 74.16 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 119.948 1.249 . . . . 0.0 111.499 176.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 26.1 mt -74.16 -49.55 32.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 175.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -59.78 -40.14 87.27 Favored 'General case' 0 C--O 1.225 -0.214 0 O-C-N 121.629 -0.669 . . . . 0.0 111.728 -176.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -63.57 -34.01 76.86 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 119.764 1.165 . . . . 0.0 111.171 -178.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -73.68 -41.29 62.85 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 122.722 0.409 . . . . 0.0 110.826 175.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.2 mp -74.75 -36.93 62.61 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 122.915 0.486 . . . . 0.0 111.25 -176.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.0 146.41 18.19 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 125.764 1.65 . . . . 0.0 110.85 -173.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 53.8 tptt -61.04 -31.66 71.3 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.565 1.146 . . . . 0.0 111.819 -175.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -68.0 -27.33 66.47 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.23 0.612 . . . . 0.0 111.192 178.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 39.0 t -96.89 -37.63 7.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 C-N-CA 124.248 1.019 . . . . 0.0 110.003 -175.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -135.55 137.17 41.75 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 119.252 0.933 . . . . 0.0 111.901 -174.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -119.08 158.34 26.05 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.861 0.864 . . . . 0.0 109.849 169.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 51.8 t -120.56 135.62 60.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 124.349 1.06 . . . . 0.0 110.543 -168.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -147.3 172.19 14.26 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.145 1.778 . . . . 0.0 111.456 -171.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -126.68 135.49 51.22 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 126.605 1.962 . . . . 0.0 106.364 170.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.0 tp -61.0 -18.54 18.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 123.759 0.824 . . . . 0.0 112.656 -172.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.99 -29.12 63.01 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 119.014 0.825 . . . . 0.0 111.304 178.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 45.7 mtmt -80.6 -24.15 39.33 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 122.922 0.489 . . . . 0.0 112.209 177.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 46.9 m -77.48 159.59 29.27 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.353 1.061 . . . . 0.0 113.337 -166.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.3 m -132.58 176.17 8.67 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 127.633 2.373 . . . . 0.0 106.632 169.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.5 tttm -50.11 -48.47 53.41 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.942 0.792 . . . . 0.0 111.96 -175.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -78.58 -11.95 59.99 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -173.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -69.96 -34.48 73.45 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.442 -0.786 . . . . 0.0 111.245 -176.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.3 mp -76.22 -35.25 59.12 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-O 119.103 -0.475 . . . . 0.0 110.832 172.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -64.25 -23.75 67.42 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 118.595 0.634 . . . . 0.0 112.175 -177.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.13 -28.87 69.73 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.78 0.832 . . . . 0.0 112.506 178.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -91.8 152.15 20.26 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 124.551 1.141 . . . . 0.0 109.68 176.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -109.92 -15.23 14.12 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.614 0.766 . . . . 0.0 111.8 174.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.4 mp -123.22 134.06 67.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 169.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 91.2 mt -124.3 147.88 47.83 Favored 'General case' 0 CA--C 1.518 -0.281 0 C-N-CA 123.651 0.781 . . . . 0.0 109.702 178.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.8 mt -130.99 107.46 9.11 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 177.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 76.2 mt -112.4 114.14 26.71 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -169.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -106.25 116.38 5.08 Favored Glycine 0 C--N 1.335 0.51 0 C-N-CA 125.475 1.512 . . . . 0.0 110.27 -177.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 16.1 tt -123.74 117.66 27.42 Favored Pre-proline 0 CA--C 1.541 0.609 0 CA-C-N 118.574 1.187 . . . . 0.0 111.749 -172.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -77.35 141.72 20.56 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 121.806 1.671 . . . . 0.0 109.288 168.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 35.3 m -91.03 142.72 27.47 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 172.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 51.0 m95 -132.96 172.66 12.32 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.948 2.099 . . . . 0.0 109.797 -175.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 33.92 53.61 0.51 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 128.918 2.887 . . . . 0.0 115.824 169.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 53.04 62.78 2.51 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.174 0.99 . . . . 0.0 111.28 176.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 87.43 52.12 3.11 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 123.713 0.673 . . . . 0.0 112.386 174.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -135.21 161.38 35.53 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.823 1.649 . . . . 0.0 108.628 171.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.12 165.57 21.47 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 168.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -67.01 147.77 52.79 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 169.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 57.9 m -53.28 -34.78 58.68 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.075 0.95 . . . . 0.0 112.741 -176.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -67.4 -44.26 79.29 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.156 0.582 . . . . 0.0 110.426 -176.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -71.4 -43.46 66.78 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.213 0.605 . . . . 0.0 109.474 176.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -60.21 -39.31 86.13 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.523 0.729 . . . . 0.0 111.737 -178.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -70.77 -24.7 62.65 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.955 0.902 . . . . 0.0 112.104 176.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -88.23 -23.59 23.5 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-O 118.326 -0.845 . . . . 0.0 112.156 178.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -51.11 -43.31 84.65 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-O 116.631 -1.652 . . . . 0.0 114.462 178.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -64.65 -15.39 49.8 Favored 'Trans proline' 0 CA--C 1.543 0.953 0 CA-C-N 122.8 2.036 . . . . 0.0 113.691 175.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.0 m -90.72 -38.84 12.79 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.783 1.233 . . . . 0.0 109.613 170.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 23.6 tp -57.84 -40.36 79.87 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 124.352 1.061 . . . . 0.0 109.946 -179.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -71.87 -7.05 46.13 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -86.15 -15.44 41.05 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 120.185 1.357 . . . . 0.0 110.412 173.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 65.1 mt -90.02 128.47 41.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 -174.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -87.5 139.54 30.44 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 168.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -126.38 20.52 7.36 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.492 1.117 . . . . 0.0 111.315 -175.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -50.55 -34.07 24.14 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 115.777 1.769 . . . . 0.0 115.777 -168.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -110.64 13.6 29.97 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-O 118.385 -1.231 . . . . 0.0 113.556 -178.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -112.33 146.97 37.34 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 119.602 1.701 . . . . 0.0 109.99 -169.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -95.83 141.88 28.75 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 176.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 16.4 t -134.76 143.04 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 173.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -124.61 145.46 49.61 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 169.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 88.9 mt -121.69 139.48 53.51 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -169.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -140.98 164.15 31.05 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 169.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -168.34 156.55 28.12 Favored Glycine 0 N--CA 1.443 -0.838 0 O-C-N 121.059 -1.026 . . . . 0.0 112.132 -178.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 33.5 m -122.32 152.65 39.9 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 -168.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -164.92 -153.38 7.47 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.501 -174.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -152.46 140.31 20.03 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.101 1.36 . . . . 0.0 110.331 -178.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -120.5 13.56 11.78 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.616 1.566 . . . . 0.0 110.816 -179.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -94.27 -43.78 8.27 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.344 1.057 . . . . 0.0 109.541 -178.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -127.82 -31.5 2.42 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.702 1.201 . . . . 0.0 111.789 177.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -90.04 24.8 2.33 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.522 0.729 . . . . 0.0 111.971 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.76 -19.34 64.9 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.212 1.405 . . . . 0.0 114.027 -170.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -99.49 7.71 45.15 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 119.527 1.058 . . . . 0.0 112.343 176.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -133.86 25.01 3.98 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 126.206 1.802 . . . . 0.0 109.494 176.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -65.84 122.56 17.59 Favored 'General case' 0 C--O 1.238 0.481 0 O-C-N 121.767 -0.583 . . . . 0.0 109.65 -168.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 93.5 m 50.61 33.85 8.75 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.669 1.588 . . . . 0.0 112.778 -177.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -52.48 -38.15 58.78 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 121.753 -0.592 . . . . 0.0 112.561 -177.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -73.12 -14.65 61.42 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -171.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -59.67 -39.3 84.02 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.158 -0.964 . . . . 0.0 111.281 -177.048 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -70.41 -23.02 77.81 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 123.239 0.447 . . . . 0.0 112.692 179.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.2 m -65.59 -29.86 70.52 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 118.28 1.04 . . . . 0.0 110.894 -177.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 6.4 mt -71.62 -48.81 50.27 Favored 'Isoleucine or valine' 0 C--N 1.345 0.372 0 CA-C-O 118.51 -0.757 . . . . 0.0 109.056 175.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 18.6 ttm-85 -53.03 -42.95 66.2 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 119.053 0.842 . . . . 0.0 109.806 178.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -59.18 -23.78 62.53 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -176.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 94.8 mt -95.2 -50.49 11.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 124.016 0.926 . . . . 0.0 109.84 175.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 20.0 pt -75.72 -24.48 16.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 119.194 0.906 . . . . 0.0 112.16 -168.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -67.93 -52.86 22.63 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-O 117.394 -1.288 . . . . 0.0 112.101 -179.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -65.77 -25.47 53.44 Favored 'Trans proline' 0 C--N 1.352 0.746 0 CA-C-N 122.137 1.799 . . . . 0.0 111.953 175.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 83.1 mmt-85 -75.82 5.31 6.51 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.03 0.932 . . . . 0.0 112.976 170.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 78.15 14.55 82.14 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-O 117.891 -1.505 . . . . 0.0 114.801 168.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.11 143.04 45.15 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 119.657 1.729 . . . . 0.0 109.19 171.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 69.7 m -88.7 125.91 35.07 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 104.419 -2.437 . . . . 0.0 104.419 167.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 21.5 mt -116.23 130.25 71.29 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 -169.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 29.8 m -130.36 175.28 11.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 124.403 1.081 . . . . 0.0 109.76 177.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 91.55 24.48 25.9 Favored Glycine 0 CA--C 1.528 0.888 0 CA-C-O 119.097 -0.835 . . . . 0.0 114.025 170.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 49.0 p-80 -60.96 150.66 32.69 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 119.262 1.531 . . . . 0.0 109.068 168.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 73.3 t-105 -136.62 133.62 19.15 Favored Pre-proline 0 CA--C 1.535 0.379 0 C-N-CA 123.697 0.799 . . . . 0.0 109.543 -169.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -69.76 146.37 59.99 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.385 2.057 . . . . 0.0 112.048 -176.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 68.4 p . . . . . 0 CA--C 1.538 0.496 0 C-N-CA 124.753 1.221 . . . . 0.0 111.814 174.545 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? . . . . . 0 N--CA 1.469 0.488 0 CA-C-O 119.238 -0.411 . . . . 0.0 111.45 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -74.57 0.57 55.38 Favored Glycine 0 CA--C 1.535 1.285 0 CA-C-N 118.813 0.733 . . . . 0.0 113.207 169.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 77.6 mt -63.05 142.63 58.31 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 119.111 1.456 . . . . 0.0 112.17 177.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -107.01 -27.86 10.39 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 125.932 1.693 . . . . 0.0 109.647 167.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -144.16 159.11 43.21 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 127.251 2.22 . . . . 0.0 106.291 175.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -53.01 -29.55 29.98 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -179.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -101.38 -7.32 23.04 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -137.91 133.25 33.59 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 120.798 1.636 . . . . 0.0 113.035 -170.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -76.25 149.01 37.23 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.436 1.095 . . . . 0.0 108.898 167.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 6.2 p -68.91 -17.61 22.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 124.977 1.311 . . . . 0.0 111.719 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -154.54 178.81 31.11 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 108.172 -1.971 . . . . 0.0 108.172 178.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -66.61 109.62 2.88 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 118.282 1.041 . . . . 0.0 108.21 173.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.418 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 171.851 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 68.6 mt . . . . . 0 N--CA 1.472 0.662 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 8.6 m -49.94 -60.1 3.24 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 126.812 2.045 . . . . 0.0 112.339 -168.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -74.73 -35.37 62.65 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 118.951 -0.547 . . . . 0.0 111.28 -167.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -67.52 -41.11 84.93 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 118.565 0.621 . . . . 0.0 110.517 176.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 64.5 mtp180 -62.02 -41.3 97.93 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 119.32 0.964 . . . . 0.0 110.537 176.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 84.9 t -70.79 -33.78 53.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-O 118.52 -0.752 . . . . 0.0 110.388 179.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -65.03 -49.53 69.78 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 120.916 1.689 . . . . 0.0 109.378 175.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -59.28 -34.84 72.76 Favored 'General case' 0 C--N 1.339 0.136 0 CA-C-O 118.599 -0.715 . . . . 0.0 110.973 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 35.8 t90 -73.03 -52.5 14.15 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 119.007 0.821 . . . . 0.0 110.728 178.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 77.1 t -65.86 -31.9 55.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 O-C-N 121.4 -0.813 . . . . 0.0 110.831 -171.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 55.8 mttm -60.21 -35.53 75.63 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 121.49 -0.756 . . . . 0.0 110.889 174.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 21.8 mm100 -70.85 -50.22 37.63 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 118.59 0.632 . . . . 0.0 110.928 173.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 2.3 pt -63.13 -30.82 50.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 119.221 0.919 . . . . 0.0 110.533 -174.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 50.8 m -61.87 -32.35 72.7 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 119.06 -0.495 . . . . 0.0 111.203 179.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -79.89 -40.89 27.31 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 119.219 0.918 . . . . 0.0 109.837 176.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -66.42 -34.88 78.94 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.455 0.702 . . . . 0.0 111.444 -177.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 95.5 mt -92.24 -1.56 57.04 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.958 1.703 . . . . 0.0 111.552 179.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 30.5 m80 56.73 21.17 5.67 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.166 1.786 . . . . 0.0 113.595 -174.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 72.5 mt . . . . . 0 N--CA 1.464 0.228 0 O-C-N 121.399 -0.813 . . . . 0.0 110.442 175.516 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.234 0 CA-C-O 120.731 0.3 . . . . 0.0 111.133 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.9 pt -106.35 -16.16 8.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 125.239 1.415 . . . . 0.0 110.926 178.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 53.7 m -112.04 124.38 52.29 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.485 1.514 . . . . 0.0 108.426 177.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -98.44 121.64 7.24 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 108.748 -1.741 . . . . 0.0 108.748 169.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 61.9 mt -96.14 96.16 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 103.773 -2.677 . . . . 0.0 103.773 176.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -99.17 119.42 37.84 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -133.5 156.72 47.26 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 123.402 0.681 . . . . 0.0 109.276 -169.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -131.93 144.82 16.57 Favored Glycine 0 C--N 1.336 0.576 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 169.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.0 m -141.14 161.85 36.88 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.208 1.403 . . . . 0.0 108.811 177.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -126.54 -54.16 1.45 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.033 0.533 . . . . 0.0 110.254 171.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.13 -3.06 56.94 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.036 0.934 . . . . 0.0 111.614 170.412 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 93.4 7.65 61.81 Favored Glycine 0 C--N 1.342 0.875 0 C-N-CA 124.561 1.077 . . . . 0.0 113.254 169.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -71.07 -43.3 68.06 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 118.657 1.228 . . . . 0.0 111.377 -173.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -65.62 -37.76 87.52 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 118.801 0.728 . . . . 0.0 110.037 -172.334 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.3 tp10 -59.79 -35.95 75.71 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.475 1.11 . . . . 0.0 111.342 179.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -64.07 -38.16 90.06 Favored 'General case' 0 CA--C 1.53 0.203 0 O-C-N 121.678 -0.638 . . . . 0.0 110.377 176.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.5 mm -68.97 -41.45 81.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 176.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.7 -39.28 70.81 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.122 0.874 . . . . 0.0 111.041 178.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -66.6 -45.72 78.24 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 118.843 -0.598 . . . . 0.0 110.856 173.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 69.1 mtm -63.86 -27.78 69.4 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 119.713 1.142 . . . . 0.0 112.003 178.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 61.6 mt -70.03 -56.19 12.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 172.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -57.55 -40.09 78.11 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.588 -0.695 . . . . 0.0 111.97 -177.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -62.98 -34.07 76.75 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 119.505 1.048 . . . . 0.0 111.522 -178.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -75.05 -41.48 58.99 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 122.849 0.46 . . . . 0.0 111.172 178.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -77.08 -32.26 56.61 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 118.886 0.766 . . . . 0.0 111.616 -177.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.07 143.54 11.47 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 124.952 1.263 . . . . 0.0 110.165 -169.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -63.58 -31.19 72.28 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.917 0.887 . . . . 0.0 111.947 -172.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -77.6 -7.66 56.71 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 46.4 t -105.28 -47.34 9.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 124.318 1.047 . . . . 0.0 109.157 176.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -131.44 140.32 49.58 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 119.386 0.994 . . . . 0.0 110.965 -176.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -132.86 147.74 52.3 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 176.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 58.0 t -99.75 137.59 26.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 C-N-CA 124.919 1.288 . . . . 0.0 110.48 -169.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -141.06 145.38 35.77 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.373 1.469 . . . . 0.0 109.392 -177.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -88.51 124.1 33.67 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 169.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.4 tp -58.32 -34.93 51.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 119.119 -0.467 . . . . 0.0 111.276 -174.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.84 -33.84 76.76 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 119.126 0.875 . . . . 0.0 112.318 -171.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -92.98 -7.61 45.4 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.125 0.57 . . . . 0.0 112.153 176.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 49.9 m -74.99 165.48 25.19 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.137 0.575 . . . . 0.0 110.096 179.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.3 m -128.72 158.94 37.19 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 124.241 1.017 . . . . 0.0 110.745 -170.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -51.2 -51.72 51.16 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.884 1.274 . . . . 0.0 111.373 -176.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -79.88 -14.27 58.77 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 122.542 0.337 . . . . 0.0 111.439 -173.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -76.67 -34.25 58.24 Favored 'General case' 0 C--N 1.34 0.166 0 O-C-N 121.599 -0.688 . . . . 0.0 111.045 -176.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.6 mp -65.76 -36.88 84.81 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 171.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -67.24 -19.47 65.53 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 123.039 0.536 . . . . 0.0 112.251 -174.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.53 -28.64 68.7 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.645 0.778 . . . . 0.0 112.05 177.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -89.37 152.46 21.5 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 123.93 0.892 . . . . 0.0 110.398 -176.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -92.51 -34.98 13.86 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.462 172.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 20.1 mt -113.78 137.99 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 -179.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 91.8 mt -124.89 134.87 52.52 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.666 0.786 . . . . 0.0 109.012 174.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.0 mp -112.85 116.2 29.67 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 104.821 -2.288 . . . . 0.0 104.821 168.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 66.6 mt -112.04 111.83 23.03 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 -172.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -105.19 106.69 2.71 Favored Glycine 0 C--N 1.338 0.648 0 C-N-CA 124.355 0.979 . . . . 0.0 112.336 -173.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.4 tp -124.62 107.44 29.21 Favored Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 126.114 1.766 . . . . 0.0 109.886 -168.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -76.21 141.74 23.58 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.095 1.863 . . . . 0.0 109.62 169.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 44.9 m -93.47 138.96 31.25 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 174.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 16.2 m95 -131.55 172.06 12.68 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 124.537 1.135 . . . . 0.0 110.606 -177.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 33.88 63.3 0.4 Allowed 'General case' 0 C--O 1.236 0.343 0 C-N-CA 128.22 2.608 . . . . 0.0 113.306 169.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.263 19.9 p90 49.67 58.96 4.86 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.633 1.173 . . . . 0.0 111.992 174.202 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.86 53.71 2.34 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-N 115.031 -0.986 . . . . 0.0 114.108 168.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -137.46 157.58 46.26 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 117.828 0.814 . . . . 0.0 110.283 167.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.84 150.59 32.23 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 168.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -62.59 152.41 35.11 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 169.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 60.9 m -57.96 -30.49 66.03 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.835 0.854 . . . . 0.0 111.83 -175.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -61.06 -39.07 88.46 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.922 0.889 . . . . 0.0 110.773 -179.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -85.09 -42.8 14.47 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 123.605 0.762 . . . . 0.0 110.671 175.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -61.51 -37.39 83.51 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.061 0.391 . . . . 0.0 111.828 -174.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -69.72 -21.96 63.43 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.529 0.732 . . . . 0.0 112.079 175.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -91.86 -23.65 19.59 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.6 0.76 . . . . 0.0 111.759 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -51.73 -41.57 78.89 Favored Pre-proline 0 CA--C 1.545 0.777 0 CA-C-O 116.539 -1.696 . . . . 0.0 114.763 179.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -64.38 -24.41 64.46 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 CA-C-N 122.991 2.104 . . . . 0.0 112.828 174.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.4 m -78.22 -40.57 37.02 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.257 0.935 . . . . 0.0 109.359 170.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 13.3 tp -59.5 -36.85 76.84 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.551 1.141 . . . . 0.0 111.151 -174.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -77.44 -6.65 54.21 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.893 0.877 . . . . 0.0 112.844 178.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 67.2 mt-10 -92.15 -23.28 19.46 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.432 1.014 . . . . 0.0 110.428 169.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 79.2 mt -73.14 147.61 9.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 176.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -116.91 137.74 52.01 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 176.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -124.82 16.11 8.65 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.458 1.103 . . . . 0.0 111.13 -171.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -59.73 126.74 28.8 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 120.062 1.301 . . . . 0.0 109.635 -179.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 72.3 2.79 55.4 Favored Glycine 0 CA--C 1.536 1.352 0 CA-C-O 118.121 -1.377 . . . . 0.0 114.605 -176.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -86.36 149.32 25.11 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 120.176 1.988 . . . . 0.0 108.036 173.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 14.9 mt -95.26 139.79 31.08 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 173.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.5 t -135.54 144.55 33.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 176.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -128.48 142.44 51.08 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 168.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 74.1 mt -105.29 149.7 25.79 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -178.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -140.15 146.76 39.21 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 176.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -165.31 143.21 8.28 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-N 119.555 1.07 . . . . 0.0 113.002 168.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 6.6 t -88.4 160.06 17.74 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 114.114 -1.043 . . . . 0.0 109.043 170.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -177.91 -174.53 44.32 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 -179.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -133.16 140.45 47.59 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.802 1.641 . . . . 0.0 109.543 174.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 22.0 pt20 -134.46 45.88 2.54 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.398 0.618 . . . . 0.0 110.584 169.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -109.17 -33.66 6.81 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.841 1.256 . . . . 0.0 108.83 168.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -127.84 -34.88 2.13 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 125.046 1.338 . . . . 0.0 111.367 173.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -90.29 26.37 1.95 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.038 0.935 . . . . 0.0 111.971 178.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.59 -14.89 62.08 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.014 -1.054 . . . . 0.0 113.685 -175.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -89.32 2.24 54.65 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 118.986 0.812 . . . . 0.0 111.868 173.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -142.58 11.86 1.89 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.152 1.381 . . . . 0.0 111.546 -173.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -67.8 127.55 33.22 Favored 'General case' 0 C--O 1.236 0.388 0 O-C-N 121.221 -0.924 . . . . 0.0 110.707 -168.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 85.2 m 50.99 31.77 6.71 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.085 1.354 . . . . 0.0 112.42 177.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -60.25 -38.44 83.47 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 121.777 -0.577 . . . . 0.0 111.354 -179.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.6 -21.96 62.6 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -169.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.9 mp -59.96 -38.02 81.26 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 119.063 0.847 . . . . 0.0 109.322 172.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.68 -34.48 88.73 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 111.306 -0.718 . . . . 0.0 111.306 175.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 4.7 m -65.68 -38.47 89.35 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.588 1.194 . . . . 0.0 110.364 177.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.1 mt -70.23 -46.1 73.11 Favored 'Isoleucine or valine' 0 C--N 1.343 0.323 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 175.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 37.5 ttt180 -53.42 -45.71 69.5 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 118.807 0.731 . . . . 0.0 110.579 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -61.85 -17.92 58.18 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.408 1.083 . . . . 0.0 112.571 -178.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 94.3 mt -95.69 -57.59 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 C-N-CA 123.997 0.919 . . . . 0.0 108.918 173.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 19.9 pt -69.05 -33.4 58.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 119.369 0.986 . . . . 0.0 112.203 -167.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -66.93 -54.06 23.01 Favored Pre-proline 0 CA--C 1.545 0.783 0 CA-C-O 117.816 -1.088 . . . . 0.0 111.006 -174.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.86 -22.39 36.53 Favored 'Trans proline' 0 C--N 1.353 0.786 0 CA-C-N 121.646 1.624 . . . . 0.0 112.677 175.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 30.4 mmm180 -79.68 11.31 3.24 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 119.015 0.825 . . . . 0.0 112.124 172.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 98.12 -2.57 59.73 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 125.463 1.506 . . . . 0.0 116.82 166.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.95 143.15 57.97 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 120.155 1.978 . . . . 0.0 111.059 -176.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 48.6 m -94.27 123.83 37.92 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 105.138 -2.171 . . . . 0.0 105.138 168.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 42.3 mt -105.86 131.77 54.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 -170.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 33.4 m -132.74 178.33 5.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 125.544 1.537 . . . . 0.0 109.258 177.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 77.35 22.89 69.44 Favored Glycine 0 CA--C 1.525 0.657 0 O-C-N 121.613 -0.679 . . . . 0.0 112.686 174.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 9.1 p-80 -61.5 113.88 2.92 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.313 1.045 . . . . 0.0 108.28 169.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 73.6 t-105 -84.06 140.85 40.02 Favored Pre-proline 0 CA--C 1.536 0.439 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 177.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -66.25 149.06 85.43 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 121.981 1.788 . . . . 0.0 111.296 179.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 81.2 p . . . . . 0 CA--C 1.537 0.469 0 C-N-CA 123.267 0.627 . . . . 0.0 111.118 169.707 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 60.0 mttt . . . . . 0 N--CA 1.47 0.551 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -76.88 0.96 64.3 Favored Glycine 0 CA--C 1.532 1.135 0 CA-C-O 118.93 -0.928 . . . . 0.0 113.214 168.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 8.3 mp -63.67 129.92 42.13 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 119.938 1.869 . . . . 0.0 110.277 178.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.06 -38.25 22.79 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.82 1.248 . . . . 0.0 108.058 167.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -153.94 166.68 32.22 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 129.548 3.139 . . . . 0.0 106.105 -174.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -52.67 -35.64 55.59 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.052 -1.03 . . . . 0.0 112.336 175.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -95.92 -7.37 36.85 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -174.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -146.28 141.09 26.98 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.814 1.188 . . . . 0.0 112.207 -172.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -83.93 160.87 20.99 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.003 1.321 . . . . 0.0 108.768 168.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 34.3 m -72.03 -7.16 8.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 O-C-N 120.963 -1.086 . . . . 0.0 112.872 179.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -166.64 -157.63 10.52 Favored Glycine 0 CA--C 1.521 0.42 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -76.97 96.24 4.32 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 169.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.346 0 N-CA-C 104.042 -2.577 . . . . 0.0 104.042 165.41 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 85.3 mt . . . . . 0 N--CA 1.463 0.194 0 CA-C-O 119.325 -0.369 . . . . 0.0 110.684 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 13.5 m -48.23 -55.61 10.07 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 123.946 0.899 . . . . 0.0 110.512 -175.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -61.85 -40.84 96.74 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.481 0.582 . . . . 0.0 111.121 -170.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -66.12 -49.92 65.8 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 177.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 87.4 mtt180 -58.73 -47.49 84.44 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 123.073 0.549 . . . . 0.0 110.219 -175.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 13.0 m -77.51 -33.69 19.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-O 118.611 -0.709 . . . . 0.0 110.729 -171.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -65.97 -47.81 73.35 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 119.841 1.2 . . . . 0.0 109.526 174.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -61.13 -40.37 93.56 Favored 'General case' 0 C--O 1.227 -0.11 0 CA-C-O 119.132 -0.461 . . . . 0.0 110.157 179.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 60.9 t90 -64.08 -47.7 79.06 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 118.71 0.686 . . . . 0.0 110.791 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 40.7 t -57.62 -40.55 75.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 118.265 0.484 . . . . 0.0 109.805 177.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 53.7 mttm -68.83 -36.96 78.82 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 118.353 -0.832 . . . . 0.0 110.227 -178.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -62.59 -55.35 27.97 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 119.106 0.867 . . . . 0.0 110.42 174.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 22.4 pt -68.58 -29.03 42.48 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.369 0 CA-C-O 119.015 -0.517 . . . . 0.0 110.409 -172.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 64.3 m -58.01 -29.67 65.49 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 119.011 0.823 . . . . 0.0 111.593 175.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -79.37 -45.46 19.51 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 119.64 1.109 . . . . 0.0 110.272 175.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -66.37 -35.03 79.3 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.516 0.726 . . . . 0.0 111.236 -175.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 73.6 mt -86.75 -3.59 59.07 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.075 1.75 . . . . 0.0 111.377 179.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 54.12 33.98 19.04 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.56 1.544 . . . . 0.0 112.51 -173.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 95.9 mt . . . . . 0 N--CA 1.464 0.265 0 O-C-N 121.549 -0.719 . . . . 0.0 110.359 173.228 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.66 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 22.4 pt -89.47 -18.96 7.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 O-C-N 121.623 -0.673 . . . . 0.0 112.091 -177.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.2 m -117.46 122.46 43.81 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 124.997 1.319 . . . . 0.0 107.521 178.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -98.45 114.28 4.97 Favored Glycine 0 C--N 1.334 0.472 0 N-CA-C 107.873 -2.091 . . . . 0.0 107.873 171.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 65.4 mt -94.69 106.75 18.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 104.872 -2.27 . . . . 0.0 104.872 174.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 11.7 m-30 -105.08 133.66 49.48 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 177.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -125.69 130.21 51.1 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.515 0.598 . . . . 0.0 112.149 -178.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -86.29 144.92 20.21 Favored Glycine 0 C--N 1.338 0.665 0 N-CA-C 108.738 -1.745 . . . . 0.0 108.738 168.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 11.0 m -158.27 169.76 23.77 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 119.12 1.46 . . . . 0.0 110.321 175.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -141.6 -49.45 0.4 Allowed 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.556 1.142 . . . . 0.0 109.124 168.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.3 p -80.56 -17.22 52.12 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.938 0.895 . . . . 0.0 112.171 170.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 103.95 7.41 41.38 Favored Glycine 0 C--N 1.342 0.885 0 C-N-CA 124.673 1.13 . . . . 0.0 113.99 171.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -65.13 -42.04 94.27 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 118.999 1.4 . . . . 0.0 112.069 -171.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -70.26 -18.41 63.13 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 118.942 0.792 . . . . 0.0 111.751 -170.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -58.81 -43.57 90.62 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 119.432 1.014 . . . . 0.0 110.036 174.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -64.4 -40.44 95.8 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 23.3 mm -66.42 -42.33 90.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 O-C-N 121.804 -0.56 . . . . 0.0 109.507 179.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.71 -40.08 86.76 Favored 'General case' 0 CA--C 1.532 0.253 0 O-C-N 121.721 -0.612 . . . . 0.0 110.579 176.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp -68.39 -39.43 81.72 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 118.336 -0.84 . . . . 0.0 111.145 176.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 64.1 mtt -59.51 -37.39 78.18 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 119.827 1.194 . . . . 0.0 110.976 175.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 51.9 mt -71.31 -51.38 34.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 177.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -62.13 -37.11 83.91 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 121.507 -0.745 . . . . 0.0 111.203 -174.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 59.1 tptt -63.13 -38.28 90.57 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 119.063 0.847 . . . . 0.0 110.812 -178.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -71.76 -41.62 68.2 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.952 0.501 . . . . 0.0 110.753 177.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.1 mp -73.21 -35.73 66.37 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.098 0.408 . . . . 0.0 111.24 -176.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 90.93 147.71 19.8 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 125.089 1.328 . . . . 0.0 110.771 -172.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -66.42 -28.3 68.51 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.694 0.798 . . . . 0.0 112.186 -171.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -69.04 -25.92 64.72 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 122.873 0.469 . . . . 0.0 111.348 176.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 31.6 t -98.52 -36.31 5.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 C-N-CA 124.481 1.112 . . . . 0.0 110.58 -174.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -135.33 144.76 46.86 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 118.777 0.717 . . . . 0.0 112.207 -177.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -129.32 154.65 46.66 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 125.288 1.435 . . . . 0.0 108.212 175.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 69.7 t -117.76 133.96 62.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 124.165 0.986 . . . . 0.0 108.901 -169.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -149.73 -174.78 4.79 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.218 1.007 . . . . 0.0 111.319 -177.639 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -135.02 141.31 46.14 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 125.224 1.41 . . . . 0.0 107.197 173.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.8 tp -59.49 -24.96 29.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 123.869 0.868 . . . . 0.0 112.906 -169.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.56 -27.81 69.21 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 118.729 0.695 . . . . 0.0 111.165 178.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -96.85 -33.78 11.52 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.751 1.22 . . . . 0.0 110.986 -179.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 19.8 m -60.38 162.11 6.56 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.332 0.653 . . . . 0.0 110.001 169.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.4 m -136.29 157.28 47.17 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.619 0.768 . . . . 0.0 110.449 -171.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -51.69 -51.71 53.86 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.23 1.012 . . . . 0.0 110.884 -179.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -75.24 -16.34 60.47 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 122.693 0.397 . . . . 0.0 111.587 -176.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -78.49 -37.98 41.99 Favored 'General case' 0 CA--C 1.53 0.19 0 O-C-N 121.541 -0.724 . . . . 0.0 110.213 179.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.0 mp -65.24 -35.05 79.86 Favored 'General case' 0 C--N 1.342 0.248 0 O-C-N 121.808 -0.558 . . . . 0.0 110.265 170.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -63.87 -23.85 67.51 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 118.81 0.732 . . . . 0.0 111.493 174.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -86.83 -31.4 20.85 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.941 0.896 . . . . 0.0 112.75 -178.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -67.55 160.17 28.28 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 123.994 0.917 . . . . 0.0 110.688 174.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -109.27 -40.17 5.01 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.493 0.717 . . . . 0.0 111.39 169.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.9 mt -112.47 125.19 69.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 177.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -113.9 132.19 56.01 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 171.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.0 mp -115.28 119.24 35.67 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 172.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 69.2 mt -117.41 109.46 16.81 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -172.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.78 123.07 6.63 Favored Glycine 0 CA--C 1.521 0.463 0 N-CA-C 108.949 -1.661 . . . . 0.0 108.949 176.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 3.4 tp -137.1 115.4 10.11 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-N 118.129 0.965 . . . . 0.0 110.125 -169.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -78.6 -173.22 1.77 Allowed 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 123.207 2.605 . . . . 0.0 109.986 169.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 95.5 m -144.45 145.96 32.19 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 119.99 -1.694 . . . . 0.0 107.592 169.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 75.0 m95 -139.71 169.74 17.17 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 125.144 1.378 . . . . 0.0 110.984 -169.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 55.88 -73.1 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 128.833 2.853 . . . . 0.0 114.642 175.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -161.76 56.25 0.26 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 127.239 2.216 . . . . 0.0 108.379 -174.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 81.72 19.66 65.33 Favored Glycine 0 CA--C 1.534 1.258 0 O-C-N 121.438 -0.789 . . . . 0.0 113.47 -179.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -88.31 154.29 20.53 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.416 1.108 . . . . 0.0 109.489 179.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.85 161.88 24.24 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 168.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.252 0.0 OUTLIER -70.93 159.85 33.94 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 170.413 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 57.7 m -53.71 -37.53 63.38 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 115.567 1.691 . . . . 0.0 115.567 -166.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -76.79 -43.97 34.63 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 119.046 0.839 . . . . 0.0 109.458 -170.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -64.18 -45.75 87.0 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.653 0.781 . . . . 0.0 109.446 173.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -58.76 -39.32 80.67 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 122.583 0.353 . . . . 0.0 111.732 179.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -71.22 -30.64 66.61 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.897 0.879 . . . . 0.0 112.253 176.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -87.34 -21.67 25.56 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 118.618 0.645 . . . . 0.0 112.562 -176.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 16.5 m-30 -50.08 -44.63 80.38 Favored Pre-proline 0 CA--C 1.546 0.799 0 CA-C-O 116.932 -1.509 . . . . 0.0 114.683 178.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -65.98 -16.32 52.1 Favored 'Trans proline' 0 CA--C 1.542 0.913 0 CA-C-N 122.598 1.964 . . . . 0.0 113.798 175.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 14.7 m -85.87 -40.31 16.09 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 119.481 1.037 . . . . 0.0 109.207 169.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 37.3 tp -59.71 -36.9 77.48 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.94 1.296 . . . . 0.0 111.572 -173.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -66.85 -15.58 63.72 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 177.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 -91.97 -14.26 29.78 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 119.261 0.937 . . . . 0.0 111.781 179.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 96.7 mt -80.65 138.39 19.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 -173.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -80.88 132.0 35.41 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.707 -0.678 . . . . 0.0 109.259 175.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -126.88 16.43 7.39 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 118.187 -0.911 . . . . 0.0 111.42 174.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 23.9 m-80 -59.41 114.31 2.62 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 120.542 1.519 . . . . 0.0 109.377 -175.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.65 4.6 66.26 Favored Glycine 0 CA--C 1.536 1.357 0 CA-C-O 118.69 -1.061 . . . . 0.0 114.123 -178.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -77.39 151.58 34.75 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 119.515 1.658 . . . . 0.0 108.224 171.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 17.8 mt -95.74 137.2 35.13 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 175.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.3 t -132.11 144.29 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 172.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -135.36 149.18 49.63 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 169.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 72.6 mt -120.52 149.13 42.9 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 -174.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -146.59 157.39 43.71 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 123.234 0.614 . . . . 0.0 109.55 172.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -170.2 166.34 39.57 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-O 122.305 0.947 . . . . 0.0 113.208 -175.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 15.2 t -142.64 162.18 36.14 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 126.754 2.021 . . . . 0.0 107.106 179.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -176.0 -170.71 39.07 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -139.42 142.88 37.44 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 127.086 2.154 . . . . 0.0 105.978 176.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.62 21.99 1.99 Allowed 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -172.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -64.5 -46.19 84.02 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 178.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -95.84 -38.18 10.41 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.174 0.59 . . . . 0.0 110.704 169.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -83.22 41.89 0.79 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.408 1.483 . . . . 0.0 111.551 -172.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.18 -21.14 66.45 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.823 1.249 . . . . 0.0 113.72 -169.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -97.36 2.85 51.05 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.716 1.207 . . . . 0.0 111.386 178.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -133.98 18.18 3.8 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.4 1.08 . . . . 0.0 112.481 -169.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -61.86 120.37 10.6 Favored 'General case' 0 CA--C 1.529 0.169 0 O-C-N 121.104 -0.997 . . . . 0.0 109.346 -176.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 80.1 m 45.88 35.76 2.51 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.557 1.543 . . . . 0.0 112.654 -176.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -49.48 -41.1 39.59 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.43 1.092 . . . . 0.0 111.911 -171.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.67 -13.88 62.47 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -171.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 34.1 mt -56.23 -41.84 76.32 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 119.837 1.199 . . . . 0.0 109.793 169.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.97 -36.42 93.05 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 178.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.0 m -62.71 -44.23 96.75 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 117.944 0.872 . . . . 0.0 109.906 177.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.7 mt -66.29 -45.48 89.64 Favored 'Isoleucine or valine' 0 C--N 1.344 0.357 0 CA-C-N 119.613 1.097 . . . . 0.0 108.908 178.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 45.6 ttt180 -54.64 -48.15 72.63 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 119.379 0.99 . . . . 0.0 110.43 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -62.08 -29.8 70.56 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.329 0.652 . . . . 0.0 111.603 -177.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 85.9 mt -81.53 -44.36 20.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-O 117.595 -1.193 . . . . 0.0 110.634 178.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.7 pt -86.88 -33.55 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 120.121 1.328 . . . . 0.0 113.003 -168.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -64.57 -37.85 27.23 Favored Pre-proline 0 CA--C 1.547 0.832 0 CA-C-O 117.946 -1.026 . . . . 0.0 112.008 -171.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -64.38 -17.1 58.5 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 122.417 2.078 . . . . 0.0 114.223 174.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 13.7 mmt180 -90.25 10.2 25.63 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.076 0.95 . . . . 0.0 111.536 -173.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 77.94 10.85 85.93 Favored Glycine 0 CA--C 1.531 1.06 0 CA-C-O 118.432 -1.205 . . . . 0.0 113.391 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -57.66 137.94 55.9 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 118.712 1.256 . . . . 0.0 109.426 171.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 55.8 m -93.96 120.87 34.8 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 168.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 36.9 mt -97.65 128.17 49.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 -176.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 34.6 m -128.79 175.44 10.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 124.983 1.313 . . . . 0.0 108.987 176.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 75.93 28.85 59.96 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-O 119.079 -0.845 . . . . 0.0 112.731 -177.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 81.4 m-70 -60.43 135.17 57.66 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 169.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 74.7 t-105 -129.99 139.7 36.44 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 124.248 1.019 . . . . 0.0 109.385 -169.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -62.08 162.39 22.99 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 121.781 1.654 . . . . 0.0 113.065 -178.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.536 0.408 0 C-N-CA 123.659 0.784 . . . . 0.0 112.015 174.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.534 0.335 0 CA-C-O 119.691 -0.195 . . . . 0.0 110.791 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -79.08 -4.9 89.05 Favored Glycine 0 C--N 1.341 0.815 0 CA-C-O 118.596 -1.114 . . . . 0.0 113.19 170.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 70.4 mt -68.96 120.09 14.3 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 120.402 2.101 . . . . 0.0 108.156 175.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -87.91 -28.69 21.37 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.635 1.174 . . . . 0.0 110.337 175.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -146.73 168.38 21.5 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.161 1.784 . . . . 0.0 107.403 171.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -57.25 -25.96 60.01 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.742 1.217 . . . . 0.0 113.57 -170.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -121.43 11.34 10.67 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.349 1.46 . . . . 0.0 113.163 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -142.72 127.53 18.22 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-N 119.404 1.002 . . . . 0.0 111.593 -175.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -80.64 152.99 28.21 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 125.061 1.344 . . . . 0.0 109.658 169.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 12.2 p -59.73 -24.95 30.58 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 C-N-CA 124.76 1.224 . . . . 0.0 111.654 171.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -156.72 171.82 34.32 Favored Glycine 0 C--N 1.337 0.629 0 C-N-CA 124.763 1.173 . . . . 0.0 110.53 -169.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -60.24 127.26 30.91 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.361 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 170.146 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 66.9 mt . . . . . 0 N--CA 1.469 0.519 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 74.3 m -47.08 -56.98 5.55 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.806 1.643 . . . . 0.0 111.992 -169.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -69.59 -39.37 77.33 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 119.245 -0.407 . . . . 0.0 111.27 -168.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -73.52 -35.04 65.53 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.456 0.571 . . . . 0.0 111.118 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 33.2 mtp180 -64.8 -41.11 96.06 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 119.341 0.973 . . . . 0.0 109.892 174.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 72.4 t -67.89 -41.33 84.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-O 118.592 -0.718 . . . . 0.0 109.634 177.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -59.26 -50.78 72.71 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 120.134 1.334 . . . . 0.0 110.283 176.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 58.1 mttm -57.41 -42.92 83.24 Favored 'General case' 0 CA--C 1.522 -0.115 0 CA-C-O 118.652 -0.69 . . . . 0.0 109.994 -178.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 60.5 t90 -66.43 -48.55 69.64 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 118.546 0.612 . . . . 0.0 110.797 -178.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 53.6 t -60.87 -36.2 70.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 118.107 0.412 . . . . 0.0 109.95 -177.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -65.94 -33.91 76.91 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 118.427 -0.797 . . . . 0.0 110.438 177.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 41.5 mm-40 -65.58 -54.77 23.31 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 119.015 0.825 . . . . 0.0 110.534 171.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 5.7 pt -64.65 -29.91 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-N 118.807 0.731 . . . . 0.0 110.633 -170.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 49.6 m -60.09 -27.01 66.64 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 118.646 -0.692 . . . . 0.0 111.774 178.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -82.41 -38.11 24.55 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 119.644 1.111 . . . . 0.0 110.717 175.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -71.36 -36.78 71.6 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.136 0.574 . . . . 0.0 111.133 -178.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 85.7 mt -85.75 -5.75 59.21 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.749 1.62 . . . . 0.0 111.306 178.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 84.7 m-70 54.63 29.99 12.49 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.81 1.644 . . . . 0.0 112.88 -171.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 80.0 mt . . . . . 0 N--CA 1.465 0.287 0 CA-C-O 118.668 -0.682 . . . . 0.0 110.723 173.324 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 ptt? . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 111.564 0.209 . . . . 0.0 111.564 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.73 155.29 26.96 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.507 0.723 . . . . 0.0 110.634 175.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.1 pt -102.1 -16.85 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 123.962 0.905 . . . . 0.0 111.718 -179.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 16.4 m -114.58 126.89 55.43 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.682 1.593 . . . . 0.0 108.671 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -102.52 119.93 6.63 Favored Glycine 0 CA--C 1.52 0.348 0 N-CA-C 107.816 -2.114 . . . . 0.0 107.816 169.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 43.5 mt -96.22 124.54 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 104.405 -2.443 . . . . 0.0 104.405 172.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -122.84 130.18 52.57 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 176.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -129.47 130.78 46.32 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 119.615 1.098 . . . . 0.0 112.551 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -81.78 152.76 32.13 Favored Glycine 0 C--N 1.339 0.697 0 N-CA-C 108.102 -1.999 . . . . 0.0 108.102 168.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 16.8 p -153.27 166.04 33.84 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 120.128 1.964 . . . . 0.0 111.413 -176.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -144.49 -58.4 0.37 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.588 0.755 . . . . 0.0 109.745 168.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.2 p -83.36 -12.42 56.55 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.691 1.197 . . . . 0.0 111.875 175.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.06 7.84 59.39 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 124.714 1.15 . . . . 0.0 113.059 175.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -65.9 -37.74 86.89 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 118.459 1.129 . . . . 0.0 110.929 -176.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.82 -24.5 66.17 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.437 0.695 . . . . 0.0 111.914 -175.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -62.21 -40.97 97.88 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 119.114 0.87 . . . . 0.0 109.733 177.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -66.28 -37.79 86.27 Favored 'General case' 0 CA--C 1.529 0.141 0 O-C-N 122.13 -0.356 . . . . 0.0 110.123 178.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 27.1 mm -62.77 -48.9 85.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 175.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.1 -39.41 86.06 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.331 0.514 . . . . 0.0 111.156 -178.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 57.8 mttm -67.99 -42.93 80.01 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 118.52 -0.752 . . . . 0.0 111.223 175.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 75.1 mtm -64.78 -28.09 69.34 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 119.938 1.245 . . . . 0.0 111.506 178.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 83.6 mt -68.63 -57.73 8.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 169.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -59.16 -39.9 83.92 Favored 'General case' 0 C--O 1.226 -0.152 0 C-N-CA 122.938 0.495 . . . . 0.0 111.601 -171.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -64.54 -34.08 77.4 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 118.616 0.644 . . . . 0.0 111.435 -176.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -73.0 -47.58 43.9 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 118.159 0.436 . . . . 0.0 110.332 177.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 54.2 mt -67.18 -34.05 76.69 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 122.698 0.399 . . . . 0.0 111.594 -178.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.59 145.95 17.73 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 125.587 1.565 . . . . 0.0 110.762 -173.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -63.52 -28.72 70.14 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.765 0.826 . . . . 0.0 111.81 -176.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -66.88 -23.91 66.06 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.092 0.557 . . . . 0.0 111.349 176.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 53.1 t -101.3 -39.11 6.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 124.592 1.157 . . . . 0.0 110.441 -175.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -132.68 145.03 50.72 Favored 'General case' 0 C--N 1.342 0.245 0 CA-C-N 119.539 1.063 . . . . 0.0 112.111 -173.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -127.01 158.68 36.29 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.754 1.222 . . . . 0.0 109.757 172.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 71.0 t -119.27 138.08 51.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 125.021 1.328 . . . . 0.0 110.257 -169.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -146.35 166.54 26.01 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.847 1.659 . . . . 0.0 111.815 -170.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -126.82 135.53 51.14 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 105.357 -2.09 . . . . 0.0 105.357 168.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.9 tp -61.97 -17.2 17.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-N 118.88 0.763 . . . . 0.0 112.99 -170.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -52.32 -37.24 55.38 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.172 0.989 . . . . 0.0 112.339 179.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.15 1.43 57.15 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.632 0.773 . . . . 0.0 112.664 -177.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 52.5 m -87.89 157.68 18.91 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 122.374 1.083 . . . . 0.0 112.204 -174.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 23.7 m -129.23 172.51 11.38 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 127.971 2.509 . . . . 0.0 104.894 167.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.5 ptmm? -58.41 -38.69 77.91 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 120.059 1.299 . . . . 0.0 111.264 -173.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -71.51 -17.12 62.35 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.87 -0.519 . . . . 0.0 111.884 -176.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -68.23 -27.05 66.03 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.69 0.796 . . . . 0.0 111.039 -175.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.3 mp -86.97 -40.19 15.01 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 123.445 0.698 . . . . 0.0 109.845 171.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -63.74 -20.93 66.14 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.275 0.63 . . . . 0.0 111.921 -175.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.36 -29.96 70.23 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.278 1.031 . . . . 0.0 112.456 174.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -96.88 151.46 19.65 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.438 1.095 . . . . 0.0 110.669 -177.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -87.25 -37.95 16.76 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.556 170.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 22.2 mt -110.54 136.44 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -177.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 74.8 mt -132.42 120.84 22.53 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 124.139 0.976 . . . . 0.0 108.558 -176.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 8.9 mp -109.67 107.39 17.42 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 105.534 -2.024 . . . . 0.0 105.534 177.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 68.0 mt -110.17 100.85 9.68 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -170.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.97 131.73 10.8 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 124.726 1.155 . . . . 0.0 110.247 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.1 tt -142.26 122.32 8.15 Favored Pre-proline 0 CA--C 1.54 0.595 0 CA-C-N 118.358 1.079 . . . . 0.0 110.215 -179.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -81.07 161.51 20.63 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 123.07 2.513 . . . . 0.0 109.33 169.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 62.2 m -118.46 141.52 48.48 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 173.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 64.9 m95 -134.6 173.84 11.21 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 124.913 1.285 . . . . 0.0 109.442 -177.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 28.73 64.2 0.11 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 127.546 2.338 . . . . 0.0 114.479 169.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 56.73 62.84 2.13 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.445 1.098 . . . . 0.0 111.66 175.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.53 14.87 72.52 Favored Glycine 0 CA--C 1.532 1.138 0 CA-C-N 115.952 -0.567 . . . . 0.0 114.274 171.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -78.07 143.55 37.3 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 124.869 1.268 . . . . 0.0 110.117 176.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -93.89 143.94 25.89 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.342 1.057 . . . . 0.0 109.027 169.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -58.9 146.41 37.74 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.979 0.419 . . . . 0.0 110.592 177.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 60.8 m -59.25 -33.04 70.55 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.169 0.988 . . . . 0.0 112.97 -168.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -66.44 -43.7 84.89 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.247 0.476 . . . . 0.0 109.901 -178.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -71.81 -43.16 66.1 Favored 'General case' 0 C--N 1.341 0.204 0 C-N-CA 123.02 0.528 . . . . 0.0 110.029 176.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -59.15 -41.56 88.61 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 118.358 0.526 . . . . 0.0 111.858 -178.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -69.3 -23.32 63.8 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.76 0.824 . . . . 0.0 112.095 176.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -90.09 -20.76 22.78 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 118.277 -0.868 . . . . 0.0 112.302 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -51.96 -41.49 79.79 Favored Pre-proline 0 CA--C 1.544 0.72 0 CA-C-O 116.706 -1.616 . . . . 0.0 114.577 178.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -65.21 -13.89 42.17 Favored 'Trans proline' 0 CA--C 1.544 0.983 0 CA-C-N 122.809 2.039 . . . . 0.0 114.073 174.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 30.5 m -93.42 -36.15 12.64 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.46 1.104 . . . . 0.0 109.803 169.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 25.9 tp -56.1 -40.14 73.23 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 124.225 1.01 . . . . 0.0 110.501 178.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -72.78 1.11 9.13 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 178.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -112.55 -7.27 13.9 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.455 1.025 . . . . 0.0 111.52 174.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 62.7 mt -75.18 139.86 18.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -177.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -75.4 117.33 17.08 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 171.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -109.95 6.38 23.12 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 118.191 -0.909 . . . . 0.0 111.183 173.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 -60.62 116.91 4.72 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 120.754 1.616 . . . . 0.0 109.281 -175.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 74.61 -1.29 52.94 Favored Glycine 0 CA--C 1.535 1.315 0 CA-C-O 118.307 -1.274 . . . . 0.0 113.935 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -67.68 137.25 55.4 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 120.039 1.919 . . . . 0.0 107.428 172.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 17.8 mt -89.24 129.33 35.83 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 172.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.1 t -129.64 136.24 59.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -175.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -129.81 147.47 51.58 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 125.115 1.366 . . . . 0.0 107.326 175.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 69.2 mt -120.34 148.51 43.65 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -176.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -143.5 157.53 44.36 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.229 0.612 . . . . 0.0 110.654 175.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -175.47 172.34 45.37 Favored Glycine 0 CA--C 1.525 0.714 0 CA-C-O 122.634 1.13 . . . . 0.0 112.3 -178.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 4.3 m -142.76 158.65 43.43 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.369 1.868 . . . . 0.0 106.749 -173.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -169.76 -174.5 38.09 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 120.072 -1.061 . . . . 0.0 114.961 -177.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -144.29 140.38 29.14 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 129.834 3.254 . . . . 0.0 104.473 177.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.15 16.49 1.19 Allowed 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.739 1.216 . . . . 0.0 112.104 -171.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -63.82 -48.62 76.08 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.653 0.66 . . . . 0.0 109.316 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -98.78 -30.4 12.44 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.035 0.534 . . . . 0.0 111.136 171.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -83.91 42.59 0.87 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.711 1.605 . . . . 0.0 110.298 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.46 -17.32 59.2 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 -167.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -108.88 5.46 24.49 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.801 0.841 . . . . 0.0 112.594 176.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -126.14 15.31 7.86 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.683 1.193 . . . . 0.0 113.015 -169.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -62.9 121.94 14.75 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 119.588 1.086 . . . . 0.0 109.528 -177.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 82.4 m 47.12 35.98 3.98 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.709 1.604 . . . . 0.0 112.303 -177.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -50.19 -42.69 51.74 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.026 1.33 . . . . 0.0 111.655 -173.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.78 -12.02 61.02 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -170.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 82.2 mt -56.94 -42.17 79.56 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 119.143 0.883 . . . . 0.0 109.614 169.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.0 -34.28 88.38 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 111.246 -0.742 . . . . 0.0 111.246 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 4.7 m -64.18 -41.84 96.94 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 117.95 0.875 . . . . 0.0 110.578 -178.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 8.5 mt -72.16 -47.09 55.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 176.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 50.5 tpt85 -57.62 -33.02 67.82 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.488 0.715 . . . . 0.0 112.119 -175.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -70.42 -29.68 66.35 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 123.432 0.693 . . . . 0.0 112.29 179.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 94.6 mt -90.68 -40.33 12.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 123.52 0.728 . . . . 0.0 110.142 -173.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 15.4 pt -74.32 -32.39 31.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 118.853 0.751 . . . . 0.0 111.991 -169.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -63.37 -53.89 48.97 Favored Pre-proline 0 CA--C 1.541 0.596 0 CA-C-O 117.363 -1.303 . . . . 0.0 112.26 -178.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -66.22 -24.6 51.0 Favored 'Trans proline' 0 C--N 1.352 0.739 0 CA-C-N 121.942 1.729 . . . . 0.0 112.223 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -77.69 0.92 21.58 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 118.718 0.69 . . . . 0.0 112.205 171.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 100.25 11.17 43.01 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-O 118.208 -1.329 . . . . 0.0 115.469 168.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.33 150.11 40.34 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 119.292 1.546 . . . . 0.0 111.475 178.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 62.0 m -104.99 123.91 48.61 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 105.482 -2.044 . . . . 0.0 105.482 167.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 12.3 mm -91.79 138.87 18.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 -171.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 27.1 m -136.86 173.33 13.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 124.751 1.22 . . . . 0.0 109.114 170.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 81.95 43.42 8.23 Favored Glycine 0 C--N 1.337 0.628 0 CA-C-O 119.229 -0.761 . . . . 0.0 114.719 169.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 20.4 p80 -62.57 158.2 18.68 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 118.265 1.032 . . . . 0.0 109.716 168.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 77.5 t-105 -141.33 131.35 12.95 Favored Pre-proline 0 CA--C 1.534 0.331 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -68.4 145.19 64.39 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 121.912 1.741 . . . . 0.0 112.117 -173.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 57.1 p -77.18 -30.39 54.85 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.119 0.568 . . . . 0.0 110.926 171.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 54.06 43.08 31.26 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.283 1.833 . . . . 0.0 110.667 -169.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.86 76.5 0.89 Allowed Glycine 0 C--N 1.339 0.718 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -176.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -49.69 131.2 21.66 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.074 0.55 . . . . 0.0 109.728 171.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -98.11 -26.68 14.5 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 -168.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -91.27 -171.57 3.0 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.437 0.695 . . . . 0.0 111.34 -168.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -67.9 -50.36 56.72 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 123.461 0.704 . . . . 0.0 111.727 -168.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -160.34 165.39 31.34 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 123.443 0.697 . . . . 0.0 110.332 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 2.4 p -152.91 135.55 15.27 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 169.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -88.36 -10.61 48.81 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 121.507 -0.746 . . . . 0.0 111.751 -173.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -77.82 -2.72 82.43 Favored Glycine 0 CA--C 1.531 1.065 0 CA-C-O 118.573 -1.126 . . . . 0.0 112.969 172.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 96.5 mt -66.51 133.29 50.06 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 120.171 1.986 . . . . 0.0 110.019 178.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -97.17 -33.82 11.35 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 166.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -145.58 162.77 36.69 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 127.378 2.271 . . . . 0.0 106.704 169.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -55.01 -28.01 48.76 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 118.942 0.792 . . . . 0.0 112.04 174.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -84.64 -19.68 32.54 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.468 1.107 . . . . 0.0 113.671 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 32.2 p-80 -153.31 137.63 16.62 Favored 'General case' 0 C--N 1.345 0.4 0 CA-C-O 123.064 1.411 . . . . 0.0 114.257 -176.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -73.05 154.09 40.59 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 125.436 1.494 . . . . 0.0 109.245 168.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 4.9 p -76.32 -18.07 15.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 124.546 1.138 . . . . 0.0 111.745 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -141.9 171.66 24.39 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 125.634 1.587 . . . . 0.0 109.373 177.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -59.03 130.15 45.61 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 172.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -139.4 95.81 2.99 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 178.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 9.5 pt -89.49 136.68 23.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-O 121.189 0.519 . . . . 0.0 111.811 -174.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -158.99 143.75 15.8 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 127.016 2.126 . . . . 0.0 107.682 173.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -153.87 101.78 2.47 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 172.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 23.5 t0 54.86 69.24 0.75 Allowed 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 122.676 1.227 . . . . 0.0 111.817 -174.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . 0.305 8.5 ptm180 58.24 6.9 0.58 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 128.298 2.639 . . . . 0.0 116.909 174.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -142.49 157.71 61.94 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-N 120.079 1.309 . . . . 0.0 108.333 175.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -73.93 114.02 3.93 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 121.789 1.66 . . . . 0.0 110.189 171.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -148.02 171.36 15.96 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 124.61 1.164 . . . . 0.0 108.481 167.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 18.1 mt 55.47 37.81 29.4 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.483 1.113 . . . . 0.0 109.032 -167.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 44.6 m -69.8 -48.18 60.06 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 126.118 1.767 . . . . 0.0 112.388 -168.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -60.85 -42.91 98.74 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -166.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -64.49 -37.87 89.04 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 118.319 0.509 . . . . 0.0 110.434 178.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 53.5 mtt85 -70.54 -44.48 67.41 Favored 'General case' 0 C--N 1.339 0.119 0 O-C-N 121.622 -0.674 . . . . 0.0 110.68 -178.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 22.5 m -73.79 -26.81 21.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 CA-C-O 118.523 -0.751 . . . . 0.0 110.613 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -62.0 -51.12 69.3 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 120.247 1.385 . . . . 0.0 109.13 170.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -58.43 -43.95 88.92 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 118.179 0.445 . . . . 0.0 110.542 179.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 73.2 t90 -67.02 -44.34 80.52 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 118.934 0.788 . . . . 0.0 110.689 -177.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 54.7 t -62.48 -38.95 82.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 55.8 mttm -66.7 -38.81 87.5 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.176 -0.952 . . . . 0.0 110.091 179.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 42.0 mm-40 -62.61 -50.94 69.25 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-N 118.538 0.608 . . . . 0.0 110.9 175.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 29.4 pt -64.7 -33.92 66.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-N 119.341 0.973 . . . . 0.0 109.973 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 57.6 m -61.76 -24.46 66.84 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 117.766 -1.111 . . . . 0.0 112.597 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -95.15 -11.32 28.35 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 120.317 1.417 . . . . 0.0 112.677 175.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -85.44 -40.03 16.87 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 119.183 0.901 . . . . 0.0 110.082 169.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 64.1 mt -84.64 -12.91 53.02 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.668 1.987 . . . . 0.0 111.609 -179.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 56.85 32.12 20.83 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.762 1.625 . . . . 0.0 112.419 -170.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 58.3 mt -75.88 -19.55 58.77 Favored 'General case' 0 C--N 1.342 0.258 0 O-C-N 121.752 -0.592 . . . . 0.0 110.733 169.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -59.78 -43.26 94.48 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 119.246 0.93 . . . . 0.0 110.377 -175.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -73.76 -6.64 48.18 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 179.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 38.9 mt -93.63 -48.61 13.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 171.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 3.4 pp -78.08 -27.88 48.63 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 -170.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -90.14 -7.01 54.72 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 118.922 0.783 . . . . 0.0 113.03 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.344 0 C-N-CA 123.31 0.644 . . . . 0.0 109.924 176.676 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.4 ttt . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.17 149.55 41.24 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.498 0.719 . . . . 0.0 110.516 175.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.0 pt -85.91 -27.09 6.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 123.087 0.555 . . . . 0.0 111.145 178.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 49.3 m -111.92 120.59 42.44 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.295 1.038 . . . . 0.0 109.318 -178.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -94.51 116.06 5.2 Favored Glycine 0 CA--C 1.52 0.376 0 N-CA-C 107.048 -2.421 . . . . 0.0 107.048 169.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 72.7 mt -95.21 97.1 6.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 104.852 -2.277 . . . . 0.0 104.852 176.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -91.71 137.83 32.05 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 176.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -136.93 159.48 41.74 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 123.592 0.757 . . . . 0.0 110.644 -176.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -131.31 147.47 18.55 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 107.739 -2.144 . . . . 0.0 107.739 167.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 29.6 m -168.44 143.02 3.36 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.375 1.588 . . . . 0.0 109.589 -179.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -91.07 -45.15 8.86 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 122.53 0.332 . . . . 0.0 111.001 170.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 82.5 p -107.47 9.13 29.7 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.014 0.926 . . . . 0.0 112.563 -175.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 79.72 13.34 82.51 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 124.128 0.87 . . . . 0.0 114.452 178.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -72.42 -46.17 56.31 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 119.515 1.658 . . . . 0.0 111.582 -177.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.5 m -74.32 -25.17 59.39 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 119.471 1.032 . . . . 0.0 109.896 179.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -58.64 -40.89 84.66 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.214 -0.929 . . . . 0.0 110.3 169.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -64.0 -36.6 84.52 Favored 'General case' 0 CA--C 1.532 0.282 0 O-C-N 121.48 -0.762 . . . . 0.0 110.905 178.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 29.6 mm -64.29 -45.99 94.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 174.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.21 -41.53 79.61 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.475 0.58 . . . . 0.0 111.215 178.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -67.86 -42.88 80.66 Favored 'General case' 0 N--CA 1.463 0.212 0 O-C-N 121.738 -0.601 . . . . 0.0 110.994 178.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.38 -23.37 64.66 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 119.248 0.931 . . . . 0.0 112.008 178.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 59.1 mt -71.22 -54.98 15.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 169.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -59.98 -38.16 81.72 Favored 'General case' 0 C--O 1.225 -0.234 0 CA-C-O 118.928 -0.558 . . . . 0.0 111.6 -173.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -59.13 -37.99 78.54 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 118.925 0.784 . . . . 0.0 110.885 -176.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -72.52 -39.93 67.2 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.101 0.561 . . . . 0.0 111.316 178.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.3 mp -75.17 -33.59 61.48 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.031 0.378 . . . . 0.0 111.131 -176.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.64 149.42 14.32 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.878 1.228 . . . . 0.0 110.93 -172.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -64.32 -28.47 69.73 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.884 0.873 . . . . 0.0 111.911 -173.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -66.87 -25.93 66.64 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.081 0.552 . . . . 0.0 111.426 178.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 39.3 t -100.75 -42.15 9.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 124.357 1.063 . . . . 0.0 109.999 -175.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -131.7 145.63 51.74 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 119.124 0.874 . . . . 0.0 111.584 -174.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -135.67 139.11 43.47 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 123.616 0.766 . . . . 0.0 109.777 178.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 92.9 t -101.99 135.07 40.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 C-N-CA 124.373 1.069 . . . . 0.0 109.523 -170.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 79.2 m-70 -141.31 137.08 32.17 Favored 'General case' 0 C--N 1.339 0.138 0 C-N-CA 124.62 1.168 . . . . 0.0 111.112 -173.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.31 131.6 43.67 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 168.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.6 tp -68.56 -33.52 60.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 O-C-N 121.551 -0.718 . . . . 0.0 111.402 -179.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.87 -40.24 94.82 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.98 0.809 . . . . 0.0 112.108 -169.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -75.27 -17.69 60.24 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 118.149 0.431 . . . . 0.0 112.038 178.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 53.1 m -75.84 163.63 27.04 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.444 0.64 . . . . 0.0 111.108 -169.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 47.1 m -127.33 168.45 14.78 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.159 1.383 . . . . 0.0 109.587 -175.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -52.05 -46.15 64.98 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.545 1.138 . . . . 0.0 111.756 -173.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -74.15 -14.4 60.95 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 122.823 0.449 . . . . 0.0 111.827 -173.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -78.82 -30.58 45.42 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 121.393 -0.817 . . . . 0.0 111.248 -170.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.2 mp -79.45 -39.18 32.89 Favored 'General case' 0 C--N 1.345 0.391 0 O-C-N 122.109 -0.37 . . . . 0.0 110.195 171.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -55.35 -28.52 54.39 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.266 1.027 . . . . 0.0 112.274 -176.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.44 -29.39 69.52 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.195 0.998 . . . . 0.0 113.438 -178.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -88.12 156.6 19.17 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.068 0.947 . . . . 0.0 110.591 -175.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -99.94 -32.32 11.03 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 123.056 0.542 . . . . 0.0 111.393 170.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.1 mp -108.77 128.16 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 172.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -114.7 128.23 56.2 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 170.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.2 mp -109.63 126.84 54.06 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 169.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 67.2 mt -123.18 118.23 27.16 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -169.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -111.66 102.66 1.44 Allowed Glycine 0 C--N 1.336 0.528 0 C-N-CA 125.464 1.507 . . . . 0.0 111.881 -170.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 17.3 tt -127.34 117.17 21.53 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 123.406 0.682 . . . . 0.0 112.165 -169.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -82.6 150.71 14.83 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 122.883 2.389 . . . . 0.0 110.321 168.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.8 m -96.83 137.98 35.08 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 178.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 19.9 m95 -133.15 175.27 9.53 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.166 1.386 . . . . 0.0 111.129 -171.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 51.06 -91.79 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 128.268 2.627 . . . . 0.0 113.445 -178.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -152.57 81.61 1.23 Allowed 'General case' 0 C--O 1.235 0.318 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 176.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 63.22 50.82 59.77 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 -175.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -121.28 154.15 36.75 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 124.583 1.153 . . . . 0.0 108.326 175.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -73.2 147.93 44.25 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.068 0.461 . . . . 0.0 110.387 169.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 16.2 tp60 -56.22 142.66 36.47 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 167.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 56.8 m -56.2 -32.05 64.03 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.05 0.94 . . . . 0.0 112.41 -170.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -57.08 -43.72 82.4 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 123.919 0.887 . . . . 0.0 110.491 178.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -81.94 -41.25 21.11 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 123.664 0.786 . . . . 0.0 110.579 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -58.01 -39.18 77.67 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.154 0.433 . . . . 0.0 111.325 -178.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -70.36 -25.85 63.46 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.466 0.706 . . . . 0.0 112.033 176.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -90.88 -23.28 20.57 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 118.613 -0.708 . . . . 0.0 112.567 -177.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 20.7 m-30 -49.36 -42.06 61.76 Favored Pre-proline 0 CA--C 1.542 0.652 0 CA-C-O 116.457 -1.735 . . . . 0.0 115.114 -178.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -64.32 -18.11 62.04 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 CA-C-N 122.934 2.084 . . . . 0.0 113.474 176.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 25.0 m -88.45 -42.4 12.16 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.095 0.958 . . . . 0.0 109.591 169.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 27.3 tp -55.8 -38.82 70.45 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.308 1.043 . . . . 0.0 111.284 -177.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -70.82 -7.75 47.59 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -178.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -95.2 -17.64 21.57 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 119.712 1.142 . . . . 0.0 111.739 171.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 97.6 mt -77.04 133.82 30.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 -173.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -82.35 140.01 33.76 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.023 0.929 . . . . 0.0 109.496 175.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -129.58 11.01 5.71 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 118.368 -0.825 . . . . 0.0 111.469 174.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -66.6 123.59 20.49 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 120.742 1.61 . . . . 0.0 109.621 -172.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.72 2.45 50.9 Favored Glycine 0 CA--C 1.537 1.443 0 CA-C-O 117.965 -1.464 . . . . 0.0 114.088 -174.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -79.81 150.25 30.77 Favored 'General case' 0 C--N 1.345 0.385 0 CA-C-N 120.222 2.011 . . . . 0.0 107.722 170.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 19.9 mt -91.71 137.45 32.36 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 171.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 16.0 t -133.73 142.73 40.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 177.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -134.3 151.0 51.02 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 170.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -113.54 145.71 40.79 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 124.367 1.067 . . . . 0.0 109.022 -174.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -143.42 159.03 43.14 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 166.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 179.31 177.4 47.69 Favored Glycine 0 N--CA 1.447 -0.598 0 O-C-N 121.184 -0.947 . . . . 0.0 113.282 -177.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 20.1 m -134.95 155.31 50.95 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.362 1.065 . . . . 0.0 109.533 -169.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -168.03 -176.09 38.26 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -177.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -132.15 110.85 10.96 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 172.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -75.22 -9.79 58.88 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 117.831 -1.081 . . . . 0.0 113.481 -168.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -110.44 -47.07 3.32 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 120.347 1.43 . . . . 0.0 110.673 -177.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -81.19 -22.27 39.02 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.993 -0.442 . . . . 0.0 111.619 -173.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -126.23 44.36 2.88 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.377 1.471 . . . . 0.0 109.047 172.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.34 -21.93 64.46 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.683 1.193 . . . . 0.0 113.829 -173.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -86.83 -2.47 58.6 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.791 0.836 . . . . 0.0 111.911 178.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -141.06 23.79 2.19 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.802 1.241 . . . . 0.0 110.968 -169.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -65.05 123.92 20.73 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 118.86 0.754 . . . . 0.0 110.713 -168.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 69.1 m 52.01 31.54 8.86 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.355 1.462 . . . . 0.0 112.981 178.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -57.51 -37.72 73.46 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.638 -0.663 . . . . 0.0 112.279 -178.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.35 -26.49 67.31 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -169.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.8 mp -62.38 -36.16 81.43 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.48 -0.763 . . . . 0.0 109.268 176.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -67.78 -29.21 73.58 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 123.651 0.643 . . . . 0.0 111.853 175.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.1 m -65.97 -36.71 84.07 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 118.801 1.301 . . . . 0.0 110.353 176.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 5.1 mt -68.69 -47.83 74.59 Favored 'Isoleucine or valine' 0 C--N 1.343 0.283 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 173.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 40.4 ttt-85 -49.89 -45.96 51.3 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 119.03 0.832 . . . . 0.0 111.037 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -60.36 -22.27 63.08 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.013 0.925 . . . . 0.0 112.759 -177.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 86.1 mt -96.2 -47.84 12.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 124.359 1.064 . . . . 0.0 109.681 178.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 30.4 pt -75.05 -31.44 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 119.464 1.029 . . . . 0.0 111.698 -170.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -66.81 -50.85 42.07 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-O 117.584 -1.198 . . . . 0.0 111.722 -176.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -67.6 -24.56 41.64 Favored 'Trans proline' 0 C--N 1.353 0.767 0 CA-C-N 122.079 1.778 . . . . 0.0 112.276 176.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 81.1 mmt-85 -75.23 6.33 4.51 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.619 0.768 . . . . 0.0 113.043 170.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 85.22 11.81 74.92 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-O 118.147 -1.363 . . . . 0.0 114.686 168.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -56.17 138.04 50.67 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 119.293 1.547 . . . . 0.0 110.433 174.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 61.7 m -90.13 118.99 30.09 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 104.392 -2.447 . . . . 0.0 104.392 167.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 47.5 mt -101.47 130.75 50.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 -170.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 34.6 m -133.03 173.89 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 125.093 1.357 . . . . 0.0 109.245 177.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 81.32 28.47 44.27 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-O 119.507 -0.607 . . . . 0.0 112.948 176.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 67.0 m80 -58.39 146.13 35.86 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 118.06 0.93 . . . . 0.0 109.593 170.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 59.2 t-105 -131.4 135.97 27.88 Favored Pre-proline 0 CA--C 1.534 0.343 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 -177.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -67.14 139.89 52.06 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.003 1.802 . . . . 0.0 110.859 -174.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.4 t -90.09 -16.84 28.85 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.459 0.704 . . . . 0.0 110.748 176.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 49.15 42.43 21.33 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.44 1.496 . . . . 0.0 111.598 -176.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 69.31 -6.26 4.47 Favored Glycine 0 CA--C 1.538 1.48 0 CA-C-O 117.69 -1.617 . . . . 0.0 115.502 -178.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . 0.285 52.6 p90 50.28 -25.56 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 131.551 3.941 . . . . 0.0 118.842 -178.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 37.1 t60 52.88 39.99 30.04 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.418 1.887 . . . . 0.0 113.256 173.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -140.41 -171.6 3.25 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.572 1.549 . . . . 0.0 108.601 175.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -69.01 -57.5 5.36 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 118.768 -0.634 . . . . 0.0 112.409 -168.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -158.35 119.83 3.51 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 119.224 0.92 . . . . 0.0 111.558 178.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 67.6 m -98.67 130.32 45.17 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 168.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -119.46 0.93 11.16 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 -169.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -81.99 6.7 65.68 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-N 118.62 0.646 . . . . 0.0 112.719 169.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 79.5 mt -64.83 142.16 58.53 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 118.586 1.193 . . . . 0.0 111.345 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -116.77 -16.89 10.61 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.999 1.32 . . . . 0.0 110.385 168.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -143.08 156.57 44.84 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 127.191 2.196 . . . . 0.0 106.126 173.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -54.76 -23.69 19.05 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.572 1.149 . . . . 0.0 113.707 -173.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -124.33 11.29 8.7 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.884 0.873 . . . . 0.0 113.334 177.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -138.42 129.36 26.83 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 120.52 -1.363 . . . . 0.0 112.096 -176.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -70.01 153.11 43.63 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.445 1.098 . . . . 0.0 109.048 168.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 9.7 p -62.44 -24.78 36.13 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 123.604 0.762 . . . . 0.0 111.244 173.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -157.9 179.4 33.65 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 123.557 0.599 . . . . 0.0 112.171 -169.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -70.92 110.01 5.4 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 123.56 0.744 . . . . 0.0 109.478 -178.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -89.41 121.66 31.87 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 167.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 11.1 tp -73.49 -32.69 37.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 120.267 -0.573 . . . . 0.0 111.221 -173.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -85.72 152.14 23.3 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.934 0.894 . . . . 0.0 110.139 175.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -153.62 18.85 0.54 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.217 1.407 . . . . 0.0 110.404 174.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -140.98 -63.07 0.47 Allowed 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.769 1.228 . . . . 0.0 109.515 -176.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -171.33 -32.09 0.02 OUTLIER 'General case' 0 C--O 1.225 -0.216 0 C-N-CA 126.776 2.03 . . . . 0.0 109.312 167.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 90.5 mm-40 -137.73 143.98 42.58 Favored Pre-proline 0 N--CA 1.449 -0.475 0 N-CA-C 105.078 -2.193 . . . . 0.0 105.078 171.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -61.02 133.64 48.4 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.368 2.046 . . . . 0.0 113.63 -167.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -118.07 162.53 18.04 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 126.535 1.934 . . . . 0.0 106.02 168.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 11.4 mt 59.39 22.71 11.17 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.669 0.788 . . . . 0.0 111.622 176.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 35.9 m -43.18 -61.13 1.41 Allowed 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 126.499 1.919 . . . . 0.0 112.737 -167.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -70.97 -35.84 72.3 Favored 'General case' 0 N--CA 1.452 -0.346 0 O-C-N 121.845 -0.535 . . . . 0.0 111.032 -169.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -72.72 -30.22 64.01 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.873 0.761 . . . . 0.0 111.278 178.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 74.1 mtp85 -63.3 -43.41 97.95 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 119.703 1.138 . . . . 0.0 109.515 172.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 66.2 t -66.03 -41.61 90.0 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.246 0 CA-C-O 118.325 -0.845 . . . . 0.0 109.023 178.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -59.94 -49.53 77.31 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 120.483 1.492 . . . . 0.0 110.487 176.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -61.84 -39.78 93.01 Favored 'General case' 0 N--CA 1.462 0.144 0 O-C-N 122.014 -0.428 . . . . 0.0 110.47 -176.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 60.9 t90 -70.73 -48.72 53.05 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 118.344 0.52 . . . . 0.0 110.642 178.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 55.6 t -60.77 -39.63 82.35 Favored 'Isoleucine or valine' 0 C--O 1.231 0.108 0 C-N-CA 123.041 0.536 . . . . 0.0 110.339 -175.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -68.0 -36.34 79.82 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 121.632 -0.668 . . . . 0.0 109.919 -177.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 46.8 mm-40 -67.73 -50.38 57.66 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 122.911 0.484 . . . . 0.0 110.677 174.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 6.3 pt -66.77 -31.87 55.47 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.313 0 CA-C-N 119.151 0.887 . . . . 0.0 110.937 -176.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 66.1 m -59.03 -37.39 76.83 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.316 0.962 . . . . 0.0 111.716 -179.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -83.69 -31.02 26.32 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 119.339 0.972 . . . . 0.0 111.788 178.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -68.4 -36.46 79.16 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 118.733 0.697 . . . . 0.0 110.783 176.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 76.9 mt -81.63 -3.3 53.1 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.881 1.673 . . . . 0.0 111.612 174.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . 0.324 1.3 p-80 50.12 19.11 0.45 Allowed 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 129.88 3.272 . . . . 0.0 114.719 -174.002 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 4.6 pp -78.25 -22.59 48.12 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 123.103 0.561 . . . . 0.0 111.505 176.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -55.29 -41.17 71.94 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.753 0.821 . . . . 0.0 109.729 168.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -73.18 -6.03 43.13 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.719 -0.613 . . . . 0.0 112.379 -179.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 56.6 mt -97.65 -54.85 6.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 124.651 1.181 . . . . 0.0 108.039 175.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.1 pp -85.83 -22.24 27.7 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -169.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 32.8 t30 -129.77 43.74 3.08 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.618 1.967 . . . . 0.0 108.169 -175.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.222 0 C-N-CA 123.687 0.795 . . . . 0.0 109.658 174.845 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.8 tpt . . . . . 0 N--CA 1.485 1.32 0 N-CA-C 110.368 -0.234 . . . . 0.0 110.368 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -57.75 151.98 16.49 Favored 'General case' 0 C--N 1.344 0.341 0 C-N-CA 123.922 0.889 . . . . 0.0 111.723 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.4 pt -119.65 -12.63 9.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 125.37 1.468 . . . . 0.0 111.537 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.1 m -114.58 127.03 55.57 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 125.35 1.46 . . . . 0.0 107.934 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -99.38 116.35 5.56 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 108.114 -1.994 . . . . 0.0 108.114 169.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 60.2 mt -92.55 119.96 41.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 N-CA-C 104.899 -2.259 . . . . 0.0 104.899 171.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -116.82 133.47 55.97 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 176.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -134.14 163.71 28.98 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 122.833 0.453 . . . . 0.0 111.591 -173.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -131.23 144.38 15.92 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 107.92 -2.072 . . . . 0.0 107.92 166.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 9.1 m -166.65 155.18 10.37 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-N 119.356 1.578 . . . . 0.0 110.127 176.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -115.61 -50.4 2.71 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.964 0.906 . . . . 0.0 109.841 167.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.6 p -86.92 8.43 23.15 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.819 1.248 . . . . 0.0 112.802 177.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 80.31 2.91 89.69 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 124.687 1.137 . . . . 0.0 115.609 169.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -70.2 -49.05 54.15 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 119.593 1.696 . . . . 0.0 112.375 -174.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 10.2 m -74.08 -26.62 60.48 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 120.546 1.521 . . . . 0.0 109.614 -178.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -60.48 -43.49 96.91 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.82 0.848 . . . . 0.0 110.157 169.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -64.69 -41.81 95.78 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 121.467 -0.771 . . . . 0.0 110.72 176.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 46.2 mm -59.29 -45.76 92.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-N 118.561 0.619 . . . . 0.0 109.332 175.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.65 -44.57 85.75 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.483 0.713 . . . . 0.0 110.952 178.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -66.52 -41.45 88.76 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 118.691 -0.671 . . . . 0.0 110.719 179.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 94.4 mtp -62.33 -40.3 95.89 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 119.531 1.059 . . . . 0.0 110.623 177.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 34.5 mt -63.33 -42.75 97.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 119.028 0.831 . . . . 0.0 109.152 175.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -59.71 -41.32 90.54 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 119.204 0.911 . . . . 0.0 110.921 177.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -64.53 -35.41 80.88 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 118.839 0.745 . . . . 0.0 110.463 178.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -67.72 -46.93 70.79 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.039 0.536 . . . . 0.0 110.697 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -76.77 -31.97 57.39 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 118.724 0.693 . . . . 0.0 111.523 -178.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.79 146.27 20.67 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 125.389 1.471 . . . . 0.0 110.798 -173.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -64.14 -28.78 70.0 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.949 0.9 . . . . 0.0 111.807 -174.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -78.58 -3.78 45.52 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 178.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 48.3 t -113.8 -38.13 2.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 124.791 1.236 . . . . 0.0 109.708 178.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -129.74 142.37 50.71 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 119.307 0.958 . . . . 0.0 111.741 -176.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -119.47 159.53 24.1 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.01 1.724 . . . . 0.0 108.493 172.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 48.4 t -133.46 130.22 56.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 C-N-CA 124.601 1.161 . . . . 0.0 109.515 -169.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -144.99 150.36 36.78 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.168 0.987 . . . . 0.0 111.625 174.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -72.45 134.84 45.55 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 166.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.2 tp -56.81 -32.33 38.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 118.697 0.68 . . . . 0.0 111.621 -173.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.65 -28.51 69.97 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.9 0.773 . . . . 0.0 112.243 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -82.06 -17.31 47.11 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.299 0.64 . . . . 0.0 110.597 178.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.9 t -75.52 174.17 10.03 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 122.117 0.961 . . . . 0.0 110.377 174.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 21.3 m -145.53 167.09 23.87 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 127.726 2.41 . . . . 0.0 107.676 -177.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -52.68 -49.79 64.57 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.294 0.638 . . . . 0.0 110.843 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -76.0 -15.78 60.08 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 122.735 0.414 . . . . 0.0 111.701 -175.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -81.62 -37.05 28.19 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 121.685 -0.635 . . . . 0.0 110.233 -178.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.78 -43.65 88.14 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-N 118.345 0.52 . . . . 0.0 109.894 168.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -62.42 -20.98 65.05 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.4 0.68 . . . . 0.0 112.321 -177.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.25 -28.08 69.49 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.449 0.7 . . . . 0.0 112.009 177.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -103.47 138.45 40.17 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.559 1.144 . . . . 0.0 110.541 -176.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -88.39 -29.85 19.95 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.0 171.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.5 mm -106.4 128.76 60.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 178.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 88.6 mt -129.22 140.58 51.42 Favored 'General case' 0 CA--C 1.52 -0.208 0 C-N-CA 123.034 0.534 . . . . 0.0 109.809 -175.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -122.36 126.87 48.95 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 172.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 67.3 mt -121.07 122.02 39.16 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -173.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -117.75 103.92 1.11 Allowed Glycine 0 CA--C 1.524 0.609 0 C-N-CA 125.349 1.452 . . . . 0.0 112.45 -169.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 16.9 tt -127.17 111.98 21.56 Favored Pre-proline 0 CA--C 1.542 0.657 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -169.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -75.76 147.84 31.68 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 122.287 1.991 . . . . 0.0 108.983 167.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 44.3 m -95.62 137.18 35.05 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 176.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 23.9 m95 -134.49 172.04 13.47 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.655 1.182 . . . . 0.0 111.43 -173.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 58.55 -79.53 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 128.565 2.746 . . . . 0.0 113.663 172.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -152.18 51.41 0.79 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.843 2.057 . . . . 0.0 108.923 -171.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.42 37.87 62.47 Favored Glycine 0 CA--C 1.525 0.661 0 O-C-N 121.56 -0.713 . . . . 0.0 111.63 -174.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -115.5 160.0 20.49 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.506 1.123 . . . . 0.0 109.791 -175.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.7 160.54 29.26 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.471 169.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -75.52 155.98 35.57 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 168.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 59.7 m -55.41 -29.79 59.22 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.84 0.856 . . . . 0.0 112.381 -177.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -65.8 -42.37 90.76 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.094 0.558 . . . . 0.0 110.691 -177.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 80.1 m95 -76.25 -44.35 37.76 Favored 'General case' 0 C--N 1.341 0.226 0 C-N-CA 122.813 0.445 . . . . 0.0 110.094 174.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -62.41 -37.11 84.53 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.792 0.437 . . . . 0.0 111.939 -172.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -71.23 -21.69 62.09 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.542 0.737 . . . . 0.0 112.018 175.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -90.16 -23.86 21.21 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.459 0.703 . . . . 0.0 111.385 179.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -51.02 -42.43 79.96 Favored Pre-proline 0 CA--C 1.544 0.714 0 CA-C-O 116.627 -1.654 . . . . 0.0 114.784 178.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -64.24 -22.94 66.55 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 CA-C-N 122.954 2.091 . . . . 0.0 113.194 174.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.3 m -81.04 -38.0 28.16 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.049 0.94 . . . . 0.0 109.738 170.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 13.4 tp -59.84 -35.23 74.32 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.79 1.236 . . . . 0.0 110.928 -175.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -79.63 -4.46 51.72 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.053 0.941 . . . . 0.0 113.035 177.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -93.73 -24.95 17.64 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 119.612 1.097 . . . . 0.0 111.176 169.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 95.7 mt -67.92 137.6 24.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 -176.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -86.83 81.03 8.3 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -177.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -70.0 -5.42 26.28 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 118.381 -0.819 . . . . 0.0 112.843 -176.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 57.1 m-80 -53.44 117.94 3.47 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 119.609 1.095 . . . . 0.0 109.513 -179.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 82.44 -4.8 76.21 Favored Glycine 0 CA--C 1.533 1.165 0 CA-C-O 117.849 -1.528 . . . . 0.0 114.47 175.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -64.56 139.68 58.79 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 120.527 2.164 . . . . 0.0 107.894 169.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.7 mt -95.96 124.97 40.2 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 106.487 -1.672 . . . . 0.0 106.487 169.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.2 t -131.07 146.49 33.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -169.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -131.41 146.49 52.29 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 169.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.2 mt -112.59 142.53 45.06 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 124.211 1.005 . . . . 0.0 109.437 -177.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 24.8 p90 -138.51 155.97 47.93 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 168.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -168.77 169.15 41.58 Favored Glycine 0 N--CA 1.447 -0.586 0 O-C-N 121.469 -0.769 . . . . 0.0 111.654 -176.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 56.5 m -136.27 156.01 49.28 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.242 1.017 . . . . 0.0 109.192 -171.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -170.89 -167.26 30.99 Favored Glycine 0 CA--C 1.526 0.777 0 O-C-N 123.256 0.348 . . . . 0.0 112.601 -173.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -138.56 141.69 39.25 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 126.509 1.924 . . . . 0.0 109.176 177.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -110.89 -11.8 14.32 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.981 1.312 . . . . 0.0 111.889 -177.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -84.95 -31.68 23.46 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 118.416 0.553 . . . . 0.0 111.245 -168.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -128.33 -39.34 1.7 Allowed 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.348 0.659 . . . . 0.0 111.714 173.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -83.15 32.97 0.44 Allowed 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 118.419 0.554 . . . . 0.0 112.149 -177.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.27 -27.68 69.21 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.654 1.182 . . . . 0.0 113.259 -172.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -79.43 -0.2 31.98 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.023 0.929 . . . . 0.0 111.602 176.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -140.91 16.56 2.3 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 125.481 1.512 . . . . 0.0 110.621 -172.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -65.43 115.05 5.28 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 119.561 1.073 . . . . 0.0 108.788 -169.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 75.9 m 53.47 34.3 17.97 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.567 1.547 . . . . 0.0 113.178 -174.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -51.01 -43.66 60.87 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.75 1.22 . . . . 0.0 111.741 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.53 -14.93 63.37 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -169.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 67.5 mt -58.09 -41.62 83.88 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 118.866 0.757 . . . . 0.0 110.055 169.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -65.38 -32.97 85.29 Favored Glycine 0 C--N 1.339 0.744 0 N-CA-C 111.245 -0.742 . . . . 0.0 111.245 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.3 m -65.37 -37.23 86.4 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 118.229 1.015 . . . . 0.0 110.704 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 5.0 mt -73.56 -44.87 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 118.952 0.796 . . . . 0.0 108.97 174.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 35.9 ttt180 -53.28 -44.14 68.01 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 119.297 0.953 . . . . 0.0 110.608 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -61.92 -16.14 48.59 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.691 1.196 . . . . 0.0 113.035 -178.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 86.8 mt -101.0 -58.35 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 124.252 1.021 . . . . 0.0 109.095 173.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 20.1 pt -68.75 -32.98 57.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 O-C-N 121.144 -0.972 . . . . 0.0 112.142 -167.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -67.99 -53.4 20.16 Favored Pre-proline 0 CA--C 1.541 0.627 0 CA-C-O 117.671 -1.157 . . . . 0.0 111.242 -176.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -68.45 -23.45 37.67 Favored 'Trans proline' 0 C--N 1.353 0.786 0 CA-C-N 121.708 1.646 . . . . 0.0 112.83 175.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 30.9 mmm180 -74.41 -0.56 17.73 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 119.343 0.974 . . . . 0.0 112.17 170.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 94.0 14.69 51.26 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-O 118.558 -1.134 . . . . 0.0 114.999 168.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.26 144.34 57.02 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 119.183 1.492 . . . . 0.0 109.411 170.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 47.0 m -93.59 119.52 32.72 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 104.163 -2.532 . . . . 0.0 104.163 167.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 21.4 mt -100.56 130.75 49.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 107.016 -1.475 . . . . 0.0 107.016 -176.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.7 m -133.05 -172.88 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 125.549 1.539 . . . . 0.0 107.948 169.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 70.57 21.3 77.66 Favored Glycine 0 CA--C 1.529 0.963 0 O-C-N 120.979 -1.075 . . . . 0.0 111.572 -171.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 21.3 p-80 -59.19 133.12 55.81 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 168.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 70.7 t-105 -115.73 130.04 24.67 Favored Pre-proline 0 C--O 1.237 0.401 0 C-N-CA 124.573 1.149 . . . . 0.0 108.827 -167.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -67.37 139.58 50.09 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 121.51 1.473 . . . . 0.0 111.034 -175.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 2.1 t -89.97 -5.84 56.27 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.763 0.825 . . . . 0.0 111.917 -174.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 50.84 49.78 20.37 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.588 1.555 . . . . 0.0 112.516 173.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 84.44 -1.85 88.45 Favored Glycine 0 CA--C 1.533 1.185 0 CA-C-O 118.781 -1.01 . . . . 0.0 114.228 176.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 38.1 t80 54.83 -100.89 0.11 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.202 1.801 . . . . 0.0 112.811 174.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 35.4 t60 61.09 44.98 9.6 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.143 1.777 . . . . 0.0 113.713 -178.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -120.81 -176.88 3.35 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.957 1.303 . . . . 0.0 107.69 167.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -82.56 -56.24 3.99 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 121.405 -0.809 . . . . 0.0 111.874 -169.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -156.65 138.12 13.97 Favored 'General case' 0 C--N 1.343 0.3 0 CA-C-N 119.221 0.919 . . . . 0.0 111.32 173.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 58.4 m -142.03 107.04 4.92 Favored 'General case' 0 CA--C 1.521 -0.14 0 C-N-CA 125.35 1.46 . . . . 0.0 107.614 178.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -77.78 -10.63 59.65 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 122.702 0.401 . . . . 0.0 110.955 -171.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -78.28 -1.65 81.55 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-O 118.215 -1.325 . . . . 0.0 114.024 169.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 59.8 mt -63.05 122.49 16.2 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 120.96 2.38 . . . . 0.0 108.21 170.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -97.92 -26.91 14.5 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.248 1.019 . . . . 0.0 110.352 177.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -144.62 160.03 41.83 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.819 2.047 . . . . 0.0 106.769 175.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -55.18 -25.94 35.73 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.931 0.892 . . . . 0.0 112.822 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -111.08 -0.65 16.53 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.471 1.108 . . . . 0.0 113.701 179.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 -141.39 133.55 27.86 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 120.206 1.366 . . . . 0.0 113.426 -175.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -77.7 152.76 33.55 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 166.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 12.5 p -58.92 -28.58 38.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 123.913 0.885 . . . . 0.0 111.323 174.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -155.51 170.53 33.49 Favored Glycine 0 C--N 1.338 0.673 0 C-N-CA 123.957 0.789 . . . . 0.0 111.418 -170.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -60.93 126.48 27.51 Favored 'General case' 0 C--N 1.334 -0.073 0 C-N-CA 124.314 1.046 . . . . 0.0 109.176 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -108.69 121.36 44.87 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 172.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 1.2 tp -77.28 165.84 2.93 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 169.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 26.6 t70 71.98 148.3 0.09 Allowed 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 127.144 2.178 . . . . 0.0 113.482 -177.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -148.29 15.23 1.02 Allowed 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.405 1.482 . . . . 0.0 111.353 175.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -154.05 -75.5 0.12 Allowed 'General case' 0 CA--C 1.536 0.432 0 O-C-N 120.983 -1.073 . . . . 0.0 109.299 170.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 24.7 ttm180 -159.44 114.49 2.43 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 168.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 61.28 136.75 0.04 OUTLIER Pre-proline 0 CA--C 1.552 1.021 0 C-N-CA 127.197 2.199 . . . . 0.0 112.195 -172.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -72.56 145.61 42.38 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.154 1.903 . . . . 0.0 113.372 -169.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -127.63 -1.02 6.14 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.518 1.127 . . . . 0.0 111.51 169.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 88.5 mt -114.45 19.47 16.16 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.544 1.537 . . . . 0.0 110.639 -176.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 93.2 m -45.49 -53.74 8.46 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 125.892 1.677 . . . . 0.0 112.165 -169.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -68.45 -38.67 81.32 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 119.226 -0.416 . . . . 0.0 111.36 -169.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -73.74 -32.87 64.08 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 118.64 0.655 . . . . 0.0 110.805 178.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 51.9 mtp85 -67.17 -45.77 75.99 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-N 118.791 0.723 . . . . 0.0 109.603 178.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 23.7 m -71.5 -31.68 43.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-O 118.083 -0.96 . . . . 0.0 110.564 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -58.8 -56.83 17.15 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 120.378 1.445 . . . . 0.0 109.59 172.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -60.54 -34.39 74.06 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 122.992 0.517 . . . . 0.0 110.798 -175.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 33.1 t90 -77.86 -50.0 13.13 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 117.975 0.352 . . . . 0.0 110.796 -178.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 66.5 t -63.87 -32.41 56.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 O-C-N 120.782 -1.199 . . . . 0.0 110.151 -176.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -59.95 -35.91 75.95 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 117.981 -1.009 . . . . 0.0 111.566 175.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . 0.251 13.2 pt20 -75.71 -50.71 14.57 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 119.552 1.069 . . . . 0.0 111.012 171.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 1.4 pt -64.51 -32.07 56.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-N 120.096 1.316 . . . . 0.0 111.552 -169.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 6.3 p -61.43 -38.47 87.27 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 118.468 -0.777 . . . . 0.0 110.858 -178.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -82.7 -36.83 25.52 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 119.724 1.147 . . . . 0.0 111.38 175.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 63.1 mt-10 -70.59 -34.02 71.71 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 118.606 0.639 . . . . 0.0 111.749 -175.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 64.1 mt -86.71 1.23 52.8 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.008 1.323 . . . . 0.0 110.971 175.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 56.17 32.35 20.03 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.856 1.662 . . . . 0.0 112.984 -176.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 90.6 mt -76.92 -37.81 54.64 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.364 0.666 . . . . 0.0 109.584 173.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -58.93 -38.76 79.74 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.34 1.056 . . . . 0.0 110.337 178.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -65.2 -12.4 50.85 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.639 0.776 . . . . 0.0 112.561 179.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 85.4 mt -108.44 -54.16 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 124.802 1.241 . . . . 0.0 108.326 -179.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.2 pp -76.97 -25.03 52.33 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -172.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 58.3 t30 -120.62 32.09 6.15 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.193 1.797 . . . . 0.0 109.762 -175.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.271 0 C-N-CA 123.931 0.892 . . . . 0.0 109.597 173.957 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.5 ttp . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 110.384 -0.228 . . . . 0.0 110.384 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.31 150.95 42.06 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.877 -0.514 . . . . 0.0 110.305 172.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.8 pt -82.71 -19.33 10.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -174.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.8 m -115.09 127.39 55.58 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.203 1.401 . . . . 0.0 108.416 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -102.63 117.4 5.78 Favored Glycine 0 CA--C 1.52 0.394 0 N-CA-C 107.914 -2.074 . . . . 0.0 107.914 170.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 64.9 mt -96.29 93.83 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 176.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -88.37 132.83 34.28 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 177.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -130.64 128.62 41.34 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 119.207 0.912 . . . . 0.0 112.167 179.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -93.53 142.85 16.18 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 107.54 -2.224 . . . . 0.0 107.54 166.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.4 t -156.14 175.18 14.31 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 119.279 1.539 . . . . 0.0 109.285 172.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -122.09 -54.78 1.9 Allowed 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.041 0.537 . . . . 0.0 110.226 169.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.1 p -94.9 -0.37 54.04 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.144 0.978 . . . . 0.0 112.597 175.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 90.15 15.36 57.63 Favored Glycine 0 C--N 1.343 0.949 0 CA-C-O 118.963 -0.91 . . . . 0.0 114.256 169.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -68.28 -39.9 82.01 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 119.787 1.794 . . . . 0.0 110.526 175.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.79 -29.52 68.27 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 119.131 0.878 . . . . 0.0 111.346 175.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -64.41 -40.34 95.58 Favored 'General case' 0 C--N 1.343 0.285 0 CA-C-N 118.819 0.736 . . . . 0.0 109.604 176.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -65.31 -41.95 93.53 Favored 'General case' 0 CA--C 1.529 0.146 0 O-C-N 121.976 -0.453 . . . . 0.0 110.335 178.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 48.1 mm -60.17 -48.6 87.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 174.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.48 -43.37 98.98 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.42 0.688 . . . . 0.0 111.538 -178.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 54.7 mttm -63.69 -44.03 94.87 Favored 'General case' 0 C--N 1.338 0.106 0 CA-C-O 118.331 -0.842 . . . . 0.0 110.386 178.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 69.6 mtm -59.39 -47.64 84.69 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-N 119.2 0.909 . . . . 0.0 109.76 177.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 62.6 mt -57.19 -46.76 84.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -62.71 -40.57 97.56 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 119.503 1.047 . . . . 0.0 111.024 -179.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -63.25 -38.34 90.76 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 119.424 1.011 . . . . 0.0 110.723 177.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -69.51 -39.44 77.55 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.187 0.595 . . . . 0.0 110.813 178.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.1 mp -79.0 -35.43 42.89 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.921 0.889 . . . . 0.0 111.655 -176.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 94.43 145.3 17.95 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 125.236 1.398 . . . . 0.0 110.903 -171.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.1 ptpt -65.32 -28.71 69.5 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -172.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -68.22 -29.52 68.37 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 122.863 0.465 . . . . 0.0 111.011 176.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 49.1 t -91.21 -37.44 9.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 C-N-CA 124.186 0.994 . . . . 0.0 110.161 -175.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -135.78 146.33 47.49 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-N 119.285 0.948 . . . . 0.0 113.222 -174.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -130.66 144.9 51.74 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.713 1.205 . . . . 0.0 109.295 171.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 80.1 t -98.14 140.49 17.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.442 0 C-N-CA 124.078 0.951 . . . . 0.0 109.051 -174.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -149.22 172.82 14.22 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.677 1.191 . . . . 0.0 111.255 -169.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -141.64 127.05 18.77 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 126.973 2.109 . . . . 0.0 107.117 -173.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.6 tp -58.91 -31.41 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-O 118.831 -0.604 . . . . 0.0 111.231 -172.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.61 -26.47 68.41 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 118.698 0.681 . . . . 0.0 111.488 -177.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -89.56 -15.35 33.06 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.48 1.112 . . . . 0.0 111.516 177.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 53.0 p -84.38 175.88 9.06 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 118.76 0.709 . . . . 0.0 111.597 -174.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.2 m -137.55 167.44 21.66 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.651 1.58 . . . . 0.0 108.361 176.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -51.41 -48.48 62.64 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.884 0.874 . . . . 0.0 111.794 -177.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -81.55 -11.69 59.07 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 122.707 0.403 . . . . 0.0 111.608 -175.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -77.56 -31.15 53.0 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 121.399 -0.813 . . . . 0.0 111.457 -172.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.6 mp -68.34 -36.7 79.65 Favored 'General case' 0 C--N 1.344 0.348 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 172.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -69.88 -14.05 62.55 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.656 0.782 . . . . 0.0 111.988 -173.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.1 -30.13 68.36 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.738 0.815 . . . . 0.0 111.709 175.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -82.81 152.17 25.78 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 123.92 0.888 . . . . 0.0 110.211 178.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -92.0 -41.6 10.45 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.208 169.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 21.7 mt -108.25 130.74 60.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 92.3 mt -113.84 130.28 56.49 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 171.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.2 mp -111.64 115.87 29.85 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 104.52 -2.4 . . . . 0.0 104.52 169.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 64.6 mt -116.27 110.48 18.8 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -171.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -93.74 125.89 8.42 Favored Glycine 0 CA--C 1.521 0.427 0 N-CA-C 109.18 -1.568 . . . . 0.0 109.18 176.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 16.5 tt -139.28 133.07 15.89 Favored Pre-proline 0 CA--C 1.537 0.48 0 CA-C-N 118.842 1.321 . . . . 0.0 111.346 -177.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -92.41 153.86 3.03 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 122.408 2.072 . . . . 0.0 110.327 176.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.7 m -108.95 126.5 53.16 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 171.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 61.9 m95 -130.57 170.9 13.65 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 125.368 1.467 . . . . 0.0 109.063 178.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 44.23 49.12 7.82 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.351 1.861 . . . . 0.0 114.279 168.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 55.08 65.02 1.61 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.379 1.071 . . . . 0.0 111.06 176.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.85 47.68 5.5 Favored Glycine 0 CA--C 1.532 1.124 0 CA-C-N 115.854 -0.612 . . . . 0.0 113.219 171.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -128.48 157.74 40.3 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.177 1.391 . . . . 0.0 108.544 168.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -90.88 175.38 7.0 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.507 0.723 . . . . 0.0 109.925 170.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -62.39 146.84 50.25 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 107.942 -1.132 . . . . 0.0 107.942 169.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 62.3 m -56.77 -41.27 77.34 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -168.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -71.01 -40.31 71.88 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.238 0.926 . . . . 0.0 110.691 -178.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -62.38 -43.86 97.83 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.328 0.651 . . . . 0.0 110.135 175.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -61.9 -42.2 98.81 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 123.513 0.725 . . . . 0.0 110.79 178.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -68.63 -18.77 64.36 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.907 0.883 . . . . 0.0 112.309 176.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 29.7 t80 -86.04 -18.76 31.61 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 121.604 -0.685 . . . . 0.0 112.343 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -54.09 -43.03 96.41 Favored Pre-proline 0 CA--C 1.543 0.706 0 CA-C-O 116.807 -1.568 . . . . 0.0 114.138 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -63.75 -21.93 69.59 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 CA-C-N 122.475 1.92 . . . . 0.0 113.554 174.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.9 m -79.47 -40.28 30.18 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 119.57 1.077 . . . . 0.0 109.357 170.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 14.5 tp -59.63 -38.65 81.91 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.18 0.992 . . . . 0.0 110.955 -174.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -76.79 -4.77 45.21 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.698 0.799 . . . . 0.0 112.981 178.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 48.3 mm-40 -98.13 -18.6 18.41 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.188 0.995 . . . . 0.0 110.535 171.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 77.5 mt -77.68 148.93 6.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 172.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -115.97 133.13 56.35 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -117.12 15.79 15.0 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.632 0.773 . . . . 0.0 111.688 -172.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 33.2 m-80 -56.36 119.28 5.75 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 120.049 1.295 . . . . 0.0 109.319 177.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 79.83 -2.84 72.42 Favored Glycine 0 CA--C 1.535 1.327 0 CA-C-O 118.493 -1.171 . . . . 0.0 114.573 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -78.06 143.73 37.17 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 119.995 1.897 . . . . 0.0 107.209 173.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 14.5 mt -92.55 135.82 33.74 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 171.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 16.8 t -133.61 134.64 56.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -124.49 146.6 48.87 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 171.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 69.0 mt -118.92 147.48 43.96 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -174.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -142.26 159.71 41.69 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 168.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -171.41 159.47 31.2 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 119.343 -1.408 . . . . 0.0 115.347 -174.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 6.9 m -107.67 142.45 37.61 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 113.405 -1.397 . . . . 0.0 108.798 -170.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -170.89 174.88 44.74 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -178.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -144.71 122.87 12.17 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.774 0.83 . . . . 0.0 110.203 177.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.512 HE22 ' CA ' ' A' ' 146' ' ' GLU . 6.9 mt-30 -78.76 71.27 5.21 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.111 1.364 . . . . 0.0 109.234 174.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -131.06 -112.32 0.25 Allowed 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 173.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -72.93 -22.66 60.69 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 119.379 0.991 . . . . 0.0 111.94 -174.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -82.98 34.06 0.45 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.107 1.763 . . . . 0.0 111.163 -177.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.39 -23.2 65.62 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 -167.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -97.91 -1.66 42.41 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 118.937 0.789 . . . . 0.0 112.142 177.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -126.39 16.29 7.69 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.306 1.442 . . . . 0.0 111.354 -169.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -63.89 125.34 24.09 Favored 'General case' 0 C--O 1.236 0.358 0 O-C-N 121.593 -0.692 . . . . 0.0 110.172 -170.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 71.1 m 48.12 32.63 3.09 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.655 1.982 . . . . 0.0 113.723 -178.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -54.75 -34.72 62.92 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.587 0.755 . . . . 0.0 112.755 -178.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -62.87 -24.99 68.07 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -174.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 69.9 mt -58.69 -45.26 89.87 Favored 'General case' 0 C--N 1.344 0.337 0 O-C-N 121.497 -0.752 . . . . 0.0 109.965 173.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -65.01 -32.7 85.07 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.7 m -64.99 -36.01 83.02 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.25 1.025 . . . . 0.0 110.72 178.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 17.8 mt -69.54 -52.85 28.44 Favored 'Isoleucine or valine' 0 C--N 1.347 0.476 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 171.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 50.5 ttt180 -51.01 -47.13 61.67 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.341 0.656 . . . . 0.0 111.16 -172.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -61.91 -16.03 47.61 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.649 1.18 . . . . 0.0 112.806 -175.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 97.9 mt -100.83 -55.82 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 C-N-CA 124.268 1.027 . . . . 0.0 109.28 173.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 48.2 pt -67.56 -34.45 68.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 119.946 1.248 . . . . 0.0 112.284 -167.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -67.65 -53.21 22.98 Favored Pre-proline 0 CA--C 1.546 0.794 0 CA-C-O 117.71 -1.138 . . . . 0.0 110.701 -175.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -68.93 -23.33 34.84 Favored 'Trans proline' 0 C--N 1.353 0.801 0 CA-C-N 121.652 1.626 . . . . 0.0 112.928 174.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 31.3 mmm180 -77.39 8.94 3.59 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 119.482 1.037 . . . . 0.0 112.274 171.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 94.73 3.33 62.52 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-O 118.194 -1.337 . . . . 0.0 116.218 167.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.1 142.87 56.36 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 119.622 1.711 . . . . 0.0 110.075 177.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 57.8 m -88.61 119.5 29.12 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 104.798 -2.297 . . . . 0.0 104.798 168.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 19.7 mm -95.19 132.86 38.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 -171.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 19.3 m -137.93 171.53 15.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 124.979 1.312 . . . . 0.0 109.039 176.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 79.51 23.21 63.1 Favored Glycine 0 CA--C 1.526 0.775 0 CA-C-O 119.048 -0.862 . . . . 0.0 113.367 175.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 28.3 p-80 -61.23 135.99 57.91 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 168.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 39.0 t-105 -122.84 135.29 25.63 Favored Pre-proline 0 CA--C 1.533 0.315 0 C-N-CA 124.759 1.224 . . . . 0.0 108.249 -169.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -66.85 139.6 52.49 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 121.83 1.687 . . . . 0.0 111.316 -174.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 65.0 p -71.01 -27.08 63.43 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.018 0.527 . . . . 0.0 111.16 -178.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 52.2 48.43 22.69 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.713 1.605 . . . . 0.0 112.382 172.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 71.78 49.89 21.51 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.566 -0.613 . . . . 0.0 111.566 175.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 17.1 p90 -56.43 -39.7 73.54 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.302 0.641 . . . . 0.0 110.965 175.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 21.4 m-70 46.37 49.06 13.37 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.622 1.969 . . . . 0.0 112.298 170.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -117.82 170.04 9.12 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.789 1.236 . . . . 0.0 109.757 -179.002 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -57.46 -48.6 78.74 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 123.234 0.614 . . . . 0.0 110.96 -169.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -152.97 174.25 14.38 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 167.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 72.4 m -153.15 136.33 15.66 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 106.02 -1.844 . . . . 0.0 106.02 168.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -107.3 -0.28 22.62 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -172.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -88.09 5.53 84.7 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 124.13 0.872 . . . . 0.0 112.419 168.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 96.1 mt -67.52 134.26 50.97 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 118.982 1.391 . . . . 0.0 110.253 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -96.21 -34.45 11.65 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 166.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -145.88 161.28 40.38 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 128.152 2.581 . . . . 0.0 105.81 168.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -58.67 -25.19 62.54 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 120.627 -1.295 . . . . 0.0 112.112 178.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -92.04 -9.6 42.18 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.201 1.0 . . . . 0.0 113.347 176.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 63.1 m80 -143.39 123.63 13.78 Favored 'General case' 0 C--N 1.346 0.426 0 CA-C-N 120.216 1.371 . . . . 0.0 112.398 -175.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -73.34 152.16 41.0 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 166.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 9.3 p -64.29 -21.71 29.61 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 O-C-N 121.811 -0.556 . . . . 0.0 111.228 175.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -155.66 175.14 33.6 Favored Glycine 0 C--N 1.339 0.705 0 C-N-CA 123.792 0.71 . . . . 0.0 111.776 -172.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -71.94 104.02 3.38 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.809 0.844 . . . . 0.0 109.12 -177.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -79.41 133.04 36.55 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 169.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 17.4 pt -65.97 -32.43 58.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-N 119.591 1.087 . . . . 0.0 111.581 -178.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.403 ' CG ' HE21 ' A' ' 91' ' ' GLN . 23.8 t0 -106.88 154.19 21.41 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.986 1.315 . . . . 0.0 109.555 -174.071 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.512 ' CA ' HE22 ' A' ' 91' ' ' GLN . 6.0 tt0 -153.47 10.91 0.44 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.255 1.422 . . . . 0.0 111.643 178.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -144.53 -67.39 0.33 Allowed 'General case' 0 C--N 1.341 0.235 0 C-N-CA 123.809 0.844 . . . . 0.0 109.71 173.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -168.65 112.24 0.57 Allowed 'General case' 0 C--O 1.237 0.445 0 C-N-CA 126.956 2.102 . . . . 0.0 105.797 169.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 58.41 149.01 0.07 OUTLIER Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 126.949 2.1 . . . . 0.0 113.416 -169.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -64.1 135.75 48.83 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.419 2.08 . . . . 0.0 111.193 178.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -124.24 -14.58 6.96 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.862 0.865 . . . . 0.0 111.895 172.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 75.2 mt -122.24 29.28 7.07 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.988 1.315 . . . . 0.0 110.353 -169.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 58.4 m -41.02 -54.44 2.78 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 127.516 2.326 . . . . 0.0 112.982 -169.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -76.8 -32.07 57.39 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -173.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -71.75 -38.84 70.33 Favored 'General case' 0 CA--C 1.529 0.157 0 O-C-N 121.913 -0.492 . . . . 0.0 109.939 178.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 74.1 mtp85 -66.49 -41.81 88.36 Favored 'General case' 0 N--CA 1.462 0.173 0 O-C-N 121.682 -0.637 . . . . 0.0 110.445 -178.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 34.4 m -70.39 -27.8 32.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 119.077 0.853 . . . . 0.0 111.195 177.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -65.49 -53.74 38.25 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 120.647 1.567 . . . . 0.0 109.583 172.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -61.63 -36.45 80.79 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 117.795 0.27 . . . . 0.0 110.888 -177.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 35.3 t90 -75.43 -46.64 31.46 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 118.178 0.445 . . . . 0.0 111.077 -178.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 42.5 t -59.89 -36.5 67.07 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.094 0 CA-C-N 118.581 0.628 . . . . 0.0 110.084 177.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -64.08 -40.84 97.14 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 117.937 -1.03 . . . . 0.0 110.654 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -69.27 -48.03 62.88 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 119.556 1.071 . . . . 0.0 110.659 175.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 7.5 pt -66.8 -29.82 47.64 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.333 0 CA-C-N 119.705 1.139 . . . . 0.0 110.759 -173.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 51.1 m -61.81 -29.29 70.06 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 117.877 -1.058 . . . . 0.0 112.459 176.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -92.16 -24.16 19.17 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 120.52 1.509 . . . . 0.0 111.641 175.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -73.02 -36.29 66.94 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 118.674 0.67 . . . . 0.0 110.794 174.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 66.1 mt -93.45 -9.16 39.48 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.349 1.86 . . . . 0.0 111.794 -179.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 39.2 m80 56.25 29.94 15.76 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.615 1.566 . . . . 0.0 112.911 -169.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 73.3 mt -72.22 -20.82 61.5 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 121.457 -0.777 . . . . 0.0 110.909 169.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -57.97 -38.25 75.71 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 118.951 0.796 . . . . 0.0 110.304 176.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -67.46 -11.27 57.48 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 121.507 -0.745 . . . . 0.0 112.423 178.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 49.9 mt -105.16 -55.88 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 124.911 1.284 . . . . 0.0 108.468 -178.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.5 pp -80.09 -23.78 41.04 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.091 0.556 . . . . 0.0 112.475 -172.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -122.18 34.85 5.04 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.99 1.716 . . . . 0.0 109.578 -176.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.142 0 C-N-CA 123.83 0.852 . . . . 0.0 109.511 174.202 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.8 ptt? . . . . . 0 N--CA 1.489 1.497 0 N-CA-C 111.627 0.232 . . . . 0.0 111.627 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -66.58 149.72 50.06 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.408 0.683 . . . . 0.0 109.821 174.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 31.0 pt -85.78 -22.69 7.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 123.393 0.677 . . . . 0.0 111.444 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 26.3 m -114.63 134.73 54.84 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.738 1.615 . . . . 0.0 109.09 -177.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -107.19 122.32 6.85 Favored Glycine 0 CA--C 1.52 0.401 0 N-CA-C 107.442 -2.263 . . . . 0.0 107.442 168.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 54.4 mt -100.62 91.69 2.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.14 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 176.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -88.16 130.33 35.08 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 -179.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 16.1 p90 -130.74 132.07 45.12 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 119.435 1.016 . . . . 0.0 112.338 179.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -86.54 149.76 22.87 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 168.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.8 m -167.9 157.78 10.17 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.936 1.368 . . . . 0.0 110.643 173.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -121.68 -52.89 2.0 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.953 0.901 . . . . 0.0 109.948 168.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.0 p -88.53 7.72 31.71 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.551 1.14 . . . . 0.0 112.733 174.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 84.92 -4.73 84.73 Favored Glycine 0 CA--C 1.533 1.174 0 N-CA-C 116.621 1.408 . . . . 0.0 116.621 168.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.88 -35.47 78.42 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 120.243 2.022 . . . . 0.0 113.696 -169.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 12.8 m -70.82 -17.29 62.76 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 119.524 1.056 . . . . 0.0 110.665 -175.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -60.19 -41.87 93.83 Favored 'General case' 0 C--N 1.342 0.278 0 O-C-N 121.118 -0.989 . . . . 0.0 110.338 175.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -64.42 -39.0 92.98 Favored 'General case' 0 C--N 1.339 0.127 0 O-C-N 122.072 -0.393 . . . . 0.0 110.306 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.0 mm -64.37 -46.37 93.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.72 -42.45 98.97 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.296 0.639 . . . . 0.0 111.531 178.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 54.8 mttm -64.57 -43.39 94.03 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 118.88 -0.581 . . . . 0.0 110.858 178.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 72.6 mtm -62.5 -39.64 94.15 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 119.169 0.895 . . . . 0.0 110.733 178.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 62.9 mt -60.11 -48.49 87.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 175.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -59.21 -39.61 83.2 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.803 0.729 . . . . 0.0 111.058 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -68.11 -36.43 79.75 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 119.432 1.014 . . . . 0.0 111.026 178.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 19.4 mm100 -65.78 -49.6 67.73 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.574 0.625 . . . . 0.0 111.529 -178.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.97 -8.22 34.34 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -175.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.42 143.3 12.22 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 125.119 1.342 . . . . 0.0 112.122 175.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.2 pttp -70.09 -23.64 63.09 Favored 'General case' 0 N--CA 1.469 0.489 0 O-C-N 121.584 -0.95 . . . . 0.0 113.082 -178.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -60.37 -34.74 74.3 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 122.985 0.514 . . . . 0.0 110.763 171.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 62.1 t -83.69 -42.48 17.42 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-O 118.001 -0.999 . . . . 0.0 110.136 178.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -132.77 147.08 52.31 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-N 119.838 1.199 . . . . 0.0 114.182 -170.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -120.97 140.87 51.29 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 123.831 0.852 . . . . 0.0 109.696 169.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 94.6 t -85.97 139.26 17.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -147.01 170.65 16.67 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.29 1.036 . . . . 0.0 111.881 -168.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -145.65 125.19 13.2 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 125.79 1.636 . . . . 0.0 108.641 -170.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.4 tp -63.08 -29.14 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-O 118.967 -0.54 . . . . 0.0 111.747 -171.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.03 -28.44 69.49 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 118.945 0.793 . . . . 0.0 111.692 -176.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -101.27 -7.21 23.24 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.674 0.79 . . . . 0.0 112.299 175.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 42.5 m -75.43 171.48 14.18 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 123.649 0.78 . . . . 0.0 110.547 177.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 14.1 m -139.26 160.53 39.6 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.819 1.248 . . . . 0.0 108.875 178.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -53.79 -46.85 71.15 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.073 0.949 . . . . 0.0 111.455 -174.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -80.92 -15.26 56.77 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 122.571 0.349 . . . . 0.0 111.551 -176.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -77.95 -29.71 50.02 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 121.439 -0.788 . . . . 0.0 111.213 -175.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -59.41 -41.5 89.6 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.111 0.564 . . . . 0.0 109.709 169.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -72.96 -13.17 61.19 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.637 0.775 . . . . 0.0 112.315 -170.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.71 -30.56 70.1 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.446 0.698 . . . . 0.0 111.91 176.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -82.37 155.96 24.45 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.99 0.916 . . . . 0.0 110.284 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -104.49 -24.3 13.04 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.821 169.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.3 mp -118.37 127.93 75.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 176.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -114.63 119.71 37.66 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 175.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.9 mp -105.98 117.95 35.34 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 105.282 -2.118 . . . . 0.0 105.282 169.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 66.9 mt -119.99 108.38 14.23 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 -169.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.81 120.32 6.52 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 125.679 1.609 . . . . 0.0 109.708 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.0 tt -134.24 112.29 12.07 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 118.104 0.952 . . . . 0.0 110.466 -176.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -74.83 143.69 29.98 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.391 2.061 . . . . 0.0 109.202 169.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 30.3 m -96.41 136.65 36.62 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 174.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 63.7 m95 -134.45 171.91 13.64 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 124.754 1.222 . . . . 0.0 109.992 -178.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 42.7 46.42 4.38 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 127.016 2.127 . . . . 0.0 114.285 167.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 57.46 69.43 0.74 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.509 1.124 . . . . 0.0 111.323 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.52 33.33 22.6 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 115.629 -0.714 . . . . 0.0 113.94 169.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -119.53 164.5 15.72 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 125.399 1.48 . . . . 0.0 109.632 175.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -96.53 170.88 8.91 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 123.983 0.913 . . . . 0.0 108.791 168.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 47.1 mm-40 -70.02 148.85 48.34 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 169.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 58.6 m -59.47 -35.18 73.59 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -168.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -72.29 -29.14 63.6 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.249 0.619 . . . . 0.0 111.469 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -78.84 -44.92 21.92 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.963 0.905 . . . . 0.0 109.349 175.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -60.42 -41.35 93.77 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.33 1.052 . . . . 0.0 111.228 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -62.66 -21.77 65.96 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.087 0.955 . . . . 0.0 112.269 178.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -85.01 -18.93 32.91 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 117.875 -1.06 . . . . 0.0 112.227 178.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -55.65 -42.75 97.65 Favored Pre-proline 0 CA--C 1.541 0.615 0 CA-C-N 121.243 1.838 . . . . 0.0 114.116 -179.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.28 -14.28 44.24 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 CA-C-N 122.603 1.965 . . . . 0.0 113.714 174.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.1 m -88.72 -42.62 11.84 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 119.195 0.907 . . . . 0.0 109.227 169.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 18.3 tp -56.62 -38.22 71.79 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 124.998 1.319 . . . . 0.0 110.841 -177.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -71.78 -1.18 13.13 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -105.97 -11.95 15.99 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.497 1.044 . . . . 0.0 111.872 172.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 98.5 mt -81.63 140.97 15.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -175.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -87.44 133.63 33.72 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 123.464 0.706 . . . . 0.0 110.133 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -126.57 15.03 7.62 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.962 0.905 . . . . 0.0 111.612 174.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 17.0 m-80 -58.73 116.12 3.51 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 119.987 1.267 . . . . 0.0 109.886 -174.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.78 1.19 58.21 Favored Glycine 0 CA--C 1.533 1.175 0 CA-C-O 118.567 -1.13 . . . . 0.0 113.803 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -74.86 147.61 40.94 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 119.628 1.714 . . . . 0.0 107.835 172.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 14.9 mt -88.77 136.04 33.21 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 174.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.2 t -132.44 139.97 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -136.71 141.56 43.08 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 175.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 62.1 mt -112.62 148.16 35.17 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -173.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -144.42 168.15 20.8 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 169.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -179.53 176.09 47.42 Favored Glycine 0 N--CA 1.447 -0.577 0 CA-C-O 122.174 0.875 . . . . 0.0 113.0 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 24.4 m -129.53 152.58 48.91 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 125.727 1.611 . . . . 0.0 107.737 -171.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -169.8 -173.79 37.55 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -177.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -147.56 166.89 25.95 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 168.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -111.47 -6.39 14.45 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.725 1.61 . . . . 0.0 111.996 -171.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -59.45 -48.25 82.35 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 123.626 0.77 . . . . 0.0 111.787 -169.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -138.18 1.99 2.27 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -173.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -111.38 27.83 9.31 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.39 1.076 . . . . 0.0 111.396 -169.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.13 -17.38 64.67 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 -169.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -94.64 -0.61 54.29 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.62 1.168 . . . . 0.0 111.995 174.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -139.08 22.61 2.6 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 125.762 1.625 . . . . 0.0 110.283 -170.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -70.76 121.03 17.24 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -169.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 74.0 m 48.3 38.92 11.22 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.617 1.167 . . . . 0.0 111.679 -177.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -61.95 -38.81 89.89 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.466 1.106 . . . . 0.0 112.061 -172.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.15 -21.34 66.33 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 114.136 1.162 . . . . 0.0 114.136 -168.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 7.1 mp -61.28 -35.22 76.72 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 119.766 1.166 . . . . 0.0 110.22 175.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.37 -33.48 86.35 Favored Glycine 0 CA--C 1.531 1.039 0 N-CA-C 111.318 -0.713 . . . . 0.0 111.318 177.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.2 m -65.05 -37.3 87.13 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 117.774 0.787 . . . . 0.0 110.361 177.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 6.0 mt -70.31 -49.15 56.34 Favored 'Isoleucine or valine' 0 C--N 1.343 0.319 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 173.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 55.8 ttt-85 -51.31 -47.21 62.68 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 118.617 0.644 . . . . 0.0 110.563 -176.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -63.23 -22.92 67.18 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.114 0.966 . . . . 0.0 112.914 -175.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 96.9 mt -91.63 -44.6 14.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 123.666 0.786 . . . . 0.0 109.379 177.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 22.4 pt -74.78 -29.43 22.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-N 118.999 0.818 . . . . 0.0 111.617 -171.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -62.03 -56.22 33.63 Favored Pre-proline 0 CA--C 1.543 0.685 0 CA-C-O 117.74 -1.124 . . . . 0.0 112.063 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -66.16 -21.79 54.96 Favored 'Trans proline' 0 C--N 1.351 0.701 0 CA-C-N 121.769 1.668 . . . . 0.0 112.612 178.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 73.0 mmt-85 -82.07 9.46 8.44 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.99 0.916 . . . . 0.0 112.841 172.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 77.51 16.16 80.62 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-O 118.367 -1.24 . . . . 0.0 114.877 168.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -59.63 144.66 47.14 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 119.036 1.418 . . . . 0.0 110.355 170.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 44.6 m -95.29 119.94 34.66 Favored 'General case' 0 C--N 1.333 -0.123 0 N-CA-C 104.663 -2.347 . . . . 0.0 104.663 167.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 15.8 mt -100.86 127.54 53.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 -171.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 31.8 m -137.44 178.23 4.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 124.983 1.313 . . . . 0.0 109.285 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 78.83 36.51 28.56 Favored Glycine 0 CA--C 1.527 0.835 0 O-C-N 121.912 -0.493 . . . . 0.0 111.976 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 68.3 m80 -63.22 142.6 58.33 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 117.615 0.707 . . . . 0.0 109.153 172.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 75.2 t-105 -123.58 129.49 24.83 Favored Pre-proline 0 CA--C 1.534 0.357 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 -174.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -67.74 144.23 64.76 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 121.437 1.425 . . . . 0.0 112.129 -170.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 71.6 p -76.91 -27.27 54.87 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.614 0.766 . . . . 0.0 111.136 177.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 52.73 42.9 31.84 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.655 1.582 . . . . 0.0 111.807 -178.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 71.4 55.23 7.85 Favored Glycine 0 C--N 1.34 0.769 0 N-CA-C 111.138 -0.785 . . . . 0.0 111.138 178.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -57.98 151.74 17.8 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 122.884 0.474 . . . . 0.0 110.265 174.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 33.0 p80 -128.83 9.44 5.86 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.932 0.893 . . . . 0.0 112.53 -177.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -74.95 162.89 28.19 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.331 1.053 . . . . 0.0 110.142 -175.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -71.19 -44.26 65.79 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 122.012 -0.43 . . . . 0.0 110.843 -170.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -160.08 134.05 7.26 Favored 'General case' 0 C--N 1.342 0.241 0 C-N-CA 124.384 1.074 . . . . 0.0 109.259 173.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 13.5 m -129.1 103.08 6.78 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 106.914 -1.514 . . . . 0.0 106.914 177.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.59 -10.86 60.14 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 120.95 -1.094 . . . . 0.0 111.795 -170.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -74.63 -0.56 59.16 Favored Glycine 0 CA--C 1.535 1.319 0 CA-C-O 118.637 -1.091 . . . . 0.0 113.412 169.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 43.7 mt -63.41 131.49 48.4 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 120.583 2.192 . . . . 0.0 109.503 174.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -100.77 -32.79 10.53 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.176 0.99 . . . . 0.0 109.323 169.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -149.49 161.78 41.44 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 127.313 2.245 . . . . 0.0 107.103 174.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -53.06 -31.78 43.4 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.328 0.651 . . . . 0.0 112.389 176.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -93.38 -11.33 32.52 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.284 1.034 . . . . 0.0 113.335 -178.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 10.9 m-70 -146.92 128.98 15.54 Favored 'General case' 0 C--N 1.346 0.431 0 CA-C-N 119.76 1.163 . . . . 0.0 113.729 -170.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -77.49 155.57 31.59 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 166.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.4 p -66.12 -22.86 30.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 C-N-CA 123.972 0.909 . . . . 0.0 111.642 178.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -158.93 169.99 35.29 Favored Glycine 0 C--N 1.338 0.659 0 CA-C-N 118.471 0.578 . . . . 0.0 112.314 -169.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -69.35 111.97 5.6 Favored 'General case' 0 CA--C 1.521 -0.144 0 C-N-CA 124.452 1.101 . . . . 0.0 109.496 -175.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -92.38 121.98 34.39 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 169.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 7.3 pt -71.08 -30.02 39.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-N 118.66 0.664 . . . . 0.0 111.276 178.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -84.32 158.59 21.13 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 118.275 0.488 . . . . 0.0 110.588 177.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -126.39 -65.16 0.99 Allowed 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 169.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -152.88 116.42 4.72 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.072 0.949 . . . . 0.0 109.588 177.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 3.5 tpm_? 48.6 95.21 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 127.776 2.43 . . . . 0.0 112.568 173.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 66.99 138.0 0.05 OUTLIER Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 126.708 2.003 . . . . 0.0 110.683 -168.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -70.13 -54.0 0.22 Allowed 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 121.604 1.536 . . . . 0.0 114.54 -167.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 57.56 174.13 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.345 1.458 . . . . 0.0 110.913 -167.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 20.7 mt 57.28 26.31 12.19 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.953 0.901 . . . . 0.0 111.986 172.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 38.8 m -46.31 -53.08 11.46 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 127.163 2.185 . . . . 0.0 112.913 -167.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -82.07 -40.54 21.83 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 119.395 -0.336 . . . . 0.0 111.038 -174.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -67.65 -28.15 67.47 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.026 0.83 . . . . 0.0 111.856 -173.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 59.6 mtp85 -62.77 -45.46 92.58 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 118.718 0.69 . . . . 0.0 110.021 175.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 17.3 m -74.34 -31.03 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-O 117.706 -1.14 . . . . 0.0 111.274 177.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -58.33 -52.07 67.14 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 120.99 1.723 . . . . 0.0 109.406 173.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -62.49 -37.79 87.37 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 122.724 0.41 . . . . 0.0 110.654 -179.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 59.2 t90 -74.91 -44.49 48.4 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 118.278 0.49 . . . . 0.0 111.644 -175.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 77.8 t -64.22 -34.0 66.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -61.25 -35.85 78.4 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 121.261 -0.899 . . . . 0.0 111.4 175.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -63.44 -55.99 19.8 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 119.177 0.899 . . . . 0.0 110.294 175.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 9.8 pt -67.08 -28.59 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 O-C-N 122.12 -0.363 . . . . 0.0 110.351 -173.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 64.2 m -60.77 -23.74 65.23 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 118.377 -0.821 . . . . 0.0 112.489 177.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -82.96 -31.9 27.37 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 119.927 1.24 . . . . 0.0 111.055 175.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -80.07 -38.31 32.03 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.713 0.805 . . . . 0.0 110.621 -178.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 5.4 mp -88.9 -3.7 58.67 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.448 1.899 . . . . 0.0 110.886 -179.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 55.63 32.85 20.06 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.847 1.659 . . . . 0.0 112.689 -174.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 47.1 mt -75.79 -19.5 58.92 Favored 'General case' 0 N--CA 1.467 0.389 0 O-C-N 121.787 -0.57 . . . . 0.0 110.519 172.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -56.81 -38.6 72.82 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.707 0.685 . . . . 0.0 110.267 175.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -67.49 -13.16 61.79 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 121.537 -0.727 . . . . 0.0 112.422 178.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 38.1 mt -99.36 -56.66 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 125.0 1.32 . . . . 0.0 108.432 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.8 pp -84.46 -22.41 30.31 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 123.554 0.742 . . . . 0.0 112.71 -169.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -121.59 35.68 4.82 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.826 1.651 . . . . 0.0 109.671 -176.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.096 0 C-N-CA 123.788 0.835 . . . . 0.0 109.504 174.697 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.8 mmm . . . . . 0 N--CA 1.489 1.481 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -60.53 145.07 49.92 Favored 'General case' 0 C--N 1.344 0.345 0 C-N-CA 123.434 0.693 . . . . 0.0 111.282 -178.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 32.4 pt -109.94 -20.53 6.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 125.189 1.396 . . . . 0.0 111.239 178.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 44.5 m -105.85 128.16 53.58 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.736 1.214 . . . . 0.0 108.146 174.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -99.82 116.19 5.51 Favored Glycine 0 CA--C 1.519 0.313 0 N-CA-C 107.198 -2.361 . . . . 0.0 107.198 169.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 46.6 mt -90.63 122.59 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 104.135 -2.543 . . . . 0.0 104.135 171.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -118.19 132.8 56.3 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 174.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -132.9 158.42 42.63 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 118.345 0.521 . . . . 0.0 111.187 -174.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -132.73 154.36 21.08 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 108.091 -2.003 . . . . 0.0 108.091 167.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 16.3 m -163.7 163.51 24.17 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 119.212 1.506 . . . . 0.0 109.491 -175.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -137.98 -52.53 0.62 Allowed 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.667 0.787 . . . . 0.0 110.379 171.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.9 p -77.52 -14.73 59.6 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.237 0.615 . . . . 0.0 111.753 170.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 104.98 8.21 36.93 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.014 1.292 . . . . 0.0 113.961 169.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -66.55 -54.29 25.26 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 119.02 1.41 . . . . 0.0 111.927 -173.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.3 m -75.78 -18.38 59.55 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 122.027 -0.421 . . . . 0.0 111.515 -166.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -59.72 -46.78 88.08 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 167.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 33.2 t30 -68.3 -39.67 81.98 Favored 'General case' 0 C--N 1.339 0.122 0 O-C-N 121.864 -0.523 . . . . 0.0 110.305 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 49.8 mm -59.48 -45.16 94.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 118.738 0.699 . . . . 0.0 109.265 175.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.73 -40.61 95.69 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.753 0.706 . . . . 0.0 111.174 178.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -64.18 -42.49 96.67 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-O 118.823 -0.608 . . . . 0.0 110.826 176.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 98.8 mtp -63.82 -44.37 93.43 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 119.35 0.977 . . . . 0.0 110.464 177.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 69.9 mt -57.26 -47.57 84.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 176.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -58.29 -42.97 87.78 Favored 'General case' 0 CA--C 1.53 0.2 0 O-C-N 121.467 -0.771 . . . . 0.0 111.157 176.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -64.0 -35.93 82.32 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 119.416 1.007 . . . . 0.0 110.683 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -69.21 -45.52 69.67 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.286 0.635 . . . . 0.0 110.936 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -79.88 -30.09 40.12 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.031 0.832 . . . . 0.0 112.101 -178.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.73 145.26 16.13 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 125.008 1.29 . . . . 0.0 110.699 -170.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.9 tttm -65.04 -31.01 72.02 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 121.889 -0.771 . . . . 0.0 111.799 -170.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -77.6 -7.06 55.8 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.063 0.545 . . . . 0.0 112.069 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 49.0 t -104.67 -43.21 7.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 124.254 1.022 . . . . 0.0 109.258 174.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -134.46 134.11 41.18 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 119.478 1.036 . . . . 0.0 111.491 -175.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -123.94 148.55 46.8 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 175.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 59.5 t -106.42 140.07 25.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 124.477 1.111 . . . . 0.0 111.158 -168.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -139.64 144.18 37.55 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.811 1.644 . . . . 0.0 109.847 177.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -83.92 126.25 32.82 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 169.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 11.0 tp -58.54 -31.23 43.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -171.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.72 -29.83 67.31 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.985 0.811 . . . . 0.0 112.024 -177.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 47.4 mtmt -76.54 -33.3 58.56 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 118.206 0.457 . . . . 0.0 110.835 177.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 57.7 m -70.77 165.01 23.98 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.678 1.191 . . . . 0.0 112.248 -174.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.5 m -133.04 174.59 10.2 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.225 1.81 . . . . 0.0 109.146 -176.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -49.05 -54.26 16.7 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.288 1.035 . . . . 0.0 111.655 -173.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -76.27 -11.83 59.98 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 122.473 0.309 . . . . 0.0 111.758 -170.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -71.22 -33.85 70.29 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 121.882 -0.512 . . . . 0.0 110.766 -174.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 8.4 mp -74.3 -38.75 63.26 Favored 'General case' 0 C--N 1.342 0.279 0 C-N-CA 122.594 0.358 . . . . 0.0 110.109 171.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -67.06 -18.14 65.21 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 122.898 0.479 . . . . 0.0 112.126 -169.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.92 -28.98 69.91 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.482 1.113 . . . . 0.0 112.527 173.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -96.16 156.94 16.12 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.147 0.979 . . . . 0.0 111.048 -175.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -99.5 -29.39 12.75 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.31 0.644 . . . . 0.0 111.514 170.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.0 mp -110.76 127.69 67.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 174.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -115.52 135.16 54.37 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 174.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.5 mp -118.74 114.13 22.23 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 172.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 51.6 mt -112.47 112.4 23.92 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 -169.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -102.58 103.4 2.43 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 125.404 1.478 . . . . 0.0 111.075 -173.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 14.6 tt -127.72 119.39 21.42 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 124.123 0.969 . . . . 0.0 111.077 -169.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -76.29 150.31 32.62 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 121.909 1.739 . . . . 0.0 110.501 170.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 19.1 m -98.3 140.78 32.07 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 169.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 42.4 m95 -136.2 174.38 10.67 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.718 1.607 . . . . 0.0 109.479 -178.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 21.52 82.27 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 128.476 2.71 . . . . 0.0 114.702 169.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 57.49 49.52 12.69 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.937 0.895 . . . . 0.0 111.927 172.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 81.03 19.0 68.27 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 123.743 0.687 . . . . 0.0 113.541 170.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -88.48 156.13 19.28 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 124.316 1.046 . . . . 0.0 110.162 178.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.97 144.5 34.69 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 169.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -59.93 149.28 32.24 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 169.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 75.4 m -61.04 -25.84 67.21 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -168.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 39.4 p30 -68.45 -36.39 78.93 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.474 0.71 . . . . 0.0 111.848 178.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -80.36 -41.43 24.72 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 118.695 0.68 . . . . 0.0 111.091 171.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -60.98 -39.34 89.25 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.505 0.593 . . . . 0.0 111.533 -176.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -67.4 -20.82 65.59 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.358 0.663 . . . . 0.0 112.168 175.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -94.43 -20.9 19.29 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.043 0.937 . . . . 0.0 111.825 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 21.6 m-30 -52.49 -40.32 74.48 Favored Pre-proline 0 CA--C 1.545 0.758 0 CA-C-O 116.67 -1.633 . . . . 0.0 114.544 178.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -64.41 -23.83 64.78 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 CA-C-N 123.103 2.144 . . . . 0.0 113.036 174.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.6 m -79.79 -38.34 33.28 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 119.239 0.927 . . . . 0.0 109.168 170.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 19.4 tp -60.64 -33.32 72.62 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.016 -1.052 . . . . 0.0 111.84 -174.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -81.97 -4.3 56.37 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.65 0.78 . . . . 0.0 112.863 176.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -96.15 -28.33 14.62 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 119.112 0.869 . . . . 0.0 109.947 170.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 88.7 mt -64.26 136.22 26.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 176.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -86.67 130.89 34.31 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 123.421 0.688 . . . . 0.0 109.548 172.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -118.03 6.7 12.13 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.17 0.988 . . . . 0.0 112.005 176.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 21.9 m-80 -56.55 115.49 2.55 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 120.463 1.483 . . . . 0.0 110.478 -173.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.71 0.37 63.55 Favored Glycine 0 CA--C 1.535 1.321 0 CA-C-O 118.548 -1.14 . . . . 0.0 114.285 178.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -75.24 147.5 40.26 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 119.679 1.739 . . . . 0.0 108.202 174.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 69.3 mt -91.24 135.86 33.5 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 175.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.8 t -135.27 130.43 51.08 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -116.3 150.23 37.97 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 169.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 79.7 mt -117.55 150.71 38.53 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 -178.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -149.03 162.07 40.66 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 170.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 171.91 150.03 6.96 Favored Glycine 0 N--CA 1.448 -0.51 0 CA-C-O 121.88 0.711 . . . . 0.0 112.789 174.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 4.5 p -78.01 164.18 25.29 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 121.321 0.581 . . . . 0.0 109.837 169.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -160.58 -162.51 12.57 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 173.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -145.63 122.58 11.34 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 127.08 2.152 . . . . 0.0 105.473 177.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -110.51 1.95 18.51 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.228 1.411 . . . . 0.0 111.474 -173.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -108.8 -45.12 3.88 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.369 1.068 . . . . 0.0 110.827 -168.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -104.3 -35.45 7.97 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.804 1.242 . . . . 0.0 109.975 178.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -98.19 40.46 1.18 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.376 1.071 . . . . 0.0 110.279 169.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.03 -21.78 65.17 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.174 1.39 . . . . 0.0 113.787 -173.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -95.96 5.95 50.01 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.986 0.914 . . . . 0.0 111.691 177.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -138.56 18.7 2.71 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.983 1.313 . . . . 0.0 110.907 -172.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 30.8 t80 -64.93 132.5 49.49 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -173.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . 0.282 28.6 p 54.95 24.41 5.86 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.675 1.99 . . . . 0.0 114.454 171.043 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -61.56 -32.49 72.57 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.146 1.378 . . . . 0.0 111.867 -174.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.24 -32.57 71.88 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 120.903 -1.123 . . . . 0.0 111.427 -178.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 7.0 mp -63.82 -43.88 94.91 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 119.658 1.117 . . . . 0.0 108.849 173.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -60.51 -34.77 87.04 Favored Glycine 0 CA--C 1.533 1.185 0 N-CA-C 111.436 -0.666 . . . . 0.0 111.436 174.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 17.0 m -65.02 -37.38 87.44 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 121.716 -0.873 . . . . 0.0 110.6 176.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 5.1 mt -67.32 -47.45 81.14 Favored 'Isoleucine or valine' 0 C--N 1.345 0.382 0 CA-C-O 117.643 -1.17 . . . . 0.0 108.967 173.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -56.92 -38.22 72.57 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 120.38 1.445 . . . . 0.0 110.928 -174.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -60.69 -25.08 66.12 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.206 1.002 . . . . 0.0 112.457 178.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 75.8 mt -94.02 -49.36 12.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 124.419 1.087 . . . . 0.0 110.041 177.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 36.5 pt -75.58 -28.37 19.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-N 120.002 1.274 . . . . 0.0 111.9 -168.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -63.13 -53.95 50.0 Favored Pre-proline 0 CA--C 1.542 0.663 0 CA-C-O 117.447 -1.263 . . . . 0.0 111.836 178.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -68.08 -20.87 43.62 Favored 'Trans proline' 0 C--N 1.351 0.707 0 CA-C-N 122.064 1.773 . . . . 0.0 112.719 176.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 31.4 mmm180 -78.58 1.98 20.8 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 119.163 0.892 . . . . 0.0 112.144 170.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 93.26 10.43 59.53 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 125.048 1.309 . . . . 0.0 115.204 168.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.94 146.79 45.55 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 119.205 1.502 . . . . 0.0 110.757 174.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 86.1 m -101.93 124.16 47.08 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 105.206 -2.146 . . . . 0.0 105.206 167.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 19.4 mm -90.76 133.28 33.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 -171.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 18.7 m -131.76 168.51 23.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.395 0 C-N-CA 125.99 1.716 . . . . 0.0 108.81 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 70.07 39.66 73.25 Favored Glycine 0 CA--C 1.527 0.792 0 O-C-N 121.691 -0.631 . . . . 0.0 113.05 177.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -64.55 134.83 55.2 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 171.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 57.6 t-105 -114.76 127.26 26.99 Favored Pre-proline 0 CA--C 1.535 0.398 0 C-N-CA 124.752 1.221 . . . . 0.0 108.494 -169.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -61.98 141.93 90.98 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 CA-C-N 121.02 1.4 . . . . 0.0 112.831 -173.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 56.7 p -74.43 -28.07 60.89 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.037 0.535 . . . . 0.0 110.991 174.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 52.95 43.34 31.8 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.05 1.74 . . . . 0.0 111.84 -179.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 70.48 56.05 8.02 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 178.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -59.16 152.92 19.31 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 116.963 0.382 . . . . 0.0 110.197 174.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 37.2 t60 -144.96 57.5 1.28 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.514 0.673 . . . . 0.0 109.714 -176.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -116.27 164.1 15.01 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 124.973 1.309 . . . . 0.0 108.637 -177.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -66.49 -43.21 86.01 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 119.4 -0.333 . . . . 0.0 110.753 -169.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -161.42 130.63 4.61 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 124.3 1.04 . . . . 0.0 109.089 169.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 13.3 m -115.34 124.66 51.84 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 174.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -100.58 -11.4 20.1 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -173.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -79.6 7.88 51.63 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-O 119.184 -0.787 . . . . 0.0 113.113 169.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 97.5 mt -64.75 138.56 58.46 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 120.178 1.989 . . . . 0.0 109.942 174.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -106.21 -31.04 8.84 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.982 1.313 . . . . 0.0 108.925 167.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -149.16 162.98 38.89 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 127.466 2.306 . . . . 0.0 106.929 171.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -54.68 -30.84 56.71 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 121.371 -0.831 . . . . 0.0 112.162 176.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -91.98 -9.77 41.74 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.322 1.049 . . . . 0.0 113.325 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 11.9 m-70 -146.71 126.34 13.35 Favored 'General case' 0 C--N 1.346 0.415 0 CA-C-N 119.569 1.077 . . . . 0.0 113.376 -170.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -75.3 153.38 37.95 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 166.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 8.9 p -65.86 -18.88 24.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 124.288 1.035 . . . . 0.0 112.395 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -166.68 179.86 40.3 Favored Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -173.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -71.07 87.86 0.77 Allowed 'General case' 0 CA--C 1.522 -0.101 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 -178.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -85.71 129.22 34.88 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 169.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 12.4 tt -134.14 129.56 53.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-O 121.711 0.767 . . . . 0.0 112.108 -176.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -157.3 166.54 32.84 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 128.728 2.811 . . . . 0.0 105.265 168.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 24.1 tp10 -139.98 -63.25 0.5 Allowed 'General case' 0 C--O 1.233 0.207 0 O-C-N 121.203 -0.936 . . . . 0.0 109.744 176.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -160.24 94.45 1.09 Allowed 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 178.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 29.3 mmm-85 53.41 87.75 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.561 1.544 . . . . 0.0 110.879 -169.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 74.93 148.91 0.12 Allowed Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 127.218 2.207 . . . . 0.0 111.531 -176.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -72.32 158.49 51.5 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 123.412 2.741 . . . . 0.0 115.425 -168.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -154.34 -174.07 4.83 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.935 2.094 . . . . 0.0 107.383 167.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 23.7 mt 59.83 29.14 18.71 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.516 1.526 . . . . 0.0 110.973 -168.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 75.0 m -56.77 -51.46 68.82 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.37 1.468 . . . . 0.0 111.563 -169.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.32 -41.22 89.96 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -167.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -70.46 -35.03 73.09 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 118.219 0.463 . . . . 0.0 110.732 177.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 58.9 mtt180 -69.21 -43.86 73.28 Favored 'General case' 0 C--O 1.233 0.208 0 O-C-N 121.555 -0.716 . . . . 0.0 110.493 -178.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 26.6 m -70.42 -29.05 37.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 119.3 0.955 . . . . 0.0 110.544 177.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -64.21 -53.9 41.9 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 120.4 1.455 . . . . 0.0 109.755 171.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -58.2 -36.79 73.64 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 118.863 -0.589 . . . . 0.0 110.641 -178.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 46.1 t90 -77.14 -50.1 13.76 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 118.469 0.577 . . . . 0.0 111.426 -177.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 45.8 t -62.02 -33.58 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 O-C-N 121.458 -0.776 . . . . 0.0 109.992 -177.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -60.16 -38.32 82.79 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-O 118.343 -0.837 . . . . 0.0 111.17 177.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -59.07 -55.01 40.62 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 118.954 0.797 . . . . 0.0 109.802 176.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 19.0 pt -68.53 -29.74 45.0 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.235 0 O-C-N 122.133 -0.354 . . . . 0.0 110.248 -174.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 35.6 m -65.34 -25.41 67.59 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 118.705 -0.664 . . . . 0.0 111.74 175.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -86.03 -39.1 17.18 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 119.547 1.067 . . . . 0.0 110.253 174.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -64.51 -40.09 94.98 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 122.933 0.493 . . . . 0.0 110.92 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.7 mp -100.02 2.33 43.31 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.686 1.594 . . . . 0.0 111.005 -175.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . 0.291 31.7 p80 50.94 26.71 2.81 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 127.022 2.129 . . . . 0.0 113.948 -174.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 55.9 mt -66.04 -21.7 66.4 Favored 'General case' 0 C--N 1.344 0.33 0 O-C-N 121.505 -0.747 . . . . 0.0 110.275 172.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -55.04 -39.55 69.3 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.608 0.763 . . . . 0.0 110.302 172.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -74.98 -1.93 24.87 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.476 -0.765 . . . . 0.0 112.312 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 31.3 mt -105.39 -55.48 5.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 C-N-CA 125.11 1.364 . . . . 0.0 108.23 175.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.4 pp -80.31 -23.93 40.3 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 123.463 0.705 . . . . 0.0 112.464 -171.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 31.7 t30 -129.07 42.11 3.37 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.956 2.102 . . . . 0.0 108.302 -176.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.135 0 C-N-CA 123.7 0.8 . . . . 0.0 109.464 173.841 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.4 ptm . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 120.498 0.189 . . . . 0.0 111.371 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.07 155.57 40.14 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.173 0.589 . . . . 0.0 109.969 172.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 27.4 pt -83.5 -23.02 8.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 -178.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.1 m -112.2 127.37 55.93 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.955 1.302 . . . . 0.0 108.391 -178.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -101.67 118.96 6.31 Favored Glycine 0 CA--C 1.519 0.331 0 N-CA-C 107.846 -2.101 . . . . 0.0 107.846 169.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 44.7 mt -95.05 118.3 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 104.37 -2.456 . . . . 0.0 104.37 171.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -114.32 127.1 55.7 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 177.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -127.81 125.06 39.1 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 118.702 0.683 . . . . 0.0 112.017 -175.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -82.12 145.43 24.45 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 168.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.4 m -159.91 161.47 34.31 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 119.083 1.442 . . . . 0.0 109.844 175.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -138.74 -48.05 0.51 Allowed 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.037 0.935 . . . . 0.0 109.817 168.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.2 p -79.29 -13.52 59.6 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.486 0.714 . . . . 0.0 111.689 169.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.03 6.53 53.84 Favored Glycine 0 C--N 1.343 0.965 0 C-N-CA 124.767 1.175 . . . . 0.0 113.813 170.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -70.16 -38.4 75.43 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 118.769 1.284 . . . . 0.0 112.553 -169.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -69.83 -17.77 63.41 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 119.548 1.067 . . . . 0.0 111.383 -174.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -60.14 -41.21 92.22 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.185 0.902 . . . . 0.0 110.179 175.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -65.96 -39.89 90.81 Favored 'General case' 0 N--CA 1.463 0.195 0 O-C-N 121.924 -0.485 . . . . 0.0 110.106 178.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 27.2 mm -60.61 -49.05 85.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 176.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.16 -41.18 92.26 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.386 0.674 . . . . 0.0 111.702 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.9 mttm -67.11 -40.25 86.84 Favored 'General case' 0 N--CA 1.461 0.119 0 O-C-N 121.661 -0.65 . . . . 0.0 111.113 177.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 70.2 mtm -66.37 -31.95 73.04 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 119.504 1.047 . . . . 0.0 111.447 177.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 76.7 mt -65.81 -54.6 25.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 171.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -62.1 -37.03 83.54 Favored 'General case' 0 C--O 1.224 -0.251 0 CA-C-O 118.952 -0.546 . . . . 0.0 111.366 -173.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -63.68 -36.06 82.6 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 119.325 0.966 . . . . 0.0 110.91 -178.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -74.86 -41.36 59.96 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.131 0.573 . . . . 0.0 110.74 177.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.3 mp -73.99 -33.27 63.76 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 118.081 0.4 . . . . 0.0 111.23 -176.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 88.13 146.47 11.96 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 124.861 1.219 . . . . 0.0 110.763 -172.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -64.79 -29.61 70.59 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.875 0.87 . . . . 0.0 111.984 -172.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -67.53 -29.71 69.18 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 122.674 0.39 . . . . 0.0 111.07 177.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 22.8 t -93.47 -37.77 8.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 C-N-CA 123.921 0.888 . . . . 0.0 110.119 -175.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -135.58 144.05 45.97 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-N 119.3 0.955 . . . . 0.0 112.82 -176.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -128.53 153.18 47.46 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.565 1.146 . . . . 0.0 109.578 173.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 77.5 t -114.25 131.62 65.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 124.655 1.182 . . . . 0.0 110.263 -168.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 -144.63 166.5 25.01 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.645 1.578 . . . . 0.0 112.219 -169.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -130.63 129.42 42.67 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 127.088 2.155 . . . . 0.0 106.332 -178.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.4 tp -61.87 -19.62 21.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 123.64 0.776 . . . . 0.0 112.299 -171.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -58.39 -30.27 66.69 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 118.676 0.671 . . . . 0.0 112.461 -175.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 60.9 pttt -98.09 -6.42 31.71 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.755 0.822 . . . . 0.0 112.619 177.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 67.2 m -76.26 158.96 31.06 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.705 0.764 . . . . 0.0 111.444 -175.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 21.8 m -130.43 175.47 8.94 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.723 2.009 . . . . 0.0 107.145 172.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -51.61 -48.83 63.1 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 118.497 0.59 . . . . 0.0 111.654 -174.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -77.67 -12.62 59.99 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -172.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -68.47 -32.92 73.25 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 118.74 0.7 . . . . 0.0 110.824 -177.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -74.91 -42.46 57.75 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 123.603 0.761 . . . . 0.0 109.502 172.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -68.94 -19.54 64.18 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.633 0.773 . . . . 0.0 111.954 -170.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.57 -29.78 70.43 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.011 0.925 . . . . 0.0 112.433 176.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -86.21 160.46 19.19 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 124.292 1.037 . . . . 0.0 110.316 178.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -111.2 -24.26 10.38 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.596 0.758 . . . . 0.0 111.802 169.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.0 mp -117.02 131.92 68.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 174.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 79.8 mt -130.56 123.7 30.17 Favored 'General case' 0 CA--C 1.523 -0.08 0 C-N-CA 123.965 0.906 . . . . 0.0 109.363 -177.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 8.1 mp -109.6 107.74 17.93 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 176.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.9 mt -108.27 108.96 20.19 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -168.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -100.42 117.39 5.86 Favored Glycine 0 CA--C 1.518 0.245 0 C-N-CA 125.516 1.531 . . . . 0.0 109.709 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 15.5 tt -129.74 118.9 18.9 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 118.43 1.115 . . . . 0.0 110.627 -176.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -79.36 150.95 22.7 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.403 2.069 . . . . 0.0 110.289 173.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 17.3 m -100.68 137.07 39.57 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 175.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 66.8 m95 -137.25 173.8 11.3 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.782 1.633 . . . . 0.0 110.599 -173.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 54.49 -89.17 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 127.976 2.51 . . . . 0.0 113.246 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -151.02 62.12 0.91 Allowed 'General case' 0 C--O 1.237 0.417 0 C-N-CA 126.168 1.787 . . . . 0.0 107.89 -173.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 67.67 54.85 16.78 Favored Glycine 0 CA--C 1.53 1.003 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 -174.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -129.24 164.6 23.1 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.104 1.362 . . . . 0.0 108.642 175.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.36 164.29 22.24 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 121.221 0.534 . . . . 0.0 110.027 170.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -70.33 150.7 46.05 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 169.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 84.0 m -56.84 -33.35 66.7 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -168.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -69.26 -40.47 77.82 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 119.092 0.86 . . . . 0.0 110.687 -177.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -72.21 -41.49 66.86 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 174.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -60.0 -40.98 91.11 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 122.697 0.399 . . . . 0.0 111.39 -178.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -70.05 -21.07 63.21 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.092 0.957 . . . . 0.0 112.018 177.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -90.91 -19.16 23.63 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 118.7 -0.666 . . . . 0.0 112.316 -178.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -51.7 -41.72 79.61 Favored Pre-proline 0 CA--C 1.543 0.709 0 CA-C-O 116.389 -1.767 . . . . 0.0 114.666 178.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -62.4 -21.18 72.36 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 CA-C-N 122.909 2.075 . . . . 0.0 113.632 175.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.2 m -84.88 -41.97 15.49 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.454 1.025 . . . . 0.0 109.124 169.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.2 tp -56.47 -38.39 71.62 Favored 'General case' 0 C--N 1.341 0.219 0 C-N-CA 124.054 0.942 . . . . 0.0 111.177 -177.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -72.66 -2.8 21.52 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -109.86 -14.81 14.22 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.325 1.05 . . . . 0.0 111.622 173.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 74.5 mt -71.8 139.63 19.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -178.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -81.21 128.38 33.71 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.905 176.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -125.58 12.31 8.02 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.829 0.851 . . . . 0.0 111.737 172.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 42.8 m-80 -62.42 116.3 4.96 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 119.647 1.112 . . . . 0.0 109.385 -171.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.66 2.18 60.0 Favored Glycine 0 CA--C 1.534 1.239 0 CA-C-O 118.671 -1.072 . . . . 0.0 113.782 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 62.1 mttm -73.31 148.27 43.7 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 119.533 1.666 . . . . 0.0 107.714 171.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 60.9 mt -90.5 137.81 32.06 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 174.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.6 t -136.01 147.96 27.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 -178.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -140.18 144.23 36.51 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 169.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.9 mp -113.48 151.27 31.7 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 123.677 0.791 . . . . 0.0 109.512 -172.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 25.9 p90 -149.2 168.46 23.21 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 168.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 177.93 157.99 19.88 Favored Glycine 0 N--CA 1.449 -0.498 0 O-C-N 121.144 -0.973 . . . . 0.0 113.445 178.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 14.2 m -110.64 153.42 25.24 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 124.805 1.242 . . . . 0.0 109.268 -169.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -163.46 -166.54 22.45 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 178.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -152.61 118.69 5.49 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 124.898 1.279 . . . . 0.0 107.699 176.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -82.67 -34.15 27.5 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -169.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -56.33 -46.67 79.8 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 123.867 0.867 . . . . 0.0 111.648 -169.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -97.17 -42.6 7.76 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 118.601 0.637 . . . . 0.0 112.245 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 -91.94 44.72 1.18 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.958 0.903 . . . . 0.0 110.357 -172.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.33 -24.66 66.6 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.258 1.423 . . . . 0.0 113.421 -169.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -104.62 10.37 34.91 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.267 1.027 . . . . 0.0 112.75 178.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -135.62 16.86 3.35 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 124.939 1.296 . . . . 0.0 111.177 -178.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -66.41 124.45 22.77 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 121.159 -0.963 . . . . 0.0 110.518 -168.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 92.6 m 49.97 36.78 12.42 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.684 1.593 . . . . 0.0 113.058 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -59.93 -36.35 76.86 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.464 -0.772 . . . . 0.0 112.549 179.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.44 -24.81 67.75 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 -167.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.8 mp -61.57 -36.35 80.41 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 120.967 -1.083 . . . . 0.0 109.902 175.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.32 -31.22 78.51 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 123.706 0.669 . . . . 0.0 111.455 177.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.9 m -66.89 -36.67 82.82 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 121.858 -0.789 . . . . 0.0 110.533 179.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 15.7 mt -71.46 -49.16 49.0 Favored 'Isoleucine or valine' 0 C--N 1.343 0.318 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 174.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 18.3 tpt180 -50.15 -44.4 52.51 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.16 0.984 . . . . 0.0 111.052 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -60.87 -28.1 68.61 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.88 0.872 . . . . 0.0 112.643 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 97.0 mt -92.9 -46.09 14.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 124.351 1.06 . . . . 0.0 109.923 -178.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 32.6 pt -78.22 -23.09 13.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 O-C-N 121.23 -0.918 . . . . 0.0 111.931 -169.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -62.91 -58.06 18.38 Favored Pre-proline 0 CA--C 1.544 0.712 0 CA-C-O 117.412 -1.28 . . . . 0.0 111.629 177.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -65.8 -23.52 55.4 Favored 'Trans proline' 0 C--N 1.352 0.761 0 CA-C-N 121.708 1.646 . . . . 0.0 112.39 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 76.6 mmt-85 -79.66 6.26 11.13 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.211 1.004 . . . . 0.0 112.807 173.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 77.73 19.2 76.13 Favored Glycine 0 CA--C 1.528 0.876 0 CA-C-O 118.271 -1.294 . . . . 0.0 114.988 168.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.03 144.36 53.57 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 119.318 1.559 . . . . 0.0 110.09 169.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 42.2 m -97.45 124.99 41.84 Favored 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 105.01 -2.218 . . . . 0.0 105.01 167.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 20.8 mt -113.44 125.8 70.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -169.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 33.3 m -127.76 178.72 4.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 124.69 1.196 . . . . 0.0 109.21 174.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 79.77 27.64 53.29 Favored Glycine 0 CA--C 1.528 0.898 0 O-C-N 121.851 -0.531 . . . . 0.0 112.57 179.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 80.8 m-70 -62.0 141.58 57.98 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 170.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 71.5 t-105 -131.12 138.03 32.01 Favored Pre-proline 0 CA--C 1.537 0.446 0 C-N-CA 124.125 0.97 . . . . 0.0 109.5 -170.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -62.93 151.29 85.27 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 121.818 1.679 . . . . 0.0 112.985 -176.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 35.5 p -70.71 -25.45 62.96 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 121.852 -0.53 . . . . 0.0 111.515 171.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 54.19 40.3 31.55 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.166 1.786 . . . . 0.0 112.593 175.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 66.46 47.35 70.63 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 111.671 -0.571 . . . . 0.0 111.671 175.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -55.58 -45.15 77.43 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.091 0.556 . . . . 0.0 110.916 -178.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 18.0 m-70 54.65 32.98 18.28 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.664 1.986 . . . . 0.0 114.638 173.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -92.84 -173.5 3.33 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 167.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -67.56 -48.6 66.46 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.656 -0.653 . . . . 0.0 110.918 -170.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -161.89 118.98 2.14 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 123.493 0.717 . . . . 0.0 110.962 174.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 11.5 p -92.17 137.65 32.18 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 166.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -121.33 2.63 10.29 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.928 1.084 . . . . 0.0 113.928 -168.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -83.95 4.98 81.36 Favored Glycine 0 CA--C 1.534 1.269 0 CA-C-O 119.518 -0.601 . . . . 0.0 112.207 169.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 9.0 mp -62.23 135.26 57.4 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 118.969 1.385 . . . . 0.0 111.71 -177.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -97.05 -29.59 13.54 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.484 1.514 . . . . 0.0 109.313 167.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -146.82 167.68 23.29 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.149 1.78 . . . . 0.0 107.327 174.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -55.64 -25.89 41.44 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.12 1.368 . . . . 0.0 113.947 -169.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -122.45 11.71 9.99 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.85 1.26 . . . . 0.0 113.574 -178.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -141.14 125.72 17.81 Favored 'General case' 0 C--N 1.343 0.304 0 CA-C-N 119.362 0.983 . . . . 0.0 111.587 -176.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -71.54 150.17 45.04 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.333 1.053 . . . . 0.0 108.31 166.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 6.1 p -67.74 -8.6 8.98 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 123.98 0.912 . . . . 0.0 112.099 175.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -168.66 176.22 43.0 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 -172.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -70.73 103.12 2.48 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 -179.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -79.62 138.54 37.46 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 169.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 8.7 tp -127.83 109.66 20.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-N 119.414 1.006 . . . . 0.0 112.335 178.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -172.1 146.11 1.89 Allowed 'General case' 0 C--O 1.236 0.344 0 C-N-CA 128.215 2.606 . . . . 0.0 106.67 166.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -91.48 -48.89 6.62 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.648 0.658 . . . . 0.0 109.631 173.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -169.31 -52.37 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.166 1.386 . . . . 0.0 109.42 -175.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 12.5 tpp85 -141.79 86.98 2.02 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 104.944 -2.243 . . . . 0.0 104.944 177.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 43.1 mm-40 67.64 147.52 0.11 Allowed Pre-proline 0 CA--C 1.545 0.764 0 C-N-CA 127.311 2.244 . . . . 0.0 111.07 -168.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -68.97 153.64 72.16 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.336 2.024 . . . . 0.0 111.806 -178.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -120.36 -32.12 4.19 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.804 1.642 . . . . 0.0 110.337 173.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 66.7 mt -99.82 27.7 5.27 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.737 1.615 . . . . 0.0 110.203 -174.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 50.5 m -41.03 -53.41 3.01 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 128.175 2.59 . . . . 0.0 111.766 -177.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -76.62 -40.74 48.39 Favored 'General case' 0 N--CA 1.452 -0.357 0 O-C-N 122.264 -0.272 . . . . 0.0 111.001 -172.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -62.9 -47.28 84.0 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 117.993 0.36 . . . . 0.0 110.377 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 47.6 mtp180 -65.71 -39.54 91.3 Favored 'General case' 0 N--CA 1.464 0.249 0 O-C-N 121.932 -0.48 . . . . 0.0 110.325 -175.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 86.4 t -72.68 -37.47 55.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-O 118.226 -0.893 . . . . 0.0 109.899 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -62.05 -49.83 74.4 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 120.722 1.601 . . . . 0.0 110.245 174.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -62.72 -34.56 77.43 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 118.898 -0.572 . . . . 0.0 110.746 -176.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 40.2 t90 -71.79 -51.63 21.64 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 118.531 0.605 . . . . 0.0 110.384 176.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 68.9 t -64.44 -35.07 73.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 O-C-N 121.533 -0.729 . . . . 0.0 110.835 -172.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -63.45 -35.53 80.74 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.404 -0.81 . . . . 0.0 110.324 177.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 53.7 mm-40 -71.63 -48.39 48.23 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.552 0.741 . . . . 0.0 111.178 174.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 3.8 pt -63.72 -32.51 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-N 119.771 1.169 . . . . 0.0 110.362 -177.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 50.2 m -61.85 -33.68 74.61 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 118.309 -0.853 . . . . 0.0 111.505 -179.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -86.41 -24.66 25.64 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 120.227 1.376 . . . . 0.0 111.954 177.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -73.74 -37.61 65.01 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 118.683 0.674 . . . . 0.0 110.701 174.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 77.7 mt -89.97 -4.79 57.26 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.058 1.743 . . . . 0.0 111.484 -178.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 82.7 m-70 56.6 25.29 9.76 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.952 1.701 . . . . 0.0 113.195 -172.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 79.8 mt -74.88 -20.15 59.85 Favored 'General case' 0 N--CA 1.464 0.246 0 O-C-N 121.456 -0.778 . . . . 0.0 110.381 172.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -58.37 -40.77 83.18 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 118.788 0.722 . . . . 0.0 110.945 -179.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -71.9 -12.13 61.12 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 122.773 0.429 . . . . 0.0 112.123 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 28.6 mt -97.52 -47.37 12.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 124.755 1.222 . . . . 0.0 108.522 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 3.0 pp -73.34 -29.44 62.66 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 123.101 0.56 . . . . 0.0 111.326 -177.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -119.93 59.82 0.87 Allowed 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.71 1.604 . . . . 0.0 108.21 174.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.218 0 CA-C-O 118.426 -0.797 . . . . 0.0 109.234 174.07 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.3 tpt . . . . . 0 N--CA 1.488 1.459 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.14 153.33 32.21 Favored 'General case' 0 C--N 1.341 0.238 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 172.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 28.6 pt -80.68 -24.73 11.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 O-C-N 122.143 -0.348 . . . . 0.0 111.351 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.1 m -113.19 130.16 56.3 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.002 1.321 . . . . 0.0 108.771 178.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -102.76 124.68 8.24 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 107.974 -2.051 . . . . 0.0 107.974 169.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 27.3 mt -103.32 94.72 3.35 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 105.248 -2.131 . . . . 0.0 105.248 177.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -90.27 129.44 36.5 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 -177.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -122.43 123.47 41.4 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 119.806 1.185 . . . . 0.0 112.637 -176.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -82.51 141.72 21.42 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 106.391 -2.684 . . . . 0.0 106.391 165.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.1 m -161.85 171.33 17.93 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 119.939 1.87 . . . . 0.0 110.452 177.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -133.93 -50.67 0.83 Allowed 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.027 0.931 . . . . 0.0 109.817 169.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 81.9 p -92.41 5.0 52.31 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.021 0.928 . . . . 0.0 112.31 177.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 76.13 18.15 79.56 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 124.032 0.825 . . . . 0.0 113.317 -175.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -76.85 -47.19 22.07 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 119.263 1.532 . . . . 0.0 111.235 -176.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 72.8 m -74.06 -23.57 59.38 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 118.968 0.804 . . . . 0.0 109.974 178.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -56.09 -46.27 79.12 Favored 'General case' 0 C--N 1.342 0.248 0 O-C-N 121.385 -0.822 . . . . 0.0 109.616 169.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -64.95 -34.28 78.05 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 121.781 -0.574 . . . . 0.0 111.033 -177.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 45.4 mm -60.43 -44.1 95.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 172.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.61 -41.51 97.57 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.702 -0.624 . . . . 0.0 111.576 177.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 29.2 mmtp -64.14 -41.87 97.03 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 121.45 -0.782 . . . . 0.0 110.276 176.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 78.7 mtp -62.24 -40.6 96.72 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.399 1.0 . . . . 0.0 110.473 178.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 55.5 mt -60.62 -49.59 83.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 174.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -58.59 -38.15 77.32 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 121.233 -0.917 . . . . 0.0 111.417 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -63.63 -34.56 78.1 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 120.077 1.308 . . . . 0.0 111.246 -178.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -72.27 -40.6 67.5 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 118.371 0.532 . . . . 0.0 110.758 174.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -80.58 -34.22 35.47 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -171.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 84.3 144.61 6.48 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 -168.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 54.0 tttp -63.41 -30.93 71.97 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 121.912 -0.758 . . . . 0.0 111.975 -171.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -64.47 -30.98 72.01 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 122.85 0.46 . . . . 0.0 111.26 178.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.1 t -92.97 -39.96 11.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 123.502 0.721 . . . . 0.0 109.927 -176.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.22 137.44 32.59 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 118.92 0.782 . . . . 0.0 112.045 -178.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -129.23 144.71 51.32 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 176.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 59.7 t -90.32 134.78 28.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 123.871 0.868 . . . . 0.0 108.777 -170.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -147.12 169.19 19.81 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.886 1.274 . . . . 0.0 111.201 -168.117 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -138.31 128.33 25.56 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 125.173 1.389 . . . . 0.0 109.036 -169.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.3 tp -63.44 -29.84 48.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 CA-C-O 118.832 -0.604 . . . . 0.0 111.708 -173.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.52 -28.53 68.62 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 119.105 0.866 . . . . 0.0 110.318 -178.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -89.23 -27.14 20.81 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.172 1.389 . . . . 0.0 110.511 177.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 21.3 m -68.64 167.05 15.95 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 124.433 1.093 . . . . 0.0 111.801 -177.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.6 m -135.12 164.56 27.38 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.481 1.512 . . . . 0.0 108.932 178.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -53.17 -54.8 30.53 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.326 1.05 . . . . 0.0 111.45 -175.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -78.28 -15.96 58.24 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 122.312 0.245 . . . . 0.0 111.195 -175.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -74.32 -30.22 61.95 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 121.772 -0.58 . . . . 0.0 110.966 -179.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.7 mp -69.17 -43.51 74.12 Favored 'General case' 0 C--N 1.343 0.305 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 169.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -62.86 -17.41 61.44 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -177.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.15 -29.08 67.88 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.654 0.782 . . . . 0.0 112.289 176.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -82.29 155.99 24.53 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.195 0.998 . . . . 0.0 110.023 177.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -108.86 -26.48 10.24 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.111 0.564 . . . . 0.0 111.673 169.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.0 mp -113.81 127.89 70.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 174.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 96.3 mt -118.05 127.5 53.86 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 124.192 0.997 . . . . 0.0 108.436 177.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.2 mp -111.85 116.31 30.46 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 104.411 -2.44 . . . . 0.0 104.411 168.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 91.1 mt -115.23 109.08 17.44 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 -169.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.69 117.6 5.61 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 108.848 -1.701 . . . . 0.0 108.848 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 15.3 tt -135.91 105.29 9.7 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-N 118.731 1.266 . . . . 0.0 109.617 178.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -71.58 150.95 58.05 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 121.91 1.74 . . . . 0.0 109.635 170.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 29.3 m -99.19 139.27 35.08 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -179.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 47.5 m95 -135.7 172.79 12.5 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.86 1.264 . . . . 0.0 111.245 -170.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 53.87 -87.27 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 127.511 2.324 . . . . 0.0 112.958 176.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -149.69 80.01 1.38 Allowed 'General case' 0 C--O 1.235 0.31 0 C-N-CA 126.379 1.872 . . . . 0.0 106.847 174.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.71 16.96 76.32 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-O 119.575 -0.57 . . . . 0.0 113.306 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -91.99 161.8 14.65 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 118.54 1.17 . . . . 0.0 110.584 -175.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.27 161.56 28.65 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 123.915 0.886 . . . . 0.0 111.284 173.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 12.8 tm0? -64.57 146.4 54.69 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 168.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 56.3 m -56.45 -39.96 74.02 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 -167.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -77.33 -39.03 49.13 Favored 'General case' 0 C--N 1.333 -0.109 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -174.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -62.74 -44.95 94.88 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 172.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -58.98 -42.04 89.01 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.319 0.648 . . . . 0.0 111.358 178.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -69.33 -27.5 65.42 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.335 0.654 . . . . 0.0 112.336 176.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -88.32 -17.8 29.87 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.627 0.771 . . . . 0.0 112.629 -177.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -51.8 -40.45 70.97 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-O 116.426 -1.75 . . . . 0.0 115.349 -179.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -61.26 -30.21 87.71 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 CA-C-N 123.197 2.178 . . . . 0.0 112.701 173.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.7 m -75.23 -42.28 55.74 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.923 0.783 . . . . 0.0 109.446 172.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 12.3 tp -58.24 -37.62 75.25 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.126 0.97 . . . . 0.0 110.387 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -67.71 -11.64 58.77 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.55 1.14 . . . . 0.0 113.202 177.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -95.91 -17.91 20.71 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 119.803 1.183 . . . . 0.0 112.179 173.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 95.7 mt -76.38 143.59 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 -172.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -89.49 132.26 35.13 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 123.507 0.723 . . . . 0.0 109.691 175.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -124.62 6.08 8.21 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.913 0.885 . . . . 0.0 112.067 177.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -66.48 124.48 22.88 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 120.358 1.435 . . . . 0.0 110.378 -169.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.26 -0.94 58.26 Favored Glycine 0 CA--C 1.537 1.424 0 CA-C-O 118.433 -1.204 . . . . 0.0 114.277 -175.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -76.67 150.45 36.36 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 119.698 1.749 . . . . 0.0 108.408 173.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 66.9 mt -95.38 138.2 33.39 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 175.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 15.2 t -136.38 147.93 27.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -178.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -138.04 147.81 44.47 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 169.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -110.2 147.3 34.02 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 124.607 1.163 . . . . 0.0 108.607 -175.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -149.04 163.9 36.19 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 167.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 174.55 143.6 4.5 Favored Glycine 0 C--N 1.33 0.215 0 O-C-N 121.251 -0.906 . . . . 0.0 111.406 173.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 53.7 m -81.44 159.7 24.2 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 175.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.9 -167.63 27.89 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.403 -0.679 . . . . 0.0 111.403 -177.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -147.64 126.41 12.64 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 126.034 1.734 . . . . 0.0 107.994 176.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -106.89 2.38 25.32 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.328 1.051 . . . . 0.0 112.214 176.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -91.22 -46.32 8.14 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 119.24 0.927 . . . . 0.0 110.05 -173.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -105.58 -44.52 4.66 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.172 0.589 . . . . 0.0 110.493 178.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -82.75 40.91 0.7 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.551 1.141 . . . . 0.0 110.482 171.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.73 -21.86 64.87 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 127.002 2.121 . . . . 0.0 114.219 -170.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -103.26 7.81 38.39 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.173 1.389 . . . . 0.0 111.699 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -137.15 17.46 2.99 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.605 1.162 . . . . 0.0 111.387 -174.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -63.54 132.63 51.89 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 119.078 0.854 . . . . 0.0 109.363 -170.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . 0.258 23.0 p 52.05 22.98 2.03 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 127.357 2.263 . . . . 0.0 114.772 173.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -52.16 -41.54 62.67 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.851 1.261 . . . . 0.0 111.401 -175.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.35 -23.08 67.26 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -172.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 63.5 mt -61.39 -40.24 93.64 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 119.1 0.864 . . . . 0.0 109.621 175.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -68.19 -28.08 73.47 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 124.037 0.827 . . . . 0.0 111.591 -179.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.3 m -65.25 -37.12 86.22 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 118.243 1.021 . . . . 0.0 110.356 178.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 8.0 mt -71.25 -46.12 67.09 Favored 'Isoleucine or valine' 0 C--N 1.343 0.304 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 173.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 40.2 ttt180 -50.54 -46.11 57.29 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 118.858 0.754 . . . . 0.0 110.754 -177.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -61.87 -23.02 66.03 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.822 0.849 . . . . 0.0 113.025 -177.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 93.6 mt -92.21 -47.78 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 124.278 1.031 . . . . 0.0 109.268 178.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 30.0 pt -82.0 -36.77 14.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 118.989 0.813 . . . . 0.0 112.59 -168.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -68.19 -47.53 39.02 Favored Pre-proline 0 CA--C 1.54 0.575 0 CA-C-O 117.902 -1.047 . . . . 0.0 112.28 -170.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -68.66 -16.37 42.16 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 CA-C-N 121.532 1.583 . . . . 0.0 112.382 175.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 90.0 mtt-85 -91.51 20.29 5.48 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.736 1.214 . . . . 0.0 111.719 176.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 79.44 10.88 85.47 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 125.906 1.717 . . . . 0.0 115.023 168.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.45 137.76 58.1 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 119.649 1.724 . . . . 0.0 109.057 170.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 35.7 m -94.42 120.63 34.96 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 105.179 -2.156 . . . . 0.0 105.179 168.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 29.6 mt -99.2 132.62 44.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 -177.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 34.4 m -130.08 178.73 4.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 125.259 1.423 . . . . 0.0 108.812 172.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 77.14 28.11 58.9 Favored Glycine 0 C--N 1.335 0.523 0 CA-C-O 119.365 -0.686 . . . . 0.0 113.76 178.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 65.3 m80 -57.17 133.45 55.05 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 169.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 57.4 t-105 -115.61 135.78 22.7 Favored Pre-proline 0 CA--C 1.535 0.374 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -177.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.7 145.56 52.05 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 121.823 1.682 . . . . 0.0 111.754 -170.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 34.9 p -72.89 -29.09 62.88 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 122.963 0.505 . . . . 0.0 110.784 169.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 53.16 40.51 31.36 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.365 1.866 . . . . 0.0 110.738 -169.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 72.64 74.71 0.76 Allowed Glycine 0 C--N 1.341 0.839 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 -175.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -48.04 124.85 8.14 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.403 0.681 . . . . 0.0 109.427 171.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -100.0 -19.81 16.38 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -168.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -89.21 -171.63 3.33 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.791 0.836 . . . . 0.0 111.166 -169.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -60.82 -55.93 27.27 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -167.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -161.06 137.22 8.29 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 123.487 0.715 . . . . 0.0 110.908 175.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 1.6 p -109.74 142.82 40.41 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 168.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -121.51 -3.51 9.35 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 122.975 0.51 . . . . 0.0 112.264 -171.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -86.65 9.34 71.67 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 123.774 0.702 . . . . 0.0 111.815 167.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 95.3 mt -60.59 141.35 56.76 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 118.636 1.218 . . . . 0.0 110.889 177.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -108.74 -31.04 7.87 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.159 1.384 . . . . 0.0 108.89 167.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -146.4 162.48 38.13 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 127.869 2.468 . . . . 0.0 106.389 169.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -55.91 -29.05 59.44 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 119.27 0.941 . . . . 0.0 112.167 176.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -89.98 -11.5 41.45 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.295 1.038 . . . . 0.0 113.406 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 7.4 m-70 -149.48 131.52 15.32 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 119.742 1.155 . . . . 0.0 113.14 -169.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -75.02 158.98 32.32 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 167.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 12.4 p -61.69 -22.83 29.24 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 C-N-CA 123.227 0.611 . . . . 0.0 111.364 173.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -161.97 -172.26 29.15 Favored Glycine 0 C--N 1.337 0.636 0 O-C-N 121.514 -0.742 . . . . 0.0 111.798 -171.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.35 86.96 1.13 Allowed 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 124.755 1.222 . . . . 0.0 109.082 179.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -81.31 109.06 15.47 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 168.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . 0.275 18.2 tt -105.89 97.24 5.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-O 121.93 0.871 . . . . 0.0 110.582 -169.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -164.42 160.93 21.18 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 127.676 2.39 . . . . 0.0 106.543 169.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -143.53 -40.18 0.3 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.774 0.83 . . . . 0.0 111.153 175.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -159.4 104.98 1.66 Allowed 'General case' 0 C--O 1.234 0.281 0 C-N-CA 123.932 0.893 . . . . 0.0 108.688 175.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 1.1 tpm_? 65.79 -51.07 0.39 Allowed 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 127.867 2.467 . . . . 0.0 113.603 -174.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -145.61 154.07 51.89 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 126.841 2.056 . . . . 0.0 107.114 174.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -64.28 146.68 90.5 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 122.0 1.8 . . . . 0.0 110.277 172.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -131.51 -24.89 2.21 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.827 1.251 . . . . 0.0 111.705 174.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 88.8 mt -89.15 28.28 1.24 Allowed 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 125.235 1.414 . . . . 0.0 109.449 169.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 83.2 m -43.14 -52.18 5.6 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 127.409 2.284 . . . . 0.0 111.696 -174.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -72.89 -33.7 66.2 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 118.888 -0.577 . . . . 0.0 110.731 -170.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -65.74 -43.47 88.89 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 118.552 0.615 . . . . 0.0 110.223 174.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -59.64 -49.6 77.13 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 178.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 98.2 t -67.33 -45.7 85.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-O 118.179 -0.915 . . . . 0.0 109.434 -176.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -53.77 -51.63 62.81 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 119.306 0.957 . . . . 0.0 110.1 -178.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 42.0 mttp -70.44 -42.17 71.9 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-O 118.838 -0.601 . . . . 0.0 110.697 -175.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 69.2 t90 -63.89 -44.5 92.83 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-N 118.943 0.792 . . . . 0.0 109.727 -178.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 54.3 t -61.96 -40.15 86.2 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 O-C-N 122.075 -0.391 . . . . 0.0 110.015 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -64.39 -40.24 95.42 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 121.369 -0.832 . . . . 0.0 110.232 178.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 20.6 mm100 -64.5 -51.46 62.83 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.321 0.51 . . . . 0.0 110.903 177.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 14.4 pt -66.01 -32.41 58.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 119.476 1.035 . . . . 0.0 110.704 -176.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 58.4 m -62.78 -26.63 68.81 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 118.139 -0.934 . . . . 0.0 112.127 -177.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -90.55 -17.69 26.57 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 120.259 1.39 . . . . 0.0 112.477 174.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -80.61 -35.71 33.72 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.25 0.932 . . . . 0.0 110.454 171.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 75.2 mt -91.63 -7.29 50.48 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.613 1.965 . . . . 0.0 111.598 -178.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 30.6 m80 56.26 24.68 8.44 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 126.076 1.75 . . . . 0.0 113.359 -172.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 86.9 mt -74.45 -20.34 60.06 Favored 'General case' 0 N--CA 1.465 0.281 0 O-C-N 121.771 -0.581 . . . . 0.0 110.387 172.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -59.23 -41.23 88.21 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 118.867 0.758 . . . . 0.0 110.785 -178.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -72.3 -8.66 56.1 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.487 0.715 . . . . 0.0 111.992 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 48.0 mt -103.96 -46.66 10.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 124.932 1.293 . . . . 0.0 108.749 -179.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.4 pp -71.97 -30.5 65.34 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.235 0.614 . . . . 0.0 111.171 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -121.82 58.65 1.01 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.674 1.59 . . . . 0.0 107.93 175.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.311 0 C-N-CA 123.302 0.641 . . . . 0.0 109.376 174.201 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.4 mtp . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 120.627 0.251 . . . . 0.0 110.586 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.94 163.01 26.95 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 169.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.5 pt -83.81 -24.77 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 O-C-N 121.958 -0.464 . . . . 0.0 111.476 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 17.3 m -112.08 131.48 55.41 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.216 1.406 . . . . 0.0 108.732 177.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -107.0 121.87 6.71 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 108.374 -1.891 . . . . 0.0 108.374 170.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 52.5 mt -99.85 100.66 10.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 177.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -97.55 124.36 41.77 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 17.8 p90 -124.41 127.6 47.78 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 119.111 0.869 . . . . 0.0 112.131 -177.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -84.14 143.52 21.23 Favored Glycine 0 C--N 1.341 0.819 0 N-CA-C 110.316 -1.114 . . . . 0.0 110.316 168.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.6 m -160.38 159.26 30.87 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 118.895 1.348 . . . . 0.0 110.739 173.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -135.6 -47.64 0.69 Allowed 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.288 1.035 . . . . 0.0 109.851 169.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.4 p -80.12 -12.38 59.67 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.555 0.742 . . . . 0.0 111.954 170.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.9 7.96 54.71 Favored Glycine 0 C--N 1.342 0.869 0 C-N-CA 124.732 1.158 . . . . 0.0 113.449 170.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -69.76 -41.79 74.71 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 118.82 1.31 . . . . 0.0 112.442 -169.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.4 m -70.02 -18.01 63.29 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 119.408 1.004 . . . . 0.0 111.27 -172.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -58.23 -42.84 87.2 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 119.116 0.871 . . . . 0.0 110.166 174.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -65.8 -38.41 88.91 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 121.915 -0.491 . . . . 0.0 110.485 -178.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 36.9 mm -65.1 -47.52 87.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 176.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.0 -38.27 85.45 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.183 0.593 . . . . 0.0 111.575 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.0 mtpt -68.22 -44.69 75.18 Favored 'General case' 0 N--CA 1.463 0.188 0 O-C-N 121.643 -0.661 . . . . 0.0 110.594 176.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 75.5 mtm -66.85 -22.72 65.98 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.352 0.978 . . . . 0.0 111.946 178.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 68.3 mt -71.31 -59.07 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 168.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -55.16 -42.19 72.81 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 118.382 -0.818 . . . . 0.0 112.349 -174.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -58.94 -32.04 69.23 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 119.65 1.114 . . . . 0.0 111.903 -175.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -75.27 -39.6 59.58 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.062 0.545 . . . . 0.0 111.538 178.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -79.39 -35.4 40.76 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 118.652 0.66 . . . . 0.0 111.508 -177.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 88.09 146.1 11.43 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 124.778 1.18 . . . . 0.0 110.353 -169.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 55.5 tttp -63.37 -31.95 73.24 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 121.953 -0.733 . . . . 0.0 112.117 -169.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -66.24 -29.14 69.33 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 122.955 0.502 . . . . 0.0 111.397 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 39.0 t -92.56 -39.67 11.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 123.878 0.871 . . . . 0.0 109.582 -177.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -140.15 132.85 28.93 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 119.241 0.928 . . . . 0.0 111.513 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -125.05 149.7 47.52 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 175.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 60.5 t -97.83 138.98 21.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 124.595 1.158 . . . . 0.0 110.101 -168.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -149.63 172.39 15.13 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.948 1.299 . . . . 0.0 111.512 -173.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -137.74 132.17 32.39 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 125.647 1.579 . . . . 0.0 108.032 -174.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.5 tp -65.8 -27.03 40.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-O 118.581 -0.723 . . . . 0.0 112.927 -168.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.11 -30.44 68.72 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 119.221 0.919 . . . . 0.0 110.297 178.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 43.8 mtmt -81.03 -31.36 34.6 Favored 'General case' 0 C--N 1.342 0.244 0 C-N-CA 123.252 0.621 . . . . 0.0 110.421 174.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.7 m -70.43 169.51 13.88 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.522 1.129 . . . . 0.0 111.654 -172.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 14.8 m -135.3 160.96 36.77 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.146 1.379 . . . . 0.0 108.733 178.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 45.2 tttm -53.6 -51.75 62.02 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.78 0.832 . . . . 0.0 111.042 -174.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.2 mp0 -73.82 -14.32 61.08 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 119.343 -0.361 . . . . 0.0 111.683 -175.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -71.71 -39.39 70.19 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 119.487 1.04 . . . . 0.0 110.675 -178.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 8.3 mp -66.22 -31.83 72.89 Favored 'General case' 0 C--N 1.343 0.315 0 C-N-CA 122.375 0.27 . . . . 0.0 110.361 173.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -70.15 -20.93 63.12 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 119.178 -0.439 . . . . 0.0 111.612 -176.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.61 -30.3 61.62 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.622 0.769 . . . . 0.0 112.559 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -76.36 151.78 36.53 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 123.681 0.792 . . . . 0.0 109.928 177.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -100.12 -31.43 11.42 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 122.709 0.404 . . . . 0.0 111.338 170.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.1 mp -110.52 128.77 66.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 175.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 96.2 mt -114.17 128.33 56.32 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 172.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.2 mp -110.27 115.81 30.36 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 105.345 -2.095 . . . . 0.0 105.345 169.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 85.8 mt -115.92 109.7 17.95 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 -169.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -100.26 119.15 6.41 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 125.966 1.746 . . . . 0.0 109.85 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.6 tt -132.74 123.85 18.5 Favored Pre-proline 0 CA--C 1.541 0.605 0 CA-C-N 118.906 1.353 . . . . 0.0 112.15 -173.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -85.59 157.09 10.6 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 123.042 2.495 . . . . 0.0 110.658 170.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.0 m -112.32 142.08 45.26 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 175.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 75.2 m95 -140.95 171.29 14.28 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.11 1.764 . . . . 0.0 111.074 -169.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 36.2 t80 50.83 -89.59 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 127.648 2.379 . . . . 0.0 112.569 -177.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -149.7 84.15 1.41 Allowed 'General case' 0 C--O 1.235 0.303 0 C-N-CA 126.652 1.981 . . . . 0.0 106.215 173.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 73.58 13.44 80.22 Favored Glycine 0 CA--C 1.534 1.235 0 CA-C-O 119.203 -0.776 . . . . 0.0 114.088 177.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -84.59 161.99 19.95 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.625 1.212 . . . . 0.0 108.915 174.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -84.95 175.1 9.28 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 166.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.4 142.44 56.95 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 168.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 58.6 m -57.61 -36.47 71.82 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 119.311 0.959 . . . . 0.0 112.998 -169.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -72.53 -28.51 62.9 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.133 0.573 . . . . 0.0 111.908 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -79.91 -41.83 25.35 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.649 1.179 . . . . 0.0 109.468 176.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -59.7 -42.21 92.47 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.564 1.146 . . . . 0.0 110.689 176.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -62.22 -19.63 63.37 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.0 0.92 . . . . 0.0 112.525 177.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -90.4 -15.31 31.24 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 118.252 -0.88 . . . . 0.0 112.294 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -54.15 -42.87 95.87 Favored Pre-proline 0 CA--C 1.541 0.632 0 CA-C-N 120.992 1.724 . . . . 0.0 113.963 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -63.14 -21.96 72.77 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 CA-C-N 122.523 1.937 . . . . 0.0 113.397 174.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.2 m -82.25 -38.8 23.91 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.462 1.028 . . . . 0.0 109.702 171.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 14.0 tp -59.02 -40.69 85.76 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.312 1.045 . . . . 0.0 109.941 -176.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -75.63 4.15 8.26 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 178.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -105.38 -16.42 14.75 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.288 1.035 . . . . 0.0 111.111 169.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 96.7 mt -75.28 140.53 17.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 179.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -88.92 131.42 35.14 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 123.543 0.737 . . . . 0.0 109.524 174.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -121.51 8.01 10.12 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.86 0.864 . . . . 0.0 111.952 177.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 29.6 m-80 -58.72 116.45 3.73 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 119.814 1.188 . . . . 0.0 109.835 -172.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.58 1.92 67.48 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-O 118.571 -1.127 . . . . 0.0 114.283 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -74.25 150.84 40.07 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 119.674 1.737 . . . . 0.0 108.581 172.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 23.8 mt -92.04 137.59 32.24 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 172.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 19.7 t -134.28 144.07 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 177.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -137.65 145.94 43.28 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 171.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.2 mp -116.34 150.23 38.02 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 123.102 0.561 . . . . 0.0 109.646 -171.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -144.27 162.86 35.33 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 167.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -171.32 168.02 41.14 Favored Glycine 0 N--CA 1.452 -0.299 0 O-C-N 120.773 -1.204 . . . . 0.0 112.778 -176.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 21.3 m -133.28 151.6 51.9 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.569 1.148 . . . . 0.0 109.223 -168.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -178.35 -174.41 44.59 Favored Glycine 0 CA--C 1.528 0.857 0 CA-C-O 121.022 0.235 . . . . 0.0 112.57 -177.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -145.4 153.2 40.95 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 128.247 2.619 . . . . 0.0 106.952 175.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.9 12.8 3.38 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.182 1.393 . . . . 0.0 111.79 -173.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -68.47 -47.5 66.94 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 177.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -106.33 -38.72 6.13 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 123.395 0.678 . . . . 0.0 111.341 175.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -84.45 39.99 0.76 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.548 1.139 . . . . 0.0 111.404 -172.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.45 -19.83 65.8 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.266 1.027 . . . . 0.0 113.126 -171.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -93.11 0.31 57.22 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.476 1.11 . . . . 0.0 111.921 175.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -139.04 20.72 2.63 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.657 1.183 . . . . 0.0 111.573 -169.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -66.24 119.66 11.9 Favored 'General case' 0 C--O 1.235 0.32 0 O-C-N 121.122 -0.986 . . . . 0.0 108.925 -172.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 67.3 m 49.01 35.03 6.17 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.848 1.659 . . . . 0.0 112.581 -174.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -52.22 -41.21 62.54 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.815 1.246 . . . . 0.0 112.061 -171.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.53 -18.09 64.51 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -169.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 39.5 mt -54.58 -42.78 71.47 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.718 0.807 . . . . 0.0 110.137 171.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.69 -34.17 89.2 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 -179.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.2 m -64.91 -36.37 84.14 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 117.959 0.88 . . . . 0.0 110.864 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 8.1 mt -67.97 -51.18 52.08 Favored 'Isoleucine or valine' 0 C--N 1.345 0.392 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 173.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 60.3 ttp85 -55.17 -44.3 75.1 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 119.514 1.052 . . . . 0.0 110.488 -175.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -58.81 -21.46 56.37 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.793 0.837 . . . . 0.0 112.683 -177.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 96.7 mt -96.34 -51.38 10.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 124.325 1.05 . . . . 0.0 109.728 176.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 31.9 pt -74.64 -32.49 29.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-N 119.674 1.124 . . . . 0.0 111.762 -169.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -67.46 -54.2 19.63 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-O 117.61 -1.186 . . . . 0.0 112.069 -174.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -66.28 -23.23 52.19 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 CA-C-N 121.483 1.565 . . . . 0.0 112.024 176.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 60.5 mtp85 -85.62 16.67 3.73 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.014 0.926 . . . . 0.0 112.319 177.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 82.19 14.4 76.91 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-O 118.157 -1.357 . . . . 0.0 116.146 166.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.68 144.45 57.02 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 119.59 1.695 . . . . 0.0 109.807 170.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 74.9 m -96.87 121.36 38.65 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 167.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 34.9 mt -102.04 128.37 54.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 -173.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 32.7 m -128.79 178.09 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 125.658 1.583 . . . . 0.0 108.72 175.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 74.57 28.91 62.46 Favored Glycine 0 CA--C 1.525 0.7 0 O-C-N 121.426 -0.796 . . . . 0.0 113.213 -179.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 80.2 m-70 -61.98 140.92 58.3 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 169.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 68.3 t-105 -129.47 135.29 27.33 Favored Pre-proline 0 CA--C 1.535 0.382 0 C-N-CA 124.042 0.937 . . . . 0.0 108.866 -173.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -65.72 143.87 75.84 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 121.974 1.783 . . . . 0.0 112.182 -170.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 57.5 p -76.14 -30.67 58.26 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.679 0.792 . . . . 0.0 111.199 177.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 52.78 39.52 28.89 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.182 1.793 . . . . 0.0 112.052 -178.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 67.54 56.15 12.56 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 16.7 p90 -54.24 -40.23 67.53 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.542 0.737 . . . . 0.0 112.111 -174.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 37.3 t60 53.57 47.7 23.34 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.925 1.69 . . . . 0.0 114.39 169.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -110.36 172.96 6.56 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.039 0.935 . . . . 0.0 108.58 166.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -61.46 -45.1 95.67 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 118.956 -0.545 . . . . 0.0 111.541 -168.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -161.06 141.93 11.44 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 123.406 0.682 . . . . 0.0 110.572 169.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 50.3 m -128.39 125.98 39.71 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 106.66 -1.608 . . . . 0.0 106.66 169.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.73 -6.36 46.33 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 121.774 -0.579 . . . . 0.0 111.915 -174.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -77.56 6.21 47.18 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.158 0.885 . . . . 0.0 113.433 173.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 93.5 mt -65.35 139.47 58.58 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 119.754 1.777 . . . . 0.0 109.864 176.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -106.14 -32.21 8.34 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.376 1.47 . . . . 0.0 108.184 167.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -146.45 161.78 39.68 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 128.143 2.577 . . . . 0.0 106.063 169.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -56.36 -29.44 61.4 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 121.108 -0.995 . . . . 0.0 112.276 176.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -90.29 -10.74 43.05 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.091 0.956 . . . . 0.0 113.448 179.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -144.81 124.74 13.49 Favored 'General case' 0 C--N 1.345 0.408 0 CA-C-N 119.862 1.21 . . . . 0.0 112.985 -171.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -73.17 153.24 40.8 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 166.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 8.4 p -64.84 -18.83 24.31 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 124.206 1.002 . . . . 0.0 112.081 178.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -161.36 176.02 37.93 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 -169.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -74.15 92.8 2.23 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -79.4 119.4 22.38 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 169.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 9.1 pt -74.99 164.61 3.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 169.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 32.0 t0 65.19 166.81 0.18 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.254 1.421 . . . . 0.0 112.164 -169.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -153.48 -42.4 0.09 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 127.065 2.146 . . . . 0.0 107.186 176.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -154.14 117.6 4.6 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 124.36 1.064 . . . . 0.0 109.472 170.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 3.3 tpm_? 49.29 66.75 1.02 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.966 2.106 . . . . 0.0 112.849 171.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 66.55 138.8 0.05 OUTLIER Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 128.525 2.73 . . . . 0.0 113.297 -178.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -70.25 153.02 67.04 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 123.198 2.598 . . . . 0.0 112.815 -173.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -111.65 -11.45 14.01 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.158 0.983 . . . . 0.0 111.46 169.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 72.5 mt -117.42 18.22 14.4 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.588 1.155 . . . . 0.0 112.166 -168.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 41.2 m -46.57 -57.53 4.66 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 125.561 1.544 . . . . 0.0 111.999 -170.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -71.03 -30.32 66.48 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 122.529 0.332 . . . . 0.0 111.237 -169.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -68.26 -46.68 69.76 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 173.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -66.98 -39.2 87.11 Favored 'General case' 0 N--CA 1.463 0.18 0 O-C-N 121.738 -0.601 . . . . 0.0 111.576 -174.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 29.0 m -71.2 -23.18 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 119.127 0.876 . . . . 0.0 111.378 177.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -74.24 -52.84 11.15 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 120.14 1.336 . . . . 0.0 109.16 170.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -58.24 -43.53 87.82 Favored 'General case' 0 N--CA 1.462 0.169 0 O-C-N 122.17 -0.331 . . . . 0.0 110.934 -175.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 58.5 t90 -67.62 -46.71 71.72 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 118.199 0.454 . . . . 0.0 110.039 -176.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 67.9 t -63.49 -38.57 82.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 O-C-N 122.015 -0.428 . . . . 0.0 110.044 -178.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -66.53 -37.02 84.1 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.368 -0.833 . . . . 0.0 110.266 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 17.8 mm100 -66.53 -51.8 52.66 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.371 0.532 . . . . 0.0 110.917 175.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 15.5 pt -65.85 -29.24 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-N 119.469 1.032 . . . . 0.0 110.8 -176.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 70.6 m -58.9 -26.62 64.47 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 117.79 -1.1 . . . . 0.0 112.386 178.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -96.31 -9.57 29.87 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 120.341 1.428 . . . . 0.0 112.769 175.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -85.16 -39.72 17.55 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 119.138 0.881 . . . . 0.0 110.0 169.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 80.5 mt -87.28 -10.98 50.95 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.836 2.054 . . . . 0.0 111.531 -179.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 55.67 32.66 19.76 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.955 1.702 . . . . 0.0 112.535 -171.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 81.2 mt -75.6 -21.57 57.67 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.804 -0.56 . . . . 0.0 110.069 169.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -57.59 -38.54 75.06 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.514 0.726 . . . . 0.0 110.406 174.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -66.86 -10.38 47.66 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 121.62 -0.675 . . . . 0.0 112.55 178.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 39.8 mt -105.66 -54.74 6.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 125.104 1.361 . . . . 0.0 108.079 -178.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.2 pp -78.14 -24.12 47.5 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 122.959 0.503 . . . . 0.0 112.278 -173.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -127.0 39.91 3.82 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.601 1.96 . . . . 0.0 108.948 -174.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.388 0 C-N-CA 123.751 0.82 . . . . 0.0 109.466 174.486 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 120.624 0.249 . . . . 0.0 110.561 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.02 153.33 43.96 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.076 0.55 . . . . 0.0 109.728 172.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 31.6 pt -85.73 -23.64 7.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 122.413 0.285 . . . . 0.0 111.592 -177.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 11.7 m -109.36 128.11 54.85 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 125.235 1.414 . . . . 0.0 108.858 179.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -103.55 122.02 7.29 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 106.927 -2.469 . . . . 0.0 106.927 168.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 57.6 mt -100.99 92.35 2.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 N-CA-C 105.144 -2.169 . . . . 0.0 105.144 177.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -88.6 132.17 34.65 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 -178.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -130.06 133.28 46.6 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 119.521 1.055 . . . . 0.0 111.617 176.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -88.02 145.5 19.27 Favored Glycine 0 C--N 1.339 0.726 0 N-CA-C 108.384 -1.886 . . . . 0.0 108.384 171.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -159.47 176.35 12.2 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 119.446 1.623 . . . . 0.0 112.903 179.139 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -146.8 -47.22 0.18 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.944 2.098 . . . . 0.0 108.802 168.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 35.8 p -84.01 -15.86 46.07 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.14 0.976 . . . . 0.0 112.606 177.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 79.62 18.9 72.23 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-O 118.823 -0.987 . . . . 0.0 112.61 -174.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -74.16 -40.52 62.53 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.628 1.714 . . . . 0.0 110.182 178.343 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -62.27 -25.78 68.03 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.457 1.103 . . . . 0.0 111.827 177.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -59.53 -42.61 92.7 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 118.729 0.695 . . . . 0.0 110.222 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -67.7 -34.39 76.79 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 121.828 -0.545 . . . . 0.0 110.459 -179.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.6 mm -64.5 -46.92 91.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 175.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.77 -41.91 92.12 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 122.982 0.513 . . . . 0.0 111.042 178.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -63.38 -42.74 98.84 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 119.03 -0.51 . . . . 0.0 110.891 176.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 72.6 mtm -68.65 -27.78 66.3 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 119.175 0.898 . . . . 0.0 111.695 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 54.2 mt -69.8 -51.23 42.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 170.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -60.54 -41.41 94.4 Favored 'General case' 0 C--O 1.225 -0.22 0 O-C-N 121.688 -0.633 . . . . 0.0 111.404 -175.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.37 -38.27 86.37 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 118.86 0.755 . . . . 0.0 110.699 -177.098 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -74.52 -37.3 63.12 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 122.879 0.472 . . . . 0.0 111.091 178.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.7 mp -74.29 -34.62 63.58 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.311 0.505 . . . . 0.0 111.198 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.59 145.08 16.61 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 125.157 1.36 . . . . 0.0 110.511 -173.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -65.59 -30.16 70.86 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.679 0.792 . . . . 0.0 112.155 -172.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -68.05 -29.47 68.45 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 122.1 -0.375 . . . . 0.0 110.887 177.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 38.9 t -91.69 -36.72 8.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 C-N-CA 124.413 1.085 . . . . 0.0 110.096 -175.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -136.55 145.78 45.41 Favored 'General case' 0 C--N 1.34 0.183 0 CA-C-N 119.366 0.985 . . . . 0.0 113.283 -172.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -131.49 141.58 49.79 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.61 1.164 . . . . 0.0 109.889 174.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 83.3 t -89.24 139.44 17.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 124.002 0.921 . . . . 0.0 109.107 -178.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -149.45 173.35 13.66 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.449 1.1 . . . . 0.0 111.425 -168.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -147.96 121.43 9.09 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 125.926 1.691 . . . . 0.0 108.081 -172.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.2 tp -60.14 -22.24 24.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 123.819 0.848 . . . . 0.0 112.267 -171.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.84 -27.91 67.04 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 118.848 0.749 . . . . 0.0 111.251 178.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt -87.69 -21.25 25.33 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.244 1.018 . . . . 0.0 111.481 178.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 70.8 m -74.91 168.79 19.24 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.6 1.16 . . . . 0.0 112.359 -169.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 68.9 m -156.58 178.33 10.45 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.32 2.248 . . . . 0.0 106.995 177.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 27.4 tptp -50.42 -46.79 56.61 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.814 0.845 . . . . 0.0 111.997 -175.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -80.19 -11.6 59.72 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -173.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -76.76 -43.03 38.67 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 121.531 -0.731 . . . . 0.0 111.464 -172.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.7 mp -75.72 -28.74 58.68 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 118.033 0.379 . . . . 0.0 111.121 178.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -63.48 -18.1 63.43 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.91 0.884 . . . . 0.0 111.422 -177.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.21 -29.59 65.33 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.316 1.046 . . . . 0.0 112.728 177.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -89.18 156.84 18.54 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.346 1.058 . . . . 0.0 110.472 -175.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -107.64 -27.12 10.52 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.621 171.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.0 mp -116.76 130.37 71.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 175.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -113.88 116.55 29.48 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 177.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -103.16 112.45 25.32 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 104.623 -2.362 . . . . 0.0 104.623 171.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.4 mt -117.18 107.68 14.76 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -170.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -90.78 105.11 3.23 Favored Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 178.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.9 tp -115.87 102.59 53.99 Favored Pre-proline 0 CA--C 1.536 0.405 0 C-N-CA 125.024 1.33 . . . . 0.0 108.86 -174.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -72.85 143.14 36.42 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 121.289 1.326 . . . . 0.0 108.675 169.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 50.0 m -90.95 137.37 32.42 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 173.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 45.2 m95 -132.98 175.87 8.99 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 125.948 1.699 . . . . 0.0 108.896 -177.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 42.54 48.18 4.57 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.844 2.058 . . . . 0.0 114.092 168.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.3 p90 48.3 66.7 0.99 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.221 1.408 . . . . 0.0 111.963 176.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 87.89 52.54 2.92 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 124.303 0.954 . . . . 0.0 111.701 175.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -143.55 164.27 30.85 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.032 1.333 . . . . 0.0 108.777 174.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -82.84 161.38 21.95 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 167.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -62.42 149.21 43.17 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 168.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 65.9 m -56.74 -36.13 69.41 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.007 0.923 . . . . 0.0 113.144 -168.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -68.85 -38.05 79.52 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 118.894 0.77 . . . . 0.0 110.756 -177.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -69.82 -46.5 65.51 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 175.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -58.52 -39.93 81.5 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 122.717 0.407 . . . . 0.0 111.65 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -68.77 -23.44 64.31 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 123.924 0.889 . . . . 0.0 112.169 177.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -95.35 -20.12 19.39 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.452 0.701 . . . . 0.0 112.328 -178.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 21.5 m-30 -49.94 -40.47 54.76 Favored Pre-proline 0 CA--C 1.544 0.746 0 CA-C-O 116.656 -1.64 . . . . 0.0 114.47 176.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -63.78 -26.83 67.85 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 CA-C-N 123.032 2.119 . . . . 0.0 113.094 174.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.4 m -78.32 -35.11 48.15 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 119.576 1.08 . . . . 0.0 109.661 171.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 16.8 tp -63.36 -27.46 69.33 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 121.185 -0.947 . . . . 0.0 111.495 -176.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -87.67 -0.12 56.46 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.974 0.91 . . . . 0.0 112.964 174.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -96.33 -36.07 11.0 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 119.384 0.993 . . . . 0.0 108.469 169.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 68.0 mt -61.34 133.66 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -85.31 136.87 33.3 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 123.387 0.675 . . . . 0.0 109.545 176.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -129.14 18.32 6.01 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.97 0.908 . . . . 0.0 110.818 175.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -58.55 112.42 1.59 Allowed 'General case' 0 C--N 1.341 0.196 0 CA-C-N 120.373 1.442 . . . . 0.0 109.925 -176.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.37 1.57 57.67 Favored Glycine 0 CA--C 1.535 1.309 0 CA-C-O 118.599 -1.111 . . . . 0.0 114.207 -178.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -75.0 154.9 37.85 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 119.971 1.886 . . . . 0.0 107.689 170.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 27.2 mt -95.63 141.88 28.6 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.0 t -135.52 144.03 35.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 176.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -141.33 146.19 36.4 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 125.105 1.362 . . . . 0.0 107.343 172.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 68.8 mt -119.59 144.98 46.8 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 -170.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -143.54 165.89 26.32 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 123.608 0.763 . . . . 0.0 109.161 170.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -175.26 164.62 35.19 Favored Glycine 0 CA--C 1.521 0.418 0 CA-C-O 122.342 0.968 . . . . 0.0 112.623 179.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 38.1 m -115.89 159.25 21.8 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 125.725 1.61 . . . . 0.0 107.765 175.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -149.17 -164.18 11.44 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 175.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -148.81 153.05 37.57 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 117.639 0.719 . . . . 0.0 110.463 174.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -113.88 -1.86 13.76 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -168.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -70.79 -42.84 69.8 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 119.577 1.08 . . . . 0.0 110.669 -177.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -136.48 -32.77 0.83 Allowed 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -177.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -85.25 18.24 2.71 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -174.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.75 -14.29 62.83 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -174.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -89.93 0.13 57.25 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.074 0.95 . . . . 0.0 111.456 173.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -132.44 26.05 4.45 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 126.237 1.815 . . . . 0.0 109.303 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -64.92 121.09 13.82 Favored 'General case' 0 N--CA 1.452 -0.356 0 O-C-N 121.671 -0.643 . . . . 0.0 110.271 -168.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 74.5 m 48.42 34.29 4.63 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.363 1.865 . . . . 0.0 113.608 -177.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -54.42 -38.6 66.45 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.136 0.974 . . . . 0.0 113.132 -177.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.27 -12.53 61.65 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -170.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 52.2 mt -57.32 -40.64 78.34 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 118.67 0.668 . . . . 0.0 109.691 169.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -63.78 -31.62 81.4 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 123.591 0.615 . . . . 0.0 111.707 -179.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.6 m -65.77 -44.62 85.26 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 117.97 0.885 . . . . 0.0 109.905 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 4.3 mt -69.95 -40.9 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 119.029 0.832 . . . . 0.0 109.207 178.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 51.9 tpt85 -56.85 -33.24 66.6 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 118.469 0.577 . . . . 0.0 111.729 177.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -74.23 -33.76 63.46 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.242 0.617 . . . . 0.0 111.852 176.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 75.8 mt -79.34 -43.57 23.79 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 123.567 0.747 . . . . 0.0 110.629 -175.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 6.1 pt -76.8 -21.06 14.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 118.773 0.715 . . . . 0.0 112.923 -168.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -62.39 -56.66 28.43 Favored Pre-proline 0 CA--C 1.544 0.718 0 CA-C-O 117.604 -1.189 . . . . 0.0 112.273 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -66.71 -16.48 50.52 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 122.339 2.026 . . . . 0.0 112.915 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 19.4 mmm180 -84.6 4.04 34.08 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.409 0.684 . . . . 0.0 112.018 172.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 79.46 16.45 77.94 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 124.583 1.087 . . . . 0.0 113.953 170.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.32 146.68 47.22 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 118.551 1.175 . . . . 0.0 111.423 177.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 67.8 m -96.92 126.84 42.35 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 104.583 -2.377 . . . . 0.0 104.583 167.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 19.9 mt -113.18 131.6 64.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 -168.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 31.0 m -136.49 -177.87 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 124.725 1.21 . . . . 0.0 109.501 177.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 81.75 39.5 11.92 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-O 119.48 -0.622 . . . . 0.0 113.577 172.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 25.5 m170 -64.52 158.11 24.99 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.438 1.119 . . . . 0.0 109.718 169.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 43.8 t-105 -135.81 135.07 21.13 Favored Pre-proline 0 CA--C 1.536 0.433 0 CA-C-O 117.955 -1.021 . . . . 0.0 108.923 173.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_exo -65.68 145.93 82.75 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 121.781 1.654 . . . . 0.0 113.366 -175.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 36.2 p -71.97 -35.59 69.59 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 121.684 -0.635 . . . . 0.0 109.819 169.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 51.7 43.98 29.54 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.082 1.753 . . . . 0.0 111.923 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 69.9 54.75 10.9 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -61.1 154.54 22.7 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 122.861 0.464 . . . . 0.0 110.822 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 43.9 t60 -134.57 44.99 2.61 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.789 0.836 . . . . 0.0 110.604 -172.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -106.01 166.48 10.47 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.653 1.181 . . . . 0.0 108.156 173.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -67.12 -45.85 75.89 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 121.954 -0.466 . . . . 0.0 110.67 -170.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -160.65 114.25 2.08 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.994 0.917 . . . . 0.0 109.176 169.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 75.1 m -87.98 125.77 34.71 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 170.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -101.7 -9.65 20.68 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.087 0.555 . . . . 0.0 112.329 -176.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -77.35 -2.21 78.53 Favored Glycine 0 CA--C 1.537 1.435 0 CA-C-N 118.763 0.71 . . . . 0.0 113.529 173.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 8.5 mp -58.31 133.14 55.43 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 119.027 1.413 . . . . 0.0 110.558 174.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -95.64 -31.41 13.27 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.067 0.947 . . . . 0.0 108.595 167.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -144.32 162.86 35.34 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 127.14 2.176 . . . . 0.0 106.764 170.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -52.64 -30.14 29.99 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.368 0.667 . . . . 0.0 112.305 175.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -86.03 -17.81 34.2 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -178.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 30.0 p-80 -154.31 141.12 19.11 Favored 'General case' 0 C--N 1.347 0.469 0 CA-C-N 120.577 1.535 . . . . 0.0 114.684 -176.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -72.14 150.67 43.6 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.356 1.463 . . . . 0.0 108.555 167.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 8.8 p -69.41 -20.61 24.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 123.373 0.669 . . . . 0.0 111.515 175.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -148.22 171.05 28.73 Favored Glycine 0 C--N 1.337 0.589 0 C-N-CA 124.72 1.152 . . . . 0.0 110.264 -177.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -67.37 112.99 4.89 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 175.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -116.89 95.29 4.94 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.875 1.27 . . . . 0.0 108.048 -174.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 2.9 pt -92.32 120.19 41.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -169.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -175.42 145.72 0.76 Allowed 'General case' 0 C--O 1.24 0.602 0 C-N-CA 130.962 3.705 . . . . 0.0 104.733 168.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -124.73 -53.14 1.67 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 119.371 0.987 . . . . 0.0 110.739 172.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -150.85 81.69 1.33 Allowed 'General case' 0 C--O 1.235 0.304 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 57.8 93.16 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.362 1.865 . . . . 0.0 109.88 -173.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 87.2 mm-40 68.72 148.27 0.12 Allowed Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 127.918 2.487 . . . . 0.0 111.023 -168.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -72.37 151.77 54.29 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 122.087 1.858 . . . . 0.0 110.591 177.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -126.12 -20.43 4.52 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.298 1.839 . . . . 0.0 111.632 170.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 79.4 mt -94.06 24.87 4.02 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.416 1.886 . . . . 0.0 109.604 172.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 26.0 m -46.9 -57.35 5.04 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 126.688 1.995 . . . . 0.0 111.187 -170.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -75.43 -33.88 60.95 Favored 'General case' 0 N--CA 1.452 -0.373 0 O-C-N 122.233 -0.292 . . . . 0.0 110.557 -171.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 25.1 mp0 -64.71 -45.46 86.48 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.307 1.043 . . . . 0.0 109.444 178.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -66.03 -40.5 91.09 Favored 'General case' 0 N--CA 1.463 0.206 0 O-C-N 121.535 -0.728 . . . . 0.0 110.246 178.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 69.8 t -68.04 -33.47 61.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 118.916 0.78 . . . . 0.0 110.087 179.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -65.31 -51.92 57.46 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 120.416 1.462 . . . . 0.0 109.621 171.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -61.32 -27.89 68.81 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 118.74 -0.648 . . . . 0.0 111.501 -177.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 36.1 t90 -81.47 -51.99 7.71 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 119.174 0.897 . . . . 0.0 110.456 177.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 77.8 t -67.2 -31.09 51.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 O-C-N 121.376 -0.828 . . . . 0.0 110.584 -170.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -61.9 -35.0 77.08 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 121.2 -0.937 . . . . 0.0 110.856 174.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 63.0 mt-30 -69.91 -49.26 53.8 Favored 'General case' 0 C--N 1.341 0.219 0 C-N-CA 123.353 0.661 . . . . 0.0 110.664 173.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 2.7 pt -62.76 -33.19 58.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-N 119.266 0.939 . . . . 0.0 109.872 -175.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 48.2 m -61.31 -30.45 70.5 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 118.478 -0.772 . . . . 0.0 111.887 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -90.44 -26.0 20.06 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.877 1.217 . . . . 0.0 112.024 176.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -72.28 -38.46 68.78 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.057 0.844 . . . . 0.0 110.758 174.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 78.3 mt -83.49 -9.36 59.03 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.804 1.642 . . . . 0.0 111.544 179.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 55.33 32.53 18.9 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.621 1.568 . . . . 0.0 112.544 -170.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 80.3 mt -76.51 -20.91 56.43 Favored 'General case' 0 N--CA 1.465 0.278 0 O-C-N 121.571 -0.706 . . . . 0.0 110.37 170.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -55.6 -38.33 69.28 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 118.991 0.814 . . . . 0.0 110.486 173.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -67.54 -11.4 57.93 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 121.736 -0.603 . . . . 0.0 112.567 178.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 42.6 mt -104.46 -55.2 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 125.096 1.358 . . . . 0.0 108.413 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.5 pp -79.1 -23.81 43.86 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.39 0.676 . . . . 0.0 112.289 -171.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -124.33 35.94 4.71 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.32 1.848 . . . . 0.0 109.33 -175.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.17 0 CA-C-O 118.327 -0.844 . . . . 0.0 109.577 174.447 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.3 tpt . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 110.329 -0.249 . . . . 0.0 110.329 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.7 152.06 41.87 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.189 0.596 . . . . 0.0 110.056 175.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 17.6 pt -88.11 -22.34 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 122.397 0.279 . . . . 0.0 111.309 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.9 m -112.43 127.19 55.96 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.725 1.21 . . . . 0.0 109.294 -174.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -100.46 115.13 5.22 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 106.88 -2.488 . . . . 0.0 106.88 167.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 84.8 mt -88.66 116.12 29.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 104.068 -2.567 . . . . 0.0 104.068 169.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -112.13 127.6 55.97 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 173.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -132.88 136.86 46.45 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 119.478 1.036 . . . . 0.0 112.234 -178.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -85.43 158.59 32.73 Favored Glycine 0 CA--C 1.533 1.197 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 167.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 17.0 m -159.53 167.63 28.12 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 119.406 1.603 . . . . 0.0 110.526 176.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -144.81 -55.89 0.33 Allowed 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.419 0.688 . . . . 0.0 110.711 169.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 39.0 p -81.73 -6.38 58.98 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.731 0.812 . . . . 0.0 112.287 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 78.5 27.68 56.86 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-O 119.501 -0.611 . . . . 0.0 111.734 -172.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -87.64 -49.73 6.96 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-N 118.193 0.996 . . . . 0.0 110.115 173.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 26.9 m -70.09 -24.0 63.15 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 118.494 0.588 . . . . 0.0 111.517 -170.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -59.31 -34.46 72.35 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 121.388 -0.82 . . . . 0.0 111.26 174.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -70.96 -31.46 68.03 Favored 'General case' 0 C--O 1.226 -0.164 0 O-C-N 121.34 -0.85 . . . . 0.0 110.053 -179.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 23.1 mm -66.59 -47.73 82.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 176.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.71 -43.13 90.01 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 122.731 0.412 . . . . 0.0 111.389 176.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -69.42 -40.0 77.53 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-O 118.787 -0.625 . . . . 0.0 111.346 -178.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 68.1 mtm -61.81 -46.29 90.13 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 119.266 0.939 . . . . 0.0 109.755 174.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 75.2 mt -58.28 -47.16 88.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 177.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -59.5 -40.31 86.62 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 119.551 1.069 . . . . 0.0 111.456 178.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 59.0 tptt -64.23 -39.36 93.8 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 119.376 0.989 . . . . 0.0 110.222 178.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -69.43 -41.12 76.77 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.729 0.811 . . . . 0.0 110.959 179.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -73.89 -38.47 64.36 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.641 1.176 . . . . 0.0 110.56 -178.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.32 145.55 17.51 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 125.598 1.571 . . . . 0.0 110.759 -171.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.6 tptp -62.54 -30.2 71.13 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.449 1.1 . . . . 0.0 111.692 -175.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -68.92 -25.1 64.41 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.293 0.637 . . . . 0.0 111.412 178.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.2 t -99.82 -36.84 5.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 C-N-CA 124.106 0.962 . . . . 0.0 110.339 -175.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -133.5 139.57 46.73 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 119.32 0.964 . . . . 0.0 113.517 -175.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -122.22 150.25 42.54 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.484 1.114 . . . . 0.0 109.486 172.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 53.1 t -111.79 139.09 37.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 123.804 0.842 . . . . 0.0 110.93 -168.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -147.33 166.45 27.07 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.72 2.008 . . . . 0.0 111.101 -171.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -124.73 134.97 52.64 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 105.73 -1.952 . . . . 0.0 105.73 169.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.8 tp -60.14 -18.91 16.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 119.271 0.941 . . . . 0.0 112.556 -173.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -51.49 -37.71 50.42 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.442 1.097 . . . . 0.0 112.223 177.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.8 -1.42 56.8 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.346 0.658 . . . . 0.0 112.52 -178.295 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 64.4 m -79.81 156.39 27.42 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 122.287 1.042 . . . . 0.0 111.474 -177.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 33.6 p -127.41 176.64 7.3 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 127.371 2.268 . . . . 0.0 106.656 169.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -56.08 -36.33 67.99 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.776 -0.578 . . . . 0.0 111.837 -177.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -86.44 -11.72 51.08 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.014 0.526 . . . . 0.0 112.325 -176.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -69.52 -33.39 72.75 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 121.346 -0.846 . . . . 0.0 112.153 -169.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.7 mp -80.95 -31.86 34.73 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 122.936 0.494 . . . . 0.0 110.437 176.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -67.93 -18.46 64.77 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 123.279 0.632 . . . . 0.0 111.884 -172.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.12 -28.31 69.55 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.761 1.224 . . . . 0.0 112.157 175.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -96.79 157.65 15.8 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.436 1.094 . . . . 0.0 110.598 -179.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -104.82 -30.48 9.85 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.219 171.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.1 mm -106.7 138.63 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 174.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 86.0 mt -132.05 129.69 40.35 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 177.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.6 mp -114.22 113.84 25.19 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 172.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 61.2 mt -110.59 109.67 20.07 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 -170.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.68 118.61 5.63 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 125.726 1.632 . . . . 0.0 109.575 178.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.7 tp -135.03 108.91 10.59 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 117.994 0.897 . . . . 0.0 109.358 -170.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -76.19 146.03 28.12 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 121.762 1.641 . . . . 0.0 110.355 170.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 42.9 m -99.19 131.7 45.03 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 175.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 8.4 m95 -137.19 174.83 10.19 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 123.916 0.886 . . . . 0.0 111.63 -170.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 60.85 -76.69 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 128.557 2.743 . . . . 0.0 113.957 171.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -149.23 39.24 0.82 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.82 1.648 . . . . 0.0 109.841 -170.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.74 56.28 6.73 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 -170.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -131.18 164.54 25.29 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.264 1.426 . . . . 0.0 108.984 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.87 161.83 28.65 Favored 'General case' 0 C--O 1.236 0.354 0 O-C-N 121.848 -0.533 . . . . 0.0 110.09 169.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -71.1 154.85 41.42 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 170.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 58.6 m -59.16 -36.92 76.12 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.858 0.863 . . . . 0.0 112.885 -169.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -65.73 -43.14 89.9 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 118.505 0.593 . . . . 0.0 110.056 -178.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -69.39 -47.42 64.27 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.381 0.672 . . . . 0.0 109.81 177.427 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -60.09 -35.87 76.16 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.425 0.69 . . . . 0.0 111.818 -177.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -70.45 -25.83 63.37 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.861 0.864 . . . . 0.0 112.248 176.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -92.76 -21.4 19.96 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.312 0.645 . . . . 0.0 112.076 -179.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 17.0 m-30 -48.66 -42.99 61.28 Favored Pre-proline 0 CA--C 1.547 0.865 0 CA-C-O 116.86 -1.543 . . . . 0.0 114.52 177.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -64.52 -23.38 64.46 Favored 'Trans proline' 0 CA--C 1.544 1.019 0 CA-C-N 122.972 2.097 . . . . 0.0 113.462 175.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.1 m -79.63 -40.28 29.6 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 119.302 0.955 . . . . 0.0 109.001 170.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 16.7 tp -60.85 -32.16 71.57 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.726 1.21 . . . . 0.0 111.798 -172.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -78.53 -11.14 59.94 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.999 0.92 . . . . 0.0 112.361 177.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -87.18 -32.92 19.56 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 119.818 1.19 . . . . 0.0 110.035 170.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 86.7 mt -63.93 143.13 15.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 -178.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -98.18 133.8 42.12 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.121 0.968 . . . . 0.0 108.865 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -124.2 14.6 9.05 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 118.306 -0.854 . . . . 0.0 111.032 178.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -56.71 115.46 2.57 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-N 119.963 1.256 . . . . 0.0 109.345 -178.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.76 2.91 62.03 Favored Glycine 0 CA--C 1.535 1.291 0 CA-C-O 118.368 -1.24 . . . . 0.0 114.174 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -79.18 147.25 32.71 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 119.675 1.737 . . . . 0.0 107.287 170.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 8.4 mt -95.09 134.27 37.99 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 178.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 15.2 t -130.86 145.28 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 178.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -136.2 151.13 49.38 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 170.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 81.5 mt -120.63 148.1 44.35 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -171.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -145.81 166.26 26.44 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 169.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 178.33 172.16 42.43 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-O 122.692 1.162 . . . . 0.0 114.566 177.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 68.7 m -123.02 151.19 42.15 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 112.936 -1.632 . . . . 0.0 109.526 -169.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -169.49 176.92 43.31 Favored Glycine 0 N--CA 1.442 -0.957 0 N-CA-C 109.634 -1.387 . . . . 0.0 109.634 -172.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -127.03 110.23 12.74 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 177.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -78.93 -6.69 56.85 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 118.692 -0.671 . . . . 0.0 112.381 -169.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -111.72 -41.71 3.99 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.49 1.041 . . . . 0.0 110.639 -176.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -82.63 -29.0 30.4 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 121.76 -0.587 . . . . 0.0 111.999 -175.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -122.65 50.64 1.48 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.298 1.439 . . . . 0.0 108.974 172.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.57 -19.76 50.92 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 126.175 1.79 . . . . 0.0 115.401 -170.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -108.44 4.08 23.92 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.207 1.003 . . . . 0.0 112.929 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -127.98 19.96 6.49 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.046 1.338 . . . . 0.0 110.689 -178.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -65.96 128.52 36.36 Favored 'General case' 0 C--O 1.234 0.285 0 O-C-N 121.458 -0.777 . . . . 0.0 110.93 -168.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 95.5 m 52.25 31.39 9.19 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.918 1.687 . . . . 0.0 113.937 176.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -56.02 -41.3 74.72 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.02 -21.12 64.14 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 -168.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 7.7 mp -60.29 -40.04 89.07 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 119.113 0.87 . . . . 0.0 109.798 172.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.12 -33.81 88.25 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 177.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 5.8 m -64.11 -38.45 91.1 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.26 1.03 . . . . 0.0 110.177 177.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 4.0 mt -66.66 -44.58 89.62 Favored 'Isoleucine or valine' 0 C--N 1.344 0.366 0 CA-C-O 117.632 -1.175 . . . . 0.0 109.075 175.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 60.3 ttp85 -55.75 -45.62 78.0 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 120.174 1.352 . . . . 0.0 110.136 178.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -60.44 -25.2 65.81 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -178.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 78.6 mt -87.27 -45.44 16.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 123.989 0.916 . . . . 0.0 110.667 176.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.6 pt -86.43 -22.86 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 120.114 1.325 . . . . 0.0 112.779 -169.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -67.34 -46.12 49.45 Favored Pre-proline 0 CA--C 1.545 0.751 0 CA-C-O 117.436 -1.268 . . . . 0.0 111.661 -177.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -60.68 -28.1 85.95 Favored 'Trans proline' 0 C--N 1.356 0.934 0 C-N-CA 122.061 1.841 . . . . 0.0 112.969 172.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 15.4 mmm180 -86.37 10.57 14.58 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.877 1.271 . . . . 0.0 111.764 -177.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 77.81 15.67 80.95 Favored Glycine 0 CA--C 1.529 0.91 0 CA-C-O 118.494 -1.17 . . . . 0.0 114.721 169.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.31 141.01 56.79 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 119.072 1.436 . . . . 0.0 109.834 173.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 55.5 m -92.73 121.96 34.66 Favored 'General case' 0 C--O 1.232 0.133 0 N-CA-C 105.337 -2.098 . . . . 0.0 105.337 168.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 43.6 mt -105.12 123.39 59.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 -171.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 26.8 m -126.15 174.77 9.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 125.149 1.379 . . . . 0.0 109.011 178.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 78.24 33.28 40.51 Favored Glycine 0 CA--C 1.527 0.796 0 O-C-N 121.844 -0.535 . . . . 0.0 112.333 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -63.86 143.88 57.5 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 169.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 72.8 t-105 -135.74 133.88 20.36 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 118.199 -0.905 . . . . 0.0 108.936 -167.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -68.32 141.77 52.71 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 121.496 1.464 . . . . 0.0 112.442 -170.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 12.6 p -70.03 -30.22 67.45 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 122.732 0.413 . . . . 0.0 110.041 169.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 54.48 44.81 28.24 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 126.39 1.876 . . . . 0.0 111.56 176.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 72.55 67.96 1.71 Allowed Glycine 0 C--N 1.34 0.775 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -177.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -48.1 125.53 9.32 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.496 0.719 . . . . 0.0 109.402 172.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -92.39 -28.09 17.1 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 -168.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -91.03 -164.77 1.23 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.736 0.814 . . . . 0.0 111.652 -169.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -67.42 -58.75 4.19 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -168.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -159.32 147.51 17.69 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 118.803 0.729 . . . . 0.0 111.291 179.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -129.64 135.18 48.22 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 125.08 1.352 . . . . 0.0 108.338 178.075 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -109.79 -5.34 15.6 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.102 0.561 . . . . 0.0 112.471 -171.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -78.1 1.21 70.45 Favored Glycine 0 CA--C 1.532 1.143 0 CA-C-N 118.871 0.759 . . . . 0.0 113.078 171.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 7.9 mp -62.88 132.69 52.98 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 118.872 1.336 . . . . 0.0 110.869 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -96.01 -29.64 14.03 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.384 1.474 . . . . 0.0 108.584 166.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -145.28 161.77 38.8 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 127.511 2.325 . . . . 0.0 106.558 170.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -53.5 -33.28 53.84 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 119.438 1.017 . . . . 0.0 112.355 176.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -89.08 -7.52 55.67 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.831 0.853 . . . . 0.0 113.245 -178.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 64.6 m80 -146.8 125.19 12.32 Favored 'General case' 0 C--N 1.347 0.491 0 CA-C-N 119.759 1.163 . . . . 0.0 113.95 -170.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -69.79 151.84 45.3 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 164.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 9.0 p -69.74 -12.61 16.26 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 123.881 0.873 . . . . 0.0 111.946 175.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -164.48 171.02 39.86 Favored Glycine 0 CA--C 1.523 0.562 0 O-C-N 121.29 -0.881 . . . . 0.0 111.187 -172.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -67.22 114.74 6.19 Favored 'General case' 0 C--N 1.334 -0.09 0 C-N-CA 123.755 0.822 . . . . 0.0 108.975 -178.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -89.98 140.47 29.6 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 170.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 9.0 tp -46.94 -46.21 8.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 C-N-CA 124.721 1.208 . . . . 0.0 113.982 -172.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -162.07 179.21 8.14 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.983 1.313 . . . . 0.0 108.791 -176.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -109.72 44.75 1.15 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.442 1.097 . . . . 0.0 109.345 169.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -157.15 166.74 32.41 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 125.068 1.347 . . . . 0.0 108.455 -170.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 25.3 ttm180 -47.09 -42.78 19.54 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.542 1.137 . . . . 0.0 111.811 168.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -127.65 159.08 67.92 Favored Pre-proline 0 CA--C 1.542 0.673 0 C-N-CA 125.017 1.327 . . . . 0.0 111.229 -167.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -67.36 121.95 9.14 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.838 2.359 . . . . 0.0 110.615 171.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -128.4 -43.6 1.43 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.893 1.677 . . . . 0.0 110.592 177.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 82.2 mt -109.96 -1.31 17.75 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 126.017 1.727 . . . . 0.0 111.438 -174.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 52.9 m -41.76 -44.98 3.42 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.563 1.945 . . . . 0.0 113.299 -175.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -70.44 -31.5 68.7 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 119.155 0.888 . . . . 0.0 111.914 -173.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -71.98 -40.26 68.7 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 169.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 72.0 mtp85 -66.67 -38.26 86.46 Favored 'General case' 0 C--O 1.225 -0.186 0 CA-C-O 118.551 -0.737 . . . . 0.0 110.974 -174.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 26.8 m -69.3 -31.29 49.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-N 119.928 1.24 . . . . 0.0 111.179 177.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -65.49 -52.63 51.47 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 120.255 1.389 . . . . 0.0 109.501 171.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 39.3 mttp -61.15 -31.08 70.8 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 118.892 -0.575 . . . . 0.0 111.448 -177.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 61.5 t90 -78.92 -51.97 8.93 Favored 'General case' 0 N--CA 1.457 -0.094 0 CA-C-N 118.845 0.748 . . . . 0.0 111.19 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 56.8 t -63.72 -31.29 52.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 O-C-N 121.563 -0.711 . . . . 0.0 110.26 -175.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -59.48 -35.44 74.11 Favored 'General case' 0 CA--C 1.532 0.26 0 O-C-N 121.283 -0.886 . . . . 0.0 111.368 174.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -63.95 -53.57 48.16 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 118.711 0.687 . . . . 0.0 109.956 172.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 2.2 pt -69.0 -26.86 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 O-C-N 121.89 -0.507 . . . . 0.0 110.373 -170.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 46.1 m -58.97 -32.5 69.7 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 119.118 -0.468 . . . . 0.0 111.199 174.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -77.98 -43.75 28.7 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.553 1.07 . . . . 0.0 110.043 175.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -67.7 -34.06 76.13 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.587 0.755 . . . . 0.0 111.629 -174.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 83.7 mt -87.16 3.88 44.58 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.576 1.551 . . . . 0.0 111.108 177.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 25.9 m80 56.18 31.61 18.66 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.182 1.793 . . . . 0.0 113.001 -177.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 92.1 mt -80.97 -29.2 35.35 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 123.623 0.769 . . . . 0.0 110.304 173.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -57.72 -37.6 73.81 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.783 0.833 . . . . 0.0 110.43 176.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -65.47 -13.43 58.79 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.681 0.793 . . . . 0.0 112.471 178.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 50.0 mt -103.69 -56.68 4.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 125.17 1.388 . . . . 0.0 108.191 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.5 pp -79.46 -23.93 42.75 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -169.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -119.11 28.69 8.1 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.691 1.596 . . . . 0.0 110.224 -175.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.37 0 C-N-CA 123.919 0.887 . . . . 0.0 109.364 173.632 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.6 tpt . . . . . 0 N--CA 1.485 1.325 0 N-CA-C 110.37 -0.233 . . . . 0.0 110.37 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -57.91 146.62 31.51 Favored 'General case' 0 C--N 1.344 0.351 0 C-N-CA 123.778 0.831 . . . . 0.0 111.385 177.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.9 pt -105.9 -14.98 8.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 125.248 1.419 . . . . 0.0 111.13 178.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 88.2 m -119.43 127.91 53.54 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.989 1.316 . . . . 0.0 108.826 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -91.28 129.34 9.75 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 107.856 -2.098 . . . . 0.0 107.856 169.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 33.0 mt -103.83 95.75 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 103.368 -2.827 . . . . 0.0 103.368 171.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 19.6 m-30 -100.16 129.65 46.21 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 -177.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 26.1 p90 -132.93 163.99 27.94 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 118.424 0.556 . . . . 0.0 110.99 -172.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -140.03 139.2 9.67 Favored Glycine 0 C--N 1.336 0.554 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 168.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.8 m -141.29 167.52 21.98 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.932 1.366 . . . . 0.0 110.696 -174.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -136.83 -50.8 0.66 Allowed 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.509 0.724 . . . . 0.0 110.157 168.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.3 p -82.48 -11.63 58.36 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.607 0.763 . . . . 0.0 112.084 171.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.92 6.59 51.93 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 124.961 1.267 . . . . 0.0 113.747 170.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -70.69 -44.05 67.77 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 118.757 1.279 . . . . 0.0 111.731 -173.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.01 -27.33 67.33 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 120.97 -1.081 . . . . 0.0 111.146 -175.175 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -62.57 -42.11 99.34 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 118.719 0.691 . . . . 0.0 109.85 172.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -63.5 -42.25 98.51 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 121.8 -0.562 . . . . 0.0 110.377 178.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 21.0 mm -62.06 -46.34 96.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 176.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.6 -41.38 94.65 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 121.929 -0.482 . . . . 0.0 111.426 -179.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.2 mtpt -65.66 -40.91 92.93 Favored 'General case' 0 C--O 1.227 -0.098 0 CA-C-O 118.49 -0.767 . . . . 0.0 110.676 177.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 61.8 mtm -62.38 -40.98 98.23 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 119.73 1.15 . . . . 0.0 110.759 176.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 70.2 mt -59.96 -47.04 93.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 176.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -63.53 -37.84 88.87 Favored 'General case' 0 CA--C 1.53 0.181 0 O-C-N 121.017 -1.052 . . . . 0.0 111.685 178.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -65.05 -34.04 77.48 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 120.115 1.325 . . . . 0.0 111.088 178.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 12.9 mm100 -70.1 -43.66 70.6 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 118.184 0.447 . . . . 0.0 110.744 175.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -82.93 -32.5 27.18 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.461 0.704 . . . . 0.0 112.434 -170.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 90.45 144.42 11.97 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 124.852 1.215 . . . . 0.0 111.117 -169.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 56.5 tptt -57.36 -35.77 70.36 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 125.281 1.432 . . . . 0.0 111.864 -175.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -82.95 -1.94 53.74 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.009 0.523 . . . . 0.0 112.351 -176.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.5 t -110.01 -46.93 6.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 123.769 0.828 . . . . 0.0 109.186 176.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -131.65 139.55 49.13 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 119.242 0.928 . . . . 0.0 110.458 -177.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -130.5 141.77 50.49 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 99.2 t -100.77 129.99 50.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 C-N-CA 124.813 1.245 . . . . 0.0 110.718 -167.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -143.97 145.37 32.19 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.945 0.898 . . . . 0.0 110.136 175.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -74.98 134.29 41.52 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 169.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.4 tp -56.53 -31.3 33.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 123.387 0.675 . . . . 0.0 112.057 -174.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.29 -32.53 70.11 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -170.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -92.07 -10.38 39.27 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -178.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 36.9 m -70.2 126.09 28.66 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 119.214 0.915 . . . . 0.0 108.73 177.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 14.5 m -73.43 168.2 19.72 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.597 0.759 . . . . 0.0 109.742 173.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -53.39 -41.11 65.59 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.585 0.754 . . . . 0.0 110.865 174.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -77.44 -15.92 59.07 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.099 0.56 . . . . 0.0 112.178 -178.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -75.27 -28.3 59.74 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 121.141 -0.974 . . . . 0.0 111.109 -176.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -68.66 -43.71 75.64 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.596 0.758 . . . . 0.0 109.024 169.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -65.65 -25.79 67.51 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.161 0.584 . . . . 0.0 112.137 -179.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.3 -30.32 70.14 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.681 0.793 . . . . 0.0 112.709 -174.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -92.57 154.85 18.16 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.35 1.06 . . . . 0.0 110.112 178.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -104.01 -21.87 13.54 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.353 0.661 . . . . 0.0 111.775 169.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.8 mp -121.65 132.74 70.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 176.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 80.0 mt -133.25 135.81 45.18 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 123.42 0.688 . . . . 0.0 109.991 178.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 7.3 mp -114.42 118.62 34.35 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 104.469 -2.419 . . . . 0.0 104.469 170.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 73.9 mt -112.48 117.72 33.17 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 123.32 0.648 . . . . 0.0 109.733 -169.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -101.4 98.82 1.84 Allowed Glycine 0 C--N 1.335 0.494 0 C-N-CA 125.713 1.625 . . . . 0.0 111.273 -173.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 2.1 tp -120.86 109.61 35.7 Favored Pre-proline 0 CA--C 1.538 0.487 0 C-N-CA 125.466 1.506 . . . . 0.0 109.476 -169.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -81.48 155.38 18.7 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.854 2.37 . . . . 0.0 110.418 173.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.7 m -101.06 136.22 41.26 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 172.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 60.7 m95 -135.51 173.53 11.62 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 125.647 1.579 . . . . 0.0 109.864 -178.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 13.4 t80 38.98 56.03 2.03 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.095 2.158 . . . . 0.0 113.443 168.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 26.2 p90 46.3 66.05 1.05 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.086 1.355 . . . . 0.0 112.088 176.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.55 52.36 3.38 Favored Glycine 0 CA--C 1.525 0.67 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.818 172.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -136.23 154.26 50.97 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 124.513 1.125 . . . . 0.0 109.116 174.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -79.28 146.08 33.18 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 169.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -59.47 147.43 36.67 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 171.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 74.5 m -58.13 -29.73 65.76 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.212 1.005 . . . . 0.0 113.546 -168.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -68.47 -32.73 72.93 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 118.891 0.769 . . . . 0.0 111.213 -178.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 92.1 m95 -79.44 -45.52 19.28 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-N 118.121 0.418 . . . . 0.0 110.085 171.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -60.54 -38.26 83.87 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.021 0.373 . . . . 0.0 111.926 -175.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -68.09 -24.75 65.08 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.581 0.753 . . . . 0.0 112.11 176.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -88.85 -25.4 22.19 Favored 'General case' 0 C--N 1.341 0.225 0 CA-C-O 118.738 -0.649 . . . . 0.0 111.914 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -49.57 -43.15 71.29 Favored Pre-proline 0 CA--C 1.546 0.819 0 CA-C-O 116.704 -1.617 . . . . 0.0 114.729 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -66.61 -15.19 46.83 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 CA-C-N 122.784 2.03 . . . . 0.0 113.774 176.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.1 m -89.78 -40.67 12.33 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.85 0.86 . . . . 0.0 109.013 169.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 31.3 tp -56.62 -38.32 71.93 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 125.017 1.327 . . . . 0.0 111.567 -176.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -68.74 -10.19 55.07 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -96.22 -7.19 36.3 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 119.646 1.112 . . . . 0.0 112.001 177.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 95.8 mt -91.57 146.39 6.32 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 -169.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -91.58 130.47 37.39 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 178.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -125.35 10.59 8.0 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 123.778 0.831 . . . . 0.0 111.768 176.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -63.89 126.55 28.01 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 120.231 1.378 . . . . 0.0 110.133 -175.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 74.84 -3.05 46.62 Favored Glycine 0 CA--C 1.538 1.474 0 CA-C-O 118.102 -1.388 . . . . 0.0 114.152 -175.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 63.1 mttm -79.61 146.16 32.69 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 120.226 2.013 . . . . 0.0 108.045 175.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 20.0 mt -95.38 131.6 41.33 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 176.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.9 t -132.25 143.14 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 178.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -129.63 156.16 44.67 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.893 1.277 . . . . 0.0 107.832 170.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 14.3 mt -122.27 145.87 47.83 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 124.324 1.05 . . . . 0.0 108.335 -175.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -141.36 156.15 45.85 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 123.851 0.86 . . . . 0.0 109.08 170.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -179.94 -169.25 39.89 Favored Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 111.394 -0.682 . . . . 0.0 111.394 -178.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 21.9 p -135.59 171.88 13.81 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 126.379 1.872 . . . . 0.0 109.196 -169.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -169.69 178.23 42.78 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 112.423 -0.271 . . . . 0.0 112.423 170.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -127.77 138.98 52.93 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 125.712 1.605 . . . . 0.0 108.201 169.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -121.28 24.99 9.74 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.274 1.029 . . . . 0.0 111.012 -172.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -119.02 -48.63 2.44 Favored 'General case' 0 C--O 1.234 0.263 0 O-C-N 121.444 -0.785 . . . . 0.0 109.903 -177.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -107.68 -33.78 7.18 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.936 0.894 . . . . 0.0 110.617 176.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -98.13 25.48 6.09 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.994 0.918 . . . . 0.0 111.925 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.17 -21.15 66.45 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -173.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -84.33 -3.01 58.0 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.905 0.882 . . . . 0.0 112.001 174.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -135.69 17.96 3.31 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.876 1.671 . . . . 0.0 109.614 -173.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -65.07 118.76 9.64 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -168.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 56.3 m 53.35 27.56 6.4 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.394 1.478 . . . . 0.0 113.2 -177.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -54.03 -38.17 64.9 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.06 1.344 . . . . 0.0 112.281 -173.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.25 -13.29 61.48 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -171.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 82.0 mt -58.97 -43.51 91.39 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 119.022 0.828 . . . . 0.0 109.759 175.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -69.98 -29.36 70.81 Favored Glycine 0 CA--C 1.529 0.91 0 N-CA-C 111.923 -0.471 . . . . 0.0 111.923 -177.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 8.3 m -63.21 -37.15 86.1 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 117.873 0.837 . . . . 0.0 111.133 -174.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.4 mt -73.82 -45.36 50.02 Favored 'Isoleucine or valine' 0 C--N 1.344 0.339 0 CA-C-O 118.452 -0.785 . . . . 0.0 108.938 176.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 37.4 ttt180 -53.33 -42.4 66.71 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 119.081 0.855 . . . . 0.0 110.738 -178.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -61.27 -17.61 54.34 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.104 0.962 . . . . 0.0 112.847 -179.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 69.7 mt -99.2 -48.33 11.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 124.66 1.184 . . . . 0.0 109.627 175.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 40.8 pt -79.9 -34.25 15.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 119.459 1.027 . . . . 0.0 112.117 -168.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -70.6 -41.67 13.01 Favored Pre-proline 0 CA--C 1.543 0.687 0 CA-C-O 117.576 -1.202 . . . . 0.0 110.88 -175.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -63.47 -30.33 71.75 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.032 1.821 . . . . 0.0 113.322 171.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -76.67 7.61 4.44 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.101 0.96 . . . . 0.0 112.328 171.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 93.33 6.64 62.68 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 125.882 1.706 . . . . 0.0 114.976 168.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.62 137.37 57.56 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 119.652 1.726 . . . . 0.0 109.424 175.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 87.3 m -90.83 122.77 33.84 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 169.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 23.1 mm -100.15 126.85 53.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 -171.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 27.6 m -130.91 179.72 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 125.024 1.329 . . . . 0.0 108.612 175.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 74.44 32.61 57.58 Favored Glycine 0 C--N 1.338 0.659 0 O-C-N 121.528 -0.733 . . . . 0.0 112.082 179.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 83.8 m-70 -64.24 143.03 58.19 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 169.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 55.1 t-105 -130.19 140.67 39.34 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-O 117.866 -1.064 . . . . 0.0 108.963 -178.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -61.31 148.42 92.97 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 CA-C-N 121.063 1.415 . . . . 0.0 114.772 -170.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 41.4 p -79.64 -9.46 59.64 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.485 0.714 . . . . 0.0 110.629 167.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 52.64 45.58 28.38 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.213 1.405 . . . . 0.0 111.228 -173.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 92.76 -1.71 71.84 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-O 118.203 -1.332 . . . . 0.0 114.032 175.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 22.7 t80 51.54 -126.22 2.37 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 118.777 1.289 . . . . 0.0 110.249 177.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 41.8 t60 56.31 39.68 30.08 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.577 1.551 . . . . 0.0 111.993 -172.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -88.53 176.09 7.3 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 168.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -65.16 -49.34 70.21 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.537 -0.727 . . . . 0.0 109.799 -174.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -162.37 140.68 8.8 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 167.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 13.0 m -145.84 131.37 18.77 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 120.765 -1.209 . . . . 0.0 108.781 174.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -104.19 -7.91 19.78 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.106 0.562 . . . . 0.0 111.978 -170.15 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -82.2 5.77 70.69 Favored Glycine 0 CA--C 1.527 0.843 0 CA-C-O 118.633 -1.093 . . . . 0.0 113.153 177.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 8.5 mp -63.16 128.15 34.54 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 119.909 1.854 . . . . 0.0 110.238 178.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.26 -37.63 25.64 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.587 1.555 . . . . 0.0 107.746 167.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -153.94 165.75 35.12 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 129.481 3.112 . . . . 0.0 106.227 -177.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -51.03 -35.92 36.88 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.275 0.943 . . . . 0.0 112.41 175.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -96.18 -3.4 44.44 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -175.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -146.54 139.42 25.4 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 120.542 1.519 . . . . 0.0 112.455 -172.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -84.91 155.54 21.63 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.613 1.565 . . . . 0.0 108.706 167.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 24.4 m -70.03 -8.65 11.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 125.127 1.371 . . . . 0.0 112.735 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -158.23 173.62 35.4 Favored Glycine 0 C--N 1.337 0.622 0 C-N-CA 124.964 1.269 . . . . 0.0 110.564 -178.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -64.94 132.02 48.2 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 124.556 1.142 . . . . 0.0 109.007 176.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -115.22 124.39 51.28 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 169.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 22.7 pt -72.91 -15.87 17.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 112.632 0.605 . . . . 0.0 112.632 -178.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -113.48 155.27 25.62 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 124.718 1.207 . . . . 0.0 107.925 168.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -136.37 -6.79 2.01 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.342 1.457 . . . . 0.0 111.279 175.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -151.87 -36.91 0.12 Allowed 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 -168.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -159.18 -62.19 0.07 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 119.697 1.135 . . . . 0.0 110.871 -173.426 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -143.93 152.96 56.62 Favored Pre-proline 0 C--O 1.234 0.272 0 C-N-CA 125.137 1.375 . . . . 0.0 108.057 -176.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -81.14 49.81 3.35 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 123.5 2.8 . . . . 0.0 112.889 -170.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -64.06 -29.03 70.2 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 120.996 -1.065 . . . . 0.0 112.007 -173.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 83.1 mt -103.15 29.99 5.16 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 125.273 1.429 . . . . 0.0 110.682 -175.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 5.0 m -48.7 -50.06 35.08 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.418 1.087 . . . . 0.0 110.892 -179.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.88 -41.81 86.62 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.641 0.655 . . . . 0.0 110.714 -171.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -61.89 -48.42 80.56 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 123.023 0.529 . . . . 0.0 109.855 177.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 75.8 mtt180 -62.54 -45.74 91.57 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 122.933 0.493 . . . . 0.0 110.114 -176.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 83.3 t -68.75 -43.72 82.71 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.118 0 CA-C-O 118.274 -0.869 . . . . 0.0 109.84 -178.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -62.38 -45.07 94.82 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 120.556 1.525 . . . . 0.0 110.124 -178.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -65.6 -39.7 91.85 Favored 'General case' 0 C--N 1.333 -0.137 0 O-C-N 121.924 -0.485 . . . . 0.0 110.239 -179.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 75.9 t90 -66.67 -45.96 77.22 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-N 118.452 0.569 . . . . 0.0 110.356 178.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 55.9 t -59.07 -41.53 83.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 45.5 mttm -62.46 -44.97 95.12 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 118.678 0.672 . . . . 0.0 109.881 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 19.8 mm100 -62.1 -52.83 62.31 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 122.852 0.461 . . . . 0.0 110.569 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 22.8 pt -68.24 -32.2 54.8 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 CA-C-O 118.811 -0.614 . . . . 0.0 110.825 -174.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 48.8 m -62.92 -30.67 71.73 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 119.188 0.904 . . . . 0.0 111.082 -178.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -77.67 -41.99 36.2 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 119.327 0.967 . . . . 0.0 110.578 175.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -68.18 -33.96 75.41 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.505 0.722 . . . . 0.0 111.708 -177.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 81.1 mt -90.62 -2.38 57.86 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.202 1.801 . . . . 0.0 111.327 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 25.2 m80 56.82 22.36 6.93 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.9 1.68 . . . . 0.0 113.478 -174.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 78.8 mt -75.61 -23.34 56.41 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 124.275 1.03 . . . . 0.0 110.536 175.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -59.17 -40.65 86.28 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 118.49 0.586 . . . . 0.0 110.421 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -65.02 -19.32 65.94 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.96 -0.462 . . . . 0.0 111.823 179.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 4.7 mm -91.33 -47.17 14.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 124.247 1.019 . . . . 0.0 108.735 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.1 pp -75.54 -26.89 58.4 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 122.985 0.514 . . . . 0.0 112.021 -174.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -72.9 -28.52 62.52 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.561 0.744 . . . . 0.0 111.915 -177.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.341 0 C-N-CA 124.258 1.023 . . . . 0.0 110.295 -177.919 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.4 ttt . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 110.378 -0.23 . . . . 0.0 110.378 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.62 149.12 50.61 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.225 0.61 . . . . 0.0 110.517 177.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 31.0 pt -87.27 -22.48 6.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 123.107 0.563 . . . . 0.0 111.375 -179.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 15.4 m -110.63 126.51 54.55 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 125.612 1.565 . . . . 0.0 108.531 178.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -102.77 123.79 7.96 Favored Glycine 0 CA--C 1.521 0.419 0 N-CA-C 107.056 -2.418 . . . . 0.0 107.056 169.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 62.3 mt -105.26 92.28 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 N-CA-C 105.338 -2.097 . . . . 0.0 105.338 178.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -88.64 135.26 33.59 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 -177.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -132.58 133.37 43.6 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 119.943 1.247 . . . . 0.0 112.596 176.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -87.97 148.14 20.74 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 108.283 -1.927 . . . . 0.0 108.283 167.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.9 m -168.35 160.46 11.36 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 119.069 1.435 . . . . 0.0 110.624 174.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -125.3 -53.36 1.61 Allowed 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.821 0.848 . . . . 0.0 109.493 167.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.8 p -85.92 6.01 30.41 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 124.944 1.298 . . . . 0.0 113.219 174.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 85.25 -7.18 76.84 Favored Glycine 0 CA--C 1.532 1.107 0 N-CA-C 117.302 1.681 . . . . 0.0 117.302 167.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.55 -36.08 77.58 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 120.51 2.155 . . . . 0.0 113.461 -170.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 11.4 m -73.02 -16.2 61.51 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 119.408 1.004 . . . . 0.0 110.791 -175.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -60.77 -42.5 97.58 Favored 'General case' 0 C--N 1.342 0.264 0 O-C-N 121.101 -0.999 . . . . 0.0 109.879 173.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -65.94 -39.04 90.14 Favored 'General case' 0 C--N 1.339 0.142 0 O-C-N 121.984 -0.448 . . . . 0.0 110.086 -178.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 41.0 mm -62.33 -47.69 91.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 176.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.34 -43.9 96.02 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 122.843 0.457 . . . . 0.0 111.345 179.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 54.9 mttm -63.85 -43.72 95.28 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 118.811 -0.614 . . . . 0.0 110.848 178.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 75.6 mtm -63.5 -37.06 85.86 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 119.328 0.967 . . . . 0.0 110.965 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 34.0 mt -65.22 -44.6 95.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 174.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -60.12 -40.13 88.64 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 119.291 0.951 . . . . 0.0 110.741 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -64.45 -34.17 77.58 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 119.007 0.821 . . . . 0.0 111.172 179.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -68.2 -51.13 49.03 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 118.689 0.677 . . . . 0.0 110.431 175.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 42.5 mt -71.16 -31.92 68.29 Favored 'General case' 0 C--N 1.341 0.227 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -174.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.63 147.21 20.86 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 125.31 1.433 . . . . 0.0 110.983 -174.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -65.05 -29.71 70.63 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.764 0.826 . . . . 0.0 112.172 -172.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -67.51 -29.37 68.77 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 122.63 0.372 . . . . 0.0 111.117 177.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 33.3 t -93.69 -36.9 7.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 C-N-CA 124.585 1.154 . . . . 0.0 110.256 -175.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -134.93 144.54 47.52 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 119.067 0.849 . . . . 0.0 112.838 -171.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -131.09 141.69 50.18 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.376 1.07 . . . . 0.0 110.058 172.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 87.9 t -88.88 141.32 14.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 123.728 0.811 . . . . 0.0 108.911 -178.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.545 ' CE1' ' HG ' ' A' ' 39' ' ' SER . 0.6 OUTLIER -145.28 169.57 17.99 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.442 1.097 . . . . 0.0 111.444 -169.026 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -144.95 121.17 10.85 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.275 1.43 . . . . 0.0 107.474 -177.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.4 tp -59.09 -21.76 20.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 123.474 0.71 . . . . 0.0 112.242 -171.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.82 -29.16 69.98 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.05 0.54 . . . . 0.0 111.725 176.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 57.8 pttt -108.49 -19.53 13.42 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.302 1.041 . . . . 0.0 112.408 178.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.545 ' HG ' ' CE1' ' A' ' 34' ' ' HIS . 1.4 m -63.88 165.32 8.84 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 119.262 0.937 . . . . 0.0 110.53 170.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 24.4 p -143.95 166.89 23.7 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.163 0.985 . . . . 0.0 110.095 -179.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -52.93 -49.19 66.49 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.369 1.067 . . . . 0.0 111.32 -172.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -80.02 -24.02 41.09 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 122.134 0.174 . . . . 0.0 111.02 -175.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -73.35 -32.77 64.73 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.068 0.547 . . . . 0.0 111.091 -179.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -59.23 -37.77 78.33 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.405 0.682 . . . . 0.0 110.966 171.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -72.17 -16.59 61.97 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 122.884 0.473 . . . . 0.0 112.257 -173.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.18 -29.01 65.77 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.473 0.709 . . . . 0.0 111.871 -178.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -79.8 157.29 27.09 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.253 1.021 . . . . 0.0 110.169 179.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -109.77 -28.8 8.62 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.107 169.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.2 mp -112.04 126.91 69.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 173.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -112.58 122.22 47.06 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 175.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.2 mp -109.71 118.27 36.09 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 171.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 60.0 mt -119.46 109.16 15.42 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -171.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.5 122.57 7.19 Favored Glycine 0 CA--C 1.521 0.407 0 C-N-CA 125.629 1.585 . . . . 0.0 110.162 -179.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 18.4 tt -136.71 109.19 9.29 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-N 118.121 0.961 . . . . 0.0 111.648 -176.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.1 140.54 31.33 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 N-CA-C 107.32 -1.839 . . . . 0.0 107.32 166.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 90.5 m -91.97 136.17 33.37 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 177.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 30.1 m95 -129.62 173.97 10.11 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.518 1.127 . . . . 0.0 111.405 -172.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 55.07 -89.88 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 127.909 2.484 . . . . 0.0 112.397 179.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -153.58 78.66 1.14 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 126.271 1.829 . . . . 0.0 106.754 175.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 65.75 51.84 43.43 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 -177.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -127.79 155.85 43.41 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.1 0.96 . . . . 0.0 109.631 176.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -79.23 166.35 22.27 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.751 0.82 . . . . 0.0 109.968 170.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 18.1 mm-40 -72.57 153.75 41.13 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 169.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 60.8 m -58.98 -37.01 75.84 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.598 0.759 . . . . 0.0 112.739 -169.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -72.14 -38.38 69.24 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 118.712 0.687 . . . . 0.0 110.579 -177.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -66.42 -46.78 75.38 Favored 'General case' 0 C--N 1.342 0.241 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 173.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -60.53 -38.75 85.44 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.331 0.652 . . . . 0.0 111.557 -178.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -70.01 -25.72 63.72 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.996 0.918 . . . . 0.0 112.189 176.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -90.71 -20.55 22.33 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.445 0.698 . . . . 0.0 112.293 -179.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 19.3 m-30 -51.02 -42.24 78.85 Favored Pre-proline 0 CA--C 1.546 0.822 0 CA-C-O 116.762 -1.589 . . . . 0.0 114.253 177.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -65.5 -21.21 60.4 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 CA-C-N 122.966 2.095 . . . . 0.0 113.402 174.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.8 m -81.95 -36.33 28.08 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 119.371 0.987 . . . . 0.0 109.604 170.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 21.7 tp -61.91 -30.8 71.13 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.059 -1.026 . . . . 0.0 111.37 -175.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -82.96 -2.36 54.91 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.163 0.985 . . . . 0.0 113.134 175.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 39.4 mm-40 -100.36 -26.03 14.02 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.331 1.052 . . . . 0.0 110.425 172.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 80.9 mt -70.69 152.76 8.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 174.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -106.99 134.83 49.56 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.533 1.133 . . . . 0.0 109.465 178.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -124.98 15.55 8.53 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.499 1.119 . . . . 0.0 111.53 177.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -56.07 115.04 2.2 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 119.646 1.112 . . . . 0.0 109.79 -178.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 74.44 3.08 65.13 Favored Glycine 0 CA--C 1.536 1.358 0 CA-C-O 118.531 -1.149 . . . . 0.0 114.294 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -80.02 148.67 31.02 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 119.385 1.593 . . . . 0.0 107.742 171.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 19.1 mt -91.44 134.33 34.72 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 178.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 19.0 t -130.96 132.78 63.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 178.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -128.32 143.32 51.0 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 176.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 77.8 mt -115.99 146.23 42.3 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -173.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -141.55 160.35 40.33 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 169.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -170.9 170.06 42.91 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-O 122.419 1.01 . . . . 0.0 113.059 -171.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 15.5 m -136.7 148.8 47.54 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 125.739 1.616 . . . . 0.0 107.367 -169.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.6 -167.29 28.05 Favored Glycine 0 CA--C 1.528 0.859 0 O-C-N 123.233 0.333 . . . . 0.0 112.604 -174.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -139.78 143.57 36.97 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.721 1.608 . . . . 0.0 109.896 -179.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -118.66 3.85 11.68 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.053 1.741 . . . . 0.0 112.268 -178.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -85.81 -47.59 9.58 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 119.699 1.136 . . . . 0.0 110.572 176.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -129.68 -37.97 1.53 Allowed 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.248 0.619 . . . . 0.0 111.825 -170.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -87.26 18.82 3.49 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.218 0.607 . . . . 0.0 112.133 174.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.67 -39.72 71.33 Favored 'General case' 0 C--N 1.342 0.247 0 C-N-CA 124.729 1.212 . . . . 0.0 112.365 -173.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -65.93 -13.96 60.68 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 118.577 0.626 . . . . 0.0 111.938 -177.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -120.83 21.57 11.39 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 126.546 1.939 . . . . 0.0 110.112 -177.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -60.34 119.32 7.73 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 118.832 0.742 . . . . 0.0 110.729 -169.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 72.2 m 47.63 32.03 2.34 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.021 1.729 . . . . 0.0 112.749 -177.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -54.87 -37.5 66.34 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.055 0.942 . . . . 0.0 112.087 -173.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.87 -14.07 62.81 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -171.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 84.9 mt -56.07 -42.98 77.52 Favored 'General case' 0 C--N 1.345 0.371 0 CA-C-N 118.961 0.801 . . . . 0.0 109.609 169.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.97 -33.15 86.47 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 -178.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.2 m -64.33 -41.37 96.82 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 118.18 0.99 . . . . 0.0 110.194 178.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 6.2 mt -68.22 -45.21 83.31 Favored 'Isoleucine or valine' 0 C--N 1.343 0.312 0 CA-C-N 119.198 0.908 . . . . 0.0 108.8 176.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 52.3 ttt-85 -52.95 -47.82 67.83 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 119.236 0.925 . . . . 0.0 110.157 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -64.98 -23.24 67.16 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 123.87 0.868 . . . . 0.0 112.381 -175.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 76.2 mt -86.2 -46.42 16.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 118.844 0.747 . . . . 0.0 109.381 175.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.0 pt -76.47 -26.27 16.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 119.363 0.983 . . . . 0.0 112.811 -169.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -64.06 -50.23 70.08 Favored Pre-proline 0 CA--C 1.547 0.832 0 CA-C-O 117.654 -1.165 . . . . 0.0 111.846 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -54.54 -29.75 61.58 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.858 2.372 . . . . 0.0 114.038 172.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 28.5 mmm180 -88.11 9.85 21.25 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.888 0.875 . . . . 0.0 111.799 -177.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 79.27 12.62 83.73 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-O 118.645 -1.086 . . . . 0.0 114.132 169.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.42 143.33 45.73 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 118.846 1.323 . . . . 0.0 110.287 173.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 48.7 m -93.15 121.11 34.17 Favored 'General case' 0 CA--C 1.528 0.108 0 N-CA-C 104.821 -2.288 . . . . 0.0 104.821 168.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 14.9 mt -102.23 126.06 56.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -168.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 6.1 m -140.98 174.28 7.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 125.928 1.691 . . . . 0.0 108.979 -170.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 74.56 37.11 47.2 Favored Glycine 0 CA--C 1.529 0.934 0 O-C-N 121.479 -0.763 . . . . 0.0 112.228 -175.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -66.56 138.88 57.8 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 173.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 70.9 t-105 -124.61 126.24 25.42 Favored Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 124.782 1.233 . . . . 0.0 108.423 -169.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -68.47 145.02 63.41 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 121.483 1.455 . . . . 0.0 112.358 -169.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 4.1 p -68.86 -34.6 75.72 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 119.234 -0.413 . . . . 0.0 110.674 169.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 50.06 52.98 13.63 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.356 1.462 . . . . 0.0 112.03 176.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 78.68 38.71 23.37 Favored Glycine 0 CA--C 1.531 1.081 0 CA-C-O 120.064 -0.298 . . . . 0.0 112.577 177.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -59.71 136.34 57.96 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.76 0.824 . . . . 0.0 109.205 173.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 42.0 t60 -143.4 16.57 1.86 Allowed 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -170.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -84.22 177.23 8.28 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.288 -0.883 . . . . 0.0 110.614 176.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -50.7 -50.54 54.87 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.02 1.328 . . . . 0.0 113.127 -168.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -151.86 176.8 11.08 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 124.057 0.943 . . . . 0.0 108.912 169.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.1 133.55 18.63 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 169.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -118.96 -11.45 9.69 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -169.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -82.69 10.0 57.64 Favored Glycine 0 CA--C 1.534 1.268 0 CA-C-N 118.773 0.715 . . . . 0.0 112.743 169.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 82.0 mt -64.67 135.73 56.21 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 118.947 1.374 . . . . 0.0 111.162 -178.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -98.21 -31.57 12.01 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.927 1.291 . . . . 0.0 108.318 166.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -149.54 163.15 38.62 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 127.756 2.422 . . . . 0.0 106.797 172.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -55.71 -30.21 60.75 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.182 -0.949 . . . . 0.0 112.088 176.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -88.07 -10.49 50.02 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 10.9 m-70 -150.94 127.58 10.84 Favored 'General case' 0 C--N 1.347 0.476 0 CA-C-N 119.843 1.201 . . . . 0.0 113.684 -169.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -73.0 151.93 41.55 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 164.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 8.0 p -66.12 -19.05 25.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 O-C-N 121.98 -0.45 . . . . 0.0 112.016 176.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -154.77 163.17 31.17 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 123.791 0.71 . . . . 0.0 111.349 -171.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -56.71 127.82 33.4 Favored 'General case' 0 CA--C 1.522 -0.121 0 C-N-CA 124.22 1.008 . . . . 0.0 108.487 177.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -120.4 115.09 22.82 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 176.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 27.7 pt -78.76 169.13 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 169.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 26.5 t70 71.73 145.13 0.07 Allowed 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 127.207 2.203 . . . . 0.0 112.938 -169.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -132.88 -1.57 3.34 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.702 1.601 . . . . 0.0 111.889 175.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -160.29 -45.8 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 120.058 1.299 . . . . 0.0 113.797 -171.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.03 -55.14 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.697 1.199 . . . . 0.0 108.561 -175.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -132.88 146.9 63.3 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 125.858 1.663 . . . . 0.0 108.256 -177.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -63.88 145.98 91.01 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 123.046 2.497 . . . . 0.0 112.84 -173.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -147.07 162.81 38.06 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 126.4 1.88 . . . . 0.0 107.436 174.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 62.0 mt 53.49 26.18 5.35 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.76 1.224 . . . . 0.0 111.694 -172.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 87.7 m -53.83 -52.43 60.39 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 125.099 1.36 . . . . 0.0 111.012 -169.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -71.44 -32.3 68.2 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 122.178 0.191 . . . . 0.0 110.786 -171.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -67.16 -44.03 80.75 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 122.995 0.518 . . . . 0.0 109.64 173.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 38.5 mtt180 -66.2 -42.83 88.27 Favored 'General case' 0 C--O 1.232 0.184 0 O-C-N 121.606 -0.684 . . . . 0.0 110.964 -177.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 28.3 m -69.09 -35.52 68.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-O 118.148 -0.929 . . . . 0.0 109.809 178.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -60.07 -49.96 75.61 Favored 'General case' 0 C--N 1.342 0.279 0 CA-C-N 120.469 1.486 . . . . 0.0 110.233 174.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 59.6 mttm -57.83 -40.01 79.04 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 118.132 0.424 . . . . 0.0 110.554 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 61.8 t90 -72.09 -45.35 61.02 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 117.872 0.305 . . . . 0.0 110.745 -177.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 75.7 t -63.68 -34.81 70.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 O-C-N 121.489 -0.757 . . . . 0.0 109.716 -179.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -62.75 -34.61 77.56 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 118.455 -0.783 . . . . 0.0 110.714 177.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -62.67 -57.19 11.88 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.992 0.814 . . . . 0.0 110.053 171.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 6.9 pt -65.61 -30.27 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 118.828 0.74 . . . . 0.0 110.369 -171.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 49.4 m -58.74 -29.09 66.46 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 117.711 -1.138 . . . . 0.0 112.151 178.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -96.86 -13.32 22.6 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 120.456 1.48 . . . . 0.0 113.118 175.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -82.82 -39.67 21.39 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 118.972 0.806 . . . . 0.0 110.34 173.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 1.9 mp -90.24 -12.61 37.47 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.556 1.942 . . . . 0.0 110.719 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 57.19 30.52 18.5 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.731 1.612 . . . . 0.0 112.703 -169.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 55.2 mt -68.92 -18.91 64.17 Favored 'General case' 0 N--CA 1.467 0.403 0 O-C-N 121.434 -0.791 . . . . 0.0 110.476 169.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -54.34 -39.48 67.14 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.541 0.736 . . . . 0.0 110.353 173.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -71.76 -4.92 30.42 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 121.575 -0.703 . . . . 0.0 112.442 -178.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 22.6 mt -109.8 -54.66 5.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 125.176 1.39 . . . . 0.0 108.446 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.5 pp -79.16 -24.08 43.51 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.347 0.659 . . . . 0.0 112.179 -173.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -126.0 40.1 3.81 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.591 1.956 . . . . 0.0 108.71 -177.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.22 0 CA-C-O 118.304 -0.855 . . . . 0.0 109.367 174.603 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.5 ptp . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 120.959 0.409 . . . . 0.0 111.691 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -66.34 159.94 25.7 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.495 0.718 . . . . 0.0 110.597 174.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.0 pt -74.51 -29.93 24.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 O-C-N 122.144 -0.347 . . . . 0.0 110.987 178.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.3 m -110.25 136.01 50.12 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 124.637 1.175 . . . . 0.0 109.338 -179.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -108.21 118.96 5.55 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 107.299 -2.32 . . . . 0.0 107.299 168.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 39.8 mt -92.83 127.49 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 104.573 -2.38 . . . . 0.0 104.573 169.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -122.87 128.94 51.03 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 176.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -123.53 127.11 47.87 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 118.979 0.809 . . . . 0.0 112.376 -177.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -87.28 141.54 17.56 Favored Glycine 0 C--N 1.338 0.692 0 N-CA-C 108.35 -1.9 . . . . 0.0 108.35 167.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 37.8 m -153.15 166.44 32.49 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.716 1.758 . . . . 0.0 110.534 176.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -145.76 -51.65 0.25 Allowed 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.283 1.033 . . . . 0.0 109.794 169.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.9 p -80.77 -15.14 57.23 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.815 0.846 . . . . 0.0 112.058 172.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.22 32.09 6.9 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 124.491 1.043 . . . . 0.0 113.058 172.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -82.58 -52.73 6.55 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 118.423 1.112 . . . . 0.0 111.772 176.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -67.58 -23.62 65.42 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 121.588 -0.695 . . . . 0.0 112.441 -167.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -60.67 -35.65 76.77 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.283 0.947 . . . . 0.0 111.032 175.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -70.09 -42.79 72.26 Favored 'General case' 0 C--N 1.34 0.16 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 26.5 mm -61.77 -42.14 93.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 178.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.13 -41.88 93.62 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 121.517 -0.739 . . . . 0.0 111.017 178.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -67.72 -39.26 84.31 Favored 'General case' 0 CA--C 1.53 0.198 0 O-C-N 121.77 -0.581 . . . . 0.0 110.77 176.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 75.2 mtp -64.62 -30.01 71.03 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 119.283 0.947 . . . . 0.0 111.653 177.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 58.9 mt -70.4 -55.99 12.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 170.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -59.13 -32.97 70.33 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 121.323 -0.861 . . . . 0.0 112.386 -173.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -66.65 -34.85 78.78 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 120.039 1.29 . . . . 0.0 111.487 179.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -75.57 -39.65 57.81 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.015 0.526 . . . . 0.0 110.663 175.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -75.26 -39.79 59.44 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.807 0.843 . . . . 0.0 111.383 -174.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.53 141.57 5.87 Favored Glycine 0 CA--C 1.531 1.034 0 N-CA-C 108.818 -1.713 . . . . 0.0 108.818 -167.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 58.3 tttp -62.1 -31.08 71.48 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 121.643 -0.916 . . . . 0.0 111.722 -172.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -65.06 -29.53 70.43 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 123.071 0.548 . . . . 0.0 111.74 178.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.2 t -92.7 -38.24 9.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 123.755 0.822 . . . . 0.0 109.68 -178.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -139.04 125.71 20.72 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 119.411 1.005 . . . . 0.0 112.028 178.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -103.31 159.58 15.43 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.408 0.683 . . . . 0.0 110.191 173.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 51.1 t -121.7 129.35 75.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 124.234 1.013 . . . . 0.0 109.971 -169.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -144.9 172.43 13.04 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.887 1.675 . . . . 0.0 111.736 -173.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -125.88 136.81 53.49 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 175.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.5 tp -60.86 -25.99 37.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 O-C-N 121.435 -0.791 . . . . 0.0 111.633 -174.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -55.03 -36.36 65.44 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.578 1.151 . . . . 0.0 112.05 178.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -105.31 0.78 27.39 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.885 1.274 . . . . 0.0 111.912 -178.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 18.4 m -88.14 175.0 7.91 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.941 0.896 . . . . 0.0 109.654 177.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 70.7 m -153.85 162.4 41.26 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 120.888 -1.132 . . . . 0.0 109.483 179.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -51.0 -47.85 61.52 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.849 1.26 . . . . 0.0 111.178 -176.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -73.67 -24.39 59.97 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.459 -174.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -77.74 -35.58 51.67 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 122.818 0.447 . . . . 0.0 110.513 176.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -64.28 -50.46 67.82 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.498 0.719 . . . . 0.0 110.34 178.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -67.74 -19.27 65.11 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -172.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.51 -29.93 69.47 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.153 0.981 . . . . 0.0 112.667 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -75.25 159.57 31.38 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 123.827 0.851 . . . . 0.0 109.861 175.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -110.21 -22.23 11.86 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.309 0.644 . . . . 0.0 112.218 170.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.0 mp -120.71 132.56 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 175.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 97.4 mt -126.87 125.66 41.99 Favored 'General case' 0 CA--C 1.519 -0.232 0 C-N-CA 124.081 0.953 . . . . 0.0 108.865 -178.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 7.4 mp -114.11 107.92 16.29 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 176.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 66.7 mt -110.54 107.71 17.43 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 -170.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.43 117.94 5.44 Favored Glycine 0 C--N 1.331 0.285 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 17.5 tt -131.61 118.22 16.75 Favored Pre-proline 0 CA--C 1.539 0.523 0 CA-C-N 118.034 0.917 . . . . 0.0 110.408 -177.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -83.33 147.19 12.66 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.754 2.302 . . . . 0.0 108.427 168.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 54.5 m -99.29 143.52 29.45 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 177.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 68.2 m95 -136.13 171.15 14.9 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 125.731 1.612 . . . . 0.0 110.242 -174.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 25.83 72.17 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 128.062 2.545 . . . . 0.0 114.394 169.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 56.69 54.6 7.13 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.128 0.971 . . . . 0.0 111.81 174.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 82.8 13.3 78.19 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-O 119.388 -0.673 . . . . 0.0 114.326 171.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -74.39 154.08 38.97 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.511 1.156 . . . . 0.0 109.873 169.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.56 165.9 23.18 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 123.508 0.723 . . . . 0.0 110.571 170.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 14.9 tm0? -61.91 145.18 53.62 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 169.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 52.4 m -60.12 -37.2 79.32 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 114.959 1.466 . . . . 0.0 114.959 -167.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -76.09 -38.21 57.25 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 118.632 0.651 . . . . 0.0 109.281 -177.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -62.77 -47.26 84.29 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.185 0.594 . . . . 0.0 109.543 173.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -59.0 -40.36 84.66 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.598 0.759 . . . . 0.0 111.431 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -69.01 -31.76 70.81 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.245 0.618 . . . . 0.0 112.098 176.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -84.84 -21.84 29.68 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 117.889 -1.053 . . . . 0.0 112.647 -177.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 18.2 m-30 -48.37 -44.65 65.06 Favored Pre-proline 0 CA--C 1.544 0.735 0 CA-C-N 121.005 1.729 . . . . 0.0 115.114 -178.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.07 -16.36 54.85 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 CA-C-N 122.731 2.011 . . . . 0.0 113.897 176.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 31.5 m -91.46 -35.14 14.51 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.185 0.994 . . . . 0.0 109.643 169.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 17.0 tp -59.39 -39.17 82.52 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.222 1.009 . . . . 0.0 110.491 -178.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -73.66 -7.99 54.19 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -93.51 -1.55 55.46 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 119.619 1.1 . . . . 0.0 111.344 178.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 66.7 mt -92.37 146.03 6.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 -175.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -86.13 121.22 28.42 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 172.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -114.08 10.54 17.45 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 118.3 -0.857 . . . . 0.0 111.715 175.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 31.6 m-80 -59.32 117.36 4.71 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 120.269 1.395 . . . . 0.0 109.791 -172.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 72.84 -1.04 41.19 Favored Glycine 0 CA--C 1.534 1.28 0 CA-C-O 118.689 -1.062 . . . . 0.0 114.212 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -72.27 144.96 48.21 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 119.602 1.701 . . . . 0.0 108.024 172.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 35.7 mt -85.17 133.51 34.19 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 177.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.1 t -132.1 135.86 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 176.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -129.35 143.9 51.03 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 175.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 67.1 mt -118.94 148.19 43.22 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -175.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -145.65 153.69 41.3 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 123.205 0.602 . . . . 0.0 110.614 175.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -174.64 164.56 35.5 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-O 121.701 0.612 . . . . 0.0 112.683 179.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 24.9 p -121.27 167.67 12.47 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 125.418 1.487 . . . . 0.0 109.253 175.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -163.74 -160.18 11.45 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 114.271 0.468 . . . . 0.0 114.271 -177.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -143.42 153.67 42.9 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 126.622 1.969 . . . . 0.0 109.991 -175.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -138.28 7.66 2.64 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.865 0.866 . . . . 0.0 112.519 168.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -69.11 -33.28 73.24 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.58 1.082 . . . . 0.0 109.285 173.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -135.22 -36.7 0.8 Allowed 'General case' 0 C--O 1.234 0.285 0 C-N-CA 123.002 0.521 . . . . 0.0 112.17 171.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -89.78 29.98 1.1 Allowed 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 118.562 0.619 . . . . 0.0 112.604 -173.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.32 -31.8 71.66 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.189 0.996 . . . . 0.0 112.801 -174.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -79.92 1.16 28.35 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.266 1.026 . . . . 0.0 112.071 178.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -134.95 19.8 3.48 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.597 1.559 . . . . 0.0 109.896 -176.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -65.59 114.82 5.2 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -171.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 72.6 m 51.27 34.99 12.55 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.54 1.536 . . . . 0.0 113.203 -173.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -50.6 -44.54 57.06 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.672 1.189 . . . . 0.0 111.489 -179.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.84 -12.88 62.01 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 -169.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 90.0 mt -58.55 -39.68 80.93 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 118.893 0.77 . . . . 0.0 109.707 169.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.9 -32.08 83.04 Favored Glycine 0 CA--C 1.528 0.848 0 N-CA-C 111.412 -0.675 . . . . 0.0 111.412 178.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.6 m -65.85 -38.58 89.24 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.358 1.079 . . . . 0.0 110.334 178.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 7.0 mt -71.82 -42.49 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 119.105 0.866 . . . . 0.0 109.004 175.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 47.5 ttt180 -53.46 -45.43 69.55 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 119.408 1.003 . . . . 0.0 110.334 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -63.85 -20.07 65.53 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.026 0.93 . . . . 0.0 112.81 -177.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 96.4 mt -92.09 -48.77 13.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 123.974 0.91 . . . . 0.0 109.661 176.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.5 pt -78.07 -33.85 18.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-N 118.921 0.782 . . . . 0.0 111.979 -168.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -70.76 -43.91 15.43 Favored Pre-proline 0 CA--C 1.544 0.715 0 CA-C-O 117.962 -1.018 . . . . 0.0 111.269 -172.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -64.6 -31.42 59.92 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.032 1.821 . . . . 0.0 113.132 173.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? -75.81 6.51 4.92 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.019 0.928 . . . . 0.0 112.259 172.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 78.52 20.16 72.24 Favored Glycine 0 CA--C 1.527 0.828 0 CA-C-O 118.686 -1.064 . . . . 0.0 114.082 169.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -59.75 142.42 53.25 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 118.725 1.263 . . . . 0.0 109.857 170.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 37.6 m -89.1 116.45 27.37 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 104.461 -2.422 . . . . 0.0 104.461 168.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 38.9 mt -90.92 130.53 39.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 -176.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 3.7 m -137.44 165.86 26.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 126.103 1.761 . . . . 0.0 108.487 -177.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 74.49 31.44 58.87 Favored Glycine 0 CA--C 1.524 0.616 0 CA-C-O 119.141 -0.811 . . . . 0.0 112.293 -175.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 83.9 m-70 -58.48 134.08 56.36 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 169.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 70.8 t-105 -113.38 124.96 30.36 Favored Pre-proline 0 C--O 1.235 0.296 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -169.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -67.95 140.31 49.87 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 121.254 1.303 . . . . 0.0 110.632 -173.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 81.1 p -74.5 -21.24 59.65 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.186 0.594 . . . . 0.0 110.876 176.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 52.52 44.05 30.41 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 126.154 1.781 . . . . 0.0 110.974 -174.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 78.69 77.49 0.88 Allowed Glycine 0 C--N 1.338 0.653 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 -171.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -43.53 131.79 4.95 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.449 1.1 . . . . 0.0 111.222 171.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 42.2 t60 -147.99 32.49 0.84 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.736 0.815 . . . . 0.0 111.175 -175.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -112.14 -178.56 3.45 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.03 1.332 . . . . 0.0 107.856 177.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -83.92 -54.91 4.53 Favored 'General case' 0 C--O 1.236 0.365 0 O-C-N 121.397 -0.815 . . . . 0.0 111.989 -168.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -156.71 140.35 15.97 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 119.131 0.878 . . . . 0.0 111.043 170.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 73.5 m -142.09 111.62 6.61 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 124.953 1.301 . . . . 0.0 107.857 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -77.89 -11.41 59.89 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 122.2 -0.313 . . . . 0.0 110.882 -173.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -78.46 0.19 76.54 Favored Glycine 0 CA--C 1.533 1.164 0 CA-C-O 118.404 -1.22 . . . . 0.0 113.798 169.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 65.0 mt -62.31 125.73 24.89 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 120.869 2.335 . . . . 0.0 108.618 171.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -91.82 -32.55 15.31 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.714 0.806 . . . . 0.0 109.541 170.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -149.78 163.02 39.1 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 127.227 2.211 . . . . 0.0 106.848 172.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -55.29 -29.55 58.41 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.392 -0.817 . . . . 0.0 112.243 175.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -90.49 -12.39 37.42 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.216 1.007 . . . . 0.0 113.486 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -147.58 128.23 14.22 Favored 'General case' 0 C--N 1.346 0.434 0 CA-C-N 119.991 1.269 . . . . 0.0 113.399 -170.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -78.45 152.32 32.19 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 166.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 10.7 p -58.15 -28.68 35.13 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 C-N-CA 124.824 1.249 . . . . 0.0 111.49 175.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -157.8 175.83 35.0 Favored Glycine 0 C--N 1.336 0.56 0 C-N-CA 125.048 1.309 . . . . 0.0 110.219 -174.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -56.96 126.6 27.87 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 124.101 0.96 . . . . 0.0 108.611 178.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -136.47 112.52 9.68 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 -179.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 33.3 pt -123.07 128.79 75.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-O 122.272 1.034 . . . . 0.0 113.038 -173.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -166.46 163.0 17.23 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 128.88 2.872 . . . . 0.0 105.821 169.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -130.79 -24.43 2.43 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.929 0.892 . . . . 0.0 112.014 171.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -168.57 -53.48 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.204 1.402 . . . . 0.0 108.244 179.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 21.6 ttm180 -152.14 112.39 4.08 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 105.423 -2.066 . . . . 0.0 105.423 168.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 67.1 149.48 0.12 Allowed Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 126.366 1.866 . . . . 0.0 111.153 -175.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -75.91 158.08 38.73 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 121.838 1.692 . . . . 0.0 113.38 -170.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -135.56 170.12 16.46 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 126.261 1.824 . . . . 0.0 106.527 167.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 23.5 mt 56.19 24.6 8.24 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.192 0.997 . . . . 0.0 111.192 -168.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 99.1 m -53.81 -50.66 65.65 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 125.697 1.599 . . . . 0.0 110.861 -169.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -71.64 -34.52 69.84 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 119.075 -0.488 . . . . 0.0 111.063 -171.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -67.53 -43.96 79.51 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 118.507 0.594 . . . . 0.0 109.687 175.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 52.1 mtt180 -64.61 -43.2 94.53 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 121.933 -0.48 . . . . 0.0 110.633 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 58.1 t -67.82 -40.18 83.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-O 118.247 -0.883 . . . . 0.0 109.8 178.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -60.69 -47.48 86.07 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 120.612 1.551 . . . . 0.0 109.909 176.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 59.3 mttm -57.98 -45.89 86.06 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 118.331 0.514 . . . . 0.0 110.184 178.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 55.1 t90 -65.62 -45.78 81.79 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 118.109 0.413 . . . . 0.0 110.513 -177.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 55.6 t -62.56 -38.64 81.98 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 C-N-CA 123.046 0.538 . . . . 0.0 110.202 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -69.8 -36.05 75.36 Favored 'General case' 0 CA--C 1.532 0.265 0 O-C-N 121.224 -0.923 . . . . 0.0 110.256 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 20.5 mm100 -64.61 -52.09 59.25 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.652 0.66 . . . . 0.0 110.634 174.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 12.3 pt -64.22 -32.69 58.46 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 CA-C-N 119.51 1.05 . . . . 0.0 110.787 -178.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 57.2 m -56.05 -36.07 67.63 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.287 0.949 . . . . 0.0 112.172 176.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -87.62 -27.17 22.67 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.9 1.227 . . . . 0.0 112.24 177.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -68.55 -32.02 71.65 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 119.357 0.981 . . . . 0.0 110.73 173.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 1.8 mp -82.69 -3.68 56.73 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.458 1.903 . . . . 0.0 110.89 174.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 54.8 35.12 23.41 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 126.126 1.771 . . . . 0.0 112.379 -177.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 70.1 mt -63.48 -27.86 69.57 Favored 'General case' 0 N--CA 1.464 0.273 0 O-C-N 121.314 -0.866 . . . . 0.0 111.301 -177.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -59.89 -37.7 80.15 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 118.346 0.521 . . . . 0.0 110.92 177.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -67.74 -21.75 65.26 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.002 0.521 . . . . 0.0 111.498 178.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 14.8 mm -86.81 -50.01 14.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 124.091 0.957 . . . . 0.0 108.428 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.6 pp -75.41 -28.37 59.38 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -172.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -98.45 17.18 19.54 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.562 1.145 . . . . 0.0 111.719 -178.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.351 0 C-N-CA 123.554 0.742 . . . . 0.0 109.569 174.47 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.1 ttp . . . . . 0 N--CA 1.487 1.421 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -60.83 141.89 56.64 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.184 0.593 . . . . 0.0 111.372 -177.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.5 pt -104.45 -24.84 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 126.051 1.741 . . . . 0.0 110.587 178.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 51.6 m -105.79 125.9 51.54 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.142 1.377 . . . . 0.0 108.547 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -100.36 116.02 5.46 Favored Glycine 0 C--N 1.331 0.295 0 N-CA-C 107.082 -2.407 . . . . 0.0 107.082 168.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 35.0 mt -92.57 122.27 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 104.304 -2.48 . . . . 0.0 104.304 172.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -118.21 128.11 54.39 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 106.633 -1.618 . . . . 0.0 106.633 176.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -123.81 132.66 53.82 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 118.574 0.625 . . . . 0.0 111.247 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -86.36 142.32 18.75 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 108.205 -1.958 . . . . 0.0 108.205 168.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.9 m -160.62 160.41 31.63 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 119.233 1.517 . . . . 0.0 110.815 173.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -137.31 -47.14 0.57 Allowed 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.89 1.276 . . . . 0.0 109.525 169.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.2 p -80.99 -12.58 59.35 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.323 1.049 . . . . 0.0 112.162 170.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.41 10.86 53.21 Favored Glycine 0 C--N 1.343 0.946 0 C-N-CA 124.799 1.19 . . . . 0.0 113.884 170.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -66.28 -47.76 72.62 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 118.835 1.318 . . . . 0.0 112.158 -172.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.1 m -74.52 -14.93 60.87 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -168.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -56.15 -43.38 78.24 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.683 0.674 . . . . 0.0 109.755 171.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -68.78 -37.63 79.44 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 121.772 -0.58 . . . . 0.0 109.906 -177.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 29.7 mm -63.83 -43.33 97.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 176.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.36 -38.92 85.39 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.58 -0.7 . . . . 0.0 110.942 177.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -68.28 -40.62 81.75 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 118.177 -0.916 . . . . 0.0 111.342 175.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 63.9 mtt -58.98 -34.26 71.63 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 120.027 1.285 . . . . 0.0 111.051 175.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 55.6 mt -71.45 -53.96 18.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 175.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -61.49 -37.03 82.19 Favored 'General case' 0 N--CA 1.462 0.161 0 O-C-N 121.364 -0.835 . . . . 0.0 111.827 -173.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -63.55 -35.72 81.41 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 119.202 0.91 . . . . 0.0 111.088 -178.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -75.33 -41.79 55.88 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 122.902 0.481 . . . . 0.0 111.05 177.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -72.47 -34.24 67.58 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 122.73 0.412 . . . . 0.0 111.083 -177.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.43 145.07 8.52 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 -169.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -58.78 -33.98 70.93 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 122.015 -0.697 . . . . 0.0 112.078 -175.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -74.64 -11.75 60.27 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.26 -174.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.2 t -106.65 -42.09 6.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 124.337 1.055 . . . . 0.0 109.586 178.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -129.4 140.25 51.4 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 119.473 1.033 . . . . 0.0 111.482 -178.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -122.58 155.29 36.6 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.556 1.142 . . . . 0.0 109.473 177.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 77.6 t -119.7 130.33 74.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 124.234 1.014 . . . . 0.0 110.071 -169.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -146.79 177.61 8.97 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.857 1.663 . . . . 0.0 111.551 -172.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -133.81 130.22 37.64 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 126.884 2.074 . . . . 0.0 105.764 178.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.2 tp -60.56 -21.35 23.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 C-N-CA 123.496 0.719 . . . . 0.0 112.137 -172.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.6 -29.52 68.03 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 118.893 0.77 . . . . 0.0 111.322 177.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -81.08 -26.75 36.04 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.097 0.559 . . . . 0.0 111.438 177.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 62.7 m -71.89 159.48 34.2 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 122.129 0.966 . . . . 0.0 112.427 -168.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 23.5 m -130.07 175.34 8.97 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.849 2.059 . . . . 0.0 107.054 173.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -53.01 -45.63 68.01 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.236 0.615 . . . . 0.0 112.002 -172.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -81.6 -11.8 58.99 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 -175.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -70.8 -32.6 69.74 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 118.98 0.809 . . . . 0.0 111.304 -176.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -69.33 -43.71 73.16 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 123.429 0.692 . . . . 0.0 109.392 173.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 77.9 mt-10 -70.79 -11.66 61.08 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.932 0.893 . . . . 0.0 112.049 -171.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.88 -29.26 69.68 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.08 0.952 . . . . 0.0 111.907 173.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -98.34 153.6 18.43 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.854 1.262 . . . . 0.0 110.348 -178.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -99.54 -27.91 13.48 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.567 174.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.2 mp -113.84 129.79 69.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 174.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -114.15 125.71 54.25 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 107.086 -1.449 . . . . 0.0 107.086 175.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.3 mp -111.89 112.35 23.94 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 173.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.1 mt -112.9 112.28 23.64 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -169.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -100.82 115.15 5.21 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 125.602 1.572 . . . . 0.0 110.126 -178.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 16.2 tt -123.02 118.17 28.2 Favored Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 118.442 1.121 . . . . 0.0 111.71 -173.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -79.63 138.19 13.37 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 121.731 1.621 . . . . 0.0 108.039 167.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 79.7 m -94.39 143.71 26.17 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 174.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 66.2 m95 -134.25 173.74 11.27 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 126.082 1.753 . . . . 0.0 109.414 -177.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 24.4 t80 32.26 64.69 0.23 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 127.902 2.481 . . . . 0.0 114.364 169.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 54.58 53.69 10.33 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.816 0.847 . . . . 0.0 111.738 171.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 82.79 55.78 2.9 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 123.551 0.596 . . . . 0.0 112.085 174.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -128.99 155.87 44.7 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 125.846 1.658 . . . . 0.0 108.355 170.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.13 161.83 27.09 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 123.133 0.573 . . . . 0.0 110.252 172.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 34.1 tp60 -67.33 143.94 56.11 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 169.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 58.4 m -55.62 -35.23 65.65 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.815 0.846 . . . . 0.0 112.51 -172.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -64.76 -41.06 96.17 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.291 0.637 . . . . 0.0 110.444 -178.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -73.31 -46.75 47.72 Favored 'General case' 0 C--N 1.34 0.185 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 177.082 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -58.26 -36.24 72.94 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.582 0.753 . . . . 0.0 112.155 -177.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -69.9 -23.58 63.26 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.736 0.815 . . . . 0.0 112.552 177.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -100.39 -15.64 17.89 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.219 1.007 . . . . 0.0 112.025 -177.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 12.8 m-30 -48.4 -45.94 68.18 Favored Pre-proline 0 CA--C 1.542 0.668 0 CA-C-O 117.09 -1.433 . . . . 0.0 113.119 171.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -65.04 -20.93 63.83 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 CA-C-N 122.577 1.956 . . . . 0.0 113.116 176.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.8 m -82.75 -35.6 26.47 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 119.589 1.086 . . . . 0.0 110.047 174.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 71.8 mt -56.91 -34.0 67.51 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 119.856 1.207 . . . . 0.0 111.205 178.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -82.53 -1.23 49.9 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 178.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -99.95 -29.58 12.49 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.122 0.969 . . . . 0.0 109.629 169.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 92.9 mt -66.4 142.91 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 C-N-CA 125.69 1.596 . . . . 0.0 107.93 177.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -88.14 130.53 35.01 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 123.547 0.739 . . . . 0.0 109.537 173.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -124.37 18.48 8.97 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.513 0.725 . . . . 0.0 111.741 172.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 23.1 m-80 -61.95 116.79 5.18 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 119.95 1.25 . . . . 0.0 109.554 -175.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.0 5.92 66.56 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-O 118.881 -0.955 . . . . 0.0 113.189 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 9.8 mmpt? -76.88 153.13 35.06 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 119.216 1.508 . . . . 0.0 107.26 172.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -95.05 141.02 29.17 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 173.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 15.5 t -134.89 146.38 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 175.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -137.59 146.88 44.55 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 170.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 75.5 mt -116.78 142.36 47.02 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -172.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -138.85 157.3 46.3 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 169.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -162.72 153.41 23.99 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-O 122.455 1.03 . . . . 0.0 112.835 -171.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 51.8 m -126.12 150.93 47.88 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 113.017 -1.592 . . . . 0.0 108.821 -168.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -177.46 175.99 47.84 Favored Glycine 0 CA--C 1.523 0.534 0 C-N-CA 121.035 -0.602 . . . . 0.0 113.544 -172.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -100.54 140.68 34.46 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 125.391 1.476 . . . . 0.0 109.007 171.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -130.15 37.85 3.85 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.219 1.007 . . . . 0.0 109.532 -179.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -113.07 -55.55 2.51 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 124.44 1.096 . . . . 0.0 108.443 172.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -113.75 -33.3 5.85 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.551 1.14 . . . . 0.0 111.198 -175.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -92.02 22.57 4.23 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.703 0.801 . . . . 0.0 112.357 -178.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.61 -33.61 74.2 Favored 'General case' 0 C--N 1.343 0.302 0 CA-C-N 120.023 1.283 . . . . 0.0 113.515 -169.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -65.03 -31.01 72.03 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 119.934 1.243 . . . . 0.0 110.284 175.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -100.18 9.17 43.19 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.745 1.618 . . . . 0.0 111.218 -177.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -65.97 118.76 10.23 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 119.114 0.87 . . . . 0.0 108.884 -169.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 60.6 m 53.24 28.71 7.45 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.967 1.307 . . . . 0.0 112.789 -175.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -53.71 -36.48 62.29 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.73 1.212 . . . . 0.0 111.731 -176.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.72 -11.78 61.15 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -174.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 32.1 mt -54.38 -47.86 72.18 Favored 'General case' 0 C--N 1.344 0.353 0 CA-C-N 119.148 0.885 . . . . 0.0 110.47 173.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.0 -29.23 74.29 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 111.745 -0.542 . . . . 0.0 111.745 -176.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.8 m -63.63 -37.63 88.06 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 117.76 0.78 . . . . 0.0 110.049 177.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 5.8 mt -67.87 -44.17 85.5 Favored 'Isoleucine or valine' 0 C--N 1.344 0.346 0 CA-C-O 117.781 -1.104 . . . . 0.0 108.938 177.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 57.7 ttp85 -56.27 -46.74 79.58 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 120.032 1.287 . . . . 0.0 110.041 177.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -59.82 -28.18 67.24 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -178.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 80.0 mt -84.28 -45.67 18.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 124.38 1.072 . . . . 0.0 110.688 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 10.5 pt -85.83 -28.1 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 119.508 1.049 . . . . 0.0 112.584 -169.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -63.56 -42.12 70.85 Favored Pre-proline 0 CA--C 1.548 0.868 0 CA-C-O 117.814 -1.089 . . . . 0.0 111.434 -174.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -61.54 -20.02 67.01 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 122.727 2.285 . . . . 0.0 114.19 172.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 23.9 mmm180 -86.9 5.01 39.09 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.065 0.946 . . . . 0.0 111.44 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 75.73 17.53 80.06 Favored Glycine 0 CA--C 1.529 0.945 0 CA-C-O 118.51 -1.161 . . . . 0.0 113.03 178.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -59.1 137.76 57.82 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 118.809 1.305 . . . . 0.0 109.482 169.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 36.6 m -94.18 126.57 39.5 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 169.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 57.1 mt -105.22 132.6 51.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -174.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 27.1 m -129.01 176.35 8.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 125.737 1.615 . . . . 0.0 108.523 172.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 80.78 26.58 53.37 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-O 119.043 -0.865 . . . . 0.0 114.023 175.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 65.1 m80 -62.3 130.45 45.38 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 168.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 65.2 t-105 -107.64 124.56 34.59 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-O 118.258 -0.877 . . . . 0.0 108.787 -169.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -71.29 146.86 51.98 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 121.501 1.468 . . . . 0.0 112.144 -172.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 33.2 p -77.37 -39.69 46.47 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.874 0.87 . . . . 0.0 111.242 179.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 50.13 47.7 23.15 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.35 1.46 . . . . 0.0 111.628 -172.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.06 61.76 2.6 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -179.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 80.6 t80 -75.43 -79.28 0.1 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.814 0.845 . . . . 0.0 109.615 178.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 34.7 t60 43.98 45.76 6.67 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.467 1.907 . . . . 0.0 112.826 177.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 30.1 t80 -78.4 -65.41 0.99 Allowed 'General case' 0 C--N 1.342 0.242 0 O-C-N 121.864 -0.522 . . . . 0.0 109.891 -173.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -126.54 -99.21 0.39 Allowed 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 168.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -157.02 42.49 0.34 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 122.66 1.219 . . . . 0.0 110.328 -174.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 8.4 m -58.73 122.69 14.15 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 113.42 -1.718 . . . . 0.0 112.129 -168.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.41 -9.81 57.4 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -175.232 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -64.75 -18.73 64.38 Favored Glycine 0 CA--C 1.536 1.404 0 CA-C-N 119.407 1.003 . . . . 0.0 112.295 169.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 91.7 mt -64.44 130.29 43.17 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.809 1.304 . . . . 0.0 109.237 175.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -93.7 -33.44 13.64 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.472 0.709 . . . . 0.0 109.386 168.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -149.87 165.78 31.53 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 126.717 2.007 . . . . 0.0 107.638 177.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -55.67 -26.79 46.54 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 121.717 -0.614 . . . . 0.0 112.108 172.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -90.55 -19.3 23.92 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.891 1.276 . . . . 0.0 114.216 -179.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 24.0 p80 -156.74 147.34 21.56 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 120.481 1.491 . . . . 0.0 114.311 -176.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -82.72 151.17 26.31 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 126.215 1.806 . . . . 0.0 108.607 168.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 5.8 p -69.19 -16.96 21.33 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 122.856 0.462 . . . . 0.0 111.612 179.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -157.45 174.06 34.91 Favored Glycine 0 C--N 1.339 0.742 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 178.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -67.08 105.63 1.73 Allowed 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 123.542 0.737 . . . . 0.0 109.219 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -82.66 131.07 35.21 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 168.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 41.5 pt -63.52 -17.44 20.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -173.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -135.27 163.69 29.42 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.985 1.314 . . . . 0.0 110.651 -174.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -133.96 -14.73 2.37 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.402 1.881 . . . . 0.0 111.906 173.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -154.06 105.04 2.69 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 121.012 1.733 . . . . 0.0 112.332 -169.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 13.9 tpt180 45.95 72.56 0.21 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.721 2.009 . . . . 0.0 113.192 169.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 67.08 148.07 0.11 Allowed Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 127.83 2.452 . . . . 0.0 113.024 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -60.15 130.15 33.09 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 122.598 2.199 . . . . 0.0 114.535 -167.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -154.17 154.04 32.85 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 127.126 2.171 . . . . 0.0 105.24 167.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 47.5 mt 57.19 30.11 17.81 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 119.284 0.947 . . . . 0.0 112.002 -172.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 87.4 m -59.42 -51.35 70.26 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 125.159 1.384 . . . . 0.0 111.118 -176.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -67.53 -31.92 72.35 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 119.398 -0.334 . . . . 0.0 111.01 -169.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 24.8 mp0 -60.81 -43.72 97.83 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.513 1.125 . . . . 0.0 109.813 174.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 68.4 mtt85 -62.8 -42.69 99.82 Favored 'General case' 0 N--CA 1.466 0.347 0 O-C-N 121.573 -0.705 . . . . 0.0 110.506 175.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 58.1 t -66.64 -37.88 80.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-O 118.753 -0.641 . . . . 0.0 109.494 -179.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -62.03 -51.04 69.59 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 120.215 1.37 . . . . 0.0 110.012 175.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 61.1 mttm -58.51 -42.63 88.14 Favored 'General case' 0 CA--C 1.529 0.153 0 O-C-N 122.119 -0.363 . . . . 0.0 110.43 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 58.0 t90 -67.85 -47.51 68.77 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 118.131 0.423 . . . . 0.0 110.641 -177.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 50.9 t -60.64 -37.91 76.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 118.365 0.53 . . . . 0.0 110.104 -178.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 56.0 mttm -64.99 -46.8 79.92 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 121.637 -0.665 . . . . 0.0 109.275 176.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 6.1 mm-40 -59.86 -46.95 87.66 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 118.695 0.679 . . . . 0.0 111.819 179.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 18.5 pt -68.74 -32.11 53.57 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.19 0 CA-C-N 119.329 0.968 . . . . 0.0 110.212 -178.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 36.0 m -61.69 -32.16 72.34 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 119.033 0.833 . . . . 0.0 110.927 172.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -72.12 -44.42 63.2 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.442 1.019 . . . . 0.0 110.192 174.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -66.75 -35.62 80.52 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.168 0.587 . . . . 0.0 111.466 -178.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 86.3 mt -84.28 -3.12 58.03 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.533 1.533 . . . . 0.0 111.452 178.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 54.53 28.24 9.48 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.837 1.655 . . . . 0.0 112.811 -173.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 85.8 mt -78.47 -26.31 46.07 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 123.233 0.613 . . . . 0.0 109.846 170.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -59.04 -39.12 81.01 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 122.901 0.481 . . . . 0.0 110.319 176.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -61.55 -23.51 66.02 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.625 0.77 . . . . 0.0 111.934 177.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 43.4 mt -89.32 -52.7 10.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 124.308 1.043 . . . . 0.0 108.217 -179.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 3.0 pp -76.89 -22.47 53.38 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -170.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -74.8 -26.67 59.9 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 118.642 0.655 . . . . 0.0 112.016 179.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.189 0 C-N-CA 124.196 0.998 . . . . 0.0 110.335 -177.885 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.3 mtt . . . . . 0 N--CA 1.488 1.468 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -60.61 146.73 44.28 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.562 0.745 . . . . 0.0 111.487 -177.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.1 pt -113.45 -18.24 7.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 126.317 1.847 . . . . 0.0 111.045 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 40.9 m -109.92 124.29 51.11 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.565 1.546 . . . . 0.0 108.845 178.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -99.43 120.24 6.79 Favored Glycine 0 CA--C 1.522 0.469 0 N-CA-C 108.437 -1.865 . . . . 0.0 108.437 169.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 55.1 mt -97.67 94.21 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 104.773 -2.306 . . . . 0.0 104.773 177.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -97.1 108.53 21.29 Favored 'General case' 0 CA--C 1.52 -0.177 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 178.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -128.25 118.45 23.31 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 118.961 0.8 . . . . 0.0 109.755 -168.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -83.8 132.98 11.46 Favored Glycine 0 C--N 1.338 0.688 0 N-CA-C 110.376 -1.089 . . . . 0.0 110.376 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.1 m -137.78 161.22 37.14 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.292 1.437 . . . . 0.0 107.959 174.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -136.13 -50.92 0.7 Allowed 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.088 0.555 . . . . 0.0 110.008 169.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -81.74 -6.4 59.01 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.424 0.689 . . . . 0.0 111.778 170.484 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.33 11.65 51.13 Favored Glycine 0 C--N 1.345 1.034 0 C-N-CA 124.615 1.102 . . . . 0.0 115.138 167.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -73.47 -46.22 49.48 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 119.324 1.562 . . . . 0.0 111.822 -177.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.76 -39.08 93.02 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 118.8 0.727 . . . . 0.0 110.601 -168.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -64.13 -27.58 69.18 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.232 -0.918 . . . . 0.0 112.096 -178.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -66.72 -37.04 83.87 Favored 'General case' 0 N--CA 1.465 0.276 0 O-C-N 121.49 -0.756 . . . . 0.0 109.984 174.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.3 mm -67.61 -43.26 87.06 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.153 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 174.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.39 -38.5 71.57 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.912 0.778 . . . . 0.0 111.059 -179.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 68.6 mttt -67.19 -42.34 84.34 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 122.955 0.502 . . . . 0.0 110.833 175.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 77.3 mtm -67.15 -29.78 69.58 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 119.281 0.946 . . . . 0.0 111.883 177.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 70.6 mt -68.73 -53.92 24.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 173.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -59.33 -37.9 78.96 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.765 -0.584 . . . . 0.0 111.193 -176.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -63.44 -39.18 93.8 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 119.116 0.871 . . . . 0.0 110.952 -179.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -71.97 -41.62 67.5 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 122.697 0.399 . . . . 0.0 110.978 177.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.9 mp -73.82 -33.44 64.17 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 118.096 0.407 . . . . 0.0 111.174 -176.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.16 143.34 12.88 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 125.26 1.409 . . . . 0.0 110.58 -171.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -65.37 -29.0 69.67 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.735 -0.862 . . . . 0.0 111.794 -174.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -77.47 -7.57 56.4 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 122.942 0.497 . . . . 0.0 112.006 177.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.0 t -108.04 -41.03 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 C-N-CA 124.421 1.088 . . . . 0.0 109.569 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -132.82 147.53 52.31 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 119.512 1.051 . . . . 0.0 112.144 -175.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.3 t0 -132.71 151.31 52.01 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.515 0.726 . . . . 0.0 110.773 173.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 97.5 t -106.9 137.48 37.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 C-N-CA 124.87 1.268 . . . . 0.0 109.648 -169.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -145.11 164.78 30.22 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.615 1.566 . . . . 0.0 110.598 -171.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -131.02 134.38 46.63 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 175.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.3 tp -65.72 -26.36 38.69 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-O 118.514 -0.755 . . . . 0.0 113.003 -168.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.99 -29.58 68.64 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 119.287 0.949 . . . . 0.0 110.479 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -84.22 -28.75 27.06 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.417 0.687 . . . . 0.0 111.325 175.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.4 m -77.32 168.4 20.09 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.137 0.975 . . . . 0.0 111.621 -169.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.3 m -131.3 159.67 37.19 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.887 1.275 . . . . 0.0 110.138 -174.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -53.25 -47.58 68.94 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.676 1.19 . . . . 0.0 111.811 -175.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -80.81 -13.42 58.97 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 122.245 -0.284 . . . . 0.0 111.63 -174.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -76.68 -31.16 57.08 Favored 'General case' 0 C--O 1.234 0.267 0 O-C-N 121.534 -0.729 . . . . 0.0 111.566 -172.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.9 mp -66.22 -35.69 81.08 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 175.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -68.83 -13.43 62.41 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.348 0.659 . . . . 0.0 112.38 -174.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.15 -29.12 68.73 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.531 0.732 . . . . 0.0 111.484 174.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -94.22 147.61 23.01 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.162 0.985 . . . . 0.0 110.381 -177.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -91.38 -33.65 15.18 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.895 173.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.2 mp -107.82 134.52 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 176.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 96.8 mt -122.07 124.36 43.76 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 174.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.3 mp -105.79 110.08 22.25 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 104.956 -2.239 . . . . 0.0 104.956 169.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 73.9 mt -109.55 111.15 22.48 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 -173.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -96.25 123.31 7.66 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 -179.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 2.1 tp -137.12 100.87 9.45 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 125.067 1.347 . . . . 0.0 109.32 -171.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.25 142.52 30.51 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.204 1.936 . . . . 0.0 109.091 168.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 59.1 m -91.84 136.84 32.85 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 177.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 24.5 m95 -135.51 168.17 19.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 120.58 1.536 . . . . 0.0 112.605 -169.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 58.66 -61.69 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 130.707 3.603 . . . . 0.0 116.32 169.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -150.98 30.08 0.64 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.448 1.899 . . . . 0.0 110.44 -169.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 73.23 48.39 19.58 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 -171.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -123.98 175.75 6.76 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.58 1.552 . . . . 0.0 108.43 177.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -79.24 158.35 27.62 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.138 -0.976 . . . . 0.0 109.54 169.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -58.95 138.11 57.58 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 172.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 99.5 m -55.78 -40.21 72.34 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -167.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -73.73 -27.1 61.01 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.366 0.667 . . . . 0.0 111.705 -177.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -77.79 -44.49 27.38 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.172 0.989 . . . . 0.0 109.541 174.194 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -58.65 -42.12 87.63 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.399 1.079 . . . . 0.0 111.06 176.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -61.8 -22.29 65.32 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.16 0.984 . . . . 0.0 112.2 177.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -90.85 -17.12 27.06 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 118.348 -0.834 . . . . 0.0 112.067 178.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 21.2 m-30 -54.98 -40.66 85.83 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-O 116.445 -1.741 . . . . 0.0 114.408 179.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -63.49 -20.27 69.43 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 CA-C-N 122.912 2.076 . . . . 0.0 113.24 173.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.4 m -82.44 -45.16 15.13 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.262 0.937 . . . . 0.0 109.14 170.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 12.9 tp -56.22 -40.16 73.63 Favored 'General case' 0 C--N 1.342 0.241 0 C-N-CA 125.077 1.351 . . . . 0.0 110.523 -175.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -72.39 -1.02 14.02 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -178.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -104.94 -12.0 16.42 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 119.647 1.112 . . . . 0.0 112.124 172.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 80.8 mt -78.23 142.04 14.67 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 -179.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -82.63 130.05 35.05 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 178.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -122.06 13.01 10.46 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 118.682 -0.675 . . . . 0.0 111.849 173.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -62.3 115.79 4.48 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-N 120.035 1.289 . . . . 0.0 108.754 -176.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 74.69 -0.72 55.7 Favored Glycine 0 CA--C 1.535 1.296 0 CA-C-O 118.459 -1.189 . . . . 0.0 114.095 -179.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -69.33 146.47 52.15 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 119.738 1.769 . . . . 0.0 107.288 169.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -90.03 137.34 32.42 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 170.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.0 t -131.97 142.35 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 177.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -131.27 141.45 49.98 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 170.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 73.3 mt -110.66 149.98 29.67 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -176.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -141.53 147.49 37.84 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 -179.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -164.96 137.58 4.79 Favored Glycine 0 CA--C 1.522 0.5 0 CA-C-N 119.216 0.916 . . . . 0.0 110.936 169.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 4.5 p -95.11 152.81 18.02 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 168.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -145.33 -158.36 7.63 Favored Glycine 0 CA--C 1.525 0.702 0 CA-C-O 121.048 0.249 . . . . 0.0 113.019 -173.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -146.9 145.38 29.8 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 127.504 2.322 . . . . 0.0 107.85 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -133.14 12.39 4.24 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.37 1.468 . . . . 0.0 109.931 177.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -81.9 -47.05 13.24 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 177.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -126.72 -33.2 2.53 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 123.949 0.9 . . . . 0.0 111.126 -175.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -91.33 33.89 0.97 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.211 1.004 . . . . 0.0 111.421 176.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.45 -20.02 62.65 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.278 1.431 . . . . 0.0 113.116 -178.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -97.62 6.6 47.79 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.912 0.885 . . . . 0.0 111.948 176.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -138.53 24.47 2.67 Favored 'General case' 0 C--O 1.237 0.411 0 O-C-N 120.854 -1.154 . . . . 0.0 110.858 -174.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -65.97 118.57 9.95 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -169.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 86.3 m 48.28 35.23 5.3 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.648 1.979 . . . . 0.0 113.636 -175.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -53.38 -41.17 65.62 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.364 0.666 . . . . 0.0 112.342 -178.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.99 -12.06 60.06 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -170.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 53.9 mt -56.22 -42.21 76.88 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 118.719 0.691 . . . . 0.0 109.647 169.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -65.0 -30.66 78.6 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.811 -0.515 . . . . 0.0 111.811 -178.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 4.3 m -64.93 -40.13 94.57 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 117.985 0.893 . . . . 0.0 110.098 179.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.7 mt -73.86 -39.85 52.43 Favored 'Isoleucine or valine' 0 C--N 1.344 0.363 0 CA-C-N 118.908 0.777 . . . . 0.0 109.271 176.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 57.7 ttt-85 -52.67 -46.64 67.29 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 119.583 1.083 . . . . 0.0 110.331 177.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -64.73 -21.59 66.79 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.596 0.758 . . . . 0.0 112.455 -176.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 95.8 mt -87.98 -46.01 15.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 123.454 0.702 . . . . 0.0 109.474 175.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 7.0 pt -77.79 -28.69 15.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-N 118.926 0.785 . . . . 0.0 112.045 -169.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -62.12 -56.86 27.35 Favored Pre-proline 0 CA--C 1.544 0.724 0 CA-C-O 117.568 -1.206 . . . . 0.0 112.167 179.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -66.23 -24.06 51.53 Favored 'Trans proline' 0 C--N 1.353 0.781 0 CA-C-N 121.96 1.736 . . . . 0.0 112.208 -179.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 79.5 mmt-85 -78.28 5.11 11.08 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.856 0.862 . . . . 0.0 112.774 172.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 77.22 20.92 74.52 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-N 119.604 1.093 . . . . 0.0 113.993 169.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.9 148.91 48.31 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 118.56 1.18 . . . . 0.0 110.589 170.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 60.2 m -97.47 124.36 41.65 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 105.01 -2.218 . . . . 0.0 105.01 167.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 48.9 mt -98.43 134.13 38.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 -175.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 29.1 m -133.14 176.63 8.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 125.582 1.553 . . . . 0.0 108.854 172.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 78.04 23.38 66.45 Favored Glycine 0 CA--C 1.529 0.926 0 CA-C-O 119.065 -0.853 . . . . 0.0 113.906 175.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 15.4 p-80 -60.3 140.85 56.87 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 118.327 1.063 . . . . 0.0 108.809 168.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 75.4 t-105 -131.19 136.48 28.84 Favored Pre-proline 0 CA--C 1.536 0.43 0 C-N-CA 124.26 1.024 . . . . 0.0 110.244 -168.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -70.36 152.3 66.13 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.466 2.111 . . . . 0.0 111.912 -176.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 22.2 p -70.82 -22.07 62.38 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.867 0.867 . . . . 0.0 112.613 174.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 53.09 38.7 28.07 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.628 1.571 . . . . 0.0 111.851 -171.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 68.77 50.36 36.49 Favored Glycine 0 C--N 1.341 0.852 0 N-CA-C 111.543 -0.623 . . . . 0.0 111.543 176.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -57.14 149.27 19.9 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 117.317 0.558 . . . . 0.0 110.942 178.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 36.1 t60 -139.63 60.49 1.57 Allowed 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.156 0.982 . . . . 0.0 109.28 -175.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -129.89 176.05 8.36 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.191 1.396 . . . . 0.0 108.942 177.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -61.59 -47.75 84.06 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 118.577 -0.725 . . . . 0.0 111.978 -168.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -163.31 133.93 4.56 Favored 'General case' 0 C--N 1.34 0.192 0 CA-C-N 119.018 0.826 . . . . 0.0 112.11 172.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 58.2 m -97.31 126.73 42.72 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 166.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -115.88 -4.96 12.04 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 -171.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -83.04 8.59 62.88 Favored Glycine 0 CA--C 1.535 1.324 0 CA-C-N 118.619 0.645 . . . . 0.0 112.775 168.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 74.9 mt -62.29 138.77 58.49 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.564 1.145 . . . . 0.0 111.204 -179.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -104.56 -26.22 12.44 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.629 1.572 . . . . 0.0 109.792 168.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -143.66 165.71 26.88 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.01 1.724 . . . . 0.0 107.219 172.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -53.61 -27.2 25.54 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.197 1.399 . . . . 0.0 114.186 -169.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -123.49 9.98 9.1 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.781 1.232 . . . . 0.0 113.58 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -137.91 130.39 29.4 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 119.788 1.176 . . . . 0.0 111.143 -172.187 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -81.39 151.44 27.93 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 124.935 1.294 . . . . 0.0 110.165 173.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 14.5 p -61.89 -29.89 47.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 123.0 0.52 . . . . 0.0 111.528 175.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -141.28 -176.36 15.57 Favored Glycine 0 CA--C 1.521 0.445 0 C-N-CA 125.305 1.431 . . . . 0.0 109.606 -175.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -60.9 125.99 25.75 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 169.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -123.3 125.21 44.62 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 171.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 20.9 tt -136.38 122.83 30.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 113.769 1.026 . . . . 0.0 113.769 -171.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -174.11 154.82 2.34 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 127.9 2.48 . . . . 0.0 106.687 167.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -137.65 106.78 6.02 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 168.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 30.8 t70 64.85 -33.38 0.15 Allowed 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 128.895 2.878 . . . . 0.0 116.901 174.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 3.2 tpm_? -149.26 -63.3 0.23 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 119.668 1.122 . . . . 0.0 110.708 -176.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -144.97 148.42 38.63 Favored Pre-proline 0 C--O 1.239 0.504 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 170.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -67.04 149.81 82.56 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.163 1.909 . . . . 0.0 111.495 -177.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -134.41 -26.33 1.44 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.95 1.3 . . . . 0.0 111.57 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 74.3 mt -92.34 33.43 1.1 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.976 1.31 . . . . 0.0 108.873 169.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 97.1 m -51.09 -53.44 34.12 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 126.988 2.115 . . . . 0.0 111.85 -174.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.59 -43.86 95.71 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 119.083 -0.484 . . . . 0.0 111.884 -166.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -67.12 -36.1 81.2 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 118.794 0.725 . . . . 0.0 111.091 -177.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 77.3 mtt85 -67.12 -47.55 70.79 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 118.825 0.738 . . . . 0.0 109.883 -179.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 16.8 m -72.41 -31.67 39.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-O 118.77 -0.633 . . . . 0.0 110.481 -176.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -63.35 -49.63 73.12 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 119.659 1.118 . . . . 0.0 109.948 171.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -58.61 -42.26 87.76 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 118.477 0.58 . . . . 0.0 109.972 178.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 66.8 t90 -64.32 -46.77 82.09 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 118.822 0.737 . . . . 0.0 110.589 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 28.5 t -56.89 -42.71 78.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 118.24 0.473 . . . . 0.0 109.863 176.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 54.7 mttm -69.01 -38.32 79.16 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 118.567 -0.73 . . . . 0.0 109.825 -176.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 19.1 mm100 -59.89 -55.45 34.04 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 118.611 0.641 . . . . 0.0 110.304 172.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 16.1 pt -65.32 -30.53 50.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 118.924 0.784 . . . . 0.0 110.642 -174.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 50.8 m -61.82 -25.74 67.69 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.747 0.703 . . . . 0.0 111.692 177.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -89.33 -28.88 19.54 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 119.599 1.091 . . . . 0.0 111.023 176.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -72.19 -37.82 69.21 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 118.663 0.665 . . . . 0.0 110.67 175.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 76.8 mt -90.83 -9.32 46.84 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.186 1.794 . . . . 0.0 111.848 -177.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 55.57 29.44 13.48 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.534 1.534 . . . . 0.0 112.759 -170.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 86.5 mt -72.08 -20.13 61.7 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.349 -0.845 . . . . 0.0 110.286 169.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -59.88 -35.24 74.39 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.952 0.796 . . . . 0.0 110.238 176.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -66.4 -11.25 50.58 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 121.404 -0.81 . . . . 0.0 112.347 177.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 22.1 mt -104.65 -55.34 5.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 125.252 1.421 . . . . 0.0 108.374 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 3.0 pp -78.88 -21.92 46.76 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.075 0.55 . . . . 0.0 112.473 -172.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -124.62 39.3 4.01 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 127.059 2.144 . . . . 0.0 108.776 -179.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.318 0 C-N-CA 123.606 0.762 . . . . 0.0 109.453 173.765 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.1 ttt . . . . . 0 N--CA 1.488 1.459 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -58.85 142.44 50.5 Favored 'General case' 0 C--N 1.344 0.33 0 C-N-CA 123.325 0.65 . . . . 0.0 111.408 -178.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.1 pt -109.89 -15.96 9.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 125.363 1.465 . . . . 0.0 111.3 178.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 28.9 m -111.77 123.69 50.77 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.201 1.4 . . . . 0.0 108.317 177.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -96.49 119.29 6.26 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 107.434 -2.267 . . . . 0.0 107.434 169.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 56.8 mt -98.07 91.88 2.64 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 105.23 -2.137 . . . . 0.0 105.23 176.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -88.48 129.08 35.53 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 178.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -128.54 133.48 48.41 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 120.011 1.278 . . . . 0.0 111.88 179.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -89.92 145.24 18.12 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 169.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 9.3 m -164.23 158.34 18.85 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.679 1.24 . . . . 0.0 109.743 172.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -125.18 -51.13 1.66 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.614 0.765 . . . . 0.0 109.432 168.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.2 p -86.35 8.11 22.84 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.097 1.359 . . . . 0.0 112.976 173.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 84.19 -9.02 64.99 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 116.963 1.545 . . . . 0.0 116.963 168.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -60.78 -37.45 81.92 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 120.23 2.015 . . . . 0.0 113.825 -169.457 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.7 m -73.55 -15.09 61.3 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 120.01 1.277 . . . . 0.0 110.799 -175.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -60.19 -41.95 94.04 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 119.643 1.111 . . . . 0.0 109.676 172.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -63.04 -41.29 99.46 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -178.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 25.7 mm -64.8 -45.06 96.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 177.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.88 -40.25 88.09 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.589 0.631 . . . . 0.0 111.04 178.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.2 mtpt -67.47 -42.09 83.56 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 118.022 -0.99 . . . . 0.0 110.72 177.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 63.4 mtt -55.66 -47.62 76.4 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 119.851 1.205 . . . . 0.0 109.721 175.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 62.1 mt -60.37 -52.69 58.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -179.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -61.79 -38.64 88.81 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.958 0.799 . . . . 0.0 111.212 -175.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -65.02 -35.86 82.53 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 118.908 0.776 . . . . 0.0 111.023 -179.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -70.64 -49.38 48.13 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.322 0.51 . . . . 0.0 110.838 175.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 54.5 mt -67.8 -32.6 73.27 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.329 0.513 . . . . 0.0 111.783 -177.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.0 145.09 14.79 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 125.407 1.48 . . . . 0.0 110.792 -173.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 22.8 ptmt -63.72 -29.53 70.74 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 121.728 -0.866 . . . . 0.0 113.184 -172.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -77.68 -11.49 59.88 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.591 179.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 22.4 t -103.57 -39.33 5.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 C-N-CA 124.283 1.033 . . . . 0.0 109.711 177.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -133.24 146.55 51.56 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 119.234 0.924 . . . . 0.0 111.94 -176.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -130.71 139.58 50.3 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.104 0.962 . . . . 0.0 109.853 175.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 98.3 t -90.4 139.27 17.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 123.655 0.782 . . . . 0.0 109.15 -177.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -148.27 172.95 13.54 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.925 1.29 . . . . 0.0 111.133 -168.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -143.79 125.63 15.2 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 125.856 1.662 . . . . 0.0 108.629 -172.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.4 tp -62.35 -28.43 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-O 118.855 -0.593 . . . . 0.0 111.723 -172.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.09 -27.89 69.7 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 118.77 0.714 . . . . 0.0 111.537 -175.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 61.9 pttt -105.45 -3.95 21.93 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.627 1.171 . . . . 0.0 112.359 176.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 50.9 m -79.25 166.85 21.71 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.398 0.679 . . . . 0.0 110.953 -179.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.4 m -134.43 163.58 29.36 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.189 1.396 . . . . 0.0 109.021 179.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 53.5 tttm -52.81 -57.25 10.8 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.024 0.93 . . . . 0.0 110.985 -174.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -75.34 -16.07 60.43 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 122.354 0.262 . . . . 0.0 111.329 -173.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -74.31 -29.29 61.56 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 122.889 0.476 . . . . 0.0 110.928 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.8 mp -71.43 -41.98 68.81 Favored 'General case' 0 C--N 1.344 0.336 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 168.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.3 -15.73 63.46 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.234 0.614 . . . . 0.0 112.264 -174.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.88 -30.06 70.12 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.324 1.05 . . . . 0.0 112.277 174.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -84.58 155.22 22.16 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 123.845 0.858 . . . . 0.0 110.059 178.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -102.45 -26.73 13.15 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.236 0.614 . . . . 0.0 111.129 169.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.9 mp -113.74 123.43 69.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 174.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -109.85 123.14 49.05 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 173.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.1 mp -109.2 120.68 43.24 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 105.43 -2.063 . . . . 0.0 105.43 169.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 59.6 mt -118.38 109.42 16.25 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 -173.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -90.05 121.24 6.09 Favored Glycine 0 N--CA 1.451 -0.323 0 N-CA-C 108.568 -1.813 . . . . 0.0 108.568 176.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 3.0 tp -141.65 103.84 5.88 Favored Pre-proline 0 CA--C 1.541 0.611 0 CA-C-N 117.741 0.771 . . . . 0.0 110.039 -169.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -76.47 147.14 28.31 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.463 2.109 . . . . 0.0 109.564 169.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 33.5 m -95.5 140.93 29.65 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 177.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 38.7 m95 -134.16 171.29 14.43 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 125.208 1.403 . . . . 0.0 111.24 -170.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 51.85 -87.59 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 127.8 2.44 . . . . 0.0 113.114 178.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -150.0 78.23 1.34 Allowed 'General case' 0 C--O 1.234 0.289 0 C-N-CA 126.682 1.993 . . . . 0.0 106.813 179.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 70.99 19.6 77.21 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 123.68 0.657 . . . . 0.0 113.337 179.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -93.12 161.33 14.47 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.582 1.153 . . . . 0.0 109.357 -176.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -79.31 159.41 27.22 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 167.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -58.18 143.88 42.59 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 168.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 60.4 m -51.74 -38.89 57.23 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.566 1.146 . . . . 0.0 113.645 -169.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -70.78 -35.63 72.66 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 118.548 0.613 . . . . 0.0 110.694 -175.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -71.5 -45.51 62.29 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 175.018 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -57.92 -41.29 82.36 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 122.738 0.415 . . . . 0.0 111.379 179.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -68.2 -25.53 65.27 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.729 0.812 . . . . 0.0 112.268 177.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -92.69 -18.65 22.72 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.55 0.74 . . . . 0.0 112.506 -178.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 19.4 m-30 -50.73 -40.61 64.46 Favored Pre-proline 0 CA--C 1.545 0.78 0 CA-C-O 116.469 -1.729 . . . . 0.0 114.633 178.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -63.2 -20.86 71.8 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 CA-C-N 123.033 2.119 . . . . 0.0 113.912 173.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.2 m -85.7 -39.05 17.64 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 119.381 0.991 . . . . 0.0 109.441 169.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 13.6 tp -58.24 -38.05 76.11 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.031 0.932 . . . . 0.0 110.697 -177.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -72.51 -3.98 27.72 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 179.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -103.13 -12.46 17.35 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.134 0.879 . . . . 0.0 111.357 173.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 79.4 mt -77.23 138.39 20.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -176.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -78.18 124.23 27.83 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.592 176.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -122.06 11.03 10.18 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.769 0.827 . . . . 0.0 111.6 172.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -63.08 114.09 3.51 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 120.012 1.278 . . . . 0.0 109.143 -171.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.17 3.65 61.54 Favored Glycine 0 CA--C 1.536 1.392 0 CA-C-O 118.546 -1.141 . . . . 0.0 113.866 -178.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -75.21 152.03 38.4 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 119.544 1.672 . . . . 0.0 108.182 170.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 20.8 mt -91.6 136.59 33.02 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 175.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 18.5 t -133.81 141.69 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -134.32 143.26 47.6 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 171.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 64.7 mt -111.86 144.42 41.2 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -177.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -140.53 154.46 46.55 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 170.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -173.54 155.66 22.65 Favored Glycine 0 N--CA 1.449 -0.476 0 CA-C-O 122.416 1.009 . . . . 0.0 112.705 176.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 64.1 m -101.96 149.87 23.78 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 169.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -145.51 -159.32 8.08 Favored Glycine 0 CA--C 1.521 0.409 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 176.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -144.79 139.51 27.85 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 124.968 1.307 . . . . 0.0 108.546 170.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -109.09 -14.7 14.48 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 123.962 0.905 . . . . 0.0 111.419 177.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -75.11 -43.62 51.79 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 119.843 1.201 . . . . 0.0 110.796 -170.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -112.87 -40.22 4.05 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 123.495 0.718 . . . . 0.0 110.755 179.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -83.89 37.86 0.62 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.533 0.733 . . . . 0.0 111.018 176.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.06 -23.64 63.92 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 126.805 2.042 . . . . 0.0 114.019 -170.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -99.34 0.26 42.52 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.321 1.448 . . . . 0.0 111.918 -179.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -131.98 16.99 4.65 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.258 1.023 . . . . 0.0 111.925 -169.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -65.15 125.88 26.35 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 121.247 -0.908 . . . . 0.0 110.27 -169.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 88.1 m 53.24 29.45 8.48 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.842 1.657 . . . . 0.0 114.349 176.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -61.43 -31.51 71.46 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.755 0.822 . . . . 0.0 111.339 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.56 -33.58 76.25 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 120.754 -1.216 . . . . 0.0 111.687 179.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 7.5 mp -63.29 -43.89 96.6 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-N 119.691 1.132 . . . . 0.0 109.633 175.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.71 -31.99 82.01 Favored Glycine 0 CA--C 1.532 1.114 0 N-CA-C 111.337 -0.705 . . . . 0.0 111.337 174.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 14.7 m -66.56 -41.42 88.65 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 117.76 0.78 . . . . 0.0 110.113 176.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 5.4 mt -65.75 -43.83 93.38 Favored 'Isoleucine or valine' 0 C--N 1.345 0.401 0 CA-C-N 119.425 1.012 . . . . 0.0 109.509 173.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 41.3 ttt180 -52.32 -45.93 65.81 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 119.381 0.991 . . . . 0.0 110.435 -178.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -62.0 -17.98 58.96 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.96 0.904 . . . . 0.0 113.035 -178.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 82.8 mt -95.4 -54.72 6.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 124.397 1.079 . . . . 0.0 109.216 175.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 23.2 pt -71.56 -33.46 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 O-C-N 121.251 -0.906 . . . . 0.0 112.195 -168.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -66.53 -50.37 47.22 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-O 117.694 -1.146 . . . . 0.0 111.486 -174.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -68.36 -24.67 36.83 Favored 'Trans proline' 0 C--N 1.354 0.836 0 CA-C-N 121.731 1.654 . . . . 0.0 112.769 174.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 7.7 mpt_? -74.76 6.76 3.63 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 119.42 1.009 . . . . 0.0 112.523 169.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 81.38 16.66 73.29 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-O 118.435 -1.203 . . . . 0.0 114.007 169.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.13 141.9 55.11 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 118.882 1.341 . . . . 0.0 109.998 170.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 88.1 m -93.13 119.34 32.24 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 104.641 -2.355 . . . . 0.0 104.641 167.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 33.6 mt -96.61 132.79 40.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 -173.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 29.9 m -129.44 172.62 15.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 C-N-CA 124.869 1.268 . . . . 0.0 109.033 175.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 77.35 27.74 59.09 Favored Glycine 0 CA--C 1.526 0.722 0 CA-C-O 119.105 -0.83 . . . . 0.0 113.542 177.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 28.9 p-80 -60.84 139.69 57.88 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 118.815 1.307 . . . . 0.0 108.678 168.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 75.6 t-105 -127.78 137.88 31.7 Favored Pre-proline 0 CA--C 1.533 0.321 0 C-N-CA 124.453 1.101 . . . . 0.0 108.245 -169.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -70.89 144.65 48.6 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 121.762 1.642 . . . . 0.0 112.347 -170.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 63.0 p -76.52 -31.14 57.48 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.471 0.708 . . . . 0.0 110.055 169.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 53.77 41.59 32.02 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.866 2.067 . . . . 0.0 110.846 -170.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 74.34 80.06 0.52 Allowed Glycine 0 CA--C 1.527 0.831 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -173.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -46.0 126.3 7.27 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.616 0.766 . . . . 0.0 109.936 172.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -94.21 -27.91 15.92 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -168.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -90.15 -170.09 2.65 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.573 0.749 . . . . 0.0 111.41 -168.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -66.56 -56.1 12.37 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -167.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -155.66 143.53 19.78 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-N 118.921 0.782 . . . . 0.0 110.873 176.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 2.4 p -123.77 138.47 54.5 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 124.513 1.125 . . . . 0.0 107.965 170.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.02 -4.77 20.12 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 122.875 0.47 . . . . 0.0 112.264 177.575 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -75.76 0.79 60.59 Favored Glycine 0 CA--C 1.535 1.295 0 CA-C-O 119.216 -0.769 . . . . 0.0 112.867 169.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 96.7 mt -64.32 139.19 58.74 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 119.468 1.634 . . . . 0.0 111.083 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -108.53 -31.07 7.93 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.456 1.503 . . . . 0.0 108.778 167.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -145.23 162.54 36.89 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 127.86 2.464 . . . . 0.0 106.181 169.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -55.65 -30.52 61.14 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 121.17 -0.956 . . . . 0.0 112.084 176.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -91.0 -9.41 46.06 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.241 1.016 . . . . 0.0 113.448 -179.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 58.7 m80 -147.36 130.94 16.81 Favored 'General case' 0 C--N 1.348 0.509 0 CA-C-N 119.93 1.241 . . . . 0.0 113.229 -171.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -76.22 155.58 34.31 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.008 0.923 . . . . 0.0 108.767 167.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 14.2 p -60.56 -32.19 50.85 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 124.144 0.978 . . . . 0.0 111.419 176.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -146.41 -177.25 20.9 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 124.905 1.241 . . . . 0.0 110.32 -172.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -62.55 123.39 18.21 Favored 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 171.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -135.05 109.93 8.72 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 -176.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 26.3 pt -122.23 141.23 43.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-O 121.807 0.813 . . . . 0.0 113.034 -172.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -162.23 -37.48 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 127.304 2.242 . . . . 0.0 108.395 168.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 59.2 tt0 65.31 -66.76 0.14 Allowed 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 128.224 2.61 . . . . 0.0 110.36 -177.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -169.98 99.11 0.29 Allowed 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 126.526 1.93 . . . . 0.0 107.104 169.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 16.4 tpp85 51.65 67.83 0.9 Allowed 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.143 1.377 . . . . 0.0 110.625 -176.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 71.39 139.02 0.06 OUTLIER Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 131.097 3.759 . . . . 0.0 111.665 178.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -77.07 162.15 32.01 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 121.341 1.361 . . . . 0.0 113.767 -167.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -110.09 -9.3 14.72 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.065 -0.97 . . . . 0.0 112.386 171.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 90.0 mt -121.56 39.44 3.85 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 125.79 1.636 . . . . 0.0 109.853 175.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 93.9 m -53.66 -58.21 8.02 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.424 1.09 . . . . 0.0 110.614 -175.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -68.91 -32.67 72.46 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 122.278 -0.264 . . . . 0.0 110.517 -169.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 25.3 mp0 -63.97 -48.47 76.33 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.234 1.014 . . . . 0.0 109.292 176.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 74.3 mtt85 -65.53 -37.18 86.0 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 118.912 0.778 . . . . 0.0 110.635 -179.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 96.3 t -64.41 -42.26 94.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-O 118.358 -0.829 . . . . 0.0 109.093 174.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -59.41 -48.71 80.59 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-N 119.832 1.196 . . . . 0.0 110.359 177.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -58.94 -44.62 91.44 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 118.088 0.403 . . . . 0.0 110.094 179.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 68.0 t90 -66.06 -44.44 84.52 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 118.363 0.529 . . . . 0.0 110.02 -175.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 79.1 t -62.77 -39.64 85.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -65.17 -38.67 91.27 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 121.389 -0.819 . . . . 0.0 110.138 178.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 43.4 mm-40 -64.35 -52.19 59.61 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 118.586 0.63 . . . . 0.0 110.964 176.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 21.0 pt -64.59 -31.72 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 119.568 1.077 . . . . 0.0 110.326 -178.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 65.6 m -60.79 -26.14 67.06 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 118.062 -0.97 . . . . 0.0 112.538 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -95.22 -10.39 30.54 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 120.117 1.326 . . . . 0.0 112.699 175.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -88.0 -39.5 14.62 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 118.981 0.809 . . . . 0.0 110.304 171.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 88.0 mt -84.51 -12.32 54.44 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.677 1.991 . . . . 0.0 111.421 178.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 30.4 m80 56.58 30.16 16.82 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.556 1.543 . . . . 0.0 112.885 -170.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 67.6 mt -72.35 -20.45 61.46 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.477 -0.764 . . . . 0.0 110.38 169.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -57.0 -38.08 72.58 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.842 0.747 . . . . 0.0 110.304 175.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -68.0 -10.23 51.89 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 121.596 -0.69 . . . . 0.0 112.419 178.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 28.7 mt -106.12 -54.18 6.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 C-N-CA 125.345 1.458 . . . . 0.0 108.567 -178.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.3 pp -78.77 -24.97 44.37 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.319 0.648 . . . . 0.0 112.145 -173.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -125.53 39.41 3.97 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.605 1.962 . . . . 0.0 108.915 -175.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.36 0 C-N-CA 123.632 0.773 . . . . 0.0 109.453 175.119 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.4 ttt . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 110.37 -0.233 . . . . 0.0 110.37 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -66.97 154.77 40.31 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.182 0.593 . . . . 0.0 110.536 177.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.7 pt -86.78 -23.9 6.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 122.269 0.228 . . . . 0.0 111.581 -178.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.9 m -112.01 130.15 55.96 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.825 1.25 . . . . 0.0 108.646 -178.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -103.95 116.35 5.35 Favored Glycine 0 CA--C 1.521 0.417 0 N-CA-C 108.241 -1.944 . . . . 0.0 108.241 169.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 74.6 mt -90.81 126.14 43.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 104.847 -2.279 . . . . 0.0 104.847 171.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -122.38 126.94 49.06 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 174.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -125.28 136.59 53.67 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 118.311 0.505 . . . . 0.0 111.027 178.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -85.93 136.86 14.63 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 108.632 -1.787 . . . . 0.0 108.632 168.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 22.6 m -157.35 158.12 35.39 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 119.395 1.598 . . . . 0.0 110.908 169.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -142.67 -42.79 0.32 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.878 1.271 . . . . 0.0 110.062 170.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.5 p -77.54 -13.28 59.95 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 122.977 0.511 . . . . 0.0 111.506 169.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 88.71 34.58 9.03 Favored Glycine 0 C--N 1.342 0.895 0 C-N-CA 124.079 0.847 . . . . 0.0 112.373 172.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -86.02 -54.12 4.67 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 117.493 0.647 . . . . 0.0 111.759 179.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.4 m -74.74 -16.62 60.73 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 118.511 -0.757 . . . . 0.0 112.21 -168.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -58.19 -35.97 72.41 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 119.605 1.093 . . . . 0.0 110.514 172.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -71.43 -40.85 70.14 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -179.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 34.4 mm -63.55 -43.5 98.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 177.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.03 -42.65 90.7 Favored 'General case' 0 CA--C 1.53 0.184 0 O-C-N 121.661 -0.65 . . . . 0.0 110.628 177.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -66.88 -39.77 87.59 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 118.434 -0.793 . . . . 0.0 111.087 176.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 63.0 mtt -61.77 -33.48 74.16 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 119.948 1.249 . . . . 0.0 111.499 176.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 26.1 mt -74.16 -49.55 32.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 175.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -59.78 -40.14 87.27 Favored 'General case' 0 C--O 1.225 -0.214 0 O-C-N 121.629 -0.669 . . . . 0.0 111.728 -176.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -63.57 -34.01 76.86 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 119.764 1.165 . . . . 0.0 111.171 -178.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -73.68 -41.29 62.85 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 122.722 0.409 . . . . 0.0 110.826 175.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.2 mp -74.75 -36.93 62.61 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 122.915 0.486 . . . . 0.0 111.25 -176.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.0 146.41 18.19 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 125.764 1.65 . . . . 0.0 110.85 -173.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 53.8 tptt -61.04 -31.66 71.3 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.565 1.146 . . . . 0.0 111.819 -175.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -68.0 -27.33 66.47 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.23 0.612 . . . . 0.0 111.192 178.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 39.0 t -96.89 -37.63 7.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 C-N-CA 124.248 1.019 . . . . 0.0 110.003 -175.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -135.55 137.17 41.75 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 119.252 0.933 . . . . 0.0 111.901 -174.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -119.08 158.34 26.05 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.861 0.864 . . . . 0.0 109.849 169.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 51.8 t -120.56 135.62 60.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 124.349 1.06 . . . . 0.0 110.543 -168.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -147.3 172.19 14.26 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.145 1.778 . . . . 0.0 111.456 -171.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -126.68 135.49 51.22 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 126.605 1.962 . . . . 0.0 106.364 170.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.0 tp -61.0 -18.54 18.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 123.759 0.824 . . . . 0.0 112.656 -172.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.99 -29.12 63.01 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 119.014 0.825 . . . . 0.0 111.304 178.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 45.7 mtmt -80.6 -24.15 39.33 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 122.922 0.489 . . . . 0.0 112.209 177.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 46.9 m -77.48 159.59 29.27 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.353 1.061 . . . . 0.0 113.337 -166.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.3 m -132.58 176.17 8.67 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 127.633 2.373 . . . . 0.0 106.632 169.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.5 tttm -50.11 -48.47 53.41 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.942 0.792 . . . . 0.0 111.96 -175.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -78.58 -11.95 59.99 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -173.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -69.96 -34.48 73.45 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.442 -0.786 . . . . 0.0 111.245 -176.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.3 mp -76.22 -35.25 59.12 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-O 119.103 -0.475 . . . . 0.0 110.832 172.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -64.25 -23.75 67.42 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 118.595 0.634 . . . . 0.0 112.175 -177.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.13 -28.87 69.73 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.78 0.832 . . . . 0.0 112.506 178.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -91.8 152.15 20.26 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 124.551 1.141 . . . . 0.0 109.68 176.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -109.92 -15.23 14.12 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.614 0.766 . . . . 0.0 111.8 174.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.4 mp -123.22 134.06 67.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 169.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 91.2 mt -124.3 147.88 47.83 Favored 'General case' 0 CA--C 1.518 -0.281 0 C-N-CA 123.651 0.781 . . . . 0.0 109.702 178.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.8 mt -130.99 107.46 9.11 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 177.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 76.2 mt -112.4 114.14 26.71 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -169.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -106.25 116.38 5.08 Favored Glycine 0 C--N 1.335 0.51 0 C-N-CA 125.475 1.512 . . . . 0.0 110.27 -177.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 16.1 tt -123.74 117.66 27.42 Favored Pre-proline 0 CA--C 1.541 0.609 0 CA-C-N 118.574 1.187 . . . . 0.0 111.749 -172.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -77.35 141.72 20.56 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 121.806 1.671 . . . . 0.0 109.288 168.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 35.3 m -91.03 142.72 27.47 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 172.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 51.0 m95 -132.96 172.66 12.32 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.948 2.099 . . . . 0.0 109.797 -175.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 33.92 53.61 0.51 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 128.918 2.887 . . . . 0.0 115.824 169.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 53.04 62.78 2.51 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.174 0.99 . . . . 0.0 111.28 176.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 87.43 52.12 3.11 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 123.713 0.673 . . . . 0.0 112.386 174.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -135.21 161.38 35.53 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.823 1.649 . . . . 0.0 108.628 171.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.12 165.57 21.47 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 168.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -67.01 147.77 52.79 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 169.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 57.9 m -53.28 -34.78 58.68 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.075 0.95 . . . . 0.0 112.741 -176.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -67.4 -44.26 79.29 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.156 0.582 . . . . 0.0 110.426 -176.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -71.4 -43.46 66.78 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.213 0.605 . . . . 0.0 109.474 176.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -60.21 -39.31 86.13 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.523 0.729 . . . . 0.0 111.737 -178.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -70.77 -24.7 62.65 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.955 0.902 . . . . 0.0 112.104 176.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -88.23 -23.59 23.5 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-O 118.326 -0.845 . . . . 0.0 112.156 178.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -51.11 -43.31 84.65 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-O 116.631 -1.652 . . . . 0.0 114.462 178.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -64.65 -15.39 49.8 Favored 'Trans proline' 0 CA--C 1.543 0.953 0 CA-C-N 122.8 2.036 . . . . 0.0 113.691 175.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.0 m -90.72 -38.84 12.79 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.783 1.233 . . . . 0.0 109.613 170.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 23.6 tp -57.84 -40.36 79.87 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 124.352 1.061 . . . . 0.0 109.946 -179.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -71.87 -7.05 46.13 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -86.15 -15.44 41.05 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 120.185 1.357 . . . . 0.0 110.412 173.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 65.1 mt -90.02 128.47 41.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 -174.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -87.5 139.54 30.44 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 168.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -126.38 20.52 7.36 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.492 1.117 . . . . 0.0 111.315 -175.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -50.55 -34.07 24.14 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 115.777 1.769 . . . . 0.0 115.777 -168.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -110.64 13.6 29.97 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-O 118.385 -1.231 . . . . 0.0 113.556 -178.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -112.33 146.97 37.34 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 119.602 1.701 . . . . 0.0 109.99 -169.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -95.83 141.88 28.75 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 176.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 16.4 t -134.76 143.04 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 173.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -124.61 145.46 49.61 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 169.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 88.9 mt -121.69 139.48 53.51 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -169.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -140.98 164.15 31.05 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 169.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -168.34 156.55 28.12 Favored Glycine 0 N--CA 1.443 -0.838 0 O-C-N 121.059 -1.026 . . . . 0.0 112.132 -178.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 33.5 m -122.32 152.65 39.9 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 -168.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -164.92 -153.38 7.47 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.501 -174.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -152.46 140.31 20.03 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.101 1.36 . . . . 0.0 110.331 -178.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -120.5 13.56 11.78 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.616 1.566 . . . . 0.0 110.816 -179.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -94.27 -43.78 8.27 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.344 1.057 . . . . 0.0 109.541 -178.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -127.82 -31.5 2.42 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.702 1.201 . . . . 0.0 111.789 177.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -90.04 24.8 2.33 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.522 0.729 . . . . 0.0 111.971 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.76 -19.34 64.9 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.212 1.405 . . . . 0.0 114.027 -170.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -99.49 7.71 45.15 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 119.527 1.058 . . . . 0.0 112.343 176.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -133.86 25.01 3.98 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 126.206 1.802 . . . . 0.0 109.494 176.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -65.84 122.56 17.59 Favored 'General case' 0 C--O 1.238 0.481 0 O-C-N 121.767 -0.583 . . . . 0.0 109.65 -168.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 93.5 m 50.61 33.85 8.75 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.669 1.588 . . . . 0.0 112.778 -177.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -52.48 -38.15 58.78 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 121.753 -0.592 . . . . 0.0 112.561 -177.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -73.12 -14.65 61.42 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -171.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -59.67 -39.3 84.02 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.158 -0.964 . . . . 0.0 111.281 -177.048 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -70.41 -23.02 77.81 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 123.239 0.447 . . . . 0.0 112.692 179.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.2 m -65.59 -29.86 70.52 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 118.28 1.04 . . . . 0.0 110.894 -177.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 6.4 mt -71.62 -48.81 50.27 Favored 'Isoleucine or valine' 0 C--N 1.345 0.372 0 CA-C-O 118.51 -0.757 . . . . 0.0 109.056 175.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 18.6 ttm-85 -53.03 -42.95 66.2 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 119.053 0.842 . . . . 0.0 109.806 178.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -59.18 -23.78 62.53 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -176.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 94.8 mt -95.2 -50.49 11.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 124.016 0.926 . . . . 0.0 109.84 175.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 20.0 pt -75.72 -24.48 16.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 119.194 0.906 . . . . 0.0 112.16 -168.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -67.93 -52.86 22.63 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-O 117.394 -1.288 . . . . 0.0 112.101 -179.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -65.77 -25.47 53.44 Favored 'Trans proline' 0 C--N 1.352 0.746 0 CA-C-N 122.137 1.799 . . . . 0.0 111.953 175.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 83.1 mmt-85 -75.82 5.31 6.51 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.03 0.932 . . . . 0.0 112.976 170.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 78.15 14.55 82.14 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-O 117.891 -1.505 . . . . 0.0 114.801 168.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.11 143.04 45.15 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 119.657 1.729 . . . . 0.0 109.19 171.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 69.7 m -88.7 125.91 35.07 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 104.419 -2.437 . . . . 0.0 104.419 167.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 21.5 mt -116.23 130.25 71.29 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 -169.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 29.8 m -130.36 175.28 11.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 124.403 1.081 . . . . 0.0 109.76 177.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 91.55 24.48 25.9 Favored Glycine 0 CA--C 1.528 0.888 0 CA-C-O 119.097 -0.835 . . . . 0.0 114.025 170.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 49.0 p-80 -60.96 150.66 32.69 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 119.262 1.531 . . . . 0.0 109.068 168.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 73.3 t-105 -136.62 133.62 19.15 Favored Pre-proline 0 CA--C 1.535 0.379 0 C-N-CA 123.697 0.799 . . . . 0.0 109.543 -169.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -69.76 146.37 59.99 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.385 2.057 . . . . 0.0 112.048 -176.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 68.4 p -74.57 -23.43 58.76 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.753 1.221 . . . . 0.0 111.814 174.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 52.73 41.87 31.61 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.673 1.589 . . . . 0.0 112.059 -171.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 68.17 52.06 29.65 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 176.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -58.91 151.55 21.52 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 122.83 0.452 . . . . 0.0 111.294 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 57.0 p-80 -119.85 0.79 10.92 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.55 1.14 . . . . 0.0 113.159 -171.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -76.21 169.97 17.2 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.326 0.65 . . . . 0.0 111.035 -177.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -57.18 -57.46 12.48 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.937 0.895 . . . . 0.0 112.602 -168.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -162.8 116.39 1.68 Allowed 'General case' 0 C--O 1.235 0.339 0 CA-C-N 118.779 0.718 . . . . 0.0 111.29 175.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 59.3 m -81.42 127.33 32.67 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 168.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -102.05 -9.85 20.22 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 122.968 0.507 . . . . 0.0 111.45 175.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -74.57 0.57 55.38 Favored Glycine 0 CA--C 1.535 1.285 0 CA-C-N 118.813 0.733 . . . . 0.0 113.207 169.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 77.6 mt -63.05 142.63 58.31 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 119.111 1.456 . . . . 0.0 112.17 177.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -107.01 -27.86 10.39 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 125.932 1.693 . . . . 0.0 109.647 167.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -144.16 159.11 43.21 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 127.251 2.22 . . . . 0.0 106.291 175.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -53.01 -29.55 29.98 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -179.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -101.38 -7.32 23.04 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -137.91 133.25 33.59 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 120.798 1.636 . . . . 0.0 113.035 -170.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -76.25 149.01 37.23 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.436 1.095 . . . . 0.0 108.898 167.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 6.2 p -68.91 -17.61 22.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 124.977 1.311 . . . . 0.0 111.719 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -154.54 178.81 31.11 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 108.172 -1.971 . . . . 0.0 108.172 178.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -66.61 109.62 2.88 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 118.282 1.041 . . . . 0.0 108.21 173.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -88.25 136.69 32.86 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 171.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 10.3 tp -133.72 119.82 34.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -175.63 155.39 1.74 Allowed 'General case' 0 C--O 1.237 0.428 0 C-N-CA 130.585 3.554 . . . . 0.0 105.0 166.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -127.15 -59.79 1.23 Allowed 'General case' 0 C--O 1.234 0.252 0 CA-C-N 119.654 1.116 . . . . 0.0 109.339 178.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -160.83 99.92 1.26 Allowed 'General case' 0 C--O 1.236 0.367 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 171.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 4.3 tpm_? 50.72 80.69 0.07 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.338 1.455 . . . . 0.0 109.997 -171.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 75.39 150.63 0.13 Allowed Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 127.057 2.143 . . . . 0.0 110.489 -168.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -74.94 155.86 43.25 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 122.649 2.232 . . . . 0.0 112.398 -177.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -132.24 -11.27 3.26 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.925 0.89 . . . . 0.0 112.968 172.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 68.6 mt -103.0 27.51 7.05 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.858 1.263 . . . . 0.0 108.959 170.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 8.6 m -49.94 -60.1 3.24 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 126.812 2.045 . . . . 0.0 112.339 -168.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -74.73 -35.37 62.65 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 118.951 -0.547 . . . . 0.0 111.28 -167.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -67.52 -41.11 84.93 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 118.565 0.621 . . . . 0.0 110.517 176.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 64.5 mtp180 -62.02 -41.3 97.93 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 119.32 0.964 . . . . 0.0 110.537 176.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 84.9 t -70.79 -33.78 53.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-O 118.52 -0.752 . . . . 0.0 110.388 179.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -65.03 -49.53 69.78 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 120.916 1.689 . . . . 0.0 109.378 175.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -59.28 -34.84 72.76 Favored 'General case' 0 C--N 1.339 0.136 0 CA-C-O 118.599 -0.715 . . . . 0.0 110.973 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 35.8 t90 -73.03 -52.5 14.15 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 119.007 0.821 . . . . 0.0 110.728 178.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 77.1 t -65.86 -31.9 55.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 O-C-N 121.4 -0.813 . . . . 0.0 110.831 -171.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 55.8 mttm -60.21 -35.53 75.63 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 121.49 -0.756 . . . . 0.0 110.889 174.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 21.8 mm100 -70.85 -50.22 37.63 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 118.59 0.632 . . . . 0.0 110.928 173.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 2.3 pt -63.13 -30.82 50.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 119.221 0.919 . . . . 0.0 110.533 -174.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 50.8 m -61.87 -32.35 72.7 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 119.06 -0.495 . . . . 0.0 111.203 179.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -79.89 -40.89 27.31 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 119.219 0.918 . . . . 0.0 109.837 176.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -66.42 -34.88 78.94 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.455 0.702 . . . . 0.0 111.444 -177.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 95.5 mt -92.24 -1.56 57.04 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.958 1.703 . . . . 0.0 111.552 179.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 30.5 m80 56.73 21.17 5.67 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.166 1.786 . . . . 0.0 113.595 -174.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 72.5 mt -73.13 -21.4 60.73 Favored 'General case' 0 N--CA 1.464 0.228 0 O-C-N 121.399 -0.813 . . . . 0.0 110.442 175.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -55.17 -39.67 69.81 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 123.839 0.856 . . . . 0.0 110.203 173.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -71.53 -6.99 44.71 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.685 -0.634 . . . . 0.0 112.357 -179.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 35.4 mt -105.21 -54.1 6.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 125.275 1.43 . . . . 0.0 108.547 179.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.6 pp -79.43 -23.66 43.03 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.69 0.796 . . . . 0.0 112.057 -173.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -129.13 44.26 3.0 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.697 1.999 . . . . 0.0 108.229 -176.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.248 0 C-N-CA 123.772 0.829 . . . . 0.0 109.657 175.239 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.0 tpt . . . . . 0 N--CA 1.487 1.41 0 N-CA-C 110.359 -0.238 . . . . 0.0 110.359 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -58.74 143.07 48.18 Favored 'General case' 0 C--N 1.344 0.357 0 C-N-CA 123.554 0.741 . . . . 0.0 111.133 179.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.9 pt -106.35 -16.16 8.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 125.239 1.415 . . . . 0.0 110.926 178.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 53.7 m -112.04 124.38 52.29 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.485 1.514 . . . . 0.0 108.426 177.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -98.44 121.64 7.24 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 108.748 -1.741 . . . . 0.0 108.748 169.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 61.9 mt -96.14 96.16 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 103.773 -2.677 . . . . 0.0 103.773 176.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -99.17 119.42 37.84 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -133.5 156.72 47.26 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 123.402 0.681 . . . . 0.0 109.276 -169.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -131.93 144.82 16.57 Favored Glycine 0 C--N 1.336 0.576 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 169.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.0 m -141.14 161.85 36.88 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.208 1.403 . . . . 0.0 108.811 177.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -126.54 -54.16 1.45 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.033 0.533 . . . . 0.0 110.254 171.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.13 -3.06 56.94 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.036 0.934 . . . . 0.0 111.614 170.412 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 93.4 7.65 61.81 Favored Glycine 0 C--N 1.342 0.875 0 C-N-CA 124.561 1.077 . . . . 0.0 113.254 169.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -71.07 -43.3 68.06 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 118.657 1.228 . . . . 0.0 111.377 -173.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -65.62 -37.76 87.52 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 118.801 0.728 . . . . 0.0 110.037 -172.334 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.3 tp10 -59.79 -35.95 75.71 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.475 1.11 . . . . 0.0 111.342 179.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -64.07 -38.16 90.06 Favored 'General case' 0 CA--C 1.53 0.203 0 O-C-N 121.678 -0.638 . . . . 0.0 110.377 176.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.5 mm -68.97 -41.45 81.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 176.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.7 -39.28 70.81 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.122 0.874 . . . . 0.0 111.041 178.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -66.6 -45.72 78.24 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 118.843 -0.598 . . . . 0.0 110.856 173.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 69.1 mtm -63.86 -27.78 69.4 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 119.713 1.142 . . . . 0.0 112.003 178.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 61.6 mt -70.03 -56.19 12.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 172.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -57.55 -40.09 78.11 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.588 -0.695 . . . . 0.0 111.97 -177.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -62.98 -34.07 76.75 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 119.505 1.048 . . . . 0.0 111.522 -178.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -75.05 -41.48 58.99 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 122.849 0.46 . . . . 0.0 111.172 178.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -77.08 -32.26 56.61 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 118.886 0.766 . . . . 0.0 111.616 -177.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.07 143.54 11.47 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 124.952 1.263 . . . . 0.0 110.165 -169.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -63.58 -31.19 72.28 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.917 0.887 . . . . 0.0 111.947 -172.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -77.6 -7.66 56.71 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 46.4 t -105.28 -47.34 9.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 124.318 1.047 . . . . 0.0 109.157 176.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -131.44 140.32 49.58 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 119.386 0.994 . . . . 0.0 110.965 -176.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -132.86 147.74 52.3 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 176.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 58.0 t -99.75 137.59 26.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 C-N-CA 124.919 1.288 . . . . 0.0 110.48 -169.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -141.06 145.38 35.77 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.373 1.469 . . . . 0.0 109.392 -177.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -88.51 124.1 33.67 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 169.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.4 tp -58.32 -34.93 51.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 119.119 -0.467 . . . . 0.0 111.276 -174.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.84 -33.84 76.76 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 119.126 0.875 . . . . 0.0 112.318 -171.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -92.98 -7.61 45.4 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.125 0.57 . . . . 0.0 112.153 176.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 49.9 m -74.99 165.48 25.19 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.137 0.575 . . . . 0.0 110.096 179.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.3 m -128.72 158.94 37.19 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 124.241 1.017 . . . . 0.0 110.745 -170.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -51.2 -51.72 51.16 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.884 1.274 . . . . 0.0 111.373 -176.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -79.88 -14.27 58.77 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 122.542 0.337 . . . . 0.0 111.439 -173.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -76.67 -34.25 58.24 Favored 'General case' 0 C--N 1.34 0.166 0 O-C-N 121.599 -0.688 . . . . 0.0 111.045 -176.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.6 mp -65.76 -36.88 84.81 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 171.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -67.24 -19.47 65.53 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 123.039 0.536 . . . . 0.0 112.251 -174.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.53 -28.64 68.7 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.645 0.778 . . . . 0.0 112.05 177.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -89.37 152.46 21.5 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 123.93 0.892 . . . . 0.0 110.398 -176.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -92.51 -34.98 13.86 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.462 172.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 20.1 mt -113.78 137.99 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 -179.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 91.8 mt -124.89 134.87 52.52 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.666 0.786 . . . . 0.0 109.012 174.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.0 mp -112.85 116.2 29.67 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 104.821 -2.288 . . . . 0.0 104.821 168.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 66.6 mt -112.04 111.83 23.03 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 -172.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -105.19 106.69 2.71 Favored Glycine 0 C--N 1.338 0.648 0 C-N-CA 124.355 0.979 . . . . 0.0 112.336 -173.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.4 tp -124.62 107.44 29.21 Favored Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 126.114 1.766 . . . . 0.0 109.886 -168.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -76.21 141.74 23.58 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.095 1.863 . . . . 0.0 109.62 169.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 44.9 m -93.47 138.96 31.25 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 174.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 16.2 m95 -131.55 172.06 12.68 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 124.537 1.135 . . . . 0.0 110.606 -177.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 33.88 63.3 0.4 Allowed 'General case' 0 C--O 1.236 0.343 0 C-N-CA 128.22 2.608 . . . . 0.0 113.306 169.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.263 19.9 p90 49.67 58.96 4.86 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.633 1.173 . . . . 0.0 111.992 174.202 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.86 53.71 2.34 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-N 115.031 -0.986 . . . . 0.0 114.108 168.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -137.46 157.58 46.26 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 117.828 0.814 . . . . 0.0 110.283 167.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.84 150.59 32.23 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 168.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -62.59 152.41 35.11 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 169.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 60.9 m -57.96 -30.49 66.03 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.835 0.854 . . . . 0.0 111.83 -175.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -61.06 -39.07 88.46 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.922 0.889 . . . . 0.0 110.773 -179.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -85.09 -42.8 14.47 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 123.605 0.762 . . . . 0.0 110.671 175.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -61.51 -37.39 83.51 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.061 0.391 . . . . 0.0 111.828 -174.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -69.72 -21.96 63.43 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.529 0.732 . . . . 0.0 112.079 175.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -91.86 -23.65 19.59 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.6 0.76 . . . . 0.0 111.759 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -51.73 -41.57 78.89 Favored Pre-proline 0 CA--C 1.545 0.777 0 CA-C-O 116.539 -1.696 . . . . 0.0 114.763 179.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -64.38 -24.41 64.46 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 CA-C-N 122.991 2.104 . . . . 0.0 112.828 174.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.4 m -78.22 -40.57 37.02 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.257 0.935 . . . . 0.0 109.359 170.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 13.3 tp -59.5 -36.85 76.84 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.551 1.141 . . . . 0.0 111.151 -174.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -77.44 -6.65 54.21 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.893 0.877 . . . . 0.0 112.844 178.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 67.2 mt-10 -92.15 -23.28 19.46 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.432 1.014 . . . . 0.0 110.428 169.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 79.2 mt -73.14 147.61 9.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 176.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -116.91 137.74 52.01 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 176.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -124.82 16.11 8.65 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.458 1.103 . . . . 0.0 111.13 -171.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -59.73 126.74 28.8 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 120.062 1.301 . . . . 0.0 109.635 -179.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 72.3 2.79 55.4 Favored Glycine 0 CA--C 1.536 1.352 0 CA-C-O 118.121 -1.377 . . . . 0.0 114.605 -176.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -86.36 149.32 25.11 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 120.176 1.988 . . . . 0.0 108.036 173.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 14.9 mt -95.26 139.79 31.08 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 173.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.5 t -135.54 144.55 33.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 176.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -128.48 142.44 51.08 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 168.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 74.1 mt -105.29 149.7 25.79 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -178.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -140.15 146.76 39.21 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 176.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -165.31 143.21 8.28 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-N 119.555 1.07 . . . . 0.0 113.002 168.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 6.6 t -88.4 160.06 17.74 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 114.114 -1.043 . . . . 0.0 109.043 170.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -177.91 -174.53 44.32 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 -179.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -133.16 140.45 47.59 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.802 1.641 . . . . 0.0 109.543 174.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 22.0 pt20 -134.46 45.88 2.54 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.398 0.618 . . . . 0.0 110.584 169.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -109.17 -33.66 6.81 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.841 1.256 . . . . 0.0 108.83 168.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -127.84 -34.88 2.13 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 125.046 1.338 . . . . 0.0 111.367 173.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -90.29 26.37 1.95 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.038 0.935 . . . . 0.0 111.971 178.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.59 -14.89 62.08 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.014 -1.054 . . . . 0.0 113.685 -175.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -89.32 2.24 54.65 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 118.986 0.812 . . . . 0.0 111.868 173.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -142.58 11.86 1.89 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.152 1.381 . . . . 0.0 111.546 -173.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -67.8 127.55 33.22 Favored 'General case' 0 C--O 1.236 0.388 0 O-C-N 121.221 -0.924 . . . . 0.0 110.707 -168.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 85.2 m 50.99 31.77 6.71 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.085 1.354 . . . . 0.0 112.42 177.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -60.25 -38.44 83.47 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 121.777 -0.577 . . . . 0.0 111.354 -179.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.6 -21.96 62.6 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -169.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.9 mp -59.96 -38.02 81.26 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 119.063 0.847 . . . . 0.0 109.322 172.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.68 -34.48 88.73 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 111.306 -0.718 . . . . 0.0 111.306 175.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 4.7 m -65.68 -38.47 89.35 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.588 1.194 . . . . 0.0 110.364 177.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.1 mt -70.23 -46.1 73.11 Favored 'Isoleucine or valine' 0 C--N 1.343 0.323 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 175.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 37.5 ttt180 -53.42 -45.71 69.5 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 118.807 0.731 . . . . 0.0 110.579 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -61.85 -17.92 58.18 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.408 1.083 . . . . 0.0 112.571 -178.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 94.3 mt -95.69 -57.59 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 C-N-CA 123.997 0.919 . . . . 0.0 108.918 173.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 19.9 pt -69.05 -33.4 58.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 119.369 0.986 . . . . 0.0 112.203 -167.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -66.93 -54.06 23.01 Favored Pre-proline 0 CA--C 1.545 0.783 0 CA-C-O 117.816 -1.088 . . . . 0.0 111.006 -174.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.86 -22.39 36.53 Favored 'Trans proline' 0 C--N 1.353 0.786 0 CA-C-N 121.646 1.624 . . . . 0.0 112.677 175.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 30.4 mmm180 -79.68 11.31 3.24 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 119.015 0.825 . . . . 0.0 112.124 172.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 98.12 -2.57 59.73 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 125.463 1.506 . . . . 0.0 116.82 166.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.95 143.15 57.97 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 120.155 1.978 . . . . 0.0 111.059 -176.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 48.6 m -94.27 123.83 37.92 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 105.138 -2.171 . . . . 0.0 105.138 168.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 42.3 mt -105.86 131.77 54.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 -170.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 33.4 m -132.74 178.33 5.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 125.544 1.537 . . . . 0.0 109.258 177.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 77.35 22.89 69.44 Favored Glycine 0 CA--C 1.525 0.657 0 O-C-N 121.613 -0.679 . . . . 0.0 112.686 174.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 9.1 p-80 -61.5 113.88 2.92 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.313 1.045 . . . . 0.0 108.28 169.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 73.6 t-105 -84.06 140.85 40.02 Favored Pre-proline 0 CA--C 1.536 0.439 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 177.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -66.25 149.06 85.43 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 121.981 1.788 . . . . 0.0 111.296 179.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 81.2 p -80.47 -11.0 59.73 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.267 0.627 . . . . 0.0 111.118 169.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 53.98 42.86 31.5 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.863 1.665 . . . . 0.0 110.968 -169.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 73.2 70.74 1.18 Allowed Glycine 0 C--N 1.339 0.717 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 -178.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -42.06 136.34 2.18 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.403 1.081 . . . . 0.0 112.838 174.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 9.1 p80 -150.63 15.65 0.78 Allowed 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 176.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -88.87 -157.05 0.42 Allowed 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 119.069 0.85 . . . . 0.0 110.428 -179.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -73.4 -82.49 0.05 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.788 0.835 . . . . 0.0 112.862 -168.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -156.64 67.32 0.56 Allowed 'General case' 0 C--N 1.342 0.26 0 CA-C-O 123.13 1.443 . . . . 0.0 110.742 -177.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 19.5 m -70.68 133.87 47.02 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 113.87 -1.514 . . . . 0.0 107.564 171.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 60.0 mttt -112.38 -1.98 14.9 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -168.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -76.88 0.96 64.3 Favored Glycine 0 CA--C 1.532 1.135 0 CA-C-O 118.93 -0.928 . . . . 0.0 113.214 168.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 8.3 mp -63.67 129.92 42.13 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 119.938 1.869 . . . . 0.0 110.277 178.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.06 -38.25 22.79 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.82 1.248 . . . . 0.0 108.058 167.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -153.94 166.68 32.22 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 129.548 3.139 . . . . 0.0 106.105 -174.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -52.67 -35.64 55.59 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.052 -1.03 . . . . 0.0 112.336 175.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -95.92 -7.37 36.85 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -174.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -146.28 141.09 26.98 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.814 1.188 . . . . 0.0 112.207 -172.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -83.93 160.87 20.99 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.003 1.321 . . . . 0.0 108.768 168.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 34.3 m -72.03 -7.16 8.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 O-C-N 120.963 -1.086 . . . . 0.0 112.872 179.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -166.64 -157.63 10.52 Favored Glycine 0 CA--C 1.521 0.42 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -76.97 96.24 4.32 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 169.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -84.77 130.13 34.73 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 104.042 -2.577 . . . . 0.0 104.042 165.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 7.9 tp -61.97 -8.75 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 N-CA-C 115.842 1.793 . . . . 0.0 115.842 -168.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.437 ' HA ' ' CZ ' ' A' ' 156' ' ' ARG . 31.7 t70 -149.95 147.58 28.06 Favored 'General case' 0 N--CA 1.452 -0.368 0 O-C-N 120.722 -1.236 . . . . 0.0 113.193 -173.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.48 14.3 2.36 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 126.752 2.021 . . . . 0.0 110.128 169.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -124.99 -54.57 1.61 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.139 1.376 . . . . 0.0 111.609 -173.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -165.23 -47.8 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 124.558 1.143 . . . . 0.0 111.178 170.046 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 -150.18 173.64 4.14 Favored Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 125.137 1.375 . . . . 0.0 110.093 -169.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -64.78 24.76 0.08 OUTLIER 'Trans proline' 0 CA--C 1.547 1.175 0 C-N-CA 124.727 3.618 . . . . 0.0 116.92 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -63.31 -26.91 68.99 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 120.509 -1.369 . . . . 0.0 112.319 -169.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 85.3 mt -109.13 27.77 9.18 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 125.021 1.329 . . . . 0.0 110.684 -175.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 13.5 m -48.23 -55.61 10.07 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 123.946 0.899 . . . . 0.0 110.512 -175.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -61.85 -40.84 96.74 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.481 0.582 . . . . 0.0 111.121 -170.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -66.12 -49.92 65.8 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 177.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.437 ' CZ ' ' HA ' ' A' ' 145' ' ' ASP . 87.4 mtt180 -58.73 -47.49 84.44 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 123.073 0.549 . . . . 0.0 110.219 -175.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 13.0 m -77.51 -33.69 19.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-O 118.611 -0.709 . . . . 0.0 110.729 -171.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -65.97 -47.81 73.35 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 119.841 1.2 . . . . 0.0 109.526 174.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -61.13 -40.37 93.56 Favored 'General case' 0 C--O 1.227 -0.11 0 CA-C-O 119.132 -0.461 . . . . 0.0 110.157 179.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 60.9 t90 -64.08 -47.7 79.06 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 118.71 0.686 . . . . 0.0 110.791 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 40.7 t -57.62 -40.55 75.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 118.265 0.484 . . . . 0.0 109.805 177.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 53.7 mttm -68.83 -36.96 78.82 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 118.353 -0.832 . . . . 0.0 110.227 -178.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -62.59 -55.35 27.97 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 119.106 0.867 . . . . 0.0 110.42 174.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 22.4 pt -68.58 -29.03 42.48 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.369 0 CA-C-O 119.015 -0.517 . . . . 0.0 110.409 -172.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 64.3 m -58.01 -29.67 65.49 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 119.011 0.823 . . . . 0.0 111.593 175.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -79.37 -45.46 19.51 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 119.64 1.109 . . . . 0.0 110.272 175.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -66.37 -35.03 79.3 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.516 0.726 . . . . 0.0 111.236 -175.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 73.6 mt -86.75 -3.59 59.07 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.075 1.75 . . . . 0.0 111.377 179.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 54.12 33.98 19.04 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.56 1.544 . . . . 0.0 112.51 -173.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 95.9 mt -81.36 -26.56 35.43 Favored 'General case' 0 N--CA 1.464 0.265 0 O-C-N 121.549 -0.719 . . . . 0.0 110.359 173.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -57.26 -37.93 73.11 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 118.64 0.654 . . . . 0.0 110.028 174.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -66.97 -10.06 45.3 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.325 0.65 . . . . 0.0 112.682 178.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 64.7 mt -106.21 -55.47 5.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 125.164 1.386 . . . . 0.0 108.126 -179.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.4 pp -78.13 -22.08 49.36 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.166 0.586 . . . . 0.0 112.182 -171.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -127.73 38.32 4.06 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.523 1.929 . . . . 0.0 109.183 -176.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.152 0 C-N-CA 123.865 0.866 . . . . 0.0 109.703 174.897 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.8 ttt . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 118.161 -0.923 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 60.08 -178.1 0.1 Allowed 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.908 1.283 . . . . 0.0 112.42 -170.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 22.4 pt -89.47 -18.96 7.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 O-C-N 121.623 -0.673 . . . . 0.0 112.091 -177.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.2 m -117.46 122.46 43.81 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 124.997 1.319 . . . . 0.0 107.521 178.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -98.45 114.28 4.97 Favored Glycine 0 C--N 1.334 0.472 0 N-CA-C 107.873 -2.091 . . . . 0.0 107.873 171.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 65.4 mt -94.69 106.75 18.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 104.872 -2.27 . . . . 0.0 104.872 174.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 11.7 m-30 -105.08 133.66 49.48 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 177.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -125.69 130.21 51.1 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.515 0.598 . . . . 0.0 112.149 -178.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -86.29 144.92 20.21 Favored Glycine 0 C--N 1.338 0.665 0 N-CA-C 108.738 -1.745 . . . . 0.0 108.738 168.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 11.0 m -158.27 169.76 23.77 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 119.12 1.46 . . . . 0.0 110.321 175.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -141.6 -49.45 0.4 Allowed 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.556 1.142 . . . . 0.0 109.124 168.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.3 p -80.56 -17.22 52.12 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.938 0.895 . . . . 0.0 112.171 170.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 103.95 7.41 41.38 Favored Glycine 0 C--N 1.342 0.885 0 C-N-CA 124.673 1.13 . . . . 0.0 113.99 171.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -65.13 -42.04 94.27 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 118.999 1.4 . . . . 0.0 112.069 -171.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -70.26 -18.41 63.13 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 118.942 0.792 . . . . 0.0 111.751 -170.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -58.81 -43.57 90.62 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 119.432 1.014 . . . . 0.0 110.036 174.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -64.4 -40.44 95.8 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 23.3 mm -66.42 -42.33 90.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 O-C-N 121.804 -0.56 . . . . 0.0 109.507 179.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.71 -40.08 86.76 Favored 'General case' 0 CA--C 1.532 0.253 0 O-C-N 121.721 -0.612 . . . . 0.0 110.579 176.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp -68.39 -39.43 81.72 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 118.336 -0.84 . . . . 0.0 111.145 176.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 64.1 mtt -59.51 -37.39 78.18 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 119.827 1.194 . . . . 0.0 110.976 175.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 51.9 mt -71.31 -51.38 34.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 177.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -62.13 -37.11 83.91 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 121.507 -0.745 . . . . 0.0 111.203 -174.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 59.1 tptt -63.13 -38.28 90.57 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 119.063 0.847 . . . . 0.0 110.812 -178.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -71.76 -41.62 68.2 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.952 0.501 . . . . 0.0 110.753 177.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.1 mp -73.21 -35.73 66.37 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.098 0.408 . . . . 0.0 111.24 -176.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 90.93 147.71 19.8 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 125.089 1.328 . . . . 0.0 110.771 -172.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -66.42 -28.3 68.51 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.694 0.798 . . . . 0.0 112.186 -171.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -69.04 -25.92 64.72 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 122.873 0.469 . . . . 0.0 111.348 176.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 31.6 t -98.52 -36.31 5.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 C-N-CA 124.481 1.112 . . . . 0.0 110.58 -174.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -135.33 144.76 46.86 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 118.777 0.717 . . . . 0.0 112.207 -177.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -129.32 154.65 46.66 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 125.288 1.435 . . . . 0.0 108.212 175.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 69.7 t -117.76 133.96 62.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 124.165 0.986 . . . . 0.0 108.901 -169.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -149.73 -174.78 4.79 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.218 1.007 . . . . 0.0 111.319 -177.639 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -135.02 141.31 46.14 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 125.224 1.41 . . . . 0.0 107.197 173.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.8 tp -59.49 -24.96 29.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 123.869 0.868 . . . . 0.0 112.906 -169.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.56 -27.81 69.21 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 118.729 0.695 . . . . 0.0 111.165 178.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -96.85 -33.78 11.52 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.751 1.22 . . . . 0.0 110.986 -179.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 19.8 m -60.38 162.11 6.56 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.332 0.653 . . . . 0.0 110.001 169.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.4 m -136.29 157.28 47.17 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.619 0.768 . . . . 0.0 110.449 -171.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -51.69 -51.71 53.86 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.23 1.012 . . . . 0.0 110.884 -179.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -75.24 -16.34 60.47 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 122.693 0.397 . . . . 0.0 111.587 -176.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -78.49 -37.98 41.99 Favored 'General case' 0 CA--C 1.53 0.19 0 O-C-N 121.541 -0.724 . . . . 0.0 110.213 179.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.0 mp -65.24 -35.05 79.86 Favored 'General case' 0 C--N 1.342 0.248 0 O-C-N 121.808 -0.558 . . . . 0.0 110.265 170.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -63.87 -23.85 67.51 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 118.81 0.732 . . . . 0.0 111.493 174.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -86.83 -31.4 20.85 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.941 0.896 . . . . 0.0 112.75 -178.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -67.55 160.17 28.28 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 123.994 0.917 . . . . 0.0 110.688 174.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -109.27 -40.17 5.01 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.493 0.717 . . . . 0.0 111.39 169.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.9 mt -112.47 125.19 69.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 177.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -113.9 132.19 56.01 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 171.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.0 mp -115.28 119.24 35.67 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 172.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 69.2 mt -117.41 109.46 16.81 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -172.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.78 123.07 6.63 Favored Glycine 0 CA--C 1.521 0.463 0 N-CA-C 108.949 -1.661 . . . . 0.0 108.949 176.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 3.4 tp -137.1 115.4 10.11 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-N 118.129 0.965 . . . . 0.0 110.125 -169.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -78.6 -173.22 1.77 Allowed 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 123.207 2.605 . . . . 0.0 109.986 169.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 95.5 m -144.45 145.96 32.19 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 119.99 -1.694 . . . . 0.0 107.592 169.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 75.0 m95 -139.71 169.74 17.17 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 125.144 1.378 . . . . 0.0 110.984 -169.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 55.88 -73.1 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 128.833 2.853 . . . . 0.0 114.642 175.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -161.76 56.25 0.26 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 127.239 2.216 . . . . 0.0 108.379 -174.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 81.72 19.66 65.33 Favored Glycine 0 CA--C 1.534 1.258 0 O-C-N 121.438 -0.789 . . . . 0.0 113.47 -179.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -88.31 154.29 20.53 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.416 1.108 . . . . 0.0 109.489 179.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.85 161.88 24.24 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 168.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.252 0.0 OUTLIER -70.93 159.85 33.94 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 170.413 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 57.7 m -53.71 -37.53 63.38 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 115.567 1.691 . . . . 0.0 115.567 -166.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -76.79 -43.97 34.63 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 119.046 0.839 . . . . 0.0 109.458 -170.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -64.18 -45.75 87.0 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.653 0.781 . . . . 0.0 109.446 173.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -58.76 -39.32 80.67 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 122.583 0.353 . . . . 0.0 111.732 179.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -71.22 -30.64 66.61 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.897 0.879 . . . . 0.0 112.253 176.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -87.34 -21.67 25.56 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 118.618 0.645 . . . . 0.0 112.562 -176.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 16.5 m-30 -50.08 -44.63 80.38 Favored Pre-proline 0 CA--C 1.546 0.799 0 CA-C-O 116.932 -1.509 . . . . 0.0 114.683 178.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -65.98 -16.32 52.1 Favored 'Trans proline' 0 CA--C 1.542 0.913 0 CA-C-N 122.598 1.964 . . . . 0.0 113.798 175.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 14.7 m -85.87 -40.31 16.09 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 119.481 1.037 . . . . 0.0 109.207 169.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 37.3 tp -59.71 -36.9 77.48 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.94 1.296 . . . . 0.0 111.572 -173.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -66.85 -15.58 63.72 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 177.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 -91.97 -14.26 29.78 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 119.261 0.937 . . . . 0.0 111.781 179.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 96.7 mt -80.65 138.39 19.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 -173.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -80.88 132.0 35.41 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.707 -0.678 . . . . 0.0 109.259 175.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -126.88 16.43 7.39 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 118.187 -0.911 . . . . 0.0 111.42 174.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 23.9 m-80 -59.41 114.31 2.62 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 120.542 1.519 . . . . 0.0 109.377 -175.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.65 4.6 66.26 Favored Glycine 0 CA--C 1.536 1.357 0 CA-C-O 118.69 -1.061 . . . . 0.0 114.123 -178.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -77.39 151.58 34.75 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 119.515 1.658 . . . . 0.0 108.224 171.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 17.8 mt -95.74 137.2 35.13 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 175.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.3 t -132.11 144.29 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 172.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -135.36 149.18 49.63 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 169.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 72.6 mt -120.52 149.13 42.9 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 -174.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -146.59 157.39 43.71 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 123.234 0.614 . . . . 0.0 109.55 172.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -170.2 166.34 39.57 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-O 122.305 0.947 . . . . 0.0 113.208 -175.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 15.2 t -142.64 162.18 36.14 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 126.754 2.021 . . . . 0.0 107.106 179.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -176.0 -170.71 39.07 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -139.42 142.88 37.44 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 127.086 2.154 . . . . 0.0 105.978 176.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.62 21.99 1.99 Allowed 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -172.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -64.5 -46.19 84.02 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 178.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -95.84 -38.18 10.41 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.174 0.59 . . . . 0.0 110.704 169.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -83.22 41.89 0.79 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.408 1.483 . . . . 0.0 111.551 -172.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.18 -21.14 66.45 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.823 1.249 . . . . 0.0 113.72 -169.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -97.36 2.85 51.05 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.716 1.207 . . . . 0.0 111.386 178.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -133.98 18.18 3.8 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.4 1.08 . . . . 0.0 112.481 -169.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -61.86 120.37 10.6 Favored 'General case' 0 CA--C 1.529 0.169 0 O-C-N 121.104 -0.997 . . . . 0.0 109.346 -176.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 80.1 m 45.88 35.76 2.51 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.557 1.543 . . . . 0.0 112.654 -176.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -49.48 -41.1 39.59 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.43 1.092 . . . . 0.0 111.911 -171.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.67 -13.88 62.47 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -171.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 34.1 mt -56.23 -41.84 76.32 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 119.837 1.199 . . . . 0.0 109.793 169.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.97 -36.42 93.05 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 178.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.0 m -62.71 -44.23 96.75 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 117.944 0.872 . . . . 0.0 109.906 177.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.7 mt -66.29 -45.48 89.64 Favored 'Isoleucine or valine' 0 C--N 1.344 0.357 0 CA-C-N 119.613 1.097 . . . . 0.0 108.908 178.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 45.6 ttt180 -54.64 -48.15 72.63 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 119.379 0.99 . . . . 0.0 110.43 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -62.08 -29.8 70.56 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.329 0.652 . . . . 0.0 111.603 -177.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 85.9 mt -81.53 -44.36 20.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-O 117.595 -1.193 . . . . 0.0 110.634 178.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.7 pt -86.88 -33.55 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 120.121 1.328 . . . . 0.0 113.003 -168.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -64.57 -37.85 27.23 Favored Pre-proline 0 CA--C 1.547 0.832 0 CA-C-O 117.946 -1.026 . . . . 0.0 112.008 -171.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -64.38 -17.1 58.5 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 122.417 2.078 . . . . 0.0 114.223 174.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 13.7 mmt180 -90.25 10.2 25.63 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.076 0.95 . . . . 0.0 111.536 -173.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 77.94 10.85 85.93 Favored Glycine 0 CA--C 1.531 1.06 0 CA-C-O 118.432 -1.205 . . . . 0.0 113.391 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -57.66 137.94 55.9 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 118.712 1.256 . . . . 0.0 109.426 171.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 55.8 m -93.96 120.87 34.8 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 168.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 36.9 mt -97.65 128.17 49.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 -176.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 34.6 m -128.79 175.44 10.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 124.983 1.313 . . . . 0.0 108.987 176.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 75.93 28.85 59.96 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-O 119.079 -0.845 . . . . 0.0 112.731 -177.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 81.4 m-70 -60.43 135.17 57.66 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 169.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 74.7 t-105 -129.99 139.7 36.44 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 124.248 1.019 . . . . 0.0 109.385 -169.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -62.08 162.39 22.99 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 121.781 1.654 . . . . 0.0 113.065 -178.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -55.01 -34.25 63.29 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.659 0.784 . . . . 0.0 112.015 174.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 42.42 55.01 4.22 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.738 1.615 . . . . 0.0 112.981 168.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 99.9 -7.92 59.28 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-O 118.656 -1.08 . . . . 0.0 114.658 175.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -59.65 133.47 56.13 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 118.974 1.387 . . . . 0.0 109.264 169.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 8.8 t-80 -154.84 40.98 0.45 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.062 0.945 . . . . 0.0 110.276 176.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -106.34 -176.37 3.06 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.956 0.902 . . . . 0.0 111.307 -170.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 -71.98 -47.02 55.1 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 118.839 -0.6 . . . . 0.0 111.191 -169.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -157.38 149.44 22.53 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 118.749 0.704 . . . . 0.0 111.413 173.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 40.0 t -140.09 126.08 19.66 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 105.444 -2.058 . . . . 0.0 105.444 167.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.63 -10.54 58.9 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.791 -175.366 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -79.08 -4.9 89.05 Favored Glycine 0 C--N 1.341 0.815 0 CA-C-O 118.596 -1.114 . . . . 0.0 113.19 170.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 70.4 mt -68.96 120.09 14.3 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 120.402 2.101 . . . . 0.0 108.156 175.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -87.91 -28.69 21.37 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.635 1.174 . . . . 0.0 110.337 175.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -146.73 168.38 21.5 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.161 1.784 . . . . 0.0 107.403 171.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -57.25 -25.96 60.01 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.742 1.217 . . . . 0.0 113.57 -170.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -121.43 11.34 10.67 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.349 1.46 . . . . 0.0 113.163 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -142.72 127.53 18.22 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-N 119.404 1.002 . . . . 0.0 111.593 -175.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -80.64 152.99 28.21 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 125.061 1.344 . . . . 0.0 109.658 169.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 12.2 p -59.73 -24.95 30.58 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 C-N-CA 124.76 1.224 . . . . 0.0 111.654 171.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -156.72 171.82 34.32 Favored Glycine 0 C--N 1.337 0.629 0 C-N-CA 124.763 1.173 . . . . 0.0 110.53 -169.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -60.24 127.26 30.91 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -117.35 121.05 40.04 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 170.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 1.5 pt -100.75 111.37 30.2 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.098 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 173.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -158.33 153.4 25.38 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 129.46 3.104 . . . . 0.0 106.342 172.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -150.58 -44.84 0.12 Allowed 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 119.736 1.153 . . . . 0.0 111.559 179.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -105.82 -111.48 0.27 Allowed 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 106.046 -1.835 . . . . 0.0 106.046 170.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 16.8 ptm180 -88.09 -16.21 34.15 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 119.777 1.171 . . . . 0.0 110.806 165.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -144.62 166.24 19.4 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 129.215 3.006 . . . . 0.0 105.776 -179.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.13 152.64 45.66 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 122.019 1.813 . . . . 0.0 112.822 179.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -130.77 -5.84 4.05 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.275 1.03 . . . . 0.0 111.88 168.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 66.9 mt -113.38 28.78 8.51 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.522 1.529 . . . . 0.0 110.078 178.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 74.3 m -47.08 -56.98 5.55 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.806 1.643 . . . . 0.0 111.992 -169.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -69.59 -39.37 77.33 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 119.245 -0.407 . . . . 0.0 111.27 -168.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -73.52 -35.04 65.53 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.456 0.571 . . . . 0.0 111.118 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 33.2 mtp180 -64.8 -41.11 96.06 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 119.341 0.973 . . . . 0.0 109.892 174.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 72.4 t -67.89 -41.33 84.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-O 118.592 -0.718 . . . . 0.0 109.634 177.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -59.26 -50.78 72.71 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 120.134 1.334 . . . . 0.0 110.283 176.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 58.1 mttm -57.41 -42.92 83.24 Favored 'General case' 0 CA--C 1.522 -0.115 0 CA-C-O 118.652 -0.69 . . . . 0.0 109.994 -178.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 60.5 t90 -66.43 -48.55 69.64 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 118.546 0.612 . . . . 0.0 110.797 -178.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 53.6 t -60.87 -36.2 70.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 118.107 0.412 . . . . 0.0 109.95 -177.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -65.94 -33.91 76.91 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 118.427 -0.797 . . . . 0.0 110.438 177.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 41.5 mm-40 -65.58 -54.77 23.31 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 119.015 0.825 . . . . 0.0 110.534 171.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 5.7 pt -64.65 -29.91 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-N 118.807 0.731 . . . . 0.0 110.633 -170.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 49.6 m -60.09 -27.01 66.64 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 118.646 -0.692 . . . . 0.0 111.774 178.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -82.41 -38.11 24.55 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 119.644 1.111 . . . . 0.0 110.717 175.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -71.36 -36.78 71.6 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.136 0.574 . . . . 0.0 111.133 -178.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 85.7 mt -85.75 -5.75 59.21 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.749 1.62 . . . . 0.0 111.306 178.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 84.7 m-70 54.63 29.99 12.49 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.81 1.644 . . . . 0.0 112.88 -171.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 80.0 mt -77.59 -20.41 54.02 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 118.668 -0.682 . . . . 0.0 110.723 173.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -56.99 -38.3 72.86 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 119.292 0.951 . . . . 0.0 110.356 174.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -66.95 -12.87 60.97 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 121.637 -0.665 . . . . 0.0 112.522 178.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 44.4 mt -103.9 -55.32 5.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 124.993 1.317 . . . . 0.0 108.566 -179.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.4 pp -79.31 -24.87 42.54 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.567 0.747 . . . . 0.0 112.179 -171.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -121.8 35.48 4.87 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.08 1.752 . . . . 0.0 109.582 -175.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.333 0 C-N-CA 123.695 0.798 . . . . 0.0 109.571 174.184 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.446 0 N-CA-C 110.634 -0.135 . . . . 0.0 110.634 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.1 pt -102.1 -16.85 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 123.962 0.905 . . . . 0.0 111.718 -179.458 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 16.4 m -114.58 126.89 55.43 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.682 1.593 . . . . 0.0 108.671 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -102.52 119.93 6.63 Favored Glycine 0 CA--C 1.52 0.348 0 N-CA-C 107.816 -2.114 . . . . 0.0 107.816 169.433 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 43.5 mt -96.22 124.54 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 104.405 -2.443 . . . . 0.0 104.405 172.003 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -122.84 130.18 52.57 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 176.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -129.47 130.78 46.32 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 119.615 1.098 . . . . 0.0 112.551 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -81.78 152.76 32.13 Favored Glycine 0 C--N 1.339 0.697 0 N-CA-C 108.102 -1.999 . . . . 0.0 108.102 168.506 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 16.8 p -153.27 166.04 33.84 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 120.128 1.964 . . . . 0.0 111.413 -176.094 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -144.49 -58.4 0.37 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.588 0.755 . . . . 0.0 109.745 168.363 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.2 p -83.36 -12.42 56.55 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.691 1.197 . . . . 0.0 111.875 175.267 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.06 7.84 59.39 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 124.714 1.15 . . . . 0.0 113.059 175.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -65.9 -37.74 86.89 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 118.459 1.129 . . . . 0.0 110.929 -176.191 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.82 -24.5 66.17 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.437 0.695 . . . . 0.0 111.914 -175.074 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -62.21 -40.97 97.88 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 119.114 0.87 . . . . 0.0 109.733 177.553 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -66.28 -37.79 86.27 Favored 'General case' 0 CA--C 1.529 0.141 0 O-C-N 122.13 -0.356 . . . . 0.0 110.123 178.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 27.1 mm -62.77 -48.9 85.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 175.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.1 -39.41 86.06 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.331 0.514 . . . . 0.0 111.156 -178.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 57.8 mttm -67.99 -42.93 80.01 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 118.52 -0.752 . . . . 0.0 111.223 175.411 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 75.1 mtm -64.78 -28.09 69.34 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 119.938 1.245 . . . . 0.0 111.506 178.172 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.402 HG21 HD23 ' A' ' 51' ' ' LEU . 83.6 mt -68.63 -57.73 8.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 169.675 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -59.16 -39.9 83.92 Favored 'General case' 0 C--O 1.226 -0.152 0 C-N-CA 122.938 0.495 . . . . 0.0 111.601 -171.209 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -64.54 -34.08 77.4 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 118.616 0.644 . . . . 0.0 111.435 -176.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -73.0 -47.58 43.9 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 118.159 0.436 . . . . 0.0 110.332 177.065 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 54.2 mt -67.18 -34.05 76.69 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 122.698 0.399 . . . . 0.0 111.594 -178.527 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.59 145.95 17.73 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 125.587 1.565 . . . . 0.0 110.762 -173.229 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -63.52 -28.72 70.14 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.765 0.826 . . . . 0.0 111.81 -176.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -66.88 -23.91 66.06 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.092 0.557 . . . . 0.0 111.349 176.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 53.1 t -101.3 -39.11 6.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 124.592 1.157 . . . . 0.0 110.441 -175.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -132.68 145.03 50.72 Favored 'General case' 0 C--N 1.342 0.245 0 CA-C-N 119.539 1.063 . . . . 0.0 112.111 -173.218 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -127.01 158.68 36.29 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.754 1.222 . . . . 0.0 109.757 172.233 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 71.0 t -119.27 138.08 51.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 125.021 1.328 . . . . 0.0 110.257 -169.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -146.35 166.54 26.01 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.847 1.659 . . . . 0.0 111.815 -170.491 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -126.82 135.53 51.14 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 105.357 -2.09 . . . . 0.0 105.357 168.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.9 tp -61.97 -17.2 17.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-N 118.88 0.763 . . . . 0.0 112.99 -170.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -52.32 -37.24 55.38 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.172 0.989 . . . . 0.0 112.339 179.186 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.15 1.43 57.15 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.632 0.773 . . . . 0.0 112.664 -177.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 52.5 m -87.89 157.68 18.91 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 122.374 1.083 . . . . 0.0 112.204 -174.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 23.7 m -129.23 172.51 11.38 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 127.971 2.509 . . . . 0.0 104.894 167.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.5 ptmm? -58.41 -38.69 77.91 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 120.059 1.299 . . . . 0.0 111.264 -173.441 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -71.51 -17.12 62.35 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.87 -0.519 . . . . 0.0 111.884 -176.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -68.23 -27.05 66.03 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.69 0.796 . . . . 0.0 111.039 -175.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.3 mp -86.97 -40.19 15.01 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 123.445 0.698 . . . . 0.0 109.845 171.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -63.74 -20.93 66.14 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.275 0.63 . . . . 0.0 111.921 -175.178 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.36 -29.96 70.23 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.278 1.031 . . . . 0.0 112.456 174.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -96.88 151.46 19.65 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.438 1.095 . . . . 0.0 110.669 -177.194 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -87.25 -37.95 16.76 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.556 170.05 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 22.2 mt -110.54 136.44 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -177.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 74.8 mt -132.42 120.84 22.53 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 124.139 0.976 . . . . 0.0 108.558 -176.119 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.402 HD23 HG21 ' A' ' 22' ' ' ILE . 8.9 mp -109.67 107.39 17.42 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 105.534 -2.024 . . . . 0.0 105.534 177.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 68.0 mt -110.17 100.85 9.68 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -170.257 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.97 131.73 10.8 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 124.726 1.155 . . . . 0.0 110.247 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.1 tt -142.26 122.32 8.15 Favored Pre-proline 0 CA--C 1.54 0.595 0 CA-C-N 118.358 1.079 . . . . 0.0 110.215 -179.002 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -81.07 161.51 20.63 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 123.07 2.513 . . . . 0.0 109.33 169.225 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 62.2 m -118.46 141.52 48.48 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 173.339 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 64.9 m95 -134.6 173.84 11.21 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 124.913 1.285 . . . . 0.0 109.442 -177.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 28.73 64.2 0.11 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 127.546 2.338 . . . . 0.0 114.479 169.095 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 56.73 62.84 2.13 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.445 1.098 . . . . 0.0 111.66 175.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.53 14.87 72.52 Favored Glycine 0 CA--C 1.532 1.138 0 CA-C-N 115.952 -0.567 . . . . 0.0 114.274 171.002 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -78.07 143.55 37.3 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 124.869 1.268 . . . . 0.0 110.117 176.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -93.89 143.94 25.89 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.342 1.057 . . . . 0.0 109.027 169.151 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -58.9 146.41 37.74 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.979 0.419 . . . . 0.0 110.592 177.116 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 60.8 m -59.25 -33.04 70.55 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.169 0.988 . . . . 0.0 112.97 -168.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -66.44 -43.7 84.89 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.247 0.476 . . . . 0.0 109.901 -178.283 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -71.81 -43.16 66.1 Favored 'General case' 0 C--N 1.341 0.204 0 C-N-CA 123.02 0.528 . . . . 0.0 110.029 176.127 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -59.15 -41.56 88.61 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 118.358 0.526 . . . . 0.0 111.858 -178.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -69.3 -23.32 63.8 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.76 0.824 . . . . 0.0 112.095 176.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -90.09 -20.76 22.78 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 118.277 -0.868 . . . . 0.0 112.302 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -51.96 -41.49 79.79 Favored Pre-proline 0 CA--C 1.544 0.72 0 CA-C-O 116.706 -1.616 . . . . 0.0 114.577 178.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -65.21 -13.89 42.17 Favored 'Trans proline' 0 CA--C 1.544 0.983 0 CA-C-N 122.809 2.039 . . . . 0.0 114.073 174.193 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 30.5 m -93.42 -36.15 12.64 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.46 1.104 . . . . 0.0 109.803 169.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.462 ' HA ' HD12 ' A' ' 76' ' ' ILE . 25.9 tp -56.1 -40.14 73.23 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 124.225 1.01 . . . . 0.0 110.501 178.549 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -72.78 1.11 9.13 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 178.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -112.55 -7.27 13.9 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.455 1.025 . . . . 0.0 111.52 174.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.462 HD12 ' HA ' ' A' ' 73' ' ' LEU . 62.7 mt -75.18 139.86 18.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -177.664 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -75.4 117.33 17.08 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 171.244 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -109.95 6.38 23.12 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 118.191 -0.909 . . . . 0.0 111.183 173.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 -60.62 116.91 4.72 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 120.754 1.616 . . . . 0.0 109.281 -175.436 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 74.61 -1.29 52.94 Favored Glycine 0 CA--C 1.535 1.315 0 CA-C-O 118.307 -1.274 . . . . 0.0 113.935 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -67.68 137.25 55.4 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 120.039 1.919 . . . . 0.0 107.428 172.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 17.8 mt -89.24 129.33 35.83 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 172.148 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.1 t -129.64 136.24 59.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -175.108 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -129.81 147.47 51.58 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 125.115 1.366 . . . . 0.0 107.326 175.224 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 69.2 mt -120.34 148.51 43.65 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -176.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -143.5 157.53 44.36 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.229 0.612 . . . . 0.0 110.654 175.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -175.47 172.34 45.37 Favored Glycine 0 CA--C 1.525 0.714 0 CA-C-O 122.634 1.13 . . . . 0.0 112.3 -178.6 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 4.3 m -142.76 158.65 43.43 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.369 1.868 . . . . 0.0 106.749 -173.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -169.76 -174.5 38.09 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 120.072 -1.061 . . . . 0.0 114.961 -177.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -144.29 140.38 29.14 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 129.834 3.254 . . . . 0.0 104.473 177.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.15 16.49 1.19 Allowed 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.739 1.216 . . . . 0.0 112.104 -171.137 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -63.82 -48.62 76.08 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.653 0.66 . . . . 0.0 109.316 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -98.78 -30.4 12.44 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.035 0.534 . . . . 0.0 111.136 171.052 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -83.91 42.59 0.87 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.711 1.605 . . . . 0.0 110.298 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.46 -17.32 59.2 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 -167.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -108.88 5.46 24.49 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.801 0.841 . . . . 0.0 112.594 176.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -126.14 15.31 7.86 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.683 1.193 . . . . 0.0 113.015 -169.281 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -62.9 121.94 14.75 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 119.588 1.086 . . . . 0.0 109.528 -177.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 82.4 m 47.12 35.98 3.98 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.709 1.604 . . . . 0.0 112.303 -177.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -50.19 -42.69 51.74 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.026 1.33 . . . . 0.0 111.655 -173.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.78 -12.02 61.02 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -170.624 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 82.2 mt -56.94 -42.17 79.56 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 119.143 0.883 . . . . 0.0 109.614 169.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.0 -34.28 88.38 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 111.246 -0.742 . . . . 0.0 111.246 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 4.7 m -64.18 -41.84 96.94 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 117.95 0.875 . . . . 0.0 110.578 -178.346 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 8.5 mt -72.16 -47.09 55.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 176.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 50.5 tpt85 -57.62 -33.02 67.82 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.488 0.715 . . . . 0.0 112.119 -175.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -70.42 -29.68 66.35 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 123.432 0.693 . . . . 0.0 112.29 179.094 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 94.6 mt -90.68 -40.33 12.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 123.52 0.728 . . . . 0.0 110.142 -173.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 15.4 pt -74.32 -32.39 31.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 118.853 0.751 . . . . 0.0 111.991 -169.013 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -63.37 -53.89 48.97 Favored Pre-proline 0 CA--C 1.541 0.596 0 CA-C-O 117.363 -1.303 . . . . 0.0 112.26 -178.013 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -66.22 -24.6 51.0 Favored 'Trans proline' 0 C--N 1.352 0.739 0 CA-C-N 121.942 1.729 . . . . 0.0 112.223 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -77.69 0.92 21.58 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 118.718 0.69 . . . . 0.0 112.205 171.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 100.25 11.17 43.01 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-O 118.208 -1.329 . . . . 0.0 115.469 168.319 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.33 150.11 40.34 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 119.292 1.546 . . . . 0.0 111.475 178.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 62.0 m -104.99 123.91 48.61 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 105.482 -2.044 . . . . 0.0 105.482 167.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 12.3 mm -91.79 138.87 18.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 -171.53 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 27.1 m -136.86 173.33 13.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 124.751 1.22 . . . . 0.0 109.114 170.323 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 81.95 43.42 8.23 Favored Glycine 0 C--N 1.337 0.628 0 CA-C-O 119.229 -0.761 . . . . 0.0 114.719 169.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 20.4 p80 -62.57 158.2 18.68 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 118.265 1.032 . . . . 0.0 109.716 168.477 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 77.5 t-105 -141.33 131.35 12.95 Favored Pre-proline 0 CA--C 1.534 0.331 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -68.4 145.19 64.39 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 121.912 1.741 . . . . 0.0 112.117 -173.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 57.1 p . . . . . 0 CA--C 1.532 0.283 0 C-N-CA 123.119 0.568 . . . . 0.0 110.926 171.988 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.473 0.695 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -77.82 -2.72 82.43 Favored Glycine 0 CA--C 1.531 1.065 0 CA-C-O 118.573 -1.126 . . . . 0.0 112.969 172.402 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 96.5 mt -66.51 133.29 50.06 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 120.171 1.986 . . . . 0.0 110.019 178.397 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -97.17 -33.82 11.35 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 166.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -145.58 162.77 36.69 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 127.378 2.271 . . . . 0.0 106.704 169.384 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -55.01 -28.01 48.76 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 118.942 0.792 . . . . 0.0 112.04 174.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -84.64 -19.68 32.54 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.468 1.107 . . . . 0.0 113.671 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 32.2 p-80 -153.31 137.63 16.62 Favored 'General case' 0 C--N 1.345 0.4 0 CA-C-O 123.064 1.411 . . . . 0.0 114.257 -176.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -73.05 154.09 40.59 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 125.436 1.494 . . . . 0.0 109.245 168.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 4.9 p -76.32 -18.07 15.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 124.546 1.138 . . . . 0.0 111.745 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -141.9 171.66 24.39 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 125.634 1.587 . . . . 0.0 109.373 177.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -59.03 130.15 45.61 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 172.221 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.19 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 178.717 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 18.1 mt . . . . . 0 CA--C 1.54 0.581 0 CA-C-O 122.41 1.1 . . . . 0.0 109.032 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 44.6 m -69.8 -48.18 60.06 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 126.118 1.767 . . . . 0.0 112.388 -168.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -60.85 -42.91 98.74 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -166.121 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -64.49 -37.87 89.04 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 118.319 0.509 . . . . 0.0 110.434 178.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 53.5 mtt85 -70.54 -44.48 67.41 Favored 'General case' 0 C--N 1.339 0.119 0 O-C-N 121.622 -0.674 . . . . 0.0 110.68 -178.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 22.5 m -73.79 -26.81 21.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 CA-C-O 118.523 -0.751 . . . . 0.0 110.613 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -62.0 -51.12 69.3 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 120.247 1.385 . . . . 0.0 109.13 170.042 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -58.43 -43.95 88.92 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 118.179 0.445 . . . . 0.0 110.542 179.066 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 73.2 t90 -67.02 -44.34 80.52 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 118.934 0.788 . . . . 0.0 110.689 -177.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 54.7 t -62.48 -38.95 82.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.031 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 55.8 mttm -66.7 -38.81 87.5 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.176 -0.952 . . . . 0.0 110.091 179.029 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 42.0 mm-40 -62.61 -50.94 69.25 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-N 118.538 0.608 . . . . 0.0 110.9 175.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 29.4 pt -64.7 -33.92 66.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-N 119.341 0.973 . . . . 0.0 109.973 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 57.6 m -61.76 -24.46 66.84 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 117.766 -1.111 . . . . 0.0 112.597 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -95.15 -11.32 28.35 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 120.317 1.417 . . . . 0.0 112.677 175.12 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -85.44 -40.03 16.87 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 119.183 0.901 . . . . 0.0 110.082 169.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 64.1 mt -84.64 -12.91 53.02 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.668 1.987 . . . . 0.0 111.609 -179.191 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 56.85 32.12 20.83 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.762 1.625 . . . . 0.0 112.419 -170.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 58.3 mt . . . . . 0 C--N 1.342 0.258 0 O-C-N 121.752 -0.592 . . . . 0.0 110.733 169.143 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.349 0 N-CA-C 110.516 -0.179 . . . . 0.0 110.516 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.0 pt -85.91 -27.09 6.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 123.087 0.555 . . . . 0.0 111.145 178.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 49.3 m -111.92 120.59 42.44 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.295 1.038 . . . . 0.0 109.318 -178.01 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -94.51 116.06 5.2 Favored Glycine 0 CA--C 1.52 0.376 0 N-CA-C 107.048 -2.421 . . . . 0.0 107.048 169.064 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 72.7 mt -95.21 97.1 6.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 104.852 -2.277 . . . . 0.0 104.852 176.363 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -91.71 137.83 32.05 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 176.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -136.93 159.48 41.74 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 123.592 0.757 . . . . 0.0 110.644 -176.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -131.31 147.47 18.55 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 107.739 -2.144 . . . . 0.0 107.739 167.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 29.6 m -168.44 143.02 3.36 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.375 1.588 . . . . 0.0 109.589 -179.219 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -91.07 -45.15 8.86 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 122.53 0.332 . . . . 0.0 111.001 170.19 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 82.5 p -107.47 9.13 29.7 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.014 0.926 . . . . 0.0 112.563 -175.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 79.72 13.34 82.51 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 124.128 0.87 . . . . 0.0 114.452 178.268 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -72.42 -46.17 56.31 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 119.515 1.658 . . . . 0.0 111.582 -177.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.5 m -74.32 -25.17 59.39 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 119.471 1.032 . . . . 0.0 109.896 179.397 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -58.64 -40.89 84.66 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.214 -0.929 . . . . 0.0 110.3 169.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -64.0 -36.6 84.52 Favored 'General case' 0 CA--C 1.532 0.282 0 O-C-N 121.48 -0.762 . . . . 0.0 110.905 178.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 29.6 mm -64.29 -45.99 94.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 174.479 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.21 -41.53 79.61 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.475 0.58 . . . . 0.0 111.215 178.054 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -67.86 -42.88 80.66 Favored 'General case' 0 N--CA 1.463 0.212 0 O-C-N 121.738 -0.601 . . . . 0.0 110.994 178.504 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.38 -23.37 64.66 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 119.248 0.931 . . . . 0.0 112.008 178.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 59.1 mt -71.22 -54.98 15.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 169.409 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -59.98 -38.16 81.72 Favored 'General case' 0 C--O 1.225 -0.234 0 CA-C-O 118.928 -0.558 . . . . 0.0 111.6 -173.43 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -59.13 -37.99 78.54 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 118.925 0.784 . . . . 0.0 110.885 -176.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -72.52 -39.93 67.2 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.101 0.561 . . . . 0.0 111.316 178.135 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.3 mp -75.17 -33.59 61.48 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.031 0.378 . . . . 0.0 111.131 -176.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.64 149.42 14.32 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.878 1.228 . . . . 0.0 110.93 -172.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -64.32 -28.47 69.73 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.884 0.873 . . . . 0.0 111.911 -173.579 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -66.87 -25.93 66.64 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.081 0.552 . . . . 0.0 111.426 178.09 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 39.3 t -100.75 -42.15 9.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 124.357 1.063 . . . . 0.0 109.999 -175.387 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -131.7 145.63 51.74 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 119.124 0.874 . . . . 0.0 111.584 -174.043 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -135.67 139.11 43.47 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 123.616 0.766 . . . . 0.0 109.777 178.072 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 92.9 t -101.99 135.07 40.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 C-N-CA 124.373 1.069 . . . . 0.0 109.523 -170.017 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 79.2 m-70 -141.31 137.08 32.17 Favored 'General case' 0 C--N 1.339 0.138 0 C-N-CA 124.62 1.168 . . . . 0.0 111.112 -173.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.31 131.6 43.67 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 168.755 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.6 tp -68.56 -33.52 60.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 O-C-N 121.551 -0.718 . . . . 0.0 111.402 -179.234 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.87 -40.24 94.82 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.98 0.809 . . . . 0.0 112.108 -169.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -75.27 -17.69 60.24 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 118.149 0.431 . . . . 0.0 112.038 178.682 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 53.1 m -75.84 163.63 27.04 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.444 0.64 . . . . 0.0 111.108 -169.148 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 47.1 m -127.33 168.45 14.78 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.159 1.383 . . . . 0.0 109.587 -175.563 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -52.05 -46.15 64.98 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.545 1.138 . . . . 0.0 111.756 -173.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -74.15 -14.4 60.95 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 122.823 0.449 . . . . 0.0 111.827 -173.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -78.82 -30.58 45.42 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 121.393 -0.817 . . . . 0.0 111.248 -170.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.2 mp -79.45 -39.18 32.89 Favored 'General case' 0 C--N 1.345 0.391 0 O-C-N 122.109 -0.37 . . . . 0.0 110.195 171.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -55.35 -28.52 54.39 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.266 1.027 . . . . 0.0 112.274 -176.185 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.44 -29.39 69.52 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.195 0.998 . . . . 0.0 113.438 -178.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -88.12 156.6 19.17 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.068 0.947 . . . . 0.0 110.591 -175.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -99.94 -32.32 11.03 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 123.056 0.542 . . . . 0.0 111.393 170.115 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.1 mp -108.77 128.16 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 172.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -114.7 128.23 56.2 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 170.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.2 mp -109.63 126.84 54.06 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 169.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 67.2 mt -123.18 118.23 27.16 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -169.112 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -111.66 102.66 1.44 Allowed Glycine 0 C--N 1.336 0.528 0 C-N-CA 125.464 1.507 . . . . 0.0 111.881 -170.2 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 17.3 tt -127.34 117.17 21.53 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 123.406 0.682 . . . . 0.0 112.165 -169.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -82.6 150.71 14.83 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 122.883 2.389 . . . . 0.0 110.321 168.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.8 m -96.83 137.98 35.08 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 178.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 19.9 m95 -133.15 175.27 9.53 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.166 1.386 . . . . 0.0 111.129 -171.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 51.06 -91.79 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 128.268 2.627 . . . . 0.0 113.445 -178.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -152.57 81.61 1.23 Allowed 'General case' 0 C--O 1.235 0.318 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 176.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 63.22 50.82 59.77 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 -175.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -121.28 154.15 36.75 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 124.583 1.153 . . . . 0.0 108.326 175.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -73.2 147.93 44.25 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.068 0.461 . . . . 0.0 110.387 169.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 16.2 tp60 -56.22 142.66 36.47 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 167.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 56.8 m -56.2 -32.05 64.03 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.05 0.94 . . . . 0.0 112.41 -170.295 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -57.08 -43.72 82.4 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 123.919 0.887 . . . . 0.0 110.491 178.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -81.94 -41.25 21.11 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 123.664 0.786 . . . . 0.0 110.579 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -58.01 -39.18 77.67 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.154 0.433 . . . . 0.0 111.325 -178.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -70.36 -25.85 63.46 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.466 0.706 . . . . 0.0 112.033 176.411 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -90.88 -23.28 20.57 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 118.613 -0.708 . . . . 0.0 112.567 -177.412 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 20.7 m-30 -49.36 -42.06 61.76 Favored Pre-proline 0 CA--C 1.542 0.652 0 CA-C-O 116.457 -1.735 . . . . 0.0 115.114 -178.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -64.32 -18.11 62.04 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 CA-C-N 122.934 2.084 . . . . 0.0 113.474 176.238 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 25.0 m -88.45 -42.4 12.16 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.095 0.958 . . . . 0.0 109.591 169.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 27.3 tp -55.8 -38.82 70.45 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.308 1.043 . . . . 0.0 111.284 -177.475 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -70.82 -7.75 47.59 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -178.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -95.2 -17.64 21.57 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 119.712 1.142 . . . . 0.0 111.739 171.22 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 97.6 mt -77.04 133.82 30.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 -173.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -82.35 140.01 33.76 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.023 0.929 . . . . 0.0 109.496 175.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -129.58 11.01 5.71 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 118.368 -0.825 . . . . 0.0 111.469 174.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -66.6 123.59 20.49 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 120.742 1.61 . . . . 0.0 109.621 -172.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.72 2.45 50.9 Favored Glycine 0 CA--C 1.537 1.443 0 CA-C-O 117.965 -1.464 . . . . 0.0 114.088 -174.206 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -79.81 150.25 30.77 Favored 'General case' 0 C--N 1.345 0.385 0 CA-C-N 120.222 2.011 . . . . 0.0 107.722 170.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 19.9 mt -91.71 137.45 32.36 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 171.225 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 16.0 t -133.73 142.73 40.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 177.086 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -134.3 151.0 51.02 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 170.309 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -113.54 145.71 40.79 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 124.367 1.067 . . . . 0.0 109.022 -174.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -143.42 159.03 43.14 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 166.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 179.31 177.4 47.69 Favored Glycine 0 N--CA 1.447 -0.598 0 O-C-N 121.184 -0.947 . . . . 0.0 113.282 -177.234 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 20.1 m -134.95 155.31 50.95 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.362 1.065 . . . . 0.0 109.533 -169.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -168.03 -176.09 38.26 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -177.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -132.15 110.85 10.96 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 172.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -75.22 -9.79 58.88 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 117.831 -1.081 . . . . 0.0 113.481 -168.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -110.44 -47.07 3.32 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 120.347 1.43 . . . . 0.0 110.673 -177.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -81.19 -22.27 39.02 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.993 -0.442 . . . . 0.0 111.619 -173.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -126.23 44.36 2.88 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.377 1.471 . . . . 0.0 109.047 172.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.34 -21.93 64.46 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.683 1.193 . . . . 0.0 113.829 -173.211 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -86.83 -2.47 58.6 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.791 0.836 . . . . 0.0 111.911 178.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -141.06 23.79 2.19 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.802 1.241 . . . . 0.0 110.968 -169.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -65.05 123.92 20.73 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 118.86 0.754 . . . . 0.0 110.713 -168.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 69.1 m 52.01 31.54 8.86 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.355 1.462 . . . . 0.0 112.981 178.473 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -57.51 -37.72 73.46 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.638 -0.663 . . . . 0.0 112.279 -178.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.35 -26.49 67.31 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -169.329 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.8 mp -62.38 -36.16 81.43 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.48 -0.763 . . . . 0.0 109.268 176.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -67.78 -29.21 73.58 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 123.651 0.643 . . . . 0.0 111.853 175.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.1 m -65.97 -36.71 84.07 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 118.801 1.301 . . . . 0.0 110.353 176.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 5.1 mt -68.69 -47.83 74.59 Favored 'Isoleucine or valine' 0 C--N 1.343 0.283 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 173.044 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 40.4 ttt-85 -49.89 -45.96 51.3 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 119.03 0.832 . . . . 0.0 111.037 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -60.36 -22.27 63.08 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.013 0.925 . . . . 0.0 112.759 -177.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 86.1 mt -96.2 -47.84 12.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 124.359 1.064 . . . . 0.0 109.681 178.106 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 30.4 pt -75.05 -31.44 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 119.464 1.029 . . . . 0.0 111.698 -170.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -66.81 -50.85 42.07 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-O 117.584 -1.198 . . . . 0.0 111.722 -176.057 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -67.6 -24.56 41.64 Favored 'Trans proline' 0 C--N 1.353 0.767 0 CA-C-N 122.079 1.778 . . . . 0.0 112.276 176.131 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 81.1 mmt-85 -75.23 6.33 4.51 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.619 0.768 . . . . 0.0 113.043 170.087 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 85.22 11.81 74.92 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-O 118.147 -1.363 . . . . 0.0 114.686 168.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -56.17 138.04 50.67 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 119.293 1.547 . . . . 0.0 110.433 174.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 61.7 m -90.13 118.99 30.09 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 104.392 -2.447 . . . . 0.0 104.392 167.133 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 47.5 mt -101.47 130.75 50.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 -170.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 34.6 m -133.03 173.89 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 125.093 1.357 . . . . 0.0 109.245 177.665 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 81.32 28.47 44.27 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-O 119.507 -0.607 . . . . 0.0 112.948 176.278 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 67.0 m80 -58.39 146.13 35.86 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 118.06 0.93 . . . . 0.0 109.593 170.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 59.2 t-105 -131.4 135.97 27.88 Favored Pre-proline 0 CA--C 1.534 0.343 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 -177.301 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -67.14 139.89 52.06 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.003 1.802 . . . . 0.0 110.859 -174.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.4 t . . . . . 0 CA--C 1.543 0.687 0 C-N-CA 123.459 0.704 . . . . 0.0 110.748 176.88 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 88.8 mttt . . . . . 0 N--CA 1.469 0.508 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -81.99 6.7 65.68 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-N 118.62 0.646 . . . . 0.0 112.719 169.275 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 79.5 mt -64.83 142.16 58.53 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 118.586 1.193 . . . . 0.0 111.345 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -116.77 -16.89 10.61 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.999 1.32 . . . . 0.0 110.385 168.449 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -143.08 156.57 44.84 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 127.191 2.196 . . . . 0.0 106.126 173.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -54.76 -23.69 19.05 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.572 1.149 . . . . 0.0 113.707 -173.042 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -124.33 11.29 8.7 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.884 0.873 . . . . 0.0 113.334 177.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -138.42 129.36 26.83 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 120.52 -1.363 . . . . 0.0 112.096 -176.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -70.01 153.11 43.63 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.445 1.098 . . . . 0.0 109.048 168.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 9.7 p -62.44 -24.78 36.13 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 123.604 0.762 . . . . 0.0 111.244 173.135 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -157.9 179.4 33.65 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 123.557 0.599 . . . . 0.0 112.171 -169.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -70.92 110.01 5.4 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 123.56 0.744 . . . . 0.0 109.478 -178.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.375 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 167.999 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 11.4 mt . . . . . 0 CA--C 1.539 0.556 0 N-CA-C 111.622 0.23 . . . . 0.0 111.622 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 35.9 m -43.18 -61.13 1.41 Allowed 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 126.499 1.919 . . . . 0.0 112.737 -167.554 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -70.97 -35.84 72.3 Favored 'General case' 0 N--CA 1.452 -0.346 0 O-C-N 121.845 -0.535 . . . . 0.0 111.032 -169.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -72.72 -30.22 64.01 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.873 0.761 . . . . 0.0 111.278 178.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 74.1 mtp85 -63.3 -43.41 97.95 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 119.703 1.138 . . . . 0.0 109.515 172.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 66.2 t -66.03 -41.61 90.0 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.246 0 CA-C-O 118.325 -0.845 . . . . 0.0 109.023 178.137 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -59.94 -49.53 77.31 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 120.483 1.492 . . . . 0.0 110.487 176.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -61.84 -39.78 93.01 Favored 'General case' 0 N--CA 1.462 0.144 0 O-C-N 122.014 -0.428 . . . . 0.0 110.47 -176.359 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 60.9 t90 -70.73 -48.72 53.05 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 118.344 0.52 . . . . 0.0 110.642 178.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 55.6 t -60.77 -39.63 82.35 Favored 'Isoleucine or valine' 0 C--O 1.231 0.108 0 C-N-CA 123.041 0.536 . . . . 0.0 110.339 -175.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -68.0 -36.34 79.82 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 121.632 -0.668 . . . . 0.0 109.919 -177.162 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 46.8 mm-40 -67.73 -50.38 57.66 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 122.911 0.484 . . . . 0.0 110.677 174.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 6.3 pt -66.77 -31.87 55.47 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.313 0 CA-C-N 119.151 0.887 . . . . 0.0 110.937 -176.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 66.1 m -59.03 -37.39 76.83 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.316 0.962 . . . . 0.0 111.716 -179.46 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -83.69 -31.02 26.32 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 119.339 0.972 . . . . 0.0 111.788 178.221 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -68.4 -36.46 79.16 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 118.733 0.697 . . . . 0.0 110.783 176.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 76.9 mt -81.63 -3.3 53.1 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.881 1.673 . . . . 0.0 111.612 174.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . 0.324 1.3 p-80 50.12 19.11 0.45 Allowed 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 129.88 3.272 . . . . 0.0 114.719 -174.002 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 4.6 pp . . . . . 0 N--CA 1.462 0.164 0 C-N-CA 123.103 0.561 . . . . 0.0 111.505 176.828 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.261 0 CA-C-O 121.093 0.473 . . . . 0.0 111.723 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.4 pt -119.65 -12.63 9.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 125.37 1.468 . . . . 0.0 111.537 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.1 m -114.58 127.03 55.57 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 125.35 1.46 . . . . 0.0 107.934 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -99.38 116.35 5.56 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 108.114 -1.994 . . . . 0.0 108.114 169.087 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 60.2 mt -92.55 119.96 41.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 N-CA-C 104.899 -2.259 . . . . 0.0 104.899 171.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -116.82 133.47 55.97 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 176.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -134.14 163.71 28.98 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 122.833 0.453 . . . . 0.0 111.591 -173.443 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -131.23 144.38 15.92 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 107.92 -2.072 . . . . 0.0 107.92 166.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 9.1 m -166.65 155.18 10.37 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-N 119.356 1.578 . . . . 0.0 110.127 176.36 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -115.61 -50.4 2.71 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.964 0.906 . . . . 0.0 109.841 167.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.6 p -86.92 8.43 23.15 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.819 1.248 . . . . 0.0 112.802 177.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 80.31 2.91 89.69 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 124.687 1.137 . . . . 0.0 115.609 169.477 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -70.2 -49.05 54.15 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 119.593 1.696 . . . . 0.0 112.375 -174.567 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 10.2 m -74.08 -26.62 60.48 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 120.546 1.521 . . . . 0.0 109.614 -178.448 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -60.48 -43.49 96.91 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.82 0.848 . . . . 0.0 110.157 169.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -64.69 -41.81 95.78 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 121.467 -0.771 . . . . 0.0 110.72 176.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 46.2 mm -59.29 -45.76 92.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-N 118.561 0.619 . . . . 0.0 109.332 175.36 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.65 -44.57 85.75 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.483 0.713 . . . . 0.0 110.952 178.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -66.52 -41.45 88.76 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 118.691 -0.671 . . . . 0.0 110.719 179.095 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 94.4 mtp -62.33 -40.3 95.89 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 119.531 1.059 . . . . 0.0 110.623 177.44 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 34.5 mt -63.33 -42.75 97.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 119.028 0.831 . . . . 0.0 109.152 175.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -59.71 -41.32 90.54 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 119.204 0.911 . . . . 0.0 110.921 177.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -64.53 -35.41 80.88 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 118.839 0.745 . . . . 0.0 110.463 178.564 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -67.72 -46.93 70.79 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.039 0.536 . . . . 0.0 110.697 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -76.77 -31.97 57.39 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 118.724 0.693 . . . . 0.0 111.523 -178.034 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.79 146.27 20.67 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 125.389 1.471 . . . . 0.0 110.798 -173.391 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -64.14 -28.78 70.0 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.949 0.9 . . . . 0.0 111.807 -174.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -78.58 -3.78 45.52 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 178.562 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 48.3 t -113.8 -38.13 2.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 124.791 1.236 . . . . 0.0 109.708 178.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -129.74 142.37 50.71 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 119.307 0.958 . . . . 0.0 111.741 -176.225 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -119.47 159.53 24.1 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.01 1.724 . . . . 0.0 108.493 172.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 48.4 t -133.46 130.22 56.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 C-N-CA 124.601 1.161 . . . . 0.0 109.515 -169.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -144.99 150.36 36.78 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.168 0.987 . . . . 0.0 111.625 174.31 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -72.45 134.84 45.55 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 166.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.2 tp -56.81 -32.33 38.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 118.697 0.68 . . . . 0.0 111.621 -173.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.65 -28.51 69.97 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.9 0.773 . . . . 0.0 112.243 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -82.06 -17.31 47.11 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.299 0.64 . . . . 0.0 110.597 178.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.9 t -75.52 174.17 10.03 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 122.117 0.961 . . . . 0.0 110.377 174.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.426 ' H ' ' HB3' ' A' ' 43' ' ' ASP . 21.3 m -145.53 167.09 23.87 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 127.726 2.41 . . . . 0.0 107.676 -177.56 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -52.68 -49.79 64.57 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.294 0.638 . . . . 0.0 110.843 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -76.0 -15.78 60.08 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 122.735 0.414 . . . . 0.0 111.701 -175.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.426 ' HB3' ' H ' ' A' ' 40' ' ' SER . 34.0 t70 -81.62 -37.05 28.19 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 121.685 -0.635 . . . . 0.0 110.233 -178.558 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.78 -43.65 88.14 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-N 118.345 0.52 . . . . 0.0 109.894 168.488 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -62.42 -20.98 65.05 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.4 0.68 . . . . 0.0 112.321 -177.02 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.25 -28.08 69.49 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.449 0.7 . . . . 0.0 112.009 177.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -103.47 138.45 40.17 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.559 1.144 . . . . 0.0 110.541 -176.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -88.39 -29.85 19.95 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.0 171.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.5 mm -106.4 128.76 60.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 178.383 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 88.6 mt -129.22 140.58 51.42 Favored 'General case' 0 CA--C 1.52 -0.208 0 C-N-CA 123.034 0.534 . . . . 0.0 109.809 -175.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -122.36 126.87 48.95 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 172.183 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 67.3 mt -121.07 122.02 39.16 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -173.296 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -117.75 103.92 1.11 Allowed Glycine 0 CA--C 1.524 0.609 0 C-N-CA 125.349 1.452 . . . . 0.0 112.45 -169.363 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 16.9 tt -127.17 111.98 21.56 Favored Pre-proline 0 CA--C 1.542 0.657 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -169.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -75.76 147.84 31.68 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 122.287 1.991 . . . . 0.0 108.983 167.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 44.3 m -95.62 137.18 35.05 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 176.369 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 23.9 m95 -134.49 172.04 13.47 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.655 1.182 . . . . 0.0 111.43 -173.014 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 58.55 -79.53 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 128.565 2.746 . . . . 0.0 113.663 172.459 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -152.18 51.41 0.79 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.843 2.057 . . . . 0.0 108.923 -171.233 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.42 37.87 62.47 Favored Glycine 0 CA--C 1.525 0.661 0 O-C-N 121.56 -0.713 . . . . 0.0 111.63 -174.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -115.5 160.0 20.49 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.506 1.123 . . . . 0.0 109.791 -175.503 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.7 160.54 29.26 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.471 169.128 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -75.52 155.98 35.57 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 168.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 59.7 m -55.41 -29.79 59.22 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.84 0.856 . . . . 0.0 112.381 -177.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -65.8 -42.37 90.76 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.094 0.558 . . . . 0.0 110.691 -177.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 80.1 m95 -76.25 -44.35 37.76 Favored 'General case' 0 C--N 1.341 0.226 0 C-N-CA 122.813 0.445 . . . . 0.0 110.094 174.129 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -62.41 -37.11 84.53 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.792 0.437 . . . . 0.0 111.939 -172.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -71.23 -21.69 62.09 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.542 0.737 . . . . 0.0 112.018 175.406 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -90.16 -23.86 21.21 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.459 0.703 . . . . 0.0 111.385 179.131 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -51.02 -42.43 79.96 Favored Pre-proline 0 CA--C 1.544 0.714 0 CA-C-O 116.627 -1.654 . . . . 0.0 114.784 178.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -64.24 -22.94 66.55 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 CA-C-N 122.954 2.091 . . . . 0.0 113.194 174.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.3 m -81.04 -38.0 28.16 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.049 0.94 . . . . 0.0 109.738 170.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 13.4 tp -59.84 -35.23 74.32 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.79 1.236 . . . . 0.0 110.928 -175.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -79.63 -4.46 51.72 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.053 0.941 . . . . 0.0 113.035 177.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -93.73 -24.95 17.64 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 119.612 1.097 . . . . 0.0 111.176 169.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 95.7 mt -67.92 137.6 24.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 -176.277 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -86.83 81.03 8.3 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -177.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -70.0 -5.42 26.28 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 118.381 -0.819 . . . . 0.0 112.843 -176.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 57.1 m-80 -53.44 117.94 3.47 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 119.609 1.095 . . . . 0.0 109.513 -179.141 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 82.44 -4.8 76.21 Favored Glycine 0 CA--C 1.533 1.165 0 CA-C-O 117.849 -1.528 . . . . 0.0 114.47 175.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -64.56 139.68 58.79 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 120.527 2.164 . . . . 0.0 107.894 169.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.7 mt -95.96 124.97 40.2 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 106.487 -1.672 . . . . 0.0 106.487 169.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.2 t -131.07 146.49 33.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -169.263 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -131.41 146.49 52.29 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 169.394 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.2 mt -112.59 142.53 45.06 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 124.211 1.005 . . . . 0.0 109.437 -177.073 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 24.8 p90 -138.51 155.97 47.93 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 168.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -168.77 169.15 41.58 Favored Glycine 0 N--CA 1.447 -0.586 0 O-C-N 121.469 -0.769 . . . . 0.0 111.654 -176.063 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 56.5 m -136.27 156.01 49.28 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.242 1.017 . . . . 0.0 109.192 -171.095 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -170.89 -167.26 30.99 Favored Glycine 0 CA--C 1.526 0.777 0 O-C-N 123.256 0.348 . . . . 0.0 112.601 -173.215 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -138.56 141.69 39.25 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 126.509 1.924 . . . . 0.0 109.176 177.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -110.89 -11.8 14.32 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.981 1.312 . . . . 0.0 111.889 -177.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -84.95 -31.68 23.46 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 118.416 0.553 . . . . 0.0 111.245 -168.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -128.33 -39.34 1.7 Allowed 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.348 0.659 . . . . 0.0 111.714 173.293 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -83.15 32.97 0.44 Allowed 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 118.419 0.554 . . . . 0.0 112.149 -177.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.27 -27.68 69.21 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.654 1.182 . . . . 0.0 113.259 -172.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -79.43 -0.2 31.98 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.023 0.929 . . . . 0.0 111.602 176.175 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -140.91 16.56 2.3 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 125.481 1.512 . . . . 0.0 110.621 -172.066 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -65.43 115.05 5.28 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 119.561 1.073 . . . . 0.0 108.788 -169.011 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 75.9 m 53.47 34.3 17.97 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.567 1.547 . . . . 0.0 113.178 -174.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -51.01 -43.66 60.87 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.75 1.22 . . . . 0.0 111.741 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.53 -14.93 63.37 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -169.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 67.5 mt -58.09 -41.62 83.88 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 118.866 0.757 . . . . 0.0 110.055 169.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -65.38 -32.97 85.29 Favored Glycine 0 C--N 1.339 0.744 0 N-CA-C 111.245 -0.742 . . . . 0.0 111.245 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.3 m -65.37 -37.23 86.4 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 118.229 1.015 . . . . 0.0 110.704 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 5.0 mt -73.56 -44.87 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 118.952 0.796 . . . . 0.0 108.97 174.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 35.9 ttt180 -53.28 -44.14 68.01 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 119.297 0.953 . . . . 0.0 110.608 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -61.92 -16.14 48.59 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.691 1.196 . . . . 0.0 113.035 -178.198 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 86.8 mt -101.0 -58.35 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 124.252 1.021 . . . . 0.0 109.095 173.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 20.1 pt -68.75 -32.98 57.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 O-C-N 121.144 -0.972 . . . . 0.0 112.142 -167.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -67.99 -53.4 20.16 Favored Pre-proline 0 CA--C 1.541 0.627 0 CA-C-O 117.671 -1.157 . . . . 0.0 111.242 -176.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -68.45 -23.45 37.67 Favored 'Trans proline' 0 C--N 1.353 0.786 0 CA-C-N 121.708 1.646 . . . . 0.0 112.83 175.261 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 30.9 mmm180 -74.41 -0.56 17.73 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 119.343 0.974 . . . . 0.0 112.17 170.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 94.0 14.69 51.26 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-O 118.558 -1.134 . . . . 0.0 114.999 168.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.26 144.34 57.02 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 119.183 1.492 . . . . 0.0 109.411 170.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 47.0 m -93.59 119.52 32.72 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 104.163 -2.532 . . . . 0.0 104.163 167.18 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 21.4 mt -100.56 130.75 49.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 107.016 -1.475 . . . . 0.0 107.016 -176.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.7 m -133.05 -172.88 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 125.549 1.539 . . . . 0.0 107.948 169.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 70.57 21.3 77.66 Favored Glycine 0 CA--C 1.529 0.963 0 O-C-N 120.979 -1.075 . . . . 0.0 111.572 -171.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 21.3 p-80 -59.19 133.12 55.81 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 168.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 70.7 t-105 -115.73 130.04 24.67 Favored Pre-proline 0 C--O 1.237 0.401 0 C-N-CA 124.573 1.149 . . . . 0.0 108.827 -167.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -67.37 139.58 50.09 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 121.51 1.473 . . . . 0.0 111.034 -175.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 2.1 t . . . . . 0 CA--C 1.545 0.764 0 C-N-CA 123.763 0.825 . . . . 0.0 111.917 -174.879 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.538 0.484 0 CA-C-O 120.052 -0.023 . . . . 0.0 110.955 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -78.28 -1.65 81.55 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-O 118.215 -1.325 . . . . 0.0 114.024 169.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 59.8 mt -63.05 122.49 16.2 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 120.96 2.38 . . . . 0.0 108.21 170.289 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -97.92 -26.91 14.5 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.248 1.019 . . . . 0.0 110.352 177.042 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -144.62 160.03 41.83 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.819 2.047 . . . . 0.0 106.769 175.18 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -55.18 -25.94 35.73 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.931 0.892 . . . . 0.0 112.822 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -111.08 -0.65 16.53 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.471 1.108 . . . . 0.0 113.701 179.159 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 -141.39 133.55 27.86 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 120.206 1.366 . . . . 0.0 113.426 -175.466 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -77.7 152.76 33.55 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 166.464 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 12.5 p -58.92 -28.58 38.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 123.913 0.885 . . . . 0.0 111.323 174.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -155.51 170.53 33.49 Favored Glycine 0 C--N 1.338 0.673 0 C-N-CA 123.957 0.789 . . . . 0.0 111.418 -170.026 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -60.93 126.48 27.51 Favored 'General case' 0 C--N 1.334 -0.073 0 C-N-CA 124.314 1.046 . . . . 0.0 109.176 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.301 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 172.24 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 88.5 mt . . . . . 0 N--CA 1.471 0.61 0 N-CA-C 110.639 -0.134 . . . . 0.0 110.639 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 93.2 m -45.49 -53.74 8.46 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 125.892 1.677 . . . . 0.0 112.165 -169.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -68.45 -38.67 81.32 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 119.226 -0.416 . . . . 0.0 111.36 -169.088 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -73.74 -32.87 64.08 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 118.64 0.655 . . . . 0.0 110.805 178.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 51.9 mtp85 -67.17 -45.77 75.99 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-N 118.791 0.723 . . . . 0.0 109.603 178.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 23.7 m -71.5 -31.68 43.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-O 118.083 -0.96 . . . . 0.0 110.564 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -58.8 -56.83 17.15 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 120.378 1.445 . . . . 0.0 109.59 172.535 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -60.54 -34.39 74.06 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 122.992 0.517 . . . . 0.0 110.798 -175.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 33.1 t90 -77.86 -50.0 13.13 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 117.975 0.352 . . . . 0.0 110.796 -178.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 66.5 t -63.87 -32.41 56.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 O-C-N 120.782 -1.199 . . . . 0.0 110.151 -176.208 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -59.95 -35.91 75.95 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 117.981 -1.009 . . . . 0.0 111.566 175.306 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . 0.251 13.2 pt20 -75.71 -50.71 14.57 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 119.552 1.069 . . . . 0.0 111.012 171.694 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 1.4 pt -64.51 -32.07 56.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-N 120.096 1.316 . . . . 0.0 111.552 -169.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 6.3 p -61.43 -38.47 87.27 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 118.468 -0.777 . . . . 0.0 110.858 -178.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -82.7 -36.83 25.52 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 119.724 1.147 . . . . 0.0 111.38 175.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 63.1 mt-10 -70.59 -34.02 71.71 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 118.606 0.639 . . . . 0.0 111.749 -175.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 64.1 mt -86.71 1.23 52.8 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.008 1.323 . . . . 0.0 110.971 175.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 56.17 32.35 20.03 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.856 1.662 . . . . 0.0 112.984 -176.149 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 90.6 mt . . . . . 0 N--CA 1.465 0.304 0 C-N-CA 123.364 0.666 . . . . 0.0 109.584 173.428 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.359 0 N-CA-C 110.305 -0.257 . . . . 0.0 110.305 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.8 pt -82.71 -19.33 10.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -174.457 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.8 m -115.09 127.39 55.58 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.203 1.401 . . . . 0.0 108.416 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -102.63 117.4 5.78 Favored Glycine 0 CA--C 1.52 0.394 0 N-CA-C 107.914 -2.074 . . . . 0.0 107.914 170.179 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 64.9 mt -96.29 93.83 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 176.578 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -88.37 132.83 34.28 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 177.123 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -130.64 128.62 41.34 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 119.207 0.912 . . . . 0.0 112.167 179.012 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -93.53 142.85 16.18 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 107.54 -2.224 . . . . 0.0 107.54 166.514 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.4 t -156.14 175.18 14.31 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 119.279 1.539 . . . . 0.0 109.285 172.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -122.09 -54.78 1.9 Allowed 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.041 0.537 . . . . 0.0 110.226 169.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.1 p -94.9 -0.37 54.04 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.144 0.978 . . . . 0.0 112.597 175.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 90.15 15.36 57.63 Favored Glycine 0 C--N 1.343 0.949 0 CA-C-O 118.963 -0.91 . . . . 0.0 114.256 169.416 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -68.28 -39.9 82.01 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 119.787 1.794 . . . . 0.0 110.526 175.587 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.79 -29.52 68.27 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 119.131 0.878 . . . . 0.0 111.346 175.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -64.41 -40.34 95.58 Favored 'General case' 0 C--N 1.343 0.285 0 CA-C-N 118.819 0.736 . . . . 0.0 109.604 176.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -65.31 -41.95 93.53 Favored 'General case' 0 CA--C 1.529 0.146 0 O-C-N 121.976 -0.453 . . . . 0.0 110.335 178.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 48.1 mm -60.17 -48.6 87.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 174.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.48 -43.37 98.98 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.42 0.688 . . . . 0.0 111.538 -178.381 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 54.7 mttm -63.69 -44.03 94.87 Favored 'General case' 0 C--N 1.338 0.106 0 CA-C-O 118.331 -0.842 . . . . 0.0 110.386 178.099 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 69.6 mtm -59.39 -47.64 84.69 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-N 119.2 0.909 . . . . 0.0 109.76 177.365 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 62.6 mt -57.19 -46.76 84.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.06 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -62.71 -40.57 97.56 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 119.503 1.047 . . . . 0.0 111.024 -179.212 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -63.25 -38.34 90.76 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 119.424 1.011 . . . . 0.0 110.723 177.121 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -69.51 -39.44 77.55 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.187 0.595 . . . . 0.0 110.813 178.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.1 mp -79.0 -35.43 42.89 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.921 0.889 . . . . 0.0 111.655 -176.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 94.43 145.3 17.95 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 125.236 1.398 . . . . 0.0 110.903 -171.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.1 ptpt -65.32 -28.71 69.5 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -172.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -68.22 -29.52 68.37 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 122.863 0.465 . . . . 0.0 111.011 176.438 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 49.1 t -91.21 -37.44 9.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 C-N-CA 124.186 0.994 . . . . 0.0 110.161 -175.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -135.78 146.33 47.49 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-N 119.285 0.948 . . . . 0.0 113.222 -174.584 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -130.66 144.9 51.74 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.713 1.205 . . . . 0.0 109.295 171.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 80.1 t -98.14 140.49 17.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.442 0 C-N-CA 124.078 0.951 . . . . 0.0 109.051 -174.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -149.22 172.82 14.22 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.677 1.191 . . . . 0.0 111.255 -169.448 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -141.64 127.05 18.77 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 126.973 2.109 . . . . 0.0 107.117 -173.527 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.6 tp -58.91 -31.41 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-O 118.831 -0.604 . . . . 0.0 111.231 -172.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.61 -26.47 68.41 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 118.698 0.681 . . . . 0.0 111.488 -177.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -89.56 -15.35 33.06 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.48 1.112 . . . . 0.0 111.516 177.036 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 53.0 p -84.38 175.88 9.06 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 118.76 0.709 . . . . 0.0 111.597 -174.318 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.2 m -137.55 167.44 21.66 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.651 1.58 . . . . 0.0 108.361 176.574 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -51.41 -48.48 62.64 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.884 0.874 . . . . 0.0 111.794 -177.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -81.55 -11.69 59.07 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 122.707 0.403 . . . . 0.0 111.608 -175.081 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -77.56 -31.15 53.0 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 121.399 -0.813 . . . . 0.0 111.457 -172.007 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.6 mp -68.34 -36.7 79.65 Favored 'General case' 0 C--N 1.344 0.348 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 172.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -69.88 -14.05 62.55 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.656 0.782 . . . . 0.0 111.988 -173.077 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.1 -30.13 68.36 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.738 0.815 . . . . 0.0 111.709 175.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -82.81 152.17 25.78 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 123.92 0.888 . . . . 0.0 110.211 178.125 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -92.0 -41.6 10.45 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.208 169.093 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 21.7 mt -108.25 130.74 60.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 92.3 mt -113.84 130.28 56.49 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 171.435 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.2 mp -111.64 115.87 29.85 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 104.52 -2.4 . . . . 0.0 104.52 169.248 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 64.6 mt -116.27 110.48 18.8 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -171.473 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -93.74 125.89 8.42 Favored Glycine 0 CA--C 1.521 0.427 0 N-CA-C 109.18 -1.568 . . . . 0.0 109.18 176.222 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 16.5 tt -139.28 133.07 15.89 Favored Pre-proline 0 CA--C 1.537 0.48 0 CA-C-N 118.842 1.321 . . . . 0.0 111.346 -177.199 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -92.41 153.86 3.03 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 122.408 2.072 . . . . 0.0 110.327 176.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.7 m -108.95 126.5 53.16 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 171.397 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 61.9 m95 -130.57 170.9 13.65 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 125.368 1.467 . . . . 0.0 109.063 178.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 44.23 49.12 7.82 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.351 1.861 . . . . 0.0 114.279 168.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 55.08 65.02 1.61 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.379 1.071 . . . . 0.0 111.06 176.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.85 47.68 5.5 Favored Glycine 0 CA--C 1.532 1.124 0 CA-C-N 115.854 -0.612 . . . . 0.0 113.219 171.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -128.48 157.74 40.3 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.177 1.391 . . . . 0.0 108.544 168.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -90.88 175.38 7.0 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.507 0.723 . . . . 0.0 109.925 170.374 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -62.39 146.84 50.25 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 107.942 -1.132 . . . . 0.0 107.942 169.261 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 62.3 m -56.77 -41.27 77.34 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -168.434 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -71.01 -40.31 71.88 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.238 0.926 . . . . 0.0 110.691 -178.011 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -62.38 -43.86 97.83 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.328 0.651 . . . . 0.0 110.135 175.599 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -61.9 -42.2 98.81 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 123.513 0.725 . . . . 0.0 110.79 178.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -68.63 -18.77 64.36 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.907 0.883 . . . . 0.0 112.309 176.408 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 29.7 t80 -86.04 -18.76 31.61 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 121.604 -0.685 . . . . 0.0 112.343 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -54.09 -43.03 96.41 Favored Pre-proline 0 CA--C 1.543 0.706 0 CA-C-O 116.807 -1.568 . . . . 0.0 114.138 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -63.75 -21.93 69.59 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 CA-C-N 122.475 1.92 . . . . 0.0 113.554 174.065 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.9 m -79.47 -40.28 30.18 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 119.57 1.077 . . . . 0.0 109.357 170.037 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 14.5 tp -59.63 -38.65 81.91 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.18 0.992 . . . . 0.0 110.955 -174.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -76.79 -4.77 45.21 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.698 0.799 . . . . 0.0 112.981 178.223 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 48.3 mm-40 -98.13 -18.6 18.41 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.188 0.995 . . . . 0.0 110.535 171.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 77.5 mt -77.68 148.93 6.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 172.071 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -115.97 133.13 56.35 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -117.12 15.79 15.0 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.632 0.773 . . . . 0.0 111.688 -172.212 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 33.2 m-80 -56.36 119.28 5.75 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 120.049 1.295 . . . . 0.0 109.319 177.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 79.83 -2.84 72.42 Favored Glycine 0 CA--C 1.535 1.327 0 CA-C-O 118.493 -1.171 . . . . 0.0 114.573 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -78.06 143.73 37.17 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 119.995 1.897 . . . . 0.0 107.209 173.435 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 14.5 mt -92.55 135.82 33.74 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 171.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 16.8 t -133.61 134.64 56.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -124.49 146.6 48.87 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 171.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 69.0 mt -118.92 147.48 43.96 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -174.178 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -142.26 159.71 41.69 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 168.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -171.41 159.47 31.2 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 119.343 -1.408 . . . . 0.0 115.347 -174.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 6.9 m -107.67 142.45 37.61 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 113.405 -1.397 . . . . 0.0 108.798 -170.103 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -170.89 174.88 44.74 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -178.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -144.71 122.87 12.17 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.774 0.83 . . . . 0.0 110.203 177.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -78.76 71.27 5.21 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.111 1.364 . . . . 0.0 109.234 174.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -131.06 -112.32 0.25 Allowed 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 173.015 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -72.93 -22.66 60.69 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 119.379 0.991 . . . . 0.0 111.94 -174.06 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -82.98 34.06 0.45 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.107 1.763 . . . . 0.0 111.163 -177.398 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.39 -23.2 65.62 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 -167.318 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -97.91 -1.66 42.41 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 118.937 0.789 . . . . 0.0 112.142 177.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -126.39 16.29 7.69 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.306 1.442 . . . . 0.0 111.354 -169.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -63.89 125.34 24.09 Favored 'General case' 0 C--O 1.236 0.358 0 O-C-N 121.593 -0.692 . . . . 0.0 110.172 -170.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 71.1 m 48.12 32.63 3.09 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.655 1.982 . . . . 0.0 113.723 -178.048 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -54.75 -34.72 62.92 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.587 0.755 . . . . 0.0 112.755 -178.324 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -62.87 -24.99 68.07 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -174.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 69.9 mt -58.69 -45.26 89.87 Favored 'General case' 0 C--N 1.344 0.337 0 O-C-N 121.497 -0.752 . . . . 0.0 109.965 173.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -65.01 -32.7 85.07 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.7 m -64.99 -36.01 83.02 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.25 1.025 . . . . 0.0 110.72 178.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 17.8 mt -69.54 -52.85 28.44 Favored 'Isoleucine or valine' 0 C--N 1.347 0.476 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 171.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 50.5 ttt180 -51.01 -47.13 61.67 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.341 0.656 . . . . 0.0 111.16 -172.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -61.91 -16.03 47.61 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.649 1.18 . . . . 0.0 112.806 -175.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 97.9 mt -100.83 -55.82 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 C-N-CA 124.268 1.027 . . . . 0.0 109.28 173.405 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 48.2 pt -67.56 -34.45 68.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 119.946 1.248 . . . . 0.0 112.284 -167.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -67.65 -53.21 22.98 Favored Pre-proline 0 CA--C 1.546 0.794 0 CA-C-O 117.71 -1.138 . . . . 0.0 110.701 -175.473 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -68.93 -23.33 34.84 Favored 'Trans proline' 0 C--N 1.353 0.801 0 CA-C-N 121.652 1.626 . . . . 0.0 112.928 174.439 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 31.3 mmm180 -77.39 8.94 3.59 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 119.482 1.037 . . . . 0.0 112.274 171.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 94.73 3.33 62.52 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-O 118.194 -1.337 . . . . 0.0 116.218 167.174 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.1 142.87 56.36 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 119.622 1.711 . . . . 0.0 110.075 177.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 57.8 m -88.61 119.5 29.12 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 104.798 -2.297 . . . . 0.0 104.798 168.347 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 19.7 mm -95.19 132.86 38.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 -171.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 19.3 m -137.93 171.53 15.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 124.979 1.312 . . . . 0.0 109.039 176.009 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 79.51 23.21 63.1 Favored Glycine 0 CA--C 1.526 0.775 0 CA-C-O 119.048 -0.862 . . . . 0.0 113.367 175.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 28.3 p-80 -61.23 135.99 57.91 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 168.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 39.0 t-105 -122.84 135.29 25.63 Favored Pre-proline 0 CA--C 1.533 0.315 0 C-N-CA 124.759 1.224 . . . . 0.0 108.249 -169.005 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -66.85 139.6 52.49 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 121.83 1.687 . . . . 0.0 111.316 -174.588 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 65.0 p . . . . . 0 CA--C 1.535 0.389 0 C-N-CA 123.018 0.527 . . . . 0.0 111.16 -178.594 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 67.6 mttm . . . . . 0 N--CA 1.472 0.631 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -88.09 5.53 84.7 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 124.13 0.872 . . . . 0.0 112.419 168.044 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 96.1 mt -67.52 134.26 50.97 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 118.982 1.391 . . . . 0.0 110.253 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -96.21 -34.45 11.65 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 166.244 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -145.88 161.28 40.38 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 128.152 2.581 . . . . 0.0 105.81 168.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -58.67 -25.19 62.54 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 120.627 -1.295 . . . . 0.0 112.112 178.437 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -92.04 -9.6 42.18 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.201 1.0 . . . . 0.0 113.347 176.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 63.1 m80 -143.39 123.63 13.78 Favored 'General case' 0 C--N 1.346 0.426 0 CA-C-N 120.216 1.371 . . . . 0.0 112.398 -175.308 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -73.34 152.16 41.0 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 166.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 9.3 p -64.29 -21.71 29.61 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 O-C-N 121.811 -0.556 . . . . 0.0 111.228 175.282 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -155.66 175.14 33.6 Favored Glycine 0 C--N 1.339 0.705 0 C-N-CA 123.792 0.71 . . . . 0.0 111.776 -172.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -71.94 104.02 3.38 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.809 0.844 . . . . 0.0 109.12 -177.476 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.297 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 169.227 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 75.2 mt . . . . . 0 N--CA 1.468 0.447 0 N-CA-C 110.353 -0.24 . . . . 0.0 110.353 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 58.4 m -41.02 -54.44 2.78 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 127.516 2.326 . . . . 0.0 112.982 -169.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -76.8 -32.07 57.39 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -173.127 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -71.75 -38.84 70.33 Favored 'General case' 0 CA--C 1.529 0.157 0 O-C-N 121.913 -0.492 . . . . 0.0 109.939 178.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 74.1 mtp85 -66.49 -41.81 88.36 Favored 'General case' 0 N--CA 1.462 0.173 0 O-C-N 121.682 -0.637 . . . . 0.0 110.445 -178.098 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 34.4 m -70.39 -27.8 32.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 119.077 0.853 . . . . 0.0 111.195 177.191 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -65.49 -53.74 38.25 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 120.647 1.567 . . . . 0.0 109.583 172.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -61.63 -36.45 80.79 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 117.795 0.27 . . . . 0.0 110.888 -177.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 35.3 t90 -75.43 -46.64 31.46 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 118.178 0.445 . . . . 0.0 111.077 -178.009 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 42.5 t -59.89 -36.5 67.07 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.094 0 CA-C-N 118.581 0.628 . . . . 0.0 110.084 177.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -64.08 -40.84 97.14 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 117.937 -1.03 . . . . 0.0 110.654 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -69.27 -48.03 62.88 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 119.556 1.071 . . . . 0.0 110.659 175.265 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 7.5 pt -66.8 -29.82 47.64 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.333 0 CA-C-N 119.705 1.139 . . . . 0.0 110.759 -173.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 51.1 m -61.81 -29.29 70.06 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 117.877 -1.058 . . . . 0.0 112.459 176.18 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -92.16 -24.16 19.17 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 120.52 1.509 . . . . 0.0 111.641 175.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -73.02 -36.29 66.94 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 118.674 0.67 . . . . 0.0 110.794 174.412 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 66.1 mt -93.45 -9.16 39.48 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.349 1.86 . . . . 0.0 111.794 -179.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 39.2 m80 56.25 29.94 15.76 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.615 1.566 . . . . 0.0 112.911 -169.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 73.3 mt . . . . . 0 N--CA 1.468 0.427 0 O-C-N 121.457 -0.777 . . . . 0.0 110.909 169.874 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.399 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 31.0 pt -85.78 -22.69 7.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 123.393 0.677 . . . . 0.0 111.444 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 26.3 m -114.63 134.73 54.84 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.738 1.615 . . . . 0.0 109.09 -177.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -107.19 122.32 6.85 Favored Glycine 0 CA--C 1.52 0.401 0 N-CA-C 107.442 -2.263 . . . . 0.0 107.442 168.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 54.4 mt -100.62 91.69 2.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.14 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 176.141 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -88.16 130.33 35.08 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 -179.166 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 16.1 p90 -130.74 132.07 45.12 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 119.435 1.016 . . . . 0.0 112.338 179.274 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -86.54 149.76 22.87 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 168.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.8 m -167.9 157.78 10.17 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.936 1.368 . . . . 0.0 110.643 173.421 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -121.68 -52.89 2.0 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.953 0.901 . . . . 0.0 109.948 168.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.0 p -88.53 7.72 31.71 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.551 1.14 . . . . 0.0 112.733 174.318 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 84.92 -4.73 84.73 Favored Glycine 0 CA--C 1.533 1.174 0 N-CA-C 116.621 1.408 . . . . 0.0 116.621 168.309 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -61.88 -35.47 78.42 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 120.243 2.022 . . . . 0.0 113.696 -169.737 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 12.8 m -70.82 -17.29 62.76 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 119.524 1.056 . . . . 0.0 110.665 -175.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -60.19 -41.87 93.83 Favored 'General case' 0 C--N 1.342 0.278 0 O-C-N 121.118 -0.989 . . . . 0.0 110.338 175.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -64.42 -39.0 92.98 Favored 'General case' 0 C--N 1.339 0.127 0 O-C-N 122.072 -0.393 . . . . 0.0 110.306 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.0 mm -64.37 -46.37 93.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.267 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.72 -42.45 98.97 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.296 0.639 . . . . 0.0 111.531 178.296 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 54.8 mttm -64.57 -43.39 94.03 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 118.88 -0.581 . . . . 0.0 110.858 178.118 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 72.6 mtm -62.5 -39.64 94.15 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 119.169 0.895 . . . . 0.0 110.733 178.427 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 62.9 mt -60.11 -48.49 87.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 175.069 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -59.21 -39.61 83.2 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.803 0.729 . . . . 0.0 111.058 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -68.11 -36.43 79.75 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 119.432 1.014 . . . . 0.0 111.026 178.061 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 19.4 mm100 -65.78 -49.6 67.73 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.574 0.625 . . . . 0.0 111.529 -178.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.97 -8.22 34.34 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -175.637 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.42 143.3 12.22 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 125.119 1.342 . . . . 0.0 112.122 175.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.2 pttp -70.09 -23.64 63.09 Favored 'General case' 0 N--CA 1.469 0.489 0 O-C-N 121.584 -0.95 . . . . 0.0 113.082 -178.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -60.37 -34.74 74.3 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 122.985 0.514 . . . . 0.0 110.763 171.243 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 62.1 t -83.69 -42.48 17.42 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-O 118.001 -0.999 . . . . 0.0 110.136 178.005 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -132.77 147.08 52.31 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-N 119.838 1.199 . . . . 0.0 114.182 -170.484 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -120.97 140.87 51.29 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 123.831 0.852 . . . . 0.0 109.696 169.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 94.6 t -85.97 139.26 17.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -147.01 170.65 16.67 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.29 1.036 . . . . 0.0 111.881 -168.169 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -145.65 125.19 13.2 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 125.79 1.636 . . . . 0.0 108.641 -170.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.4 tp -63.08 -29.14 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-O 118.967 -0.54 . . . . 0.0 111.747 -171.363 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.03 -28.44 69.49 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 118.945 0.793 . . . . 0.0 111.692 -176.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -101.27 -7.21 23.24 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.674 0.79 . . . . 0.0 112.299 175.224 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 42.5 m -75.43 171.48 14.18 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 123.649 0.78 . . . . 0.0 110.547 177.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 14.1 m -139.26 160.53 39.6 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.819 1.248 . . . . 0.0 108.875 178.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -53.79 -46.85 71.15 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.073 0.949 . . . . 0.0 111.455 -174.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -80.92 -15.26 56.77 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 122.571 0.349 . . . . 0.0 111.551 -176.375 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -77.95 -29.71 50.02 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 121.439 -0.788 . . . . 0.0 111.213 -175.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -59.41 -41.5 89.6 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.111 0.564 . . . . 0.0 109.709 169.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -72.96 -13.17 61.19 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.637 0.775 . . . . 0.0 112.315 -170.236 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.71 -30.56 70.1 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.446 0.698 . . . . 0.0 111.91 176.565 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -82.37 155.96 24.45 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.99 0.916 . . . . 0.0 110.284 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -104.49 -24.3 13.04 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.821 169.397 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.3 mp -118.37 127.93 75.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 176.253 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -114.63 119.71 37.66 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 175.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.9 mp -105.98 117.95 35.34 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 105.282 -2.118 . . . . 0.0 105.282 169.169 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 66.9 mt -119.99 108.38 14.23 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 -169.644 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.81 120.32 6.52 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 125.679 1.609 . . . . 0.0 109.708 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.0 tt -134.24 112.29 12.07 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 118.104 0.952 . . . . 0.0 110.466 -176.403 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -74.83 143.69 29.98 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.391 2.061 . . . . 0.0 109.202 169.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 30.3 m -96.41 136.65 36.62 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 174.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 63.7 m95 -134.45 171.91 13.64 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 124.754 1.222 . . . . 0.0 109.992 -178.161 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 42.7 46.42 4.38 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 127.016 2.127 . . . . 0.0 114.285 167.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 57.46 69.43 0.74 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.509 1.124 . . . . 0.0 111.323 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.52 33.33 22.6 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 115.629 -0.714 . . . . 0.0 113.94 169.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -119.53 164.5 15.72 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 125.399 1.48 . . . . 0.0 109.632 175.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -96.53 170.88 8.91 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 123.983 0.913 . . . . 0.0 108.791 168.261 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 47.1 mm-40 -70.02 148.85 48.34 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 169.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 58.6 m -59.47 -35.18 73.59 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -168.365 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -72.29 -29.14 63.6 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.249 0.619 . . . . 0.0 111.469 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -78.84 -44.92 21.92 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.963 0.905 . . . . 0.0 109.349 175.186 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -60.42 -41.35 93.77 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.33 1.052 . . . . 0.0 111.228 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -62.66 -21.77 65.96 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.087 0.955 . . . . 0.0 112.269 178.217 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -85.01 -18.93 32.91 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 117.875 -1.06 . . . . 0.0 112.227 178.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -55.65 -42.75 97.65 Favored Pre-proline 0 CA--C 1.541 0.615 0 CA-C-N 121.243 1.838 . . . . 0.0 114.116 -179.121 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.28 -14.28 44.24 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 CA-C-N 122.603 1.965 . . . . 0.0 113.714 174.515 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.1 m -88.72 -42.62 11.84 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 119.195 0.907 . . . . 0.0 109.227 169.288 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 18.3 tp -56.62 -38.22 71.79 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 124.998 1.319 . . . . 0.0 110.841 -177.415 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -71.78 -1.18 13.13 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -105.97 -11.95 15.99 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.497 1.044 . . . . 0.0 111.872 172.277 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 98.5 mt -81.63 140.97 15.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -175.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -87.44 133.63 33.72 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 123.464 0.706 . . . . 0.0 110.133 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -126.57 15.03 7.62 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.962 0.905 . . . . 0.0 111.612 174.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 17.0 m-80 -58.73 116.12 3.51 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 119.987 1.267 . . . . 0.0 109.886 -174.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.78 1.19 58.21 Favored Glycine 0 CA--C 1.533 1.175 0 CA-C-O 118.567 -1.13 . . . . 0.0 113.803 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -74.86 147.61 40.94 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 119.628 1.714 . . . . 0.0 107.835 172.037 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 14.9 mt -88.77 136.04 33.21 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 174.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.2 t -132.44 139.97 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.263 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -136.71 141.56 43.08 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 175.141 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 62.1 mt -112.62 148.16 35.17 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -173.164 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -144.42 168.15 20.8 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 169.33 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -179.53 176.09 47.42 Favored Glycine 0 N--CA 1.447 -0.577 0 CA-C-O 122.174 0.875 . . . . 0.0 113.0 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 24.4 m -129.53 152.58 48.91 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 125.727 1.611 . . . . 0.0 107.737 -171.085 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -169.8 -173.79 37.55 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -177.082 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -147.56 166.89 25.95 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 168.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -111.47 -6.39 14.45 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.725 1.61 . . . . 0.0 111.996 -171.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -59.45 -48.25 82.35 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 123.626 0.77 . . . . 0.0 111.787 -169.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -138.18 1.99 2.27 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -173.282 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -111.38 27.83 9.31 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.39 1.076 . . . . 0.0 111.396 -169.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.13 -17.38 64.67 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 -169.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -94.64 -0.61 54.29 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.62 1.168 . . . . 0.0 111.995 174.242 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -139.08 22.61 2.6 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 125.762 1.625 . . . . 0.0 110.283 -170.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -70.76 121.03 17.24 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -169.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 74.0 m 48.3 38.92 11.22 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.617 1.167 . . . . 0.0 111.679 -177.053 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -61.95 -38.81 89.89 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.466 1.106 . . . . 0.0 112.061 -172.053 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.15 -21.34 66.33 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 114.136 1.162 . . . . 0.0 114.136 -168.125 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 7.1 mp -61.28 -35.22 76.72 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 119.766 1.166 . . . . 0.0 110.22 175.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.37 -33.48 86.35 Favored Glycine 0 CA--C 1.531 1.039 0 N-CA-C 111.318 -0.713 . . . . 0.0 111.318 177.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.2 m -65.05 -37.3 87.13 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 117.774 0.787 . . . . 0.0 110.361 177.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 6.0 mt -70.31 -49.15 56.34 Favored 'Isoleucine or valine' 0 C--N 1.343 0.319 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 173.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 55.8 ttt-85 -51.31 -47.21 62.68 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 118.617 0.644 . . . . 0.0 110.563 -176.094 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -63.23 -22.92 67.18 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.114 0.966 . . . . 0.0 112.914 -175.183 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 96.9 mt -91.63 -44.6 14.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 123.666 0.786 . . . . 0.0 109.379 177.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 22.4 pt -74.78 -29.43 22.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-N 118.999 0.818 . . . . 0.0 111.617 -171.109 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -62.03 -56.22 33.63 Favored Pre-proline 0 CA--C 1.543 0.685 0 CA-C-O 117.74 -1.124 . . . . 0.0 112.063 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -66.16 -21.79 54.96 Favored 'Trans proline' 0 C--N 1.351 0.701 0 CA-C-N 121.769 1.668 . . . . 0.0 112.612 178.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 73.0 mmt-85 -82.07 9.46 8.44 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.99 0.916 . . . . 0.0 112.841 172.105 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 77.51 16.16 80.62 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-O 118.367 -1.24 . . . . 0.0 114.877 168.432 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -59.63 144.66 47.14 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 119.036 1.418 . . . . 0.0 110.355 170.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 44.6 m -95.29 119.94 34.66 Favored 'General case' 0 C--N 1.333 -0.123 0 N-CA-C 104.663 -2.347 . . . . 0.0 104.663 167.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 15.8 mt -100.86 127.54 53.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 -171.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 31.8 m -137.44 178.23 4.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 124.983 1.313 . . . . 0.0 109.285 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 78.83 36.51 28.56 Favored Glycine 0 CA--C 1.527 0.835 0 O-C-N 121.912 -0.493 . . . . 0.0 111.976 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 68.3 m80 -63.22 142.6 58.33 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 117.615 0.707 . . . . 0.0 109.153 172.006 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 75.2 t-105 -123.58 129.49 24.83 Favored Pre-proline 0 CA--C 1.534 0.357 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 -174.327 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -67.74 144.23 64.76 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 121.437 1.425 . . . . 0.0 112.129 -170.022 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 71.6 p . . . . . 0 CA--C 1.537 0.454 0 C-N-CA 123.614 0.766 . . . . 0.0 111.136 177.923 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.837 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -74.63 -0.56 59.16 Favored Glycine 0 CA--C 1.535 1.319 0 CA-C-O 118.637 -1.091 . . . . 0.0 113.412 169.235 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 43.7 mt -63.41 131.49 48.4 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 120.583 2.192 . . . . 0.0 109.503 174.225 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -100.77 -32.79 10.53 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.176 0.99 . . . . 0.0 109.323 169.033 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -149.49 161.78 41.44 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 127.313 2.245 . . . . 0.0 107.103 174.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -53.06 -31.78 43.4 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.328 0.651 . . . . 0.0 112.389 176.207 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -93.38 -11.33 32.52 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.284 1.034 . . . . 0.0 113.335 -178.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 10.9 m-70 -146.92 128.98 15.54 Favored 'General case' 0 C--N 1.346 0.431 0 CA-C-N 119.76 1.163 . . . . 0.0 113.729 -170.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -77.49 155.57 31.59 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 166.457 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.4 p -66.12 -22.86 30.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 C-N-CA 123.972 0.909 . . . . 0.0 111.642 178.202 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -158.93 169.99 35.29 Favored Glycine 0 C--N 1.338 0.659 0 CA-C-N 118.471 0.578 . . . . 0.0 112.314 -169.552 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -69.35 111.97 5.6 Favored 'General case' 0 CA--C 1.521 -0.144 0 C-N-CA 124.452 1.101 . . . . 0.0 109.496 -175.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.332 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 169.606 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 20.7 mt . . . . . 0 CA--C 1.541 0.623 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 38.8 m -46.31 -53.08 11.46 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 127.163 2.185 . . . . 0.0 112.913 -167.117 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -82.07 -40.54 21.83 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 119.395 -0.336 . . . . 0.0 111.038 -174.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -67.65 -28.15 67.47 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.026 0.83 . . . . 0.0 111.856 -173.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 59.6 mtp85 -62.77 -45.46 92.58 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 118.718 0.69 . . . . 0.0 110.021 175.644 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 17.3 m -74.34 -31.03 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-O 117.706 -1.14 . . . . 0.0 111.274 177.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -58.33 -52.07 67.14 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 120.99 1.723 . . . . 0.0 109.406 173.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -62.49 -37.79 87.37 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 122.724 0.41 . . . . 0.0 110.654 -179.156 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 59.2 t90 -74.91 -44.49 48.4 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 118.278 0.49 . . . . 0.0 111.644 -175.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 77.8 t -64.22 -34.0 66.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -61.25 -35.85 78.4 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 121.261 -0.899 . . . . 0.0 111.4 175.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -63.44 -55.99 19.8 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 119.177 0.899 . . . . 0.0 110.294 175.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 9.8 pt -67.08 -28.59 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 O-C-N 122.12 -0.363 . . . . 0.0 110.351 -173.071 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 64.2 m -60.77 -23.74 65.23 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 118.377 -0.821 . . . . 0.0 112.489 177.181 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -82.96 -31.9 27.37 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 119.927 1.24 . . . . 0.0 111.055 175.373 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -80.07 -38.31 32.03 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.713 0.805 . . . . 0.0 110.621 -178.055 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 5.4 mp -88.9 -3.7 58.67 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.448 1.899 . . . . 0.0 110.886 -179.038 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 55.63 32.85 20.06 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.847 1.659 . . . . 0.0 112.689 -174.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 47.1 mt . . . . . 0 N--CA 1.467 0.389 0 O-C-N 121.787 -0.57 . . . . 0.0 110.519 172.308 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.268 0 CA-C-O 120.722 0.296 . . . . 0.0 111.282 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 32.4 pt -109.94 -20.53 6.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 125.189 1.396 . . . . 0.0 111.239 178.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 44.5 m -105.85 128.16 53.58 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.736 1.214 . . . . 0.0 108.146 174.475 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -99.82 116.19 5.51 Favored Glycine 0 CA--C 1.519 0.313 0 N-CA-C 107.198 -2.361 . . . . 0.0 107.198 169.035 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 46.6 mt -90.63 122.59 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 104.135 -2.543 . . . . 0.0 104.135 171.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -118.19 132.8 56.3 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 174.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -132.9 158.42 42.63 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 118.345 0.521 . . . . 0.0 111.187 -174.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -132.73 154.36 21.08 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 108.091 -2.003 . . . . 0.0 108.091 167.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 16.3 m -163.7 163.51 24.17 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 119.212 1.506 . . . . 0.0 109.491 -175.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -137.98 -52.53 0.62 Allowed 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.667 0.787 . . . . 0.0 110.379 171.485 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.9 p -77.52 -14.73 59.6 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.237 0.615 . . . . 0.0 111.753 170.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 104.98 8.21 36.93 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.014 1.292 . . . . 0.0 113.961 169.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -66.55 -54.29 25.26 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 119.02 1.41 . . . . 0.0 111.927 -173.264 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.3 m -75.78 -18.38 59.55 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 122.027 -0.421 . . . . 0.0 111.515 -166.255 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -59.72 -46.78 88.08 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 167.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 33.2 t30 -68.3 -39.67 81.98 Favored 'General case' 0 C--N 1.339 0.122 0 O-C-N 121.864 -0.523 . . . . 0.0 110.305 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 49.8 mm -59.48 -45.16 94.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 118.738 0.699 . . . . 0.0 109.265 175.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.73 -40.61 95.69 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.753 0.706 . . . . 0.0 111.174 178.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -64.18 -42.49 96.67 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-O 118.823 -0.608 . . . . 0.0 110.826 176.3 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 98.8 mtp -63.82 -44.37 93.43 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 119.35 0.977 . . . . 0.0 110.464 177.168 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 69.9 mt -57.26 -47.57 84.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 176.389 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.403 ' NE2' ' HA ' ' A' ' 32' ' ' ASP . 27.3 tt0 -58.29 -42.97 87.78 Favored 'General case' 0 CA--C 1.53 0.2 0 O-C-N 121.467 -0.771 . . . . 0.0 111.157 176.697 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -64.0 -35.93 82.32 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 119.416 1.007 . . . . 0.0 110.683 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -69.21 -45.52 69.67 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.286 0.635 . . . . 0.0 110.936 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -79.88 -30.09 40.12 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.031 0.832 . . . . 0.0 112.101 -178.117 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.73 145.26 16.13 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 125.008 1.29 . . . . 0.0 110.699 -170.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.9 tttm -65.04 -31.01 72.02 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 121.889 -0.771 . . . . 0.0 111.799 -170.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -77.6 -7.06 55.8 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.063 0.545 . . . . 0.0 112.069 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 49.0 t -104.67 -43.21 7.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 124.254 1.022 . . . . 0.0 109.258 174.503 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -134.46 134.11 41.18 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 119.478 1.036 . . . . 0.0 111.491 -175.41 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.403 ' HA ' ' NE2' ' A' ' 23' ' ' GLN . 15.5 t70 -123.94 148.55 46.8 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 175.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 59.5 t -106.42 140.07 25.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 124.477 1.111 . . . . 0.0 111.158 -168.193 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -139.64 144.18 37.55 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.811 1.644 . . . . 0.0 109.847 177.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -83.92 126.25 32.82 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 169.516 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 11.0 tp -58.54 -31.23 43.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -171.101 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.72 -29.83 67.31 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.985 0.811 . . . . 0.0 112.024 -177.564 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 47.4 mtmt -76.54 -33.3 58.56 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 118.206 0.457 . . . . 0.0 110.835 177.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 57.7 m -70.77 165.01 23.98 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.678 1.191 . . . . 0.0 112.248 -174.128 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.5 m -133.04 174.59 10.2 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.225 1.81 . . . . 0.0 109.146 -176.284 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -49.05 -54.26 16.7 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.288 1.035 . . . . 0.0 111.655 -173.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -76.27 -11.83 59.98 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 122.473 0.309 . . . . 0.0 111.758 -170.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -71.22 -33.85 70.29 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 121.882 -0.512 . . . . 0.0 110.766 -174.275 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 8.4 mp -74.3 -38.75 63.26 Favored 'General case' 0 C--N 1.342 0.279 0 C-N-CA 122.594 0.358 . . . . 0.0 110.109 171.38 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -67.06 -18.14 65.21 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 122.898 0.479 . . . . 0.0 112.126 -169.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.92 -28.98 69.91 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.482 1.113 . . . . 0.0 112.527 173.38 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -96.16 156.94 16.12 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.147 0.979 . . . . 0.0 111.048 -175.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -99.5 -29.39 12.75 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.31 0.644 . . . . 0.0 111.514 170.082 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.0 mp -110.76 127.69 67.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 174.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -115.52 135.16 54.37 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 174.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.5 mp -118.74 114.13 22.23 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 172.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 51.6 mt -112.47 112.4 23.92 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 -169.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -102.58 103.4 2.43 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 125.404 1.478 . . . . 0.0 111.075 -173.352 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 14.6 tt -127.72 119.39 21.42 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 124.123 0.969 . . . . 0.0 111.077 -169.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -76.29 150.31 32.62 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 121.909 1.739 . . . . 0.0 110.501 170.162 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 19.1 m -98.3 140.78 32.07 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 169.47 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 42.4 m95 -136.2 174.38 10.67 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.718 1.607 . . . . 0.0 109.479 -178.147 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 21.52 82.27 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 128.476 2.71 . . . . 0.0 114.702 169.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 57.49 49.52 12.69 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.937 0.895 . . . . 0.0 111.927 172.182 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 81.03 19.0 68.27 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 123.743 0.687 . . . . 0.0 113.541 170.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -88.48 156.13 19.28 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 124.316 1.046 . . . . 0.0 110.162 178.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.97 144.5 34.69 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 169.293 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -59.93 149.28 32.24 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 169.446 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 75.4 m -61.04 -25.84 67.21 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -168.384 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 39.4 p30 -68.45 -36.39 78.93 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.474 0.71 . . . . 0.0 111.848 178.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -80.36 -41.43 24.72 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 118.695 0.68 . . . . 0.0 111.091 171.09 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -60.98 -39.34 89.25 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.505 0.593 . . . . 0.0 111.533 -176.555 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -67.4 -20.82 65.59 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.358 0.663 . . . . 0.0 112.168 175.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -94.43 -20.9 19.29 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.043 0.937 . . . . 0.0 111.825 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 21.6 m-30 -52.49 -40.32 74.48 Favored Pre-proline 0 CA--C 1.545 0.758 0 CA-C-O 116.67 -1.633 . . . . 0.0 114.544 178.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -64.41 -23.83 64.78 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 CA-C-N 123.103 2.144 . . . . 0.0 113.036 174.259 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.6 m -79.79 -38.34 33.28 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 119.239 0.927 . . . . 0.0 109.168 170.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 19.4 tp -60.64 -33.32 72.62 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.016 -1.052 . . . . 0.0 111.84 -174.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -81.97 -4.3 56.37 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.65 0.78 . . . . 0.0 112.863 176.324 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -96.15 -28.33 14.62 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 119.112 0.869 . . . . 0.0 109.947 170.477 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 88.7 mt -64.26 136.22 26.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 176.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -86.67 130.89 34.31 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 123.421 0.688 . . . . 0.0 109.548 172.203 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -118.03 6.7 12.13 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.17 0.988 . . . . 0.0 112.005 176.696 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 21.9 m-80 -56.55 115.49 2.55 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 120.463 1.483 . . . . 0.0 110.478 -173.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.71 0.37 63.55 Favored Glycine 0 CA--C 1.535 1.321 0 CA-C-O 118.548 -1.14 . . . . 0.0 114.285 178.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -75.24 147.5 40.26 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 119.679 1.739 . . . . 0.0 108.202 174.123 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 69.3 mt -91.24 135.86 33.5 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 175.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.8 t -135.27 130.43 51.08 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -116.3 150.23 37.97 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 169.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 79.7 mt -117.55 150.71 38.53 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 -178.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -149.03 162.07 40.66 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 170.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 171.91 150.03 6.96 Favored Glycine 0 N--CA 1.448 -0.51 0 CA-C-O 121.88 0.711 . . . . 0.0 112.789 174.373 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 4.5 p -78.01 164.18 25.29 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 121.321 0.581 . . . . 0.0 109.837 169.352 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -160.58 -162.51 12.57 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 173.263 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -145.63 122.58 11.34 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 127.08 2.152 . . . . 0.0 105.473 177.359 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -110.51 1.95 18.51 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.228 1.411 . . . . 0.0 111.474 -173.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -108.8 -45.12 3.88 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.369 1.068 . . . . 0.0 110.827 -168.127 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -104.3 -35.45 7.97 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.804 1.242 . . . . 0.0 109.975 178.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -98.19 40.46 1.18 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.376 1.071 . . . . 0.0 110.279 169.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.03 -21.78 65.17 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.174 1.39 . . . . 0.0 113.787 -173.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -95.96 5.95 50.01 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.986 0.914 . . . . 0.0 111.691 177.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -138.56 18.7 2.71 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.983 1.313 . . . . 0.0 110.907 -172.024 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 30.8 t80 -64.93 132.5 49.49 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -173.427 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . 0.282 28.6 p 54.95 24.41 5.86 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.675 1.99 . . . . 0.0 114.454 171.043 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -61.56 -32.49 72.57 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.146 1.378 . . . . 0.0 111.867 -174.191 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.24 -32.57 71.88 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 120.903 -1.123 . . . . 0.0 111.427 -178.499 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 7.0 mp -63.82 -43.88 94.91 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 119.658 1.117 . . . . 0.0 108.849 173.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -60.51 -34.77 87.04 Favored Glycine 0 CA--C 1.533 1.185 0 N-CA-C 111.436 -0.666 . . . . 0.0 111.436 174.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 17.0 m -65.02 -37.38 87.44 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 121.716 -0.873 . . . . 0.0 110.6 176.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 5.1 mt -67.32 -47.45 81.14 Favored 'Isoleucine or valine' 0 C--N 1.345 0.382 0 CA-C-O 117.643 -1.17 . . . . 0.0 108.967 173.099 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -56.92 -38.22 72.57 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 120.38 1.445 . . . . 0.0 110.928 -174.372 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -60.69 -25.08 66.12 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.206 1.002 . . . . 0.0 112.457 178.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 75.8 mt -94.02 -49.36 12.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 124.419 1.087 . . . . 0.0 110.041 177.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 36.5 pt -75.58 -28.37 19.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-N 120.002 1.274 . . . . 0.0 111.9 -168.499 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -63.13 -53.95 50.0 Favored Pre-proline 0 CA--C 1.542 0.663 0 CA-C-O 117.447 -1.263 . . . . 0.0 111.836 178.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -68.08 -20.87 43.62 Favored 'Trans proline' 0 C--N 1.351 0.707 0 CA-C-N 122.064 1.773 . . . . 0.0 112.719 176.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 31.4 mmm180 -78.58 1.98 20.8 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 119.163 0.892 . . . . 0.0 112.144 170.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 93.26 10.43 59.53 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 125.048 1.309 . . . . 0.0 115.204 168.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.94 146.79 45.55 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 119.205 1.502 . . . . 0.0 110.757 174.251 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 86.1 m -101.93 124.16 47.08 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 105.206 -2.146 . . . . 0.0 105.206 167.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 19.4 mm -90.76 133.28 33.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 -171.412 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 18.7 m -131.76 168.51 23.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.395 0 C-N-CA 125.99 1.716 . . . . 0.0 108.81 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 70.07 39.66 73.25 Favored Glycine 0 CA--C 1.527 0.792 0 O-C-N 121.691 -0.631 . . . . 0.0 113.05 177.271 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -64.55 134.83 55.2 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 171.328 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 57.6 t-105 -114.76 127.26 26.99 Favored Pre-proline 0 CA--C 1.535 0.398 0 C-N-CA 124.752 1.221 . . . . 0.0 108.494 -169.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -61.98 141.93 90.98 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 CA-C-N 121.02 1.4 . . . . 0.0 112.831 -173.117 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 56.7 p . . . . . 0 CA--C 1.534 0.335 0 C-N-CA 123.037 0.535 . . . . 0.0 110.991 174.409 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.47 0.535 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -79.6 7.88 51.63 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-O 119.184 -0.787 . . . . 0.0 113.113 169.474 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 97.5 mt -64.75 138.56 58.46 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 120.178 1.989 . . . . 0.0 109.942 174.258 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -106.21 -31.04 8.84 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.982 1.313 . . . . 0.0 108.925 167.434 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -149.16 162.98 38.89 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 127.466 2.306 . . . . 0.0 106.929 171.022 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -54.68 -30.84 56.71 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 121.371 -0.831 . . . . 0.0 112.162 176.293 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -91.98 -9.77 41.74 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.322 1.049 . . . . 0.0 113.325 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 11.9 m-70 -146.71 126.34 13.35 Favored 'General case' 0 C--N 1.346 0.415 0 CA-C-N 119.569 1.077 . . . . 0.0 113.376 -170.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -75.3 153.38 37.95 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 166.049 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 8.9 p -65.86 -18.88 24.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 124.288 1.035 . . . . 0.0 112.395 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -166.68 179.86 40.3 Favored Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -173.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -71.07 87.86 0.77 Allowed 'General case' 0 CA--C 1.522 -0.101 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 -178.451 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.475 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 169.319 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 23.7 mt . . . . . 0 N--CA 1.474 0.731 0 CA-C-O 121.474 0.654 . . . . 0.0 110.973 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 75.0 m -56.77 -51.46 68.82 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.37 1.468 . . . . 0.0 111.563 -169.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.32 -41.22 89.96 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -167.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -70.46 -35.03 73.09 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 118.219 0.463 . . . . 0.0 110.732 177.093 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 58.9 mtt180 -69.21 -43.86 73.28 Favored 'General case' 0 C--O 1.233 0.208 0 O-C-N 121.555 -0.716 . . . . 0.0 110.493 -178.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 26.6 m -70.42 -29.05 37.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 119.3 0.955 . . . . 0.0 110.544 177.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -64.21 -53.9 41.9 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 120.4 1.455 . . . . 0.0 109.755 171.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -58.2 -36.79 73.64 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 118.863 -0.589 . . . . 0.0 110.641 -178.203 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 46.1 t90 -77.14 -50.1 13.76 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 118.469 0.577 . . . . 0.0 111.426 -177.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 45.8 t -62.02 -33.58 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 O-C-N 121.458 -0.776 . . . . 0.0 109.992 -177.612 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -60.16 -38.32 82.79 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-O 118.343 -0.837 . . . . 0.0 111.17 177.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -59.07 -55.01 40.62 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 118.954 0.797 . . . . 0.0 109.802 176.574 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 19.0 pt -68.53 -29.74 45.0 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.235 0 O-C-N 122.133 -0.354 . . . . 0.0 110.248 -174.042 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 35.6 m -65.34 -25.41 67.59 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 118.705 -0.664 . . . . 0.0 111.74 175.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -86.03 -39.1 17.18 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 119.547 1.067 . . . . 0.0 110.253 174.304 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -64.51 -40.09 94.98 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 122.933 0.493 . . . . 0.0 110.92 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.7 mp -100.02 2.33 43.31 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.686 1.594 . . . . 0.0 111.005 -175.011 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . 0.291 31.7 p80 50.94 26.71 2.81 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 127.022 2.129 . . . . 0.0 113.948 -174.464 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 55.9 mt . . . . . 0 C--N 1.344 0.33 0 O-C-N 121.505 -0.747 . . . . 0.0 110.275 172.851 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.389 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 27.4 pt -83.5 -23.02 8.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 -178.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.1 m -112.2 127.37 55.93 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.955 1.302 . . . . 0.0 108.391 -178.295 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -101.67 118.96 6.31 Favored Glycine 0 CA--C 1.519 0.331 0 N-CA-C 107.846 -2.101 . . . . 0.0 107.846 169.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 44.7 mt -95.05 118.3 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 104.37 -2.456 . . . . 0.0 104.37 171.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -114.32 127.1 55.7 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 177.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -127.81 125.06 39.1 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 118.702 0.683 . . . . 0.0 112.017 -175.179 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -82.12 145.43 24.45 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 168.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.4 m -159.91 161.47 34.31 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 119.083 1.442 . . . . 0.0 109.844 175.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -138.74 -48.05 0.51 Allowed 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.037 0.935 . . . . 0.0 109.817 168.002 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.2 p -79.29 -13.52 59.6 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.486 0.714 . . . . 0.0 111.689 169.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.03 6.53 53.84 Favored Glycine 0 C--N 1.343 0.965 0 C-N-CA 124.767 1.175 . . . . 0.0 113.813 170.169 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -70.16 -38.4 75.43 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 118.769 1.284 . . . . 0.0 112.553 -169.666 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -69.83 -17.77 63.41 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 119.548 1.067 . . . . 0.0 111.383 -174.536 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -60.14 -41.21 92.22 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.185 0.902 . . . . 0.0 110.179 175.168 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -65.96 -39.89 90.81 Favored 'General case' 0 N--CA 1.463 0.195 0 O-C-N 121.924 -0.485 . . . . 0.0 110.106 178.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 27.2 mm -60.61 -49.05 85.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 176.462 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.16 -41.18 92.26 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.386 0.674 . . . . 0.0 111.702 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.9 mttm -67.11 -40.25 86.84 Favored 'General case' 0 N--CA 1.461 0.119 0 O-C-N 121.661 -0.65 . . . . 0.0 111.113 177.334 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 70.2 mtm -66.37 -31.95 73.04 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 119.504 1.047 . . . . 0.0 111.447 177.478 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.407 HG21 HD23 ' A' ' 51' ' ' LEU . 76.7 mt -65.81 -54.6 25.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 171.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -62.1 -37.03 83.54 Favored 'General case' 0 C--O 1.224 -0.251 0 CA-C-O 118.952 -0.546 . . . . 0.0 111.366 -173.112 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -63.68 -36.06 82.6 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 119.325 0.966 . . . . 0.0 110.91 -178.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -74.86 -41.36 59.96 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.131 0.573 . . . . 0.0 110.74 177.404 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.3 mp -73.99 -33.27 63.76 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 118.081 0.4 . . . . 0.0 111.23 -176.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 88.13 146.47 11.96 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 124.861 1.219 . . . . 0.0 110.763 -172.138 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -64.79 -29.61 70.59 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.875 0.87 . . . . 0.0 111.984 -172.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -67.53 -29.71 69.18 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 122.674 0.39 . . . . 0.0 111.07 177.385 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 22.8 t -93.47 -37.77 8.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 C-N-CA 123.921 0.888 . . . . 0.0 110.119 -175.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -135.58 144.05 45.97 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-N 119.3 0.955 . . . . 0.0 112.82 -176.051 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -128.53 153.18 47.46 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.565 1.146 . . . . 0.0 109.578 173.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 77.5 t -114.25 131.62 65.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 124.655 1.182 . . . . 0.0 110.263 -168.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 -144.63 166.5 25.01 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.645 1.578 . . . . 0.0 112.219 -169.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -130.63 129.42 42.67 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 127.088 2.155 . . . . 0.0 106.332 -178.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.4 tp -61.87 -19.62 21.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 123.64 0.776 . . . . 0.0 112.299 -171.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -58.39 -30.27 66.69 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 118.676 0.671 . . . . 0.0 112.461 -175.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 60.9 pttt -98.09 -6.42 31.71 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.755 0.822 . . . . 0.0 112.619 177.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 67.2 m -76.26 158.96 31.06 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.705 0.764 . . . . 0.0 111.444 -175.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 21.8 m -130.43 175.47 8.94 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.723 2.009 . . . . 0.0 107.145 172.225 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -51.61 -48.83 63.1 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 118.497 0.59 . . . . 0.0 111.654 -174.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -77.67 -12.62 59.99 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -172.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -68.47 -32.92 73.25 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 118.74 0.7 . . . . 0.0 110.824 -177.027 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -74.91 -42.46 57.75 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 123.603 0.761 . . . . 0.0 109.502 172.318 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -68.94 -19.54 64.18 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.633 0.773 . . . . 0.0 111.954 -170.096 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.57 -29.78 70.43 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.011 0.925 . . . . 0.0 112.433 176.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -86.21 160.46 19.19 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 124.292 1.037 . . . . 0.0 110.316 178.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -111.2 -24.26 10.38 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.596 0.758 . . . . 0.0 111.802 169.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.0 mp -117.02 131.92 68.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 174.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 79.8 mt -130.56 123.7 30.17 Favored 'General case' 0 CA--C 1.523 -0.08 0 C-N-CA 123.965 0.906 . . . . 0.0 109.363 -177.267 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.407 HD23 HG21 ' A' ' 22' ' ' ILE . 8.1 mp -109.6 107.74 17.93 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 176.247 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.9 mt -108.27 108.96 20.19 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -168.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -100.42 117.39 5.86 Favored Glycine 0 CA--C 1.518 0.245 0 C-N-CA 125.516 1.531 . . . . 0.0 109.709 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 15.5 tt -129.74 118.9 18.9 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 118.43 1.115 . . . . 0.0 110.627 -176.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -79.36 150.95 22.7 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.403 2.069 . . . . 0.0 110.289 173.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 17.3 m -100.68 137.07 39.57 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 175.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 66.8 m95 -137.25 173.8 11.3 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.782 1.633 . . . . 0.0 110.599 -173.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 54.49 -89.17 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 127.976 2.51 . . . . 0.0 113.246 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -151.02 62.12 0.91 Allowed 'General case' 0 C--O 1.237 0.417 0 C-N-CA 126.168 1.787 . . . . 0.0 107.89 -173.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 67.67 54.85 16.78 Favored Glycine 0 CA--C 1.53 1.003 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 -174.291 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -129.24 164.6 23.1 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.104 1.362 . . . . 0.0 108.642 175.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.36 164.29 22.24 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 121.221 0.534 . . . . 0.0 110.027 170.329 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -70.33 150.7 46.05 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 169.275 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 84.0 m -56.84 -33.35 66.7 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -168.198 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -69.26 -40.47 77.82 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 119.092 0.86 . . . . 0.0 110.687 -177.487 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -72.21 -41.49 66.86 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 174.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -60.0 -40.98 91.11 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 122.697 0.399 . . . . 0.0 111.39 -178.332 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -70.05 -21.07 63.21 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.092 0.957 . . . . 0.0 112.018 177.419 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -90.91 -19.16 23.63 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 118.7 -0.666 . . . . 0.0 112.316 -178.463 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -51.7 -41.72 79.61 Favored Pre-proline 0 CA--C 1.543 0.709 0 CA-C-O 116.389 -1.767 . . . . 0.0 114.666 178.289 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -62.4 -21.18 72.36 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 CA-C-N 122.909 2.075 . . . . 0.0 113.632 175.327 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.2 m -84.88 -41.97 15.49 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.454 1.025 . . . . 0.0 109.124 169.736 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.2 tp -56.47 -38.39 71.62 Favored 'General case' 0 C--N 1.341 0.219 0 C-N-CA 124.054 0.942 . . . . 0.0 111.177 -177.005 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -72.66 -2.8 21.52 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -109.86 -14.81 14.22 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.325 1.05 . . . . 0.0 111.622 173.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 74.5 mt -71.8 139.63 19.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -178.134 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -81.21 128.38 33.71 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.905 176.117 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -125.58 12.31 8.02 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.829 0.851 . . . . 0.0 111.737 172.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 42.8 m-80 -62.42 116.3 4.96 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 119.647 1.112 . . . . 0.0 109.385 -171.25 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.66 2.18 60.0 Favored Glycine 0 CA--C 1.534 1.239 0 CA-C-O 118.671 -1.072 . . . . 0.0 113.782 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 62.1 mttm -73.31 148.27 43.7 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 119.533 1.666 . . . . 0.0 107.714 171.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 60.9 mt -90.5 137.81 32.06 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 174.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.6 t -136.01 147.96 27.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 -178.301 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -140.18 144.23 36.51 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 169.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.9 mp -113.48 151.27 31.7 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 123.677 0.791 . . . . 0.0 109.512 -172.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 25.9 p90 -149.2 168.46 23.21 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 168.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.451 ' HA3' HD11 ' A' ' 102' ' ' LEU . . . 177.93 157.99 19.88 Favored Glycine 0 N--CA 1.449 -0.498 0 O-C-N 121.144 -0.973 . . . . 0.0 113.445 178.462 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 14.2 m -110.64 153.42 25.24 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 124.805 1.242 . . . . 0.0 109.268 -169.015 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -163.46 -166.54 22.45 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 178.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -152.61 118.69 5.49 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 124.898 1.279 . . . . 0.0 107.699 176.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -82.67 -34.15 27.5 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -169.153 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -56.33 -46.67 79.8 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 123.867 0.867 . . . . 0.0 111.648 -169.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -97.17 -42.6 7.76 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 118.601 0.637 . . . . 0.0 112.245 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 -91.94 44.72 1.18 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.958 0.903 . . . . 0.0 110.357 -172.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.33 -24.66 66.6 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.258 1.423 . . . . 0.0 113.421 -169.478 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -104.62 10.37 34.91 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.267 1.027 . . . . 0.0 112.75 178.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -135.62 16.86 3.35 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 124.939 1.296 . . . . 0.0 111.177 -178.254 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -66.41 124.45 22.77 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 121.159 -0.963 . . . . 0.0 110.518 -168.273 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 92.6 m 49.97 36.78 12.42 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.684 1.593 . . . . 0.0 113.058 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -59.93 -36.35 76.86 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.464 -0.772 . . . . 0.0 112.549 179.412 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.44 -24.81 67.75 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 -167.513 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.451 HD11 ' HA3' ' A' ' 87' ' ' GLY . 6.8 mp -61.57 -36.35 80.41 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 120.967 -1.083 . . . . 0.0 109.902 175.647 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.32 -31.22 78.51 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 123.706 0.669 . . . . 0.0 111.455 177.482 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.9 m -66.89 -36.67 82.82 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 121.858 -0.789 . . . . 0.0 110.533 179.103 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 15.7 mt -71.46 -49.16 49.0 Favored 'Isoleucine or valine' 0 C--N 1.343 0.318 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 174.013 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 18.3 tpt180 -50.15 -44.4 52.51 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.16 0.984 . . . . 0.0 111.052 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -60.87 -28.1 68.61 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.88 0.872 . . . . 0.0 112.643 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 97.0 mt -92.9 -46.09 14.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 124.351 1.06 . . . . 0.0 109.923 -178.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 32.6 pt -78.22 -23.09 13.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 O-C-N 121.23 -0.918 . . . . 0.0 111.931 -169.564 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -62.91 -58.06 18.38 Favored Pre-proline 0 CA--C 1.544 0.712 0 CA-C-O 117.412 -1.28 . . . . 0.0 111.629 177.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -65.8 -23.52 55.4 Favored 'Trans proline' 0 C--N 1.352 0.761 0 CA-C-N 121.708 1.646 . . . . 0.0 112.39 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 76.6 mmt-85 -79.66 6.26 11.13 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.211 1.004 . . . . 0.0 112.807 173.243 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 77.73 19.2 76.13 Favored Glycine 0 CA--C 1.528 0.876 0 CA-C-O 118.271 -1.294 . . . . 0.0 114.988 168.287 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.03 144.36 53.57 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 119.318 1.559 . . . . 0.0 110.09 169.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 42.2 m -97.45 124.99 41.84 Favored 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 105.01 -2.218 . . . . 0.0 105.01 167.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 20.8 mt -113.44 125.8 70.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -169.259 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 33.3 m -127.76 178.72 4.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 124.69 1.196 . . . . 0.0 109.21 174.58 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 79.77 27.64 53.29 Favored Glycine 0 CA--C 1.528 0.898 0 O-C-N 121.851 -0.531 . . . . 0.0 112.57 179.12 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 80.8 m-70 -62.0 141.58 57.98 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 170.523 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 71.5 t-105 -131.12 138.03 32.01 Favored Pre-proline 0 CA--C 1.537 0.446 0 C-N-CA 124.125 0.97 . . . . 0.0 109.5 -170.02 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -62.93 151.29 85.27 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 121.818 1.679 . . . . 0.0 112.985 -176.07 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 35.5 p . . . . . 0 CA--C 1.536 0.435 0 O-C-N 121.852 -0.53 . . . . 0.0 111.515 171.511 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 90.0 mttt . . . . . 0 N--CA 1.471 0.589 0 N-CA-C 113.928 1.084 . . . . 0.0 113.928 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -83.95 4.98 81.36 Favored Glycine 0 CA--C 1.534 1.269 0 CA-C-O 119.518 -0.601 . . . . 0.0 112.207 169.313 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 9.0 mp -62.23 135.26 57.4 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 118.969 1.385 . . . . 0.0 111.71 -177.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -97.05 -29.59 13.54 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.484 1.514 . . . . 0.0 109.313 167.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -146.82 167.68 23.29 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.149 1.78 . . . . 0.0 107.327 174.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -55.64 -25.89 41.44 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.12 1.368 . . . . 0.0 113.947 -169.557 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -122.45 11.71 9.99 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.85 1.26 . . . . 0.0 113.574 -178.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -141.14 125.72 17.81 Favored 'General case' 0 C--N 1.343 0.304 0 CA-C-N 119.362 0.983 . . . . 0.0 111.587 -176.492 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -71.54 150.17 45.04 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.333 1.053 . . . . 0.0 108.31 166.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 6.1 p -67.74 -8.6 8.98 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 123.98 0.912 . . . . 0.0 112.099 175.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -168.66 176.22 43.0 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 -172.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -70.73 103.12 2.48 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 -179.234 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.365 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 169.0 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 66.7 mt . . . . . 0 CA--C 1.531 0.248 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 50.5 m -41.03 -53.41 3.01 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 128.175 2.59 . . . . 0.0 111.766 -177.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -76.62 -40.74 48.39 Favored 'General case' 0 N--CA 1.452 -0.357 0 O-C-N 122.264 -0.272 . . . . 0.0 111.001 -172.324 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -62.9 -47.28 84.0 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 117.993 0.36 . . . . 0.0 110.377 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 47.6 mtp180 -65.71 -39.54 91.3 Favored 'General case' 0 N--CA 1.464 0.249 0 O-C-N 121.932 -0.48 . . . . 0.0 110.325 -175.251 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 86.4 t -72.68 -37.47 55.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-O 118.226 -0.893 . . . . 0.0 109.899 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -62.05 -49.83 74.4 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 120.722 1.601 . . . . 0.0 110.245 174.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -62.72 -34.56 77.43 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 118.898 -0.572 . . . . 0.0 110.746 -176.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 40.2 t90 -71.79 -51.63 21.64 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 118.531 0.605 . . . . 0.0 110.384 176.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 68.9 t -64.44 -35.07 73.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 O-C-N 121.533 -0.729 . . . . 0.0 110.835 -172.001 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -63.45 -35.53 80.74 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.404 -0.81 . . . . 0.0 110.324 177.376 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 53.7 mm-40 -71.63 -48.39 48.23 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.552 0.741 . . . . 0.0 111.178 174.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 3.8 pt -63.72 -32.51 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-N 119.771 1.169 . . . . 0.0 110.362 -177.113 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 50.2 m -61.85 -33.68 74.61 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 118.309 -0.853 . . . . 0.0 111.505 -179.091 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -86.41 -24.66 25.64 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 120.227 1.376 . . . . 0.0 111.954 177.418 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -73.74 -37.61 65.01 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 118.683 0.674 . . . . 0.0 110.701 174.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 77.7 mt -89.97 -4.79 57.26 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.058 1.743 . . . . 0.0 111.484 -178.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 82.7 m-70 56.6 25.29 9.76 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.952 1.701 . . . . 0.0 113.195 -172.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 79.8 mt . . . . . 0 N--CA 1.464 0.246 0 O-C-N 121.456 -0.778 . . . . 0.0 110.381 172.006 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.224 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 28.6 pt -80.68 -24.73 11.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 O-C-N 122.143 -0.348 . . . . 0.0 111.351 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.1 m -113.19 130.16 56.3 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.002 1.321 . . . . 0.0 108.771 178.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -102.76 124.68 8.24 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 107.974 -2.051 . . . . 0.0 107.974 169.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 27.3 mt -103.32 94.72 3.35 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 105.248 -2.131 . . . . 0.0 105.248 177.018 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -90.27 129.44 36.5 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 -177.3 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -122.43 123.47 41.4 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 119.806 1.185 . . . . 0.0 112.637 -176.372 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -82.51 141.72 21.42 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 106.391 -2.684 . . . . 0.0 106.391 165.37 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.1 m -161.85 171.33 17.93 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 119.939 1.87 . . . . 0.0 110.452 177.297 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -133.93 -50.67 0.83 Allowed 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.027 0.931 . . . . 0.0 109.817 169.206 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 81.9 p -92.41 5.0 52.31 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.021 0.928 . . . . 0.0 112.31 177.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 76.13 18.15 79.56 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 124.032 0.825 . . . . 0.0 113.317 -175.382 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -76.85 -47.19 22.07 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 119.263 1.532 . . . . 0.0 111.235 -176.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 72.8 m -74.06 -23.57 59.38 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 118.968 0.804 . . . . 0.0 109.974 178.291 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -56.09 -46.27 79.12 Favored 'General case' 0 C--N 1.342 0.248 0 O-C-N 121.385 -0.822 . . . . 0.0 109.616 169.426 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -64.95 -34.28 78.05 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 121.781 -0.574 . . . . 0.0 111.033 -177.288 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 45.4 mm -60.43 -44.1 95.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 172.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.61 -41.51 97.57 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.702 -0.624 . . . . 0.0 111.576 177.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 29.2 mmtp -64.14 -41.87 97.03 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 121.45 -0.782 . . . . 0.0 110.276 176.101 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 78.7 mtp -62.24 -40.6 96.72 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.399 1.0 . . . . 0.0 110.473 178.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 55.5 mt -60.62 -49.59 83.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 174.121 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -58.59 -38.15 77.32 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 121.233 -0.917 . . . . 0.0 111.417 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -63.63 -34.56 78.1 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 120.077 1.308 . . . . 0.0 111.246 -178.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -72.27 -40.6 67.5 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 118.371 0.532 . . . . 0.0 110.758 174.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -80.58 -34.22 35.47 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -171.496 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 84.3 144.61 6.48 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 -168.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 54.0 tttp -63.41 -30.93 71.97 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 121.912 -0.758 . . . . 0.0 111.975 -171.04 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -64.47 -30.98 72.01 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 122.85 0.46 . . . . 0.0 111.26 178.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.1 t -92.97 -39.96 11.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 123.502 0.721 . . . . 0.0 109.927 -176.465 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.22 137.44 32.59 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 118.92 0.782 . . . . 0.0 112.045 -178.1 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -129.23 144.71 51.32 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 176.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 59.7 t -90.32 134.78 28.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 123.871 0.868 . . . . 0.0 108.777 -170.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -147.12 169.19 19.81 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.886 1.274 . . . . 0.0 111.201 -168.117 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -138.31 128.33 25.56 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 125.173 1.389 . . . . 0.0 109.036 -169.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.3 tp -63.44 -29.84 48.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 CA-C-O 118.832 -0.604 . . . . 0.0 111.708 -173.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.52 -28.53 68.62 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 119.105 0.866 . . . . 0.0 110.318 -178.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -89.23 -27.14 20.81 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.172 1.389 . . . . 0.0 110.511 177.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 21.3 m -68.64 167.05 15.95 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 124.433 1.093 . . . . 0.0 111.801 -177.339 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.6 m -135.12 164.56 27.38 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.481 1.512 . . . . 0.0 108.932 178.09 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -53.17 -54.8 30.53 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.326 1.05 . . . . 0.0 111.45 -175.486 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -78.28 -15.96 58.24 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 122.312 0.245 . . . . 0.0 111.195 -175.282 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -74.32 -30.22 61.95 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 121.772 -0.58 . . . . 0.0 110.966 -179.029 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.7 mp -69.17 -43.51 74.12 Favored 'General case' 0 C--N 1.343 0.305 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 169.376 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -62.86 -17.41 61.44 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -177.288 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.15 -29.08 67.88 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.654 0.782 . . . . 0.0 112.289 176.495 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -82.29 155.99 24.53 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.195 0.998 . . . . 0.0 110.023 177.299 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -108.86 -26.48 10.24 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.111 0.564 . . . . 0.0 111.673 169.651 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.0 mp -113.81 127.89 70.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 174.202 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 96.3 mt -118.05 127.5 53.86 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 124.192 0.997 . . . . 0.0 108.436 177.265 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.2 mp -111.85 116.31 30.46 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 104.411 -2.44 . . . . 0.0 104.411 168.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 91.1 mt -115.23 109.08 17.44 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 -169.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.69 117.6 5.61 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 108.848 -1.701 . . . . 0.0 108.848 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 15.3 tt -135.91 105.29 9.7 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-N 118.731 1.266 . . . . 0.0 109.617 178.474 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -71.58 150.95 58.05 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 121.91 1.74 . . . . 0.0 109.635 170.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 29.3 m -99.19 139.27 35.08 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -179.056 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 47.5 m95 -135.7 172.79 12.5 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.86 1.264 . . . . 0.0 111.245 -170.133 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 53.87 -87.27 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 127.511 2.324 . . . . 0.0 112.958 176.57 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -149.69 80.01 1.38 Allowed 'General case' 0 C--O 1.235 0.31 0 C-N-CA 126.379 1.872 . . . . 0.0 106.847 174.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.71 16.96 76.32 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-O 119.575 -0.57 . . . . 0.0 113.306 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -91.99 161.8 14.65 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 118.54 1.17 . . . . 0.0 110.584 -175.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.27 161.56 28.65 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 123.915 0.886 . . . . 0.0 111.284 173.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 12.8 tm0? -64.57 146.4 54.69 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 168.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 56.3 m -56.45 -39.96 74.02 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 -167.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -77.33 -39.03 49.13 Favored 'General case' 0 C--N 1.333 -0.109 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -174.435 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -62.74 -44.95 94.88 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 172.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -58.98 -42.04 89.01 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.319 0.648 . . . . 0.0 111.358 178.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -69.33 -27.5 65.42 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.335 0.654 . . . . 0.0 112.336 176.548 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -88.32 -17.8 29.87 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.627 0.771 . . . . 0.0 112.629 -177.499 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -51.8 -40.45 70.97 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-O 116.426 -1.75 . . . . 0.0 115.349 -179.113 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -61.26 -30.21 87.71 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 CA-C-N 123.197 2.178 . . . . 0.0 112.701 173.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.7 m -75.23 -42.28 55.74 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.923 0.783 . . . . 0.0 109.446 172.384 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 12.3 tp -58.24 -37.62 75.25 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.126 0.97 . . . . 0.0 110.387 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -67.71 -11.64 58.77 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.55 1.14 . . . . 0.0 113.202 177.331 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -95.91 -17.91 20.71 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 119.803 1.183 . . . . 0.0 112.179 173.374 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 95.7 mt -76.38 143.59 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 -172.584 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -89.49 132.26 35.13 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 123.507 0.723 . . . . 0.0 109.691 175.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -124.62 6.08 8.21 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.913 0.885 . . . . 0.0 112.067 177.284 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -66.48 124.48 22.88 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 120.358 1.435 . . . . 0.0 110.378 -169.527 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.26 -0.94 58.26 Favored Glycine 0 CA--C 1.537 1.424 0 CA-C-O 118.433 -1.204 . . . . 0.0 114.277 -175.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -76.67 150.45 36.36 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 119.698 1.749 . . . . 0.0 108.408 173.451 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 66.9 mt -95.38 138.2 33.39 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 175.304 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 15.2 t -136.38 147.93 27.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -178.029 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -138.04 147.81 44.47 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 169.285 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -110.2 147.3 34.02 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 124.607 1.163 . . . . 0.0 108.607 -175.295 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -149.04 163.9 36.19 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 167.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 174.55 143.6 4.5 Favored Glycine 0 C--N 1.33 0.215 0 O-C-N 121.251 -0.906 . . . . 0.0 111.406 173.497 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 53.7 m -81.44 159.7 24.2 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 175.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.9 -167.63 27.89 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.403 -0.679 . . . . 0.0 111.403 -177.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -147.64 126.41 12.64 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 126.034 1.734 . . . . 0.0 107.994 176.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -106.89 2.38 25.32 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.328 1.051 . . . . 0.0 112.214 176.346 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -91.22 -46.32 8.14 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 119.24 0.927 . . . . 0.0 110.05 -173.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -105.58 -44.52 4.66 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.172 0.589 . . . . 0.0 110.493 178.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -82.75 40.91 0.7 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.551 1.141 . . . . 0.0 110.482 171.205 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.73 -21.86 64.87 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 127.002 2.121 . . . . 0.0 114.219 -170.489 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -103.26 7.81 38.39 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.173 1.389 . . . . 0.0 111.699 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -137.15 17.46 2.99 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.605 1.162 . . . . 0.0 111.387 -174.506 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -63.54 132.63 51.89 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 119.078 0.854 . . . . 0.0 109.363 -170.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . 0.258 23.0 p 52.05 22.98 2.03 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 127.357 2.263 . . . . 0.0 114.772 173.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -52.16 -41.54 62.67 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.851 1.261 . . . . 0.0 111.401 -175.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.35 -23.08 67.26 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -172.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 63.5 mt -61.39 -40.24 93.64 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 119.1 0.864 . . . . 0.0 109.621 175.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -68.19 -28.08 73.47 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 124.037 0.827 . . . . 0.0 111.591 -179.384 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.3 m -65.25 -37.12 86.22 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 118.243 1.021 . . . . 0.0 110.356 178.281 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 8.0 mt -71.25 -46.12 67.09 Favored 'Isoleucine or valine' 0 C--N 1.343 0.304 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 173.144 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 40.2 ttt180 -50.54 -46.11 57.29 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 118.858 0.754 . . . . 0.0 110.754 -177.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -61.87 -23.02 66.03 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.822 0.849 . . . . 0.0 113.025 -177.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 93.6 mt -92.21 -47.78 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 124.278 1.031 . . . . 0.0 109.268 178.448 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 30.0 pt -82.0 -36.77 14.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 118.989 0.813 . . . . 0.0 112.59 -168.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -68.19 -47.53 39.02 Favored Pre-proline 0 CA--C 1.54 0.575 0 CA-C-O 117.902 -1.047 . . . . 0.0 112.28 -170.331 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -68.66 -16.37 42.16 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 CA-C-N 121.532 1.583 . . . . 0.0 112.382 175.102 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 90.0 mtt-85 -91.51 20.29 5.48 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.736 1.214 . . . . 0.0 111.719 176.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 79.44 10.88 85.47 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 125.906 1.717 . . . . 0.0 115.023 168.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.45 137.76 58.1 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 119.649 1.724 . . . . 0.0 109.057 170.121 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 35.7 m -94.42 120.63 34.96 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 105.179 -2.156 . . . . 0.0 105.179 168.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 29.6 mt -99.2 132.62 44.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 -177.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 34.4 m -130.08 178.73 4.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 125.259 1.423 . . . . 0.0 108.812 172.117 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 77.14 28.11 58.9 Favored Glycine 0 C--N 1.335 0.523 0 CA-C-O 119.365 -0.686 . . . . 0.0 113.76 178.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 65.3 m80 -57.17 133.45 55.05 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 169.266 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 57.4 t-105 -115.61 135.78 22.7 Favored Pre-proline 0 CA--C 1.535 0.374 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -177.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.7 145.56 52.05 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 121.823 1.682 . . . . 0.0 111.754 -170.596 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 34.9 p . . . . . 0 CA--C 1.534 0.343 0 C-N-CA 122.963 0.505 . . . . 0.0 110.784 169.819 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 83.5 mttt . . . . . 0 N--CA 1.468 0.431 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -86.65 9.34 71.67 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 123.774 0.702 . . . . 0.0 111.815 167.393 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 95.3 mt -60.59 141.35 56.76 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 118.636 1.218 . . . . 0.0 110.889 177.462 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -108.74 -31.04 7.87 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.159 1.384 . . . . 0.0 108.89 167.037 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -146.4 162.48 38.13 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 127.869 2.468 . . . . 0.0 106.389 169.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -55.91 -29.05 59.44 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 119.27 0.941 . . . . 0.0 112.167 176.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -89.98 -11.5 41.45 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.295 1.038 . . . . 0.0 113.406 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 7.4 m-70 -149.48 131.52 15.32 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 119.742 1.155 . . . . 0.0 113.14 -169.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -75.02 158.98 32.32 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 167.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 12.4 p -61.69 -22.83 29.24 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 C-N-CA 123.227 0.611 . . . . 0.0 111.364 173.326 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -161.97 -172.26 29.15 Favored Glycine 0 C--N 1.337 0.636 0 O-C-N 121.514 -0.742 . . . . 0.0 111.798 -171.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.35 86.96 1.13 Allowed 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 124.755 1.222 . . . . 0.0 109.082 179.185 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.419 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 168.949 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 88.8 mt . . . . . 0 N--CA 1.465 0.308 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 83.2 m -43.14 -52.18 5.6 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 127.409 2.284 . . . . 0.0 111.696 -174.084 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -72.89 -33.7 66.2 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 118.888 -0.577 . . . . 0.0 110.731 -170.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -65.74 -43.47 88.89 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 118.552 0.615 . . . . 0.0 110.223 174.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -59.64 -49.6 77.13 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 178.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 98.2 t -67.33 -45.7 85.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-O 118.179 -0.915 . . . . 0.0 109.434 -176.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -53.77 -51.63 62.81 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 119.306 0.957 . . . . 0.0 110.1 -178.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 42.0 mttp -70.44 -42.17 71.9 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-O 118.838 -0.601 . . . . 0.0 110.697 -175.382 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 69.2 t90 -63.89 -44.5 92.83 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-N 118.943 0.792 . . . . 0.0 109.727 -178.16 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 54.3 t -61.96 -40.15 86.2 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 O-C-N 122.075 -0.391 . . . . 0.0 110.015 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -64.39 -40.24 95.42 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 121.369 -0.832 . . . . 0.0 110.232 178.246 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 20.6 mm100 -64.5 -51.46 62.83 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.321 0.51 . . . . 0.0 110.903 177.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 14.4 pt -66.01 -32.41 58.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 119.476 1.035 . . . . 0.0 110.704 -176.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 58.4 m -62.78 -26.63 68.81 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 118.139 -0.934 . . . . 0.0 112.127 -177.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -90.55 -17.69 26.57 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 120.259 1.39 . . . . 0.0 112.477 174.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -80.61 -35.71 33.72 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.25 0.932 . . . . 0.0 110.454 171.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 75.2 mt -91.63 -7.29 50.48 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.613 1.965 . . . . 0.0 111.598 -178.203 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 30.6 m80 56.26 24.68 8.44 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 126.076 1.75 . . . . 0.0 113.359 -172.158 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 86.9 mt . . . . . 0 N--CA 1.465 0.281 0 O-C-N 121.771 -0.581 . . . . 0.0 110.387 172.555 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.38 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.5 pt -83.81 -24.77 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 O-C-N 121.958 -0.464 . . . . 0.0 111.476 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 17.3 m -112.08 131.48 55.41 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.216 1.406 . . . . 0.0 108.732 177.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -107.0 121.87 6.71 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 108.374 -1.891 . . . . 0.0 108.374 170.24 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 52.5 mt -99.85 100.66 10.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 177.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -97.55 124.36 41.77 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 17.8 p90 -124.41 127.6 47.78 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 119.111 0.869 . . . . 0.0 112.131 -177.294 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -84.14 143.52 21.23 Favored Glycine 0 C--N 1.341 0.819 0 N-CA-C 110.316 -1.114 . . . . 0.0 110.316 168.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.6 m -160.38 159.26 30.87 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 118.895 1.348 . . . . 0.0 110.739 173.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -135.6 -47.64 0.69 Allowed 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.288 1.035 . . . . 0.0 109.851 169.169 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.4 p -80.12 -12.38 59.67 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.555 0.742 . . . . 0.0 111.954 170.115 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.9 7.96 54.71 Favored Glycine 0 C--N 1.342 0.869 0 C-N-CA 124.732 1.158 . . . . 0.0 113.449 170.106 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -69.76 -41.79 74.71 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 118.82 1.31 . . . . 0.0 112.442 -169.601 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.4 m -70.02 -18.01 63.29 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 119.408 1.004 . . . . 0.0 111.27 -172.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -58.23 -42.84 87.2 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 119.116 0.871 . . . . 0.0 110.166 174.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -65.8 -38.41 88.91 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 121.915 -0.491 . . . . 0.0 110.485 -178.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 36.9 mm -65.1 -47.52 87.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 176.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.0 -38.27 85.45 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.183 0.593 . . . . 0.0 111.575 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.0 mtpt -68.22 -44.69 75.18 Favored 'General case' 0 N--CA 1.463 0.188 0 O-C-N 121.643 -0.661 . . . . 0.0 110.594 176.317 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 75.5 mtm -66.85 -22.72 65.98 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.352 0.978 . . . . 0.0 111.946 178.039 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 68.3 mt -71.31 -59.07 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 168.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -55.16 -42.19 72.81 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 118.382 -0.818 . . . . 0.0 112.349 -174.317 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -58.94 -32.04 69.23 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 119.65 1.114 . . . . 0.0 111.903 -175.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -75.27 -39.6 59.58 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.062 0.545 . . . . 0.0 111.538 178.207 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -79.39 -35.4 40.76 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 118.652 0.66 . . . . 0.0 111.508 -177.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 88.09 146.1 11.43 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 124.778 1.18 . . . . 0.0 110.353 -169.016 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 55.5 tttp -63.37 -31.95 73.24 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 121.953 -0.733 . . . . 0.0 112.117 -169.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -66.24 -29.14 69.33 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 122.955 0.502 . . . . 0.0 111.397 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 39.0 t -92.56 -39.67 11.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 123.878 0.871 . . . . 0.0 109.582 -177.374 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -140.15 132.85 28.93 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 119.241 0.928 . . . . 0.0 111.513 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -125.05 149.7 47.52 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 175.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 60.5 t -97.83 138.98 21.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 124.595 1.158 . . . . 0.0 110.101 -168.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -149.63 172.39 15.13 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.948 1.299 . . . . 0.0 111.512 -173.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -137.74 132.17 32.39 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 125.647 1.579 . . . . 0.0 108.032 -174.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.5 tp -65.8 -27.03 40.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-O 118.581 -0.723 . . . . 0.0 112.927 -168.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.11 -30.44 68.72 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 119.221 0.919 . . . . 0.0 110.297 178.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 43.8 mtmt -81.03 -31.36 34.6 Favored 'General case' 0 C--N 1.342 0.244 0 C-N-CA 123.252 0.621 . . . . 0.0 110.421 174.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.7 m -70.43 169.51 13.88 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.522 1.129 . . . . 0.0 111.654 -172.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 14.8 m -135.3 160.96 36.77 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.146 1.379 . . . . 0.0 108.733 178.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 45.2 tttm -53.6 -51.75 62.02 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.78 0.832 . . . . 0.0 111.042 -174.34 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.2 mp0 -73.82 -14.32 61.08 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 119.343 -0.361 . . . . 0.0 111.683 -175.194 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -71.71 -39.39 70.19 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 119.487 1.04 . . . . 0.0 110.675 -178.238 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 8.3 mp -66.22 -31.83 72.89 Favored 'General case' 0 C--N 1.343 0.315 0 C-N-CA 122.375 0.27 . . . . 0.0 110.361 173.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -70.15 -20.93 63.12 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 119.178 -0.439 . . . . 0.0 111.612 -176.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.61 -30.3 61.62 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.622 0.769 . . . . 0.0 112.559 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -76.36 151.78 36.53 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 123.681 0.792 . . . . 0.0 109.928 177.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -100.12 -31.43 11.42 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 122.709 0.404 . . . . 0.0 111.338 170.2 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.1 mp -110.52 128.77 66.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 175.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 96.2 mt -114.17 128.33 56.32 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 172.348 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.2 mp -110.27 115.81 30.36 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 105.345 -2.095 . . . . 0.0 105.345 169.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 85.8 mt -115.92 109.7 17.95 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 -169.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -100.26 119.15 6.41 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 125.966 1.746 . . . . 0.0 109.85 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.6 tt -132.74 123.85 18.5 Favored Pre-proline 0 CA--C 1.541 0.605 0 CA-C-N 118.906 1.353 . . . . 0.0 112.15 -173.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -85.59 157.09 10.6 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 123.042 2.495 . . . . 0.0 110.658 170.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.0 m -112.32 142.08 45.26 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 175.103 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 75.2 m95 -140.95 171.29 14.28 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.11 1.764 . . . . 0.0 111.074 -169.566 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 36.2 t80 50.83 -89.59 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 127.648 2.379 . . . . 0.0 112.569 -177.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -149.7 84.15 1.41 Allowed 'General case' 0 C--O 1.235 0.303 0 C-N-CA 126.652 1.981 . . . . 0.0 106.215 173.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 73.58 13.44 80.22 Favored Glycine 0 CA--C 1.534 1.235 0 CA-C-O 119.203 -0.776 . . . . 0.0 114.088 177.061 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -84.59 161.99 19.95 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.625 1.212 . . . . 0.0 108.915 174.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -84.95 175.1 9.28 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 166.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.4 142.44 56.95 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 168.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 58.6 m -57.61 -36.47 71.82 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 119.311 0.959 . . . . 0.0 112.998 -169.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -72.53 -28.51 62.9 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.133 0.573 . . . . 0.0 111.908 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -79.91 -41.83 25.35 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.649 1.179 . . . . 0.0 109.468 176.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -59.7 -42.21 92.47 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.564 1.146 . . . . 0.0 110.689 176.385 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -62.22 -19.63 63.37 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.0 0.92 . . . . 0.0 112.525 177.319 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -90.4 -15.31 31.24 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 118.252 -0.88 . . . . 0.0 112.294 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -54.15 -42.87 95.87 Favored Pre-proline 0 CA--C 1.541 0.632 0 CA-C-N 120.992 1.724 . . . . 0.0 113.963 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -63.14 -21.96 72.77 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 CA-C-N 122.523 1.937 . . . . 0.0 113.397 174.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.2 m -82.25 -38.8 23.91 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.462 1.028 . . . . 0.0 109.702 171.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 14.0 tp -59.02 -40.69 85.76 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.312 1.045 . . . . 0.0 109.941 -176.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -75.63 4.15 8.26 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 178.479 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -105.38 -16.42 14.75 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.288 1.035 . . . . 0.0 111.111 169.273 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 96.7 mt -75.28 140.53 17.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 179.046 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -88.92 131.42 35.14 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 123.543 0.737 . . . . 0.0 109.524 174.184 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -121.51 8.01 10.12 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.86 0.864 . . . . 0.0 111.952 177.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 29.6 m-80 -58.72 116.45 3.73 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 119.814 1.188 . . . . 0.0 109.835 -172.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.58 1.92 67.48 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-O 118.571 -1.127 . . . . 0.0 114.283 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -74.25 150.84 40.07 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 119.674 1.737 . . . . 0.0 108.581 172.055 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 23.8 mt -92.04 137.59 32.24 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 172.312 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 19.7 t -134.28 144.07 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 177.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -137.65 145.94 43.28 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 171.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.2 mp -116.34 150.23 38.02 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 123.102 0.561 . . . . 0.0 109.646 -171.246 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -144.27 162.86 35.33 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 167.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -171.32 168.02 41.14 Favored Glycine 0 N--CA 1.452 -0.299 0 O-C-N 120.773 -1.204 . . . . 0.0 112.778 -176.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 21.3 m -133.28 151.6 51.9 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.569 1.148 . . . . 0.0 109.223 -168.559 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -178.35 -174.41 44.59 Favored Glycine 0 CA--C 1.528 0.857 0 CA-C-O 121.022 0.235 . . . . 0.0 112.57 -177.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -145.4 153.2 40.95 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 128.247 2.619 . . . . 0.0 106.952 175.349 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.9 12.8 3.38 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.182 1.393 . . . . 0.0 111.79 -173.643 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -68.47 -47.5 66.94 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 177.142 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -106.33 -38.72 6.13 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 123.395 0.678 . . . . 0.0 111.341 175.29 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -84.45 39.99 0.76 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.548 1.139 . . . . 0.0 111.404 -172.531 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.45 -19.83 65.8 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.266 1.027 . . . . 0.0 113.126 -171.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -93.11 0.31 57.22 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.476 1.11 . . . . 0.0 111.921 175.641 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -139.04 20.72 2.63 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.657 1.183 . . . . 0.0 111.573 -169.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -66.24 119.66 11.9 Favored 'General case' 0 C--O 1.235 0.32 0 O-C-N 121.122 -0.986 . . . . 0.0 108.925 -172.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 67.3 m 49.01 35.03 6.17 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.848 1.659 . . . . 0.0 112.581 -174.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -52.22 -41.21 62.54 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.815 1.246 . . . . 0.0 112.061 -171.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.53 -18.09 64.51 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -169.354 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 39.5 mt -54.58 -42.78 71.47 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.718 0.807 . . . . 0.0 110.137 171.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.69 -34.17 89.2 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 -179.153 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.2 m -64.91 -36.37 84.14 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 117.959 0.88 . . . . 0.0 110.864 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 8.1 mt -67.97 -51.18 52.08 Favored 'Isoleucine or valine' 0 C--N 1.345 0.392 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 173.337 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 60.3 ttp85 -55.17 -44.3 75.1 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 119.514 1.052 . . . . 0.0 110.488 -175.21 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -58.81 -21.46 56.37 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.793 0.837 . . . . 0.0 112.683 -177.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 96.7 mt -96.34 -51.38 10.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 124.325 1.05 . . . . 0.0 109.728 176.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 31.9 pt -74.64 -32.49 29.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-N 119.674 1.124 . . . . 0.0 111.762 -169.148 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -67.46 -54.2 19.63 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-O 117.61 -1.186 . . . . 0.0 112.069 -174.161 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -66.28 -23.23 52.19 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 CA-C-N 121.483 1.565 . . . . 0.0 112.024 176.549 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 60.5 mtp85 -85.62 16.67 3.73 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.014 0.926 . . . . 0.0 112.319 177.055 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 82.19 14.4 76.91 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-O 118.157 -1.357 . . . . 0.0 116.146 166.441 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.68 144.45 57.02 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 119.59 1.695 . . . . 0.0 109.807 170.04 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 74.9 m -96.87 121.36 38.65 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 167.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 34.9 mt -102.04 128.37 54.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 -173.246 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 32.7 m -128.79 178.09 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 125.658 1.583 . . . . 0.0 108.72 175.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 74.57 28.91 62.46 Favored Glycine 0 CA--C 1.525 0.7 0 O-C-N 121.426 -0.796 . . . . 0.0 113.213 -179.246 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 80.2 m-70 -61.98 140.92 58.3 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 169.651 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 68.3 t-105 -129.47 135.29 27.33 Favored Pre-proline 0 CA--C 1.535 0.382 0 C-N-CA 124.042 0.937 . . . . 0.0 108.866 -173.1 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -65.72 143.87 75.84 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 121.974 1.783 . . . . 0.0 112.182 -170.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 57.5 p . . . . . 0 CA--C 1.536 0.424 0 C-N-CA 123.679 0.792 . . . . 0.0 111.199 177.637 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.716 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -77.56 6.21 47.18 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.158 0.885 . . . . 0.0 113.433 173.24 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 93.5 mt -65.35 139.47 58.58 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 119.754 1.777 . . . . 0.0 109.864 176.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -106.14 -32.21 8.34 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.376 1.47 . . . . 0.0 108.184 167.086 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -146.45 161.78 39.68 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 128.143 2.577 . . . . 0.0 106.063 169.306 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -56.36 -29.44 61.4 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 121.108 -0.995 . . . . 0.0 112.276 176.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -90.29 -10.74 43.05 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.091 0.956 . . . . 0.0 113.448 179.068 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -144.81 124.74 13.49 Favored 'General case' 0 C--N 1.345 0.408 0 CA-C-N 119.862 1.21 . . . . 0.0 112.985 -171.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -73.17 153.24 40.8 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 166.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 8.4 p -64.84 -18.83 24.31 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 124.206 1.002 . . . . 0.0 112.081 178.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -161.36 176.02 37.93 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 -169.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -74.15 92.8 2.23 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.529 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 169.48 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 72.5 mt . . . . . 0 N--CA 1.467 0.417 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 41.2 m -46.57 -57.53 4.66 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 125.561 1.544 . . . . 0.0 111.999 -170.368 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -71.03 -30.32 66.48 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 122.529 0.332 . . . . 0.0 111.237 -169.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -68.26 -46.68 69.76 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 173.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -66.98 -39.2 87.11 Favored 'General case' 0 N--CA 1.463 0.18 0 O-C-N 121.738 -0.601 . . . . 0.0 111.576 -174.483 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 29.0 m -71.2 -23.18 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 119.127 0.876 . . . . 0.0 111.378 177.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -74.24 -52.84 11.15 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 120.14 1.336 . . . . 0.0 109.16 170.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -58.24 -43.53 87.82 Favored 'General case' 0 N--CA 1.462 0.169 0 O-C-N 122.17 -0.331 . . . . 0.0 110.934 -175.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 58.5 t90 -67.62 -46.71 71.72 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 118.199 0.454 . . . . 0.0 110.039 -176.027 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 67.9 t -63.49 -38.57 82.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 O-C-N 122.015 -0.428 . . . . 0.0 110.044 -178.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -66.53 -37.02 84.1 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.368 -0.833 . . . . 0.0 110.266 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 17.8 mm100 -66.53 -51.8 52.66 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.371 0.532 . . . . 0.0 110.917 175.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 15.5 pt -65.85 -29.24 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-N 119.469 1.032 . . . . 0.0 110.8 -176.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 70.6 m -58.9 -26.62 64.47 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 117.79 -1.1 . . . . 0.0 112.386 178.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -96.31 -9.57 29.87 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 120.341 1.428 . . . . 0.0 112.769 175.523 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -85.16 -39.72 17.55 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 119.138 0.881 . . . . 0.0 110.0 169.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 80.5 mt -87.28 -10.98 50.95 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.836 2.054 . . . . 0.0 111.531 -179.238 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 55.67 32.66 19.76 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.955 1.702 . . . . 0.0 112.535 -171.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 81.2 mt . . . . . 0 N--CA 1.466 0.366 0 O-C-N 121.804 -0.56 . . . . 0.0 110.069 169.26 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.361 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 31.6 pt -85.73 -23.64 7.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 122.413 0.285 . . . . 0.0 111.592 -177.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 11.7 m -109.36 128.11 54.85 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 125.235 1.414 . . . . 0.0 108.858 179.128 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -103.55 122.02 7.29 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 106.927 -2.469 . . . . 0.0 106.927 168.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 57.6 mt -100.99 92.35 2.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 N-CA-C 105.144 -2.169 . . . . 0.0 105.144 177.165 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -88.6 132.17 34.65 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 -178.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -130.06 133.28 46.6 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 119.521 1.055 . . . . 0.0 111.617 176.467 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -88.02 145.5 19.27 Favored Glycine 0 C--N 1.339 0.726 0 N-CA-C 108.384 -1.886 . . . . 0.0 108.384 171.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -159.47 176.35 12.2 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 119.446 1.623 . . . . 0.0 112.903 179.139 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -146.8 -47.22 0.18 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.944 2.098 . . . . 0.0 108.802 168.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 35.8 p -84.01 -15.86 46.07 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.14 0.976 . . . . 0.0 112.606 177.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 79.62 18.9 72.23 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-O 118.823 -0.987 . . . . 0.0 112.61 -174.371 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -74.16 -40.52 62.53 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.628 1.714 . . . . 0.0 110.182 178.343 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -62.27 -25.78 68.03 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.457 1.103 . . . . 0.0 111.827 177.304 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -59.53 -42.61 92.7 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 118.729 0.695 . . . . 0.0 110.222 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -67.7 -34.39 76.79 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 121.828 -0.545 . . . . 0.0 110.459 -179.149 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.6 mm -64.5 -46.92 91.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 175.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.77 -41.91 92.12 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 122.982 0.513 . . . . 0.0 111.042 178.458 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -63.38 -42.74 98.84 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 119.03 -0.51 . . . . 0.0 110.891 176.346 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 72.6 mtm -68.65 -27.78 66.3 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 119.175 0.898 . . . . 0.0 111.695 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 54.2 mt -69.8 -51.23 42.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 170.723 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -60.54 -41.41 94.4 Favored 'General case' 0 C--O 1.225 -0.22 0 O-C-N 121.688 -0.633 . . . . 0.0 111.404 -175.113 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.37 -38.27 86.37 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 118.86 0.755 . . . . 0.0 110.699 -177.098 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -74.52 -37.3 63.12 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 122.879 0.472 . . . . 0.0 111.091 178.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.7 mp -74.29 -34.62 63.58 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.311 0.505 . . . . 0.0 111.198 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.59 145.08 16.61 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 125.157 1.36 . . . . 0.0 110.511 -173.258 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -65.59 -30.16 70.86 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.679 0.792 . . . . 0.0 112.155 -172.481 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -68.05 -29.47 68.45 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 122.1 -0.375 . . . . 0.0 110.887 177.06 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 38.9 t -91.69 -36.72 8.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 C-N-CA 124.413 1.085 . . . . 0.0 110.096 -175.537 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -136.55 145.78 45.41 Favored 'General case' 0 C--N 1.34 0.183 0 CA-C-N 119.366 0.985 . . . . 0.0 113.283 -172.351 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -131.49 141.58 49.79 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.61 1.164 . . . . 0.0 109.889 174.515 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 83.3 t -89.24 139.44 17.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 124.002 0.921 . . . . 0.0 109.107 -178.269 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -149.45 173.35 13.66 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.449 1.1 . . . . 0.0 111.425 -168.196 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -147.96 121.43 9.09 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 125.926 1.691 . . . . 0.0 108.081 -172.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.2 tp -60.14 -22.24 24.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 123.819 0.848 . . . . 0.0 112.267 -171.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.84 -27.91 67.04 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 118.848 0.749 . . . . 0.0 111.251 178.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt -87.69 -21.25 25.33 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.244 1.018 . . . . 0.0 111.481 178.427 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 70.8 m -74.91 168.79 19.24 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.6 1.16 . . . . 0.0 112.359 -169.381 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 68.9 m -156.58 178.33 10.45 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.32 2.248 . . . . 0.0 106.995 177.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 27.4 tptp -50.42 -46.79 56.61 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.814 0.845 . . . . 0.0 111.997 -175.266 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -80.19 -11.6 59.72 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -173.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -76.76 -43.03 38.67 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 121.531 -0.731 . . . . 0.0 111.464 -172.401 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.7 mp -75.72 -28.74 58.68 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 118.033 0.379 . . . . 0.0 111.121 178.339 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -63.48 -18.1 63.43 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.91 0.884 . . . . 0.0 111.422 -177.166 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.21 -29.59 65.33 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.316 1.046 . . . . 0.0 112.728 177.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -89.18 156.84 18.54 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.346 1.058 . . . . 0.0 110.472 -175.491 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -107.64 -27.12 10.52 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.621 171.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.0 mp -116.76 130.37 71.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 175.723 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -113.88 116.55 29.48 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 177.199 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -103.16 112.45 25.32 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 104.623 -2.362 . . . . 0.0 104.623 171.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.4 mt -117.18 107.68 14.76 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -170.08 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -90.78 105.11 3.23 Favored Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 178.03 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.9 tp -115.87 102.59 53.99 Favored Pre-proline 0 CA--C 1.536 0.405 0 C-N-CA 125.024 1.33 . . . . 0.0 108.86 -174.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -72.85 143.14 36.42 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 121.289 1.326 . . . . 0.0 108.675 169.023 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 50.0 m -90.95 137.37 32.42 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 173.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 45.2 m95 -132.98 175.87 8.99 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 125.948 1.699 . . . . 0.0 108.896 -177.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 42.54 48.18 4.57 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.844 2.058 . . . . 0.0 114.092 168.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.3 p90 48.3 66.7 0.99 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.221 1.408 . . . . 0.0 111.963 176.329 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 87.89 52.54 2.92 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 124.303 0.954 . . . . 0.0 111.701 175.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -143.55 164.27 30.85 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.032 1.333 . . . . 0.0 108.777 174.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -82.84 161.38 21.95 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 167.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -62.42 149.21 43.17 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 168.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 65.9 m -56.74 -36.13 69.41 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.007 0.923 . . . . 0.0 113.144 -168.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -68.85 -38.05 79.52 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 118.894 0.77 . . . . 0.0 110.756 -177.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -69.82 -46.5 65.51 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 175.259 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -58.52 -39.93 81.5 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 122.717 0.407 . . . . 0.0 111.65 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -68.77 -23.44 64.31 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 123.924 0.889 . . . . 0.0 112.169 177.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -95.35 -20.12 19.39 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.452 0.701 . . . . 0.0 112.328 -178.066 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 21.5 m-30 -49.94 -40.47 54.76 Favored Pre-proline 0 CA--C 1.544 0.746 0 CA-C-O 116.656 -1.64 . . . . 0.0 114.47 176.25 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -63.78 -26.83 67.85 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 CA-C-N 123.032 2.119 . . . . 0.0 113.094 174.034 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.4 m -78.32 -35.11 48.15 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 119.576 1.08 . . . . 0.0 109.661 171.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 16.8 tp -63.36 -27.46 69.33 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 121.185 -0.947 . . . . 0.0 111.495 -176.224 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -87.67 -0.12 56.46 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.974 0.91 . . . . 0.0 112.964 174.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -96.33 -36.07 11.0 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 119.384 0.993 . . . . 0.0 108.469 169.05 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 68.0 mt -61.34 133.66 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -85.31 136.87 33.3 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 123.387 0.675 . . . . 0.0 109.545 176.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -129.14 18.32 6.01 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.97 0.908 . . . . 0.0 110.818 175.178 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -58.55 112.42 1.59 Allowed 'General case' 0 C--N 1.341 0.196 0 CA-C-N 120.373 1.442 . . . . 0.0 109.925 -176.112 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.37 1.57 57.67 Favored Glycine 0 CA--C 1.535 1.309 0 CA-C-O 118.599 -1.111 . . . . 0.0 114.207 -178.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -75.0 154.9 37.85 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 119.971 1.886 . . . . 0.0 107.689 170.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 27.2 mt -95.63 141.88 28.6 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.0 t -135.52 144.03 35.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 176.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -141.33 146.19 36.4 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 125.105 1.362 . . . . 0.0 107.343 172.166 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 68.8 mt -119.59 144.98 46.8 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 -170.497 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -143.54 165.89 26.32 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 123.608 0.763 . . . . 0.0 109.161 170.362 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -175.26 164.62 35.19 Favored Glycine 0 CA--C 1.521 0.418 0 CA-C-O 122.342 0.968 . . . . 0.0 112.623 179.336 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 38.1 m -115.89 159.25 21.8 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 125.725 1.61 . . . . 0.0 107.765 175.211 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -149.17 -164.18 11.44 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 175.276 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -148.81 153.05 37.57 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 117.639 0.719 . . . . 0.0 110.463 174.568 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -113.88 -1.86 13.76 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -168.536 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -70.79 -42.84 69.8 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 119.577 1.08 . . . . 0.0 110.669 -177.119 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -136.48 -32.77 0.83 Allowed 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -177.09 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -85.25 18.24 2.71 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -174.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.75 -14.29 62.83 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -174.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -89.93 0.13 57.25 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.074 0.95 . . . . 0.0 111.456 173.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -132.44 26.05 4.45 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 126.237 1.815 . . . . 0.0 109.303 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -64.92 121.09 13.82 Favored 'General case' 0 N--CA 1.452 -0.356 0 O-C-N 121.671 -0.643 . . . . 0.0 110.271 -168.113 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 74.5 m 48.42 34.29 4.63 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.363 1.865 . . . . 0.0 113.608 -177.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -54.42 -38.6 66.45 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.136 0.974 . . . . 0.0 113.132 -177.371 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.27 -12.53 61.65 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -170.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 52.2 mt -57.32 -40.64 78.34 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 118.67 0.668 . . . . 0.0 109.691 169.284 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -63.78 -31.62 81.4 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 123.591 0.615 . . . . 0.0 111.707 -179.363 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.6 m -65.77 -44.62 85.26 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 117.97 0.885 . . . . 0.0 109.905 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 4.3 mt -69.95 -40.9 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 119.029 0.832 . . . . 0.0 109.207 178.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 51.9 tpt85 -56.85 -33.24 66.6 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 118.469 0.577 . . . . 0.0 111.729 177.14 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -74.23 -33.76 63.46 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.242 0.617 . . . . 0.0 111.852 176.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 75.8 mt -79.34 -43.57 23.79 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 123.567 0.747 . . . . 0.0 110.629 -175.437 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 6.1 pt -76.8 -21.06 14.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 118.773 0.715 . . . . 0.0 112.923 -168.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -62.39 -56.66 28.43 Favored Pre-proline 0 CA--C 1.544 0.718 0 CA-C-O 117.604 -1.189 . . . . 0.0 112.273 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -66.71 -16.48 50.52 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 122.339 2.026 . . . . 0.0 112.915 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 19.4 mmm180 -84.6 4.04 34.08 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.409 0.684 . . . . 0.0 112.018 172.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 79.46 16.45 77.94 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 124.583 1.087 . . . . 0.0 113.953 170.032 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.32 146.68 47.22 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 118.551 1.175 . . . . 0.0 111.423 177.307 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 67.8 m -96.92 126.84 42.35 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 104.583 -2.377 . . . . 0.0 104.583 167.214 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 19.9 mt -113.18 131.6 64.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 -168.061 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 31.0 m -136.49 -177.87 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 124.725 1.21 . . . . 0.0 109.501 177.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 81.75 39.5 11.92 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-O 119.48 -0.622 . . . . 0.0 113.577 172.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 25.5 m170 -64.52 158.11 24.99 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.438 1.119 . . . . 0.0 109.718 169.502 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 43.8 t-105 -135.81 135.07 21.13 Favored Pre-proline 0 CA--C 1.536 0.433 0 CA-C-O 117.955 -1.021 . . . . 0.0 108.923 173.366 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_exo -65.68 145.93 82.75 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 121.781 1.654 . . . . 0.0 113.366 -175.535 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 36.2 p . . . . . 0 CA--C 1.534 0.361 0 O-C-N 121.684 -0.635 . . . . 0.0 109.819 169.821 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? . . . . . 0 N--CA 1.47 0.531 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -77.35 -2.21 78.53 Favored Glycine 0 CA--C 1.537 1.435 0 CA-C-N 118.763 0.71 . . . . 0.0 113.529 173.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 8.5 mp -58.31 133.14 55.43 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 119.027 1.413 . . . . 0.0 110.558 174.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -95.64 -31.41 13.27 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.067 0.947 . . . . 0.0 108.595 167.179 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -144.32 162.86 35.34 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 127.14 2.176 . . . . 0.0 106.764 170.568 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -52.64 -30.14 29.99 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.368 0.667 . . . . 0.0 112.305 175.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -86.03 -17.81 34.2 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -178.251 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 30.0 p-80 -154.31 141.12 19.11 Favored 'General case' 0 C--N 1.347 0.469 0 CA-C-N 120.577 1.535 . . . . 0.0 114.684 -176.063 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -72.14 150.67 43.6 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.356 1.463 . . . . 0.0 108.555 167.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 8.8 p -69.41 -20.61 24.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 123.373 0.669 . . . . 0.0 111.515 175.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -148.22 171.05 28.73 Favored Glycine 0 C--N 1.337 0.589 0 C-N-CA 124.72 1.152 . . . . 0.0 110.264 -177.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -67.37 112.99 4.89 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 175.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.282 0 C-N-CA 124.875 1.27 . . . . 0.0 108.048 -174.498 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 79.4 mt . . . . . 0 CA--C 1.535 0.402 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 26.0 m -46.9 -57.35 5.04 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 126.688 1.995 . . . . 0.0 111.187 -170.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -75.43 -33.88 60.95 Favored 'General case' 0 N--CA 1.452 -0.373 0 O-C-N 122.233 -0.292 . . . . 0.0 110.557 -171.001 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 25.1 mp0 -64.71 -45.46 86.48 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.307 1.043 . . . . 0.0 109.444 178.313 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -66.03 -40.5 91.09 Favored 'General case' 0 N--CA 1.463 0.206 0 O-C-N 121.535 -0.728 . . . . 0.0 110.246 178.102 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 69.8 t -68.04 -33.47 61.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 118.916 0.78 . . . . 0.0 110.087 179.224 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -65.31 -51.92 57.46 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 120.416 1.462 . . . . 0.0 109.621 171.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -61.32 -27.89 68.81 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 118.74 -0.648 . . . . 0.0 111.501 -177.304 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 36.1 t90 -81.47 -51.99 7.71 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 119.174 0.897 . . . . 0.0 110.456 177.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 77.8 t -67.2 -31.09 51.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 O-C-N 121.376 -0.828 . . . . 0.0 110.584 -170.62 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -61.9 -35.0 77.08 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 121.2 -0.937 . . . . 0.0 110.856 174.3 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 63.0 mt-30 -69.91 -49.26 53.8 Favored 'General case' 0 C--N 1.341 0.219 0 C-N-CA 123.353 0.661 . . . . 0.0 110.664 173.081 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 2.7 pt -62.76 -33.19 58.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-N 119.266 0.939 . . . . 0.0 109.872 -175.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 48.2 m -61.31 -30.45 70.5 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 118.478 -0.772 . . . . 0.0 111.887 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -90.44 -26.0 20.06 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.877 1.217 . . . . 0.0 112.024 176.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -72.28 -38.46 68.78 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.057 0.844 . . . . 0.0 110.758 174.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 78.3 mt -83.49 -9.36 59.03 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.804 1.642 . . . . 0.0 111.544 179.236 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 55.33 32.53 18.9 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.621 1.568 . . . . 0.0 112.544 -170.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 80.3 mt . . . . . 0 N--CA 1.465 0.278 0 O-C-N 121.571 -0.706 . . . . 0.0 110.37 170.019 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.315 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 17.6 pt -88.11 -22.34 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 122.397 0.279 . . . . 0.0 111.309 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.9 m -112.43 127.19 55.96 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.725 1.21 . . . . 0.0 109.294 -174.505 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -100.46 115.13 5.22 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 106.88 -2.488 . . . . 0.0 106.88 167.637 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 84.8 mt -88.66 116.12 29.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 104.068 -2.567 . . . . 0.0 104.068 169.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -112.13 127.6 55.97 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 173.258 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -132.88 136.86 46.45 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 119.478 1.036 . . . . 0.0 112.234 -178.114 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -85.43 158.59 32.73 Favored Glycine 0 CA--C 1.533 1.197 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 167.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 17.0 m -159.53 167.63 28.12 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 119.406 1.603 . . . . 0.0 110.526 176.126 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -144.81 -55.89 0.33 Allowed 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.419 0.688 . . . . 0.0 110.711 169.326 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 39.0 p -81.73 -6.38 58.98 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.731 0.812 . . . . 0.0 112.287 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 78.5 27.68 56.86 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-O 119.501 -0.611 . . . . 0.0 111.734 -172.116 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -87.64 -49.73 6.96 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-N 118.193 0.996 . . . . 0.0 110.115 173.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 26.9 m -70.09 -24.0 63.15 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 118.494 0.588 . . . . 0.0 111.517 -170.462 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -59.31 -34.46 72.35 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 121.388 -0.82 . . . . 0.0 111.26 174.191 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -70.96 -31.46 68.03 Favored 'General case' 0 C--O 1.226 -0.164 0 O-C-N 121.34 -0.85 . . . . 0.0 110.053 -179.12 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 23.1 mm -66.59 -47.73 82.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 176.515 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.71 -43.13 90.01 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 122.731 0.412 . . . . 0.0 111.389 176.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -69.42 -40.0 77.53 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-O 118.787 -0.625 . . . . 0.0 111.346 -178.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 68.1 mtm -61.81 -46.29 90.13 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 119.266 0.939 . . . . 0.0 109.755 174.594 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 75.2 mt -58.28 -47.16 88.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 177.496 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -59.5 -40.31 86.62 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 119.551 1.069 . . . . 0.0 111.456 178.657 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 59.0 tptt -64.23 -39.36 93.8 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 119.376 0.989 . . . . 0.0 110.222 178.554 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -69.43 -41.12 76.77 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.729 0.811 . . . . 0.0 110.959 179.343 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -73.89 -38.47 64.36 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.641 1.176 . . . . 0.0 110.56 -178.305 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.32 145.55 17.51 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 125.598 1.571 . . . . 0.0 110.759 -171.625 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.6 tptp -62.54 -30.2 71.13 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.449 1.1 . . . . 0.0 111.692 -175.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -68.92 -25.1 64.41 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.293 0.637 . . . . 0.0 111.412 178.034 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.2 t -99.82 -36.84 5.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 C-N-CA 124.106 0.962 . . . . 0.0 110.339 -175.212 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -133.5 139.57 46.73 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 119.32 0.964 . . . . 0.0 113.517 -175.193 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -122.22 150.25 42.54 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.484 1.114 . . . . 0.0 109.486 172.351 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 53.1 t -111.79 139.09 37.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 123.804 0.842 . . . . 0.0 110.93 -168.489 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -147.33 166.45 27.07 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.72 2.008 . . . . 0.0 111.101 -171.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -124.73 134.97 52.64 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 105.73 -1.952 . . . . 0.0 105.73 169.597 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.8 tp -60.14 -18.91 16.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 119.271 0.941 . . . . 0.0 112.556 -173.539 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -51.49 -37.71 50.42 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.442 1.097 . . . . 0.0 112.223 177.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.8 -1.42 56.8 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.346 0.658 . . . . 0.0 112.52 -178.295 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 64.4 m -79.81 156.39 27.42 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 122.287 1.042 . . . . 0.0 111.474 -177.277 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 33.6 p -127.41 176.64 7.3 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 127.371 2.268 . . . . 0.0 106.656 169.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -56.08 -36.33 67.99 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.776 -0.578 . . . . 0.0 111.837 -177.305 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -86.44 -11.72 51.08 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.014 0.526 . . . . 0.0 112.325 -176.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -69.52 -33.39 72.75 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 121.346 -0.846 . . . . 0.0 112.153 -169.385 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.7 mp -80.95 -31.86 34.73 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 122.936 0.494 . . . . 0.0 110.437 176.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -67.93 -18.46 64.77 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 123.279 0.632 . . . . 0.0 111.884 -172.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.12 -28.31 69.55 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.761 1.224 . . . . 0.0 112.157 175.013 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -96.79 157.65 15.8 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.436 1.094 . . . . 0.0 110.598 -179.252 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -104.82 -30.48 9.85 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.219 171.241 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.1 mm -106.7 138.63 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 174.237 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 86.0 mt -132.05 129.69 40.35 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 177.214 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.6 mp -114.22 113.84 25.19 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 172.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 61.2 mt -110.59 109.67 20.07 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 -170.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.68 118.61 5.63 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 125.726 1.632 . . . . 0.0 109.575 178.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.7 tp -135.03 108.91 10.59 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 117.994 0.897 . . . . 0.0 109.358 -170.709 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -76.19 146.03 28.12 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 121.762 1.641 . . . . 0.0 110.355 170.285 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 42.9 m -99.19 131.7 45.03 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 175.542 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 8.4 m95 -137.19 174.83 10.19 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 123.916 0.886 . . . . 0.0 111.63 -170.345 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 60.85 -76.69 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 128.557 2.743 . . . . 0.0 113.957 171.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -149.23 39.24 0.82 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.82 1.648 . . . . 0.0 109.841 -170.346 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.74 56.28 6.73 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 -170.026 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -131.18 164.54 25.29 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.264 1.426 . . . . 0.0 108.984 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.87 161.83 28.65 Favored 'General case' 0 C--O 1.236 0.354 0 O-C-N 121.848 -0.533 . . . . 0.0 110.09 169.579 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -71.1 154.85 41.42 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 170.594 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 58.6 m -59.16 -36.92 76.12 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.858 0.863 . . . . 0.0 112.885 -169.363 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -65.73 -43.14 89.9 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 118.505 0.593 . . . . 0.0 110.056 -178.4 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -69.39 -47.42 64.27 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.381 0.672 . . . . 0.0 109.81 177.427 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -60.09 -35.87 76.16 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.425 0.69 . . . . 0.0 111.818 -177.424 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -70.45 -25.83 63.37 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.861 0.864 . . . . 0.0 112.248 176.146 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -92.76 -21.4 19.96 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.312 0.645 . . . . 0.0 112.076 -179.039 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 17.0 m-30 -48.66 -42.99 61.28 Favored Pre-proline 0 CA--C 1.547 0.865 0 CA-C-O 116.86 -1.543 . . . . 0.0 114.52 177.133 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -64.52 -23.38 64.46 Favored 'Trans proline' 0 CA--C 1.544 1.019 0 CA-C-N 122.972 2.097 . . . . 0.0 113.462 175.475 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.1 m -79.63 -40.28 29.6 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 119.302 0.955 . . . . 0.0 109.001 170.46 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 16.7 tp -60.85 -32.16 71.57 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.726 1.21 . . . . 0.0 111.798 -172.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -78.53 -11.14 59.94 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.999 0.92 . . . . 0.0 112.361 177.472 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -87.18 -32.92 19.56 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 119.818 1.19 . . . . 0.0 110.035 170.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 86.7 mt -63.93 143.13 15.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 -178.513 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -98.18 133.8 42.12 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.121 0.968 . . . . 0.0 108.865 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -124.2 14.6 9.05 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 118.306 -0.854 . . . . 0.0 111.032 178.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -56.71 115.46 2.57 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-N 119.963 1.256 . . . . 0.0 109.345 -178.512 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.76 2.91 62.03 Favored Glycine 0 CA--C 1.535 1.291 0 CA-C-O 118.368 -1.24 . . . . 0.0 114.174 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -79.18 147.25 32.71 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 119.675 1.737 . . . . 0.0 107.287 170.266 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 8.4 mt -95.09 134.27 37.99 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 178.238 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 15.2 t -130.86 145.28 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 178.599 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -136.2 151.13 49.38 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 170.225 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 81.5 mt -120.63 148.1 44.35 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -171.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -145.81 166.26 26.44 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 169.305 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 178.33 172.16 42.43 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-O 122.692 1.162 . . . . 0.0 114.566 177.159 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 68.7 m -123.02 151.19 42.15 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 112.936 -1.632 . . . . 0.0 109.526 -169.63 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -169.49 176.92 43.31 Favored Glycine 0 N--CA 1.442 -0.957 0 N-CA-C 109.634 -1.387 . . . . 0.0 109.634 -172.336 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -127.03 110.23 12.74 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 177.339 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -78.93 -6.69 56.85 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 118.692 -0.671 . . . . 0.0 112.381 -169.709 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -111.72 -41.71 3.99 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.49 1.041 . . . . 0.0 110.639 -176.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -82.63 -29.0 30.4 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 121.76 -0.587 . . . . 0.0 111.999 -175.677 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -122.65 50.64 1.48 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.298 1.439 . . . . 0.0 108.974 172.318 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.57 -19.76 50.92 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 126.175 1.79 . . . . 0.0 115.401 -170.629 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -108.44 4.08 23.92 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.207 1.003 . . . . 0.0 112.929 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -127.98 19.96 6.49 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.046 1.338 . . . . 0.0 110.689 -178.557 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -65.96 128.52 36.36 Favored 'General case' 0 C--O 1.234 0.285 0 O-C-N 121.458 -0.777 . . . . 0.0 110.93 -168.354 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 95.5 m 52.25 31.39 9.19 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.918 1.687 . . . . 0.0 113.937 176.184 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -56.02 -41.3 74.72 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.02 -21.12 64.14 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 -168.144 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 7.7 mp -60.29 -40.04 89.07 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 119.113 0.87 . . . . 0.0 109.798 172.198 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.12 -33.81 88.25 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 177.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 5.8 m -64.11 -38.45 91.1 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.26 1.03 . . . . 0.0 110.177 177.361 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 4.0 mt -66.66 -44.58 89.62 Favored 'Isoleucine or valine' 0 C--N 1.344 0.366 0 CA-C-O 117.632 -1.175 . . . . 0.0 109.075 175.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 60.3 ttp85 -55.75 -45.62 78.0 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 120.174 1.352 . . . . 0.0 110.136 178.118 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -60.44 -25.2 65.81 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -178.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 78.6 mt -87.27 -45.44 16.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 123.989 0.916 . . . . 0.0 110.667 176.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.6 pt -86.43 -22.86 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 120.114 1.325 . . . . 0.0 112.779 -169.468 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -67.34 -46.12 49.45 Favored Pre-proline 0 CA--C 1.545 0.751 0 CA-C-O 117.436 -1.268 . . . . 0.0 111.661 -177.748 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -60.68 -28.1 85.95 Favored 'Trans proline' 0 C--N 1.356 0.934 0 C-N-CA 122.061 1.841 . . . . 0.0 112.969 172.705 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 15.4 mmm180 -86.37 10.57 14.58 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.877 1.271 . . . . 0.0 111.764 -177.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 77.81 15.67 80.95 Favored Glycine 0 CA--C 1.529 0.91 0 CA-C-O 118.494 -1.17 . . . . 0.0 114.721 169.066 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.31 141.01 56.79 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 119.072 1.436 . . . . 0.0 109.834 173.207 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 55.5 m -92.73 121.96 34.66 Favored 'General case' 0 C--O 1.232 0.133 0 N-CA-C 105.337 -2.098 . . . . 0.0 105.337 168.623 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 43.6 mt -105.12 123.39 59.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 -171.296 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 26.8 m -126.15 174.77 9.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 125.149 1.379 . . . . 0.0 109.011 178.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 78.24 33.28 40.51 Favored Glycine 0 CA--C 1.527 0.796 0 O-C-N 121.844 -0.535 . . . . 0.0 112.333 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -63.86 143.88 57.5 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 169.451 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' TRP . . . . . 0.421 ' HE1' ' NH2' ' A' ' 156' ' ' ARG . 72.8 t-105 -135.74 133.88 20.36 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 118.199 -0.905 . . . . 0.0 108.936 -167.71 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -68.32 141.77 52.71 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 121.496 1.464 . . . . 0.0 112.442 -170.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 12.6 p . . . . . 0 CA--C 1.536 0.442 0 C-N-CA 122.732 0.413 . . . . 0.0 110.041 169.202 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? . . . . . 0 N--CA 1.47 0.572 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -78.1 1.21 70.45 Favored Glycine 0 CA--C 1.532 1.143 0 CA-C-N 118.871 0.759 . . . . 0.0 113.078 171.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 7.9 mp -62.88 132.69 52.98 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 118.872 1.336 . . . . 0.0 110.869 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -96.01 -29.64 14.03 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.384 1.474 . . . . 0.0 108.584 166.64 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -145.28 161.77 38.8 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 127.511 2.325 . . . . 0.0 106.558 170.165 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -53.5 -33.28 53.84 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 119.438 1.017 . . . . 0.0 112.355 176.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -89.08 -7.52 55.67 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.831 0.853 . . . . 0.0 113.245 -178.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 64.6 m80 -146.8 125.19 12.32 Favored 'General case' 0 C--N 1.347 0.491 0 CA-C-N 119.759 1.163 . . . . 0.0 113.95 -170.642 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -69.79 151.84 45.3 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 164.136 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 9.0 p -69.74 -12.61 16.26 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 123.881 0.873 . . . . 0.0 111.946 175.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -164.48 171.02 39.86 Favored Glycine 0 CA--C 1.523 0.562 0 O-C-N 121.29 -0.881 . . . . 0.0 111.187 -172.028 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -67.22 114.74 6.19 Favored 'General case' 0 C--N 1.334 -0.09 0 C-N-CA 123.755 0.822 . . . . 0.0 108.975 -178.472 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.206 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 170.638 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 82.2 mt . . . . . 0 N--CA 1.463 0.196 0 N-CA-C 111.438 0.162 . . . . 0.0 111.438 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 52.9 m -41.76 -44.98 3.42 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.563 1.945 . . . . 0.0 113.299 -175.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -70.44 -31.5 68.7 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 119.155 0.888 . . . . 0.0 111.914 -173.36 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -71.98 -40.26 68.7 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 169.571 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.421 ' NH2' ' HE1' ' A' ' 120' ' ' TRP . 72.0 mtp85 -66.67 -38.26 86.46 Favored 'General case' 0 C--O 1.225 -0.186 0 CA-C-O 118.551 -0.737 . . . . 0.0 110.974 -174.25 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 26.8 m -69.3 -31.29 49.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-N 119.928 1.24 . . . . 0.0 111.179 177.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -65.49 -52.63 51.47 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 120.255 1.389 . . . . 0.0 109.501 171.358 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 39.3 mttp -61.15 -31.08 70.8 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 118.892 -0.575 . . . . 0.0 111.448 -177.732 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 61.5 t90 -78.92 -51.97 8.93 Favored 'General case' 0 N--CA 1.457 -0.094 0 CA-C-N 118.845 0.748 . . . . 0.0 111.19 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 56.8 t -63.72 -31.29 52.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 O-C-N 121.563 -0.711 . . . . 0.0 110.26 -175.534 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -59.48 -35.44 74.11 Favored 'General case' 0 CA--C 1.532 0.26 0 O-C-N 121.283 -0.886 . . . . 0.0 111.368 174.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -63.95 -53.57 48.16 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 118.711 0.687 . . . . 0.0 109.956 172.635 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 2.2 pt -69.0 -26.86 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 O-C-N 121.89 -0.507 . . . . 0.0 110.373 -170.071 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 46.1 m -58.97 -32.5 69.7 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 119.118 -0.468 . . . . 0.0 111.199 174.487 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -77.98 -43.75 28.7 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.553 1.07 . . . . 0.0 110.043 175.175 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -67.7 -34.06 76.13 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.587 0.755 . . . . 0.0 111.629 -174.396 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 83.7 mt -87.16 3.88 44.58 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.576 1.551 . . . . 0.0 111.108 177.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 25.9 m80 56.18 31.61 18.66 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.182 1.793 . . . . 0.0 113.001 -177.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 92.1 mt . . . . . 0 N--CA 1.464 0.255 0 C-N-CA 123.623 0.769 . . . . 0.0 110.304 173.714 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.248 0 CA-C-O 120.836 0.351 . . . . 0.0 111.385 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.9 pt -105.9 -14.98 8.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 125.248 1.419 . . . . 0.0 111.13 178.644 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 88.2 m -119.43 127.91 53.54 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.989 1.316 . . . . 0.0 108.826 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -91.28 129.34 9.75 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 107.856 -2.098 . . . . 0.0 107.856 169.359 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 33.0 mt -103.83 95.75 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 103.368 -2.827 . . . . 0.0 103.368 171.133 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 19.6 m-30 -100.16 129.65 46.21 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 -177.583 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 26.1 p90 -132.93 163.99 27.94 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 118.424 0.556 . . . . 0.0 110.99 -172.149 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -140.03 139.2 9.67 Favored Glycine 0 C--N 1.336 0.554 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 168.077 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.8 m -141.29 167.52 21.98 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.932 1.366 . . . . 0.0 110.696 -174.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -136.83 -50.8 0.66 Allowed 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.509 0.724 . . . . 0.0 110.157 168.24 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.3 p -82.48 -11.63 58.36 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.607 0.763 . . . . 0.0 112.084 171.629 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.92 6.59 51.93 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 124.961 1.267 . . . . 0.0 113.747 170.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -70.69 -44.05 67.77 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 118.757 1.279 . . . . 0.0 111.731 -173.213 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.01 -27.33 67.33 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 120.97 -1.081 . . . . 0.0 111.146 -175.175 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -62.57 -42.11 99.34 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 118.719 0.691 . . . . 0.0 109.85 172.146 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -63.5 -42.25 98.51 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 121.8 -0.562 . . . . 0.0 110.377 178.523 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 21.0 mm -62.06 -46.34 96.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 176.448 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.6 -41.38 94.65 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 121.929 -0.482 . . . . 0.0 111.426 -179.22 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.2 mtpt -65.66 -40.91 92.93 Favored 'General case' 0 C--O 1.227 -0.098 0 CA-C-O 118.49 -0.767 . . . . 0.0 110.676 177.2 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 61.8 mtm -62.38 -40.98 98.23 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 119.73 1.15 . . . . 0.0 110.759 176.217 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 70.2 mt -59.96 -47.04 93.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 176.742 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -63.53 -37.84 88.87 Favored 'General case' 0 CA--C 1.53 0.181 0 O-C-N 121.017 -1.052 . . . . 0.0 111.685 178.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -65.05 -34.04 77.48 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 120.115 1.325 . . . . 0.0 111.088 178.308 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 12.9 mm100 -70.1 -43.66 70.6 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 118.184 0.447 . . . . 0.0 110.744 175.206 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -82.93 -32.5 27.18 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.461 0.704 . . . . 0.0 112.434 -170.414 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 90.45 144.42 11.97 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 124.852 1.215 . . . . 0.0 111.117 -169.738 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 56.5 tptt -57.36 -35.77 70.36 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 125.281 1.432 . . . . 0.0 111.864 -175.479 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -82.95 -1.94 53.74 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.009 0.523 . . . . 0.0 112.351 -176.249 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.5 t -110.01 -46.93 6.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 123.769 0.828 . . . . 0.0 109.186 176.536 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -131.65 139.55 49.13 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 119.242 0.928 . . . . 0.0 110.458 -177.4 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -130.5 141.77 50.49 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 99.2 t -100.77 129.99 50.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 C-N-CA 124.813 1.245 . . . . 0.0 110.718 -167.722 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -143.97 145.37 32.19 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.945 0.898 . . . . 0.0 110.136 175.624 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -74.98 134.29 41.52 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 169.048 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.4 tp -56.53 -31.3 33.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 123.387 0.675 . . . . 0.0 112.057 -174.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.29 -32.53 70.11 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -170.353 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -92.07 -10.38 39.27 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -178.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 36.9 m -70.2 126.09 28.66 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 119.214 0.915 . . . . 0.0 108.73 177.727 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 14.5 m -73.43 168.2 19.72 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.597 0.759 . . . . 0.0 109.742 173.164 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -53.39 -41.11 65.59 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.585 0.754 . . . . 0.0 110.865 174.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -77.44 -15.92 59.07 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.099 0.56 . . . . 0.0 112.178 -178.072 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -75.27 -28.3 59.74 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 121.141 -0.974 . . . . 0.0 111.109 -176.083 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -68.66 -43.71 75.64 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.596 0.758 . . . . 0.0 109.024 169.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -65.65 -25.79 67.51 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.161 0.584 . . . . 0.0 112.137 -179.139 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.3 -30.32 70.14 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.681 0.793 . . . . 0.0 112.709 -174.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -92.57 154.85 18.16 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.35 1.06 . . . . 0.0 110.112 178.432 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -104.01 -21.87 13.54 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.353 0.661 . . . . 0.0 111.775 169.727 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.8 mp -121.65 132.74 70.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 176.414 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 80.0 mt -133.25 135.81 45.18 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 123.42 0.688 . . . . 0.0 109.991 178.417 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 7.3 mp -114.42 118.62 34.35 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 104.469 -2.419 . . . . 0.0 104.469 170.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 73.9 mt -112.48 117.72 33.17 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 123.32 0.648 . . . . 0.0 109.733 -169.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -101.4 98.82 1.84 Allowed Glycine 0 C--N 1.335 0.494 0 C-N-CA 125.713 1.625 . . . . 0.0 111.273 -173.554 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 2.1 tp -120.86 109.61 35.7 Favored Pre-proline 0 CA--C 1.538 0.487 0 C-N-CA 125.466 1.506 . . . . 0.0 109.476 -169.089 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -81.48 155.38 18.7 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.854 2.37 . . . . 0.0 110.418 173.633 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.7 m -101.06 136.22 41.26 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 172.437 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 60.7 m95 -135.51 173.53 11.62 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 125.647 1.579 . . . . 0.0 109.864 -178.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 13.4 t80 38.98 56.03 2.03 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.095 2.158 . . . . 0.0 113.443 168.271 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 26.2 p90 46.3 66.05 1.05 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.086 1.355 . . . . 0.0 112.088 176.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.55 52.36 3.38 Favored Glycine 0 CA--C 1.525 0.67 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.818 172.049 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -136.23 154.26 50.97 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 124.513 1.125 . . . . 0.0 109.116 174.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -79.28 146.08 33.18 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 169.689 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -59.47 147.43 36.67 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 171.167 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 74.5 m -58.13 -29.73 65.76 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.212 1.005 . . . . 0.0 113.546 -168.353 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -68.47 -32.73 72.93 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 118.891 0.769 . . . . 0.0 111.213 -178.441 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 92.1 m95 -79.44 -45.52 19.28 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-N 118.121 0.418 . . . . 0.0 110.085 171.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -60.54 -38.26 83.87 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.021 0.373 . . . . 0.0 111.926 -175.143 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -68.09 -24.75 65.08 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.581 0.753 . . . . 0.0 112.11 176.112 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -88.85 -25.4 22.19 Favored 'General case' 0 C--N 1.341 0.225 0 CA-C-O 118.738 -0.649 . . . . 0.0 111.914 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -49.57 -43.15 71.29 Favored Pre-proline 0 CA--C 1.546 0.819 0 CA-C-O 116.704 -1.617 . . . . 0.0 114.729 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -66.61 -15.19 46.83 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 CA-C-N 122.784 2.03 . . . . 0.0 113.774 176.739 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.1 m -89.78 -40.67 12.33 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.85 0.86 . . . . 0.0 109.013 169.502 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.5 ' HA ' HD12 ' A' ' 76' ' ' ILE . 31.3 tp -56.62 -38.32 71.93 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 125.017 1.327 . . . . 0.0 111.567 -176.679 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -68.74 -10.19 55.07 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -96.22 -7.19 36.3 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 119.646 1.112 . . . . 0.0 112.001 177.229 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.5 HD12 ' HA ' ' A' ' 73' ' ' LEU . 95.8 mt -91.57 146.39 6.32 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 -169.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -91.58 130.47 37.39 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 178.449 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -125.35 10.59 8.0 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 123.778 0.831 . . . . 0.0 111.768 176.432 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -63.89 126.55 28.01 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 120.231 1.378 . . . . 0.0 110.133 -175.028 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 74.84 -3.05 46.62 Favored Glycine 0 CA--C 1.538 1.474 0 CA-C-O 118.102 -1.388 . . . . 0.0 114.152 -175.571 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 63.1 mttm -79.61 146.16 32.69 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 120.226 2.013 . . . . 0.0 108.045 175.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 20.0 mt -95.38 131.6 41.33 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 176.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.9 t -132.25 143.14 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 178.546 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -129.63 156.16 44.67 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.893 1.277 . . . . 0.0 107.832 170.597 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 14.3 mt -122.27 145.87 47.83 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 124.324 1.05 . . . . 0.0 108.335 -175.419 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -141.36 156.15 45.85 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 123.851 0.86 . . . . 0.0 109.08 170.097 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -179.94 -169.25 39.89 Favored Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 111.394 -0.682 . . . . 0.0 111.394 -178.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 21.9 p -135.59 171.88 13.81 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 126.379 1.872 . . . . 0.0 109.196 -169.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -169.69 178.23 42.78 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 112.423 -0.271 . . . . 0.0 112.423 170.127 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -127.77 138.98 52.93 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 125.712 1.605 . . . . 0.0 108.201 169.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -121.28 24.99 9.74 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.274 1.029 . . . . 0.0 111.012 -172.519 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -119.02 -48.63 2.44 Favored 'General case' 0 C--O 1.234 0.263 0 O-C-N 121.444 -0.785 . . . . 0.0 109.903 -177.074 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -107.68 -33.78 7.18 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.936 0.894 . . . . 0.0 110.617 176.103 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -98.13 25.48 6.09 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.994 0.918 . . . . 0.0 111.925 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.17 -21.15 66.45 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -173.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -84.33 -3.01 58.0 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.905 0.882 . . . . 0.0 112.001 174.834 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -135.69 17.96 3.31 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.876 1.671 . . . . 0.0 109.614 -173.479 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -65.07 118.76 9.64 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -168.732 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 56.3 m 53.35 27.56 6.4 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.394 1.478 . . . . 0.0 113.2 -177.774 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -54.03 -38.17 64.9 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.06 1.344 . . . . 0.0 112.281 -173.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.25 -13.29 61.48 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -171.404 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 82.0 mt -58.97 -43.51 91.39 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 119.022 0.828 . . . . 0.0 109.759 175.488 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -69.98 -29.36 70.81 Favored Glycine 0 CA--C 1.529 0.91 0 N-CA-C 111.923 -0.471 . . . . 0.0 111.923 -177.08 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 8.3 m -63.21 -37.15 86.1 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 117.873 0.837 . . . . 0.0 111.133 -174.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.4 mt -73.82 -45.36 50.02 Favored 'Isoleucine or valine' 0 C--N 1.344 0.339 0 CA-C-O 118.452 -0.785 . . . . 0.0 108.938 176.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 37.4 ttt180 -53.33 -42.4 66.71 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 119.081 0.855 . . . . 0.0 110.738 -178.363 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -61.27 -17.61 54.34 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.104 0.962 . . . . 0.0 112.847 -179.495 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 69.7 mt -99.2 -48.33 11.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 124.66 1.184 . . . . 0.0 109.627 175.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 40.8 pt -79.9 -34.25 15.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 119.459 1.027 . . . . 0.0 112.117 -168.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -70.6 -41.67 13.01 Favored Pre-proline 0 CA--C 1.543 0.687 0 CA-C-O 117.576 -1.202 . . . . 0.0 110.88 -175.294 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -63.47 -30.33 71.75 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.032 1.821 . . . . 0.0 113.322 171.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -76.67 7.61 4.44 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.101 0.96 . . . . 0.0 112.328 171.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 93.33 6.64 62.68 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 125.882 1.706 . . . . 0.0 114.976 168.524 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.62 137.37 57.56 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 119.652 1.726 . . . . 0.0 109.424 175.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 87.3 m -90.83 122.77 33.84 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 169.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 23.1 mm -100.15 126.85 53.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 -171.138 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 27.6 m -130.91 179.72 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 125.024 1.329 . . . . 0.0 108.612 175.282 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 74.44 32.61 57.58 Favored Glycine 0 C--N 1.338 0.659 0 O-C-N 121.528 -0.733 . . . . 0.0 112.082 179.288 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 83.8 m-70 -64.24 143.03 58.19 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 169.573 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 55.1 t-105 -130.19 140.67 39.34 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-O 117.866 -1.064 . . . . 0.0 108.963 -178.291 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -61.31 148.42 92.97 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 CA-C-N 121.063 1.415 . . . . 0.0 114.772 -170.806 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 41.4 p . . . . . 0 CA--C 1.537 0.469 0 C-N-CA 123.485 0.714 . . . . 0.0 110.629 167.958 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.471 0.595 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -82.2 5.77 70.69 Favored Glycine 0 CA--C 1.527 0.843 0 CA-C-O 118.633 -1.093 . . . . 0.0 113.153 177.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 8.5 mp -63.16 128.15 34.54 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 119.909 1.854 . . . . 0.0 110.238 178.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.26 -37.63 25.64 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.587 1.555 . . . . 0.0 107.746 167.348 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -153.94 165.75 35.12 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 129.481 3.112 . . . . 0.0 106.227 -177.337 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -51.03 -35.92 36.88 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.275 0.943 . . . . 0.0 112.41 175.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -96.18 -3.4 44.44 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -175.376 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -146.54 139.42 25.4 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 120.542 1.519 . . . . 0.0 112.455 -172.191 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -84.91 155.54 21.63 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.613 1.565 . . . . 0.0 108.706 167.261 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 24.4 m -70.03 -8.65 11.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 125.127 1.371 . . . . 0.0 112.735 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -158.23 173.62 35.4 Favored Glycine 0 C--N 1.337 0.622 0 C-N-CA 124.964 1.269 . . . . 0.0 110.564 -178.448 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -64.94 132.02 48.2 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 124.556 1.142 . . . . 0.0 109.007 176.096 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.309 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 169.286 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 83.1 mt . . . . . 0 N--CA 1.464 0.246 0 N-CA-C 110.682 -0.118 . . . . 0.0 110.682 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 5.0 m -48.7 -50.06 35.08 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.418 1.087 . . . . 0.0 110.892 -179.113 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.88 -41.81 86.62 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.641 0.655 . . . . 0.0 110.714 -171.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -61.89 -48.42 80.56 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 123.023 0.529 . . . . 0.0 109.855 177.134 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 75.8 mtt180 -62.54 -45.74 91.57 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 122.933 0.493 . . . . 0.0 110.114 -176.792 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 83.3 t -68.75 -43.72 82.71 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.118 0 CA-C-O 118.274 -0.869 . . . . 0.0 109.84 -178.037 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -62.38 -45.07 94.82 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 120.556 1.525 . . . . 0.0 110.124 -178.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -65.6 -39.7 91.85 Favored 'General case' 0 C--N 1.333 -0.137 0 O-C-N 121.924 -0.485 . . . . 0.0 110.239 -179.474 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 75.9 t90 -66.67 -45.96 77.22 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-N 118.452 0.569 . . . . 0.0 110.356 178.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 55.9 t -59.07 -41.53 83.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.327 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 45.5 mttm -62.46 -44.97 95.12 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 118.678 0.672 . . . . 0.0 109.881 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 19.8 mm100 -62.1 -52.83 62.31 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 122.852 0.461 . . . . 0.0 110.569 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 22.8 pt -68.24 -32.2 54.8 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 CA-C-O 118.811 -0.614 . . . . 0.0 110.825 -174.113 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 48.8 m -62.92 -30.67 71.73 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 119.188 0.904 . . . . 0.0 111.082 -178.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -77.67 -41.99 36.2 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 119.327 0.967 . . . . 0.0 110.578 175.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -68.18 -33.96 75.41 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.505 0.722 . . . . 0.0 111.708 -177.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 81.1 mt -90.62 -2.38 57.86 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.202 1.801 . . . . 0.0 111.327 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 25.2 m80 56.82 22.36 6.93 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.9 1.68 . . . . 0.0 113.478 -174.014 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 78.8 mt . . . . . 0 N--CA 1.464 0.226 0 C-N-CA 124.275 1.03 . . . . 0.0 110.536 175.96 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.347 0 N-CA-C 110.517 -0.179 . . . . 0.0 110.517 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 31.0 pt -87.27 -22.48 6.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 123.107 0.563 . . . . 0.0 111.375 -179.033 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 15.4 m -110.63 126.51 54.55 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 125.612 1.565 . . . . 0.0 108.531 178.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -102.77 123.79 7.96 Favored Glycine 0 CA--C 1.521 0.419 0 N-CA-C 107.056 -2.418 . . . . 0.0 107.056 169.032 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 62.3 mt -105.26 92.28 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 N-CA-C 105.338 -2.097 . . . . 0.0 105.338 178.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -88.64 135.26 33.59 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 -177.316 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -132.58 133.37 43.6 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 119.943 1.247 . . . . 0.0 112.596 176.08 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -87.97 148.14 20.74 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 108.283 -1.927 . . . . 0.0 108.283 167.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.9 m -168.35 160.46 11.36 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 119.069 1.435 . . . . 0.0 110.624 174.625 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -125.3 -53.36 1.61 Allowed 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.821 0.848 . . . . 0.0 109.493 167.686 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.8 p -85.92 6.01 30.41 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 124.944 1.298 . . . . 0.0 113.219 174.773 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 85.25 -7.18 76.84 Favored Glycine 0 CA--C 1.532 1.107 0 N-CA-C 117.302 1.681 . . . . 0.0 117.302 167.601 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.55 -36.08 77.58 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 120.51 2.155 . . . . 0.0 113.461 -170.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 11.4 m -73.02 -16.2 61.51 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 119.408 1.004 . . . . 0.0 110.791 -175.45 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -60.77 -42.5 97.58 Favored 'General case' 0 C--N 1.342 0.264 0 O-C-N 121.101 -0.999 . . . . 0.0 109.879 173.168 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -65.94 -39.04 90.14 Favored 'General case' 0 C--N 1.339 0.142 0 O-C-N 121.984 -0.448 . . . . 0.0 110.086 -178.067 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 41.0 mm -62.33 -47.69 91.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 176.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.34 -43.9 96.02 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 122.843 0.457 . . . . 0.0 111.345 179.674 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 54.9 mttm -63.85 -43.72 95.28 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 118.811 -0.614 . . . . 0.0 110.848 178.288 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 75.6 mtm -63.5 -37.06 85.86 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 119.328 0.967 . . . . 0.0 110.965 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 34.0 mt -65.22 -44.6 95.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 174.648 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -60.12 -40.13 88.64 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 119.291 0.951 . . . . 0.0 110.741 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -64.45 -34.17 77.58 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 119.007 0.821 . . . . 0.0 111.172 179.06 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -68.2 -51.13 49.03 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 118.689 0.677 . . . . 0.0 110.431 175.334 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 42.5 mt -71.16 -31.92 68.29 Favored 'General case' 0 C--N 1.341 0.227 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -174.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.63 147.21 20.86 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 125.31 1.433 . . . . 0.0 110.983 -174.231 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -65.05 -29.71 70.63 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.764 0.826 . . . . 0.0 112.172 -172.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -67.51 -29.37 68.77 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 122.63 0.372 . . . . 0.0 111.117 177.342 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 33.3 t -93.69 -36.9 7.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 C-N-CA 124.585 1.154 . . . . 0.0 110.256 -175.53 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -134.93 144.54 47.52 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 119.067 0.849 . . . . 0.0 112.838 -171.742 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -131.09 141.69 50.18 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.376 1.07 . . . . 0.0 110.058 172.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 87.9 t -88.88 141.32 14.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 123.728 0.811 . . . . 0.0 108.911 -178.323 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -145.28 169.57 17.99 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.442 1.097 . . . . 0.0 111.444 -169.026 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -144.95 121.17 10.85 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.275 1.43 . . . . 0.0 107.474 -177.039 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.4 tp -59.09 -21.76 20.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 123.474 0.71 . . . . 0.0 112.242 -171.231 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.82 -29.16 69.98 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.05 0.54 . . . . 0.0 111.725 176.635 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 57.8 pttt -108.49 -19.53 13.42 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.302 1.041 . . . . 0.0 112.408 178.022 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.4 m -63.88 165.32 8.84 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 119.262 0.937 . . . . 0.0 110.53 170.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 24.4 p -143.95 166.89 23.7 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.163 0.985 . . . . 0.0 110.095 -179.409 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -52.93 -49.19 66.49 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.369 1.067 . . . . 0.0 111.32 -172.095 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -80.02 -24.02 41.09 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 122.134 0.174 . . . . 0.0 111.02 -175.173 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -73.35 -32.77 64.73 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.068 0.547 . . . . 0.0 111.091 -179.044 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -59.23 -37.77 78.33 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.405 0.682 . . . . 0.0 110.966 171.198 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -72.17 -16.59 61.97 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 122.884 0.473 . . . . 0.0 112.257 -173.302 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.18 -29.01 65.77 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.473 0.709 . . . . 0.0 111.871 -178.114 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -79.8 157.29 27.09 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.253 1.021 . . . . 0.0 110.169 179.13 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -109.77 -28.8 8.62 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.107 169.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.2 mp -112.04 126.91 69.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 173.519 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -112.58 122.22 47.06 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 175.2 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.2 mp -109.71 118.27 36.09 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 171.332 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 60.0 mt -119.46 109.16 15.42 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -171.509 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.5 122.57 7.19 Favored Glycine 0 CA--C 1.521 0.407 0 C-N-CA 125.629 1.585 . . . . 0.0 110.162 -179.113 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 18.4 tt -136.71 109.19 9.29 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-N 118.121 0.961 . . . . 0.0 111.648 -176.508 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.1 140.54 31.33 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 N-CA-C 107.32 -1.839 . . . . 0.0 107.32 166.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 90.5 m -91.97 136.17 33.37 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 177.67 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 30.1 m95 -129.62 173.97 10.11 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.518 1.127 . . . . 0.0 111.405 -172.569 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 55.07 -89.88 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 127.909 2.484 . . . . 0.0 112.397 179.143 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -153.58 78.66 1.14 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 126.271 1.829 . . . . 0.0 106.754 175.639 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 65.75 51.84 43.43 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 -177.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -127.79 155.85 43.41 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.1 0.96 . . . . 0.0 109.631 176.376 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -79.23 166.35 22.27 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.751 0.82 . . . . 0.0 109.968 170.357 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 18.1 mm-40 -72.57 153.75 41.13 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 169.128 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 60.8 m -58.98 -37.01 75.84 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.598 0.759 . . . . 0.0 112.739 -169.08 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -72.14 -38.38 69.24 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 118.712 0.687 . . . . 0.0 110.579 -177.026 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -66.42 -46.78 75.38 Favored 'General case' 0 C--N 1.342 0.241 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 173.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -60.53 -38.75 85.44 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.331 0.652 . . . . 0.0 111.557 -178.669 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -70.01 -25.72 63.72 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.996 0.918 . . . . 0.0 112.189 176.459 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -90.71 -20.55 22.33 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.445 0.698 . . . . 0.0 112.293 -179.554 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 19.3 m-30 -51.02 -42.24 78.85 Favored Pre-proline 0 CA--C 1.546 0.822 0 CA-C-O 116.762 -1.589 . . . . 0.0 114.253 177.058 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -65.5 -21.21 60.4 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 CA-C-N 122.966 2.095 . . . . 0.0 113.402 174.238 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.8 m -81.95 -36.33 28.08 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 119.371 0.987 . . . . 0.0 109.604 170.512 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 21.7 tp -61.91 -30.8 71.13 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.059 -1.026 . . . . 0.0 111.37 -175.476 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -82.96 -2.36 54.91 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.163 0.985 . . . . 0.0 113.134 175.584 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 39.4 mm-40 -100.36 -26.03 14.02 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.331 1.052 . . . . 0.0 110.425 172.518 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 80.9 mt -70.69 152.76 8.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 174.507 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -106.99 134.83 49.56 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.533 1.133 . . . . 0.0 109.465 178.44 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -124.98 15.55 8.53 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.499 1.119 . . . . 0.0 111.53 177.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -56.07 115.04 2.2 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 119.646 1.112 . . . . 0.0 109.79 -178.445 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 74.44 3.08 65.13 Favored Glycine 0 CA--C 1.536 1.358 0 CA-C-O 118.531 -1.149 . . . . 0.0 114.294 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -80.02 148.67 31.02 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 119.385 1.593 . . . . 0.0 107.742 171.028 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 19.1 mt -91.44 134.33 34.72 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 178.433 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 19.0 t -130.96 132.78 63.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 178.264 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -128.32 143.32 51.0 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 176.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 77.8 mt -115.99 146.23 42.3 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -173.521 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -141.55 160.35 40.33 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 169.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -170.9 170.06 42.91 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-O 122.419 1.01 . . . . 0.0 113.059 -171.111 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 15.5 m -136.7 148.8 47.54 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 125.739 1.616 . . . . 0.0 107.367 -169.755 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.6 -167.29 28.05 Favored Glycine 0 CA--C 1.528 0.859 0 O-C-N 123.233 0.333 . . . . 0.0 112.604 -174.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -139.78 143.57 36.97 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.721 1.608 . . . . 0.0 109.896 -179.472 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -118.66 3.85 11.68 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.053 1.741 . . . . 0.0 112.268 -178.288 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -85.81 -47.59 9.58 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 119.699 1.136 . . . . 0.0 110.572 176.105 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -129.68 -37.97 1.53 Allowed 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.248 0.619 . . . . 0.0 111.825 -170.022 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -87.26 18.82 3.49 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.218 0.607 . . . . 0.0 112.133 174.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.67 -39.72 71.33 Favored 'General case' 0 C--N 1.342 0.247 0 C-N-CA 124.729 1.212 . . . . 0.0 112.365 -173.546 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -65.93 -13.96 60.68 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 118.577 0.626 . . . . 0.0 111.938 -177.724 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -120.83 21.57 11.39 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 126.546 1.939 . . . . 0.0 110.112 -177.717 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -60.34 119.32 7.73 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 118.832 0.742 . . . . 0.0 110.729 -169.324 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 72.2 m 47.63 32.03 2.34 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.021 1.729 . . . . 0.0 112.749 -177.183 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -54.87 -37.5 66.34 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.055 0.942 . . . . 0.0 112.087 -173.283 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.87 -14.07 62.81 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -171.16 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 84.9 mt -56.07 -42.98 77.52 Favored 'General case' 0 C--N 1.345 0.371 0 CA-C-N 118.961 0.801 . . . . 0.0 109.609 169.64 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.97 -33.15 86.47 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 -178.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.2 m -64.33 -41.37 96.82 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 118.18 0.99 . . . . 0.0 110.194 178.31 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 6.2 mt -68.22 -45.21 83.31 Favored 'Isoleucine or valine' 0 C--N 1.343 0.312 0 CA-C-N 119.198 0.908 . . . . 0.0 108.8 176.158 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 52.3 ttt-85 -52.95 -47.82 67.83 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 119.236 0.925 . . . . 0.0 110.157 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -64.98 -23.24 67.16 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 123.87 0.868 . . . . 0.0 112.381 -175.773 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 76.2 mt -86.2 -46.42 16.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 118.844 0.747 . . . . 0.0 109.381 175.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.0 pt -76.47 -26.27 16.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 119.363 0.983 . . . . 0.0 112.811 -169.269 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -64.06 -50.23 70.08 Favored Pre-proline 0 CA--C 1.547 0.832 0 CA-C-O 117.654 -1.165 . . . . 0.0 111.846 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -54.54 -29.75 61.58 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.858 2.372 . . . . 0.0 114.038 172.11 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 28.5 mmm180 -88.11 9.85 21.25 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.888 0.875 . . . . 0.0 111.799 -177.393 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 79.27 12.62 83.73 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-O 118.645 -1.086 . . . . 0.0 114.132 169.405 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.42 143.33 45.73 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 118.846 1.323 . . . . 0.0 110.287 173.449 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 48.7 m -93.15 121.11 34.17 Favored 'General case' 0 CA--C 1.528 0.108 0 N-CA-C 104.821 -2.288 . . . . 0.0 104.821 168.173 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 14.9 mt -102.23 126.06 56.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -168.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 6.1 m -140.98 174.28 7.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 125.928 1.691 . . . . 0.0 108.979 -170.194 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 74.56 37.11 47.2 Favored Glycine 0 CA--C 1.529 0.934 0 O-C-N 121.479 -0.763 . . . . 0.0 112.228 -175.5 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -66.56 138.88 57.8 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 173.385 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 70.9 t-105 -124.61 126.24 25.42 Favored Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 124.782 1.233 . . . . 0.0 108.423 -169.44 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -68.47 145.02 63.41 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 121.483 1.455 . . . . 0.0 112.358 -169.676 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 4.1 p . . . . . 0 CA--C 1.534 0.344 0 CA-C-O 119.234 -0.413 . . . . 0.0 110.674 169.988 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt . . . . . 0 N--CA 1.469 0.486 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -82.69 10.0 57.64 Favored Glycine 0 CA--C 1.534 1.268 0 CA-C-N 118.773 0.715 . . . . 0.0 112.743 169.602 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 82.0 mt -64.67 135.73 56.21 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 118.947 1.374 . . . . 0.0 111.162 -178.673 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -98.21 -31.57 12.01 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.927 1.291 . . . . 0.0 108.318 166.595 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -149.54 163.15 38.62 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 127.756 2.422 . . . . 0.0 106.797 172.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -55.71 -30.21 60.75 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.182 -0.949 . . . . 0.0 112.088 176.15 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -88.07 -10.49 50.02 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 10.9 m-70 -150.94 127.58 10.84 Favored 'General case' 0 C--N 1.347 0.476 0 CA-C-N 119.843 1.201 . . . . 0.0 113.684 -169.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -73.0 151.93 41.55 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 164.65 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 8.0 p -66.12 -19.05 25.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 O-C-N 121.98 -0.45 . . . . 0.0 112.016 176.422 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -154.77 163.17 31.17 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 123.791 0.71 . . . . 0.0 111.349 -171.493 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -56.71 127.82 33.4 Favored 'General case' 0 CA--C 1.522 -0.121 0 C-N-CA 124.22 1.008 . . . . 0.0 108.487 177.419 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.355 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 176.478 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 62.0 mt . . . . . 0 N--CA 1.471 0.607 0 N-CA-C 111.694 0.257 . . . . 0.0 111.694 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 87.7 m -53.83 -52.43 60.39 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 125.099 1.36 . . . . 0.0 111.012 -169.337 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -71.44 -32.3 68.2 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 122.178 0.191 . . . . 0.0 110.786 -171.779 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -67.16 -44.03 80.75 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 122.995 0.518 . . . . 0.0 109.64 173.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 38.5 mtt180 -66.2 -42.83 88.27 Favored 'General case' 0 C--O 1.232 0.184 0 O-C-N 121.606 -0.684 . . . . 0.0 110.964 -177.125 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 28.3 m -69.09 -35.52 68.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-O 118.148 -0.929 . . . . 0.0 109.809 178.145 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -60.07 -49.96 75.61 Favored 'General case' 0 C--N 1.342 0.279 0 CA-C-N 120.469 1.486 . . . . 0.0 110.233 174.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 59.6 mttm -57.83 -40.01 79.04 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 118.132 0.424 . . . . 0.0 110.554 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 61.8 t90 -72.09 -45.35 61.02 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 117.872 0.305 . . . . 0.0 110.745 -177.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 75.7 t -63.68 -34.81 70.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 O-C-N 121.489 -0.757 . . . . 0.0 109.716 -179.519 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -62.75 -34.61 77.56 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 118.455 -0.783 . . . . 0.0 110.714 177.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -62.67 -57.19 11.88 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.992 0.814 . . . . 0.0 110.053 171.54 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 6.9 pt -65.61 -30.27 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 118.828 0.74 . . . . 0.0 110.369 -171.547 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 49.4 m -58.74 -29.09 66.46 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 117.711 -1.138 . . . . 0.0 112.151 178.091 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -96.86 -13.32 22.6 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 120.456 1.48 . . . . 0.0 113.118 175.63 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -82.82 -39.67 21.39 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 118.972 0.806 . . . . 0.0 110.34 173.03 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 1.9 mp -90.24 -12.61 37.47 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.556 1.942 . . . . 0.0 110.719 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 57.19 30.52 18.5 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.731 1.612 . . . . 0.0 112.703 -169.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 55.2 mt . . . . . 0 N--CA 1.467 0.403 0 O-C-N 121.434 -0.791 . . . . 0.0 110.476 169.485 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.301 0 N-CA-C 110.597 -0.149 . . . . 0.0 110.597 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.0 pt -74.51 -29.93 24.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 O-C-N 122.144 -0.347 . . . . 0.0 110.987 178.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.3 m -110.25 136.01 50.12 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 124.637 1.175 . . . . 0.0 109.338 -179.611 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -108.21 118.96 5.55 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 107.299 -2.32 . . . . 0.0 107.299 168.559 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 39.8 mt -92.83 127.49 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 104.573 -2.38 . . . . 0.0 104.573 169.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -122.87 128.94 51.03 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 176.652 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -123.53 127.11 47.87 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 118.979 0.809 . . . . 0.0 112.376 -177.43 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -87.28 141.54 17.56 Favored Glycine 0 C--N 1.338 0.692 0 N-CA-C 108.35 -1.9 . . . . 0.0 108.35 167.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 37.8 m -153.15 166.44 32.49 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.716 1.758 . . . . 0.0 110.534 176.535 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -145.76 -51.65 0.25 Allowed 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.283 1.033 . . . . 0.0 109.794 169.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.9 p -80.77 -15.14 57.23 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.815 0.846 . . . . 0.0 112.058 172.565 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.22 32.09 6.9 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 124.491 1.043 . . . . 0.0 113.058 172.45 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -82.58 -52.73 6.55 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 118.423 1.112 . . . . 0.0 111.772 176.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -67.58 -23.62 65.42 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 121.588 -0.695 . . . . 0.0 112.441 -167.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -60.67 -35.65 76.77 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.283 0.947 . . . . 0.0 111.032 175.547 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -70.09 -42.79 72.26 Favored 'General case' 0 C--N 1.34 0.16 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.194 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 26.5 mm -61.77 -42.14 93.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 178.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.13 -41.88 93.62 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 121.517 -0.739 . . . . 0.0 111.017 178.488 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -67.72 -39.26 84.31 Favored 'General case' 0 CA--C 1.53 0.198 0 O-C-N 121.77 -0.581 . . . . 0.0 110.77 176.22 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 75.2 mtp -64.62 -30.01 71.03 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 119.283 0.947 . . . . 0.0 111.653 177.645 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 58.9 mt -70.4 -55.99 12.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 170.02 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -59.13 -32.97 70.33 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 121.323 -0.861 . . . . 0.0 112.386 -173.299 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -66.65 -34.85 78.78 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 120.039 1.29 . . . . 0.0 111.487 179.222 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -75.57 -39.65 57.81 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.015 0.526 . . . . 0.0 110.663 175.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -75.26 -39.79 59.44 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.807 0.843 . . . . 0.0 111.383 -174.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.53 141.57 5.87 Favored Glycine 0 CA--C 1.531 1.034 0 N-CA-C 108.818 -1.713 . . . . 0.0 108.818 -167.07 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 58.3 tttp -62.1 -31.08 71.48 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 121.643 -0.916 . . . . 0.0 111.722 -172.358 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -65.06 -29.53 70.43 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 123.071 0.548 . . . . 0.0 111.74 178.259 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.2 t -92.7 -38.24 9.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 123.755 0.822 . . . . 0.0 109.68 -178.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -139.04 125.71 20.72 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 119.411 1.005 . . . . 0.0 112.028 178.218 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -103.31 159.58 15.43 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.408 0.683 . . . . 0.0 110.191 173.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 51.1 t -121.7 129.35 75.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 124.234 1.013 . . . . 0.0 109.971 -169.124 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -144.9 172.43 13.04 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.887 1.675 . . . . 0.0 111.736 -173.306 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -125.88 136.81 53.49 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 175.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.5 tp -60.86 -25.99 37.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 O-C-N 121.435 -0.791 . . . . 0.0 111.633 -174.566 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -55.03 -36.36 65.44 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.578 1.151 . . . . 0.0 112.05 178.399 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -105.31 0.78 27.39 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.885 1.274 . . . . 0.0 111.912 -178.052 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 18.4 m -88.14 175.0 7.91 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.941 0.896 . . . . 0.0 109.654 177.704 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 70.7 m -153.85 162.4 41.26 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 120.888 -1.132 . . . . 0.0 109.483 179.31 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -51.0 -47.85 61.52 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.849 1.26 . . . . 0.0 111.178 -176.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -73.67 -24.39 59.97 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.459 -174.406 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -77.74 -35.58 51.67 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 122.818 0.447 . . . . 0.0 110.513 176.644 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -64.28 -50.46 67.82 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.498 0.719 . . . . 0.0 110.34 178.294 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -67.74 -19.27 65.11 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -172.657 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.51 -29.93 69.47 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.153 0.981 . . . . 0.0 112.667 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -75.25 159.57 31.38 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 123.827 0.851 . . . . 0.0 109.861 175.183 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -110.21 -22.23 11.86 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.309 0.644 . . . . 0.0 112.218 170.523 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.0 mp -120.71 132.56 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 175.762 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 97.4 mt -126.87 125.66 41.99 Favored 'General case' 0 CA--C 1.519 -0.232 0 C-N-CA 124.081 0.953 . . . . 0.0 108.865 -178.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 7.4 mp -114.11 107.92 16.29 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 176.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 66.7 mt -110.54 107.71 17.43 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 -170.122 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.43 117.94 5.44 Favored Glycine 0 C--N 1.331 0.285 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 17.5 tt -131.61 118.22 16.75 Favored Pre-proline 0 CA--C 1.539 0.523 0 CA-C-N 118.034 0.917 . . . . 0.0 110.408 -177.249 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -83.33 147.19 12.66 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.754 2.302 . . . . 0.0 108.427 168.156 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 54.5 m -99.29 143.52 29.45 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 177.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 68.2 m95 -136.13 171.15 14.9 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 125.731 1.612 . . . . 0.0 110.242 -174.673 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 25.83 72.17 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 128.062 2.545 . . . . 0.0 114.394 169.351 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 56.69 54.6 7.13 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.128 0.971 . . . . 0.0 111.81 174.532 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 82.8 13.3 78.19 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-O 119.388 -0.673 . . . . 0.0 114.326 171.382 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -74.39 154.08 38.97 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.511 1.156 . . . . 0.0 109.873 169.761 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.56 165.9 23.18 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 123.508 0.723 . . . . 0.0 110.571 170.527 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 14.9 tm0? -61.91 145.18 53.62 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 169.433 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 52.4 m -60.12 -37.2 79.32 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 114.959 1.466 . . . . 0.0 114.959 -167.18 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -76.09 -38.21 57.25 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 118.632 0.651 . . . . 0.0 109.281 -177.723 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -62.77 -47.26 84.29 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.185 0.594 . . . . 0.0 109.543 173.464 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -59.0 -40.36 84.66 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.598 0.759 . . . . 0.0 111.431 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -69.01 -31.76 70.81 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.245 0.618 . . . . 0.0 112.098 176.372 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -84.84 -21.84 29.68 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 117.889 -1.053 . . . . 0.0 112.647 -177.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 18.2 m-30 -48.37 -44.65 65.06 Favored Pre-proline 0 CA--C 1.544 0.735 0 CA-C-N 121.005 1.729 . . . . 0.0 115.114 -178.407 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.07 -16.36 54.85 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 CA-C-N 122.731 2.011 . . . . 0.0 113.897 176.258 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 31.5 m -91.46 -35.14 14.51 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.185 0.994 . . . . 0.0 109.643 169.473 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.45 ' HA ' HD12 ' A' ' 76' ' ' ILE . 17.0 tp -59.39 -39.17 82.52 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.222 1.009 . . . . 0.0 110.491 -178.339 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -73.66 -7.99 54.19 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -93.51 -1.55 55.46 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 119.619 1.1 . . . . 0.0 111.344 178.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.45 HD12 ' HA ' ' A' ' 73' ' ' LEU . 66.7 mt -92.37 146.03 6.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 -175.427 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -86.13 121.22 28.42 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 172.182 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -114.08 10.54 17.45 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 118.3 -0.857 . . . . 0.0 111.715 175.352 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 31.6 m-80 -59.32 117.36 4.71 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 120.269 1.395 . . . . 0.0 109.791 -172.006 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 72.84 -1.04 41.19 Favored Glycine 0 CA--C 1.534 1.28 0 CA-C-O 118.689 -1.062 . . . . 0.0 114.212 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -72.27 144.96 48.21 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 119.602 1.701 . . . . 0.0 108.024 172.781 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 35.7 mt -85.17 133.51 34.19 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 177.611 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.1 t -132.1 135.86 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 176.695 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -129.35 143.9 51.03 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 175.361 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 67.1 mt -118.94 148.19 43.22 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -175.233 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -145.65 153.69 41.3 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 123.205 0.602 . . . . 0.0 110.614 175.285 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -174.64 164.56 35.5 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-O 121.701 0.612 . . . . 0.0 112.683 179.636 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 24.9 p -121.27 167.67 12.47 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 125.418 1.487 . . . . 0.0 109.253 175.494 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -163.74 -160.18 11.45 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 114.271 0.468 . . . . 0.0 114.271 -177.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -143.42 153.67 42.9 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 126.622 1.969 . . . . 0.0 109.991 -175.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -138.28 7.66 2.64 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.865 0.866 . . . . 0.0 112.519 168.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -69.11 -33.28 73.24 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.58 1.082 . . . . 0.0 109.285 173.414 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -135.22 -36.7 0.8 Allowed 'General case' 0 C--O 1.234 0.285 0 C-N-CA 123.002 0.521 . . . . 0.0 112.17 171.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -89.78 29.98 1.1 Allowed 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 118.562 0.619 . . . . 0.0 112.604 -173.473 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.32 -31.8 71.66 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.189 0.996 . . . . 0.0 112.801 -174.023 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -79.92 1.16 28.35 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.266 1.026 . . . . 0.0 112.071 178.116 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -134.95 19.8 3.48 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.597 1.559 . . . . 0.0 109.896 -176.526 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -65.59 114.82 5.2 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -171.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 72.6 m 51.27 34.99 12.55 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.54 1.536 . . . . 0.0 113.203 -173.674 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -50.6 -44.54 57.06 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.672 1.189 . . . . 0.0 111.489 -179.287 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.84 -12.88 62.01 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 -169.01 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 90.0 mt -58.55 -39.68 80.93 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 118.893 0.77 . . . . 0.0 109.707 169.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.9 -32.08 83.04 Favored Glycine 0 CA--C 1.528 0.848 0 N-CA-C 111.412 -0.675 . . . . 0.0 111.412 178.555 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.6 m -65.85 -38.58 89.24 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.358 1.079 . . . . 0.0 110.334 178.308 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 7.0 mt -71.82 -42.49 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 119.105 0.866 . . . . 0.0 109.004 175.054 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 47.5 ttt180 -53.46 -45.43 69.55 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 119.408 1.003 . . . . 0.0 110.334 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -63.85 -20.07 65.53 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.026 0.93 . . . . 0.0 112.81 -177.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 96.4 mt -92.09 -48.77 13.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 123.974 0.91 . . . . 0.0 109.661 176.334 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.5 pt -78.07 -33.85 18.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-N 118.921 0.782 . . . . 0.0 111.979 -168.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -70.76 -43.91 15.43 Favored Pre-proline 0 CA--C 1.544 0.715 0 CA-C-O 117.962 -1.018 . . . . 0.0 111.269 -172.254 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -64.6 -31.42 59.92 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.032 1.821 . . . . 0.0 113.132 173.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? -75.81 6.51 4.92 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.019 0.928 . . . . 0.0 112.259 172.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 78.52 20.16 72.24 Favored Glycine 0 CA--C 1.527 0.828 0 CA-C-O 118.686 -1.064 . . . . 0.0 114.082 169.273 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -59.75 142.42 53.25 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 118.725 1.263 . . . . 0.0 109.857 170.769 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 37.6 m -89.1 116.45 27.37 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 104.461 -2.422 . . . . 0.0 104.461 168.573 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 38.9 mt -90.92 130.53 39.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 -176.104 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 3.7 m -137.44 165.86 26.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 126.103 1.761 . . . . 0.0 108.487 -177.17 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 74.49 31.44 58.87 Favored Glycine 0 CA--C 1.524 0.616 0 CA-C-O 119.141 -0.811 . . . . 0.0 112.293 -175.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 83.9 m-70 -58.48 134.08 56.36 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 169.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 70.8 t-105 -113.38 124.96 30.36 Favored Pre-proline 0 C--O 1.235 0.296 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -169.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -67.95 140.31 49.87 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 121.254 1.303 . . . . 0.0 110.632 -173.682 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 81.1 p . . . . . 0 CA--C 1.535 0.391 0 C-N-CA 123.186 0.594 . . . . 0.0 110.876 176.472 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.537 0.47 0 N-CA-C 110.882 -0.044 . . . . 0.0 110.882 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -78.46 0.19 76.54 Favored Glycine 0 CA--C 1.533 1.164 0 CA-C-O 118.404 -1.22 . . . . 0.0 113.798 169.598 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 65.0 mt -62.31 125.73 24.89 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 120.869 2.335 . . . . 0.0 108.618 171.407 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -91.82 -32.55 15.31 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.714 0.806 . . . . 0.0 109.541 170.594 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -149.78 163.02 39.1 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 127.227 2.211 . . . . 0.0 106.848 172.094 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -55.29 -29.55 58.41 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.392 -0.817 . . . . 0.0 112.243 175.508 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -90.49 -12.39 37.42 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.216 1.007 . . . . 0.0 113.486 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -147.58 128.23 14.22 Favored 'General case' 0 C--N 1.346 0.434 0 CA-C-N 119.991 1.269 . . . . 0.0 113.399 -170.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -78.45 152.32 32.19 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 166.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 10.7 p -58.15 -28.68 35.13 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 C-N-CA 124.824 1.249 . . . . 0.0 111.49 175.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -157.8 175.83 35.0 Favored Glycine 0 C--N 1.336 0.56 0 C-N-CA 125.048 1.309 . . . . 0.0 110.219 -174.477 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -56.96 126.6 27.87 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 124.101 0.96 . . . . 0.0 108.611 178.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.377 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 -179.674 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 23.5 mt . . . . . 0 N--CA 1.473 0.7 0 CA-C-O 120.709 0.29 . . . . 0.0 111.192 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 99.1 m -53.81 -50.66 65.65 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 125.697 1.599 . . . . 0.0 110.861 -169.476 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -71.64 -34.52 69.84 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 119.075 -0.488 . . . . 0.0 111.063 -171.085 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -67.53 -43.96 79.51 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 118.507 0.594 . . . . 0.0 109.687 175.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 52.1 mtt180 -64.61 -43.2 94.53 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 121.933 -0.48 . . . . 0.0 110.633 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 58.1 t -67.82 -40.18 83.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-O 118.247 -0.883 . . . . 0.0 109.8 178.339 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -60.69 -47.48 86.07 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 120.612 1.551 . . . . 0.0 109.909 176.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 59.3 mttm -57.98 -45.89 86.06 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 118.331 0.514 . . . . 0.0 110.184 178.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 55.1 t90 -65.62 -45.78 81.79 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 118.109 0.413 . . . . 0.0 110.513 -177.509 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 55.6 t -62.56 -38.64 81.98 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 C-N-CA 123.046 0.538 . . . . 0.0 110.202 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -69.8 -36.05 75.36 Favored 'General case' 0 CA--C 1.532 0.265 0 O-C-N 121.224 -0.923 . . . . 0.0 110.256 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 20.5 mm100 -64.61 -52.09 59.25 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.652 0.66 . . . . 0.0 110.634 174.132 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 12.3 pt -64.22 -32.69 58.46 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 CA-C-N 119.51 1.05 . . . . 0.0 110.787 -178.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 57.2 m -56.05 -36.07 67.63 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.287 0.949 . . . . 0.0 112.172 176.54 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -87.62 -27.17 22.67 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.9 1.227 . . . . 0.0 112.24 177.063 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -68.55 -32.02 71.65 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 119.357 0.981 . . . . 0.0 110.73 173.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 1.8 mp -82.69 -3.68 56.73 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.458 1.903 . . . . 0.0 110.89 174.646 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 54.8 35.12 23.41 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 126.126 1.771 . . . . 0.0 112.379 -177.174 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 70.1 mt . . . . . 0 N--CA 1.464 0.273 0 O-C-N 121.314 -0.866 . . . . 0.0 111.301 -177.776 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.29 0 CA-C-O 121.025 0.441 . . . . 0.0 111.372 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.5 pt -104.45 -24.84 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 126.051 1.741 . . . . 0.0 110.587 178.161 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 51.6 m -105.79 125.9 51.54 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.142 1.377 . . . . 0.0 108.547 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -100.36 116.02 5.46 Favored Glycine 0 C--N 1.331 0.295 0 N-CA-C 107.082 -2.407 . . . . 0.0 107.082 168.676 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 35.0 mt -92.57 122.27 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 104.304 -2.48 . . . . 0.0 104.304 172.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -118.21 128.11 54.39 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 106.633 -1.618 . . . . 0.0 106.633 176.706 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -123.81 132.66 53.82 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 118.574 0.625 . . . . 0.0 111.247 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -86.36 142.32 18.75 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 108.205 -1.958 . . . . 0.0 108.205 168.403 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.9 m -160.62 160.41 31.63 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 119.233 1.517 . . . . 0.0 110.815 173.581 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -137.31 -47.14 0.57 Allowed 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.89 1.276 . . . . 0.0 109.525 169.817 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.2 p -80.99 -12.58 59.35 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.323 1.049 . . . . 0.0 112.162 170.46 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.41 10.86 53.21 Favored Glycine 0 C--N 1.343 0.946 0 C-N-CA 124.799 1.19 . . . . 0.0 113.884 170.166 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -66.28 -47.76 72.62 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 118.835 1.318 . . . . 0.0 112.158 -172.207 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.1 m -74.52 -14.93 60.87 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -168.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -56.15 -43.38 78.24 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.683 0.674 . . . . 0.0 109.755 171.626 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -68.78 -37.63 79.44 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 121.772 -0.58 . . . . 0.0 109.906 -177.274 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 29.7 mm -63.83 -43.33 97.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 176.238 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.36 -38.92 85.39 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.58 -0.7 . . . . 0.0 110.942 177.11 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -68.28 -40.62 81.75 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 118.177 -0.916 . . . . 0.0 111.342 175.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 63.9 mtt -58.98 -34.26 71.63 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 120.027 1.285 . . . . 0.0 111.051 175.494 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 55.6 mt -71.45 -53.96 18.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 175.8 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -61.49 -37.03 82.19 Favored 'General case' 0 N--CA 1.462 0.161 0 O-C-N 121.364 -0.835 . . . . 0.0 111.827 -173.239 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -63.55 -35.72 81.41 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 119.202 0.91 . . . . 0.0 111.088 -178.499 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -75.33 -41.79 55.88 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 122.902 0.481 . . . . 0.0 111.05 177.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -72.47 -34.24 67.58 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 122.73 0.412 . . . . 0.0 111.083 -177.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.43 145.07 8.52 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 -169.097 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -58.78 -33.98 70.93 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 122.015 -0.697 . . . . 0.0 112.078 -175.441 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -74.64 -11.75 60.27 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.26 -174.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.2 t -106.65 -42.09 6.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 124.337 1.055 . . . . 0.0 109.586 178.379 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -129.4 140.25 51.4 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 119.473 1.033 . . . . 0.0 111.482 -178.081 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -122.58 155.29 36.6 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.556 1.142 . . . . 0.0 109.473 177.286 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 77.6 t -119.7 130.33 74.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 124.234 1.014 . . . . 0.0 110.071 -169.179 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -146.79 177.61 8.97 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.857 1.663 . . . . 0.0 111.551 -172.426 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -133.81 130.22 37.64 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 126.884 2.074 . . . . 0.0 105.764 178.609 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.2 tp -60.56 -21.35 23.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 C-N-CA 123.496 0.719 . . . . 0.0 112.137 -172.35 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.6 -29.52 68.03 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 118.893 0.77 . . . . 0.0 111.322 177.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -81.08 -26.75 36.04 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.097 0.559 . . . . 0.0 111.438 177.074 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 62.7 m -71.89 159.48 34.2 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 122.129 0.966 . . . . 0.0 112.427 -168.606 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 23.5 m -130.07 175.34 8.97 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.849 2.059 . . . . 0.0 107.054 173.033 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -53.01 -45.63 68.01 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.236 0.615 . . . . 0.0 112.002 -172.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -81.6 -11.8 58.99 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 -175.096 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -70.8 -32.6 69.74 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 118.98 0.809 . . . . 0.0 111.304 -176.218 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -69.33 -43.71 73.16 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 123.429 0.692 . . . . 0.0 109.392 173.017 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 77.9 mt-10 -70.79 -11.66 61.08 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.932 0.893 . . . . 0.0 112.049 -171.705 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.88 -29.26 69.68 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.08 0.952 . . . . 0.0 111.907 173.592 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -98.34 153.6 18.43 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.854 1.262 . . . . 0.0 110.348 -178.246 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -99.54 -27.91 13.48 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.567 174.645 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.2 mp -113.84 129.79 69.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 174.286 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -114.15 125.71 54.25 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 107.086 -1.449 . . . . 0.0 107.086 175.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.3 mp -111.89 112.35 23.94 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 173.573 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.1 mt -112.9 112.28 23.64 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -169.808 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -100.82 115.15 5.21 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 125.602 1.572 . . . . 0.0 110.126 -178.477 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 16.2 tt -123.02 118.17 28.2 Favored Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 118.442 1.121 . . . . 0.0 111.71 -173.765 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -79.63 138.19 13.37 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 121.731 1.621 . . . . 0.0 108.039 167.565 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 79.7 m -94.39 143.71 26.17 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 174.145 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 66.2 m95 -134.25 173.74 11.27 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 126.082 1.753 . . . . 0.0 109.414 -177.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 24.4 t80 32.26 64.69 0.23 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 127.902 2.481 . . . . 0.0 114.364 169.666 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 54.58 53.69 10.33 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.816 0.847 . . . . 0.0 111.738 171.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 82.79 55.78 2.9 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 123.551 0.596 . . . . 0.0 112.085 174.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -128.99 155.87 44.7 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 125.846 1.658 . . . . 0.0 108.355 170.031 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.13 161.83 27.09 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 123.133 0.573 . . . . 0.0 110.252 172.125 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 34.1 tp60 -67.33 143.94 56.11 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 169.508 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 58.4 m -55.62 -35.23 65.65 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.815 0.846 . . . . 0.0 112.51 -172.294 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -64.76 -41.06 96.17 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.291 0.637 . . . . 0.0 110.444 -178.431 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -73.31 -46.75 47.72 Favored 'General case' 0 C--N 1.34 0.185 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 177.082 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -58.26 -36.24 72.94 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.582 0.753 . . . . 0.0 112.155 -177.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -69.9 -23.58 63.26 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.736 0.815 . . . . 0.0 112.552 177.099 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -100.39 -15.64 17.89 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.219 1.007 . . . . 0.0 112.025 -177.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 12.8 m-30 -48.4 -45.94 68.18 Favored Pre-proline 0 CA--C 1.542 0.668 0 CA-C-O 117.09 -1.433 . . . . 0.0 113.119 171.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -65.04 -20.93 63.83 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 CA-C-N 122.577 1.956 . . . . 0.0 113.116 176.216 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.8 m -82.75 -35.6 26.47 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 119.589 1.086 . . . . 0.0 110.047 174.278 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 71.8 mt -56.91 -34.0 67.51 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 119.856 1.207 . . . . 0.0 111.205 178.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -82.53 -1.23 49.9 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 178.298 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -99.95 -29.58 12.49 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.122 0.969 . . . . 0.0 109.629 169.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 92.9 mt -66.4 142.91 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 C-N-CA 125.69 1.596 . . . . 0.0 107.93 177.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -88.14 130.53 35.01 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 123.547 0.739 . . . . 0.0 109.537 173.177 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -124.37 18.48 8.97 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.513 0.725 . . . . 0.0 111.741 172.424 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 23.1 m-80 -61.95 116.79 5.18 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 119.95 1.25 . . . . 0.0 109.554 -175.097 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.0 5.92 66.56 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-O 118.881 -0.955 . . . . 0.0 113.189 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 9.8 mmpt? -76.88 153.13 35.06 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 119.216 1.508 . . . . 0.0 107.26 172.386 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -95.05 141.02 29.17 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 173.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 15.5 t -134.89 146.38 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 175.79 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -137.59 146.88 44.55 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 170.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 75.5 mt -116.78 142.36 47.02 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -172.662 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -138.85 157.3 46.3 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 169.73 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -162.72 153.41 23.99 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-O 122.455 1.03 . . . . 0.0 112.835 -171.031 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 51.8 m -126.12 150.93 47.88 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 113.017 -1.592 . . . . 0.0 108.821 -168.403 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -177.46 175.99 47.84 Favored Glycine 0 CA--C 1.523 0.534 0 C-N-CA 121.035 -0.602 . . . . 0.0 113.544 -172.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -100.54 140.68 34.46 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 125.391 1.476 . . . . 0.0 109.007 171.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -130.15 37.85 3.85 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.219 1.007 . . . . 0.0 109.532 -179.222 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -113.07 -55.55 2.51 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 124.44 1.096 . . . . 0.0 108.443 172.445 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -113.75 -33.3 5.85 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.551 1.14 . . . . 0.0 111.198 -175.419 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -92.02 22.57 4.23 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.703 0.801 . . . . 0.0 112.357 -178.706 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.61 -33.61 74.2 Favored 'General case' 0 C--N 1.343 0.302 0 CA-C-N 120.023 1.283 . . . . 0.0 113.515 -169.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -65.03 -31.01 72.03 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 119.934 1.243 . . . . 0.0 110.284 175.184 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -100.18 9.17 43.19 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.745 1.618 . . . . 0.0 111.218 -177.469 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -65.97 118.76 10.23 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 119.114 0.87 . . . . 0.0 108.884 -169.576 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 60.6 m 53.24 28.71 7.45 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.967 1.307 . . . . 0.0 112.789 -175.632 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -53.71 -36.48 62.29 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.73 1.212 . . . . 0.0 111.731 -176.423 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.72 -11.78 61.15 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -174.156 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 32.1 mt -54.38 -47.86 72.18 Favored 'General case' 0 C--N 1.344 0.353 0 CA-C-N 119.148 0.885 . . . . 0.0 110.47 173.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.0 -29.23 74.29 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 111.745 -0.542 . . . . 0.0 111.745 -176.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.8 m -63.63 -37.63 88.06 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 117.76 0.78 . . . . 0.0 110.049 177.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 5.8 mt -67.87 -44.17 85.5 Favored 'Isoleucine or valine' 0 C--N 1.344 0.346 0 CA-C-O 117.781 -1.104 . . . . 0.0 108.938 177.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 57.7 ttp85 -56.27 -46.74 79.58 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 120.032 1.287 . . . . 0.0 110.041 177.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -59.82 -28.18 67.24 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -178.249 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 80.0 mt -84.28 -45.67 18.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 124.38 1.072 . . . . 0.0 110.688 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 10.5 pt -85.83 -28.1 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 119.508 1.049 . . . . 0.0 112.584 -169.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -63.56 -42.12 70.85 Favored Pre-proline 0 CA--C 1.548 0.868 0 CA-C-O 117.814 -1.089 . . . . 0.0 111.434 -174.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -61.54 -20.02 67.01 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 122.727 2.285 . . . . 0.0 114.19 172.127 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 23.9 mmm180 -86.9 5.01 39.09 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.065 0.946 . . . . 0.0 111.44 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 75.73 17.53 80.06 Favored Glycine 0 CA--C 1.529 0.945 0 CA-C-O 118.51 -1.161 . . . . 0.0 113.03 178.75 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -59.1 137.76 57.82 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 118.809 1.305 . . . . 0.0 109.482 169.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 36.6 m -94.18 126.57 39.5 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 169.41 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 57.1 mt -105.22 132.6 51.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -174.008 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 27.1 m -129.01 176.35 8.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 125.737 1.615 . . . . 0.0 108.523 172.499 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 80.78 26.58 53.37 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-O 119.043 -0.865 . . . . 0.0 114.023 175.295 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 65.1 m80 -62.3 130.45 45.38 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 168.125 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 65.2 t-105 -107.64 124.56 34.59 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-O 118.258 -0.877 . . . . 0.0 108.787 -169.75 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -71.29 146.86 51.98 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 121.501 1.468 . . . . 0.0 112.144 -172.055 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 33.2 p . . . . . 0 CA--C 1.531 0.227 0 C-N-CA 123.874 0.87 . . . . 0.0 111.242 179.158 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.789 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -64.75 -18.73 64.38 Favored Glycine 0 CA--C 1.536 1.404 0 CA-C-N 119.407 1.003 . . . . 0.0 112.295 169.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 91.7 mt -64.44 130.29 43.17 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.809 1.304 . . . . 0.0 109.237 175.808 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -93.7 -33.44 13.64 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.472 0.709 . . . . 0.0 109.386 168.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -149.87 165.78 31.53 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 126.717 2.007 . . . . 0.0 107.638 177.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -55.67 -26.79 46.54 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 121.717 -0.614 . . . . 0.0 112.108 172.639 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -90.55 -19.3 23.92 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.891 1.276 . . . . 0.0 114.216 -179.039 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 24.0 p80 -156.74 147.34 21.56 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 120.481 1.491 . . . . 0.0 114.311 -176.457 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -82.72 151.17 26.31 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 126.215 1.806 . . . . 0.0 108.607 168.11 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 5.8 p -69.19 -16.96 21.33 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 122.856 0.462 . . . . 0.0 111.612 179.431 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -157.45 174.06 34.91 Favored Glycine 0 C--N 1.339 0.742 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 178.599 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -67.08 105.63 1.73 Allowed 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 123.542 0.737 . . . . 0.0 109.219 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.366 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 168.195 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 47.5 mt . . . . . 0 N--CA 1.474 0.744 0 CA-C-O 121.57 0.7 . . . . 0.0 112.002 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 87.4 m -59.42 -51.35 70.26 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 125.159 1.384 . . . . 0.0 111.118 -176.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -67.53 -31.92 72.35 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 119.398 -0.334 . . . . 0.0 111.01 -169.297 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 24.8 mp0 -60.81 -43.72 97.83 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.513 1.125 . . . . 0.0 109.813 174.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 68.4 mtt85 -62.8 -42.69 99.82 Favored 'General case' 0 N--CA 1.466 0.347 0 O-C-N 121.573 -0.705 . . . . 0.0 110.506 175.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 58.1 t -66.64 -37.88 80.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-O 118.753 -0.641 . . . . 0.0 109.494 -179.104 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -62.03 -51.04 69.59 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 120.215 1.37 . . . . 0.0 110.012 175.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 61.1 mttm -58.51 -42.63 88.14 Favored 'General case' 0 CA--C 1.529 0.153 0 O-C-N 122.119 -0.363 . . . . 0.0 110.43 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 58.0 t90 -67.85 -47.51 68.77 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 118.131 0.423 . . . . 0.0 110.641 -177.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 50.9 t -60.64 -37.91 76.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 118.365 0.53 . . . . 0.0 110.104 -178.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 56.0 mttm -64.99 -46.8 79.92 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 121.637 -0.665 . . . . 0.0 109.275 176.635 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 6.1 mm-40 -59.86 -46.95 87.66 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 118.695 0.679 . . . . 0.0 111.819 179.358 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 18.5 pt -68.74 -32.11 53.57 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.19 0 CA-C-N 119.329 0.968 . . . . 0.0 110.212 -178.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 36.0 m -61.69 -32.16 72.34 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 119.033 0.833 . . . . 0.0 110.927 172.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -72.12 -44.42 63.2 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.442 1.019 . . . . 0.0 110.192 174.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -66.75 -35.62 80.52 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.168 0.587 . . . . 0.0 111.466 -178.459 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 86.3 mt -84.28 -3.12 58.03 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.533 1.533 . . . . 0.0 111.452 178.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 54.53 28.24 9.48 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.837 1.655 . . . . 0.0 112.811 -173.489 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 85.8 mt . . . . . 0 N--CA 1.464 0.231 0 C-N-CA 123.233 0.613 . . . . 0.0 109.846 170.077 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.323 0 CA-C-O 121.006 0.431 . . . . 0.0 111.487 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.1 pt -113.45 -18.24 7.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 126.317 1.847 . . . . 0.0 111.045 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 40.9 m -109.92 124.29 51.11 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.565 1.546 . . . . 0.0 108.845 178.543 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -99.43 120.24 6.79 Favored Glycine 0 CA--C 1.522 0.469 0 N-CA-C 108.437 -1.865 . . . . 0.0 108.437 169.474 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 55.1 mt -97.67 94.21 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 104.773 -2.306 . . . . 0.0 104.773 177.217 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -97.1 108.53 21.29 Favored 'General case' 0 CA--C 1.52 -0.177 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 178.4 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -128.25 118.45 23.31 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 118.961 0.8 . . . . 0.0 109.755 -168.302 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -83.8 132.98 11.46 Favored Glycine 0 C--N 1.338 0.688 0 N-CA-C 110.376 -1.089 . . . . 0.0 110.376 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.1 m -137.78 161.22 37.14 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.292 1.437 . . . . 0.0 107.959 174.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -136.13 -50.92 0.7 Allowed 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.088 0.555 . . . . 0.0 110.008 169.029 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -81.74 -6.4 59.01 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.424 0.689 . . . . 0.0 111.778 170.484 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.33 11.65 51.13 Favored Glycine 0 C--N 1.345 1.034 0 C-N-CA 124.615 1.102 . . . . 0.0 115.138 167.4 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -73.47 -46.22 49.48 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 119.324 1.562 . . . . 0.0 111.822 -177.385 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.76 -39.08 93.02 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 118.8 0.727 . . . . 0.0 110.601 -168.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -64.13 -27.58 69.18 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.232 -0.918 . . . . 0.0 112.096 -178.462 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -66.72 -37.04 83.87 Favored 'General case' 0 N--CA 1.465 0.276 0 O-C-N 121.49 -0.756 . . . . 0.0 109.984 174.156 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.3 mm -67.61 -43.26 87.06 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.153 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 174.162 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.39 -38.5 71.57 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.912 0.778 . . . . 0.0 111.059 -179.485 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 68.6 mttt -67.19 -42.34 84.34 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 122.955 0.502 . . . . 0.0 110.833 175.706 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 77.3 mtm -67.15 -29.78 69.58 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 119.281 0.946 . . . . 0.0 111.883 177.223 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 70.6 mt -68.73 -53.92 24.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 173.314 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -59.33 -37.9 78.96 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.765 -0.584 . . . . 0.0 111.193 -176.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -63.44 -39.18 93.8 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 119.116 0.871 . . . . 0.0 110.952 -179.116 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -71.97 -41.62 67.5 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 122.697 0.399 . . . . 0.0 110.978 177.379 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.9 mp -73.82 -33.44 64.17 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 118.096 0.407 . . . . 0.0 111.174 -176.171 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.16 143.34 12.88 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 125.26 1.409 . . . . 0.0 110.58 -171.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -65.37 -29.0 69.67 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.735 -0.862 . . . . 0.0 111.794 -174.391 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -77.47 -7.57 56.4 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 122.942 0.497 . . . . 0.0 112.006 177.316 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.0 t -108.04 -41.03 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 C-N-CA 124.421 1.088 . . . . 0.0 109.569 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -132.82 147.53 52.31 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 119.512 1.051 . . . . 0.0 112.144 -175.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.3 t0 -132.71 151.31 52.01 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.515 0.726 . . . . 0.0 110.773 173.153 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 97.5 t -106.9 137.48 37.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 C-N-CA 124.87 1.268 . . . . 0.0 109.648 -169.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -145.11 164.78 30.22 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.615 1.566 . . . . 0.0 110.598 -171.699 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -131.02 134.38 46.63 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 175.334 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.407 ' HB ' ' CH2' ' A' ' 66' ' ' TRP . 1.3 tp -65.72 -26.36 38.69 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-O 118.514 -0.755 . . . . 0.0 113.003 -168.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.99 -29.58 68.64 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 119.287 0.949 . . . . 0.0 110.479 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -84.22 -28.75 27.06 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.417 0.687 . . . . 0.0 111.325 175.577 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.4 m -77.32 168.4 20.09 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.137 0.975 . . . . 0.0 111.621 -169.656 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.3 m -131.3 159.67 37.19 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.887 1.275 . . . . 0.0 110.138 -174.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -53.25 -47.58 68.94 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.676 1.19 . . . . 0.0 111.811 -175.106 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -80.81 -13.42 58.97 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 122.245 -0.284 . . . . 0.0 111.63 -174.226 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -76.68 -31.16 57.08 Favored 'General case' 0 C--O 1.234 0.267 0 O-C-N 121.534 -0.729 . . . . 0.0 111.566 -172.11 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.9 mp -66.22 -35.69 81.08 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 175.776 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -68.83 -13.43 62.41 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.348 0.659 . . . . 0.0 112.38 -174.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.15 -29.12 68.73 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.531 0.732 . . . . 0.0 111.484 174.488 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -94.22 147.61 23.01 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.162 0.985 . . . . 0.0 110.381 -177.33 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -91.38 -33.65 15.18 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.895 173.017 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.2 mp -107.82 134.52 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 176.71 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 96.8 mt -122.07 124.36 43.76 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 174.207 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.3 mp -105.79 110.08 22.25 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 104.956 -2.239 . . . . 0.0 104.956 169.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 73.9 mt -109.55 111.15 22.48 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 -173.092 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -96.25 123.31 7.66 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 -179.512 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 2.1 tp -137.12 100.87 9.45 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 125.067 1.347 . . . . 0.0 109.32 -171.046 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.25 142.52 30.51 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.204 1.936 . . . . 0.0 109.091 168.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 59.1 m -91.84 136.84 32.85 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 177.37 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 24.5 m95 -135.51 168.17 19.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 120.58 1.536 . . . . 0.0 112.605 -169.735 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 58.66 -61.69 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 130.707 3.603 . . . . 0.0 116.32 169.428 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -150.98 30.08 0.64 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.448 1.899 . . . . 0.0 110.44 -169.539 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 73.23 48.39 19.58 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 -171.264 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -123.98 175.75 6.76 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.58 1.552 . . . . 0.0 108.43 177.074 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -79.24 158.35 27.62 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.138 -0.976 . . . . 0.0 109.54 169.064 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -58.95 138.11 57.58 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 172.344 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 99.5 m -55.78 -40.21 72.34 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -167.356 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -73.73 -27.1 61.01 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.366 0.667 . . . . 0.0 111.705 -177.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.407 ' CH2' ' HB ' ' A' ' 36' ' ' ILE . 1.0 OUTLIER -77.79 -44.49 27.38 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.172 0.989 . . . . 0.0 109.541 174.194 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -58.65 -42.12 87.63 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.399 1.079 . . . . 0.0 111.06 176.46 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -61.8 -22.29 65.32 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.16 0.984 . . . . 0.0 112.2 177.714 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -90.85 -17.12 27.06 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 118.348 -0.834 . . . . 0.0 112.067 178.158 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 21.2 m-30 -54.98 -40.66 85.83 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-O 116.445 -1.741 . . . . 0.0 114.408 179.019 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -63.49 -20.27 69.43 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 CA-C-N 122.912 2.076 . . . . 0.0 113.24 173.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.4 m -82.44 -45.16 15.13 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.262 0.937 . . . . 0.0 109.14 170.093 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 12.9 tp -56.22 -40.16 73.63 Favored 'General case' 0 C--N 1.342 0.241 0 C-N-CA 125.077 1.351 . . . . 0.0 110.523 -175.793 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -72.39 -1.02 14.02 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -178.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -104.94 -12.0 16.42 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 119.647 1.112 . . . . 0.0 112.124 172.5 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 80.8 mt -78.23 142.04 14.67 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 -179.533 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -82.63 130.05 35.05 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 178.05 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -122.06 13.01 10.46 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 118.682 -0.675 . . . . 0.0 111.849 173.409 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -62.3 115.79 4.48 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-N 120.035 1.289 . . . . 0.0 108.754 -176.75 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 74.69 -0.72 55.7 Favored Glycine 0 CA--C 1.535 1.296 0 CA-C-O 118.459 -1.189 . . . . 0.0 114.095 -179.299 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -69.33 146.47 52.15 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 119.738 1.769 . . . . 0.0 107.288 169.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -90.03 137.34 32.42 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 170.631 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.0 t -131.97 142.35 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 177.606 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -131.27 141.45 49.98 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 170.146 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 73.3 mt -110.66 149.98 29.67 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -176.631 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.454 ' CE2' HD12 ' A' ' 142' ' ' LEU . 14.4 t80 -141.53 147.49 37.84 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 -179.373 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -164.96 137.58 4.79 Favored Glycine 0 CA--C 1.522 0.5 0 CA-C-N 119.216 0.916 . . . . 0.0 110.936 169.432 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 4.5 p -95.11 152.81 18.02 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 168.595 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -145.33 -158.36 7.63 Favored Glycine 0 CA--C 1.525 0.702 0 CA-C-O 121.048 0.249 . . . . 0.0 113.019 -173.603 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -146.9 145.38 29.8 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 127.504 2.322 . . . . 0.0 107.85 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -133.14 12.39 4.24 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.37 1.468 . . . . 0.0 109.931 177.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -81.9 -47.05 13.24 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 177.035 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -126.72 -33.2 2.53 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 123.949 0.9 . . . . 0.0 111.126 -175.637 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -91.33 33.89 0.97 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.211 1.004 . . . . 0.0 111.421 176.776 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.45 -20.02 62.65 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.278 1.431 . . . . 0.0 113.116 -178.129 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -97.62 6.6 47.79 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.912 0.885 . . . . 0.0 111.948 176.171 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -138.53 24.47 2.67 Favored 'General case' 0 C--O 1.237 0.411 0 O-C-N 120.854 -1.154 . . . . 0.0 110.858 -174.087 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -65.97 118.57 9.95 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -169.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 86.3 m 48.28 35.23 5.3 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.648 1.979 . . . . 0.0 113.636 -175.837 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -53.38 -41.17 65.62 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.364 0.666 . . . . 0.0 112.342 -178.128 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.99 -12.06 60.06 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -170.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 53.9 mt -56.22 -42.21 76.88 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 118.719 0.691 . . . . 0.0 109.647 169.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -65.0 -30.66 78.6 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.811 -0.515 . . . . 0.0 111.811 -178.687 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 4.3 m -64.93 -40.13 94.57 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 117.985 0.893 . . . . 0.0 110.098 179.049 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.7 mt -73.86 -39.85 52.43 Favored 'Isoleucine or valine' 0 C--N 1.344 0.363 0 CA-C-N 118.908 0.777 . . . . 0.0 109.271 176.268 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 57.7 ttt-85 -52.67 -46.64 67.29 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 119.583 1.083 . . . . 0.0 110.331 177.317 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -64.73 -21.59 66.79 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.596 0.758 . . . . 0.0 112.455 -176.309 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 95.8 mt -87.98 -46.01 15.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 123.454 0.702 . . . . 0.0 109.474 175.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 7.0 pt -77.79 -28.69 15.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-N 118.926 0.785 . . . . 0.0 112.045 -169.265 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -62.12 -56.86 27.35 Favored Pre-proline 0 CA--C 1.544 0.724 0 CA-C-O 117.568 -1.206 . . . . 0.0 112.167 179.303 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -66.23 -24.06 51.53 Favored 'Trans proline' 0 C--N 1.353 0.781 0 CA-C-N 121.96 1.736 . . . . 0.0 112.208 -179.367 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 79.5 mmt-85 -78.28 5.11 11.08 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.856 0.862 . . . . 0.0 112.774 172.508 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 77.22 20.92 74.52 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-N 119.604 1.093 . . . . 0.0 113.993 169.262 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.9 148.91 48.31 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 118.56 1.18 . . . . 0.0 110.589 170.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 60.2 m -97.47 124.36 41.65 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 105.01 -2.218 . . . . 0.0 105.01 167.019 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 48.9 mt -98.43 134.13 38.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 -175.6 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 29.1 m -133.14 176.63 8.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 125.582 1.553 . . . . 0.0 108.854 172.257 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 78.04 23.38 66.45 Favored Glycine 0 CA--C 1.529 0.926 0 CA-C-O 119.065 -0.853 . . . . 0.0 113.906 175.589 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 15.4 p-80 -60.3 140.85 56.87 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 118.327 1.063 . . . . 0.0 108.809 168.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 75.4 t-105 -131.19 136.48 28.84 Favored Pre-proline 0 CA--C 1.536 0.43 0 C-N-CA 124.26 1.024 . . . . 0.0 110.244 -168.749 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -70.36 152.3 66.13 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.466 2.111 . . . . 0.0 111.912 -176.055 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 22.2 p . . . . . 0 CA--C 1.537 0.48 0 C-N-CA 123.867 0.867 . . . . 0.0 112.613 174.283 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 84.3 mttt . . . . . 0 N--CA 1.473 0.69 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -83.04 8.59 62.88 Favored Glycine 0 CA--C 1.535 1.324 0 CA-C-N 118.619 0.645 . . . . 0.0 112.775 168.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 74.9 mt -62.29 138.77 58.49 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.564 1.145 . . . . 0.0 111.204 -179.045 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -104.56 -26.22 12.44 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.629 1.572 . . . . 0.0 109.792 168.833 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -143.66 165.71 26.88 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.01 1.724 . . . . 0.0 107.219 172.632 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -53.61 -27.2 25.54 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.197 1.399 . . . . 0.0 114.186 -169.368 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -123.49 9.98 9.1 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.781 1.232 . . . . 0.0 113.58 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -137.91 130.39 29.4 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 119.788 1.176 . . . . 0.0 111.143 -172.187 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -81.39 151.44 27.93 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 124.935 1.294 . . . . 0.0 110.165 173.506 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 14.5 p -61.89 -29.89 47.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 123.0 0.52 . . . . 0.0 111.528 175.591 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -141.28 -176.36 15.57 Favored Glycine 0 CA--C 1.521 0.445 0 C-N-CA 125.305 1.431 . . . . 0.0 109.606 -175.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.454 HD12 ' CE2' ' A' ' 86' ' ' PHE . 3.3 tm? -60.9 125.99 25.75 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 169.715 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.355 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 171.243 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 74.3 mt . . . . . 0 CA--C 1.539 0.539 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 97.1 m -51.09 -53.44 34.12 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 126.988 2.115 . . . . 0.0 111.85 -174.096 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.59 -43.86 95.71 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 119.083 -0.484 . . . . 0.0 111.884 -166.649 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -67.12 -36.1 81.2 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 118.794 0.725 . . . . 0.0 111.091 -177.003 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 77.3 mtt85 -67.12 -47.55 70.79 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 118.825 0.738 . . . . 0.0 109.883 -179.139 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 16.8 m -72.41 -31.67 39.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-O 118.77 -0.633 . . . . 0.0 110.481 -176.03 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -63.35 -49.63 73.12 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 119.659 1.118 . . . . 0.0 109.948 171.17 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -58.61 -42.26 87.76 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 118.477 0.58 . . . . 0.0 109.972 178.66 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 66.8 t90 -64.32 -46.77 82.09 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 118.822 0.737 . . . . 0.0 110.589 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 28.5 t -56.89 -42.71 78.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 118.24 0.473 . . . . 0.0 109.863 176.561 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 54.7 mttm -69.01 -38.32 79.16 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 118.567 -0.73 . . . . 0.0 109.825 -176.13 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 19.1 mm100 -59.89 -55.45 34.04 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 118.611 0.641 . . . . 0.0 110.304 172.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 16.1 pt -65.32 -30.53 50.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 118.924 0.784 . . . . 0.0 110.642 -174.172 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 50.8 m -61.82 -25.74 67.69 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.747 0.703 . . . . 0.0 111.692 177.385 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -89.33 -28.88 19.54 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 119.599 1.091 . . . . 0.0 111.023 176.667 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -72.19 -37.82 69.21 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 118.663 0.665 . . . . 0.0 110.67 175.245 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 76.8 mt -90.83 -9.32 46.84 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.186 1.794 . . . . 0.0 111.848 -177.281 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 55.57 29.44 13.48 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.534 1.534 . . . . 0.0 112.759 -170.113 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 86.5 mt . . . . . 0 N--CA 1.466 0.366 0 O-C-N 121.349 -0.845 . . . . 0.0 110.286 169.362 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.297 0 CA-C-O 120.769 0.319 . . . . 0.0 111.408 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.1 pt -109.89 -15.96 9.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 125.363 1.465 . . . . 0.0 111.3 178.612 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 28.9 m -111.77 123.69 50.77 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.201 1.4 . . . . 0.0 108.317 177.406 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -96.49 119.29 6.26 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 107.434 -2.267 . . . . 0.0 107.434 169.468 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 56.8 mt -98.07 91.88 2.64 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 105.23 -2.137 . . . . 0.0 105.23 176.263 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -88.48 129.08 35.53 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 178.357 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -128.54 133.48 48.41 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 120.011 1.278 . . . . 0.0 111.88 179.646 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -89.92 145.24 18.12 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 169.726 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 9.3 m -164.23 158.34 18.85 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.679 1.24 . . . . 0.0 109.743 172.27 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -125.18 -51.13 1.66 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.614 0.765 . . . . 0.0 109.432 168.207 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.2 p -86.35 8.11 22.84 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.097 1.359 . . . . 0.0 112.976 173.343 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 84.19 -9.02 64.99 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 116.963 1.545 . . . . 0.0 116.963 168.138 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -60.78 -37.45 81.92 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 120.23 2.015 . . . . 0.0 113.825 -169.457 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.7 m -73.55 -15.09 61.3 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 120.01 1.277 . . . . 0.0 110.799 -175.697 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -60.19 -41.95 94.04 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 119.643 1.111 . . . . 0.0 109.676 172.337 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -63.04 -41.29 99.46 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -178.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 25.7 mm -64.8 -45.06 96.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 177.738 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.88 -40.25 88.09 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.589 0.631 . . . . 0.0 111.04 178.012 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.2 mtpt -67.47 -42.09 83.56 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 118.022 -0.99 . . . . 0.0 110.72 177.753 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 63.4 mtt -55.66 -47.62 76.4 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 119.851 1.205 . . . . 0.0 109.721 175.686 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 62.1 mt -60.37 -52.69 58.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -179.573 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -61.79 -38.64 88.81 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.958 0.799 . . . . 0.0 111.212 -175.6 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -65.02 -35.86 82.53 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 118.908 0.776 . . . . 0.0 111.023 -179.191 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -70.64 -49.38 48.13 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.322 0.51 . . . . 0.0 110.838 175.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 54.5 mt -67.8 -32.6 73.27 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.329 0.513 . . . . 0.0 111.783 -177.308 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.0 145.09 14.79 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 125.407 1.48 . . . . 0.0 110.792 -173.562 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 22.8 ptmt -63.72 -29.53 70.74 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 121.728 -0.866 . . . . 0.0 113.184 -172.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -77.68 -11.49 59.88 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.591 179.167 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 22.4 t -103.57 -39.33 5.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 C-N-CA 124.283 1.033 . . . . 0.0 109.711 177.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -133.24 146.55 51.56 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 119.234 0.924 . . . . 0.0 111.94 -176.203 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -130.71 139.58 50.3 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.104 0.962 . . . . 0.0 109.853 175.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 98.3 t -90.4 139.27 17.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 123.655 0.782 . . . . 0.0 109.15 -177.534 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -148.27 172.95 13.54 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.925 1.29 . . . . 0.0 111.133 -168.559 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -143.79 125.63 15.2 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 125.856 1.662 . . . . 0.0 108.629 -172.796 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.4 tp -62.35 -28.43 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-O 118.855 -0.593 . . . . 0.0 111.723 -172.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.09 -27.89 69.7 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 118.77 0.714 . . . . 0.0 111.537 -175.009 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 61.9 pttt -105.45 -3.95 21.93 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.627 1.171 . . . . 0.0 112.359 176.768 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 50.9 m -79.25 166.85 21.71 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.398 0.679 . . . . 0.0 110.953 -179.651 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.4 m -134.43 163.58 29.36 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.189 1.396 . . . . 0.0 109.021 179.396 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 53.5 tttm -52.81 -57.25 10.8 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.024 0.93 . . . . 0.0 110.985 -174.799 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -75.34 -16.07 60.43 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 122.354 0.262 . . . . 0.0 111.329 -173.096 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -74.31 -29.29 61.56 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 122.889 0.476 . . . . 0.0 110.928 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.8 mp -71.43 -41.98 68.81 Favored 'General case' 0 C--N 1.344 0.336 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 168.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.3 -15.73 63.46 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.234 0.614 . . . . 0.0 112.264 -174.306 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.88 -30.06 70.12 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.324 1.05 . . . . 0.0 112.277 174.687 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -84.58 155.22 22.16 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 123.845 0.858 . . . . 0.0 110.059 178.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -102.45 -26.73 13.15 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.236 0.614 . . . . 0.0 111.129 169.348 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.9 mp -113.74 123.43 69.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 174.541 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -109.85 123.14 49.05 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 173.399 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.1 mp -109.2 120.68 43.24 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 105.43 -2.063 . . . . 0.0 105.43 169.796 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 59.6 mt -118.38 109.42 16.25 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 -173.249 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -90.05 121.24 6.09 Favored Glycine 0 N--CA 1.451 -0.323 0 N-CA-C 108.568 -1.813 . . . . 0.0 108.568 176.503 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 3.0 tp -141.65 103.84 5.88 Favored Pre-proline 0 CA--C 1.541 0.611 0 CA-C-N 117.741 0.771 . . . . 0.0 110.039 -169.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -76.47 147.14 28.31 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.463 2.109 . . . . 0.0 109.564 169.012 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 33.5 m -95.5 140.93 29.65 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 177.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 38.7 m95 -134.16 171.29 14.43 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 125.208 1.403 . . . . 0.0 111.24 -170.281 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 51.85 -87.59 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 127.8 2.44 . . . . 0.0 113.114 178.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -150.0 78.23 1.34 Allowed 'General case' 0 C--O 1.234 0.289 0 C-N-CA 126.682 1.993 . . . . 0.0 106.813 179.654 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 70.99 19.6 77.21 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 123.68 0.657 . . . . 0.0 113.337 179.39 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -93.12 161.33 14.47 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.582 1.153 . . . . 0.0 109.357 -176.757 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -79.31 159.41 27.22 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 167.367 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -58.18 143.88 42.59 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 168.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 60.4 m -51.74 -38.89 57.23 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.566 1.146 . . . . 0.0 113.645 -169.008 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -70.78 -35.63 72.66 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 118.548 0.613 . . . . 0.0 110.694 -175.497 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -71.5 -45.51 62.29 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 175.018 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -57.92 -41.29 82.36 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 122.738 0.415 . . . . 0.0 111.379 179.216 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -68.2 -25.53 65.27 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.729 0.812 . . . . 0.0 112.268 177.456 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -92.69 -18.65 22.72 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.55 0.74 . . . . 0.0 112.506 -178.23 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 19.4 m-30 -50.73 -40.61 64.46 Favored Pre-proline 0 CA--C 1.545 0.78 0 CA-C-O 116.469 -1.729 . . . . 0.0 114.633 178.324 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -63.2 -20.86 71.8 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 CA-C-N 123.033 2.119 . . . . 0.0 113.912 173.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.2 m -85.7 -39.05 17.64 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 119.381 0.991 . . . . 0.0 109.441 169.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 13.6 tp -58.24 -38.05 76.11 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.031 0.932 . . . . 0.0 110.697 -177.49 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -72.51 -3.98 27.72 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 179.22 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -103.13 -12.46 17.35 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.134 0.879 . . . . 0.0 111.357 173.286 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 79.4 mt -77.23 138.39 20.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -176.172 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -78.18 124.23 27.83 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.592 176.673 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -122.06 11.03 10.18 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.769 0.827 . . . . 0.0 111.6 172.455 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -63.08 114.09 3.51 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 120.012 1.278 . . . . 0.0 109.143 -171.571 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.17 3.65 61.54 Favored Glycine 0 CA--C 1.536 1.392 0 CA-C-O 118.546 -1.141 . . . . 0.0 113.866 -178.8 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -75.21 152.03 38.4 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 119.544 1.672 . . . . 0.0 108.182 170.467 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 20.8 mt -91.6 136.59 33.02 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 175.533 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 18.5 t -133.81 141.69 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.13 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -134.32 143.26 47.6 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 171.253 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 64.7 mt -111.86 144.42 41.2 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -177.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -140.53 154.46 46.55 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 170.004 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -173.54 155.66 22.65 Favored Glycine 0 N--CA 1.449 -0.476 0 CA-C-O 122.416 1.009 . . . . 0.0 112.705 176.711 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 64.1 m -101.96 149.87 23.78 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 169.449 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -145.51 -159.32 8.08 Favored Glycine 0 CA--C 1.521 0.409 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 176.005 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -144.79 139.51 27.85 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 124.968 1.307 . . . . 0.0 108.546 170.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -109.09 -14.7 14.48 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 123.962 0.905 . . . . 0.0 111.419 177.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -75.11 -43.62 51.79 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 119.843 1.201 . . . . 0.0 110.796 -170.06 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -112.87 -40.22 4.05 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 123.495 0.718 . . . . 0.0 110.755 179.032 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -83.89 37.86 0.62 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.533 0.733 . . . . 0.0 111.018 176.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.06 -23.64 63.92 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 126.805 2.042 . . . . 0.0 114.019 -170.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -99.34 0.26 42.52 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.321 1.448 . . . . 0.0 111.918 -179.115 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -131.98 16.99 4.65 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.258 1.023 . . . . 0.0 111.925 -169.127 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -65.15 125.88 26.35 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 121.247 -0.908 . . . . 0.0 110.27 -169.31 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 88.1 m 53.24 29.45 8.48 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.842 1.657 . . . . 0.0 114.349 176.028 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -61.43 -31.51 71.46 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.755 0.822 . . . . 0.0 111.339 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.56 -33.58 76.25 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 120.754 -1.216 . . . . 0.0 111.687 179.031 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 7.5 mp -63.29 -43.89 96.6 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-N 119.691 1.132 . . . . 0.0 109.633 175.473 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.71 -31.99 82.01 Favored Glycine 0 CA--C 1.532 1.114 0 N-CA-C 111.337 -0.705 . . . . 0.0 111.337 174.76 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 14.7 m -66.56 -41.42 88.65 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 117.76 0.78 . . . . 0.0 110.113 176.082 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 5.4 mt -65.75 -43.83 93.38 Favored 'Isoleucine or valine' 0 C--N 1.345 0.401 0 CA-C-N 119.425 1.012 . . . . 0.0 109.509 173.549 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 41.3 ttt180 -52.32 -45.93 65.81 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 119.381 0.991 . . . . 0.0 110.435 -178.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -62.0 -17.98 58.96 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.96 0.904 . . . . 0.0 113.035 -178.126 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 82.8 mt -95.4 -54.72 6.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 124.397 1.079 . . . . 0.0 109.216 175.219 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 23.2 pt -71.56 -33.46 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 O-C-N 121.251 -0.906 . . . . 0.0 112.195 -168.416 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -66.53 -50.37 47.22 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-O 117.694 -1.146 . . . . 0.0 111.486 -174.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -68.36 -24.67 36.83 Favored 'Trans proline' 0 C--N 1.354 0.836 0 CA-C-N 121.731 1.654 . . . . 0.0 112.769 174.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 7.7 mpt_? -74.76 6.76 3.63 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 119.42 1.009 . . . . 0.0 112.523 169.739 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 81.38 16.66 73.29 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-O 118.435 -1.203 . . . . 0.0 114.007 169.028 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.13 141.9 55.11 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 118.882 1.341 . . . . 0.0 109.998 170.164 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 88.1 m -93.13 119.34 32.24 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 104.641 -2.355 . . . . 0.0 104.641 167.321 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 33.6 mt -96.61 132.79 40.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 -173.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 29.9 m -129.44 172.62 15.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 C-N-CA 124.869 1.268 . . . . 0.0 109.033 175.472 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 77.35 27.74 59.09 Favored Glycine 0 CA--C 1.526 0.722 0 CA-C-O 119.105 -0.83 . . . . 0.0 113.542 177.224 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 28.9 p-80 -60.84 139.69 57.88 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 118.815 1.307 . . . . 0.0 108.678 168.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 75.6 t-105 -127.78 137.88 31.7 Favored Pre-proline 0 CA--C 1.533 0.321 0 C-N-CA 124.453 1.101 . . . . 0.0 108.245 -169.642 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -70.89 144.65 48.6 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 121.762 1.642 . . . . 0.0 112.347 -170.426 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 63.0 p . . . . . 0 CA--C 1.536 0.419 0 C-N-CA 123.471 0.708 . . . . 0.0 110.055 169.367 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.836 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -75.76 0.79 60.59 Favored Glycine 0 CA--C 1.535 1.295 0 CA-C-O 119.216 -0.769 . . . . 0.0 112.867 169.724 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 96.7 mt -64.32 139.19 58.74 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 119.468 1.634 . . . . 0.0 111.083 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -108.53 -31.07 7.93 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.456 1.503 . . . . 0.0 108.778 167.207 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -145.23 162.54 36.89 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 127.86 2.464 . . . . 0.0 106.181 169.382 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -55.65 -30.52 61.14 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 121.17 -0.956 . . . . 0.0 112.084 176.238 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -91.0 -9.41 46.06 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.241 1.016 . . . . 0.0 113.448 -179.572 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 58.7 m80 -147.36 130.94 16.81 Favored 'General case' 0 C--N 1.348 0.509 0 CA-C-N 119.93 1.241 . . . . 0.0 113.229 -171.336 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -76.22 155.58 34.31 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.008 0.923 . . . . 0.0 108.767 167.354 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 14.2 p -60.56 -32.19 50.85 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 124.144 0.978 . . . . 0.0 111.419 176.438 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -146.41 -177.25 20.9 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 124.905 1.241 . . . . 0.0 110.32 -172.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -62.55 123.39 18.21 Favored 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 171.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.374 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 -176.654 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 90.0 mt . . . . . 0 N--CA 1.468 0.458 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 93.9 m -53.66 -58.21 8.02 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.424 1.09 . . . . 0.0 110.614 -175.009 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -68.91 -32.67 72.46 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 122.278 -0.264 . . . . 0.0 110.517 -169.813 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 25.3 mp0 -63.97 -48.47 76.33 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.234 1.014 . . . . 0.0 109.292 176.718 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 74.3 mtt85 -65.53 -37.18 86.0 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 118.912 0.778 . . . . 0.0 110.635 -179.334 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 96.3 t -64.41 -42.26 94.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-O 118.358 -0.829 . . . . 0.0 109.093 174.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -59.41 -48.71 80.59 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-N 119.832 1.196 . . . . 0.0 110.359 177.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -58.94 -44.62 91.44 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 118.088 0.403 . . . . 0.0 110.094 179.378 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 68.0 t90 -66.06 -44.44 84.52 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 118.363 0.529 . . . . 0.0 110.02 -175.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 79.1 t -62.77 -39.64 85.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.281 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -65.17 -38.67 91.27 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 121.389 -0.819 . . . . 0.0 110.138 178.576 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 43.4 mm-40 -64.35 -52.19 59.61 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 118.586 0.63 . . . . 0.0 110.964 176.268 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 21.0 pt -64.59 -31.72 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 119.568 1.077 . . . . 0.0 110.326 -178.41 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 65.6 m -60.79 -26.14 67.06 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 118.062 -0.97 . . . . 0.0 112.538 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -95.22 -10.39 30.54 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 120.117 1.326 . . . . 0.0 112.699 175.59 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -88.0 -39.5 14.62 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 118.981 0.809 . . . . 0.0 110.304 171.572 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 88.0 mt -84.51 -12.32 54.44 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.677 1.991 . . . . 0.0 111.421 178.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 30.4 m80 56.58 30.16 16.82 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.556 1.543 . . . . 0.0 112.885 -170.048 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 67.6 mt . . . . . 0 N--CA 1.466 0.366 0 O-C-N 121.477 -0.764 . . . . 0.0 110.38 169.532 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.33 0 N-CA-C 110.536 -0.172 . . . . 0.0 110.536 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.7 pt -86.78 -23.9 6.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 122.269 0.228 . . . . 0.0 111.581 -178.054 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.9 m -112.01 130.15 55.96 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.825 1.25 . . . . 0.0 108.646 -178.063 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -103.95 116.35 5.35 Favored Glycine 0 CA--C 1.521 0.417 0 N-CA-C 108.241 -1.944 . . . . 0.0 108.241 169.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 74.6 mt -90.81 126.14 43.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 104.847 -2.279 . . . . 0.0 104.847 171.019 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -122.38 126.94 49.06 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 174.377 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -125.28 136.59 53.67 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 118.311 0.505 . . . . 0.0 111.027 178.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -85.93 136.86 14.63 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 108.632 -1.787 . . . . 0.0 108.632 168.159 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 22.6 m -157.35 158.12 35.39 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 119.395 1.598 . . . . 0.0 110.908 169.333 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -142.67 -42.79 0.32 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.878 1.271 . . . . 0.0 110.062 170.346 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.5 p -77.54 -13.28 59.95 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 122.977 0.511 . . . . 0.0 111.506 169.811 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 88.71 34.58 9.03 Favored Glycine 0 C--N 1.342 0.895 0 C-N-CA 124.079 0.847 . . . . 0.0 112.373 172.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -86.02 -54.12 4.67 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 117.493 0.647 . . . . 0.0 111.759 179.489 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.4 m -74.74 -16.62 60.73 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 118.511 -0.757 . . . . 0.0 112.21 -168.107 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -58.19 -35.97 72.41 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 119.605 1.093 . . . . 0.0 110.514 172.319 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -71.43 -40.85 70.14 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -179.55 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 34.4 mm -63.55 -43.5 98.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 177.547 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.03 -42.65 90.7 Favored 'General case' 0 CA--C 1.53 0.184 0 O-C-N 121.661 -0.65 . . . . 0.0 110.628 177.392 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -66.88 -39.77 87.59 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 118.434 -0.793 . . . . 0.0 111.087 176.618 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 63.0 mtt -61.77 -33.48 74.16 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 119.948 1.249 . . . . 0.0 111.499 176.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 26.1 mt -74.16 -49.55 32.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 175.351 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -59.78 -40.14 87.27 Favored 'General case' 0 C--O 1.225 -0.214 0 O-C-N 121.629 -0.669 . . . . 0.0 111.728 -176.389 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -63.57 -34.01 76.86 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 119.764 1.165 . . . . 0.0 111.171 -178.418 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -73.68 -41.29 62.85 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 122.722 0.409 . . . . 0.0 110.826 175.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.2 mp -74.75 -36.93 62.61 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 122.915 0.486 . . . . 0.0 111.25 -176.099 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.0 146.41 18.19 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 125.764 1.65 . . . . 0.0 110.85 -173.281 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 53.8 tptt -61.04 -31.66 71.3 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.565 1.146 . . . . 0.0 111.819 -175.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -68.0 -27.33 66.47 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.23 0.612 . . . . 0.0 111.192 178.531 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 39.0 t -96.89 -37.63 7.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 C-N-CA 124.248 1.019 . . . . 0.0 110.003 -175.71 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -135.55 137.17 41.75 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 119.252 0.933 . . . . 0.0 111.901 -174.48 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -119.08 158.34 26.05 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.861 0.864 . . . . 0.0 109.849 169.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 51.8 t -120.56 135.62 60.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 124.349 1.06 . . . . 0.0 110.543 -168.69 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -147.3 172.19 14.26 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.145 1.778 . . . . 0.0 111.456 -171.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -126.68 135.49 51.22 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 126.605 1.962 . . . . 0.0 106.364 170.275 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.0 tp -61.0 -18.54 18.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 123.759 0.824 . . . . 0.0 112.656 -172.75 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.99 -29.12 63.01 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 119.014 0.825 . . . . 0.0 111.304 178.402 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 45.7 mtmt -80.6 -24.15 39.33 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 122.922 0.489 . . . . 0.0 112.209 177.311 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 46.9 m -77.48 159.59 29.27 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.353 1.061 . . . . 0.0 113.337 -166.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.3 m -132.58 176.17 8.67 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 127.633 2.373 . . . . 0.0 106.632 169.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.5 tttm -50.11 -48.47 53.41 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.942 0.792 . . . . 0.0 111.96 -175.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -78.58 -11.95 59.99 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -173.141 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -69.96 -34.48 73.45 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.442 -0.786 . . . . 0.0 111.245 -176.68 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.3 mp -76.22 -35.25 59.12 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-O 119.103 -0.475 . . . . 0.0 110.832 172.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -64.25 -23.75 67.42 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 118.595 0.634 . . . . 0.0 112.175 -177.667 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.13 -28.87 69.73 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.78 0.832 . . . . 0.0 112.506 178.801 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -91.8 152.15 20.26 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 124.551 1.141 . . . . 0.0 109.68 176.555 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -109.92 -15.23 14.12 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.614 0.766 . . . . 0.0 111.8 174.814 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.4 mp -123.22 134.06 67.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 169.78 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 91.2 mt -124.3 147.88 47.83 Favored 'General case' 0 CA--C 1.518 -0.281 0 C-N-CA 123.651 0.781 . . . . 0.0 109.702 178.403 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.8 mt -130.99 107.46 9.11 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 177.452 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 76.2 mt -112.4 114.14 26.71 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -169.437 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -106.25 116.38 5.08 Favored Glycine 0 C--N 1.335 0.51 0 C-N-CA 125.475 1.512 . . . . 0.0 110.27 -177.781 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 16.1 tt -123.74 117.66 27.42 Favored Pre-proline 0 CA--C 1.541 0.609 0 CA-C-N 118.574 1.187 . . . . 0.0 111.749 -172.656 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -77.35 141.72 20.56 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 121.806 1.671 . . . . 0.0 109.288 168.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 35.3 m -91.03 142.72 27.47 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 172.412 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 51.0 m95 -132.96 172.66 12.32 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.948 2.099 . . . . 0.0 109.797 -175.661 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 33.92 53.61 0.51 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 128.918 2.887 . . . . 0.0 115.824 169.755 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 53.04 62.78 2.51 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.174 0.99 . . . . 0.0 111.28 176.479 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 87.43 52.12 3.11 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 123.713 0.673 . . . . 0.0 112.386 174.168 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -135.21 161.38 35.53 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.823 1.649 . . . . 0.0 108.628 171.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.12 165.57 21.47 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 168.55 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -67.01 147.77 52.79 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 169.392 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 57.9 m -53.28 -34.78 58.68 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.075 0.95 . . . . 0.0 112.741 -176.313 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -67.4 -44.26 79.29 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.156 0.582 . . . . 0.0 110.426 -176.254 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -71.4 -43.46 66.78 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.213 0.605 . . . . 0.0 109.474 176.57 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -60.21 -39.31 86.13 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.523 0.729 . . . . 0.0 111.737 -178.365 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -70.77 -24.7 62.65 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.955 0.902 . . . . 0.0 112.104 176.096 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -88.23 -23.59 23.5 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-O 118.326 -0.845 . . . . 0.0 112.156 178.51 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -51.11 -43.31 84.65 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-O 116.631 -1.652 . . . . 0.0 114.462 178.416 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -64.65 -15.39 49.8 Favored 'Trans proline' 0 CA--C 1.543 0.953 0 CA-C-N 122.8 2.036 . . . . 0.0 113.691 175.488 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.0 m -90.72 -38.84 12.79 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.783 1.233 . . . . 0.0 109.613 170.684 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 23.6 tp -57.84 -40.36 79.87 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 124.352 1.061 . . . . 0.0 109.946 -179.335 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -71.87 -7.05 46.13 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -86.15 -15.44 41.05 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 120.185 1.357 . . . . 0.0 110.412 173.012 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 65.1 mt -90.02 128.47 41.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 -174.277 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -87.5 139.54 30.44 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 168.462 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -126.38 20.52 7.36 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.492 1.117 . . . . 0.0 111.315 -175.403 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -50.55 -34.07 24.14 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 115.777 1.769 . . . . 0.0 115.777 -168.663 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -110.64 13.6 29.97 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-O 118.385 -1.231 . . . . 0.0 113.556 -178.815 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -112.33 146.97 37.34 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 119.602 1.701 . . . . 0.0 109.99 -169.749 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -95.83 141.88 28.75 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 176.381 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 16.4 t -134.76 143.04 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 173.775 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -124.61 145.46 49.61 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 169.261 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 88.9 mt -121.69 139.48 53.51 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -169.801 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -140.98 164.15 31.05 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 169.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -168.34 156.55 28.12 Favored Glycine 0 N--CA 1.443 -0.838 0 O-C-N 121.059 -1.026 . . . . 0.0 112.132 -178.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 33.5 m -122.32 152.65 39.9 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 -168.698 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -164.92 -153.38 7.47 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.501 -174.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -152.46 140.31 20.03 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.101 1.36 . . . . 0.0 110.331 -178.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -120.5 13.56 11.78 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.616 1.566 . . . . 0.0 110.816 -179.084 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -94.27 -43.78 8.27 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.344 1.057 . . . . 0.0 109.541 -178.362 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -127.82 -31.5 2.42 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.702 1.201 . . . . 0.0 111.789 177.296 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -90.04 24.8 2.33 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.522 0.729 . . . . 0.0 111.971 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.76 -19.34 64.9 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.212 1.405 . . . . 0.0 114.027 -170.08 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -99.49 7.71 45.15 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 119.527 1.058 . . . . 0.0 112.343 176.057 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -133.86 25.01 3.98 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 126.206 1.802 . . . . 0.0 109.494 176.177 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -65.84 122.56 17.59 Favored 'General case' 0 C--O 1.238 0.481 0 O-C-N 121.767 -0.583 . . . . 0.0 109.65 -168.662 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 93.5 m 50.61 33.85 8.75 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.669 1.588 . . . . 0.0 112.778 -177.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -52.48 -38.15 58.78 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 121.753 -0.592 . . . . 0.0 112.561 -177.303 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -73.12 -14.65 61.42 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -171.567 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -59.67 -39.3 84.02 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.158 -0.964 . . . . 0.0 111.281 -177.048 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -70.41 -23.02 77.81 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 123.239 0.447 . . . . 0.0 112.692 179.554 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.2 m -65.59 -29.86 70.52 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 118.28 1.04 . . . . 0.0 110.894 -177.218 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 6.4 mt -71.62 -48.81 50.27 Favored 'Isoleucine or valine' 0 C--N 1.345 0.372 0 CA-C-O 118.51 -0.757 . . . . 0.0 109.056 175.672 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 18.6 ttm-85 -53.03 -42.95 66.2 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 119.053 0.842 . . . . 0.0 109.806 178.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -59.18 -23.78 62.53 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -176.529 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 94.8 mt -95.2 -50.49 11.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 124.016 0.926 . . . . 0.0 109.84 175.597 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 20.0 pt -75.72 -24.48 16.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 119.194 0.906 . . . . 0.0 112.16 -168.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -67.93 -52.86 22.63 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-O 117.394 -1.288 . . . . 0.0 112.101 -179.477 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -65.77 -25.47 53.44 Favored 'Trans proline' 0 C--N 1.352 0.746 0 CA-C-N 122.137 1.799 . . . . 0.0 111.953 175.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 83.1 mmt-85 -75.82 5.31 6.51 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.03 0.932 . . . . 0.0 112.976 170.12 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 78.15 14.55 82.14 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-O 117.891 -1.505 . . . . 0.0 114.801 168.721 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.11 143.04 45.15 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 119.657 1.729 . . . . 0.0 109.19 171.532 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 69.7 m -88.7 125.91 35.07 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 104.419 -2.437 . . . . 0.0 104.419 167.642 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 21.5 mt -116.23 130.25 71.29 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 -169.486 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 29.8 m -130.36 175.28 11.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 124.403 1.081 . . . . 0.0 109.76 177.226 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 91.55 24.48 25.9 Favored Glycine 0 CA--C 1.528 0.888 0 CA-C-O 119.097 -0.835 . . . . 0.0 114.025 170.295 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 49.0 p-80 -60.96 150.66 32.69 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 119.262 1.531 . . . . 0.0 109.068 168.248 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 73.3 t-105 -136.62 133.62 19.15 Favored Pre-proline 0 CA--C 1.535 0.379 0 C-N-CA 123.697 0.799 . . . . 0.0 109.543 -169.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -69.76 146.37 59.99 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.385 2.057 . . . . 0.0 112.048 -176.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 68.4 p . . . . . 0 CA--C 1.538 0.496 0 C-N-CA 124.753 1.221 . . . . 0.0 111.814 174.545 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? . . . . . 0 N--CA 1.469 0.488 0 CA-C-O 119.238 -0.411 . . . . 0.0 111.45 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -74.57 0.57 55.38 Favored Glycine 0 CA--C 1.535 1.285 0 CA-C-N 118.813 0.733 . . . . 0.0 113.207 169.7 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 77.6 mt -63.05 142.63 58.31 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 119.111 1.456 . . . . 0.0 112.17 177.548 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -107.01 -27.86 10.39 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 125.932 1.693 . . . . 0.0 109.647 167.42 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -144.16 159.11 43.21 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 127.251 2.22 . . . . 0.0 106.291 175.407 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -53.01 -29.55 29.98 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -179.085 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -101.38 -7.32 23.04 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -137.91 133.25 33.59 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 120.798 1.636 . . . . 0.0 113.035 -170.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -76.25 149.01 37.23 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.436 1.095 . . . . 0.0 108.898 167.757 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 6.2 p -68.91 -17.61 22.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 124.977 1.311 . . . . 0.0 111.719 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -154.54 178.81 31.11 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 108.172 -1.971 . . . . 0.0 108.172 178.722 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -66.61 109.62 2.88 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 118.282 1.041 . . . . 0.0 108.21 173.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.418 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 171.851 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 68.6 mt . . . . . 0 N--CA 1.472 0.662 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 8.6 m -49.94 -60.1 3.24 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 126.812 2.045 . . . . 0.0 112.339 -168.56 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -74.73 -35.37 62.65 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 118.951 -0.547 . . . . 0.0 111.28 -167.451 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -67.52 -41.11 84.93 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 118.565 0.621 . . . . 0.0 110.517 176.483 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 64.5 mtp180 -62.02 -41.3 97.93 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 119.32 0.964 . . . . 0.0 110.537 176.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 84.9 t -70.79 -33.78 53.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-O 118.52 -0.752 . . . . 0.0 110.388 179.05 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -65.03 -49.53 69.78 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 120.916 1.689 . . . . 0.0 109.378 175.722 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -59.28 -34.84 72.76 Favored 'General case' 0 C--N 1.339 0.136 0 CA-C-O 118.599 -0.715 . . . . 0.0 110.973 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 35.8 t90 -73.03 -52.5 14.15 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 119.007 0.821 . . . . 0.0 110.728 178.326 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 77.1 t -65.86 -31.9 55.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 O-C-N 121.4 -0.813 . . . . 0.0 110.831 -171.281 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 55.8 mttm -60.21 -35.53 75.63 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 121.49 -0.756 . . . . 0.0 110.889 174.811 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 21.8 mm100 -70.85 -50.22 37.63 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 118.59 0.632 . . . . 0.0 110.928 173.573 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 2.3 pt -63.13 -30.82 50.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 119.221 0.919 . . . . 0.0 110.533 -174.765 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 50.8 m -61.87 -32.35 72.7 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 119.06 -0.495 . . . . 0.0 111.203 179.155 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -79.89 -40.89 27.31 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 119.219 0.918 . . . . 0.0 109.837 176.609 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -66.42 -34.88 78.94 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.455 0.702 . . . . 0.0 111.444 -177.575 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 95.5 mt -92.24 -1.56 57.04 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.958 1.703 . . . . 0.0 111.552 179.169 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 30.5 m80 56.73 21.17 5.67 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.166 1.786 . . . . 0.0 113.595 -174.441 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 72.5 mt . . . . . 0 N--CA 1.464 0.228 0 O-C-N 121.399 -0.813 . . . . 0.0 110.442 175.516 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.234 0 CA-C-O 120.731 0.3 . . . . 0.0 111.133 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.9 pt -106.35 -16.16 8.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 125.239 1.415 . . . . 0.0 110.926 178.513 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 53.7 m -112.04 124.38 52.29 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.485 1.514 . . . . 0.0 108.426 177.473 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -98.44 121.64 7.24 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 108.748 -1.741 . . . . 0.0 108.748 169.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 61.9 mt -96.14 96.16 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 103.773 -2.677 . . . . 0.0 103.773 176.244 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -99.17 119.42 37.84 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -133.5 156.72 47.26 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 123.402 0.681 . . . . 0.0 109.276 -169.056 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -131.93 144.82 16.57 Favored Glycine 0 C--N 1.336 0.576 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 169.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.0 m -141.14 161.85 36.88 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.208 1.403 . . . . 0.0 108.811 177.79 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -126.54 -54.16 1.45 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.033 0.533 . . . . 0.0 110.254 171.261 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.13 -3.06 56.94 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.036 0.934 . . . . 0.0 111.614 170.412 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 93.4 7.65 61.81 Favored Glycine 0 C--N 1.342 0.875 0 C-N-CA 124.561 1.077 . . . . 0.0 113.254 169.711 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -71.07 -43.3 68.06 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 118.657 1.228 . . . . 0.0 111.377 -173.677 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -65.62 -37.76 87.52 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 118.801 0.728 . . . . 0.0 110.037 -172.334 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.3 tp10 -59.79 -35.95 75.71 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.475 1.11 . . . . 0.0 111.342 179.449 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -64.07 -38.16 90.06 Favored 'General case' 0 CA--C 1.53 0.203 0 O-C-N 121.678 -0.638 . . . . 0.0 110.377 176.593 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.5 mm -68.97 -41.45 81.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 176.638 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.7 -39.28 70.81 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.122 0.874 . . . . 0.0 111.041 178.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -66.6 -45.72 78.24 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 118.843 -0.598 . . . . 0.0 110.856 173.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 69.1 mtm -63.86 -27.78 69.4 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 119.713 1.142 . . . . 0.0 112.003 178.59 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 61.6 mt -70.03 -56.19 12.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 172.825 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -57.55 -40.09 78.11 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.588 -0.695 . . . . 0.0 111.97 -177.054 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -62.98 -34.07 76.75 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 119.505 1.048 . . . . 0.0 111.522 -178.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -75.05 -41.48 58.99 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 122.849 0.46 . . . . 0.0 111.172 178.068 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -77.08 -32.26 56.61 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 118.886 0.766 . . . . 0.0 111.616 -177.779 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.07 143.54 11.47 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 124.952 1.263 . . . . 0.0 110.165 -169.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -63.58 -31.19 72.28 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.917 0.887 . . . . 0.0 111.947 -172.609 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -77.6 -7.66 56.71 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 46.4 t -105.28 -47.34 9.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 124.318 1.047 . . . . 0.0 109.157 176.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -131.44 140.32 49.58 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 119.386 0.994 . . . . 0.0 110.965 -176.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -132.86 147.74 52.3 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 176.684 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 58.0 t -99.75 137.59 26.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 C-N-CA 124.919 1.288 . . . . 0.0 110.48 -169.316 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -141.06 145.38 35.77 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.373 1.469 . . . . 0.0 109.392 -177.201 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -88.51 124.1 33.67 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 169.705 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.4 tp -58.32 -34.93 51.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 119.119 -0.467 . . . . 0.0 111.276 -174.594 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.84 -33.84 76.76 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 119.126 0.875 . . . . 0.0 112.318 -171.639 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -92.98 -7.61 45.4 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.125 0.57 . . . . 0.0 112.153 176.686 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 49.9 m -74.99 165.48 25.19 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.137 0.575 . . . . 0.0 110.096 179.109 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.3 m -128.72 158.94 37.19 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 124.241 1.017 . . . . 0.0 110.745 -170.375 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -51.2 -51.72 51.16 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.884 1.274 . . . . 0.0 111.373 -176.025 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -79.88 -14.27 58.77 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 122.542 0.337 . . . . 0.0 111.439 -173.609 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -76.67 -34.25 58.24 Favored 'General case' 0 C--N 1.34 0.166 0 O-C-N 121.599 -0.688 . . . . 0.0 111.045 -176.223 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.6 mp -65.76 -36.88 84.81 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 171.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -67.24 -19.47 65.53 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 123.039 0.536 . . . . 0.0 112.251 -174.573 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.53 -28.64 68.7 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.645 0.778 . . . . 0.0 112.05 177.713 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -89.37 152.46 21.5 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 123.93 0.892 . . . . 0.0 110.398 -176.248 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -92.51 -34.98 13.86 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.462 172.119 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 20.1 mt -113.78 137.99 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 -179.367 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 91.8 mt -124.89 134.87 52.52 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.666 0.786 . . . . 0.0 109.012 174.845 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.0 mp -112.85 116.2 29.67 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 104.821 -2.288 . . . . 0.0 104.821 168.817 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 66.6 mt -112.04 111.83 23.03 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 -172.506 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -105.19 106.69 2.71 Favored Glycine 0 C--N 1.338 0.648 0 C-N-CA 124.355 0.979 . . . . 0.0 112.336 -173.48 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.4 tp -124.62 107.44 29.21 Favored Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 126.114 1.766 . . . . 0.0 109.886 -168.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -76.21 141.74 23.58 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.095 1.863 . . . . 0.0 109.62 169.569 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 44.9 m -93.47 138.96 31.25 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 174.399 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 16.2 m95 -131.55 172.06 12.68 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 124.537 1.135 . . . . 0.0 110.606 -177.157 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 33.88 63.3 0.4 Allowed 'General case' 0 C--O 1.236 0.343 0 C-N-CA 128.22 2.608 . . . . 0.0 113.306 169.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.263 19.9 p90 49.67 58.96 4.86 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.633 1.173 . . . . 0.0 111.992 174.202 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.86 53.71 2.34 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-N 115.031 -0.986 . . . . 0.0 114.108 168.246 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -137.46 157.58 46.26 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 117.828 0.814 . . . . 0.0 110.283 167.594 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.84 150.59 32.23 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 168.752 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -62.59 152.41 35.11 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 169.351 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 60.9 m -57.96 -30.49 66.03 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.835 0.854 . . . . 0.0 111.83 -175.475 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -61.06 -39.07 88.46 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.922 0.889 . . . . 0.0 110.773 -179.067 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -85.09 -42.8 14.47 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 123.605 0.762 . . . . 0.0 110.671 175.835 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -61.51 -37.39 83.51 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.061 0.391 . . . . 0.0 111.828 -174.584 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -69.72 -21.96 63.43 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.529 0.732 . . . . 0.0 112.079 175.653 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -91.86 -23.65 19.59 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.6 0.76 . . . . 0.0 111.759 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -51.73 -41.57 78.89 Favored Pre-proline 0 CA--C 1.545 0.777 0 CA-C-O 116.539 -1.696 . . . . 0.0 114.763 179.07 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -64.38 -24.41 64.46 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 CA-C-N 122.991 2.104 . . . . 0.0 112.828 174.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.4 m -78.22 -40.57 37.02 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.257 0.935 . . . . 0.0 109.359 170.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 13.3 tp -59.5 -36.85 76.84 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.551 1.141 . . . . 0.0 111.151 -174.346 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -77.44 -6.65 54.21 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.893 0.877 . . . . 0.0 112.844 178.547 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 67.2 mt-10 -92.15 -23.28 19.46 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.432 1.014 . . . . 0.0 110.428 169.295 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 79.2 mt -73.14 147.61 9.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 176.459 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -116.91 137.74 52.01 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 176.845 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -124.82 16.11 8.65 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.458 1.103 . . . . 0.0 111.13 -171.373 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -59.73 126.74 28.8 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 120.062 1.301 . . . . 0.0 109.635 -179.431 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 72.3 2.79 55.4 Favored Glycine 0 CA--C 1.536 1.352 0 CA-C-O 118.121 -1.377 . . . . 0.0 114.605 -176.068 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -86.36 149.32 25.11 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 120.176 1.988 . . . . 0.0 108.036 173.081 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 14.9 mt -95.26 139.79 31.08 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 173.546 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.5 t -135.54 144.55 33.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 176.576 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -128.48 142.44 51.08 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 168.717 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 74.1 mt -105.29 149.7 25.79 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -178.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.433 ' CE2' HD12 ' A' ' 142' ' ' LEU . 15.1 t80 -140.15 146.76 39.21 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 176.738 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.485 ' HA3' HD11 ' A' ' 102' ' ' LEU . . . -165.31 143.21 8.28 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-N 119.555 1.07 . . . . 0.0 113.002 168.892 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 6.6 t -88.4 160.06 17.74 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 114.114 -1.043 . . . . 0.0 109.043 170.539 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -177.91 -174.53 44.32 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 -179.365 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -133.16 140.45 47.59 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.802 1.641 . . . . 0.0 109.543 174.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 22.0 pt20 -134.46 45.88 2.54 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.398 0.618 . . . . 0.0 110.584 169.142 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -109.17 -33.66 6.81 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.841 1.256 . . . . 0.0 108.83 168.65 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -127.84 -34.88 2.13 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 125.046 1.338 . . . . 0.0 111.367 173.594 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -90.29 26.37 1.95 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.038 0.935 . . . . 0.0 111.971 178.641 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.59 -14.89 62.08 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.014 -1.054 . . . . 0.0 113.685 -175.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -89.32 2.24 54.65 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 118.986 0.812 . . . . 0.0 111.868 173.53 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -142.58 11.86 1.89 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.152 1.381 . . . . 0.0 111.546 -173.035 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -67.8 127.55 33.22 Favored 'General case' 0 C--O 1.236 0.388 0 O-C-N 121.221 -0.924 . . . . 0.0 110.707 -168.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 85.2 m 50.99 31.77 6.71 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.085 1.354 . . . . 0.0 112.42 177.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -60.25 -38.44 83.47 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 121.777 -0.577 . . . . 0.0 111.354 -179.46 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.6 -21.96 62.6 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -169.745 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.485 HD11 ' HA3' ' A' ' 87' ' ' GLY . 6.9 mp -59.96 -38.02 81.26 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 119.063 0.847 . . . . 0.0 109.322 172.409 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.68 -34.48 88.73 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 111.306 -0.718 . . . . 0.0 111.306 175.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 4.7 m -65.68 -38.47 89.35 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.588 1.194 . . . . 0.0 110.364 177.156 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.1 mt -70.23 -46.1 73.11 Favored 'Isoleucine or valine' 0 C--N 1.343 0.323 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 175.674 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 37.5 ttt180 -53.42 -45.71 69.5 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 118.807 0.731 . . . . 0.0 110.579 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -61.85 -17.92 58.18 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.408 1.083 . . . . 0.0 112.571 -178.144 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 94.3 mt -95.69 -57.59 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 C-N-CA 123.997 0.919 . . . . 0.0 108.918 173.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 19.9 pt -69.05 -33.4 58.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 119.369 0.986 . . . . 0.0 112.203 -167.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -66.93 -54.06 23.01 Favored Pre-proline 0 CA--C 1.545 0.783 0 CA-C-O 117.816 -1.088 . . . . 0.0 111.006 -174.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.86 -22.39 36.53 Favored 'Trans proline' 0 C--N 1.353 0.786 0 CA-C-N 121.646 1.624 . . . . 0.0 112.677 175.081 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 30.4 mmm180 -79.68 11.31 3.24 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 119.015 0.825 . . . . 0.0 112.124 172.475 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 98.12 -2.57 59.73 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 125.463 1.506 . . . . 0.0 116.82 166.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.95 143.15 57.97 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 120.155 1.978 . . . . 0.0 111.059 -176.156 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 48.6 m -94.27 123.83 37.92 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 105.138 -2.171 . . . . 0.0 105.138 168.382 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 42.3 mt -105.86 131.77 54.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 -170.512 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 33.4 m -132.74 178.33 5.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 125.544 1.537 . . . . 0.0 109.258 177.12 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 77.35 22.89 69.44 Favored Glycine 0 CA--C 1.525 0.657 0 O-C-N 121.613 -0.679 . . . . 0.0 112.686 174.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 9.1 p-80 -61.5 113.88 2.92 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.313 1.045 . . . . 0.0 108.28 169.334 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 73.6 t-105 -84.06 140.85 40.02 Favored Pre-proline 0 CA--C 1.536 0.439 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 177.142 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -66.25 149.06 85.43 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 121.981 1.788 . . . . 0.0 111.296 179.088 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 81.2 p . . . . . 0 CA--C 1.537 0.469 0 C-N-CA 123.267 0.627 . . . . 0.0 111.118 169.707 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 60.0 mttt . . . . . 0 N--CA 1.47 0.551 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -76.88 0.96 64.3 Favored Glycine 0 CA--C 1.532 1.135 0 CA-C-O 118.93 -0.928 . . . . 0.0 113.214 168.757 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 8.3 mp -63.67 129.92 42.13 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 119.938 1.869 . . . . 0.0 110.277 178.07 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.06 -38.25 22.79 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.82 1.248 . . . . 0.0 108.058 167.247 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -153.94 166.68 32.22 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 129.548 3.139 . . . . 0.0 106.105 -174.77 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -52.67 -35.64 55.59 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.052 -1.03 . . . . 0.0 112.336 175.534 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -95.92 -7.37 36.85 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -174.082 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -146.28 141.09 26.98 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.814 1.188 . . . . 0.0 112.207 -172.167 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -83.93 160.87 20.99 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.003 1.321 . . . . 0.0 108.768 168.709 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 34.3 m -72.03 -7.16 8.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 O-C-N 120.963 -1.086 . . . . 0.0 112.872 179.029 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -166.64 -157.63 10.52 Favored Glycine 0 CA--C 1.521 0.42 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.433 HD12 ' CE2' ' A' ' 86' ' ' PHE . 2.8 tm? -76.97 96.24 4.32 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 169.456 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.346 0 N-CA-C 104.042 -2.577 . . . . 0.0 104.042 165.41 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 85.3 mt . . . . . 0 N--CA 1.463 0.194 0 CA-C-O 119.325 -0.369 . . . . 0.0 110.684 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 13.5 m -48.23 -55.61 10.07 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 123.946 0.899 . . . . 0.0 110.512 -175.604 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -61.85 -40.84 96.74 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.481 0.582 . . . . 0.0 111.121 -170.252 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -66.12 -49.92 65.8 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 177.329 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 87.4 mtt180 -58.73 -47.49 84.44 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 123.073 0.549 . . . . 0.0 110.219 -175.679 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 13.0 m -77.51 -33.69 19.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-O 118.611 -0.709 . . . . 0.0 110.729 -171.376 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -65.97 -47.81 73.35 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 119.841 1.2 . . . . 0.0 109.526 174.243 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -61.13 -40.37 93.56 Favored 'General case' 0 C--O 1.227 -0.11 0 CA-C-O 119.132 -0.461 . . . . 0.0 110.157 179.138 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 60.9 t90 -64.08 -47.7 79.06 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 118.71 0.686 . . . . 0.0 110.791 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 40.7 t -57.62 -40.55 75.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 118.265 0.484 . . . . 0.0 109.805 177.78 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 53.7 mttm -68.83 -36.96 78.82 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 118.353 -0.832 . . . . 0.0 110.227 -178.315 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -62.59 -55.35 27.97 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 119.106 0.867 . . . . 0.0 110.42 174.381 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 22.4 pt -68.58 -29.03 42.48 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.369 0 CA-C-O 119.015 -0.517 . . . . 0.0 110.409 -172.022 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 64.3 m -58.01 -29.67 65.49 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 119.011 0.823 . . . . 0.0 111.593 175.256 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -79.37 -45.46 19.51 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 119.64 1.109 . . . . 0.0 110.272 175.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -66.37 -35.03 79.3 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.516 0.726 . . . . 0.0 111.236 -175.776 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 73.6 mt -86.75 -3.59 59.07 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.075 1.75 . . . . 0.0 111.377 179.405 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 54.12 33.98 19.04 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.56 1.544 . . . . 0.0 112.51 -173.549 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 95.9 mt . . . . . 0 N--CA 1.464 0.265 0 O-C-N 121.549 -0.719 . . . . 0.0 110.359 173.228 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.66 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 22.4 pt -89.47 -18.96 7.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 O-C-N 121.623 -0.673 . . . . 0.0 112.091 -177.267 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.2 m -117.46 122.46 43.81 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 124.997 1.319 . . . . 0.0 107.521 178.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -98.45 114.28 4.97 Favored Glycine 0 C--N 1.334 0.472 0 N-CA-C 107.873 -2.091 . . . . 0.0 107.873 171.249 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 65.4 mt -94.69 106.75 18.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 104.872 -2.27 . . . . 0.0 104.872 174.574 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 11.7 m-30 -105.08 133.66 49.48 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 177.256 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -125.69 130.21 51.1 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.515 0.598 . . . . 0.0 112.149 -178.144 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -86.29 144.92 20.21 Favored Glycine 0 C--N 1.338 0.665 0 N-CA-C 108.738 -1.745 . . . . 0.0 108.738 168.405 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 11.0 m -158.27 169.76 23.77 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 119.12 1.46 . . . . 0.0 110.321 175.75 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -141.6 -49.45 0.4 Allowed 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.556 1.142 . . . . 0.0 109.124 168.221 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.3 p -80.56 -17.22 52.12 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.938 0.895 . . . . 0.0 112.171 170.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 103.95 7.41 41.38 Favored Glycine 0 C--N 1.342 0.885 0 C-N-CA 124.673 1.13 . . . . 0.0 113.99 171.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -65.13 -42.04 94.27 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 118.999 1.4 . . . . 0.0 112.069 -171.151 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -70.26 -18.41 63.13 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 118.942 0.792 . . . . 0.0 111.751 -170.743 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -58.81 -43.57 90.62 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 119.432 1.014 . . . . 0.0 110.036 174.678 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -64.4 -40.44 95.8 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.383 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 23.3 mm -66.42 -42.33 90.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 O-C-N 121.804 -0.56 . . . . 0.0 109.507 179.23 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.71 -40.08 86.76 Favored 'General case' 0 CA--C 1.532 0.253 0 O-C-N 121.721 -0.612 . . . . 0.0 110.579 176.794 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp -68.39 -39.43 81.72 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 118.336 -0.84 . . . . 0.0 111.145 176.712 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 64.1 mtt -59.51 -37.39 78.18 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 119.827 1.194 . . . . 0.0 110.976 175.483 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 51.9 mt -71.31 -51.38 34.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 177.325 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -62.13 -37.11 83.91 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 121.507 -0.745 . . . . 0.0 111.203 -174.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 59.1 tptt -63.13 -38.28 90.57 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 119.063 0.847 . . . . 0.0 110.812 -178.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -71.76 -41.62 68.2 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.952 0.501 . . . . 0.0 110.753 177.371 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.1 mp -73.21 -35.73 66.37 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.098 0.408 . . . . 0.0 111.24 -176.192 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 90.93 147.71 19.8 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 125.089 1.328 . . . . 0.0 110.771 -172.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -66.42 -28.3 68.51 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.694 0.798 . . . . 0.0 112.186 -171.347 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -69.04 -25.92 64.72 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 122.873 0.469 . . . . 0.0 111.348 176.46 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 31.6 t -98.52 -36.31 5.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 C-N-CA 124.481 1.112 . . . . 0.0 110.58 -174.149 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -135.33 144.76 46.86 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 118.777 0.717 . . . . 0.0 112.207 -177.266 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -129.32 154.65 46.66 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 125.288 1.435 . . . . 0.0 108.212 175.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 69.7 t -117.76 133.96 62.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 124.165 0.986 . . . . 0.0 108.901 -169.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -149.73 -174.78 4.79 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.218 1.007 . . . . 0.0 111.319 -177.639 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -135.02 141.31 46.14 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 125.224 1.41 . . . . 0.0 107.197 173.77 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.8 tp -59.49 -24.96 29.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 123.869 0.868 . . . . 0.0 112.906 -169.279 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.56 -27.81 69.21 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 118.729 0.695 . . . . 0.0 111.165 178.27 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -96.85 -33.78 11.52 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.751 1.22 . . . . 0.0 110.986 -179.37 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 19.8 m -60.38 162.11 6.56 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.332 0.653 . . . . 0.0 110.001 169.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.4 m -136.29 157.28 47.17 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.619 0.768 . . . . 0.0 110.449 -171.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -51.69 -51.71 53.86 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.23 1.012 . . . . 0.0 110.884 -179.48 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -75.24 -16.34 60.47 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 122.693 0.397 . . . . 0.0 111.587 -176.054 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -78.49 -37.98 41.99 Favored 'General case' 0 CA--C 1.53 0.19 0 O-C-N 121.541 -0.724 . . . . 0.0 110.213 179.23 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.0 mp -65.24 -35.05 79.86 Favored 'General case' 0 C--N 1.342 0.248 0 O-C-N 121.808 -0.558 . . . . 0.0 110.265 170.653 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -63.87 -23.85 67.51 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 118.81 0.732 . . . . 0.0 111.493 174.38 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -86.83 -31.4 20.85 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.941 0.896 . . . . 0.0 112.75 -178.218 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -67.55 160.17 28.28 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 123.994 0.917 . . . . 0.0 110.688 174.119 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -109.27 -40.17 5.01 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.493 0.717 . . . . 0.0 111.39 169.4 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.9 mt -112.47 125.19 69.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 177.105 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -113.9 132.19 56.01 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 171.343 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.0 mp -115.28 119.24 35.67 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 172.331 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 69.2 mt -117.41 109.46 16.81 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -172.744 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.78 123.07 6.63 Favored Glycine 0 CA--C 1.521 0.463 0 N-CA-C 108.949 -1.661 . . . . 0.0 108.949 176.145 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 3.4 tp -137.1 115.4 10.11 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-N 118.129 0.965 . . . . 0.0 110.125 -169.734 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -78.6 -173.22 1.77 Allowed 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 123.207 2.605 . . . . 0.0 109.986 169.431 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 95.5 m -144.45 145.96 32.19 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 119.99 -1.694 . . . . 0.0 107.592 169.616 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 75.0 m95 -139.71 169.74 17.17 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 125.144 1.378 . . . . 0.0 110.984 -169.622 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 55.88 -73.1 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 128.833 2.853 . . . . 0.0 114.642 175.629 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -161.76 56.25 0.26 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 127.239 2.216 . . . . 0.0 108.379 -174.496 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 81.72 19.66 65.33 Favored Glycine 0 CA--C 1.534 1.258 0 O-C-N 121.438 -0.789 . . . . 0.0 113.47 -179.015 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -88.31 154.29 20.53 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.416 1.108 . . . . 0.0 109.489 179.604 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.85 161.88 24.24 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 168.095 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.252 0.0 OUTLIER -70.93 159.85 33.94 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 170.413 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 57.7 m -53.71 -37.53 63.38 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 115.567 1.691 . . . . 0.0 115.567 -166.599 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -76.79 -43.97 34.63 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 119.046 0.839 . . . . 0.0 109.458 -170.192 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -64.18 -45.75 87.0 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.653 0.781 . . . . 0.0 109.446 173.589 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -58.76 -39.32 80.67 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 122.583 0.353 . . . . 0.0 111.732 179.337 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -71.22 -30.64 66.61 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.897 0.879 . . . . 0.0 112.253 176.542 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -87.34 -21.67 25.56 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 118.618 0.645 . . . . 0.0 112.562 -176.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 16.5 m-30 -50.08 -44.63 80.38 Favored Pre-proline 0 CA--C 1.546 0.799 0 CA-C-O 116.932 -1.509 . . . . 0.0 114.683 178.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -65.98 -16.32 52.1 Favored 'Trans proline' 0 CA--C 1.542 0.913 0 CA-C-N 122.598 1.964 . . . . 0.0 113.798 175.173 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 14.7 m -85.87 -40.31 16.09 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 119.481 1.037 . . . . 0.0 109.207 169.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.435 ' HA ' HD12 ' A' ' 76' ' ' ILE . 37.3 tp -59.71 -36.9 77.48 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.94 1.296 . . . . 0.0 111.572 -173.189 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -66.85 -15.58 63.72 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 177.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 -91.97 -14.26 29.78 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 119.261 0.937 . . . . 0.0 111.781 179.397 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.435 HD12 ' HA ' ' A' ' 73' ' ' LEU . 96.7 mt -80.65 138.39 19.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 -173.043 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -80.88 132.0 35.41 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.707 -0.678 . . . . 0.0 109.259 175.467 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -126.88 16.43 7.39 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 118.187 -0.911 . . . . 0.0 111.42 174.704 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 23.9 m-80 -59.41 114.31 2.62 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 120.542 1.519 . . . . 0.0 109.377 -175.369 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.65 4.6 66.26 Favored Glycine 0 CA--C 1.536 1.357 0 CA-C-O 118.69 -1.061 . . . . 0.0 114.123 -178.806 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -77.39 151.58 34.75 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 119.515 1.658 . . . . 0.0 108.224 171.3 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 17.8 mt -95.74 137.2 35.13 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 175.002 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.3 t -132.11 144.29 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 172.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -135.36 149.18 49.63 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 169.845 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 72.6 mt -120.52 149.13 42.9 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 -174.665 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -146.59 157.39 43.71 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 123.234 0.614 . . . . 0.0 109.55 172.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -170.2 166.34 39.57 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-O 122.305 0.947 . . . . 0.0 113.208 -175.677 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 15.2 t -142.64 162.18 36.14 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 126.754 2.021 . . . . 0.0 107.106 179.333 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -176.0 -170.71 39.07 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -139.42 142.88 37.44 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 127.086 2.154 . . . . 0.0 105.978 176.486 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.62 21.99 1.99 Allowed 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -172.802 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -64.5 -46.19 84.02 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 178.795 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -95.84 -38.18 10.41 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.174 0.59 . . . . 0.0 110.704 169.287 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -83.22 41.89 0.79 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.408 1.483 . . . . 0.0 111.551 -172.079 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.18 -21.14 66.45 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.823 1.249 . . . . 0.0 113.72 -169.431 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -97.36 2.85 51.05 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.716 1.207 . . . . 0.0 111.386 178.301 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -133.98 18.18 3.8 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.4 1.08 . . . . 0.0 112.481 -169.35 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -61.86 120.37 10.6 Favored 'General case' 0 CA--C 1.529 0.169 0 O-C-N 121.104 -0.997 . . . . 0.0 109.346 -176.16 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 80.1 m 45.88 35.76 2.51 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.557 1.543 . . . . 0.0 112.654 -176.253 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -49.48 -41.1 39.59 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.43 1.092 . . . . 0.0 111.911 -171.784 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.67 -13.88 62.47 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -171.76 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 34.1 mt -56.23 -41.84 76.32 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 119.837 1.199 . . . . 0.0 109.793 169.639 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.97 -36.42 93.05 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 178.817 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.0 m -62.71 -44.23 96.75 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 117.944 0.872 . . . . 0.0 109.906 177.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.7 mt -66.29 -45.48 89.64 Favored 'Isoleucine or valine' 0 C--N 1.344 0.357 0 CA-C-N 119.613 1.097 . . . . 0.0 108.908 178.716 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 45.6 ttt180 -54.64 -48.15 72.63 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 119.379 0.99 . . . . 0.0 110.43 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -62.08 -29.8 70.56 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.329 0.652 . . . . 0.0 111.603 -177.769 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 85.9 mt -81.53 -44.36 20.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-O 117.595 -1.193 . . . . 0.0 110.634 178.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.7 pt -86.88 -33.55 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 120.121 1.328 . . . . 0.0 113.003 -168.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -64.57 -37.85 27.23 Favored Pre-proline 0 CA--C 1.547 0.832 0 CA-C-O 117.946 -1.026 . . . . 0.0 112.008 -171.078 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -64.38 -17.1 58.5 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 122.417 2.078 . . . . 0.0 114.223 174.256 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 13.7 mmt180 -90.25 10.2 25.63 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.076 0.95 . . . . 0.0 111.536 -173.696 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 77.94 10.85 85.93 Favored Glycine 0 CA--C 1.531 1.06 0 CA-C-O 118.432 -1.205 . . . . 0.0 113.391 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -57.66 137.94 55.9 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 118.712 1.256 . . . . 0.0 109.426 171.208 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 55.8 m -93.96 120.87 34.8 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 168.742 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 36.9 mt -97.65 128.17 49.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 -176.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 34.6 m -128.79 175.44 10.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 124.983 1.313 . . . . 0.0 108.987 176.409 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 75.93 28.85 59.96 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-O 119.079 -0.845 . . . . 0.0 112.731 -177.233 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 81.4 m-70 -60.43 135.17 57.66 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 169.726 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 74.7 t-105 -129.99 139.7 36.44 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 124.248 1.019 . . . . 0.0 109.385 -169.098 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -62.08 162.39 22.99 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 121.781 1.654 . . . . 0.0 113.065 -178.171 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.536 0.408 0 C-N-CA 123.659 0.784 . . . . 0.0 112.015 174.57 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.534 0.335 0 CA-C-O 119.691 -0.195 . . . . 0.0 110.791 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -79.08 -4.9 89.05 Favored Glycine 0 C--N 1.341 0.815 0 CA-C-O 118.596 -1.114 . . . . 0.0 113.19 170.658 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 70.4 mt -68.96 120.09 14.3 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 120.402 2.101 . . . . 0.0 108.156 175.071 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -87.91 -28.69 21.37 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.635 1.174 . . . . 0.0 110.337 175.429 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -146.73 168.38 21.5 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.161 1.784 . . . . 0.0 107.403 171.435 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -57.25 -25.96 60.01 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.742 1.217 . . . . 0.0 113.57 -170.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -121.43 11.34 10.67 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.349 1.46 . . . . 0.0 113.163 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -142.72 127.53 18.22 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-N 119.404 1.002 . . . . 0.0 111.593 -175.685 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -80.64 152.99 28.21 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 125.061 1.344 . . . . 0.0 109.658 169.033 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 12.2 p -59.73 -24.95 30.58 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 C-N-CA 124.76 1.224 . . . . 0.0 111.654 171.133 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -156.72 171.82 34.32 Favored Glycine 0 C--N 1.337 0.629 0 C-N-CA 124.763 1.173 . . . . 0.0 110.53 -169.709 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -60.24 127.26 30.91 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.361 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 170.146 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 66.9 mt . . . . . 0 N--CA 1.469 0.519 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 74.3 m -47.08 -56.98 5.55 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.806 1.643 . . . . 0.0 111.992 -169.526 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -69.59 -39.37 77.33 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 119.245 -0.407 . . . . 0.0 111.27 -168.728 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -73.52 -35.04 65.53 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.456 0.571 . . . . 0.0 111.118 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 33.2 mtp180 -64.8 -41.11 96.06 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 119.341 0.973 . . . . 0.0 109.892 174.791 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 72.4 t -67.89 -41.33 84.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-O 118.592 -0.718 . . . . 0.0 109.634 177.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -59.26 -50.78 72.71 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 120.134 1.334 . . . . 0.0 110.283 176.364 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 58.1 mttm -57.41 -42.92 83.24 Favored 'General case' 0 CA--C 1.522 -0.115 0 CA-C-O 118.652 -0.69 . . . . 0.0 109.994 -178.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 60.5 t90 -66.43 -48.55 69.64 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 118.546 0.612 . . . . 0.0 110.797 -178.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 53.6 t -60.87 -36.2 70.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 118.107 0.412 . . . . 0.0 109.95 -177.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -65.94 -33.91 76.91 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 118.427 -0.797 . . . . 0.0 110.438 177.719 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 41.5 mm-40 -65.58 -54.77 23.31 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 119.015 0.825 . . . . 0.0 110.534 171.18 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 5.7 pt -64.65 -29.91 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-N 118.807 0.731 . . . . 0.0 110.633 -170.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 49.6 m -60.09 -27.01 66.64 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 118.646 -0.692 . . . . 0.0 111.774 178.409 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -82.41 -38.11 24.55 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 119.644 1.111 . . . . 0.0 110.717 175.76 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -71.36 -36.78 71.6 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.136 0.574 . . . . 0.0 111.133 -178.512 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 85.7 mt -85.75 -5.75 59.21 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.749 1.62 . . . . 0.0 111.306 178.427 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 84.7 m-70 54.63 29.99 12.49 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.81 1.644 . . . . 0.0 112.88 -171.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 80.0 mt . . . . . 0 N--CA 1.465 0.287 0 CA-C-O 118.668 -0.682 . . . . 0.0 110.723 173.324 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 ptt? . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 111.564 0.209 . . . . 0.0 111.564 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.73 155.29 26.96 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.507 0.723 . . . . 0.0 110.634 175.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.1 pt -102.1 -16.85 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 123.962 0.905 . . . . 0.0 111.718 -179.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 16.4 m -114.58 126.89 55.43 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.682 1.593 . . . . 0.0 108.671 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -102.52 119.93 6.63 Favored Glycine 0 CA--C 1.52 0.348 0 N-CA-C 107.816 -2.114 . . . . 0.0 107.816 169.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 43.5 mt -96.22 124.54 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 104.405 -2.443 . . . . 0.0 104.405 172.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -122.84 130.18 52.57 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 176.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -129.47 130.78 46.32 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 119.615 1.098 . . . . 0.0 112.551 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -81.78 152.76 32.13 Favored Glycine 0 C--N 1.339 0.697 0 N-CA-C 108.102 -1.999 . . . . 0.0 108.102 168.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 16.8 p -153.27 166.04 33.84 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 120.128 1.964 . . . . 0.0 111.413 -176.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -144.49 -58.4 0.37 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.588 0.755 . . . . 0.0 109.745 168.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.2 p -83.36 -12.42 56.55 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.691 1.197 . . . . 0.0 111.875 175.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.06 7.84 59.39 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 124.714 1.15 . . . . 0.0 113.059 175.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -65.9 -37.74 86.89 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 118.459 1.129 . . . . 0.0 110.929 -176.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.82 -24.5 66.17 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.437 0.695 . . . . 0.0 111.914 -175.074 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -62.21 -40.97 97.88 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 119.114 0.87 . . . . 0.0 109.733 177.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -66.28 -37.79 86.27 Favored 'General case' 0 CA--C 1.529 0.141 0 O-C-N 122.13 -0.356 . . . . 0.0 110.123 178.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 27.1 mm -62.77 -48.9 85.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 175.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.1 -39.41 86.06 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.331 0.514 . . . . 0.0 111.156 -178.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 57.8 mttm -67.99 -42.93 80.01 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 118.52 -0.752 . . . . 0.0 111.223 175.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 75.1 mtm -64.78 -28.09 69.34 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 119.938 1.245 . . . . 0.0 111.506 178.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.402 HG21 HD23 ' A' ' 51' ' ' LEU . 83.6 mt -68.63 -57.73 8.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 169.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -59.16 -39.9 83.92 Favored 'General case' 0 C--O 1.226 -0.152 0 C-N-CA 122.938 0.495 . . . . 0.0 111.601 -171.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -64.54 -34.08 77.4 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 118.616 0.644 . . . . 0.0 111.435 -176.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -73.0 -47.58 43.9 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 118.159 0.436 . . . . 0.0 110.332 177.065 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 54.2 mt -67.18 -34.05 76.69 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 122.698 0.399 . . . . 0.0 111.594 -178.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.59 145.95 17.73 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 125.587 1.565 . . . . 0.0 110.762 -173.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -63.52 -28.72 70.14 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.765 0.826 . . . . 0.0 111.81 -176.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -66.88 -23.91 66.06 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.092 0.557 . . . . 0.0 111.349 176.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 53.1 t -101.3 -39.11 6.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 124.592 1.157 . . . . 0.0 110.441 -175.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -132.68 145.03 50.72 Favored 'General case' 0 C--N 1.342 0.245 0 CA-C-N 119.539 1.063 . . . . 0.0 112.111 -173.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -127.01 158.68 36.29 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.754 1.222 . . . . 0.0 109.757 172.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 71.0 t -119.27 138.08 51.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 125.021 1.328 . . . . 0.0 110.257 -169.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -146.35 166.54 26.01 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.847 1.659 . . . . 0.0 111.815 -170.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -126.82 135.53 51.14 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 105.357 -2.09 . . . . 0.0 105.357 168.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.9 tp -61.97 -17.2 17.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-N 118.88 0.763 . . . . 0.0 112.99 -170.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -52.32 -37.24 55.38 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.172 0.989 . . . . 0.0 112.339 179.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.15 1.43 57.15 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.632 0.773 . . . . 0.0 112.664 -177.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 52.5 m -87.89 157.68 18.91 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 122.374 1.083 . . . . 0.0 112.204 -174.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 23.7 m -129.23 172.51 11.38 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 127.971 2.509 . . . . 0.0 104.894 167.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.5 ptmm? -58.41 -38.69 77.91 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 120.059 1.299 . . . . 0.0 111.264 -173.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -71.51 -17.12 62.35 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.87 -0.519 . . . . 0.0 111.884 -176.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -68.23 -27.05 66.03 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.69 0.796 . . . . 0.0 111.039 -175.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.3 mp -86.97 -40.19 15.01 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 123.445 0.698 . . . . 0.0 109.845 171.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -63.74 -20.93 66.14 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.275 0.63 . . . . 0.0 111.921 -175.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.36 -29.96 70.23 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.278 1.031 . . . . 0.0 112.456 174.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -96.88 151.46 19.65 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.438 1.095 . . . . 0.0 110.669 -177.194 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -87.25 -37.95 16.76 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.556 170.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 22.2 mt -110.54 136.44 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -177.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 74.8 mt -132.42 120.84 22.53 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 124.139 0.976 . . . . 0.0 108.558 -176.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.402 HD23 HG21 ' A' ' 22' ' ' ILE . 8.9 mp -109.67 107.39 17.42 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 105.534 -2.024 . . . . 0.0 105.534 177.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 68.0 mt -110.17 100.85 9.68 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -170.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.97 131.73 10.8 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 124.726 1.155 . . . . 0.0 110.247 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.1 tt -142.26 122.32 8.15 Favored Pre-proline 0 CA--C 1.54 0.595 0 CA-C-N 118.358 1.079 . . . . 0.0 110.215 -179.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -81.07 161.51 20.63 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 123.07 2.513 . . . . 0.0 109.33 169.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 62.2 m -118.46 141.52 48.48 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 173.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 64.9 m95 -134.6 173.84 11.21 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 124.913 1.285 . . . . 0.0 109.442 -177.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 28.73 64.2 0.11 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 127.546 2.338 . . . . 0.0 114.479 169.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 56.73 62.84 2.13 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.445 1.098 . . . . 0.0 111.66 175.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.53 14.87 72.52 Favored Glycine 0 CA--C 1.532 1.138 0 CA-C-N 115.952 -0.567 . . . . 0.0 114.274 171.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -78.07 143.55 37.3 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 124.869 1.268 . . . . 0.0 110.117 176.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -93.89 143.94 25.89 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.342 1.057 . . . . 0.0 109.027 169.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -58.9 146.41 37.74 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.979 0.419 . . . . 0.0 110.592 177.116 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 60.8 m -59.25 -33.04 70.55 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.169 0.988 . . . . 0.0 112.97 -168.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -66.44 -43.7 84.89 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.247 0.476 . . . . 0.0 109.901 -178.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -71.81 -43.16 66.1 Favored 'General case' 0 C--N 1.341 0.204 0 C-N-CA 123.02 0.528 . . . . 0.0 110.029 176.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -59.15 -41.56 88.61 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 118.358 0.526 . . . . 0.0 111.858 -178.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -69.3 -23.32 63.8 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.76 0.824 . . . . 0.0 112.095 176.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -90.09 -20.76 22.78 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 118.277 -0.868 . . . . 0.0 112.302 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -51.96 -41.49 79.79 Favored Pre-proline 0 CA--C 1.544 0.72 0 CA-C-O 116.706 -1.616 . . . . 0.0 114.577 178.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -65.21 -13.89 42.17 Favored 'Trans proline' 0 CA--C 1.544 0.983 0 CA-C-N 122.809 2.039 . . . . 0.0 114.073 174.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 30.5 m -93.42 -36.15 12.64 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.46 1.104 . . . . 0.0 109.803 169.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.462 ' HA ' HD12 ' A' ' 76' ' ' ILE . 25.9 tp -56.1 -40.14 73.23 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 124.225 1.01 . . . . 0.0 110.501 178.549 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -72.78 1.11 9.13 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 178.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -112.55 -7.27 13.9 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.455 1.025 . . . . 0.0 111.52 174.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.462 HD12 ' HA ' ' A' ' 73' ' ' LEU . 62.7 mt -75.18 139.86 18.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -177.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -75.4 117.33 17.08 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 171.244 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -109.95 6.38 23.12 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 118.191 -0.909 . . . . 0.0 111.183 173.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 -60.62 116.91 4.72 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 120.754 1.616 . . . . 0.0 109.281 -175.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 74.61 -1.29 52.94 Favored Glycine 0 CA--C 1.535 1.315 0 CA-C-O 118.307 -1.274 . . . . 0.0 113.935 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -67.68 137.25 55.4 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 120.039 1.919 . . . . 0.0 107.428 172.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 17.8 mt -89.24 129.33 35.83 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 172.148 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.1 t -129.64 136.24 59.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -175.108 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -129.81 147.47 51.58 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 125.115 1.366 . . . . 0.0 107.326 175.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 69.2 mt -120.34 148.51 43.65 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -176.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -143.5 157.53 44.36 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.229 0.612 . . . . 0.0 110.654 175.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -175.47 172.34 45.37 Favored Glycine 0 CA--C 1.525 0.714 0 CA-C-O 122.634 1.13 . . . . 0.0 112.3 -178.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 4.3 m -142.76 158.65 43.43 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.369 1.868 . . . . 0.0 106.749 -173.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -169.76 -174.5 38.09 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 120.072 -1.061 . . . . 0.0 114.961 -177.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -144.29 140.38 29.14 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 129.834 3.254 . . . . 0.0 104.473 177.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.15 16.49 1.19 Allowed 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.739 1.216 . . . . 0.0 112.104 -171.137 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -63.82 -48.62 76.08 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.653 0.66 . . . . 0.0 109.316 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -98.78 -30.4 12.44 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.035 0.534 . . . . 0.0 111.136 171.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -83.91 42.59 0.87 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.711 1.605 . . . . 0.0 110.298 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.46 -17.32 59.2 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 -167.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -108.88 5.46 24.49 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.801 0.841 . . . . 0.0 112.594 176.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -126.14 15.31 7.86 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.683 1.193 . . . . 0.0 113.015 -169.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -62.9 121.94 14.75 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 119.588 1.086 . . . . 0.0 109.528 -177.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 82.4 m 47.12 35.98 3.98 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.709 1.604 . . . . 0.0 112.303 -177.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -50.19 -42.69 51.74 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.026 1.33 . . . . 0.0 111.655 -173.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.78 -12.02 61.02 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -170.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 82.2 mt -56.94 -42.17 79.56 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 119.143 0.883 . . . . 0.0 109.614 169.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.0 -34.28 88.38 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 111.246 -0.742 . . . . 0.0 111.246 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 4.7 m -64.18 -41.84 96.94 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 117.95 0.875 . . . . 0.0 110.578 -178.346 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 8.5 mt -72.16 -47.09 55.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 176.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 50.5 tpt85 -57.62 -33.02 67.82 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.488 0.715 . . . . 0.0 112.119 -175.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -70.42 -29.68 66.35 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 123.432 0.693 . . . . 0.0 112.29 179.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 94.6 mt -90.68 -40.33 12.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 123.52 0.728 . . . . 0.0 110.142 -173.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 15.4 pt -74.32 -32.39 31.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 118.853 0.751 . . . . 0.0 111.991 -169.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -63.37 -53.89 48.97 Favored Pre-proline 0 CA--C 1.541 0.596 0 CA-C-O 117.363 -1.303 . . . . 0.0 112.26 -178.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -66.22 -24.6 51.0 Favored 'Trans proline' 0 C--N 1.352 0.739 0 CA-C-N 121.942 1.729 . . . . 0.0 112.223 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -77.69 0.92 21.58 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 118.718 0.69 . . . . 0.0 112.205 171.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 100.25 11.17 43.01 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-O 118.208 -1.329 . . . . 0.0 115.469 168.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.33 150.11 40.34 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 119.292 1.546 . . . . 0.0 111.475 178.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 62.0 m -104.99 123.91 48.61 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 105.482 -2.044 . . . . 0.0 105.482 167.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 12.3 mm -91.79 138.87 18.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 -171.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 27.1 m -136.86 173.33 13.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 124.751 1.22 . . . . 0.0 109.114 170.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 81.95 43.42 8.23 Favored Glycine 0 C--N 1.337 0.628 0 CA-C-O 119.229 -0.761 . . . . 0.0 114.719 169.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 20.4 p80 -62.57 158.2 18.68 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 118.265 1.032 . . . . 0.0 109.716 168.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 77.5 t-105 -141.33 131.35 12.95 Favored Pre-proline 0 CA--C 1.534 0.331 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -68.4 145.19 64.39 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 121.912 1.741 . . . . 0.0 112.117 -173.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 57.1 p -77.18 -30.39 54.85 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.119 0.568 . . . . 0.0 110.926 171.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 54.06 43.08 31.26 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.283 1.833 . . . . 0.0 110.667 -169.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.86 76.5 0.89 Allowed Glycine 0 C--N 1.339 0.718 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -176.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -49.69 131.2 21.66 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.074 0.55 . . . . 0.0 109.728 171.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -98.11 -26.68 14.5 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 -168.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -91.27 -171.57 3.0 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.437 0.695 . . . . 0.0 111.34 -168.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -67.9 -50.36 56.72 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 123.461 0.704 . . . . 0.0 111.727 -168.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -160.34 165.39 31.34 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 123.443 0.697 . . . . 0.0 110.332 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 2.4 p -152.91 135.55 15.27 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 169.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -88.36 -10.61 48.81 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 121.507 -0.746 . . . . 0.0 111.751 -173.385 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -77.82 -2.72 82.43 Favored Glycine 0 CA--C 1.531 1.065 0 CA-C-O 118.573 -1.126 . . . . 0.0 112.969 172.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 96.5 mt -66.51 133.29 50.06 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 120.171 1.986 . . . . 0.0 110.019 178.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -97.17 -33.82 11.35 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 166.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -145.58 162.77 36.69 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 127.378 2.271 . . . . 0.0 106.704 169.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -55.01 -28.01 48.76 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 118.942 0.792 . . . . 0.0 112.04 174.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -84.64 -19.68 32.54 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.468 1.107 . . . . 0.0 113.671 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 32.2 p-80 -153.31 137.63 16.62 Favored 'General case' 0 C--N 1.345 0.4 0 CA-C-O 123.064 1.411 . . . . 0.0 114.257 -176.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -73.05 154.09 40.59 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 125.436 1.494 . . . . 0.0 109.245 168.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 4.9 p -76.32 -18.07 15.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 124.546 1.138 . . . . 0.0 111.745 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -141.9 171.66 24.39 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 125.634 1.587 . . . . 0.0 109.373 177.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -59.03 130.15 45.61 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 172.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -139.4 95.81 2.99 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 178.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 9.5 pt -89.49 136.68 23.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-O 121.189 0.519 . . . . 0.0 111.811 -174.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -158.99 143.75 15.8 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 127.016 2.126 . . . . 0.0 107.682 173.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -153.87 101.78 2.47 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 172.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 23.5 t0 54.86 69.24 0.75 Allowed 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 122.676 1.227 . . . . 0.0 111.817 -174.033 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . 0.305 8.5 ptm180 58.24 6.9 0.58 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 128.298 2.639 . . . . 0.0 116.909 174.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -142.49 157.71 61.94 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-N 120.079 1.309 . . . . 0.0 108.333 175.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -73.93 114.02 3.93 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 121.789 1.66 . . . . 0.0 110.189 171.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -148.02 171.36 15.96 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 124.61 1.164 . . . . 0.0 108.481 167.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 18.1 mt 55.47 37.81 29.4 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.483 1.113 . . . . 0.0 109.032 -167.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 44.6 m -69.8 -48.18 60.06 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 126.118 1.767 . . . . 0.0 112.388 -168.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -60.85 -42.91 98.74 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -166.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -64.49 -37.87 89.04 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 118.319 0.509 . . . . 0.0 110.434 178.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 53.5 mtt85 -70.54 -44.48 67.41 Favored 'General case' 0 C--N 1.339 0.119 0 O-C-N 121.622 -0.674 . . . . 0.0 110.68 -178.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 22.5 m -73.79 -26.81 21.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 CA-C-O 118.523 -0.751 . . . . 0.0 110.613 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -62.0 -51.12 69.3 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 120.247 1.385 . . . . 0.0 109.13 170.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -58.43 -43.95 88.92 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 118.179 0.445 . . . . 0.0 110.542 179.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 73.2 t90 -67.02 -44.34 80.52 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 118.934 0.788 . . . . 0.0 110.689 -177.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 54.7 t -62.48 -38.95 82.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 55.8 mttm -66.7 -38.81 87.5 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.176 -0.952 . . . . 0.0 110.091 179.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 42.0 mm-40 -62.61 -50.94 69.25 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-N 118.538 0.608 . . . . 0.0 110.9 175.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 29.4 pt -64.7 -33.92 66.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-N 119.341 0.973 . . . . 0.0 109.973 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 57.6 m -61.76 -24.46 66.84 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 117.766 -1.111 . . . . 0.0 112.597 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -95.15 -11.32 28.35 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 120.317 1.417 . . . . 0.0 112.677 175.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -85.44 -40.03 16.87 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 119.183 0.901 . . . . 0.0 110.082 169.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 64.1 mt -84.64 -12.91 53.02 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.668 1.987 . . . . 0.0 111.609 -179.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 56.85 32.12 20.83 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.762 1.625 . . . . 0.0 112.419 -170.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 58.3 mt -75.88 -19.55 58.77 Favored 'General case' 0 C--N 1.342 0.258 0 O-C-N 121.752 -0.592 . . . . 0.0 110.733 169.143 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -59.78 -43.26 94.48 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 119.246 0.93 . . . . 0.0 110.377 -175.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -73.76 -6.64 48.18 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 179.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 38.9 mt -93.63 -48.61 13.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 171.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 3.4 pp -78.08 -27.88 48.63 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 -170.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -90.14 -7.01 54.72 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 118.922 0.783 . . . . 0.0 113.03 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.344 0 C-N-CA 123.31 0.644 . . . . 0.0 109.924 176.676 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.4 ttt . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.17 149.55 41.24 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.498 0.719 . . . . 0.0 110.516 175.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.0 pt -85.91 -27.09 6.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 123.087 0.555 . . . . 0.0 111.145 178.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 49.3 m -111.92 120.59 42.44 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.295 1.038 . . . . 0.0 109.318 -178.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -94.51 116.06 5.2 Favored Glycine 0 CA--C 1.52 0.376 0 N-CA-C 107.048 -2.421 . . . . 0.0 107.048 169.064 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 72.7 mt -95.21 97.1 6.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 104.852 -2.277 . . . . 0.0 104.852 176.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -91.71 137.83 32.05 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 176.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -136.93 159.48 41.74 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 123.592 0.757 . . . . 0.0 110.644 -176.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -131.31 147.47 18.55 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 107.739 -2.144 . . . . 0.0 107.739 167.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 29.6 m -168.44 143.02 3.36 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.375 1.588 . . . . 0.0 109.589 -179.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -91.07 -45.15 8.86 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 122.53 0.332 . . . . 0.0 111.001 170.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 82.5 p -107.47 9.13 29.7 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.014 0.926 . . . . 0.0 112.563 -175.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 79.72 13.34 82.51 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 124.128 0.87 . . . . 0.0 114.452 178.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -72.42 -46.17 56.31 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 119.515 1.658 . . . . 0.0 111.582 -177.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.5 m -74.32 -25.17 59.39 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 119.471 1.032 . . . . 0.0 109.896 179.397 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -58.64 -40.89 84.66 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.214 -0.929 . . . . 0.0 110.3 169.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -64.0 -36.6 84.52 Favored 'General case' 0 CA--C 1.532 0.282 0 O-C-N 121.48 -0.762 . . . . 0.0 110.905 178.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 29.6 mm -64.29 -45.99 94.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 174.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.21 -41.53 79.61 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.475 0.58 . . . . 0.0 111.215 178.054 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -67.86 -42.88 80.66 Favored 'General case' 0 N--CA 1.463 0.212 0 O-C-N 121.738 -0.601 . . . . 0.0 110.994 178.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.38 -23.37 64.66 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 119.248 0.931 . . . . 0.0 112.008 178.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 59.1 mt -71.22 -54.98 15.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 169.409 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -59.98 -38.16 81.72 Favored 'General case' 0 C--O 1.225 -0.234 0 CA-C-O 118.928 -0.558 . . . . 0.0 111.6 -173.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -59.13 -37.99 78.54 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 118.925 0.784 . . . . 0.0 110.885 -176.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -72.52 -39.93 67.2 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.101 0.561 . . . . 0.0 111.316 178.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.3 mp -75.17 -33.59 61.48 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.031 0.378 . . . . 0.0 111.131 -176.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.64 149.42 14.32 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.878 1.228 . . . . 0.0 110.93 -172.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -64.32 -28.47 69.73 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.884 0.873 . . . . 0.0 111.911 -173.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -66.87 -25.93 66.64 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.081 0.552 . . . . 0.0 111.426 178.09 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 39.3 t -100.75 -42.15 9.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 124.357 1.063 . . . . 0.0 109.999 -175.387 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -131.7 145.63 51.74 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 119.124 0.874 . . . . 0.0 111.584 -174.043 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -135.67 139.11 43.47 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 123.616 0.766 . . . . 0.0 109.777 178.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 92.9 t -101.99 135.07 40.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 C-N-CA 124.373 1.069 . . . . 0.0 109.523 -170.017 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 79.2 m-70 -141.31 137.08 32.17 Favored 'General case' 0 C--N 1.339 0.138 0 C-N-CA 124.62 1.168 . . . . 0.0 111.112 -173.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.31 131.6 43.67 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 168.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.6 tp -68.56 -33.52 60.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 O-C-N 121.551 -0.718 . . . . 0.0 111.402 -179.234 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.87 -40.24 94.82 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.98 0.809 . . . . 0.0 112.108 -169.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -75.27 -17.69 60.24 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 118.149 0.431 . . . . 0.0 112.038 178.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 53.1 m -75.84 163.63 27.04 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.444 0.64 . . . . 0.0 111.108 -169.148 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 47.1 m -127.33 168.45 14.78 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.159 1.383 . . . . 0.0 109.587 -175.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -52.05 -46.15 64.98 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.545 1.138 . . . . 0.0 111.756 -173.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -74.15 -14.4 60.95 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 122.823 0.449 . . . . 0.0 111.827 -173.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -78.82 -30.58 45.42 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 121.393 -0.817 . . . . 0.0 111.248 -170.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.2 mp -79.45 -39.18 32.89 Favored 'General case' 0 C--N 1.345 0.391 0 O-C-N 122.109 -0.37 . . . . 0.0 110.195 171.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -55.35 -28.52 54.39 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.266 1.027 . . . . 0.0 112.274 -176.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.44 -29.39 69.52 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.195 0.998 . . . . 0.0 113.438 -178.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -88.12 156.6 19.17 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.068 0.947 . . . . 0.0 110.591 -175.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -99.94 -32.32 11.03 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 123.056 0.542 . . . . 0.0 111.393 170.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.1 mp -108.77 128.16 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 172.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -114.7 128.23 56.2 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 170.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.2 mp -109.63 126.84 54.06 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 169.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 67.2 mt -123.18 118.23 27.16 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -169.112 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -111.66 102.66 1.44 Allowed Glycine 0 C--N 1.336 0.528 0 C-N-CA 125.464 1.507 . . . . 0.0 111.881 -170.2 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 17.3 tt -127.34 117.17 21.53 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 123.406 0.682 . . . . 0.0 112.165 -169.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -82.6 150.71 14.83 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 122.883 2.389 . . . . 0.0 110.321 168.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.8 m -96.83 137.98 35.08 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 178.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 19.9 m95 -133.15 175.27 9.53 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.166 1.386 . . . . 0.0 111.129 -171.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 51.06 -91.79 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 128.268 2.627 . . . . 0.0 113.445 -178.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -152.57 81.61 1.23 Allowed 'General case' 0 C--O 1.235 0.318 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 176.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 63.22 50.82 59.77 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 -175.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -121.28 154.15 36.75 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 124.583 1.153 . . . . 0.0 108.326 175.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -73.2 147.93 44.25 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.068 0.461 . . . . 0.0 110.387 169.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 16.2 tp60 -56.22 142.66 36.47 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 167.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 56.8 m -56.2 -32.05 64.03 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.05 0.94 . . . . 0.0 112.41 -170.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -57.08 -43.72 82.4 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 123.919 0.887 . . . . 0.0 110.491 178.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -81.94 -41.25 21.11 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 123.664 0.786 . . . . 0.0 110.579 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -58.01 -39.18 77.67 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.154 0.433 . . . . 0.0 111.325 -178.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -70.36 -25.85 63.46 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.466 0.706 . . . . 0.0 112.033 176.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -90.88 -23.28 20.57 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 118.613 -0.708 . . . . 0.0 112.567 -177.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 20.7 m-30 -49.36 -42.06 61.76 Favored Pre-proline 0 CA--C 1.542 0.652 0 CA-C-O 116.457 -1.735 . . . . 0.0 115.114 -178.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -64.32 -18.11 62.04 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 CA-C-N 122.934 2.084 . . . . 0.0 113.474 176.238 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 25.0 m -88.45 -42.4 12.16 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.095 0.958 . . . . 0.0 109.591 169.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 27.3 tp -55.8 -38.82 70.45 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.308 1.043 . . . . 0.0 111.284 -177.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -70.82 -7.75 47.59 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -178.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -95.2 -17.64 21.57 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 119.712 1.142 . . . . 0.0 111.739 171.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 97.6 mt -77.04 133.82 30.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 -173.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -82.35 140.01 33.76 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.023 0.929 . . . . 0.0 109.496 175.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -129.58 11.01 5.71 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 118.368 -0.825 . . . . 0.0 111.469 174.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -66.6 123.59 20.49 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 120.742 1.61 . . . . 0.0 109.621 -172.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.72 2.45 50.9 Favored Glycine 0 CA--C 1.537 1.443 0 CA-C-O 117.965 -1.464 . . . . 0.0 114.088 -174.206 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -79.81 150.25 30.77 Favored 'General case' 0 C--N 1.345 0.385 0 CA-C-N 120.222 2.011 . . . . 0.0 107.722 170.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 19.9 mt -91.71 137.45 32.36 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 171.225 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 16.0 t -133.73 142.73 40.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 177.086 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -134.3 151.0 51.02 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 170.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -113.54 145.71 40.79 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 124.367 1.067 . . . . 0.0 109.022 -174.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -143.42 159.03 43.14 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 166.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 179.31 177.4 47.69 Favored Glycine 0 N--CA 1.447 -0.598 0 O-C-N 121.184 -0.947 . . . . 0.0 113.282 -177.234 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 20.1 m -134.95 155.31 50.95 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.362 1.065 . . . . 0.0 109.533 -169.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -168.03 -176.09 38.26 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -177.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -132.15 110.85 10.96 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 172.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -75.22 -9.79 58.88 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 117.831 -1.081 . . . . 0.0 113.481 -168.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -110.44 -47.07 3.32 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 120.347 1.43 . . . . 0.0 110.673 -177.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -81.19 -22.27 39.02 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.993 -0.442 . . . . 0.0 111.619 -173.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -126.23 44.36 2.88 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.377 1.471 . . . . 0.0 109.047 172.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.34 -21.93 64.46 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.683 1.193 . . . . 0.0 113.829 -173.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -86.83 -2.47 58.6 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.791 0.836 . . . . 0.0 111.911 178.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -141.06 23.79 2.19 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.802 1.241 . . . . 0.0 110.968 -169.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -65.05 123.92 20.73 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 118.86 0.754 . . . . 0.0 110.713 -168.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 69.1 m 52.01 31.54 8.86 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.355 1.462 . . . . 0.0 112.981 178.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -57.51 -37.72 73.46 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.638 -0.663 . . . . 0.0 112.279 -178.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.35 -26.49 67.31 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -169.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.8 mp -62.38 -36.16 81.43 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.48 -0.763 . . . . 0.0 109.268 176.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -67.78 -29.21 73.58 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 123.651 0.643 . . . . 0.0 111.853 175.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.1 m -65.97 -36.71 84.07 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 118.801 1.301 . . . . 0.0 110.353 176.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 5.1 mt -68.69 -47.83 74.59 Favored 'Isoleucine or valine' 0 C--N 1.343 0.283 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 173.044 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 40.4 ttt-85 -49.89 -45.96 51.3 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 119.03 0.832 . . . . 0.0 111.037 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -60.36 -22.27 63.08 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.013 0.925 . . . . 0.0 112.759 -177.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 86.1 mt -96.2 -47.84 12.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 124.359 1.064 . . . . 0.0 109.681 178.106 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 30.4 pt -75.05 -31.44 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 119.464 1.029 . . . . 0.0 111.698 -170.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -66.81 -50.85 42.07 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-O 117.584 -1.198 . . . . 0.0 111.722 -176.057 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -67.6 -24.56 41.64 Favored 'Trans proline' 0 C--N 1.353 0.767 0 CA-C-N 122.079 1.778 . . . . 0.0 112.276 176.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 81.1 mmt-85 -75.23 6.33 4.51 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.619 0.768 . . . . 0.0 113.043 170.087 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 85.22 11.81 74.92 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-O 118.147 -1.363 . . . . 0.0 114.686 168.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -56.17 138.04 50.67 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 119.293 1.547 . . . . 0.0 110.433 174.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 61.7 m -90.13 118.99 30.09 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 104.392 -2.447 . . . . 0.0 104.392 167.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 47.5 mt -101.47 130.75 50.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 -170.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 34.6 m -133.03 173.89 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 125.093 1.357 . . . . 0.0 109.245 177.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 81.32 28.47 44.27 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-O 119.507 -0.607 . . . . 0.0 112.948 176.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 67.0 m80 -58.39 146.13 35.86 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 118.06 0.93 . . . . 0.0 109.593 170.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 59.2 t-105 -131.4 135.97 27.88 Favored Pre-proline 0 CA--C 1.534 0.343 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 -177.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -67.14 139.89 52.06 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.003 1.802 . . . . 0.0 110.859 -174.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.4 t -90.09 -16.84 28.85 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.459 0.704 . . . . 0.0 110.748 176.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 49.15 42.43 21.33 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.44 1.496 . . . . 0.0 111.598 -176.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 69.31 -6.26 4.47 Favored Glycine 0 CA--C 1.538 1.48 0 CA-C-O 117.69 -1.617 . . . . 0.0 115.502 -178.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . 0.285 52.6 p90 50.28 -25.56 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 131.551 3.941 . . . . 0.0 118.842 -178.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 37.1 t60 52.88 39.99 30.04 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.418 1.887 . . . . 0.0 113.256 173.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -140.41 -171.6 3.25 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.572 1.549 . . . . 0.0 108.601 175.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -69.01 -57.5 5.36 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 118.768 -0.634 . . . . 0.0 112.409 -168.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -158.35 119.83 3.51 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 119.224 0.92 . . . . 0.0 111.558 178.252 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 67.6 m -98.67 130.32 45.17 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 168.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -119.46 0.93 11.16 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 -169.002 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -81.99 6.7 65.68 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-N 118.62 0.646 . . . . 0.0 112.719 169.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 79.5 mt -64.83 142.16 58.53 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 118.586 1.193 . . . . 0.0 111.345 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -116.77 -16.89 10.61 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.999 1.32 . . . . 0.0 110.385 168.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -143.08 156.57 44.84 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 127.191 2.196 . . . . 0.0 106.126 173.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -54.76 -23.69 19.05 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.572 1.149 . . . . 0.0 113.707 -173.042 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -124.33 11.29 8.7 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.884 0.873 . . . . 0.0 113.334 177.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -138.42 129.36 26.83 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 120.52 -1.363 . . . . 0.0 112.096 -176.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -70.01 153.11 43.63 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.445 1.098 . . . . 0.0 109.048 168.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 9.7 p -62.44 -24.78 36.13 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 123.604 0.762 . . . . 0.0 111.244 173.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -157.9 179.4 33.65 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 123.557 0.599 . . . . 0.0 112.171 -169.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -70.92 110.01 5.4 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 123.56 0.744 . . . . 0.0 109.478 -178.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -89.41 121.66 31.87 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 167.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 11.1 tp -73.49 -32.69 37.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 120.267 -0.573 . . . . 0.0 111.221 -173.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -85.72 152.14 23.3 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.934 0.894 . . . . 0.0 110.139 175.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -153.62 18.85 0.54 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.217 1.407 . . . . 0.0 110.404 174.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -140.98 -63.07 0.47 Allowed 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.769 1.228 . . . . 0.0 109.515 -176.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -171.33 -32.09 0.02 OUTLIER 'General case' 0 C--O 1.225 -0.216 0 C-N-CA 126.776 2.03 . . . . 0.0 109.312 167.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 90.5 mm-40 -137.73 143.98 42.58 Favored Pre-proline 0 N--CA 1.449 -0.475 0 N-CA-C 105.078 -2.193 . . . . 0.0 105.078 171.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -61.02 133.64 48.4 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.368 2.046 . . . . 0.0 113.63 -167.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -118.07 162.53 18.04 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 126.535 1.934 . . . . 0.0 106.02 168.05 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 11.4 mt 59.39 22.71 11.17 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.669 0.788 . . . . 0.0 111.622 176.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 35.9 m -43.18 -61.13 1.41 Allowed 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 126.499 1.919 . . . . 0.0 112.737 -167.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -70.97 -35.84 72.3 Favored 'General case' 0 N--CA 1.452 -0.346 0 O-C-N 121.845 -0.535 . . . . 0.0 111.032 -169.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -72.72 -30.22 64.01 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.873 0.761 . . . . 0.0 111.278 178.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 74.1 mtp85 -63.3 -43.41 97.95 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 119.703 1.138 . . . . 0.0 109.515 172.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 66.2 t -66.03 -41.61 90.0 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.246 0 CA-C-O 118.325 -0.845 . . . . 0.0 109.023 178.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -59.94 -49.53 77.31 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 120.483 1.492 . . . . 0.0 110.487 176.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -61.84 -39.78 93.01 Favored 'General case' 0 N--CA 1.462 0.144 0 O-C-N 122.014 -0.428 . . . . 0.0 110.47 -176.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 60.9 t90 -70.73 -48.72 53.05 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 118.344 0.52 . . . . 0.0 110.642 178.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 55.6 t -60.77 -39.63 82.35 Favored 'Isoleucine or valine' 0 C--O 1.231 0.108 0 C-N-CA 123.041 0.536 . . . . 0.0 110.339 -175.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -68.0 -36.34 79.82 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 121.632 -0.668 . . . . 0.0 109.919 -177.162 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 46.8 mm-40 -67.73 -50.38 57.66 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 122.911 0.484 . . . . 0.0 110.677 174.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 6.3 pt -66.77 -31.87 55.47 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.313 0 CA-C-N 119.151 0.887 . . . . 0.0 110.937 -176.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 66.1 m -59.03 -37.39 76.83 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.316 0.962 . . . . 0.0 111.716 -179.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -83.69 -31.02 26.32 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 119.339 0.972 . . . . 0.0 111.788 178.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -68.4 -36.46 79.16 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 118.733 0.697 . . . . 0.0 110.783 176.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 76.9 mt -81.63 -3.3 53.1 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.881 1.673 . . . . 0.0 111.612 174.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . 0.324 1.3 p-80 50.12 19.11 0.45 Allowed 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 129.88 3.272 . . . . 0.0 114.719 -174.002 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 4.6 pp -78.25 -22.59 48.12 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 123.103 0.561 . . . . 0.0 111.505 176.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -55.29 -41.17 71.94 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.753 0.821 . . . . 0.0 109.729 168.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -73.18 -6.03 43.13 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.719 -0.613 . . . . 0.0 112.379 -179.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 56.6 mt -97.65 -54.85 6.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 124.651 1.181 . . . . 0.0 108.039 175.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.1 pp -85.83 -22.24 27.7 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -169.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 32.8 t30 -129.77 43.74 3.08 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.618 1.967 . . . . 0.0 108.169 -175.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.222 0 C-N-CA 123.687 0.795 . . . . 0.0 109.658 174.845 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.8 tpt . . . . . 0 N--CA 1.485 1.32 0 N-CA-C 110.368 -0.234 . . . . 0.0 110.368 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -57.75 151.98 16.49 Favored 'General case' 0 C--N 1.344 0.341 0 C-N-CA 123.922 0.889 . . . . 0.0 111.723 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.4 pt -119.65 -12.63 9.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 125.37 1.468 . . . . 0.0 111.537 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.1 m -114.58 127.03 55.57 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 125.35 1.46 . . . . 0.0 107.934 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -99.38 116.35 5.56 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 108.114 -1.994 . . . . 0.0 108.114 169.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 60.2 mt -92.55 119.96 41.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 N-CA-C 104.899 -2.259 . . . . 0.0 104.899 171.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -116.82 133.47 55.97 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 176.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -134.14 163.71 28.98 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 122.833 0.453 . . . . 0.0 111.591 -173.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -131.23 144.38 15.92 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 107.92 -2.072 . . . . 0.0 107.92 166.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 9.1 m -166.65 155.18 10.37 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-N 119.356 1.578 . . . . 0.0 110.127 176.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -115.61 -50.4 2.71 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.964 0.906 . . . . 0.0 109.841 167.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.6 p -86.92 8.43 23.15 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.819 1.248 . . . . 0.0 112.802 177.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 80.31 2.91 89.69 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 124.687 1.137 . . . . 0.0 115.609 169.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -70.2 -49.05 54.15 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 119.593 1.696 . . . . 0.0 112.375 -174.567 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 10.2 m -74.08 -26.62 60.48 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 120.546 1.521 . . . . 0.0 109.614 -178.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -60.48 -43.49 96.91 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.82 0.848 . . . . 0.0 110.157 169.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -64.69 -41.81 95.78 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 121.467 -0.771 . . . . 0.0 110.72 176.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 46.2 mm -59.29 -45.76 92.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-N 118.561 0.619 . . . . 0.0 109.332 175.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.65 -44.57 85.75 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.483 0.713 . . . . 0.0 110.952 178.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -66.52 -41.45 88.76 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 118.691 -0.671 . . . . 0.0 110.719 179.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 94.4 mtp -62.33 -40.3 95.89 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 119.531 1.059 . . . . 0.0 110.623 177.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 34.5 mt -63.33 -42.75 97.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 119.028 0.831 . . . . 0.0 109.152 175.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -59.71 -41.32 90.54 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 119.204 0.911 . . . . 0.0 110.921 177.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -64.53 -35.41 80.88 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 118.839 0.745 . . . . 0.0 110.463 178.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -67.72 -46.93 70.79 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.039 0.536 . . . . 0.0 110.697 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -76.77 -31.97 57.39 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 118.724 0.693 . . . . 0.0 111.523 -178.034 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.79 146.27 20.67 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 125.389 1.471 . . . . 0.0 110.798 -173.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -64.14 -28.78 70.0 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.949 0.9 . . . . 0.0 111.807 -174.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -78.58 -3.78 45.52 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 178.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 48.3 t -113.8 -38.13 2.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 124.791 1.236 . . . . 0.0 109.708 178.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -129.74 142.37 50.71 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 119.307 0.958 . . . . 0.0 111.741 -176.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -119.47 159.53 24.1 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.01 1.724 . . . . 0.0 108.493 172.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 48.4 t -133.46 130.22 56.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 C-N-CA 124.601 1.161 . . . . 0.0 109.515 -169.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -144.99 150.36 36.78 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.168 0.987 . . . . 0.0 111.625 174.31 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -72.45 134.84 45.55 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 166.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.2 tp -56.81 -32.33 38.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 118.697 0.68 . . . . 0.0 111.621 -173.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.65 -28.51 69.97 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.9 0.773 . . . . 0.0 112.243 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -82.06 -17.31 47.11 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.299 0.64 . . . . 0.0 110.597 178.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.9 t -75.52 174.17 10.03 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 122.117 0.961 . . . . 0.0 110.377 174.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.426 ' H ' ' HB3' ' A' ' 43' ' ' ASP . 21.3 m -145.53 167.09 23.87 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 127.726 2.41 . . . . 0.0 107.676 -177.56 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -52.68 -49.79 64.57 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.294 0.638 . . . . 0.0 110.843 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -76.0 -15.78 60.08 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 122.735 0.414 . . . . 0.0 111.701 -175.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.426 ' HB3' ' H ' ' A' ' 40' ' ' SER . 34.0 t70 -81.62 -37.05 28.19 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 121.685 -0.635 . . . . 0.0 110.233 -178.558 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.78 -43.65 88.14 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-N 118.345 0.52 . . . . 0.0 109.894 168.488 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -62.42 -20.98 65.05 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.4 0.68 . . . . 0.0 112.321 -177.02 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.25 -28.08 69.49 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.449 0.7 . . . . 0.0 112.009 177.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -103.47 138.45 40.17 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.559 1.144 . . . . 0.0 110.541 -176.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -88.39 -29.85 19.95 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.0 171.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.5 mm -106.4 128.76 60.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 178.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 88.6 mt -129.22 140.58 51.42 Favored 'General case' 0 CA--C 1.52 -0.208 0 C-N-CA 123.034 0.534 . . . . 0.0 109.809 -175.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -122.36 126.87 48.95 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 172.183 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 67.3 mt -121.07 122.02 39.16 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -173.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -117.75 103.92 1.11 Allowed Glycine 0 CA--C 1.524 0.609 0 C-N-CA 125.349 1.452 . . . . 0.0 112.45 -169.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 16.9 tt -127.17 111.98 21.56 Favored Pre-proline 0 CA--C 1.542 0.657 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -169.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -75.76 147.84 31.68 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 122.287 1.991 . . . . 0.0 108.983 167.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 44.3 m -95.62 137.18 35.05 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 176.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 23.9 m95 -134.49 172.04 13.47 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.655 1.182 . . . . 0.0 111.43 -173.014 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 58.55 -79.53 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 128.565 2.746 . . . . 0.0 113.663 172.459 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -152.18 51.41 0.79 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.843 2.057 . . . . 0.0 108.923 -171.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.42 37.87 62.47 Favored Glycine 0 CA--C 1.525 0.661 0 O-C-N 121.56 -0.713 . . . . 0.0 111.63 -174.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -115.5 160.0 20.49 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.506 1.123 . . . . 0.0 109.791 -175.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.7 160.54 29.26 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.471 169.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -75.52 155.98 35.57 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 168.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 59.7 m -55.41 -29.79 59.22 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.84 0.856 . . . . 0.0 112.381 -177.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -65.8 -42.37 90.76 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.094 0.558 . . . . 0.0 110.691 -177.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 80.1 m95 -76.25 -44.35 37.76 Favored 'General case' 0 C--N 1.341 0.226 0 C-N-CA 122.813 0.445 . . . . 0.0 110.094 174.129 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -62.41 -37.11 84.53 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.792 0.437 . . . . 0.0 111.939 -172.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -71.23 -21.69 62.09 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.542 0.737 . . . . 0.0 112.018 175.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -90.16 -23.86 21.21 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.459 0.703 . . . . 0.0 111.385 179.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -51.02 -42.43 79.96 Favored Pre-proline 0 CA--C 1.544 0.714 0 CA-C-O 116.627 -1.654 . . . . 0.0 114.784 178.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -64.24 -22.94 66.55 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 CA-C-N 122.954 2.091 . . . . 0.0 113.194 174.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.3 m -81.04 -38.0 28.16 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.049 0.94 . . . . 0.0 109.738 170.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 13.4 tp -59.84 -35.23 74.32 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.79 1.236 . . . . 0.0 110.928 -175.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -79.63 -4.46 51.72 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.053 0.941 . . . . 0.0 113.035 177.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -93.73 -24.95 17.64 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 119.612 1.097 . . . . 0.0 111.176 169.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 95.7 mt -67.92 137.6 24.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 -176.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -86.83 81.03 8.3 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -177.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -70.0 -5.42 26.28 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 118.381 -0.819 . . . . 0.0 112.843 -176.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 57.1 m-80 -53.44 117.94 3.47 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 119.609 1.095 . . . . 0.0 109.513 -179.141 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 82.44 -4.8 76.21 Favored Glycine 0 CA--C 1.533 1.165 0 CA-C-O 117.849 -1.528 . . . . 0.0 114.47 175.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -64.56 139.68 58.79 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 120.527 2.164 . . . . 0.0 107.894 169.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.7 mt -95.96 124.97 40.2 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 106.487 -1.672 . . . . 0.0 106.487 169.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.2 t -131.07 146.49 33.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -169.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -131.41 146.49 52.29 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 169.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.2 mt -112.59 142.53 45.06 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 124.211 1.005 . . . . 0.0 109.437 -177.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 24.8 p90 -138.51 155.97 47.93 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 168.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -168.77 169.15 41.58 Favored Glycine 0 N--CA 1.447 -0.586 0 O-C-N 121.469 -0.769 . . . . 0.0 111.654 -176.063 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 56.5 m -136.27 156.01 49.28 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.242 1.017 . . . . 0.0 109.192 -171.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -170.89 -167.26 30.99 Favored Glycine 0 CA--C 1.526 0.777 0 O-C-N 123.256 0.348 . . . . 0.0 112.601 -173.215 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -138.56 141.69 39.25 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 126.509 1.924 . . . . 0.0 109.176 177.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -110.89 -11.8 14.32 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.981 1.312 . . . . 0.0 111.889 -177.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -84.95 -31.68 23.46 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 118.416 0.553 . . . . 0.0 111.245 -168.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -128.33 -39.34 1.7 Allowed 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.348 0.659 . . . . 0.0 111.714 173.293 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -83.15 32.97 0.44 Allowed 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 118.419 0.554 . . . . 0.0 112.149 -177.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.27 -27.68 69.21 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.654 1.182 . . . . 0.0 113.259 -172.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -79.43 -0.2 31.98 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.023 0.929 . . . . 0.0 111.602 176.175 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -140.91 16.56 2.3 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 125.481 1.512 . . . . 0.0 110.621 -172.066 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -65.43 115.05 5.28 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 119.561 1.073 . . . . 0.0 108.788 -169.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 75.9 m 53.47 34.3 17.97 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.567 1.547 . . . . 0.0 113.178 -174.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -51.01 -43.66 60.87 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.75 1.22 . . . . 0.0 111.741 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.53 -14.93 63.37 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -169.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 67.5 mt -58.09 -41.62 83.88 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 118.866 0.757 . . . . 0.0 110.055 169.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -65.38 -32.97 85.29 Favored Glycine 0 C--N 1.339 0.744 0 N-CA-C 111.245 -0.742 . . . . 0.0 111.245 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.3 m -65.37 -37.23 86.4 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 118.229 1.015 . . . . 0.0 110.704 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 5.0 mt -73.56 -44.87 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 118.952 0.796 . . . . 0.0 108.97 174.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 35.9 ttt180 -53.28 -44.14 68.01 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 119.297 0.953 . . . . 0.0 110.608 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -61.92 -16.14 48.59 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.691 1.196 . . . . 0.0 113.035 -178.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 86.8 mt -101.0 -58.35 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 124.252 1.021 . . . . 0.0 109.095 173.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 20.1 pt -68.75 -32.98 57.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 O-C-N 121.144 -0.972 . . . . 0.0 112.142 -167.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -67.99 -53.4 20.16 Favored Pre-proline 0 CA--C 1.541 0.627 0 CA-C-O 117.671 -1.157 . . . . 0.0 111.242 -176.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -68.45 -23.45 37.67 Favored 'Trans proline' 0 C--N 1.353 0.786 0 CA-C-N 121.708 1.646 . . . . 0.0 112.83 175.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 30.9 mmm180 -74.41 -0.56 17.73 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 119.343 0.974 . . . . 0.0 112.17 170.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 94.0 14.69 51.26 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-O 118.558 -1.134 . . . . 0.0 114.999 168.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.26 144.34 57.02 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 119.183 1.492 . . . . 0.0 109.411 170.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 47.0 m -93.59 119.52 32.72 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 104.163 -2.532 . . . . 0.0 104.163 167.18 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 21.4 mt -100.56 130.75 49.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 107.016 -1.475 . . . . 0.0 107.016 -176.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.7 m -133.05 -172.88 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 125.549 1.539 . . . . 0.0 107.948 169.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 70.57 21.3 77.66 Favored Glycine 0 CA--C 1.529 0.963 0 O-C-N 120.979 -1.075 . . . . 0.0 111.572 -171.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 21.3 p-80 -59.19 133.12 55.81 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 168.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 70.7 t-105 -115.73 130.04 24.67 Favored Pre-proline 0 C--O 1.237 0.401 0 C-N-CA 124.573 1.149 . . . . 0.0 108.827 -167.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -67.37 139.58 50.09 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 121.51 1.473 . . . . 0.0 111.034 -175.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 2.1 t -89.97 -5.84 56.27 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.763 0.825 . . . . 0.0 111.917 -174.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 50.84 49.78 20.37 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.588 1.555 . . . . 0.0 112.516 173.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 84.44 -1.85 88.45 Favored Glycine 0 CA--C 1.533 1.185 0 CA-C-O 118.781 -1.01 . . . . 0.0 114.228 176.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 38.1 t80 54.83 -100.89 0.11 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.202 1.801 . . . . 0.0 112.811 174.273 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 35.4 t60 61.09 44.98 9.6 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.143 1.777 . . . . 0.0 113.713 -178.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -120.81 -176.88 3.35 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.957 1.303 . . . . 0.0 107.69 167.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -82.56 -56.24 3.99 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 121.405 -0.809 . . . . 0.0 111.874 -169.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -156.65 138.12 13.97 Favored 'General case' 0 C--N 1.343 0.3 0 CA-C-N 119.221 0.919 . . . . 0.0 111.32 173.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 58.4 m -142.03 107.04 4.92 Favored 'General case' 0 CA--C 1.521 -0.14 0 C-N-CA 125.35 1.46 . . . . 0.0 107.614 178.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -77.78 -10.63 59.65 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 122.702 0.401 . . . . 0.0 110.955 -171.315 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -78.28 -1.65 81.55 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-O 118.215 -1.325 . . . . 0.0 114.024 169.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 59.8 mt -63.05 122.49 16.2 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 120.96 2.38 . . . . 0.0 108.21 170.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -97.92 -26.91 14.5 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.248 1.019 . . . . 0.0 110.352 177.042 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -144.62 160.03 41.83 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.819 2.047 . . . . 0.0 106.769 175.18 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -55.18 -25.94 35.73 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.931 0.892 . . . . 0.0 112.822 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -111.08 -0.65 16.53 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.471 1.108 . . . . 0.0 113.701 179.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 -141.39 133.55 27.86 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 120.206 1.366 . . . . 0.0 113.426 -175.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -77.7 152.76 33.55 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 166.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 12.5 p -58.92 -28.58 38.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 123.913 0.885 . . . . 0.0 111.323 174.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -155.51 170.53 33.49 Favored Glycine 0 C--N 1.338 0.673 0 C-N-CA 123.957 0.789 . . . . 0.0 111.418 -170.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -60.93 126.48 27.51 Favored 'General case' 0 C--N 1.334 -0.073 0 C-N-CA 124.314 1.046 . . . . 0.0 109.176 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -108.69 121.36 44.87 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 172.24 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 1.2 tp -77.28 165.84 2.93 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 169.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 26.6 t70 71.98 148.3 0.09 Allowed 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 127.144 2.178 . . . . 0.0 113.482 -177.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -148.29 15.23 1.02 Allowed 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.405 1.482 . . . . 0.0 111.353 175.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -154.05 -75.5 0.12 Allowed 'General case' 0 CA--C 1.536 0.432 0 O-C-N 120.983 -1.073 . . . . 0.0 109.299 170.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 24.7 ttm180 -159.44 114.49 2.43 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 168.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 61.28 136.75 0.04 OUTLIER Pre-proline 0 CA--C 1.552 1.021 0 C-N-CA 127.197 2.199 . . . . 0.0 112.195 -172.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -72.56 145.61 42.38 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.154 1.903 . . . . 0.0 113.372 -169.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -127.63 -1.02 6.14 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.518 1.127 . . . . 0.0 111.51 169.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 88.5 mt -114.45 19.47 16.16 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.544 1.537 . . . . 0.0 110.639 -176.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 93.2 m -45.49 -53.74 8.46 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 125.892 1.677 . . . . 0.0 112.165 -169.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -68.45 -38.67 81.32 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 119.226 -0.416 . . . . 0.0 111.36 -169.088 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -73.74 -32.87 64.08 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 118.64 0.655 . . . . 0.0 110.805 178.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 51.9 mtp85 -67.17 -45.77 75.99 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-N 118.791 0.723 . . . . 0.0 109.603 178.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 23.7 m -71.5 -31.68 43.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-O 118.083 -0.96 . . . . 0.0 110.564 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -58.8 -56.83 17.15 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 120.378 1.445 . . . . 0.0 109.59 172.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -60.54 -34.39 74.06 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 122.992 0.517 . . . . 0.0 110.798 -175.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 33.1 t90 -77.86 -50.0 13.13 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 117.975 0.352 . . . . 0.0 110.796 -178.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 66.5 t -63.87 -32.41 56.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 O-C-N 120.782 -1.199 . . . . 0.0 110.151 -176.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -59.95 -35.91 75.95 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 117.981 -1.009 . . . . 0.0 111.566 175.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . 0.251 13.2 pt20 -75.71 -50.71 14.57 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 119.552 1.069 . . . . 0.0 111.012 171.694 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 1.4 pt -64.51 -32.07 56.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-N 120.096 1.316 . . . . 0.0 111.552 -169.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 6.3 p -61.43 -38.47 87.27 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 118.468 -0.777 . . . . 0.0 110.858 -178.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -82.7 -36.83 25.52 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 119.724 1.147 . . . . 0.0 111.38 175.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 63.1 mt-10 -70.59 -34.02 71.71 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 118.606 0.639 . . . . 0.0 111.749 -175.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 64.1 mt -86.71 1.23 52.8 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.008 1.323 . . . . 0.0 110.971 175.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 56.17 32.35 20.03 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.856 1.662 . . . . 0.0 112.984 -176.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 90.6 mt -76.92 -37.81 54.64 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.364 0.666 . . . . 0.0 109.584 173.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -58.93 -38.76 79.74 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.34 1.056 . . . . 0.0 110.337 178.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -65.2 -12.4 50.85 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.639 0.776 . . . . 0.0 112.561 179.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 85.4 mt -108.44 -54.16 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 124.802 1.241 . . . . 0.0 108.326 -179.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.2 pp -76.97 -25.03 52.33 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -172.053 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 58.3 t30 -120.62 32.09 6.15 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.193 1.797 . . . . 0.0 109.762 -175.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.271 0 C-N-CA 123.931 0.892 . . . . 0.0 109.597 173.957 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.5 ttp . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 110.384 -0.228 . . . . 0.0 110.384 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.31 150.95 42.06 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.877 -0.514 . . . . 0.0 110.305 172.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.8 pt -82.71 -19.33 10.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -174.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.8 m -115.09 127.39 55.58 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.203 1.401 . . . . 0.0 108.416 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -102.63 117.4 5.78 Favored Glycine 0 CA--C 1.52 0.394 0 N-CA-C 107.914 -2.074 . . . . 0.0 107.914 170.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 64.9 mt -96.29 93.83 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 176.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -88.37 132.83 34.28 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 177.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -130.64 128.62 41.34 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 119.207 0.912 . . . . 0.0 112.167 179.012 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -93.53 142.85 16.18 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 107.54 -2.224 . . . . 0.0 107.54 166.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.4 t -156.14 175.18 14.31 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 119.279 1.539 . . . . 0.0 109.285 172.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -122.09 -54.78 1.9 Allowed 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.041 0.537 . . . . 0.0 110.226 169.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.1 p -94.9 -0.37 54.04 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.144 0.978 . . . . 0.0 112.597 175.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 90.15 15.36 57.63 Favored Glycine 0 C--N 1.343 0.949 0 CA-C-O 118.963 -0.91 . . . . 0.0 114.256 169.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -68.28 -39.9 82.01 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 119.787 1.794 . . . . 0.0 110.526 175.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.79 -29.52 68.27 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 119.131 0.878 . . . . 0.0 111.346 175.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -64.41 -40.34 95.58 Favored 'General case' 0 C--N 1.343 0.285 0 CA-C-N 118.819 0.736 . . . . 0.0 109.604 176.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -65.31 -41.95 93.53 Favored 'General case' 0 CA--C 1.529 0.146 0 O-C-N 121.976 -0.453 . . . . 0.0 110.335 178.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 48.1 mm -60.17 -48.6 87.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 174.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.48 -43.37 98.98 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.42 0.688 . . . . 0.0 111.538 -178.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 54.7 mttm -63.69 -44.03 94.87 Favored 'General case' 0 C--N 1.338 0.106 0 CA-C-O 118.331 -0.842 . . . . 0.0 110.386 178.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 69.6 mtm -59.39 -47.64 84.69 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-N 119.2 0.909 . . . . 0.0 109.76 177.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 62.6 mt -57.19 -46.76 84.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -62.71 -40.57 97.56 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 119.503 1.047 . . . . 0.0 111.024 -179.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -63.25 -38.34 90.76 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 119.424 1.011 . . . . 0.0 110.723 177.121 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -69.51 -39.44 77.55 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.187 0.595 . . . . 0.0 110.813 178.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.1 mp -79.0 -35.43 42.89 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.921 0.889 . . . . 0.0 111.655 -176.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 94.43 145.3 17.95 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 125.236 1.398 . . . . 0.0 110.903 -171.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.1 ptpt -65.32 -28.71 69.5 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -172.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -68.22 -29.52 68.37 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 122.863 0.465 . . . . 0.0 111.011 176.438 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 49.1 t -91.21 -37.44 9.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 C-N-CA 124.186 0.994 . . . . 0.0 110.161 -175.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -135.78 146.33 47.49 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-N 119.285 0.948 . . . . 0.0 113.222 -174.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -130.66 144.9 51.74 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.713 1.205 . . . . 0.0 109.295 171.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 80.1 t -98.14 140.49 17.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.442 0 C-N-CA 124.078 0.951 . . . . 0.0 109.051 -174.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -149.22 172.82 14.22 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.677 1.191 . . . . 0.0 111.255 -169.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -141.64 127.05 18.77 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 126.973 2.109 . . . . 0.0 107.117 -173.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.6 tp -58.91 -31.41 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-O 118.831 -0.604 . . . . 0.0 111.231 -172.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.61 -26.47 68.41 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 118.698 0.681 . . . . 0.0 111.488 -177.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -89.56 -15.35 33.06 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.48 1.112 . . . . 0.0 111.516 177.036 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 53.0 p -84.38 175.88 9.06 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 118.76 0.709 . . . . 0.0 111.597 -174.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.2 m -137.55 167.44 21.66 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.651 1.58 . . . . 0.0 108.361 176.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -51.41 -48.48 62.64 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.884 0.874 . . . . 0.0 111.794 -177.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -81.55 -11.69 59.07 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 122.707 0.403 . . . . 0.0 111.608 -175.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -77.56 -31.15 53.0 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 121.399 -0.813 . . . . 0.0 111.457 -172.007 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.6 mp -68.34 -36.7 79.65 Favored 'General case' 0 C--N 1.344 0.348 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 172.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -69.88 -14.05 62.55 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.656 0.782 . . . . 0.0 111.988 -173.077 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.1 -30.13 68.36 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.738 0.815 . . . . 0.0 111.709 175.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -82.81 152.17 25.78 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 123.92 0.888 . . . . 0.0 110.211 178.125 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -92.0 -41.6 10.45 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.208 169.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 21.7 mt -108.25 130.74 60.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 92.3 mt -113.84 130.28 56.49 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 171.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.2 mp -111.64 115.87 29.85 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 104.52 -2.4 . . . . 0.0 104.52 169.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 64.6 mt -116.27 110.48 18.8 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -171.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -93.74 125.89 8.42 Favored Glycine 0 CA--C 1.521 0.427 0 N-CA-C 109.18 -1.568 . . . . 0.0 109.18 176.222 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 16.5 tt -139.28 133.07 15.89 Favored Pre-proline 0 CA--C 1.537 0.48 0 CA-C-N 118.842 1.321 . . . . 0.0 111.346 -177.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -92.41 153.86 3.03 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 122.408 2.072 . . . . 0.0 110.327 176.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.7 m -108.95 126.5 53.16 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 171.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 61.9 m95 -130.57 170.9 13.65 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 125.368 1.467 . . . . 0.0 109.063 178.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 44.23 49.12 7.82 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.351 1.861 . . . . 0.0 114.279 168.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 55.08 65.02 1.61 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.379 1.071 . . . . 0.0 111.06 176.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.85 47.68 5.5 Favored Glycine 0 CA--C 1.532 1.124 0 CA-C-N 115.854 -0.612 . . . . 0.0 113.219 171.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -128.48 157.74 40.3 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.177 1.391 . . . . 0.0 108.544 168.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -90.88 175.38 7.0 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.507 0.723 . . . . 0.0 109.925 170.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -62.39 146.84 50.25 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 107.942 -1.132 . . . . 0.0 107.942 169.261 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 62.3 m -56.77 -41.27 77.34 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -168.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -71.01 -40.31 71.88 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.238 0.926 . . . . 0.0 110.691 -178.011 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -62.38 -43.86 97.83 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.328 0.651 . . . . 0.0 110.135 175.599 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -61.9 -42.2 98.81 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 123.513 0.725 . . . . 0.0 110.79 178.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -68.63 -18.77 64.36 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.907 0.883 . . . . 0.0 112.309 176.408 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 29.7 t80 -86.04 -18.76 31.61 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 121.604 -0.685 . . . . 0.0 112.343 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -54.09 -43.03 96.41 Favored Pre-proline 0 CA--C 1.543 0.706 0 CA-C-O 116.807 -1.568 . . . . 0.0 114.138 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -63.75 -21.93 69.59 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 CA-C-N 122.475 1.92 . . . . 0.0 113.554 174.065 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.9 m -79.47 -40.28 30.18 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 119.57 1.077 . . . . 0.0 109.357 170.037 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 14.5 tp -59.63 -38.65 81.91 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.18 0.992 . . . . 0.0 110.955 -174.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -76.79 -4.77 45.21 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.698 0.799 . . . . 0.0 112.981 178.223 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 48.3 mm-40 -98.13 -18.6 18.41 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.188 0.995 . . . . 0.0 110.535 171.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 77.5 mt -77.68 148.93 6.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 172.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -115.97 133.13 56.35 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -117.12 15.79 15.0 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.632 0.773 . . . . 0.0 111.688 -172.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 33.2 m-80 -56.36 119.28 5.75 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 120.049 1.295 . . . . 0.0 109.319 177.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 79.83 -2.84 72.42 Favored Glycine 0 CA--C 1.535 1.327 0 CA-C-O 118.493 -1.171 . . . . 0.0 114.573 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -78.06 143.73 37.17 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 119.995 1.897 . . . . 0.0 107.209 173.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 14.5 mt -92.55 135.82 33.74 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 171.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 16.8 t -133.61 134.64 56.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -124.49 146.6 48.87 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 171.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 69.0 mt -118.92 147.48 43.96 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -174.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -142.26 159.71 41.69 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 168.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -171.41 159.47 31.2 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 119.343 -1.408 . . . . 0.0 115.347 -174.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 6.9 m -107.67 142.45 37.61 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 113.405 -1.397 . . . . 0.0 108.798 -170.103 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -170.89 174.88 44.74 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -178.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -144.71 122.87 12.17 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.774 0.83 . . . . 0.0 110.203 177.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -78.76 71.27 5.21 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.111 1.364 . . . . 0.0 109.234 174.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -131.06 -112.32 0.25 Allowed 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 173.015 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -72.93 -22.66 60.69 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 119.379 0.991 . . . . 0.0 111.94 -174.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -82.98 34.06 0.45 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.107 1.763 . . . . 0.0 111.163 -177.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.39 -23.2 65.62 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 -167.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -97.91 -1.66 42.41 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 118.937 0.789 . . . . 0.0 112.142 177.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -126.39 16.29 7.69 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.306 1.442 . . . . 0.0 111.354 -169.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -63.89 125.34 24.09 Favored 'General case' 0 C--O 1.236 0.358 0 O-C-N 121.593 -0.692 . . . . 0.0 110.172 -170.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 71.1 m 48.12 32.63 3.09 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.655 1.982 . . . . 0.0 113.723 -178.048 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -54.75 -34.72 62.92 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.587 0.755 . . . . 0.0 112.755 -178.324 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -62.87 -24.99 68.07 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -174.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 69.9 mt -58.69 -45.26 89.87 Favored 'General case' 0 C--N 1.344 0.337 0 O-C-N 121.497 -0.752 . . . . 0.0 109.965 173.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -65.01 -32.7 85.07 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.7 m -64.99 -36.01 83.02 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.25 1.025 . . . . 0.0 110.72 178.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 17.8 mt -69.54 -52.85 28.44 Favored 'Isoleucine or valine' 0 C--N 1.347 0.476 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 171.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 50.5 ttt180 -51.01 -47.13 61.67 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.341 0.656 . . . . 0.0 111.16 -172.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -61.91 -16.03 47.61 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.649 1.18 . . . . 0.0 112.806 -175.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 97.9 mt -100.83 -55.82 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 C-N-CA 124.268 1.027 . . . . 0.0 109.28 173.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 48.2 pt -67.56 -34.45 68.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 119.946 1.248 . . . . 0.0 112.284 -167.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -67.65 -53.21 22.98 Favored Pre-proline 0 CA--C 1.546 0.794 0 CA-C-O 117.71 -1.138 . . . . 0.0 110.701 -175.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -68.93 -23.33 34.84 Favored 'Trans proline' 0 C--N 1.353 0.801 0 CA-C-N 121.652 1.626 . . . . 0.0 112.928 174.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 31.3 mmm180 -77.39 8.94 3.59 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 119.482 1.037 . . . . 0.0 112.274 171.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 94.73 3.33 62.52 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-O 118.194 -1.337 . . . . 0.0 116.218 167.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.1 142.87 56.36 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 119.622 1.711 . . . . 0.0 110.075 177.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 57.8 m -88.61 119.5 29.12 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 104.798 -2.297 . . . . 0.0 104.798 168.347 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 19.7 mm -95.19 132.86 38.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 -171.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 19.3 m -137.93 171.53 15.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 124.979 1.312 . . . . 0.0 109.039 176.009 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 79.51 23.21 63.1 Favored Glycine 0 CA--C 1.526 0.775 0 CA-C-O 119.048 -0.862 . . . . 0.0 113.367 175.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 28.3 p-80 -61.23 135.99 57.91 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 168.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 39.0 t-105 -122.84 135.29 25.63 Favored Pre-proline 0 CA--C 1.533 0.315 0 C-N-CA 124.759 1.224 . . . . 0.0 108.249 -169.005 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -66.85 139.6 52.49 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 121.83 1.687 . . . . 0.0 111.316 -174.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 65.0 p -71.01 -27.08 63.43 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.018 0.527 . . . . 0.0 111.16 -178.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 52.2 48.43 22.69 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.713 1.605 . . . . 0.0 112.382 172.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 71.78 49.89 21.51 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.566 -0.613 . . . . 0.0 111.566 175.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 17.1 p90 -56.43 -39.7 73.54 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.302 0.641 . . . . 0.0 110.965 175.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 21.4 m-70 46.37 49.06 13.37 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.622 1.969 . . . . 0.0 112.298 170.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -117.82 170.04 9.12 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.789 1.236 . . . . 0.0 109.757 -179.002 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -57.46 -48.6 78.74 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 123.234 0.614 . . . . 0.0 110.96 -169.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -152.97 174.25 14.38 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 167.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 72.4 m -153.15 136.33 15.66 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 106.02 -1.844 . . . . 0.0 106.02 168.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -107.3 -0.28 22.62 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -172.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -88.09 5.53 84.7 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 124.13 0.872 . . . . 0.0 112.419 168.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 96.1 mt -67.52 134.26 50.97 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 118.982 1.391 . . . . 0.0 110.253 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -96.21 -34.45 11.65 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 166.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -145.88 161.28 40.38 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 128.152 2.581 . . . . 0.0 105.81 168.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -58.67 -25.19 62.54 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 120.627 -1.295 . . . . 0.0 112.112 178.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -92.04 -9.6 42.18 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.201 1.0 . . . . 0.0 113.347 176.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 63.1 m80 -143.39 123.63 13.78 Favored 'General case' 0 C--N 1.346 0.426 0 CA-C-N 120.216 1.371 . . . . 0.0 112.398 -175.308 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -73.34 152.16 41.0 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 166.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 9.3 p -64.29 -21.71 29.61 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 O-C-N 121.811 -0.556 . . . . 0.0 111.228 175.282 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -155.66 175.14 33.6 Favored Glycine 0 C--N 1.339 0.705 0 C-N-CA 123.792 0.71 . . . . 0.0 111.776 -172.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -71.94 104.02 3.38 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.809 0.844 . . . . 0.0 109.12 -177.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -79.41 133.04 36.55 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 169.227 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 17.4 pt -65.97 -32.43 58.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-N 119.591 1.087 . . . . 0.0 111.581 -178.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -106.88 154.19 21.41 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.986 1.315 . . . . 0.0 109.555 -174.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -153.47 10.91 0.44 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.255 1.422 . . . . 0.0 111.643 178.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -144.53 -67.39 0.33 Allowed 'General case' 0 C--N 1.341 0.235 0 C-N-CA 123.809 0.844 . . . . 0.0 109.71 173.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -168.65 112.24 0.57 Allowed 'General case' 0 C--O 1.237 0.445 0 C-N-CA 126.956 2.102 . . . . 0.0 105.797 169.163 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 58.41 149.01 0.07 OUTLIER Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 126.949 2.1 . . . . 0.0 113.416 -169.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -64.1 135.75 48.83 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.419 2.08 . . . . 0.0 111.193 178.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -124.24 -14.58 6.96 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.862 0.865 . . . . 0.0 111.895 172.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 75.2 mt -122.24 29.28 7.07 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.988 1.315 . . . . 0.0 110.353 -169.034 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 58.4 m -41.02 -54.44 2.78 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 127.516 2.326 . . . . 0.0 112.982 -169.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -76.8 -32.07 57.39 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -173.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -71.75 -38.84 70.33 Favored 'General case' 0 CA--C 1.529 0.157 0 O-C-N 121.913 -0.492 . . . . 0.0 109.939 178.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 74.1 mtp85 -66.49 -41.81 88.36 Favored 'General case' 0 N--CA 1.462 0.173 0 O-C-N 121.682 -0.637 . . . . 0.0 110.445 -178.098 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 34.4 m -70.39 -27.8 32.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 119.077 0.853 . . . . 0.0 111.195 177.191 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -65.49 -53.74 38.25 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 120.647 1.567 . . . . 0.0 109.583 172.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -61.63 -36.45 80.79 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 117.795 0.27 . . . . 0.0 110.888 -177.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 35.3 t90 -75.43 -46.64 31.46 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 118.178 0.445 . . . . 0.0 111.077 -178.009 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 42.5 t -59.89 -36.5 67.07 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.094 0 CA-C-N 118.581 0.628 . . . . 0.0 110.084 177.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -64.08 -40.84 97.14 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 117.937 -1.03 . . . . 0.0 110.654 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -69.27 -48.03 62.88 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 119.556 1.071 . . . . 0.0 110.659 175.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 7.5 pt -66.8 -29.82 47.64 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.333 0 CA-C-N 119.705 1.139 . . . . 0.0 110.759 -173.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 51.1 m -61.81 -29.29 70.06 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 117.877 -1.058 . . . . 0.0 112.459 176.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -92.16 -24.16 19.17 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 120.52 1.509 . . . . 0.0 111.641 175.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -73.02 -36.29 66.94 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 118.674 0.67 . . . . 0.0 110.794 174.412 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 66.1 mt -93.45 -9.16 39.48 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.349 1.86 . . . . 0.0 111.794 -179.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 39.2 m80 56.25 29.94 15.76 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.615 1.566 . . . . 0.0 112.911 -169.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 73.3 mt -72.22 -20.82 61.5 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 121.457 -0.777 . . . . 0.0 110.909 169.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -57.97 -38.25 75.71 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 118.951 0.796 . . . . 0.0 110.304 176.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -67.46 -11.27 57.48 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 121.507 -0.745 . . . . 0.0 112.423 178.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 49.9 mt -105.16 -55.88 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 124.911 1.284 . . . . 0.0 108.468 -178.251 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.5 pp -80.09 -23.78 41.04 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.091 0.556 . . . . 0.0 112.475 -172.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -122.18 34.85 5.04 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.99 1.716 . . . . 0.0 109.578 -176.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.142 0 C-N-CA 123.83 0.852 . . . . 0.0 109.511 174.202 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.8 ptt? . . . . . 0 N--CA 1.489 1.497 0 N-CA-C 111.627 0.232 . . . . 0.0 111.627 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -66.58 149.72 50.06 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.408 0.683 . . . . 0.0 109.821 174.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 31.0 pt -85.78 -22.69 7.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 123.393 0.677 . . . . 0.0 111.444 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 26.3 m -114.63 134.73 54.84 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.738 1.615 . . . . 0.0 109.09 -177.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -107.19 122.32 6.85 Favored Glycine 0 CA--C 1.52 0.401 0 N-CA-C 107.442 -2.263 . . . . 0.0 107.442 168.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 54.4 mt -100.62 91.69 2.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.14 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 176.141 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -88.16 130.33 35.08 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 -179.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 16.1 p90 -130.74 132.07 45.12 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 119.435 1.016 . . . . 0.0 112.338 179.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -86.54 149.76 22.87 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 168.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.8 m -167.9 157.78 10.17 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.936 1.368 . . . . 0.0 110.643 173.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -121.68 -52.89 2.0 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.953 0.901 . . . . 0.0 109.948 168.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.0 p -88.53 7.72 31.71 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.551 1.14 . . . . 0.0 112.733 174.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 84.92 -4.73 84.73 Favored Glycine 0 CA--C 1.533 1.174 0 N-CA-C 116.621 1.408 . . . . 0.0 116.621 168.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.88 -35.47 78.42 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 120.243 2.022 . . . . 0.0 113.696 -169.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 12.8 m -70.82 -17.29 62.76 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 119.524 1.056 . . . . 0.0 110.665 -175.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -60.19 -41.87 93.83 Favored 'General case' 0 C--N 1.342 0.278 0 O-C-N 121.118 -0.989 . . . . 0.0 110.338 175.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -64.42 -39.0 92.98 Favored 'General case' 0 C--N 1.339 0.127 0 O-C-N 122.072 -0.393 . . . . 0.0 110.306 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.0 mm -64.37 -46.37 93.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.72 -42.45 98.97 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.296 0.639 . . . . 0.0 111.531 178.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 54.8 mttm -64.57 -43.39 94.03 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 118.88 -0.581 . . . . 0.0 110.858 178.118 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 72.6 mtm -62.5 -39.64 94.15 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 119.169 0.895 . . . . 0.0 110.733 178.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 62.9 mt -60.11 -48.49 87.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 175.069 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -59.21 -39.61 83.2 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.803 0.729 . . . . 0.0 111.058 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -68.11 -36.43 79.75 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 119.432 1.014 . . . . 0.0 111.026 178.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 19.4 mm100 -65.78 -49.6 67.73 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.574 0.625 . . . . 0.0 111.529 -178.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.97 -8.22 34.34 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -175.637 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.42 143.3 12.22 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 125.119 1.342 . . . . 0.0 112.122 175.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.2 pttp -70.09 -23.64 63.09 Favored 'General case' 0 N--CA 1.469 0.489 0 O-C-N 121.584 -0.95 . . . . 0.0 113.082 -178.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -60.37 -34.74 74.3 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 122.985 0.514 . . . . 0.0 110.763 171.243 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 62.1 t -83.69 -42.48 17.42 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-O 118.001 -0.999 . . . . 0.0 110.136 178.005 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -132.77 147.08 52.31 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-N 119.838 1.199 . . . . 0.0 114.182 -170.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -120.97 140.87 51.29 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 123.831 0.852 . . . . 0.0 109.696 169.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 94.6 t -85.97 139.26 17.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -147.01 170.65 16.67 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.29 1.036 . . . . 0.0 111.881 -168.169 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -145.65 125.19 13.2 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 125.79 1.636 . . . . 0.0 108.641 -170.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.4 tp -63.08 -29.14 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-O 118.967 -0.54 . . . . 0.0 111.747 -171.363 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.03 -28.44 69.49 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 118.945 0.793 . . . . 0.0 111.692 -176.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -101.27 -7.21 23.24 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.674 0.79 . . . . 0.0 112.299 175.224 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 42.5 m -75.43 171.48 14.18 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 123.649 0.78 . . . . 0.0 110.547 177.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 14.1 m -139.26 160.53 39.6 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.819 1.248 . . . . 0.0 108.875 178.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -53.79 -46.85 71.15 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.073 0.949 . . . . 0.0 111.455 -174.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -80.92 -15.26 56.77 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 122.571 0.349 . . . . 0.0 111.551 -176.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -77.95 -29.71 50.02 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 121.439 -0.788 . . . . 0.0 111.213 -175.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -59.41 -41.5 89.6 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.111 0.564 . . . . 0.0 109.709 169.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -72.96 -13.17 61.19 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.637 0.775 . . . . 0.0 112.315 -170.236 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.71 -30.56 70.1 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.446 0.698 . . . . 0.0 111.91 176.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -82.37 155.96 24.45 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.99 0.916 . . . . 0.0 110.284 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -104.49 -24.3 13.04 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.821 169.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.3 mp -118.37 127.93 75.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 176.253 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -114.63 119.71 37.66 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 175.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.9 mp -105.98 117.95 35.34 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 105.282 -2.118 . . . . 0.0 105.282 169.169 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 66.9 mt -119.99 108.38 14.23 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 -169.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.81 120.32 6.52 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 125.679 1.609 . . . . 0.0 109.708 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.0 tt -134.24 112.29 12.07 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 118.104 0.952 . . . . 0.0 110.466 -176.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -74.83 143.69 29.98 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.391 2.061 . . . . 0.0 109.202 169.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 30.3 m -96.41 136.65 36.62 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 174.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 63.7 m95 -134.45 171.91 13.64 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 124.754 1.222 . . . . 0.0 109.992 -178.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 42.7 46.42 4.38 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 127.016 2.127 . . . . 0.0 114.285 167.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 57.46 69.43 0.74 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.509 1.124 . . . . 0.0 111.323 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.52 33.33 22.6 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 115.629 -0.714 . . . . 0.0 113.94 169.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -119.53 164.5 15.72 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 125.399 1.48 . . . . 0.0 109.632 175.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -96.53 170.88 8.91 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 123.983 0.913 . . . . 0.0 108.791 168.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 47.1 mm-40 -70.02 148.85 48.34 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 169.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 58.6 m -59.47 -35.18 73.59 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -168.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -72.29 -29.14 63.6 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.249 0.619 . . . . 0.0 111.469 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -78.84 -44.92 21.92 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.963 0.905 . . . . 0.0 109.349 175.186 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -60.42 -41.35 93.77 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.33 1.052 . . . . 0.0 111.228 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -62.66 -21.77 65.96 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.087 0.955 . . . . 0.0 112.269 178.217 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -85.01 -18.93 32.91 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 117.875 -1.06 . . . . 0.0 112.227 178.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -55.65 -42.75 97.65 Favored Pre-proline 0 CA--C 1.541 0.615 0 CA-C-N 121.243 1.838 . . . . 0.0 114.116 -179.121 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.28 -14.28 44.24 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 CA-C-N 122.603 1.965 . . . . 0.0 113.714 174.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.1 m -88.72 -42.62 11.84 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 119.195 0.907 . . . . 0.0 109.227 169.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 18.3 tp -56.62 -38.22 71.79 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 124.998 1.319 . . . . 0.0 110.841 -177.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -71.78 -1.18 13.13 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -105.97 -11.95 15.99 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.497 1.044 . . . . 0.0 111.872 172.277 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 98.5 mt -81.63 140.97 15.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -175.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -87.44 133.63 33.72 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 123.464 0.706 . . . . 0.0 110.133 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -126.57 15.03 7.62 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.962 0.905 . . . . 0.0 111.612 174.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 17.0 m-80 -58.73 116.12 3.51 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 119.987 1.267 . . . . 0.0 109.886 -174.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.78 1.19 58.21 Favored Glycine 0 CA--C 1.533 1.175 0 CA-C-O 118.567 -1.13 . . . . 0.0 113.803 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -74.86 147.61 40.94 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 119.628 1.714 . . . . 0.0 107.835 172.037 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 14.9 mt -88.77 136.04 33.21 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 174.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.2 t -132.44 139.97 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.263 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -136.71 141.56 43.08 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 175.141 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 62.1 mt -112.62 148.16 35.17 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -173.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -144.42 168.15 20.8 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 169.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -179.53 176.09 47.42 Favored Glycine 0 N--CA 1.447 -0.577 0 CA-C-O 122.174 0.875 . . . . 0.0 113.0 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 24.4 m -129.53 152.58 48.91 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 125.727 1.611 . . . . 0.0 107.737 -171.085 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -169.8 -173.79 37.55 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -177.082 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -147.56 166.89 25.95 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 168.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -111.47 -6.39 14.45 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.725 1.61 . . . . 0.0 111.996 -171.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -59.45 -48.25 82.35 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 123.626 0.77 . . . . 0.0 111.787 -169.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -138.18 1.99 2.27 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -173.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -111.38 27.83 9.31 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.39 1.076 . . . . 0.0 111.396 -169.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.13 -17.38 64.67 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 -169.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -94.64 -0.61 54.29 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.62 1.168 . . . . 0.0 111.995 174.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -139.08 22.61 2.6 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 125.762 1.625 . . . . 0.0 110.283 -170.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -70.76 121.03 17.24 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -169.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 74.0 m 48.3 38.92 11.22 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.617 1.167 . . . . 0.0 111.679 -177.053 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -61.95 -38.81 89.89 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.466 1.106 . . . . 0.0 112.061 -172.053 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.15 -21.34 66.33 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 114.136 1.162 . . . . 0.0 114.136 -168.125 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 7.1 mp -61.28 -35.22 76.72 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 119.766 1.166 . . . . 0.0 110.22 175.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.37 -33.48 86.35 Favored Glycine 0 CA--C 1.531 1.039 0 N-CA-C 111.318 -0.713 . . . . 0.0 111.318 177.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.2 m -65.05 -37.3 87.13 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 117.774 0.787 . . . . 0.0 110.361 177.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 6.0 mt -70.31 -49.15 56.34 Favored 'Isoleucine or valine' 0 C--N 1.343 0.319 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 173.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 55.8 ttt-85 -51.31 -47.21 62.68 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 118.617 0.644 . . . . 0.0 110.563 -176.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -63.23 -22.92 67.18 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.114 0.966 . . . . 0.0 112.914 -175.183 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 96.9 mt -91.63 -44.6 14.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 123.666 0.786 . . . . 0.0 109.379 177.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 22.4 pt -74.78 -29.43 22.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-N 118.999 0.818 . . . . 0.0 111.617 -171.109 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -62.03 -56.22 33.63 Favored Pre-proline 0 CA--C 1.543 0.685 0 CA-C-O 117.74 -1.124 . . . . 0.0 112.063 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -66.16 -21.79 54.96 Favored 'Trans proline' 0 C--N 1.351 0.701 0 CA-C-N 121.769 1.668 . . . . 0.0 112.612 178.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 73.0 mmt-85 -82.07 9.46 8.44 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.99 0.916 . . . . 0.0 112.841 172.105 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 77.51 16.16 80.62 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-O 118.367 -1.24 . . . . 0.0 114.877 168.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -59.63 144.66 47.14 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 119.036 1.418 . . . . 0.0 110.355 170.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 44.6 m -95.29 119.94 34.66 Favored 'General case' 0 C--N 1.333 -0.123 0 N-CA-C 104.663 -2.347 . . . . 0.0 104.663 167.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 15.8 mt -100.86 127.54 53.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 -171.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 31.8 m -137.44 178.23 4.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 124.983 1.313 . . . . 0.0 109.285 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 78.83 36.51 28.56 Favored Glycine 0 CA--C 1.527 0.835 0 O-C-N 121.912 -0.493 . . . . 0.0 111.976 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 68.3 m80 -63.22 142.6 58.33 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 117.615 0.707 . . . . 0.0 109.153 172.006 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 75.2 t-105 -123.58 129.49 24.83 Favored Pre-proline 0 CA--C 1.534 0.357 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 -174.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -67.74 144.23 64.76 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 121.437 1.425 . . . . 0.0 112.129 -170.022 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 71.6 p -76.91 -27.27 54.87 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.614 0.766 . . . . 0.0 111.136 177.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 52.73 42.9 31.84 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.655 1.582 . . . . 0.0 111.807 -178.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 71.4 55.23 7.85 Favored Glycine 0 C--N 1.34 0.769 0 N-CA-C 111.138 -0.785 . . . . 0.0 111.138 178.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -57.98 151.74 17.8 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 122.884 0.474 . . . . 0.0 110.265 174.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 33.0 p80 -128.83 9.44 5.86 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.932 0.893 . . . . 0.0 112.53 -177.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -74.95 162.89 28.19 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.331 1.053 . . . . 0.0 110.142 -175.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -71.19 -44.26 65.79 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 122.012 -0.43 . . . . 0.0 110.843 -170.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -160.08 134.05 7.26 Favored 'General case' 0 C--N 1.342 0.241 0 C-N-CA 124.384 1.074 . . . . 0.0 109.259 173.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 13.5 m -129.1 103.08 6.78 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 106.914 -1.514 . . . . 0.0 106.914 177.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.59 -10.86 60.14 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 120.95 -1.094 . . . . 0.0 111.795 -170.079 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -74.63 -0.56 59.16 Favored Glycine 0 CA--C 1.535 1.319 0 CA-C-O 118.637 -1.091 . . . . 0.0 113.412 169.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 43.7 mt -63.41 131.49 48.4 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 120.583 2.192 . . . . 0.0 109.503 174.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -100.77 -32.79 10.53 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.176 0.99 . . . . 0.0 109.323 169.033 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -149.49 161.78 41.44 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 127.313 2.245 . . . . 0.0 107.103 174.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -53.06 -31.78 43.4 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.328 0.651 . . . . 0.0 112.389 176.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -93.38 -11.33 32.52 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.284 1.034 . . . . 0.0 113.335 -178.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 10.9 m-70 -146.92 128.98 15.54 Favored 'General case' 0 C--N 1.346 0.431 0 CA-C-N 119.76 1.163 . . . . 0.0 113.729 -170.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -77.49 155.57 31.59 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 166.457 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.4 p -66.12 -22.86 30.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 C-N-CA 123.972 0.909 . . . . 0.0 111.642 178.202 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -158.93 169.99 35.29 Favored Glycine 0 C--N 1.338 0.659 0 CA-C-N 118.471 0.578 . . . . 0.0 112.314 -169.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -69.35 111.97 5.6 Favored 'General case' 0 CA--C 1.521 -0.144 0 C-N-CA 124.452 1.101 . . . . 0.0 109.496 -175.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -92.38 121.98 34.39 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 169.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 7.3 pt -71.08 -30.02 39.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-N 118.66 0.664 . . . . 0.0 111.276 178.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -84.32 158.59 21.13 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 118.275 0.488 . . . . 0.0 110.588 177.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -126.39 -65.16 0.99 Allowed 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 169.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -152.88 116.42 4.72 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.072 0.949 . . . . 0.0 109.588 177.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 3.5 tpm_? 48.6 95.21 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 127.776 2.43 . . . . 0.0 112.568 173.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 66.99 138.0 0.05 OUTLIER Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 126.708 2.003 . . . . 0.0 110.683 -168.095 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -70.13 -54.0 0.22 Allowed 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 121.604 1.536 . . . . 0.0 114.54 -167.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 57.56 174.13 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.345 1.458 . . . . 0.0 110.913 -167.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 20.7 mt 57.28 26.31 12.19 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.953 0.901 . . . . 0.0 111.986 172.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 38.8 m -46.31 -53.08 11.46 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 127.163 2.185 . . . . 0.0 112.913 -167.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -82.07 -40.54 21.83 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 119.395 -0.336 . . . . 0.0 111.038 -174.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -67.65 -28.15 67.47 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.026 0.83 . . . . 0.0 111.856 -173.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 59.6 mtp85 -62.77 -45.46 92.58 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 118.718 0.69 . . . . 0.0 110.021 175.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 17.3 m -74.34 -31.03 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-O 117.706 -1.14 . . . . 0.0 111.274 177.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -58.33 -52.07 67.14 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 120.99 1.723 . . . . 0.0 109.406 173.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -62.49 -37.79 87.37 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 122.724 0.41 . . . . 0.0 110.654 -179.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 59.2 t90 -74.91 -44.49 48.4 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 118.278 0.49 . . . . 0.0 111.644 -175.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 77.8 t -64.22 -34.0 66.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -61.25 -35.85 78.4 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 121.261 -0.899 . . . . 0.0 111.4 175.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -63.44 -55.99 19.8 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 119.177 0.899 . . . . 0.0 110.294 175.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 9.8 pt -67.08 -28.59 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 O-C-N 122.12 -0.363 . . . . 0.0 110.351 -173.071 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 64.2 m -60.77 -23.74 65.23 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 118.377 -0.821 . . . . 0.0 112.489 177.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -82.96 -31.9 27.37 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 119.927 1.24 . . . . 0.0 111.055 175.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -80.07 -38.31 32.03 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.713 0.805 . . . . 0.0 110.621 -178.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 5.4 mp -88.9 -3.7 58.67 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.448 1.899 . . . . 0.0 110.886 -179.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 55.63 32.85 20.06 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.847 1.659 . . . . 0.0 112.689 -174.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 47.1 mt -75.79 -19.5 58.92 Favored 'General case' 0 N--CA 1.467 0.389 0 O-C-N 121.787 -0.57 . . . . 0.0 110.519 172.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -56.81 -38.6 72.82 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.707 0.685 . . . . 0.0 110.267 175.173 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -67.49 -13.16 61.79 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 121.537 -0.727 . . . . 0.0 112.422 178.028 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 38.1 mt -99.36 -56.66 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 125.0 1.32 . . . . 0.0 108.432 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.8 pp -84.46 -22.41 30.31 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 123.554 0.742 . . . . 0.0 112.71 -169.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -121.59 35.68 4.82 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.826 1.651 . . . . 0.0 109.671 -176.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.096 0 C-N-CA 123.788 0.835 . . . . 0.0 109.504 174.697 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.8 mmm . . . . . 0 N--CA 1.489 1.481 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -60.53 145.07 49.92 Favored 'General case' 0 C--N 1.344 0.345 0 C-N-CA 123.434 0.693 . . . . 0.0 111.282 -178.219 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 32.4 pt -109.94 -20.53 6.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 125.189 1.396 . . . . 0.0 111.239 178.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 44.5 m -105.85 128.16 53.58 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.736 1.214 . . . . 0.0 108.146 174.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -99.82 116.19 5.51 Favored Glycine 0 CA--C 1.519 0.313 0 N-CA-C 107.198 -2.361 . . . . 0.0 107.198 169.035 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 46.6 mt -90.63 122.59 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 104.135 -2.543 . . . . 0.0 104.135 171.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -118.19 132.8 56.3 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 174.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -132.9 158.42 42.63 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 118.345 0.521 . . . . 0.0 111.187 -174.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -132.73 154.36 21.08 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 108.091 -2.003 . . . . 0.0 108.091 167.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 16.3 m -163.7 163.51 24.17 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 119.212 1.506 . . . . 0.0 109.491 -175.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -137.98 -52.53 0.62 Allowed 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.667 0.787 . . . . 0.0 110.379 171.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.9 p -77.52 -14.73 59.6 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.237 0.615 . . . . 0.0 111.753 170.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 104.98 8.21 36.93 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.014 1.292 . . . . 0.0 113.961 169.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -66.55 -54.29 25.26 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 119.02 1.41 . . . . 0.0 111.927 -173.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.3 m -75.78 -18.38 59.55 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 122.027 -0.421 . . . . 0.0 111.515 -166.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -59.72 -46.78 88.08 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 167.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 33.2 t30 -68.3 -39.67 81.98 Favored 'General case' 0 C--N 1.339 0.122 0 O-C-N 121.864 -0.523 . . . . 0.0 110.305 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 49.8 mm -59.48 -45.16 94.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 118.738 0.699 . . . . 0.0 109.265 175.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.73 -40.61 95.69 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.753 0.706 . . . . 0.0 111.174 178.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -64.18 -42.49 96.67 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-O 118.823 -0.608 . . . . 0.0 110.826 176.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 98.8 mtp -63.82 -44.37 93.43 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 119.35 0.977 . . . . 0.0 110.464 177.168 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 69.9 mt -57.26 -47.57 84.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 176.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.403 ' NE2' ' HA ' ' A' ' 32' ' ' ASP . 27.3 tt0 -58.29 -42.97 87.78 Favored 'General case' 0 CA--C 1.53 0.2 0 O-C-N 121.467 -0.771 . . . . 0.0 111.157 176.697 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -64.0 -35.93 82.32 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 119.416 1.007 . . . . 0.0 110.683 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -69.21 -45.52 69.67 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.286 0.635 . . . . 0.0 110.936 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -79.88 -30.09 40.12 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.031 0.832 . . . . 0.0 112.101 -178.117 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.73 145.26 16.13 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 125.008 1.29 . . . . 0.0 110.699 -170.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.9 tttm -65.04 -31.01 72.02 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 121.889 -0.771 . . . . 0.0 111.799 -170.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -77.6 -7.06 55.8 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.063 0.545 . . . . 0.0 112.069 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 49.0 t -104.67 -43.21 7.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 124.254 1.022 . . . . 0.0 109.258 174.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -134.46 134.11 41.18 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 119.478 1.036 . . . . 0.0 111.491 -175.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.403 ' HA ' ' NE2' ' A' ' 23' ' ' GLN . 15.5 t70 -123.94 148.55 46.8 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 175.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 59.5 t -106.42 140.07 25.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 124.477 1.111 . . . . 0.0 111.158 -168.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -139.64 144.18 37.55 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.811 1.644 . . . . 0.0 109.847 177.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -83.92 126.25 32.82 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 169.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 11.0 tp -58.54 -31.23 43.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -171.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.72 -29.83 67.31 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.985 0.811 . . . . 0.0 112.024 -177.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 47.4 mtmt -76.54 -33.3 58.56 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 118.206 0.457 . . . . 0.0 110.835 177.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 57.7 m -70.77 165.01 23.98 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.678 1.191 . . . . 0.0 112.248 -174.128 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.5 m -133.04 174.59 10.2 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.225 1.81 . . . . 0.0 109.146 -176.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -49.05 -54.26 16.7 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.288 1.035 . . . . 0.0 111.655 -173.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -76.27 -11.83 59.98 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 122.473 0.309 . . . . 0.0 111.758 -170.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -71.22 -33.85 70.29 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 121.882 -0.512 . . . . 0.0 110.766 -174.275 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 8.4 mp -74.3 -38.75 63.26 Favored 'General case' 0 C--N 1.342 0.279 0 C-N-CA 122.594 0.358 . . . . 0.0 110.109 171.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -67.06 -18.14 65.21 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 122.898 0.479 . . . . 0.0 112.126 -169.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.92 -28.98 69.91 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.482 1.113 . . . . 0.0 112.527 173.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -96.16 156.94 16.12 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.147 0.979 . . . . 0.0 111.048 -175.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -99.5 -29.39 12.75 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.31 0.644 . . . . 0.0 111.514 170.082 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.0 mp -110.76 127.69 67.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 174.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -115.52 135.16 54.37 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 174.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.5 mp -118.74 114.13 22.23 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 172.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 51.6 mt -112.47 112.4 23.92 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 -169.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -102.58 103.4 2.43 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 125.404 1.478 . . . . 0.0 111.075 -173.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 14.6 tt -127.72 119.39 21.42 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 124.123 0.969 . . . . 0.0 111.077 -169.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -76.29 150.31 32.62 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 121.909 1.739 . . . . 0.0 110.501 170.162 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 19.1 m -98.3 140.78 32.07 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 169.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 42.4 m95 -136.2 174.38 10.67 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.718 1.607 . . . . 0.0 109.479 -178.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.458 ' CE1' HM73 ' A' ' 201' ' ' FMN . 75.5 m-85 21.52 82.27 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 128.476 2.71 . . . . 0.0 114.702 169.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 57.49 49.52 12.69 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.937 0.895 . . . . 0.0 111.927 172.182 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 81.03 19.0 68.27 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 123.743 0.687 . . . . 0.0 113.541 170.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -88.48 156.13 19.28 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 124.316 1.046 . . . . 0.0 110.162 178.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.97 144.5 34.69 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 169.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -59.93 149.28 32.24 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 169.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 75.4 m -61.04 -25.84 67.21 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -168.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 39.4 p30 -68.45 -36.39 78.93 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.474 0.71 . . . . 0.0 111.848 178.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -80.36 -41.43 24.72 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 118.695 0.68 . . . . 0.0 111.091 171.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -60.98 -39.34 89.25 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.505 0.593 . . . . 0.0 111.533 -176.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -67.4 -20.82 65.59 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.358 0.663 . . . . 0.0 112.168 175.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -94.43 -20.9 19.29 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.043 0.937 . . . . 0.0 111.825 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 21.6 m-30 -52.49 -40.32 74.48 Favored Pre-proline 0 CA--C 1.545 0.758 0 CA-C-O 116.67 -1.633 . . . . 0.0 114.544 178.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -64.41 -23.83 64.78 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 CA-C-N 123.103 2.144 . . . . 0.0 113.036 174.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.6 m -79.79 -38.34 33.28 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 119.239 0.927 . . . . 0.0 109.168 170.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 19.4 tp -60.64 -33.32 72.62 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.016 -1.052 . . . . 0.0 111.84 -174.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -81.97 -4.3 56.37 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.65 0.78 . . . . 0.0 112.863 176.324 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -96.15 -28.33 14.62 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 119.112 0.869 . . . . 0.0 109.947 170.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 88.7 mt -64.26 136.22 26.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 176.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -86.67 130.89 34.31 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 123.421 0.688 . . . . 0.0 109.548 172.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -118.03 6.7 12.13 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.17 0.988 . . . . 0.0 112.005 176.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 21.9 m-80 -56.55 115.49 2.55 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 120.463 1.483 . . . . 0.0 110.478 -173.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.71 0.37 63.55 Favored Glycine 0 CA--C 1.535 1.321 0 CA-C-O 118.548 -1.14 . . . . 0.0 114.285 178.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -75.24 147.5 40.26 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 119.679 1.739 . . . . 0.0 108.202 174.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 69.3 mt -91.24 135.86 33.5 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 175.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.8 t -135.27 130.43 51.08 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -116.3 150.23 37.97 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 169.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 79.7 mt -117.55 150.71 38.53 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 -178.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -149.03 162.07 40.66 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 170.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 171.91 150.03 6.96 Favored Glycine 0 N--CA 1.448 -0.51 0 CA-C-O 121.88 0.711 . . . . 0.0 112.789 174.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 4.5 p -78.01 164.18 25.29 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 121.321 0.581 . . . . 0.0 109.837 169.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -160.58 -162.51 12.57 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 173.263 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -145.63 122.58 11.34 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 127.08 2.152 . . . . 0.0 105.473 177.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -110.51 1.95 18.51 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.228 1.411 . . . . 0.0 111.474 -173.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -108.8 -45.12 3.88 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.369 1.068 . . . . 0.0 110.827 -168.127 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -104.3 -35.45 7.97 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.804 1.242 . . . . 0.0 109.975 178.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -98.19 40.46 1.18 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.376 1.071 . . . . 0.0 110.279 169.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.03 -21.78 65.17 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.174 1.39 . . . . 0.0 113.787 -173.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -95.96 5.95 50.01 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.986 0.914 . . . . 0.0 111.691 177.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -138.56 18.7 2.71 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.983 1.313 . . . . 0.0 110.907 -172.024 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 30.8 t80 -64.93 132.5 49.49 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -173.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . 0.282 28.6 p 54.95 24.41 5.86 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.675 1.99 . . . . 0.0 114.454 171.043 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -61.56 -32.49 72.57 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.146 1.378 . . . . 0.0 111.867 -174.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.24 -32.57 71.88 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 120.903 -1.123 . . . . 0.0 111.427 -178.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 7.0 mp -63.82 -43.88 94.91 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 119.658 1.117 . . . . 0.0 108.849 173.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -60.51 -34.77 87.04 Favored Glycine 0 CA--C 1.533 1.185 0 N-CA-C 111.436 -0.666 . . . . 0.0 111.436 174.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 17.0 m -65.02 -37.38 87.44 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 121.716 -0.873 . . . . 0.0 110.6 176.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 5.1 mt -67.32 -47.45 81.14 Favored 'Isoleucine or valine' 0 C--N 1.345 0.382 0 CA-C-O 117.643 -1.17 . . . . 0.0 108.967 173.099 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -56.92 -38.22 72.57 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 120.38 1.445 . . . . 0.0 110.928 -174.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -60.69 -25.08 66.12 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.206 1.002 . . . . 0.0 112.457 178.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 75.8 mt -94.02 -49.36 12.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 124.419 1.087 . . . . 0.0 110.041 177.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 36.5 pt -75.58 -28.37 19.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-N 120.002 1.274 . . . . 0.0 111.9 -168.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -63.13 -53.95 50.0 Favored Pre-proline 0 CA--C 1.542 0.663 0 CA-C-O 117.447 -1.263 . . . . 0.0 111.836 178.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -68.08 -20.87 43.62 Favored 'Trans proline' 0 C--N 1.351 0.707 0 CA-C-N 122.064 1.773 . . . . 0.0 112.719 176.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 31.4 mmm180 -78.58 1.98 20.8 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 119.163 0.892 . . . . 0.0 112.144 170.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 93.26 10.43 59.53 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 125.048 1.309 . . . . 0.0 115.204 168.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.94 146.79 45.55 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 119.205 1.502 . . . . 0.0 110.757 174.251 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 86.1 m -101.93 124.16 47.08 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 105.206 -2.146 . . . . 0.0 105.206 167.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 19.4 mm -90.76 133.28 33.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 -171.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 18.7 m -131.76 168.51 23.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.395 0 C-N-CA 125.99 1.716 . . . . 0.0 108.81 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 70.07 39.66 73.25 Favored Glycine 0 CA--C 1.527 0.792 0 O-C-N 121.691 -0.631 . . . . 0.0 113.05 177.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -64.55 134.83 55.2 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 171.328 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 57.6 t-105 -114.76 127.26 26.99 Favored Pre-proline 0 CA--C 1.535 0.398 0 C-N-CA 124.752 1.221 . . . . 0.0 108.494 -169.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -61.98 141.93 90.98 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 CA-C-N 121.02 1.4 . . . . 0.0 112.831 -173.117 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 56.7 p -74.43 -28.07 60.89 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.037 0.535 . . . . 0.0 110.991 174.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 52.95 43.34 31.8 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.05 1.74 . . . . 0.0 111.84 -179.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 70.48 56.05 8.02 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 178.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -59.16 152.92 19.31 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 116.963 0.382 . . . . 0.0 110.197 174.029 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 37.2 t60 -144.96 57.5 1.28 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.514 0.673 . . . . 0.0 109.714 -176.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -116.27 164.1 15.01 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 124.973 1.309 . . . . 0.0 108.637 -177.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -66.49 -43.21 86.01 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 119.4 -0.333 . . . . 0.0 110.753 -169.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -161.42 130.63 4.61 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 124.3 1.04 . . . . 0.0 109.089 169.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 13.3 m -115.34 124.66 51.84 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 174.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -100.58 -11.4 20.1 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -173.059 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -79.6 7.88 51.63 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-O 119.184 -0.787 . . . . 0.0 113.113 169.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 97.5 mt -64.75 138.56 58.46 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 120.178 1.989 . . . . 0.0 109.942 174.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -106.21 -31.04 8.84 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.982 1.313 . . . . 0.0 108.925 167.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -149.16 162.98 38.89 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 127.466 2.306 . . . . 0.0 106.929 171.022 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -54.68 -30.84 56.71 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 121.371 -0.831 . . . . 0.0 112.162 176.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -91.98 -9.77 41.74 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.322 1.049 . . . . 0.0 113.325 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 11.9 m-70 -146.71 126.34 13.35 Favored 'General case' 0 C--N 1.346 0.415 0 CA-C-N 119.569 1.077 . . . . 0.0 113.376 -170.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -75.3 153.38 37.95 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 166.049 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 8.9 p -65.86 -18.88 24.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 124.288 1.035 . . . . 0.0 112.395 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -166.68 179.86 40.3 Favored Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -173.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -71.07 87.86 0.77 Allowed 'General case' 0 CA--C 1.522 -0.101 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 -178.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -85.71 129.22 34.88 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 169.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 12.4 tt -134.14 129.56 53.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-O 121.711 0.767 . . . . 0.0 112.108 -176.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -157.3 166.54 32.84 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 128.728 2.811 . . . . 0.0 105.265 168.162 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 24.1 tp10 -139.98 -63.25 0.5 Allowed 'General case' 0 C--O 1.233 0.207 0 O-C-N 121.203 -0.936 . . . . 0.0 109.744 176.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -160.24 94.45 1.09 Allowed 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 178.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 29.3 mmm-85 53.41 87.75 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.561 1.544 . . . . 0.0 110.879 -169.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 74.93 148.91 0.12 Allowed Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 127.218 2.207 . . . . 0.0 111.531 -176.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -72.32 158.49 51.5 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 123.412 2.741 . . . . 0.0 115.425 -168.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -154.34 -174.07 4.83 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.935 2.094 . . . . 0.0 107.383 167.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 23.7 mt 59.83 29.14 18.71 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.516 1.526 . . . . 0.0 110.973 -168.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 75.0 m -56.77 -51.46 68.82 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.37 1.468 . . . . 0.0 111.563 -169.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.32 -41.22 89.96 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -167.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -70.46 -35.03 73.09 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 118.219 0.463 . . . . 0.0 110.732 177.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 58.9 mtt180 -69.21 -43.86 73.28 Favored 'General case' 0 C--O 1.233 0.208 0 O-C-N 121.555 -0.716 . . . . 0.0 110.493 -178.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 26.6 m -70.42 -29.05 37.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 119.3 0.955 . . . . 0.0 110.544 177.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -64.21 -53.9 41.9 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 120.4 1.455 . . . . 0.0 109.755 171.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -58.2 -36.79 73.64 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 118.863 -0.589 . . . . 0.0 110.641 -178.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 46.1 t90 -77.14 -50.1 13.76 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 118.469 0.577 . . . . 0.0 111.426 -177.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 45.8 t -62.02 -33.58 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 O-C-N 121.458 -0.776 . . . . 0.0 109.992 -177.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -60.16 -38.32 82.79 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-O 118.343 -0.837 . . . . 0.0 111.17 177.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -59.07 -55.01 40.62 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 118.954 0.797 . . . . 0.0 109.802 176.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 19.0 pt -68.53 -29.74 45.0 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.235 0 O-C-N 122.133 -0.354 . . . . 0.0 110.248 -174.042 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 35.6 m -65.34 -25.41 67.59 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 118.705 -0.664 . . . . 0.0 111.74 175.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -86.03 -39.1 17.18 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 119.547 1.067 . . . . 0.0 110.253 174.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -64.51 -40.09 94.98 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 122.933 0.493 . . . . 0.0 110.92 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.7 mp -100.02 2.33 43.31 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.686 1.594 . . . . 0.0 111.005 -175.011 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . 0.291 31.7 p80 50.94 26.71 2.81 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 127.022 2.129 . . . . 0.0 113.948 -174.464 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 55.9 mt -66.04 -21.7 66.4 Favored 'General case' 0 C--N 1.344 0.33 0 O-C-N 121.505 -0.747 . . . . 0.0 110.275 172.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -55.04 -39.55 69.3 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.608 0.763 . . . . 0.0 110.302 172.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -74.98 -1.93 24.87 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.476 -0.765 . . . . 0.0 112.312 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 31.3 mt -105.39 -55.48 5.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 C-N-CA 125.11 1.364 . . . . 0.0 108.23 175.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.4 pp -80.31 -23.93 40.3 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 123.463 0.705 . . . . 0.0 112.464 -171.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 31.7 t30 -129.07 42.11 3.37 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.956 2.102 . . . . 0.0 108.302 -176.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.135 0 C-N-CA 123.7 0.8 . . . . 0.0 109.464 173.841 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 201' ' ' FMN . . . . . 0.458 HM73 ' CE1' ' A' ' 58' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.4 ptm . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 120.498 0.189 . . . . 0.0 111.371 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.07 155.57 40.14 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.173 0.589 . . . . 0.0 109.969 172.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 27.4 pt -83.5 -23.02 8.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 -178.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.1 m -112.2 127.37 55.93 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.955 1.302 . . . . 0.0 108.391 -178.295 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -101.67 118.96 6.31 Favored Glycine 0 CA--C 1.519 0.331 0 N-CA-C 107.846 -2.101 . . . . 0.0 107.846 169.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 44.7 mt -95.05 118.3 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 104.37 -2.456 . . . . 0.0 104.37 171.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -114.32 127.1 55.7 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 177.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -127.81 125.06 39.1 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 118.702 0.683 . . . . 0.0 112.017 -175.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -82.12 145.43 24.45 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 168.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.4 m -159.91 161.47 34.31 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 119.083 1.442 . . . . 0.0 109.844 175.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -138.74 -48.05 0.51 Allowed 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.037 0.935 . . . . 0.0 109.817 168.002 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.2 p -79.29 -13.52 59.6 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.486 0.714 . . . . 0.0 111.689 169.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.03 6.53 53.84 Favored Glycine 0 C--N 1.343 0.965 0 C-N-CA 124.767 1.175 . . . . 0.0 113.813 170.169 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -70.16 -38.4 75.43 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 118.769 1.284 . . . . 0.0 112.553 -169.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -69.83 -17.77 63.41 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 119.548 1.067 . . . . 0.0 111.383 -174.536 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -60.14 -41.21 92.22 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.185 0.902 . . . . 0.0 110.179 175.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -65.96 -39.89 90.81 Favored 'General case' 0 N--CA 1.463 0.195 0 O-C-N 121.924 -0.485 . . . . 0.0 110.106 178.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 27.2 mm -60.61 -49.05 85.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 176.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.16 -41.18 92.26 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.386 0.674 . . . . 0.0 111.702 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.9 mttm -67.11 -40.25 86.84 Favored 'General case' 0 N--CA 1.461 0.119 0 O-C-N 121.661 -0.65 . . . . 0.0 111.113 177.334 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 70.2 mtm -66.37 -31.95 73.04 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 119.504 1.047 . . . . 0.0 111.447 177.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.407 HG21 HD23 ' A' ' 51' ' ' LEU . 76.7 mt -65.81 -54.6 25.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 171.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -62.1 -37.03 83.54 Favored 'General case' 0 C--O 1.224 -0.251 0 CA-C-O 118.952 -0.546 . . . . 0.0 111.366 -173.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -63.68 -36.06 82.6 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 119.325 0.966 . . . . 0.0 110.91 -178.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -74.86 -41.36 59.96 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.131 0.573 . . . . 0.0 110.74 177.404 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.3 mp -73.99 -33.27 63.76 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 118.081 0.4 . . . . 0.0 111.23 -176.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 88.13 146.47 11.96 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 124.861 1.219 . . . . 0.0 110.763 -172.138 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -64.79 -29.61 70.59 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.875 0.87 . . . . 0.0 111.984 -172.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -67.53 -29.71 69.18 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 122.674 0.39 . . . . 0.0 111.07 177.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 22.8 t -93.47 -37.77 8.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 C-N-CA 123.921 0.888 . . . . 0.0 110.119 -175.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -135.58 144.05 45.97 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-N 119.3 0.955 . . . . 0.0 112.82 -176.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -128.53 153.18 47.46 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.565 1.146 . . . . 0.0 109.578 173.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 77.5 t -114.25 131.62 65.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 124.655 1.182 . . . . 0.0 110.263 -168.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 -144.63 166.5 25.01 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.645 1.578 . . . . 0.0 112.219 -169.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -130.63 129.42 42.67 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 127.088 2.155 . . . . 0.0 106.332 -178.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.4 tp -61.87 -19.62 21.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 123.64 0.776 . . . . 0.0 112.299 -171.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -58.39 -30.27 66.69 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 118.676 0.671 . . . . 0.0 112.461 -175.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 60.9 pttt -98.09 -6.42 31.71 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.755 0.822 . . . . 0.0 112.619 177.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 67.2 m -76.26 158.96 31.06 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.705 0.764 . . . . 0.0 111.444 -175.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 21.8 m -130.43 175.47 8.94 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.723 2.009 . . . . 0.0 107.145 172.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -51.61 -48.83 63.1 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 118.497 0.59 . . . . 0.0 111.654 -174.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -77.67 -12.62 59.99 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -172.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -68.47 -32.92 73.25 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 118.74 0.7 . . . . 0.0 110.824 -177.027 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -74.91 -42.46 57.75 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 123.603 0.761 . . . . 0.0 109.502 172.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -68.94 -19.54 64.18 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.633 0.773 . . . . 0.0 111.954 -170.096 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.57 -29.78 70.43 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.011 0.925 . . . . 0.0 112.433 176.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -86.21 160.46 19.19 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 124.292 1.037 . . . . 0.0 110.316 178.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -111.2 -24.26 10.38 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.596 0.758 . . . . 0.0 111.802 169.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.0 mp -117.02 131.92 68.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 174.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 79.8 mt -130.56 123.7 30.17 Favored 'General case' 0 CA--C 1.523 -0.08 0 C-N-CA 123.965 0.906 . . . . 0.0 109.363 -177.267 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.407 HD23 HG21 ' A' ' 22' ' ' ILE . 8.1 mp -109.6 107.74 17.93 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 176.247 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.9 mt -108.27 108.96 20.19 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -168.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -100.42 117.39 5.86 Favored Glycine 0 CA--C 1.518 0.245 0 C-N-CA 125.516 1.531 . . . . 0.0 109.709 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 15.5 tt -129.74 118.9 18.9 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 118.43 1.115 . . . . 0.0 110.627 -176.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -79.36 150.95 22.7 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.403 2.069 . . . . 0.0 110.289 173.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 17.3 m -100.68 137.07 39.57 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 175.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 66.8 m95 -137.25 173.8 11.3 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.782 1.633 . . . . 0.0 110.599 -173.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 54.49 -89.17 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 127.976 2.51 . . . . 0.0 113.246 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -151.02 62.12 0.91 Allowed 'General case' 0 C--O 1.237 0.417 0 C-N-CA 126.168 1.787 . . . . 0.0 107.89 -173.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 67.67 54.85 16.78 Favored Glycine 0 CA--C 1.53 1.003 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 -174.291 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -129.24 164.6 23.1 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.104 1.362 . . . . 0.0 108.642 175.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.36 164.29 22.24 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 121.221 0.534 . . . . 0.0 110.027 170.329 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -70.33 150.7 46.05 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 169.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 84.0 m -56.84 -33.35 66.7 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -168.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -69.26 -40.47 77.82 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 119.092 0.86 . . . . 0.0 110.687 -177.487 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -72.21 -41.49 66.86 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 174.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -60.0 -40.98 91.11 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 122.697 0.399 . . . . 0.0 111.39 -178.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -70.05 -21.07 63.21 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.092 0.957 . . . . 0.0 112.018 177.419 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -90.91 -19.16 23.63 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 118.7 -0.666 . . . . 0.0 112.316 -178.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -51.7 -41.72 79.61 Favored Pre-proline 0 CA--C 1.543 0.709 0 CA-C-O 116.389 -1.767 . . . . 0.0 114.666 178.289 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -62.4 -21.18 72.36 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 CA-C-N 122.909 2.075 . . . . 0.0 113.632 175.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.2 m -84.88 -41.97 15.49 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.454 1.025 . . . . 0.0 109.124 169.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.2 tp -56.47 -38.39 71.62 Favored 'General case' 0 C--N 1.341 0.219 0 C-N-CA 124.054 0.942 . . . . 0.0 111.177 -177.005 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -72.66 -2.8 21.52 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -109.86 -14.81 14.22 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.325 1.05 . . . . 0.0 111.622 173.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 74.5 mt -71.8 139.63 19.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -178.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -81.21 128.38 33.71 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.905 176.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -125.58 12.31 8.02 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.829 0.851 . . . . 0.0 111.737 172.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 42.8 m-80 -62.42 116.3 4.96 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 119.647 1.112 . . . . 0.0 109.385 -171.25 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.66 2.18 60.0 Favored Glycine 0 CA--C 1.534 1.239 0 CA-C-O 118.671 -1.072 . . . . 0.0 113.782 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 62.1 mttm -73.31 148.27 43.7 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 119.533 1.666 . . . . 0.0 107.714 171.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 60.9 mt -90.5 137.81 32.06 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 174.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.6 t -136.01 147.96 27.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 -178.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -140.18 144.23 36.51 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 169.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.9 mp -113.48 151.27 31.7 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 123.677 0.791 . . . . 0.0 109.512 -172.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 25.9 p90 -149.2 168.46 23.21 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 168.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.451 ' HA3' HD11 ' A' ' 102' ' ' LEU . . . 177.93 157.99 19.88 Favored Glycine 0 N--CA 1.449 -0.498 0 O-C-N 121.144 -0.973 . . . . 0.0 113.445 178.462 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 14.2 m -110.64 153.42 25.24 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 124.805 1.242 . . . . 0.0 109.268 -169.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -163.46 -166.54 22.45 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 178.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -152.61 118.69 5.49 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 124.898 1.279 . . . . 0.0 107.699 176.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -82.67 -34.15 27.5 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -169.153 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -56.33 -46.67 79.8 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 123.867 0.867 . . . . 0.0 111.648 -169.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -97.17 -42.6 7.76 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 118.601 0.637 . . . . 0.0 112.245 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 -91.94 44.72 1.18 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.958 0.903 . . . . 0.0 110.357 -172.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.33 -24.66 66.6 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.258 1.423 . . . . 0.0 113.421 -169.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -104.62 10.37 34.91 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.267 1.027 . . . . 0.0 112.75 178.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -135.62 16.86 3.35 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 124.939 1.296 . . . . 0.0 111.177 -178.254 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -66.41 124.45 22.77 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 121.159 -0.963 . . . . 0.0 110.518 -168.273 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 92.6 m 49.97 36.78 12.42 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.684 1.593 . . . . 0.0 113.058 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -59.93 -36.35 76.86 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.464 -0.772 . . . . 0.0 112.549 179.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.44 -24.81 67.75 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 -167.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.451 HD11 ' HA3' ' A' ' 87' ' ' GLY . 6.8 mp -61.57 -36.35 80.41 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 120.967 -1.083 . . . . 0.0 109.902 175.647 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.32 -31.22 78.51 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 123.706 0.669 . . . . 0.0 111.455 177.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.9 m -66.89 -36.67 82.82 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 121.858 -0.789 . . . . 0.0 110.533 179.103 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 15.7 mt -71.46 -49.16 49.0 Favored 'Isoleucine or valine' 0 C--N 1.343 0.318 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 174.013 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 18.3 tpt180 -50.15 -44.4 52.51 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.16 0.984 . . . . 0.0 111.052 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -60.87 -28.1 68.61 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.88 0.872 . . . . 0.0 112.643 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 97.0 mt -92.9 -46.09 14.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 124.351 1.06 . . . . 0.0 109.923 -178.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 32.6 pt -78.22 -23.09 13.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 O-C-N 121.23 -0.918 . . . . 0.0 111.931 -169.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -62.91 -58.06 18.38 Favored Pre-proline 0 CA--C 1.544 0.712 0 CA-C-O 117.412 -1.28 . . . . 0.0 111.629 177.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -65.8 -23.52 55.4 Favored 'Trans proline' 0 C--N 1.352 0.761 0 CA-C-N 121.708 1.646 . . . . 0.0 112.39 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 76.6 mmt-85 -79.66 6.26 11.13 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.211 1.004 . . . . 0.0 112.807 173.243 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 77.73 19.2 76.13 Favored Glycine 0 CA--C 1.528 0.876 0 CA-C-O 118.271 -1.294 . . . . 0.0 114.988 168.287 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.03 144.36 53.57 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 119.318 1.559 . . . . 0.0 110.09 169.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 42.2 m -97.45 124.99 41.84 Favored 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 105.01 -2.218 . . . . 0.0 105.01 167.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 20.8 mt -113.44 125.8 70.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -169.259 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 33.3 m -127.76 178.72 4.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 124.69 1.196 . . . . 0.0 109.21 174.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 79.77 27.64 53.29 Favored Glycine 0 CA--C 1.528 0.898 0 O-C-N 121.851 -0.531 . . . . 0.0 112.57 179.12 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 80.8 m-70 -62.0 141.58 57.98 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 170.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 71.5 t-105 -131.12 138.03 32.01 Favored Pre-proline 0 CA--C 1.537 0.446 0 C-N-CA 124.125 0.97 . . . . 0.0 109.5 -170.02 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -62.93 151.29 85.27 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 121.818 1.679 . . . . 0.0 112.985 -176.07 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 35.5 p -70.71 -25.45 62.96 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 121.852 -0.53 . . . . 0.0 111.515 171.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 54.19 40.3 31.55 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.166 1.786 . . . . 0.0 112.593 175.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 66.46 47.35 70.63 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 111.671 -0.571 . . . . 0.0 111.671 175.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -55.58 -45.15 77.43 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.091 0.556 . . . . 0.0 110.916 -178.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 18.0 m-70 54.65 32.98 18.28 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.664 1.986 . . . . 0.0 114.638 173.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -92.84 -173.5 3.33 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 167.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -67.56 -48.6 66.46 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.656 -0.653 . . . . 0.0 110.918 -170.022 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -161.89 118.98 2.14 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 123.493 0.717 . . . . 0.0 110.962 174.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 11.5 p -92.17 137.65 32.18 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 166.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -121.33 2.63 10.29 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.928 1.084 . . . . 0.0 113.928 -168.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -83.95 4.98 81.36 Favored Glycine 0 CA--C 1.534 1.269 0 CA-C-O 119.518 -0.601 . . . . 0.0 112.207 169.313 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 9.0 mp -62.23 135.26 57.4 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 118.969 1.385 . . . . 0.0 111.71 -177.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -97.05 -29.59 13.54 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.484 1.514 . . . . 0.0 109.313 167.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -146.82 167.68 23.29 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.149 1.78 . . . . 0.0 107.327 174.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -55.64 -25.89 41.44 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.12 1.368 . . . . 0.0 113.947 -169.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -122.45 11.71 9.99 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.85 1.26 . . . . 0.0 113.574 -178.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -141.14 125.72 17.81 Favored 'General case' 0 C--N 1.343 0.304 0 CA-C-N 119.362 0.983 . . . . 0.0 111.587 -176.492 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -71.54 150.17 45.04 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.333 1.053 . . . . 0.0 108.31 166.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 6.1 p -67.74 -8.6 8.98 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 123.98 0.912 . . . . 0.0 112.099 175.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -168.66 176.22 43.0 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 -172.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -70.73 103.12 2.48 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 -179.234 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -79.62 138.54 37.46 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 169.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 8.7 tp -127.83 109.66 20.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-N 119.414 1.006 . . . . 0.0 112.335 178.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -172.1 146.11 1.89 Allowed 'General case' 0 C--O 1.236 0.344 0 C-N-CA 128.215 2.606 . . . . 0.0 106.67 166.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -91.48 -48.89 6.62 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.648 0.658 . . . . 0.0 109.631 173.396 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -169.31 -52.37 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.166 1.386 . . . . 0.0 109.42 -175.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 12.5 tpp85 -141.79 86.98 2.02 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 104.944 -2.243 . . . . 0.0 104.944 177.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 43.1 mm-40 67.64 147.52 0.11 Allowed Pre-proline 0 CA--C 1.545 0.764 0 C-N-CA 127.311 2.244 . . . . 0.0 111.07 -168.235 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -68.97 153.64 72.16 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.336 2.024 . . . . 0.0 111.806 -178.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -120.36 -32.12 4.19 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.804 1.642 . . . . 0.0 110.337 173.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 66.7 mt -99.82 27.7 5.27 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.737 1.615 . . . . 0.0 110.203 -174.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 50.5 m -41.03 -53.41 3.01 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 128.175 2.59 . . . . 0.0 111.766 -177.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -76.62 -40.74 48.39 Favored 'General case' 0 N--CA 1.452 -0.357 0 O-C-N 122.264 -0.272 . . . . 0.0 111.001 -172.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -62.9 -47.28 84.0 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 117.993 0.36 . . . . 0.0 110.377 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 47.6 mtp180 -65.71 -39.54 91.3 Favored 'General case' 0 N--CA 1.464 0.249 0 O-C-N 121.932 -0.48 . . . . 0.0 110.325 -175.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 86.4 t -72.68 -37.47 55.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-O 118.226 -0.893 . . . . 0.0 109.899 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -62.05 -49.83 74.4 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 120.722 1.601 . . . . 0.0 110.245 174.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -62.72 -34.56 77.43 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 118.898 -0.572 . . . . 0.0 110.746 -176.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 40.2 t90 -71.79 -51.63 21.64 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 118.531 0.605 . . . . 0.0 110.384 176.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 68.9 t -64.44 -35.07 73.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 O-C-N 121.533 -0.729 . . . . 0.0 110.835 -172.001 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -63.45 -35.53 80.74 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.404 -0.81 . . . . 0.0 110.324 177.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 53.7 mm-40 -71.63 -48.39 48.23 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.552 0.741 . . . . 0.0 111.178 174.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 3.8 pt -63.72 -32.51 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-N 119.771 1.169 . . . . 0.0 110.362 -177.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 50.2 m -61.85 -33.68 74.61 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 118.309 -0.853 . . . . 0.0 111.505 -179.091 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -86.41 -24.66 25.64 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 120.227 1.376 . . . . 0.0 111.954 177.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -73.74 -37.61 65.01 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 118.683 0.674 . . . . 0.0 110.701 174.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 77.7 mt -89.97 -4.79 57.26 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.058 1.743 . . . . 0.0 111.484 -178.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 82.7 m-70 56.6 25.29 9.76 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.952 1.701 . . . . 0.0 113.195 -172.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 79.8 mt -74.88 -20.15 59.85 Favored 'General case' 0 N--CA 1.464 0.246 0 O-C-N 121.456 -0.778 . . . . 0.0 110.381 172.006 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -58.37 -40.77 83.18 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 118.788 0.722 . . . . 0.0 110.945 -179.147 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -71.9 -12.13 61.12 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 122.773 0.429 . . . . 0.0 112.123 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 28.6 mt -97.52 -47.37 12.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 124.755 1.222 . . . . 0.0 108.522 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 3.0 pp -73.34 -29.44 62.66 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 123.101 0.56 . . . . 0.0 111.326 -177.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -119.93 59.82 0.87 Allowed 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.71 1.604 . . . . 0.0 108.21 174.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.218 0 CA-C-O 118.426 -0.797 . . . . 0.0 109.234 174.07 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.3 tpt . . . . . 0 N--CA 1.488 1.459 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.14 153.33 32.21 Favored 'General case' 0 C--N 1.341 0.238 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 172.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 28.6 pt -80.68 -24.73 11.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 O-C-N 122.143 -0.348 . . . . 0.0 111.351 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.1 m -113.19 130.16 56.3 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.002 1.321 . . . . 0.0 108.771 178.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -102.76 124.68 8.24 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 107.974 -2.051 . . . . 0.0 107.974 169.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 27.3 mt -103.32 94.72 3.35 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 105.248 -2.131 . . . . 0.0 105.248 177.018 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -90.27 129.44 36.5 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 -177.3 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -122.43 123.47 41.4 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 119.806 1.185 . . . . 0.0 112.637 -176.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -82.51 141.72 21.42 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 106.391 -2.684 . . . . 0.0 106.391 165.37 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.1 m -161.85 171.33 17.93 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 119.939 1.87 . . . . 0.0 110.452 177.297 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -133.93 -50.67 0.83 Allowed 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.027 0.931 . . . . 0.0 109.817 169.206 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 81.9 p -92.41 5.0 52.31 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.021 0.928 . . . . 0.0 112.31 177.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 76.13 18.15 79.56 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 124.032 0.825 . . . . 0.0 113.317 -175.382 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -76.85 -47.19 22.07 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 119.263 1.532 . . . . 0.0 111.235 -176.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 72.8 m -74.06 -23.57 59.38 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 118.968 0.804 . . . . 0.0 109.974 178.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -56.09 -46.27 79.12 Favored 'General case' 0 C--N 1.342 0.248 0 O-C-N 121.385 -0.822 . . . . 0.0 109.616 169.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -64.95 -34.28 78.05 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 121.781 -0.574 . . . . 0.0 111.033 -177.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 45.4 mm -60.43 -44.1 95.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 172.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.61 -41.51 97.57 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.702 -0.624 . . . . 0.0 111.576 177.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 29.2 mmtp -64.14 -41.87 97.03 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 121.45 -0.782 . . . . 0.0 110.276 176.101 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 78.7 mtp -62.24 -40.6 96.72 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.399 1.0 . . . . 0.0 110.473 178.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 55.5 mt -60.62 -49.59 83.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 174.121 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -58.59 -38.15 77.32 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 121.233 -0.917 . . . . 0.0 111.417 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -63.63 -34.56 78.1 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 120.077 1.308 . . . . 0.0 111.246 -178.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -72.27 -40.6 67.5 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 118.371 0.532 . . . . 0.0 110.758 174.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -80.58 -34.22 35.47 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -171.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 84.3 144.61 6.48 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 -168.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 54.0 tttp -63.41 -30.93 71.97 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 121.912 -0.758 . . . . 0.0 111.975 -171.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -64.47 -30.98 72.01 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 122.85 0.46 . . . . 0.0 111.26 178.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.1 t -92.97 -39.96 11.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 123.502 0.721 . . . . 0.0 109.927 -176.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.22 137.44 32.59 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 118.92 0.782 . . . . 0.0 112.045 -178.1 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -129.23 144.71 51.32 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 176.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 59.7 t -90.32 134.78 28.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 123.871 0.868 . . . . 0.0 108.777 -170.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -147.12 169.19 19.81 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.886 1.274 . . . . 0.0 111.201 -168.117 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -138.31 128.33 25.56 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 125.173 1.389 . . . . 0.0 109.036 -169.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.3 tp -63.44 -29.84 48.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 CA-C-O 118.832 -0.604 . . . . 0.0 111.708 -173.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.52 -28.53 68.62 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 119.105 0.866 . . . . 0.0 110.318 -178.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -89.23 -27.14 20.81 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.172 1.389 . . . . 0.0 110.511 177.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 21.3 m -68.64 167.05 15.95 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 124.433 1.093 . . . . 0.0 111.801 -177.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.6 m -135.12 164.56 27.38 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.481 1.512 . . . . 0.0 108.932 178.09 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -53.17 -54.8 30.53 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.326 1.05 . . . . 0.0 111.45 -175.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -78.28 -15.96 58.24 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 122.312 0.245 . . . . 0.0 111.195 -175.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -74.32 -30.22 61.95 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 121.772 -0.58 . . . . 0.0 110.966 -179.029 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.7 mp -69.17 -43.51 74.12 Favored 'General case' 0 C--N 1.343 0.305 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 169.376 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -62.86 -17.41 61.44 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -177.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.15 -29.08 67.88 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.654 0.782 . . . . 0.0 112.289 176.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -82.29 155.99 24.53 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.195 0.998 . . . . 0.0 110.023 177.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -108.86 -26.48 10.24 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.111 0.564 . . . . 0.0 111.673 169.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.0 mp -113.81 127.89 70.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 174.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 96.3 mt -118.05 127.5 53.86 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 124.192 0.997 . . . . 0.0 108.436 177.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.2 mp -111.85 116.31 30.46 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 104.411 -2.44 . . . . 0.0 104.411 168.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 91.1 mt -115.23 109.08 17.44 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 -169.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.69 117.6 5.61 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 108.848 -1.701 . . . . 0.0 108.848 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 15.3 tt -135.91 105.29 9.7 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-N 118.731 1.266 . . . . 0.0 109.617 178.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -71.58 150.95 58.05 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 121.91 1.74 . . . . 0.0 109.635 170.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 29.3 m -99.19 139.27 35.08 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -179.056 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 47.5 m95 -135.7 172.79 12.5 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.86 1.264 . . . . 0.0 111.245 -170.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 53.87 -87.27 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 127.511 2.324 . . . . 0.0 112.958 176.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -149.69 80.01 1.38 Allowed 'General case' 0 C--O 1.235 0.31 0 C-N-CA 126.379 1.872 . . . . 0.0 106.847 174.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.71 16.96 76.32 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-O 119.575 -0.57 . . . . 0.0 113.306 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -91.99 161.8 14.65 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 118.54 1.17 . . . . 0.0 110.584 -175.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.27 161.56 28.65 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 123.915 0.886 . . . . 0.0 111.284 173.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 12.8 tm0? -64.57 146.4 54.69 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 168.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 56.3 m -56.45 -39.96 74.02 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 -167.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -77.33 -39.03 49.13 Favored 'General case' 0 C--N 1.333 -0.109 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -174.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -62.74 -44.95 94.88 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 172.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -58.98 -42.04 89.01 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.319 0.648 . . . . 0.0 111.358 178.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -69.33 -27.5 65.42 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.335 0.654 . . . . 0.0 112.336 176.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -88.32 -17.8 29.87 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.627 0.771 . . . . 0.0 112.629 -177.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -51.8 -40.45 70.97 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-O 116.426 -1.75 . . . . 0.0 115.349 -179.113 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -61.26 -30.21 87.71 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 CA-C-N 123.197 2.178 . . . . 0.0 112.701 173.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.7 m -75.23 -42.28 55.74 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.923 0.783 . . . . 0.0 109.446 172.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 12.3 tp -58.24 -37.62 75.25 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.126 0.97 . . . . 0.0 110.387 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -67.71 -11.64 58.77 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.55 1.14 . . . . 0.0 113.202 177.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -95.91 -17.91 20.71 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 119.803 1.183 . . . . 0.0 112.179 173.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 95.7 mt -76.38 143.59 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 -172.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -89.49 132.26 35.13 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 123.507 0.723 . . . . 0.0 109.691 175.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -124.62 6.08 8.21 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.913 0.885 . . . . 0.0 112.067 177.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -66.48 124.48 22.88 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 120.358 1.435 . . . . 0.0 110.378 -169.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.26 -0.94 58.26 Favored Glycine 0 CA--C 1.537 1.424 0 CA-C-O 118.433 -1.204 . . . . 0.0 114.277 -175.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -76.67 150.45 36.36 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 119.698 1.749 . . . . 0.0 108.408 173.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 66.9 mt -95.38 138.2 33.39 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 175.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 15.2 t -136.38 147.93 27.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -178.029 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -138.04 147.81 44.47 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 169.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -110.2 147.3 34.02 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 124.607 1.163 . . . . 0.0 108.607 -175.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -149.04 163.9 36.19 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 167.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 174.55 143.6 4.5 Favored Glycine 0 C--N 1.33 0.215 0 O-C-N 121.251 -0.906 . . . . 0.0 111.406 173.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 53.7 m -81.44 159.7 24.2 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 175.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.9 -167.63 27.89 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.403 -0.679 . . . . 0.0 111.403 -177.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -147.64 126.41 12.64 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 126.034 1.734 . . . . 0.0 107.994 176.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -106.89 2.38 25.32 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.328 1.051 . . . . 0.0 112.214 176.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -91.22 -46.32 8.14 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 119.24 0.927 . . . . 0.0 110.05 -173.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -105.58 -44.52 4.66 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.172 0.589 . . . . 0.0 110.493 178.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -82.75 40.91 0.7 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.551 1.141 . . . . 0.0 110.482 171.205 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.73 -21.86 64.87 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 127.002 2.121 . . . . 0.0 114.219 -170.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -103.26 7.81 38.39 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.173 1.389 . . . . 0.0 111.699 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -137.15 17.46 2.99 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.605 1.162 . . . . 0.0 111.387 -174.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -63.54 132.63 51.89 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 119.078 0.854 . . . . 0.0 109.363 -170.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . 0.258 23.0 p 52.05 22.98 2.03 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 127.357 2.263 . . . . 0.0 114.772 173.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -52.16 -41.54 62.67 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.851 1.261 . . . . 0.0 111.401 -175.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.35 -23.08 67.26 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -172.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 63.5 mt -61.39 -40.24 93.64 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 119.1 0.864 . . . . 0.0 109.621 175.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -68.19 -28.08 73.47 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 124.037 0.827 . . . . 0.0 111.591 -179.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.3 m -65.25 -37.12 86.22 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 118.243 1.021 . . . . 0.0 110.356 178.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 8.0 mt -71.25 -46.12 67.09 Favored 'Isoleucine or valine' 0 C--N 1.343 0.304 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 173.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 40.2 ttt180 -50.54 -46.11 57.29 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 118.858 0.754 . . . . 0.0 110.754 -177.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -61.87 -23.02 66.03 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.822 0.849 . . . . 0.0 113.025 -177.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 93.6 mt -92.21 -47.78 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 124.278 1.031 . . . . 0.0 109.268 178.448 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 30.0 pt -82.0 -36.77 14.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 118.989 0.813 . . . . 0.0 112.59 -168.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -68.19 -47.53 39.02 Favored Pre-proline 0 CA--C 1.54 0.575 0 CA-C-O 117.902 -1.047 . . . . 0.0 112.28 -170.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -68.66 -16.37 42.16 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 CA-C-N 121.532 1.583 . . . . 0.0 112.382 175.102 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 90.0 mtt-85 -91.51 20.29 5.48 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.736 1.214 . . . . 0.0 111.719 176.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 79.44 10.88 85.47 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 125.906 1.717 . . . . 0.0 115.023 168.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.45 137.76 58.1 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 119.649 1.724 . . . . 0.0 109.057 170.121 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 35.7 m -94.42 120.63 34.96 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 105.179 -2.156 . . . . 0.0 105.179 168.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 29.6 mt -99.2 132.62 44.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 -177.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 34.4 m -130.08 178.73 4.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 125.259 1.423 . . . . 0.0 108.812 172.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 77.14 28.11 58.9 Favored Glycine 0 C--N 1.335 0.523 0 CA-C-O 119.365 -0.686 . . . . 0.0 113.76 178.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 65.3 m80 -57.17 133.45 55.05 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 169.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 57.4 t-105 -115.61 135.78 22.7 Favored Pre-proline 0 CA--C 1.535 0.374 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -177.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.7 145.56 52.05 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 121.823 1.682 . . . . 0.0 111.754 -170.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 34.9 p -72.89 -29.09 62.88 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 122.963 0.505 . . . . 0.0 110.784 169.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 53.16 40.51 31.36 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.365 1.866 . . . . 0.0 110.738 -169.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 72.64 74.71 0.76 Allowed Glycine 0 C--N 1.341 0.839 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 -175.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -48.04 124.85 8.14 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.403 0.681 . . . . 0.0 109.427 171.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -100.0 -19.81 16.38 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -168.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -89.21 -171.63 3.33 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.791 0.836 . . . . 0.0 111.166 -169.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -60.82 -55.93 27.27 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -167.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -161.06 137.22 8.29 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 123.487 0.715 . . . . 0.0 110.908 175.045 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 1.6 p -109.74 142.82 40.41 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 168.003 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -121.51 -3.51 9.35 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 122.975 0.51 . . . . 0.0 112.264 -171.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -86.65 9.34 71.67 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 123.774 0.702 . . . . 0.0 111.815 167.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 95.3 mt -60.59 141.35 56.76 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 118.636 1.218 . . . . 0.0 110.889 177.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -108.74 -31.04 7.87 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.159 1.384 . . . . 0.0 108.89 167.037 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -146.4 162.48 38.13 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 127.869 2.468 . . . . 0.0 106.389 169.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -55.91 -29.05 59.44 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 119.27 0.941 . . . . 0.0 112.167 176.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -89.98 -11.5 41.45 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.295 1.038 . . . . 0.0 113.406 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 7.4 m-70 -149.48 131.52 15.32 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 119.742 1.155 . . . . 0.0 113.14 -169.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -75.02 158.98 32.32 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 167.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 12.4 p -61.69 -22.83 29.24 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 C-N-CA 123.227 0.611 . . . . 0.0 111.364 173.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -161.97 -172.26 29.15 Favored Glycine 0 C--N 1.337 0.636 0 O-C-N 121.514 -0.742 . . . . 0.0 111.798 -171.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.35 86.96 1.13 Allowed 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 124.755 1.222 . . . . 0.0 109.082 179.185 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -81.31 109.06 15.47 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 168.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . 0.275 18.2 tt -105.89 97.24 5.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-O 121.93 0.871 . . . . 0.0 110.582 -169.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -164.42 160.93 21.18 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 127.676 2.39 . . . . 0.0 106.543 169.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -143.53 -40.18 0.3 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.774 0.83 . . . . 0.0 111.153 175.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -159.4 104.98 1.66 Allowed 'General case' 0 C--O 1.234 0.281 0 C-N-CA 123.932 0.893 . . . . 0.0 108.688 175.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 1.1 tpm_? 65.79 -51.07 0.39 Allowed 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 127.867 2.467 . . . . 0.0 113.603 -174.378 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -145.61 154.07 51.89 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 126.841 2.056 . . . . 0.0 107.114 174.192 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -64.28 146.68 90.5 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 122.0 1.8 . . . . 0.0 110.277 172.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -131.51 -24.89 2.21 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.827 1.251 . . . . 0.0 111.705 174.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 88.8 mt -89.15 28.28 1.24 Allowed 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 125.235 1.414 . . . . 0.0 109.449 169.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 83.2 m -43.14 -52.18 5.6 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 127.409 2.284 . . . . 0.0 111.696 -174.084 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -72.89 -33.7 66.2 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 118.888 -0.577 . . . . 0.0 110.731 -170.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -65.74 -43.47 88.89 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 118.552 0.615 . . . . 0.0 110.223 174.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -59.64 -49.6 77.13 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 178.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 98.2 t -67.33 -45.7 85.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-O 118.179 -0.915 . . . . 0.0 109.434 -176.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -53.77 -51.63 62.81 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 119.306 0.957 . . . . 0.0 110.1 -178.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 42.0 mttp -70.44 -42.17 71.9 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-O 118.838 -0.601 . . . . 0.0 110.697 -175.382 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 69.2 t90 -63.89 -44.5 92.83 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-N 118.943 0.792 . . . . 0.0 109.727 -178.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 54.3 t -61.96 -40.15 86.2 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 O-C-N 122.075 -0.391 . . . . 0.0 110.015 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -64.39 -40.24 95.42 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 121.369 -0.832 . . . . 0.0 110.232 178.246 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 20.6 mm100 -64.5 -51.46 62.83 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.321 0.51 . . . . 0.0 110.903 177.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 14.4 pt -66.01 -32.41 58.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 119.476 1.035 . . . . 0.0 110.704 -176.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 58.4 m -62.78 -26.63 68.81 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 118.139 -0.934 . . . . 0.0 112.127 -177.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -90.55 -17.69 26.57 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 120.259 1.39 . . . . 0.0 112.477 174.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -80.61 -35.71 33.72 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.25 0.932 . . . . 0.0 110.454 171.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 75.2 mt -91.63 -7.29 50.48 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.613 1.965 . . . . 0.0 111.598 -178.203 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 30.6 m80 56.26 24.68 8.44 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 126.076 1.75 . . . . 0.0 113.359 -172.158 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 86.9 mt -74.45 -20.34 60.06 Favored 'General case' 0 N--CA 1.465 0.281 0 O-C-N 121.771 -0.581 . . . . 0.0 110.387 172.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -59.23 -41.23 88.21 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 118.867 0.758 . . . . 0.0 110.785 -178.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -72.3 -8.66 56.1 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.487 0.715 . . . . 0.0 111.992 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 48.0 mt -103.96 -46.66 10.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 124.932 1.293 . . . . 0.0 108.749 -179.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.4 pp -71.97 -30.5 65.34 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.235 0.614 . . . . 0.0 111.171 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -121.82 58.65 1.01 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.674 1.59 . . . . 0.0 107.93 175.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.311 0 C-N-CA 123.302 0.641 . . . . 0.0 109.376 174.201 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.4 mtp . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 120.627 0.251 . . . . 0.0 110.586 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.94 163.01 26.95 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 169.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.5 pt -83.81 -24.77 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 O-C-N 121.958 -0.464 . . . . 0.0 111.476 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 17.3 m -112.08 131.48 55.41 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.216 1.406 . . . . 0.0 108.732 177.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -107.0 121.87 6.71 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 108.374 -1.891 . . . . 0.0 108.374 170.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 52.5 mt -99.85 100.66 10.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 177.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -97.55 124.36 41.77 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 17.8 p90 -124.41 127.6 47.78 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 119.111 0.869 . . . . 0.0 112.131 -177.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -84.14 143.52 21.23 Favored Glycine 0 C--N 1.341 0.819 0 N-CA-C 110.316 -1.114 . . . . 0.0 110.316 168.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.6 m -160.38 159.26 30.87 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 118.895 1.348 . . . . 0.0 110.739 173.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -135.6 -47.64 0.69 Allowed 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.288 1.035 . . . . 0.0 109.851 169.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.4 p -80.12 -12.38 59.67 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.555 0.742 . . . . 0.0 111.954 170.115 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.9 7.96 54.71 Favored Glycine 0 C--N 1.342 0.869 0 C-N-CA 124.732 1.158 . . . . 0.0 113.449 170.106 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -69.76 -41.79 74.71 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 118.82 1.31 . . . . 0.0 112.442 -169.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.4 m -70.02 -18.01 63.29 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 119.408 1.004 . . . . 0.0 111.27 -172.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -58.23 -42.84 87.2 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 119.116 0.871 . . . . 0.0 110.166 174.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -65.8 -38.41 88.91 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 121.915 -0.491 . . . . 0.0 110.485 -178.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 36.9 mm -65.1 -47.52 87.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 176.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.0 -38.27 85.45 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.183 0.593 . . . . 0.0 111.575 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.0 mtpt -68.22 -44.69 75.18 Favored 'General case' 0 N--CA 1.463 0.188 0 O-C-N 121.643 -0.661 . . . . 0.0 110.594 176.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 75.5 mtm -66.85 -22.72 65.98 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.352 0.978 . . . . 0.0 111.946 178.039 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 68.3 mt -71.31 -59.07 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 168.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -55.16 -42.19 72.81 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 118.382 -0.818 . . . . 0.0 112.349 -174.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -58.94 -32.04 69.23 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 119.65 1.114 . . . . 0.0 111.903 -175.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -75.27 -39.6 59.58 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.062 0.545 . . . . 0.0 111.538 178.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -79.39 -35.4 40.76 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 118.652 0.66 . . . . 0.0 111.508 -177.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 88.09 146.1 11.43 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 124.778 1.18 . . . . 0.0 110.353 -169.016 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 55.5 tttp -63.37 -31.95 73.24 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 121.953 -0.733 . . . . 0.0 112.117 -169.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -66.24 -29.14 69.33 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 122.955 0.502 . . . . 0.0 111.397 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 39.0 t -92.56 -39.67 11.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 123.878 0.871 . . . . 0.0 109.582 -177.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -140.15 132.85 28.93 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 119.241 0.928 . . . . 0.0 111.513 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -125.05 149.7 47.52 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 175.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 60.5 t -97.83 138.98 21.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 124.595 1.158 . . . . 0.0 110.101 -168.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -149.63 172.39 15.13 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.948 1.299 . . . . 0.0 111.512 -173.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -137.74 132.17 32.39 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 125.647 1.579 . . . . 0.0 108.032 -174.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.5 tp -65.8 -27.03 40.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-O 118.581 -0.723 . . . . 0.0 112.927 -168.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.11 -30.44 68.72 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 119.221 0.919 . . . . 0.0 110.297 178.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 43.8 mtmt -81.03 -31.36 34.6 Favored 'General case' 0 C--N 1.342 0.244 0 C-N-CA 123.252 0.621 . . . . 0.0 110.421 174.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.7 m -70.43 169.51 13.88 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.522 1.129 . . . . 0.0 111.654 -172.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 14.8 m -135.3 160.96 36.77 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.146 1.379 . . . . 0.0 108.733 178.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 45.2 tttm -53.6 -51.75 62.02 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.78 0.832 . . . . 0.0 111.042 -174.34 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.2 mp0 -73.82 -14.32 61.08 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 119.343 -0.361 . . . . 0.0 111.683 -175.194 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -71.71 -39.39 70.19 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 119.487 1.04 . . . . 0.0 110.675 -178.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 8.3 mp -66.22 -31.83 72.89 Favored 'General case' 0 C--N 1.343 0.315 0 C-N-CA 122.375 0.27 . . . . 0.0 110.361 173.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -70.15 -20.93 63.12 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 119.178 -0.439 . . . . 0.0 111.612 -176.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.61 -30.3 61.62 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.622 0.769 . . . . 0.0 112.559 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -76.36 151.78 36.53 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 123.681 0.792 . . . . 0.0 109.928 177.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -100.12 -31.43 11.42 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 122.709 0.404 . . . . 0.0 111.338 170.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.1 mp -110.52 128.77 66.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 175.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 96.2 mt -114.17 128.33 56.32 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 172.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.2 mp -110.27 115.81 30.36 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 105.345 -2.095 . . . . 0.0 105.345 169.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 85.8 mt -115.92 109.7 17.95 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 -169.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -100.26 119.15 6.41 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 125.966 1.746 . . . . 0.0 109.85 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.6 tt -132.74 123.85 18.5 Favored Pre-proline 0 CA--C 1.541 0.605 0 CA-C-N 118.906 1.353 . . . . 0.0 112.15 -173.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -85.59 157.09 10.6 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 123.042 2.495 . . . . 0.0 110.658 170.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.0 m -112.32 142.08 45.26 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 175.103 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 75.2 m95 -140.95 171.29 14.28 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.11 1.764 . . . . 0.0 111.074 -169.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 36.2 t80 50.83 -89.59 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 127.648 2.379 . . . . 0.0 112.569 -177.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -149.7 84.15 1.41 Allowed 'General case' 0 C--O 1.235 0.303 0 C-N-CA 126.652 1.981 . . . . 0.0 106.215 173.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 73.58 13.44 80.22 Favored Glycine 0 CA--C 1.534 1.235 0 CA-C-O 119.203 -0.776 . . . . 0.0 114.088 177.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -84.59 161.99 19.95 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.625 1.212 . . . . 0.0 108.915 174.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -84.95 175.1 9.28 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 166.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.4 142.44 56.95 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 168.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 58.6 m -57.61 -36.47 71.82 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 119.311 0.959 . . . . 0.0 112.998 -169.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -72.53 -28.51 62.9 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.133 0.573 . . . . 0.0 111.908 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -79.91 -41.83 25.35 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.649 1.179 . . . . 0.0 109.468 176.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -59.7 -42.21 92.47 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.564 1.146 . . . . 0.0 110.689 176.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -62.22 -19.63 63.37 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.0 0.92 . . . . 0.0 112.525 177.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -90.4 -15.31 31.24 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 118.252 -0.88 . . . . 0.0 112.294 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -54.15 -42.87 95.87 Favored Pre-proline 0 CA--C 1.541 0.632 0 CA-C-N 120.992 1.724 . . . . 0.0 113.963 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -63.14 -21.96 72.77 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 CA-C-N 122.523 1.937 . . . . 0.0 113.397 174.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.2 m -82.25 -38.8 23.91 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.462 1.028 . . . . 0.0 109.702 171.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 14.0 tp -59.02 -40.69 85.76 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.312 1.045 . . . . 0.0 109.941 -176.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -75.63 4.15 8.26 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 178.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -105.38 -16.42 14.75 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.288 1.035 . . . . 0.0 111.111 169.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 96.7 mt -75.28 140.53 17.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 179.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -88.92 131.42 35.14 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 123.543 0.737 . . . . 0.0 109.524 174.184 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -121.51 8.01 10.12 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.86 0.864 . . . . 0.0 111.952 177.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 29.6 m-80 -58.72 116.45 3.73 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 119.814 1.188 . . . . 0.0 109.835 -172.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.58 1.92 67.48 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-O 118.571 -1.127 . . . . 0.0 114.283 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -74.25 150.84 40.07 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 119.674 1.737 . . . . 0.0 108.581 172.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 23.8 mt -92.04 137.59 32.24 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 172.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 19.7 t -134.28 144.07 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 177.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -137.65 145.94 43.28 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 171.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.2 mp -116.34 150.23 38.02 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 123.102 0.561 . . . . 0.0 109.646 -171.246 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -144.27 162.86 35.33 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 167.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -171.32 168.02 41.14 Favored Glycine 0 N--CA 1.452 -0.299 0 O-C-N 120.773 -1.204 . . . . 0.0 112.778 -176.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 21.3 m -133.28 151.6 51.9 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.569 1.148 . . . . 0.0 109.223 -168.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -178.35 -174.41 44.59 Favored Glycine 0 CA--C 1.528 0.857 0 CA-C-O 121.022 0.235 . . . . 0.0 112.57 -177.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -145.4 153.2 40.95 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 128.247 2.619 . . . . 0.0 106.952 175.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.9 12.8 3.38 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.182 1.393 . . . . 0.0 111.79 -173.643 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -68.47 -47.5 66.94 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 177.142 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -106.33 -38.72 6.13 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 123.395 0.678 . . . . 0.0 111.341 175.29 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -84.45 39.99 0.76 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.548 1.139 . . . . 0.0 111.404 -172.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.45 -19.83 65.8 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.266 1.027 . . . . 0.0 113.126 -171.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -93.11 0.31 57.22 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.476 1.11 . . . . 0.0 111.921 175.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -139.04 20.72 2.63 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.657 1.183 . . . . 0.0 111.573 -169.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -66.24 119.66 11.9 Favored 'General case' 0 C--O 1.235 0.32 0 O-C-N 121.122 -0.986 . . . . 0.0 108.925 -172.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 67.3 m 49.01 35.03 6.17 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.848 1.659 . . . . 0.0 112.581 -174.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -52.22 -41.21 62.54 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.815 1.246 . . . . 0.0 112.061 -171.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.53 -18.09 64.51 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -169.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 39.5 mt -54.58 -42.78 71.47 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.718 0.807 . . . . 0.0 110.137 171.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.69 -34.17 89.2 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 -179.153 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.2 m -64.91 -36.37 84.14 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 117.959 0.88 . . . . 0.0 110.864 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 8.1 mt -67.97 -51.18 52.08 Favored 'Isoleucine or valine' 0 C--N 1.345 0.392 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 173.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 60.3 ttp85 -55.17 -44.3 75.1 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 119.514 1.052 . . . . 0.0 110.488 -175.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -58.81 -21.46 56.37 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.793 0.837 . . . . 0.0 112.683 -177.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 96.7 mt -96.34 -51.38 10.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 124.325 1.05 . . . . 0.0 109.728 176.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 31.9 pt -74.64 -32.49 29.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-N 119.674 1.124 . . . . 0.0 111.762 -169.148 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -67.46 -54.2 19.63 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-O 117.61 -1.186 . . . . 0.0 112.069 -174.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -66.28 -23.23 52.19 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 CA-C-N 121.483 1.565 . . . . 0.0 112.024 176.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 60.5 mtp85 -85.62 16.67 3.73 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.014 0.926 . . . . 0.0 112.319 177.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 82.19 14.4 76.91 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-O 118.157 -1.357 . . . . 0.0 116.146 166.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.68 144.45 57.02 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 119.59 1.695 . . . . 0.0 109.807 170.04 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 74.9 m -96.87 121.36 38.65 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 167.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 34.9 mt -102.04 128.37 54.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 -173.246 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 32.7 m -128.79 178.09 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 125.658 1.583 . . . . 0.0 108.72 175.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 74.57 28.91 62.46 Favored Glycine 0 CA--C 1.525 0.7 0 O-C-N 121.426 -0.796 . . . . 0.0 113.213 -179.246 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 80.2 m-70 -61.98 140.92 58.3 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 169.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 68.3 t-105 -129.47 135.29 27.33 Favored Pre-proline 0 CA--C 1.535 0.382 0 C-N-CA 124.042 0.937 . . . . 0.0 108.866 -173.1 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -65.72 143.87 75.84 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 121.974 1.783 . . . . 0.0 112.182 -170.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 57.5 p -76.14 -30.67 58.26 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.679 0.792 . . . . 0.0 111.199 177.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 52.78 39.52 28.89 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.182 1.793 . . . . 0.0 112.052 -178.094 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 67.54 56.15 12.56 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 16.7 p90 -54.24 -40.23 67.53 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.542 0.737 . . . . 0.0 112.111 -174.141 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 37.3 t60 53.57 47.7 23.34 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.925 1.69 . . . . 0.0 114.39 169.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -110.36 172.96 6.56 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.039 0.935 . . . . 0.0 108.58 166.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -61.46 -45.1 95.67 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 118.956 -0.545 . . . . 0.0 111.541 -168.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -161.06 141.93 11.44 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 123.406 0.682 . . . . 0.0 110.572 169.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 50.3 m -128.39 125.98 39.71 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 106.66 -1.608 . . . . 0.0 106.66 169.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.73 -6.36 46.33 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 121.774 -0.579 . . . . 0.0 111.915 -174.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -77.56 6.21 47.18 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.158 0.885 . . . . 0.0 113.433 173.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 93.5 mt -65.35 139.47 58.58 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 119.754 1.777 . . . . 0.0 109.864 176.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -106.14 -32.21 8.34 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.376 1.47 . . . . 0.0 108.184 167.086 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -146.45 161.78 39.68 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 128.143 2.577 . . . . 0.0 106.063 169.306 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -56.36 -29.44 61.4 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 121.108 -0.995 . . . . 0.0 112.276 176.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -90.29 -10.74 43.05 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.091 0.956 . . . . 0.0 113.448 179.068 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -144.81 124.74 13.49 Favored 'General case' 0 C--N 1.345 0.408 0 CA-C-N 119.862 1.21 . . . . 0.0 112.985 -171.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -73.17 153.24 40.8 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 166.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 8.4 p -64.84 -18.83 24.31 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 124.206 1.002 . . . . 0.0 112.081 178.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -161.36 176.02 37.93 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 -169.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -74.15 92.8 2.23 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -79.4 119.4 22.38 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 169.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 9.1 pt -74.99 164.61 3.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 169.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 32.0 t0 65.19 166.81 0.18 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.254 1.421 . . . . 0.0 112.164 -169.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -153.48 -42.4 0.09 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 127.065 2.146 . . . . 0.0 107.186 176.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -154.14 117.6 4.6 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 124.36 1.064 . . . . 0.0 109.472 170.056 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 3.3 tpm_? 49.29 66.75 1.02 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.966 2.106 . . . . 0.0 112.849 171.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 66.55 138.8 0.05 OUTLIER Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 128.525 2.73 . . . . 0.0 113.297 -178.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -70.25 153.02 67.04 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 123.198 2.598 . . . . 0.0 112.815 -173.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -111.65 -11.45 14.01 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.158 0.983 . . . . 0.0 111.46 169.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 72.5 mt -117.42 18.22 14.4 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.588 1.155 . . . . 0.0 112.166 -168.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 41.2 m -46.57 -57.53 4.66 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 125.561 1.544 . . . . 0.0 111.999 -170.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -71.03 -30.32 66.48 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 122.529 0.332 . . . . 0.0 111.237 -169.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -68.26 -46.68 69.76 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 173.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -66.98 -39.2 87.11 Favored 'General case' 0 N--CA 1.463 0.18 0 O-C-N 121.738 -0.601 . . . . 0.0 111.576 -174.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 29.0 m -71.2 -23.18 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 119.127 0.876 . . . . 0.0 111.378 177.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -74.24 -52.84 11.15 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 120.14 1.336 . . . . 0.0 109.16 170.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -58.24 -43.53 87.82 Favored 'General case' 0 N--CA 1.462 0.169 0 O-C-N 122.17 -0.331 . . . . 0.0 110.934 -175.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 58.5 t90 -67.62 -46.71 71.72 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 118.199 0.454 . . . . 0.0 110.039 -176.027 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 67.9 t -63.49 -38.57 82.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 O-C-N 122.015 -0.428 . . . . 0.0 110.044 -178.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -66.53 -37.02 84.1 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.368 -0.833 . . . . 0.0 110.266 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 17.8 mm100 -66.53 -51.8 52.66 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.371 0.532 . . . . 0.0 110.917 175.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 15.5 pt -65.85 -29.24 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-N 119.469 1.032 . . . . 0.0 110.8 -176.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 70.6 m -58.9 -26.62 64.47 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 117.79 -1.1 . . . . 0.0 112.386 178.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -96.31 -9.57 29.87 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 120.341 1.428 . . . . 0.0 112.769 175.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -85.16 -39.72 17.55 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 119.138 0.881 . . . . 0.0 110.0 169.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 80.5 mt -87.28 -10.98 50.95 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.836 2.054 . . . . 0.0 111.531 -179.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 55.67 32.66 19.76 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.955 1.702 . . . . 0.0 112.535 -171.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 81.2 mt -75.6 -21.57 57.67 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.804 -0.56 . . . . 0.0 110.069 169.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -57.59 -38.54 75.06 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.514 0.726 . . . . 0.0 110.406 174.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -66.86 -10.38 47.66 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 121.62 -0.675 . . . . 0.0 112.55 178.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 39.8 mt -105.66 -54.74 6.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 125.104 1.361 . . . . 0.0 108.079 -178.17 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.2 pp -78.14 -24.12 47.5 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 122.959 0.503 . . . . 0.0 112.278 -173.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -127.0 39.91 3.82 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.601 1.96 . . . . 0.0 108.948 -174.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.388 0 C-N-CA 123.751 0.82 . . . . 0.0 109.466 174.486 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 120.624 0.249 . . . . 0.0 110.561 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.02 153.33 43.96 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.076 0.55 . . . . 0.0 109.728 172.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 31.6 pt -85.73 -23.64 7.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 122.413 0.285 . . . . 0.0 111.592 -177.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 11.7 m -109.36 128.11 54.85 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 125.235 1.414 . . . . 0.0 108.858 179.128 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -103.55 122.02 7.29 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 106.927 -2.469 . . . . 0.0 106.927 168.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 57.6 mt -100.99 92.35 2.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 N-CA-C 105.144 -2.169 . . . . 0.0 105.144 177.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -88.6 132.17 34.65 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 -178.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -130.06 133.28 46.6 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 119.521 1.055 . . . . 0.0 111.617 176.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -88.02 145.5 19.27 Favored Glycine 0 C--N 1.339 0.726 0 N-CA-C 108.384 -1.886 . . . . 0.0 108.384 171.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -159.47 176.35 12.2 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 119.446 1.623 . . . . 0.0 112.903 179.139 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -146.8 -47.22 0.18 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.944 2.098 . . . . 0.0 108.802 168.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 35.8 p -84.01 -15.86 46.07 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.14 0.976 . . . . 0.0 112.606 177.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 79.62 18.9 72.23 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-O 118.823 -0.987 . . . . 0.0 112.61 -174.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -74.16 -40.52 62.53 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.628 1.714 . . . . 0.0 110.182 178.343 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -62.27 -25.78 68.03 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.457 1.103 . . . . 0.0 111.827 177.304 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -59.53 -42.61 92.7 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 118.729 0.695 . . . . 0.0 110.222 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -67.7 -34.39 76.79 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 121.828 -0.545 . . . . 0.0 110.459 -179.149 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.6 mm -64.5 -46.92 91.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 175.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.77 -41.91 92.12 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 122.982 0.513 . . . . 0.0 111.042 178.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -63.38 -42.74 98.84 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 119.03 -0.51 . . . . 0.0 110.891 176.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 72.6 mtm -68.65 -27.78 66.3 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 119.175 0.898 . . . . 0.0 111.695 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 54.2 mt -69.8 -51.23 42.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 170.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -60.54 -41.41 94.4 Favored 'General case' 0 C--O 1.225 -0.22 0 O-C-N 121.688 -0.633 . . . . 0.0 111.404 -175.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.37 -38.27 86.37 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 118.86 0.755 . . . . 0.0 110.699 -177.098 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -74.52 -37.3 63.12 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 122.879 0.472 . . . . 0.0 111.091 178.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.7 mp -74.29 -34.62 63.58 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.311 0.505 . . . . 0.0 111.198 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.59 145.08 16.61 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 125.157 1.36 . . . . 0.0 110.511 -173.258 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -65.59 -30.16 70.86 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.679 0.792 . . . . 0.0 112.155 -172.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -68.05 -29.47 68.45 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 122.1 -0.375 . . . . 0.0 110.887 177.06 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 38.9 t -91.69 -36.72 8.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 C-N-CA 124.413 1.085 . . . . 0.0 110.096 -175.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -136.55 145.78 45.41 Favored 'General case' 0 C--N 1.34 0.183 0 CA-C-N 119.366 0.985 . . . . 0.0 113.283 -172.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -131.49 141.58 49.79 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.61 1.164 . . . . 0.0 109.889 174.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 83.3 t -89.24 139.44 17.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 124.002 0.921 . . . . 0.0 109.107 -178.269 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -149.45 173.35 13.66 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.449 1.1 . . . . 0.0 111.425 -168.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -147.96 121.43 9.09 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 125.926 1.691 . . . . 0.0 108.081 -172.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.2 tp -60.14 -22.24 24.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 123.819 0.848 . . . . 0.0 112.267 -171.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.84 -27.91 67.04 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 118.848 0.749 . . . . 0.0 111.251 178.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt -87.69 -21.25 25.33 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.244 1.018 . . . . 0.0 111.481 178.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 70.8 m -74.91 168.79 19.24 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.6 1.16 . . . . 0.0 112.359 -169.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 68.9 m -156.58 178.33 10.45 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.32 2.248 . . . . 0.0 106.995 177.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 27.4 tptp -50.42 -46.79 56.61 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.814 0.845 . . . . 0.0 111.997 -175.266 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -80.19 -11.6 59.72 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -173.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -76.76 -43.03 38.67 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 121.531 -0.731 . . . . 0.0 111.464 -172.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.7 mp -75.72 -28.74 58.68 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 118.033 0.379 . . . . 0.0 111.121 178.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -63.48 -18.1 63.43 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.91 0.884 . . . . 0.0 111.422 -177.166 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.21 -29.59 65.33 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.316 1.046 . . . . 0.0 112.728 177.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -89.18 156.84 18.54 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.346 1.058 . . . . 0.0 110.472 -175.491 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -107.64 -27.12 10.52 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.621 171.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.0 mp -116.76 130.37 71.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 175.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -113.88 116.55 29.48 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 177.199 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -103.16 112.45 25.32 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 104.623 -2.362 . . . . 0.0 104.623 171.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.4 mt -117.18 107.68 14.76 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -170.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -90.78 105.11 3.23 Favored Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 178.03 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.9 tp -115.87 102.59 53.99 Favored Pre-proline 0 CA--C 1.536 0.405 0 C-N-CA 125.024 1.33 . . . . 0.0 108.86 -174.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -72.85 143.14 36.42 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 121.289 1.326 . . . . 0.0 108.675 169.023 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 50.0 m -90.95 137.37 32.42 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 173.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 45.2 m95 -132.98 175.87 8.99 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 125.948 1.699 . . . . 0.0 108.896 -177.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 42.54 48.18 4.57 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.844 2.058 . . . . 0.0 114.092 168.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.3 p90 48.3 66.7 0.99 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.221 1.408 . . . . 0.0 111.963 176.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 87.89 52.54 2.92 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 124.303 0.954 . . . . 0.0 111.701 175.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -143.55 164.27 30.85 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.032 1.333 . . . . 0.0 108.777 174.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -82.84 161.38 21.95 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 167.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -62.42 149.21 43.17 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 168.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 65.9 m -56.74 -36.13 69.41 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.007 0.923 . . . . 0.0 113.144 -168.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -68.85 -38.05 79.52 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 118.894 0.77 . . . . 0.0 110.756 -177.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -69.82 -46.5 65.51 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 175.259 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -58.52 -39.93 81.5 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 122.717 0.407 . . . . 0.0 111.65 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -68.77 -23.44 64.31 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 123.924 0.889 . . . . 0.0 112.169 177.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -95.35 -20.12 19.39 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.452 0.701 . . . . 0.0 112.328 -178.066 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 21.5 m-30 -49.94 -40.47 54.76 Favored Pre-proline 0 CA--C 1.544 0.746 0 CA-C-O 116.656 -1.64 . . . . 0.0 114.47 176.25 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -63.78 -26.83 67.85 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 CA-C-N 123.032 2.119 . . . . 0.0 113.094 174.034 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.4 m -78.32 -35.11 48.15 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 119.576 1.08 . . . . 0.0 109.661 171.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 16.8 tp -63.36 -27.46 69.33 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 121.185 -0.947 . . . . 0.0 111.495 -176.224 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -87.67 -0.12 56.46 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.974 0.91 . . . . 0.0 112.964 174.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -96.33 -36.07 11.0 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 119.384 0.993 . . . . 0.0 108.469 169.05 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 68.0 mt -61.34 133.66 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -85.31 136.87 33.3 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 123.387 0.675 . . . . 0.0 109.545 176.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -129.14 18.32 6.01 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.97 0.908 . . . . 0.0 110.818 175.178 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -58.55 112.42 1.59 Allowed 'General case' 0 C--N 1.341 0.196 0 CA-C-N 120.373 1.442 . . . . 0.0 109.925 -176.112 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.37 1.57 57.67 Favored Glycine 0 CA--C 1.535 1.309 0 CA-C-O 118.599 -1.111 . . . . 0.0 114.207 -178.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -75.0 154.9 37.85 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 119.971 1.886 . . . . 0.0 107.689 170.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 27.2 mt -95.63 141.88 28.6 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.0 t -135.52 144.03 35.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 176.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -141.33 146.19 36.4 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 125.105 1.362 . . . . 0.0 107.343 172.166 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 68.8 mt -119.59 144.98 46.8 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 -170.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -143.54 165.89 26.32 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 123.608 0.763 . . . . 0.0 109.161 170.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -175.26 164.62 35.19 Favored Glycine 0 CA--C 1.521 0.418 0 CA-C-O 122.342 0.968 . . . . 0.0 112.623 179.336 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 38.1 m -115.89 159.25 21.8 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 125.725 1.61 . . . . 0.0 107.765 175.211 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -149.17 -164.18 11.44 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 175.276 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -148.81 153.05 37.57 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 117.639 0.719 . . . . 0.0 110.463 174.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -113.88 -1.86 13.76 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -168.536 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -70.79 -42.84 69.8 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 119.577 1.08 . . . . 0.0 110.669 -177.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -136.48 -32.77 0.83 Allowed 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -177.09 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -85.25 18.24 2.71 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -174.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.75 -14.29 62.83 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -174.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -89.93 0.13 57.25 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.074 0.95 . . . . 0.0 111.456 173.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -132.44 26.05 4.45 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 126.237 1.815 . . . . 0.0 109.303 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -64.92 121.09 13.82 Favored 'General case' 0 N--CA 1.452 -0.356 0 O-C-N 121.671 -0.643 . . . . 0.0 110.271 -168.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 74.5 m 48.42 34.29 4.63 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.363 1.865 . . . . 0.0 113.608 -177.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -54.42 -38.6 66.45 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.136 0.974 . . . . 0.0 113.132 -177.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.27 -12.53 61.65 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -170.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 52.2 mt -57.32 -40.64 78.34 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 118.67 0.668 . . . . 0.0 109.691 169.284 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -63.78 -31.62 81.4 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 123.591 0.615 . . . . 0.0 111.707 -179.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.6 m -65.77 -44.62 85.26 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 117.97 0.885 . . . . 0.0 109.905 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 4.3 mt -69.95 -40.9 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 119.029 0.832 . . . . 0.0 109.207 178.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 51.9 tpt85 -56.85 -33.24 66.6 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 118.469 0.577 . . . . 0.0 111.729 177.14 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -74.23 -33.76 63.46 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.242 0.617 . . . . 0.0 111.852 176.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 75.8 mt -79.34 -43.57 23.79 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 123.567 0.747 . . . . 0.0 110.629 -175.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 6.1 pt -76.8 -21.06 14.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 118.773 0.715 . . . . 0.0 112.923 -168.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -62.39 -56.66 28.43 Favored Pre-proline 0 CA--C 1.544 0.718 0 CA-C-O 117.604 -1.189 . . . . 0.0 112.273 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -66.71 -16.48 50.52 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 122.339 2.026 . . . . 0.0 112.915 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 19.4 mmm180 -84.6 4.04 34.08 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.409 0.684 . . . . 0.0 112.018 172.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 79.46 16.45 77.94 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 124.583 1.087 . . . . 0.0 113.953 170.032 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.32 146.68 47.22 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 118.551 1.175 . . . . 0.0 111.423 177.307 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 67.8 m -96.92 126.84 42.35 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 104.583 -2.377 . . . . 0.0 104.583 167.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 19.9 mt -113.18 131.6 64.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 -168.061 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 31.0 m -136.49 -177.87 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 124.725 1.21 . . . . 0.0 109.501 177.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 81.75 39.5 11.92 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-O 119.48 -0.622 . . . . 0.0 113.577 172.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 25.5 m170 -64.52 158.11 24.99 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.438 1.119 . . . . 0.0 109.718 169.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 43.8 t-105 -135.81 135.07 21.13 Favored Pre-proline 0 CA--C 1.536 0.433 0 CA-C-O 117.955 -1.021 . . . . 0.0 108.923 173.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_exo -65.68 145.93 82.75 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 121.781 1.654 . . . . 0.0 113.366 -175.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 36.2 p -71.97 -35.59 69.59 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 121.684 -0.635 . . . . 0.0 109.819 169.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 51.7 43.98 29.54 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.082 1.753 . . . . 0.0 111.923 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 69.9 54.75 10.9 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -61.1 154.54 22.7 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 122.861 0.464 . . . . 0.0 110.822 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 43.9 t60 -134.57 44.99 2.61 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.789 0.836 . . . . 0.0 110.604 -172.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -106.01 166.48 10.47 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.653 1.181 . . . . 0.0 108.156 173.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -67.12 -45.85 75.89 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 121.954 -0.466 . . . . 0.0 110.67 -170.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -160.65 114.25 2.08 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.994 0.917 . . . . 0.0 109.176 169.192 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 75.1 m -87.98 125.77 34.71 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 170.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -101.7 -9.65 20.68 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.087 0.555 . . . . 0.0 112.329 -176.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -77.35 -2.21 78.53 Favored Glycine 0 CA--C 1.537 1.435 0 CA-C-N 118.763 0.71 . . . . 0.0 113.529 173.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 8.5 mp -58.31 133.14 55.43 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 119.027 1.413 . . . . 0.0 110.558 174.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -95.64 -31.41 13.27 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.067 0.947 . . . . 0.0 108.595 167.179 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -144.32 162.86 35.34 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 127.14 2.176 . . . . 0.0 106.764 170.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -52.64 -30.14 29.99 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.368 0.667 . . . . 0.0 112.305 175.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -86.03 -17.81 34.2 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -178.251 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 30.0 p-80 -154.31 141.12 19.11 Favored 'General case' 0 C--N 1.347 0.469 0 CA-C-N 120.577 1.535 . . . . 0.0 114.684 -176.063 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -72.14 150.67 43.6 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.356 1.463 . . . . 0.0 108.555 167.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 8.8 p -69.41 -20.61 24.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 123.373 0.669 . . . . 0.0 111.515 175.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -148.22 171.05 28.73 Favored Glycine 0 C--N 1.337 0.589 0 C-N-CA 124.72 1.152 . . . . 0.0 110.264 -177.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -67.37 112.99 4.89 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 175.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -116.89 95.29 4.94 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.875 1.27 . . . . 0.0 108.048 -174.498 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 2.9 pt -92.32 120.19 41.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -169.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -175.42 145.72 0.76 Allowed 'General case' 0 C--O 1.24 0.602 0 C-N-CA 130.962 3.705 . . . . 0.0 104.733 168.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -124.73 -53.14 1.67 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 119.371 0.987 . . . . 0.0 110.739 172.088 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -150.85 81.69 1.33 Allowed 'General case' 0 C--O 1.235 0.304 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 57.8 93.16 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.362 1.865 . . . . 0.0 109.88 -173.444 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 87.2 mm-40 68.72 148.27 0.12 Allowed Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 127.918 2.487 . . . . 0.0 111.023 -168.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -72.37 151.77 54.29 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 122.087 1.858 . . . . 0.0 110.591 177.151 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -126.12 -20.43 4.52 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.298 1.839 . . . . 0.0 111.632 170.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 79.4 mt -94.06 24.87 4.02 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.416 1.886 . . . . 0.0 109.604 172.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 26.0 m -46.9 -57.35 5.04 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 126.688 1.995 . . . . 0.0 111.187 -170.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -75.43 -33.88 60.95 Favored 'General case' 0 N--CA 1.452 -0.373 0 O-C-N 122.233 -0.292 . . . . 0.0 110.557 -171.001 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 25.1 mp0 -64.71 -45.46 86.48 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.307 1.043 . . . . 0.0 109.444 178.313 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -66.03 -40.5 91.09 Favored 'General case' 0 N--CA 1.463 0.206 0 O-C-N 121.535 -0.728 . . . . 0.0 110.246 178.102 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 69.8 t -68.04 -33.47 61.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 118.916 0.78 . . . . 0.0 110.087 179.224 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -65.31 -51.92 57.46 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 120.416 1.462 . . . . 0.0 109.621 171.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -61.32 -27.89 68.81 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 118.74 -0.648 . . . . 0.0 111.501 -177.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 36.1 t90 -81.47 -51.99 7.71 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 119.174 0.897 . . . . 0.0 110.456 177.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 77.8 t -67.2 -31.09 51.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 O-C-N 121.376 -0.828 . . . . 0.0 110.584 -170.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -61.9 -35.0 77.08 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 121.2 -0.937 . . . . 0.0 110.856 174.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 63.0 mt-30 -69.91 -49.26 53.8 Favored 'General case' 0 C--N 1.341 0.219 0 C-N-CA 123.353 0.661 . . . . 0.0 110.664 173.081 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 2.7 pt -62.76 -33.19 58.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-N 119.266 0.939 . . . . 0.0 109.872 -175.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 48.2 m -61.31 -30.45 70.5 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 118.478 -0.772 . . . . 0.0 111.887 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -90.44 -26.0 20.06 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.877 1.217 . . . . 0.0 112.024 176.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -72.28 -38.46 68.78 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.057 0.844 . . . . 0.0 110.758 174.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 78.3 mt -83.49 -9.36 59.03 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.804 1.642 . . . . 0.0 111.544 179.236 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 55.33 32.53 18.9 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.621 1.568 . . . . 0.0 112.544 -170.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 80.3 mt -76.51 -20.91 56.43 Favored 'General case' 0 N--CA 1.465 0.278 0 O-C-N 121.571 -0.706 . . . . 0.0 110.37 170.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -55.6 -38.33 69.28 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 118.991 0.814 . . . . 0.0 110.486 173.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -67.54 -11.4 57.93 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 121.736 -0.603 . . . . 0.0 112.567 178.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 42.6 mt -104.46 -55.2 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 125.096 1.358 . . . . 0.0 108.413 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.5 pp -79.1 -23.81 43.86 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.39 0.676 . . . . 0.0 112.289 -171.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -124.33 35.94 4.71 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.32 1.848 . . . . 0.0 109.33 -175.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.17 0 CA-C-O 118.327 -0.844 . . . . 0.0 109.577 174.447 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.3 tpt . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 110.329 -0.249 . . . . 0.0 110.329 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.7 152.06 41.87 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.189 0.596 . . . . 0.0 110.056 175.405 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 17.6 pt -88.11 -22.34 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 122.397 0.279 . . . . 0.0 111.309 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.9 m -112.43 127.19 55.96 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.725 1.21 . . . . 0.0 109.294 -174.505 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -100.46 115.13 5.22 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 106.88 -2.488 . . . . 0.0 106.88 167.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 84.8 mt -88.66 116.12 29.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 104.068 -2.567 . . . . 0.0 104.068 169.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -112.13 127.6 55.97 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 173.258 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -132.88 136.86 46.45 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 119.478 1.036 . . . . 0.0 112.234 -178.114 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -85.43 158.59 32.73 Favored Glycine 0 CA--C 1.533 1.197 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 167.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 17.0 m -159.53 167.63 28.12 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 119.406 1.603 . . . . 0.0 110.526 176.126 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -144.81 -55.89 0.33 Allowed 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.419 0.688 . . . . 0.0 110.711 169.326 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 39.0 p -81.73 -6.38 58.98 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.731 0.812 . . . . 0.0 112.287 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 78.5 27.68 56.86 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-O 119.501 -0.611 . . . . 0.0 111.734 -172.116 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -87.64 -49.73 6.96 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-N 118.193 0.996 . . . . 0.0 110.115 173.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 26.9 m -70.09 -24.0 63.15 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 118.494 0.588 . . . . 0.0 111.517 -170.462 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -59.31 -34.46 72.35 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 121.388 -0.82 . . . . 0.0 111.26 174.191 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -70.96 -31.46 68.03 Favored 'General case' 0 C--O 1.226 -0.164 0 O-C-N 121.34 -0.85 . . . . 0.0 110.053 -179.12 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 23.1 mm -66.59 -47.73 82.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 176.515 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.71 -43.13 90.01 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 122.731 0.412 . . . . 0.0 111.389 176.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -69.42 -40.0 77.53 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-O 118.787 -0.625 . . . . 0.0 111.346 -178.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 68.1 mtm -61.81 -46.29 90.13 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 119.266 0.939 . . . . 0.0 109.755 174.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 75.2 mt -58.28 -47.16 88.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 177.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -59.5 -40.31 86.62 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 119.551 1.069 . . . . 0.0 111.456 178.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 59.0 tptt -64.23 -39.36 93.8 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 119.376 0.989 . . . . 0.0 110.222 178.554 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -69.43 -41.12 76.77 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.729 0.811 . . . . 0.0 110.959 179.343 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -73.89 -38.47 64.36 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.641 1.176 . . . . 0.0 110.56 -178.305 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.32 145.55 17.51 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 125.598 1.571 . . . . 0.0 110.759 -171.625 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.6 tptp -62.54 -30.2 71.13 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.449 1.1 . . . . 0.0 111.692 -175.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -68.92 -25.1 64.41 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.293 0.637 . . . . 0.0 111.412 178.034 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.2 t -99.82 -36.84 5.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 C-N-CA 124.106 0.962 . . . . 0.0 110.339 -175.212 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -133.5 139.57 46.73 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 119.32 0.964 . . . . 0.0 113.517 -175.193 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -122.22 150.25 42.54 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.484 1.114 . . . . 0.0 109.486 172.351 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 53.1 t -111.79 139.09 37.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 123.804 0.842 . . . . 0.0 110.93 -168.489 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -147.33 166.45 27.07 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.72 2.008 . . . . 0.0 111.101 -171.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -124.73 134.97 52.64 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 105.73 -1.952 . . . . 0.0 105.73 169.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.8 tp -60.14 -18.91 16.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 119.271 0.941 . . . . 0.0 112.556 -173.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -51.49 -37.71 50.42 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.442 1.097 . . . . 0.0 112.223 177.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.8 -1.42 56.8 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.346 0.658 . . . . 0.0 112.52 -178.295 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 64.4 m -79.81 156.39 27.42 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 122.287 1.042 . . . . 0.0 111.474 -177.277 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 33.6 p -127.41 176.64 7.3 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 127.371 2.268 . . . . 0.0 106.656 169.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -56.08 -36.33 67.99 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.776 -0.578 . . . . 0.0 111.837 -177.305 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -86.44 -11.72 51.08 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.014 0.526 . . . . 0.0 112.325 -176.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -69.52 -33.39 72.75 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 121.346 -0.846 . . . . 0.0 112.153 -169.385 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.7 mp -80.95 -31.86 34.73 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 122.936 0.494 . . . . 0.0 110.437 176.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -67.93 -18.46 64.77 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 123.279 0.632 . . . . 0.0 111.884 -172.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.12 -28.31 69.55 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.761 1.224 . . . . 0.0 112.157 175.013 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -96.79 157.65 15.8 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.436 1.094 . . . . 0.0 110.598 -179.252 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -104.82 -30.48 9.85 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.219 171.241 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.1 mm -106.7 138.63 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 174.237 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 86.0 mt -132.05 129.69 40.35 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 177.214 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.6 mp -114.22 113.84 25.19 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 172.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 61.2 mt -110.59 109.67 20.07 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 -170.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.68 118.61 5.63 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 125.726 1.632 . . . . 0.0 109.575 178.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.7 tp -135.03 108.91 10.59 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 117.994 0.897 . . . . 0.0 109.358 -170.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -76.19 146.03 28.12 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 121.762 1.641 . . . . 0.0 110.355 170.285 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 42.9 m -99.19 131.7 45.03 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 175.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 8.4 m95 -137.19 174.83 10.19 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 123.916 0.886 . . . . 0.0 111.63 -170.345 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 60.85 -76.69 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 128.557 2.743 . . . . 0.0 113.957 171.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -149.23 39.24 0.82 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.82 1.648 . . . . 0.0 109.841 -170.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.74 56.28 6.73 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 -170.026 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -131.18 164.54 25.29 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.264 1.426 . . . . 0.0 108.984 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.87 161.83 28.65 Favored 'General case' 0 C--O 1.236 0.354 0 O-C-N 121.848 -0.533 . . . . 0.0 110.09 169.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -71.1 154.85 41.42 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 170.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 58.6 m -59.16 -36.92 76.12 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.858 0.863 . . . . 0.0 112.885 -169.363 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -65.73 -43.14 89.9 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 118.505 0.593 . . . . 0.0 110.056 -178.4 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -69.39 -47.42 64.27 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.381 0.672 . . . . 0.0 109.81 177.427 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -60.09 -35.87 76.16 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.425 0.69 . . . . 0.0 111.818 -177.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -70.45 -25.83 63.37 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.861 0.864 . . . . 0.0 112.248 176.146 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -92.76 -21.4 19.96 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.312 0.645 . . . . 0.0 112.076 -179.039 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 17.0 m-30 -48.66 -42.99 61.28 Favored Pre-proline 0 CA--C 1.547 0.865 0 CA-C-O 116.86 -1.543 . . . . 0.0 114.52 177.133 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -64.52 -23.38 64.46 Favored 'Trans proline' 0 CA--C 1.544 1.019 0 CA-C-N 122.972 2.097 . . . . 0.0 113.462 175.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.1 m -79.63 -40.28 29.6 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 119.302 0.955 . . . . 0.0 109.001 170.46 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 16.7 tp -60.85 -32.16 71.57 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.726 1.21 . . . . 0.0 111.798 -172.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -78.53 -11.14 59.94 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.999 0.92 . . . . 0.0 112.361 177.472 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -87.18 -32.92 19.56 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 119.818 1.19 . . . . 0.0 110.035 170.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 86.7 mt -63.93 143.13 15.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 -178.513 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -98.18 133.8 42.12 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.121 0.968 . . . . 0.0 108.865 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -124.2 14.6 9.05 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 118.306 -0.854 . . . . 0.0 111.032 178.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -56.71 115.46 2.57 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-N 119.963 1.256 . . . . 0.0 109.345 -178.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.76 2.91 62.03 Favored Glycine 0 CA--C 1.535 1.291 0 CA-C-O 118.368 -1.24 . . . . 0.0 114.174 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -79.18 147.25 32.71 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 119.675 1.737 . . . . 0.0 107.287 170.266 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 8.4 mt -95.09 134.27 37.99 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 178.238 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 15.2 t -130.86 145.28 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 178.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -136.2 151.13 49.38 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 170.225 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 81.5 mt -120.63 148.1 44.35 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -171.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -145.81 166.26 26.44 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 169.305 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 178.33 172.16 42.43 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-O 122.692 1.162 . . . . 0.0 114.566 177.159 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 68.7 m -123.02 151.19 42.15 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 112.936 -1.632 . . . . 0.0 109.526 -169.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -169.49 176.92 43.31 Favored Glycine 0 N--CA 1.442 -0.957 0 N-CA-C 109.634 -1.387 . . . . 0.0 109.634 -172.336 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -127.03 110.23 12.74 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 177.339 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -78.93 -6.69 56.85 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 118.692 -0.671 . . . . 0.0 112.381 -169.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -111.72 -41.71 3.99 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.49 1.041 . . . . 0.0 110.639 -176.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -82.63 -29.0 30.4 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 121.76 -0.587 . . . . 0.0 111.999 -175.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -122.65 50.64 1.48 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.298 1.439 . . . . 0.0 108.974 172.318 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.57 -19.76 50.92 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 126.175 1.79 . . . . 0.0 115.401 -170.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -108.44 4.08 23.92 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.207 1.003 . . . . 0.0 112.929 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -127.98 19.96 6.49 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.046 1.338 . . . . 0.0 110.689 -178.557 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -65.96 128.52 36.36 Favored 'General case' 0 C--O 1.234 0.285 0 O-C-N 121.458 -0.777 . . . . 0.0 110.93 -168.354 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 95.5 m 52.25 31.39 9.19 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.918 1.687 . . . . 0.0 113.937 176.184 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -56.02 -41.3 74.72 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.02 -21.12 64.14 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 -168.144 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 7.7 mp -60.29 -40.04 89.07 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 119.113 0.87 . . . . 0.0 109.798 172.198 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.12 -33.81 88.25 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 177.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 5.8 m -64.11 -38.45 91.1 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.26 1.03 . . . . 0.0 110.177 177.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 4.0 mt -66.66 -44.58 89.62 Favored 'Isoleucine or valine' 0 C--N 1.344 0.366 0 CA-C-O 117.632 -1.175 . . . . 0.0 109.075 175.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 60.3 ttp85 -55.75 -45.62 78.0 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 120.174 1.352 . . . . 0.0 110.136 178.118 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -60.44 -25.2 65.81 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -178.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 78.6 mt -87.27 -45.44 16.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 123.989 0.916 . . . . 0.0 110.667 176.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.6 pt -86.43 -22.86 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 120.114 1.325 . . . . 0.0 112.779 -169.468 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -67.34 -46.12 49.45 Favored Pre-proline 0 CA--C 1.545 0.751 0 CA-C-O 117.436 -1.268 . . . . 0.0 111.661 -177.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -60.68 -28.1 85.95 Favored 'Trans proline' 0 C--N 1.356 0.934 0 C-N-CA 122.061 1.841 . . . . 0.0 112.969 172.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 15.4 mmm180 -86.37 10.57 14.58 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.877 1.271 . . . . 0.0 111.764 -177.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 77.81 15.67 80.95 Favored Glycine 0 CA--C 1.529 0.91 0 CA-C-O 118.494 -1.17 . . . . 0.0 114.721 169.066 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.31 141.01 56.79 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 119.072 1.436 . . . . 0.0 109.834 173.207 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 55.5 m -92.73 121.96 34.66 Favored 'General case' 0 C--O 1.232 0.133 0 N-CA-C 105.337 -2.098 . . . . 0.0 105.337 168.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 43.6 mt -105.12 123.39 59.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 -171.296 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 26.8 m -126.15 174.77 9.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 125.149 1.379 . . . . 0.0 109.011 178.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 78.24 33.28 40.51 Favored Glycine 0 CA--C 1.527 0.796 0 O-C-N 121.844 -0.535 . . . . 0.0 112.333 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -63.86 143.88 57.5 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 169.451 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' TRP . . . . . 0.421 ' HE1' ' NH2' ' A' ' 156' ' ' ARG . 72.8 t-105 -135.74 133.88 20.36 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 118.199 -0.905 . . . . 0.0 108.936 -167.71 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -68.32 141.77 52.71 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 121.496 1.464 . . . . 0.0 112.442 -170.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 12.6 p -70.03 -30.22 67.45 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 122.732 0.413 . . . . 0.0 110.041 169.202 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 54.48 44.81 28.24 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 126.39 1.876 . . . . 0.0 111.56 176.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 72.55 67.96 1.71 Allowed Glycine 0 C--N 1.34 0.775 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -177.151 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -48.1 125.53 9.32 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.496 0.719 . . . . 0.0 109.402 172.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -92.39 -28.09 17.1 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 -168.2 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -91.03 -164.77 1.23 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.736 0.814 . . . . 0.0 111.652 -169.167 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -67.42 -58.75 4.19 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -168.069 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -159.32 147.51 17.69 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 118.803 0.729 . . . . 0.0 111.291 179.008 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -129.64 135.18 48.22 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 125.08 1.352 . . . . 0.0 108.338 178.075 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -109.79 -5.34 15.6 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.102 0.561 . . . . 0.0 112.471 -171.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -78.1 1.21 70.45 Favored Glycine 0 CA--C 1.532 1.143 0 CA-C-N 118.871 0.759 . . . . 0.0 113.078 171.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 7.9 mp -62.88 132.69 52.98 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 118.872 1.336 . . . . 0.0 110.869 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -96.01 -29.64 14.03 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.384 1.474 . . . . 0.0 108.584 166.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -145.28 161.77 38.8 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 127.511 2.325 . . . . 0.0 106.558 170.165 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -53.5 -33.28 53.84 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 119.438 1.017 . . . . 0.0 112.355 176.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -89.08 -7.52 55.67 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.831 0.853 . . . . 0.0 113.245 -178.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 64.6 m80 -146.8 125.19 12.32 Favored 'General case' 0 C--N 1.347 0.491 0 CA-C-N 119.759 1.163 . . . . 0.0 113.95 -170.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -69.79 151.84 45.3 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 164.136 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 9.0 p -69.74 -12.61 16.26 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 123.881 0.873 . . . . 0.0 111.946 175.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -164.48 171.02 39.86 Favored Glycine 0 CA--C 1.523 0.562 0 O-C-N 121.29 -0.881 . . . . 0.0 111.187 -172.028 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -67.22 114.74 6.19 Favored 'General case' 0 C--N 1.334 -0.09 0 C-N-CA 123.755 0.822 . . . . 0.0 108.975 -178.472 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -89.98 140.47 29.6 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 170.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 9.0 tp -46.94 -46.21 8.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 C-N-CA 124.721 1.208 . . . . 0.0 113.982 -172.329 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -162.07 179.21 8.14 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.983 1.313 . . . . 0.0 108.791 -176.581 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -109.72 44.75 1.15 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.442 1.097 . . . . 0.0 109.345 169.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -157.15 166.74 32.41 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 125.068 1.347 . . . . 0.0 108.455 -170.405 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 25.3 ttm180 -47.09 -42.78 19.54 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.542 1.137 . . . . 0.0 111.811 168.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -127.65 159.08 67.92 Favored Pre-proline 0 CA--C 1.542 0.673 0 C-N-CA 125.017 1.327 . . . . 0.0 111.229 -167.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -67.36 121.95 9.14 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.838 2.359 . . . . 0.0 110.615 171.107 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -128.4 -43.6 1.43 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.893 1.677 . . . . 0.0 110.592 177.375 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 82.2 mt -109.96 -1.31 17.75 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 126.017 1.727 . . . . 0.0 111.438 -174.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 52.9 m -41.76 -44.98 3.42 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.563 1.945 . . . . 0.0 113.299 -175.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -70.44 -31.5 68.7 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 119.155 0.888 . . . . 0.0 111.914 -173.36 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -71.98 -40.26 68.7 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 169.571 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.421 ' NH2' ' HE1' ' A' ' 120' ' ' TRP . 72.0 mtp85 -66.67 -38.26 86.46 Favored 'General case' 0 C--O 1.225 -0.186 0 CA-C-O 118.551 -0.737 . . . . 0.0 110.974 -174.25 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 26.8 m -69.3 -31.29 49.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-N 119.928 1.24 . . . . 0.0 111.179 177.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -65.49 -52.63 51.47 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 120.255 1.389 . . . . 0.0 109.501 171.358 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 39.3 mttp -61.15 -31.08 70.8 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 118.892 -0.575 . . . . 0.0 111.448 -177.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 61.5 t90 -78.92 -51.97 8.93 Favored 'General case' 0 N--CA 1.457 -0.094 0 CA-C-N 118.845 0.748 . . . . 0.0 111.19 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 56.8 t -63.72 -31.29 52.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 O-C-N 121.563 -0.711 . . . . 0.0 110.26 -175.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -59.48 -35.44 74.11 Favored 'General case' 0 CA--C 1.532 0.26 0 O-C-N 121.283 -0.886 . . . . 0.0 111.368 174.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -63.95 -53.57 48.16 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 118.711 0.687 . . . . 0.0 109.956 172.635 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 2.2 pt -69.0 -26.86 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 O-C-N 121.89 -0.507 . . . . 0.0 110.373 -170.071 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 46.1 m -58.97 -32.5 69.7 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 119.118 -0.468 . . . . 0.0 111.199 174.487 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -77.98 -43.75 28.7 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.553 1.07 . . . . 0.0 110.043 175.175 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -67.7 -34.06 76.13 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.587 0.755 . . . . 0.0 111.629 -174.396 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 83.7 mt -87.16 3.88 44.58 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.576 1.551 . . . . 0.0 111.108 177.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 25.9 m80 56.18 31.61 18.66 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.182 1.793 . . . . 0.0 113.001 -177.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 92.1 mt -80.97 -29.2 35.35 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 123.623 0.769 . . . . 0.0 110.304 173.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -57.72 -37.6 73.81 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.783 0.833 . . . . 0.0 110.43 176.068 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -65.47 -13.43 58.79 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.681 0.793 . . . . 0.0 112.471 178.196 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 50.0 mt -103.69 -56.68 4.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 125.17 1.388 . . . . 0.0 108.191 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.5 pp -79.46 -23.93 42.75 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -169.477 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -119.11 28.69 8.1 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.691 1.596 . . . . 0.0 110.224 -175.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.37 0 C-N-CA 123.919 0.887 . . . . 0.0 109.364 173.632 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.6 tpt . . . . . 0 N--CA 1.485 1.325 0 N-CA-C 110.37 -0.233 . . . . 0.0 110.37 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -57.91 146.62 31.51 Favored 'General case' 0 C--N 1.344 0.351 0 C-N-CA 123.778 0.831 . . . . 0.0 111.385 177.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.9 pt -105.9 -14.98 8.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 125.248 1.419 . . . . 0.0 111.13 178.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 88.2 m -119.43 127.91 53.54 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.989 1.316 . . . . 0.0 108.826 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -91.28 129.34 9.75 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 107.856 -2.098 . . . . 0.0 107.856 169.359 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 33.0 mt -103.83 95.75 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 103.368 -2.827 . . . . 0.0 103.368 171.133 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 19.6 m-30 -100.16 129.65 46.21 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 -177.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 26.1 p90 -132.93 163.99 27.94 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 118.424 0.556 . . . . 0.0 110.99 -172.149 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -140.03 139.2 9.67 Favored Glycine 0 C--N 1.336 0.554 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 168.077 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.8 m -141.29 167.52 21.98 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.932 1.366 . . . . 0.0 110.696 -174.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -136.83 -50.8 0.66 Allowed 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.509 0.724 . . . . 0.0 110.157 168.24 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.3 p -82.48 -11.63 58.36 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.607 0.763 . . . . 0.0 112.084 171.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.92 6.59 51.93 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 124.961 1.267 . . . . 0.0 113.747 170.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -70.69 -44.05 67.77 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 118.757 1.279 . . . . 0.0 111.731 -173.213 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.01 -27.33 67.33 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 120.97 -1.081 . . . . 0.0 111.146 -175.175 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -62.57 -42.11 99.34 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 118.719 0.691 . . . . 0.0 109.85 172.146 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -63.5 -42.25 98.51 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 121.8 -0.562 . . . . 0.0 110.377 178.523 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 21.0 mm -62.06 -46.34 96.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 176.448 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.6 -41.38 94.65 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 121.929 -0.482 . . . . 0.0 111.426 -179.22 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.2 mtpt -65.66 -40.91 92.93 Favored 'General case' 0 C--O 1.227 -0.098 0 CA-C-O 118.49 -0.767 . . . . 0.0 110.676 177.2 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 61.8 mtm -62.38 -40.98 98.23 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 119.73 1.15 . . . . 0.0 110.759 176.217 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 70.2 mt -59.96 -47.04 93.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 176.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -63.53 -37.84 88.87 Favored 'General case' 0 CA--C 1.53 0.181 0 O-C-N 121.017 -1.052 . . . . 0.0 111.685 178.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -65.05 -34.04 77.48 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 120.115 1.325 . . . . 0.0 111.088 178.308 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 12.9 mm100 -70.1 -43.66 70.6 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 118.184 0.447 . . . . 0.0 110.744 175.206 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -82.93 -32.5 27.18 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.461 0.704 . . . . 0.0 112.434 -170.414 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 90.45 144.42 11.97 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 124.852 1.215 . . . . 0.0 111.117 -169.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 56.5 tptt -57.36 -35.77 70.36 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 125.281 1.432 . . . . 0.0 111.864 -175.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -82.95 -1.94 53.74 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.009 0.523 . . . . 0.0 112.351 -176.249 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.5 t -110.01 -46.93 6.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 123.769 0.828 . . . . 0.0 109.186 176.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -131.65 139.55 49.13 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 119.242 0.928 . . . . 0.0 110.458 -177.4 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -130.5 141.77 50.49 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 99.2 t -100.77 129.99 50.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 C-N-CA 124.813 1.245 . . . . 0.0 110.718 -167.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -143.97 145.37 32.19 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.945 0.898 . . . . 0.0 110.136 175.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -74.98 134.29 41.52 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 169.048 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.4 tp -56.53 -31.3 33.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 123.387 0.675 . . . . 0.0 112.057 -174.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.29 -32.53 70.11 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -170.353 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -92.07 -10.38 39.27 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -178.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 36.9 m -70.2 126.09 28.66 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 119.214 0.915 . . . . 0.0 108.73 177.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 14.5 m -73.43 168.2 19.72 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.597 0.759 . . . . 0.0 109.742 173.164 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -53.39 -41.11 65.59 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.585 0.754 . . . . 0.0 110.865 174.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -77.44 -15.92 59.07 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.099 0.56 . . . . 0.0 112.178 -178.072 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -75.27 -28.3 59.74 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 121.141 -0.974 . . . . 0.0 111.109 -176.083 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -68.66 -43.71 75.64 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.596 0.758 . . . . 0.0 109.024 169.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -65.65 -25.79 67.51 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.161 0.584 . . . . 0.0 112.137 -179.139 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.3 -30.32 70.14 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.681 0.793 . . . . 0.0 112.709 -174.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -92.57 154.85 18.16 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.35 1.06 . . . . 0.0 110.112 178.432 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -104.01 -21.87 13.54 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.353 0.661 . . . . 0.0 111.775 169.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.8 mp -121.65 132.74 70.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 176.414 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 80.0 mt -133.25 135.81 45.18 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 123.42 0.688 . . . . 0.0 109.991 178.417 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 7.3 mp -114.42 118.62 34.35 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 104.469 -2.419 . . . . 0.0 104.469 170.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 73.9 mt -112.48 117.72 33.17 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 123.32 0.648 . . . . 0.0 109.733 -169.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -101.4 98.82 1.84 Allowed Glycine 0 C--N 1.335 0.494 0 C-N-CA 125.713 1.625 . . . . 0.0 111.273 -173.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 2.1 tp -120.86 109.61 35.7 Favored Pre-proline 0 CA--C 1.538 0.487 0 C-N-CA 125.466 1.506 . . . . 0.0 109.476 -169.089 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -81.48 155.38 18.7 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.854 2.37 . . . . 0.0 110.418 173.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.7 m -101.06 136.22 41.26 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 172.437 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 60.7 m95 -135.51 173.53 11.62 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 125.647 1.579 . . . . 0.0 109.864 -178.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 13.4 t80 38.98 56.03 2.03 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.095 2.158 . . . . 0.0 113.443 168.271 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 26.2 p90 46.3 66.05 1.05 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.086 1.355 . . . . 0.0 112.088 176.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.55 52.36 3.38 Favored Glycine 0 CA--C 1.525 0.67 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.818 172.049 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -136.23 154.26 50.97 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 124.513 1.125 . . . . 0.0 109.116 174.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -79.28 146.08 33.18 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 169.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -59.47 147.43 36.67 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 171.167 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 74.5 m -58.13 -29.73 65.76 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.212 1.005 . . . . 0.0 113.546 -168.353 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -68.47 -32.73 72.93 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 118.891 0.769 . . . . 0.0 111.213 -178.441 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 92.1 m95 -79.44 -45.52 19.28 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-N 118.121 0.418 . . . . 0.0 110.085 171.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -60.54 -38.26 83.87 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.021 0.373 . . . . 0.0 111.926 -175.143 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -68.09 -24.75 65.08 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.581 0.753 . . . . 0.0 112.11 176.112 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -88.85 -25.4 22.19 Favored 'General case' 0 C--N 1.341 0.225 0 CA-C-O 118.738 -0.649 . . . . 0.0 111.914 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -49.57 -43.15 71.29 Favored Pre-proline 0 CA--C 1.546 0.819 0 CA-C-O 116.704 -1.617 . . . . 0.0 114.729 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -66.61 -15.19 46.83 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 CA-C-N 122.784 2.03 . . . . 0.0 113.774 176.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.1 m -89.78 -40.67 12.33 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.85 0.86 . . . . 0.0 109.013 169.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.5 ' HA ' HD12 ' A' ' 76' ' ' ILE . 31.3 tp -56.62 -38.32 71.93 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 125.017 1.327 . . . . 0.0 111.567 -176.679 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -68.74 -10.19 55.07 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -96.22 -7.19 36.3 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 119.646 1.112 . . . . 0.0 112.001 177.229 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.5 HD12 ' HA ' ' A' ' 73' ' ' LEU . 95.8 mt -91.57 146.39 6.32 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 -169.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -91.58 130.47 37.39 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 178.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -125.35 10.59 8.0 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 123.778 0.831 . . . . 0.0 111.768 176.432 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -63.89 126.55 28.01 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 120.231 1.378 . . . . 0.0 110.133 -175.028 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 74.84 -3.05 46.62 Favored Glycine 0 CA--C 1.538 1.474 0 CA-C-O 118.102 -1.388 . . . . 0.0 114.152 -175.571 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 63.1 mttm -79.61 146.16 32.69 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 120.226 2.013 . . . . 0.0 108.045 175.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 20.0 mt -95.38 131.6 41.33 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 176.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.9 t -132.25 143.14 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 178.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -129.63 156.16 44.67 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.893 1.277 . . . . 0.0 107.832 170.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 14.3 mt -122.27 145.87 47.83 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 124.324 1.05 . . . . 0.0 108.335 -175.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -141.36 156.15 45.85 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 123.851 0.86 . . . . 0.0 109.08 170.097 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -179.94 -169.25 39.89 Favored Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 111.394 -0.682 . . . . 0.0 111.394 -178.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 21.9 p -135.59 171.88 13.81 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 126.379 1.872 . . . . 0.0 109.196 -169.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -169.69 178.23 42.78 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 112.423 -0.271 . . . . 0.0 112.423 170.127 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -127.77 138.98 52.93 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 125.712 1.605 . . . . 0.0 108.201 169.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -121.28 24.99 9.74 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.274 1.029 . . . . 0.0 111.012 -172.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -119.02 -48.63 2.44 Favored 'General case' 0 C--O 1.234 0.263 0 O-C-N 121.444 -0.785 . . . . 0.0 109.903 -177.074 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -107.68 -33.78 7.18 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.936 0.894 . . . . 0.0 110.617 176.103 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -98.13 25.48 6.09 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.994 0.918 . . . . 0.0 111.925 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.17 -21.15 66.45 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -173.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -84.33 -3.01 58.0 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.905 0.882 . . . . 0.0 112.001 174.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -135.69 17.96 3.31 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.876 1.671 . . . . 0.0 109.614 -173.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -65.07 118.76 9.64 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -168.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 56.3 m 53.35 27.56 6.4 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.394 1.478 . . . . 0.0 113.2 -177.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -54.03 -38.17 64.9 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.06 1.344 . . . . 0.0 112.281 -173.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.25 -13.29 61.48 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -171.404 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 82.0 mt -58.97 -43.51 91.39 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 119.022 0.828 . . . . 0.0 109.759 175.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -69.98 -29.36 70.81 Favored Glycine 0 CA--C 1.529 0.91 0 N-CA-C 111.923 -0.471 . . . . 0.0 111.923 -177.08 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 8.3 m -63.21 -37.15 86.1 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 117.873 0.837 . . . . 0.0 111.133 -174.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.4 mt -73.82 -45.36 50.02 Favored 'Isoleucine or valine' 0 C--N 1.344 0.339 0 CA-C-O 118.452 -0.785 . . . . 0.0 108.938 176.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 37.4 ttt180 -53.33 -42.4 66.71 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 119.081 0.855 . . . . 0.0 110.738 -178.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -61.27 -17.61 54.34 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.104 0.962 . . . . 0.0 112.847 -179.495 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 69.7 mt -99.2 -48.33 11.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 124.66 1.184 . . . . 0.0 109.627 175.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 40.8 pt -79.9 -34.25 15.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 119.459 1.027 . . . . 0.0 112.117 -168.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -70.6 -41.67 13.01 Favored Pre-proline 0 CA--C 1.543 0.687 0 CA-C-O 117.576 -1.202 . . . . 0.0 110.88 -175.294 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -63.47 -30.33 71.75 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.032 1.821 . . . . 0.0 113.322 171.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -76.67 7.61 4.44 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.101 0.96 . . . . 0.0 112.328 171.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 93.33 6.64 62.68 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 125.882 1.706 . . . . 0.0 114.976 168.524 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.62 137.37 57.56 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 119.652 1.726 . . . . 0.0 109.424 175.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 87.3 m -90.83 122.77 33.84 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 169.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 23.1 mm -100.15 126.85 53.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 -171.138 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 27.6 m -130.91 179.72 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 125.024 1.329 . . . . 0.0 108.612 175.282 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 74.44 32.61 57.58 Favored Glycine 0 C--N 1.338 0.659 0 O-C-N 121.528 -0.733 . . . . 0.0 112.082 179.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 83.8 m-70 -64.24 143.03 58.19 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 169.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 55.1 t-105 -130.19 140.67 39.34 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-O 117.866 -1.064 . . . . 0.0 108.963 -178.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -61.31 148.42 92.97 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 CA-C-N 121.063 1.415 . . . . 0.0 114.772 -170.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 41.4 p -79.64 -9.46 59.64 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.485 0.714 . . . . 0.0 110.629 167.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 52.64 45.58 28.38 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.213 1.405 . . . . 0.0 111.228 -173.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 92.76 -1.71 71.84 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-O 118.203 -1.332 . . . . 0.0 114.032 175.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 22.7 t80 51.54 -126.22 2.37 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 118.777 1.289 . . . . 0.0 110.249 177.032 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 41.8 t60 56.31 39.68 30.08 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.577 1.551 . . . . 0.0 111.993 -172.316 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -88.53 176.09 7.3 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 168.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -65.16 -49.34 70.21 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.537 -0.727 . . . . 0.0 109.799 -174.088 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -162.37 140.68 8.8 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 167.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 13.0 m -145.84 131.37 18.77 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 120.765 -1.209 . . . . 0.0 108.781 174.579 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -104.19 -7.91 19.78 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.106 0.562 . . . . 0.0 111.978 -170.15 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -82.2 5.77 70.69 Favored Glycine 0 CA--C 1.527 0.843 0 CA-C-O 118.633 -1.093 . . . . 0.0 113.153 177.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 8.5 mp -63.16 128.15 34.54 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 119.909 1.854 . . . . 0.0 110.238 178.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.26 -37.63 25.64 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.587 1.555 . . . . 0.0 107.746 167.348 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -153.94 165.75 35.12 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 129.481 3.112 . . . . 0.0 106.227 -177.337 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -51.03 -35.92 36.88 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.275 0.943 . . . . 0.0 112.41 175.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -96.18 -3.4 44.44 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -175.376 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -146.54 139.42 25.4 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 120.542 1.519 . . . . 0.0 112.455 -172.191 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -84.91 155.54 21.63 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.613 1.565 . . . . 0.0 108.706 167.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 24.4 m -70.03 -8.65 11.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 125.127 1.371 . . . . 0.0 112.735 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -158.23 173.62 35.4 Favored Glycine 0 C--N 1.337 0.622 0 C-N-CA 124.964 1.269 . . . . 0.0 110.564 -178.448 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -64.94 132.02 48.2 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 124.556 1.142 . . . . 0.0 109.007 176.096 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -115.22 124.39 51.28 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 169.286 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 22.7 pt -72.91 -15.87 17.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 112.632 0.605 . . . . 0.0 112.632 -178.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -113.48 155.27 25.62 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 124.718 1.207 . . . . 0.0 107.925 168.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -136.37 -6.79 2.01 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.342 1.457 . . . . 0.0 111.279 175.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -151.87 -36.91 0.12 Allowed 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 -168.135 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -159.18 -62.19 0.07 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 119.697 1.135 . . . . 0.0 110.871 -173.426 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -143.93 152.96 56.62 Favored Pre-proline 0 C--O 1.234 0.272 0 C-N-CA 125.137 1.375 . . . . 0.0 108.057 -176.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -81.14 49.81 3.35 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 123.5 2.8 . . . . 0.0 112.889 -170.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -64.06 -29.03 70.2 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 120.996 -1.065 . . . . 0.0 112.007 -173.372 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 83.1 mt -103.15 29.99 5.16 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 125.273 1.429 . . . . 0.0 110.682 -175.128 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 5.0 m -48.7 -50.06 35.08 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.418 1.087 . . . . 0.0 110.892 -179.113 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.88 -41.81 86.62 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.641 0.655 . . . . 0.0 110.714 -171.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -61.89 -48.42 80.56 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 123.023 0.529 . . . . 0.0 109.855 177.134 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 75.8 mtt180 -62.54 -45.74 91.57 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 122.933 0.493 . . . . 0.0 110.114 -176.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 83.3 t -68.75 -43.72 82.71 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.118 0 CA-C-O 118.274 -0.869 . . . . 0.0 109.84 -178.037 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -62.38 -45.07 94.82 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 120.556 1.525 . . . . 0.0 110.124 -178.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -65.6 -39.7 91.85 Favored 'General case' 0 C--N 1.333 -0.137 0 O-C-N 121.924 -0.485 . . . . 0.0 110.239 -179.474 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 75.9 t90 -66.67 -45.96 77.22 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-N 118.452 0.569 . . . . 0.0 110.356 178.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 55.9 t -59.07 -41.53 83.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.327 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 45.5 mttm -62.46 -44.97 95.12 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 118.678 0.672 . . . . 0.0 109.881 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 19.8 mm100 -62.1 -52.83 62.31 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 122.852 0.461 . . . . 0.0 110.569 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 22.8 pt -68.24 -32.2 54.8 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 CA-C-O 118.811 -0.614 . . . . 0.0 110.825 -174.113 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 48.8 m -62.92 -30.67 71.73 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 119.188 0.904 . . . . 0.0 111.082 -178.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -77.67 -41.99 36.2 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 119.327 0.967 . . . . 0.0 110.578 175.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -68.18 -33.96 75.41 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.505 0.722 . . . . 0.0 111.708 -177.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 81.1 mt -90.62 -2.38 57.86 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.202 1.801 . . . . 0.0 111.327 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 25.2 m80 56.82 22.36 6.93 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.9 1.68 . . . . 0.0 113.478 -174.014 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 78.8 mt -75.61 -23.34 56.41 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 124.275 1.03 . . . . 0.0 110.536 175.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -59.17 -40.65 86.28 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 118.49 0.586 . . . . 0.0 110.421 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -65.02 -19.32 65.94 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.96 -0.462 . . . . 0.0 111.823 179.498 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 4.7 mm -91.33 -47.17 14.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 124.247 1.019 . . . . 0.0 108.735 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.1 pp -75.54 -26.89 58.4 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 122.985 0.514 . . . . 0.0 112.021 -174.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -72.9 -28.52 62.52 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.561 0.744 . . . . 0.0 111.915 -177.031 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.341 0 C-N-CA 124.258 1.023 . . . . 0.0 110.295 -177.919 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.4 ttt . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 110.378 -0.23 . . . . 0.0 110.378 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.62 149.12 50.61 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.225 0.61 . . . . 0.0 110.517 177.463 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 31.0 pt -87.27 -22.48 6.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 123.107 0.563 . . . . 0.0 111.375 -179.033 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 15.4 m -110.63 126.51 54.55 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 125.612 1.565 . . . . 0.0 108.531 178.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -102.77 123.79 7.96 Favored Glycine 0 CA--C 1.521 0.419 0 N-CA-C 107.056 -2.418 . . . . 0.0 107.056 169.032 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 62.3 mt -105.26 92.28 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 N-CA-C 105.338 -2.097 . . . . 0.0 105.338 178.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -88.64 135.26 33.59 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 -177.316 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -132.58 133.37 43.6 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 119.943 1.247 . . . . 0.0 112.596 176.08 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -87.97 148.14 20.74 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 108.283 -1.927 . . . . 0.0 108.283 167.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.9 m -168.35 160.46 11.36 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 119.069 1.435 . . . . 0.0 110.624 174.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -125.3 -53.36 1.61 Allowed 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.821 0.848 . . . . 0.0 109.493 167.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.8 p -85.92 6.01 30.41 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 124.944 1.298 . . . . 0.0 113.219 174.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 85.25 -7.18 76.84 Favored Glycine 0 CA--C 1.532 1.107 0 N-CA-C 117.302 1.681 . . . . 0.0 117.302 167.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.55 -36.08 77.58 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 120.51 2.155 . . . . 0.0 113.461 -170.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 11.4 m -73.02 -16.2 61.51 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 119.408 1.004 . . . . 0.0 110.791 -175.45 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -60.77 -42.5 97.58 Favored 'General case' 0 C--N 1.342 0.264 0 O-C-N 121.101 -0.999 . . . . 0.0 109.879 173.168 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -65.94 -39.04 90.14 Favored 'General case' 0 C--N 1.339 0.142 0 O-C-N 121.984 -0.448 . . . . 0.0 110.086 -178.067 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 41.0 mm -62.33 -47.69 91.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 176.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.34 -43.9 96.02 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 122.843 0.457 . . . . 0.0 111.345 179.674 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 54.9 mttm -63.85 -43.72 95.28 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 118.811 -0.614 . . . . 0.0 110.848 178.288 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 75.6 mtm -63.5 -37.06 85.86 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 119.328 0.967 . . . . 0.0 110.965 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 34.0 mt -65.22 -44.6 95.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 174.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -60.12 -40.13 88.64 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 119.291 0.951 . . . . 0.0 110.741 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -64.45 -34.17 77.58 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 119.007 0.821 . . . . 0.0 111.172 179.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -68.2 -51.13 49.03 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 118.689 0.677 . . . . 0.0 110.431 175.334 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 42.5 mt -71.16 -31.92 68.29 Favored 'General case' 0 C--N 1.341 0.227 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -174.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.63 147.21 20.86 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 125.31 1.433 . . . . 0.0 110.983 -174.231 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -65.05 -29.71 70.63 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.764 0.826 . . . . 0.0 112.172 -172.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -67.51 -29.37 68.77 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 122.63 0.372 . . . . 0.0 111.117 177.342 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 33.3 t -93.69 -36.9 7.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 C-N-CA 124.585 1.154 . . . . 0.0 110.256 -175.53 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -134.93 144.54 47.52 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 119.067 0.849 . . . . 0.0 112.838 -171.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -131.09 141.69 50.18 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.376 1.07 . . . . 0.0 110.058 172.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 87.9 t -88.88 141.32 14.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 123.728 0.811 . . . . 0.0 108.911 -178.323 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -145.28 169.57 17.99 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.442 1.097 . . . . 0.0 111.444 -169.026 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -144.95 121.17 10.85 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.275 1.43 . . . . 0.0 107.474 -177.039 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.4 tp -59.09 -21.76 20.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 123.474 0.71 . . . . 0.0 112.242 -171.231 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.82 -29.16 69.98 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.05 0.54 . . . . 0.0 111.725 176.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 57.8 pttt -108.49 -19.53 13.42 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.302 1.041 . . . . 0.0 112.408 178.022 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.4 m -63.88 165.32 8.84 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 119.262 0.937 . . . . 0.0 110.53 170.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 24.4 p -143.95 166.89 23.7 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.163 0.985 . . . . 0.0 110.095 -179.409 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -52.93 -49.19 66.49 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.369 1.067 . . . . 0.0 111.32 -172.095 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -80.02 -24.02 41.09 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 122.134 0.174 . . . . 0.0 111.02 -175.173 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -73.35 -32.77 64.73 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.068 0.547 . . . . 0.0 111.091 -179.044 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -59.23 -37.77 78.33 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.405 0.682 . . . . 0.0 110.966 171.198 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -72.17 -16.59 61.97 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 122.884 0.473 . . . . 0.0 112.257 -173.302 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.18 -29.01 65.77 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.473 0.709 . . . . 0.0 111.871 -178.114 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -79.8 157.29 27.09 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.253 1.021 . . . . 0.0 110.169 179.13 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -109.77 -28.8 8.62 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.107 169.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.2 mp -112.04 126.91 69.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 173.519 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -112.58 122.22 47.06 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 175.2 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.2 mp -109.71 118.27 36.09 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 171.332 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 60.0 mt -119.46 109.16 15.42 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -171.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.5 122.57 7.19 Favored Glycine 0 CA--C 1.521 0.407 0 C-N-CA 125.629 1.585 . . . . 0.0 110.162 -179.113 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 18.4 tt -136.71 109.19 9.29 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-N 118.121 0.961 . . . . 0.0 111.648 -176.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.1 140.54 31.33 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 N-CA-C 107.32 -1.839 . . . . 0.0 107.32 166.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 90.5 m -91.97 136.17 33.37 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 177.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 30.1 m95 -129.62 173.97 10.11 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.518 1.127 . . . . 0.0 111.405 -172.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 55.07 -89.88 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 127.909 2.484 . . . . 0.0 112.397 179.143 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -153.58 78.66 1.14 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 126.271 1.829 . . . . 0.0 106.754 175.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 65.75 51.84 43.43 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 -177.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -127.79 155.85 43.41 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.1 0.96 . . . . 0.0 109.631 176.376 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -79.23 166.35 22.27 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.751 0.82 . . . . 0.0 109.968 170.357 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 18.1 mm-40 -72.57 153.75 41.13 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 169.128 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 60.8 m -58.98 -37.01 75.84 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.598 0.759 . . . . 0.0 112.739 -169.08 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -72.14 -38.38 69.24 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 118.712 0.687 . . . . 0.0 110.579 -177.026 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -66.42 -46.78 75.38 Favored 'General case' 0 C--N 1.342 0.241 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 173.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -60.53 -38.75 85.44 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.331 0.652 . . . . 0.0 111.557 -178.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -70.01 -25.72 63.72 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.996 0.918 . . . . 0.0 112.189 176.459 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -90.71 -20.55 22.33 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.445 0.698 . . . . 0.0 112.293 -179.554 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 19.3 m-30 -51.02 -42.24 78.85 Favored Pre-proline 0 CA--C 1.546 0.822 0 CA-C-O 116.762 -1.589 . . . . 0.0 114.253 177.058 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -65.5 -21.21 60.4 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 CA-C-N 122.966 2.095 . . . . 0.0 113.402 174.238 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.8 m -81.95 -36.33 28.08 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 119.371 0.987 . . . . 0.0 109.604 170.512 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 21.7 tp -61.91 -30.8 71.13 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.059 -1.026 . . . . 0.0 111.37 -175.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -82.96 -2.36 54.91 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.163 0.985 . . . . 0.0 113.134 175.584 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 39.4 mm-40 -100.36 -26.03 14.02 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.331 1.052 . . . . 0.0 110.425 172.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 80.9 mt -70.69 152.76 8.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 174.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -106.99 134.83 49.56 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.533 1.133 . . . . 0.0 109.465 178.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -124.98 15.55 8.53 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.499 1.119 . . . . 0.0 111.53 177.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -56.07 115.04 2.2 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 119.646 1.112 . . . . 0.0 109.79 -178.445 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 74.44 3.08 65.13 Favored Glycine 0 CA--C 1.536 1.358 0 CA-C-O 118.531 -1.149 . . . . 0.0 114.294 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -80.02 148.67 31.02 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 119.385 1.593 . . . . 0.0 107.742 171.028 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 19.1 mt -91.44 134.33 34.72 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 178.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 19.0 t -130.96 132.78 63.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 178.264 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -128.32 143.32 51.0 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 176.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 77.8 mt -115.99 146.23 42.3 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -173.521 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -141.55 160.35 40.33 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 169.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -170.9 170.06 42.91 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-O 122.419 1.01 . . . . 0.0 113.059 -171.111 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 15.5 m -136.7 148.8 47.54 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 125.739 1.616 . . . . 0.0 107.367 -169.755 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.6 -167.29 28.05 Favored Glycine 0 CA--C 1.528 0.859 0 O-C-N 123.233 0.333 . . . . 0.0 112.604 -174.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -139.78 143.57 36.97 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.721 1.608 . . . . 0.0 109.896 -179.472 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -118.66 3.85 11.68 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.053 1.741 . . . . 0.0 112.268 -178.288 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -85.81 -47.59 9.58 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 119.699 1.136 . . . . 0.0 110.572 176.105 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -129.68 -37.97 1.53 Allowed 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.248 0.619 . . . . 0.0 111.825 -170.022 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -87.26 18.82 3.49 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.218 0.607 . . . . 0.0 112.133 174.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.67 -39.72 71.33 Favored 'General case' 0 C--N 1.342 0.247 0 C-N-CA 124.729 1.212 . . . . 0.0 112.365 -173.546 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -65.93 -13.96 60.68 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 118.577 0.626 . . . . 0.0 111.938 -177.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -120.83 21.57 11.39 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 126.546 1.939 . . . . 0.0 110.112 -177.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -60.34 119.32 7.73 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 118.832 0.742 . . . . 0.0 110.729 -169.324 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 72.2 m 47.63 32.03 2.34 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.021 1.729 . . . . 0.0 112.749 -177.183 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -54.87 -37.5 66.34 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.055 0.942 . . . . 0.0 112.087 -173.283 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.87 -14.07 62.81 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -171.16 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 84.9 mt -56.07 -42.98 77.52 Favored 'General case' 0 C--N 1.345 0.371 0 CA-C-N 118.961 0.801 . . . . 0.0 109.609 169.64 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.97 -33.15 86.47 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 -178.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.2 m -64.33 -41.37 96.82 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 118.18 0.99 . . . . 0.0 110.194 178.31 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 6.2 mt -68.22 -45.21 83.31 Favored 'Isoleucine or valine' 0 C--N 1.343 0.312 0 CA-C-N 119.198 0.908 . . . . 0.0 108.8 176.158 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 52.3 ttt-85 -52.95 -47.82 67.83 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 119.236 0.925 . . . . 0.0 110.157 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -64.98 -23.24 67.16 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 123.87 0.868 . . . . 0.0 112.381 -175.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 76.2 mt -86.2 -46.42 16.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 118.844 0.747 . . . . 0.0 109.381 175.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.0 pt -76.47 -26.27 16.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 119.363 0.983 . . . . 0.0 112.811 -169.269 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -64.06 -50.23 70.08 Favored Pre-proline 0 CA--C 1.547 0.832 0 CA-C-O 117.654 -1.165 . . . . 0.0 111.846 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -54.54 -29.75 61.58 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.858 2.372 . . . . 0.0 114.038 172.11 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 28.5 mmm180 -88.11 9.85 21.25 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.888 0.875 . . . . 0.0 111.799 -177.393 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 79.27 12.62 83.73 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-O 118.645 -1.086 . . . . 0.0 114.132 169.405 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.42 143.33 45.73 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 118.846 1.323 . . . . 0.0 110.287 173.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 48.7 m -93.15 121.11 34.17 Favored 'General case' 0 CA--C 1.528 0.108 0 N-CA-C 104.821 -2.288 . . . . 0.0 104.821 168.173 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 14.9 mt -102.23 126.06 56.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -168.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 6.1 m -140.98 174.28 7.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 125.928 1.691 . . . . 0.0 108.979 -170.194 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 74.56 37.11 47.2 Favored Glycine 0 CA--C 1.529 0.934 0 O-C-N 121.479 -0.763 . . . . 0.0 112.228 -175.5 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -66.56 138.88 57.8 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 173.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 70.9 t-105 -124.61 126.24 25.42 Favored Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 124.782 1.233 . . . . 0.0 108.423 -169.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -68.47 145.02 63.41 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 121.483 1.455 . . . . 0.0 112.358 -169.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 4.1 p -68.86 -34.6 75.72 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 119.234 -0.413 . . . . 0.0 110.674 169.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 50.06 52.98 13.63 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.356 1.462 . . . . 0.0 112.03 176.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 78.68 38.71 23.37 Favored Glycine 0 CA--C 1.531 1.081 0 CA-C-O 120.064 -0.298 . . . . 0.0 112.577 177.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -59.71 136.34 57.96 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.76 0.824 . . . . 0.0 109.205 173.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 42.0 t60 -143.4 16.57 1.86 Allowed 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -170.288 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -84.22 177.23 8.28 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.288 -0.883 . . . . 0.0 110.614 176.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -50.7 -50.54 54.87 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.02 1.328 . . . . 0.0 113.127 -168.458 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -151.86 176.8 11.08 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 124.057 0.943 . . . . 0.0 108.912 169.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.1 133.55 18.63 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 169.649 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -118.96 -11.45 9.69 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -169.225 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -82.69 10.0 57.64 Favored Glycine 0 CA--C 1.534 1.268 0 CA-C-N 118.773 0.715 . . . . 0.0 112.743 169.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 82.0 mt -64.67 135.73 56.21 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 118.947 1.374 . . . . 0.0 111.162 -178.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -98.21 -31.57 12.01 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.927 1.291 . . . . 0.0 108.318 166.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -149.54 163.15 38.62 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 127.756 2.422 . . . . 0.0 106.797 172.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -55.71 -30.21 60.75 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.182 -0.949 . . . . 0.0 112.088 176.15 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -88.07 -10.49 50.02 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 10.9 m-70 -150.94 127.58 10.84 Favored 'General case' 0 C--N 1.347 0.476 0 CA-C-N 119.843 1.201 . . . . 0.0 113.684 -169.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -73.0 151.93 41.55 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 164.65 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 8.0 p -66.12 -19.05 25.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 O-C-N 121.98 -0.45 . . . . 0.0 112.016 176.422 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -154.77 163.17 31.17 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 123.791 0.71 . . . . 0.0 111.349 -171.493 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -56.71 127.82 33.4 Favored 'General case' 0 CA--C 1.522 -0.121 0 C-N-CA 124.22 1.008 . . . . 0.0 108.487 177.419 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -120.4 115.09 22.82 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 176.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 27.7 pt -78.76 169.13 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 169.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 26.5 t70 71.73 145.13 0.07 Allowed 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 127.207 2.203 . . . . 0.0 112.938 -169.204 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -132.88 -1.57 3.34 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.702 1.601 . . . . 0.0 111.889 175.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -160.29 -45.8 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 120.058 1.299 . . . . 0.0 113.797 -171.172 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.03 -55.14 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.697 1.199 . . . . 0.0 108.561 -175.372 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -132.88 146.9 63.3 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 125.858 1.663 . . . . 0.0 108.256 -177.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -63.88 145.98 91.01 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 123.046 2.497 . . . . 0.0 112.84 -173.214 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -147.07 162.81 38.06 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 126.4 1.88 . . . . 0.0 107.436 174.243 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 62.0 mt 53.49 26.18 5.35 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.76 1.224 . . . . 0.0 111.694 -172.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 87.7 m -53.83 -52.43 60.39 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 125.099 1.36 . . . . 0.0 111.012 -169.337 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -71.44 -32.3 68.2 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 122.178 0.191 . . . . 0.0 110.786 -171.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -67.16 -44.03 80.75 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 122.995 0.518 . . . . 0.0 109.64 173.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 38.5 mtt180 -66.2 -42.83 88.27 Favored 'General case' 0 C--O 1.232 0.184 0 O-C-N 121.606 -0.684 . . . . 0.0 110.964 -177.125 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 28.3 m -69.09 -35.52 68.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-O 118.148 -0.929 . . . . 0.0 109.809 178.145 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -60.07 -49.96 75.61 Favored 'General case' 0 C--N 1.342 0.279 0 CA-C-N 120.469 1.486 . . . . 0.0 110.233 174.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 59.6 mttm -57.83 -40.01 79.04 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 118.132 0.424 . . . . 0.0 110.554 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 61.8 t90 -72.09 -45.35 61.02 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 117.872 0.305 . . . . 0.0 110.745 -177.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 75.7 t -63.68 -34.81 70.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 O-C-N 121.489 -0.757 . . . . 0.0 109.716 -179.519 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -62.75 -34.61 77.56 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 118.455 -0.783 . . . . 0.0 110.714 177.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -62.67 -57.19 11.88 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.992 0.814 . . . . 0.0 110.053 171.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 6.9 pt -65.61 -30.27 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 118.828 0.74 . . . . 0.0 110.369 -171.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 49.4 m -58.74 -29.09 66.46 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 117.711 -1.138 . . . . 0.0 112.151 178.091 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -96.86 -13.32 22.6 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 120.456 1.48 . . . . 0.0 113.118 175.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -82.82 -39.67 21.39 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 118.972 0.806 . . . . 0.0 110.34 173.03 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 1.9 mp -90.24 -12.61 37.47 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.556 1.942 . . . . 0.0 110.719 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 57.19 30.52 18.5 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.731 1.612 . . . . 0.0 112.703 -169.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 55.2 mt -68.92 -18.91 64.17 Favored 'General case' 0 N--CA 1.467 0.403 0 O-C-N 121.434 -0.791 . . . . 0.0 110.476 169.485 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -54.34 -39.48 67.14 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.541 0.736 . . . . 0.0 110.353 173.369 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -71.76 -4.92 30.42 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 121.575 -0.703 . . . . 0.0 112.442 -178.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 22.6 mt -109.8 -54.66 5.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 125.176 1.39 . . . . 0.0 108.446 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.5 pp -79.16 -24.08 43.51 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.347 0.659 . . . . 0.0 112.179 -173.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -126.0 40.1 3.81 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.591 1.956 . . . . 0.0 108.71 -177.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.22 0 CA-C-O 118.304 -0.855 . . . . 0.0 109.367 174.603 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.5 ptp . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 120.959 0.409 . . . . 0.0 111.691 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -66.34 159.94 25.7 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.495 0.718 . . . . 0.0 110.597 174.035 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.0 pt -74.51 -29.93 24.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 O-C-N 122.144 -0.347 . . . . 0.0 110.987 178.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.3 m -110.25 136.01 50.12 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 124.637 1.175 . . . . 0.0 109.338 -179.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -108.21 118.96 5.55 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 107.299 -2.32 . . . . 0.0 107.299 168.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 39.8 mt -92.83 127.49 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 104.573 -2.38 . . . . 0.0 104.573 169.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -122.87 128.94 51.03 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 176.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -123.53 127.11 47.87 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 118.979 0.809 . . . . 0.0 112.376 -177.43 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -87.28 141.54 17.56 Favored Glycine 0 C--N 1.338 0.692 0 N-CA-C 108.35 -1.9 . . . . 0.0 108.35 167.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 37.8 m -153.15 166.44 32.49 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.716 1.758 . . . . 0.0 110.534 176.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -145.76 -51.65 0.25 Allowed 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.283 1.033 . . . . 0.0 109.794 169.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.9 p -80.77 -15.14 57.23 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.815 0.846 . . . . 0.0 112.058 172.565 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.22 32.09 6.9 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 124.491 1.043 . . . . 0.0 113.058 172.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -82.58 -52.73 6.55 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 118.423 1.112 . . . . 0.0 111.772 176.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -67.58 -23.62 65.42 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 121.588 -0.695 . . . . 0.0 112.441 -167.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -60.67 -35.65 76.77 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.283 0.947 . . . . 0.0 111.032 175.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -70.09 -42.79 72.26 Favored 'General case' 0 C--N 1.34 0.16 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.194 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 26.5 mm -61.77 -42.14 93.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 178.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.13 -41.88 93.62 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 121.517 -0.739 . . . . 0.0 111.017 178.488 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -67.72 -39.26 84.31 Favored 'General case' 0 CA--C 1.53 0.198 0 O-C-N 121.77 -0.581 . . . . 0.0 110.77 176.22 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 75.2 mtp -64.62 -30.01 71.03 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 119.283 0.947 . . . . 0.0 111.653 177.645 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 58.9 mt -70.4 -55.99 12.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 170.02 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -59.13 -32.97 70.33 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 121.323 -0.861 . . . . 0.0 112.386 -173.299 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -66.65 -34.85 78.78 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 120.039 1.29 . . . . 0.0 111.487 179.222 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -75.57 -39.65 57.81 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.015 0.526 . . . . 0.0 110.663 175.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -75.26 -39.79 59.44 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.807 0.843 . . . . 0.0 111.383 -174.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.53 141.57 5.87 Favored Glycine 0 CA--C 1.531 1.034 0 N-CA-C 108.818 -1.713 . . . . 0.0 108.818 -167.07 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 58.3 tttp -62.1 -31.08 71.48 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 121.643 -0.916 . . . . 0.0 111.722 -172.358 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -65.06 -29.53 70.43 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 123.071 0.548 . . . . 0.0 111.74 178.259 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.2 t -92.7 -38.24 9.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 123.755 0.822 . . . . 0.0 109.68 -178.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -139.04 125.71 20.72 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 119.411 1.005 . . . . 0.0 112.028 178.218 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -103.31 159.58 15.43 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.408 0.683 . . . . 0.0 110.191 173.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 51.1 t -121.7 129.35 75.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 124.234 1.013 . . . . 0.0 109.971 -169.124 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -144.9 172.43 13.04 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.887 1.675 . . . . 0.0 111.736 -173.306 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -125.88 136.81 53.49 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 175.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.5 tp -60.86 -25.99 37.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 O-C-N 121.435 -0.791 . . . . 0.0 111.633 -174.566 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -55.03 -36.36 65.44 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.578 1.151 . . . . 0.0 112.05 178.399 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -105.31 0.78 27.39 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.885 1.274 . . . . 0.0 111.912 -178.052 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 18.4 m -88.14 175.0 7.91 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.941 0.896 . . . . 0.0 109.654 177.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 70.7 m -153.85 162.4 41.26 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 120.888 -1.132 . . . . 0.0 109.483 179.31 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -51.0 -47.85 61.52 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.849 1.26 . . . . 0.0 111.178 -176.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -73.67 -24.39 59.97 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.459 -174.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -77.74 -35.58 51.67 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 122.818 0.447 . . . . 0.0 110.513 176.644 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -64.28 -50.46 67.82 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.498 0.719 . . . . 0.0 110.34 178.294 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -67.74 -19.27 65.11 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -172.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.51 -29.93 69.47 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.153 0.981 . . . . 0.0 112.667 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -75.25 159.57 31.38 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 123.827 0.851 . . . . 0.0 109.861 175.183 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -110.21 -22.23 11.86 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.309 0.644 . . . . 0.0 112.218 170.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.0 mp -120.71 132.56 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 175.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 97.4 mt -126.87 125.66 41.99 Favored 'General case' 0 CA--C 1.519 -0.232 0 C-N-CA 124.081 0.953 . . . . 0.0 108.865 -178.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 7.4 mp -114.11 107.92 16.29 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 176.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 66.7 mt -110.54 107.71 17.43 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 -170.122 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.43 117.94 5.44 Favored Glycine 0 C--N 1.331 0.285 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 17.5 tt -131.61 118.22 16.75 Favored Pre-proline 0 CA--C 1.539 0.523 0 CA-C-N 118.034 0.917 . . . . 0.0 110.408 -177.249 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -83.33 147.19 12.66 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.754 2.302 . . . . 0.0 108.427 168.156 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 54.5 m -99.29 143.52 29.45 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 177.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 68.2 m95 -136.13 171.15 14.9 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 125.731 1.612 . . . . 0.0 110.242 -174.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.423 ' CE1' HM73 ' A' ' 201' ' ' FMN . 69.1 m-85 25.83 72.17 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 128.062 2.545 . . . . 0.0 114.394 169.351 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 56.69 54.6 7.13 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.128 0.971 . . . . 0.0 111.81 174.532 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 82.8 13.3 78.19 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-O 119.388 -0.673 . . . . 0.0 114.326 171.382 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -74.39 154.08 38.97 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.511 1.156 . . . . 0.0 109.873 169.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.56 165.9 23.18 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 123.508 0.723 . . . . 0.0 110.571 170.527 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 14.9 tm0? -61.91 145.18 53.62 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 169.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 52.4 m -60.12 -37.2 79.32 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 114.959 1.466 . . . . 0.0 114.959 -167.18 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -76.09 -38.21 57.25 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 118.632 0.651 . . . . 0.0 109.281 -177.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -62.77 -47.26 84.29 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.185 0.594 . . . . 0.0 109.543 173.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -59.0 -40.36 84.66 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.598 0.759 . . . . 0.0 111.431 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -69.01 -31.76 70.81 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.245 0.618 . . . . 0.0 112.098 176.372 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -84.84 -21.84 29.68 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 117.889 -1.053 . . . . 0.0 112.647 -177.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 18.2 m-30 -48.37 -44.65 65.06 Favored Pre-proline 0 CA--C 1.544 0.735 0 CA-C-N 121.005 1.729 . . . . 0.0 115.114 -178.407 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.07 -16.36 54.85 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 CA-C-N 122.731 2.011 . . . . 0.0 113.897 176.258 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 31.5 m -91.46 -35.14 14.51 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.185 0.994 . . . . 0.0 109.643 169.473 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.45 ' HA ' HD12 ' A' ' 76' ' ' ILE . 17.0 tp -59.39 -39.17 82.52 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.222 1.009 . . . . 0.0 110.491 -178.339 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -73.66 -7.99 54.19 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -93.51 -1.55 55.46 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 119.619 1.1 . . . . 0.0 111.344 178.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.45 HD12 ' HA ' ' A' ' 73' ' ' LEU . 66.7 mt -92.37 146.03 6.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 -175.427 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -86.13 121.22 28.42 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 172.182 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -114.08 10.54 17.45 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 118.3 -0.857 . . . . 0.0 111.715 175.352 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 31.6 m-80 -59.32 117.36 4.71 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 120.269 1.395 . . . . 0.0 109.791 -172.006 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 72.84 -1.04 41.19 Favored Glycine 0 CA--C 1.534 1.28 0 CA-C-O 118.689 -1.062 . . . . 0.0 114.212 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -72.27 144.96 48.21 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 119.602 1.701 . . . . 0.0 108.024 172.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 35.7 mt -85.17 133.51 34.19 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 177.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.1 t -132.1 135.86 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 176.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -129.35 143.9 51.03 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 175.361 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 67.1 mt -118.94 148.19 43.22 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -175.233 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -145.65 153.69 41.3 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 123.205 0.602 . . . . 0.0 110.614 175.285 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -174.64 164.56 35.5 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-O 121.701 0.612 . . . . 0.0 112.683 179.636 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 24.9 p -121.27 167.67 12.47 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 125.418 1.487 . . . . 0.0 109.253 175.494 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -163.74 -160.18 11.45 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 114.271 0.468 . . . . 0.0 114.271 -177.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -143.42 153.67 42.9 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 126.622 1.969 . . . . 0.0 109.991 -175.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -138.28 7.66 2.64 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.865 0.866 . . . . 0.0 112.519 168.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -69.11 -33.28 73.24 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.58 1.082 . . . . 0.0 109.285 173.414 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -135.22 -36.7 0.8 Allowed 'General case' 0 C--O 1.234 0.285 0 C-N-CA 123.002 0.521 . . . . 0.0 112.17 171.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -89.78 29.98 1.1 Allowed 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 118.562 0.619 . . . . 0.0 112.604 -173.473 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.32 -31.8 71.66 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.189 0.996 . . . . 0.0 112.801 -174.023 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -79.92 1.16 28.35 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.266 1.026 . . . . 0.0 112.071 178.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -134.95 19.8 3.48 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.597 1.559 . . . . 0.0 109.896 -176.526 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -65.59 114.82 5.2 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -171.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 72.6 m 51.27 34.99 12.55 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.54 1.536 . . . . 0.0 113.203 -173.674 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -50.6 -44.54 57.06 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.672 1.189 . . . . 0.0 111.489 -179.287 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.84 -12.88 62.01 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 -169.01 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 90.0 mt -58.55 -39.68 80.93 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 118.893 0.77 . . . . 0.0 109.707 169.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.9 -32.08 83.04 Favored Glycine 0 CA--C 1.528 0.848 0 N-CA-C 111.412 -0.675 . . . . 0.0 111.412 178.555 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.6 m -65.85 -38.58 89.24 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.358 1.079 . . . . 0.0 110.334 178.308 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 7.0 mt -71.82 -42.49 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 119.105 0.866 . . . . 0.0 109.004 175.054 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 47.5 ttt180 -53.46 -45.43 69.55 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 119.408 1.003 . . . . 0.0 110.334 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -63.85 -20.07 65.53 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.026 0.93 . . . . 0.0 112.81 -177.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 96.4 mt -92.09 -48.77 13.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 123.974 0.91 . . . . 0.0 109.661 176.334 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.5 pt -78.07 -33.85 18.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-N 118.921 0.782 . . . . 0.0 111.979 -168.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -70.76 -43.91 15.43 Favored Pre-proline 0 CA--C 1.544 0.715 0 CA-C-O 117.962 -1.018 . . . . 0.0 111.269 -172.254 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -64.6 -31.42 59.92 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.032 1.821 . . . . 0.0 113.132 173.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? -75.81 6.51 4.92 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.019 0.928 . . . . 0.0 112.259 172.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 78.52 20.16 72.24 Favored Glycine 0 CA--C 1.527 0.828 0 CA-C-O 118.686 -1.064 . . . . 0.0 114.082 169.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -59.75 142.42 53.25 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 118.725 1.263 . . . . 0.0 109.857 170.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 37.6 m -89.1 116.45 27.37 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 104.461 -2.422 . . . . 0.0 104.461 168.573 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 38.9 mt -90.92 130.53 39.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 -176.104 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 3.7 m -137.44 165.86 26.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 126.103 1.761 . . . . 0.0 108.487 -177.17 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 74.49 31.44 58.87 Favored Glycine 0 CA--C 1.524 0.616 0 CA-C-O 119.141 -0.811 . . . . 0.0 112.293 -175.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 83.9 m-70 -58.48 134.08 56.36 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 169.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 70.8 t-105 -113.38 124.96 30.36 Favored Pre-proline 0 C--O 1.235 0.296 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -169.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -67.95 140.31 49.87 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 121.254 1.303 . . . . 0.0 110.632 -173.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 81.1 p -74.5 -21.24 59.65 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.186 0.594 . . . . 0.0 110.876 176.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 52.52 44.05 30.41 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 126.154 1.781 . . . . 0.0 110.974 -174.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 78.69 77.49 0.88 Allowed Glycine 0 C--N 1.338 0.653 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 -171.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -43.53 131.79 4.95 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.449 1.1 . . . . 0.0 111.222 171.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 42.2 t60 -147.99 32.49 0.84 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.736 0.815 . . . . 0.0 111.175 -175.004 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -112.14 -178.56 3.45 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.03 1.332 . . . . 0.0 107.856 177.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -83.92 -54.91 4.53 Favored 'General case' 0 C--O 1.236 0.365 0 O-C-N 121.397 -0.815 . . . . 0.0 111.989 -168.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -156.71 140.35 15.97 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 119.131 0.878 . . . . 0.0 111.043 170.373 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 73.5 m -142.09 111.62 6.61 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 124.953 1.301 . . . . 0.0 107.857 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -77.89 -11.41 59.89 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 122.2 -0.313 . . . . 0.0 110.882 -173.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -78.46 0.19 76.54 Favored Glycine 0 CA--C 1.533 1.164 0 CA-C-O 118.404 -1.22 . . . . 0.0 113.798 169.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 65.0 mt -62.31 125.73 24.89 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 120.869 2.335 . . . . 0.0 108.618 171.407 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -91.82 -32.55 15.31 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.714 0.806 . . . . 0.0 109.541 170.594 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -149.78 163.02 39.1 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 127.227 2.211 . . . . 0.0 106.848 172.094 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -55.29 -29.55 58.41 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.392 -0.817 . . . . 0.0 112.243 175.508 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -90.49 -12.39 37.42 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.216 1.007 . . . . 0.0 113.486 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -147.58 128.23 14.22 Favored 'General case' 0 C--N 1.346 0.434 0 CA-C-N 119.991 1.269 . . . . 0.0 113.399 -170.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -78.45 152.32 32.19 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 166.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 10.7 p -58.15 -28.68 35.13 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 C-N-CA 124.824 1.249 . . . . 0.0 111.49 175.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -157.8 175.83 35.0 Favored Glycine 0 C--N 1.336 0.56 0 C-N-CA 125.048 1.309 . . . . 0.0 110.219 -174.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -56.96 126.6 27.87 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 124.101 0.96 . . . . 0.0 108.611 178.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -136.47 112.52 9.68 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 -179.674 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 33.3 pt -123.07 128.79 75.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-O 122.272 1.034 . . . . 0.0 113.038 -173.104 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -166.46 163.0 17.23 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 128.88 2.872 . . . . 0.0 105.821 169.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -130.79 -24.43 2.43 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.929 0.892 . . . . 0.0 112.014 171.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -168.57 -53.48 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.204 1.402 . . . . 0.0 108.244 179.161 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 21.6 ttm180 -152.14 112.39 4.08 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 105.423 -2.066 . . . . 0.0 105.423 168.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 67.1 149.48 0.12 Allowed Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 126.366 1.866 . . . . 0.0 111.153 -175.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -75.91 158.08 38.73 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 121.838 1.692 . . . . 0.0 113.38 -170.368 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -135.56 170.12 16.46 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 126.261 1.824 . . . . 0.0 106.527 167.228 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 23.5 mt 56.19 24.6 8.24 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.192 0.997 . . . . 0.0 111.192 -168.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 99.1 m -53.81 -50.66 65.65 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 125.697 1.599 . . . . 0.0 110.861 -169.476 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -71.64 -34.52 69.84 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 119.075 -0.488 . . . . 0.0 111.063 -171.085 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -67.53 -43.96 79.51 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 118.507 0.594 . . . . 0.0 109.687 175.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 52.1 mtt180 -64.61 -43.2 94.53 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 121.933 -0.48 . . . . 0.0 110.633 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 58.1 t -67.82 -40.18 83.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-O 118.247 -0.883 . . . . 0.0 109.8 178.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -60.69 -47.48 86.07 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 120.612 1.551 . . . . 0.0 109.909 176.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 59.3 mttm -57.98 -45.89 86.06 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 118.331 0.514 . . . . 0.0 110.184 178.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 55.1 t90 -65.62 -45.78 81.79 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 118.109 0.413 . . . . 0.0 110.513 -177.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 55.6 t -62.56 -38.64 81.98 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 C-N-CA 123.046 0.538 . . . . 0.0 110.202 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -69.8 -36.05 75.36 Favored 'General case' 0 CA--C 1.532 0.265 0 O-C-N 121.224 -0.923 . . . . 0.0 110.256 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 20.5 mm100 -64.61 -52.09 59.25 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.652 0.66 . . . . 0.0 110.634 174.132 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 12.3 pt -64.22 -32.69 58.46 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 CA-C-N 119.51 1.05 . . . . 0.0 110.787 -178.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 57.2 m -56.05 -36.07 67.63 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.287 0.949 . . . . 0.0 112.172 176.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -87.62 -27.17 22.67 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.9 1.227 . . . . 0.0 112.24 177.063 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -68.55 -32.02 71.65 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 119.357 0.981 . . . . 0.0 110.73 173.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 1.8 mp -82.69 -3.68 56.73 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.458 1.903 . . . . 0.0 110.89 174.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 54.8 35.12 23.41 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 126.126 1.771 . . . . 0.0 112.379 -177.174 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 70.1 mt -63.48 -27.86 69.57 Favored 'General case' 0 N--CA 1.464 0.273 0 O-C-N 121.314 -0.866 . . . . 0.0 111.301 -177.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -59.89 -37.7 80.15 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 118.346 0.521 . . . . 0.0 110.92 177.375 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -67.74 -21.75 65.26 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.002 0.521 . . . . 0.0 111.498 178.086 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 14.8 mm -86.81 -50.01 14.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 124.091 0.957 . . . . 0.0 108.428 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.6 pp -75.41 -28.37 59.38 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -172.184 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -98.45 17.18 19.54 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.562 1.145 . . . . 0.0 111.719 -178.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.351 0 C-N-CA 123.554 0.742 . . . . 0.0 109.569 174.47 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 201' ' ' FMN . . . . . 0.423 HM73 ' CE1' ' A' ' 58' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.1 ttp . . . . . 0 N--CA 1.487 1.421 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -60.83 141.89 56.64 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.184 0.593 . . . . 0.0 111.372 -177.515 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.5 pt -104.45 -24.84 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 126.051 1.741 . . . . 0.0 110.587 178.161 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 51.6 m -105.79 125.9 51.54 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.142 1.377 . . . . 0.0 108.547 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -100.36 116.02 5.46 Favored Glycine 0 C--N 1.331 0.295 0 N-CA-C 107.082 -2.407 . . . . 0.0 107.082 168.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 35.0 mt -92.57 122.27 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 104.304 -2.48 . . . . 0.0 104.304 172.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -118.21 128.11 54.39 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 106.633 -1.618 . . . . 0.0 106.633 176.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -123.81 132.66 53.82 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 118.574 0.625 . . . . 0.0 111.247 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -86.36 142.32 18.75 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 108.205 -1.958 . . . . 0.0 108.205 168.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.9 m -160.62 160.41 31.63 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 119.233 1.517 . . . . 0.0 110.815 173.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -137.31 -47.14 0.57 Allowed 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.89 1.276 . . . . 0.0 109.525 169.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.2 p -80.99 -12.58 59.35 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.323 1.049 . . . . 0.0 112.162 170.46 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.41 10.86 53.21 Favored Glycine 0 C--N 1.343 0.946 0 C-N-CA 124.799 1.19 . . . . 0.0 113.884 170.166 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -66.28 -47.76 72.62 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 118.835 1.318 . . . . 0.0 112.158 -172.207 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.1 m -74.52 -14.93 60.87 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -168.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -56.15 -43.38 78.24 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.683 0.674 . . . . 0.0 109.755 171.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -68.78 -37.63 79.44 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 121.772 -0.58 . . . . 0.0 109.906 -177.274 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 29.7 mm -63.83 -43.33 97.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 176.238 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.36 -38.92 85.39 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.58 -0.7 . . . . 0.0 110.942 177.11 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -68.28 -40.62 81.75 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 118.177 -0.916 . . . . 0.0 111.342 175.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 63.9 mtt -58.98 -34.26 71.63 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 120.027 1.285 . . . . 0.0 111.051 175.494 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 55.6 mt -71.45 -53.96 18.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 175.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -61.49 -37.03 82.19 Favored 'General case' 0 N--CA 1.462 0.161 0 O-C-N 121.364 -0.835 . . . . 0.0 111.827 -173.239 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -63.55 -35.72 81.41 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 119.202 0.91 . . . . 0.0 111.088 -178.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -75.33 -41.79 55.88 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 122.902 0.481 . . . . 0.0 111.05 177.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -72.47 -34.24 67.58 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 122.73 0.412 . . . . 0.0 111.083 -177.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.43 145.07 8.52 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 -169.097 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -58.78 -33.98 70.93 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 122.015 -0.697 . . . . 0.0 112.078 -175.441 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -74.64 -11.75 60.27 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.26 -174.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.2 t -106.65 -42.09 6.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 124.337 1.055 . . . . 0.0 109.586 178.379 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -129.4 140.25 51.4 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 119.473 1.033 . . . . 0.0 111.482 -178.081 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -122.58 155.29 36.6 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.556 1.142 . . . . 0.0 109.473 177.286 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 77.6 t -119.7 130.33 74.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 124.234 1.014 . . . . 0.0 110.071 -169.179 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -146.79 177.61 8.97 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.857 1.663 . . . . 0.0 111.551 -172.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -133.81 130.22 37.64 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 126.884 2.074 . . . . 0.0 105.764 178.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.2 tp -60.56 -21.35 23.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 C-N-CA 123.496 0.719 . . . . 0.0 112.137 -172.35 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.6 -29.52 68.03 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 118.893 0.77 . . . . 0.0 111.322 177.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -81.08 -26.75 36.04 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.097 0.559 . . . . 0.0 111.438 177.074 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 62.7 m -71.89 159.48 34.2 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 122.129 0.966 . . . . 0.0 112.427 -168.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 23.5 m -130.07 175.34 8.97 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.849 2.059 . . . . 0.0 107.054 173.033 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -53.01 -45.63 68.01 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.236 0.615 . . . . 0.0 112.002 -172.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -81.6 -11.8 58.99 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 -175.096 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -70.8 -32.6 69.74 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 118.98 0.809 . . . . 0.0 111.304 -176.218 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -69.33 -43.71 73.16 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 123.429 0.692 . . . . 0.0 109.392 173.017 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 77.9 mt-10 -70.79 -11.66 61.08 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.932 0.893 . . . . 0.0 112.049 -171.705 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.88 -29.26 69.68 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.08 0.952 . . . . 0.0 111.907 173.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -98.34 153.6 18.43 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.854 1.262 . . . . 0.0 110.348 -178.246 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -99.54 -27.91 13.48 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.567 174.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.2 mp -113.84 129.79 69.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 174.286 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -114.15 125.71 54.25 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 107.086 -1.449 . . . . 0.0 107.086 175.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.3 mp -111.89 112.35 23.94 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 173.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.1 mt -112.9 112.28 23.64 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -169.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -100.82 115.15 5.21 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 125.602 1.572 . . . . 0.0 110.126 -178.477 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 16.2 tt -123.02 118.17 28.2 Favored Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 118.442 1.121 . . . . 0.0 111.71 -173.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -79.63 138.19 13.37 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 121.731 1.621 . . . . 0.0 108.039 167.565 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 79.7 m -94.39 143.71 26.17 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 174.145 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 66.2 m95 -134.25 173.74 11.27 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 126.082 1.753 . . . . 0.0 109.414 -177.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 24.4 t80 32.26 64.69 0.23 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 127.902 2.481 . . . . 0.0 114.364 169.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 54.58 53.69 10.33 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.816 0.847 . . . . 0.0 111.738 171.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 82.79 55.78 2.9 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 123.551 0.596 . . . . 0.0 112.085 174.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -128.99 155.87 44.7 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 125.846 1.658 . . . . 0.0 108.355 170.031 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.13 161.83 27.09 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 123.133 0.573 . . . . 0.0 110.252 172.125 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 34.1 tp60 -67.33 143.94 56.11 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 169.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 58.4 m -55.62 -35.23 65.65 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.815 0.846 . . . . 0.0 112.51 -172.294 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -64.76 -41.06 96.17 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.291 0.637 . . . . 0.0 110.444 -178.431 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -73.31 -46.75 47.72 Favored 'General case' 0 C--N 1.34 0.185 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 177.082 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -58.26 -36.24 72.94 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.582 0.753 . . . . 0.0 112.155 -177.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -69.9 -23.58 63.26 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.736 0.815 . . . . 0.0 112.552 177.099 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -100.39 -15.64 17.89 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.219 1.007 . . . . 0.0 112.025 -177.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 12.8 m-30 -48.4 -45.94 68.18 Favored Pre-proline 0 CA--C 1.542 0.668 0 CA-C-O 117.09 -1.433 . . . . 0.0 113.119 171.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -65.04 -20.93 63.83 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 CA-C-N 122.577 1.956 . . . . 0.0 113.116 176.216 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.8 m -82.75 -35.6 26.47 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 119.589 1.086 . . . . 0.0 110.047 174.278 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 71.8 mt -56.91 -34.0 67.51 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 119.856 1.207 . . . . 0.0 111.205 178.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -82.53 -1.23 49.9 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 178.298 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -99.95 -29.58 12.49 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.122 0.969 . . . . 0.0 109.629 169.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 92.9 mt -66.4 142.91 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 C-N-CA 125.69 1.596 . . . . 0.0 107.93 177.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -88.14 130.53 35.01 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 123.547 0.739 . . . . 0.0 109.537 173.177 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -124.37 18.48 8.97 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.513 0.725 . . . . 0.0 111.741 172.424 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 23.1 m-80 -61.95 116.79 5.18 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 119.95 1.25 . . . . 0.0 109.554 -175.097 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.0 5.92 66.56 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-O 118.881 -0.955 . . . . 0.0 113.189 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 9.8 mmpt? -76.88 153.13 35.06 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 119.216 1.508 . . . . 0.0 107.26 172.386 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -95.05 141.02 29.17 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 173.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 15.5 t -134.89 146.38 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 175.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -137.59 146.88 44.55 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 170.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 75.5 mt -116.78 142.36 47.02 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -172.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -138.85 157.3 46.3 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 169.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -162.72 153.41 23.99 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-O 122.455 1.03 . . . . 0.0 112.835 -171.031 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 51.8 m -126.12 150.93 47.88 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 113.017 -1.592 . . . . 0.0 108.821 -168.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -177.46 175.99 47.84 Favored Glycine 0 CA--C 1.523 0.534 0 C-N-CA 121.035 -0.602 . . . . 0.0 113.544 -172.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -100.54 140.68 34.46 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 125.391 1.476 . . . . 0.0 109.007 171.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -130.15 37.85 3.85 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.219 1.007 . . . . 0.0 109.532 -179.222 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -113.07 -55.55 2.51 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 124.44 1.096 . . . . 0.0 108.443 172.445 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -113.75 -33.3 5.85 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.551 1.14 . . . . 0.0 111.198 -175.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -92.02 22.57 4.23 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.703 0.801 . . . . 0.0 112.357 -178.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.61 -33.61 74.2 Favored 'General case' 0 C--N 1.343 0.302 0 CA-C-N 120.023 1.283 . . . . 0.0 113.515 -169.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -65.03 -31.01 72.03 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 119.934 1.243 . . . . 0.0 110.284 175.184 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -100.18 9.17 43.19 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.745 1.618 . . . . 0.0 111.218 -177.469 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -65.97 118.76 10.23 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 119.114 0.87 . . . . 0.0 108.884 -169.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 60.6 m 53.24 28.71 7.45 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.967 1.307 . . . . 0.0 112.789 -175.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -53.71 -36.48 62.29 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.73 1.212 . . . . 0.0 111.731 -176.423 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.72 -11.78 61.15 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -174.156 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 32.1 mt -54.38 -47.86 72.18 Favored 'General case' 0 C--N 1.344 0.353 0 CA-C-N 119.148 0.885 . . . . 0.0 110.47 173.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.0 -29.23 74.29 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 111.745 -0.542 . . . . 0.0 111.745 -176.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.8 m -63.63 -37.63 88.06 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 117.76 0.78 . . . . 0.0 110.049 177.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 5.8 mt -67.87 -44.17 85.5 Favored 'Isoleucine or valine' 0 C--N 1.344 0.346 0 CA-C-O 117.781 -1.104 . . . . 0.0 108.938 177.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 57.7 ttp85 -56.27 -46.74 79.58 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 120.032 1.287 . . . . 0.0 110.041 177.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -59.82 -28.18 67.24 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -178.249 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 80.0 mt -84.28 -45.67 18.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 124.38 1.072 . . . . 0.0 110.688 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 10.5 pt -85.83 -28.1 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 119.508 1.049 . . . . 0.0 112.584 -169.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -63.56 -42.12 70.85 Favored Pre-proline 0 CA--C 1.548 0.868 0 CA-C-O 117.814 -1.089 . . . . 0.0 111.434 -174.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -61.54 -20.02 67.01 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 122.727 2.285 . . . . 0.0 114.19 172.127 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 23.9 mmm180 -86.9 5.01 39.09 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.065 0.946 . . . . 0.0 111.44 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 75.73 17.53 80.06 Favored Glycine 0 CA--C 1.529 0.945 0 CA-C-O 118.51 -1.161 . . . . 0.0 113.03 178.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -59.1 137.76 57.82 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 118.809 1.305 . . . . 0.0 109.482 169.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 36.6 m -94.18 126.57 39.5 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 169.41 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 57.1 mt -105.22 132.6 51.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -174.008 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 27.1 m -129.01 176.35 8.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 125.737 1.615 . . . . 0.0 108.523 172.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 80.78 26.58 53.37 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-O 119.043 -0.865 . . . . 0.0 114.023 175.295 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 65.1 m80 -62.3 130.45 45.38 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 168.125 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 65.2 t-105 -107.64 124.56 34.59 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-O 118.258 -0.877 . . . . 0.0 108.787 -169.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -71.29 146.86 51.98 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 121.501 1.468 . . . . 0.0 112.144 -172.055 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 33.2 p -77.37 -39.69 46.47 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.874 0.87 . . . . 0.0 111.242 179.158 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 50.13 47.7 23.15 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.35 1.46 . . . . 0.0 111.628 -172.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.06 61.76 2.6 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -179.168 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 80.6 t80 -75.43 -79.28 0.1 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.814 0.845 . . . . 0.0 109.615 178.082 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 34.7 t60 43.98 45.76 6.67 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.467 1.907 . . . . 0.0 112.826 177.41 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 30.1 t80 -78.4 -65.41 0.99 Allowed 'General case' 0 C--N 1.342 0.242 0 O-C-N 121.864 -0.522 . . . . 0.0 109.891 -173.084 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -126.54 -99.21 0.39 Allowed 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 168.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -157.02 42.49 0.34 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 122.66 1.219 . . . . 0.0 110.328 -174.232 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 8.4 m -58.73 122.69 14.15 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 113.42 -1.718 . . . . 0.0 112.129 -168.12 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.41 -9.81 57.4 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -175.232 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -64.75 -18.73 64.38 Favored Glycine 0 CA--C 1.536 1.404 0 CA-C-N 119.407 1.003 . . . . 0.0 112.295 169.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 91.7 mt -64.44 130.29 43.17 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.809 1.304 . . . . 0.0 109.237 175.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -93.7 -33.44 13.64 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.472 0.709 . . . . 0.0 109.386 168.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -149.87 165.78 31.53 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 126.717 2.007 . . . . 0.0 107.638 177.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -55.67 -26.79 46.54 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 121.717 -0.614 . . . . 0.0 112.108 172.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -90.55 -19.3 23.92 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.891 1.276 . . . . 0.0 114.216 -179.039 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 24.0 p80 -156.74 147.34 21.56 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 120.481 1.491 . . . . 0.0 114.311 -176.457 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -82.72 151.17 26.31 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 126.215 1.806 . . . . 0.0 108.607 168.11 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 5.8 p -69.19 -16.96 21.33 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 122.856 0.462 . . . . 0.0 111.612 179.431 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -157.45 174.06 34.91 Favored Glycine 0 C--N 1.339 0.742 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 178.599 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -67.08 105.63 1.73 Allowed 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 123.542 0.737 . . . . 0.0 109.219 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -82.66 131.07 35.21 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 168.195 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 41.5 pt -63.52 -17.44 20.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -173.351 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -135.27 163.69 29.42 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.985 1.314 . . . . 0.0 110.651 -174.252 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -133.96 -14.73 2.37 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.402 1.881 . . . . 0.0 111.906 173.453 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -154.06 105.04 2.69 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 121.012 1.733 . . . . 0.0 112.332 -169.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 13.9 tpt180 45.95 72.56 0.21 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.721 2.009 . . . . 0.0 113.192 169.059 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 67.08 148.07 0.11 Allowed Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 127.83 2.452 . . . . 0.0 113.024 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -60.15 130.15 33.09 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 122.598 2.199 . . . . 0.0 114.535 -167.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -154.17 154.04 32.85 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 127.126 2.171 . . . . 0.0 105.24 167.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 47.5 mt 57.19 30.11 17.81 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 119.284 0.947 . . . . 0.0 112.002 -172.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 87.4 m -59.42 -51.35 70.26 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 125.159 1.384 . . . . 0.0 111.118 -176.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -67.53 -31.92 72.35 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 119.398 -0.334 . . . . 0.0 111.01 -169.297 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 24.8 mp0 -60.81 -43.72 97.83 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.513 1.125 . . . . 0.0 109.813 174.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 68.4 mtt85 -62.8 -42.69 99.82 Favored 'General case' 0 N--CA 1.466 0.347 0 O-C-N 121.573 -0.705 . . . . 0.0 110.506 175.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 58.1 t -66.64 -37.88 80.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-O 118.753 -0.641 . . . . 0.0 109.494 -179.104 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -62.03 -51.04 69.59 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 120.215 1.37 . . . . 0.0 110.012 175.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 61.1 mttm -58.51 -42.63 88.14 Favored 'General case' 0 CA--C 1.529 0.153 0 O-C-N 122.119 -0.363 . . . . 0.0 110.43 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 58.0 t90 -67.85 -47.51 68.77 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 118.131 0.423 . . . . 0.0 110.641 -177.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 50.9 t -60.64 -37.91 76.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 118.365 0.53 . . . . 0.0 110.104 -178.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 56.0 mttm -64.99 -46.8 79.92 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 121.637 -0.665 . . . . 0.0 109.275 176.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 6.1 mm-40 -59.86 -46.95 87.66 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 118.695 0.679 . . . . 0.0 111.819 179.358 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 18.5 pt -68.74 -32.11 53.57 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.19 0 CA-C-N 119.329 0.968 . . . . 0.0 110.212 -178.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 36.0 m -61.69 -32.16 72.34 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 119.033 0.833 . . . . 0.0 110.927 172.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -72.12 -44.42 63.2 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.442 1.019 . . . . 0.0 110.192 174.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -66.75 -35.62 80.52 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.168 0.587 . . . . 0.0 111.466 -178.459 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 86.3 mt -84.28 -3.12 58.03 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.533 1.533 . . . . 0.0 111.452 178.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 54.53 28.24 9.48 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.837 1.655 . . . . 0.0 112.811 -173.489 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 85.8 mt -78.47 -26.31 46.07 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 123.233 0.613 . . . . 0.0 109.846 170.077 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -59.04 -39.12 81.01 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 122.901 0.481 . . . . 0.0 110.319 176.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -61.55 -23.51 66.02 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.625 0.77 . . . . 0.0 111.934 177.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 43.4 mt -89.32 -52.7 10.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 124.308 1.043 . . . . 0.0 108.217 -179.543 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 3.0 pp -76.89 -22.47 53.38 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -170.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -74.8 -26.67 59.9 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 118.642 0.655 . . . . 0.0 112.016 179.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.189 0 C-N-CA 124.196 0.998 . . . . 0.0 110.335 -177.885 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.3 mtt . . . . . 0 N--CA 1.488 1.468 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -60.61 146.73 44.28 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.562 0.745 . . . . 0.0 111.487 -177.501 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.1 pt -113.45 -18.24 7.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 126.317 1.847 . . . . 0.0 111.045 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 40.9 m -109.92 124.29 51.11 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.565 1.546 . . . . 0.0 108.845 178.543 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -99.43 120.24 6.79 Favored Glycine 0 CA--C 1.522 0.469 0 N-CA-C 108.437 -1.865 . . . . 0.0 108.437 169.474 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 55.1 mt -97.67 94.21 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 104.773 -2.306 . . . . 0.0 104.773 177.217 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -97.1 108.53 21.29 Favored 'General case' 0 CA--C 1.52 -0.177 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 178.4 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -128.25 118.45 23.31 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 118.961 0.8 . . . . 0.0 109.755 -168.302 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -83.8 132.98 11.46 Favored Glycine 0 C--N 1.338 0.688 0 N-CA-C 110.376 -1.089 . . . . 0.0 110.376 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.1 m -137.78 161.22 37.14 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.292 1.437 . . . . 0.0 107.959 174.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -136.13 -50.92 0.7 Allowed 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.088 0.555 . . . . 0.0 110.008 169.029 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -81.74 -6.4 59.01 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.424 0.689 . . . . 0.0 111.778 170.484 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.33 11.65 51.13 Favored Glycine 0 C--N 1.345 1.034 0 C-N-CA 124.615 1.102 . . . . 0.0 115.138 167.4 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -73.47 -46.22 49.48 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 119.324 1.562 . . . . 0.0 111.822 -177.385 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.76 -39.08 93.02 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 118.8 0.727 . . . . 0.0 110.601 -168.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -64.13 -27.58 69.18 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.232 -0.918 . . . . 0.0 112.096 -178.462 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -66.72 -37.04 83.87 Favored 'General case' 0 N--CA 1.465 0.276 0 O-C-N 121.49 -0.756 . . . . 0.0 109.984 174.156 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.3 mm -67.61 -43.26 87.06 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.153 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 174.162 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.39 -38.5 71.57 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.912 0.778 . . . . 0.0 111.059 -179.485 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 68.6 mttt -67.19 -42.34 84.34 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 122.955 0.502 . . . . 0.0 110.833 175.706 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 77.3 mtm -67.15 -29.78 69.58 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 119.281 0.946 . . . . 0.0 111.883 177.223 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 70.6 mt -68.73 -53.92 24.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 173.314 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -59.33 -37.9 78.96 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.765 -0.584 . . . . 0.0 111.193 -176.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -63.44 -39.18 93.8 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 119.116 0.871 . . . . 0.0 110.952 -179.116 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -71.97 -41.62 67.5 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 122.697 0.399 . . . . 0.0 110.978 177.379 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.9 mp -73.82 -33.44 64.17 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 118.096 0.407 . . . . 0.0 111.174 -176.171 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.16 143.34 12.88 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 125.26 1.409 . . . . 0.0 110.58 -171.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -65.37 -29.0 69.67 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.735 -0.862 . . . . 0.0 111.794 -174.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -77.47 -7.57 56.4 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 122.942 0.497 . . . . 0.0 112.006 177.316 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.0 t -108.04 -41.03 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 C-N-CA 124.421 1.088 . . . . 0.0 109.569 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -132.82 147.53 52.31 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 119.512 1.051 . . . . 0.0 112.144 -175.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.3 t0 -132.71 151.31 52.01 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.515 0.726 . . . . 0.0 110.773 173.153 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 97.5 t -106.9 137.48 37.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 C-N-CA 124.87 1.268 . . . . 0.0 109.648 -169.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -145.11 164.78 30.22 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.615 1.566 . . . . 0.0 110.598 -171.699 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -131.02 134.38 46.63 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 175.334 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.407 ' HB ' ' CH2' ' A' ' 66' ' ' TRP . 1.3 tp -65.72 -26.36 38.69 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-O 118.514 -0.755 . . . . 0.0 113.003 -168.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.99 -29.58 68.64 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 119.287 0.949 . . . . 0.0 110.479 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -84.22 -28.75 27.06 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.417 0.687 . . . . 0.0 111.325 175.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.4 m -77.32 168.4 20.09 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.137 0.975 . . . . 0.0 111.621 -169.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.3 m -131.3 159.67 37.19 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.887 1.275 . . . . 0.0 110.138 -174.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -53.25 -47.58 68.94 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.676 1.19 . . . . 0.0 111.811 -175.106 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -80.81 -13.42 58.97 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 122.245 -0.284 . . . . 0.0 111.63 -174.226 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -76.68 -31.16 57.08 Favored 'General case' 0 C--O 1.234 0.267 0 O-C-N 121.534 -0.729 . . . . 0.0 111.566 -172.11 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.9 mp -66.22 -35.69 81.08 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 175.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -68.83 -13.43 62.41 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.348 0.659 . . . . 0.0 112.38 -174.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.15 -29.12 68.73 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.531 0.732 . . . . 0.0 111.484 174.488 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -94.22 147.61 23.01 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.162 0.985 . . . . 0.0 110.381 -177.33 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -91.38 -33.65 15.18 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.895 173.017 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.2 mp -107.82 134.52 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 176.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 96.8 mt -122.07 124.36 43.76 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 174.207 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.3 mp -105.79 110.08 22.25 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 104.956 -2.239 . . . . 0.0 104.956 169.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 73.9 mt -109.55 111.15 22.48 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 -173.092 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -96.25 123.31 7.66 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 -179.512 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 2.1 tp -137.12 100.87 9.45 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 125.067 1.347 . . . . 0.0 109.32 -171.046 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.25 142.52 30.51 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.204 1.936 . . . . 0.0 109.091 168.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 59.1 m -91.84 136.84 32.85 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 177.37 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 24.5 m95 -135.51 168.17 19.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 120.58 1.536 . . . . 0.0 112.605 -169.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 58.66 -61.69 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 130.707 3.603 . . . . 0.0 116.32 169.428 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -150.98 30.08 0.64 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.448 1.899 . . . . 0.0 110.44 -169.539 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 73.23 48.39 19.58 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 -171.264 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -123.98 175.75 6.76 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.58 1.552 . . . . 0.0 108.43 177.074 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -79.24 158.35 27.62 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.138 -0.976 . . . . 0.0 109.54 169.064 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -58.95 138.11 57.58 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 172.344 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 99.5 m -55.78 -40.21 72.34 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -167.356 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -73.73 -27.1 61.01 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.366 0.667 . . . . 0.0 111.705 -177.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.407 ' CH2' ' HB ' ' A' ' 36' ' ' ILE . 1.0 OUTLIER -77.79 -44.49 27.38 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.172 0.989 . . . . 0.0 109.541 174.194 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -58.65 -42.12 87.63 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.399 1.079 . . . . 0.0 111.06 176.46 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -61.8 -22.29 65.32 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.16 0.984 . . . . 0.0 112.2 177.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -90.85 -17.12 27.06 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 118.348 -0.834 . . . . 0.0 112.067 178.158 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 21.2 m-30 -54.98 -40.66 85.83 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-O 116.445 -1.741 . . . . 0.0 114.408 179.019 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -63.49 -20.27 69.43 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 CA-C-N 122.912 2.076 . . . . 0.0 113.24 173.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.4 m -82.44 -45.16 15.13 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.262 0.937 . . . . 0.0 109.14 170.093 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 12.9 tp -56.22 -40.16 73.63 Favored 'General case' 0 C--N 1.342 0.241 0 C-N-CA 125.077 1.351 . . . . 0.0 110.523 -175.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -72.39 -1.02 14.02 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -178.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -104.94 -12.0 16.42 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 119.647 1.112 . . . . 0.0 112.124 172.5 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 80.8 mt -78.23 142.04 14.67 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 -179.533 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -82.63 130.05 35.05 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 178.05 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -122.06 13.01 10.46 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 118.682 -0.675 . . . . 0.0 111.849 173.409 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -62.3 115.79 4.48 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-N 120.035 1.289 . . . . 0.0 108.754 -176.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 74.69 -0.72 55.7 Favored Glycine 0 CA--C 1.535 1.296 0 CA-C-O 118.459 -1.189 . . . . 0.0 114.095 -179.299 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -69.33 146.47 52.15 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 119.738 1.769 . . . . 0.0 107.288 169.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -90.03 137.34 32.42 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 170.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.0 t -131.97 142.35 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 177.606 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -131.27 141.45 49.98 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 170.146 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 73.3 mt -110.66 149.98 29.67 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -176.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.454 ' CE2' HD12 ' A' ' 142' ' ' LEU . 14.4 t80 -141.53 147.49 37.84 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 -179.373 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -164.96 137.58 4.79 Favored Glycine 0 CA--C 1.522 0.5 0 CA-C-N 119.216 0.916 . . . . 0.0 110.936 169.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 4.5 p -95.11 152.81 18.02 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 168.595 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -145.33 -158.36 7.63 Favored Glycine 0 CA--C 1.525 0.702 0 CA-C-O 121.048 0.249 . . . . 0.0 113.019 -173.603 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -146.9 145.38 29.8 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 127.504 2.322 . . . . 0.0 107.85 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -133.14 12.39 4.24 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.37 1.468 . . . . 0.0 109.931 177.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -81.9 -47.05 13.24 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 177.035 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -126.72 -33.2 2.53 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 123.949 0.9 . . . . 0.0 111.126 -175.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -91.33 33.89 0.97 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.211 1.004 . . . . 0.0 111.421 176.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.45 -20.02 62.65 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.278 1.431 . . . . 0.0 113.116 -178.129 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -97.62 6.6 47.79 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.912 0.885 . . . . 0.0 111.948 176.171 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -138.53 24.47 2.67 Favored 'General case' 0 C--O 1.237 0.411 0 O-C-N 120.854 -1.154 . . . . 0.0 110.858 -174.087 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -65.97 118.57 9.95 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -169.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 86.3 m 48.28 35.23 5.3 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.648 1.979 . . . . 0.0 113.636 -175.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -53.38 -41.17 65.62 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.364 0.666 . . . . 0.0 112.342 -178.128 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.99 -12.06 60.06 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -170.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 53.9 mt -56.22 -42.21 76.88 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 118.719 0.691 . . . . 0.0 109.647 169.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -65.0 -30.66 78.6 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.811 -0.515 . . . . 0.0 111.811 -178.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 4.3 m -64.93 -40.13 94.57 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 117.985 0.893 . . . . 0.0 110.098 179.049 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.7 mt -73.86 -39.85 52.43 Favored 'Isoleucine or valine' 0 C--N 1.344 0.363 0 CA-C-N 118.908 0.777 . . . . 0.0 109.271 176.268 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 57.7 ttt-85 -52.67 -46.64 67.29 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 119.583 1.083 . . . . 0.0 110.331 177.317 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -64.73 -21.59 66.79 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.596 0.758 . . . . 0.0 112.455 -176.309 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 95.8 mt -87.98 -46.01 15.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 123.454 0.702 . . . . 0.0 109.474 175.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 7.0 pt -77.79 -28.69 15.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-N 118.926 0.785 . . . . 0.0 112.045 -169.265 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -62.12 -56.86 27.35 Favored Pre-proline 0 CA--C 1.544 0.724 0 CA-C-O 117.568 -1.206 . . . . 0.0 112.167 179.303 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -66.23 -24.06 51.53 Favored 'Trans proline' 0 C--N 1.353 0.781 0 CA-C-N 121.96 1.736 . . . . 0.0 112.208 -179.367 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 79.5 mmt-85 -78.28 5.11 11.08 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.856 0.862 . . . . 0.0 112.774 172.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 77.22 20.92 74.52 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-N 119.604 1.093 . . . . 0.0 113.993 169.262 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.9 148.91 48.31 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 118.56 1.18 . . . . 0.0 110.589 170.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 60.2 m -97.47 124.36 41.65 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 105.01 -2.218 . . . . 0.0 105.01 167.019 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 48.9 mt -98.43 134.13 38.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 -175.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 29.1 m -133.14 176.63 8.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 125.582 1.553 . . . . 0.0 108.854 172.257 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 78.04 23.38 66.45 Favored Glycine 0 CA--C 1.529 0.926 0 CA-C-O 119.065 -0.853 . . . . 0.0 113.906 175.589 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 15.4 p-80 -60.3 140.85 56.87 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 118.327 1.063 . . . . 0.0 108.809 168.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 75.4 t-105 -131.19 136.48 28.84 Favored Pre-proline 0 CA--C 1.536 0.43 0 C-N-CA 124.26 1.024 . . . . 0.0 110.244 -168.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -70.36 152.3 66.13 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.466 2.111 . . . . 0.0 111.912 -176.055 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 22.2 p -70.82 -22.07 62.38 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.867 0.867 . . . . 0.0 112.613 174.283 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 53.09 38.7 28.07 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.628 1.571 . . . . 0.0 111.851 -171.525 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 68.77 50.36 36.49 Favored Glycine 0 C--N 1.341 0.852 0 N-CA-C 111.543 -0.623 . . . . 0.0 111.543 176.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -57.14 149.27 19.9 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 117.317 0.558 . . . . 0.0 110.942 178.309 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 36.1 t60 -139.63 60.49 1.57 Allowed 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.156 0.982 . . . . 0.0 109.28 -175.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -129.89 176.05 8.36 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.191 1.396 . . . . 0.0 108.942 177.036 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -61.59 -47.75 84.06 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 118.577 -0.725 . . . . 0.0 111.978 -168.148 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -163.31 133.93 4.56 Favored 'General case' 0 C--N 1.34 0.192 0 CA-C-N 119.018 0.826 . . . . 0.0 112.11 172.157 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 58.2 m -97.31 126.73 42.72 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 166.497 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -115.88 -4.96 12.04 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 -171.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -83.04 8.59 62.88 Favored Glycine 0 CA--C 1.535 1.324 0 CA-C-N 118.619 0.645 . . . . 0.0 112.775 168.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 74.9 mt -62.29 138.77 58.49 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.564 1.145 . . . . 0.0 111.204 -179.045 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -104.56 -26.22 12.44 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.629 1.572 . . . . 0.0 109.792 168.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -143.66 165.71 26.88 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.01 1.724 . . . . 0.0 107.219 172.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -53.61 -27.2 25.54 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.197 1.399 . . . . 0.0 114.186 -169.368 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -123.49 9.98 9.1 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.781 1.232 . . . . 0.0 113.58 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -137.91 130.39 29.4 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 119.788 1.176 . . . . 0.0 111.143 -172.187 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -81.39 151.44 27.93 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 124.935 1.294 . . . . 0.0 110.165 173.506 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 14.5 p -61.89 -29.89 47.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 123.0 0.52 . . . . 0.0 111.528 175.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -141.28 -176.36 15.57 Favored Glycine 0 CA--C 1.521 0.445 0 C-N-CA 125.305 1.431 . . . . 0.0 109.606 -175.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.454 HD12 ' CE2' ' A' ' 86' ' ' PHE . 3.3 tm? -60.9 125.99 25.75 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 169.715 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -123.3 125.21 44.62 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 171.243 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 20.9 tt -136.38 122.83 30.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 113.769 1.026 . . . . 0.0 113.769 -171.18 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -174.11 154.82 2.34 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 127.9 2.48 . . . . 0.0 106.687 167.207 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -137.65 106.78 6.02 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 168.242 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 30.8 t70 64.85 -33.38 0.15 Allowed 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 128.895 2.878 . . . . 0.0 116.901 174.438 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 3.2 tpm_? -149.26 -63.3 0.23 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 119.668 1.122 . . . . 0.0 110.708 -176.686 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -144.97 148.42 38.63 Favored Pre-proline 0 C--O 1.239 0.504 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 170.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -67.04 149.81 82.56 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.163 1.909 . . . . 0.0 111.495 -177.624 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -134.41 -26.33 1.44 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.95 1.3 . . . . 0.0 111.57 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 74.3 mt -92.34 33.43 1.1 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.976 1.31 . . . . 0.0 108.873 169.362 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 97.1 m -51.09 -53.44 34.12 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 126.988 2.115 . . . . 0.0 111.85 -174.096 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.59 -43.86 95.71 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 119.083 -0.484 . . . . 0.0 111.884 -166.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -67.12 -36.1 81.2 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 118.794 0.725 . . . . 0.0 111.091 -177.003 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 77.3 mtt85 -67.12 -47.55 70.79 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 118.825 0.738 . . . . 0.0 109.883 -179.139 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 16.8 m -72.41 -31.67 39.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-O 118.77 -0.633 . . . . 0.0 110.481 -176.03 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -63.35 -49.63 73.12 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 119.659 1.118 . . . . 0.0 109.948 171.17 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -58.61 -42.26 87.76 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 118.477 0.58 . . . . 0.0 109.972 178.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 66.8 t90 -64.32 -46.77 82.09 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 118.822 0.737 . . . . 0.0 110.589 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 28.5 t -56.89 -42.71 78.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 118.24 0.473 . . . . 0.0 109.863 176.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 54.7 mttm -69.01 -38.32 79.16 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 118.567 -0.73 . . . . 0.0 109.825 -176.13 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 19.1 mm100 -59.89 -55.45 34.04 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 118.611 0.641 . . . . 0.0 110.304 172.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 16.1 pt -65.32 -30.53 50.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 118.924 0.784 . . . . 0.0 110.642 -174.172 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 50.8 m -61.82 -25.74 67.69 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.747 0.703 . . . . 0.0 111.692 177.385 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -89.33 -28.88 19.54 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 119.599 1.091 . . . . 0.0 111.023 176.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -72.19 -37.82 69.21 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 118.663 0.665 . . . . 0.0 110.67 175.245 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 76.8 mt -90.83 -9.32 46.84 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.186 1.794 . . . . 0.0 111.848 -177.281 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 55.57 29.44 13.48 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.534 1.534 . . . . 0.0 112.759 -170.113 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 86.5 mt -72.08 -20.13 61.7 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.349 -0.845 . . . . 0.0 110.286 169.362 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -59.88 -35.24 74.39 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.952 0.796 . . . . 0.0 110.238 176.108 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -66.4 -11.25 50.58 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 121.404 -0.81 . . . . 0.0 112.347 177.542 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 22.1 mt -104.65 -55.34 5.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 125.252 1.421 . . . . 0.0 108.374 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 3.0 pp -78.88 -21.92 46.76 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.075 0.55 . . . . 0.0 112.473 -172.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -124.62 39.3 4.01 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 127.059 2.144 . . . . 0.0 108.776 -179.356 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.318 0 C-N-CA 123.606 0.762 . . . . 0.0 109.453 173.765 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.1 ttt . . . . . 0 N--CA 1.488 1.459 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -58.85 142.44 50.5 Favored 'General case' 0 C--N 1.344 0.33 0 C-N-CA 123.325 0.65 . . . . 0.0 111.408 -178.382 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.1 pt -109.89 -15.96 9.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 125.363 1.465 . . . . 0.0 111.3 178.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 28.9 m -111.77 123.69 50.77 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.201 1.4 . . . . 0.0 108.317 177.406 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -96.49 119.29 6.26 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 107.434 -2.267 . . . . 0.0 107.434 169.468 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 56.8 mt -98.07 91.88 2.64 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 105.23 -2.137 . . . . 0.0 105.23 176.263 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -88.48 129.08 35.53 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 178.357 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -128.54 133.48 48.41 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 120.011 1.278 . . . . 0.0 111.88 179.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -89.92 145.24 18.12 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 169.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 9.3 m -164.23 158.34 18.85 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.679 1.24 . . . . 0.0 109.743 172.27 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -125.18 -51.13 1.66 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.614 0.765 . . . . 0.0 109.432 168.207 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.2 p -86.35 8.11 22.84 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.097 1.359 . . . . 0.0 112.976 173.343 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 84.19 -9.02 64.99 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 116.963 1.545 . . . . 0.0 116.963 168.138 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -60.78 -37.45 81.92 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 120.23 2.015 . . . . 0.0 113.825 -169.457 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.7 m -73.55 -15.09 61.3 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 120.01 1.277 . . . . 0.0 110.799 -175.697 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -60.19 -41.95 94.04 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 119.643 1.111 . . . . 0.0 109.676 172.337 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -63.04 -41.29 99.46 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -178.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 25.7 mm -64.8 -45.06 96.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 177.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.88 -40.25 88.09 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.589 0.631 . . . . 0.0 111.04 178.012 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.2 mtpt -67.47 -42.09 83.56 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 118.022 -0.99 . . . . 0.0 110.72 177.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 63.4 mtt -55.66 -47.62 76.4 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 119.851 1.205 . . . . 0.0 109.721 175.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 62.1 mt -60.37 -52.69 58.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -179.573 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -61.79 -38.64 88.81 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.958 0.799 . . . . 0.0 111.212 -175.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -65.02 -35.86 82.53 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 118.908 0.776 . . . . 0.0 111.023 -179.191 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -70.64 -49.38 48.13 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.322 0.51 . . . . 0.0 110.838 175.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 54.5 mt -67.8 -32.6 73.27 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.329 0.513 . . . . 0.0 111.783 -177.308 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.0 145.09 14.79 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 125.407 1.48 . . . . 0.0 110.792 -173.562 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 22.8 ptmt -63.72 -29.53 70.74 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 121.728 -0.866 . . . . 0.0 113.184 -172.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -77.68 -11.49 59.88 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.591 179.167 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 22.4 t -103.57 -39.33 5.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 C-N-CA 124.283 1.033 . . . . 0.0 109.711 177.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -133.24 146.55 51.56 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 119.234 0.924 . . . . 0.0 111.94 -176.203 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -130.71 139.58 50.3 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.104 0.962 . . . . 0.0 109.853 175.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 98.3 t -90.4 139.27 17.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 123.655 0.782 . . . . 0.0 109.15 -177.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -148.27 172.95 13.54 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.925 1.29 . . . . 0.0 111.133 -168.559 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -143.79 125.63 15.2 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 125.856 1.662 . . . . 0.0 108.629 -172.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.4 tp -62.35 -28.43 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-O 118.855 -0.593 . . . . 0.0 111.723 -172.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.09 -27.89 69.7 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 118.77 0.714 . . . . 0.0 111.537 -175.009 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 61.9 pttt -105.45 -3.95 21.93 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.627 1.171 . . . . 0.0 112.359 176.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 50.9 m -79.25 166.85 21.71 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.398 0.679 . . . . 0.0 110.953 -179.651 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.4 m -134.43 163.58 29.36 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.189 1.396 . . . . 0.0 109.021 179.396 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 53.5 tttm -52.81 -57.25 10.8 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.024 0.93 . . . . 0.0 110.985 -174.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -75.34 -16.07 60.43 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 122.354 0.262 . . . . 0.0 111.329 -173.096 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -74.31 -29.29 61.56 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 122.889 0.476 . . . . 0.0 110.928 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.8 mp -71.43 -41.98 68.81 Favored 'General case' 0 C--N 1.344 0.336 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 168.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.3 -15.73 63.46 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.234 0.614 . . . . 0.0 112.264 -174.306 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.88 -30.06 70.12 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.324 1.05 . . . . 0.0 112.277 174.687 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -84.58 155.22 22.16 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 123.845 0.858 . . . . 0.0 110.059 178.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -102.45 -26.73 13.15 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.236 0.614 . . . . 0.0 111.129 169.348 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.9 mp -113.74 123.43 69.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 174.541 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -109.85 123.14 49.05 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 173.399 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.1 mp -109.2 120.68 43.24 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 105.43 -2.063 . . . . 0.0 105.43 169.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 59.6 mt -118.38 109.42 16.25 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 -173.249 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -90.05 121.24 6.09 Favored Glycine 0 N--CA 1.451 -0.323 0 N-CA-C 108.568 -1.813 . . . . 0.0 108.568 176.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 3.0 tp -141.65 103.84 5.88 Favored Pre-proline 0 CA--C 1.541 0.611 0 CA-C-N 117.741 0.771 . . . . 0.0 110.039 -169.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -76.47 147.14 28.31 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.463 2.109 . . . . 0.0 109.564 169.012 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 33.5 m -95.5 140.93 29.65 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 177.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 38.7 m95 -134.16 171.29 14.43 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 125.208 1.403 . . . . 0.0 111.24 -170.281 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 51.85 -87.59 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 127.8 2.44 . . . . 0.0 113.114 178.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -150.0 78.23 1.34 Allowed 'General case' 0 C--O 1.234 0.289 0 C-N-CA 126.682 1.993 . . . . 0.0 106.813 179.654 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 70.99 19.6 77.21 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 123.68 0.657 . . . . 0.0 113.337 179.39 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -93.12 161.33 14.47 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.582 1.153 . . . . 0.0 109.357 -176.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -79.31 159.41 27.22 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 167.367 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -58.18 143.88 42.59 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 168.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 60.4 m -51.74 -38.89 57.23 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.566 1.146 . . . . 0.0 113.645 -169.008 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -70.78 -35.63 72.66 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 118.548 0.613 . . . . 0.0 110.694 -175.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -71.5 -45.51 62.29 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 175.018 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -57.92 -41.29 82.36 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 122.738 0.415 . . . . 0.0 111.379 179.216 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -68.2 -25.53 65.27 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.729 0.812 . . . . 0.0 112.268 177.456 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -92.69 -18.65 22.72 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.55 0.74 . . . . 0.0 112.506 -178.23 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 19.4 m-30 -50.73 -40.61 64.46 Favored Pre-proline 0 CA--C 1.545 0.78 0 CA-C-O 116.469 -1.729 . . . . 0.0 114.633 178.324 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -63.2 -20.86 71.8 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 CA-C-N 123.033 2.119 . . . . 0.0 113.912 173.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.2 m -85.7 -39.05 17.64 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 119.381 0.991 . . . . 0.0 109.441 169.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 13.6 tp -58.24 -38.05 76.11 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.031 0.932 . . . . 0.0 110.697 -177.49 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -72.51 -3.98 27.72 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 179.22 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -103.13 -12.46 17.35 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.134 0.879 . . . . 0.0 111.357 173.286 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 79.4 mt -77.23 138.39 20.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -176.172 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -78.18 124.23 27.83 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.592 176.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -122.06 11.03 10.18 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.769 0.827 . . . . 0.0 111.6 172.455 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -63.08 114.09 3.51 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 120.012 1.278 . . . . 0.0 109.143 -171.571 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.17 3.65 61.54 Favored Glycine 0 CA--C 1.536 1.392 0 CA-C-O 118.546 -1.141 . . . . 0.0 113.866 -178.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -75.21 152.03 38.4 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 119.544 1.672 . . . . 0.0 108.182 170.467 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 20.8 mt -91.6 136.59 33.02 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 175.533 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 18.5 t -133.81 141.69 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.13 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -134.32 143.26 47.6 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 171.253 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 64.7 mt -111.86 144.42 41.2 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -177.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -140.53 154.46 46.55 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 170.004 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -173.54 155.66 22.65 Favored Glycine 0 N--CA 1.449 -0.476 0 CA-C-O 122.416 1.009 . . . . 0.0 112.705 176.711 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 64.1 m -101.96 149.87 23.78 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 169.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -145.51 -159.32 8.08 Favored Glycine 0 CA--C 1.521 0.409 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 176.005 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -144.79 139.51 27.85 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 124.968 1.307 . . . . 0.0 108.546 170.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -109.09 -14.7 14.48 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 123.962 0.905 . . . . 0.0 111.419 177.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -75.11 -43.62 51.79 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 119.843 1.201 . . . . 0.0 110.796 -170.06 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -112.87 -40.22 4.05 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 123.495 0.718 . . . . 0.0 110.755 179.032 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -83.89 37.86 0.62 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.533 0.733 . . . . 0.0 111.018 176.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.06 -23.64 63.92 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 126.805 2.042 . . . . 0.0 114.019 -170.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -99.34 0.26 42.52 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.321 1.448 . . . . 0.0 111.918 -179.115 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -131.98 16.99 4.65 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.258 1.023 . . . . 0.0 111.925 -169.127 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -65.15 125.88 26.35 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 121.247 -0.908 . . . . 0.0 110.27 -169.31 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 88.1 m 53.24 29.45 8.48 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.842 1.657 . . . . 0.0 114.349 176.028 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -61.43 -31.51 71.46 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.755 0.822 . . . . 0.0 111.339 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.56 -33.58 76.25 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 120.754 -1.216 . . . . 0.0 111.687 179.031 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 7.5 mp -63.29 -43.89 96.6 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-N 119.691 1.132 . . . . 0.0 109.633 175.473 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.71 -31.99 82.01 Favored Glycine 0 CA--C 1.532 1.114 0 N-CA-C 111.337 -0.705 . . . . 0.0 111.337 174.76 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 14.7 m -66.56 -41.42 88.65 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 117.76 0.78 . . . . 0.0 110.113 176.082 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 5.4 mt -65.75 -43.83 93.38 Favored 'Isoleucine or valine' 0 C--N 1.345 0.401 0 CA-C-N 119.425 1.012 . . . . 0.0 109.509 173.549 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 41.3 ttt180 -52.32 -45.93 65.81 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 119.381 0.991 . . . . 0.0 110.435 -178.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -62.0 -17.98 58.96 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.96 0.904 . . . . 0.0 113.035 -178.126 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 82.8 mt -95.4 -54.72 6.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 124.397 1.079 . . . . 0.0 109.216 175.219 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 23.2 pt -71.56 -33.46 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 O-C-N 121.251 -0.906 . . . . 0.0 112.195 -168.416 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -66.53 -50.37 47.22 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-O 117.694 -1.146 . . . . 0.0 111.486 -174.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -68.36 -24.67 36.83 Favored 'Trans proline' 0 C--N 1.354 0.836 0 CA-C-N 121.731 1.654 . . . . 0.0 112.769 174.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 7.7 mpt_? -74.76 6.76 3.63 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 119.42 1.009 . . . . 0.0 112.523 169.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 81.38 16.66 73.29 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-O 118.435 -1.203 . . . . 0.0 114.007 169.028 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.13 141.9 55.11 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 118.882 1.341 . . . . 0.0 109.998 170.164 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 88.1 m -93.13 119.34 32.24 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 104.641 -2.355 . . . . 0.0 104.641 167.321 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 33.6 mt -96.61 132.79 40.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 -173.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 29.9 m -129.44 172.62 15.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 C-N-CA 124.869 1.268 . . . . 0.0 109.033 175.472 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 77.35 27.74 59.09 Favored Glycine 0 CA--C 1.526 0.722 0 CA-C-O 119.105 -0.83 . . . . 0.0 113.542 177.224 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 28.9 p-80 -60.84 139.69 57.88 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 118.815 1.307 . . . . 0.0 108.678 168.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 75.6 t-105 -127.78 137.88 31.7 Favored Pre-proline 0 CA--C 1.533 0.321 0 C-N-CA 124.453 1.101 . . . . 0.0 108.245 -169.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -70.89 144.65 48.6 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 121.762 1.642 . . . . 0.0 112.347 -170.426 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 63.0 p -76.52 -31.14 57.48 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.471 0.708 . . . . 0.0 110.055 169.367 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 53.77 41.59 32.02 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.866 2.067 . . . . 0.0 110.846 -170.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 74.34 80.06 0.52 Allowed Glycine 0 CA--C 1.527 0.831 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -173.043 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -46.0 126.3 7.27 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.616 0.766 . . . . 0.0 109.936 172.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -94.21 -27.91 15.92 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -168.374 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -90.15 -170.09 2.65 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.573 0.749 . . . . 0.0 111.41 -168.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -66.56 -56.1 12.37 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -167.206 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -155.66 143.53 19.78 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-N 118.921 0.782 . . . . 0.0 110.873 176.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 2.4 p -123.77 138.47 54.5 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 124.513 1.125 . . . . 0.0 107.965 170.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.02 -4.77 20.12 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 122.875 0.47 . . . . 0.0 112.264 177.575 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -75.76 0.79 60.59 Favored Glycine 0 CA--C 1.535 1.295 0 CA-C-O 119.216 -0.769 . . . . 0.0 112.867 169.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 96.7 mt -64.32 139.19 58.74 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 119.468 1.634 . . . . 0.0 111.083 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -108.53 -31.07 7.93 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.456 1.503 . . . . 0.0 108.778 167.207 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -145.23 162.54 36.89 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 127.86 2.464 . . . . 0.0 106.181 169.382 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -55.65 -30.52 61.14 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 121.17 -0.956 . . . . 0.0 112.084 176.238 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -91.0 -9.41 46.06 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.241 1.016 . . . . 0.0 113.448 -179.572 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 58.7 m80 -147.36 130.94 16.81 Favored 'General case' 0 C--N 1.348 0.509 0 CA-C-N 119.93 1.241 . . . . 0.0 113.229 -171.336 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -76.22 155.58 34.31 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.008 0.923 . . . . 0.0 108.767 167.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 14.2 p -60.56 -32.19 50.85 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 124.144 0.978 . . . . 0.0 111.419 176.438 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -146.41 -177.25 20.9 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 124.905 1.241 . . . . 0.0 110.32 -172.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -62.55 123.39 18.21 Favored 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 171.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -135.05 109.93 8.72 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 -176.654 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 26.3 pt -122.23 141.23 43.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-O 121.807 0.813 . . . . 0.0 113.034 -172.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -162.23 -37.48 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 127.304 2.242 . . . . 0.0 108.395 168.587 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 59.2 tt0 65.31 -66.76 0.14 Allowed 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 128.224 2.61 . . . . 0.0 110.36 -177.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -169.98 99.11 0.29 Allowed 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 126.526 1.93 . . . . 0.0 107.104 169.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 16.4 tpp85 51.65 67.83 0.9 Allowed 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.143 1.377 . . . . 0.0 110.625 -176.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' GLN . . . . . 0.406 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 3.0 mm-40 71.39 139.02 0.06 OUTLIER Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 131.097 3.759 . . . . 0.0 111.665 178.035 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 149' ' ' GLN . 3.0 Cg_exo -77.07 162.15 32.01 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 121.341 1.361 . . . . 0.0 113.767 -167.257 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -110.09 -9.3 14.72 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.065 -0.97 . . . . 0.0 112.386 171.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 90.0 mt -121.56 39.44 3.85 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 125.79 1.636 . . . . 0.0 109.853 175.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 93.9 m -53.66 -58.21 8.02 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.424 1.09 . . . . 0.0 110.614 -175.009 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -68.91 -32.67 72.46 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 122.278 -0.264 . . . . 0.0 110.517 -169.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 25.3 mp0 -63.97 -48.47 76.33 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.234 1.014 . . . . 0.0 109.292 176.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 74.3 mtt85 -65.53 -37.18 86.0 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 118.912 0.778 . . . . 0.0 110.635 -179.334 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 96.3 t -64.41 -42.26 94.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-O 118.358 -0.829 . . . . 0.0 109.093 174.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -59.41 -48.71 80.59 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-N 119.832 1.196 . . . . 0.0 110.359 177.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -58.94 -44.62 91.44 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 118.088 0.403 . . . . 0.0 110.094 179.378 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 68.0 t90 -66.06 -44.44 84.52 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 118.363 0.529 . . . . 0.0 110.02 -175.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 79.1 t -62.77 -39.64 85.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.281 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -65.17 -38.67 91.27 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 121.389 -0.819 . . . . 0.0 110.138 178.576 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 43.4 mm-40 -64.35 -52.19 59.61 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 118.586 0.63 . . . . 0.0 110.964 176.268 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 21.0 pt -64.59 -31.72 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 119.568 1.077 . . . . 0.0 110.326 -178.41 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 65.6 m -60.79 -26.14 67.06 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 118.062 -0.97 . . . . 0.0 112.538 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -95.22 -10.39 30.54 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 120.117 1.326 . . . . 0.0 112.699 175.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -88.0 -39.5 14.62 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 118.981 0.809 . . . . 0.0 110.304 171.572 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 88.0 mt -84.51 -12.32 54.44 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.677 1.991 . . . . 0.0 111.421 178.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 30.4 m80 56.58 30.16 16.82 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.556 1.543 . . . . 0.0 112.885 -170.048 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 67.6 mt -72.35 -20.45 61.46 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.477 -0.764 . . . . 0.0 110.38 169.532 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -57.0 -38.08 72.58 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.842 0.747 . . . . 0.0 110.304 175.441 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -68.0 -10.23 51.89 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 121.596 -0.69 . . . . 0.0 112.419 178.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 28.7 mt -106.12 -54.18 6.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 C-N-CA 125.345 1.458 . . . . 0.0 108.567 -178.451 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.3 pp -78.77 -24.97 44.37 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.319 0.648 . . . . 0.0 112.145 -173.231 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -125.53 39.41 3.97 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.605 1.962 . . . . 0.0 108.915 -175.256 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.36 0 C-N-CA 123.632 0.773 . . . . 0.0 109.453 175.119 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.4 ttt . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 110.37 -0.233 . . . . 0.0 110.37 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -66.97 154.77 40.31 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.182 0.593 . . . . 0.0 110.536 177.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.7 pt -86.78 -23.9 6.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 122.269 0.228 . . . . 0.0 111.581 -178.054 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.9 m -112.01 130.15 55.96 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.825 1.25 . . . . 0.0 108.646 -178.063 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -103.95 116.35 5.35 Favored Glycine 0 CA--C 1.521 0.417 0 N-CA-C 108.241 -1.944 . . . . 0.0 108.241 169.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 74.6 mt -90.81 126.14 43.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 104.847 -2.279 . . . . 0.0 104.847 171.019 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -122.38 126.94 49.06 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 174.377 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -125.28 136.59 53.67 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 118.311 0.505 . . . . 0.0 111.027 178.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -85.93 136.86 14.63 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 108.632 -1.787 . . . . 0.0 108.632 168.159 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 22.6 m -157.35 158.12 35.39 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 119.395 1.598 . . . . 0.0 110.908 169.333 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -142.67 -42.79 0.32 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.878 1.271 . . . . 0.0 110.062 170.346 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.5 p -77.54 -13.28 59.95 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 122.977 0.511 . . . . 0.0 111.506 169.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 88.71 34.58 9.03 Favored Glycine 0 C--N 1.342 0.895 0 C-N-CA 124.079 0.847 . . . . 0.0 112.373 172.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -86.02 -54.12 4.67 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 117.493 0.647 . . . . 0.0 111.759 179.489 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.4 m -74.74 -16.62 60.73 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 118.511 -0.757 . . . . 0.0 112.21 -168.107 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -58.19 -35.97 72.41 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 119.605 1.093 . . . . 0.0 110.514 172.319 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -71.43 -40.85 70.14 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -179.55 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 34.4 mm -63.55 -43.5 98.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 177.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.03 -42.65 90.7 Favored 'General case' 0 CA--C 1.53 0.184 0 O-C-N 121.661 -0.65 . . . . 0.0 110.628 177.392 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -66.88 -39.77 87.59 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 118.434 -0.793 . . . . 0.0 111.087 176.618 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 63.0 mtt -61.77 -33.48 74.16 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 119.948 1.249 . . . . 0.0 111.499 176.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 26.1 mt -74.16 -49.55 32.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 175.351 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -59.78 -40.14 87.27 Favored 'General case' 0 C--O 1.225 -0.214 0 O-C-N 121.629 -0.669 . . . . 0.0 111.728 -176.389 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -63.57 -34.01 76.86 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 119.764 1.165 . . . . 0.0 111.171 -178.418 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -73.68 -41.29 62.85 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 122.722 0.409 . . . . 0.0 110.826 175.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.2 mp -74.75 -36.93 62.61 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 122.915 0.486 . . . . 0.0 111.25 -176.099 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.0 146.41 18.19 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 125.764 1.65 . . . . 0.0 110.85 -173.281 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 53.8 tptt -61.04 -31.66 71.3 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.565 1.146 . . . . 0.0 111.819 -175.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -68.0 -27.33 66.47 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.23 0.612 . . . . 0.0 111.192 178.531 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 39.0 t -96.89 -37.63 7.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 C-N-CA 124.248 1.019 . . . . 0.0 110.003 -175.71 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -135.55 137.17 41.75 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 119.252 0.933 . . . . 0.0 111.901 -174.48 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -119.08 158.34 26.05 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.861 0.864 . . . . 0.0 109.849 169.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 51.8 t -120.56 135.62 60.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 124.349 1.06 . . . . 0.0 110.543 -168.69 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -147.3 172.19 14.26 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.145 1.778 . . . . 0.0 111.456 -171.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -126.68 135.49 51.22 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 126.605 1.962 . . . . 0.0 106.364 170.275 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.0 tp -61.0 -18.54 18.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 123.759 0.824 . . . . 0.0 112.656 -172.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.99 -29.12 63.01 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 119.014 0.825 . . . . 0.0 111.304 178.402 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 45.7 mtmt -80.6 -24.15 39.33 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 122.922 0.489 . . . . 0.0 112.209 177.311 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 46.9 m -77.48 159.59 29.27 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.353 1.061 . . . . 0.0 113.337 -166.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.3 m -132.58 176.17 8.67 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 127.633 2.373 . . . . 0.0 106.632 169.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.5 tttm -50.11 -48.47 53.41 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.942 0.792 . . . . 0.0 111.96 -175.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -78.58 -11.95 59.99 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -173.141 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -69.96 -34.48 73.45 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.442 -0.786 . . . . 0.0 111.245 -176.68 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.3 mp -76.22 -35.25 59.12 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-O 119.103 -0.475 . . . . 0.0 110.832 172.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -64.25 -23.75 67.42 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 118.595 0.634 . . . . 0.0 112.175 -177.667 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.13 -28.87 69.73 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.78 0.832 . . . . 0.0 112.506 178.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -91.8 152.15 20.26 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 124.551 1.141 . . . . 0.0 109.68 176.555 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -109.92 -15.23 14.12 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.614 0.766 . . . . 0.0 111.8 174.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.4 mp -123.22 134.06 67.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 169.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 91.2 mt -124.3 147.88 47.83 Favored 'General case' 0 CA--C 1.518 -0.281 0 C-N-CA 123.651 0.781 . . . . 0.0 109.702 178.403 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.8 mt -130.99 107.46 9.11 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 177.452 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 76.2 mt -112.4 114.14 26.71 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -169.437 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -106.25 116.38 5.08 Favored Glycine 0 C--N 1.335 0.51 0 C-N-CA 125.475 1.512 . . . . 0.0 110.27 -177.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 16.1 tt -123.74 117.66 27.42 Favored Pre-proline 0 CA--C 1.541 0.609 0 CA-C-N 118.574 1.187 . . . . 0.0 111.749 -172.656 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -77.35 141.72 20.56 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 121.806 1.671 . . . . 0.0 109.288 168.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 35.3 m -91.03 142.72 27.47 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 172.412 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 51.0 m95 -132.96 172.66 12.32 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.948 2.099 . . . . 0.0 109.797 -175.661 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 33.92 53.61 0.51 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 128.918 2.887 . . . . 0.0 115.824 169.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 53.04 62.78 2.51 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.174 0.99 . . . . 0.0 111.28 176.479 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 87.43 52.12 3.11 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 123.713 0.673 . . . . 0.0 112.386 174.168 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -135.21 161.38 35.53 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.823 1.649 . . . . 0.0 108.628 171.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.12 165.57 21.47 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 168.55 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -67.01 147.77 52.79 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 169.392 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 57.9 m -53.28 -34.78 58.68 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.075 0.95 . . . . 0.0 112.741 -176.313 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -67.4 -44.26 79.29 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.156 0.582 . . . . 0.0 110.426 -176.254 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -71.4 -43.46 66.78 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.213 0.605 . . . . 0.0 109.474 176.57 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -60.21 -39.31 86.13 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.523 0.729 . . . . 0.0 111.737 -178.365 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -70.77 -24.7 62.65 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.955 0.902 . . . . 0.0 112.104 176.096 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -88.23 -23.59 23.5 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-O 118.326 -0.845 . . . . 0.0 112.156 178.51 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -51.11 -43.31 84.65 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-O 116.631 -1.652 . . . . 0.0 114.462 178.416 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -64.65 -15.39 49.8 Favored 'Trans proline' 0 CA--C 1.543 0.953 0 CA-C-N 122.8 2.036 . . . . 0.0 113.691 175.488 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.0 m -90.72 -38.84 12.79 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.783 1.233 . . . . 0.0 109.613 170.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 23.6 tp -57.84 -40.36 79.87 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 124.352 1.061 . . . . 0.0 109.946 -179.335 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -71.87 -7.05 46.13 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -86.15 -15.44 41.05 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 120.185 1.357 . . . . 0.0 110.412 173.012 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 65.1 mt -90.02 128.47 41.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 -174.277 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -87.5 139.54 30.44 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 168.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -126.38 20.52 7.36 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.492 1.117 . . . . 0.0 111.315 -175.403 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -50.55 -34.07 24.14 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 115.777 1.769 . . . . 0.0 115.777 -168.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -110.64 13.6 29.97 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-O 118.385 -1.231 . . . . 0.0 113.556 -178.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -112.33 146.97 37.34 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 119.602 1.701 . . . . 0.0 109.99 -169.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -95.83 141.88 28.75 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 176.381 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 16.4 t -134.76 143.04 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 173.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -124.61 145.46 49.61 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 169.261 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 88.9 mt -121.69 139.48 53.51 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -169.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -140.98 164.15 31.05 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 169.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -168.34 156.55 28.12 Favored Glycine 0 N--CA 1.443 -0.838 0 O-C-N 121.059 -1.026 . . . . 0.0 112.132 -178.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 33.5 m -122.32 152.65 39.9 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 -168.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -164.92 -153.38 7.47 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.501 -174.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -152.46 140.31 20.03 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.101 1.36 . . . . 0.0 110.331 -178.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -120.5 13.56 11.78 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.616 1.566 . . . . 0.0 110.816 -179.084 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -94.27 -43.78 8.27 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.344 1.057 . . . . 0.0 109.541 -178.362 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -127.82 -31.5 2.42 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.702 1.201 . . . . 0.0 111.789 177.296 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -90.04 24.8 2.33 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.522 0.729 . . . . 0.0 111.971 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.76 -19.34 64.9 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.212 1.405 . . . . 0.0 114.027 -170.08 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -99.49 7.71 45.15 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 119.527 1.058 . . . . 0.0 112.343 176.057 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -133.86 25.01 3.98 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 126.206 1.802 . . . . 0.0 109.494 176.177 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -65.84 122.56 17.59 Favored 'General case' 0 C--O 1.238 0.481 0 O-C-N 121.767 -0.583 . . . . 0.0 109.65 -168.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 93.5 m 50.61 33.85 8.75 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.669 1.588 . . . . 0.0 112.778 -177.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -52.48 -38.15 58.78 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 121.753 -0.592 . . . . 0.0 112.561 -177.303 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -73.12 -14.65 61.42 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -171.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -59.67 -39.3 84.02 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.158 -0.964 . . . . 0.0 111.281 -177.048 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -70.41 -23.02 77.81 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 123.239 0.447 . . . . 0.0 112.692 179.554 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.2 m -65.59 -29.86 70.52 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 118.28 1.04 . . . . 0.0 110.894 -177.218 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 6.4 mt -71.62 -48.81 50.27 Favored 'Isoleucine or valine' 0 C--N 1.345 0.372 0 CA-C-O 118.51 -0.757 . . . . 0.0 109.056 175.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 18.6 ttm-85 -53.03 -42.95 66.2 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 119.053 0.842 . . . . 0.0 109.806 178.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -59.18 -23.78 62.53 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -176.529 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 94.8 mt -95.2 -50.49 11.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 124.016 0.926 . . . . 0.0 109.84 175.597 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 20.0 pt -75.72 -24.48 16.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 119.194 0.906 . . . . 0.0 112.16 -168.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -67.93 -52.86 22.63 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-O 117.394 -1.288 . . . . 0.0 112.101 -179.477 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -65.77 -25.47 53.44 Favored 'Trans proline' 0 C--N 1.352 0.746 0 CA-C-N 122.137 1.799 . . . . 0.0 111.953 175.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 83.1 mmt-85 -75.82 5.31 6.51 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.03 0.932 . . . . 0.0 112.976 170.12 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 78.15 14.55 82.14 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-O 117.891 -1.505 . . . . 0.0 114.801 168.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.11 143.04 45.15 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 119.657 1.729 . . . . 0.0 109.19 171.532 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 69.7 m -88.7 125.91 35.07 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 104.419 -2.437 . . . . 0.0 104.419 167.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 21.5 mt -116.23 130.25 71.29 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 -169.486 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 29.8 m -130.36 175.28 11.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 124.403 1.081 . . . . 0.0 109.76 177.226 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 91.55 24.48 25.9 Favored Glycine 0 CA--C 1.528 0.888 0 CA-C-O 119.097 -0.835 . . . . 0.0 114.025 170.295 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 49.0 p-80 -60.96 150.66 32.69 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 119.262 1.531 . . . . 0.0 109.068 168.248 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 73.3 t-105 -136.62 133.62 19.15 Favored Pre-proline 0 CA--C 1.535 0.379 0 C-N-CA 123.697 0.799 . . . . 0.0 109.543 -169.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -69.76 146.37 59.99 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.385 2.057 . . . . 0.0 112.048 -176.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 68.4 p -74.57 -23.43 58.76 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.753 1.221 . . . . 0.0 111.814 174.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 52.73 41.87 31.61 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.673 1.589 . . . . 0.0 112.059 -171.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 68.17 52.06 29.65 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 176.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -58.91 151.55 21.52 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 122.83 0.452 . . . . 0.0 111.294 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 57.0 p-80 -119.85 0.79 10.92 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.55 1.14 . . . . 0.0 113.159 -171.127 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -76.21 169.97 17.2 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.326 0.65 . . . . 0.0 111.035 -177.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -57.18 -57.46 12.48 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.937 0.895 . . . . 0.0 112.602 -168.022 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -162.8 116.39 1.68 Allowed 'General case' 0 C--O 1.235 0.339 0 CA-C-N 118.779 0.718 . . . . 0.0 111.29 175.479 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 59.3 m -81.42 127.33 32.67 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 168.157 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -102.05 -9.85 20.22 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 122.968 0.507 . . . . 0.0 111.45 175.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -74.57 0.57 55.38 Favored Glycine 0 CA--C 1.535 1.285 0 CA-C-N 118.813 0.733 . . . . 0.0 113.207 169.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 77.6 mt -63.05 142.63 58.31 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 119.111 1.456 . . . . 0.0 112.17 177.548 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -107.01 -27.86 10.39 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 125.932 1.693 . . . . 0.0 109.647 167.42 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -144.16 159.11 43.21 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 127.251 2.22 . . . . 0.0 106.291 175.407 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -53.01 -29.55 29.98 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -179.085 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -101.38 -7.32 23.04 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -137.91 133.25 33.59 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 120.798 1.636 . . . . 0.0 113.035 -170.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -76.25 149.01 37.23 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.436 1.095 . . . . 0.0 108.898 167.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 6.2 p -68.91 -17.61 22.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 124.977 1.311 . . . . 0.0 111.719 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -154.54 178.81 31.11 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 108.172 -1.971 . . . . 0.0 108.172 178.722 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -66.61 109.62 2.88 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 118.282 1.041 . . . . 0.0 108.21 173.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -88.25 136.69 32.86 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 171.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 10.3 tp -133.72 119.82 34.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -175.63 155.39 1.74 Allowed 'General case' 0 C--O 1.237 0.428 0 C-N-CA 130.585 3.554 . . . . 0.0 105.0 166.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -127.15 -59.79 1.23 Allowed 'General case' 0 C--O 1.234 0.252 0 CA-C-N 119.654 1.116 . . . . 0.0 109.339 178.677 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -160.83 99.92 1.26 Allowed 'General case' 0 C--O 1.236 0.367 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 171.418 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 4.3 tpm_? 50.72 80.69 0.07 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.338 1.455 . . . . 0.0 109.997 -171.243 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 75.39 150.63 0.13 Allowed Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 127.057 2.143 . . . . 0.0 110.489 -168.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -74.94 155.86 43.25 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 122.649 2.232 . . . . 0.0 112.398 -177.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -132.24 -11.27 3.26 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.925 0.89 . . . . 0.0 112.968 172.104 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 68.6 mt -103.0 27.51 7.05 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.858 1.263 . . . . 0.0 108.959 170.136 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 8.6 m -49.94 -60.1 3.24 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 126.812 2.045 . . . . 0.0 112.339 -168.56 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -74.73 -35.37 62.65 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 118.951 -0.547 . . . . 0.0 111.28 -167.451 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -67.52 -41.11 84.93 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 118.565 0.621 . . . . 0.0 110.517 176.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 64.5 mtp180 -62.02 -41.3 97.93 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 119.32 0.964 . . . . 0.0 110.537 176.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 84.9 t -70.79 -33.78 53.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-O 118.52 -0.752 . . . . 0.0 110.388 179.05 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -65.03 -49.53 69.78 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 120.916 1.689 . . . . 0.0 109.378 175.722 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -59.28 -34.84 72.76 Favored 'General case' 0 C--N 1.339 0.136 0 CA-C-O 118.599 -0.715 . . . . 0.0 110.973 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 35.8 t90 -73.03 -52.5 14.15 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 119.007 0.821 . . . . 0.0 110.728 178.326 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 77.1 t -65.86 -31.9 55.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 O-C-N 121.4 -0.813 . . . . 0.0 110.831 -171.281 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 55.8 mttm -60.21 -35.53 75.63 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 121.49 -0.756 . . . . 0.0 110.889 174.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 21.8 mm100 -70.85 -50.22 37.63 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 118.59 0.632 . . . . 0.0 110.928 173.573 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 2.3 pt -63.13 -30.82 50.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 119.221 0.919 . . . . 0.0 110.533 -174.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 50.8 m -61.87 -32.35 72.7 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 119.06 -0.495 . . . . 0.0 111.203 179.155 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -79.89 -40.89 27.31 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 119.219 0.918 . . . . 0.0 109.837 176.609 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -66.42 -34.88 78.94 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.455 0.702 . . . . 0.0 111.444 -177.575 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 95.5 mt -92.24 -1.56 57.04 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.958 1.703 . . . . 0.0 111.552 179.169 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 30.5 m80 56.73 21.17 5.67 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.166 1.786 . . . . 0.0 113.595 -174.441 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 72.5 mt -73.13 -21.4 60.73 Favored 'General case' 0 N--CA 1.464 0.228 0 O-C-N 121.399 -0.813 . . . . 0.0 110.442 175.516 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -55.17 -39.67 69.81 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 123.839 0.856 . . . . 0.0 110.203 173.389 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -71.53 -6.99 44.71 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.685 -0.634 . . . . 0.0 112.357 -179.602 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 35.4 mt -105.21 -54.1 6.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 125.275 1.43 . . . . 0.0 108.547 179.122 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.6 pp -79.43 -23.66 43.03 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.69 0.796 . . . . 0.0 112.057 -173.47 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -129.13 44.26 3.0 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.697 1.999 . . . . 0.0 108.229 -176.671 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.248 0 C-N-CA 123.772 0.829 . . . . 0.0 109.657 175.239 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.0 tpt . . . . . 0 N--CA 1.487 1.41 0 N-CA-C 110.359 -0.238 . . . . 0.0 110.359 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -58.74 143.07 48.18 Favored 'General case' 0 C--N 1.344 0.357 0 C-N-CA 123.554 0.741 . . . . 0.0 111.133 179.084 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.9 pt -106.35 -16.16 8.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 125.239 1.415 . . . . 0.0 110.926 178.513 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 53.7 m -112.04 124.38 52.29 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.485 1.514 . . . . 0.0 108.426 177.473 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -98.44 121.64 7.24 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 108.748 -1.741 . . . . 0.0 108.748 169.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 61.9 mt -96.14 96.16 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 103.773 -2.677 . . . . 0.0 103.773 176.244 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -99.17 119.42 37.84 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -133.5 156.72 47.26 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 123.402 0.681 . . . . 0.0 109.276 -169.056 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -131.93 144.82 16.57 Favored Glycine 0 C--N 1.336 0.576 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 169.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.0 m -141.14 161.85 36.88 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.208 1.403 . . . . 0.0 108.811 177.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -126.54 -54.16 1.45 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.033 0.533 . . . . 0.0 110.254 171.261 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.13 -3.06 56.94 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.036 0.934 . . . . 0.0 111.614 170.412 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 93.4 7.65 61.81 Favored Glycine 0 C--N 1.342 0.875 0 C-N-CA 124.561 1.077 . . . . 0.0 113.254 169.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -71.07 -43.3 68.06 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 118.657 1.228 . . . . 0.0 111.377 -173.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -65.62 -37.76 87.52 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 118.801 0.728 . . . . 0.0 110.037 -172.334 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.3 tp10 -59.79 -35.95 75.71 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.475 1.11 . . . . 0.0 111.342 179.449 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -64.07 -38.16 90.06 Favored 'General case' 0 CA--C 1.53 0.203 0 O-C-N 121.678 -0.638 . . . . 0.0 110.377 176.593 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.5 mm -68.97 -41.45 81.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 176.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.7 -39.28 70.81 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.122 0.874 . . . . 0.0 111.041 178.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -66.6 -45.72 78.24 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 118.843 -0.598 . . . . 0.0 110.856 173.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 69.1 mtm -63.86 -27.78 69.4 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 119.713 1.142 . . . . 0.0 112.003 178.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 61.6 mt -70.03 -56.19 12.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 172.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -57.55 -40.09 78.11 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.588 -0.695 . . . . 0.0 111.97 -177.054 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -62.98 -34.07 76.75 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 119.505 1.048 . . . . 0.0 111.522 -178.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -75.05 -41.48 58.99 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 122.849 0.46 . . . . 0.0 111.172 178.068 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -77.08 -32.26 56.61 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 118.886 0.766 . . . . 0.0 111.616 -177.779 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.07 143.54 11.47 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 124.952 1.263 . . . . 0.0 110.165 -169.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -63.58 -31.19 72.28 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.917 0.887 . . . . 0.0 111.947 -172.609 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -77.6 -7.66 56.71 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 46.4 t -105.28 -47.34 9.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 124.318 1.047 . . . . 0.0 109.157 176.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -131.44 140.32 49.58 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 119.386 0.994 . . . . 0.0 110.965 -176.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -132.86 147.74 52.3 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 176.684 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 58.0 t -99.75 137.59 26.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 C-N-CA 124.919 1.288 . . . . 0.0 110.48 -169.316 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -141.06 145.38 35.77 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.373 1.469 . . . . 0.0 109.392 -177.201 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -88.51 124.1 33.67 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 169.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.4 tp -58.32 -34.93 51.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 119.119 -0.467 . . . . 0.0 111.276 -174.594 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.84 -33.84 76.76 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 119.126 0.875 . . . . 0.0 112.318 -171.639 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -92.98 -7.61 45.4 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.125 0.57 . . . . 0.0 112.153 176.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 49.9 m -74.99 165.48 25.19 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.137 0.575 . . . . 0.0 110.096 179.109 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.3 m -128.72 158.94 37.19 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 124.241 1.017 . . . . 0.0 110.745 -170.375 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -51.2 -51.72 51.16 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.884 1.274 . . . . 0.0 111.373 -176.025 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -79.88 -14.27 58.77 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 122.542 0.337 . . . . 0.0 111.439 -173.609 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -76.67 -34.25 58.24 Favored 'General case' 0 C--N 1.34 0.166 0 O-C-N 121.599 -0.688 . . . . 0.0 111.045 -176.223 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.6 mp -65.76 -36.88 84.81 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 171.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -67.24 -19.47 65.53 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 123.039 0.536 . . . . 0.0 112.251 -174.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.53 -28.64 68.7 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.645 0.778 . . . . 0.0 112.05 177.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -89.37 152.46 21.5 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 123.93 0.892 . . . . 0.0 110.398 -176.248 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -92.51 -34.98 13.86 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.462 172.119 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 20.1 mt -113.78 137.99 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 -179.367 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 91.8 mt -124.89 134.87 52.52 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.666 0.786 . . . . 0.0 109.012 174.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.0 mp -112.85 116.2 29.67 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 104.821 -2.288 . . . . 0.0 104.821 168.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 66.6 mt -112.04 111.83 23.03 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 -172.506 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -105.19 106.69 2.71 Favored Glycine 0 C--N 1.338 0.648 0 C-N-CA 124.355 0.979 . . . . 0.0 112.336 -173.48 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.4 tp -124.62 107.44 29.21 Favored Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 126.114 1.766 . . . . 0.0 109.886 -168.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -76.21 141.74 23.58 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.095 1.863 . . . . 0.0 109.62 169.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 44.9 m -93.47 138.96 31.25 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 174.399 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 16.2 m95 -131.55 172.06 12.68 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 124.537 1.135 . . . . 0.0 110.606 -177.157 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 33.88 63.3 0.4 Allowed 'General case' 0 C--O 1.236 0.343 0 C-N-CA 128.22 2.608 . . . . 0.0 113.306 169.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.263 19.9 p90 49.67 58.96 4.86 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.633 1.173 . . . . 0.0 111.992 174.202 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.86 53.71 2.34 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-N 115.031 -0.986 . . . . 0.0 114.108 168.246 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -137.46 157.58 46.26 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 117.828 0.814 . . . . 0.0 110.283 167.594 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.84 150.59 32.23 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 168.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -62.59 152.41 35.11 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 169.351 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 60.9 m -57.96 -30.49 66.03 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.835 0.854 . . . . 0.0 111.83 -175.475 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -61.06 -39.07 88.46 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.922 0.889 . . . . 0.0 110.773 -179.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -85.09 -42.8 14.47 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 123.605 0.762 . . . . 0.0 110.671 175.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -61.51 -37.39 83.51 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.061 0.391 . . . . 0.0 111.828 -174.584 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -69.72 -21.96 63.43 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.529 0.732 . . . . 0.0 112.079 175.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -91.86 -23.65 19.59 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.6 0.76 . . . . 0.0 111.759 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -51.73 -41.57 78.89 Favored Pre-proline 0 CA--C 1.545 0.777 0 CA-C-O 116.539 -1.696 . . . . 0.0 114.763 179.07 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -64.38 -24.41 64.46 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 CA-C-N 122.991 2.104 . . . . 0.0 112.828 174.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.4 m -78.22 -40.57 37.02 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.257 0.935 . . . . 0.0 109.359 170.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 13.3 tp -59.5 -36.85 76.84 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.551 1.141 . . . . 0.0 111.151 -174.346 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -77.44 -6.65 54.21 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.893 0.877 . . . . 0.0 112.844 178.547 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 67.2 mt-10 -92.15 -23.28 19.46 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.432 1.014 . . . . 0.0 110.428 169.295 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 79.2 mt -73.14 147.61 9.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 176.459 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -116.91 137.74 52.01 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 176.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -124.82 16.11 8.65 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.458 1.103 . . . . 0.0 111.13 -171.373 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -59.73 126.74 28.8 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 120.062 1.301 . . . . 0.0 109.635 -179.431 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 72.3 2.79 55.4 Favored Glycine 0 CA--C 1.536 1.352 0 CA-C-O 118.121 -1.377 . . . . 0.0 114.605 -176.068 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -86.36 149.32 25.11 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 120.176 1.988 . . . . 0.0 108.036 173.081 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 14.9 mt -95.26 139.79 31.08 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 173.546 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.5 t -135.54 144.55 33.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 176.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -128.48 142.44 51.08 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 168.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 74.1 mt -105.29 149.7 25.79 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -178.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.433 ' CE2' HD12 ' A' ' 142' ' ' LEU . 15.1 t80 -140.15 146.76 39.21 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 176.738 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.485 ' HA3' HD11 ' A' ' 102' ' ' LEU . . . -165.31 143.21 8.28 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-N 119.555 1.07 . . . . 0.0 113.002 168.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 6.6 t -88.4 160.06 17.74 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 114.114 -1.043 . . . . 0.0 109.043 170.539 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -177.91 -174.53 44.32 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 -179.365 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -133.16 140.45 47.59 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.802 1.641 . . . . 0.0 109.543 174.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 22.0 pt20 -134.46 45.88 2.54 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.398 0.618 . . . . 0.0 110.584 169.142 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -109.17 -33.66 6.81 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.841 1.256 . . . . 0.0 108.83 168.65 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -127.84 -34.88 2.13 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 125.046 1.338 . . . . 0.0 111.367 173.594 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -90.29 26.37 1.95 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.038 0.935 . . . . 0.0 111.971 178.641 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.59 -14.89 62.08 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.014 -1.054 . . . . 0.0 113.685 -175.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -89.32 2.24 54.65 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 118.986 0.812 . . . . 0.0 111.868 173.53 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -142.58 11.86 1.89 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.152 1.381 . . . . 0.0 111.546 -173.035 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -67.8 127.55 33.22 Favored 'General case' 0 C--O 1.236 0.388 0 O-C-N 121.221 -0.924 . . . . 0.0 110.707 -168.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 85.2 m 50.99 31.77 6.71 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.085 1.354 . . . . 0.0 112.42 177.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -60.25 -38.44 83.47 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 121.777 -0.577 . . . . 0.0 111.354 -179.46 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.6 -21.96 62.6 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -169.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.485 HD11 ' HA3' ' A' ' 87' ' ' GLY . 6.9 mp -59.96 -38.02 81.26 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 119.063 0.847 . . . . 0.0 109.322 172.409 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.68 -34.48 88.73 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 111.306 -0.718 . . . . 0.0 111.306 175.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 4.7 m -65.68 -38.47 89.35 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.588 1.194 . . . . 0.0 110.364 177.156 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.1 mt -70.23 -46.1 73.11 Favored 'Isoleucine or valine' 0 C--N 1.343 0.323 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 175.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 37.5 ttt180 -53.42 -45.71 69.5 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 118.807 0.731 . . . . 0.0 110.579 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -61.85 -17.92 58.18 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.408 1.083 . . . . 0.0 112.571 -178.144 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 94.3 mt -95.69 -57.59 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 C-N-CA 123.997 0.919 . . . . 0.0 108.918 173.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 19.9 pt -69.05 -33.4 58.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 119.369 0.986 . . . . 0.0 112.203 -167.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -66.93 -54.06 23.01 Favored Pre-proline 0 CA--C 1.545 0.783 0 CA-C-O 117.816 -1.088 . . . . 0.0 111.006 -174.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.86 -22.39 36.53 Favored 'Trans proline' 0 C--N 1.353 0.786 0 CA-C-N 121.646 1.624 . . . . 0.0 112.677 175.081 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 30.4 mmm180 -79.68 11.31 3.24 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 119.015 0.825 . . . . 0.0 112.124 172.475 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 98.12 -2.57 59.73 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 125.463 1.506 . . . . 0.0 116.82 166.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.95 143.15 57.97 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 120.155 1.978 . . . . 0.0 111.059 -176.156 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 48.6 m -94.27 123.83 37.92 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 105.138 -2.171 . . . . 0.0 105.138 168.382 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 42.3 mt -105.86 131.77 54.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 -170.512 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 33.4 m -132.74 178.33 5.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 125.544 1.537 . . . . 0.0 109.258 177.12 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 77.35 22.89 69.44 Favored Glycine 0 CA--C 1.525 0.657 0 O-C-N 121.613 -0.679 . . . . 0.0 112.686 174.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 9.1 p-80 -61.5 113.88 2.92 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.313 1.045 . . . . 0.0 108.28 169.334 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 73.6 t-105 -84.06 140.85 40.02 Favored Pre-proline 0 CA--C 1.536 0.439 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 177.142 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -66.25 149.06 85.43 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 121.981 1.788 . . . . 0.0 111.296 179.088 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 81.2 p -80.47 -11.0 59.73 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.267 0.627 . . . . 0.0 111.118 169.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 53.98 42.86 31.5 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.863 1.665 . . . . 0.0 110.968 -169.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 73.2 70.74 1.18 Allowed Glycine 0 C--N 1.339 0.717 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 -178.282 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -42.06 136.34 2.18 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.403 1.081 . . . . 0.0 112.838 174.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 9.1 p80 -150.63 15.65 0.78 Allowed 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 176.417 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -88.87 -157.05 0.42 Allowed 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 119.069 0.85 . . . . 0.0 110.428 -179.507 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -73.4 -82.49 0.05 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.788 0.835 . . . . 0.0 112.862 -168.295 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -156.64 67.32 0.56 Allowed 'General case' 0 C--N 1.342 0.26 0 CA-C-O 123.13 1.443 . . . . 0.0 110.742 -177.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 19.5 m -70.68 133.87 47.02 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 113.87 -1.514 . . . . 0.0 107.564 171.51 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 60.0 mttt -112.38 -1.98 14.9 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -168.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -76.88 0.96 64.3 Favored Glycine 0 CA--C 1.532 1.135 0 CA-C-O 118.93 -0.928 . . . . 0.0 113.214 168.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 8.3 mp -63.67 129.92 42.13 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 119.938 1.869 . . . . 0.0 110.277 178.07 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.06 -38.25 22.79 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.82 1.248 . . . . 0.0 108.058 167.247 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -153.94 166.68 32.22 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 129.548 3.139 . . . . 0.0 106.105 -174.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -52.67 -35.64 55.59 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.052 -1.03 . . . . 0.0 112.336 175.534 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -95.92 -7.37 36.85 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -174.082 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -146.28 141.09 26.98 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.814 1.188 . . . . 0.0 112.207 -172.167 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -83.93 160.87 20.99 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.003 1.321 . . . . 0.0 108.768 168.709 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 34.3 m -72.03 -7.16 8.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 O-C-N 120.963 -1.086 . . . . 0.0 112.872 179.029 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -166.64 -157.63 10.52 Favored Glycine 0 CA--C 1.521 0.42 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.433 HD12 ' CE2' ' A' ' 86' ' ' PHE . 2.8 tm? -76.97 96.24 4.32 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 169.456 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -84.77 130.13 34.73 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 104.042 -2.577 . . . . 0.0 104.042 165.41 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 7.9 tp -61.97 -8.75 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 N-CA-C 115.842 1.793 . . . . 0.0 115.842 -168.246 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.448 ' HA ' ' CZ ' ' A' ' 156' ' ' ARG . 31.7 t70 -149.95 147.58 28.06 Favored 'General case' 0 N--CA 1.452 -0.368 0 O-C-N 120.722 -1.236 . . . . 0.0 113.193 -173.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.48 14.3 2.36 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 126.752 2.021 . . . . 0.0 110.128 169.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -124.99 -54.57 1.61 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.139 1.376 . . . . 0.0 111.609 -173.546 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -165.23 -47.8 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 124.558 1.143 . . . . 0.0 111.178 170.046 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 -150.18 173.64 4.14 Favored Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 125.137 1.375 . . . . 0.0 110.093 -169.562 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -64.78 24.76 0.08 OUTLIER 'Trans proline' 0 CA--C 1.547 1.175 0 C-N-CA 124.727 3.618 . . . . 0.0 116.92 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -63.31 -26.91 68.99 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 120.509 -1.369 . . . . 0.0 112.319 -169.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 85.3 mt -109.13 27.77 9.18 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 125.021 1.329 . . . . 0.0 110.684 -175.228 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 13.5 m -48.23 -55.61 10.07 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 123.946 0.899 . . . . 0.0 110.512 -175.604 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -61.85 -40.84 96.74 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.481 0.582 . . . . 0.0 111.121 -170.252 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -66.12 -49.92 65.8 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 177.329 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.448 ' CZ ' ' HA ' ' A' ' 145' ' ' ASP . 87.4 mtt180 -58.73 -47.49 84.44 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 123.073 0.549 . . . . 0.0 110.219 -175.679 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 13.0 m -77.51 -33.69 19.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-O 118.611 -0.709 . . . . 0.0 110.729 -171.376 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -65.97 -47.81 73.35 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 119.841 1.2 . . . . 0.0 109.526 174.243 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -61.13 -40.37 93.56 Favored 'General case' 0 C--O 1.227 -0.11 0 CA-C-O 119.132 -0.461 . . . . 0.0 110.157 179.138 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 60.9 t90 -64.08 -47.7 79.06 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 118.71 0.686 . . . . 0.0 110.791 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 40.7 t -57.62 -40.55 75.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 118.265 0.484 . . . . 0.0 109.805 177.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 53.7 mttm -68.83 -36.96 78.82 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 118.353 -0.832 . . . . 0.0 110.227 -178.315 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -62.59 -55.35 27.97 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 119.106 0.867 . . . . 0.0 110.42 174.381 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 22.4 pt -68.58 -29.03 42.48 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.369 0 CA-C-O 119.015 -0.517 . . . . 0.0 110.409 -172.022 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 64.3 m -58.01 -29.67 65.49 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 119.011 0.823 . . . . 0.0 111.593 175.256 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -79.37 -45.46 19.51 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 119.64 1.109 . . . . 0.0 110.272 175.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -66.37 -35.03 79.3 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.516 0.726 . . . . 0.0 111.236 -175.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 73.6 mt -86.75 -3.59 59.07 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.075 1.75 . . . . 0.0 111.377 179.405 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 54.12 33.98 19.04 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.56 1.544 . . . . 0.0 112.51 -173.549 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 95.9 mt -81.36 -26.56 35.43 Favored 'General case' 0 N--CA 1.464 0.265 0 O-C-N 121.549 -0.719 . . . . 0.0 110.359 173.228 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -57.26 -37.93 73.11 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 118.64 0.654 . . . . 0.0 110.028 174.271 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -66.97 -10.06 45.3 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.325 0.65 . . . . 0.0 112.682 178.643 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 64.7 mt -106.21 -55.47 5.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 125.164 1.386 . . . . 0.0 108.126 -179.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.4 pp -78.13 -22.08 49.36 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.166 0.586 . . . . 0.0 112.182 -171.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -127.73 38.32 4.06 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.523 1.929 . . . . 0.0 109.183 -176.304 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.152 0 C-N-CA 123.865 0.866 . . . . 0.0 109.703 174.897 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.8 ttt . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 118.161 -0.923 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 60.08 -178.1 0.1 Allowed 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.908 1.283 . . . . 0.0 112.42 -170.205 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 22.4 pt -89.47 -18.96 7.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 O-C-N 121.623 -0.673 . . . . 0.0 112.091 -177.267 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.2 m -117.46 122.46 43.81 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 124.997 1.319 . . . . 0.0 107.521 178.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -98.45 114.28 4.97 Favored Glycine 0 C--N 1.334 0.472 0 N-CA-C 107.873 -2.091 . . . . 0.0 107.873 171.249 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 65.4 mt -94.69 106.75 18.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 104.872 -2.27 . . . . 0.0 104.872 174.574 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 11.7 m-30 -105.08 133.66 49.48 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 177.256 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -125.69 130.21 51.1 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.515 0.598 . . . . 0.0 112.149 -178.144 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -86.29 144.92 20.21 Favored Glycine 0 C--N 1.338 0.665 0 N-CA-C 108.738 -1.745 . . . . 0.0 108.738 168.405 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 11.0 m -158.27 169.76 23.77 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 119.12 1.46 . . . . 0.0 110.321 175.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -141.6 -49.45 0.4 Allowed 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.556 1.142 . . . . 0.0 109.124 168.221 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.3 p -80.56 -17.22 52.12 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.938 0.895 . . . . 0.0 112.171 170.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 103.95 7.41 41.38 Favored Glycine 0 C--N 1.342 0.885 0 C-N-CA 124.673 1.13 . . . . 0.0 113.99 171.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -65.13 -42.04 94.27 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 118.999 1.4 . . . . 0.0 112.069 -171.151 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -70.26 -18.41 63.13 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 118.942 0.792 . . . . 0.0 111.751 -170.743 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -58.81 -43.57 90.62 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 119.432 1.014 . . . . 0.0 110.036 174.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -64.4 -40.44 95.8 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.383 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 23.3 mm -66.42 -42.33 90.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 O-C-N 121.804 -0.56 . . . . 0.0 109.507 179.23 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.71 -40.08 86.76 Favored 'General case' 0 CA--C 1.532 0.253 0 O-C-N 121.721 -0.612 . . . . 0.0 110.579 176.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp -68.39 -39.43 81.72 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 118.336 -0.84 . . . . 0.0 111.145 176.712 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 64.1 mtt -59.51 -37.39 78.18 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 119.827 1.194 . . . . 0.0 110.976 175.483 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 51.9 mt -71.31 -51.38 34.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 177.325 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -62.13 -37.11 83.91 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 121.507 -0.745 . . . . 0.0 111.203 -174.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 59.1 tptt -63.13 -38.28 90.57 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 119.063 0.847 . . . . 0.0 110.812 -178.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -71.76 -41.62 68.2 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.952 0.501 . . . . 0.0 110.753 177.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.1 mp -73.21 -35.73 66.37 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.098 0.408 . . . . 0.0 111.24 -176.192 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 90.93 147.71 19.8 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 125.089 1.328 . . . . 0.0 110.771 -172.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -66.42 -28.3 68.51 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.694 0.798 . . . . 0.0 112.186 -171.347 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -69.04 -25.92 64.72 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 122.873 0.469 . . . . 0.0 111.348 176.46 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 31.6 t -98.52 -36.31 5.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 C-N-CA 124.481 1.112 . . . . 0.0 110.58 -174.149 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -135.33 144.76 46.86 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 118.777 0.717 . . . . 0.0 112.207 -177.266 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -129.32 154.65 46.66 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 125.288 1.435 . . . . 0.0 108.212 175.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 69.7 t -117.76 133.96 62.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 124.165 0.986 . . . . 0.0 108.901 -169.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -149.73 -174.78 4.79 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.218 1.007 . . . . 0.0 111.319 -177.639 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -135.02 141.31 46.14 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 125.224 1.41 . . . . 0.0 107.197 173.77 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.8 tp -59.49 -24.96 29.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 123.869 0.868 . . . . 0.0 112.906 -169.279 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.56 -27.81 69.21 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 118.729 0.695 . . . . 0.0 111.165 178.27 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -96.85 -33.78 11.52 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.751 1.22 . . . . 0.0 110.986 -179.37 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 19.8 m -60.38 162.11 6.56 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.332 0.653 . . . . 0.0 110.001 169.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.4 m -136.29 157.28 47.17 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.619 0.768 . . . . 0.0 110.449 -171.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -51.69 -51.71 53.86 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.23 1.012 . . . . 0.0 110.884 -179.48 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -75.24 -16.34 60.47 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 122.693 0.397 . . . . 0.0 111.587 -176.054 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -78.49 -37.98 41.99 Favored 'General case' 0 CA--C 1.53 0.19 0 O-C-N 121.541 -0.724 . . . . 0.0 110.213 179.23 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.0 mp -65.24 -35.05 79.86 Favored 'General case' 0 C--N 1.342 0.248 0 O-C-N 121.808 -0.558 . . . . 0.0 110.265 170.653 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -63.87 -23.85 67.51 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 118.81 0.732 . . . . 0.0 111.493 174.38 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -86.83 -31.4 20.85 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.941 0.896 . . . . 0.0 112.75 -178.218 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -67.55 160.17 28.28 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 123.994 0.917 . . . . 0.0 110.688 174.119 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -109.27 -40.17 5.01 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.493 0.717 . . . . 0.0 111.39 169.4 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.9 mt -112.47 125.19 69.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 177.105 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -113.9 132.19 56.01 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 171.343 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.0 mp -115.28 119.24 35.67 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 172.331 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 69.2 mt -117.41 109.46 16.81 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -172.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.78 123.07 6.63 Favored Glycine 0 CA--C 1.521 0.463 0 N-CA-C 108.949 -1.661 . . . . 0.0 108.949 176.145 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 3.4 tp -137.1 115.4 10.11 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-N 118.129 0.965 . . . . 0.0 110.125 -169.734 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -78.6 -173.22 1.77 Allowed 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 123.207 2.605 . . . . 0.0 109.986 169.431 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 95.5 m -144.45 145.96 32.19 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 119.99 -1.694 . . . . 0.0 107.592 169.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 75.0 m95 -139.71 169.74 17.17 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 125.144 1.378 . . . . 0.0 110.984 -169.622 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 55.88 -73.1 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 128.833 2.853 . . . . 0.0 114.642 175.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -161.76 56.25 0.26 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 127.239 2.216 . . . . 0.0 108.379 -174.496 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 81.72 19.66 65.33 Favored Glycine 0 CA--C 1.534 1.258 0 O-C-N 121.438 -0.789 . . . . 0.0 113.47 -179.015 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -88.31 154.29 20.53 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.416 1.108 . . . . 0.0 109.489 179.604 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.85 161.88 24.24 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 168.095 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.252 0.0 OUTLIER -70.93 159.85 33.94 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 170.413 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 57.7 m -53.71 -37.53 63.38 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 115.567 1.691 . . . . 0.0 115.567 -166.599 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -76.79 -43.97 34.63 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 119.046 0.839 . . . . 0.0 109.458 -170.192 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -64.18 -45.75 87.0 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.653 0.781 . . . . 0.0 109.446 173.589 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -58.76 -39.32 80.67 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 122.583 0.353 . . . . 0.0 111.732 179.337 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -71.22 -30.64 66.61 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.897 0.879 . . . . 0.0 112.253 176.542 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -87.34 -21.67 25.56 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 118.618 0.645 . . . . 0.0 112.562 -176.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 16.5 m-30 -50.08 -44.63 80.38 Favored Pre-proline 0 CA--C 1.546 0.799 0 CA-C-O 116.932 -1.509 . . . . 0.0 114.683 178.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -65.98 -16.32 52.1 Favored 'Trans proline' 0 CA--C 1.542 0.913 0 CA-C-N 122.598 1.964 . . . . 0.0 113.798 175.173 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 14.7 m -85.87 -40.31 16.09 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 119.481 1.037 . . . . 0.0 109.207 169.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.435 ' HA ' HD12 ' A' ' 76' ' ' ILE . 37.3 tp -59.71 -36.9 77.48 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.94 1.296 . . . . 0.0 111.572 -173.189 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -66.85 -15.58 63.72 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 177.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 -91.97 -14.26 29.78 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 119.261 0.937 . . . . 0.0 111.781 179.397 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.435 HD12 ' HA ' ' A' ' 73' ' ' LEU . 96.7 mt -80.65 138.39 19.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 -173.043 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -80.88 132.0 35.41 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.707 -0.678 . . . . 0.0 109.259 175.467 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -126.88 16.43 7.39 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 118.187 -0.911 . . . . 0.0 111.42 174.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 23.9 m-80 -59.41 114.31 2.62 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 120.542 1.519 . . . . 0.0 109.377 -175.369 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.65 4.6 66.26 Favored Glycine 0 CA--C 1.536 1.357 0 CA-C-O 118.69 -1.061 . . . . 0.0 114.123 -178.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -77.39 151.58 34.75 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 119.515 1.658 . . . . 0.0 108.224 171.3 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 17.8 mt -95.74 137.2 35.13 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 175.002 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.3 t -132.11 144.29 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 172.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -135.36 149.18 49.63 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 169.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 72.6 mt -120.52 149.13 42.9 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 -174.665 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -146.59 157.39 43.71 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 123.234 0.614 . . . . 0.0 109.55 172.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -170.2 166.34 39.57 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-O 122.305 0.947 . . . . 0.0 113.208 -175.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 15.2 t -142.64 162.18 36.14 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 126.754 2.021 . . . . 0.0 107.106 179.333 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -176.0 -170.71 39.07 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -139.42 142.88 37.44 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 127.086 2.154 . . . . 0.0 105.978 176.486 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.62 21.99 1.99 Allowed 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -172.802 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -64.5 -46.19 84.02 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 178.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -95.84 -38.18 10.41 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.174 0.59 . . . . 0.0 110.704 169.287 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -83.22 41.89 0.79 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.408 1.483 . . . . 0.0 111.551 -172.079 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.18 -21.14 66.45 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.823 1.249 . . . . 0.0 113.72 -169.431 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -97.36 2.85 51.05 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.716 1.207 . . . . 0.0 111.386 178.301 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -133.98 18.18 3.8 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.4 1.08 . . . . 0.0 112.481 -169.35 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -61.86 120.37 10.6 Favored 'General case' 0 CA--C 1.529 0.169 0 O-C-N 121.104 -0.997 . . . . 0.0 109.346 -176.16 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 80.1 m 45.88 35.76 2.51 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.557 1.543 . . . . 0.0 112.654 -176.253 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -49.48 -41.1 39.59 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.43 1.092 . . . . 0.0 111.911 -171.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.67 -13.88 62.47 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -171.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 34.1 mt -56.23 -41.84 76.32 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 119.837 1.199 . . . . 0.0 109.793 169.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.97 -36.42 93.05 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 178.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.0 m -62.71 -44.23 96.75 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 117.944 0.872 . . . . 0.0 109.906 177.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.7 mt -66.29 -45.48 89.64 Favored 'Isoleucine or valine' 0 C--N 1.344 0.357 0 CA-C-N 119.613 1.097 . . . . 0.0 108.908 178.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 45.6 ttt180 -54.64 -48.15 72.63 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 119.379 0.99 . . . . 0.0 110.43 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -62.08 -29.8 70.56 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.329 0.652 . . . . 0.0 111.603 -177.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 85.9 mt -81.53 -44.36 20.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-O 117.595 -1.193 . . . . 0.0 110.634 178.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.7 pt -86.88 -33.55 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 120.121 1.328 . . . . 0.0 113.003 -168.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -64.57 -37.85 27.23 Favored Pre-proline 0 CA--C 1.547 0.832 0 CA-C-O 117.946 -1.026 . . . . 0.0 112.008 -171.078 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -64.38 -17.1 58.5 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 122.417 2.078 . . . . 0.0 114.223 174.256 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 13.7 mmt180 -90.25 10.2 25.63 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.076 0.95 . . . . 0.0 111.536 -173.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 77.94 10.85 85.93 Favored Glycine 0 CA--C 1.531 1.06 0 CA-C-O 118.432 -1.205 . . . . 0.0 113.391 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -57.66 137.94 55.9 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 118.712 1.256 . . . . 0.0 109.426 171.208 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 55.8 m -93.96 120.87 34.8 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 168.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 36.9 mt -97.65 128.17 49.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 -176.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 34.6 m -128.79 175.44 10.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 124.983 1.313 . . . . 0.0 108.987 176.409 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 75.93 28.85 59.96 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-O 119.079 -0.845 . . . . 0.0 112.731 -177.233 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 81.4 m-70 -60.43 135.17 57.66 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 169.726 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 74.7 t-105 -129.99 139.7 36.44 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 124.248 1.019 . . . . 0.0 109.385 -169.098 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -62.08 162.39 22.99 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 121.781 1.654 . . . . 0.0 113.065 -178.171 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -55.01 -34.25 63.29 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.659 0.784 . . . . 0.0 112.015 174.57 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 42.42 55.01 4.22 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.738 1.615 . . . . 0.0 112.981 168.652 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 99.9 -7.92 59.28 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-O 118.656 -1.08 . . . . 0.0 114.658 175.337 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -59.65 133.47 56.13 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 118.974 1.387 . . . . 0.0 109.264 169.729 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 8.8 t-80 -154.84 40.98 0.45 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.062 0.945 . . . . 0.0 110.276 176.351 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -106.34 -176.37 3.06 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.956 0.902 . . . . 0.0 111.307 -170.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 -71.98 -47.02 55.1 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 118.839 -0.6 . . . . 0.0 111.191 -169.406 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -157.38 149.44 22.53 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 118.749 0.704 . . . . 0.0 111.413 173.149 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 40.0 t -140.09 126.08 19.66 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 105.444 -2.058 . . . . 0.0 105.444 167.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.63 -10.54 58.9 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.791 -175.366 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -79.08 -4.9 89.05 Favored Glycine 0 C--N 1.341 0.815 0 CA-C-O 118.596 -1.114 . . . . 0.0 113.19 170.658 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 70.4 mt -68.96 120.09 14.3 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 120.402 2.101 . . . . 0.0 108.156 175.071 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -87.91 -28.69 21.37 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.635 1.174 . . . . 0.0 110.337 175.429 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -146.73 168.38 21.5 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.161 1.784 . . . . 0.0 107.403 171.435 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -57.25 -25.96 60.01 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.742 1.217 . . . . 0.0 113.57 -170.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -121.43 11.34 10.67 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.349 1.46 . . . . 0.0 113.163 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -142.72 127.53 18.22 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-N 119.404 1.002 . . . . 0.0 111.593 -175.685 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -80.64 152.99 28.21 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 125.061 1.344 . . . . 0.0 109.658 169.033 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 12.2 p -59.73 -24.95 30.58 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 C-N-CA 124.76 1.224 . . . . 0.0 111.654 171.133 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -156.72 171.82 34.32 Favored Glycine 0 C--N 1.337 0.629 0 C-N-CA 124.763 1.173 . . . . 0.0 110.53 -169.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -60.24 127.26 30.91 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -117.35 121.05 40.04 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 170.146 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 1.5 pt -100.75 111.37 30.2 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.098 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 173.352 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -158.33 153.4 25.38 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 129.46 3.104 . . . . 0.0 106.342 172.538 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -150.58 -44.84 0.12 Allowed 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 119.736 1.153 . . . . 0.0 111.559 179.034 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -105.82 -111.48 0.27 Allowed 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 106.046 -1.835 . . . . 0.0 106.046 170.627 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 16.8 ptm180 -88.09 -16.21 34.15 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 119.777 1.171 . . . . 0.0 110.806 165.582 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -144.62 166.24 19.4 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 129.215 3.006 . . . . 0.0 105.776 -179.532 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.13 152.64 45.66 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 122.019 1.813 . . . . 0.0 112.822 179.421 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -130.77 -5.84 4.05 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.275 1.03 . . . . 0.0 111.88 168.244 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 66.9 mt -113.38 28.78 8.51 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.522 1.529 . . . . 0.0 110.078 178.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 74.3 m -47.08 -56.98 5.55 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.806 1.643 . . . . 0.0 111.992 -169.526 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -69.59 -39.37 77.33 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 119.245 -0.407 . . . . 0.0 111.27 -168.728 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -73.52 -35.04 65.53 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.456 0.571 . . . . 0.0 111.118 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 33.2 mtp180 -64.8 -41.11 96.06 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 119.341 0.973 . . . . 0.0 109.892 174.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 72.4 t -67.89 -41.33 84.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-O 118.592 -0.718 . . . . 0.0 109.634 177.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -59.26 -50.78 72.71 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 120.134 1.334 . . . . 0.0 110.283 176.364 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 58.1 mttm -57.41 -42.92 83.24 Favored 'General case' 0 CA--C 1.522 -0.115 0 CA-C-O 118.652 -0.69 . . . . 0.0 109.994 -178.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 60.5 t90 -66.43 -48.55 69.64 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 118.546 0.612 . . . . 0.0 110.797 -178.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 53.6 t -60.87 -36.2 70.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 118.107 0.412 . . . . 0.0 109.95 -177.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -65.94 -33.91 76.91 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 118.427 -0.797 . . . . 0.0 110.438 177.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 41.5 mm-40 -65.58 -54.77 23.31 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 119.015 0.825 . . . . 0.0 110.534 171.18 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 5.7 pt -64.65 -29.91 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-N 118.807 0.731 . . . . 0.0 110.633 -170.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 49.6 m -60.09 -27.01 66.64 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 118.646 -0.692 . . . . 0.0 111.774 178.409 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -82.41 -38.11 24.55 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 119.644 1.111 . . . . 0.0 110.717 175.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -71.36 -36.78 71.6 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.136 0.574 . . . . 0.0 111.133 -178.512 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 85.7 mt -85.75 -5.75 59.21 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.749 1.62 . . . . 0.0 111.306 178.427 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 84.7 m-70 54.63 29.99 12.49 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.81 1.644 . . . . 0.0 112.88 -171.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 80.0 mt -77.59 -20.41 54.02 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 118.668 -0.682 . . . . 0.0 110.723 173.324 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -56.99 -38.3 72.86 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 119.292 0.951 . . . . 0.0 110.356 174.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -66.95 -12.87 60.97 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 121.637 -0.665 . . . . 0.0 112.522 178.492 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 44.4 mt -103.9 -55.32 5.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 124.993 1.317 . . . . 0.0 108.566 -179.031 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.4 pp -79.31 -24.87 42.54 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.567 0.747 . . . . 0.0 112.179 -171.44 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -121.8 35.48 4.87 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.08 1.752 . . . . 0.0 109.582 -175.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.333 0 C-N-CA 123.695 0.798 . . . . 0.0 109.571 174.184 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.446 0 N-CA-C 110.634 -0.135 . . . . 0.0 110.634 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.1 pt -102.1 -16.85 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 123.962 0.905 . . . . 0.0 111.718 -179.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 16.4 m -114.58 126.89 55.43 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.682 1.593 . . . . 0.0 108.671 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -102.52 119.93 6.63 Favored Glycine 0 CA--C 1.52 0.348 0 N-CA-C 107.816 -2.114 . . . . 0.0 107.816 169.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 43.5 mt -96.22 124.54 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 104.405 -2.443 . . . . 0.0 104.405 172.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -122.84 130.18 52.57 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 176.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -129.47 130.78 46.32 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 119.615 1.098 . . . . 0.0 112.551 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -81.78 152.76 32.13 Favored Glycine 0 C--N 1.339 0.697 0 N-CA-C 108.102 -1.999 . . . . 0.0 108.102 168.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 16.8 p -153.27 166.04 33.84 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 120.128 1.964 . . . . 0.0 111.413 -176.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -144.49 -58.4 0.37 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.588 0.755 . . . . 0.0 109.745 168.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.2 p -83.36 -12.42 56.55 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.691 1.197 . . . . 0.0 111.875 175.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.06 7.84 59.39 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 124.714 1.15 . . . . 0.0 113.059 175.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -65.9 -37.74 86.89 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 118.459 1.129 . . . . 0.0 110.929 -176.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.82 -24.5 66.17 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.437 0.695 . . . . 0.0 111.914 -175.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -62.21 -40.97 97.88 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 119.114 0.87 . . . . 0.0 109.733 177.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -66.28 -37.79 86.27 Favored 'General case' 0 CA--C 1.529 0.141 0 O-C-N 122.13 -0.356 . . . . 0.0 110.123 178.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 27.1 mm -62.77 -48.9 85.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 175.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.1 -39.41 86.06 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.331 0.514 . . . . 0.0 111.156 -178.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 57.8 mttm -67.99 -42.93 80.01 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 118.52 -0.752 . . . . 0.0 111.223 175.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 75.1 mtm -64.78 -28.09 69.34 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 119.938 1.245 . . . . 0.0 111.506 178.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.402 HG21 HD23 ' A' ' 51' ' ' LEU . 83.6 mt -68.63 -57.73 8.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 169.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -59.16 -39.9 83.92 Favored 'General case' 0 C--O 1.226 -0.152 0 C-N-CA 122.938 0.495 . . . . 0.0 111.601 -171.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -64.54 -34.08 77.4 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 118.616 0.644 . . . . 0.0 111.435 -176.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -73.0 -47.58 43.9 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 118.159 0.436 . . . . 0.0 110.332 177.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 54.2 mt -67.18 -34.05 76.69 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 122.698 0.399 . . . . 0.0 111.594 -178.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.59 145.95 17.73 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 125.587 1.565 . . . . 0.0 110.762 -173.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -63.52 -28.72 70.14 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.765 0.826 . . . . 0.0 111.81 -176.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -66.88 -23.91 66.06 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.092 0.557 . . . . 0.0 111.349 176.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 53.1 t -101.3 -39.11 6.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 124.592 1.157 . . . . 0.0 110.441 -175.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -132.68 145.03 50.72 Favored 'General case' 0 C--N 1.342 0.245 0 CA-C-N 119.539 1.063 . . . . 0.0 112.111 -173.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -127.01 158.68 36.29 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.754 1.222 . . . . 0.0 109.757 172.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 71.0 t -119.27 138.08 51.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 125.021 1.328 . . . . 0.0 110.257 -169.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -146.35 166.54 26.01 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.847 1.659 . . . . 0.0 111.815 -170.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -126.82 135.53 51.14 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 105.357 -2.09 . . . . 0.0 105.357 168.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.9 tp -61.97 -17.2 17.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-N 118.88 0.763 . . . . 0.0 112.99 -170.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -52.32 -37.24 55.38 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.172 0.989 . . . . 0.0 112.339 179.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.15 1.43 57.15 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.632 0.773 . . . . 0.0 112.664 -177.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 52.5 m -87.89 157.68 18.91 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 122.374 1.083 . . . . 0.0 112.204 -174.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 23.7 m -129.23 172.51 11.38 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 127.971 2.509 . . . . 0.0 104.894 167.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.5 ptmm? -58.41 -38.69 77.91 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 120.059 1.299 . . . . 0.0 111.264 -173.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -71.51 -17.12 62.35 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.87 -0.519 . . . . 0.0 111.884 -176.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -68.23 -27.05 66.03 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.69 0.796 . . . . 0.0 111.039 -175.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.3 mp -86.97 -40.19 15.01 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 123.445 0.698 . . . . 0.0 109.845 171.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -63.74 -20.93 66.14 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.275 0.63 . . . . 0.0 111.921 -175.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.36 -29.96 70.23 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.278 1.031 . . . . 0.0 112.456 174.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -96.88 151.46 19.65 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.438 1.095 . . . . 0.0 110.669 -177.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -87.25 -37.95 16.76 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.556 170.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 22.2 mt -110.54 136.44 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -177.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 74.8 mt -132.42 120.84 22.53 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 124.139 0.976 . . . . 0.0 108.558 -176.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.402 HD23 HG21 ' A' ' 22' ' ' ILE . 8.9 mp -109.67 107.39 17.42 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 105.534 -2.024 . . . . 0.0 105.534 177.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 68.0 mt -110.17 100.85 9.68 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -170.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.97 131.73 10.8 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 124.726 1.155 . . . . 0.0 110.247 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.1 tt -142.26 122.32 8.15 Favored Pre-proline 0 CA--C 1.54 0.595 0 CA-C-N 118.358 1.079 . . . . 0.0 110.215 -179.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -81.07 161.51 20.63 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 123.07 2.513 . . . . 0.0 109.33 169.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 62.2 m -118.46 141.52 48.48 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 173.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 64.9 m95 -134.6 173.84 11.21 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 124.913 1.285 . . . . 0.0 109.442 -177.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 28.73 64.2 0.11 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 127.546 2.338 . . . . 0.0 114.479 169.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 56.73 62.84 2.13 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.445 1.098 . . . . 0.0 111.66 175.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.53 14.87 72.52 Favored Glycine 0 CA--C 1.532 1.138 0 CA-C-N 115.952 -0.567 . . . . 0.0 114.274 171.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -78.07 143.55 37.3 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 124.869 1.268 . . . . 0.0 110.117 176.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -93.89 143.94 25.89 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.342 1.057 . . . . 0.0 109.027 169.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -58.9 146.41 37.74 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.979 0.419 . . . . 0.0 110.592 177.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 60.8 m -59.25 -33.04 70.55 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.169 0.988 . . . . 0.0 112.97 -168.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -66.44 -43.7 84.89 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.247 0.476 . . . . 0.0 109.901 -178.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -71.81 -43.16 66.1 Favored 'General case' 0 C--N 1.341 0.204 0 C-N-CA 123.02 0.528 . . . . 0.0 110.029 176.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -59.15 -41.56 88.61 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 118.358 0.526 . . . . 0.0 111.858 -178.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -69.3 -23.32 63.8 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.76 0.824 . . . . 0.0 112.095 176.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -90.09 -20.76 22.78 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 118.277 -0.868 . . . . 0.0 112.302 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -51.96 -41.49 79.79 Favored Pre-proline 0 CA--C 1.544 0.72 0 CA-C-O 116.706 -1.616 . . . . 0.0 114.577 178.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -65.21 -13.89 42.17 Favored 'Trans proline' 0 CA--C 1.544 0.983 0 CA-C-N 122.809 2.039 . . . . 0.0 114.073 174.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 30.5 m -93.42 -36.15 12.64 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.46 1.104 . . . . 0.0 109.803 169.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.462 ' HA ' HD12 ' A' ' 76' ' ' ILE . 25.9 tp -56.1 -40.14 73.23 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 124.225 1.01 . . . . 0.0 110.501 178.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -72.78 1.11 9.13 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 178.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -112.55 -7.27 13.9 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.455 1.025 . . . . 0.0 111.52 174.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.462 HD12 ' HA ' ' A' ' 73' ' ' LEU . 62.7 mt -75.18 139.86 18.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -177.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -75.4 117.33 17.08 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 171.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -109.95 6.38 23.12 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 118.191 -0.909 . . . . 0.0 111.183 173.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 -60.62 116.91 4.72 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 120.754 1.616 . . . . 0.0 109.281 -175.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 74.61 -1.29 52.94 Favored Glycine 0 CA--C 1.535 1.315 0 CA-C-O 118.307 -1.274 . . . . 0.0 113.935 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -67.68 137.25 55.4 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 120.039 1.919 . . . . 0.0 107.428 172.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 17.8 mt -89.24 129.33 35.83 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 172.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.1 t -129.64 136.24 59.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -175.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -129.81 147.47 51.58 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 125.115 1.366 . . . . 0.0 107.326 175.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 69.2 mt -120.34 148.51 43.65 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -176.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -143.5 157.53 44.36 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.229 0.612 . . . . 0.0 110.654 175.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -175.47 172.34 45.37 Favored Glycine 0 CA--C 1.525 0.714 0 CA-C-O 122.634 1.13 . . . . 0.0 112.3 -178.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 4.3 m -142.76 158.65 43.43 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.369 1.868 . . . . 0.0 106.749 -173.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -169.76 -174.5 38.09 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 120.072 -1.061 . . . . 0.0 114.961 -177.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -144.29 140.38 29.14 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 129.834 3.254 . . . . 0.0 104.473 177.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.15 16.49 1.19 Allowed 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.739 1.216 . . . . 0.0 112.104 -171.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -63.82 -48.62 76.08 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.653 0.66 . . . . 0.0 109.316 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -98.78 -30.4 12.44 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.035 0.534 . . . . 0.0 111.136 171.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -83.91 42.59 0.87 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.711 1.605 . . . . 0.0 110.298 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.46 -17.32 59.2 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 -167.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -108.88 5.46 24.49 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.801 0.841 . . . . 0.0 112.594 176.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -126.14 15.31 7.86 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.683 1.193 . . . . 0.0 113.015 -169.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -62.9 121.94 14.75 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 119.588 1.086 . . . . 0.0 109.528 -177.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 82.4 m 47.12 35.98 3.98 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.709 1.604 . . . . 0.0 112.303 -177.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -50.19 -42.69 51.74 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.026 1.33 . . . . 0.0 111.655 -173.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.78 -12.02 61.02 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -170.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 82.2 mt -56.94 -42.17 79.56 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 119.143 0.883 . . . . 0.0 109.614 169.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.0 -34.28 88.38 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 111.246 -0.742 . . . . 0.0 111.246 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 4.7 m -64.18 -41.84 96.94 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 117.95 0.875 . . . . 0.0 110.578 -178.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 8.5 mt -72.16 -47.09 55.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 176.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 50.5 tpt85 -57.62 -33.02 67.82 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.488 0.715 . . . . 0.0 112.119 -175.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -70.42 -29.68 66.35 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 123.432 0.693 . . . . 0.0 112.29 179.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 94.6 mt -90.68 -40.33 12.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 123.52 0.728 . . . . 0.0 110.142 -173.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 15.4 pt -74.32 -32.39 31.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 118.853 0.751 . . . . 0.0 111.991 -169.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -63.37 -53.89 48.97 Favored Pre-proline 0 CA--C 1.541 0.596 0 CA-C-O 117.363 -1.303 . . . . 0.0 112.26 -178.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -66.22 -24.6 51.0 Favored 'Trans proline' 0 C--N 1.352 0.739 0 CA-C-N 121.942 1.729 . . . . 0.0 112.223 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -77.69 0.92 21.58 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 118.718 0.69 . . . . 0.0 112.205 171.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 100.25 11.17 43.01 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-O 118.208 -1.329 . . . . 0.0 115.469 168.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.33 150.11 40.34 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 119.292 1.546 . . . . 0.0 111.475 178.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 62.0 m -104.99 123.91 48.61 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 105.482 -2.044 . . . . 0.0 105.482 167.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 12.3 mm -91.79 138.87 18.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 -171.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 27.1 m -136.86 173.33 13.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 124.751 1.22 . . . . 0.0 109.114 170.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 81.95 43.42 8.23 Favored Glycine 0 C--N 1.337 0.628 0 CA-C-O 119.229 -0.761 . . . . 0.0 114.719 169.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 20.4 p80 -62.57 158.2 18.68 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 118.265 1.032 . . . . 0.0 109.716 168.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 77.5 t-105 -141.33 131.35 12.95 Favored Pre-proline 0 CA--C 1.534 0.331 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -68.4 145.19 64.39 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 121.912 1.741 . . . . 0.0 112.117 -173.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 57.1 p . . . . . 0 CA--C 1.532 0.283 0 C-N-CA 123.119 0.568 . . . . 0.0 110.926 171.988 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.473 0.695 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -77.82 -2.72 82.43 Favored Glycine 0 CA--C 1.531 1.065 0 CA-C-O 118.573 -1.126 . . . . 0.0 112.969 172.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 96.5 mt -66.51 133.29 50.06 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 120.171 1.986 . . . . 0.0 110.019 178.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -97.17 -33.82 11.35 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 166.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -145.58 162.77 36.69 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 127.378 2.271 . . . . 0.0 106.704 169.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -55.01 -28.01 48.76 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 118.942 0.792 . . . . 0.0 112.04 174.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -84.64 -19.68 32.54 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.468 1.107 . . . . 0.0 113.671 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 32.2 p-80 -153.31 137.63 16.62 Favored 'General case' 0 C--N 1.345 0.4 0 CA-C-O 123.064 1.411 . . . . 0.0 114.257 -176.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -73.05 154.09 40.59 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 125.436 1.494 . . . . 0.0 109.245 168.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 4.9 p -76.32 -18.07 15.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 124.546 1.138 . . . . 0.0 111.745 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -141.9 171.66 24.39 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 125.634 1.587 . . . . 0.0 109.373 177.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -59.03 130.15 45.61 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 172.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.19 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 178.717 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 18.1 mt . . . . . 0 CA--C 1.54 0.581 0 CA-C-O 122.41 1.1 . . . . 0.0 109.032 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 44.6 m -69.8 -48.18 60.06 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 126.118 1.767 . . . . 0.0 112.388 -168.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -60.85 -42.91 98.74 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -166.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -64.49 -37.87 89.04 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 118.319 0.509 . . . . 0.0 110.434 178.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 53.5 mtt85 -70.54 -44.48 67.41 Favored 'General case' 0 C--N 1.339 0.119 0 O-C-N 121.622 -0.674 . . . . 0.0 110.68 -178.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 22.5 m -73.79 -26.81 21.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 CA-C-O 118.523 -0.751 . . . . 0.0 110.613 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -62.0 -51.12 69.3 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 120.247 1.385 . . . . 0.0 109.13 170.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -58.43 -43.95 88.92 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 118.179 0.445 . . . . 0.0 110.542 179.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 73.2 t90 -67.02 -44.34 80.52 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 118.934 0.788 . . . . 0.0 110.689 -177.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 54.7 t -62.48 -38.95 82.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 55.8 mttm -66.7 -38.81 87.5 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.176 -0.952 . . . . 0.0 110.091 179.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 42.0 mm-40 -62.61 -50.94 69.25 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-N 118.538 0.608 . . . . 0.0 110.9 175.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 29.4 pt -64.7 -33.92 66.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-N 119.341 0.973 . . . . 0.0 109.973 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 57.6 m -61.76 -24.46 66.84 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 117.766 -1.111 . . . . 0.0 112.597 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -95.15 -11.32 28.35 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 120.317 1.417 . . . . 0.0 112.677 175.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -85.44 -40.03 16.87 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 119.183 0.901 . . . . 0.0 110.082 169.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 64.1 mt -84.64 -12.91 53.02 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.668 1.987 . . . . 0.0 111.609 -179.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 56.85 32.12 20.83 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.762 1.625 . . . . 0.0 112.419 -170.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 58.3 mt . . . . . 0 C--N 1.342 0.258 0 O-C-N 121.752 -0.592 . . . . 0.0 110.733 169.143 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.349 0 N-CA-C 110.516 -0.179 . . . . 0.0 110.516 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.0 pt -85.91 -27.09 6.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 123.087 0.555 . . . . 0.0 111.145 178.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 49.3 m -111.92 120.59 42.44 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.295 1.038 . . . . 0.0 109.318 -178.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -94.51 116.06 5.2 Favored Glycine 0 CA--C 1.52 0.376 0 N-CA-C 107.048 -2.421 . . . . 0.0 107.048 169.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 72.7 mt -95.21 97.1 6.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 104.852 -2.277 . . . . 0.0 104.852 176.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -91.71 137.83 32.05 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 176.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -136.93 159.48 41.74 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 123.592 0.757 . . . . 0.0 110.644 -176.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -131.31 147.47 18.55 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 107.739 -2.144 . . . . 0.0 107.739 167.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 29.6 m -168.44 143.02 3.36 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.375 1.588 . . . . 0.0 109.589 -179.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -91.07 -45.15 8.86 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 122.53 0.332 . . . . 0.0 111.001 170.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 82.5 p -107.47 9.13 29.7 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.014 0.926 . . . . 0.0 112.563 -175.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 79.72 13.34 82.51 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 124.128 0.87 . . . . 0.0 114.452 178.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -72.42 -46.17 56.31 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 119.515 1.658 . . . . 0.0 111.582 -177.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.5 m -74.32 -25.17 59.39 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 119.471 1.032 . . . . 0.0 109.896 179.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -58.64 -40.89 84.66 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.214 -0.929 . . . . 0.0 110.3 169.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -64.0 -36.6 84.52 Favored 'General case' 0 CA--C 1.532 0.282 0 O-C-N 121.48 -0.762 . . . . 0.0 110.905 178.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 29.6 mm -64.29 -45.99 94.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 174.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.21 -41.53 79.61 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.475 0.58 . . . . 0.0 111.215 178.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -67.86 -42.88 80.66 Favored 'General case' 0 N--CA 1.463 0.212 0 O-C-N 121.738 -0.601 . . . . 0.0 110.994 178.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.38 -23.37 64.66 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 119.248 0.931 . . . . 0.0 112.008 178.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 59.1 mt -71.22 -54.98 15.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 169.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -59.98 -38.16 81.72 Favored 'General case' 0 C--O 1.225 -0.234 0 CA-C-O 118.928 -0.558 . . . . 0.0 111.6 -173.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -59.13 -37.99 78.54 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 118.925 0.784 . . . . 0.0 110.885 -176.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -72.52 -39.93 67.2 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.101 0.561 . . . . 0.0 111.316 178.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.3 mp -75.17 -33.59 61.48 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.031 0.378 . . . . 0.0 111.131 -176.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.64 149.42 14.32 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.878 1.228 . . . . 0.0 110.93 -172.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -64.32 -28.47 69.73 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.884 0.873 . . . . 0.0 111.911 -173.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -66.87 -25.93 66.64 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.081 0.552 . . . . 0.0 111.426 178.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 39.3 t -100.75 -42.15 9.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 124.357 1.063 . . . . 0.0 109.999 -175.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -131.7 145.63 51.74 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 119.124 0.874 . . . . 0.0 111.584 -174.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -135.67 139.11 43.47 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 123.616 0.766 . . . . 0.0 109.777 178.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 92.9 t -101.99 135.07 40.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 C-N-CA 124.373 1.069 . . . . 0.0 109.523 -170.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 79.2 m-70 -141.31 137.08 32.17 Favored 'General case' 0 C--N 1.339 0.138 0 C-N-CA 124.62 1.168 . . . . 0.0 111.112 -173.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.31 131.6 43.67 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 168.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.6 tp -68.56 -33.52 60.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 O-C-N 121.551 -0.718 . . . . 0.0 111.402 -179.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.87 -40.24 94.82 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.98 0.809 . . . . 0.0 112.108 -169.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -75.27 -17.69 60.24 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 118.149 0.431 . . . . 0.0 112.038 178.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 53.1 m -75.84 163.63 27.04 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.444 0.64 . . . . 0.0 111.108 -169.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 47.1 m -127.33 168.45 14.78 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.159 1.383 . . . . 0.0 109.587 -175.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -52.05 -46.15 64.98 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.545 1.138 . . . . 0.0 111.756 -173.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -74.15 -14.4 60.95 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 122.823 0.449 . . . . 0.0 111.827 -173.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -78.82 -30.58 45.42 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 121.393 -0.817 . . . . 0.0 111.248 -170.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.2 mp -79.45 -39.18 32.89 Favored 'General case' 0 C--N 1.345 0.391 0 O-C-N 122.109 -0.37 . . . . 0.0 110.195 171.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -55.35 -28.52 54.39 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.266 1.027 . . . . 0.0 112.274 -176.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.44 -29.39 69.52 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.195 0.998 . . . . 0.0 113.438 -178.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -88.12 156.6 19.17 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.068 0.947 . . . . 0.0 110.591 -175.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -99.94 -32.32 11.03 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 123.056 0.542 . . . . 0.0 111.393 170.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.1 mp -108.77 128.16 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 172.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -114.7 128.23 56.2 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 170.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.2 mp -109.63 126.84 54.06 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 169.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 67.2 mt -123.18 118.23 27.16 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -169.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -111.66 102.66 1.44 Allowed Glycine 0 C--N 1.336 0.528 0 C-N-CA 125.464 1.507 . . . . 0.0 111.881 -170.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 17.3 tt -127.34 117.17 21.53 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 123.406 0.682 . . . . 0.0 112.165 -169.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -82.6 150.71 14.83 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 122.883 2.389 . . . . 0.0 110.321 168.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.8 m -96.83 137.98 35.08 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 178.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 19.9 m95 -133.15 175.27 9.53 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.166 1.386 . . . . 0.0 111.129 -171.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 51.06 -91.79 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 128.268 2.627 . . . . 0.0 113.445 -178.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -152.57 81.61 1.23 Allowed 'General case' 0 C--O 1.235 0.318 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 176.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 63.22 50.82 59.77 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 -175.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -121.28 154.15 36.75 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 124.583 1.153 . . . . 0.0 108.326 175.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -73.2 147.93 44.25 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.068 0.461 . . . . 0.0 110.387 169.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 16.2 tp60 -56.22 142.66 36.47 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 167.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 56.8 m -56.2 -32.05 64.03 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.05 0.94 . . . . 0.0 112.41 -170.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -57.08 -43.72 82.4 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 123.919 0.887 . . . . 0.0 110.491 178.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -81.94 -41.25 21.11 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 123.664 0.786 . . . . 0.0 110.579 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -58.01 -39.18 77.67 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.154 0.433 . . . . 0.0 111.325 -178.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -70.36 -25.85 63.46 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.466 0.706 . . . . 0.0 112.033 176.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -90.88 -23.28 20.57 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 118.613 -0.708 . . . . 0.0 112.567 -177.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 20.7 m-30 -49.36 -42.06 61.76 Favored Pre-proline 0 CA--C 1.542 0.652 0 CA-C-O 116.457 -1.735 . . . . 0.0 115.114 -178.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -64.32 -18.11 62.04 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 CA-C-N 122.934 2.084 . . . . 0.0 113.474 176.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 25.0 m -88.45 -42.4 12.16 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.095 0.958 . . . . 0.0 109.591 169.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 27.3 tp -55.8 -38.82 70.45 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.308 1.043 . . . . 0.0 111.284 -177.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -70.82 -7.75 47.59 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -178.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -95.2 -17.64 21.57 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 119.712 1.142 . . . . 0.0 111.739 171.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 97.6 mt -77.04 133.82 30.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 -173.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -82.35 140.01 33.76 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.023 0.929 . . . . 0.0 109.496 175.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -129.58 11.01 5.71 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 118.368 -0.825 . . . . 0.0 111.469 174.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -66.6 123.59 20.49 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 120.742 1.61 . . . . 0.0 109.621 -172.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.72 2.45 50.9 Favored Glycine 0 CA--C 1.537 1.443 0 CA-C-O 117.965 -1.464 . . . . 0.0 114.088 -174.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -79.81 150.25 30.77 Favored 'General case' 0 C--N 1.345 0.385 0 CA-C-N 120.222 2.011 . . . . 0.0 107.722 170.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 19.9 mt -91.71 137.45 32.36 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 171.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 16.0 t -133.73 142.73 40.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 177.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -134.3 151.0 51.02 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 170.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -113.54 145.71 40.79 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 124.367 1.067 . . . . 0.0 109.022 -174.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -143.42 159.03 43.14 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 166.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 179.31 177.4 47.69 Favored Glycine 0 N--CA 1.447 -0.598 0 O-C-N 121.184 -0.947 . . . . 0.0 113.282 -177.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 20.1 m -134.95 155.31 50.95 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.362 1.065 . . . . 0.0 109.533 -169.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -168.03 -176.09 38.26 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -177.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -132.15 110.85 10.96 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 172.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -75.22 -9.79 58.88 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 117.831 -1.081 . . . . 0.0 113.481 -168.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -110.44 -47.07 3.32 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 120.347 1.43 . . . . 0.0 110.673 -177.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -81.19 -22.27 39.02 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.993 -0.442 . . . . 0.0 111.619 -173.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -126.23 44.36 2.88 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.377 1.471 . . . . 0.0 109.047 172.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.34 -21.93 64.46 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.683 1.193 . . . . 0.0 113.829 -173.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -86.83 -2.47 58.6 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.791 0.836 . . . . 0.0 111.911 178.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -141.06 23.79 2.19 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.802 1.241 . . . . 0.0 110.968 -169.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -65.05 123.92 20.73 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 118.86 0.754 . . . . 0.0 110.713 -168.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 69.1 m 52.01 31.54 8.86 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.355 1.462 . . . . 0.0 112.981 178.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -57.51 -37.72 73.46 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.638 -0.663 . . . . 0.0 112.279 -178.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.35 -26.49 67.31 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -169.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.8 mp -62.38 -36.16 81.43 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.48 -0.763 . . . . 0.0 109.268 176.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -67.78 -29.21 73.58 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 123.651 0.643 . . . . 0.0 111.853 175.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.1 m -65.97 -36.71 84.07 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 118.801 1.301 . . . . 0.0 110.353 176.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 5.1 mt -68.69 -47.83 74.59 Favored 'Isoleucine or valine' 0 C--N 1.343 0.283 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 173.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 40.4 ttt-85 -49.89 -45.96 51.3 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 119.03 0.832 . . . . 0.0 111.037 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -60.36 -22.27 63.08 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.013 0.925 . . . . 0.0 112.759 -177.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 86.1 mt -96.2 -47.84 12.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 124.359 1.064 . . . . 0.0 109.681 178.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 30.4 pt -75.05 -31.44 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 119.464 1.029 . . . . 0.0 111.698 -170.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -66.81 -50.85 42.07 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-O 117.584 -1.198 . . . . 0.0 111.722 -176.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -67.6 -24.56 41.64 Favored 'Trans proline' 0 C--N 1.353 0.767 0 CA-C-N 122.079 1.778 . . . . 0.0 112.276 176.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 81.1 mmt-85 -75.23 6.33 4.51 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.619 0.768 . . . . 0.0 113.043 170.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 85.22 11.81 74.92 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-O 118.147 -1.363 . . . . 0.0 114.686 168.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -56.17 138.04 50.67 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 119.293 1.547 . . . . 0.0 110.433 174.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 61.7 m -90.13 118.99 30.09 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 104.392 -2.447 . . . . 0.0 104.392 167.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 47.5 mt -101.47 130.75 50.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 -170.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 34.6 m -133.03 173.89 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 125.093 1.357 . . . . 0.0 109.245 177.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 81.32 28.47 44.27 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-O 119.507 -0.607 . . . . 0.0 112.948 176.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 67.0 m80 -58.39 146.13 35.86 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 118.06 0.93 . . . . 0.0 109.593 170.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 59.2 t-105 -131.4 135.97 27.88 Favored Pre-proline 0 CA--C 1.534 0.343 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 -177.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -67.14 139.89 52.06 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.003 1.802 . . . . 0.0 110.859 -174.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.4 t . . . . . 0 CA--C 1.543 0.687 0 C-N-CA 123.459 0.704 . . . . 0.0 110.748 176.88 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 88.8 mttt . . . . . 0 N--CA 1.469 0.508 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -81.99 6.7 65.68 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-N 118.62 0.646 . . . . 0.0 112.719 169.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 79.5 mt -64.83 142.16 58.53 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 118.586 1.193 . . . . 0.0 111.345 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -116.77 -16.89 10.61 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.999 1.32 . . . . 0.0 110.385 168.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -143.08 156.57 44.84 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 127.191 2.196 . . . . 0.0 106.126 173.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -54.76 -23.69 19.05 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.572 1.149 . . . . 0.0 113.707 -173.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -124.33 11.29 8.7 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.884 0.873 . . . . 0.0 113.334 177.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -138.42 129.36 26.83 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 120.52 -1.363 . . . . 0.0 112.096 -176.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -70.01 153.11 43.63 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.445 1.098 . . . . 0.0 109.048 168.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 9.7 p -62.44 -24.78 36.13 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 123.604 0.762 . . . . 0.0 111.244 173.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -157.9 179.4 33.65 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 123.557 0.599 . . . . 0.0 112.171 -169.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -70.92 110.01 5.4 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 123.56 0.744 . . . . 0.0 109.478 -178.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.375 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 167.999 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 11.4 mt . . . . . 0 CA--C 1.539 0.556 0 N-CA-C 111.622 0.23 . . . . 0.0 111.622 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 35.9 m -43.18 -61.13 1.41 Allowed 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 126.499 1.919 . . . . 0.0 112.737 -167.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -70.97 -35.84 72.3 Favored 'General case' 0 N--CA 1.452 -0.346 0 O-C-N 121.845 -0.535 . . . . 0.0 111.032 -169.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -72.72 -30.22 64.01 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.873 0.761 . . . . 0.0 111.278 178.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 74.1 mtp85 -63.3 -43.41 97.95 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 119.703 1.138 . . . . 0.0 109.515 172.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 66.2 t -66.03 -41.61 90.0 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.246 0 CA-C-O 118.325 -0.845 . . . . 0.0 109.023 178.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -59.94 -49.53 77.31 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 120.483 1.492 . . . . 0.0 110.487 176.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -61.84 -39.78 93.01 Favored 'General case' 0 N--CA 1.462 0.144 0 O-C-N 122.014 -0.428 . . . . 0.0 110.47 -176.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 60.9 t90 -70.73 -48.72 53.05 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 118.344 0.52 . . . . 0.0 110.642 178.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 55.6 t -60.77 -39.63 82.35 Favored 'Isoleucine or valine' 0 C--O 1.231 0.108 0 C-N-CA 123.041 0.536 . . . . 0.0 110.339 -175.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -68.0 -36.34 79.82 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 121.632 -0.668 . . . . 0.0 109.919 -177.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 46.8 mm-40 -67.73 -50.38 57.66 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 122.911 0.484 . . . . 0.0 110.677 174.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 6.3 pt -66.77 -31.87 55.47 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.313 0 CA-C-N 119.151 0.887 . . . . 0.0 110.937 -176.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 66.1 m -59.03 -37.39 76.83 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.316 0.962 . . . . 0.0 111.716 -179.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -83.69 -31.02 26.32 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 119.339 0.972 . . . . 0.0 111.788 178.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -68.4 -36.46 79.16 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 118.733 0.697 . . . . 0.0 110.783 176.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 76.9 mt -81.63 -3.3 53.1 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.881 1.673 . . . . 0.0 111.612 174.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . 0.324 1.3 p-80 50.12 19.11 0.45 Allowed 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 129.88 3.272 . . . . 0.0 114.719 -174.002 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 4.6 pp . . . . . 0 N--CA 1.462 0.164 0 C-N-CA 123.103 0.561 . . . . 0.0 111.505 176.828 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.261 0 CA-C-O 121.093 0.473 . . . . 0.0 111.723 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.4 pt -119.65 -12.63 9.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 125.37 1.468 . . . . 0.0 111.537 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.1 m -114.58 127.03 55.57 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 125.35 1.46 . . . . 0.0 107.934 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -99.38 116.35 5.56 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 108.114 -1.994 . . . . 0.0 108.114 169.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 60.2 mt -92.55 119.96 41.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 N-CA-C 104.899 -2.259 . . . . 0.0 104.899 171.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -116.82 133.47 55.97 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 176.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -134.14 163.71 28.98 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 122.833 0.453 . . . . 0.0 111.591 -173.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -131.23 144.38 15.92 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 107.92 -2.072 . . . . 0.0 107.92 166.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 9.1 m -166.65 155.18 10.37 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-N 119.356 1.578 . . . . 0.0 110.127 176.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -115.61 -50.4 2.71 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.964 0.906 . . . . 0.0 109.841 167.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.6 p -86.92 8.43 23.15 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.819 1.248 . . . . 0.0 112.802 177.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 80.31 2.91 89.69 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 124.687 1.137 . . . . 0.0 115.609 169.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -70.2 -49.05 54.15 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 119.593 1.696 . . . . 0.0 112.375 -174.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 10.2 m -74.08 -26.62 60.48 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 120.546 1.521 . . . . 0.0 109.614 -178.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -60.48 -43.49 96.91 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.82 0.848 . . . . 0.0 110.157 169.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -64.69 -41.81 95.78 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 121.467 -0.771 . . . . 0.0 110.72 176.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 46.2 mm -59.29 -45.76 92.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-N 118.561 0.619 . . . . 0.0 109.332 175.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.65 -44.57 85.75 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.483 0.713 . . . . 0.0 110.952 178.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -66.52 -41.45 88.76 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 118.691 -0.671 . . . . 0.0 110.719 179.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 94.4 mtp -62.33 -40.3 95.89 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 119.531 1.059 . . . . 0.0 110.623 177.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 34.5 mt -63.33 -42.75 97.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 119.028 0.831 . . . . 0.0 109.152 175.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -59.71 -41.32 90.54 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 119.204 0.911 . . . . 0.0 110.921 177.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -64.53 -35.41 80.88 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 118.839 0.745 . . . . 0.0 110.463 178.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -67.72 -46.93 70.79 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.039 0.536 . . . . 0.0 110.697 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -76.77 -31.97 57.39 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 118.724 0.693 . . . . 0.0 111.523 -178.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.79 146.27 20.67 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 125.389 1.471 . . . . 0.0 110.798 -173.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -64.14 -28.78 70.0 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.949 0.9 . . . . 0.0 111.807 -174.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -78.58 -3.78 45.52 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 178.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 48.3 t -113.8 -38.13 2.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 124.791 1.236 . . . . 0.0 109.708 178.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -129.74 142.37 50.71 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 119.307 0.958 . . . . 0.0 111.741 -176.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -119.47 159.53 24.1 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.01 1.724 . . . . 0.0 108.493 172.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 48.4 t -133.46 130.22 56.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 C-N-CA 124.601 1.161 . . . . 0.0 109.515 -169.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -144.99 150.36 36.78 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.168 0.987 . . . . 0.0 111.625 174.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -72.45 134.84 45.55 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 166.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.2 tp -56.81 -32.33 38.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 118.697 0.68 . . . . 0.0 111.621 -173.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.65 -28.51 69.97 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.9 0.773 . . . . 0.0 112.243 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -82.06 -17.31 47.11 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.299 0.64 . . . . 0.0 110.597 178.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.9 t -75.52 174.17 10.03 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 122.117 0.961 . . . . 0.0 110.377 174.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.426 ' H ' ' HB3' ' A' ' 43' ' ' ASP . 21.3 m -145.53 167.09 23.87 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 127.726 2.41 . . . . 0.0 107.676 -177.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -52.68 -49.79 64.57 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.294 0.638 . . . . 0.0 110.843 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -76.0 -15.78 60.08 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 122.735 0.414 . . . . 0.0 111.701 -175.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.426 ' HB3' ' H ' ' A' ' 40' ' ' SER . 34.0 t70 -81.62 -37.05 28.19 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 121.685 -0.635 . . . . 0.0 110.233 -178.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.78 -43.65 88.14 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-N 118.345 0.52 . . . . 0.0 109.894 168.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -62.42 -20.98 65.05 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.4 0.68 . . . . 0.0 112.321 -177.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.25 -28.08 69.49 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.449 0.7 . . . . 0.0 112.009 177.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -103.47 138.45 40.17 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.559 1.144 . . . . 0.0 110.541 -176.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -88.39 -29.85 19.95 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.0 171.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.5 mm -106.4 128.76 60.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 178.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 88.6 mt -129.22 140.58 51.42 Favored 'General case' 0 CA--C 1.52 -0.208 0 C-N-CA 123.034 0.534 . . . . 0.0 109.809 -175.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -122.36 126.87 48.95 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 172.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 67.3 mt -121.07 122.02 39.16 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -173.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -117.75 103.92 1.11 Allowed Glycine 0 CA--C 1.524 0.609 0 C-N-CA 125.349 1.452 . . . . 0.0 112.45 -169.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 16.9 tt -127.17 111.98 21.56 Favored Pre-proline 0 CA--C 1.542 0.657 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -169.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -75.76 147.84 31.68 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 122.287 1.991 . . . . 0.0 108.983 167.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 44.3 m -95.62 137.18 35.05 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 176.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 23.9 m95 -134.49 172.04 13.47 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.655 1.182 . . . . 0.0 111.43 -173.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 58.55 -79.53 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 128.565 2.746 . . . . 0.0 113.663 172.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -152.18 51.41 0.79 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.843 2.057 . . . . 0.0 108.923 -171.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.42 37.87 62.47 Favored Glycine 0 CA--C 1.525 0.661 0 O-C-N 121.56 -0.713 . . . . 0.0 111.63 -174.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -115.5 160.0 20.49 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.506 1.123 . . . . 0.0 109.791 -175.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.7 160.54 29.26 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.471 169.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -75.52 155.98 35.57 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 168.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 59.7 m -55.41 -29.79 59.22 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.84 0.856 . . . . 0.0 112.381 -177.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -65.8 -42.37 90.76 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.094 0.558 . . . . 0.0 110.691 -177.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 80.1 m95 -76.25 -44.35 37.76 Favored 'General case' 0 C--N 1.341 0.226 0 C-N-CA 122.813 0.445 . . . . 0.0 110.094 174.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -62.41 -37.11 84.53 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.792 0.437 . . . . 0.0 111.939 -172.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -71.23 -21.69 62.09 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.542 0.737 . . . . 0.0 112.018 175.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -90.16 -23.86 21.21 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.459 0.703 . . . . 0.0 111.385 179.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -51.02 -42.43 79.96 Favored Pre-proline 0 CA--C 1.544 0.714 0 CA-C-O 116.627 -1.654 . . . . 0.0 114.784 178.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -64.24 -22.94 66.55 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 CA-C-N 122.954 2.091 . . . . 0.0 113.194 174.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.3 m -81.04 -38.0 28.16 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.049 0.94 . . . . 0.0 109.738 170.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 13.4 tp -59.84 -35.23 74.32 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.79 1.236 . . . . 0.0 110.928 -175.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -79.63 -4.46 51.72 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.053 0.941 . . . . 0.0 113.035 177.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -93.73 -24.95 17.64 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 119.612 1.097 . . . . 0.0 111.176 169.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 95.7 mt -67.92 137.6 24.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 -176.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -86.83 81.03 8.3 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -177.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -70.0 -5.42 26.28 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 118.381 -0.819 . . . . 0.0 112.843 -176.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 57.1 m-80 -53.44 117.94 3.47 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 119.609 1.095 . . . . 0.0 109.513 -179.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 82.44 -4.8 76.21 Favored Glycine 0 CA--C 1.533 1.165 0 CA-C-O 117.849 -1.528 . . . . 0.0 114.47 175.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -64.56 139.68 58.79 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 120.527 2.164 . . . . 0.0 107.894 169.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.7 mt -95.96 124.97 40.2 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 106.487 -1.672 . . . . 0.0 106.487 169.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.2 t -131.07 146.49 33.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -169.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -131.41 146.49 52.29 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 169.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.2 mt -112.59 142.53 45.06 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 124.211 1.005 . . . . 0.0 109.437 -177.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 24.8 p90 -138.51 155.97 47.93 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 168.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -168.77 169.15 41.58 Favored Glycine 0 N--CA 1.447 -0.586 0 O-C-N 121.469 -0.769 . . . . 0.0 111.654 -176.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 56.5 m -136.27 156.01 49.28 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.242 1.017 . . . . 0.0 109.192 -171.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -170.89 -167.26 30.99 Favored Glycine 0 CA--C 1.526 0.777 0 O-C-N 123.256 0.348 . . . . 0.0 112.601 -173.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -138.56 141.69 39.25 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 126.509 1.924 . . . . 0.0 109.176 177.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -110.89 -11.8 14.32 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.981 1.312 . . . . 0.0 111.889 -177.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -84.95 -31.68 23.46 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 118.416 0.553 . . . . 0.0 111.245 -168.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -128.33 -39.34 1.7 Allowed 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.348 0.659 . . . . 0.0 111.714 173.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -83.15 32.97 0.44 Allowed 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 118.419 0.554 . . . . 0.0 112.149 -177.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.27 -27.68 69.21 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.654 1.182 . . . . 0.0 113.259 -172.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -79.43 -0.2 31.98 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.023 0.929 . . . . 0.0 111.602 176.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -140.91 16.56 2.3 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 125.481 1.512 . . . . 0.0 110.621 -172.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -65.43 115.05 5.28 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 119.561 1.073 . . . . 0.0 108.788 -169.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 75.9 m 53.47 34.3 17.97 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.567 1.547 . . . . 0.0 113.178 -174.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -51.01 -43.66 60.87 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.75 1.22 . . . . 0.0 111.741 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.53 -14.93 63.37 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -169.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 67.5 mt -58.09 -41.62 83.88 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 118.866 0.757 . . . . 0.0 110.055 169.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -65.38 -32.97 85.29 Favored Glycine 0 C--N 1.339 0.744 0 N-CA-C 111.245 -0.742 . . . . 0.0 111.245 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.3 m -65.37 -37.23 86.4 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 118.229 1.015 . . . . 0.0 110.704 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 5.0 mt -73.56 -44.87 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 118.952 0.796 . . . . 0.0 108.97 174.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 35.9 ttt180 -53.28 -44.14 68.01 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 119.297 0.953 . . . . 0.0 110.608 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -61.92 -16.14 48.59 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.691 1.196 . . . . 0.0 113.035 -178.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 86.8 mt -101.0 -58.35 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 124.252 1.021 . . . . 0.0 109.095 173.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 20.1 pt -68.75 -32.98 57.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 O-C-N 121.144 -0.972 . . . . 0.0 112.142 -167.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -67.99 -53.4 20.16 Favored Pre-proline 0 CA--C 1.541 0.627 0 CA-C-O 117.671 -1.157 . . . . 0.0 111.242 -176.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -68.45 -23.45 37.67 Favored 'Trans proline' 0 C--N 1.353 0.786 0 CA-C-N 121.708 1.646 . . . . 0.0 112.83 175.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 30.9 mmm180 -74.41 -0.56 17.73 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 119.343 0.974 . . . . 0.0 112.17 170.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 94.0 14.69 51.26 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-O 118.558 -1.134 . . . . 0.0 114.999 168.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.26 144.34 57.02 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 119.183 1.492 . . . . 0.0 109.411 170.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 47.0 m -93.59 119.52 32.72 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 104.163 -2.532 . . . . 0.0 104.163 167.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 21.4 mt -100.56 130.75 49.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 107.016 -1.475 . . . . 0.0 107.016 -176.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.7 m -133.05 -172.88 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 125.549 1.539 . . . . 0.0 107.948 169.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 70.57 21.3 77.66 Favored Glycine 0 CA--C 1.529 0.963 0 O-C-N 120.979 -1.075 . . . . 0.0 111.572 -171.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 21.3 p-80 -59.19 133.12 55.81 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 168.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 70.7 t-105 -115.73 130.04 24.67 Favored Pre-proline 0 C--O 1.237 0.401 0 C-N-CA 124.573 1.149 . . . . 0.0 108.827 -167.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -67.37 139.58 50.09 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 121.51 1.473 . . . . 0.0 111.034 -175.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 2.1 t . . . . . 0 CA--C 1.545 0.764 0 C-N-CA 123.763 0.825 . . . . 0.0 111.917 -174.879 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.538 0.484 0 CA-C-O 120.052 -0.023 . . . . 0.0 110.955 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -78.28 -1.65 81.55 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-O 118.215 -1.325 . . . . 0.0 114.024 169.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 59.8 mt -63.05 122.49 16.2 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 120.96 2.38 . . . . 0.0 108.21 170.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -97.92 -26.91 14.5 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.248 1.019 . . . . 0.0 110.352 177.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -144.62 160.03 41.83 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.819 2.047 . . . . 0.0 106.769 175.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -55.18 -25.94 35.73 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.931 0.892 . . . . 0.0 112.822 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -111.08 -0.65 16.53 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.471 1.108 . . . . 0.0 113.701 179.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 -141.39 133.55 27.86 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 120.206 1.366 . . . . 0.0 113.426 -175.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -77.7 152.76 33.55 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 166.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 12.5 p -58.92 -28.58 38.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 123.913 0.885 . . . . 0.0 111.323 174.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -155.51 170.53 33.49 Favored Glycine 0 C--N 1.338 0.673 0 C-N-CA 123.957 0.789 . . . . 0.0 111.418 -170.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -60.93 126.48 27.51 Favored 'General case' 0 C--N 1.334 -0.073 0 C-N-CA 124.314 1.046 . . . . 0.0 109.176 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.301 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 172.24 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 88.5 mt . . . . . 0 N--CA 1.471 0.61 0 N-CA-C 110.639 -0.134 . . . . 0.0 110.639 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 93.2 m -45.49 -53.74 8.46 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 125.892 1.677 . . . . 0.0 112.165 -169.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -68.45 -38.67 81.32 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 119.226 -0.416 . . . . 0.0 111.36 -169.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -73.74 -32.87 64.08 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 118.64 0.655 . . . . 0.0 110.805 178.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 51.9 mtp85 -67.17 -45.77 75.99 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-N 118.791 0.723 . . . . 0.0 109.603 178.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 23.7 m -71.5 -31.68 43.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-O 118.083 -0.96 . . . . 0.0 110.564 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -58.8 -56.83 17.15 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 120.378 1.445 . . . . 0.0 109.59 172.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -60.54 -34.39 74.06 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 122.992 0.517 . . . . 0.0 110.798 -175.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 33.1 t90 -77.86 -50.0 13.13 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 117.975 0.352 . . . . 0.0 110.796 -178.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 66.5 t -63.87 -32.41 56.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 O-C-N 120.782 -1.199 . . . . 0.0 110.151 -176.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -59.95 -35.91 75.95 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 117.981 -1.009 . . . . 0.0 111.566 175.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . 0.251 13.2 pt20 -75.71 -50.71 14.57 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 119.552 1.069 . . . . 0.0 111.012 171.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 1.4 pt -64.51 -32.07 56.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-N 120.096 1.316 . . . . 0.0 111.552 -169.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 6.3 p -61.43 -38.47 87.27 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 118.468 -0.777 . . . . 0.0 110.858 -178.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -82.7 -36.83 25.52 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 119.724 1.147 . . . . 0.0 111.38 175.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 63.1 mt-10 -70.59 -34.02 71.71 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 118.606 0.639 . . . . 0.0 111.749 -175.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 64.1 mt -86.71 1.23 52.8 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.008 1.323 . . . . 0.0 110.971 175.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 56.17 32.35 20.03 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.856 1.662 . . . . 0.0 112.984 -176.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 90.6 mt . . . . . 0 N--CA 1.465 0.304 0 C-N-CA 123.364 0.666 . . . . 0.0 109.584 173.428 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.359 0 N-CA-C 110.305 -0.257 . . . . 0.0 110.305 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.8 pt -82.71 -19.33 10.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -174.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.8 m -115.09 127.39 55.58 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.203 1.401 . . . . 0.0 108.416 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -102.63 117.4 5.78 Favored Glycine 0 CA--C 1.52 0.394 0 N-CA-C 107.914 -2.074 . . . . 0.0 107.914 170.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 64.9 mt -96.29 93.83 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 176.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -88.37 132.83 34.28 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 177.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -130.64 128.62 41.34 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 119.207 0.912 . . . . 0.0 112.167 179.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -93.53 142.85 16.18 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 107.54 -2.224 . . . . 0.0 107.54 166.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.4 t -156.14 175.18 14.31 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 119.279 1.539 . . . . 0.0 109.285 172.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -122.09 -54.78 1.9 Allowed 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.041 0.537 . . . . 0.0 110.226 169.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.1 p -94.9 -0.37 54.04 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.144 0.978 . . . . 0.0 112.597 175.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 90.15 15.36 57.63 Favored Glycine 0 C--N 1.343 0.949 0 CA-C-O 118.963 -0.91 . . . . 0.0 114.256 169.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -68.28 -39.9 82.01 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 119.787 1.794 . . . . 0.0 110.526 175.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.79 -29.52 68.27 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 119.131 0.878 . . . . 0.0 111.346 175.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -64.41 -40.34 95.58 Favored 'General case' 0 C--N 1.343 0.285 0 CA-C-N 118.819 0.736 . . . . 0.0 109.604 176.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -65.31 -41.95 93.53 Favored 'General case' 0 CA--C 1.529 0.146 0 O-C-N 121.976 -0.453 . . . . 0.0 110.335 178.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 48.1 mm -60.17 -48.6 87.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 174.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.48 -43.37 98.98 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.42 0.688 . . . . 0.0 111.538 -178.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 54.7 mttm -63.69 -44.03 94.87 Favored 'General case' 0 C--N 1.338 0.106 0 CA-C-O 118.331 -0.842 . . . . 0.0 110.386 178.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 69.6 mtm -59.39 -47.64 84.69 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-N 119.2 0.909 . . . . 0.0 109.76 177.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 62.6 mt -57.19 -46.76 84.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -62.71 -40.57 97.56 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 119.503 1.047 . . . . 0.0 111.024 -179.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -63.25 -38.34 90.76 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 119.424 1.011 . . . . 0.0 110.723 177.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -69.51 -39.44 77.55 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.187 0.595 . . . . 0.0 110.813 178.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.1 mp -79.0 -35.43 42.89 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.921 0.889 . . . . 0.0 111.655 -176.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 94.43 145.3 17.95 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 125.236 1.398 . . . . 0.0 110.903 -171.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.1 ptpt -65.32 -28.71 69.5 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -172.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -68.22 -29.52 68.37 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 122.863 0.465 . . . . 0.0 111.011 176.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 49.1 t -91.21 -37.44 9.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 C-N-CA 124.186 0.994 . . . . 0.0 110.161 -175.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -135.78 146.33 47.49 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-N 119.285 0.948 . . . . 0.0 113.222 -174.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -130.66 144.9 51.74 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.713 1.205 . . . . 0.0 109.295 171.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 80.1 t -98.14 140.49 17.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.442 0 C-N-CA 124.078 0.951 . . . . 0.0 109.051 -174.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -149.22 172.82 14.22 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.677 1.191 . . . . 0.0 111.255 -169.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -141.64 127.05 18.77 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 126.973 2.109 . . . . 0.0 107.117 -173.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.6 tp -58.91 -31.41 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-O 118.831 -0.604 . . . . 0.0 111.231 -172.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.61 -26.47 68.41 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 118.698 0.681 . . . . 0.0 111.488 -177.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -89.56 -15.35 33.06 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.48 1.112 . . . . 0.0 111.516 177.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 53.0 p -84.38 175.88 9.06 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 118.76 0.709 . . . . 0.0 111.597 -174.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.2 m -137.55 167.44 21.66 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.651 1.58 . . . . 0.0 108.361 176.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -51.41 -48.48 62.64 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.884 0.874 . . . . 0.0 111.794 -177.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -81.55 -11.69 59.07 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 122.707 0.403 . . . . 0.0 111.608 -175.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -77.56 -31.15 53.0 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 121.399 -0.813 . . . . 0.0 111.457 -172.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.6 mp -68.34 -36.7 79.65 Favored 'General case' 0 C--N 1.344 0.348 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 172.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -69.88 -14.05 62.55 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.656 0.782 . . . . 0.0 111.988 -173.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.1 -30.13 68.36 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.738 0.815 . . . . 0.0 111.709 175.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -82.81 152.17 25.78 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 123.92 0.888 . . . . 0.0 110.211 178.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -92.0 -41.6 10.45 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.208 169.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 21.7 mt -108.25 130.74 60.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 92.3 mt -113.84 130.28 56.49 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 171.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.2 mp -111.64 115.87 29.85 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 104.52 -2.4 . . . . 0.0 104.52 169.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 64.6 mt -116.27 110.48 18.8 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -171.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -93.74 125.89 8.42 Favored Glycine 0 CA--C 1.521 0.427 0 N-CA-C 109.18 -1.568 . . . . 0.0 109.18 176.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 16.5 tt -139.28 133.07 15.89 Favored Pre-proline 0 CA--C 1.537 0.48 0 CA-C-N 118.842 1.321 . . . . 0.0 111.346 -177.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -92.41 153.86 3.03 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 122.408 2.072 . . . . 0.0 110.327 176.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.7 m -108.95 126.5 53.16 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 171.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 61.9 m95 -130.57 170.9 13.65 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 125.368 1.467 . . . . 0.0 109.063 178.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 44.23 49.12 7.82 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.351 1.861 . . . . 0.0 114.279 168.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 55.08 65.02 1.61 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.379 1.071 . . . . 0.0 111.06 176.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.85 47.68 5.5 Favored Glycine 0 CA--C 1.532 1.124 0 CA-C-N 115.854 -0.612 . . . . 0.0 113.219 171.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -128.48 157.74 40.3 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.177 1.391 . . . . 0.0 108.544 168.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -90.88 175.38 7.0 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.507 0.723 . . . . 0.0 109.925 170.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -62.39 146.84 50.25 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 107.942 -1.132 . . . . 0.0 107.942 169.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 62.3 m -56.77 -41.27 77.34 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -168.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -71.01 -40.31 71.88 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.238 0.926 . . . . 0.0 110.691 -178.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -62.38 -43.86 97.83 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.328 0.651 . . . . 0.0 110.135 175.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -61.9 -42.2 98.81 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 123.513 0.725 . . . . 0.0 110.79 178.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -68.63 -18.77 64.36 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.907 0.883 . . . . 0.0 112.309 176.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 29.7 t80 -86.04 -18.76 31.61 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 121.604 -0.685 . . . . 0.0 112.343 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -54.09 -43.03 96.41 Favored Pre-proline 0 CA--C 1.543 0.706 0 CA-C-O 116.807 -1.568 . . . . 0.0 114.138 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -63.75 -21.93 69.59 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 CA-C-N 122.475 1.92 . . . . 0.0 113.554 174.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.9 m -79.47 -40.28 30.18 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 119.57 1.077 . . . . 0.0 109.357 170.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 14.5 tp -59.63 -38.65 81.91 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.18 0.992 . . . . 0.0 110.955 -174.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -76.79 -4.77 45.21 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.698 0.799 . . . . 0.0 112.981 178.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 48.3 mm-40 -98.13 -18.6 18.41 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.188 0.995 . . . . 0.0 110.535 171.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 77.5 mt -77.68 148.93 6.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 172.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -115.97 133.13 56.35 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -117.12 15.79 15.0 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.632 0.773 . . . . 0.0 111.688 -172.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 33.2 m-80 -56.36 119.28 5.75 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 120.049 1.295 . . . . 0.0 109.319 177.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 79.83 -2.84 72.42 Favored Glycine 0 CA--C 1.535 1.327 0 CA-C-O 118.493 -1.171 . . . . 0.0 114.573 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -78.06 143.73 37.17 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 119.995 1.897 . . . . 0.0 107.209 173.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 14.5 mt -92.55 135.82 33.74 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 171.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 16.8 t -133.61 134.64 56.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -124.49 146.6 48.87 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 171.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 69.0 mt -118.92 147.48 43.96 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -174.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -142.26 159.71 41.69 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 168.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -171.41 159.47 31.2 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 119.343 -1.408 . . . . 0.0 115.347 -174.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 6.9 m -107.67 142.45 37.61 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 113.405 -1.397 . . . . 0.0 108.798 -170.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -170.89 174.88 44.74 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -178.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -144.71 122.87 12.17 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.774 0.83 . . . . 0.0 110.203 177.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -78.76 71.27 5.21 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.111 1.364 . . . . 0.0 109.234 174.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -131.06 -112.32 0.25 Allowed 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 173.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -72.93 -22.66 60.69 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 119.379 0.991 . . . . 0.0 111.94 -174.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -82.98 34.06 0.45 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.107 1.763 . . . . 0.0 111.163 -177.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.39 -23.2 65.62 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 -167.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -97.91 -1.66 42.41 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 118.937 0.789 . . . . 0.0 112.142 177.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -126.39 16.29 7.69 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.306 1.442 . . . . 0.0 111.354 -169.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -63.89 125.34 24.09 Favored 'General case' 0 C--O 1.236 0.358 0 O-C-N 121.593 -0.692 . . . . 0.0 110.172 -170.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 71.1 m 48.12 32.63 3.09 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.655 1.982 . . . . 0.0 113.723 -178.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -54.75 -34.72 62.92 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.587 0.755 . . . . 0.0 112.755 -178.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -62.87 -24.99 68.07 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -174.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 69.9 mt -58.69 -45.26 89.87 Favored 'General case' 0 C--N 1.344 0.337 0 O-C-N 121.497 -0.752 . . . . 0.0 109.965 173.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -65.01 -32.7 85.07 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.7 m -64.99 -36.01 83.02 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.25 1.025 . . . . 0.0 110.72 178.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 17.8 mt -69.54 -52.85 28.44 Favored 'Isoleucine or valine' 0 C--N 1.347 0.476 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 171.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 50.5 ttt180 -51.01 -47.13 61.67 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.341 0.656 . . . . 0.0 111.16 -172.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -61.91 -16.03 47.61 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.649 1.18 . . . . 0.0 112.806 -175.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 97.9 mt -100.83 -55.82 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 C-N-CA 124.268 1.027 . . . . 0.0 109.28 173.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 48.2 pt -67.56 -34.45 68.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 119.946 1.248 . . . . 0.0 112.284 -167.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -67.65 -53.21 22.98 Favored Pre-proline 0 CA--C 1.546 0.794 0 CA-C-O 117.71 -1.138 . . . . 0.0 110.701 -175.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -68.93 -23.33 34.84 Favored 'Trans proline' 0 C--N 1.353 0.801 0 CA-C-N 121.652 1.626 . . . . 0.0 112.928 174.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 31.3 mmm180 -77.39 8.94 3.59 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 119.482 1.037 . . . . 0.0 112.274 171.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 94.73 3.33 62.52 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-O 118.194 -1.337 . . . . 0.0 116.218 167.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.1 142.87 56.36 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 119.622 1.711 . . . . 0.0 110.075 177.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 57.8 m -88.61 119.5 29.12 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 104.798 -2.297 . . . . 0.0 104.798 168.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 19.7 mm -95.19 132.86 38.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 -171.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 19.3 m -137.93 171.53 15.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 124.979 1.312 . . . . 0.0 109.039 176.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 79.51 23.21 63.1 Favored Glycine 0 CA--C 1.526 0.775 0 CA-C-O 119.048 -0.862 . . . . 0.0 113.367 175.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 28.3 p-80 -61.23 135.99 57.91 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 168.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 39.0 t-105 -122.84 135.29 25.63 Favored Pre-proline 0 CA--C 1.533 0.315 0 C-N-CA 124.759 1.224 . . . . 0.0 108.249 -169.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -66.85 139.6 52.49 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 121.83 1.687 . . . . 0.0 111.316 -174.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 65.0 p . . . . . 0 CA--C 1.535 0.389 0 C-N-CA 123.018 0.527 . . . . 0.0 111.16 -178.594 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 67.6 mttm . . . . . 0 N--CA 1.472 0.631 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -88.09 5.53 84.7 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 124.13 0.872 . . . . 0.0 112.419 168.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 96.1 mt -67.52 134.26 50.97 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 118.982 1.391 . . . . 0.0 110.253 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -96.21 -34.45 11.65 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 166.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -145.88 161.28 40.38 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 128.152 2.581 . . . . 0.0 105.81 168.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -58.67 -25.19 62.54 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 120.627 -1.295 . . . . 0.0 112.112 178.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -92.04 -9.6 42.18 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.201 1.0 . . . . 0.0 113.347 176.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 63.1 m80 -143.39 123.63 13.78 Favored 'General case' 0 C--N 1.346 0.426 0 CA-C-N 120.216 1.371 . . . . 0.0 112.398 -175.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -73.34 152.16 41.0 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 166.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 9.3 p -64.29 -21.71 29.61 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 O-C-N 121.811 -0.556 . . . . 0.0 111.228 175.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -155.66 175.14 33.6 Favored Glycine 0 C--N 1.339 0.705 0 C-N-CA 123.792 0.71 . . . . 0.0 111.776 -172.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -71.94 104.02 3.38 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.809 0.844 . . . . 0.0 109.12 -177.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.297 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 169.227 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 75.2 mt . . . . . 0 N--CA 1.468 0.447 0 N-CA-C 110.353 -0.24 . . . . 0.0 110.353 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 58.4 m -41.02 -54.44 2.78 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 127.516 2.326 . . . . 0.0 112.982 -169.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -76.8 -32.07 57.39 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -173.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -71.75 -38.84 70.33 Favored 'General case' 0 CA--C 1.529 0.157 0 O-C-N 121.913 -0.492 . . . . 0.0 109.939 178.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 74.1 mtp85 -66.49 -41.81 88.36 Favored 'General case' 0 N--CA 1.462 0.173 0 O-C-N 121.682 -0.637 . . . . 0.0 110.445 -178.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 34.4 m -70.39 -27.8 32.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 119.077 0.853 . . . . 0.0 111.195 177.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -65.49 -53.74 38.25 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 120.647 1.567 . . . . 0.0 109.583 172.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -61.63 -36.45 80.79 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 117.795 0.27 . . . . 0.0 110.888 -177.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 35.3 t90 -75.43 -46.64 31.46 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 118.178 0.445 . . . . 0.0 111.077 -178.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 42.5 t -59.89 -36.5 67.07 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.094 0 CA-C-N 118.581 0.628 . . . . 0.0 110.084 177.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -64.08 -40.84 97.14 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 117.937 -1.03 . . . . 0.0 110.654 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -69.27 -48.03 62.88 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 119.556 1.071 . . . . 0.0 110.659 175.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 7.5 pt -66.8 -29.82 47.64 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.333 0 CA-C-N 119.705 1.139 . . . . 0.0 110.759 -173.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 51.1 m -61.81 -29.29 70.06 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 117.877 -1.058 . . . . 0.0 112.459 176.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -92.16 -24.16 19.17 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 120.52 1.509 . . . . 0.0 111.641 175.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -73.02 -36.29 66.94 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 118.674 0.67 . . . . 0.0 110.794 174.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 66.1 mt -93.45 -9.16 39.48 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.349 1.86 . . . . 0.0 111.794 -179.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 39.2 m80 56.25 29.94 15.76 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.615 1.566 . . . . 0.0 112.911 -169.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 73.3 mt . . . . . 0 N--CA 1.468 0.427 0 O-C-N 121.457 -0.777 . . . . 0.0 110.909 169.874 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.399 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 31.0 pt -85.78 -22.69 7.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 123.393 0.677 . . . . 0.0 111.444 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 26.3 m -114.63 134.73 54.84 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.738 1.615 . . . . 0.0 109.09 -177.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -107.19 122.32 6.85 Favored Glycine 0 CA--C 1.52 0.401 0 N-CA-C 107.442 -2.263 . . . . 0.0 107.442 168.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 54.4 mt -100.62 91.69 2.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.14 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 176.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -88.16 130.33 35.08 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 -179.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 16.1 p90 -130.74 132.07 45.12 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 119.435 1.016 . . . . 0.0 112.338 179.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -86.54 149.76 22.87 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 168.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.8 m -167.9 157.78 10.17 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.936 1.368 . . . . 0.0 110.643 173.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -121.68 -52.89 2.0 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.953 0.901 . . . . 0.0 109.948 168.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.0 p -88.53 7.72 31.71 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.551 1.14 . . . . 0.0 112.733 174.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 84.92 -4.73 84.73 Favored Glycine 0 CA--C 1.533 1.174 0 N-CA-C 116.621 1.408 . . . . 0.0 116.621 168.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.88 -35.47 78.42 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 120.243 2.022 . . . . 0.0 113.696 -169.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 12.8 m -70.82 -17.29 62.76 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 119.524 1.056 . . . . 0.0 110.665 -175.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -60.19 -41.87 93.83 Favored 'General case' 0 C--N 1.342 0.278 0 O-C-N 121.118 -0.989 . . . . 0.0 110.338 175.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -64.42 -39.0 92.98 Favored 'General case' 0 C--N 1.339 0.127 0 O-C-N 122.072 -0.393 . . . . 0.0 110.306 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.0 mm -64.37 -46.37 93.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.72 -42.45 98.97 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.296 0.639 . . . . 0.0 111.531 178.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 54.8 mttm -64.57 -43.39 94.03 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 118.88 -0.581 . . . . 0.0 110.858 178.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 72.6 mtm -62.5 -39.64 94.15 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 119.169 0.895 . . . . 0.0 110.733 178.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 62.9 mt -60.11 -48.49 87.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 175.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -59.21 -39.61 83.2 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.803 0.729 . . . . 0.0 111.058 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -68.11 -36.43 79.75 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 119.432 1.014 . . . . 0.0 111.026 178.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 19.4 mm100 -65.78 -49.6 67.73 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.574 0.625 . . . . 0.0 111.529 -178.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.97 -8.22 34.34 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -175.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.42 143.3 12.22 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 125.119 1.342 . . . . 0.0 112.122 175.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.2 pttp -70.09 -23.64 63.09 Favored 'General case' 0 N--CA 1.469 0.489 0 O-C-N 121.584 -0.95 . . . . 0.0 113.082 -178.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -60.37 -34.74 74.3 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 122.985 0.514 . . . . 0.0 110.763 171.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 62.1 t -83.69 -42.48 17.42 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-O 118.001 -0.999 . . . . 0.0 110.136 178.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -132.77 147.08 52.31 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-N 119.838 1.199 . . . . 0.0 114.182 -170.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -120.97 140.87 51.29 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 123.831 0.852 . . . . 0.0 109.696 169.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 94.6 t -85.97 139.26 17.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -147.01 170.65 16.67 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.29 1.036 . . . . 0.0 111.881 -168.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -145.65 125.19 13.2 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 125.79 1.636 . . . . 0.0 108.641 -170.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.4 tp -63.08 -29.14 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-O 118.967 -0.54 . . . . 0.0 111.747 -171.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.03 -28.44 69.49 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 118.945 0.793 . . . . 0.0 111.692 -176.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -101.27 -7.21 23.24 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.674 0.79 . . . . 0.0 112.299 175.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 42.5 m -75.43 171.48 14.18 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 123.649 0.78 . . . . 0.0 110.547 177.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 14.1 m -139.26 160.53 39.6 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.819 1.248 . . . . 0.0 108.875 178.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -53.79 -46.85 71.15 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.073 0.949 . . . . 0.0 111.455 -174.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -80.92 -15.26 56.77 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 122.571 0.349 . . . . 0.0 111.551 -176.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -77.95 -29.71 50.02 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 121.439 -0.788 . . . . 0.0 111.213 -175.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -59.41 -41.5 89.6 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.111 0.564 . . . . 0.0 109.709 169.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -72.96 -13.17 61.19 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.637 0.775 . . . . 0.0 112.315 -170.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.71 -30.56 70.1 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.446 0.698 . . . . 0.0 111.91 176.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -82.37 155.96 24.45 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.99 0.916 . . . . 0.0 110.284 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -104.49 -24.3 13.04 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.821 169.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.3 mp -118.37 127.93 75.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 176.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -114.63 119.71 37.66 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 175.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.9 mp -105.98 117.95 35.34 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 105.282 -2.118 . . . . 0.0 105.282 169.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 66.9 mt -119.99 108.38 14.23 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 -169.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.81 120.32 6.52 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 125.679 1.609 . . . . 0.0 109.708 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.0 tt -134.24 112.29 12.07 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 118.104 0.952 . . . . 0.0 110.466 -176.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -74.83 143.69 29.98 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.391 2.061 . . . . 0.0 109.202 169.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 30.3 m -96.41 136.65 36.62 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 174.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 63.7 m95 -134.45 171.91 13.64 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 124.754 1.222 . . . . 0.0 109.992 -178.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 42.7 46.42 4.38 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 127.016 2.127 . . . . 0.0 114.285 167.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 57.46 69.43 0.74 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.509 1.124 . . . . 0.0 111.323 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.52 33.33 22.6 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 115.629 -0.714 . . . . 0.0 113.94 169.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -119.53 164.5 15.72 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 125.399 1.48 . . . . 0.0 109.632 175.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -96.53 170.88 8.91 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 123.983 0.913 . . . . 0.0 108.791 168.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 47.1 mm-40 -70.02 148.85 48.34 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 169.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 58.6 m -59.47 -35.18 73.59 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -168.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -72.29 -29.14 63.6 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.249 0.619 . . . . 0.0 111.469 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -78.84 -44.92 21.92 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.963 0.905 . . . . 0.0 109.349 175.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -60.42 -41.35 93.77 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.33 1.052 . . . . 0.0 111.228 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -62.66 -21.77 65.96 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.087 0.955 . . . . 0.0 112.269 178.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -85.01 -18.93 32.91 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 117.875 -1.06 . . . . 0.0 112.227 178.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -55.65 -42.75 97.65 Favored Pre-proline 0 CA--C 1.541 0.615 0 CA-C-N 121.243 1.838 . . . . 0.0 114.116 -179.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.28 -14.28 44.24 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 CA-C-N 122.603 1.965 . . . . 0.0 113.714 174.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.1 m -88.72 -42.62 11.84 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 119.195 0.907 . . . . 0.0 109.227 169.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 18.3 tp -56.62 -38.22 71.79 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 124.998 1.319 . . . . 0.0 110.841 -177.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -71.78 -1.18 13.13 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -105.97 -11.95 15.99 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.497 1.044 . . . . 0.0 111.872 172.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 98.5 mt -81.63 140.97 15.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -175.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -87.44 133.63 33.72 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 123.464 0.706 . . . . 0.0 110.133 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -126.57 15.03 7.62 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.962 0.905 . . . . 0.0 111.612 174.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 17.0 m-80 -58.73 116.12 3.51 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 119.987 1.267 . . . . 0.0 109.886 -174.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.78 1.19 58.21 Favored Glycine 0 CA--C 1.533 1.175 0 CA-C-O 118.567 -1.13 . . . . 0.0 113.803 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -74.86 147.61 40.94 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 119.628 1.714 . . . . 0.0 107.835 172.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 14.9 mt -88.77 136.04 33.21 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 174.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.2 t -132.44 139.97 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -136.71 141.56 43.08 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 175.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 62.1 mt -112.62 148.16 35.17 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -173.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -144.42 168.15 20.8 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 169.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -179.53 176.09 47.42 Favored Glycine 0 N--CA 1.447 -0.577 0 CA-C-O 122.174 0.875 . . . . 0.0 113.0 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 24.4 m -129.53 152.58 48.91 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 125.727 1.611 . . . . 0.0 107.737 -171.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -169.8 -173.79 37.55 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -177.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -147.56 166.89 25.95 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 168.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -111.47 -6.39 14.45 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.725 1.61 . . . . 0.0 111.996 -171.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -59.45 -48.25 82.35 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 123.626 0.77 . . . . 0.0 111.787 -169.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -138.18 1.99 2.27 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -173.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -111.38 27.83 9.31 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.39 1.076 . . . . 0.0 111.396 -169.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.13 -17.38 64.67 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 -169.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -94.64 -0.61 54.29 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.62 1.168 . . . . 0.0 111.995 174.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -139.08 22.61 2.6 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 125.762 1.625 . . . . 0.0 110.283 -170.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -70.76 121.03 17.24 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -169.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 74.0 m 48.3 38.92 11.22 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.617 1.167 . . . . 0.0 111.679 -177.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -61.95 -38.81 89.89 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.466 1.106 . . . . 0.0 112.061 -172.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.15 -21.34 66.33 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 114.136 1.162 . . . . 0.0 114.136 -168.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 7.1 mp -61.28 -35.22 76.72 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 119.766 1.166 . . . . 0.0 110.22 175.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.37 -33.48 86.35 Favored Glycine 0 CA--C 1.531 1.039 0 N-CA-C 111.318 -0.713 . . . . 0.0 111.318 177.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.2 m -65.05 -37.3 87.13 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 117.774 0.787 . . . . 0.0 110.361 177.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 6.0 mt -70.31 -49.15 56.34 Favored 'Isoleucine or valine' 0 C--N 1.343 0.319 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 173.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 55.8 ttt-85 -51.31 -47.21 62.68 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 118.617 0.644 . . . . 0.0 110.563 -176.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -63.23 -22.92 67.18 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.114 0.966 . . . . 0.0 112.914 -175.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 96.9 mt -91.63 -44.6 14.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 123.666 0.786 . . . . 0.0 109.379 177.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 22.4 pt -74.78 -29.43 22.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-N 118.999 0.818 . . . . 0.0 111.617 -171.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -62.03 -56.22 33.63 Favored Pre-proline 0 CA--C 1.543 0.685 0 CA-C-O 117.74 -1.124 . . . . 0.0 112.063 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -66.16 -21.79 54.96 Favored 'Trans proline' 0 C--N 1.351 0.701 0 CA-C-N 121.769 1.668 . . . . 0.0 112.612 178.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 73.0 mmt-85 -82.07 9.46 8.44 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.99 0.916 . . . . 0.0 112.841 172.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 77.51 16.16 80.62 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-O 118.367 -1.24 . . . . 0.0 114.877 168.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -59.63 144.66 47.14 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 119.036 1.418 . . . . 0.0 110.355 170.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 44.6 m -95.29 119.94 34.66 Favored 'General case' 0 C--N 1.333 -0.123 0 N-CA-C 104.663 -2.347 . . . . 0.0 104.663 167.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 15.8 mt -100.86 127.54 53.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 -171.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 31.8 m -137.44 178.23 4.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 124.983 1.313 . . . . 0.0 109.285 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 78.83 36.51 28.56 Favored Glycine 0 CA--C 1.527 0.835 0 O-C-N 121.912 -0.493 . . . . 0.0 111.976 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 68.3 m80 -63.22 142.6 58.33 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 117.615 0.707 . . . . 0.0 109.153 172.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 75.2 t-105 -123.58 129.49 24.83 Favored Pre-proline 0 CA--C 1.534 0.357 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 -174.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -67.74 144.23 64.76 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 121.437 1.425 . . . . 0.0 112.129 -170.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 71.6 p . . . . . 0 CA--C 1.537 0.454 0 C-N-CA 123.614 0.766 . . . . 0.0 111.136 177.923 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.837 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -74.63 -0.56 59.16 Favored Glycine 0 CA--C 1.535 1.319 0 CA-C-O 118.637 -1.091 . . . . 0.0 113.412 169.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 43.7 mt -63.41 131.49 48.4 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 120.583 2.192 . . . . 0.0 109.503 174.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -100.77 -32.79 10.53 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.176 0.99 . . . . 0.0 109.323 169.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -149.49 161.78 41.44 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 127.313 2.245 . . . . 0.0 107.103 174.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -53.06 -31.78 43.4 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.328 0.651 . . . . 0.0 112.389 176.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -93.38 -11.33 32.52 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.284 1.034 . . . . 0.0 113.335 -178.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 10.9 m-70 -146.92 128.98 15.54 Favored 'General case' 0 C--N 1.346 0.431 0 CA-C-N 119.76 1.163 . . . . 0.0 113.729 -170.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -77.49 155.57 31.59 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 166.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.4 p -66.12 -22.86 30.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 C-N-CA 123.972 0.909 . . . . 0.0 111.642 178.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -158.93 169.99 35.29 Favored Glycine 0 C--N 1.338 0.659 0 CA-C-N 118.471 0.578 . . . . 0.0 112.314 -169.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -69.35 111.97 5.6 Favored 'General case' 0 CA--C 1.521 -0.144 0 C-N-CA 124.452 1.101 . . . . 0.0 109.496 -175.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.332 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 169.606 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 20.7 mt . . . . . 0 CA--C 1.541 0.623 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 38.8 m -46.31 -53.08 11.46 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 127.163 2.185 . . . . 0.0 112.913 -167.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -82.07 -40.54 21.83 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 119.395 -0.336 . . . . 0.0 111.038 -174.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -67.65 -28.15 67.47 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.026 0.83 . . . . 0.0 111.856 -173.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 59.6 mtp85 -62.77 -45.46 92.58 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 118.718 0.69 . . . . 0.0 110.021 175.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 17.3 m -74.34 -31.03 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-O 117.706 -1.14 . . . . 0.0 111.274 177.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -58.33 -52.07 67.14 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 120.99 1.723 . . . . 0.0 109.406 173.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -62.49 -37.79 87.37 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 122.724 0.41 . . . . 0.0 110.654 -179.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 59.2 t90 -74.91 -44.49 48.4 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 118.278 0.49 . . . . 0.0 111.644 -175.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 77.8 t -64.22 -34.0 66.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -61.25 -35.85 78.4 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 121.261 -0.899 . . . . 0.0 111.4 175.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -63.44 -55.99 19.8 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 119.177 0.899 . . . . 0.0 110.294 175.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 9.8 pt -67.08 -28.59 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 O-C-N 122.12 -0.363 . . . . 0.0 110.351 -173.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 64.2 m -60.77 -23.74 65.23 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 118.377 -0.821 . . . . 0.0 112.489 177.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -82.96 -31.9 27.37 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 119.927 1.24 . . . . 0.0 111.055 175.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -80.07 -38.31 32.03 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.713 0.805 . . . . 0.0 110.621 -178.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 5.4 mp -88.9 -3.7 58.67 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.448 1.899 . . . . 0.0 110.886 -179.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 55.63 32.85 20.06 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.847 1.659 . . . . 0.0 112.689 -174.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 47.1 mt . . . . . 0 N--CA 1.467 0.389 0 O-C-N 121.787 -0.57 . . . . 0.0 110.519 172.308 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.268 0 CA-C-O 120.722 0.296 . . . . 0.0 111.282 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 32.4 pt -109.94 -20.53 6.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 125.189 1.396 . . . . 0.0 111.239 178.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 44.5 m -105.85 128.16 53.58 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.736 1.214 . . . . 0.0 108.146 174.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -99.82 116.19 5.51 Favored Glycine 0 CA--C 1.519 0.313 0 N-CA-C 107.198 -2.361 . . . . 0.0 107.198 169.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 46.6 mt -90.63 122.59 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 104.135 -2.543 . . . . 0.0 104.135 171.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -118.19 132.8 56.3 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 174.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -132.9 158.42 42.63 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 118.345 0.521 . . . . 0.0 111.187 -174.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -132.73 154.36 21.08 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 108.091 -2.003 . . . . 0.0 108.091 167.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 16.3 m -163.7 163.51 24.17 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 119.212 1.506 . . . . 0.0 109.491 -175.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -137.98 -52.53 0.62 Allowed 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.667 0.787 . . . . 0.0 110.379 171.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.9 p -77.52 -14.73 59.6 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.237 0.615 . . . . 0.0 111.753 170.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 104.98 8.21 36.93 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.014 1.292 . . . . 0.0 113.961 169.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -66.55 -54.29 25.26 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 119.02 1.41 . . . . 0.0 111.927 -173.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.3 m -75.78 -18.38 59.55 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 122.027 -0.421 . . . . 0.0 111.515 -166.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -59.72 -46.78 88.08 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 167.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 33.2 t30 -68.3 -39.67 81.98 Favored 'General case' 0 C--N 1.339 0.122 0 O-C-N 121.864 -0.523 . . . . 0.0 110.305 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 49.8 mm -59.48 -45.16 94.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 118.738 0.699 . . . . 0.0 109.265 175.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.73 -40.61 95.69 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.753 0.706 . . . . 0.0 111.174 178.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -64.18 -42.49 96.67 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-O 118.823 -0.608 . . . . 0.0 110.826 176.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 98.8 mtp -63.82 -44.37 93.43 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 119.35 0.977 . . . . 0.0 110.464 177.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 69.9 mt -57.26 -47.57 84.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 176.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.403 ' NE2' ' HA ' ' A' ' 32' ' ' ASP . 27.3 tt0 -58.29 -42.97 87.78 Favored 'General case' 0 CA--C 1.53 0.2 0 O-C-N 121.467 -0.771 . . . . 0.0 111.157 176.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -64.0 -35.93 82.32 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 119.416 1.007 . . . . 0.0 110.683 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -69.21 -45.52 69.67 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.286 0.635 . . . . 0.0 110.936 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -79.88 -30.09 40.12 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.031 0.832 . . . . 0.0 112.101 -178.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.73 145.26 16.13 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 125.008 1.29 . . . . 0.0 110.699 -170.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.9 tttm -65.04 -31.01 72.02 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 121.889 -0.771 . . . . 0.0 111.799 -170.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -77.6 -7.06 55.8 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.063 0.545 . . . . 0.0 112.069 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 49.0 t -104.67 -43.21 7.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 124.254 1.022 . . . . 0.0 109.258 174.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -134.46 134.11 41.18 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 119.478 1.036 . . . . 0.0 111.491 -175.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.403 ' HA ' ' NE2' ' A' ' 23' ' ' GLN . 15.5 t70 -123.94 148.55 46.8 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 175.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 59.5 t -106.42 140.07 25.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 124.477 1.111 . . . . 0.0 111.158 -168.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -139.64 144.18 37.55 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.811 1.644 . . . . 0.0 109.847 177.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -83.92 126.25 32.82 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 169.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 11.0 tp -58.54 -31.23 43.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -171.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.72 -29.83 67.31 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.985 0.811 . . . . 0.0 112.024 -177.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 47.4 mtmt -76.54 -33.3 58.56 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 118.206 0.457 . . . . 0.0 110.835 177.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 57.7 m -70.77 165.01 23.98 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.678 1.191 . . . . 0.0 112.248 -174.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.5 m -133.04 174.59 10.2 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.225 1.81 . . . . 0.0 109.146 -176.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -49.05 -54.26 16.7 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.288 1.035 . . . . 0.0 111.655 -173.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -76.27 -11.83 59.98 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 122.473 0.309 . . . . 0.0 111.758 -170.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -71.22 -33.85 70.29 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 121.882 -0.512 . . . . 0.0 110.766 -174.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 8.4 mp -74.3 -38.75 63.26 Favored 'General case' 0 C--N 1.342 0.279 0 C-N-CA 122.594 0.358 . . . . 0.0 110.109 171.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -67.06 -18.14 65.21 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 122.898 0.479 . . . . 0.0 112.126 -169.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.92 -28.98 69.91 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.482 1.113 . . . . 0.0 112.527 173.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -96.16 156.94 16.12 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.147 0.979 . . . . 0.0 111.048 -175.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -99.5 -29.39 12.75 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.31 0.644 . . . . 0.0 111.514 170.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.0 mp -110.76 127.69 67.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 174.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -115.52 135.16 54.37 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 174.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.5 mp -118.74 114.13 22.23 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 172.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 51.6 mt -112.47 112.4 23.92 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 -169.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -102.58 103.4 2.43 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 125.404 1.478 . . . . 0.0 111.075 -173.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 14.6 tt -127.72 119.39 21.42 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 124.123 0.969 . . . . 0.0 111.077 -169.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -76.29 150.31 32.62 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 121.909 1.739 . . . . 0.0 110.501 170.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 19.1 m -98.3 140.78 32.07 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 169.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 42.4 m95 -136.2 174.38 10.67 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.718 1.607 . . . . 0.0 109.479 -178.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 21.52 82.27 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 128.476 2.71 . . . . 0.0 114.702 169.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 57.49 49.52 12.69 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.937 0.895 . . . . 0.0 111.927 172.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 81.03 19.0 68.27 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 123.743 0.687 . . . . 0.0 113.541 170.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -88.48 156.13 19.28 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 124.316 1.046 . . . . 0.0 110.162 178.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.97 144.5 34.69 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 169.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -59.93 149.28 32.24 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 169.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 75.4 m -61.04 -25.84 67.21 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -168.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 39.4 p30 -68.45 -36.39 78.93 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.474 0.71 . . . . 0.0 111.848 178.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -80.36 -41.43 24.72 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 118.695 0.68 . . . . 0.0 111.091 171.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -60.98 -39.34 89.25 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.505 0.593 . . . . 0.0 111.533 -176.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -67.4 -20.82 65.59 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.358 0.663 . . . . 0.0 112.168 175.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -94.43 -20.9 19.29 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.043 0.937 . . . . 0.0 111.825 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 21.6 m-30 -52.49 -40.32 74.48 Favored Pre-proline 0 CA--C 1.545 0.758 0 CA-C-O 116.67 -1.633 . . . . 0.0 114.544 178.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -64.41 -23.83 64.78 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 CA-C-N 123.103 2.144 . . . . 0.0 113.036 174.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.6 m -79.79 -38.34 33.28 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 119.239 0.927 . . . . 0.0 109.168 170.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 19.4 tp -60.64 -33.32 72.62 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.016 -1.052 . . . . 0.0 111.84 -174.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -81.97 -4.3 56.37 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.65 0.78 . . . . 0.0 112.863 176.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -96.15 -28.33 14.62 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 119.112 0.869 . . . . 0.0 109.947 170.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 88.7 mt -64.26 136.22 26.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 176.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -86.67 130.89 34.31 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 123.421 0.688 . . . . 0.0 109.548 172.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -118.03 6.7 12.13 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.17 0.988 . . . . 0.0 112.005 176.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 21.9 m-80 -56.55 115.49 2.55 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 120.463 1.483 . . . . 0.0 110.478 -173.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.71 0.37 63.55 Favored Glycine 0 CA--C 1.535 1.321 0 CA-C-O 118.548 -1.14 . . . . 0.0 114.285 178.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -75.24 147.5 40.26 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 119.679 1.739 . . . . 0.0 108.202 174.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 69.3 mt -91.24 135.86 33.5 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 175.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.8 t -135.27 130.43 51.08 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -116.3 150.23 37.97 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 169.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 79.7 mt -117.55 150.71 38.53 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 -178.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -149.03 162.07 40.66 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 170.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 171.91 150.03 6.96 Favored Glycine 0 N--CA 1.448 -0.51 0 CA-C-O 121.88 0.711 . . . . 0.0 112.789 174.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 4.5 p -78.01 164.18 25.29 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 121.321 0.581 . . . . 0.0 109.837 169.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -160.58 -162.51 12.57 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 173.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -145.63 122.58 11.34 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 127.08 2.152 . . . . 0.0 105.473 177.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -110.51 1.95 18.51 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.228 1.411 . . . . 0.0 111.474 -173.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -108.8 -45.12 3.88 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.369 1.068 . . . . 0.0 110.827 -168.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -104.3 -35.45 7.97 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.804 1.242 . . . . 0.0 109.975 178.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -98.19 40.46 1.18 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.376 1.071 . . . . 0.0 110.279 169.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.03 -21.78 65.17 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.174 1.39 . . . . 0.0 113.787 -173.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -95.96 5.95 50.01 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.986 0.914 . . . . 0.0 111.691 177.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -138.56 18.7 2.71 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.983 1.313 . . . . 0.0 110.907 -172.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 30.8 t80 -64.93 132.5 49.49 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -173.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . 0.282 28.6 p 54.95 24.41 5.86 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.675 1.99 . . . . 0.0 114.454 171.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -61.56 -32.49 72.57 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.146 1.378 . . . . 0.0 111.867 -174.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.24 -32.57 71.88 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 120.903 -1.123 . . . . 0.0 111.427 -178.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 7.0 mp -63.82 -43.88 94.91 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 119.658 1.117 . . . . 0.0 108.849 173.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -60.51 -34.77 87.04 Favored Glycine 0 CA--C 1.533 1.185 0 N-CA-C 111.436 -0.666 . . . . 0.0 111.436 174.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 17.0 m -65.02 -37.38 87.44 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 121.716 -0.873 . . . . 0.0 110.6 176.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 5.1 mt -67.32 -47.45 81.14 Favored 'Isoleucine or valine' 0 C--N 1.345 0.382 0 CA-C-O 117.643 -1.17 . . . . 0.0 108.967 173.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -56.92 -38.22 72.57 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 120.38 1.445 . . . . 0.0 110.928 -174.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -60.69 -25.08 66.12 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.206 1.002 . . . . 0.0 112.457 178.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 75.8 mt -94.02 -49.36 12.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 124.419 1.087 . . . . 0.0 110.041 177.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 36.5 pt -75.58 -28.37 19.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-N 120.002 1.274 . . . . 0.0 111.9 -168.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -63.13 -53.95 50.0 Favored Pre-proline 0 CA--C 1.542 0.663 0 CA-C-O 117.447 -1.263 . . . . 0.0 111.836 178.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -68.08 -20.87 43.62 Favored 'Trans proline' 0 C--N 1.351 0.707 0 CA-C-N 122.064 1.773 . . . . 0.0 112.719 176.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 31.4 mmm180 -78.58 1.98 20.8 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 119.163 0.892 . . . . 0.0 112.144 170.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 93.26 10.43 59.53 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 125.048 1.309 . . . . 0.0 115.204 168.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.94 146.79 45.55 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 119.205 1.502 . . . . 0.0 110.757 174.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 86.1 m -101.93 124.16 47.08 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 105.206 -2.146 . . . . 0.0 105.206 167.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 19.4 mm -90.76 133.28 33.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 -171.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 18.7 m -131.76 168.51 23.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.395 0 C-N-CA 125.99 1.716 . . . . 0.0 108.81 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 70.07 39.66 73.25 Favored Glycine 0 CA--C 1.527 0.792 0 O-C-N 121.691 -0.631 . . . . 0.0 113.05 177.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -64.55 134.83 55.2 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 171.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 57.6 t-105 -114.76 127.26 26.99 Favored Pre-proline 0 CA--C 1.535 0.398 0 C-N-CA 124.752 1.221 . . . . 0.0 108.494 -169.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -61.98 141.93 90.98 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 CA-C-N 121.02 1.4 . . . . 0.0 112.831 -173.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 56.7 p . . . . . 0 CA--C 1.534 0.335 0 C-N-CA 123.037 0.535 . . . . 0.0 110.991 174.409 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.47 0.535 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -79.6 7.88 51.63 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-O 119.184 -0.787 . . . . 0.0 113.113 169.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 97.5 mt -64.75 138.56 58.46 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 120.178 1.989 . . . . 0.0 109.942 174.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -106.21 -31.04 8.84 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.982 1.313 . . . . 0.0 108.925 167.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -149.16 162.98 38.89 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 127.466 2.306 . . . . 0.0 106.929 171.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -54.68 -30.84 56.71 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 121.371 -0.831 . . . . 0.0 112.162 176.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -91.98 -9.77 41.74 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.322 1.049 . . . . 0.0 113.325 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 11.9 m-70 -146.71 126.34 13.35 Favored 'General case' 0 C--N 1.346 0.415 0 CA-C-N 119.569 1.077 . . . . 0.0 113.376 -170.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -75.3 153.38 37.95 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 166.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 8.9 p -65.86 -18.88 24.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 124.288 1.035 . . . . 0.0 112.395 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -166.68 179.86 40.3 Favored Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -173.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -71.07 87.86 0.77 Allowed 'General case' 0 CA--C 1.522 -0.101 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 -178.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.475 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 169.319 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 23.7 mt . . . . . 0 N--CA 1.474 0.731 0 CA-C-O 121.474 0.654 . . . . 0.0 110.973 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 75.0 m -56.77 -51.46 68.82 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.37 1.468 . . . . 0.0 111.563 -169.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.32 -41.22 89.96 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -167.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -70.46 -35.03 73.09 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 118.219 0.463 . . . . 0.0 110.732 177.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 58.9 mtt180 -69.21 -43.86 73.28 Favored 'General case' 0 C--O 1.233 0.208 0 O-C-N 121.555 -0.716 . . . . 0.0 110.493 -178.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 26.6 m -70.42 -29.05 37.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 119.3 0.955 . . . . 0.0 110.544 177.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -64.21 -53.9 41.9 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 120.4 1.455 . . . . 0.0 109.755 171.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -58.2 -36.79 73.64 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 118.863 -0.589 . . . . 0.0 110.641 -178.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 46.1 t90 -77.14 -50.1 13.76 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 118.469 0.577 . . . . 0.0 111.426 -177.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 45.8 t -62.02 -33.58 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 O-C-N 121.458 -0.776 . . . . 0.0 109.992 -177.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -60.16 -38.32 82.79 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-O 118.343 -0.837 . . . . 0.0 111.17 177.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -59.07 -55.01 40.62 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 118.954 0.797 . . . . 0.0 109.802 176.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 19.0 pt -68.53 -29.74 45.0 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.235 0 O-C-N 122.133 -0.354 . . . . 0.0 110.248 -174.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 35.6 m -65.34 -25.41 67.59 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 118.705 -0.664 . . . . 0.0 111.74 175.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -86.03 -39.1 17.18 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 119.547 1.067 . . . . 0.0 110.253 174.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -64.51 -40.09 94.98 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 122.933 0.493 . . . . 0.0 110.92 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.7 mp -100.02 2.33 43.31 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.686 1.594 . . . . 0.0 111.005 -175.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . 0.291 31.7 p80 50.94 26.71 2.81 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 127.022 2.129 . . . . 0.0 113.948 -174.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 55.9 mt . . . . . 0 C--N 1.344 0.33 0 O-C-N 121.505 -0.747 . . . . 0.0 110.275 172.851 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.389 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 27.4 pt -83.5 -23.02 8.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 -178.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.1 m -112.2 127.37 55.93 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.955 1.302 . . . . 0.0 108.391 -178.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -101.67 118.96 6.31 Favored Glycine 0 CA--C 1.519 0.331 0 N-CA-C 107.846 -2.101 . . . . 0.0 107.846 169.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 44.7 mt -95.05 118.3 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 104.37 -2.456 . . . . 0.0 104.37 171.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -114.32 127.1 55.7 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 177.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -127.81 125.06 39.1 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 118.702 0.683 . . . . 0.0 112.017 -175.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -82.12 145.43 24.45 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 168.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.4 m -159.91 161.47 34.31 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 119.083 1.442 . . . . 0.0 109.844 175.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -138.74 -48.05 0.51 Allowed 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.037 0.935 . . . . 0.0 109.817 168.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.2 p -79.29 -13.52 59.6 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.486 0.714 . . . . 0.0 111.689 169.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.03 6.53 53.84 Favored Glycine 0 C--N 1.343 0.965 0 C-N-CA 124.767 1.175 . . . . 0.0 113.813 170.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -70.16 -38.4 75.43 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 118.769 1.284 . . . . 0.0 112.553 -169.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -69.83 -17.77 63.41 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 119.548 1.067 . . . . 0.0 111.383 -174.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -60.14 -41.21 92.22 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.185 0.902 . . . . 0.0 110.179 175.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -65.96 -39.89 90.81 Favored 'General case' 0 N--CA 1.463 0.195 0 O-C-N 121.924 -0.485 . . . . 0.0 110.106 178.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 27.2 mm -60.61 -49.05 85.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 176.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.16 -41.18 92.26 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.386 0.674 . . . . 0.0 111.702 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.9 mttm -67.11 -40.25 86.84 Favored 'General case' 0 N--CA 1.461 0.119 0 O-C-N 121.661 -0.65 . . . . 0.0 111.113 177.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 70.2 mtm -66.37 -31.95 73.04 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 119.504 1.047 . . . . 0.0 111.447 177.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.407 HG21 HD23 ' A' ' 51' ' ' LEU . 76.7 mt -65.81 -54.6 25.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 171.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -62.1 -37.03 83.54 Favored 'General case' 0 C--O 1.224 -0.251 0 CA-C-O 118.952 -0.546 . . . . 0.0 111.366 -173.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -63.68 -36.06 82.6 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 119.325 0.966 . . . . 0.0 110.91 -178.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -74.86 -41.36 59.96 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.131 0.573 . . . . 0.0 110.74 177.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.3 mp -73.99 -33.27 63.76 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 118.081 0.4 . . . . 0.0 111.23 -176.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 88.13 146.47 11.96 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 124.861 1.219 . . . . 0.0 110.763 -172.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -64.79 -29.61 70.59 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.875 0.87 . . . . 0.0 111.984 -172.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -67.53 -29.71 69.18 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 122.674 0.39 . . . . 0.0 111.07 177.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 22.8 t -93.47 -37.77 8.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 C-N-CA 123.921 0.888 . . . . 0.0 110.119 -175.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -135.58 144.05 45.97 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-N 119.3 0.955 . . . . 0.0 112.82 -176.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -128.53 153.18 47.46 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.565 1.146 . . . . 0.0 109.578 173.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 77.5 t -114.25 131.62 65.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 124.655 1.182 . . . . 0.0 110.263 -168.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 -144.63 166.5 25.01 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.645 1.578 . . . . 0.0 112.219 -169.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -130.63 129.42 42.67 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 127.088 2.155 . . . . 0.0 106.332 -178.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.4 tp -61.87 -19.62 21.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 123.64 0.776 . . . . 0.0 112.299 -171.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -58.39 -30.27 66.69 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 118.676 0.671 . . . . 0.0 112.461 -175.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 60.9 pttt -98.09 -6.42 31.71 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.755 0.822 . . . . 0.0 112.619 177.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 67.2 m -76.26 158.96 31.06 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.705 0.764 . . . . 0.0 111.444 -175.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 21.8 m -130.43 175.47 8.94 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.723 2.009 . . . . 0.0 107.145 172.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -51.61 -48.83 63.1 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 118.497 0.59 . . . . 0.0 111.654 -174.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -77.67 -12.62 59.99 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -172.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -68.47 -32.92 73.25 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 118.74 0.7 . . . . 0.0 110.824 -177.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -74.91 -42.46 57.75 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 123.603 0.761 . . . . 0.0 109.502 172.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -68.94 -19.54 64.18 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.633 0.773 . . . . 0.0 111.954 -170.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.57 -29.78 70.43 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.011 0.925 . . . . 0.0 112.433 176.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -86.21 160.46 19.19 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 124.292 1.037 . . . . 0.0 110.316 178.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -111.2 -24.26 10.38 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.596 0.758 . . . . 0.0 111.802 169.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.0 mp -117.02 131.92 68.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 174.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 79.8 mt -130.56 123.7 30.17 Favored 'General case' 0 CA--C 1.523 -0.08 0 C-N-CA 123.965 0.906 . . . . 0.0 109.363 -177.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.407 HD23 HG21 ' A' ' 22' ' ' ILE . 8.1 mp -109.6 107.74 17.93 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 176.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.9 mt -108.27 108.96 20.19 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -168.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -100.42 117.39 5.86 Favored Glycine 0 CA--C 1.518 0.245 0 C-N-CA 125.516 1.531 . . . . 0.0 109.709 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 15.5 tt -129.74 118.9 18.9 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 118.43 1.115 . . . . 0.0 110.627 -176.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -79.36 150.95 22.7 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.403 2.069 . . . . 0.0 110.289 173.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 17.3 m -100.68 137.07 39.57 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 175.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 66.8 m95 -137.25 173.8 11.3 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.782 1.633 . . . . 0.0 110.599 -173.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 54.49 -89.17 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 127.976 2.51 . . . . 0.0 113.246 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -151.02 62.12 0.91 Allowed 'General case' 0 C--O 1.237 0.417 0 C-N-CA 126.168 1.787 . . . . 0.0 107.89 -173.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 67.67 54.85 16.78 Favored Glycine 0 CA--C 1.53 1.003 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 -174.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -129.24 164.6 23.1 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.104 1.362 . . . . 0.0 108.642 175.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.36 164.29 22.24 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 121.221 0.534 . . . . 0.0 110.027 170.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -70.33 150.7 46.05 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 169.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 84.0 m -56.84 -33.35 66.7 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -168.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -69.26 -40.47 77.82 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 119.092 0.86 . . . . 0.0 110.687 -177.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -72.21 -41.49 66.86 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 174.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -60.0 -40.98 91.11 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 122.697 0.399 . . . . 0.0 111.39 -178.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -70.05 -21.07 63.21 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.092 0.957 . . . . 0.0 112.018 177.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -90.91 -19.16 23.63 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 118.7 -0.666 . . . . 0.0 112.316 -178.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -51.7 -41.72 79.61 Favored Pre-proline 0 CA--C 1.543 0.709 0 CA-C-O 116.389 -1.767 . . . . 0.0 114.666 178.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -62.4 -21.18 72.36 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 CA-C-N 122.909 2.075 . . . . 0.0 113.632 175.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.2 m -84.88 -41.97 15.49 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.454 1.025 . . . . 0.0 109.124 169.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.2 tp -56.47 -38.39 71.62 Favored 'General case' 0 C--N 1.341 0.219 0 C-N-CA 124.054 0.942 . . . . 0.0 111.177 -177.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -72.66 -2.8 21.52 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -109.86 -14.81 14.22 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.325 1.05 . . . . 0.0 111.622 173.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 74.5 mt -71.8 139.63 19.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -178.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -81.21 128.38 33.71 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.905 176.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -125.58 12.31 8.02 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.829 0.851 . . . . 0.0 111.737 172.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 42.8 m-80 -62.42 116.3 4.96 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 119.647 1.112 . . . . 0.0 109.385 -171.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.66 2.18 60.0 Favored Glycine 0 CA--C 1.534 1.239 0 CA-C-O 118.671 -1.072 . . . . 0.0 113.782 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 62.1 mttm -73.31 148.27 43.7 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 119.533 1.666 . . . . 0.0 107.714 171.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 60.9 mt -90.5 137.81 32.06 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 174.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.6 t -136.01 147.96 27.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 -178.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -140.18 144.23 36.51 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 169.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.9 mp -113.48 151.27 31.7 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 123.677 0.791 . . . . 0.0 109.512 -172.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 25.9 p90 -149.2 168.46 23.21 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 168.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.451 ' HA3' HD11 ' A' ' 102' ' ' LEU . . . 177.93 157.99 19.88 Favored Glycine 0 N--CA 1.449 -0.498 0 O-C-N 121.144 -0.973 . . . . 0.0 113.445 178.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 14.2 m -110.64 153.42 25.24 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 124.805 1.242 . . . . 0.0 109.268 -169.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -163.46 -166.54 22.45 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 178.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -152.61 118.69 5.49 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 124.898 1.279 . . . . 0.0 107.699 176.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -82.67 -34.15 27.5 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -169.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -56.33 -46.67 79.8 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 123.867 0.867 . . . . 0.0 111.648 -169.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -97.17 -42.6 7.76 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 118.601 0.637 . . . . 0.0 112.245 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 -91.94 44.72 1.18 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.958 0.903 . . . . 0.0 110.357 -172.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.33 -24.66 66.6 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.258 1.423 . . . . 0.0 113.421 -169.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -104.62 10.37 34.91 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.267 1.027 . . . . 0.0 112.75 178.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -135.62 16.86 3.35 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 124.939 1.296 . . . . 0.0 111.177 -178.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -66.41 124.45 22.77 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 121.159 -0.963 . . . . 0.0 110.518 -168.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 92.6 m 49.97 36.78 12.42 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.684 1.593 . . . . 0.0 113.058 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -59.93 -36.35 76.86 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.464 -0.772 . . . . 0.0 112.549 179.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.44 -24.81 67.75 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 -167.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.451 HD11 ' HA3' ' A' ' 87' ' ' GLY . 6.8 mp -61.57 -36.35 80.41 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 120.967 -1.083 . . . . 0.0 109.902 175.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.32 -31.22 78.51 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 123.706 0.669 . . . . 0.0 111.455 177.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.9 m -66.89 -36.67 82.82 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 121.858 -0.789 . . . . 0.0 110.533 179.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 15.7 mt -71.46 -49.16 49.0 Favored 'Isoleucine or valine' 0 C--N 1.343 0.318 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 174.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 18.3 tpt180 -50.15 -44.4 52.51 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.16 0.984 . . . . 0.0 111.052 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -60.87 -28.1 68.61 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.88 0.872 . . . . 0.0 112.643 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 97.0 mt -92.9 -46.09 14.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 124.351 1.06 . . . . 0.0 109.923 -178.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 32.6 pt -78.22 -23.09 13.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 O-C-N 121.23 -0.918 . . . . 0.0 111.931 -169.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -62.91 -58.06 18.38 Favored Pre-proline 0 CA--C 1.544 0.712 0 CA-C-O 117.412 -1.28 . . . . 0.0 111.629 177.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -65.8 -23.52 55.4 Favored 'Trans proline' 0 C--N 1.352 0.761 0 CA-C-N 121.708 1.646 . . . . 0.0 112.39 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 76.6 mmt-85 -79.66 6.26 11.13 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.211 1.004 . . . . 0.0 112.807 173.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 77.73 19.2 76.13 Favored Glycine 0 CA--C 1.528 0.876 0 CA-C-O 118.271 -1.294 . . . . 0.0 114.988 168.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.03 144.36 53.57 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 119.318 1.559 . . . . 0.0 110.09 169.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 42.2 m -97.45 124.99 41.84 Favored 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 105.01 -2.218 . . . . 0.0 105.01 167.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 20.8 mt -113.44 125.8 70.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -169.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 33.3 m -127.76 178.72 4.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 124.69 1.196 . . . . 0.0 109.21 174.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 79.77 27.64 53.29 Favored Glycine 0 CA--C 1.528 0.898 0 O-C-N 121.851 -0.531 . . . . 0.0 112.57 179.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 80.8 m-70 -62.0 141.58 57.98 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 170.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 71.5 t-105 -131.12 138.03 32.01 Favored Pre-proline 0 CA--C 1.537 0.446 0 C-N-CA 124.125 0.97 . . . . 0.0 109.5 -170.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -62.93 151.29 85.27 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 121.818 1.679 . . . . 0.0 112.985 -176.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 35.5 p . . . . . 0 CA--C 1.536 0.435 0 O-C-N 121.852 -0.53 . . . . 0.0 111.515 171.511 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 90.0 mttt . . . . . 0 N--CA 1.471 0.589 0 N-CA-C 113.928 1.084 . . . . 0.0 113.928 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -83.95 4.98 81.36 Favored Glycine 0 CA--C 1.534 1.269 0 CA-C-O 119.518 -0.601 . . . . 0.0 112.207 169.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 9.0 mp -62.23 135.26 57.4 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 118.969 1.385 . . . . 0.0 111.71 -177.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -97.05 -29.59 13.54 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.484 1.514 . . . . 0.0 109.313 167.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -146.82 167.68 23.29 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.149 1.78 . . . . 0.0 107.327 174.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -55.64 -25.89 41.44 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.12 1.368 . . . . 0.0 113.947 -169.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -122.45 11.71 9.99 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.85 1.26 . . . . 0.0 113.574 -178.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -141.14 125.72 17.81 Favored 'General case' 0 C--N 1.343 0.304 0 CA-C-N 119.362 0.983 . . . . 0.0 111.587 -176.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -71.54 150.17 45.04 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.333 1.053 . . . . 0.0 108.31 166.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 6.1 p -67.74 -8.6 8.98 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 123.98 0.912 . . . . 0.0 112.099 175.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -168.66 176.22 43.0 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 -172.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -70.73 103.12 2.48 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 -179.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.365 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 169.0 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 66.7 mt . . . . . 0 CA--C 1.531 0.248 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 50.5 m -41.03 -53.41 3.01 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 128.175 2.59 . . . . 0.0 111.766 -177.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -76.62 -40.74 48.39 Favored 'General case' 0 N--CA 1.452 -0.357 0 O-C-N 122.264 -0.272 . . . . 0.0 111.001 -172.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -62.9 -47.28 84.0 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 117.993 0.36 . . . . 0.0 110.377 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 47.6 mtp180 -65.71 -39.54 91.3 Favored 'General case' 0 N--CA 1.464 0.249 0 O-C-N 121.932 -0.48 . . . . 0.0 110.325 -175.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 86.4 t -72.68 -37.47 55.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-O 118.226 -0.893 . . . . 0.0 109.899 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -62.05 -49.83 74.4 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 120.722 1.601 . . . . 0.0 110.245 174.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -62.72 -34.56 77.43 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 118.898 -0.572 . . . . 0.0 110.746 -176.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 40.2 t90 -71.79 -51.63 21.64 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 118.531 0.605 . . . . 0.0 110.384 176.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 68.9 t -64.44 -35.07 73.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 O-C-N 121.533 -0.729 . . . . 0.0 110.835 -172.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -63.45 -35.53 80.74 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.404 -0.81 . . . . 0.0 110.324 177.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 53.7 mm-40 -71.63 -48.39 48.23 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.552 0.741 . . . . 0.0 111.178 174.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 3.8 pt -63.72 -32.51 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-N 119.771 1.169 . . . . 0.0 110.362 -177.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 50.2 m -61.85 -33.68 74.61 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 118.309 -0.853 . . . . 0.0 111.505 -179.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -86.41 -24.66 25.64 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 120.227 1.376 . . . . 0.0 111.954 177.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -73.74 -37.61 65.01 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 118.683 0.674 . . . . 0.0 110.701 174.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 77.7 mt -89.97 -4.79 57.26 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.058 1.743 . . . . 0.0 111.484 -178.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 82.7 m-70 56.6 25.29 9.76 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.952 1.701 . . . . 0.0 113.195 -172.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 79.8 mt . . . . . 0 N--CA 1.464 0.246 0 O-C-N 121.456 -0.778 . . . . 0.0 110.381 172.006 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.224 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 28.6 pt -80.68 -24.73 11.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 O-C-N 122.143 -0.348 . . . . 0.0 111.351 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.1 m -113.19 130.16 56.3 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.002 1.321 . . . . 0.0 108.771 178.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -102.76 124.68 8.24 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 107.974 -2.051 . . . . 0.0 107.974 169.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 27.3 mt -103.32 94.72 3.35 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 105.248 -2.131 . . . . 0.0 105.248 177.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -90.27 129.44 36.5 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 -177.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -122.43 123.47 41.4 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 119.806 1.185 . . . . 0.0 112.637 -176.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -82.51 141.72 21.42 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 106.391 -2.684 . . . . 0.0 106.391 165.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.1 m -161.85 171.33 17.93 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 119.939 1.87 . . . . 0.0 110.452 177.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -133.93 -50.67 0.83 Allowed 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.027 0.931 . . . . 0.0 109.817 169.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 81.9 p -92.41 5.0 52.31 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.021 0.928 . . . . 0.0 112.31 177.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 76.13 18.15 79.56 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 124.032 0.825 . . . . 0.0 113.317 -175.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -76.85 -47.19 22.07 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 119.263 1.532 . . . . 0.0 111.235 -176.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 72.8 m -74.06 -23.57 59.38 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 118.968 0.804 . . . . 0.0 109.974 178.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -56.09 -46.27 79.12 Favored 'General case' 0 C--N 1.342 0.248 0 O-C-N 121.385 -0.822 . . . . 0.0 109.616 169.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -64.95 -34.28 78.05 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 121.781 -0.574 . . . . 0.0 111.033 -177.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 45.4 mm -60.43 -44.1 95.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 172.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.61 -41.51 97.57 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.702 -0.624 . . . . 0.0 111.576 177.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 29.2 mmtp -64.14 -41.87 97.03 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 121.45 -0.782 . . . . 0.0 110.276 176.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 78.7 mtp -62.24 -40.6 96.72 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.399 1.0 . . . . 0.0 110.473 178.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 55.5 mt -60.62 -49.59 83.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 174.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -58.59 -38.15 77.32 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 121.233 -0.917 . . . . 0.0 111.417 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -63.63 -34.56 78.1 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 120.077 1.308 . . . . 0.0 111.246 -178.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -72.27 -40.6 67.5 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 118.371 0.532 . . . . 0.0 110.758 174.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -80.58 -34.22 35.47 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -171.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 84.3 144.61 6.48 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 -168.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 54.0 tttp -63.41 -30.93 71.97 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 121.912 -0.758 . . . . 0.0 111.975 -171.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -64.47 -30.98 72.01 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 122.85 0.46 . . . . 0.0 111.26 178.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.1 t -92.97 -39.96 11.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 123.502 0.721 . . . . 0.0 109.927 -176.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.22 137.44 32.59 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 118.92 0.782 . . . . 0.0 112.045 -178.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -129.23 144.71 51.32 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 176.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 59.7 t -90.32 134.78 28.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 123.871 0.868 . . . . 0.0 108.777 -170.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -147.12 169.19 19.81 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.886 1.274 . . . . 0.0 111.201 -168.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -138.31 128.33 25.56 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 125.173 1.389 . . . . 0.0 109.036 -169.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.3 tp -63.44 -29.84 48.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 CA-C-O 118.832 -0.604 . . . . 0.0 111.708 -173.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.52 -28.53 68.62 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 119.105 0.866 . . . . 0.0 110.318 -178.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -89.23 -27.14 20.81 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.172 1.389 . . . . 0.0 110.511 177.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 21.3 m -68.64 167.05 15.95 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 124.433 1.093 . . . . 0.0 111.801 -177.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.6 m -135.12 164.56 27.38 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.481 1.512 . . . . 0.0 108.932 178.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -53.17 -54.8 30.53 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.326 1.05 . . . . 0.0 111.45 -175.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -78.28 -15.96 58.24 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 122.312 0.245 . . . . 0.0 111.195 -175.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -74.32 -30.22 61.95 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 121.772 -0.58 . . . . 0.0 110.966 -179.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.7 mp -69.17 -43.51 74.12 Favored 'General case' 0 C--N 1.343 0.305 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 169.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -62.86 -17.41 61.44 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -177.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.15 -29.08 67.88 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.654 0.782 . . . . 0.0 112.289 176.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -82.29 155.99 24.53 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.195 0.998 . . . . 0.0 110.023 177.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -108.86 -26.48 10.24 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.111 0.564 . . . . 0.0 111.673 169.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.0 mp -113.81 127.89 70.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 174.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 96.3 mt -118.05 127.5 53.86 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 124.192 0.997 . . . . 0.0 108.436 177.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.2 mp -111.85 116.31 30.46 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 104.411 -2.44 . . . . 0.0 104.411 168.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 91.1 mt -115.23 109.08 17.44 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 -169.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.69 117.6 5.61 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 108.848 -1.701 . . . . 0.0 108.848 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 15.3 tt -135.91 105.29 9.7 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-N 118.731 1.266 . . . . 0.0 109.617 178.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -71.58 150.95 58.05 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 121.91 1.74 . . . . 0.0 109.635 170.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 29.3 m -99.19 139.27 35.08 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -179.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 47.5 m95 -135.7 172.79 12.5 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.86 1.264 . . . . 0.0 111.245 -170.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 53.87 -87.27 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 127.511 2.324 . . . . 0.0 112.958 176.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -149.69 80.01 1.38 Allowed 'General case' 0 C--O 1.235 0.31 0 C-N-CA 126.379 1.872 . . . . 0.0 106.847 174.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.71 16.96 76.32 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-O 119.575 -0.57 . . . . 0.0 113.306 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -91.99 161.8 14.65 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 118.54 1.17 . . . . 0.0 110.584 -175.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.27 161.56 28.65 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 123.915 0.886 . . . . 0.0 111.284 173.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 12.8 tm0? -64.57 146.4 54.69 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 168.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 56.3 m -56.45 -39.96 74.02 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 -167.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -77.33 -39.03 49.13 Favored 'General case' 0 C--N 1.333 -0.109 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -174.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -62.74 -44.95 94.88 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 172.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -58.98 -42.04 89.01 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.319 0.648 . . . . 0.0 111.358 178.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -69.33 -27.5 65.42 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.335 0.654 . . . . 0.0 112.336 176.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -88.32 -17.8 29.87 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.627 0.771 . . . . 0.0 112.629 -177.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -51.8 -40.45 70.97 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-O 116.426 -1.75 . . . . 0.0 115.349 -179.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -61.26 -30.21 87.71 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 CA-C-N 123.197 2.178 . . . . 0.0 112.701 173.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.7 m -75.23 -42.28 55.74 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.923 0.783 . . . . 0.0 109.446 172.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 12.3 tp -58.24 -37.62 75.25 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.126 0.97 . . . . 0.0 110.387 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -67.71 -11.64 58.77 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.55 1.14 . . . . 0.0 113.202 177.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -95.91 -17.91 20.71 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 119.803 1.183 . . . . 0.0 112.179 173.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 95.7 mt -76.38 143.59 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 -172.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -89.49 132.26 35.13 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 123.507 0.723 . . . . 0.0 109.691 175.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -124.62 6.08 8.21 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.913 0.885 . . . . 0.0 112.067 177.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -66.48 124.48 22.88 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 120.358 1.435 . . . . 0.0 110.378 -169.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.26 -0.94 58.26 Favored Glycine 0 CA--C 1.537 1.424 0 CA-C-O 118.433 -1.204 . . . . 0.0 114.277 -175.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -76.67 150.45 36.36 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 119.698 1.749 . . . . 0.0 108.408 173.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 66.9 mt -95.38 138.2 33.39 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 175.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 15.2 t -136.38 147.93 27.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -178.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -138.04 147.81 44.47 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 169.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -110.2 147.3 34.02 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 124.607 1.163 . . . . 0.0 108.607 -175.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -149.04 163.9 36.19 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 167.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 174.55 143.6 4.5 Favored Glycine 0 C--N 1.33 0.215 0 O-C-N 121.251 -0.906 . . . . 0.0 111.406 173.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 53.7 m -81.44 159.7 24.2 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 175.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.9 -167.63 27.89 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.403 -0.679 . . . . 0.0 111.403 -177.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -147.64 126.41 12.64 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 126.034 1.734 . . . . 0.0 107.994 176.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -106.89 2.38 25.32 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.328 1.051 . . . . 0.0 112.214 176.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -91.22 -46.32 8.14 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 119.24 0.927 . . . . 0.0 110.05 -173.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -105.58 -44.52 4.66 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.172 0.589 . . . . 0.0 110.493 178.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -82.75 40.91 0.7 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.551 1.141 . . . . 0.0 110.482 171.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.73 -21.86 64.87 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 127.002 2.121 . . . . 0.0 114.219 -170.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -103.26 7.81 38.39 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.173 1.389 . . . . 0.0 111.699 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -137.15 17.46 2.99 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.605 1.162 . . . . 0.0 111.387 -174.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -63.54 132.63 51.89 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 119.078 0.854 . . . . 0.0 109.363 -170.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . 0.258 23.0 p 52.05 22.98 2.03 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 127.357 2.263 . . . . 0.0 114.772 173.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -52.16 -41.54 62.67 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.851 1.261 . . . . 0.0 111.401 -175.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.35 -23.08 67.26 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -172.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 63.5 mt -61.39 -40.24 93.64 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 119.1 0.864 . . . . 0.0 109.621 175.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -68.19 -28.08 73.47 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 124.037 0.827 . . . . 0.0 111.591 -179.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.3 m -65.25 -37.12 86.22 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 118.243 1.021 . . . . 0.0 110.356 178.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 8.0 mt -71.25 -46.12 67.09 Favored 'Isoleucine or valine' 0 C--N 1.343 0.304 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 173.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 40.2 ttt180 -50.54 -46.11 57.29 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 118.858 0.754 . . . . 0.0 110.754 -177.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -61.87 -23.02 66.03 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.822 0.849 . . . . 0.0 113.025 -177.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 93.6 mt -92.21 -47.78 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 124.278 1.031 . . . . 0.0 109.268 178.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 30.0 pt -82.0 -36.77 14.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 118.989 0.813 . . . . 0.0 112.59 -168.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -68.19 -47.53 39.02 Favored Pre-proline 0 CA--C 1.54 0.575 0 CA-C-O 117.902 -1.047 . . . . 0.0 112.28 -170.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -68.66 -16.37 42.16 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 CA-C-N 121.532 1.583 . . . . 0.0 112.382 175.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 90.0 mtt-85 -91.51 20.29 5.48 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.736 1.214 . . . . 0.0 111.719 176.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 79.44 10.88 85.47 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 125.906 1.717 . . . . 0.0 115.023 168.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.45 137.76 58.1 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 119.649 1.724 . . . . 0.0 109.057 170.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 35.7 m -94.42 120.63 34.96 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 105.179 -2.156 . . . . 0.0 105.179 168.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 29.6 mt -99.2 132.62 44.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 -177.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 34.4 m -130.08 178.73 4.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 125.259 1.423 . . . . 0.0 108.812 172.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 77.14 28.11 58.9 Favored Glycine 0 C--N 1.335 0.523 0 CA-C-O 119.365 -0.686 . . . . 0.0 113.76 178.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 65.3 m80 -57.17 133.45 55.05 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 169.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 57.4 t-105 -115.61 135.78 22.7 Favored Pre-proline 0 CA--C 1.535 0.374 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -177.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.7 145.56 52.05 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 121.823 1.682 . . . . 0.0 111.754 -170.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 34.9 p . . . . . 0 CA--C 1.534 0.343 0 C-N-CA 122.963 0.505 . . . . 0.0 110.784 169.819 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 83.5 mttt . . . . . 0 N--CA 1.468 0.431 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -86.65 9.34 71.67 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 123.774 0.702 . . . . 0.0 111.815 167.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 95.3 mt -60.59 141.35 56.76 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 118.636 1.218 . . . . 0.0 110.889 177.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -108.74 -31.04 7.87 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.159 1.384 . . . . 0.0 108.89 167.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -146.4 162.48 38.13 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 127.869 2.468 . . . . 0.0 106.389 169.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -55.91 -29.05 59.44 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 119.27 0.941 . . . . 0.0 112.167 176.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -89.98 -11.5 41.45 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.295 1.038 . . . . 0.0 113.406 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 7.4 m-70 -149.48 131.52 15.32 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 119.742 1.155 . . . . 0.0 113.14 -169.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -75.02 158.98 32.32 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 167.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 12.4 p -61.69 -22.83 29.24 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 C-N-CA 123.227 0.611 . . . . 0.0 111.364 173.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -161.97 -172.26 29.15 Favored Glycine 0 C--N 1.337 0.636 0 O-C-N 121.514 -0.742 . . . . 0.0 111.798 -171.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.35 86.96 1.13 Allowed 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 124.755 1.222 . . . . 0.0 109.082 179.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.419 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 168.949 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 88.8 mt . . . . . 0 N--CA 1.465 0.308 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 83.2 m -43.14 -52.18 5.6 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 127.409 2.284 . . . . 0.0 111.696 -174.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -72.89 -33.7 66.2 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 118.888 -0.577 . . . . 0.0 110.731 -170.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -65.74 -43.47 88.89 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 118.552 0.615 . . . . 0.0 110.223 174.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -59.64 -49.6 77.13 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 178.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 98.2 t -67.33 -45.7 85.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-O 118.179 -0.915 . . . . 0.0 109.434 -176.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -53.77 -51.63 62.81 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 119.306 0.957 . . . . 0.0 110.1 -178.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 42.0 mttp -70.44 -42.17 71.9 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-O 118.838 -0.601 . . . . 0.0 110.697 -175.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 69.2 t90 -63.89 -44.5 92.83 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-N 118.943 0.792 . . . . 0.0 109.727 -178.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 54.3 t -61.96 -40.15 86.2 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 O-C-N 122.075 -0.391 . . . . 0.0 110.015 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -64.39 -40.24 95.42 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 121.369 -0.832 . . . . 0.0 110.232 178.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 20.6 mm100 -64.5 -51.46 62.83 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.321 0.51 . . . . 0.0 110.903 177.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 14.4 pt -66.01 -32.41 58.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 119.476 1.035 . . . . 0.0 110.704 -176.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 58.4 m -62.78 -26.63 68.81 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 118.139 -0.934 . . . . 0.0 112.127 -177.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -90.55 -17.69 26.57 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 120.259 1.39 . . . . 0.0 112.477 174.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -80.61 -35.71 33.72 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.25 0.932 . . . . 0.0 110.454 171.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 75.2 mt -91.63 -7.29 50.48 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.613 1.965 . . . . 0.0 111.598 -178.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 30.6 m80 56.26 24.68 8.44 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 126.076 1.75 . . . . 0.0 113.359 -172.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 86.9 mt . . . . . 0 N--CA 1.465 0.281 0 O-C-N 121.771 -0.581 . . . . 0.0 110.387 172.555 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.38 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.5 pt -83.81 -24.77 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 O-C-N 121.958 -0.464 . . . . 0.0 111.476 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 17.3 m -112.08 131.48 55.41 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.216 1.406 . . . . 0.0 108.732 177.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -107.0 121.87 6.71 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 108.374 -1.891 . . . . 0.0 108.374 170.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 52.5 mt -99.85 100.66 10.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 177.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -97.55 124.36 41.77 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 17.8 p90 -124.41 127.6 47.78 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 119.111 0.869 . . . . 0.0 112.131 -177.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -84.14 143.52 21.23 Favored Glycine 0 C--N 1.341 0.819 0 N-CA-C 110.316 -1.114 . . . . 0.0 110.316 168.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.6 m -160.38 159.26 30.87 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 118.895 1.348 . . . . 0.0 110.739 173.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -135.6 -47.64 0.69 Allowed 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.288 1.035 . . . . 0.0 109.851 169.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.4 p -80.12 -12.38 59.67 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.555 0.742 . . . . 0.0 111.954 170.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.9 7.96 54.71 Favored Glycine 0 C--N 1.342 0.869 0 C-N-CA 124.732 1.158 . . . . 0.0 113.449 170.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -69.76 -41.79 74.71 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 118.82 1.31 . . . . 0.0 112.442 -169.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.4 m -70.02 -18.01 63.29 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 119.408 1.004 . . . . 0.0 111.27 -172.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -58.23 -42.84 87.2 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 119.116 0.871 . . . . 0.0 110.166 174.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -65.8 -38.41 88.91 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 121.915 -0.491 . . . . 0.0 110.485 -178.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 36.9 mm -65.1 -47.52 87.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 176.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.0 -38.27 85.45 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.183 0.593 . . . . 0.0 111.575 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.0 mtpt -68.22 -44.69 75.18 Favored 'General case' 0 N--CA 1.463 0.188 0 O-C-N 121.643 -0.661 . . . . 0.0 110.594 176.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 75.5 mtm -66.85 -22.72 65.98 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.352 0.978 . . . . 0.0 111.946 178.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 68.3 mt -71.31 -59.07 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 168.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -55.16 -42.19 72.81 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 118.382 -0.818 . . . . 0.0 112.349 -174.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -58.94 -32.04 69.23 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 119.65 1.114 . . . . 0.0 111.903 -175.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -75.27 -39.6 59.58 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.062 0.545 . . . . 0.0 111.538 178.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -79.39 -35.4 40.76 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 118.652 0.66 . . . . 0.0 111.508 -177.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 88.09 146.1 11.43 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 124.778 1.18 . . . . 0.0 110.353 -169.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 55.5 tttp -63.37 -31.95 73.24 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 121.953 -0.733 . . . . 0.0 112.117 -169.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -66.24 -29.14 69.33 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 122.955 0.502 . . . . 0.0 111.397 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 39.0 t -92.56 -39.67 11.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 123.878 0.871 . . . . 0.0 109.582 -177.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -140.15 132.85 28.93 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 119.241 0.928 . . . . 0.0 111.513 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -125.05 149.7 47.52 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 175.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 60.5 t -97.83 138.98 21.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 124.595 1.158 . . . . 0.0 110.101 -168.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -149.63 172.39 15.13 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.948 1.299 . . . . 0.0 111.512 -173.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -137.74 132.17 32.39 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 125.647 1.579 . . . . 0.0 108.032 -174.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.5 tp -65.8 -27.03 40.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-O 118.581 -0.723 . . . . 0.0 112.927 -168.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.11 -30.44 68.72 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 119.221 0.919 . . . . 0.0 110.297 178.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 43.8 mtmt -81.03 -31.36 34.6 Favored 'General case' 0 C--N 1.342 0.244 0 C-N-CA 123.252 0.621 . . . . 0.0 110.421 174.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.7 m -70.43 169.51 13.88 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.522 1.129 . . . . 0.0 111.654 -172.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 14.8 m -135.3 160.96 36.77 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.146 1.379 . . . . 0.0 108.733 178.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 45.2 tttm -53.6 -51.75 62.02 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.78 0.832 . . . . 0.0 111.042 -174.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.2 mp0 -73.82 -14.32 61.08 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 119.343 -0.361 . . . . 0.0 111.683 -175.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -71.71 -39.39 70.19 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 119.487 1.04 . . . . 0.0 110.675 -178.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 8.3 mp -66.22 -31.83 72.89 Favored 'General case' 0 C--N 1.343 0.315 0 C-N-CA 122.375 0.27 . . . . 0.0 110.361 173.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -70.15 -20.93 63.12 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 119.178 -0.439 . . . . 0.0 111.612 -176.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.61 -30.3 61.62 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.622 0.769 . . . . 0.0 112.559 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -76.36 151.78 36.53 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 123.681 0.792 . . . . 0.0 109.928 177.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -100.12 -31.43 11.42 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 122.709 0.404 . . . . 0.0 111.338 170.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.1 mp -110.52 128.77 66.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 175.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 96.2 mt -114.17 128.33 56.32 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 172.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.2 mp -110.27 115.81 30.36 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 105.345 -2.095 . . . . 0.0 105.345 169.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 85.8 mt -115.92 109.7 17.95 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 -169.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -100.26 119.15 6.41 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 125.966 1.746 . . . . 0.0 109.85 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.6 tt -132.74 123.85 18.5 Favored Pre-proline 0 CA--C 1.541 0.605 0 CA-C-N 118.906 1.353 . . . . 0.0 112.15 -173.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -85.59 157.09 10.6 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 123.042 2.495 . . . . 0.0 110.658 170.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.0 m -112.32 142.08 45.26 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 175.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 75.2 m95 -140.95 171.29 14.28 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.11 1.764 . . . . 0.0 111.074 -169.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 36.2 t80 50.83 -89.59 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 127.648 2.379 . . . . 0.0 112.569 -177.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -149.7 84.15 1.41 Allowed 'General case' 0 C--O 1.235 0.303 0 C-N-CA 126.652 1.981 . . . . 0.0 106.215 173.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 73.58 13.44 80.22 Favored Glycine 0 CA--C 1.534 1.235 0 CA-C-O 119.203 -0.776 . . . . 0.0 114.088 177.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -84.59 161.99 19.95 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.625 1.212 . . . . 0.0 108.915 174.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -84.95 175.1 9.28 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 166.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.4 142.44 56.95 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 168.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 58.6 m -57.61 -36.47 71.82 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 119.311 0.959 . . . . 0.0 112.998 -169.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -72.53 -28.51 62.9 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.133 0.573 . . . . 0.0 111.908 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -79.91 -41.83 25.35 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.649 1.179 . . . . 0.0 109.468 176.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -59.7 -42.21 92.47 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.564 1.146 . . . . 0.0 110.689 176.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -62.22 -19.63 63.37 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.0 0.92 . . . . 0.0 112.525 177.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -90.4 -15.31 31.24 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 118.252 -0.88 . . . . 0.0 112.294 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -54.15 -42.87 95.87 Favored Pre-proline 0 CA--C 1.541 0.632 0 CA-C-N 120.992 1.724 . . . . 0.0 113.963 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -63.14 -21.96 72.77 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 CA-C-N 122.523 1.937 . . . . 0.0 113.397 174.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.2 m -82.25 -38.8 23.91 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.462 1.028 . . . . 0.0 109.702 171.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 14.0 tp -59.02 -40.69 85.76 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.312 1.045 . . . . 0.0 109.941 -176.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -75.63 4.15 8.26 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 178.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -105.38 -16.42 14.75 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.288 1.035 . . . . 0.0 111.111 169.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 96.7 mt -75.28 140.53 17.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 179.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -88.92 131.42 35.14 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 123.543 0.737 . . . . 0.0 109.524 174.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -121.51 8.01 10.12 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.86 0.864 . . . . 0.0 111.952 177.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 29.6 m-80 -58.72 116.45 3.73 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 119.814 1.188 . . . . 0.0 109.835 -172.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.58 1.92 67.48 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-O 118.571 -1.127 . . . . 0.0 114.283 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -74.25 150.84 40.07 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 119.674 1.737 . . . . 0.0 108.581 172.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 23.8 mt -92.04 137.59 32.24 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 172.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 19.7 t -134.28 144.07 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 177.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -137.65 145.94 43.28 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 171.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.2 mp -116.34 150.23 38.02 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 123.102 0.561 . . . . 0.0 109.646 -171.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -144.27 162.86 35.33 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 167.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -171.32 168.02 41.14 Favored Glycine 0 N--CA 1.452 -0.299 0 O-C-N 120.773 -1.204 . . . . 0.0 112.778 -176.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 21.3 m -133.28 151.6 51.9 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.569 1.148 . . . . 0.0 109.223 -168.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -178.35 -174.41 44.59 Favored Glycine 0 CA--C 1.528 0.857 0 CA-C-O 121.022 0.235 . . . . 0.0 112.57 -177.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -145.4 153.2 40.95 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 128.247 2.619 . . . . 0.0 106.952 175.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.9 12.8 3.38 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.182 1.393 . . . . 0.0 111.79 -173.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -68.47 -47.5 66.94 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 177.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -106.33 -38.72 6.13 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 123.395 0.678 . . . . 0.0 111.341 175.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -84.45 39.99 0.76 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.548 1.139 . . . . 0.0 111.404 -172.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.45 -19.83 65.8 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.266 1.027 . . . . 0.0 113.126 -171.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -93.11 0.31 57.22 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.476 1.11 . . . . 0.0 111.921 175.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -139.04 20.72 2.63 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.657 1.183 . . . . 0.0 111.573 -169.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -66.24 119.66 11.9 Favored 'General case' 0 C--O 1.235 0.32 0 O-C-N 121.122 -0.986 . . . . 0.0 108.925 -172.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 67.3 m 49.01 35.03 6.17 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.848 1.659 . . . . 0.0 112.581 -174.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -52.22 -41.21 62.54 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.815 1.246 . . . . 0.0 112.061 -171.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.53 -18.09 64.51 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -169.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 39.5 mt -54.58 -42.78 71.47 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.718 0.807 . . . . 0.0 110.137 171.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.69 -34.17 89.2 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 -179.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.2 m -64.91 -36.37 84.14 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 117.959 0.88 . . . . 0.0 110.864 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 8.1 mt -67.97 -51.18 52.08 Favored 'Isoleucine or valine' 0 C--N 1.345 0.392 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 173.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 60.3 ttp85 -55.17 -44.3 75.1 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 119.514 1.052 . . . . 0.0 110.488 -175.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -58.81 -21.46 56.37 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.793 0.837 . . . . 0.0 112.683 -177.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 96.7 mt -96.34 -51.38 10.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 124.325 1.05 . . . . 0.0 109.728 176.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 31.9 pt -74.64 -32.49 29.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-N 119.674 1.124 . . . . 0.0 111.762 -169.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -67.46 -54.2 19.63 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-O 117.61 -1.186 . . . . 0.0 112.069 -174.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -66.28 -23.23 52.19 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 CA-C-N 121.483 1.565 . . . . 0.0 112.024 176.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 60.5 mtp85 -85.62 16.67 3.73 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.014 0.926 . . . . 0.0 112.319 177.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 82.19 14.4 76.91 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-O 118.157 -1.357 . . . . 0.0 116.146 166.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.68 144.45 57.02 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 119.59 1.695 . . . . 0.0 109.807 170.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 74.9 m -96.87 121.36 38.65 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 167.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 34.9 mt -102.04 128.37 54.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 -173.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 32.7 m -128.79 178.09 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 125.658 1.583 . . . . 0.0 108.72 175.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 74.57 28.91 62.46 Favored Glycine 0 CA--C 1.525 0.7 0 O-C-N 121.426 -0.796 . . . . 0.0 113.213 -179.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 80.2 m-70 -61.98 140.92 58.3 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 169.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 68.3 t-105 -129.47 135.29 27.33 Favored Pre-proline 0 CA--C 1.535 0.382 0 C-N-CA 124.042 0.937 . . . . 0.0 108.866 -173.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -65.72 143.87 75.84 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 121.974 1.783 . . . . 0.0 112.182 -170.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 57.5 p . . . . . 0 CA--C 1.536 0.424 0 C-N-CA 123.679 0.792 . . . . 0.0 111.199 177.637 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.716 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -77.56 6.21 47.18 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.158 0.885 . . . . 0.0 113.433 173.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 93.5 mt -65.35 139.47 58.58 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 119.754 1.777 . . . . 0.0 109.864 176.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -106.14 -32.21 8.34 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.376 1.47 . . . . 0.0 108.184 167.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -146.45 161.78 39.68 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 128.143 2.577 . . . . 0.0 106.063 169.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -56.36 -29.44 61.4 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 121.108 -0.995 . . . . 0.0 112.276 176.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -90.29 -10.74 43.05 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.091 0.956 . . . . 0.0 113.448 179.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -144.81 124.74 13.49 Favored 'General case' 0 C--N 1.345 0.408 0 CA-C-N 119.862 1.21 . . . . 0.0 112.985 -171.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -73.17 153.24 40.8 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 166.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 8.4 p -64.84 -18.83 24.31 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 124.206 1.002 . . . . 0.0 112.081 178.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -161.36 176.02 37.93 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 -169.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -74.15 92.8 2.23 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.529 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 169.48 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 72.5 mt . . . . . 0 N--CA 1.467 0.417 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 41.2 m -46.57 -57.53 4.66 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 125.561 1.544 . . . . 0.0 111.999 -170.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -71.03 -30.32 66.48 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 122.529 0.332 . . . . 0.0 111.237 -169.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -68.26 -46.68 69.76 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 173.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -66.98 -39.2 87.11 Favored 'General case' 0 N--CA 1.463 0.18 0 O-C-N 121.738 -0.601 . . . . 0.0 111.576 -174.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 29.0 m -71.2 -23.18 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 119.127 0.876 . . . . 0.0 111.378 177.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -74.24 -52.84 11.15 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 120.14 1.336 . . . . 0.0 109.16 170.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -58.24 -43.53 87.82 Favored 'General case' 0 N--CA 1.462 0.169 0 O-C-N 122.17 -0.331 . . . . 0.0 110.934 -175.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 58.5 t90 -67.62 -46.71 71.72 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 118.199 0.454 . . . . 0.0 110.039 -176.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 67.9 t -63.49 -38.57 82.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 O-C-N 122.015 -0.428 . . . . 0.0 110.044 -178.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -66.53 -37.02 84.1 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.368 -0.833 . . . . 0.0 110.266 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 17.8 mm100 -66.53 -51.8 52.66 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.371 0.532 . . . . 0.0 110.917 175.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 15.5 pt -65.85 -29.24 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-N 119.469 1.032 . . . . 0.0 110.8 -176.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 70.6 m -58.9 -26.62 64.47 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 117.79 -1.1 . . . . 0.0 112.386 178.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -96.31 -9.57 29.87 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 120.341 1.428 . . . . 0.0 112.769 175.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -85.16 -39.72 17.55 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 119.138 0.881 . . . . 0.0 110.0 169.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 80.5 mt -87.28 -10.98 50.95 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.836 2.054 . . . . 0.0 111.531 -179.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 55.67 32.66 19.76 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.955 1.702 . . . . 0.0 112.535 -171.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 81.2 mt . . . . . 0 N--CA 1.466 0.366 0 O-C-N 121.804 -0.56 . . . . 0.0 110.069 169.26 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.361 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 31.6 pt -85.73 -23.64 7.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 122.413 0.285 . . . . 0.0 111.592 -177.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 11.7 m -109.36 128.11 54.85 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 125.235 1.414 . . . . 0.0 108.858 179.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -103.55 122.02 7.29 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 106.927 -2.469 . . . . 0.0 106.927 168.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 57.6 mt -100.99 92.35 2.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 N-CA-C 105.144 -2.169 . . . . 0.0 105.144 177.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -88.6 132.17 34.65 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 -178.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -130.06 133.28 46.6 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 119.521 1.055 . . . . 0.0 111.617 176.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -88.02 145.5 19.27 Favored Glycine 0 C--N 1.339 0.726 0 N-CA-C 108.384 -1.886 . . . . 0.0 108.384 171.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -159.47 176.35 12.2 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 119.446 1.623 . . . . 0.0 112.903 179.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -146.8 -47.22 0.18 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.944 2.098 . . . . 0.0 108.802 168.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 35.8 p -84.01 -15.86 46.07 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.14 0.976 . . . . 0.0 112.606 177.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 79.62 18.9 72.23 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-O 118.823 -0.987 . . . . 0.0 112.61 -174.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -74.16 -40.52 62.53 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.628 1.714 . . . . 0.0 110.182 178.343 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -62.27 -25.78 68.03 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.457 1.103 . . . . 0.0 111.827 177.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -59.53 -42.61 92.7 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 118.729 0.695 . . . . 0.0 110.222 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -67.7 -34.39 76.79 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 121.828 -0.545 . . . . 0.0 110.459 -179.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.6 mm -64.5 -46.92 91.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 175.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.77 -41.91 92.12 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 122.982 0.513 . . . . 0.0 111.042 178.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -63.38 -42.74 98.84 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 119.03 -0.51 . . . . 0.0 110.891 176.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 72.6 mtm -68.65 -27.78 66.3 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 119.175 0.898 . . . . 0.0 111.695 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 54.2 mt -69.8 -51.23 42.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 170.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -60.54 -41.41 94.4 Favored 'General case' 0 C--O 1.225 -0.22 0 O-C-N 121.688 -0.633 . . . . 0.0 111.404 -175.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.37 -38.27 86.37 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 118.86 0.755 . . . . 0.0 110.699 -177.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -74.52 -37.3 63.12 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 122.879 0.472 . . . . 0.0 111.091 178.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.7 mp -74.29 -34.62 63.58 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.311 0.505 . . . . 0.0 111.198 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.59 145.08 16.61 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 125.157 1.36 . . . . 0.0 110.511 -173.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -65.59 -30.16 70.86 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.679 0.792 . . . . 0.0 112.155 -172.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -68.05 -29.47 68.45 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 122.1 -0.375 . . . . 0.0 110.887 177.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 38.9 t -91.69 -36.72 8.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 C-N-CA 124.413 1.085 . . . . 0.0 110.096 -175.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -136.55 145.78 45.41 Favored 'General case' 0 C--N 1.34 0.183 0 CA-C-N 119.366 0.985 . . . . 0.0 113.283 -172.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -131.49 141.58 49.79 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.61 1.164 . . . . 0.0 109.889 174.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 83.3 t -89.24 139.44 17.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 124.002 0.921 . . . . 0.0 109.107 -178.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -149.45 173.35 13.66 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.449 1.1 . . . . 0.0 111.425 -168.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -147.96 121.43 9.09 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 125.926 1.691 . . . . 0.0 108.081 -172.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.2 tp -60.14 -22.24 24.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 123.819 0.848 . . . . 0.0 112.267 -171.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.84 -27.91 67.04 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 118.848 0.749 . . . . 0.0 111.251 178.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt -87.69 -21.25 25.33 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.244 1.018 . . . . 0.0 111.481 178.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 70.8 m -74.91 168.79 19.24 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.6 1.16 . . . . 0.0 112.359 -169.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 68.9 m -156.58 178.33 10.45 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.32 2.248 . . . . 0.0 106.995 177.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 27.4 tptp -50.42 -46.79 56.61 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.814 0.845 . . . . 0.0 111.997 -175.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -80.19 -11.6 59.72 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -173.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -76.76 -43.03 38.67 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 121.531 -0.731 . . . . 0.0 111.464 -172.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.7 mp -75.72 -28.74 58.68 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 118.033 0.379 . . . . 0.0 111.121 178.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -63.48 -18.1 63.43 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.91 0.884 . . . . 0.0 111.422 -177.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.21 -29.59 65.33 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.316 1.046 . . . . 0.0 112.728 177.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -89.18 156.84 18.54 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.346 1.058 . . . . 0.0 110.472 -175.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -107.64 -27.12 10.52 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.621 171.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.0 mp -116.76 130.37 71.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 175.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -113.88 116.55 29.48 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 177.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -103.16 112.45 25.32 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 104.623 -2.362 . . . . 0.0 104.623 171.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.4 mt -117.18 107.68 14.76 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -170.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -90.78 105.11 3.23 Favored Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 178.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.9 tp -115.87 102.59 53.99 Favored Pre-proline 0 CA--C 1.536 0.405 0 C-N-CA 125.024 1.33 . . . . 0.0 108.86 -174.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -72.85 143.14 36.42 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 121.289 1.326 . . . . 0.0 108.675 169.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 50.0 m -90.95 137.37 32.42 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 173.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 45.2 m95 -132.98 175.87 8.99 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 125.948 1.699 . . . . 0.0 108.896 -177.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 42.54 48.18 4.57 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.844 2.058 . . . . 0.0 114.092 168.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.3 p90 48.3 66.7 0.99 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.221 1.408 . . . . 0.0 111.963 176.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 87.89 52.54 2.92 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 124.303 0.954 . . . . 0.0 111.701 175.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -143.55 164.27 30.85 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.032 1.333 . . . . 0.0 108.777 174.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -82.84 161.38 21.95 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 167.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -62.42 149.21 43.17 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 168.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 65.9 m -56.74 -36.13 69.41 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.007 0.923 . . . . 0.0 113.144 -168.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -68.85 -38.05 79.52 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 118.894 0.77 . . . . 0.0 110.756 -177.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -69.82 -46.5 65.51 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 175.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -58.52 -39.93 81.5 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 122.717 0.407 . . . . 0.0 111.65 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -68.77 -23.44 64.31 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 123.924 0.889 . . . . 0.0 112.169 177.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -95.35 -20.12 19.39 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.452 0.701 . . . . 0.0 112.328 -178.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 21.5 m-30 -49.94 -40.47 54.76 Favored Pre-proline 0 CA--C 1.544 0.746 0 CA-C-O 116.656 -1.64 . . . . 0.0 114.47 176.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -63.78 -26.83 67.85 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 CA-C-N 123.032 2.119 . . . . 0.0 113.094 174.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.4 m -78.32 -35.11 48.15 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 119.576 1.08 . . . . 0.0 109.661 171.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 16.8 tp -63.36 -27.46 69.33 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 121.185 -0.947 . . . . 0.0 111.495 -176.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -87.67 -0.12 56.46 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.974 0.91 . . . . 0.0 112.964 174.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -96.33 -36.07 11.0 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 119.384 0.993 . . . . 0.0 108.469 169.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 68.0 mt -61.34 133.66 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -85.31 136.87 33.3 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 123.387 0.675 . . . . 0.0 109.545 176.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -129.14 18.32 6.01 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.97 0.908 . . . . 0.0 110.818 175.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -58.55 112.42 1.59 Allowed 'General case' 0 C--N 1.341 0.196 0 CA-C-N 120.373 1.442 . . . . 0.0 109.925 -176.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.37 1.57 57.67 Favored Glycine 0 CA--C 1.535 1.309 0 CA-C-O 118.599 -1.111 . . . . 0.0 114.207 -178.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -75.0 154.9 37.85 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 119.971 1.886 . . . . 0.0 107.689 170.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 27.2 mt -95.63 141.88 28.6 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.0 t -135.52 144.03 35.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 176.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -141.33 146.19 36.4 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 125.105 1.362 . . . . 0.0 107.343 172.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 68.8 mt -119.59 144.98 46.8 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 -170.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -143.54 165.89 26.32 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 123.608 0.763 . . . . 0.0 109.161 170.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -175.26 164.62 35.19 Favored Glycine 0 CA--C 1.521 0.418 0 CA-C-O 122.342 0.968 . . . . 0.0 112.623 179.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 38.1 m -115.89 159.25 21.8 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 125.725 1.61 . . . . 0.0 107.765 175.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -149.17 -164.18 11.44 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 175.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -148.81 153.05 37.57 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 117.639 0.719 . . . . 0.0 110.463 174.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -113.88 -1.86 13.76 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -168.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -70.79 -42.84 69.8 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 119.577 1.08 . . . . 0.0 110.669 -177.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -136.48 -32.77 0.83 Allowed 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -177.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -85.25 18.24 2.71 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -174.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.75 -14.29 62.83 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -174.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -89.93 0.13 57.25 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.074 0.95 . . . . 0.0 111.456 173.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -132.44 26.05 4.45 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 126.237 1.815 . . . . 0.0 109.303 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -64.92 121.09 13.82 Favored 'General case' 0 N--CA 1.452 -0.356 0 O-C-N 121.671 -0.643 . . . . 0.0 110.271 -168.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 74.5 m 48.42 34.29 4.63 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.363 1.865 . . . . 0.0 113.608 -177.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -54.42 -38.6 66.45 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.136 0.974 . . . . 0.0 113.132 -177.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.27 -12.53 61.65 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -170.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 52.2 mt -57.32 -40.64 78.34 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 118.67 0.668 . . . . 0.0 109.691 169.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -63.78 -31.62 81.4 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 123.591 0.615 . . . . 0.0 111.707 -179.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.6 m -65.77 -44.62 85.26 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 117.97 0.885 . . . . 0.0 109.905 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 4.3 mt -69.95 -40.9 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 119.029 0.832 . . . . 0.0 109.207 178.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 51.9 tpt85 -56.85 -33.24 66.6 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 118.469 0.577 . . . . 0.0 111.729 177.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -74.23 -33.76 63.46 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.242 0.617 . . . . 0.0 111.852 176.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 75.8 mt -79.34 -43.57 23.79 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 123.567 0.747 . . . . 0.0 110.629 -175.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 6.1 pt -76.8 -21.06 14.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 118.773 0.715 . . . . 0.0 112.923 -168.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -62.39 -56.66 28.43 Favored Pre-proline 0 CA--C 1.544 0.718 0 CA-C-O 117.604 -1.189 . . . . 0.0 112.273 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -66.71 -16.48 50.52 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 122.339 2.026 . . . . 0.0 112.915 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 19.4 mmm180 -84.6 4.04 34.08 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.409 0.684 . . . . 0.0 112.018 172.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 79.46 16.45 77.94 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 124.583 1.087 . . . . 0.0 113.953 170.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.32 146.68 47.22 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 118.551 1.175 . . . . 0.0 111.423 177.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 67.8 m -96.92 126.84 42.35 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 104.583 -2.377 . . . . 0.0 104.583 167.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 19.9 mt -113.18 131.6 64.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 -168.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 31.0 m -136.49 -177.87 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 124.725 1.21 . . . . 0.0 109.501 177.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 81.75 39.5 11.92 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-O 119.48 -0.622 . . . . 0.0 113.577 172.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 25.5 m170 -64.52 158.11 24.99 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.438 1.119 . . . . 0.0 109.718 169.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 43.8 t-105 -135.81 135.07 21.13 Favored Pre-proline 0 CA--C 1.536 0.433 0 CA-C-O 117.955 -1.021 . . . . 0.0 108.923 173.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_exo -65.68 145.93 82.75 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 121.781 1.654 . . . . 0.0 113.366 -175.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 36.2 p . . . . . 0 CA--C 1.534 0.361 0 O-C-N 121.684 -0.635 . . . . 0.0 109.819 169.821 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? . . . . . 0 N--CA 1.47 0.531 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -77.35 -2.21 78.53 Favored Glycine 0 CA--C 1.537 1.435 0 CA-C-N 118.763 0.71 . . . . 0.0 113.529 173.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 8.5 mp -58.31 133.14 55.43 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 119.027 1.413 . . . . 0.0 110.558 174.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -95.64 -31.41 13.27 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.067 0.947 . . . . 0.0 108.595 167.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -144.32 162.86 35.34 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 127.14 2.176 . . . . 0.0 106.764 170.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -52.64 -30.14 29.99 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.368 0.667 . . . . 0.0 112.305 175.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -86.03 -17.81 34.2 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -178.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 30.0 p-80 -154.31 141.12 19.11 Favored 'General case' 0 C--N 1.347 0.469 0 CA-C-N 120.577 1.535 . . . . 0.0 114.684 -176.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -72.14 150.67 43.6 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.356 1.463 . . . . 0.0 108.555 167.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 8.8 p -69.41 -20.61 24.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 123.373 0.669 . . . . 0.0 111.515 175.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -148.22 171.05 28.73 Favored Glycine 0 C--N 1.337 0.589 0 C-N-CA 124.72 1.152 . . . . 0.0 110.264 -177.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -67.37 112.99 4.89 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 175.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.282 0 C-N-CA 124.875 1.27 . . . . 0.0 108.048 -174.498 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 79.4 mt . . . . . 0 CA--C 1.535 0.402 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 26.0 m -46.9 -57.35 5.04 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 126.688 1.995 . . . . 0.0 111.187 -170.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -75.43 -33.88 60.95 Favored 'General case' 0 N--CA 1.452 -0.373 0 O-C-N 122.233 -0.292 . . . . 0.0 110.557 -171.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 25.1 mp0 -64.71 -45.46 86.48 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.307 1.043 . . . . 0.0 109.444 178.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -66.03 -40.5 91.09 Favored 'General case' 0 N--CA 1.463 0.206 0 O-C-N 121.535 -0.728 . . . . 0.0 110.246 178.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 69.8 t -68.04 -33.47 61.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 118.916 0.78 . . . . 0.0 110.087 179.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -65.31 -51.92 57.46 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 120.416 1.462 . . . . 0.0 109.621 171.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -61.32 -27.89 68.81 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 118.74 -0.648 . . . . 0.0 111.501 -177.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 36.1 t90 -81.47 -51.99 7.71 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 119.174 0.897 . . . . 0.0 110.456 177.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 77.8 t -67.2 -31.09 51.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 O-C-N 121.376 -0.828 . . . . 0.0 110.584 -170.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -61.9 -35.0 77.08 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 121.2 -0.937 . . . . 0.0 110.856 174.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 63.0 mt-30 -69.91 -49.26 53.8 Favored 'General case' 0 C--N 1.341 0.219 0 C-N-CA 123.353 0.661 . . . . 0.0 110.664 173.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 2.7 pt -62.76 -33.19 58.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-N 119.266 0.939 . . . . 0.0 109.872 -175.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 48.2 m -61.31 -30.45 70.5 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 118.478 -0.772 . . . . 0.0 111.887 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -90.44 -26.0 20.06 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.877 1.217 . . . . 0.0 112.024 176.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -72.28 -38.46 68.78 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.057 0.844 . . . . 0.0 110.758 174.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 78.3 mt -83.49 -9.36 59.03 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.804 1.642 . . . . 0.0 111.544 179.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 55.33 32.53 18.9 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.621 1.568 . . . . 0.0 112.544 -170.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 80.3 mt . . . . . 0 N--CA 1.465 0.278 0 O-C-N 121.571 -0.706 . . . . 0.0 110.37 170.019 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.315 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 17.6 pt -88.11 -22.34 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 122.397 0.279 . . . . 0.0 111.309 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.9 m -112.43 127.19 55.96 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.725 1.21 . . . . 0.0 109.294 -174.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -100.46 115.13 5.22 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 106.88 -2.488 . . . . 0.0 106.88 167.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 84.8 mt -88.66 116.12 29.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 104.068 -2.567 . . . . 0.0 104.068 169.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -112.13 127.6 55.97 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 173.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -132.88 136.86 46.45 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 119.478 1.036 . . . . 0.0 112.234 -178.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -85.43 158.59 32.73 Favored Glycine 0 CA--C 1.533 1.197 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 167.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 17.0 m -159.53 167.63 28.12 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 119.406 1.603 . . . . 0.0 110.526 176.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -144.81 -55.89 0.33 Allowed 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.419 0.688 . . . . 0.0 110.711 169.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 39.0 p -81.73 -6.38 58.98 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.731 0.812 . . . . 0.0 112.287 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 78.5 27.68 56.86 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-O 119.501 -0.611 . . . . 0.0 111.734 -172.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -87.64 -49.73 6.96 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-N 118.193 0.996 . . . . 0.0 110.115 173.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 26.9 m -70.09 -24.0 63.15 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 118.494 0.588 . . . . 0.0 111.517 -170.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -59.31 -34.46 72.35 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 121.388 -0.82 . . . . 0.0 111.26 174.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -70.96 -31.46 68.03 Favored 'General case' 0 C--O 1.226 -0.164 0 O-C-N 121.34 -0.85 . . . . 0.0 110.053 -179.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 23.1 mm -66.59 -47.73 82.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 176.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.71 -43.13 90.01 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 122.731 0.412 . . . . 0.0 111.389 176.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -69.42 -40.0 77.53 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-O 118.787 -0.625 . . . . 0.0 111.346 -178.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 68.1 mtm -61.81 -46.29 90.13 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 119.266 0.939 . . . . 0.0 109.755 174.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 75.2 mt -58.28 -47.16 88.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 177.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -59.5 -40.31 86.62 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 119.551 1.069 . . . . 0.0 111.456 178.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 59.0 tptt -64.23 -39.36 93.8 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 119.376 0.989 . . . . 0.0 110.222 178.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -69.43 -41.12 76.77 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.729 0.811 . . . . 0.0 110.959 179.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -73.89 -38.47 64.36 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.641 1.176 . . . . 0.0 110.56 -178.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.32 145.55 17.51 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 125.598 1.571 . . . . 0.0 110.759 -171.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.6 tptp -62.54 -30.2 71.13 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.449 1.1 . . . . 0.0 111.692 -175.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -68.92 -25.1 64.41 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.293 0.637 . . . . 0.0 111.412 178.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.2 t -99.82 -36.84 5.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 C-N-CA 124.106 0.962 . . . . 0.0 110.339 -175.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -133.5 139.57 46.73 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 119.32 0.964 . . . . 0.0 113.517 -175.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -122.22 150.25 42.54 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.484 1.114 . . . . 0.0 109.486 172.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 53.1 t -111.79 139.09 37.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 123.804 0.842 . . . . 0.0 110.93 -168.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -147.33 166.45 27.07 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.72 2.008 . . . . 0.0 111.101 -171.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -124.73 134.97 52.64 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 105.73 -1.952 . . . . 0.0 105.73 169.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.8 tp -60.14 -18.91 16.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 119.271 0.941 . . . . 0.0 112.556 -173.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -51.49 -37.71 50.42 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.442 1.097 . . . . 0.0 112.223 177.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.8 -1.42 56.8 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.346 0.658 . . . . 0.0 112.52 -178.295 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 64.4 m -79.81 156.39 27.42 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 122.287 1.042 . . . . 0.0 111.474 -177.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 33.6 p -127.41 176.64 7.3 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 127.371 2.268 . . . . 0.0 106.656 169.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -56.08 -36.33 67.99 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.776 -0.578 . . . . 0.0 111.837 -177.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -86.44 -11.72 51.08 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.014 0.526 . . . . 0.0 112.325 -176.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -69.52 -33.39 72.75 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 121.346 -0.846 . . . . 0.0 112.153 -169.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.7 mp -80.95 -31.86 34.73 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 122.936 0.494 . . . . 0.0 110.437 176.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -67.93 -18.46 64.77 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 123.279 0.632 . . . . 0.0 111.884 -172.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.12 -28.31 69.55 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.761 1.224 . . . . 0.0 112.157 175.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -96.79 157.65 15.8 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.436 1.094 . . . . 0.0 110.598 -179.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -104.82 -30.48 9.85 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.219 171.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.1 mm -106.7 138.63 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 174.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 86.0 mt -132.05 129.69 40.35 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 177.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.6 mp -114.22 113.84 25.19 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 172.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 61.2 mt -110.59 109.67 20.07 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 -170.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.68 118.61 5.63 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 125.726 1.632 . . . . 0.0 109.575 178.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.7 tp -135.03 108.91 10.59 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 117.994 0.897 . . . . 0.0 109.358 -170.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -76.19 146.03 28.12 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 121.762 1.641 . . . . 0.0 110.355 170.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 42.9 m -99.19 131.7 45.03 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 175.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 8.4 m95 -137.19 174.83 10.19 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 123.916 0.886 . . . . 0.0 111.63 -170.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 60.85 -76.69 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 128.557 2.743 . . . . 0.0 113.957 171.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -149.23 39.24 0.82 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.82 1.648 . . . . 0.0 109.841 -170.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.74 56.28 6.73 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 -170.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -131.18 164.54 25.29 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.264 1.426 . . . . 0.0 108.984 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.87 161.83 28.65 Favored 'General case' 0 C--O 1.236 0.354 0 O-C-N 121.848 -0.533 . . . . 0.0 110.09 169.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -71.1 154.85 41.42 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 170.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 58.6 m -59.16 -36.92 76.12 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.858 0.863 . . . . 0.0 112.885 -169.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -65.73 -43.14 89.9 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 118.505 0.593 . . . . 0.0 110.056 -178.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -69.39 -47.42 64.27 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.381 0.672 . . . . 0.0 109.81 177.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -60.09 -35.87 76.16 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.425 0.69 . . . . 0.0 111.818 -177.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -70.45 -25.83 63.37 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.861 0.864 . . . . 0.0 112.248 176.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -92.76 -21.4 19.96 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.312 0.645 . . . . 0.0 112.076 -179.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 17.0 m-30 -48.66 -42.99 61.28 Favored Pre-proline 0 CA--C 1.547 0.865 0 CA-C-O 116.86 -1.543 . . . . 0.0 114.52 177.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -64.52 -23.38 64.46 Favored 'Trans proline' 0 CA--C 1.544 1.019 0 CA-C-N 122.972 2.097 . . . . 0.0 113.462 175.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.1 m -79.63 -40.28 29.6 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 119.302 0.955 . . . . 0.0 109.001 170.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 16.7 tp -60.85 -32.16 71.57 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.726 1.21 . . . . 0.0 111.798 -172.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -78.53 -11.14 59.94 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.999 0.92 . . . . 0.0 112.361 177.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -87.18 -32.92 19.56 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 119.818 1.19 . . . . 0.0 110.035 170.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 86.7 mt -63.93 143.13 15.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 -178.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -98.18 133.8 42.12 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.121 0.968 . . . . 0.0 108.865 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -124.2 14.6 9.05 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 118.306 -0.854 . . . . 0.0 111.032 178.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -56.71 115.46 2.57 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-N 119.963 1.256 . . . . 0.0 109.345 -178.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.76 2.91 62.03 Favored Glycine 0 CA--C 1.535 1.291 0 CA-C-O 118.368 -1.24 . . . . 0.0 114.174 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -79.18 147.25 32.71 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 119.675 1.737 . . . . 0.0 107.287 170.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 8.4 mt -95.09 134.27 37.99 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 178.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 15.2 t -130.86 145.28 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 178.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -136.2 151.13 49.38 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 170.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 81.5 mt -120.63 148.1 44.35 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -171.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -145.81 166.26 26.44 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 169.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 178.33 172.16 42.43 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-O 122.692 1.162 . . . . 0.0 114.566 177.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 68.7 m -123.02 151.19 42.15 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 112.936 -1.632 . . . . 0.0 109.526 -169.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -169.49 176.92 43.31 Favored Glycine 0 N--CA 1.442 -0.957 0 N-CA-C 109.634 -1.387 . . . . 0.0 109.634 -172.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -127.03 110.23 12.74 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 177.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -78.93 -6.69 56.85 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 118.692 -0.671 . . . . 0.0 112.381 -169.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -111.72 -41.71 3.99 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.49 1.041 . . . . 0.0 110.639 -176.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -82.63 -29.0 30.4 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 121.76 -0.587 . . . . 0.0 111.999 -175.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -122.65 50.64 1.48 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.298 1.439 . . . . 0.0 108.974 172.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.57 -19.76 50.92 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 126.175 1.79 . . . . 0.0 115.401 -170.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -108.44 4.08 23.92 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.207 1.003 . . . . 0.0 112.929 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -127.98 19.96 6.49 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.046 1.338 . . . . 0.0 110.689 -178.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -65.96 128.52 36.36 Favored 'General case' 0 C--O 1.234 0.285 0 O-C-N 121.458 -0.777 . . . . 0.0 110.93 -168.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 95.5 m 52.25 31.39 9.19 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.918 1.687 . . . . 0.0 113.937 176.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -56.02 -41.3 74.72 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.02 -21.12 64.14 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 -168.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 7.7 mp -60.29 -40.04 89.07 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 119.113 0.87 . . . . 0.0 109.798 172.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.12 -33.81 88.25 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 177.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 5.8 m -64.11 -38.45 91.1 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.26 1.03 . . . . 0.0 110.177 177.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 4.0 mt -66.66 -44.58 89.62 Favored 'Isoleucine or valine' 0 C--N 1.344 0.366 0 CA-C-O 117.632 -1.175 . . . . 0.0 109.075 175.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 60.3 ttp85 -55.75 -45.62 78.0 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 120.174 1.352 . . . . 0.0 110.136 178.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -60.44 -25.2 65.81 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -178.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 78.6 mt -87.27 -45.44 16.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 123.989 0.916 . . . . 0.0 110.667 176.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.6 pt -86.43 -22.86 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 120.114 1.325 . . . . 0.0 112.779 -169.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -67.34 -46.12 49.45 Favored Pre-proline 0 CA--C 1.545 0.751 0 CA-C-O 117.436 -1.268 . . . . 0.0 111.661 -177.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -60.68 -28.1 85.95 Favored 'Trans proline' 0 C--N 1.356 0.934 0 C-N-CA 122.061 1.841 . . . . 0.0 112.969 172.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 15.4 mmm180 -86.37 10.57 14.58 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.877 1.271 . . . . 0.0 111.764 -177.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 77.81 15.67 80.95 Favored Glycine 0 CA--C 1.529 0.91 0 CA-C-O 118.494 -1.17 . . . . 0.0 114.721 169.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.31 141.01 56.79 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 119.072 1.436 . . . . 0.0 109.834 173.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 55.5 m -92.73 121.96 34.66 Favored 'General case' 0 C--O 1.232 0.133 0 N-CA-C 105.337 -2.098 . . . . 0.0 105.337 168.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 43.6 mt -105.12 123.39 59.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 -171.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 26.8 m -126.15 174.77 9.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 125.149 1.379 . . . . 0.0 109.011 178.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 78.24 33.28 40.51 Favored Glycine 0 CA--C 1.527 0.796 0 O-C-N 121.844 -0.535 . . . . 0.0 112.333 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -63.86 143.88 57.5 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 169.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . 0.421 ' HE1' ' NH2' ' A' ' 156' ' ' ARG . 72.8 t-105 -135.74 133.88 20.36 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 118.199 -0.905 . . . . 0.0 108.936 -167.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -68.32 141.77 52.71 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 121.496 1.464 . . . . 0.0 112.442 -170.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 12.6 p . . . . . 0 CA--C 1.536 0.442 0 C-N-CA 122.732 0.413 . . . . 0.0 110.041 169.202 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? . . . . . 0 N--CA 1.47 0.572 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -78.1 1.21 70.45 Favored Glycine 0 CA--C 1.532 1.143 0 CA-C-N 118.871 0.759 . . . . 0.0 113.078 171.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 7.9 mp -62.88 132.69 52.98 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 118.872 1.336 . . . . 0.0 110.869 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -96.01 -29.64 14.03 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.384 1.474 . . . . 0.0 108.584 166.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -145.28 161.77 38.8 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 127.511 2.325 . . . . 0.0 106.558 170.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -53.5 -33.28 53.84 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 119.438 1.017 . . . . 0.0 112.355 176.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -89.08 -7.52 55.67 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.831 0.853 . . . . 0.0 113.245 -178.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 64.6 m80 -146.8 125.19 12.32 Favored 'General case' 0 C--N 1.347 0.491 0 CA-C-N 119.759 1.163 . . . . 0.0 113.95 -170.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -69.79 151.84 45.3 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 164.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 9.0 p -69.74 -12.61 16.26 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 123.881 0.873 . . . . 0.0 111.946 175.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -164.48 171.02 39.86 Favored Glycine 0 CA--C 1.523 0.562 0 O-C-N 121.29 -0.881 . . . . 0.0 111.187 -172.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -67.22 114.74 6.19 Favored 'General case' 0 C--N 1.334 -0.09 0 C-N-CA 123.755 0.822 . . . . 0.0 108.975 -178.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.206 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 170.638 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 82.2 mt . . . . . 0 N--CA 1.463 0.196 0 N-CA-C 111.438 0.162 . . . . 0.0 111.438 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 52.9 m -41.76 -44.98 3.42 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.563 1.945 . . . . 0.0 113.299 -175.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -70.44 -31.5 68.7 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 119.155 0.888 . . . . 0.0 111.914 -173.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -71.98 -40.26 68.7 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 169.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.421 ' NH2' ' HE1' ' A' ' 120' ' ' TRP . 72.0 mtp85 -66.67 -38.26 86.46 Favored 'General case' 0 C--O 1.225 -0.186 0 CA-C-O 118.551 -0.737 . . . . 0.0 110.974 -174.25 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 26.8 m -69.3 -31.29 49.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-N 119.928 1.24 . . . . 0.0 111.179 177.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -65.49 -52.63 51.47 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 120.255 1.389 . . . . 0.0 109.501 171.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 39.3 mttp -61.15 -31.08 70.8 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 118.892 -0.575 . . . . 0.0 111.448 -177.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 61.5 t90 -78.92 -51.97 8.93 Favored 'General case' 0 N--CA 1.457 -0.094 0 CA-C-N 118.845 0.748 . . . . 0.0 111.19 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 56.8 t -63.72 -31.29 52.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 O-C-N 121.563 -0.711 . . . . 0.0 110.26 -175.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -59.48 -35.44 74.11 Favored 'General case' 0 CA--C 1.532 0.26 0 O-C-N 121.283 -0.886 . . . . 0.0 111.368 174.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -63.95 -53.57 48.16 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 118.711 0.687 . . . . 0.0 109.956 172.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 2.2 pt -69.0 -26.86 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 O-C-N 121.89 -0.507 . . . . 0.0 110.373 -170.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 46.1 m -58.97 -32.5 69.7 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 119.118 -0.468 . . . . 0.0 111.199 174.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -77.98 -43.75 28.7 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.553 1.07 . . . . 0.0 110.043 175.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -67.7 -34.06 76.13 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.587 0.755 . . . . 0.0 111.629 -174.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 83.7 mt -87.16 3.88 44.58 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.576 1.551 . . . . 0.0 111.108 177.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 25.9 m80 56.18 31.61 18.66 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.182 1.793 . . . . 0.0 113.001 -177.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 92.1 mt . . . . . 0 N--CA 1.464 0.255 0 C-N-CA 123.623 0.769 . . . . 0.0 110.304 173.714 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.248 0 CA-C-O 120.836 0.351 . . . . 0.0 111.385 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.9 pt -105.9 -14.98 8.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 125.248 1.419 . . . . 0.0 111.13 178.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 88.2 m -119.43 127.91 53.54 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.989 1.316 . . . . 0.0 108.826 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -91.28 129.34 9.75 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 107.856 -2.098 . . . . 0.0 107.856 169.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 33.0 mt -103.83 95.75 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 103.368 -2.827 . . . . 0.0 103.368 171.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 19.6 m-30 -100.16 129.65 46.21 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 -177.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 26.1 p90 -132.93 163.99 27.94 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 118.424 0.556 . . . . 0.0 110.99 -172.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -140.03 139.2 9.67 Favored Glycine 0 C--N 1.336 0.554 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 168.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.8 m -141.29 167.52 21.98 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.932 1.366 . . . . 0.0 110.696 -174.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -136.83 -50.8 0.66 Allowed 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.509 0.724 . . . . 0.0 110.157 168.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.3 p -82.48 -11.63 58.36 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.607 0.763 . . . . 0.0 112.084 171.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.92 6.59 51.93 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 124.961 1.267 . . . . 0.0 113.747 170.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -70.69 -44.05 67.77 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 118.757 1.279 . . . . 0.0 111.731 -173.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.01 -27.33 67.33 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 120.97 -1.081 . . . . 0.0 111.146 -175.175 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -62.57 -42.11 99.34 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 118.719 0.691 . . . . 0.0 109.85 172.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -63.5 -42.25 98.51 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 121.8 -0.562 . . . . 0.0 110.377 178.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 21.0 mm -62.06 -46.34 96.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 176.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.6 -41.38 94.65 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 121.929 -0.482 . . . . 0.0 111.426 -179.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.2 mtpt -65.66 -40.91 92.93 Favored 'General case' 0 C--O 1.227 -0.098 0 CA-C-O 118.49 -0.767 . . . . 0.0 110.676 177.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 61.8 mtm -62.38 -40.98 98.23 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 119.73 1.15 . . . . 0.0 110.759 176.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 70.2 mt -59.96 -47.04 93.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 176.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -63.53 -37.84 88.87 Favored 'General case' 0 CA--C 1.53 0.181 0 O-C-N 121.017 -1.052 . . . . 0.0 111.685 178.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -65.05 -34.04 77.48 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 120.115 1.325 . . . . 0.0 111.088 178.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 12.9 mm100 -70.1 -43.66 70.6 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 118.184 0.447 . . . . 0.0 110.744 175.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -82.93 -32.5 27.18 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.461 0.704 . . . . 0.0 112.434 -170.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 90.45 144.42 11.97 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 124.852 1.215 . . . . 0.0 111.117 -169.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 56.5 tptt -57.36 -35.77 70.36 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 125.281 1.432 . . . . 0.0 111.864 -175.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -82.95 -1.94 53.74 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.009 0.523 . . . . 0.0 112.351 -176.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.5 t -110.01 -46.93 6.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 123.769 0.828 . . . . 0.0 109.186 176.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -131.65 139.55 49.13 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 119.242 0.928 . . . . 0.0 110.458 -177.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -130.5 141.77 50.49 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 99.2 t -100.77 129.99 50.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 C-N-CA 124.813 1.245 . . . . 0.0 110.718 -167.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -143.97 145.37 32.19 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.945 0.898 . . . . 0.0 110.136 175.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -74.98 134.29 41.52 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 169.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.4 tp -56.53 -31.3 33.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 123.387 0.675 . . . . 0.0 112.057 -174.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.29 -32.53 70.11 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -170.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -92.07 -10.38 39.27 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -178.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 36.9 m -70.2 126.09 28.66 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 119.214 0.915 . . . . 0.0 108.73 177.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 14.5 m -73.43 168.2 19.72 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.597 0.759 . . . . 0.0 109.742 173.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -53.39 -41.11 65.59 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.585 0.754 . . . . 0.0 110.865 174.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -77.44 -15.92 59.07 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.099 0.56 . . . . 0.0 112.178 -178.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -75.27 -28.3 59.74 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 121.141 -0.974 . . . . 0.0 111.109 -176.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -68.66 -43.71 75.64 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.596 0.758 . . . . 0.0 109.024 169.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -65.65 -25.79 67.51 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.161 0.584 . . . . 0.0 112.137 -179.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.3 -30.32 70.14 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.681 0.793 . . . . 0.0 112.709 -174.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -92.57 154.85 18.16 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.35 1.06 . . . . 0.0 110.112 178.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -104.01 -21.87 13.54 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.353 0.661 . . . . 0.0 111.775 169.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.8 mp -121.65 132.74 70.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 176.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 80.0 mt -133.25 135.81 45.18 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 123.42 0.688 . . . . 0.0 109.991 178.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 7.3 mp -114.42 118.62 34.35 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 104.469 -2.419 . . . . 0.0 104.469 170.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 73.9 mt -112.48 117.72 33.17 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 123.32 0.648 . . . . 0.0 109.733 -169.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -101.4 98.82 1.84 Allowed Glycine 0 C--N 1.335 0.494 0 C-N-CA 125.713 1.625 . . . . 0.0 111.273 -173.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 2.1 tp -120.86 109.61 35.7 Favored Pre-proline 0 CA--C 1.538 0.487 0 C-N-CA 125.466 1.506 . . . . 0.0 109.476 -169.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -81.48 155.38 18.7 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.854 2.37 . . . . 0.0 110.418 173.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.7 m -101.06 136.22 41.26 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 172.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 60.7 m95 -135.51 173.53 11.62 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 125.647 1.579 . . . . 0.0 109.864 -178.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 13.4 t80 38.98 56.03 2.03 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.095 2.158 . . . . 0.0 113.443 168.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 26.2 p90 46.3 66.05 1.05 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.086 1.355 . . . . 0.0 112.088 176.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.55 52.36 3.38 Favored Glycine 0 CA--C 1.525 0.67 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.818 172.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -136.23 154.26 50.97 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 124.513 1.125 . . . . 0.0 109.116 174.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -79.28 146.08 33.18 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 169.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -59.47 147.43 36.67 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 171.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 74.5 m -58.13 -29.73 65.76 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.212 1.005 . . . . 0.0 113.546 -168.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -68.47 -32.73 72.93 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 118.891 0.769 . . . . 0.0 111.213 -178.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 92.1 m95 -79.44 -45.52 19.28 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-N 118.121 0.418 . . . . 0.0 110.085 171.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -60.54 -38.26 83.87 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.021 0.373 . . . . 0.0 111.926 -175.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -68.09 -24.75 65.08 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.581 0.753 . . . . 0.0 112.11 176.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -88.85 -25.4 22.19 Favored 'General case' 0 C--N 1.341 0.225 0 CA-C-O 118.738 -0.649 . . . . 0.0 111.914 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -49.57 -43.15 71.29 Favored Pre-proline 0 CA--C 1.546 0.819 0 CA-C-O 116.704 -1.617 . . . . 0.0 114.729 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -66.61 -15.19 46.83 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 CA-C-N 122.784 2.03 . . . . 0.0 113.774 176.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.1 m -89.78 -40.67 12.33 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.85 0.86 . . . . 0.0 109.013 169.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.5 ' HA ' HD12 ' A' ' 76' ' ' ILE . 31.3 tp -56.62 -38.32 71.93 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 125.017 1.327 . . . . 0.0 111.567 -176.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -68.74 -10.19 55.07 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -96.22 -7.19 36.3 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 119.646 1.112 . . . . 0.0 112.001 177.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.5 HD12 ' HA ' ' A' ' 73' ' ' LEU . 95.8 mt -91.57 146.39 6.32 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 -169.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -91.58 130.47 37.39 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 178.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -125.35 10.59 8.0 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 123.778 0.831 . . . . 0.0 111.768 176.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -63.89 126.55 28.01 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 120.231 1.378 . . . . 0.0 110.133 -175.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 74.84 -3.05 46.62 Favored Glycine 0 CA--C 1.538 1.474 0 CA-C-O 118.102 -1.388 . . . . 0.0 114.152 -175.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 63.1 mttm -79.61 146.16 32.69 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 120.226 2.013 . . . . 0.0 108.045 175.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 20.0 mt -95.38 131.6 41.33 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 176.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.9 t -132.25 143.14 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 178.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -129.63 156.16 44.67 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.893 1.277 . . . . 0.0 107.832 170.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 14.3 mt -122.27 145.87 47.83 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 124.324 1.05 . . . . 0.0 108.335 -175.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -141.36 156.15 45.85 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 123.851 0.86 . . . . 0.0 109.08 170.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -179.94 -169.25 39.89 Favored Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 111.394 -0.682 . . . . 0.0 111.394 -178.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 21.9 p -135.59 171.88 13.81 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 126.379 1.872 . . . . 0.0 109.196 -169.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -169.69 178.23 42.78 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 112.423 -0.271 . . . . 0.0 112.423 170.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -127.77 138.98 52.93 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 125.712 1.605 . . . . 0.0 108.201 169.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -121.28 24.99 9.74 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.274 1.029 . . . . 0.0 111.012 -172.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -119.02 -48.63 2.44 Favored 'General case' 0 C--O 1.234 0.263 0 O-C-N 121.444 -0.785 . . . . 0.0 109.903 -177.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -107.68 -33.78 7.18 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.936 0.894 . . . . 0.0 110.617 176.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -98.13 25.48 6.09 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.994 0.918 . . . . 0.0 111.925 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.17 -21.15 66.45 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -173.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -84.33 -3.01 58.0 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.905 0.882 . . . . 0.0 112.001 174.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -135.69 17.96 3.31 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.876 1.671 . . . . 0.0 109.614 -173.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -65.07 118.76 9.64 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -168.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 56.3 m 53.35 27.56 6.4 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.394 1.478 . . . . 0.0 113.2 -177.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -54.03 -38.17 64.9 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.06 1.344 . . . . 0.0 112.281 -173.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.25 -13.29 61.48 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -171.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 82.0 mt -58.97 -43.51 91.39 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 119.022 0.828 . . . . 0.0 109.759 175.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -69.98 -29.36 70.81 Favored Glycine 0 CA--C 1.529 0.91 0 N-CA-C 111.923 -0.471 . . . . 0.0 111.923 -177.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 8.3 m -63.21 -37.15 86.1 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 117.873 0.837 . . . . 0.0 111.133 -174.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.4 mt -73.82 -45.36 50.02 Favored 'Isoleucine or valine' 0 C--N 1.344 0.339 0 CA-C-O 118.452 -0.785 . . . . 0.0 108.938 176.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 37.4 ttt180 -53.33 -42.4 66.71 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 119.081 0.855 . . . . 0.0 110.738 -178.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -61.27 -17.61 54.34 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.104 0.962 . . . . 0.0 112.847 -179.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 69.7 mt -99.2 -48.33 11.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 124.66 1.184 . . . . 0.0 109.627 175.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 40.8 pt -79.9 -34.25 15.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 119.459 1.027 . . . . 0.0 112.117 -168.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -70.6 -41.67 13.01 Favored Pre-proline 0 CA--C 1.543 0.687 0 CA-C-O 117.576 -1.202 . . . . 0.0 110.88 -175.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -63.47 -30.33 71.75 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.032 1.821 . . . . 0.0 113.322 171.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -76.67 7.61 4.44 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.101 0.96 . . . . 0.0 112.328 171.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 93.33 6.64 62.68 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 125.882 1.706 . . . . 0.0 114.976 168.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.62 137.37 57.56 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 119.652 1.726 . . . . 0.0 109.424 175.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 87.3 m -90.83 122.77 33.84 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 169.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 23.1 mm -100.15 126.85 53.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 -171.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 27.6 m -130.91 179.72 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 125.024 1.329 . . . . 0.0 108.612 175.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 74.44 32.61 57.58 Favored Glycine 0 C--N 1.338 0.659 0 O-C-N 121.528 -0.733 . . . . 0.0 112.082 179.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 83.8 m-70 -64.24 143.03 58.19 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 169.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 55.1 t-105 -130.19 140.67 39.34 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-O 117.866 -1.064 . . . . 0.0 108.963 -178.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -61.31 148.42 92.97 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 CA-C-N 121.063 1.415 . . . . 0.0 114.772 -170.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 41.4 p . . . . . 0 CA--C 1.537 0.469 0 C-N-CA 123.485 0.714 . . . . 0.0 110.629 167.958 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.471 0.595 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -82.2 5.77 70.69 Favored Glycine 0 CA--C 1.527 0.843 0 CA-C-O 118.633 -1.093 . . . . 0.0 113.153 177.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 8.5 mp -63.16 128.15 34.54 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 119.909 1.854 . . . . 0.0 110.238 178.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.26 -37.63 25.64 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.587 1.555 . . . . 0.0 107.746 167.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -153.94 165.75 35.12 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 129.481 3.112 . . . . 0.0 106.227 -177.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -51.03 -35.92 36.88 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.275 0.943 . . . . 0.0 112.41 175.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -96.18 -3.4 44.44 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -175.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -146.54 139.42 25.4 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 120.542 1.519 . . . . 0.0 112.455 -172.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -84.91 155.54 21.63 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.613 1.565 . . . . 0.0 108.706 167.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 24.4 m -70.03 -8.65 11.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 125.127 1.371 . . . . 0.0 112.735 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -158.23 173.62 35.4 Favored Glycine 0 C--N 1.337 0.622 0 C-N-CA 124.964 1.269 . . . . 0.0 110.564 -178.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -64.94 132.02 48.2 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 124.556 1.142 . . . . 0.0 109.007 176.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.309 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 169.286 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 83.1 mt . . . . . 0 N--CA 1.464 0.246 0 N-CA-C 110.682 -0.118 . . . . 0.0 110.682 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 5.0 m -48.7 -50.06 35.08 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.418 1.087 . . . . 0.0 110.892 -179.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.88 -41.81 86.62 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.641 0.655 . . . . 0.0 110.714 -171.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -61.89 -48.42 80.56 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 123.023 0.529 . . . . 0.0 109.855 177.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 75.8 mtt180 -62.54 -45.74 91.57 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 122.933 0.493 . . . . 0.0 110.114 -176.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 83.3 t -68.75 -43.72 82.71 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.118 0 CA-C-O 118.274 -0.869 . . . . 0.0 109.84 -178.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -62.38 -45.07 94.82 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 120.556 1.525 . . . . 0.0 110.124 -178.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -65.6 -39.7 91.85 Favored 'General case' 0 C--N 1.333 -0.137 0 O-C-N 121.924 -0.485 . . . . 0.0 110.239 -179.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 75.9 t90 -66.67 -45.96 77.22 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-N 118.452 0.569 . . . . 0.0 110.356 178.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 55.9 t -59.07 -41.53 83.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 45.5 mttm -62.46 -44.97 95.12 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 118.678 0.672 . . . . 0.0 109.881 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 19.8 mm100 -62.1 -52.83 62.31 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 122.852 0.461 . . . . 0.0 110.569 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 22.8 pt -68.24 -32.2 54.8 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 CA-C-O 118.811 -0.614 . . . . 0.0 110.825 -174.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 48.8 m -62.92 -30.67 71.73 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 119.188 0.904 . . . . 0.0 111.082 -178.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -77.67 -41.99 36.2 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 119.327 0.967 . . . . 0.0 110.578 175.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -68.18 -33.96 75.41 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.505 0.722 . . . . 0.0 111.708 -177.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 81.1 mt -90.62 -2.38 57.86 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.202 1.801 . . . . 0.0 111.327 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 25.2 m80 56.82 22.36 6.93 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.9 1.68 . . . . 0.0 113.478 -174.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 78.8 mt . . . . . 0 N--CA 1.464 0.226 0 C-N-CA 124.275 1.03 . . . . 0.0 110.536 175.96 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.347 0 N-CA-C 110.517 -0.179 . . . . 0.0 110.517 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 31.0 pt -87.27 -22.48 6.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 123.107 0.563 . . . . 0.0 111.375 -179.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 15.4 m -110.63 126.51 54.55 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 125.612 1.565 . . . . 0.0 108.531 178.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -102.77 123.79 7.96 Favored Glycine 0 CA--C 1.521 0.419 0 N-CA-C 107.056 -2.418 . . . . 0.0 107.056 169.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 62.3 mt -105.26 92.28 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 N-CA-C 105.338 -2.097 . . . . 0.0 105.338 178.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -88.64 135.26 33.59 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 -177.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -132.58 133.37 43.6 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 119.943 1.247 . . . . 0.0 112.596 176.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -87.97 148.14 20.74 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 108.283 -1.927 . . . . 0.0 108.283 167.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.9 m -168.35 160.46 11.36 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 119.069 1.435 . . . . 0.0 110.624 174.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -125.3 -53.36 1.61 Allowed 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.821 0.848 . . . . 0.0 109.493 167.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.8 p -85.92 6.01 30.41 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 124.944 1.298 . . . . 0.0 113.219 174.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 85.25 -7.18 76.84 Favored Glycine 0 CA--C 1.532 1.107 0 N-CA-C 117.302 1.681 . . . . 0.0 117.302 167.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.55 -36.08 77.58 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 120.51 2.155 . . . . 0.0 113.461 -170.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 11.4 m -73.02 -16.2 61.51 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 119.408 1.004 . . . . 0.0 110.791 -175.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -60.77 -42.5 97.58 Favored 'General case' 0 C--N 1.342 0.264 0 O-C-N 121.101 -0.999 . . . . 0.0 109.879 173.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -65.94 -39.04 90.14 Favored 'General case' 0 C--N 1.339 0.142 0 O-C-N 121.984 -0.448 . . . . 0.0 110.086 -178.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 41.0 mm -62.33 -47.69 91.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 176.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.34 -43.9 96.02 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 122.843 0.457 . . . . 0.0 111.345 179.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 54.9 mttm -63.85 -43.72 95.28 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 118.811 -0.614 . . . . 0.0 110.848 178.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 75.6 mtm -63.5 -37.06 85.86 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 119.328 0.967 . . . . 0.0 110.965 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 34.0 mt -65.22 -44.6 95.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 174.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -60.12 -40.13 88.64 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 119.291 0.951 . . . . 0.0 110.741 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -64.45 -34.17 77.58 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 119.007 0.821 . . . . 0.0 111.172 179.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -68.2 -51.13 49.03 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 118.689 0.677 . . . . 0.0 110.431 175.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 42.5 mt -71.16 -31.92 68.29 Favored 'General case' 0 C--N 1.341 0.227 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -174.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.63 147.21 20.86 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 125.31 1.433 . . . . 0.0 110.983 -174.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -65.05 -29.71 70.63 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.764 0.826 . . . . 0.0 112.172 -172.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -67.51 -29.37 68.77 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 122.63 0.372 . . . . 0.0 111.117 177.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 33.3 t -93.69 -36.9 7.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 C-N-CA 124.585 1.154 . . . . 0.0 110.256 -175.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -134.93 144.54 47.52 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 119.067 0.849 . . . . 0.0 112.838 -171.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -131.09 141.69 50.18 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.376 1.07 . . . . 0.0 110.058 172.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 87.9 t -88.88 141.32 14.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 123.728 0.811 . . . . 0.0 108.911 -178.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -145.28 169.57 17.99 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.442 1.097 . . . . 0.0 111.444 -169.026 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -144.95 121.17 10.85 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.275 1.43 . . . . 0.0 107.474 -177.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.4 tp -59.09 -21.76 20.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 123.474 0.71 . . . . 0.0 112.242 -171.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.82 -29.16 69.98 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.05 0.54 . . . . 0.0 111.725 176.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 57.8 pttt -108.49 -19.53 13.42 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.302 1.041 . . . . 0.0 112.408 178.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.4 m -63.88 165.32 8.84 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 119.262 0.937 . . . . 0.0 110.53 170.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 24.4 p -143.95 166.89 23.7 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.163 0.985 . . . . 0.0 110.095 -179.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -52.93 -49.19 66.49 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.369 1.067 . . . . 0.0 111.32 -172.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -80.02 -24.02 41.09 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 122.134 0.174 . . . . 0.0 111.02 -175.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -73.35 -32.77 64.73 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.068 0.547 . . . . 0.0 111.091 -179.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -59.23 -37.77 78.33 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.405 0.682 . . . . 0.0 110.966 171.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -72.17 -16.59 61.97 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 122.884 0.473 . . . . 0.0 112.257 -173.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.18 -29.01 65.77 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.473 0.709 . . . . 0.0 111.871 -178.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -79.8 157.29 27.09 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.253 1.021 . . . . 0.0 110.169 179.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -109.77 -28.8 8.62 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.107 169.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.2 mp -112.04 126.91 69.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 173.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -112.58 122.22 47.06 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 175.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.2 mp -109.71 118.27 36.09 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 171.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 60.0 mt -119.46 109.16 15.42 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -171.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.5 122.57 7.19 Favored Glycine 0 CA--C 1.521 0.407 0 C-N-CA 125.629 1.585 . . . . 0.0 110.162 -179.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 18.4 tt -136.71 109.19 9.29 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-N 118.121 0.961 . . . . 0.0 111.648 -176.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.1 140.54 31.33 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 N-CA-C 107.32 -1.839 . . . . 0.0 107.32 166.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 90.5 m -91.97 136.17 33.37 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 177.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 30.1 m95 -129.62 173.97 10.11 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.518 1.127 . . . . 0.0 111.405 -172.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 55.07 -89.88 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 127.909 2.484 . . . . 0.0 112.397 179.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -153.58 78.66 1.14 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 126.271 1.829 . . . . 0.0 106.754 175.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 65.75 51.84 43.43 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 -177.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -127.79 155.85 43.41 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.1 0.96 . . . . 0.0 109.631 176.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -79.23 166.35 22.27 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.751 0.82 . . . . 0.0 109.968 170.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 18.1 mm-40 -72.57 153.75 41.13 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 169.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 60.8 m -58.98 -37.01 75.84 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.598 0.759 . . . . 0.0 112.739 -169.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -72.14 -38.38 69.24 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 118.712 0.687 . . . . 0.0 110.579 -177.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -66.42 -46.78 75.38 Favored 'General case' 0 C--N 1.342 0.241 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 173.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -60.53 -38.75 85.44 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.331 0.652 . . . . 0.0 111.557 -178.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -70.01 -25.72 63.72 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.996 0.918 . . . . 0.0 112.189 176.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -90.71 -20.55 22.33 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.445 0.698 . . . . 0.0 112.293 -179.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 19.3 m-30 -51.02 -42.24 78.85 Favored Pre-proline 0 CA--C 1.546 0.822 0 CA-C-O 116.762 -1.589 . . . . 0.0 114.253 177.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -65.5 -21.21 60.4 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 CA-C-N 122.966 2.095 . . . . 0.0 113.402 174.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.8 m -81.95 -36.33 28.08 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 119.371 0.987 . . . . 0.0 109.604 170.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 21.7 tp -61.91 -30.8 71.13 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.059 -1.026 . . . . 0.0 111.37 -175.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -82.96 -2.36 54.91 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.163 0.985 . . . . 0.0 113.134 175.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 39.4 mm-40 -100.36 -26.03 14.02 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.331 1.052 . . . . 0.0 110.425 172.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 80.9 mt -70.69 152.76 8.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 174.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -106.99 134.83 49.56 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.533 1.133 . . . . 0.0 109.465 178.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -124.98 15.55 8.53 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.499 1.119 . . . . 0.0 111.53 177.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -56.07 115.04 2.2 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 119.646 1.112 . . . . 0.0 109.79 -178.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 74.44 3.08 65.13 Favored Glycine 0 CA--C 1.536 1.358 0 CA-C-O 118.531 -1.149 . . . . 0.0 114.294 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -80.02 148.67 31.02 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 119.385 1.593 . . . . 0.0 107.742 171.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 19.1 mt -91.44 134.33 34.72 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 178.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 19.0 t -130.96 132.78 63.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 178.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -128.32 143.32 51.0 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 176.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 77.8 mt -115.99 146.23 42.3 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -173.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -141.55 160.35 40.33 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 169.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -170.9 170.06 42.91 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-O 122.419 1.01 . . . . 0.0 113.059 -171.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 15.5 m -136.7 148.8 47.54 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 125.739 1.616 . . . . 0.0 107.367 -169.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.6 -167.29 28.05 Favored Glycine 0 CA--C 1.528 0.859 0 O-C-N 123.233 0.333 . . . . 0.0 112.604 -174.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -139.78 143.57 36.97 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.721 1.608 . . . . 0.0 109.896 -179.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -118.66 3.85 11.68 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.053 1.741 . . . . 0.0 112.268 -178.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -85.81 -47.59 9.58 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 119.699 1.136 . . . . 0.0 110.572 176.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -129.68 -37.97 1.53 Allowed 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.248 0.619 . . . . 0.0 111.825 -170.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -87.26 18.82 3.49 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.218 0.607 . . . . 0.0 112.133 174.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.67 -39.72 71.33 Favored 'General case' 0 C--N 1.342 0.247 0 C-N-CA 124.729 1.212 . . . . 0.0 112.365 -173.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -65.93 -13.96 60.68 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 118.577 0.626 . . . . 0.0 111.938 -177.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -120.83 21.57 11.39 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 126.546 1.939 . . . . 0.0 110.112 -177.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -60.34 119.32 7.73 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 118.832 0.742 . . . . 0.0 110.729 -169.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 72.2 m 47.63 32.03 2.34 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.021 1.729 . . . . 0.0 112.749 -177.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -54.87 -37.5 66.34 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.055 0.942 . . . . 0.0 112.087 -173.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.87 -14.07 62.81 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -171.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 84.9 mt -56.07 -42.98 77.52 Favored 'General case' 0 C--N 1.345 0.371 0 CA-C-N 118.961 0.801 . . . . 0.0 109.609 169.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.97 -33.15 86.47 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 -178.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.2 m -64.33 -41.37 96.82 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 118.18 0.99 . . . . 0.0 110.194 178.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 6.2 mt -68.22 -45.21 83.31 Favored 'Isoleucine or valine' 0 C--N 1.343 0.312 0 CA-C-N 119.198 0.908 . . . . 0.0 108.8 176.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 52.3 ttt-85 -52.95 -47.82 67.83 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 119.236 0.925 . . . . 0.0 110.157 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -64.98 -23.24 67.16 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 123.87 0.868 . . . . 0.0 112.381 -175.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 76.2 mt -86.2 -46.42 16.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 118.844 0.747 . . . . 0.0 109.381 175.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.0 pt -76.47 -26.27 16.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 119.363 0.983 . . . . 0.0 112.811 -169.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -64.06 -50.23 70.08 Favored Pre-proline 0 CA--C 1.547 0.832 0 CA-C-O 117.654 -1.165 . . . . 0.0 111.846 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -54.54 -29.75 61.58 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.858 2.372 . . . . 0.0 114.038 172.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 28.5 mmm180 -88.11 9.85 21.25 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.888 0.875 . . . . 0.0 111.799 -177.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 79.27 12.62 83.73 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-O 118.645 -1.086 . . . . 0.0 114.132 169.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.42 143.33 45.73 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 118.846 1.323 . . . . 0.0 110.287 173.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 48.7 m -93.15 121.11 34.17 Favored 'General case' 0 CA--C 1.528 0.108 0 N-CA-C 104.821 -2.288 . . . . 0.0 104.821 168.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 14.9 mt -102.23 126.06 56.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -168.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 6.1 m -140.98 174.28 7.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 125.928 1.691 . . . . 0.0 108.979 -170.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 74.56 37.11 47.2 Favored Glycine 0 CA--C 1.529 0.934 0 O-C-N 121.479 -0.763 . . . . 0.0 112.228 -175.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -66.56 138.88 57.8 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 173.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 70.9 t-105 -124.61 126.24 25.42 Favored Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 124.782 1.233 . . . . 0.0 108.423 -169.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -68.47 145.02 63.41 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 121.483 1.455 . . . . 0.0 112.358 -169.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 4.1 p . . . . . 0 CA--C 1.534 0.344 0 CA-C-O 119.234 -0.413 . . . . 0.0 110.674 169.988 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt . . . . . 0 N--CA 1.469 0.486 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -82.69 10.0 57.64 Favored Glycine 0 CA--C 1.534 1.268 0 CA-C-N 118.773 0.715 . . . . 0.0 112.743 169.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 82.0 mt -64.67 135.73 56.21 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 118.947 1.374 . . . . 0.0 111.162 -178.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -98.21 -31.57 12.01 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.927 1.291 . . . . 0.0 108.318 166.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -149.54 163.15 38.62 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 127.756 2.422 . . . . 0.0 106.797 172.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -55.71 -30.21 60.75 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.182 -0.949 . . . . 0.0 112.088 176.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -88.07 -10.49 50.02 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 10.9 m-70 -150.94 127.58 10.84 Favored 'General case' 0 C--N 1.347 0.476 0 CA-C-N 119.843 1.201 . . . . 0.0 113.684 -169.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -73.0 151.93 41.55 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 164.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 8.0 p -66.12 -19.05 25.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 O-C-N 121.98 -0.45 . . . . 0.0 112.016 176.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -154.77 163.17 31.17 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 123.791 0.71 . . . . 0.0 111.349 -171.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -56.71 127.82 33.4 Favored 'General case' 0 CA--C 1.522 -0.121 0 C-N-CA 124.22 1.008 . . . . 0.0 108.487 177.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.355 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 176.478 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 62.0 mt . . . . . 0 N--CA 1.471 0.607 0 N-CA-C 111.694 0.257 . . . . 0.0 111.694 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 87.7 m -53.83 -52.43 60.39 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 125.099 1.36 . . . . 0.0 111.012 -169.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -71.44 -32.3 68.2 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 122.178 0.191 . . . . 0.0 110.786 -171.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -67.16 -44.03 80.75 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 122.995 0.518 . . . . 0.0 109.64 173.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 38.5 mtt180 -66.2 -42.83 88.27 Favored 'General case' 0 C--O 1.232 0.184 0 O-C-N 121.606 -0.684 . . . . 0.0 110.964 -177.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 28.3 m -69.09 -35.52 68.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-O 118.148 -0.929 . . . . 0.0 109.809 178.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -60.07 -49.96 75.61 Favored 'General case' 0 C--N 1.342 0.279 0 CA-C-N 120.469 1.486 . . . . 0.0 110.233 174.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 59.6 mttm -57.83 -40.01 79.04 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 118.132 0.424 . . . . 0.0 110.554 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 61.8 t90 -72.09 -45.35 61.02 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 117.872 0.305 . . . . 0.0 110.745 -177.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 75.7 t -63.68 -34.81 70.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 O-C-N 121.489 -0.757 . . . . 0.0 109.716 -179.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -62.75 -34.61 77.56 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 118.455 -0.783 . . . . 0.0 110.714 177.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -62.67 -57.19 11.88 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.992 0.814 . . . . 0.0 110.053 171.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 6.9 pt -65.61 -30.27 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 118.828 0.74 . . . . 0.0 110.369 -171.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 49.4 m -58.74 -29.09 66.46 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 117.711 -1.138 . . . . 0.0 112.151 178.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -96.86 -13.32 22.6 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 120.456 1.48 . . . . 0.0 113.118 175.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -82.82 -39.67 21.39 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 118.972 0.806 . . . . 0.0 110.34 173.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 1.9 mp -90.24 -12.61 37.47 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.556 1.942 . . . . 0.0 110.719 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 57.19 30.52 18.5 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.731 1.612 . . . . 0.0 112.703 -169.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 55.2 mt . . . . . 0 N--CA 1.467 0.403 0 O-C-N 121.434 -0.791 . . . . 0.0 110.476 169.485 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.301 0 N-CA-C 110.597 -0.149 . . . . 0.0 110.597 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.0 pt -74.51 -29.93 24.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 O-C-N 122.144 -0.347 . . . . 0.0 110.987 178.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.3 m -110.25 136.01 50.12 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 124.637 1.175 . . . . 0.0 109.338 -179.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -108.21 118.96 5.55 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 107.299 -2.32 . . . . 0.0 107.299 168.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 39.8 mt -92.83 127.49 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 104.573 -2.38 . . . . 0.0 104.573 169.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -122.87 128.94 51.03 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 176.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -123.53 127.11 47.87 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 118.979 0.809 . . . . 0.0 112.376 -177.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -87.28 141.54 17.56 Favored Glycine 0 C--N 1.338 0.692 0 N-CA-C 108.35 -1.9 . . . . 0.0 108.35 167.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 37.8 m -153.15 166.44 32.49 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.716 1.758 . . . . 0.0 110.534 176.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -145.76 -51.65 0.25 Allowed 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.283 1.033 . . . . 0.0 109.794 169.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.9 p -80.77 -15.14 57.23 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.815 0.846 . . . . 0.0 112.058 172.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.22 32.09 6.9 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 124.491 1.043 . . . . 0.0 113.058 172.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -82.58 -52.73 6.55 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 118.423 1.112 . . . . 0.0 111.772 176.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -67.58 -23.62 65.42 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 121.588 -0.695 . . . . 0.0 112.441 -167.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -60.67 -35.65 76.77 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.283 0.947 . . . . 0.0 111.032 175.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -70.09 -42.79 72.26 Favored 'General case' 0 C--N 1.34 0.16 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 26.5 mm -61.77 -42.14 93.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 178.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.13 -41.88 93.62 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 121.517 -0.739 . . . . 0.0 111.017 178.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -67.72 -39.26 84.31 Favored 'General case' 0 CA--C 1.53 0.198 0 O-C-N 121.77 -0.581 . . . . 0.0 110.77 176.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 75.2 mtp -64.62 -30.01 71.03 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 119.283 0.947 . . . . 0.0 111.653 177.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 58.9 mt -70.4 -55.99 12.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 170.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -59.13 -32.97 70.33 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 121.323 -0.861 . . . . 0.0 112.386 -173.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -66.65 -34.85 78.78 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 120.039 1.29 . . . . 0.0 111.487 179.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -75.57 -39.65 57.81 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.015 0.526 . . . . 0.0 110.663 175.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -75.26 -39.79 59.44 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.807 0.843 . . . . 0.0 111.383 -174.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.53 141.57 5.87 Favored Glycine 0 CA--C 1.531 1.034 0 N-CA-C 108.818 -1.713 . . . . 0.0 108.818 -167.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 58.3 tttp -62.1 -31.08 71.48 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 121.643 -0.916 . . . . 0.0 111.722 -172.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -65.06 -29.53 70.43 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 123.071 0.548 . . . . 0.0 111.74 178.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.2 t -92.7 -38.24 9.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 123.755 0.822 . . . . 0.0 109.68 -178.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -139.04 125.71 20.72 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 119.411 1.005 . . . . 0.0 112.028 178.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -103.31 159.58 15.43 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.408 0.683 . . . . 0.0 110.191 173.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 51.1 t -121.7 129.35 75.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 124.234 1.013 . . . . 0.0 109.971 -169.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -144.9 172.43 13.04 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.887 1.675 . . . . 0.0 111.736 -173.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -125.88 136.81 53.49 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 175.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.5 tp -60.86 -25.99 37.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 O-C-N 121.435 -0.791 . . . . 0.0 111.633 -174.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -55.03 -36.36 65.44 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.578 1.151 . . . . 0.0 112.05 178.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -105.31 0.78 27.39 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.885 1.274 . . . . 0.0 111.912 -178.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 18.4 m -88.14 175.0 7.91 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.941 0.896 . . . . 0.0 109.654 177.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 70.7 m -153.85 162.4 41.26 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 120.888 -1.132 . . . . 0.0 109.483 179.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -51.0 -47.85 61.52 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.849 1.26 . . . . 0.0 111.178 -176.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -73.67 -24.39 59.97 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.459 -174.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -77.74 -35.58 51.67 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 122.818 0.447 . . . . 0.0 110.513 176.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -64.28 -50.46 67.82 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.498 0.719 . . . . 0.0 110.34 178.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -67.74 -19.27 65.11 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -172.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.51 -29.93 69.47 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.153 0.981 . . . . 0.0 112.667 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -75.25 159.57 31.38 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 123.827 0.851 . . . . 0.0 109.861 175.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -110.21 -22.23 11.86 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.309 0.644 . . . . 0.0 112.218 170.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.0 mp -120.71 132.56 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 175.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 97.4 mt -126.87 125.66 41.99 Favored 'General case' 0 CA--C 1.519 -0.232 0 C-N-CA 124.081 0.953 . . . . 0.0 108.865 -178.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 7.4 mp -114.11 107.92 16.29 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 176.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 66.7 mt -110.54 107.71 17.43 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 -170.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.43 117.94 5.44 Favored Glycine 0 C--N 1.331 0.285 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 17.5 tt -131.61 118.22 16.75 Favored Pre-proline 0 CA--C 1.539 0.523 0 CA-C-N 118.034 0.917 . . . . 0.0 110.408 -177.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -83.33 147.19 12.66 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.754 2.302 . . . . 0.0 108.427 168.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 54.5 m -99.29 143.52 29.45 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 177.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 68.2 m95 -136.13 171.15 14.9 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 125.731 1.612 . . . . 0.0 110.242 -174.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 25.83 72.17 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 128.062 2.545 . . . . 0.0 114.394 169.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 56.69 54.6 7.13 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.128 0.971 . . . . 0.0 111.81 174.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 82.8 13.3 78.19 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-O 119.388 -0.673 . . . . 0.0 114.326 171.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -74.39 154.08 38.97 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.511 1.156 . . . . 0.0 109.873 169.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.56 165.9 23.18 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 123.508 0.723 . . . . 0.0 110.571 170.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 14.9 tm0? -61.91 145.18 53.62 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 169.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 52.4 m -60.12 -37.2 79.32 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 114.959 1.466 . . . . 0.0 114.959 -167.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -76.09 -38.21 57.25 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 118.632 0.651 . . . . 0.0 109.281 -177.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -62.77 -47.26 84.29 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.185 0.594 . . . . 0.0 109.543 173.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -59.0 -40.36 84.66 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.598 0.759 . . . . 0.0 111.431 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -69.01 -31.76 70.81 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.245 0.618 . . . . 0.0 112.098 176.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -84.84 -21.84 29.68 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 117.889 -1.053 . . . . 0.0 112.647 -177.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 18.2 m-30 -48.37 -44.65 65.06 Favored Pre-proline 0 CA--C 1.544 0.735 0 CA-C-N 121.005 1.729 . . . . 0.0 115.114 -178.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.07 -16.36 54.85 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 CA-C-N 122.731 2.011 . . . . 0.0 113.897 176.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 31.5 m -91.46 -35.14 14.51 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.185 0.994 . . . . 0.0 109.643 169.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.45 ' HA ' HD12 ' A' ' 76' ' ' ILE . 17.0 tp -59.39 -39.17 82.52 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.222 1.009 . . . . 0.0 110.491 -178.339 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -73.66 -7.99 54.19 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -93.51 -1.55 55.46 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 119.619 1.1 . . . . 0.0 111.344 178.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.45 HD12 ' HA ' ' A' ' 73' ' ' LEU . 66.7 mt -92.37 146.03 6.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 -175.427 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -86.13 121.22 28.42 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 172.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -114.08 10.54 17.45 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 118.3 -0.857 . . . . 0.0 111.715 175.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 31.6 m-80 -59.32 117.36 4.71 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 120.269 1.395 . . . . 0.0 109.791 -172.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 72.84 -1.04 41.19 Favored Glycine 0 CA--C 1.534 1.28 0 CA-C-O 118.689 -1.062 . . . . 0.0 114.212 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -72.27 144.96 48.21 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 119.602 1.701 . . . . 0.0 108.024 172.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 35.7 mt -85.17 133.51 34.19 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 177.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.1 t -132.1 135.86 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 176.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -129.35 143.9 51.03 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 175.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 67.1 mt -118.94 148.19 43.22 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -175.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -145.65 153.69 41.3 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 123.205 0.602 . . . . 0.0 110.614 175.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -174.64 164.56 35.5 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-O 121.701 0.612 . . . . 0.0 112.683 179.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 24.9 p -121.27 167.67 12.47 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 125.418 1.487 . . . . 0.0 109.253 175.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -163.74 -160.18 11.45 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 114.271 0.468 . . . . 0.0 114.271 -177.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -143.42 153.67 42.9 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 126.622 1.969 . . . . 0.0 109.991 -175.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -138.28 7.66 2.64 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.865 0.866 . . . . 0.0 112.519 168.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -69.11 -33.28 73.24 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.58 1.082 . . . . 0.0 109.285 173.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -135.22 -36.7 0.8 Allowed 'General case' 0 C--O 1.234 0.285 0 C-N-CA 123.002 0.521 . . . . 0.0 112.17 171.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -89.78 29.98 1.1 Allowed 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 118.562 0.619 . . . . 0.0 112.604 -173.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.32 -31.8 71.66 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.189 0.996 . . . . 0.0 112.801 -174.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -79.92 1.16 28.35 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.266 1.026 . . . . 0.0 112.071 178.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -134.95 19.8 3.48 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.597 1.559 . . . . 0.0 109.896 -176.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -65.59 114.82 5.2 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -171.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 72.6 m 51.27 34.99 12.55 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.54 1.536 . . . . 0.0 113.203 -173.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -50.6 -44.54 57.06 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.672 1.189 . . . . 0.0 111.489 -179.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.84 -12.88 62.01 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 -169.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 90.0 mt -58.55 -39.68 80.93 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 118.893 0.77 . . . . 0.0 109.707 169.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.9 -32.08 83.04 Favored Glycine 0 CA--C 1.528 0.848 0 N-CA-C 111.412 -0.675 . . . . 0.0 111.412 178.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.6 m -65.85 -38.58 89.24 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.358 1.079 . . . . 0.0 110.334 178.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 7.0 mt -71.82 -42.49 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 119.105 0.866 . . . . 0.0 109.004 175.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 47.5 ttt180 -53.46 -45.43 69.55 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 119.408 1.003 . . . . 0.0 110.334 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -63.85 -20.07 65.53 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.026 0.93 . . . . 0.0 112.81 -177.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 96.4 mt -92.09 -48.77 13.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 123.974 0.91 . . . . 0.0 109.661 176.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.5 pt -78.07 -33.85 18.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-N 118.921 0.782 . . . . 0.0 111.979 -168.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -70.76 -43.91 15.43 Favored Pre-proline 0 CA--C 1.544 0.715 0 CA-C-O 117.962 -1.018 . . . . 0.0 111.269 -172.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -64.6 -31.42 59.92 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.032 1.821 . . . . 0.0 113.132 173.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? -75.81 6.51 4.92 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.019 0.928 . . . . 0.0 112.259 172.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 78.52 20.16 72.24 Favored Glycine 0 CA--C 1.527 0.828 0 CA-C-O 118.686 -1.064 . . . . 0.0 114.082 169.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -59.75 142.42 53.25 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 118.725 1.263 . . . . 0.0 109.857 170.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 37.6 m -89.1 116.45 27.37 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 104.461 -2.422 . . . . 0.0 104.461 168.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 38.9 mt -90.92 130.53 39.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 -176.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 3.7 m -137.44 165.86 26.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 126.103 1.761 . . . . 0.0 108.487 -177.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 74.49 31.44 58.87 Favored Glycine 0 CA--C 1.524 0.616 0 CA-C-O 119.141 -0.811 . . . . 0.0 112.293 -175.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 83.9 m-70 -58.48 134.08 56.36 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 169.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 70.8 t-105 -113.38 124.96 30.36 Favored Pre-proline 0 C--O 1.235 0.296 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -169.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -67.95 140.31 49.87 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 121.254 1.303 . . . . 0.0 110.632 -173.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 81.1 p . . . . . 0 CA--C 1.535 0.391 0 C-N-CA 123.186 0.594 . . . . 0.0 110.876 176.472 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.537 0.47 0 N-CA-C 110.882 -0.044 . . . . 0.0 110.882 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -78.46 0.19 76.54 Favored Glycine 0 CA--C 1.533 1.164 0 CA-C-O 118.404 -1.22 . . . . 0.0 113.798 169.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 65.0 mt -62.31 125.73 24.89 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 120.869 2.335 . . . . 0.0 108.618 171.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -91.82 -32.55 15.31 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.714 0.806 . . . . 0.0 109.541 170.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -149.78 163.02 39.1 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 127.227 2.211 . . . . 0.0 106.848 172.094 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -55.29 -29.55 58.41 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.392 -0.817 . . . . 0.0 112.243 175.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -90.49 -12.39 37.42 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.216 1.007 . . . . 0.0 113.486 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -147.58 128.23 14.22 Favored 'General case' 0 C--N 1.346 0.434 0 CA-C-N 119.991 1.269 . . . . 0.0 113.399 -170.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -78.45 152.32 32.19 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 166.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 10.7 p -58.15 -28.68 35.13 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 C-N-CA 124.824 1.249 . . . . 0.0 111.49 175.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -157.8 175.83 35.0 Favored Glycine 0 C--N 1.336 0.56 0 C-N-CA 125.048 1.309 . . . . 0.0 110.219 -174.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -56.96 126.6 27.87 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 124.101 0.96 . . . . 0.0 108.611 178.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.377 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 -179.674 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 23.5 mt . . . . . 0 N--CA 1.473 0.7 0 CA-C-O 120.709 0.29 . . . . 0.0 111.192 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 99.1 m -53.81 -50.66 65.65 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 125.697 1.599 . . . . 0.0 110.861 -169.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -71.64 -34.52 69.84 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 119.075 -0.488 . . . . 0.0 111.063 -171.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -67.53 -43.96 79.51 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 118.507 0.594 . . . . 0.0 109.687 175.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 52.1 mtt180 -64.61 -43.2 94.53 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 121.933 -0.48 . . . . 0.0 110.633 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 58.1 t -67.82 -40.18 83.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-O 118.247 -0.883 . . . . 0.0 109.8 178.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -60.69 -47.48 86.07 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 120.612 1.551 . . . . 0.0 109.909 176.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 59.3 mttm -57.98 -45.89 86.06 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 118.331 0.514 . . . . 0.0 110.184 178.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 55.1 t90 -65.62 -45.78 81.79 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 118.109 0.413 . . . . 0.0 110.513 -177.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 55.6 t -62.56 -38.64 81.98 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 C-N-CA 123.046 0.538 . . . . 0.0 110.202 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -69.8 -36.05 75.36 Favored 'General case' 0 CA--C 1.532 0.265 0 O-C-N 121.224 -0.923 . . . . 0.0 110.256 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 20.5 mm100 -64.61 -52.09 59.25 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.652 0.66 . . . . 0.0 110.634 174.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 12.3 pt -64.22 -32.69 58.46 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 CA-C-N 119.51 1.05 . . . . 0.0 110.787 -178.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 57.2 m -56.05 -36.07 67.63 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.287 0.949 . . . . 0.0 112.172 176.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -87.62 -27.17 22.67 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.9 1.227 . . . . 0.0 112.24 177.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -68.55 -32.02 71.65 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 119.357 0.981 . . . . 0.0 110.73 173.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 1.8 mp -82.69 -3.68 56.73 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.458 1.903 . . . . 0.0 110.89 174.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 54.8 35.12 23.41 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 126.126 1.771 . . . . 0.0 112.379 -177.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 70.1 mt . . . . . 0 N--CA 1.464 0.273 0 O-C-N 121.314 -0.866 . . . . 0.0 111.301 -177.776 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.29 0 CA-C-O 121.025 0.441 . . . . 0.0 111.372 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.5 pt -104.45 -24.84 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 126.051 1.741 . . . . 0.0 110.587 178.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 51.6 m -105.79 125.9 51.54 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.142 1.377 . . . . 0.0 108.547 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -100.36 116.02 5.46 Favored Glycine 0 C--N 1.331 0.295 0 N-CA-C 107.082 -2.407 . . . . 0.0 107.082 168.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 35.0 mt -92.57 122.27 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 104.304 -2.48 . . . . 0.0 104.304 172.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -118.21 128.11 54.39 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 106.633 -1.618 . . . . 0.0 106.633 176.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -123.81 132.66 53.82 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 118.574 0.625 . . . . 0.0 111.247 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -86.36 142.32 18.75 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 108.205 -1.958 . . . . 0.0 108.205 168.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.9 m -160.62 160.41 31.63 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 119.233 1.517 . . . . 0.0 110.815 173.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -137.31 -47.14 0.57 Allowed 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.89 1.276 . . . . 0.0 109.525 169.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.2 p -80.99 -12.58 59.35 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.323 1.049 . . . . 0.0 112.162 170.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.41 10.86 53.21 Favored Glycine 0 C--N 1.343 0.946 0 C-N-CA 124.799 1.19 . . . . 0.0 113.884 170.166 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -66.28 -47.76 72.62 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 118.835 1.318 . . . . 0.0 112.158 -172.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.1 m -74.52 -14.93 60.87 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -168.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -56.15 -43.38 78.24 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.683 0.674 . . . . 0.0 109.755 171.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -68.78 -37.63 79.44 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 121.772 -0.58 . . . . 0.0 109.906 -177.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 29.7 mm -63.83 -43.33 97.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 176.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.36 -38.92 85.39 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.58 -0.7 . . . . 0.0 110.942 177.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -68.28 -40.62 81.75 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 118.177 -0.916 . . . . 0.0 111.342 175.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 63.9 mtt -58.98 -34.26 71.63 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 120.027 1.285 . . . . 0.0 111.051 175.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 55.6 mt -71.45 -53.96 18.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 175.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -61.49 -37.03 82.19 Favored 'General case' 0 N--CA 1.462 0.161 0 O-C-N 121.364 -0.835 . . . . 0.0 111.827 -173.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -63.55 -35.72 81.41 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 119.202 0.91 . . . . 0.0 111.088 -178.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -75.33 -41.79 55.88 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 122.902 0.481 . . . . 0.0 111.05 177.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -72.47 -34.24 67.58 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 122.73 0.412 . . . . 0.0 111.083 -177.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.43 145.07 8.52 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 -169.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -58.78 -33.98 70.93 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 122.015 -0.697 . . . . 0.0 112.078 -175.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -74.64 -11.75 60.27 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.26 -174.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.2 t -106.65 -42.09 6.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 124.337 1.055 . . . . 0.0 109.586 178.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -129.4 140.25 51.4 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 119.473 1.033 . . . . 0.0 111.482 -178.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -122.58 155.29 36.6 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.556 1.142 . . . . 0.0 109.473 177.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 77.6 t -119.7 130.33 74.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 124.234 1.014 . . . . 0.0 110.071 -169.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -146.79 177.61 8.97 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.857 1.663 . . . . 0.0 111.551 -172.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -133.81 130.22 37.64 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 126.884 2.074 . . . . 0.0 105.764 178.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.2 tp -60.56 -21.35 23.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 C-N-CA 123.496 0.719 . . . . 0.0 112.137 -172.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.6 -29.52 68.03 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 118.893 0.77 . . . . 0.0 111.322 177.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -81.08 -26.75 36.04 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.097 0.559 . . . . 0.0 111.438 177.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 62.7 m -71.89 159.48 34.2 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 122.129 0.966 . . . . 0.0 112.427 -168.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 23.5 m -130.07 175.34 8.97 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.849 2.059 . . . . 0.0 107.054 173.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -53.01 -45.63 68.01 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.236 0.615 . . . . 0.0 112.002 -172.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -81.6 -11.8 58.99 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 -175.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -70.8 -32.6 69.74 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 118.98 0.809 . . . . 0.0 111.304 -176.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -69.33 -43.71 73.16 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 123.429 0.692 . . . . 0.0 109.392 173.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 77.9 mt-10 -70.79 -11.66 61.08 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.932 0.893 . . . . 0.0 112.049 -171.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.88 -29.26 69.68 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.08 0.952 . . . . 0.0 111.907 173.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -98.34 153.6 18.43 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.854 1.262 . . . . 0.0 110.348 -178.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -99.54 -27.91 13.48 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.567 174.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.2 mp -113.84 129.79 69.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 174.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -114.15 125.71 54.25 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 107.086 -1.449 . . . . 0.0 107.086 175.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.3 mp -111.89 112.35 23.94 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 173.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.1 mt -112.9 112.28 23.64 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -169.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -100.82 115.15 5.21 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 125.602 1.572 . . . . 0.0 110.126 -178.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 16.2 tt -123.02 118.17 28.2 Favored Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 118.442 1.121 . . . . 0.0 111.71 -173.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -79.63 138.19 13.37 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 121.731 1.621 . . . . 0.0 108.039 167.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 79.7 m -94.39 143.71 26.17 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 174.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 66.2 m95 -134.25 173.74 11.27 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 126.082 1.753 . . . . 0.0 109.414 -177.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 24.4 t80 32.26 64.69 0.23 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 127.902 2.481 . . . . 0.0 114.364 169.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 54.58 53.69 10.33 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.816 0.847 . . . . 0.0 111.738 171.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 82.79 55.78 2.9 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 123.551 0.596 . . . . 0.0 112.085 174.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -128.99 155.87 44.7 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 125.846 1.658 . . . . 0.0 108.355 170.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.13 161.83 27.09 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 123.133 0.573 . . . . 0.0 110.252 172.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 34.1 tp60 -67.33 143.94 56.11 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 169.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 58.4 m -55.62 -35.23 65.65 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.815 0.846 . . . . 0.0 112.51 -172.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -64.76 -41.06 96.17 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.291 0.637 . . . . 0.0 110.444 -178.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -73.31 -46.75 47.72 Favored 'General case' 0 C--N 1.34 0.185 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 177.082 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -58.26 -36.24 72.94 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.582 0.753 . . . . 0.0 112.155 -177.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -69.9 -23.58 63.26 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.736 0.815 . . . . 0.0 112.552 177.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -100.39 -15.64 17.89 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.219 1.007 . . . . 0.0 112.025 -177.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 12.8 m-30 -48.4 -45.94 68.18 Favored Pre-proline 0 CA--C 1.542 0.668 0 CA-C-O 117.09 -1.433 . . . . 0.0 113.119 171.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -65.04 -20.93 63.83 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 CA-C-N 122.577 1.956 . . . . 0.0 113.116 176.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.8 m -82.75 -35.6 26.47 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 119.589 1.086 . . . . 0.0 110.047 174.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 71.8 mt -56.91 -34.0 67.51 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 119.856 1.207 . . . . 0.0 111.205 178.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -82.53 -1.23 49.9 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 178.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -99.95 -29.58 12.49 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.122 0.969 . . . . 0.0 109.629 169.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 92.9 mt -66.4 142.91 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 C-N-CA 125.69 1.596 . . . . 0.0 107.93 177.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -88.14 130.53 35.01 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 123.547 0.739 . . . . 0.0 109.537 173.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -124.37 18.48 8.97 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.513 0.725 . . . . 0.0 111.741 172.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 23.1 m-80 -61.95 116.79 5.18 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 119.95 1.25 . . . . 0.0 109.554 -175.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.0 5.92 66.56 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-O 118.881 -0.955 . . . . 0.0 113.189 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 9.8 mmpt? -76.88 153.13 35.06 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 119.216 1.508 . . . . 0.0 107.26 172.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -95.05 141.02 29.17 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 173.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 15.5 t -134.89 146.38 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 175.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -137.59 146.88 44.55 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 170.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 75.5 mt -116.78 142.36 47.02 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -172.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -138.85 157.3 46.3 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 169.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -162.72 153.41 23.99 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-O 122.455 1.03 . . . . 0.0 112.835 -171.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 51.8 m -126.12 150.93 47.88 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 113.017 -1.592 . . . . 0.0 108.821 -168.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -177.46 175.99 47.84 Favored Glycine 0 CA--C 1.523 0.534 0 C-N-CA 121.035 -0.602 . . . . 0.0 113.544 -172.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -100.54 140.68 34.46 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 125.391 1.476 . . . . 0.0 109.007 171.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -130.15 37.85 3.85 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.219 1.007 . . . . 0.0 109.532 -179.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -113.07 -55.55 2.51 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 124.44 1.096 . . . . 0.0 108.443 172.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -113.75 -33.3 5.85 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.551 1.14 . . . . 0.0 111.198 -175.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -92.02 22.57 4.23 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.703 0.801 . . . . 0.0 112.357 -178.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.61 -33.61 74.2 Favored 'General case' 0 C--N 1.343 0.302 0 CA-C-N 120.023 1.283 . . . . 0.0 113.515 -169.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -65.03 -31.01 72.03 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 119.934 1.243 . . . . 0.0 110.284 175.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -100.18 9.17 43.19 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.745 1.618 . . . . 0.0 111.218 -177.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -65.97 118.76 10.23 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 119.114 0.87 . . . . 0.0 108.884 -169.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 60.6 m 53.24 28.71 7.45 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.967 1.307 . . . . 0.0 112.789 -175.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -53.71 -36.48 62.29 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.73 1.212 . . . . 0.0 111.731 -176.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.72 -11.78 61.15 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -174.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 32.1 mt -54.38 -47.86 72.18 Favored 'General case' 0 C--N 1.344 0.353 0 CA-C-N 119.148 0.885 . . . . 0.0 110.47 173.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.0 -29.23 74.29 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 111.745 -0.542 . . . . 0.0 111.745 -176.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.8 m -63.63 -37.63 88.06 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 117.76 0.78 . . . . 0.0 110.049 177.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 5.8 mt -67.87 -44.17 85.5 Favored 'Isoleucine or valine' 0 C--N 1.344 0.346 0 CA-C-O 117.781 -1.104 . . . . 0.0 108.938 177.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 57.7 ttp85 -56.27 -46.74 79.58 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 120.032 1.287 . . . . 0.0 110.041 177.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -59.82 -28.18 67.24 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -178.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 80.0 mt -84.28 -45.67 18.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 124.38 1.072 . . . . 0.0 110.688 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 10.5 pt -85.83 -28.1 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 119.508 1.049 . . . . 0.0 112.584 -169.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -63.56 -42.12 70.85 Favored Pre-proline 0 CA--C 1.548 0.868 0 CA-C-O 117.814 -1.089 . . . . 0.0 111.434 -174.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -61.54 -20.02 67.01 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 122.727 2.285 . . . . 0.0 114.19 172.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 23.9 mmm180 -86.9 5.01 39.09 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.065 0.946 . . . . 0.0 111.44 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 75.73 17.53 80.06 Favored Glycine 0 CA--C 1.529 0.945 0 CA-C-O 118.51 -1.161 . . . . 0.0 113.03 178.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -59.1 137.76 57.82 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 118.809 1.305 . . . . 0.0 109.482 169.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 36.6 m -94.18 126.57 39.5 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 169.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 57.1 mt -105.22 132.6 51.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -174.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 27.1 m -129.01 176.35 8.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 125.737 1.615 . . . . 0.0 108.523 172.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 80.78 26.58 53.37 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-O 119.043 -0.865 . . . . 0.0 114.023 175.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 65.1 m80 -62.3 130.45 45.38 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 168.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 65.2 t-105 -107.64 124.56 34.59 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-O 118.258 -0.877 . . . . 0.0 108.787 -169.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -71.29 146.86 51.98 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 121.501 1.468 . . . . 0.0 112.144 -172.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 33.2 p . . . . . 0 CA--C 1.531 0.227 0 C-N-CA 123.874 0.87 . . . . 0.0 111.242 179.158 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.789 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -64.75 -18.73 64.38 Favored Glycine 0 CA--C 1.536 1.404 0 CA-C-N 119.407 1.003 . . . . 0.0 112.295 169.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 91.7 mt -64.44 130.29 43.17 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.809 1.304 . . . . 0.0 109.237 175.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -93.7 -33.44 13.64 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.472 0.709 . . . . 0.0 109.386 168.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -149.87 165.78 31.53 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 126.717 2.007 . . . . 0.0 107.638 177.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -55.67 -26.79 46.54 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 121.717 -0.614 . . . . 0.0 112.108 172.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -90.55 -19.3 23.92 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.891 1.276 . . . . 0.0 114.216 -179.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 24.0 p80 -156.74 147.34 21.56 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 120.481 1.491 . . . . 0.0 114.311 -176.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -82.72 151.17 26.31 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 126.215 1.806 . . . . 0.0 108.607 168.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 5.8 p -69.19 -16.96 21.33 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 122.856 0.462 . . . . 0.0 111.612 179.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -157.45 174.06 34.91 Favored Glycine 0 C--N 1.339 0.742 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 178.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -67.08 105.63 1.73 Allowed 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 123.542 0.737 . . . . 0.0 109.219 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.366 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 168.195 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 47.5 mt . . . . . 0 N--CA 1.474 0.744 0 CA-C-O 121.57 0.7 . . . . 0.0 112.002 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 87.4 m -59.42 -51.35 70.26 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 125.159 1.384 . . . . 0.0 111.118 -176.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -67.53 -31.92 72.35 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 119.398 -0.334 . . . . 0.0 111.01 -169.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 24.8 mp0 -60.81 -43.72 97.83 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.513 1.125 . . . . 0.0 109.813 174.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 68.4 mtt85 -62.8 -42.69 99.82 Favored 'General case' 0 N--CA 1.466 0.347 0 O-C-N 121.573 -0.705 . . . . 0.0 110.506 175.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 58.1 t -66.64 -37.88 80.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-O 118.753 -0.641 . . . . 0.0 109.494 -179.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -62.03 -51.04 69.59 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 120.215 1.37 . . . . 0.0 110.012 175.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 61.1 mttm -58.51 -42.63 88.14 Favored 'General case' 0 CA--C 1.529 0.153 0 O-C-N 122.119 -0.363 . . . . 0.0 110.43 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 58.0 t90 -67.85 -47.51 68.77 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 118.131 0.423 . . . . 0.0 110.641 -177.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 50.9 t -60.64 -37.91 76.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 118.365 0.53 . . . . 0.0 110.104 -178.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 56.0 mttm -64.99 -46.8 79.92 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 121.637 -0.665 . . . . 0.0 109.275 176.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 6.1 mm-40 -59.86 -46.95 87.66 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 118.695 0.679 . . . . 0.0 111.819 179.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 18.5 pt -68.74 -32.11 53.57 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.19 0 CA-C-N 119.329 0.968 . . . . 0.0 110.212 -178.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 36.0 m -61.69 -32.16 72.34 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 119.033 0.833 . . . . 0.0 110.927 172.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -72.12 -44.42 63.2 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.442 1.019 . . . . 0.0 110.192 174.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -66.75 -35.62 80.52 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.168 0.587 . . . . 0.0 111.466 -178.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 86.3 mt -84.28 -3.12 58.03 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.533 1.533 . . . . 0.0 111.452 178.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 54.53 28.24 9.48 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.837 1.655 . . . . 0.0 112.811 -173.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 85.8 mt . . . . . 0 N--CA 1.464 0.231 0 C-N-CA 123.233 0.613 . . . . 0.0 109.846 170.077 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.323 0 CA-C-O 121.006 0.431 . . . . 0.0 111.487 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.1 pt -113.45 -18.24 7.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 126.317 1.847 . . . . 0.0 111.045 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 40.9 m -109.92 124.29 51.11 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.565 1.546 . . . . 0.0 108.845 178.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -99.43 120.24 6.79 Favored Glycine 0 CA--C 1.522 0.469 0 N-CA-C 108.437 -1.865 . . . . 0.0 108.437 169.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 55.1 mt -97.67 94.21 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 104.773 -2.306 . . . . 0.0 104.773 177.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -97.1 108.53 21.29 Favored 'General case' 0 CA--C 1.52 -0.177 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 178.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -128.25 118.45 23.31 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 118.961 0.8 . . . . 0.0 109.755 -168.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -83.8 132.98 11.46 Favored Glycine 0 C--N 1.338 0.688 0 N-CA-C 110.376 -1.089 . . . . 0.0 110.376 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.1 m -137.78 161.22 37.14 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.292 1.437 . . . . 0.0 107.959 174.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -136.13 -50.92 0.7 Allowed 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.088 0.555 . . . . 0.0 110.008 169.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -81.74 -6.4 59.01 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.424 0.689 . . . . 0.0 111.778 170.484 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.33 11.65 51.13 Favored Glycine 0 C--N 1.345 1.034 0 C-N-CA 124.615 1.102 . . . . 0.0 115.138 167.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -73.47 -46.22 49.48 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 119.324 1.562 . . . . 0.0 111.822 -177.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.76 -39.08 93.02 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 118.8 0.727 . . . . 0.0 110.601 -168.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -64.13 -27.58 69.18 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.232 -0.918 . . . . 0.0 112.096 -178.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -66.72 -37.04 83.87 Favored 'General case' 0 N--CA 1.465 0.276 0 O-C-N 121.49 -0.756 . . . . 0.0 109.984 174.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.3 mm -67.61 -43.26 87.06 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.153 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 174.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.39 -38.5 71.57 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.912 0.778 . . . . 0.0 111.059 -179.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 68.6 mttt -67.19 -42.34 84.34 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 122.955 0.502 . . . . 0.0 110.833 175.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 77.3 mtm -67.15 -29.78 69.58 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 119.281 0.946 . . . . 0.0 111.883 177.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 70.6 mt -68.73 -53.92 24.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 173.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -59.33 -37.9 78.96 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.765 -0.584 . . . . 0.0 111.193 -176.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -63.44 -39.18 93.8 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 119.116 0.871 . . . . 0.0 110.952 -179.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -71.97 -41.62 67.5 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 122.697 0.399 . . . . 0.0 110.978 177.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.9 mp -73.82 -33.44 64.17 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 118.096 0.407 . . . . 0.0 111.174 -176.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.16 143.34 12.88 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 125.26 1.409 . . . . 0.0 110.58 -171.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -65.37 -29.0 69.67 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.735 -0.862 . . . . 0.0 111.794 -174.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -77.47 -7.57 56.4 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 122.942 0.497 . . . . 0.0 112.006 177.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.0 t -108.04 -41.03 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 C-N-CA 124.421 1.088 . . . . 0.0 109.569 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -132.82 147.53 52.31 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 119.512 1.051 . . . . 0.0 112.144 -175.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.3 t0 -132.71 151.31 52.01 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.515 0.726 . . . . 0.0 110.773 173.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 97.5 t -106.9 137.48 37.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 C-N-CA 124.87 1.268 . . . . 0.0 109.648 -169.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -145.11 164.78 30.22 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.615 1.566 . . . . 0.0 110.598 -171.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -131.02 134.38 46.63 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 175.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.407 ' HB ' ' CH2' ' A' ' 66' ' ' TRP . 1.3 tp -65.72 -26.36 38.69 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-O 118.514 -0.755 . . . . 0.0 113.003 -168.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.99 -29.58 68.64 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 119.287 0.949 . . . . 0.0 110.479 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -84.22 -28.75 27.06 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.417 0.687 . . . . 0.0 111.325 175.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.4 m -77.32 168.4 20.09 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.137 0.975 . . . . 0.0 111.621 -169.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.3 m -131.3 159.67 37.19 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.887 1.275 . . . . 0.0 110.138 -174.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -53.25 -47.58 68.94 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.676 1.19 . . . . 0.0 111.811 -175.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -80.81 -13.42 58.97 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 122.245 -0.284 . . . . 0.0 111.63 -174.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -76.68 -31.16 57.08 Favored 'General case' 0 C--O 1.234 0.267 0 O-C-N 121.534 -0.729 . . . . 0.0 111.566 -172.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.9 mp -66.22 -35.69 81.08 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 175.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -68.83 -13.43 62.41 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.348 0.659 . . . . 0.0 112.38 -174.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.15 -29.12 68.73 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.531 0.732 . . . . 0.0 111.484 174.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -94.22 147.61 23.01 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.162 0.985 . . . . 0.0 110.381 -177.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -91.38 -33.65 15.18 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.895 173.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.2 mp -107.82 134.52 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 176.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 96.8 mt -122.07 124.36 43.76 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 174.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.3 mp -105.79 110.08 22.25 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 104.956 -2.239 . . . . 0.0 104.956 169.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 73.9 mt -109.55 111.15 22.48 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 -173.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -96.25 123.31 7.66 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 -179.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 2.1 tp -137.12 100.87 9.45 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 125.067 1.347 . . . . 0.0 109.32 -171.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.25 142.52 30.51 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.204 1.936 . . . . 0.0 109.091 168.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 59.1 m -91.84 136.84 32.85 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 177.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 24.5 m95 -135.51 168.17 19.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 120.58 1.536 . . . . 0.0 112.605 -169.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 58.66 -61.69 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 130.707 3.603 . . . . 0.0 116.32 169.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -150.98 30.08 0.64 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.448 1.899 . . . . 0.0 110.44 -169.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 73.23 48.39 19.58 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 -171.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -123.98 175.75 6.76 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.58 1.552 . . . . 0.0 108.43 177.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -79.24 158.35 27.62 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.138 -0.976 . . . . 0.0 109.54 169.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -58.95 138.11 57.58 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 172.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 99.5 m -55.78 -40.21 72.34 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -167.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -73.73 -27.1 61.01 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.366 0.667 . . . . 0.0 111.705 -177.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.407 ' CH2' ' HB ' ' A' ' 36' ' ' ILE . 1.0 OUTLIER -77.79 -44.49 27.38 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.172 0.989 . . . . 0.0 109.541 174.194 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -58.65 -42.12 87.63 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.399 1.079 . . . . 0.0 111.06 176.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -61.8 -22.29 65.32 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.16 0.984 . . . . 0.0 112.2 177.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -90.85 -17.12 27.06 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 118.348 -0.834 . . . . 0.0 112.067 178.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 21.2 m-30 -54.98 -40.66 85.83 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-O 116.445 -1.741 . . . . 0.0 114.408 179.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -63.49 -20.27 69.43 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 CA-C-N 122.912 2.076 . . . . 0.0 113.24 173.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.4 m -82.44 -45.16 15.13 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.262 0.937 . . . . 0.0 109.14 170.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 12.9 tp -56.22 -40.16 73.63 Favored 'General case' 0 C--N 1.342 0.241 0 C-N-CA 125.077 1.351 . . . . 0.0 110.523 -175.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -72.39 -1.02 14.02 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -178.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -104.94 -12.0 16.42 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 119.647 1.112 . . . . 0.0 112.124 172.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 80.8 mt -78.23 142.04 14.67 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 -179.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -82.63 130.05 35.05 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 178.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -122.06 13.01 10.46 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 118.682 -0.675 . . . . 0.0 111.849 173.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -62.3 115.79 4.48 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-N 120.035 1.289 . . . . 0.0 108.754 -176.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 74.69 -0.72 55.7 Favored Glycine 0 CA--C 1.535 1.296 0 CA-C-O 118.459 -1.189 . . . . 0.0 114.095 -179.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -69.33 146.47 52.15 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 119.738 1.769 . . . . 0.0 107.288 169.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -90.03 137.34 32.42 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 170.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.0 t -131.97 142.35 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 177.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -131.27 141.45 49.98 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 170.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 73.3 mt -110.66 149.98 29.67 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -176.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.454 ' CE2' HD12 ' A' ' 142' ' ' LEU . 14.4 t80 -141.53 147.49 37.84 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 -179.373 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -164.96 137.58 4.79 Favored Glycine 0 CA--C 1.522 0.5 0 CA-C-N 119.216 0.916 . . . . 0.0 110.936 169.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 4.5 p -95.11 152.81 18.02 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 168.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -145.33 -158.36 7.63 Favored Glycine 0 CA--C 1.525 0.702 0 CA-C-O 121.048 0.249 . . . . 0.0 113.019 -173.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -146.9 145.38 29.8 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 127.504 2.322 . . . . 0.0 107.85 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -133.14 12.39 4.24 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.37 1.468 . . . . 0.0 109.931 177.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -81.9 -47.05 13.24 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 177.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -126.72 -33.2 2.53 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 123.949 0.9 . . . . 0.0 111.126 -175.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -91.33 33.89 0.97 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.211 1.004 . . . . 0.0 111.421 176.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.45 -20.02 62.65 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.278 1.431 . . . . 0.0 113.116 -178.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -97.62 6.6 47.79 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.912 0.885 . . . . 0.0 111.948 176.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -138.53 24.47 2.67 Favored 'General case' 0 C--O 1.237 0.411 0 O-C-N 120.854 -1.154 . . . . 0.0 110.858 -174.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -65.97 118.57 9.95 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -169.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 86.3 m 48.28 35.23 5.3 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.648 1.979 . . . . 0.0 113.636 -175.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -53.38 -41.17 65.62 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.364 0.666 . . . . 0.0 112.342 -178.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.99 -12.06 60.06 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -170.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 53.9 mt -56.22 -42.21 76.88 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 118.719 0.691 . . . . 0.0 109.647 169.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -65.0 -30.66 78.6 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.811 -0.515 . . . . 0.0 111.811 -178.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 4.3 m -64.93 -40.13 94.57 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 117.985 0.893 . . . . 0.0 110.098 179.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.7 mt -73.86 -39.85 52.43 Favored 'Isoleucine or valine' 0 C--N 1.344 0.363 0 CA-C-N 118.908 0.777 . . . . 0.0 109.271 176.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 57.7 ttt-85 -52.67 -46.64 67.29 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 119.583 1.083 . . . . 0.0 110.331 177.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -64.73 -21.59 66.79 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.596 0.758 . . . . 0.0 112.455 -176.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 95.8 mt -87.98 -46.01 15.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 123.454 0.702 . . . . 0.0 109.474 175.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 7.0 pt -77.79 -28.69 15.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-N 118.926 0.785 . . . . 0.0 112.045 -169.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -62.12 -56.86 27.35 Favored Pre-proline 0 CA--C 1.544 0.724 0 CA-C-O 117.568 -1.206 . . . . 0.0 112.167 179.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -66.23 -24.06 51.53 Favored 'Trans proline' 0 C--N 1.353 0.781 0 CA-C-N 121.96 1.736 . . . . 0.0 112.208 -179.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 79.5 mmt-85 -78.28 5.11 11.08 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.856 0.862 . . . . 0.0 112.774 172.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 77.22 20.92 74.52 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-N 119.604 1.093 . . . . 0.0 113.993 169.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.9 148.91 48.31 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 118.56 1.18 . . . . 0.0 110.589 170.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 60.2 m -97.47 124.36 41.65 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 105.01 -2.218 . . . . 0.0 105.01 167.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 48.9 mt -98.43 134.13 38.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 -175.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 29.1 m -133.14 176.63 8.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 125.582 1.553 . . . . 0.0 108.854 172.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 78.04 23.38 66.45 Favored Glycine 0 CA--C 1.529 0.926 0 CA-C-O 119.065 -0.853 . . . . 0.0 113.906 175.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 15.4 p-80 -60.3 140.85 56.87 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 118.327 1.063 . . . . 0.0 108.809 168.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 75.4 t-105 -131.19 136.48 28.84 Favored Pre-proline 0 CA--C 1.536 0.43 0 C-N-CA 124.26 1.024 . . . . 0.0 110.244 -168.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -70.36 152.3 66.13 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.466 2.111 . . . . 0.0 111.912 -176.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 22.2 p . . . . . 0 CA--C 1.537 0.48 0 C-N-CA 123.867 0.867 . . . . 0.0 112.613 174.283 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 84.3 mttt . . . . . 0 N--CA 1.473 0.69 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -83.04 8.59 62.88 Favored Glycine 0 CA--C 1.535 1.324 0 CA-C-N 118.619 0.645 . . . . 0.0 112.775 168.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 74.9 mt -62.29 138.77 58.49 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.564 1.145 . . . . 0.0 111.204 -179.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -104.56 -26.22 12.44 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.629 1.572 . . . . 0.0 109.792 168.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -143.66 165.71 26.88 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.01 1.724 . . . . 0.0 107.219 172.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -53.61 -27.2 25.54 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.197 1.399 . . . . 0.0 114.186 -169.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -123.49 9.98 9.1 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.781 1.232 . . . . 0.0 113.58 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -137.91 130.39 29.4 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 119.788 1.176 . . . . 0.0 111.143 -172.187 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -81.39 151.44 27.93 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 124.935 1.294 . . . . 0.0 110.165 173.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 14.5 p -61.89 -29.89 47.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 123.0 0.52 . . . . 0.0 111.528 175.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -141.28 -176.36 15.57 Favored Glycine 0 CA--C 1.521 0.445 0 C-N-CA 125.305 1.431 . . . . 0.0 109.606 -175.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.454 HD12 ' CE2' ' A' ' 86' ' ' PHE . 3.3 tm? -60.9 125.99 25.75 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 169.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.355 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 171.243 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 74.3 mt . . . . . 0 CA--C 1.539 0.539 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 97.1 m -51.09 -53.44 34.12 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 126.988 2.115 . . . . 0.0 111.85 -174.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.59 -43.86 95.71 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 119.083 -0.484 . . . . 0.0 111.884 -166.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -67.12 -36.1 81.2 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 118.794 0.725 . . . . 0.0 111.091 -177.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 77.3 mtt85 -67.12 -47.55 70.79 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 118.825 0.738 . . . . 0.0 109.883 -179.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 16.8 m -72.41 -31.67 39.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-O 118.77 -0.633 . . . . 0.0 110.481 -176.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -63.35 -49.63 73.12 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 119.659 1.118 . . . . 0.0 109.948 171.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -58.61 -42.26 87.76 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 118.477 0.58 . . . . 0.0 109.972 178.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 66.8 t90 -64.32 -46.77 82.09 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 118.822 0.737 . . . . 0.0 110.589 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 28.5 t -56.89 -42.71 78.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 118.24 0.473 . . . . 0.0 109.863 176.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 54.7 mttm -69.01 -38.32 79.16 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 118.567 -0.73 . . . . 0.0 109.825 -176.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 19.1 mm100 -59.89 -55.45 34.04 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 118.611 0.641 . . . . 0.0 110.304 172.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 16.1 pt -65.32 -30.53 50.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 118.924 0.784 . . . . 0.0 110.642 -174.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 50.8 m -61.82 -25.74 67.69 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.747 0.703 . . . . 0.0 111.692 177.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -89.33 -28.88 19.54 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 119.599 1.091 . . . . 0.0 111.023 176.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -72.19 -37.82 69.21 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 118.663 0.665 . . . . 0.0 110.67 175.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 76.8 mt -90.83 -9.32 46.84 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.186 1.794 . . . . 0.0 111.848 -177.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 55.57 29.44 13.48 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.534 1.534 . . . . 0.0 112.759 -170.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 86.5 mt . . . . . 0 N--CA 1.466 0.366 0 O-C-N 121.349 -0.845 . . . . 0.0 110.286 169.362 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.297 0 CA-C-O 120.769 0.319 . . . . 0.0 111.408 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.1 pt -109.89 -15.96 9.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 125.363 1.465 . . . . 0.0 111.3 178.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 28.9 m -111.77 123.69 50.77 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.201 1.4 . . . . 0.0 108.317 177.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -96.49 119.29 6.26 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 107.434 -2.267 . . . . 0.0 107.434 169.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 56.8 mt -98.07 91.88 2.64 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 105.23 -2.137 . . . . 0.0 105.23 176.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -88.48 129.08 35.53 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 178.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -128.54 133.48 48.41 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 120.011 1.278 . . . . 0.0 111.88 179.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -89.92 145.24 18.12 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 169.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 9.3 m -164.23 158.34 18.85 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.679 1.24 . . . . 0.0 109.743 172.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -125.18 -51.13 1.66 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.614 0.765 . . . . 0.0 109.432 168.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.2 p -86.35 8.11 22.84 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.097 1.359 . . . . 0.0 112.976 173.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 84.19 -9.02 64.99 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 116.963 1.545 . . . . 0.0 116.963 168.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -60.78 -37.45 81.92 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 120.23 2.015 . . . . 0.0 113.825 -169.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.7 m -73.55 -15.09 61.3 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 120.01 1.277 . . . . 0.0 110.799 -175.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -60.19 -41.95 94.04 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 119.643 1.111 . . . . 0.0 109.676 172.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -63.04 -41.29 99.46 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -178.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 25.7 mm -64.8 -45.06 96.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 177.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.88 -40.25 88.09 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.589 0.631 . . . . 0.0 111.04 178.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.2 mtpt -67.47 -42.09 83.56 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 118.022 -0.99 . . . . 0.0 110.72 177.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 63.4 mtt -55.66 -47.62 76.4 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 119.851 1.205 . . . . 0.0 109.721 175.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 62.1 mt -60.37 -52.69 58.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -179.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -61.79 -38.64 88.81 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.958 0.799 . . . . 0.0 111.212 -175.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -65.02 -35.86 82.53 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 118.908 0.776 . . . . 0.0 111.023 -179.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -70.64 -49.38 48.13 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.322 0.51 . . . . 0.0 110.838 175.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 54.5 mt -67.8 -32.6 73.27 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.329 0.513 . . . . 0.0 111.783 -177.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.0 145.09 14.79 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 125.407 1.48 . . . . 0.0 110.792 -173.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 22.8 ptmt -63.72 -29.53 70.74 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 121.728 -0.866 . . . . 0.0 113.184 -172.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -77.68 -11.49 59.88 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.591 179.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 22.4 t -103.57 -39.33 5.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 C-N-CA 124.283 1.033 . . . . 0.0 109.711 177.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -133.24 146.55 51.56 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 119.234 0.924 . . . . 0.0 111.94 -176.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -130.71 139.58 50.3 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.104 0.962 . . . . 0.0 109.853 175.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 98.3 t -90.4 139.27 17.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 123.655 0.782 . . . . 0.0 109.15 -177.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -148.27 172.95 13.54 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.925 1.29 . . . . 0.0 111.133 -168.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -143.79 125.63 15.2 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 125.856 1.662 . . . . 0.0 108.629 -172.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.4 tp -62.35 -28.43 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-O 118.855 -0.593 . . . . 0.0 111.723 -172.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.09 -27.89 69.7 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 118.77 0.714 . . . . 0.0 111.537 -175.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 61.9 pttt -105.45 -3.95 21.93 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.627 1.171 . . . . 0.0 112.359 176.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 50.9 m -79.25 166.85 21.71 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.398 0.679 . . . . 0.0 110.953 -179.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.4 m -134.43 163.58 29.36 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.189 1.396 . . . . 0.0 109.021 179.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 53.5 tttm -52.81 -57.25 10.8 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.024 0.93 . . . . 0.0 110.985 -174.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -75.34 -16.07 60.43 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 122.354 0.262 . . . . 0.0 111.329 -173.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -74.31 -29.29 61.56 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 122.889 0.476 . . . . 0.0 110.928 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.8 mp -71.43 -41.98 68.81 Favored 'General case' 0 C--N 1.344 0.336 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 168.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.3 -15.73 63.46 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.234 0.614 . . . . 0.0 112.264 -174.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.88 -30.06 70.12 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.324 1.05 . . . . 0.0 112.277 174.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -84.58 155.22 22.16 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 123.845 0.858 . . . . 0.0 110.059 178.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -102.45 -26.73 13.15 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.236 0.614 . . . . 0.0 111.129 169.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.9 mp -113.74 123.43 69.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 174.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -109.85 123.14 49.05 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 173.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.1 mp -109.2 120.68 43.24 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 105.43 -2.063 . . . . 0.0 105.43 169.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 59.6 mt -118.38 109.42 16.25 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 -173.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -90.05 121.24 6.09 Favored Glycine 0 N--CA 1.451 -0.323 0 N-CA-C 108.568 -1.813 . . . . 0.0 108.568 176.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 3.0 tp -141.65 103.84 5.88 Favored Pre-proline 0 CA--C 1.541 0.611 0 CA-C-N 117.741 0.771 . . . . 0.0 110.039 -169.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -76.47 147.14 28.31 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.463 2.109 . . . . 0.0 109.564 169.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 33.5 m -95.5 140.93 29.65 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 177.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 38.7 m95 -134.16 171.29 14.43 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 125.208 1.403 . . . . 0.0 111.24 -170.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 51.85 -87.59 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 127.8 2.44 . . . . 0.0 113.114 178.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -150.0 78.23 1.34 Allowed 'General case' 0 C--O 1.234 0.289 0 C-N-CA 126.682 1.993 . . . . 0.0 106.813 179.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 70.99 19.6 77.21 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 123.68 0.657 . . . . 0.0 113.337 179.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -93.12 161.33 14.47 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.582 1.153 . . . . 0.0 109.357 -176.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -79.31 159.41 27.22 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 167.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -58.18 143.88 42.59 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 168.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 60.4 m -51.74 -38.89 57.23 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.566 1.146 . . . . 0.0 113.645 -169.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -70.78 -35.63 72.66 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 118.548 0.613 . . . . 0.0 110.694 -175.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -71.5 -45.51 62.29 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 175.018 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -57.92 -41.29 82.36 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 122.738 0.415 . . . . 0.0 111.379 179.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -68.2 -25.53 65.27 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.729 0.812 . . . . 0.0 112.268 177.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -92.69 -18.65 22.72 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.55 0.74 . . . . 0.0 112.506 -178.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 19.4 m-30 -50.73 -40.61 64.46 Favored Pre-proline 0 CA--C 1.545 0.78 0 CA-C-O 116.469 -1.729 . . . . 0.0 114.633 178.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -63.2 -20.86 71.8 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 CA-C-N 123.033 2.119 . . . . 0.0 113.912 173.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.2 m -85.7 -39.05 17.64 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 119.381 0.991 . . . . 0.0 109.441 169.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 13.6 tp -58.24 -38.05 76.11 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.031 0.932 . . . . 0.0 110.697 -177.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -72.51 -3.98 27.72 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 179.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -103.13 -12.46 17.35 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.134 0.879 . . . . 0.0 111.357 173.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 79.4 mt -77.23 138.39 20.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -176.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -78.18 124.23 27.83 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.592 176.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -122.06 11.03 10.18 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.769 0.827 . . . . 0.0 111.6 172.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -63.08 114.09 3.51 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 120.012 1.278 . . . . 0.0 109.143 -171.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.17 3.65 61.54 Favored Glycine 0 CA--C 1.536 1.392 0 CA-C-O 118.546 -1.141 . . . . 0.0 113.866 -178.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -75.21 152.03 38.4 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 119.544 1.672 . . . . 0.0 108.182 170.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 20.8 mt -91.6 136.59 33.02 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 175.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 18.5 t -133.81 141.69 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -134.32 143.26 47.6 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 171.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 64.7 mt -111.86 144.42 41.2 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -177.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -140.53 154.46 46.55 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 170.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -173.54 155.66 22.65 Favored Glycine 0 N--CA 1.449 -0.476 0 CA-C-O 122.416 1.009 . . . . 0.0 112.705 176.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 64.1 m -101.96 149.87 23.78 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 169.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -145.51 -159.32 8.08 Favored Glycine 0 CA--C 1.521 0.409 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 176.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -144.79 139.51 27.85 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 124.968 1.307 . . . . 0.0 108.546 170.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -109.09 -14.7 14.48 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 123.962 0.905 . . . . 0.0 111.419 177.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -75.11 -43.62 51.79 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 119.843 1.201 . . . . 0.0 110.796 -170.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -112.87 -40.22 4.05 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 123.495 0.718 . . . . 0.0 110.755 179.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -83.89 37.86 0.62 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.533 0.733 . . . . 0.0 111.018 176.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.06 -23.64 63.92 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 126.805 2.042 . . . . 0.0 114.019 -170.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -99.34 0.26 42.52 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.321 1.448 . . . . 0.0 111.918 -179.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -131.98 16.99 4.65 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.258 1.023 . . . . 0.0 111.925 -169.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -65.15 125.88 26.35 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 121.247 -0.908 . . . . 0.0 110.27 -169.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 88.1 m 53.24 29.45 8.48 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.842 1.657 . . . . 0.0 114.349 176.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -61.43 -31.51 71.46 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.755 0.822 . . . . 0.0 111.339 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.56 -33.58 76.25 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 120.754 -1.216 . . . . 0.0 111.687 179.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 7.5 mp -63.29 -43.89 96.6 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-N 119.691 1.132 . . . . 0.0 109.633 175.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.71 -31.99 82.01 Favored Glycine 0 CA--C 1.532 1.114 0 N-CA-C 111.337 -0.705 . . . . 0.0 111.337 174.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 14.7 m -66.56 -41.42 88.65 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 117.76 0.78 . . . . 0.0 110.113 176.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 5.4 mt -65.75 -43.83 93.38 Favored 'Isoleucine or valine' 0 C--N 1.345 0.401 0 CA-C-N 119.425 1.012 . . . . 0.0 109.509 173.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 41.3 ttt180 -52.32 -45.93 65.81 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 119.381 0.991 . . . . 0.0 110.435 -178.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -62.0 -17.98 58.96 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.96 0.904 . . . . 0.0 113.035 -178.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 82.8 mt -95.4 -54.72 6.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 124.397 1.079 . . . . 0.0 109.216 175.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 23.2 pt -71.56 -33.46 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 O-C-N 121.251 -0.906 . . . . 0.0 112.195 -168.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -66.53 -50.37 47.22 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-O 117.694 -1.146 . . . . 0.0 111.486 -174.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -68.36 -24.67 36.83 Favored 'Trans proline' 0 C--N 1.354 0.836 0 CA-C-N 121.731 1.654 . . . . 0.0 112.769 174.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 7.7 mpt_? -74.76 6.76 3.63 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 119.42 1.009 . . . . 0.0 112.523 169.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 81.38 16.66 73.29 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-O 118.435 -1.203 . . . . 0.0 114.007 169.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.13 141.9 55.11 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 118.882 1.341 . . . . 0.0 109.998 170.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 88.1 m -93.13 119.34 32.24 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 104.641 -2.355 . . . . 0.0 104.641 167.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 33.6 mt -96.61 132.79 40.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 -173.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 29.9 m -129.44 172.62 15.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 C-N-CA 124.869 1.268 . . . . 0.0 109.033 175.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 77.35 27.74 59.09 Favored Glycine 0 CA--C 1.526 0.722 0 CA-C-O 119.105 -0.83 . . . . 0.0 113.542 177.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 28.9 p-80 -60.84 139.69 57.88 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 118.815 1.307 . . . . 0.0 108.678 168.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 75.6 t-105 -127.78 137.88 31.7 Favored Pre-proline 0 CA--C 1.533 0.321 0 C-N-CA 124.453 1.101 . . . . 0.0 108.245 -169.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -70.89 144.65 48.6 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 121.762 1.642 . . . . 0.0 112.347 -170.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 63.0 p . . . . . 0 CA--C 1.536 0.419 0 C-N-CA 123.471 0.708 . . . . 0.0 110.055 169.367 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.836 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -75.76 0.79 60.59 Favored Glycine 0 CA--C 1.535 1.295 0 CA-C-O 119.216 -0.769 . . . . 0.0 112.867 169.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 96.7 mt -64.32 139.19 58.74 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 119.468 1.634 . . . . 0.0 111.083 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -108.53 -31.07 7.93 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.456 1.503 . . . . 0.0 108.778 167.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -145.23 162.54 36.89 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 127.86 2.464 . . . . 0.0 106.181 169.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -55.65 -30.52 61.14 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 121.17 -0.956 . . . . 0.0 112.084 176.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -91.0 -9.41 46.06 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.241 1.016 . . . . 0.0 113.448 -179.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 58.7 m80 -147.36 130.94 16.81 Favored 'General case' 0 C--N 1.348 0.509 0 CA-C-N 119.93 1.241 . . . . 0.0 113.229 -171.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -76.22 155.58 34.31 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.008 0.923 . . . . 0.0 108.767 167.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 14.2 p -60.56 -32.19 50.85 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 124.144 0.978 . . . . 0.0 111.419 176.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -146.41 -177.25 20.9 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 124.905 1.241 . . . . 0.0 110.32 -172.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -62.55 123.39 18.21 Favored 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 171.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.374 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 -176.654 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 90.0 mt . . . . . 0 N--CA 1.468 0.458 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 93.9 m -53.66 -58.21 8.02 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.424 1.09 . . . . 0.0 110.614 -175.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -68.91 -32.67 72.46 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 122.278 -0.264 . . . . 0.0 110.517 -169.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 25.3 mp0 -63.97 -48.47 76.33 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.234 1.014 . . . . 0.0 109.292 176.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 74.3 mtt85 -65.53 -37.18 86.0 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 118.912 0.778 . . . . 0.0 110.635 -179.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 96.3 t -64.41 -42.26 94.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-O 118.358 -0.829 . . . . 0.0 109.093 174.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -59.41 -48.71 80.59 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-N 119.832 1.196 . . . . 0.0 110.359 177.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -58.94 -44.62 91.44 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 118.088 0.403 . . . . 0.0 110.094 179.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 68.0 t90 -66.06 -44.44 84.52 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 118.363 0.529 . . . . 0.0 110.02 -175.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 79.1 t -62.77 -39.64 85.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -65.17 -38.67 91.27 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 121.389 -0.819 . . . . 0.0 110.138 178.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 43.4 mm-40 -64.35 -52.19 59.61 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 118.586 0.63 . . . . 0.0 110.964 176.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 21.0 pt -64.59 -31.72 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 119.568 1.077 . . . . 0.0 110.326 -178.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 65.6 m -60.79 -26.14 67.06 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 118.062 -0.97 . . . . 0.0 112.538 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -95.22 -10.39 30.54 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 120.117 1.326 . . . . 0.0 112.699 175.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -88.0 -39.5 14.62 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 118.981 0.809 . . . . 0.0 110.304 171.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 88.0 mt -84.51 -12.32 54.44 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.677 1.991 . . . . 0.0 111.421 178.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 30.4 m80 56.58 30.16 16.82 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.556 1.543 . . . . 0.0 112.885 -170.048 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 67.6 mt . . . . . 0 N--CA 1.466 0.366 0 O-C-N 121.477 -0.764 . . . . 0.0 110.38 169.532 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.33 0 N-CA-C 110.536 -0.172 . . . . 0.0 110.536 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.7 pt -86.78 -23.9 6.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 122.269 0.228 . . . . 0.0 111.581 -178.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.9 m -112.01 130.15 55.96 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.825 1.25 . . . . 0.0 108.646 -178.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -103.95 116.35 5.35 Favored Glycine 0 CA--C 1.521 0.417 0 N-CA-C 108.241 -1.944 . . . . 0.0 108.241 169.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 74.6 mt -90.81 126.14 43.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 104.847 -2.279 . . . . 0.0 104.847 171.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -122.38 126.94 49.06 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 174.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -125.28 136.59 53.67 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 118.311 0.505 . . . . 0.0 111.027 178.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -85.93 136.86 14.63 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 108.632 -1.787 . . . . 0.0 108.632 168.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 22.6 m -157.35 158.12 35.39 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 119.395 1.598 . . . . 0.0 110.908 169.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -142.67 -42.79 0.32 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.878 1.271 . . . . 0.0 110.062 170.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.5 p -77.54 -13.28 59.95 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 122.977 0.511 . . . . 0.0 111.506 169.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 88.71 34.58 9.03 Favored Glycine 0 C--N 1.342 0.895 0 C-N-CA 124.079 0.847 . . . . 0.0 112.373 172.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -86.02 -54.12 4.67 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 117.493 0.647 . . . . 0.0 111.759 179.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.4 m -74.74 -16.62 60.73 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 118.511 -0.757 . . . . 0.0 112.21 -168.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -58.19 -35.97 72.41 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 119.605 1.093 . . . . 0.0 110.514 172.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -71.43 -40.85 70.14 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -179.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 34.4 mm -63.55 -43.5 98.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 177.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.03 -42.65 90.7 Favored 'General case' 0 CA--C 1.53 0.184 0 O-C-N 121.661 -0.65 . . . . 0.0 110.628 177.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -66.88 -39.77 87.59 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 118.434 -0.793 . . . . 0.0 111.087 176.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 63.0 mtt -61.77 -33.48 74.16 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 119.948 1.249 . . . . 0.0 111.499 176.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 26.1 mt -74.16 -49.55 32.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 175.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -59.78 -40.14 87.27 Favored 'General case' 0 C--O 1.225 -0.214 0 O-C-N 121.629 -0.669 . . . . 0.0 111.728 -176.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -63.57 -34.01 76.86 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 119.764 1.165 . . . . 0.0 111.171 -178.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -73.68 -41.29 62.85 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 122.722 0.409 . . . . 0.0 110.826 175.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.2 mp -74.75 -36.93 62.61 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 122.915 0.486 . . . . 0.0 111.25 -176.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.0 146.41 18.19 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 125.764 1.65 . . . . 0.0 110.85 -173.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 53.8 tptt -61.04 -31.66 71.3 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.565 1.146 . . . . 0.0 111.819 -175.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -68.0 -27.33 66.47 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.23 0.612 . . . . 0.0 111.192 178.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 39.0 t -96.89 -37.63 7.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 C-N-CA 124.248 1.019 . . . . 0.0 110.003 -175.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -135.55 137.17 41.75 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 119.252 0.933 . . . . 0.0 111.901 -174.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -119.08 158.34 26.05 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.861 0.864 . . . . 0.0 109.849 169.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 51.8 t -120.56 135.62 60.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 124.349 1.06 . . . . 0.0 110.543 -168.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -147.3 172.19 14.26 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.145 1.778 . . . . 0.0 111.456 -171.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -126.68 135.49 51.22 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 126.605 1.962 . . . . 0.0 106.364 170.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.0 tp -61.0 -18.54 18.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 123.759 0.824 . . . . 0.0 112.656 -172.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.99 -29.12 63.01 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 119.014 0.825 . . . . 0.0 111.304 178.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 45.7 mtmt -80.6 -24.15 39.33 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 122.922 0.489 . . . . 0.0 112.209 177.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 46.9 m -77.48 159.59 29.27 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.353 1.061 . . . . 0.0 113.337 -166.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.3 m -132.58 176.17 8.67 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 127.633 2.373 . . . . 0.0 106.632 169.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.5 tttm -50.11 -48.47 53.41 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.942 0.792 . . . . 0.0 111.96 -175.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -78.58 -11.95 59.99 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -173.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -69.96 -34.48 73.45 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.442 -0.786 . . . . 0.0 111.245 -176.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.3 mp -76.22 -35.25 59.12 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-O 119.103 -0.475 . . . . 0.0 110.832 172.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -64.25 -23.75 67.42 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 118.595 0.634 . . . . 0.0 112.175 -177.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.13 -28.87 69.73 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.78 0.832 . . . . 0.0 112.506 178.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -91.8 152.15 20.26 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 124.551 1.141 . . . . 0.0 109.68 176.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -109.92 -15.23 14.12 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.614 0.766 . . . . 0.0 111.8 174.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.4 mp -123.22 134.06 67.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 169.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 91.2 mt -124.3 147.88 47.83 Favored 'General case' 0 CA--C 1.518 -0.281 0 C-N-CA 123.651 0.781 . . . . 0.0 109.702 178.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.8 mt -130.99 107.46 9.11 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 177.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 76.2 mt -112.4 114.14 26.71 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -169.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -106.25 116.38 5.08 Favored Glycine 0 C--N 1.335 0.51 0 C-N-CA 125.475 1.512 . . . . 0.0 110.27 -177.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 16.1 tt -123.74 117.66 27.42 Favored Pre-proline 0 CA--C 1.541 0.609 0 CA-C-N 118.574 1.187 . . . . 0.0 111.749 -172.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -77.35 141.72 20.56 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 121.806 1.671 . . . . 0.0 109.288 168.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 35.3 m -91.03 142.72 27.47 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 172.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 51.0 m95 -132.96 172.66 12.32 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.948 2.099 . . . . 0.0 109.797 -175.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 33.92 53.61 0.51 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 128.918 2.887 . . . . 0.0 115.824 169.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 53.04 62.78 2.51 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.174 0.99 . . . . 0.0 111.28 176.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 87.43 52.12 3.11 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 123.713 0.673 . . . . 0.0 112.386 174.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -135.21 161.38 35.53 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.823 1.649 . . . . 0.0 108.628 171.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.12 165.57 21.47 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 168.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -67.01 147.77 52.79 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 169.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 57.9 m -53.28 -34.78 58.68 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.075 0.95 . . . . 0.0 112.741 -176.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -67.4 -44.26 79.29 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.156 0.582 . . . . 0.0 110.426 -176.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -71.4 -43.46 66.78 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.213 0.605 . . . . 0.0 109.474 176.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -60.21 -39.31 86.13 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.523 0.729 . . . . 0.0 111.737 -178.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -70.77 -24.7 62.65 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.955 0.902 . . . . 0.0 112.104 176.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -88.23 -23.59 23.5 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-O 118.326 -0.845 . . . . 0.0 112.156 178.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -51.11 -43.31 84.65 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-O 116.631 -1.652 . . . . 0.0 114.462 178.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -64.65 -15.39 49.8 Favored 'Trans proline' 0 CA--C 1.543 0.953 0 CA-C-N 122.8 2.036 . . . . 0.0 113.691 175.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.0 m -90.72 -38.84 12.79 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.783 1.233 . . . . 0.0 109.613 170.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 23.6 tp -57.84 -40.36 79.87 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 124.352 1.061 . . . . 0.0 109.946 -179.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -71.87 -7.05 46.13 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -86.15 -15.44 41.05 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 120.185 1.357 . . . . 0.0 110.412 173.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 65.1 mt -90.02 128.47 41.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 -174.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -87.5 139.54 30.44 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 168.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -126.38 20.52 7.36 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.492 1.117 . . . . 0.0 111.315 -175.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -50.55 -34.07 24.14 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 115.777 1.769 . . . . 0.0 115.777 -168.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -110.64 13.6 29.97 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-O 118.385 -1.231 . . . . 0.0 113.556 -178.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -112.33 146.97 37.34 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 119.602 1.701 . . . . 0.0 109.99 -169.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -95.83 141.88 28.75 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 176.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 16.4 t -134.76 143.04 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 173.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -124.61 145.46 49.61 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 169.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 88.9 mt -121.69 139.48 53.51 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -169.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -140.98 164.15 31.05 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 169.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -168.34 156.55 28.12 Favored Glycine 0 N--CA 1.443 -0.838 0 O-C-N 121.059 -1.026 . . . . 0.0 112.132 -178.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 33.5 m -122.32 152.65 39.9 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 -168.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -164.92 -153.38 7.47 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.501 -174.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -152.46 140.31 20.03 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.101 1.36 . . . . 0.0 110.331 -178.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -120.5 13.56 11.78 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.616 1.566 . . . . 0.0 110.816 -179.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -94.27 -43.78 8.27 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.344 1.057 . . . . 0.0 109.541 -178.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -127.82 -31.5 2.42 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.702 1.201 . . . . 0.0 111.789 177.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -90.04 24.8 2.33 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.522 0.729 . . . . 0.0 111.971 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.76 -19.34 64.9 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.212 1.405 . . . . 0.0 114.027 -170.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -99.49 7.71 45.15 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 119.527 1.058 . . . . 0.0 112.343 176.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -133.86 25.01 3.98 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 126.206 1.802 . . . . 0.0 109.494 176.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -65.84 122.56 17.59 Favored 'General case' 0 C--O 1.238 0.481 0 O-C-N 121.767 -0.583 . . . . 0.0 109.65 -168.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 93.5 m 50.61 33.85 8.75 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.669 1.588 . . . . 0.0 112.778 -177.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -52.48 -38.15 58.78 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 121.753 -0.592 . . . . 0.0 112.561 -177.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -73.12 -14.65 61.42 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -171.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -59.67 -39.3 84.02 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.158 -0.964 . . . . 0.0 111.281 -177.048 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -70.41 -23.02 77.81 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 123.239 0.447 . . . . 0.0 112.692 179.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.2 m -65.59 -29.86 70.52 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 118.28 1.04 . . . . 0.0 110.894 -177.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 6.4 mt -71.62 -48.81 50.27 Favored 'Isoleucine or valine' 0 C--N 1.345 0.372 0 CA-C-O 118.51 -0.757 . . . . 0.0 109.056 175.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 18.6 ttm-85 -53.03 -42.95 66.2 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 119.053 0.842 . . . . 0.0 109.806 178.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -59.18 -23.78 62.53 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -176.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 94.8 mt -95.2 -50.49 11.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 124.016 0.926 . . . . 0.0 109.84 175.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 20.0 pt -75.72 -24.48 16.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 119.194 0.906 . . . . 0.0 112.16 -168.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -67.93 -52.86 22.63 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-O 117.394 -1.288 . . . . 0.0 112.101 -179.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -65.77 -25.47 53.44 Favored 'Trans proline' 0 C--N 1.352 0.746 0 CA-C-N 122.137 1.799 . . . . 0.0 111.953 175.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 83.1 mmt-85 -75.82 5.31 6.51 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.03 0.932 . . . . 0.0 112.976 170.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 78.15 14.55 82.14 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-O 117.891 -1.505 . . . . 0.0 114.801 168.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.11 143.04 45.15 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 119.657 1.729 . . . . 0.0 109.19 171.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 69.7 m -88.7 125.91 35.07 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 104.419 -2.437 . . . . 0.0 104.419 167.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 21.5 mt -116.23 130.25 71.29 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 -169.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 29.8 m -130.36 175.28 11.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 124.403 1.081 . . . . 0.0 109.76 177.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 91.55 24.48 25.9 Favored Glycine 0 CA--C 1.528 0.888 0 CA-C-O 119.097 -0.835 . . . . 0.0 114.025 170.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 49.0 p-80 -60.96 150.66 32.69 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 119.262 1.531 . . . . 0.0 109.068 168.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 73.3 t-105 -136.62 133.62 19.15 Favored Pre-proline 0 CA--C 1.535 0.379 0 C-N-CA 123.697 0.799 . . . . 0.0 109.543 -169.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -69.76 146.37 59.99 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.385 2.057 . . . . 0.0 112.048 -176.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 68.4 p . . . . . 0 CA--C 1.538 0.496 0 C-N-CA 124.753 1.221 . . . . 0.0 111.814 174.545 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? . . . . . 0 N--CA 1.469 0.488 0 CA-C-O 119.238 -0.411 . . . . 0.0 111.45 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -74.57 0.57 55.38 Favored Glycine 0 CA--C 1.535 1.285 0 CA-C-N 118.813 0.733 . . . . 0.0 113.207 169.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 77.6 mt -63.05 142.63 58.31 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 119.111 1.456 . . . . 0.0 112.17 177.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -107.01 -27.86 10.39 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 125.932 1.693 . . . . 0.0 109.647 167.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -144.16 159.11 43.21 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 127.251 2.22 . . . . 0.0 106.291 175.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -53.01 -29.55 29.98 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -179.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -101.38 -7.32 23.04 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -137.91 133.25 33.59 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 120.798 1.636 . . . . 0.0 113.035 -170.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -76.25 149.01 37.23 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.436 1.095 . . . . 0.0 108.898 167.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 6.2 p -68.91 -17.61 22.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 124.977 1.311 . . . . 0.0 111.719 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -154.54 178.81 31.11 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 108.172 -1.971 . . . . 0.0 108.172 178.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -66.61 109.62 2.88 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 118.282 1.041 . . . . 0.0 108.21 173.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.418 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 171.851 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 68.6 mt . . . . . 0 N--CA 1.472 0.662 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 8.6 m -49.94 -60.1 3.24 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 126.812 2.045 . . . . 0.0 112.339 -168.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -74.73 -35.37 62.65 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 118.951 -0.547 . . . . 0.0 111.28 -167.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -67.52 -41.11 84.93 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 118.565 0.621 . . . . 0.0 110.517 176.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 64.5 mtp180 -62.02 -41.3 97.93 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 119.32 0.964 . . . . 0.0 110.537 176.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 84.9 t -70.79 -33.78 53.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-O 118.52 -0.752 . . . . 0.0 110.388 179.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -65.03 -49.53 69.78 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 120.916 1.689 . . . . 0.0 109.378 175.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -59.28 -34.84 72.76 Favored 'General case' 0 C--N 1.339 0.136 0 CA-C-O 118.599 -0.715 . . . . 0.0 110.973 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 35.8 t90 -73.03 -52.5 14.15 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 119.007 0.821 . . . . 0.0 110.728 178.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 77.1 t -65.86 -31.9 55.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 O-C-N 121.4 -0.813 . . . . 0.0 110.831 -171.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 55.8 mttm -60.21 -35.53 75.63 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 121.49 -0.756 . . . . 0.0 110.889 174.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 21.8 mm100 -70.85 -50.22 37.63 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 118.59 0.632 . . . . 0.0 110.928 173.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 2.3 pt -63.13 -30.82 50.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 119.221 0.919 . . . . 0.0 110.533 -174.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 50.8 m -61.87 -32.35 72.7 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 119.06 -0.495 . . . . 0.0 111.203 179.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -79.89 -40.89 27.31 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 119.219 0.918 . . . . 0.0 109.837 176.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -66.42 -34.88 78.94 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.455 0.702 . . . . 0.0 111.444 -177.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 95.5 mt -92.24 -1.56 57.04 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.958 1.703 . . . . 0.0 111.552 179.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 30.5 m80 56.73 21.17 5.67 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.166 1.786 . . . . 0.0 113.595 -174.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 72.5 mt . . . . . 0 N--CA 1.464 0.228 0 O-C-N 121.399 -0.813 . . . . 0.0 110.442 175.516 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.234 0 CA-C-O 120.731 0.3 . . . . 0.0 111.133 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.9 pt -106.35 -16.16 8.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 125.239 1.415 . . . . 0.0 110.926 178.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 53.7 m -112.04 124.38 52.29 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.485 1.514 . . . . 0.0 108.426 177.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -98.44 121.64 7.24 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 108.748 -1.741 . . . . 0.0 108.748 169.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 61.9 mt -96.14 96.16 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 103.773 -2.677 . . . . 0.0 103.773 176.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -99.17 119.42 37.84 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -133.5 156.72 47.26 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 123.402 0.681 . . . . 0.0 109.276 -169.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -131.93 144.82 16.57 Favored Glycine 0 C--N 1.336 0.576 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 169.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.0 m -141.14 161.85 36.88 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.208 1.403 . . . . 0.0 108.811 177.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -126.54 -54.16 1.45 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.033 0.533 . . . . 0.0 110.254 171.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.13 -3.06 56.94 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.036 0.934 . . . . 0.0 111.614 170.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 93.4 7.65 61.81 Favored Glycine 0 C--N 1.342 0.875 0 C-N-CA 124.561 1.077 . . . . 0.0 113.254 169.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -71.07 -43.3 68.06 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 118.657 1.228 . . . . 0.0 111.377 -173.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -65.62 -37.76 87.52 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 118.801 0.728 . . . . 0.0 110.037 -172.334 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.3 tp10 -59.79 -35.95 75.71 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.475 1.11 . . . . 0.0 111.342 179.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -64.07 -38.16 90.06 Favored 'General case' 0 CA--C 1.53 0.203 0 O-C-N 121.678 -0.638 . . . . 0.0 110.377 176.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.5 mm -68.97 -41.45 81.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 176.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.7 -39.28 70.81 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.122 0.874 . . . . 0.0 111.041 178.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -66.6 -45.72 78.24 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 118.843 -0.598 . . . . 0.0 110.856 173.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 69.1 mtm -63.86 -27.78 69.4 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 119.713 1.142 . . . . 0.0 112.003 178.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 61.6 mt -70.03 -56.19 12.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 172.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -57.55 -40.09 78.11 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.588 -0.695 . . . . 0.0 111.97 -177.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -62.98 -34.07 76.75 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 119.505 1.048 . . . . 0.0 111.522 -178.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -75.05 -41.48 58.99 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 122.849 0.46 . . . . 0.0 111.172 178.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -77.08 -32.26 56.61 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 118.886 0.766 . . . . 0.0 111.616 -177.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.07 143.54 11.47 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 124.952 1.263 . . . . 0.0 110.165 -169.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -63.58 -31.19 72.28 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.917 0.887 . . . . 0.0 111.947 -172.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -77.6 -7.66 56.71 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 46.4 t -105.28 -47.34 9.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 124.318 1.047 . . . . 0.0 109.157 176.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -131.44 140.32 49.58 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 119.386 0.994 . . . . 0.0 110.965 -176.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -132.86 147.74 52.3 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 176.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 58.0 t -99.75 137.59 26.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 C-N-CA 124.919 1.288 . . . . 0.0 110.48 -169.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -141.06 145.38 35.77 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.373 1.469 . . . . 0.0 109.392 -177.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -88.51 124.1 33.67 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 169.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.4 tp -58.32 -34.93 51.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 119.119 -0.467 . . . . 0.0 111.276 -174.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.84 -33.84 76.76 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 119.126 0.875 . . . . 0.0 112.318 -171.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -92.98 -7.61 45.4 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.125 0.57 . . . . 0.0 112.153 176.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 49.9 m -74.99 165.48 25.19 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.137 0.575 . . . . 0.0 110.096 179.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.3 m -128.72 158.94 37.19 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 124.241 1.017 . . . . 0.0 110.745 -170.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -51.2 -51.72 51.16 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.884 1.274 . . . . 0.0 111.373 -176.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -79.88 -14.27 58.77 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 122.542 0.337 . . . . 0.0 111.439 -173.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -76.67 -34.25 58.24 Favored 'General case' 0 C--N 1.34 0.166 0 O-C-N 121.599 -0.688 . . . . 0.0 111.045 -176.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.6 mp -65.76 -36.88 84.81 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 171.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -67.24 -19.47 65.53 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 123.039 0.536 . . . . 0.0 112.251 -174.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.53 -28.64 68.7 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.645 0.778 . . . . 0.0 112.05 177.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -89.37 152.46 21.5 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 123.93 0.892 . . . . 0.0 110.398 -176.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -92.51 -34.98 13.86 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.462 172.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 20.1 mt -113.78 137.99 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 -179.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 91.8 mt -124.89 134.87 52.52 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.666 0.786 . . . . 0.0 109.012 174.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.0 mp -112.85 116.2 29.67 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 104.821 -2.288 . . . . 0.0 104.821 168.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 66.6 mt -112.04 111.83 23.03 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 -172.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -105.19 106.69 2.71 Favored Glycine 0 C--N 1.338 0.648 0 C-N-CA 124.355 0.979 . . . . 0.0 112.336 -173.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.4 tp -124.62 107.44 29.21 Favored Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 126.114 1.766 . . . . 0.0 109.886 -168.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -76.21 141.74 23.58 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.095 1.863 . . . . 0.0 109.62 169.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 44.9 m -93.47 138.96 31.25 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 174.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 16.2 m95 -131.55 172.06 12.68 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 124.537 1.135 . . . . 0.0 110.606 -177.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 33.88 63.3 0.4 Allowed 'General case' 0 C--O 1.236 0.343 0 C-N-CA 128.22 2.608 . . . . 0.0 113.306 169.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.263 19.9 p90 49.67 58.96 4.86 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.633 1.173 . . . . 0.0 111.992 174.202 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.86 53.71 2.34 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-N 115.031 -0.986 . . . . 0.0 114.108 168.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -137.46 157.58 46.26 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 117.828 0.814 . . . . 0.0 110.283 167.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.84 150.59 32.23 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 168.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -62.59 152.41 35.11 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 169.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 60.9 m -57.96 -30.49 66.03 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.835 0.854 . . . . 0.0 111.83 -175.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -61.06 -39.07 88.46 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.922 0.889 . . . . 0.0 110.773 -179.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -85.09 -42.8 14.47 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 123.605 0.762 . . . . 0.0 110.671 175.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -61.51 -37.39 83.51 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.061 0.391 . . . . 0.0 111.828 -174.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -69.72 -21.96 63.43 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.529 0.732 . . . . 0.0 112.079 175.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -91.86 -23.65 19.59 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.6 0.76 . . . . 0.0 111.759 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -51.73 -41.57 78.89 Favored Pre-proline 0 CA--C 1.545 0.777 0 CA-C-O 116.539 -1.696 . . . . 0.0 114.763 179.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -64.38 -24.41 64.46 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 CA-C-N 122.991 2.104 . . . . 0.0 112.828 174.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.4 m -78.22 -40.57 37.02 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.257 0.935 . . . . 0.0 109.359 170.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 13.3 tp -59.5 -36.85 76.84 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.551 1.141 . . . . 0.0 111.151 -174.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -77.44 -6.65 54.21 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.893 0.877 . . . . 0.0 112.844 178.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 67.2 mt-10 -92.15 -23.28 19.46 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.432 1.014 . . . . 0.0 110.428 169.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 79.2 mt -73.14 147.61 9.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 176.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -116.91 137.74 52.01 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 176.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -124.82 16.11 8.65 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.458 1.103 . . . . 0.0 111.13 -171.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -59.73 126.74 28.8 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 120.062 1.301 . . . . 0.0 109.635 -179.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 72.3 2.79 55.4 Favored Glycine 0 CA--C 1.536 1.352 0 CA-C-O 118.121 -1.377 . . . . 0.0 114.605 -176.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -86.36 149.32 25.11 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 120.176 1.988 . . . . 0.0 108.036 173.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 14.9 mt -95.26 139.79 31.08 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 173.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.5 t -135.54 144.55 33.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 176.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -128.48 142.44 51.08 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 168.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 74.1 mt -105.29 149.7 25.79 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -178.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.433 ' CE2' HD12 ' A' ' 142' ' ' LEU . 15.1 t80 -140.15 146.76 39.21 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 176.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.485 ' HA3' HD11 ' A' ' 102' ' ' LEU . . . -165.31 143.21 8.28 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-N 119.555 1.07 . . . . 0.0 113.002 168.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 6.6 t -88.4 160.06 17.74 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 114.114 -1.043 . . . . 0.0 109.043 170.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -177.91 -174.53 44.32 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 -179.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -133.16 140.45 47.59 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.802 1.641 . . . . 0.0 109.543 174.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 22.0 pt20 -134.46 45.88 2.54 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.398 0.618 . . . . 0.0 110.584 169.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -109.17 -33.66 6.81 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.841 1.256 . . . . 0.0 108.83 168.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -127.84 -34.88 2.13 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 125.046 1.338 . . . . 0.0 111.367 173.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -90.29 26.37 1.95 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.038 0.935 . . . . 0.0 111.971 178.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.59 -14.89 62.08 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.014 -1.054 . . . . 0.0 113.685 -175.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -89.32 2.24 54.65 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 118.986 0.812 . . . . 0.0 111.868 173.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -142.58 11.86 1.89 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.152 1.381 . . . . 0.0 111.546 -173.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -67.8 127.55 33.22 Favored 'General case' 0 C--O 1.236 0.388 0 O-C-N 121.221 -0.924 . . . . 0.0 110.707 -168.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 85.2 m 50.99 31.77 6.71 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.085 1.354 . . . . 0.0 112.42 177.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -60.25 -38.44 83.47 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 121.777 -0.577 . . . . 0.0 111.354 -179.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.6 -21.96 62.6 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -169.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.485 HD11 ' HA3' ' A' ' 87' ' ' GLY . 6.9 mp -59.96 -38.02 81.26 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 119.063 0.847 . . . . 0.0 109.322 172.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.68 -34.48 88.73 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 111.306 -0.718 . . . . 0.0 111.306 175.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 4.7 m -65.68 -38.47 89.35 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.588 1.194 . . . . 0.0 110.364 177.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.1 mt -70.23 -46.1 73.11 Favored 'Isoleucine or valine' 0 C--N 1.343 0.323 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 175.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 37.5 ttt180 -53.42 -45.71 69.5 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 118.807 0.731 . . . . 0.0 110.579 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -61.85 -17.92 58.18 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.408 1.083 . . . . 0.0 112.571 -178.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 94.3 mt -95.69 -57.59 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 C-N-CA 123.997 0.919 . . . . 0.0 108.918 173.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 19.9 pt -69.05 -33.4 58.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 119.369 0.986 . . . . 0.0 112.203 -167.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -66.93 -54.06 23.01 Favored Pre-proline 0 CA--C 1.545 0.783 0 CA-C-O 117.816 -1.088 . . . . 0.0 111.006 -174.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.86 -22.39 36.53 Favored 'Trans proline' 0 C--N 1.353 0.786 0 CA-C-N 121.646 1.624 . . . . 0.0 112.677 175.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 30.4 mmm180 -79.68 11.31 3.24 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 119.015 0.825 . . . . 0.0 112.124 172.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 98.12 -2.57 59.73 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 125.463 1.506 . . . . 0.0 116.82 166.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.95 143.15 57.97 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 120.155 1.978 . . . . 0.0 111.059 -176.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 48.6 m -94.27 123.83 37.92 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 105.138 -2.171 . . . . 0.0 105.138 168.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 42.3 mt -105.86 131.77 54.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 -170.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 33.4 m -132.74 178.33 5.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 125.544 1.537 . . . . 0.0 109.258 177.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 77.35 22.89 69.44 Favored Glycine 0 CA--C 1.525 0.657 0 O-C-N 121.613 -0.679 . . . . 0.0 112.686 174.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 9.1 p-80 -61.5 113.88 2.92 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.313 1.045 . . . . 0.0 108.28 169.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 73.6 t-105 -84.06 140.85 40.02 Favored Pre-proline 0 CA--C 1.536 0.439 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 177.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -66.25 149.06 85.43 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 121.981 1.788 . . . . 0.0 111.296 179.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 81.2 p . . . . . 0 CA--C 1.537 0.469 0 C-N-CA 123.267 0.627 . . . . 0.0 111.118 169.707 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 60.0 mttt . . . . . 0 N--CA 1.47 0.551 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -76.88 0.96 64.3 Favored Glycine 0 CA--C 1.532 1.135 0 CA-C-O 118.93 -0.928 . . . . 0.0 113.214 168.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 8.3 mp -63.67 129.92 42.13 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 119.938 1.869 . . . . 0.0 110.277 178.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.06 -38.25 22.79 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.82 1.248 . . . . 0.0 108.058 167.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -153.94 166.68 32.22 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 129.548 3.139 . . . . 0.0 106.105 -174.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -52.67 -35.64 55.59 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.052 -1.03 . . . . 0.0 112.336 175.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -95.92 -7.37 36.85 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -174.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -146.28 141.09 26.98 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.814 1.188 . . . . 0.0 112.207 -172.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -83.93 160.87 20.99 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.003 1.321 . . . . 0.0 108.768 168.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 34.3 m -72.03 -7.16 8.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 O-C-N 120.963 -1.086 . . . . 0.0 112.872 179.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -166.64 -157.63 10.52 Favored Glycine 0 CA--C 1.521 0.42 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.433 HD12 ' CE2' ' A' ' 86' ' ' PHE . 2.8 tm? -76.97 96.24 4.32 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 169.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.346 0 N-CA-C 104.042 -2.577 . . . . 0.0 104.042 165.41 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 85.3 mt . . . . . 0 N--CA 1.463 0.194 0 CA-C-O 119.325 -0.369 . . . . 0.0 110.684 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 13.5 m -48.23 -55.61 10.07 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 123.946 0.899 . . . . 0.0 110.512 -175.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -61.85 -40.84 96.74 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.481 0.582 . . . . 0.0 111.121 -170.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -66.12 -49.92 65.8 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 177.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 87.4 mtt180 -58.73 -47.49 84.44 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 123.073 0.549 . . . . 0.0 110.219 -175.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 13.0 m -77.51 -33.69 19.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-O 118.611 -0.709 . . . . 0.0 110.729 -171.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -65.97 -47.81 73.35 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 119.841 1.2 . . . . 0.0 109.526 174.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -61.13 -40.37 93.56 Favored 'General case' 0 C--O 1.227 -0.11 0 CA-C-O 119.132 -0.461 . . . . 0.0 110.157 179.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 60.9 t90 -64.08 -47.7 79.06 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 118.71 0.686 . . . . 0.0 110.791 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 40.7 t -57.62 -40.55 75.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 118.265 0.484 . . . . 0.0 109.805 177.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 53.7 mttm -68.83 -36.96 78.82 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 118.353 -0.832 . . . . 0.0 110.227 -178.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -62.59 -55.35 27.97 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 119.106 0.867 . . . . 0.0 110.42 174.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 22.4 pt -68.58 -29.03 42.48 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.369 0 CA-C-O 119.015 -0.517 . . . . 0.0 110.409 -172.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 64.3 m -58.01 -29.67 65.49 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 119.011 0.823 . . . . 0.0 111.593 175.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -79.37 -45.46 19.51 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 119.64 1.109 . . . . 0.0 110.272 175.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -66.37 -35.03 79.3 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.516 0.726 . . . . 0.0 111.236 -175.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 73.6 mt -86.75 -3.59 59.07 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.075 1.75 . . . . 0.0 111.377 179.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 54.12 33.98 19.04 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.56 1.544 . . . . 0.0 112.51 -173.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 95.9 mt . . . . . 0 N--CA 1.464 0.265 0 O-C-N 121.549 -0.719 . . . . 0.0 110.359 173.228 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.66 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 22.4 pt -89.47 -18.96 7.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 O-C-N 121.623 -0.673 . . . . 0.0 112.091 -177.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.2 m -117.46 122.46 43.81 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 124.997 1.319 . . . . 0.0 107.521 178.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -98.45 114.28 4.97 Favored Glycine 0 C--N 1.334 0.472 0 N-CA-C 107.873 -2.091 . . . . 0.0 107.873 171.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 65.4 mt -94.69 106.75 18.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 104.872 -2.27 . . . . 0.0 104.872 174.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 11.7 m-30 -105.08 133.66 49.48 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 177.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -125.69 130.21 51.1 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.515 0.598 . . . . 0.0 112.149 -178.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -86.29 144.92 20.21 Favored Glycine 0 C--N 1.338 0.665 0 N-CA-C 108.738 -1.745 . . . . 0.0 108.738 168.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 11.0 m -158.27 169.76 23.77 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 119.12 1.46 . . . . 0.0 110.321 175.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -141.6 -49.45 0.4 Allowed 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.556 1.142 . . . . 0.0 109.124 168.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.3 p -80.56 -17.22 52.12 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.938 0.895 . . . . 0.0 112.171 170.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 103.95 7.41 41.38 Favored Glycine 0 C--N 1.342 0.885 0 C-N-CA 124.673 1.13 . . . . 0.0 113.99 171.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -65.13 -42.04 94.27 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 118.999 1.4 . . . . 0.0 112.069 -171.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -70.26 -18.41 63.13 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 118.942 0.792 . . . . 0.0 111.751 -170.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -58.81 -43.57 90.62 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 119.432 1.014 . . . . 0.0 110.036 174.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -64.4 -40.44 95.8 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 23.3 mm -66.42 -42.33 90.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 O-C-N 121.804 -0.56 . . . . 0.0 109.507 179.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.71 -40.08 86.76 Favored 'General case' 0 CA--C 1.532 0.253 0 O-C-N 121.721 -0.612 . . . . 0.0 110.579 176.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp -68.39 -39.43 81.72 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 118.336 -0.84 . . . . 0.0 111.145 176.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 64.1 mtt -59.51 -37.39 78.18 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 119.827 1.194 . . . . 0.0 110.976 175.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 51.9 mt -71.31 -51.38 34.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 177.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -62.13 -37.11 83.91 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 121.507 -0.745 . . . . 0.0 111.203 -174.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 59.1 tptt -63.13 -38.28 90.57 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 119.063 0.847 . . . . 0.0 110.812 -178.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -71.76 -41.62 68.2 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.952 0.501 . . . . 0.0 110.753 177.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.1 mp -73.21 -35.73 66.37 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.098 0.408 . . . . 0.0 111.24 -176.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 90.93 147.71 19.8 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 125.089 1.328 . . . . 0.0 110.771 -172.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -66.42 -28.3 68.51 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.694 0.798 . . . . 0.0 112.186 -171.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -69.04 -25.92 64.72 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 122.873 0.469 . . . . 0.0 111.348 176.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 31.6 t -98.52 -36.31 5.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 C-N-CA 124.481 1.112 . . . . 0.0 110.58 -174.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -135.33 144.76 46.86 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 118.777 0.717 . . . . 0.0 112.207 -177.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -129.32 154.65 46.66 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 125.288 1.435 . . . . 0.0 108.212 175.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 69.7 t -117.76 133.96 62.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 124.165 0.986 . . . . 0.0 108.901 -169.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -149.73 -174.78 4.79 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.218 1.007 . . . . 0.0 111.319 -177.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -135.02 141.31 46.14 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 125.224 1.41 . . . . 0.0 107.197 173.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.8 tp -59.49 -24.96 29.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 123.869 0.868 . . . . 0.0 112.906 -169.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.56 -27.81 69.21 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 118.729 0.695 . . . . 0.0 111.165 178.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -96.85 -33.78 11.52 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.751 1.22 . . . . 0.0 110.986 -179.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 19.8 m -60.38 162.11 6.56 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.332 0.653 . . . . 0.0 110.001 169.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.4 m -136.29 157.28 47.17 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.619 0.768 . . . . 0.0 110.449 -171.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -51.69 -51.71 53.86 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.23 1.012 . . . . 0.0 110.884 -179.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -75.24 -16.34 60.47 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 122.693 0.397 . . . . 0.0 111.587 -176.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -78.49 -37.98 41.99 Favored 'General case' 0 CA--C 1.53 0.19 0 O-C-N 121.541 -0.724 . . . . 0.0 110.213 179.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.0 mp -65.24 -35.05 79.86 Favored 'General case' 0 C--N 1.342 0.248 0 O-C-N 121.808 -0.558 . . . . 0.0 110.265 170.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -63.87 -23.85 67.51 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 118.81 0.732 . . . . 0.0 111.493 174.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -86.83 -31.4 20.85 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.941 0.896 . . . . 0.0 112.75 -178.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -67.55 160.17 28.28 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 123.994 0.917 . . . . 0.0 110.688 174.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -109.27 -40.17 5.01 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.493 0.717 . . . . 0.0 111.39 169.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.9 mt -112.47 125.19 69.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 177.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -113.9 132.19 56.01 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 171.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.0 mp -115.28 119.24 35.67 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 172.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 69.2 mt -117.41 109.46 16.81 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -172.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.78 123.07 6.63 Favored Glycine 0 CA--C 1.521 0.463 0 N-CA-C 108.949 -1.661 . . . . 0.0 108.949 176.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 3.4 tp -137.1 115.4 10.11 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-N 118.129 0.965 . . . . 0.0 110.125 -169.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -78.6 -173.22 1.77 Allowed 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 123.207 2.605 . . . . 0.0 109.986 169.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 95.5 m -144.45 145.96 32.19 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 119.99 -1.694 . . . . 0.0 107.592 169.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 75.0 m95 -139.71 169.74 17.17 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 125.144 1.378 . . . . 0.0 110.984 -169.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 55.88 -73.1 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 128.833 2.853 . . . . 0.0 114.642 175.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -161.76 56.25 0.26 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 127.239 2.216 . . . . 0.0 108.379 -174.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 81.72 19.66 65.33 Favored Glycine 0 CA--C 1.534 1.258 0 O-C-N 121.438 -0.789 . . . . 0.0 113.47 -179.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -88.31 154.29 20.53 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.416 1.108 . . . . 0.0 109.489 179.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.85 161.88 24.24 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 168.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.252 0.0 OUTLIER -70.93 159.85 33.94 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 170.413 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 57.7 m -53.71 -37.53 63.38 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 115.567 1.691 . . . . 0.0 115.567 -166.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -76.79 -43.97 34.63 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 119.046 0.839 . . . . 0.0 109.458 -170.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -64.18 -45.75 87.0 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.653 0.781 . . . . 0.0 109.446 173.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -58.76 -39.32 80.67 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 122.583 0.353 . . . . 0.0 111.732 179.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -71.22 -30.64 66.61 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.897 0.879 . . . . 0.0 112.253 176.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -87.34 -21.67 25.56 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 118.618 0.645 . . . . 0.0 112.562 -176.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 16.5 m-30 -50.08 -44.63 80.38 Favored Pre-proline 0 CA--C 1.546 0.799 0 CA-C-O 116.932 -1.509 . . . . 0.0 114.683 178.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -65.98 -16.32 52.1 Favored 'Trans proline' 0 CA--C 1.542 0.913 0 CA-C-N 122.598 1.964 . . . . 0.0 113.798 175.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 14.7 m -85.87 -40.31 16.09 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 119.481 1.037 . . . . 0.0 109.207 169.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.435 ' HA ' HD12 ' A' ' 76' ' ' ILE . 37.3 tp -59.71 -36.9 77.48 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.94 1.296 . . . . 0.0 111.572 -173.189 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -66.85 -15.58 63.72 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 177.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 -91.97 -14.26 29.78 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 119.261 0.937 . . . . 0.0 111.781 179.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.435 HD12 ' HA ' ' A' ' 73' ' ' LEU . 96.7 mt -80.65 138.39 19.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 -173.043 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -80.88 132.0 35.41 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.707 -0.678 . . . . 0.0 109.259 175.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -126.88 16.43 7.39 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 118.187 -0.911 . . . . 0.0 111.42 174.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 23.9 m-80 -59.41 114.31 2.62 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 120.542 1.519 . . . . 0.0 109.377 -175.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.65 4.6 66.26 Favored Glycine 0 CA--C 1.536 1.357 0 CA-C-O 118.69 -1.061 . . . . 0.0 114.123 -178.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -77.39 151.58 34.75 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 119.515 1.658 . . . . 0.0 108.224 171.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 17.8 mt -95.74 137.2 35.13 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 175.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.3 t -132.11 144.29 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 172.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -135.36 149.18 49.63 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 169.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 72.6 mt -120.52 149.13 42.9 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 -174.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -146.59 157.39 43.71 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 123.234 0.614 . . . . 0.0 109.55 172.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -170.2 166.34 39.57 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-O 122.305 0.947 . . . . 0.0 113.208 -175.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 15.2 t -142.64 162.18 36.14 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 126.754 2.021 . . . . 0.0 107.106 179.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -176.0 -170.71 39.07 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -139.42 142.88 37.44 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 127.086 2.154 . . . . 0.0 105.978 176.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.62 21.99 1.99 Allowed 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -172.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -64.5 -46.19 84.02 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 178.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -95.84 -38.18 10.41 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.174 0.59 . . . . 0.0 110.704 169.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -83.22 41.89 0.79 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.408 1.483 . . . . 0.0 111.551 -172.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.18 -21.14 66.45 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.823 1.249 . . . . 0.0 113.72 -169.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -97.36 2.85 51.05 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.716 1.207 . . . . 0.0 111.386 178.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -133.98 18.18 3.8 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.4 1.08 . . . . 0.0 112.481 -169.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -61.86 120.37 10.6 Favored 'General case' 0 CA--C 1.529 0.169 0 O-C-N 121.104 -0.997 . . . . 0.0 109.346 -176.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 80.1 m 45.88 35.76 2.51 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.557 1.543 . . . . 0.0 112.654 -176.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -49.48 -41.1 39.59 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.43 1.092 . . . . 0.0 111.911 -171.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.67 -13.88 62.47 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -171.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 34.1 mt -56.23 -41.84 76.32 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 119.837 1.199 . . . . 0.0 109.793 169.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.97 -36.42 93.05 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 178.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.0 m -62.71 -44.23 96.75 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 117.944 0.872 . . . . 0.0 109.906 177.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.7 mt -66.29 -45.48 89.64 Favored 'Isoleucine or valine' 0 C--N 1.344 0.357 0 CA-C-N 119.613 1.097 . . . . 0.0 108.908 178.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 45.6 ttt180 -54.64 -48.15 72.63 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 119.379 0.99 . . . . 0.0 110.43 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -62.08 -29.8 70.56 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.329 0.652 . . . . 0.0 111.603 -177.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 85.9 mt -81.53 -44.36 20.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-O 117.595 -1.193 . . . . 0.0 110.634 178.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.7 pt -86.88 -33.55 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 120.121 1.328 . . . . 0.0 113.003 -168.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -64.57 -37.85 27.23 Favored Pre-proline 0 CA--C 1.547 0.832 0 CA-C-O 117.946 -1.026 . . . . 0.0 112.008 -171.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -64.38 -17.1 58.5 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 122.417 2.078 . . . . 0.0 114.223 174.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 13.7 mmt180 -90.25 10.2 25.63 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.076 0.95 . . . . 0.0 111.536 -173.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 77.94 10.85 85.93 Favored Glycine 0 CA--C 1.531 1.06 0 CA-C-O 118.432 -1.205 . . . . 0.0 113.391 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -57.66 137.94 55.9 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 118.712 1.256 . . . . 0.0 109.426 171.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 55.8 m -93.96 120.87 34.8 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 168.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 36.9 mt -97.65 128.17 49.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 -176.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 34.6 m -128.79 175.44 10.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 124.983 1.313 . . . . 0.0 108.987 176.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 75.93 28.85 59.96 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-O 119.079 -0.845 . . . . 0.0 112.731 -177.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 81.4 m-70 -60.43 135.17 57.66 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 169.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 74.7 t-105 -129.99 139.7 36.44 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 124.248 1.019 . . . . 0.0 109.385 -169.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -62.08 162.39 22.99 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 121.781 1.654 . . . . 0.0 113.065 -178.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.536 0.408 0 C-N-CA 123.659 0.784 . . . . 0.0 112.015 174.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.534 0.335 0 CA-C-O 119.691 -0.195 . . . . 0.0 110.791 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -79.08 -4.9 89.05 Favored Glycine 0 C--N 1.341 0.815 0 CA-C-O 118.596 -1.114 . . . . 0.0 113.19 170.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 70.4 mt -68.96 120.09 14.3 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 120.402 2.101 . . . . 0.0 108.156 175.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -87.91 -28.69 21.37 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.635 1.174 . . . . 0.0 110.337 175.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -146.73 168.38 21.5 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.161 1.784 . . . . 0.0 107.403 171.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -57.25 -25.96 60.01 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.742 1.217 . . . . 0.0 113.57 -170.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -121.43 11.34 10.67 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.349 1.46 . . . . 0.0 113.163 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -142.72 127.53 18.22 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-N 119.404 1.002 . . . . 0.0 111.593 -175.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -80.64 152.99 28.21 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 125.061 1.344 . . . . 0.0 109.658 169.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 12.2 p -59.73 -24.95 30.58 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 C-N-CA 124.76 1.224 . . . . 0.0 111.654 171.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -156.72 171.82 34.32 Favored Glycine 0 C--N 1.337 0.629 0 C-N-CA 124.763 1.173 . . . . 0.0 110.53 -169.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -60.24 127.26 30.91 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.361 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 170.146 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 66.9 mt . . . . . 0 N--CA 1.469 0.519 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 74.3 m -47.08 -56.98 5.55 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.806 1.643 . . . . 0.0 111.992 -169.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -69.59 -39.37 77.33 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 119.245 -0.407 . . . . 0.0 111.27 -168.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -73.52 -35.04 65.53 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.456 0.571 . . . . 0.0 111.118 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 33.2 mtp180 -64.8 -41.11 96.06 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 119.341 0.973 . . . . 0.0 109.892 174.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 72.4 t -67.89 -41.33 84.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-O 118.592 -0.718 . . . . 0.0 109.634 177.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -59.26 -50.78 72.71 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 120.134 1.334 . . . . 0.0 110.283 176.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 58.1 mttm -57.41 -42.92 83.24 Favored 'General case' 0 CA--C 1.522 -0.115 0 CA-C-O 118.652 -0.69 . . . . 0.0 109.994 -178.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 60.5 t90 -66.43 -48.55 69.64 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 118.546 0.612 . . . . 0.0 110.797 -178.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 53.6 t -60.87 -36.2 70.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 118.107 0.412 . . . . 0.0 109.95 -177.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -65.94 -33.91 76.91 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 118.427 -0.797 . . . . 0.0 110.438 177.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 41.5 mm-40 -65.58 -54.77 23.31 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 119.015 0.825 . . . . 0.0 110.534 171.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 5.7 pt -64.65 -29.91 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-N 118.807 0.731 . . . . 0.0 110.633 -170.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 49.6 m -60.09 -27.01 66.64 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 118.646 -0.692 . . . . 0.0 111.774 178.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -82.41 -38.11 24.55 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 119.644 1.111 . . . . 0.0 110.717 175.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -71.36 -36.78 71.6 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.136 0.574 . . . . 0.0 111.133 -178.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 85.7 mt -85.75 -5.75 59.21 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.749 1.62 . . . . 0.0 111.306 178.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 84.7 m-70 54.63 29.99 12.49 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.81 1.644 . . . . 0.0 112.88 -171.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 80.0 mt . . . . . 0 N--CA 1.465 0.287 0 CA-C-O 118.668 -0.682 . . . . 0.0 110.723 173.324 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 ptt? . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 111.564 0.209 . . . . 0.0 111.564 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.73 155.29 26.96 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.507 0.723 . . . . 0.0 110.634 175.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.1 pt -102.1 -16.85 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 123.962 0.905 . . . . 0.0 111.718 -179.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 16.4 m -114.58 126.89 55.43 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.682 1.593 . . . . 0.0 108.671 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -102.52 119.93 6.63 Favored Glycine 0 CA--C 1.52 0.348 0 N-CA-C 107.816 -2.114 . . . . 0.0 107.816 169.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 43.5 mt -96.22 124.54 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 104.405 -2.443 . . . . 0.0 104.405 172.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -122.84 130.18 52.57 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 176.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -129.47 130.78 46.32 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 119.615 1.098 . . . . 0.0 112.551 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -81.78 152.76 32.13 Favored Glycine 0 C--N 1.339 0.697 0 N-CA-C 108.102 -1.999 . . . . 0.0 108.102 168.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 16.8 p -153.27 166.04 33.84 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 120.128 1.964 . . . . 0.0 111.413 -176.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -144.49 -58.4 0.37 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.588 0.755 . . . . 0.0 109.745 168.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.2 p -83.36 -12.42 56.55 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.691 1.197 . . . . 0.0 111.875 175.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.06 7.84 59.39 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 124.714 1.15 . . . . 0.0 113.059 175.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -65.9 -37.74 86.89 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 118.459 1.129 . . . . 0.0 110.929 -176.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.82 -24.5 66.17 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.437 0.695 . . . . 0.0 111.914 -175.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -62.21 -40.97 97.88 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 119.114 0.87 . . . . 0.0 109.733 177.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -66.28 -37.79 86.27 Favored 'General case' 0 CA--C 1.529 0.141 0 O-C-N 122.13 -0.356 . . . . 0.0 110.123 178.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 27.1 mm -62.77 -48.9 85.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 175.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.1 -39.41 86.06 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.331 0.514 . . . . 0.0 111.156 -178.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 57.8 mttm -67.99 -42.93 80.01 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 118.52 -0.752 . . . . 0.0 111.223 175.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 75.1 mtm -64.78 -28.09 69.34 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 119.938 1.245 . . . . 0.0 111.506 178.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.402 HG21 HD23 ' A' ' 51' ' ' LEU . 83.6 mt -68.63 -57.73 8.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 169.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -59.16 -39.9 83.92 Favored 'General case' 0 C--O 1.226 -0.152 0 C-N-CA 122.938 0.495 . . . . 0.0 111.601 -171.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -64.54 -34.08 77.4 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 118.616 0.644 . . . . 0.0 111.435 -176.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -73.0 -47.58 43.9 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 118.159 0.436 . . . . 0.0 110.332 177.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 54.2 mt -67.18 -34.05 76.69 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 122.698 0.399 . . . . 0.0 111.594 -178.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.59 145.95 17.73 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 125.587 1.565 . . . . 0.0 110.762 -173.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -63.52 -28.72 70.14 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.765 0.826 . . . . 0.0 111.81 -176.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -66.88 -23.91 66.06 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.092 0.557 . . . . 0.0 111.349 176.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 53.1 t -101.3 -39.11 6.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 124.592 1.157 . . . . 0.0 110.441 -175.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -132.68 145.03 50.72 Favored 'General case' 0 C--N 1.342 0.245 0 CA-C-N 119.539 1.063 . . . . 0.0 112.111 -173.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -127.01 158.68 36.29 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.754 1.222 . . . . 0.0 109.757 172.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 71.0 t -119.27 138.08 51.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 125.021 1.328 . . . . 0.0 110.257 -169.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -146.35 166.54 26.01 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.847 1.659 . . . . 0.0 111.815 -170.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -126.82 135.53 51.14 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 105.357 -2.09 . . . . 0.0 105.357 168.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.9 tp -61.97 -17.2 17.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-N 118.88 0.763 . . . . 0.0 112.99 -170.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -52.32 -37.24 55.38 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.172 0.989 . . . . 0.0 112.339 179.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.15 1.43 57.15 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.632 0.773 . . . . 0.0 112.664 -177.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 52.5 m -87.89 157.68 18.91 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 122.374 1.083 . . . . 0.0 112.204 -174.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 23.7 m -129.23 172.51 11.38 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 127.971 2.509 . . . . 0.0 104.894 167.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.5 ptmm? -58.41 -38.69 77.91 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 120.059 1.299 . . . . 0.0 111.264 -173.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -71.51 -17.12 62.35 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.87 -0.519 . . . . 0.0 111.884 -176.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -68.23 -27.05 66.03 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.69 0.796 . . . . 0.0 111.039 -175.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.3 mp -86.97 -40.19 15.01 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 123.445 0.698 . . . . 0.0 109.845 171.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -63.74 -20.93 66.14 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.275 0.63 . . . . 0.0 111.921 -175.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.36 -29.96 70.23 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.278 1.031 . . . . 0.0 112.456 174.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -96.88 151.46 19.65 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.438 1.095 . . . . 0.0 110.669 -177.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -87.25 -37.95 16.76 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.556 170.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 22.2 mt -110.54 136.44 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -177.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 74.8 mt -132.42 120.84 22.53 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 124.139 0.976 . . . . 0.0 108.558 -176.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.402 HD23 HG21 ' A' ' 22' ' ' ILE . 8.9 mp -109.67 107.39 17.42 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 105.534 -2.024 . . . . 0.0 105.534 177.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 68.0 mt -110.17 100.85 9.68 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -170.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.97 131.73 10.8 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 124.726 1.155 . . . . 0.0 110.247 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.1 tt -142.26 122.32 8.15 Favored Pre-proline 0 CA--C 1.54 0.595 0 CA-C-N 118.358 1.079 . . . . 0.0 110.215 -179.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -81.07 161.51 20.63 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 123.07 2.513 . . . . 0.0 109.33 169.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 62.2 m -118.46 141.52 48.48 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 173.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 64.9 m95 -134.6 173.84 11.21 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 124.913 1.285 . . . . 0.0 109.442 -177.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 28.73 64.2 0.11 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 127.546 2.338 . . . . 0.0 114.479 169.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 56.73 62.84 2.13 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.445 1.098 . . . . 0.0 111.66 175.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.53 14.87 72.52 Favored Glycine 0 CA--C 1.532 1.138 0 CA-C-N 115.952 -0.567 . . . . 0.0 114.274 171.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -78.07 143.55 37.3 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 124.869 1.268 . . . . 0.0 110.117 176.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -93.89 143.94 25.89 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.342 1.057 . . . . 0.0 109.027 169.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -58.9 146.41 37.74 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.979 0.419 . . . . 0.0 110.592 177.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 60.8 m -59.25 -33.04 70.55 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.169 0.988 . . . . 0.0 112.97 -168.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -66.44 -43.7 84.89 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.247 0.476 . . . . 0.0 109.901 -178.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -71.81 -43.16 66.1 Favored 'General case' 0 C--N 1.341 0.204 0 C-N-CA 123.02 0.528 . . . . 0.0 110.029 176.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -59.15 -41.56 88.61 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 118.358 0.526 . . . . 0.0 111.858 -178.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -69.3 -23.32 63.8 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.76 0.824 . . . . 0.0 112.095 176.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -90.09 -20.76 22.78 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 118.277 -0.868 . . . . 0.0 112.302 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -51.96 -41.49 79.79 Favored Pre-proline 0 CA--C 1.544 0.72 0 CA-C-O 116.706 -1.616 . . . . 0.0 114.577 178.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -65.21 -13.89 42.17 Favored 'Trans proline' 0 CA--C 1.544 0.983 0 CA-C-N 122.809 2.039 . . . . 0.0 114.073 174.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 30.5 m -93.42 -36.15 12.64 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.46 1.104 . . . . 0.0 109.803 169.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.462 ' HA ' HD12 ' A' ' 76' ' ' ILE . 25.9 tp -56.1 -40.14 73.23 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 124.225 1.01 . . . . 0.0 110.501 178.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -72.78 1.11 9.13 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 178.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -112.55 -7.27 13.9 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.455 1.025 . . . . 0.0 111.52 174.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.462 HD12 ' HA ' ' A' ' 73' ' ' LEU . 62.7 mt -75.18 139.86 18.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -177.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -75.4 117.33 17.08 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 171.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -109.95 6.38 23.12 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 118.191 -0.909 . . . . 0.0 111.183 173.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 -60.62 116.91 4.72 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 120.754 1.616 . . . . 0.0 109.281 -175.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 74.61 -1.29 52.94 Favored Glycine 0 CA--C 1.535 1.315 0 CA-C-O 118.307 -1.274 . . . . 0.0 113.935 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -67.68 137.25 55.4 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 120.039 1.919 . . . . 0.0 107.428 172.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 17.8 mt -89.24 129.33 35.83 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 172.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.1 t -129.64 136.24 59.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -175.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -129.81 147.47 51.58 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 125.115 1.366 . . . . 0.0 107.326 175.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 69.2 mt -120.34 148.51 43.65 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -176.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -143.5 157.53 44.36 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.229 0.612 . . . . 0.0 110.654 175.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -175.47 172.34 45.37 Favored Glycine 0 CA--C 1.525 0.714 0 CA-C-O 122.634 1.13 . . . . 0.0 112.3 -178.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 4.3 m -142.76 158.65 43.43 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.369 1.868 . . . . 0.0 106.749 -173.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -169.76 -174.5 38.09 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 120.072 -1.061 . . . . 0.0 114.961 -177.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -144.29 140.38 29.14 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 129.834 3.254 . . . . 0.0 104.473 177.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.15 16.49 1.19 Allowed 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.739 1.216 . . . . 0.0 112.104 -171.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -63.82 -48.62 76.08 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.653 0.66 . . . . 0.0 109.316 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -98.78 -30.4 12.44 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.035 0.534 . . . . 0.0 111.136 171.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -83.91 42.59 0.87 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.711 1.605 . . . . 0.0 110.298 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.46 -17.32 59.2 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 -167.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -108.88 5.46 24.49 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.801 0.841 . . . . 0.0 112.594 176.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -126.14 15.31 7.86 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.683 1.193 . . . . 0.0 113.015 -169.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -62.9 121.94 14.75 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 119.588 1.086 . . . . 0.0 109.528 -177.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 82.4 m 47.12 35.98 3.98 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.709 1.604 . . . . 0.0 112.303 -177.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -50.19 -42.69 51.74 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.026 1.33 . . . . 0.0 111.655 -173.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.78 -12.02 61.02 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -170.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 82.2 mt -56.94 -42.17 79.56 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 119.143 0.883 . . . . 0.0 109.614 169.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.0 -34.28 88.38 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 111.246 -0.742 . . . . 0.0 111.246 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 4.7 m -64.18 -41.84 96.94 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 117.95 0.875 . . . . 0.0 110.578 -178.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 8.5 mt -72.16 -47.09 55.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 176.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 50.5 tpt85 -57.62 -33.02 67.82 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.488 0.715 . . . . 0.0 112.119 -175.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -70.42 -29.68 66.35 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 123.432 0.693 . . . . 0.0 112.29 179.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 94.6 mt -90.68 -40.33 12.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 123.52 0.728 . . . . 0.0 110.142 -173.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 15.4 pt -74.32 -32.39 31.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 118.853 0.751 . . . . 0.0 111.991 -169.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -63.37 -53.89 48.97 Favored Pre-proline 0 CA--C 1.541 0.596 0 CA-C-O 117.363 -1.303 . . . . 0.0 112.26 -178.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -66.22 -24.6 51.0 Favored 'Trans proline' 0 C--N 1.352 0.739 0 CA-C-N 121.942 1.729 . . . . 0.0 112.223 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -77.69 0.92 21.58 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 118.718 0.69 . . . . 0.0 112.205 171.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 100.25 11.17 43.01 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-O 118.208 -1.329 . . . . 0.0 115.469 168.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.33 150.11 40.34 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 119.292 1.546 . . . . 0.0 111.475 178.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 62.0 m -104.99 123.91 48.61 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 105.482 -2.044 . . . . 0.0 105.482 167.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 12.3 mm -91.79 138.87 18.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 -171.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 27.1 m -136.86 173.33 13.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 124.751 1.22 . . . . 0.0 109.114 170.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 81.95 43.42 8.23 Favored Glycine 0 C--N 1.337 0.628 0 CA-C-O 119.229 -0.761 . . . . 0.0 114.719 169.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 20.4 p80 -62.57 158.2 18.68 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 118.265 1.032 . . . . 0.0 109.716 168.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 77.5 t-105 -141.33 131.35 12.95 Favored Pre-proline 0 CA--C 1.534 0.331 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -68.4 145.19 64.39 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 121.912 1.741 . . . . 0.0 112.117 -173.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 57.1 p -77.18 -30.39 54.85 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.119 0.568 . . . . 0.0 110.926 171.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 54.06 43.08 31.26 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.283 1.833 . . . . 0.0 110.667 -169.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.86 76.5 0.89 Allowed Glycine 0 C--N 1.339 0.718 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -176.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -49.69 131.2 21.66 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.074 0.55 . . . . 0.0 109.728 171.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -98.11 -26.68 14.5 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 -168.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -91.27 -171.57 3.0 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.437 0.695 . . . . 0.0 111.34 -168.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -67.9 -50.36 56.72 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 123.461 0.704 . . . . 0.0 111.727 -168.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -160.34 165.39 31.34 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 123.443 0.697 . . . . 0.0 110.332 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 2.4 p -152.91 135.55 15.27 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 169.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -88.36 -10.61 48.81 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 121.507 -0.746 . . . . 0.0 111.751 -173.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -77.82 -2.72 82.43 Favored Glycine 0 CA--C 1.531 1.065 0 CA-C-O 118.573 -1.126 . . . . 0.0 112.969 172.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 96.5 mt -66.51 133.29 50.06 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 120.171 1.986 . . . . 0.0 110.019 178.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -97.17 -33.82 11.35 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 166.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -145.58 162.77 36.69 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 127.378 2.271 . . . . 0.0 106.704 169.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -55.01 -28.01 48.76 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 118.942 0.792 . . . . 0.0 112.04 174.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -84.64 -19.68 32.54 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.468 1.107 . . . . 0.0 113.671 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 32.2 p-80 -153.31 137.63 16.62 Favored 'General case' 0 C--N 1.345 0.4 0 CA-C-O 123.064 1.411 . . . . 0.0 114.257 -176.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -73.05 154.09 40.59 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 125.436 1.494 . . . . 0.0 109.245 168.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 4.9 p -76.32 -18.07 15.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 124.546 1.138 . . . . 0.0 111.745 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -141.9 171.66 24.39 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 125.634 1.587 . . . . 0.0 109.373 177.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -59.03 130.15 45.61 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 172.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -139.4 95.81 2.99 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 178.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 9.5 pt -89.49 136.68 23.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-O 121.189 0.519 . . . . 0.0 111.811 -174.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -158.99 143.75 15.8 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 127.016 2.126 . . . . 0.0 107.682 173.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -153.87 101.78 2.47 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 172.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 23.5 t0 54.86 69.24 0.75 Allowed 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 122.676 1.227 . . . . 0.0 111.817 -174.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . 0.305 8.5 ptm180 58.24 6.9 0.58 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 128.298 2.639 . . . . 0.0 116.909 174.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -142.49 157.71 61.94 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-N 120.079 1.309 . . . . 0.0 108.333 175.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -73.93 114.02 3.93 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 121.789 1.66 . . . . 0.0 110.189 171.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -148.02 171.36 15.96 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 124.61 1.164 . . . . 0.0 108.481 167.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 18.1 mt 55.47 37.81 29.4 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.483 1.113 . . . . 0.0 109.032 -167.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 44.6 m -69.8 -48.18 60.06 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 126.118 1.767 . . . . 0.0 112.388 -168.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -60.85 -42.91 98.74 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -166.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -64.49 -37.87 89.04 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 118.319 0.509 . . . . 0.0 110.434 178.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 53.5 mtt85 -70.54 -44.48 67.41 Favored 'General case' 0 C--N 1.339 0.119 0 O-C-N 121.622 -0.674 . . . . 0.0 110.68 -178.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 22.5 m -73.79 -26.81 21.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 CA-C-O 118.523 -0.751 . . . . 0.0 110.613 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -62.0 -51.12 69.3 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 120.247 1.385 . . . . 0.0 109.13 170.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -58.43 -43.95 88.92 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 118.179 0.445 . . . . 0.0 110.542 179.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 73.2 t90 -67.02 -44.34 80.52 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 118.934 0.788 . . . . 0.0 110.689 -177.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 54.7 t -62.48 -38.95 82.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 55.8 mttm -66.7 -38.81 87.5 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.176 -0.952 . . . . 0.0 110.091 179.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 42.0 mm-40 -62.61 -50.94 69.25 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-N 118.538 0.608 . . . . 0.0 110.9 175.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 29.4 pt -64.7 -33.92 66.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-N 119.341 0.973 . . . . 0.0 109.973 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 57.6 m -61.76 -24.46 66.84 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 117.766 -1.111 . . . . 0.0 112.597 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -95.15 -11.32 28.35 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 120.317 1.417 . . . . 0.0 112.677 175.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -85.44 -40.03 16.87 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 119.183 0.901 . . . . 0.0 110.082 169.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 64.1 mt -84.64 -12.91 53.02 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.668 1.987 . . . . 0.0 111.609 -179.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 56.85 32.12 20.83 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.762 1.625 . . . . 0.0 112.419 -170.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 58.3 mt -75.88 -19.55 58.77 Favored 'General case' 0 C--N 1.342 0.258 0 O-C-N 121.752 -0.592 . . . . 0.0 110.733 169.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -59.78 -43.26 94.48 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 119.246 0.93 . . . . 0.0 110.377 -175.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -73.76 -6.64 48.18 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 179.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 38.9 mt -93.63 -48.61 13.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 171.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 3.4 pp -78.08 -27.88 48.63 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 -170.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -90.14 -7.01 54.72 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 118.922 0.783 . . . . 0.0 113.03 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.344 0 C-N-CA 123.31 0.644 . . . . 0.0 109.924 176.676 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.4 ttt . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.17 149.55 41.24 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.498 0.719 . . . . 0.0 110.516 175.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.0 pt -85.91 -27.09 6.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 123.087 0.555 . . . . 0.0 111.145 178.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 49.3 m -111.92 120.59 42.44 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.295 1.038 . . . . 0.0 109.318 -178.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -94.51 116.06 5.2 Favored Glycine 0 CA--C 1.52 0.376 0 N-CA-C 107.048 -2.421 . . . . 0.0 107.048 169.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 72.7 mt -95.21 97.1 6.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 104.852 -2.277 . . . . 0.0 104.852 176.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -91.71 137.83 32.05 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 176.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -136.93 159.48 41.74 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 123.592 0.757 . . . . 0.0 110.644 -176.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -131.31 147.47 18.55 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 107.739 -2.144 . . . . 0.0 107.739 167.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 29.6 m -168.44 143.02 3.36 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.375 1.588 . . . . 0.0 109.589 -179.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -91.07 -45.15 8.86 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 122.53 0.332 . . . . 0.0 111.001 170.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 82.5 p -107.47 9.13 29.7 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.014 0.926 . . . . 0.0 112.563 -175.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 79.72 13.34 82.51 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 124.128 0.87 . . . . 0.0 114.452 178.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -72.42 -46.17 56.31 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 119.515 1.658 . . . . 0.0 111.582 -177.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.5 m -74.32 -25.17 59.39 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 119.471 1.032 . . . . 0.0 109.896 179.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -58.64 -40.89 84.66 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.214 -0.929 . . . . 0.0 110.3 169.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -64.0 -36.6 84.52 Favored 'General case' 0 CA--C 1.532 0.282 0 O-C-N 121.48 -0.762 . . . . 0.0 110.905 178.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 29.6 mm -64.29 -45.99 94.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 174.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.21 -41.53 79.61 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.475 0.58 . . . . 0.0 111.215 178.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -67.86 -42.88 80.66 Favored 'General case' 0 N--CA 1.463 0.212 0 O-C-N 121.738 -0.601 . . . . 0.0 110.994 178.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.38 -23.37 64.66 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 119.248 0.931 . . . . 0.0 112.008 178.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 59.1 mt -71.22 -54.98 15.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 169.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -59.98 -38.16 81.72 Favored 'General case' 0 C--O 1.225 -0.234 0 CA-C-O 118.928 -0.558 . . . . 0.0 111.6 -173.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -59.13 -37.99 78.54 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 118.925 0.784 . . . . 0.0 110.885 -176.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -72.52 -39.93 67.2 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.101 0.561 . . . . 0.0 111.316 178.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.3 mp -75.17 -33.59 61.48 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.031 0.378 . . . . 0.0 111.131 -176.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.64 149.42 14.32 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.878 1.228 . . . . 0.0 110.93 -172.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -64.32 -28.47 69.73 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.884 0.873 . . . . 0.0 111.911 -173.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -66.87 -25.93 66.64 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.081 0.552 . . . . 0.0 111.426 178.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 39.3 t -100.75 -42.15 9.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 124.357 1.063 . . . . 0.0 109.999 -175.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -131.7 145.63 51.74 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 119.124 0.874 . . . . 0.0 111.584 -174.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -135.67 139.11 43.47 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 123.616 0.766 . . . . 0.0 109.777 178.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 92.9 t -101.99 135.07 40.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 C-N-CA 124.373 1.069 . . . . 0.0 109.523 -170.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 79.2 m-70 -141.31 137.08 32.17 Favored 'General case' 0 C--N 1.339 0.138 0 C-N-CA 124.62 1.168 . . . . 0.0 111.112 -173.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.31 131.6 43.67 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 168.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.6 tp -68.56 -33.52 60.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 O-C-N 121.551 -0.718 . . . . 0.0 111.402 -179.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.87 -40.24 94.82 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.98 0.809 . . . . 0.0 112.108 -169.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -75.27 -17.69 60.24 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 118.149 0.431 . . . . 0.0 112.038 178.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 53.1 m -75.84 163.63 27.04 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.444 0.64 . . . . 0.0 111.108 -169.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 47.1 m -127.33 168.45 14.78 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.159 1.383 . . . . 0.0 109.587 -175.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -52.05 -46.15 64.98 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.545 1.138 . . . . 0.0 111.756 -173.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -74.15 -14.4 60.95 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 122.823 0.449 . . . . 0.0 111.827 -173.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -78.82 -30.58 45.42 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 121.393 -0.817 . . . . 0.0 111.248 -170.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.2 mp -79.45 -39.18 32.89 Favored 'General case' 0 C--N 1.345 0.391 0 O-C-N 122.109 -0.37 . . . . 0.0 110.195 171.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -55.35 -28.52 54.39 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.266 1.027 . . . . 0.0 112.274 -176.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.44 -29.39 69.52 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.195 0.998 . . . . 0.0 113.438 -178.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -88.12 156.6 19.17 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.068 0.947 . . . . 0.0 110.591 -175.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -99.94 -32.32 11.03 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 123.056 0.542 . . . . 0.0 111.393 170.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.1 mp -108.77 128.16 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 172.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -114.7 128.23 56.2 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 170.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.2 mp -109.63 126.84 54.06 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 169.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 67.2 mt -123.18 118.23 27.16 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -169.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -111.66 102.66 1.44 Allowed Glycine 0 C--N 1.336 0.528 0 C-N-CA 125.464 1.507 . . . . 0.0 111.881 -170.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 17.3 tt -127.34 117.17 21.53 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 123.406 0.682 . . . . 0.0 112.165 -169.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -82.6 150.71 14.83 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 122.883 2.389 . . . . 0.0 110.321 168.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.8 m -96.83 137.98 35.08 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 178.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 19.9 m95 -133.15 175.27 9.53 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.166 1.386 . . . . 0.0 111.129 -171.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 51.06 -91.79 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 128.268 2.627 . . . . 0.0 113.445 -178.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -152.57 81.61 1.23 Allowed 'General case' 0 C--O 1.235 0.318 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 176.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 63.22 50.82 59.77 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 -175.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -121.28 154.15 36.75 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 124.583 1.153 . . . . 0.0 108.326 175.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -73.2 147.93 44.25 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.068 0.461 . . . . 0.0 110.387 169.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 16.2 tp60 -56.22 142.66 36.47 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 167.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 56.8 m -56.2 -32.05 64.03 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.05 0.94 . . . . 0.0 112.41 -170.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -57.08 -43.72 82.4 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 123.919 0.887 . . . . 0.0 110.491 178.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -81.94 -41.25 21.11 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 123.664 0.786 . . . . 0.0 110.579 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -58.01 -39.18 77.67 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.154 0.433 . . . . 0.0 111.325 -178.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -70.36 -25.85 63.46 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.466 0.706 . . . . 0.0 112.033 176.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -90.88 -23.28 20.57 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 118.613 -0.708 . . . . 0.0 112.567 -177.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 20.7 m-30 -49.36 -42.06 61.76 Favored Pre-proline 0 CA--C 1.542 0.652 0 CA-C-O 116.457 -1.735 . . . . 0.0 115.114 -178.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -64.32 -18.11 62.04 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 CA-C-N 122.934 2.084 . . . . 0.0 113.474 176.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 25.0 m -88.45 -42.4 12.16 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.095 0.958 . . . . 0.0 109.591 169.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 27.3 tp -55.8 -38.82 70.45 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.308 1.043 . . . . 0.0 111.284 -177.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -70.82 -7.75 47.59 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -178.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -95.2 -17.64 21.57 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 119.712 1.142 . . . . 0.0 111.739 171.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 97.6 mt -77.04 133.82 30.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 -173.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -82.35 140.01 33.76 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.023 0.929 . . . . 0.0 109.496 175.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -129.58 11.01 5.71 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 118.368 -0.825 . . . . 0.0 111.469 174.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -66.6 123.59 20.49 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 120.742 1.61 . . . . 0.0 109.621 -172.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.72 2.45 50.9 Favored Glycine 0 CA--C 1.537 1.443 0 CA-C-O 117.965 -1.464 . . . . 0.0 114.088 -174.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -79.81 150.25 30.77 Favored 'General case' 0 C--N 1.345 0.385 0 CA-C-N 120.222 2.011 . . . . 0.0 107.722 170.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 19.9 mt -91.71 137.45 32.36 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 171.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 16.0 t -133.73 142.73 40.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 177.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -134.3 151.0 51.02 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 170.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -113.54 145.71 40.79 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 124.367 1.067 . . . . 0.0 109.022 -174.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -143.42 159.03 43.14 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 166.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 179.31 177.4 47.69 Favored Glycine 0 N--CA 1.447 -0.598 0 O-C-N 121.184 -0.947 . . . . 0.0 113.282 -177.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 20.1 m -134.95 155.31 50.95 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.362 1.065 . . . . 0.0 109.533 -169.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -168.03 -176.09 38.26 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -177.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -132.15 110.85 10.96 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 172.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -75.22 -9.79 58.88 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 117.831 -1.081 . . . . 0.0 113.481 -168.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -110.44 -47.07 3.32 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 120.347 1.43 . . . . 0.0 110.673 -177.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -81.19 -22.27 39.02 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.993 -0.442 . . . . 0.0 111.619 -173.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -126.23 44.36 2.88 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.377 1.471 . . . . 0.0 109.047 172.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.34 -21.93 64.46 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.683 1.193 . . . . 0.0 113.829 -173.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -86.83 -2.47 58.6 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.791 0.836 . . . . 0.0 111.911 178.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -141.06 23.79 2.19 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.802 1.241 . . . . 0.0 110.968 -169.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -65.05 123.92 20.73 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 118.86 0.754 . . . . 0.0 110.713 -168.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 69.1 m 52.01 31.54 8.86 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.355 1.462 . . . . 0.0 112.981 178.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -57.51 -37.72 73.46 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.638 -0.663 . . . . 0.0 112.279 -178.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.35 -26.49 67.31 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -169.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.8 mp -62.38 -36.16 81.43 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.48 -0.763 . . . . 0.0 109.268 176.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -67.78 -29.21 73.58 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 123.651 0.643 . . . . 0.0 111.853 175.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.1 m -65.97 -36.71 84.07 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 118.801 1.301 . . . . 0.0 110.353 176.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 5.1 mt -68.69 -47.83 74.59 Favored 'Isoleucine or valine' 0 C--N 1.343 0.283 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 173.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 40.4 ttt-85 -49.89 -45.96 51.3 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 119.03 0.832 . . . . 0.0 111.037 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -60.36 -22.27 63.08 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.013 0.925 . . . . 0.0 112.759 -177.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 86.1 mt -96.2 -47.84 12.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 124.359 1.064 . . . . 0.0 109.681 178.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 30.4 pt -75.05 -31.44 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 119.464 1.029 . . . . 0.0 111.698 -170.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -66.81 -50.85 42.07 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-O 117.584 -1.198 . . . . 0.0 111.722 -176.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -67.6 -24.56 41.64 Favored 'Trans proline' 0 C--N 1.353 0.767 0 CA-C-N 122.079 1.778 . . . . 0.0 112.276 176.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 81.1 mmt-85 -75.23 6.33 4.51 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.619 0.768 . . . . 0.0 113.043 170.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 85.22 11.81 74.92 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-O 118.147 -1.363 . . . . 0.0 114.686 168.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -56.17 138.04 50.67 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 119.293 1.547 . . . . 0.0 110.433 174.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 61.7 m -90.13 118.99 30.09 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 104.392 -2.447 . . . . 0.0 104.392 167.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 47.5 mt -101.47 130.75 50.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 -170.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 34.6 m -133.03 173.89 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 125.093 1.357 . . . . 0.0 109.245 177.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 81.32 28.47 44.27 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-O 119.507 -0.607 . . . . 0.0 112.948 176.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 67.0 m80 -58.39 146.13 35.86 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 118.06 0.93 . . . . 0.0 109.593 170.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 59.2 t-105 -131.4 135.97 27.88 Favored Pre-proline 0 CA--C 1.534 0.343 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 -177.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -67.14 139.89 52.06 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.003 1.802 . . . . 0.0 110.859 -174.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.4 t -90.09 -16.84 28.85 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.459 0.704 . . . . 0.0 110.748 176.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 49.15 42.43 21.33 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.44 1.496 . . . . 0.0 111.598 -176.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 69.31 -6.26 4.47 Favored Glycine 0 CA--C 1.538 1.48 0 CA-C-O 117.69 -1.617 . . . . 0.0 115.502 -178.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . 0.285 52.6 p90 50.28 -25.56 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 131.551 3.941 . . . . 0.0 118.842 -178.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 37.1 t60 52.88 39.99 30.04 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.418 1.887 . . . . 0.0 113.256 173.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -140.41 -171.6 3.25 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.572 1.549 . . . . 0.0 108.601 175.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -69.01 -57.5 5.36 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 118.768 -0.634 . . . . 0.0 112.409 -168.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -158.35 119.83 3.51 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 119.224 0.92 . . . . 0.0 111.558 178.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 67.6 m -98.67 130.32 45.17 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 168.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -119.46 0.93 11.16 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 -169.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -81.99 6.7 65.68 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-N 118.62 0.646 . . . . 0.0 112.719 169.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 79.5 mt -64.83 142.16 58.53 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 118.586 1.193 . . . . 0.0 111.345 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -116.77 -16.89 10.61 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.999 1.32 . . . . 0.0 110.385 168.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -143.08 156.57 44.84 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 127.191 2.196 . . . . 0.0 106.126 173.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -54.76 -23.69 19.05 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.572 1.149 . . . . 0.0 113.707 -173.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -124.33 11.29 8.7 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.884 0.873 . . . . 0.0 113.334 177.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -138.42 129.36 26.83 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 120.52 -1.363 . . . . 0.0 112.096 -176.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -70.01 153.11 43.63 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.445 1.098 . . . . 0.0 109.048 168.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 9.7 p -62.44 -24.78 36.13 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 123.604 0.762 . . . . 0.0 111.244 173.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -157.9 179.4 33.65 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 123.557 0.599 . . . . 0.0 112.171 -169.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -70.92 110.01 5.4 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 123.56 0.744 . . . . 0.0 109.478 -178.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -89.41 121.66 31.87 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 167.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 11.1 tp -73.49 -32.69 37.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 120.267 -0.573 . . . . 0.0 111.221 -173.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -85.72 152.14 23.3 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.934 0.894 . . . . 0.0 110.139 175.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -153.62 18.85 0.54 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.217 1.407 . . . . 0.0 110.404 174.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -140.98 -63.07 0.47 Allowed 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.769 1.228 . . . . 0.0 109.515 -176.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -171.33 -32.09 0.02 OUTLIER 'General case' 0 C--O 1.225 -0.216 0 C-N-CA 126.776 2.03 . . . . 0.0 109.312 167.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 90.5 mm-40 -137.73 143.98 42.58 Favored Pre-proline 0 N--CA 1.449 -0.475 0 N-CA-C 105.078 -2.193 . . . . 0.0 105.078 171.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -61.02 133.64 48.4 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.368 2.046 . . . . 0.0 113.63 -167.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -118.07 162.53 18.04 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 126.535 1.934 . . . . 0.0 106.02 168.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 11.4 mt 59.39 22.71 11.17 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.669 0.788 . . . . 0.0 111.622 176.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 35.9 m -43.18 -61.13 1.41 Allowed 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 126.499 1.919 . . . . 0.0 112.737 -167.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -70.97 -35.84 72.3 Favored 'General case' 0 N--CA 1.452 -0.346 0 O-C-N 121.845 -0.535 . . . . 0.0 111.032 -169.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -72.72 -30.22 64.01 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.873 0.761 . . . . 0.0 111.278 178.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 74.1 mtp85 -63.3 -43.41 97.95 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 119.703 1.138 . . . . 0.0 109.515 172.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 66.2 t -66.03 -41.61 90.0 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.246 0 CA-C-O 118.325 -0.845 . . . . 0.0 109.023 178.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -59.94 -49.53 77.31 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 120.483 1.492 . . . . 0.0 110.487 176.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -61.84 -39.78 93.01 Favored 'General case' 0 N--CA 1.462 0.144 0 O-C-N 122.014 -0.428 . . . . 0.0 110.47 -176.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 60.9 t90 -70.73 -48.72 53.05 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 118.344 0.52 . . . . 0.0 110.642 178.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 55.6 t -60.77 -39.63 82.35 Favored 'Isoleucine or valine' 0 C--O 1.231 0.108 0 C-N-CA 123.041 0.536 . . . . 0.0 110.339 -175.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -68.0 -36.34 79.82 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 121.632 -0.668 . . . . 0.0 109.919 -177.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 46.8 mm-40 -67.73 -50.38 57.66 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 122.911 0.484 . . . . 0.0 110.677 174.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 6.3 pt -66.77 -31.87 55.47 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.313 0 CA-C-N 119.151 0.887 . . . . 0.0 110.937 -176.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 66.1 m -59.03 -37.39 76.83 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.316 0.962 . . . . 0.0 111.716 -179.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -83.69 -31.02 26.32 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 119.339 0.972 . . . . 0.0 111.788 178.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -68.4 -36.46 79.16 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 118.733 0.697 . . . . 0.0 110.783 176.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 76.9 mt -81.63 -3.3 53.1 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.881 1.673 . . . . 0.0 111.612 174.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . 0.324 1.3 p-80 50.12 19.11 0.45 Allowed 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 129.88 3.272 . . . . 0.0 114.719 -174.002 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 4.6 pp -78.25 -22.59 48.12 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 123.103 0.561 . . . . 0.0 111.505 176.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -55.29 -41.17 71.94 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.753 0.821 . . . . 0.0 109.729 168.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -73.18 -6.03 43.13 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.719 -0.613 . . . . 0.0 112.379 -179.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 56.6 mt -97.65 -54.85 6.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 124.651 1.181 . . . . 0.0 108.039 175.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.1 pp -85.83 -22.24 27.7 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -169.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 32.8 t30 -129.77 43.74 3.08 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.618 1.967 . . . . 0.0 108.169 -175.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.222 0 C-N-CA 123.687 0.795 . . . . 0.0 109.658 174.845 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.8 tpt . . . . . 0 N--CA 1.485 1.32 0 N-CA-C 110.368 -0.234 . . . . 0.0 110.368 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -57.75 151.98 16.49 Favored 'General case' 0 C--N 1.344 0.341 0 C-N-CA 123.922 0.889 . . . . 0.0 111.723 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.4 pt -119.65 -12.63 9.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 125.37 1.468 . . . . 0.0 111.537 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.1 m -114.58 127.03 55.57 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 125.35 1.46 . . . . 0.0 107.934 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -99.38 116.35 5.56 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 108.114 -1.994 . . . . 0.0 108.114 169.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 60.2 mt -92.55 119.96 41.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 N-CA-C 104.899 -2.259 . . . . 0.0 104.899 171.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -116.82 133.47 55.97 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 176.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -134.14 163.71 28.98 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 122.833 0.453 . . . . 0.0 111.591 -173.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -131.23 144.38 15.92 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 107.92 -2.072 . . . . 0.0 107.92 166.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 9.1 m -166.65 155.18 10.37 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-N 119.356 1.578 . . . . 0.0 110.127 176.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -115.61 -50.4 2.71 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.964 0.906 . . . . 0.0 109.841 167.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.6 p -86.92 8.43 23.15 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.819 1.248 . . . . 0.0 112.802 177.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 80.31 2.91 89.69 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 124.687 1.137 . . . . 0.0 115.609 169.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -70.2 -49.05 54.15 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 119.593 1.696 . . . . 0.0 112.375 -174.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 10.2 m -74.08 -26.62 60.48 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 120.546 1.521 . . . . 0.0 109.614 -178.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -60.48 -43.49 96.91 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.82 0.848 . . . . 0.0 110.157 169.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -64.69 -41.81 95.78 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 121.467 -0.771 . . . . 0.0 110.72 176.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 46.2 mm -59.29 -45.76 92.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-N 118.561 0.619 . . . . 0.0 109.332 175.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.65 -44.57 85.75 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.483 0.713 . . . . 0.0 110.952 178.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -66.52 -41.45 88.76 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 118.691 -0.671 . . . . 0.0 110.719 179.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 94.4 mtp -62.33 -40.3 95.89 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 119.531 1.059 . . . . 0.0 110.623 177.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 34.5 mt -63.33 -42.75 97.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 119.028 0.831 . . . . 0.0 109.152 175.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -59.71 -41.32 90.54 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 119.204 0.911 . . . . 0.0 110.921 177.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -64.53 -35.41 80.88 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 118.839 0.745 . . . . 0.0 110.463 178.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -67.72 -46.93 70.79 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.039 0.536 . . . . 0.0 110.697 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -76.77 -31.97 57.39 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 118.724 0.693 . . . . 0.0 111.523 -178.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.79 146.27 20.67 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 125.389 1.471 . . . . 0.0 110.798 -173.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -64.14 -28.78 70.0 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.949 0.9 . . . . 0.0 111.807 -174.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -78.58 -3.78 45.52 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 178.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 48.3 t -113.8 -38.13 2.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 124.791 1.236 . . . . 0.0 109.708 178.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -129.74 142.37 50.71 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 119.307 0.958 . . . . 0.0 111.741 -176.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -119.47 159.53 24.1 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.01 1.724 . . . . 0.0 108.493 172.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 48.4 t -133.46 130.22 56.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 C-N-CA 124.601 1.161 . . . . 0.0 109.515 -169.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -144.99 150.36 36.78 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.168 0.987 . . . . 0.0 111.625 174.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -72.45 134.84 45.55 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 166.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.2 tp -56.81 -32.33 38.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 118.697 0.68 . . . . 0.0 111.621 -173.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.65 -28.51 69.97 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.9 0.773 . . . . 0.0 112.243 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -82.06 -17.31 47.11 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.299 0.64 . . . . 0.0 110.597 178.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.9 t -75.52 174.17 10.03 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 122.117 0.961 . . . . 0.0 110.377 174.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.426 ' H ' ' HB3' ' A' ' 43' ' ' ASP . 21.3 m -145.53 167.09 23.87 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 127.726 2.41 . . . . 0.0 107.676 -177.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -52.68 -49.79 64.57 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.294 0.638 . . . . 0.0 110.843 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -76.0 -15.78 60.08 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 122.735 0.414 . . . . 0.0 111.701 -175.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.426 ' HB3' ' H ' ' A' ' 40' ' ' SER . 34.0 t70 -81.62 -37.05 28.19 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 121.685 -0.635 . . . . 0.0 110.233 -178.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.78 -43.65 88.14 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-N 118.345 0.52 . . . . 0.0 109.894 168.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -62.42 -20.98 65.05 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.4 0.68 . . . . 0.0 112.321 -177.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.25 -28.08 69.49 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.449 0.7 . . . . 0.0 112.009 177.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -103.47 138.45 40.17 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.559 1.144 . . . . 0.0 110.541 -176.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -88.39 -29.85 19.95 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.0 171.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.5 mm -106.4 128.76 60.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 178.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 88.6 mt -129.22 140.58 51.42 Favored 'General case' 0 CA--C 1.52 -0.208 0 C-N-CA 123.034 0.534 . . . . 0.0 109.809 -175.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -122.36 126.87 48.95 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 172.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 67.3 mt -121.07 122.02 39.16 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -173.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -117.75 103.92 1.11 Allowed Glycine 0 CA--C 1.524 0.609 0 C-N-CA 125.349 1.452 . . . . 0.0 112.45 -169.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 16.9 tt -127.17 111.98 21.56 Favored Pre-proline 0 CA--C 1.542 0.657 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -169.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -75.76 147.84 31.68 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 122.287 1.991 . . . . 0.0 108.983 167.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 44.3 m -95.62 137.18 35.05 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 176.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 23.9 m95 -134.49 172.04 13.47 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.655 1.182 . . . . 0.0 111.43 -173.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 58.55 -79.53 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 128.565 2.746 . . . . 0.0 113.663 172.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -152.18 51.41 0.79 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.843 2.057 . . . . 0.0 108.923 -171.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.42 37.87 62.47 Favored Glycine 0 CA--C 1.525 0.661 0 O-C-N 121.56 -0.713 . . . . 0.0 111.63 -174.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -115.5 160.0 20.49 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.506 1.123 . . . . 0.0 109.791 -175.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.7 160.54 29.26 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.471 169.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -75.52 155.98 35.57 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 168.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 59.7 m -55.41 -29.79 59.22 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.84 0.856 . . . . 0.0 112.381 -177.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -65.8 -42.37 90.76 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.094 0.558 . . . . 0.0 110.691 -177.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 80.1 m95 -76.25 -44.35 37.76 Favored 'General case' 0 C--N 1.341 0.226 0 C-N-CA 122.813 0.445 . . . . 0.0 110.094 174.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -62.41 -37.11 84.53 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.792 0.437 . . . . 0.0 111.939 -172.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -71.23 -21.69 62.09 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.542 0.737 . . . . 0.0 112.018 175.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -90.16 -23.86 21.21 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.459 0.703 . . . . 0.0 111.385 179.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -51.02 -42.43 79.96 Favored Pre-proline 0 CA--C 1.544 0.714 0 CA-C-O 116.627 -1.654 . . . . 0.0 114.784 178.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -64.24 -22.94 66.55 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 CA-C-N 122.954 2.091 . . . . 0.0 113.194 174.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.3 m -81.04 -38.0 28.16 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.049 0.94 . . . . 0.0 109.738 170.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 13.4 tp -59.84 -35.23 74.32 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.79 1.236 . . . . 0.0 110.928 -175.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -79.63 -4.46 51.72 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.053 0.941 . . . . 0.0 113.035 177.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -93.73 -24.95 17.64 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 119.612 1.097 . . . . 0.0 111.176 169.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 95.7 mt -67.92 137.6 24.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 -176.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -86.83 81.03 8.3 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -177.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -70.0 -5.42 26.28 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 118.381 -0.819 . . . . 0.0 112.843 -176.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 57.1 m-80 -53.44 117.94 3.47 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 119.609 1.095 . . . . 0.0 109.513 -179.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 82.44 -4.8 76.21 Favored Glycine 0 CA--C 1.533 1.165 0 CA-C-O 117.849 -1.528 . . . . 0.0 114.47 175.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -64.56 139.68 58.79 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 120.527 2.164 . . . . 0.0 107.894 169.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.7 mt -95.96 124.97 40.2 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 106.487 -1.672 . . . . 0.0 106.487 169.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.2 t -131.07 146.49 33.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -169.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -131.41 146.49 52.29 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 169.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.2 mt -112.59 142.53 45.06 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 124.211 1.005 . . . . 0.0 109.437 -177.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 24.8 p90 -138.51 155.97 47.93 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 168.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -168.77 169.15 41.58 Favored Glycine 0 N--CA 1.447 -0.586 0 O-C-N 121.469 -0.769 . . . . 0.0 111.654 -176.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 56.5 m -136.27 156.01 49.28 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.242 1.017 . . . . 0.0 109.192 -171.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -170.89 -167.26 30.99 Favored Glycine 0 CA--C 1.526 0.777 0 O-C-N 123.256 0.348 . . . . 0.0 112.601 -173.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -138.56 141.69 39.25 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 126.509 1.924 . . . . 0.0 109.176 177.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -110.89 -11.8 14.32 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.981 1.312 . . . . 0.0 111.889 -177.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -84.95 -31.68 23.46 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 118.416 0.553 . . . . 0.0 111.245 -168.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -128.33 -39.34 1.7 Allowed 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.348 0.659 . . . . 0.0 111.714 173.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -83.15 32.97 0.44 Allowed 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 118.419 0.554 . . . . 0.0 112.149 -177.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.27 -27.68 69.21 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.654 1.182 . . . . 0.0 113.259 -172.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -79.43 -0.2 31.98 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.023 0.929 . . . . 0.0 111.602 176.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -140.91 16.56 2.3 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 125.481 1.512 . . . . 0.0 110.621 -172.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -65.43 115.05 5.28 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 119.561 1.073 . . . . 0.0 108.788 -169.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 75.9 m 53.47 34.3 17.97 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.567 1.547 . . . . 0.0 113.178 -174.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -51.01 -43.66 60.87 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.75 1.22 . . . . 0.0 111.741 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.53 -14.93 63.37 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -169.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 67.5 mt -58.09 -41.62 83.88 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 118.866 0.757 . . . . 0.0 110.055 169.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -65.38 -32.97 85.29 Favored Glycine 0 C--N 1.339 0.744 0 N-CA-C 111.245 -0.742 . . . . 0.0 111.245 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.3 m -65.37 -37.23 86.4 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 118.229 1.015 . . . . 0.0 110.704 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 5.0 mt -73.56 -44.87 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 118.952 0.796 . . . . 0.0 108.97 174.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 35.9 ttt180 -53.28 -44.14 68.01 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 119.297 0.953 . . . . 0.0 110.608 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -61.92 -16.14 48.59 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.691 1.196 . . . . 0.0 113.035 -178.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 86.8 mt -101.0 -58.35 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 124.252 1.021 . . . . 0.0 109.095 173.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 20.1 pt -68.75 -32.98 57.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 O-C-N 121.144 -0.972 . . . . 0.0 112.142 -167.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -67.99 -53.4 20.16 Favored Pre-proline 0 CA--C 1.541 0.627 0 CA-C-O 117.671 -1.157 . . . . 0.0 111.242 -176.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -68.45 -23.45 37.67 Favored 'Trans proline' 0 C--N 1.353 0.786 0 CA-C-N 121.708 1.646 . . . . 0.0 112.83 175.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 30.9 mmm180 -74.41 -0.56 17.73 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 119.343 0.974 . . . . 0.0 112.17 170.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 94.0 14.69 51.26 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-O 118.558 -1.134 . . . . 0.0 114.999 168.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.26 144.34 57.02 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 119.183 1.492 . . . . 0.0 109.411 170.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 47.0 m -93.59 119.52 32.72 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 104.163 -2.532 . . . . 0.0 104.163 167.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 21.4 mt -100.56 130.75 49.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 107.016 -1.475 . . . . 0.0 107.016 -176.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.7 m -133.05 -172.88 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 125.549 1.539 . . . . 0.0 107.948 169.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 70.57 21.3 77.66 Favored Glycine 0 CA--C 1.529 0.963 0 O-C-N 120.979 -1.075 . . . . 0.0 111.572 -171.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 21.3 p-80 -59.19 133.12 55.81 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 168.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 70.7 t-105 -115.73 130.04 24.67 Favored Pre-proline 0 C--O 1.237 0.401 0 C-N-CA 124.573 1.149 . . . . 0.0 108.827 -167.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -67.37 139.58 50.09 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 121.51 1.473 . . . . 0.0 111.034 -175.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 2.1 t -89.97 -5.84 56.27 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.763 0.825 . . . . 0.0 111.917 -174.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 50.84 49.78 20.37 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.588 1.555 . . . . 0.0 112.516 173.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 84.44 -1.85 88.45 Favored Glycine 0 CA--C 1.533 1.185 0 CA-C-O 118.781 -1.01 . . . . 0.0 114.228 176.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 38.1 t80 54.83 -100.89 0.11 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.202 1.801 . . . . 0.0 112.811 174.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 35.4 t60 61.09 44.98 9.6 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.143 1.777 . . . . 0.0 113.713 -178.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -120.81 -176.88 3.35 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.957 1.303 . . . . 0.0 107.69 167.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -82.56 -56.24 3.99 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 121.405 -0.809 . . . . 0.0 111.874 -169.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -156.65 138.12 13.97 Favored 'General case' 0 C--N 1.343 0.3 0 CA-C-N 119.221 0.919 . . . . 0.0 111.32 173.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 58.4 m -142.03 107.04 4.92 Favored 'General case' 0 CA--C 1.521 -0.14 0 C-N-CA 125.35 1.46 . . . . 0.0 107.614 178.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -77.78 -10.63 59.65 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 122.702 0.401 . . . . 0.0 110.955 -171.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -78.28 -1.65 81.55 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-O 118.215 -1.325 . . . . 0.0 114.024 169.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 59.8 mt -63.05 122.49 16.2 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 120.96 2.38 . . . . 0.0 108.21 170.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -97.92 -26.91 14.5 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.248 1.019 . . . . 0.0 110.352 177.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -144.62 160.03 41.83 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.819 2.047 . . . . 0.0 106.769 175.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -55.18 -25.94 35.73 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.931 0.892 . . . . 0.0 112.822 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -111.08 -0.65 16.53 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.471 1.108 . . . . 0.0 113.701 179.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 -141.39 133.55 27.86 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 120.206 1.366 . . . . 0.0 113.426 -175.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -77.7 152.76 33.55 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 166.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 12.5 p -58.92 -28.58 38.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 123.913 0.885 . . . . 0.0 111.323 174.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -155.51 170.53 33.49 Favored Glycine 0 C--N 1.338 0.673 0 C-N-CA 123.957 0.789 . . . . 0.0 111.418 -170.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -60.93 126.48 27.51 Favored 'General case' 0 C--N 1.334 -0.073 0 C-N-CA 124.314 1.046 . . . . 0.0 109.176 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -108.69 121.36 44.87 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 172.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 1.2 tp -77.28 165.84 2.93 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 169.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 26.6 t70 71.98 148.3 0.09 Allowed 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 127.144 2.178 . . . . 0.0 113.482 -177.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -148.29 15.23 1.02 Allowed 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.405 1.482 . . . . 0.0 111.353 175.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -154.05 -75.5 0.12 Allowed 'General case' 0 CA--C 1.536 0.432 0 O-C-N 120.983 -1.073 . . . . 0.0 109.299 170.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 24.7 ttm180 -159.44 114.49 2.43 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 168.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 61.28 136.75 0.04 OUTLIER Pre-proline 0 CA--C 1.552 1.021 0 C-N-CA 127.197 2.199 . . . . 0.0 112.195 -172.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -72.56 145.61 42.38 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.154 1.903 . . . . 0.0 113.372 -169.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -127.63 -1.02 6.14 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.518 1.127 . . . . 0.0 111.51 169.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 88.5 mt -114.45 19.47 16.16 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.544 1.537 . . . . 0.0 110.639 -176.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 93.2 m -45.49 -53.74 8.46 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 125.892 1.677 . . . . 0.0 112.165 -169.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -68.45 -38.67 81.32 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 119.226 -0.416 . . . . 0.0 111.36 -169.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -73.74 -32.87 64.08 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 118.64 0.655 . . . . 0.0 110.805 178.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 51.9 mtp85 -67.17 -45.77 75.99 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-N 118.791 0.723 . . . . 0.0 109.603 178.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 23.7 m -71.5 -31.68 43.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-O 118.083 -0.96 . . . . 0.0 110.564 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -58.8 -56.83 17.15 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 120.378 1.445 . . . . 0.0 109.59 172.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -60.54 -34.39 74.06 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 122.992 0.517 . . . . 0.0 110.798 -175.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 33.1 t90 -77.86 -50.0 13.13 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 117.975 0.352 . . . . 0.0 110.796 -178.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 66.5 t -63.87 -32.41 56.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 O-C-N 120.782 -1.199 . . . . 0.0 110.151 -176.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -59.95 -35.91 75.95 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 117.981 -1.009 . . . . 0.0 111.566 175.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . 0.251 13.2 pt20 -75.71 -50.71 14.57 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 119.552 1.069 . . . . 0.0 111.012 171.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 1.4 pt -64.51 -32.07 56.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-N 120.096 1.316 . . . . 0.0 111.552 -169.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 6.3 p -61.43 -38.47 87.27 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 118.468 -0.777 . . . . 0.0 110.858 -178.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -82.7 -36.83 25.52 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 119.724 1.147 . . . . 0.0 111.38 175.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 63.1 mt-10 -70.59 -34.02 71.71 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 118.606 0.639 . . . . 0.0 111.749 -175.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 64.1 mt -86.71 1.23 52.8 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.008 1.323 . . . . 0.0 110.971 175.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 56.17 32.35 20.03 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.856 1.662 . . . . 0.0 112.984 -176.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 90.6 mt -76.92 -37.81 54.64 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.364 0.666 . . . . 0.0 109.584 173.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -58.93 -38.76 79.74 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.34 1.056 . . . . 0.0 110.337 178.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -65.2 -12.4 50.85 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.639 0.776 . . . . 0.0 112.561 179.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 85.4 mt -108.44 -54.16 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 124.802 1.241 . . . . 0.0 108.326 -179.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.2 pp -76.97 -25.03 52.33 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -172.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 58.3 t30 -120.62 32.09 6.15 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.193 1.797 . . . . 0.0 109.762 -175.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.271 0 C-N-CA 123.931 0.892 . . . . 0.0 109.597 173.957 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.5 ttp . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 110.384 -0.228 . . . . 0.0 110.384 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.31 150.95 42.06 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.877 -0.514 . . . . 0.0 110.305 172.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.8 pt -82.71 -19.33 10.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -174.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.8 m -115.09 127.39 55.58 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.203 1.401 . . . . 0.0 108.416 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -102.63 117.4 5.78 Favored Glycine 0 CA--C 1.52 0.394 0 N-CA-C 107.914 -2.074 . . . . 0.0 107.914 170.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 64.9 mt -96.29 93.83 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 176.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -88.37 132.83 34.28 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 177.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -130.64 128.62 41.34 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 119.207 0.912 . . . . 0.0 112.167 179.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -93.53 142.85 16.18 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 107.54 -2.224 . . . . 0.0 107.54 166.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.4 t -156.14 175.18 14.31 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 119.279 1.539 . . . . 0.0 109.285 172.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -122.09 -54.78 1.9 Allowed 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.041 0.537 . . . . 0.0 110.226 169.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.1 p -94.9 -0.37 54.04 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.144 0.978 . . . . 0.0 112.597 175.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 90.15 15.36 57.63 Favored Glycine 0 C--N 1.343 0.949 0 CA-C-O 118.963 -0.91 . . . . 0.0 114.256 169.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -68.28 -39.9 82.01 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 119.787 1.794 . . . . 0.0 110.526 175.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.79 -29.52 68.27 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 119.131 0.878 . . . . 0.0 111.346 175.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -64.41 -40.34 95.58 Favored 'General case' 0 C--N 1.343 0.285 0 CA-C-N 118.819 0.736 . . . . 0.0 109.604 176.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -65.31 -41.95 93.53 Favored 'General case' 0 CA--C 1.529 0.146 0 O-C-N 121.976 -0.453 . . . . 0.0 110.335 178.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 48.1 mm -60.17 -48.6 87.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 174.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.48 -43.37 98.98 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.42 0.688 . . . . 0.0 111.538 -178.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 54.7 mttm -63.69 -44.03 94.87 Favored 'General case' 0 C--N 1.338 0.106 0 CA-C-O 118.331 -0.842 . . . . 0.0 110.386 178.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 69.6 mtm -59.39 -47.64 84.69 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-N 119.2 0.909 . . . . 0.0 109.76 177.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 62.6 mt -57.19 -46.76 84.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -62.71 -40.57 97.56 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 119.503 1.047 . . . . 0.0 111.024 -179.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -63.25 -38.34 90.76 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 119.424 1.011 . . . . 0.0 110.723 177.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -69.51 -39.44 77.55 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.187 0.595 . . . . 0.0 110.813 178.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.1 mp -79.0 -35.43 42.89 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.921 0.889 . . . . 0.0 111.655 -176.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 94.43 145.3 17.95 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 125.236 1.398 . . . . 0.0 110.903 -171.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.1 ptpt -65.32 -28.71 69.5 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -172.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -68.22 -29.52 68.37 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 122.863 0.465 . . . . 0.0 111.011 176.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 49.1 t -91.21 -37.44 9.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 C-N-CA 124.186 0.994 . . . . 0.0 110.161 -175.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -135.78 146.33 47.49 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-N 119.285 0.948 . . . . 0.0 113.222 -174.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -130.66 144.9 51.74 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.713 1.205 . . . . 0.0 109.295 171.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 80.1 t -98.14 140.49 17.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.442 0 C-N-CA 124.078 0.951 . . . . 0.0 109.051 -174.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -149.22 172.82 14.22 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.677 1.191 . . . . 0.0 111.255 -169.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -141.64 127.05 18.77 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 126.973 2.109 . . . . 0.0 107.117 -173.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.6 tp -58.91 -31.41 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-O 118.831 -0.604 . . . . 0.0 111.231 -172.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.61 -26.47 68.41 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 118.698 0.681 . . . . 0.0 111.488 -177.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -89.56 -15.35 33.06 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.48 1.112 . . . . 0.0 111.516 177.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 53.0 p -84.38 175.88 9.06 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 118.76 0.709 . . . . 0.0 111.597 -174.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.2 m -137.55 167.44 21.66 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.651 1.58 . . . . 0.0 108.361 176.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -51.41 -48.48 62.64 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.884 0.874 . . . . 0.0 111.794 -177.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -81.55 -11.69 59.07 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 122.707 0.403 . . . . 0.0 111.608 -175.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -77.56 -31.15 53.0 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 121.399 -0.813 . . . . 0.0 111.457 -172.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.6 mp -68.34 -36.7 79.65 Favored 'General case' 0 C--N 1.344 0.348 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 172.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -69.88 -14.05 62.55 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.656 0.782 . . . . 0.0 111.988 -173.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.1 -30.13 68.36 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.738 0.815 . . . . 0.0 111.709 175.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -82.81 152.17 25.78 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 123.92 0.888 . . . . 0.0 110.211 178.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -92.0 -41.6 10.45 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.208 169.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 21.7 mt -108.25 130.74 60.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 92.3 mt -113.84 130.28 56.49 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 171.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.2 mp -111.64 115.87 29.85 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 104.52 -2.4 . . . . 0.0 104.52 169.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 64.6 mt -116.27 110.48 18.8 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -171.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -93.74 125.89 8.42 Favored Glycine 0 CA--C 1.521 0.427 0 N-CA-C 109.18 -1.568 . . . . 0.0 109.18 176.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 16.5 tt -139.28 133.07 15.89 Favored Pre-proline 0 CA--C 1.537 0.48 0 CA-C-N 118.842 1.321 . . . . 0.0 111.346 -177.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -92.41 153.86 3.03 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 122.408 2.072 . . . . 0.0 110.327 176.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.7 m -108.95 126.5 53.16 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 171.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 61.9 m95 -130.57 170.9 13.65 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 125.368 1.467 . . . . 0.0 109.063 178.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 44.23 49.12 7.82 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.351 1.861 . . . . 0.0 114.279 168.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 55.08 65.02 1.61 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.379 1.071 . . . . 0.0 111.06 176.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.85 47.68 5.5 Favored Glycine 0 CA--C 1.532 1.124 0 CA-C-N 115.854 -0.612 . . . . 0.0 113.219 171.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -128.48 157.74 40.3 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.177 1.391 . . . . 0.0 108.544 168.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -90.88 175.38 7.0 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.507 0.723 . . . . 0.0 109.925 170.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -62.39 146.84 50.25 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 107.942 -1.132 . . . . 0.0 107.942 169.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 62.3 m -56.77 -41.27 77.34 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -168.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -71.01 -40.31 71.88 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.238 0.926 . . . . 0.0 110.691 -178.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -62.38 -43.86 97.83 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.328 0.651 . . . . 0.0 110.135 175.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -61.9 -42.2 98.81 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 123.513 0.725 . . . . 0.0 110.79 178.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -68.63 -18.77 64.36 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.907 0.883 . . . . 0.0 112.309 176.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 29.7 t80 -86.04 -18.76 31.61 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 121.604 -0.685 . . . . 0.0 112.343 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -54.09 -43.03 96.41 Favored Pre-proline 0 CA--C 1.543 0.706 0 CA-C-O 116.807 -1.568 . . . . 0.0 114.138 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -63.75 -21.93 69.59 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 CA-C-N 122.475 1.92 . . . . 0.0 113.554 174.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.9 m -79.47 -40.28 30.18 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 119.57 1.077 . . . . 0.0 109.357 170.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 14.5 tp -59.63 -38.65 81.91 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.18 0.992 . . . . 0.0 110.955 -174.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -76.79 -4.77 45.21 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.698 0.799 . . . . 0.0 112.981 178.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 48.3 mm-40 -98.13 -18.6 18.41 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.188 0.995 . . . . 0.0 110.535 171.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 77.5 mt -77.68 148.93 6.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 172.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -115.97 133.13 56.35 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -117.12 15.79 15.0 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.632 0.773 . . . . 0.0 111.688 -172.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 33.2 m-80 -56.36 119.28 5.75 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 120.049 1.295 . . . . 0.0 109.319 177.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 79.83 -2.84 72.42 Favored Glycine 0 CA--C 1.535 1.327 0 CA-C-O 118.493 -1.171 . . . . 0.0 114.573 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -78.06 143.73 37.17 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 119.995 1.897 . . . . 0.0 107.209 173.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 14.5 mt -92.55 135.82 33.74 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 171.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 16.8 t -133.61 134.64 56.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -124.49 146.6 48.87 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 171.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 69.0 mt -118.92 147.48 43.96 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -174.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -142.26 159.71 41.69 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 168.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -171.41 159.47 31.2 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 119.343 -1.408 . . . . 0.0 115.347 -174.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 6.9 m -107.67 142.45 37.61 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 113.405 -1.397 . . . . 0.0 108.798 -170.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -170.89 174.88 44.74 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -178.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -144.71 122.87 12.17 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.774 0.83 . . . . 0.0 110.203 177.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.546 HE22 ' CA ' ' A' ' 146' ' ' GLU . 6.9 mt-30 -78.76 71.27 5.21 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.111 1.364 . . . . 0.0 109.234 174.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -131.06 -112.32 0.25 Allowed 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 173.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -72.93 -22.66 60.69 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 119.379 0.991 . . . . 0.0 111.94 -174.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -82.98 34.06 0.45 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.107 1.763 . . . . 0.0 111.163 -177.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.39 -23.2 65.62 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 -167.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -97.91 -1.66 42.41 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 118.937 0.789 . . . . 0.0 112.142 177.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -126.39 16.29 7.69 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.306 1.442 . . . . 0.0 111.354 -169.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -63.89 125.34 24.09 Favored 'General case' 0 C--O 1.236 0.358 0 O-C-N 121.593 -0.692 . . . . 0.0 110.172 -170.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 71.1 m 48.12 32.63 3.09 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.655 1.982 . . . . 0.0 113.723 -178.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -54.75 -34.72 62.92 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.587 0.755 . . . . 0.0 112.755 -178.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -62.87 -24.99 68.07 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -174.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 69.9 mt -58.69 -45.26 89.87 Favored 'General case' 0 C--N 1.344 0.337 0 O-C-N 121.497 -0.752 . . . . 0.0 109.965 173.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -65.01 -32.7 85.07 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.7 m -64.99 -36.01 83.02 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.25 1.025 . . . . 0.0 110.72 178.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 17.8 mt -69.54 -52.85 28.44 Favored 'Isoleucine or valine' 0 C--N 1.347 0.476 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 171.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 50.5 ttt180 -51.01 -47.13 61.67 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.341 0.656 . . . . 0.0 111.16 -172.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -61.91 -16.03 47.61 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.649 1.18 . . . . 0.0 112.806 -175.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 97.9 mt -100.83 -55.82 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 C-N-CA 124.268 1.027 . . . . 0.0 109.28 173.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 48.2 pt -67.56 -34.45 68.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 119.946 1.248 . . . . 0.0 112.284 -167.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -67.65 -53.21 22.98 Favored Pre-proline 0 CA--C 1.546 0.794 0 CA-C-O 117.71 -1.138 . . . . 0.0 110.701 -175.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -68.93 -23.33 34.84 Favored 'Trans proline' 0 C--N 1.353 0.801 0 CA-C-N 121.652 1.626 . . . . 0.0 112.928 174.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 31.3 mmm180 -77.39 8.94 3.59 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 119.482 1.037 . . . . 0.0 112.274 171.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 94.73 3.33 62.52 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-O 118.194 -1.337 . . . . 0.0 116.218 167.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.1 142.87 56.36 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 119.622 1.711 . . . . 0.0 110.075 177.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 57.8 m -88.61 119.5 29.12 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 104.798 -2.297 . . . . 0.0 104.798 168.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 19.7 mm -95.19 132.86 38.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 -171.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 19.3 m -137.93 171.53 15.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 124.979 1.312 . . . . 0.0 109.039 176.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 79.51 23.21 63.1 Favored Glycine 0 CA--C 1.526 0.775 0 CA-C-O 119.048 -0.862 . . . . 0.0 113.367 175.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 28.3 p-80 -61.23 135.99 57.91 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 168.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 39.0 t-105 -122.84 135.29 25.63 Favored Pre-proline 0 CA--C 1.533 0.315 0 C-N-CA 124.759 1.224 . . . . 0.0 108.249 -169.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -66.85 139.6 52.49 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 121.83 1.687 . . . . 0.0 111.316 -174.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 65.0 p -71.01 -27.08 63.43 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.018 0.527 . . . . 0.0 111.16 -178.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 52.2 48.43 22.69 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.713 1.605 . . . . 0.0 112.382 172.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 71.78 49.89 21.51 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.566 -0.613 . . . . 0.0 111.566 175.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 17.1 p90 -56.43 -39.7 73.54 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.302 0.641 . . . . 0.0 110.965 175.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 21.4 m-70 46.37 49.06 13.37 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.622 1.969 . . . . 0.0 112.298 170.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -117.82 170.04 9.12 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.789 1.236 . . . . 0.0 109.757 -179.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -57.46 -48.6 78.74 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 123.234 0.614 . . . . 0.0 110.96 -169.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -152.97 174.25 14.38 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 167.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 72.4 m -153.15 136.33 15.66 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 106.02 -1.844 . . . . 0.0 106.02 168.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -107.3 -0.28 22.62 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -172.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -88.09 5.53 84.7 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 124.13 0.872 . . . . 0.0 112.419 168.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 96.1 mt -67.52 134.26 50.97 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 118.982 1.391 . . . . 0.0 110.253 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -96.21 -34.45 11.65 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 166.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -145.88 161.28 40.38 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 128.152 2.581 . . . . 0.0 105.81 168.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -58.67 -25.19 62.54 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 120.627 -1.295 . . . . 0.0 112.112 178.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -92.04 -9.6 42.18 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.201 1.0 . . . . 0.0 113.347 176.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 63.1 m80 -143.39 123.63 13.78 Favored 'General case' 0 C--N 1.346 0.426 0 CA-C-N 120.216 1.371 . . . . 0.0 112.398 -175.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -73.34 152.16 41.0 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 166.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 9.3 p -64.29 -21.71 29.61 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 O-C-N 121.811 -0.556 . . . . 0.0 111.228 175.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -155.66 175.14 33.6 Favored Glycine 0 C--N 1.339 0.705 0 C-N-CA 123.792 0.71 . . . . 0.0 111.776 -172.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -71.94 104.02 3.38 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.809 0.844 . . . . 0.0 109.12 -177.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -79.41 133.04 36.55 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 169.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 17.4 pt -65.97 -32.43 58.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-N 119.591 1.087 . . . . 0.0 111.581 -178.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.415 ' CG ' HE21 ' A' ' 91' ' ' GLN . 23.8 t0 -106.88 154.19 21.41 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.986 1.315 . . . . 0.0 109.555 -174.071 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.546 ' CA ' HE22 ' A' ' 91' ' ' GLN . 6.0 tt0 -153.47 10.91 0.44 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.255 1.422 . . . . 0.0 111.643 178.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -144.53 -67.39 0.33 Allowed 'General case' 0 C--N 1.341 0.235 0 C-N-CA 123.809 0.844 . . . . 0.0 109.71 173.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -168.65 112.24 0.57 Allowed 'General case' 0 C--O 1.237 0.445 0 C-N-CA 126.956 2.102 . . . . 0.0 105.797 169.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 58.41 149.01 0.07 OUTLIER Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 126.949 2.1 . . . . 0.0 113.416 -169.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -64.1 135.75 48.83 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.419 2.08 . . . . 0.0 111.193 178.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -124.24 -14.58 6.96 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.862 0.865 . . . . 0.0 111.895 172.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 75.2 mt -122.24 29.28 7.07 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.988 1.315 . . . . 0.0 110.353 -169.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 58.4 m -41.02 -54.44 2.78 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 127.516 2.326 . . . . 0.0 112.982 -169.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -76.8 -32.07 57.39 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -173.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -71.75 -38.84 70.33 Favored 'General case' 0 CA--C 1.529 0.157 0 O-C-N 121.913 -0.492 . . . . 0.0 109.939 178.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 74.1 mtp85 -66.49 -41.81 88.36 Favored 'General case' 0 N--CA 1.462 0.173 0 O-C-N 121.682 -0.637 . . . . 0.0 110.445 -178.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 34.4 m -70.39 -27.8 32.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 119.077 0.853 . . . . 0.0 111.195 177.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -65.49 -53.74 38.25 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 120.647 1.567 . . . . 0.0 109.583 172.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -61.63 -36.45 80.79 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 117.795 0.27 . . . . 0.0 110.888 -177.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 35.3 t90 -75.43 -46.64 31.46 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 118.178 0.445 . . . . 0.0 111.077 -178.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 42.5 t -59.89 -36.5 67.07 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.094 0 CA-C-N 118.581 0.628 . . . . 0.0 110.084 177.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -64.08 -40.84 97.14 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 117.937 -1.03 . . . . 0.0 110.654 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -69.27 -48.03 62.88 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 119.556 1.071 . . . . 0.0 110.659 175.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 7.5 pt -66.8 -29.82 47.64 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.333 0 CA-C-N 119.705 1.139 . . . . 0.0 110.759 -173.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 51.1 m -61.81 -29.29 70.06 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 117.877 -1.058 . . . . 0.0 112.459 176.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -92.16 -24.16 19.17 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 120.52 1.509 . . . . 0.0 111.641 175.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -73.02 -36.29 66.94 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 118.674 0.67 . . . . 0.0 110.794 174.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 66.1 mt -93.45 -9.16 39.48 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.349 1.86 . . . . 0.0 111.794 -179.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 39.2 m80 56.25 29.94 15.76 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.615 1.566 . . . . 0.0 112.911 -169.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 73.3 mt -72.22 -20.82 61.5 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 121.457 -0.777 . . . . 0.0 110.909 169.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -57.97 -38.25 75.71 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 118.951 0.796 . . . . 0.0 110.304 176.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -67.46 -11.27 57.48 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 121.507 -0.745 . . . . 0.0 112.423 178.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 49.9 mt -105.16 -55.88 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 124.911 1.284 . . . . 0.0 108.468 -178.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.5 pp -80.09 -23.78 41.04 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.091 0.556 . . . . 0.0 112.475 -172.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -122.18 34.85 5.04 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.99 1.716 . . . . 0.0 109.578 -176.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.142 0 C-N-CA 123.83 0.852 . . . . 0.0 109.511 174.202 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.8 ptt? . . . . . 0 N--CA 1.489 1.497 0 N-CA-C 111.627 0.232 . . . . 0.0 111.627 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -66.58 149.72 50.06 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.408 0.683 . . . . 0.0 109.821 174.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 31.0 pt -85.78 -22.69 7.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 123.393 0.677 . . . . 0.0 111.444 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 26.3 m -114.63 134.73 54.84 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.738 1.615 . . . . 0.0 109.09 -177.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -107.19 122.32 6.85 Favored Glycine 0 CA--C 1.52 0.401 0 N-CA-C 107.442 -2.263 . . . . 0.0 107.442 168.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 54.4 mt -100.62 91.69 2.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.14 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 176.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -88.16 130.33 35.08 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 -179.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 16.1 p90 -130.74 132.07 45.12 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 119.435 1.016 . . . . 0.0 112.338 179.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -86.54 149.76 22.87 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 168.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.8 m -167.9 157.78 10.17 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.936 1.368 . . . . 0.0 110.643 173.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -121.68 -52.89 2.0 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.953 0.901 . . . . 0.0 109.948 168.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.0 p -88.53 7.72 31.71 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.551 1.14 . . . . 0.0 112.733 174.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 84.92 -4.73 84.73 Favored Glycine 0 CA--C 1.533 1.174 0 N-CA-C 116.621 1.408 . . . . 0.0 116.621 168.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.88 -35.47 78.42 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 120.243 2.022 . . . . 0.0 113.696 -169.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 12.8 m -70.82 -17.29 62.76 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 119.524 1.056 . . . . 0.0 110.665 -175.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -60.19 -41.87 93.83 Favored 'General case' 0 C--N 1.342 0.278 0 O-C-N 121.118 -0.989 . . . . 0.0 110.338 175.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -64.42 -39.0 92.98 Favored 'General case' 0 C--N 1.339 0.127 0 O-C-N 122.072 -0.393 . . . . 0.0 110.306 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.0 mm -64.37 -46.37 93.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.72 -42.45 98.97 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.296 0.639 . . . . 0.0 111.531 178.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 54.8 mttm -64.57 -43.39 94.03 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 118.88 -0.581 . . . . 0.0 110.858 178.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 72.6 mtm -62.5 -39.64 94.15 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 119.169 0.895 . . . . 0.0 110.733 178.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 62.9 mt -60.11 -48.49 87.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 175.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -59.21 -39.61 83.2 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.803 0.729 . . . . 0.0 111.058 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -68.11 -36.43 79.75 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 119.432 1.014 . . . . 0.0 111.026 178.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 19.4 mm100 -65.78 -49.6 67.73 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.574 0.625 . . . . 0.0 111.529 -178.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.97 -8.22 34.34 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -175.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.42 143.3 12.22 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 125.119 1.342 . . . . 0.0 112.122 175.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.2 pttp -70.09 -23.64 63.09 Favored 'General case' 0 N--CA 1.469 0.489 0 O-C-N 121.584 -0.95 . . . . 0.0 113.082 -178.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -60.37 -34.74 74.3 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 122.985 0.514 . . . . 0.0 110.763 171.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 62.1 t -83.69 -42.48 17.42 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-O 118.001 -0.999 . . . . 0.0 110.136 178.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -132.77 147.08 52.31 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-N 119.838 1.199 . . . . 0.0 114.182 -170.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -120.97 140.87 51.29 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 123.831 0.852 . . . . 0.0 109.696 169.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 94.6 t -85.97 139.26 17.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -147.01 170.65 16.67 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.29 1.036 . . . . 0.0 111.881 -168.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -145.65 125.19 13.2 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 125.79 1.636 . . . . 0.0 108.641 -170.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.4 tp -63.08 -29.14 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-O 118.967 -0.54 . . . . 0.0 111.747 -171.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.03 -28.44 69.49 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 118.945 0.793 . . . . 0.0 111.692 -176.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -101.27 -7.21 23.24 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.674 0.79 . . . . 0.0 112.299 175.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 42.5 m -75.43 171.48 14.18 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 123.649 0.78 . . . . 0.0 110.547 177.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 14.1 m -139.26 160.53 39.6 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.819 1.248 . . . . 0.0 108.875 178.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -53.79 -46.85 71.15 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.073 0.949 . . . . 0.0 111.455 -174.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -80.92 -15.26 56.77 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 122.571 0.349 . . . . 0.0 111.551 -176.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -77.95 -29.71 50.02 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 121.439 -0.788 . . . . 0.0 111.213 -175.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -59.41 -41.5 89.6 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.111 0.564 . . . . 0.0 109.709 169.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -72.96 -13.17 61.19 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.637 0.775 . . . . 0.0 112.315 -170.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.71 -30.56 70.1 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.446 0.698 . . . . 0.0 111.91 176.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -82.37 155.96 24.45 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.99 0.916 . . . . 0.0 110.284 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -104.49 -24.3 13.04 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.821 169.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.3 mp -118.37 127.93 75.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 176.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -114.63 119.71 37.66 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 175.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.9 mp -105.98 117.95 35.34 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 105.282 -2.118 . . . . 0.0 105.282 169.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 66.9 mt -119.99 108.38 14.23 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 -169.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.81 120.32 6.52 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 125.679 1.609 . . . . 0.0 109.708 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.0 tt -134.24 112.29 12.07 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 118.104 0.952 . . . . 0.0 110.466 -176.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -74.83 143.69 29.98 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.391 2.061 . . . . 0.0 109.202 169.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 30.3 m -96.41 136.65 36.62 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 174.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 63.7 m95 -134.45 171.91 13.64 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 124.754 1.222 . . . . 0.0 109.992 -178.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 42.7 46.42 4.38 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 127.016 2.127 . . . . 0.0 114.285 167.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 57.46 69.43 0.74 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.509 1.124 . . . . 0.0 111.323 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.52 33.33 22.6 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 115.629 -0.714 . . . . 0.0 113.94 169.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -119.53 164.5 15.72 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 125.399 1.48 . . . . 0.0 109.632 175.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -96.53 170.88 8.91 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 123.983 0.913 . . . . 0.0 108.791 168.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 47.1 mm-40 -70.02 148.85 48.34 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 169.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 58.6 m -59.47 -35.18 73.59 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -168.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -72.29 -29.14 63.6 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.249 0.619 . . . . 0.0 111.469 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -78.84 -44.92 21.92 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.963 0.905 . . . . 0.0 109.349 175.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -60.42 -41.35 93.77 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.33 1.052 . . . . 0.0 111.228 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -62.66 -21.77 65.96 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.087 0.955 . . . . 0.0 112.269 178.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -85.01 -18.93 32.91 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 117.875 -1.06 . . . . 0.0 112.227 178.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -55.65 -42.75 97.65 Favored Pre-proline 0 CA--C 1.541 0.615 0 CA-C-N 121.243 1.838 . . . . 0.0 114.116 -179.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.28 -14.28 44.24 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 CA-C-N 122.603 1.965 . . . . 0.0 113.714 174.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.1 m -88.72 -42.62 11.84 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 119.195 0.907 . . . . 0.0 109.227 169.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 18.3 tp -56.62 -38.22 71.79 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 124.998 1.319 . . . . 0.0 110.841 -177.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -71.78 -1.18 13.13 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -105.97 -11.95 15.99 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.497 1.044 . . . . 0.0 111.872 172.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 98.5 mt -81.63 140.97 15.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -175.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -87.44 133.63 33.72 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 123.464 0.706 . . . . 0.0 110.133 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -126.57 15.03 7.62 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.962 0.905 . . . . 0.0 111.612 174.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 17.0 m-80 -58.73 116.12 3.51 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 119.987 1.267 . . . . 0.0 109.886 -174.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.78 1.19 58.21 Favored Glycine 0 CA--C 1.533 1.175 0 CA-C-O 118.567 -1.13 . . . . 0.0 113.803 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -74.86 147.61 40.94 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 119.628 1.714 . . . . 0.0 107.835 172.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 14.9 mt -88.77 136.04 33.21 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 174.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.2 t -132.44 139.97 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -136.71 141.56 43.08 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 175.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 62.1 mt -112.62 148.16 35.17 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -173.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -144.42 168.15 20.8 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 169.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -179.53 176.09 47.42 Favored Glycine 0 N--CA 1.447 -0.577 0 CA-C-O 122.174 0.875 . . . . 0.0 113.0 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 24.4 m -129.53 152.58 48.91 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 125.727 1.611 . . . . 0.0 107.737 -171.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -169.8 -173.79 37.55 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -177.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -147.56 166.89 25.95 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 168.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -111.47 -6.39 14.45 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.725 1.61 . . . . 0.0 111.996 -171.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -59.45 -48.25 82.35 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 123.626 0.77 . . . . 0.0 111.787 -169.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -138.18 1.99 2.27 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -173.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -111.38 27.83 9.31 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.39 1.076 . . . . 0.0 111.396 -169.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.13 -17.38 64.67 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 -169.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -94.64 -0.61 54.29 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.62 1.168 . . . . 0.0 111.995 174.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -139.08 22.61 2.6 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 125.762 1.625 . . . . 0.0 110.283 -170.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -70.76 121.03 17.24 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -169.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 74.0 m 48.3 38.92 11.22 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.617 1.167 . . . . 0.0 111.679 -177.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -61.95 -38.81 89.89 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.466 1.106 . . . . 0.0 112.061 -172.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.15 -21.34 66.33 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 114.136 1.162 . . . . 0.0 114.136 -168.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 7.1 mp -61.28 -35.22 76.72 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 119.766 1.166 . . . . 0.0 110.22 175.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.37 -33.48 86.35 Favored Glycine 0 CA--C 1.531 1.039 0 N-CA-C 111.318 -0.713 . . . . 0.0 111.318 177.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.2 m -65.05 -37.3 87.13 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 117.774 0.787 . . . . 0.0 110.361 177.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 6.0 mt -70.31 -49.15 56.34 Favored 'Isoleucine or valine' 0 C--N 1.343 0.319 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 173.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 55.8 ttt-85 -51.31 -47.21 62.68 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 118.617 0.644 . . . . 0.0 110.563 -176.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -63.23 -22.92 67.18 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.114 0.966 . . . . 0.0 112.914 -175.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 96.9 mt -91.63 -44.6 14.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 123.666 0.786 . . . . 0.0 109.379 177.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 22.4 pt -74.78 -29.43 22.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-N 118.999 0.818 . . . . 0.0 111.617 -171.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -62.03 -56.22 33.63 Favored Pre-proline 0 CA--C 1.543 0.685 0 CA-C-O 117.74 -1.124 . . . . 0.0 112.063 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -66.16 -21.79 54.96 Favored 'Trans proline' 0 C--N 1.351 0.701 0 CA-C-N 121.769 1.668 . . . . 0.0 112.612 178.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 73.0 mmt-85 -82.07 9.46 8.44 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.99 0.916 . . . . 0.0 112.841 172.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 77.51 16.16 80.62 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-O 118.367 -1.24 . . . . 0.0 114.877 168.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -59.63 144.66 47.14 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 119.036 1.418 . . . . 0.0 110.355 170.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 44.6 m -95.29 119.94 34.66 Favored 'General case' 0 C--N 1.333 -0.123 0 N-CA-C 104.663 -2.347 . . . . 0.0 104.663 167.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 15.8 mt -100.86 127.54 53.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 -171.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 31.8 m -137.44 178.23 4.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 124.983 1.313 . . . . 0.0 109.285 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 78.83 36.51 28.56 Favored Glycine 0 CA--C 1.527 0.835 0 O-C-N 121.912 -0.493 . . . . 0.0 111.976 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 68.3 m80 -63.22 142.6 58.33 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 117.615 0.707 . . . . 0.0 109.153 172.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 75.2 t-105 -123.58 129.49 24.83 Favored Pre-proline 0 CA--C 1.534 0.357 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 -174.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -67.74 144.23 64.76 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 121.437 1.425 . . . . 0.0 112.129 -170.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 71.6 p -76.91 -27.27 54.87 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.614 0.766 . . . . 0.0 111.136 177.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 52.73 42.9 31.84 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.655 1.582 . . . . 0.0 111.807 -178.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 71.4 55.23 7.85 Favored Glycine 0 C--N 1.34 0.769 0 N-CA-C 111.138 -0.785 . . . . 0.0 111.138 178.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -57.98 151.74 17.8 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 122.884 0.474 . . . . 0.0 110.265 174.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 33.0 p80 -128.83 9.44 5.86 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.932 0.893 . . . . 0.0 112.53 -177.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -74.95 162.89 28.19 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.331 1.053 . . . . 0.0 110.142 -175.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -71.19 -44.26 65.79 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 122.012 -0.43 . . . . 0.0 110.843 -170.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -160.08 134.05 7.26 Favored 'General case' 0 C--N 1.342 0.241 0 C-N-CA 124.384 1.074 . . . . 0.0 109.259 173.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 13.5 m -129.1 103.08 6.78 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 106.914 -1.514 . . . . 0.0 106.914 177.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.59 -10.86 60.14 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 120.95 -1.094 . . . . 0.0 111.795 -170.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -74.63 -0.56 59.16 Favored Glycine 0 CA--C 1.535 1.319 0 CA-C-O 118.637 -1.091 . . . . 0.0 113.412 169.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 43.7 mt -63.41 131.49 48.4 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 120.583 2.192 . . . . 0.0 109.503 174.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -100.77 -32.79 10.53 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.176 0.99 . . . . 0.0 109.323 169.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -149.49 161.78 41.44 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 127.313 2.245 . . . . 0.0 107.103 174.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -53.06 -31.78 43.4 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.328 0.651 . . . . 0.0 112.389 176.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -93.38 -11.33 32.52 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.284 1.034 . . . . 0.0 113.335 -178.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 10.9 m-70 -146.92 128.98 15.54 Favored 'General case' 0 C--N 1.346 0.431 0 CA-C-N 119.76 1.163 . . . . 0.0 113.729 -170.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -77.49 155.57 31.59 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 166.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.4 p -66.12 -22.86 30.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 C-N-CA 123.972 0.909 . . . . 0.0 111.642 178.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -158.93 169.99 35.29 Favored Glycine 0 C--N 1.338 0.659 0 CA-C-N 118.471 0.578 . . . . 0.0 112.314 -169.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -69.35 111.97 5.6 Favored 'General case' 0 CA--C 1.521 -0.144 0 C-N-CA 124.452 1.101 . . . . 0.0 109.496 -175.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -92.38 121.98 34.39 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 169.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 7.3 pt -71.08 -30.02 39.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-N 118.66 0.664 . . . . 0.0 111.276 178.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -84.32 158.59 21.13 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 118.275 0.488 . . . . 0.0 110.588 177.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -126.39 -65.16 0.99 Allowed 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 169.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -152.88 116.42 4.72 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.072 0.949 . . . . 0.0 109.588 177.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 3.5 tpm_? 48.6 95.21 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 127.776 2.43 . . . . 0.0 112.568 173.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 66.99 138.0 0.05 OUTLIER Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 126.708 2.003 . . . . 0.0 110.683 -168.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -70.13 -54.0 0.22 Allowed 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 121.604 1.536 . . . . 0.0 114.54 -167.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 57.56 174.13 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.345 1.458 . . . . 0.0 110.913 -167.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 20.7 mt 57.28 26.31 12.19 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.953 0.901 . . . . 0.0 111.986 172.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 38.8 m -46.31 -53.08 11.46 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 127.163 2.185 . . . . 0.0 112.913 -167.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -82.07 -40.54 21.83 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 119.395 -0.336 . . . . 0.0 111.038 -174.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -67.65 -28.15 67.47 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.026 0.83 . . . . 0.0 111.856 -173.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 59.6 mtp85 -62.77 -45.46 92.58 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 118.718 0.69 . . . . 0.0 110.021 175.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 17.3 m -74.34 -31.03 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-O 117.706 -1.14 . . . . 0.0 111.274 177.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -58.33 -52.07 67.14 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 120.99 1.723 . . . . 0.0 109.406 173.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -62.49 -37.79 87.37 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 122.724 0.41 . . . . 0.0 110.654 -179.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 59.2 t90 -74.91 -44.49 48.4 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 118.278 0.49 . . . . 0.0 111.644 -175.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 77.8 t -64.22 -34.0 66.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -61.25 -35.85 78.4 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 121.261 -0.899 . . . . 0.0 111.4 175.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -63.44 -55.99 19.8 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 119.177 0.899 . . . . 0.0 110.294 175.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 9.8 pt -67.08 -28.59 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 O-C-N 122.12 -0.363 . . . . 0.0 110.351 -173.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 64.2 m -60.77 -23.74 65.23 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 118.377 -0.821 . . . . 0.0 112.489 177.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -82.96 -31.9 27.37 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 119.927 1.24 . . . . 0.0 111.055 175.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -80.07 -38.31 32.03 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.713 0.805 . . . . 0.0 110.621 -178.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 5.4 mp -88.9 -3.7 58.67 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.448 1.899 . . . . 0.0 110.886 -179.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 55.63 32.85 20.06 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.847 1.659 . . . . 0.0 112.689 -174.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 47.1 mt -75.79 -19.5 58.92 Favored 'General case' 0 N--CA 1.467 0.389 0 O-C-N 121.787 -0.57 . . . . 0.0 110.519 172.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -56.81 -38.6 72.82 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.707 0.685 . . . . 0.0 110.267 175.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -67.49 -13.16 61.79 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 121.537 -0.727 . . . . 0.0 112.422 178.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 38.1 mt -99.36 -56.66 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 125.0 1.32 . . . . 0.0 108.432 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.8 pp -84.46 -22.41 30.31 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 123.554 0.742 . . . . 0.0 112.71 -169.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -121.59 35.68 4.82 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.826 1.651 . . . . 0.0 109.671 -176.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.096 0 C-N-CA 123.788 0.835 . . . . 0.0 109.504 174.697 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.8 mmm . . . . . 0 N--CA 1.489 1.481 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -60.53 145.07 49.92 Favored 'General case' 0 C--N 1.344 0.345 0 C-N-CA 123.434 0.693 . . . . 0.0 111.282 -178.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 32.4 pt -109.94 -20.53 6.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 125.189 1.396 . . . . 0.0 111.239 178.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 44.5 m -105.85 128.16 53.58 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.736 1.214 . . . . 0.0 108.146 174.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -99.82 116.19 5.51 Favored Glycine 0 CA--C 1.519 0.313 0 N-CA-C 107.198 -2.361 . . . . 0.0 107.198 169.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 46.6 mt -90.63 122.59 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 104.135 -2.543 . . . . 0.0 104.135 171.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -118.19 132.8 56.3 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 174.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -132.9 158.42 42.63 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 118.345 0.521 . . . . 0.0 111.187 -174.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -132.73 154.36 21.08 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 108.091 -2.003 . . . . 0.0 108.091 167.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 16.3 m -163.7 163.51 24.17 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 119.212 1.506 . . . . 0.0 109.491 -175.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -137.98 -52.53 0.62 Allowed 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.667 0.787 . . . . 0.0 110.379 171.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.9 p -77.52 -14.73 59.6 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.237 0.615 . . . . 0.0 111.753 170.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 104.98 8.21 36.93 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.014 1.292 . . . . 0.0 113.961 169.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -66.55 -54.29 25.26 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 119.02 1.41 . . . . 0.0 111.927 -173.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.3 m -75.78 -18.38 59.55 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 122.027 -0.421 . . . . 0.0 111.515 -166.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -59.72 -46.78 88.08 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 167.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 33.2 t30 -68.3 -39.67 81.98 Favored 'General case' 0 C--N 1.339 0.122 0 O-C-N 121.864 -0.523 . . . . 0.0 110.305 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 49.8 mm -59.48 -45.16 94.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 118.738 0.699 . . . . 0.0 109.265 175.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.73 -40.61 95.69 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.753 0.706 . . . . 0.0 111.174 178.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -64.18 -42.49 96.67 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-O 118.823 -0.608 . . . . 0.0 110.826 176.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 98.8 mtp -63.82 -44.37 93.43 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 119.35 0.977 . . . . 0.0 110.464 177.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 69.9 mt -57.26 -47.57 84.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 176.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.403 ' NE2' ' HA ' ' A' ' 32' ' ' ASP . 27.3 tt0 -58.29 -42.97 87.78 Favored 'General case' 0 CA--C 1.53 0.2 0 O-C-N 121.467 -0.771 . . . . 0.0 111.157 176.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -64.0 -35.93 82.32 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 119.416 1.007 . . . . 0.0 110.683 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -69.21 -45.52 69.67 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.286 0.635 . . . . 0.0 110.936 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -79.88 -30.09 40.12 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.031 0.832 . . . . 0.0 112.101 -178.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.73 145.26 16.13 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 125.008 1.29 . . . . 0.0 110.699 -170.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.9 tttm -65.04 -31.01 72.02 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 121.889 -0.771 . . . . 0.0 111.799 -170.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -77.6 -7.06 55.8 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.063 0.545 . . . . 0.0 112.069 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 49.0 t -104.67 -43.21 7.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 124.254 1.022 . . . . 0.0 109.258 174.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -134.46 134.11 41.18 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 119.478 1.036 . . . . 0.0 111.491 -175.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.403 ' HA ' ' NE2' ' A' ' 23' ' ' GLN . 15.5 t70 -123.94 148.55 46.8 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 175.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 59.5 t -106.42 140.07 25.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 124.477 1.111 . . . . 0.0 111.158 -168.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -139.64 144.18 37.55 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.811 1.644 . . . . 0.0 109.847 177.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -83.92 126.25 32.82 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 169.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 11.0 tp -58.54 -31.23 43.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -171.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.72 -29.83 67.31 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.985 0.811 . . . . 0.0 112.024 -177.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 47.4 mtmt -76.54 -33.3 58.56 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 118.206 0.457 . . . . 0.0 110.835 177.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 57.7 m -70.77 165.01 23.98 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.678 1.191 . . . . 0.0 112.248 -174.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.5 m -133.04 174.59 10.2 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.225 1.81 . . . . 0.0 109.146 -176.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -49.05 -54.26 16.7 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.288 1.035 . . . . 0.0 111.655 -173.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -76.27 -11.83 59.98 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 122.473 0.309 . . . . 0.0 111.758 -170.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -71.22 -33.85 70.29 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 121.882 -0.512 . . . . 0.0 110.766 -174.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 8.4 mp -74.3 -38.75 63.26 Favored 'General case' 0 C--N 1.342 0.279 0 C-N-CA 122.594 0.358 . . . . 0.0 110.109 171.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -67.06 -18.14 65.21 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 122.898 0.479 . . . . 0.0 112.126 -169.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.92 -28.98 69.91 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.482 1.113 . . . . 0.0 112.527 173.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -96.16 156.94 16.12 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.147 0.979 . . . . 0.0 111.048 -175.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -99.5 -29.39 12.75 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.31 0.644 . . . . 0.0 111.514 170.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.0 mp -110.76 127.69 67.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 174.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -115.52 135.16 54.37 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 174.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.5 mp -118.74 114.13 22.23 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 172.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 51.6 mt -112.47 112.4 23.92 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 -169.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -102.58 103.4 2.43 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 125.404 1.478 . . . . 0.0 111.075 -173.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 14.6 tt -127.72 119.39 21.42 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 124.123 0.969 . . . . 0.0 111.077 -169.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -76.29 150.31 32.62 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 121.909 1.739 . . . . 0.0 110.501 170.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 19.1 m -98.3 140.78 32.07 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 169.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 42.4 m95 -136.2 174.38 10.67 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.718 1.607 . . . . 0.0 109.479 -178.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.458 ' CE1' HM73 ' A' ' 201' ' ' FMN . 75.5 m-85 21.52 82.27 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 128.476 2.71 . . . . 0.0 114.702 169.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 57.49 49.52 12.69 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.937 0.895 . . . . 0.0 111.927 172.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 81.03 19.0 68.27 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 123.743 0.687 . . . . 0.0 113.541 170.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -88.48 156.13 19.28 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 124.316 1.046 . . . . 0.0 110.162 178.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.97 144.5 34.69 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 169.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -59.93 149.28 32.24 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 169.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 75.4 m -61.04 -25.84 67.21 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -168.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 39.4 p30 -68.45 -36.39 78.93 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.474 0.71 . . . . 0.0 111.848 178.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -80.36 -41.43 24.72 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 118.695 0.68 . . . . 0.0 111.091 171.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -60.98 -39.34 89.25 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.505 0.593 . . . . 0.0 111.533 -176.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -67.4 -20.82 65.59 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.358 0.663 . . . . 0.0 112.168 175.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -94.43 -20.9 19.29 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.043 0.937 . . . . 0.0 111.825 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 21.6 m-30 -52.49 -40.32 74.48 Favored Pre-proline 0 CA--C 1.545 0.758 0 CA-C-O 116.67 -1.633 . . . . 0.0 114.544 178.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -64.41 -23.83 64.78 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 CA-C-N 123.103 2.144 . . . . 0.0 113.036 174.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.6 m -79.79 -38.34 33.28 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 119.239 0.927 . . . . 0.0 109.168 170.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 19.4 tp -60.64 -33.32 72.62 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.016 -1.052 . . . . 0.0 111.84 -174.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -81.97 -4.3 56.37 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.65 0.78 . . . . 0.0 112.863 176.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -96.15 -28.33 14.62 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 119.112 0.869 . . . . 0.0 109.947 170.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 88.7 mt -64.26 136.22 26.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 176.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -86.67 130.89 34.31 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 123.421 0.688 . . . . 0.0 109.548 172.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -118.03 6.7 12.13 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.17 0.988 . . . . 0.0 112.005 176.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 21.9 m-80 -56.55 115.49 2.55 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 120.463 1.483 . . . . 0.0 110.478 -173.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.71 0.37 63.55 Favored Glycine 0 CA--C 1.535 1.321 0 CA-C-O 118.548 -1.14 . . . . 0.0 114.285 178.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -75.24 147.5 40.26 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 119.679 1.739 . . . . 0.0 108.202 174.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 69.3 mt -91.24 135.86 33.5 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 175.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.8 t -135.27 130.43 51.08 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -116.3 150.23 37.97 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 169.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 79.7 mt -117.55 150.71 38.53 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 -178.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -149.03 162.07 40.66 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 170.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 171.91 150.03 6.96 Favored Glycine 0 N--CA 1.448 -0.51 0 CA-C-O 121.88 0.711 . . . . 0.0 112.789 174.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 4.5 p -78.01 164.18 25.29 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 121.321 0.581 . . . . 0.0 109.837 169.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -160.58 -162.51 12.57 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 173.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -145.63 122.58 11.34 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 127.08 2.152 . . . . 0.0 105.473 177.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -110.51 1.95 18.51 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.228 1.411 . . . . 0.0 111.474 -173.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -108.8 -45.12 3.88 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.369 1.068 . . . . 0.0 110.827 -168.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -104.3 -35.45 7.97 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.804 1.242 . . . . 0.0 109.975 178.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -98.19 40.46 1.18 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.376 1.071 . . . . 0.0 110.279 169.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.03 -21.78 65.17 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.174 1.39 . . . . 0.0 113.787 -173.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -95.96 5.95 50.01 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.986 0.914 . . . . 0.0 111.691 177.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -138.56 18.7 2.71 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.983 1.313 . . . . 0.0 110.907 -172.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 30.8 t80 -64.93 132.5 49.49 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -173.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . 0.282 28.6 p 54.95 24.41 5.86 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.675 1.99 . . . . 0.0 114.454 171.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -61.56 -32.49 72.57 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.146 1.378 . . . . 0.0 111.867 -174.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.24 -32.57 71.88 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 120.903 -1.123 . . . . 0.0 111.427 -178.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 7.0 mp -63.82 -43.88 94.91 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 119.658 1.117 . . . . 0.0 108.849 173.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -60.51 -34.77 87.04 Favored Glycine 0 CA--C 1.533 1.185 0 N-CA-C 111.436 -0.666 . . . . 0.0 111.436 174.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 17.0 m -65.02 -37.38 87.44 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 121.716 -0.873 . . . . 0.0 110.6 176.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 5.1 mt -67.32 -47.45 81.14 Favored 'Isoleucine or valine' 0 C--N 1.345 0.382 0 CA-C-O 117.643 -1.17 . . . . 0.0 108.967 173.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -56.92 -38.22 72.57 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 120.38 1.445 . . . . 0.0 110.928 -174.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -60.69 -25.08 66.12 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.206 1.002 . . . . 0.0 112.457 178.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 75.8 mt -94.02 -49.36 12.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 124.419 1.087 . . . . 0.0 110.041 177.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 36.5 pt -75.58 -28.37 19.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-N 120.002 1.274 . . . . 0.0 111.9 -168.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -63.13 -53.95 50.0 Favored Pre-proline 0 CA--C 1.542 0.663 0 CA-C-O 117.447 -1.263 . . . . 0.0 111.836 178.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -68.08 -20.87 43.62 Favored 'Trans proline' 0 C--N 1.351 0.707 0 CA-C-N 122.064 1.773 . . . . 0.0 112.719 176.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 31.4 mmm180 -78.58 1.98 20.8 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 119.163 0.892 . . . . 0.0 112.144 170.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 93.26 10.43 59.53 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 125.048 1.309 . . . . 0.0 115.204 168.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.94 146.79 45.55 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 119.205 1.502 . . . . 0.0 110.757 174.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 86.1 m -101.93 124.16 47.08 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 105.206 -2.146 . . . . 0.0 105.206 167.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 19.4 mm -90.76 133.28 33.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 -171.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 18.7 m -131.76 168.51 23.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.395 0 C-N-CA 125.99 1.716 . . . . 0.0 108.81 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 70.07 39.66 73.25 Favored Glycine 0 CA--C 1.527 0.792 0 O-C-N 121.691 -0.631 . . . . 0.0 113.05 177.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -64.55 134.83 55.2 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 171.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 57.6 t-105 -114.76 127.26 26.99 Favored Pre-proline 0 CA--C 1.535 0.398 0 C-N-CA 124.752 1.221 . . . . 0.0 108.494 -169.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -61.98 141.93 90.98 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 CA-C-N 121.02 1.4 . . . . 0.0 112.831 -173.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 56.7 p -74.43 -28.07 60.89 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.037 0.535 . . . . 0.0 110.991 174.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 52.95 43.34 31.8 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.05 1.74 . . . . 0.0 111.84 -179.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 70.48 56.05 8.02 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 178.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -59.16 152.92 19.31 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 116.963 0.382 . . . . 0.0 110.197 174.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 37.2 t60 -144.96 57.5 1.28 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.514 0.673 . . . . 0.0 109.714 -176.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -116.27 164.1 15.01 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 124.973 1.309 . . . . 0.0 108.637 -177.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -66.49 -43.21 86.01 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 119.4 -0.333 . . . . 0.0 110.753 -169.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -161.42 130.63 4.61 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 124.3 1.04 . . . . 0.0 109.089 169.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 13.3 m -115.34 124.66 51.84 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 174.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -100.58 -11.4 20.1 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -173.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -79.6 7.88 51.63 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-O 119.184 -0.787 . . . . 0.0 113.113 169.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 97.5 mt -64.75 138.56 58.46 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 120.178 1.989 . . . . 0.0 109.942 174.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -106.21 -31.04 8.84 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.982 1.313 . . . . 0.0 108.925 167.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -149.16 162.98 38.89 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 127.466 2.306 . . . . 0.0 106.929 171.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -54.68 -30.84 56.71 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 121.371 -0.831 . . . . 0.0 112.162 176.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -91.98 -9.77 41.74 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.322 1.049 . . . . 0.0 113.325 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 11.9 m-70 -146.71 126.34 13.35 Favored 'General case' 0 C--N 1.346 0.415 0 CA-C-N 119.569 1.077 . . . . 0.0 113.376 -170.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -75.3 153.38 37.95 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 166.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 8.9 p -65.86 -18.88 24.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 124.288 1.035 . . . . 0.0 112.395 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -166.68 179.86 40.3 Favored Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -173.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -71.07 87.86 0.77 Allowed 'General case' 0 CA--C 1.522 -0.101 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 -178.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -85.71 129.22 34.88 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 169.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 12.4 tt -134.14 129.56 53.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-O 121.711 0.767 . . . . 0.0 112.108 -176.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -157.3 166.54 32.84 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 128.728 2.811 . . . . 0.0 105.265 168.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 24.1 tp10 -139.98 -63.25 0.5 Allowed 'General case' 0 C--O 1.233 0.207 0 O-C-N 121.203 -0.936 . . . . 0.0 109.744 176.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -160.24 94.45 1.09 Allowed 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 178.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 29.3 mmm-85 53.41 87.75 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.561 1.544 . . . . 0.0 110.879 -169.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 74.93 148.91 0.12 Allowed Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 127.218 2.207 . . . . 0.0 111.531 -176.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -72.32 158.49 51.5 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 123.412 2.741 . . . . 0.0 115.425 -168.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -154.34 -174.07 4.83 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.935 2.094 . . . . 0.0 107.383 167.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 23.7 mt 59.83 29.14 18.71 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.516 1.526 . . . . 0.0 110.973 -168.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 75.0 m -56.77 -51.46 68.82 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.37 1.468 . . . . 0.0 111.563 -169.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.32 -41.22 89.96 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -167.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -70.46 -35.03 73.09 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 118.219 0.463 . . . . 0.0 110.732 177.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 58.9 mtt180 -69.21 -43.86 73.28 Favored 'General case' 0 C--O 1.233 0.208 0 O-C-N 121.555 -0.716 . . . . 0.0 110.493 -178.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 26.6 m -70.42 -29.05 37.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 119.3 0.955 . . . . 0.0 110.544 177.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -64.21 -53.9 41.9 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 120.4 1.455 . . . . 0.0 109.755 171.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -58.2 -36.79 73.64 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 118.863 -0.589 . . . . 0.0 110.641 -178.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 46.1 t90 -77.14 -50.1 13.76 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 118.469 0.577 . . . . 0.0 111.426 -177.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 45.8 t -62.02 -33.58 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 O-C-N 121.458 -0.776 . . . . 0.0 109.992 -177.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -60.16 -38.32 82.79 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-O 118.343 -0.837 . . . . 0.0 111.17 177.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -59.07 -55.01 40.62 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 118.954 0.797 . . . . 0.0 109.802 176.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 19.0 pt -68.53 -29.74 45.0 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.235 0 O-C-N 122.133 -0.354 . . . . 0.0 110.248 -174.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 35.6 m -65.34 -25.41 67.59 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 118.705 -0.664 . . . . 0.0 111.74 175.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -86.03 -39.1 17.18 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 119.547 1.067 . . . . 0.0 110.253 174.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -64.51 -40.09 94.98 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 122.933 0.493 . . . . 0.0 110.92 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.7 mp -100.02 2.33 43.31 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.686 1.594 . . . . 0.0 111.005 -175.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . 0.291 31.7 p80 50.94 26.71 2.81 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 127.022 2.129 . . . . 0.0 113.948 -174.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 55.9 mt -66.04 -21.7 66.4 Favored 'General case' 0 C--N 1.344 0.33 0 O-C-N 121.505 -0.747 . . . . 0.0 110.275 172.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -55.04 -39.55 69.3 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.608 0.763 . . . . 0.0 110.302 172.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -74.98 -1.93 24.87 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.476 -0.765 . . . . 0.0 112.312 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 31.3 mt -105.39 -55.48 5.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 C-N-CA 125.11 1.364 . . . . 0.0 108.23 175.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.4 pp -80.31 -23.93 40.3 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 123.463 0.705 . . . . 0.0 112.464 -171.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 31.7 t30 -129.07 42.11 3.37 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.956 2.102 . . . . 0.0 108.302 -176.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.135 0 C-N-CA 123.7 0.8 . . . . 0.0 109.464 173.841 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' FMN . . . . . 0.458 HM73 ' CE1' ' A' ' 58' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.4 ptm . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 120.498 0.189 . . . . 0.0 111.371 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.07 155.57 40.14 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.173 0.589 . . . . 0.0 109.969 172.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 27.4 pt -83.5 -23.02 8.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 -178.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.1 m -112.2 127.37 55.93 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.955 1.302 . . . . 0.0 108.391 -178.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -101.67 118.96 6.31 Favored Glycine 0 CA--C 1.519 0.331 0 N-CA-C 107.846 -2.101 . . . . 0.0 107.846 169.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 44.7 mt -95.05 118.3 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 104.37 -2.456 . . . . 0.0 104.37 171.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -114.32 127.1 55.7 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 177.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -127.81 125.06 39.1 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 118.702 0.683 . . . . 0.0 112.017 -175.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -82.12 145.43 24.45 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 168.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.4 m -159.91 161.47 34.31 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 119.083 1.442 . . . . 0.0 109.844 175.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -138.74 -48.05 0.51 Allowed 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.037 0.935 . . . . 0.0 109.817 168.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.2 p -79.29 -13.52 59.6 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.486 0.714 . . . . 0.0 111.689 169.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.03 6.53 53.84 Favored Glycine 0 C--N 1.343 0.965 0 C-N-CA 124.767 1.175 . . . . 0.0 113.813 170.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -70.16 -38.4 75.43 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 118.769 1.284 . . . . 0.0 112.553 -169.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -69.83 -17.77 63.41 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 119.548 1.067 . . . . 0.0 111.383 -174.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -60.14 -41.21 92.22 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.185 0.902 . . . . 0.0 110.179 175.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -65.96 -39.89 90.81 Favored 'General case' 0 N--CA 1.463 0.195 0 O-C-N 121.924 -0.485 . . . . 0.0 110.106 178.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 27.2 mm -60.61 -49.05 85.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 176.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.16 -41.18 92.26 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.386 0.674 . . . . 0.0 111.702 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.9 mttm -67.11 -40.25 86.84 Favored 'General case' 0 N--CA 1.461 0.119 0 O-C-N 121.661 -0.65 . . . . 0.0 111.113 177.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 70.2 mtm -66.37 -31.95 73.04 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 119.504 1.047 . . . . 0.0 111.447 177.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.407 HG21 HD23 ' A' ' 51' ' ' LEU . 76.7 mt -65.81 -54.6 25.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 171.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -62.1 -37.03 83.54 Favored 'General case' 0 C--O 1.224 -0.251 0 CA-C-O 118.952 -0.546 . . . . 0.0 111.366 -173.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -63.68 -36.06 82.6 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 119.325 0.966 . . . . 0.0 110.91 -178.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -74.86 -41.36 59.96 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.131 0.573 . . . . 0.0 110.74 177.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.3 mp -73.99 -33.27 63.76 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 118.081 0.4 . . . . 0.0 111.23 -176.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 88.13 146.47 11.96 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 124.861 1.219 . . . . 0.0 110.763 -172.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -64.79 -29.61 70.59 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.875 0.87 . . . . 0.0 111.984 -172.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -67.53 -29.71 69.18 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 122.674 0.39 . . . . 0.0 111.07 177.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 22.8 t -93.47 -37.77 8.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 C-N-CA 123.921 0.888 . . . . 0.0 110.119 -175.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -135.58 144.05 45.97 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-N 119.3 0.955 . . . . 0.0 112.82 -176.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -128.53 153.18 47.46 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.565 1.146 . . . . 0.0 109.578 173.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 77.5 t -114.25 131.62 65.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 124.655 1.182 . . . . 0.0 110.263 -168.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 -144.63 166.5 25.01 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.645 1.578 . . . . 0.0 112.219 -169.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -130.63 129.42 42.67 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 127.088 2.155 . . . . 0.0 106.332 -178.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.4 tp -61.87 -19.62 21.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 123.64 0.776 . . . . 0.0 112.299 -171.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -58.39 -30.27 66.69 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 118.676 0.671 . . . . 0.0 112.461 -175.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 60.9 pttt -98.09 -6.42 31.71 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.755 0.822 . . . . 0.0 112.619 177.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 67.2 m -76.26 158.96 31.06 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.705 0.764 . . . . 0.0 111.444 -175.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 21.8 m -130.43 175.47 8.94 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.723 2.009 . . . . 0.0 107.145 172.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -51.61 -48.83 63.1 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 118.497 0.59 . . . . 0.0 111.654 -174.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -77.67 -12.62 59.99 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -172.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -68.47 -32.92 73.25 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 118.74 0.7 . . . . 0.0 110.824 -177.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -74.91 -42.46 57.75 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 123.603 0.761 . . . . 0.0 109.502 172.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -68.94 -19.54 64.18 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.633 0.773 . . . . 0.0 111.954 -170.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.57 -29.78 70.43 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.011 0.925 . . . . 0.0 112.433 176.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -86.21 160.46 19.19 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 124.292 1.037 . . . . 0.0 110.316 178.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -111.2 -24.26 10.38 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.596 0.758 . . . . 0.0 111.802 169.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.0 mp -117.02 131.92 68.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 174.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 79.8 mt -130.56 123.7 30.17 Favored 'General case' 0 CA--C 1.523 -0.08 0 C-N-CA 123.965 0.906 . . . . 0.0 109.363 -177.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.407 HD23 HG21 ' A' ' 22' ' ' ILE . 8.1 mp -109.6 107.74 17.93 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 176.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.9 mt -108.27 108.96 20.19 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -168.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -100.42 117.39 5.86 Favored Glycine 0 CA--C 1.518 0.245 0 C-N-CA 125.516 1.531 . . . . 0.0 109.709 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 15.5 tt -129.74 118.9 18.9 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 118.43 1.115 . . . . 0.0 110.627 -176.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -79.36 150.95 22.7 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.403 2.069 . . . . 0.0 110.289 173.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 17.3 m -100.68 137.07 39.57 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 175.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 66.8 m95 -137.25 173.8 11.3 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.782 1.633 . . . . 0.0 110.599 -173.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 54.49 -89.17 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 127.976 2.51 . . . . 0.0 113.246 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -151.02 62.12 0.91 Allowed 'General case' 0 C--O 1.237 0.417 0 C-N-CA 126.168 1.787 . . . . 0.0 107.89 -173.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 67.67 54.85 16.78 Favored Glycine 0 CA--C 1.53 1.003 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 -174.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -129.24 164.6 23.1 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.104 1.362 . . . . 0.0 108.642 175.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.36 164.29 22.24 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 121.221 0.534 . . . . 0.0 110.027 170.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -70.33 150.7 46.05 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 169.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 84.0 m -56.84 -33.35 66.7 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -168.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -69.26 -40.47 77.82 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 119.092 0.86 . . . . 0.0 110.687 -177.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -72.21 -41.49 66.86 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 174.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -60.0 -40.98 91.11 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 122.697 0.399 . . . . 0.0 111.39 -178.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -70.05 -21.07 63.21 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.092 0.957 . . . . 0.0 112.018 177.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -90.91 -19.16 23.63 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 118.7 -0.666 . . . . 0.0 112.316 -178.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -51.7 -41.72 79.61 Favored Pre-proline 0 CA--C 1.543 0.709 0 CA-C-O 116.389 -1.767 . . . . 0.0 114.666 178.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -62.4 -21.18 72.36 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 CA-C-N 122.909 2.075 . . . . 0.0 113.632 175.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.2 m -84.88 -41.97 15.49 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.454 1.025 . . . . 0.0 109.124 169.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.2 tp -56.47 -38.39 71.62 Favored 'General case' 0 C--N 1.341 0.219 0 C-N-CA 124.054 0.942 . . . . 0.0 111.177 -177.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -72.66 -2.8 21.52 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -109.86 -14.81 14.22 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.325 1.05 . . . . 0.0 111.622 173.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 74.5 mt -71.8 139.63 19.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -178.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -81.21 128.38 33.71 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.905 176.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -125.58 12.31 8.02 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.829 0.851 . . . . 0.0 111.737 172.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 42.8 m-80 -62.42 116.3 4.96 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 119.647 1.112 . . . . 0.0 109.385 -171.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.66 2.18 60.0 Favored Glycine 0 CA--C 1.534 1.239 0 CA-C-O 118.671 -1.072 . . . . 0.0 113.782 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 62.1 mttm -73.31 148.27 43.7 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 119.533 1.666 . . . . 0.0 107.714 171.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 60.9 mt -90.5 137.81 32.06 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 174.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.6 t -136.01 147.96 27.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 -178.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -140.18 144.23 36.51 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 169.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.9 mp -113.48 151.27 31.7 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 123.677 0.791 . . . . 0.0 109.512 -172.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 25.9 p90 -149.2 168.46 23.21 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 168.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.451 ' HA3' HD11 ' A' ' 102' ' ' LEU . . . 177.93 157.99 19.88 Favored Glycine 0 N--CA 1.449 -0.498 0 O-C-N 121.144 -0.973 . . . . 0.0 113.445 178.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 14.2 m -110.64 153.42 25.24 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 124.805 1.242 . . . . 0.0 109.268 -169.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -163.46 -166.54 22.45 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 178.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -152.61 118.69 5.49 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 124.898 1.279 . . . . 0.0 107.699 176.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -82.67 -34.15 27.5 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -169.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -56.33 -46.67 79.8 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 123.867 0.867 . . . . 0.0 111.648 -169.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -97.17 -42.6 7.76 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 118.601 0.637 . . . . 0.0 112.245 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 -91.94 44.72 1.18 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.958 0.903 . . . . 0.0 110.357 -172.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.33 -24.66 66.6 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.258 1.423 . . . . 0.0 113.421 -169.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -104.62 10.37 34.91 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.267 1.027 . . . . 0.0 112.75 178.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -135.62 16.86 3.35 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 124.939 1.296 . . . . 0.0 111.177 -178.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -66.41 124.45 22.77 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 121.159 -0.963 . . . . 0.0 110.518 -168.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 92.6 m 49.97 36.78 12.42 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.684 1.593 . . . . 0.0 113.058 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -59.93 -36.35 76.86 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.464 -0.772 . . . . 0.0 112.549 179.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.44 -24.81 67.75 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 -167.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.451 HD11 ' HA3' ' A' ' 87' ' ' GLY . 6.8 mp -61.57 -36.35 80.41 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 120.967 -1.083 . . . . 0.0 109.902 175.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.32 -31.22 78.51 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 123.706 0.669 . . . . 0.0 111.455 177.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.9 m -66.89 -36.67 82.82 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 121.858 -0.789 . . . . 0.0 110.533 179.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 15.7 mt -71.46 -49.16 49.0 Favored 'Isoleucine or valine' 0 C--N 1.343 0.318 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 174.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 18.3 tpt180 -50.15 -44.4 52.51 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.16 0.984 . . . . 0.0 111.052 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -60.87 -28.1 68.61 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.88 0.872 . . . . 0.0 112.643 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 97.0 mt -92.9 -46.09 14.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 124.351 1.06 . . . . 0.0 109.923 -178.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 32.6 pt -78.22 -23.09 13.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 O-C-N 121.23 -0.918 . . . . 0.0 111.931 -169.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -62.91 -58.06 18.38 Favored Pre-proline 0 CA--C 1.544 0.712 0 CA-C-O 117.412 -1.28 . . . . 0.0 111.629 177.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -65.8 -23.52 55.4 Favored 'Trans proline' 0 C--N 1.352 0.761 0 CA-C-N 121.708 1.646 . . . . 0.0 112.39 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 76.6 mmt-85 -79.66 6.26 11.13 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.211 1.004 . . . . 0.0 112.807 173.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 77.73 19.2 76.13 Favored Glycine 0 CA--C 1.528 0.876 0 CA-C-O 118.271 -1.294 . . . . 0.0 114.988 168.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.03 144.36 53.57 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 119.318 1.559 . . . . 0.0 110.09 169.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 42.2 m -97.45 124.99 41.84 Favored 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 105.01 -2.218 . . . . 0.0 105.01 167.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 20.8 mt -113.44 125.8 70.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -169.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 33.3 m -127.76 178.72 4.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 124.69 1.196 . . . . 0.0 109.21 174.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 79.77 27.64 53.29 Favored Glycine 0 CA--C 1.528 0.898 0 O-C-N 121.851 -0.531 . . . . 0.0 112.57 179.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 80.8 m-70 -62.0 141.58 57.98 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 170.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 71.5 t-105 -131.12 138.03 32.01 Favored Pre-proline 0 CA--C 1.537 0.446 0 C-N-CA 124.125 0.97 . . . . 0.0 109.5 -170.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -62.93 151.29 85.27 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 121.818 1.679 . . . . 0.0 112.985 -176.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 35.5 p -70.71 -25.45 62.96 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 121.852 -0.53 . . . . 0.0 111.515 171.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 54.19 40.3 31.55 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.166 1.786 . . . . 0.0 112.593 175.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 66.46 47.35 70.63 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 111.671 -0.571 . . . . 0.0 111.671 175.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -55.58 -45.15 77.43 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.091 0.556 . . . . 0.0 110.916 -178.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 18.0 m-70 54.65 32.98 18.28 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.664 1.986 . . . . 0.0 114.638 173.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -92.84 -173.5 3.33 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 167.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -67.56 -48.6 66.46 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.656 -0.653 . . . . 0.0 110.918 -170.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -161.89 118.98 2.14 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 123.493 0.717 . . . . 0.0 110.962 174.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 11.5 p -92.17 137.65 32.18 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 166.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -121.33 2.63 10.29 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.928 1.084 . . . . 0.0 113.928 -168.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -83.95 4.98 81.36 Favored Glycine 0 CA--C 1.534 1.269 0 CA-C-O 119.518 -0.601 . . . . 0.0 112.207 169.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 9.0 mp -62.23 135.26 57.4 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 118.969 1.385 . . . . 0.0 111.71 -177.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -97.05 -29.59 13.54 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.484 1.514 . . . . 0.0 109.313 167.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -146.82 167.68 23.29 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.149 1.78 . . . . 0.0 107.327 174.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -55.64 -25.89 41.44 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.12 1.368 . . . . 0.0 113.947 -169.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -122.45 11.71 9.99 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.85 1.26 . . . . 0.0 113.574 -178.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -141.14 125.72 17.81 Favored 'General case' 0 C--N 1.343 0.304 0 CA-C-N 119.362 0.983 . . . . 0.0 111.587 -176.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -71.54 150.17 45.04 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.333 1.053 . . . . 0.0 108.31 166.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 6.1 p -67.74 -8.6 8.98 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 123.98 0.912 . . . . 0.0 112.099 175.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -168.66 176.22 43.0 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 -172.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -70.73 103.12 2.48 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 -179.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -79.62 138.54 37.46 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 169.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 8.7 tp -127.83 109.66 20.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-N 119.414 1.006 . . . . 0.0 112.335 178.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -172.1 146.11 1.89 Allowed 'General case' 0 C--O 1.236 0.344 0 C-N-CA 128.215 2.606 . . . . 0.0 106.67 166.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -91.48 -48.89 6.62 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.648 0.658 . . . . 0.0 109.631 173.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -169.31 -52.37 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.166 1.386 . . . . 0.0 109.42 -175.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 12.5 tpp85 -141.79 86.98 2.02 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 104.944 -2.243 . . . . 0.0 104.944 177.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 43.1 mm-40 67.64 147.52 0.11 Allowed Pre-proline 0 CA--C 1.545 0.764 0 C-N-CA 127.311 2.244 . . . . 0.0 111.07 -168.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -68.97 153.64 72.16 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.336 2.024 . . . . 0.0 111.806 -178.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -120.36 -32.12 4.19 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.804 1.642 . . . . 0.0 110.337 173.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 66.7 mt -99.82 27.7 5.27 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.737 1.615 . . . . 0.0 110.203 -174.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 50.5 m -41.03 -53.41 3.01 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 128.175 2.59 . . . . 0.0 111.766 -177.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -76.62 -40.74 48.39 Favored 'General case' 0 N--CA 1.452 -0.357 0 O-C-N 122.264 -0.272 . . . . 0.0 111.001 -172.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -62.9 -47.28 84.0 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 117.993 0.36 . . . . 0.0 110.377 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 47.6 mtp180 -65.71 -39.54 91.3 Favored 'General case' 0 N--CA 1.464 0.249 0 O-C-N 121.932 -0.48 . . . . 0.0 110.325 -175.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 86.4 t -72.68 -37.47 55.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-O 118.226 -0.893 . . . . 0.0 109.899 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -62.05 -49.83 74.4 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 120.722 1.601 . . . . 0.0 110.245 174.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -62.72 -34.56 77.43 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 118.898 -0.572 . . . . 0.0 110.746 -176.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 40.2 t90 -71.79 -51.63 21.64 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 118.531 0.605 . . . . 0.0 110.384 176.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 68.9 t -64.44 -35.07 73.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 O-C-N 121.533 -0.729 . . . . 0.0 110.835 -172.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -63.45 -35.53 80.74 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.404 -0.81 . . . . 0.0 110.324 177.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 53.7 mm-40 -71.63 -48.39 48.23 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.552 0.741 . . . . 0.0 111.178 174.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 3.8 pt -63.72 -32.51 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-N 119.771 1.169 . . . . 0.0 110.362 -177.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 50.2 m -61.85 -33.68 74.61 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 118.309 -0.853 . . . . 0.0 111.505 -179.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -86.41 -24.66 25.64 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 120.227 1.376 . . . . 0.0 111.954 177.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -73.74 -37.61 65.01 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 118.683 0.674 . . . . 0.0 110.701 174.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 77.7 mt -89.97 -4.79 57.26 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.058 1.743 . . . . 0.0 111.484 -178.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 82.7 m-70 56.6 25.29 9.76 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.952 1.701 . . . . 0.0 113.195 -172.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 79.8 mt -74.88 -20.15 59.85 Favored 'General case' 0 N--CA 1.464 0.246 0 O-C-N 121.456 -0.778 . . . . 0.0 110.381 172.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -58.37 -40.77 83.18 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 118.788 0.722 . . . . 0.0 110.945 -179.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -71.9 -12.13 61.12 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 122.773 0.429 . . . . 0.0 112.123 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 28.6 mt -97.52 -47.37 12.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 124.755 1.222 . . . . 0.0 108.522 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 3.0 pp -73.34 -29.44 62.66 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 123.101 0.56 . . . . 0.0 111.326 -177.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -119.93 59.82 0.87 Allowed 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.71 1.604 . . . . 0.0 108.21 174.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.218 0 CA-C-O 118.426 -0.797 . . . . 0.0 109.234 174.07 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.3 tpt . . . . . 0 N--CA 1.488 1.459 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.14 153.33 32.21 Favored 'General case' 0 C--N 1.341 0.238 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 172.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 28.6 pt -80.68 -24.73 11.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 O-C-N 122.143 -0.348 . . . . 0.0 111.351 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.1 m -113.19 130.16 56.3 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.002 1.321 . . . . 0.0 108.771 178.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -102.76 124.68 8.24 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 107.974 -2.051 . . . . 0.0 107.974 169.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 27.3 mt -103.32 94.72 3.35 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 105.248 -2.131 . . . . 0.0 105.248 177.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -90.27 129.44 36.5 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 -177.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -122.43 123.47 41.4 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 119.806 1.185 . . . . 0.0 112.637 -176.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -82.51 141.72 21.42 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 106.391 -2.684 . . . . 0.0 106.391 165.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.1 m -161.85 171.33 17.93 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 119.939 1.87 . . . . 0.0 110.452 177.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -133.93 -50.67 0.83 Allowed 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.027 0.931 . . . . 0.0 109.817 169.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 81.9 p -92.41 5.0 52.31 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.021 0.928 . . . . 0.0 112.31 177.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 76.13 18.15 79.56 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 124.032 0.825 . . . . 0.0 113.317 -175.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -76.85 -47.19 22.07 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 119.263 1.532 . . . . 0.0 111.235 -176.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 72.8 m -74.06 -23.57 59.38 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 118.968 0.804 . . . . 0.0 109.974 178.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -56.09 -46.27 79.12 Favored 'General case' 0 C--N 1.342 0.248 0 O-C-N 121.385 -0.822 . . . . 0.0 109.616 169.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -64.95 -34.28 78.05 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 121.781 -0.574 . . . . 0.0 111.033 -177.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 45.4 mm -60.43 -44.1 95.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 172.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.61 -41.51 97.57 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.702 -0.624 . . . . 0.0 111.576 177.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 29.2 mmtp -64.14 -41.87 97.03 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 121.45 -0.782 . . . . 0.0 110.276 176.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 78.7 mtp -62.24 -40.6 96.72 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.399 1.0 . . . . 0.0 110.473 178.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 55.5 mt -60.62 -49.59 83.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 174.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -58.59 -38.15 77.32 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 121.233 -0.917 . . . . 0.0 111.417 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -63.63 -34.56 78.1 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 120.077 1.308 . . . . 0.0 111.246 -178.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -72.27 -40.6 67.5 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 118.371 0.532 . . . . 0.0 110.758 174.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -80.58 -34.22 35.47 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -171.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 84.3 144.61 6.48 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 -168.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 54.0 tttp -63.41 -30.93 71.97 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 121.912 -0.758 . . . . 0.0 111.975 -171.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -64.47 -30.98 72.01 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 122.85 0.46 . . . . 0.0 111.26 178.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.1 t -92.97 -39.96 11.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 123.502 0.721 . . . . 0.0 109.927 -176.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.22 137.44 32.59 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 118.92 0.782 . . . . 0.0 112.045 -178.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -129.23 144.71 51.32 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 176.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 59.7 t -90.32 134.78 28.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 123.871 0.868 . . . . 0.0 108.777 -170.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -147.12 169.19 19.81 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.886 1.274 . . . . 0.0 111.201 -168.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -138.31 128.33 25.56 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 125.173 1.389 . . . . 0.0 109.036 -169.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.3 tp -63.44 -29.84 48.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 CA-C-O 118.832 -0.604 . . . . 0.0 111.708 -173.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.52 -28.53 68.62 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 119.105 0.866 . . . . 0.0 110.318 -178.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -89.23 -27.14 20.81 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.172 1.389 . . . . 0.0 110.511 177.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 21.3 m -68.64 167.05 15.95 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 124.433 1.093 . . . . 0.0 111.801 -177.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.6 m -135.12 164.56 27.38 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.481 1.512 . . . . 0.0 108.932 178.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -53.17 -54.8 30.53 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.326 1.05 . . . . 0.0 111.45 -175.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -78.28 -15.96 58.24 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 122.312 0.245 . . . . 0.0 111.195 -175.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -74.32 -30.22 61.95 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 121.772 -0.58 . . . . 0.0 110.966 -179.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.7 mp -69.17 -43.51 74.12 Favored 'General case' 0 C--N 1.343 0.305 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 169.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -62.86 -17.41 61.44 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -177.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.15 -29.08 67.88 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.654 0.782 . . . . 0.0 112.289 176.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -82.29 155.99 24.53 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.195 0.998 . . . . 0.0 110.023 177.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -108.86 -26.48 10.24 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.111 0.564 . . . . 0.0 111.673 169.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.0 mp -113.81 127.89 70.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 174.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 96.3 mt -118.05 127.5 53.86 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 124.192 0.997 . . . . 0.0 108.436 177.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.2 mp -111.85 116.31 30.46 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 104.411 -2.44 . . . . 0.0 104.411 168.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 91.1 mt -115.23 109.08 17.44 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 -169.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.69 117.6 5.61 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 108.848 -1.701 . . . . 0.0 108.848 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 15.3 tt -135.91 105.29 9.7 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-N 118.731 1.266 . . . . 0.0 109.617 178.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -71.58 150.95 58.05 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 121.91 1.74 . . . . 0.0 109.635 170.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 29.3 m -99.19 139.27 35.08 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -179.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 47.5 m95 -135.7 172.79 12.5 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.86 1.264 . . . . 0.0 111.245 -170.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 53.87 -87.27 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 127.511 2.324 . . . . 0.0 112.958 176.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -149.69 80.01 1.38 Allowed 'General case' 0 C--O 1.235 0.31 0 C-N-CA 126.379 1.872 . . . . 0.0 106.847 174.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.71 16.96 76.32 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-O 119.575 -0.57 . . . . 0.0 113.306 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -91.99 161.8 14.65 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 118.54 1.17 . . . . 0.0 110.584 -175.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.27 161.56 28.65 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 123.915 0.886 . . . . 0.0 111.284 173.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 12.8 tm0? -64.57 146.4 54.69 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 168.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 56.3 m -56.45 -39.96 74.02 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 -167.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -77.33 -39.03 49.13 Favored 'General case' 0 C--N 1.333 -0.109 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -174.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -62.74 -44.95 94.88 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 172.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -58.98 -42.04 89.01 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.319 0.648 . . . . 0.0 111.358 178.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -69.33 -27.5 65.42 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.335 0.654 . . . . 0.0 112.336 176.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -88.32 -17.8 29.87 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.627 0.771 . . . . 0.0 112.629 -177.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -51.8 -40.45 70.97 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-O 116.426 -1.75 . . . . 0.0 115.349 -179.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -61.26 -30.21 87.71 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 CA-C-N 123.197 2.178 . . . . 0.0 112.701 173.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.7 m -75.23 -42.28 55.74 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.923 0.783 . . . . 0.0 109.446 172.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 12.3 tp -58.24 -37.62 75.25 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.126 0.97 . . . . 0.0 110.387 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -67.71 -11.64 58.77 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.55 1.14 . . . . 0.0 113.202 177.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -95.91 -17.91 20.71 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 119.803 1.183 . . . . 0.0 112.179 173.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 95.7 mt -76.38 143.59 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 -172.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -89.49 132.26 35.13 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 123.507 0.723 . . . . 0.0 109.691 175.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -124.62 6.08 8.21 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.913 0.885 . . . . 0.0 112.067 177.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -66.48 124.48 22.88 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 120.358 1.435 . . . . 0.0 110.378 -169.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.26 -0.94 58.26 Favored Glycine 0 CA--C 1.537 1.424 0 CA-C-O 118.433 -1.204 . . . . 0.0 114.277 -175.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -76.67 150.45 36.36 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 119.698 1.749 . . . . 0.0 108.408 173.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 66.9 mt -95.38 138.2 33.39 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 175.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 15.2 t -136.38 147.93 27.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -178.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -138.04 147.81 44.47 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 169.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -110.2 147.3 34.02 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 124.607 1.163 . . . . 0.0 108.607 -175.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -149.04 163.9 36.19 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 167.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 174.55 143.6 4.5 Favored Glycine 0 C--N 1.33 0.215 0 O-C-N 121.251 -0.906 . . . . 0.0 111.406 173.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 53.7 m -81.44 159.7 24.2 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 175.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.9 -167.63 27.89 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.403 -0.679 . . . . 0.0 111.403 -177.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -147.64 126.41 12.64 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 126.034 1.734 . . . . 0.0 107.994 176.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -106.89 2.38 25.32 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.328 1.051 . . . . 0.0 112.214 176.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -91.22 -46.32 8.14 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 119.24 0.927 . . . . 0.0 110.05 -173.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -105.58 -44.52 4.66 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.172 0.589 . . . . 0.0 110.493 178.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -82.75 40.91 0.7 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.551 1.141 . . . . 0.0 110.482 171.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.73 -21.86 64.87 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 127.002 2.121 . . . . 0.0 114.219 -170.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -103.26 7.81 38.39 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.173 1.389 . . . . 0.0 111.699 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -137.15 17.46 2.99 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.605 1.162 . . . . 0.0 111.387 -174.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -63.54 132.63 51.89 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 119.078 0.854 . . . . 0.0 109.363 -170.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . 0.258 23.0 p 52.05 22.98 2.03 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 127.357 2.263 . . . . 0.0 114.772 173.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -52.16 -41.54 62.67 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.851 1.261 . . . . 0.0 111.401 -175.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.35 -23.08 67.26 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -172.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 63.5 mt -61.39 -40.24 93.64 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 119.1 0.864 . . . . 0.0 109.621 175.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -68.19 -28.08 73.47 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 124.037 0.827 . . . . 0.0 111.591 -179.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.3 m -65.25 -37.12 86.22 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 118.243 1.021 . . . . 0.0 110.356 178.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 8.0 mt -71.25 -46.12 67.09 Favored 'Isoleucine or valine' 0 C--N 1.343 0.304 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 173.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 40.2 ttt180 -50.54 -46.11 57.29 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 118.858 0.754 . . . . 0.0 110.754 -177.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -61.87 -23.02 66.03 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.822 0.849 . . . . 0.0 113.025 -177.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 93.6 mt -92.21 -47.78 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 124.278 1.031 . . . . 0.0 109.268 178.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 30.0 pt -82.0 -36.77 14.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 118.989 0.813 . . . . 0.0 112.59 -168.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -68.19 -47.53 39.02 Favored Pre-proline 0 CA--C 1.54 0.575 0 CA-C-O 117.902 -1.047 . . . . 0.0 112.28 -170.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -68.66 -16.37 42.16 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 CA-C-N 121.532 1.583 . . . . 0.0 112.382 175.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 90.0 mtt-85 -91.51 20.29 5.48 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.736 1.214 . . . . 0.0 111.719 176.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 79.44 10.88 85.47 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 125.906 1.717 . . . . 0.0 115.023 168.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.45 137.76 58.1 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 119.649 1.724 . . . . 0.0 109.057 170.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 35.7 m -94.42 120.63 34.96 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 105.179 -2.156 . . . . 0.0 105.179 168.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 29.6 mt -99.2 132.62 44.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 -177.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 34.4 m -130.08 178.73 4.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 125.259 1.423 . . . . 0.0 108.812 172.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 77.14 28.11 58.9 Favored Glycine 0 C--N 1.335 0.523 0 CA-C-O 119.365 -0.686 . . . . 0.0 113.76 178.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 65.3 m80 -57.17 133.45 55.05 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 169.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 57.4 t-105 -115.61 135.78 22.7 Favored Pre-proline 0 CA--C 1.535 0.374 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -177.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.7 145.56 52.05 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 121.823 1.682 . . . . 0.0 111.754 -170.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 34.9 p -72.89 -29.09 62.88 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 122.963 0.505 . . . . 0.0 110.784 169.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 53.16 40.51 31.36 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.365 1.866 . . . . 0.0 110.738 -169.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 72.64 74.71 0.76 Allowed Glycine 0 C--N 1.341 0.839 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 -175.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -48.04 124.85 8.14 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.403 0.681 . . . . 0.0 109.427 171.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -100.0 -19.81 16.38 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -168.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -89.21 -171.63 3.33 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.791 0.836 . . . . 0.0 111.166 -169.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -60.82 -55.93 27.27 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -167.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -161.06 137.22 8.29 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 123.487 0.715 . . . . 0.0 110.908 175.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 1.6 p -109.74 142.82 40.41 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 168.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -121.51 -3.51 9.35 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 122.975 0.51 . . . . 0.0 112.264 -171.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -86.65 9.34 71.67 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 123.774 0.702 . . . . 0.0 111.815 167.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 95.3 mt -60.59 141.35 56.76 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 118.636 1.218 . . . . 0.0 110.889 177.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -108.74 -31.04 7.87 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.159 1.384 . . . . 0.0 108.89 167.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -146.4 162.48 38.13 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 127.869 2.468 . . . . 0.0 106.389 169.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -55.91 -29.05 59.44 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 119.27 0.941 . . . . 0.0 112.167 176.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -89.98 -11.5 41.45 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.295 1.038 . . . . 0.0 113.406 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 7.4 m-70 -149.48 131.52 15.32 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 119.742 1.155 . . . . 0.0 113.14 -169.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -75.02 158.98 32.32 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 167.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 12.4 p -61.69 -22.83 29.24 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 C-N-CA 123.227 0.611 . . . . 0.0 111.364 173.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -161.97 -172.26 29.15 Favored Glycine 0 C--N 1.337 0.636 0 O-C-N 121.514 -0.742 . . . . 0.0 111.798 -171.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.35 86.96 1.13 Allowed 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 124.755 1.222 . . . . 0.0 109.082 179.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -81.31 109.06 15.47 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 168.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . 0.275 18.2 tt -105.89 97.24 5.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-O 121.93 0.871 . . . . 0.0 110.582 -169.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -164.42 160.93 21.18 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 127.676 2.39 . . . . 0.0 106.543 169.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -143.53 -40.18 0.3 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.774 0.83 . . . . 0.0 111.153 175.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -159.4 104.98 1.66 Allowed 'General case' 0 C--O 1.234 0.281 0 C-N-CA 123.932 0.893 . . . . 0.0 108.688 175.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 1.1 tpm_? 65.79 -51.07 0.39 Allowed 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 127.867 2.467 . . . . 0.0 113.603 -174.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -145.61 154.07 51.89 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 126.841 2.056 . . . . 0.0 107.114 174.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -64.28 146.68 90.5 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 122.0 1.8 . . . . 0.0 110.277 172.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -131.51 -24.89 2.21 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.827 1.251 . . . . 0.0 111.705 174.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 88.8 mt -89.15 28.28 1.24 Allowed 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 125.235 1.414 . . . . 0.0 109.449 169.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 83.2 m -43.14 -52.18 5.6 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 127.409 2.284 . . . . 0.0 111.696 -174.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -72.89 -33.7 66.2 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 118.888 -0.577 . . . . 0.0 110.731 -170.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -65.74 -43.47 88.89 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 118.552 0.615 . . . . 0.0 110.223 174.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -59.64 -49.6 77.13 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 178.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 98.2 t -67.33 -45.7 85.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-O 118.179 -0.915 . . . . 0.0 109.434 -176.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -53.77 -51.63 62.81 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 119.306 0.957 . . . . 0.0 110.1 -178.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 42.0 mttp -70.44 -42.17 71.9 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-O 118.838 -0.601 . . . . 0.0 110.697 -175.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 69.2 t90 -63.89 -44.5 92.83 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-N 118.943 0.792 . . . . 0.0 109.727 -178.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 54.3 t -61.96 -40.15 86.2 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 O-C-N 122.075 -0.391 . . . . 0.0 110.015 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -64.39 -40.24 95.42 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 121.369 -0.832 . . . . 0.0 110.232 178.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 20.6 mm100 -64.5 -51.46 62.83 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.321 0.51 . . . . 0.0 110.903 177.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 14.4 pt -66.01 -32.41 58.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 119.476 1.035 . . . . 0.0 110.704 -176.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 58.4 m -62.78 -26.63 68.81 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 118.139 -0.934 . . . . 0.0 112.127 -177.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -90.55 -17.69 26.57 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 120.259 1.39 . . . . 0.0 112.477 174.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -80.61 -35.71 33.72 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.25 0.932 . . . . 0.0 110.454 171.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 75.2 mt -91.63 -7.29 50.48 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.613 1.965 . . . . 0.0 111.598 -178.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 30.6 m80 56.26 24.68 8.44 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 126.076 1.75 . . . . 0.0 113.359 -172.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 86.9 mt -74.45 -20.34 60.06 Favored 'General case' 0 N--CA 1.465 0.281 0 O-C-N 121.771 -0.581 . . . . 0.0 110.387 172.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -59.23 -41.23 88.21 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 118.867 0.758 . . . . 0.0 110.785 -178.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -72.3 -8.66 56.1 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.487 0.715 . . . . 0.0 111.992 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 48.0 mt -103.96 -46.66 10.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 124.932 1.293 . . . . 0.0 108.749 -179.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.4 pp -71.97 -30.5 65.34 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.235 0.614 . . . . 0.0 111.171 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -121.82 58.65 1.01 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.674 1.59 . . . . 0.0 107.93 175.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.311 0 C-N-CA 123.302 0.641 . . . . 0.0 109.376 174.201 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.4 mtp . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 120.627 0.251 . . . . 0.0 110.586 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.94 163.01 26.95 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 169.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.5 pt -83.81 -24.77 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 O-C-N 121.958 -0.464 . . . . 0.0 111.476 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 17.3 m -112.08 131.48 55.41 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.216 1.406 . . . . 0.0 108.732 177.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -107.0 121.87 6.71 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 108.374 -1.891 . . . . 0.0 108.374 170.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 52.5 mt -99.85 100.66 10.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 177.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -97.55 124.36 41.77 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 17.8 p90 -124.41 127.6 47.78 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 119.111 0.869 . . . . 0.0 112.131 -177.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -84.14 143.52 21.23 Favored Glycine 0 C--N 1.341 0.819 0 N-CA-C 110.316 -1.114 . . . . 0.0 110.316 168.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.6 m -160.38 159.26 30.87 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 118.895 1.348 . . . . 0.0 110.739 173.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -135.6 -47.64 0.69 Allowed 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.288 1.035 . . . . 0.0 109.851 169.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.4 p -80.12 -12.38 59.67 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.555 0.742 . . . . 0.0 111.954 170.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.9 7.96 54.71 Favored Glycine 0 C--N 1.342 0.869 0 C-N-CA 124.732 1.158 . . . . 0.0 113.449 170.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -69.76 -41.79 74.71 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 118.82 1.31 . . . . 0.0 112.442 -169.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.4 m -70.02 -18.01 63.29 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 119.408 1.004 . . . . 0.0 111.27 -172.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -58.23 -42.84 87.2 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 119.116 0.871 . . . . 0.0 110.166 174.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -65.8 -38.41 88.91 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 121.915 -0.491 . . . . 0.0 110.485 -178.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 36.9 mm -65.1 -47.52 87.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 176.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.0 -38.27 85.45 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.183 0.593 . . . . 0.0 111.575 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.0 mtpt -68.22 -44.69 75.18 Favored 'General case' 0 N--CA 1.463 0.188 0 O-C-N 121.643 -0.661 . . . . 0.0 110.594 176.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 75.5 mtm -66.85 -22.72 65.98 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.352 0.978 . . . . 0.0 111.946 178.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 68.3 mt -71.31 -59.07 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 168.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -55.16 -42.19 72.81 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 118.382 -0.818 . . . . 0.0 112.349 -174.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -58.94 -32.04 69.23 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 119.65 1.114 . . . . 0.0 111.903 -175.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -75.27 -39.6 59.58 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.062 0.545 . . . . 0.0 111.538 178.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -79.39 -35.4 40.76 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 118.652 0.66 . . . . 0.0 111.508 -177.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 88.09 146.1 11.43 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 124.778 1.18 . . . . 0.0 110.353 -169.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 55.5 tttp -63.37 -31.95 73.24 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 121.953 -0.733 . . . . 0.0 112.117 -169.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -66.24 -29.14 69.33 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 122.955 0.502 . . . . 0.0 111.397 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 39.0 t -92.56 -39.67 11.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 123.878 0.871 . . . . 0.0 109.582 -177.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -140.15 132.85 28.93 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 119.241 0.928 . . . . 0.0 111.513 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -125.05 149.7 47.52 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 175.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 60.5 t -97.83 138.98 21.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 124.595 1.158 . . . . 0.0 110.101 -168.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -149.63 172.39 15.13 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.948 1.299 . . . . 0.0 111.512 -173.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -137.74 132.17 32.39 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 125.647 1.579 . . . . 0.0 108.032 -174.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.5 tp -65.8 -27.03 40.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-O 118.581 -0.723 . . . . 0.0 112.927 -168.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.11 -30.44 68.72 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 119.221 0.919 . . . . 0.0 110.297 178.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 43.8 mtmt -81.03 -31.36 34.6 Favored 'General case' 0 C--N 1.342 0.244 0 C-N-CA 123.252 0.621 . . . . 0.0 110.421 174.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.7 m -70.43 169.51 13.88 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.522 1.129 . . . . 0.0 111.654 -172.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 14.8 m -135.3 160.96 36.77 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.146 1.379 . . . . 0.0 108.733 178.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 45.2 tttm -53.6 -51.75 62.02 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.78 0.832 . . . . 0.0 111.042 -174.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.2 mp0 -73.82 -14.32 61.08 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 119.343 -0.361 . . . . 0.0 111.683 -175.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -71.71 -39.39 70.19 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 119.487 1.04 . . . . 0.0 110.675 -178.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 8.3 mp -66.22 -31.83 72.89 Favored 'General case' 0 C--N 1.343 0.315 0 C-N-CA 122.375 0.27 . . . . 0.0 110.361 173.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -70.15 -20.93 63.12 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 119.178 -0.439 . . . . 0.0 111.612 -176.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.61 -30.3 61.62 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.622 0.769 . . . . 0.0 112.559 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -76.36 151.78 36.53 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 123.681 0.792 . . . . 0.0 109.928 177.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -100.12 -31.43 11.42 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 122.709 0.404 . . . . 0.0 111.338 170.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.1 mp -110.52 128.77 66.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 175.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 96.2 mt -114.17 128.33 56.32 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 172.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.2 mp -110.27 115.81 30.36 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 105.345 -2.095 . . . . 0.0 105.345 169.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 85.8 mt -115.92 109.7 17.95 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 -169.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -100.26 119.15 6.41 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 125.966 1.746 . . . . 0.0 109.85 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.6 tt -132.74 123.85 18.5 Favored Pre-proline 0 CA--C 1.541 0.605 0 CA-C-N 118.906 1.353 . . . . 0.0 112.15 -173.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -85.59 157.09 10.6 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 123.042 2.495 . . . . 0.0 110.658 170.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.0 m -112.32 142.08 45.26 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 175.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 75.2 m95 -140.95 171.29 14.28 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.11 1.764 . . . . 0.0 111.074 -169.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 36.2 t80 50.83 -89.59 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 127.648 2.379 . . . . 0.0 112.569 -177.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -149.7 84.15 1.41 Allowed 'General case' 0 C--O 1.235 0.303 0 C-N-CA 126.652 1.981 . . . . 0.0 106.215 173.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 73.58 13.44 80.22 Favored Glycine 0 CA--C 1.534 1.235 0 CA-C-O 119.203 -0.776 . . . . 0.0 114.088 177.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -84.59 161.99 19.95 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.625 1.212 . . . . 0.0 108.915 174.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -84.95 175.1 9.28 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 166.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.4 142.44 56.95 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 168.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 58.6 m -57.61 -36.47 71.82 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 119.311 0.959 . . . . 0.0 112.998 -169.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -72.53 -28.51 62.9 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.133 0.573 . . . . 0.0 111.908 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -79.91 -41.83 25.35 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.649 1.179 . . . . 0.0 109.468 176.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -59.7 -42.21 92.47 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.564 1.146 . . . . 0.0 110.689 176.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -62.22 -19.63 63.37 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.0 0.92 . . . . 0.0 112.525 177.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -90.4 -15.31 31.24 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 118.252 -0.88 . . . . 0.0 112.294 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -54.15 -42.87 95.87 Favored Pre-proline 0 CA--C 1.541 0.632 0 CA-C-N 120.992 1.724 . . . . 0.0 113.963 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -63.14 -21.96 72.77 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 CA-C-N 122.523 1.937 . . . . 0.0 113.397 174.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.2 m -82.25 -38.8 23.91 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.462 1.028 . . . . 0.0 109.702 171.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 14.0 tp -59.02 -40.69 85.76 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.312 1.045 . . . . 0.0 109.941 -176.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -75.63 4.15 8.26 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 178.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -105.38 -16.42 14.75 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.288 1.035 . . . . 0.0 111.111 169.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 96.7 mt -75.28 140.53 17.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 179.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -88.92 131.42 35.14 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 123.543 0.737 . . . . 0.0 109.524 174.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -121.51 8.01 10.12 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.86 0.864 . . . . 0.0 111.952 177.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 29.6 m-80 -58.72 116.45 3.73 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 119.814 1.188 . . . . 0.0 109.835 -172.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.58 1.92 67.48 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-O 118.571 -1.127 . . . . 0.0 114.283 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -74.25 150.84 40.07 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 119.674 1.737 . . . . 0.0 108.581 172.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 23.8 mt -92.04 137.59 32.24 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 172.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 19.7 t -134.28 144.07 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 177.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -137.65 145.94 43.28 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 171.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.2 mp -116.34 150.23 38.02 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 123.102 0.561 . . . . 0.0 109.646 -171.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -144.27 162.86 35.33 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 167.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -171.32 168.02 41.14 Favored Glycine 0 N--CA 1.452 -0.299 0 O-C-N 120.773 -1.204 . . . . 0.0 112.778 -176.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 21.3 m -133.28 151.6 51.9 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.569 1.148 . . . . 0.0 109.223 -168.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -178.35 -174.41 44.59 Favored Glycine 0 CA--C 1.528 0.857 0 CA-C-O 121.022 0.235 . . . . 0.0 112.57 -177.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -145.4 153.2 40.95 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 128.247 2.619 . . . . 0.0 106.952 175.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.9 12.8 3.38 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.182 1.393 . . . . 0.0 111.79 -173.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -68.47 -47.5 66.94 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 177.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -106.33 -38.72 6.13 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 123.395 0.678 . . . . 0.0 111.341 175.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -84.45 39.99 0.76 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.548 1.139 . . . . 0.0 111.404 -172.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.45 -19.83 65.8 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.266 1.027 . . . . 0.0 113.126 -171.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -93.11 0.31 57.22 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.476 1.11 . . . . 0.0 111.921 175.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -139.04 20.72 2.63 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.657 1.183 . . . . 0.0 111.573 -169.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -66.24 119.66 11.9 Favored 'General case' 0 C--O 1.235 0.32 0 O-C-N 121.122 -0.986 . . . . 0.0 108.925 -172.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 67.3 m 49.01 35.03 6.17 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.848 1.659 . . . . 0.0 112.581 -174.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -52.22 -41.21 62.54 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.815 1.246 . . . . 0.0 112.061 -171.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.53 -18.09 64.51 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -169.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 39.5 mt -54.58 -42.78 71.47 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.718 0.807 . . . . 0.0 110.137 171.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.69 -34.17 89.2 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 -179.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.2 m -64.91 -36.37 84.14 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 117.959 0.88 . . . . 0.0 110.864 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 8.1 mt -67.97 -51.18 52.08 Favored 'Isoleucine or valine' 0 C--N 1.345 0.392 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 173.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 60.3 ttp85 -55.17 -44.3 75.1 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 119.514 1.052 . . . . 0.0 110.488 -175.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -58.81 -21.46 56.37 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.793 0.837 . . . . 0.0 112.683 -177.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 96.7 mt -96.34 -51.38 10.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 124.325 1.05 . . . . 0.0 109.728 176.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 31.9 pt -74.64 -32.49 29.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-N 119.674 1.124 . . . . 0.0 111.762 -169.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -67.46 -54.2 19.63 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-O 117.61 -1.186 . . . . 0.0 112.069 -174.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -66.28 -23.23 52.19 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 CA-C-N 121.483 1.565 . . . . 0.0 112.024 176.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 60.5 mtp85 -85.62 16.67 3.73 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.014 0.926 . . . . 0.0 112.319 177.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 82.19 14.4 76.91 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-O 118.157 -1.357 . . . . 0.0 116.146 166.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.68 144.45 57.02 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 119.59 1.695 . . . . 0.0 109.807 170.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 74.9 m -96.87 121.36 38.65 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 167.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 34.9 mt -102.04 128.37 54.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 -173.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 32.7 m -128.79 178.09 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 125.658 1.583 . . . . 0.0 108.72 175.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 74.57 28.91 62.46 Favored Glycine 0 CA--C 1.525 0.7 0 O-C-N 121.426 -0.796 . . . . 0.0 113.213 -179.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 80.2 m-70 -61.98 140.92 58.3 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 169.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 68.3 t-105 -129.47 135.29 27.33 Favored Pre-proline 0 CA--C 1.535 0.382 0 C-N-CA 124.042 0.937 . . . . 0.0 108.866 -173.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -65.72 143.87 75.84 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 121.974 1.783 . . . . 0.0 112.182 -170.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 57.5 p -76.14 -30.67 58.26 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.679 0.792 . . . . 0.0 111.199 177.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 52.78 39.52 28.89 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.182 1.793 . . . . 0.0 112.052 -178.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 67.54 56.15 12.56 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 16.7 p90 -54.24 -40.23 67.53 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.542 0.737 . . . . 0.0 112.111 -174.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 37.3 t60 53.57 47.7 23.34 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.925 1.69 . . . . 0.0 114.39 169.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -110.36 172.96 6.56 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.039 0.935 . . . . 0.0 108.58 166.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -61.46 -45.1 95.67 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 118.956 -0.545 . . . . 0.0 111.541 -168.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -161.06 141.93 11.44 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 123.406 0.682 . . . . 0.0 110.572 169.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 50.3 m -128.39 125.98 39.71 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 106.66 -1.608 . . . . 0.0 106.66 169.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.73 -6.36 46.33 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 121.774 -0.579 . . . . 0.0 111.915 -174.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -77.56 6.21 47.18 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.158 0.885 . . . . 0.0 113.433 173.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 93.5 mt -65.35 139.47 58.58 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 119.754 1.777 . . . . 0.0 109.864 176.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -106.14 -32.21 8.34 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.376 1.47 . . . . 0.0 108.184 167.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -146.45 161.78 39.68 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 128.143 2.577 . . . . 0.0 106.063 169.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -56.36 -29.44 61.4 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 121.108 -0.995 . . . . 0.0 112.276 176.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -90.29 -10.74 43.05 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.091 0.956 . . . . 0.0 113.448 179.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -144.81 124.74 13.49 Favored 'General case' 0 C--N 1.345 0.408 0 CA-C-N 119.862 1.21 . . . . 0.0 112.985 -171.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -73.17 153.24 40.8 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 166.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 8.4 p -64.84 -18.83 24.31 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 124.206 1.002 . . . . 0.0 112.081 178.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -161.36 176.02 37.93 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 -169.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -74.15 92.8 2.23 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -79.4 119.4 22.38 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 169.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 9.1 pt -74.99 164.61 3.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 169.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 32.0 t0 65.19 166.81 0.18 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.254 1.421 . . . . 0.0 112.164 -169.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -153.48 -42.4 0.09 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 127.065 2.146 . . . . 0.0 107.186 176.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -154.14 117.6 4.6 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 124.36 1.064 . . . . 0.0 109.472 170.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 3.3 tpm_? 49.29 66.75 1.02 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.966 2.106 . . . . 0.0 112.849 171.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 66.55 138.8 0.05 OUTLIER Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 128.525 2.73 . . . . 0.0 113.297 -178.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -70.25 153.02 67.04 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 123.198 2.598 . . . . 0.0 112.815 -173.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -111.65 -11.45 14.01 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.158 0.983 . . . . 0.0 111.46 169.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 72.5 mt -117.42 18.22 14.4 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.588 1.155 . . . . 0.0 112.166 -168.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 41.2 m -46.57 -57.53 4.66 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 125.561 1.544 . . . . 0.0 111.999 -170.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -71.03 -30.32 66.48 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 122.529 0.332 . . . . 0.0 111.237 -169.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -68.26 -46.68 69.76 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 173.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -66.98 -39.2 87.11 Favored 'General case' 0 N--CA 1.463 0.18 0 O-C-N 121.738 -0.601 . . . . 0.0 111.576 -174.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 29.0 m -71.2 -23.18 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 119.127 0.876 . . . . 0.0 111.378 177.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -74.24 -52.84 11.15 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 120.14 1.336 . . . . 0.0 109.16 170.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -58.24 -43.53 87.82 Favored 'General case' 0 N--CA 1.462 0.169 0 O-C-N 122.17 -0.331 . . . . 0.0 110.934 -175.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 58.5 t90 -67.62 -46.71 71.72 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 118.199 0.454 . . . . 0.0 110.039 -176.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 67.9 t -63.49 -38.57 82.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 O-C-N 122.015 -0.428 . . . . 0.0 110.044 -178.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -66.53 -37.02 84.1 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.368 -0.833 . . . . 0.0 110.266 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 17.8 mm100 -66.53 -51.8 52.66 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.371 0.532 . . . . 0.0 110.917 175.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 15.5 pt -65.85 -29.24 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-N 119.469 1.032 . . . . 0.0 110.8 -176.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 70.6 m -58.9 -26.62 64.47 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 117.79 -1.1 . . . . 0.0 112.386 178.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -96.31 -9.57 29.87 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 120.341 1.428 . . . . 0.0 112.769 175.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -85.16 -39.72 17.55 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 119.138 0.881 . . . . 0.0 110.0 169.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 80.5 mt -87.28 -10.98 50.95 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.836 2.054 . . . . 0.0 111.531 -179.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 55.67 32.66 19.76 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.955 1.702 . . . . 0.0 112.535 -171.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 81.2 mt -75.6 -21.57 57.67 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.804 -0.56 . . . . 0.0 110.069 169.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -57.59 -38.54 75.06 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.514 0.726 . . . . 0.0 110.406 174.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -66.86 -10.38 47.66 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 121.62 -0.675 . . . . 0.0 112.55 178.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 39.8 mt -105.66 -54.74 6.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 125.104 1.361 . . . . 0.0 108.079 -178.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.2 pp -78.14 -24.12 47.5 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 122.959 0.503 . . . . 0.0 112.278 -173.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -127.0 39.91 3.82 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.601 1.96 . . . . 0.0 108.948 -174.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.388 0 C-N-CA 123.751 0.82 . . . . 0.0 109.466 174.486 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 120.624 0.249 . . . . 0.0 110.561 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.02 153.33 43.96 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.076 0.55 . . . . 0.0 109.728 172.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 31.6 pt -85.73 -23.64 7.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 122.413 0.285 . . . . 0.0 111.592 -177.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 11.7 m -109.36 128.11 54.85 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 125.235 1.414 . . . . 0.0 108.858 179.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -103.55 122.02 7.29 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 106.927 -2.469 . . . . 0.0 106.927 168.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 57.6 mt -100.99 92.35 2.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 N-CA-C 105.144 -2.169 . . . . 0.0 105.144 177.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -88.6 132.17 34.65 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 -178.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -130.06 133.28 46.6 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 119.521 1.055 . . . . 0.0 111.617 176.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -88.02 145.5 19.27 Favored Glycine 0 C--N 1.339 0.726 0 N-CA-C 108.384 -1.886 . . . . 0.0 108.384 171.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -159.47 176.35 12.2 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 119.446 1.623 . . . . 0.0 112.903 179.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -146.8 -47.22 0.18 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.944 2.098 . . . . 0.0 108.802 168.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 35.8 p -84.01 -15.86 46.07 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.14 0.976 . . . . 0.0 112.606 177.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 79.62 18.9 72.23 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-O 118.823 -0.987 . . . . 0.0 112.61 -174.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -74.16 -40.52 62.53 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.628 1.714 . . . . 0.0 110.182 178.343 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -62.27 -25.78 68.03 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.457 1.103 . . . . 0.0 111.827 177.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -59.53 -42.61 92.7 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 118.729 0.695 . . . . 0.0 110.222 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -67.7 -34.39 76.79 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 121.828 -0.545 . . . . 0.0 110.459 -179.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.6 mm -64.5 -46.92 91.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 175.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.77 -41.91 92.12 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 122.982 0.513 . . . . 0.0 111.042 178.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -63.38 -42.74 98.84 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 119.03 -0.51 . . . . 0.0 110.891 176.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 72.6 mtm -68.65 -27.78 66.3 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 119.175 0.898 . . . . 0.0 111.695 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 54.2 mt -69.8 -51.23 42.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 170.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -60.54 -41.41 94.4 Favored 'General case' 0 C--O 1.225 -0.22 0 O-C-N 121.688 -0.633 . . . . 0.0 111.404 -175.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.37 -38.27 86.37 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 118.86 0.755 . . . . 0.0 110.699 -177.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -74.52 -37.3 63.12 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 122.879 0.472 . . . . 0.0 111.091 178.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.7 mp -74.29 -34.62 63.58 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.311 0.505 . . . . 0.0 111.198 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.59 145.08 16.61 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 125.157 1.36 . . . . 0.0 110.511 -173.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -65.59 -30.16 70.86 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.679 0.792 . . . . 0.0 112.155 -172.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -68.05 -29.47 68.45 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 122.1 -0.375 . . . . 0.0 110.887 177.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 38.9 t -91.69 -36.72 8.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 C-N-CA 124.413 1.085 . . . . 0.0 110.096 -175.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -136.55 145.78 45.41 Favored 'General case' 0 C--N 1.34 0.183 0 CA-C-N 119.366 0.985 . . . . 0.0 113.283 -172.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -131.49 141.58 49.79 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.61 1.164 . . . . 0.0 109.889 174.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 83.3 t -89.24 139.44 17.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 124.002 0.921 . . . . 0.0 109.107 -178.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -149.45 173.35 13.66 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.449 1.1 . . . . 0.0 111.425 -168.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -147.96 121.43 9.09 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 125.926 1.691 . . . . 0.0 108.081 -172.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.2 tp -60.14 -22.24 24.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 123.819 0.848 . . . . 0.0 112.267 -171.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.84 -27.91 67.04 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 118.848 0.749 . . . . 0.0 111.251 178.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt -87.69 -21.25 25.33 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.244 1.018 . . . . 0.0 111.481 178.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 70.8 m -74.91 168.79 19.24 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.6 1.16 . . . . 0.0 112.359 -169.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 68.9 m -156.58 178.33 10.45 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.32 2.248 . . . . 0.0 106.995 177.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 27.4 tptp -50.42 -46.79 56.61 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.814 0.845 . . . . 0.0 111.997 -175.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -80.19 -11.6 59.72 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -173.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -76.76 -43.03 38.67 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 121.531 -0.731 . . . . 0.0 111.464 -172.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.7 mp -75.72 -28.74 58.68 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 118.033 0.379 . . . . 0.0 111.121 178.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -63.48 -18.1 63.43 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.91 0.884 . . . . 0.0 111.422 -177.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.21 -29.59 65.33 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.316 1.046 . . . . 0.0 112.728 177.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -89.18 156.84 18.54 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.346 1.058 . . . . 0.0 110.472 -175.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -107.64 -27.12 10.52 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.621 171.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.0 mp -116.76 130.37 71.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 175.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -113.88 116.55 29.48 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 177.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -103.16 112.45 25.32 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 104.623 -2.362 . . . . 0.0 104.623 171.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.4 mt -117.18 107.68 14.76 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -170.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -90.78 105.11 3.23 Favored Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 178.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.9 tp -115.87 102.59 53.99 Favored Pre-proline 0 CA--C 1.536 0.405 0 C-N-CA 125.024 1.33 . . . . 0.0 108.86 -174.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -72.85 143.14 36.42 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 121.289 1.326 . . . . 0.0 108.675 169.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 50.0 m -90.95 137.37 32.42 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 173.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 45.2 m95 -132.98 175.87 8.99 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 125.948 1.699 . . . . 0.0 108.896 -177.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 42.54 48.18 4.57 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.844 2.058 . . . . 0.0 114.092 168.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.3 p90 48.3 66.7 0.99 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.221 1.408 . . . . 0.0 111.963 176.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 87.89 52.54 2.92 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 124.303 0.954 . . . . 0.0 111.701 175.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -143.55 164.27 30.85 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.032 1.333 . . . . 0.0 108.777 174.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -82.84 161.38 21.95 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 167.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -62.42 149.21 43.17 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 168.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 65.9 m -56.74 -36.13 69.41 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.007 0.923 . . . . 0.0 113.144 -168.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -68.85 -38.05 79.52 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 118.894 0.77 . . . . 0.0 110.756 -177.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -69.82 -46.5 65.51 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 175.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -58.52 -39.93 81.5 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 122.717 0.407 . . . . 0.0 111.65 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -68.77 -23.44 64.31 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 123.924 0.889 . . . . 0.0 112.169 177.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -95.35 -20.12 19.39 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.452 0.701 . . . . 0.0 112.328 -178.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 21.5 m-30 -49.94 -40.47 54.76 Favored Pre-proline 0 CA--C 1.544 0.746 0 CA-C-O 116.656 -1.64 . . . . 0.0 114.47 176.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -63.78 -26.83 67.85 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 CA-C-N 123.032 2.119 . . . . 0.0 113.094 174.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.4 m -78.32 -35.11 48.15 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 119.576 1.08 . . . . 0.0 109.661 171.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 16.8 tp -63.36 -27.46 69.33 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 121.185 -0.947 . . . . 0.0 111.495 -176.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -87.67 -0.12 56.46 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.974 0.91 . . . . 0.0 112.964 174.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -96.33 -36.07 11.0 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 119.384 0.993 . . . . 0.0 108.469 169.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 68.0 mt -61.34 133.66 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -85.31 136.87 33.3 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 123.387 0.675 . . . . 0.0 109.545 176.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -129.14 18.32 6.01 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.97 0.908 . . . . 0.0 110.818 175.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -58.55 112.42 1.59 Allowed 'General case' 0 C--N 1.341 0.196 0 CA-C-N 120.373 1.442 . . . . 0.0 109.925 -176.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.37 1.57 57.67 Favored Glycine 0 CA--C 1.535 1.309 0 CA-C-O 118.599 -1.111 . . . . 0.0 114.207 -178.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -75.0 154.9 37.85 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 119.971 1.886 . . . . 0.0 107.689 170.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 27.2 mt -95.63 141.88 28.6 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.0 t -135.52 144.03 35.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 176.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -141.33 146.19 36.4 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 125.105 1.362 . . . . 0.0 107.343 172.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 68.8 mt -119.59 144.98 46.8 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 -170.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -143.54 165.89 26.32 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 123.608 0.763 . . . . 0.0 109.161 170.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -175.26 164.62 35.19 Favored Glycine 0 CA--C 1.521 0.418 0 CA-C-O 122.342 0.968 . . . . 0.0 112.623 179.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 38.1 m -115.89 159.25 21.8 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 125.725 1.61 . . . . 0.0 107.765 175.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -149.17 -164.18 11.44 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 175.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -148.81 153.05 37.57 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 117.639 0.719 . . . . 0.0 110.463 174.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -113.88 -1.86 13.76 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -168.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -70.79 -42.84 69.8 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 119.577 1.08 . . . . 0.0 110.669 -177.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -136.48 -32.77 0.83 Allowed 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -177.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -85.25 18.24 2.71 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -174.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.75 -14.29 62.83 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -174.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -89.93 0.13 57.25 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.074 0.95 . . . . 0.0 111.456 173.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -132.44 26.05 4.45 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 126.237 1.815 . . . . 0.0 109.303 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -64.92 121.09 13.82 Favored 'General case' 0 N--CA 1.452 -0.356 0 O-C-N 121.671 -0.643 . . . . 0.0 110.271 -168.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 74.5 m 48.42 34.29 4.63 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.363 1.865 . . . . 0.0 113.608 -177.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -54.42 -38.6 66.45 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.136 0.974 . . . . 0.0 113.132 -177.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.27 -12.53 61.65 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -170.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 52.2 mt -57.32 -40.64 78.34 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 118.67 0.668 . . . . 0.0 109.691 169.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -63.78 -31.62 81.4 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 123.591 0.615 . . . . 0.0 111.707 -179.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.6 m -65.77 -44.62 85.26 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 117.97 0.885 . . . . 0.0 109.905 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 4.3 mt -69.95 -40.9 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 119.029 0.832 . . . . 0.0 109.207 178.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 51.9 tpt85 -56.85 -33.24 66.6 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 118.469 0.577 . . . . 0.0 111.729 177.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -74.23 -33.76 63.46 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.242 0.617 . . . . 0.0 111.852 176.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 75.8 mt -79.34 -43.57 23.79 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 123.567 0.747 . . . . 0.0 110.629 -175.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 6.1 pt -76.8 -21.06 14.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 118.773 0.715 . . . . 0.0 112.923 -168.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -62.39 -56.66 28.43 Favored Pre-proline 0 CA--C 1.544 0.718 0 CA-C-O 117.604 -1.189 . . . . 0.0 112.273 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -66.71 -16.48 50.52 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 122.339 2.026 . . . . 0.0 112.915 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 19.4 mmm180 -84.6 4.04 34.08 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.409 0.684 . . . . 0.0 112.018 172.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 79.46 16.45 77.94 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 124.583 1.087 . . . . 0.0 113.953 170.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.32 146.68 47.22 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 118.551 1.175 . . . . 0.0 111.423 177.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 67.8 m -96.92 126.84 42.35 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 104.583 -2.377 . . . . 0.0 104.583 167.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 19.9 mt -113.18 131.6 64.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 -168.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 31.0 m -136.49 -177.87 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 124.725 1.21 . . . . 0.0 109.501 177.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 81.75 39.5 11.92 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-O 119.48 -0.622 . . . . 0.0 113.577 172.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 25.5 m170 -64.52 158.11 24.99 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.438 1.119 . . . . 0.0 109.718 169.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 43.8 t-105 -135.81 135.07 21.13 Favored Pre-proline 0 CA--C 1.536 0.433 0 CA-C-O 117.955 -1.021 . . . . 0.0 108.923 173.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_exo -65.68 145.93 82.75 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 121.781 1.654 . . . . 0.0 113.366 -175.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 36.2 p -71.97 -35.59 69.59 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 121.684 -0.635 . . . . 0.0 109.819 169.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 51.7 43.98 29.54 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.082 1.753 . . . . 0.0 111.923 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 69.9 54.75 10.9 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -61.1 154.54 22.7 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 122.861 0.464 . . . . 0.0 110.822 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 43.9 t60 -134.57 44.99 2.61 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.789 0.836 . . . . 0.0 110.604 -172.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -106.01 166.48 10.47 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.653 1.181 . . . . 0.0 108.156 173.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -67.12 -45.85 75.89 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 121.954 -0.466 . . . . 0.0 110.67 -170.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -160.65 114.25 2.08 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.994 0.917 . . . . 0.0 109.176 169.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 75.1 m -87.98 125.77 34.71 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 170.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -101.7 -9.65 20.68 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.087 0.555 . . . . 0.0 112.329 -176.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -77.35 -2.21 78.53 Favored Glycine 0 CA--C 1.537 1.435 0 CA-C-N 118.763 0.71 . . . . 0.0 113.529 173.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 8.5 mp -58.31 133.14 55.43 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 119.027 1.413 . . . . 0.0 110.558 174.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -95.64 -31.41 13.27 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.067 0.947 . . . . 0.0 108.595 167.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -144.32 162.86 35.34 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 127.14 2.176 . . . . 0.0 106.764 170.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -52.64 -30.14 29.99 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.368 0.667 . . . . 0.0 112.305 175.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -86.03 -17.81 34.2 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -178.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 30.0 p-80 -154.31 141.12 19.11 Favored 'General case' 0 C--N 1.347 0.469 0 CA-C-N 120.577 1.535 . . . . 0.0 114.684 -176.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -72.14 150.67 43.6 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.356 1.463 . . . . 0.0 108.555 167.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 8.8 p -69.41 -20.61 24.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 123.373 0.669 . . . . 0.0 111.515 175.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -148.22 171.05 28.73 Favored Glycine 0 C--N 1.337 0.589 0 C-N-CA 124.72 1.152 . . . . 0.0 110.264 -177.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -67.37 112.99 4.89 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 175.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -116.89 95.29 4.94 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.875 1.27 . . . . 0.0 108.048 -174.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 2.9 pt -92.32 120.19 41.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -169.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -175.42 145.72 0.76 Allowed 'General case' 0 C--O 1.24 0.602 0 C-N-CA 130.962 3.705 . . . . 0.0 104.733 168.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -124.73 -53.14 1.67 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 119.371 0.987 . . . . 0.0 110.739 172.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -150.85 81.69 1.33 Allowed 'General case' 0 C--O 1.235 0.304 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 57.8 93.16 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.362 1.865 . . . . 0.0 109.88 -173.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 87.2 mm-40 68.72 148.27 0.12 Allowed Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 127.918 2.487 . . . . 0.0 111.023 -168.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -72.37 151.77 54.29 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 122.087 1.858 . . . . 0.0 110.591 177.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -126.12 -20.43 4.52 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.298 1.839 . . . . 0.0 111.632 170.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 79.4 mt -94.06 24.87 4.02 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.416 1.886 . . . . 0.0 109.604 172.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 26.0 m -46.9 -57.35 5.04 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 126.688 1.995 . . . . 0.0 111.187 -170.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -75.43 -33.88 60.95 Favored 'General case' 0 N--CA 1.452 -0.373 0 O-C-N 122.233 -0.292 . . . . 0.0 110.557 -171.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 25.1 mp0 -64.71 -45.46 86.48 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.307 1.043 . . . . 0.0 109.444 178.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -66.03 -40.5 91.09 Favored 'General case' 0 N--CA 1.463 0.206 0 O-C-N 121.535 -0.728 . . . . 0.0 110.246 178.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 69.8 t -68.04 -33.47 61.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 118.916 0.78 . . . . 0.0 110.087 179.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -65.31 -51.92 57.46 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 120.416 1.462 . . . . 0.0 109.621 171.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -61.32 -27.89 68.81 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 118.74 -0.648 . . . . 0.0 111.501 -177.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 36.1 t90 -81.47 -51.99 7.71 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 119.174 0.897 . . . . 0.0 110.456 177.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 77.8 t -67.2 -31.09 51.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 O-C-N 121.376 -0.828 . . . . 0.0 110.584 -170.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -61.9 -35.0 77.08 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 121.2 -0.937 . . . . 0.0 110.856 174.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 63.0 mt-30 -69.91 -49.26 53.8 Favored 'General case' 0 C--N 1.341 0.219 0 C-N-CA 123.353 0.661 . . . . 0.0 110.664 173.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 2.7 pt -62.76 -33.19 58.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-N 119.266 0.939 . . . . 0.0 109.872 -175.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 48.2 m -61.31 -30.45 70.5 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 118.478 -0.772 . . . . 0.0 111.887 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -90.44 -26.0 20.06 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.877 1.217 . . . . 0.0 112.024 176.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -72.28 -38.46 68.78 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.057 0.844 . . . . 0.0 110.758 174.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 78.3 mt -83.49 -9.36 59.03 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.804 1.642 . . . . 0.0 111.544 179.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 55.33 32.53 18.9 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.621 1.568 . . . . 0.0 112.544 -170.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 80.3 mt -76.51 -20.91 56.43 Favored 'General case' 0 N--CA 1.465 0.278 0 O-C-N 121.571 -0.706 . . . . 0.0 110.37 170.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -55.6 -38.33 69.28 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 118.991 0.814 . . . . 0.0 110.486 173.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -67.54 -11.4 57.93 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 121.736 -0.603 . . . . 0.0 112.567 178.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 42.6 mt -104.46 -55.2 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 125.096 1.358 . . . . 0.0 108.413 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.5 pp -79.1 -23.81 43.86 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.39 0.676 . . . . 0.0 112.289 -171.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -124.33 35.94 4.71 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.32 1.848 . . . . 0.0 109.33 -175.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.17 0 CA-C-O 118.327 -0.844 . . . . 0.0 109.577 174.447 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.3 tpt . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 110.329 -0.249 . . . . 0.0 110.329 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.7 152.06 41.87 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.189 0.596 . . . . 0.0 110.056 175.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 17.6 pt -88.11 -22.34 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 122.397 0.279 . . . . 0.0 111.309 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.9 m -112.43 127.19 55.96 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.725 1.21 . . . . 0.0 109.294 -174.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -100.46 115.13 5.22 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 106.88 -2.488 . . . . 0.0 106.88 167.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 84.8 mt -88.66 116.12 29.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 104.068 -2.567 . . . . 0.0 104.068 169.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -112.13 127.6 55.97 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 173.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -132.88 136.86 46.45 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 119.478 1.036 . . . . 0.0 112.234 -178.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -85.43 158.59 32.73 Favored Glycine 0 CA--C 1.533 1.197 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 167.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 17.0 m -159.53 167.63 28.12 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 119.406 1.603 . . . . 0.0 110.526 176.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -144.81 -55.89 0.33 Allowed 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.419 0.688 . . . . 0.0 110.711 169.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 39.0 p -81.73 -6.38 58.98 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.731 0.812 . . . . 0.0 112.287 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 78.5 27.68 56.86 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-O 119.501 -0.611 . . . . 0.0 111.734 -172.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -87.64 -49.73 6.96 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-N 118.193 0.996 . . . . 0.0 110.115 173.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 26.9 m -70.09 -24.0 63.15 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 118.494 0.588 . . . . 0.0 111.517 -170.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -59.31 -34.46 72.35 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 121.388 -0.82 . . . . 0.0 111.26 174.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -70.96 -31.46 68.03 Favored 'General case' 0 C--O 1.226 -0.164 0 O-C-N 121.34 -0.85 . . . . 0.0 110.053 -179.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 23.1 mm -66.59 -47.73 82.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 176.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.71 -43.13 90.01 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 122.731 0.412 . . . . 0.0 111.389 176.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -69.42 -40.0 77.53 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-O 118.787 -0.625 . . . . 0.0 111.346 -178.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 68.1 mtm -61.81 -46.29 90.13 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 119.266 0.939 . . . . 0.0 109.755 174.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 75.2 mt -58.28 -47.16 88.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 177.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -59.5 -40.31 86.62 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 119.551 1.069 . . . . 0.0 111.456 178.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 59.0 tptt -64.23 -39.36 93.8 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 119.376 0.989 . . . . 0.0 110.222 178.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -69.43 -41.12 76.77 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.729 0.811 . . . . 0.0 110.959 179.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -73.89 -38.47 64.36 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.641 1.176 . . . . 0.0 110.56 -178.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.32 145.55 17.51 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 125.598 1.571 . . . . 0.0 110.759 -171.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.6 tptp -62.54 -30.2 71.13 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.449 1.1 . . . . 0.0 111.692 -175.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -68.92 -25.1 64.41 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.293 0.637 . . . . 0.0 111.412 178.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.2 t -99.82 -36.84 5.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 C-N-CA 124.106 0.962 . . . . 0.0 110.339 -175.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -133.5 139.57 46.73 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 119.32 0.964 . . . . 0.0 113.517 -175.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -122.22 150.25 42.54 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.484 1.114 . . . . 0.0 109.486 172.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 53.1 t -111.79 139.09 37.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 123.804 0.842 . . . . 0.0 110.93 -168.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -147.33 166.45 27.07 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.72 2.008 . . . . 0.0 111.101 -171.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -124.73 134.97 52.64 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 105.73 -1.952 . . . . 0.0 105.73 169.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.8 tp -60.14 -18.91 16.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 119.271 0.941 . . . . 0.0 112.556 -173.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -51.49 -37.71 50.42 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.442 1.097 . . . . 0.0 112.223 177.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.8 -1.42 56.8 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.346 0.658 . . . . 0.0 112.52 -178.295 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 64.4 m -79.81 156.39 27.42 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 122.287 1.042 . . . . 0.0 111.474 -177.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 33.6 p -127.41 176.64 7.3 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 127.371 2.268 . . . . 0.0 106.656 169.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -56.08 -36.33 67.99 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.776 -0.578 . . . . 0.0 111.837 -177.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -86.44 -11.72 51.08 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.014 0.526 . . . . 0.0 112.325 -176.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -69.52 -33.39 72.75 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 121.346 -0.846 . . . . 0.0 112.153 -169.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.7 mp -80.95 -31.86 34.73 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 122.936 0.494 . . . . 0.0 110.437 176.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -67.93 -18.46 64.77 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 123.279 0.632 . . . . 0.0 111.884 -172.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.12 -28.31 69.55 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.761 1.224 . . . . 0.0 112.157 175.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -96.79 157.65 15.8 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.436 1.094 . . . . 0.0 110.598 -179.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -104.82 -30.48 9.85 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.219 171.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.1 mm -106.7 138.63 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 174.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 86.0 mt -132.05 129.69 40.35 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 177.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.6 mp -114.22 113.84 25.19 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 172.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 61.2 mt -110.59 109.67 20.07 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 -170.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.68 118.61 5.63 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 125.726 1.632 . . . . 0.0 109.575 178.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.7 tp -135.03 108.91 10.59 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 117.994 0.897 . . . . 0.0 109.358 -170.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -76.19 146.03 28.12 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 121.762 1.641 . . . . 0.0 110.355 170.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 42.9 m -99.19 131.7 45.03 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 175.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 8.4 m95 -137.19 174.83 10.19 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 123.916 0.886 . . . . 0.0 111.63 -170.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 60.85 -76.69 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 128.557 2.743 . . . . 0.0 113.957 171.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -149.23 39.24 0.82 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.82 1.648 . . . . 0.0 109.841 -170.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.74 56.28 6.73 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 -170.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -131.18 164.54 25.29 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.264 1.426 . . . . 0.0 108.984 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.87 161.83 28.65 Favored 'General case' 0 C--O 1.236 0.354 0 O-C-N 121.848 -0.533 . . . . 0.0 110.09 169.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -71.1 154.85 41.42 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 170.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 58.6 m -59.16 -36.92 76.12 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.858 0.863 . . . . 0.0 112.885 -169.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -65.73 -43.14 89.9 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 118.505 0.593 . . . . 0.0 110.056 -178.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -69.39 -47.42 64.27 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.381 0.672 . . . . 0.0 109.81 177.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -60.09 -35.87 76.16 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.425 0.69 . . . . 0.0 111.818 -177.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -70.45 -25.83 63.37 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.861 0.864 . . . . 0.0 112.248 176.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -92.76 -21.4 19.96 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.312 0.645 . . . . 0.0 112.076 -179.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 17.0 m-30 -48.66 -42.99 61.28 Favored Pre-proline 0 CA--C 1.547 0.865 0 CA-C-O 116.86 -1.543 . . . . 0.0 114.52 177.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -64.52 -23.38 64.46 Favored 'Trans proline' 0 CA--C 1.544 1.019 0 CA-C-N 122.972 2.097 . . . . 0.0 113.462 175.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.1 m -79.63 -40.28 29.6 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 119.302 0.955 . . . . 0.0 109.001 170.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 16.7 tp -60.85 -32.16 71.57 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.726 1.21 . . . . 0.0 111.798 -172.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -78.53 -11.14 59.94 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.999 0.92 . . . . 0.0 112.361 177.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -87.18 -32.92 19.56 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 119.818 1.19 . . . . 0.0 110.035 170.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 86.7 mt -63.93 143.13 15.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 -178.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -98.18 133.8 42.12 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.121 0.968 . . . . 0.0 108.865 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -124.2 14.6 9.05 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 118.306 -0.854 . . . . 0.0 111.032 178.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -56.71 115.46 2.57 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-N 119.963 1.256 . . . . 0.0 109.345 -178.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.76 2.91 62.03 Favored Glycine 0 CA--C 1.535 1.291 0 CA-C-O 118.368 -1.24 . . . . 0.0 114.174 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -79.18 147.25 32.71 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 119.675 1.737 . . . . 0.0 107.287 170.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 8.4 mt -95.09 134.27 37.99 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 178.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 15.2 t -130.86 145.28 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 178.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -136.2 151.13 49.38 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 170.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 81.5 mt -120.63 148.1 44.35 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -171.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -145.81 166.26 26.44 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 169.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 178.33 172.16 42.43 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-O 122.692 1.162 . . . . 0.0 114.566 177.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 68.7 m -123.02 151.19 42.15 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 112.936 -1.632 . . . . 0.0 109.526 -169.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -169.49 176.92 43.31 Favored Glycine 0 N--CA 1.442 -0.957 0 N-CA-C 109.634 -1.387 . . . . 0.0 109.634 -172.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -127.03 110.23 12.74 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 177.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -78.93 -6.69 56.85 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 118.692 -0.671 . . . . 0.0 112.381 -169.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -111.72 -41.71 3.99 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.49 1.041 . . . . 0.0 110.639 -176.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -82.63 -29.0 30.4 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 121.76 -0.587 . . . . 0.0 111.999 -175.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -122.65 50.64 1.48 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.298 1.439 . . . . 0.0 108.974 172.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.57 -19.76 50.92 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 126.175 1.79 . . . . 0.0 115.401 -170.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -108.44 4.08 23.92 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.207 1.003 . . . . 0.0 112.929 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -127.98 19.96 6.49 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.046 1.338 . . . . 0.0 110.689 -178.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -65.96 128.52 36.36 Favored 'General case' 0 C--O 1.234 0.285 0 O-C-N 121.458 -0.777 . . . . 0.0 110.93 -168.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 95.5 m 52.25 31.39 9.19 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.918 1.687 . . . . 0.0 113.937 176.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -56.02 -41.3 74.72 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.02 -21.12 64.14 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 -168.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 7.7 mp -60.29 -40.04 89.07 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 119.113 0.87 . . . . 0.0 109.798 172.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.12 -33.81 88.25 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 177.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 5.8 m -64.11 -38.45 91.1 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.26 1.03 . . . . 0.0 110.177 177.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 4.0 mt -66.66 -44.58 89.62 Favored 'Isoleucine or valine' 0 C--N 1.344 0.366 0 CA-C-O 117.632 -1.175 . . . . 0.0 109.075 175.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 60.3 ttp85 -55.75 -45.62 78.0 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 120.174 1.352 . . . . 0.0 110.136 178.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -60.44 -25.2 65.81 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -178.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 78.6 mt -87.27 -45.44 16.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 123.989 0.916 . . . . 0.0 110.667 176.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.6 pt -86.43 -22.86 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 120.114 1.325 . . . . 0.0 112.779 -169.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -67.34 -46.12 49.45 Favored Pre-proline 0 CA--C 1.545 0.751 0 CA-C-O 117.436 -1.268 . . . . 0.0 111.661 -177.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -60.68 -28.1 85.95 Favored 'Trans proline' 0 C--N 1.356 0.934 0 C-N-CA 122.061 1.841 . . . . 0.0 112.969 172.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 15.4 mmm180 -86.37 10.57 14.58 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.877 1.271 . . . . 0.0 111.764 -177.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 77.81 15.67 80.95 Favored Glycine 0 CA--C 1.529 0.91 0 CA-C-O 118.494 -1.17 . . . . 0.0 114.721 169.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.31 141.01 56.79 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 119.072 1.436 . . . . 0.0 109.834 173.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 55.5 m -92.73 121.96 34.66 Favored 'General case' 0 C--O 1.232 0.133 0 N-CA-C 105.337 -2.098 . . . . 0.0 105.337 168.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 43.6 mt -105.12 123.39 59.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 -171.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 26.8 m -126.15 174.77 9.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 125.149 1.379 . . . . 0.0 109.011 178.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 78.24 33.28 40.51 Favored Glycine 0 CA--C 1.527 0.796 0 O-C-N 121.844 -0.535 . . . . 0.0 112.333 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -63.86 143.88 57.5 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 169.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . 0.421 ' HE1' ' NH2' ' A' ' 156' ' ' ARG . 72.8 t-105 -135.74 133.88 20.36 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 118.199 -0.905 . . . . 0.0 108.936 -167.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -68.32 141.77 52.71 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 121.496 1.464 . . . . 0.0 112.442 -170.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 12.6 p -70.03 -30.22 67.45 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 122.732 0.413 . . . . 0.0 110.041 169.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 54.48 44.81 28.24 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 126.39 1.876 . . . . 0.0 111.56 176.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 72.55 67.96 1.71 Allowed Glycine 0 C--N 1.34 0.775 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -177.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -48.1 125.53 9.32 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.496 0.719 . . . . 0.0 109.402 172.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -92.39 -28.09 17.1 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 -168.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -91.03 -164.77 1.23 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.736 0.814 . . . . 0.0 111.652 -169.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -67.42 -58.75 4.19 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -168.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -159.32 147.51 17.69 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 118.803 0.729 . . . . 0.0 111.291 179.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -129.64 135.18 48.22 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 125.08 1.352 . . . . 0.0 108.338 178.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -109.79 -5.34 15.6 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.102 0.561 . . . . 0.0 112.471 -171.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -78.1 1.21 70.45 Favored Glycine 0 CA--C 1.532 1.143 0 CA-C-N 118.871 0.759 . . . . 0.0 113.078 171.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 7.9 mp -62.88 132.69 52.98 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 118.872 1.336 . . . . 0.0 110.869 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -96.01 -29.64 14.03 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.384 1.474 . . . . 0.0 108.584 166.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -145.28 161.77 38.8 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 127.511 2.325 . . . . 0.0 106.558 170.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -53.5 -33.28 53.84 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 119.438 1.017 . . . . 0.0 112.355 176.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -89.08 -7.52 55.67 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.831 0.853 . . . . 0.0 113.245 -178.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 64.6 m80 -146.8 125.19 12.32 Favored 'General case' 0 C--N 1.347 0.491 0 CA-C-N 119.759 1.163 . . . . 0.0 113.95 -170.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -69.79 151.84 45.3 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 164.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 9.0 p -69.74 -12.61 16.26 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 123.881 0.873 . . . . 0.0 111.946 175.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -164.48 171.02 39.86 Favored Glycine 0 CA--C 1.523 0.562 0 O-C-N 121.29 -0.881 . . . . 0.0 111.187 -172.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -67.22 114.74 6.19 Favored 'General case' 0 C--N 1.334 -0.09 0 C-N-CA 123.755 0.822 . . . . 0.0 108.975 -178.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -89.98 140.47 29.6 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 170.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 9.0 tp -46.94 -46.21 8.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 C-N-CA 124.721 1.208 . . . . 0.0 113.982 -172.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -162.07 179.21 8.14 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.983 1.313 . . . . 0.0 108.791 -176.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -109.72 44.75 1.15 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.442 1.097 . . . . 0.0 109.345 169.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -157.15 166.74 32.41 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 125.068 1.347 . . . . 0.0 108.455 -170.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 25.3 ttm180 -47.09 -42.78 19.54 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.542 1.137 . . . . 0.0 111.811 168.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -127.65 159.08 67.92 Favored Pre-proline 0 CA--C 1.542 0.673 0 C-N-CA 125.017 1.327 . . . . 0.0 111.229 -167.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -67.36 121.95 9.14 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.838 2.359 . . . . 0.0 110.615 171.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -128.4 -43.6 1.43 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.893 1.677 . . . . 0.0 110.592 177.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 82.2 mt -109.96 -1.31 17.75 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 126.017 1.727 . . . . 0.0 111.438 -174.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 52.9 m -41.76 -44.98 3.42 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.563 1.945 . . . . 0.0 113.299 -175.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -70.44 -31.5 68.7 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 119.155 0.888 . . . . 0.0 111.914 -173.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -71.98 -40.26 68.7 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 169.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.421 ' NH2' ' HE1' ' A' ' 120' ' ' TRP . 72.0 mtp85 -66.67 -38.26 86.46 Favored 'General case' 0 C--O 1.225 -0.186 0 CA-C-O 118.551 -0.737 . . . . 0.0 110.974 -174.25 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 26.8 m -69.3 -31.29 49.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-N 119.928 1.24 . . . . 0.0 111.179 177.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -65.49 -52.63 51.47 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 120.255 1.389 . . . . 0.0 109.501 171.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 39.3 mttp -61.15 -31.08 70.8 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 118.892 -0.575 . . . . 0.0 111.448 -177.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 61.5 t90 -78.92 -51.97 8.93 Favored 'General case' 0 N--CA 1.457 -0.094 0 CA-C-N 118.845 0.748 . . . . 0.0 111.19 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 56.8 t -63.72 -31.29 52.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 O-C-N 121.563 -0.711 . . . . 0.0 110.26 -175.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -59.48 -35.44 74.11 Favored 'General case' 0 CA--C 1.532 0.26 0 O-C-N 121.283 -0.886 . . . . 0.0 111.368 174.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -63.95 -53.57 48.16 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 118.711 0.687 . . . . 0.0 109.956 172.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 2.2 pt -69.0 -26.86 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 O-C-N 121.89 -0.507 . . . . 0.0 110.373 -170.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 46.1 m -58.97 -32.5 69.7 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 119.118 -0.468 . . . . 0.0 111.199 174.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -77.98 -43.75 28.7 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.553 1.07 . . . . 0.0 110.043 175.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -67.7 -34.06 76.13 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.587 0.755 . . . . 0.0 111.629 -174.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 83.7 mt -87.16 3.88 44.58 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.576 1.551 . . . . 0.0 111.108 177.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 25.9 m80 56.18 31.61 18.66 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.182 1.793 . . . . 0.0 113.001 -177.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 92.1 mt -80.97 -29.2 35.35 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 123.623 0.769 . . . . 0.0 110.304 173.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -57.72 -37.6 73.81 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.783 0.833 . . . . 0.0 110.43 176.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -65.47 -13.43 58.79 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.681 0.793 . . . . 0.0 112.471 178.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 50.0 mt -103.69 -56.68 4.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 125.17 1.388 . . . . 0.0 108.191 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.5 pp -79.46 -23.93 42.75 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -169.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -119.11 28.69 8.1 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.691 1.596 . . . . 0.0 110.224 -175.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.37 0 C-N-CA 123.919 0.887 . . . . 0.0 109.364 173.632 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.6 tpt . . . . . 0 N--CA 1.485 1.325 0 N-CA-C 110.37 -0.233 . . . . 0.0 110.37 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -57.91 146.62 31.51 Favored 'General case' 0 C--N 1.344 0.351 0 C-N-CA 123.778 0.831 . . . . 0.0 111.385 177.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.9 pt -105.9 -14.98 8.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 125.248 1.419 . . . . 0.0 111.13 178.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 88.2 m -119.43 127.91 53.54 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.989 1.316 . . . . 0.0 108.826 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -91.28 129.34 9.75 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 107.856 -2.098 . . . . 0.0 107.856 169.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 33.0 mt -103.83 95.75 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 103.368 -2.827 . . . . 0.0 103.368 171.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 19.6 m-30 -100.16 129.65 46.21 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 -177.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 26.1 p90 -132.93 163.99 27.94 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 118.424 0.556 . . . . 0.0 110.99 -172.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -140.03 139.2 9.67 Favored Glycine 0 C--N 1.336 0.554 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 168.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.8 m -141.29 167.52 21.98 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.932 1.366 . . . . 0.0 110.696 -174.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -136.83 -50.8 0.66 Allowed 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.509 0.724 . . . . 0.0 110.157 168.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.3 p -82.48 -11.63 58.36 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.607 0.763 . . . . 0.0 112.084 171.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.92 6.59 51.93 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 124.961 1.267 . . . . 0.0 113.747 170.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -70.69 -44.05 67.77 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 118.757 1.279 . . . . 0.0 111.731 -173.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.01 -27.33 67.33 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 120.97 -1.081 . . . . 0.0 111.146 -175.175 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -62.57 -42.11 99.34 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 118.719 0.691 . . . . 0.0 109.85 172.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -63.5 -42.25 98.51 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 121.8 -0.562 . . . . 0.0 110.377 178.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 21.0 mm -62.06 -46.34 96.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 176.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.6 -41.38 94.65 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 121.929 -0.482 . . . . 0.0 111.426 -179.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.2 mtpt -65.66 -40.91 92.93 Favored 'General case' 0 C--O 1.227 -0.098 0 CA-C-O 118.49 -0.767 . . . . 0.0 110.676 177.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 61.8 mtm -62.38 -40.98 98.23 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 119.73 1.15 . . . . 0.0 110.759 176.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 70.2 mt -59.96 -47.04 93.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 176.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -63.53 -37.84 88.87 Favored 'General case' 0 CA--C 1.53 0.181 0 O-C-N 121.017 -1.052 . . . . 0.0 111.685 178.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -65.05 -34.04 77.48 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 120.115 1.325 . . . . 0.0 111.088 178.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 12.9 mm100 -70.1 -43.66 70.6 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 118.184 0.447 . . . . 0.0 110.744 175.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -82.93 -32.5 27.18 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.461 0.704 . . . . 0.0 112.434 -170.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 90.45 144.42 11.97 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 124.852 1.215 . . . . 0.0 111.117 -169.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 56.5 tptt -57.36 -35.77 70.36 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 125.281 1.432 . . . . 0.0 111.864 -175.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -82.95 -1.94 53.74 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.009 0.523 . . . . 0.0 112.351 -176.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.5 t -110.01 -46.93 6.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 123.769 0.828 . . . . 0.0 109.186 176.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -131.65 139.55 49.13 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 119.242 0.928 . . . . 0.0 110.458 -177.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -130.5 141.77 50.49 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 99.2 t -100.77 129.99 50.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 C-N-CA 124.813 1.245 . . . . 0.0 110.718 -167.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -143.97 145.37 32.19 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.945 0.898 . . . . 0.0 110.136 175.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -74.98 134.29 41.52 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 169.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.4 tp -56.53 -31.3 33.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 123.387 0.675 . . . . 0.0 112.057 -174.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.29 -32.53 70.11 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -170.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -92.07 -10.38 39.27 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -178.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 36.9 m -70.2 126.09 28.66 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 119.214 0.915 . . . . 0.0 108.73 177.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 14.5 m -73.43 168.2 19.72 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.597 0.759 . . . . 0.0 109.742 173.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -53.39 -41.11 65.59 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.585 0.754 . . . . 0.0 110.865 174.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -77.44 -15.92 59.07 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.099 0.56 . . . . 0.0 112.178 -178.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -75.27 -28.3 59.74 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 121.141 -0.974 . . . . 0.0 111.109 -176.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -68.66 -43.71 75.64 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.596 0.758 . . . . 0.0 109.024 169.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -65.65 -25.79 67.51 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.161 0.584 . . . . 0.0 112.137 -179.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.3 -30.32 70.14 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.681 0.793 . . . . 0.0 112.709 -174.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -92.57 154.85 18.16 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.35 1.06 . . . . 0.0 110.112 178.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -104.01 -21.87 13.54 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.353 0.661 . . . . 0.0 111.775 169.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.8 mp -121.65 132.74 70.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 176.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 80.0 mt -133.25 135.81 45.18 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 123.42 0.688 . . . . 0.0 109.991 178.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 7.3 mp -114.42 118.62 34.35 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 104.469 -2.419 . . . . 0.0 104.469 170.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 73.9 mt -112.48 117.72 33.17 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 123.32 0.648 . . . . 0.0 109.733 -169.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -101.4 98.82 1.84 Allowed Glycine 0 C--N 1.335 0.494 0 C-N-CA 125.713 1.625 . . . . 0.0 111.273 -173.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 2.1 tp -120.86 109.61 35.7 Favored Pre-proline 0 CA--C 1.538 0.487 0 C-N-CA 125.466 1.506 . . . . 0.0 109.476 -169.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -81.48 155.38 18.7 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.854 2.37 . . . . 0.0 110.418 173.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.7 m -101.06 136.22 41.26 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 172.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 60.7 m95 -135.51 173.53 11.62 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 125.647 1.579 . . . . 0.0 109.864 -178.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 13.4 t80 38.98 56.03 2.03 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.095 2.158 . . . . 0.0 113.443 168.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 26.2 p90 46.3 66.05 1.05 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.086 1.355 . . . . 0.0 112.088 176.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.55 52.36 3.38 Favored Glycine 0 CA--C 1.525 0.67 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.818 172.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -136.23 154.26 50.97 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 124.513 1.125 . . . . 0.0 109.116 174.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -79.28 146.08 33.18 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 169.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -59.47 147.43 36.67 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 171.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 74.5 m -58.13 -29.73 65.76 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.212 1.005 . . . . 0.0 113.546 -168.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -68.47 -32.73 72.93 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 118.891 0.769 . . . . 0.0 111.213 -178.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 92.1 m95 -79.44 -45.52 19.28 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-N 118.121 0.418 . . . . 0.0 110.085 171.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -60.54 -38.26 83.87 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.021 0.373 . . . . 0.0 111.926 -175.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -68.09 -24.75 65.08 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.581 0.753 . . . . 0.0 112.11 176.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -88.85 -25.4 22.19 Favored 'General case' 0 C--N 1.341 0.225 0 CA-C-O 118.738 -0.649 . . . . 0.0 111.914 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -49.57 -43.15 71.29 Favored Pre-proline 0 CA--C 1.546 0.819 0 CA-C-O 116.704 -1.617 . . . . 0.0 114.729 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -66.61 -15.19 46.83 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 CA-C-N 122.784 2.03 . . . . 0.0 113.774 176.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.1 m -89.78 -40.67 12.33 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.85 0.86 . . . . 0.0 109.013 169.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.5 ' HA ' HD12 ' A' ' 76' ' ' ILE . 31.3 tp -56.62 -38.32 71.93 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 125.017 1.327 . . . . 0.0 111.567 -176.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -68.74 -10.19 55.07 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -96.22 -7.19 36.3 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 119.646 1.112 . . . . 0.0 112.001 177.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.5 HD12 ' HA ' ' A' ' 73' ' ' LEU . 95.8 mt -91.57 146.39 6.32 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 -169.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -91.58 130.47 37.39 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 178.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -125.35 10.59 8.0 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 123.778 0.831 . . . . 0.0 111.768 176.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -63.89 126.55 28.01 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 120.231 1.378 . . . . 0.0 110.133 -175.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 74.84 -3.05 46.62 Favored Glycine 0 CA--C 1.538 1.474 0 CA-C-O 118.102 -1.388 . . . . 0.0 114.152 -175.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 63.1 mttm -79.61 146.16 32.69 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 120.226 2.013 . . . . 0.0 108.045 175.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 20.0 mt -95.38 131.6 41.33 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 176.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.9 t -132.25 143.14 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 178.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -129.63 156.16 44.67 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.893 1.277 . . . . 0.0 107.832 170.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 14.3 mt -122.27 145.87 47.83 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 124.324 1.05 . . . . 0.0 108.335 -175.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -141.36 156.15 45.85 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 123.851 0.86 . . . . 0.0 109.08 170.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -179.94 -169.25 39.89 Favored Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 111.394 -0.682 . . . . 0.0 111.394 -178.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 21.9 p -135.59 171.88 13.81 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 126.379 1.872 . . . . 0.0 109.196 -169.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -169.69 178.23 42.78 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 112.423 -0.271 . . . . 0.0 112.423 170.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -127.77 138.98 52.93 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 125.712 1.605 . . . . 0.0 108.201 169.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -121.28 24.99 9.74 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.274 1.029 . . . . 0.0 111.012 -172.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -119.02 -48.63 2.44 Favored 'General case' 0 C--O 1.234 0.263 0 O-C-N 121.444 -0.785 . . . . 0.0 109.903 -177.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -107.68 -33.78 7.18 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.936 0.894 . . . . 0.0 110.617 176.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -98.13 25.48 6.09 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.994 0.918 . . . . 0.0 111.925 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.17 -21.15 66.45 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -173.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -84.33 -3.01 58.0 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.905 0.882 . . . . 0.0 112.001 174.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -135.69 17.96 3.31 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.876 1.671 . . . . 0.0 109.614 -173.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -65.07 118.76 9.64 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -168.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 56.3 m 53.35 27.56 6.4 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.394 1.478 . . . . 0.0 113.2 -177.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -54.03 -38.17 64.9 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.06 1.344 . . . . 0.0 112.281 -173.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.25 -13.29 61.48 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -171.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 82.0 mt -58.97 -43.51 91.39 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 119.022 0.828 . . . . 0.0 109.759 175.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -69.98 -29.36 70.81 Favored Glycine 0 CA--C 1.529 0.91 0 N-CA-C 111.923 -0.471 . . . . 0.0 111.923 -177.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 8.3 m -63.21 -37.15 86.1 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 117.873 0.837 . . . . 0.0 111.133 -174.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.4 mt -73.82 -45.36 50.02 Favored 'Isoleucine or valine' 0 C--N 1.344 0.339 0 CA-C-O 118.452 -0.785 . . . . 0.0 108.938 176.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 37.4 ttt180 -53.33 -42.4 66.71 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 119.081 0.855 . . . . 0.0 110.738 -178.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -61.27 -17.61 54.34 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.104 0.962 . . . . 0.0 112.847 -179.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 69.7 mt -99.2 -48.33 11.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 124.66 1.184 . . . . 0.0 109.627 175.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 40.8 pt -79.9 -34.25 15.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 119.459 1.027 . . . . 0.0 112.117 -168.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -70.6 -41.67 13.01 Favored Pre-proline 0 CA--C 1.543 0.687 0 CA-C-O 117.576 -1.202 . . . . 0.0 110.88 -175.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -63.47 -30.33 71.75 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.032 1.821 . . . . 0.0 113.322 171.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -76.67 7.61 4.44 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.101 0.96 . . . . 0.0 112.328 171.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 93.33 6.64 62.68 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 125.882 1.706 . . . . 0.0 114.976 168.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.62 137.37 57.56 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 119.652 1.726 . . . . 0.0 109.424 175.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 87.3 m -90.83 122.77 33.84 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 169.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 23.1 mm -100.15 126.85 53.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 -171.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 27.6 m -130.91 179.72 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 125.024 1.329 . . . . 0.0 108.612 175.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 74.44 32.61 57.58 Favored Glycine 0 C--N 1.338 0.659 0 O-C-N 121.528 -0.733 . . . . 0.0 112.082 179.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 83.8 m-70 -64.24 143.03 58.19 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 169.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 55.1 t-105 -130.19 140.67 39.34 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-O 117.866 -1.064 . . . . 0.0 108.963 -178.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -61.31 148.42 92.97 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 CA-C-N 121.063 1.415 . . . . 0.0 114.772 -170.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 41.4 p -79.64 -9.46 59.64 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.485 0.714 . . . . 0.0 110.629 167.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 52.64 45.58 28.38 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.213 1.405 . . . . 0.0 111.228 -173.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 92.76 -1.71 71.84 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-O 118.203 -1.332 . . . . 0.0 114.032 175.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 22.7 t80 51.54 -126.22 2.37 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 118.777 1.289 . . . . 0.0 110.249 177.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 41.8 t60 56.31 39.68 30.08 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.577 1.551 . . . . 0.0 111.993 -172.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -88.53 176.09 7.3 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 168.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -65.16 -49.34 70.21 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.537 -0.727 . . . . 0.0 109.799 -174.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -162.37 140.68 8.8 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 167.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 13.0 m -145.84 131.37 18.77 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 120.765 -1.209 . . . . 0.0 108.781 174.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -104.19 -7.91 19.78 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.106 0.562 . . . . 0.0 111.978 -170.15 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -82.2 5.77 70.69 Favored Glycine 0 CA--C 1.527 0.843 0 CA-C-O 118.633 -1.093 . . . . 0.0 113.153 177.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 8.5 mp -63.16 128.15 34.54 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 119.909 1.854 . . . . 0.0 110.238 178.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.26 -37.63 25.64 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.587 1.555 . . . . 0.0 107.746 167.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -153.94 165.75 35.12 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 129.481 3.112 . . . . 0.0 106.227 -177.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -51.03 -35.92 36.88 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.275 0.943 . . . . 0.0 112.41 175.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -96.18 -3.4 44.44 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -175.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -146.54 139.42 25.4 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 120.542 1.519 . . . . 0.0 112.455 -172.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -84.91 155.54 21.63 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.613 1.565 . . . . 0.0 108.706 167.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 24.4 m -70.03 -8.65 11.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 125.127 1.371 . . . . 0.0 112.735 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -158.23 173.62 35.4 Favored Glycine 0 C--N 1.337 0.622 0 C-N-CA 124.964 1.269 . . . . 0.0 110.564 -178.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -64.94 132.02 48.2 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 124.556 1.142 . . . . 0.0 109.007 176.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -115.22 124.39 51.28 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 169.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 22.7 pt -72.91 -15.87 17.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 112.632 0.605 . . . . 0.0 112.632 -178.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -113.48 155.27 25.62 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 124.718 1.207 . . . . 0.0 107.925 168.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -136.37 -6.79 2.01 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.342 1.457 . . . . 0.0 111.279 175.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -151.87 -36.91 0.12 Allowed 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 -168.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -159.18 -62.19 0.07 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 119.697 1.135 . . . . 0.0 110.871 -173.426 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -143.93 152.96 56.62 Favored Pre-proline 0 C--O 1.234 0.272 0 C-N-CA 125.137 1.375 . . . . 0.0 108.057 -176.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -81.14 49.81 3.35 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 123.5 2.8 . . . . 0.0 112.889 -170.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -64.06 -29.03 70.2 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 120.996 -1.065 . . . . 0.0 112.007 -173.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 83.1 mt -103.15 29.99 5.16 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 125.273 1.429 . . . . 0.0 110.682 -175.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 5.0 m -48.7 -50.06 35.08 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.418 1.087 . . . . 0.0 110.892 -179.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.88 -41.81 86.62 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.641 0.655 . . . . 0.0 110.714 -171.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -61.89 -48.42 80.56 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 123.023 0.529 . . . . 0.0 109.855 177.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 75.8 mtt180 -62.54 -45.74 91.57 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 122.933 0.493 . . . . 0.0 110.114 -176.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 83.3 t -68.75 -43.72 82.71 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.118 0 CA-C-O 118.274 -0.869 . . . . 0.0 109.84 -178.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -62.38 -45.07 94.82 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 120.556 1.525 . . . . 0.0 110.124 -178.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -65.6 -39.7 91.85 Favored 'General case' 0 C--N 1.333 -0.137 0 O-C-N 121.924 -0.485 . . . . 0.0 110.239 -179.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 75.9 t90 -66.67 -45.96 77.22 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-N 118.452 0.569 . . . . 0.0 110.356 178.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 55.9 t -59.07 -41.53 83.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 45.5 mttm -62.46 -44.97 95.12 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 118.678 0.672 . . . . 0.0 109.881 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 19.8 mm100 -62.1 -52.83 62.31 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 122.852 0.461 . . . . 0.0 110.569 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 22.8 pt -68.24 -32.2 54.8 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 CA-C-O 118.811 -0.614 . . . . 0.0 110.825 -174.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 48.8 m -62.92 -30.67 71.73 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 119.188 0.904 . . . . 0.0 111.082 -178.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -77.67 -41.99 36.2 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 119.327 0.967 . . . . 0.0 110.578 175.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -68.18 -33.96 75.41 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.505 0.722 . . . . 0.0 111.708 -177.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 81.1 mt -90.62 -2.38 57.86 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.202 1.801 . . . . 0.0 111.327 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 25.2 m80 56.82 22.36 6.93 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.9 1.68 . . . . 0.0 113.478 -174.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 78.8 mt -75.61 -23.34 56.41 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 124.275 1.03 . . . . 0.0 110.536 175.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -59.17 -40.65 86.28 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 118.49 0.586 . . . . 0.0 110.421 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -65.02 -19.32 65.94 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.96 -0.462 . . . . 0.0 111.823 179.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 4.7 mm -91.33 -47.17 14.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 124.247 1.019 . . . . 0.0 108.735 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.1 pp -75.54 -26.89 58.4 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 122.985 0.514 . . . . 0.0 112.021 -174.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -72.9 -28.52 62.52 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.561 0.744 . . . . 0.0 111.915 -177.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.341 0 C-N-CA 124.258 1.023 . . . . 0.0 110.295 -177.919 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.4 ttt . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 110.378 -0.23 . . . . 0.0 110.378 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.62 149.12 50.61 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.225 0.61 . . . . 0.0 110.517 177.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 31.0 pt -87.27 -22.48 6.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 123.107 0.563 . . . . 0.0 111.375 -179.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 15.4 m -110.63 126.51 54.55 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 125.612 1.565 . . . . 0.0 108.531 178.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -102.77 123.79 7.96 Favored Glycine 0 CA--C 1.521 0.419 0 N-CA-C 107.056 -2.418 . . . . 0.0 107.056 169.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 62.3 mt -105.26 92.28 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 N-CA-C 105.338 -2.097 . . . . 0.0 105.338 178.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -88.64 135.26 33.59 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 -177.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -132.58 133.37 43.6 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 119.943 1.247 . . . . 0.0 112.596 176.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -87.97 148.14 20.74 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 108.283 -1.927 . . . . 0.0 108.283 167.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.9 m -168.35 160.46 11.36 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 119.069 1.435 . . . . 0.0 110.624 174.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -125.3 -53.36 1.61 Allowed 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.821 0.848 . . . . 0.0 109.493 167.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.8 p -85.92 6.01 30.41 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 124.944 1.298 . . . . 0.0 113.219 174.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 85.25 -7.18 76.84 Favored Glycine 0 CA--C 1.532 1.107 0 N-CA-C 117.302 1.681 . . . . 0.0 117.302 167.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.55 -36.08 77.58 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 120.51 2.155 . . . . 0.0 113.461 -170.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 11.4 m -73.02 -16.2 61.51 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 119.408 1.004 . . . . 0.0 110.791 -175.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -60.77 -42.5 97.58 Favored 'General case' 0 C--N 1.342 0.264 0 O-C-N 121.101 -0.999 . . . . 0.0 109.879 173.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -65.94 -39.04 90.14 Favored 'General case' 0 C--N 1.339 0.142 0 O-C-N 121.984 -0.448 . . . . 0.0 110.086 -178.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 41.0 mm -62.33 -47.69 91.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 176.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.34 -43.9 96.02 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 122.843 0.457 . . . . 0.0 111.345 179.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 54.9 mttm -63.85 -43.72 95.28 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 118.811 -0.614 . . . . 0.0 110.848 178.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 75.6 mtm -63.5 -37.06 85.86 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 119.328 0.967 . . . . 0.0 110.965 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 34.0 mt -65.22 -44.6 95.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 174.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -60.12 -40.13 88.64 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 119.291 0.951 . . . . 0.0 110.741 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -64.45 -34.17 77.58 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 119.007 0.821 . . . . 0.0 111.172 179.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -68.2 -51.13 49.03 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 118.689 0.677 . . . . 0.0 110.431 175.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 42.5 mt -71.16 -31.92 68.29 Favored 'General case' 0 C--N 1.341 0.227 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -174.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.63 147.21 20.86 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 125.31 1.433 . . . . 0.0 110.983 -174.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -65.05 -29.71 70.63 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.764 0.826 . . . . 0.0 112.172 -172.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -67.51 -29.37 68.77 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 122.63 0.372 . . . . 0.0 111.117 177.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 33.3 t -93.69 -36.9 7.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 C-N-CA 124.585 1.154 . . . . 0.0 110.256 -175.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -134.93 144.54 47.52 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 119.067 0.849 . . . . 0.0 112.838 -171.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -131.09 141.69 50.18 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.376 1.07 . . . . 0.0 110.058 172.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 87.9 t -88.88 141.32 14.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 123.728 0.811 . . . . 0.0 108.911 -178.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -145.28 169.57 17.99 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.442 1.097 . . . . 0.0 111.444 -169.026 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -144.95 121.17 10.85 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.275 1.43 . . . . 0.0 107.474 -177.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.4 tp -59.09 -21.76 20.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 123.474 0.71 . . . . 0.0 112.242 -171.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.82 -29.16 69.98 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.05 0.54 . . . . 0.0 111.725 176.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 57.8 pttt -108.49 -19.53 13.42 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.302 1.041 . . . . 0.0 112.408 178.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.4 m -63.88 165.32 8.84 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 119.262 0.937 . . . . 0.0 110.53 170.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 24.4 p -143.95 166.89 23.7 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.163 0.985 . . . . 0.0 110.095 -179.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -52.93 -49.19 66.49 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.369 1.067 . . . . 0.0 111.32 -172.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -80.02 -24.02 41.09 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 122.134 0.174 . . . . 0.0 111.02 -175.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -73.35 -32.77 64.73 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.068 0.547 . . . . 0.0 111.091 -179.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -59.23 -37.77 78.33 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.405 0.682 . . . . 0.0 110.966 171.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -72.17 -16.59 61.97 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 122.884 0.473 . . . . 0.0 112.257 -173.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.18 -29.01 65.77 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.473 0.709 . . . . 0.0 111.871 -178.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -79.8 157.29 27.09 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.253 1.021 . . . . 0.0 110.169 179.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -109.77 -28.8 8.62 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.107 169.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.2 mp -112.04 126.91 69.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 173.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -112.58 122.22 47.06 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 175.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.2 mp -109.71 118.27 36.09 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 171.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 60.0 mt -119.46 109.16 15.42 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -171.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.5 122.57 7.19 Favored Glycine 0 CA--C 1.521 0.407 0 C-N-CA 125.629 1.585 . . . . 0.0 110.162 -179.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 18.4 tt -136.71 109.19 9.29 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-N 118.121 0.961 . . . . 0.0 111.648 -176.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.1 140.54 31.33 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 N-CA-C 107.32 -1.839 . . . . 0.0 107.32 166.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 90.5 m -91.97 136.17 33.37 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 177.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 30.1 m95 -129.62 173.97 10.11 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.518 1.127 . . . . 0.0 111.405 -172.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 55.07 -89.88 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 127.909 2.484 . . . . 0.0 112.397 179.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -153.58 78.66 1.14 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 126.271 1.829 . . . . 0.0 106.754 175.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 65.75 51.84 43.43 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 -177.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -127.79 155.85 43.41 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.1 0.96 . . . . 0.0 109.631 176.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -79.23 166.35 22.27 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.751 0.82 . . . . 0.0 109.968 170.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 18.1 mm-40 -72.57 153.75 41.13 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 169.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 60.8 m -58.98 -37.01 75.84 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.598 0.759 . . . . 0.0 112.739 -169.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -72.14 -38.38 69.24 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 118.712 0.687 . . . . 0.0 110.579 -177.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -66.42 -46.78 75.38 Favored 'General case' 0 C--N 1.342 0.241 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 173.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -60.53 -38.75 85.44 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.331 0.652 . . . . 0.0 111.557 -178.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -70.01 -25.72 63.72 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.996 0.918 . . . . 0.0 112.189 176.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -90.71 -20.55 22.33 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.445 0.698 . . . . 0.0 112.293 -179.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 19.3 m-30 -51.02 -42.24 78.85 Favored Pre-proline 0 CA--C 1.546 0.822 0 CA-C-O 116.762 -1.589 . . . . 0.0 114.253 177.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -65.5 -21.21 60.4 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 CA-C-N 122.966 2.095 . . . . 0.0 113.402 174.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.8 m -81.95 -36.33 28.08 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 119.371 0.987 . . . . 0.0 109.604 170.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 21.7 tp -61.91 -30.8 71.13 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.059 -1.026 . . . . 0.0 111.37 -175.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -82.96 -2.36 54.91 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.163 0.985 . . . . 0.0 113.134 175.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 39.4 mm-40 -100.36 -26.03 14.02 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.331 1.052 . . . . 0.0 110.425 172.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 80.9 mt -70.69 152.76 8.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 174.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -106.99 134.83 49.56 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.533 1.133 . . . . 0.0 109.465 178.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -124.98 15.55 8.53 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.499 1.119 . . . . 0.0 111.53 177.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -56.07 115.04 2.2 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 119.646 1.112 . . . . 0.0 109.79 -178.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 74.44 3.08 65.13 Favored Glycine 0 CA--C 1.536 1.358 0 CA-C-O 118.531 -1.149 . . . . 0.0 114.294 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -80.02 148.67 31.02 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 119.385 1.593 . . . . 0.0 107.742 171.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 19.1 mt -91.44 134.33 34.72 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 178.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 19.0 t -130.96 132.78 63.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 178.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -128.32 143.32 51.0 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 176.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 77.8 mt -115.99 146.23 42.3 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -173.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -141.55 160.35 40.33 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 169.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -170.9 170.06 42.91 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-O 122.419 1.01 . . . . 0.0 113.059 -171.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 15.5 m -136.7 148.8 47.54 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 125.739 1.616 . . . . 0.0 107.367 -169.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.6 -167.29 28.05 Favored Glycine 0 CA--C 1.528 0.859 0 O-C-N 123.233 0.333 . . . . 0.0 112.604 -174.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -139.78 143.57 36.97 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.721 1.608 . . . . 0.0 109.896 -179.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.411 HE22 ' C ' ' A' ' 145' ' ' ASP . 6.7 mt-30 -118.66 3.85 11.68 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.053 1.741 . . . . 0.0 112.268 -178.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -85.81 -47.59 9.58 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 119.699 1.136 . . . . 0.0 110.572 176.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -129.68 -37.97 1.53 Allowed 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.248 0.619 . . . . 0.0 111.825 -170.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -87.26 18.82 3.49 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.218 0.607 . . . . 0.0 112.133 174.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.67 -39.72 71.33 Favored 'General case' 0 C--N 1.342 0.247 0 C-N-CA 124.729 1.212 . . . . 0.0 112.365 -173.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -65.93 -13.96 60.68 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 118.577 0.626 . . . . 0.0 111.938 -177.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -120.83 21.57 11.39 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 126.546 1.939 . . . . 0.0 110.112 -177.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -60.34 119.32 7.73 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 118.832 0.742 . . . . 0.0 110.729 -169.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 72.2 m 47.63 32.03 2.34 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.021 1.729 . . . . 0.0 112.749 -177.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -54.87 -37.5 66.34 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.055 0.942 . . . . 0.0 112.087 -173.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.87 -14.07 62.81 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -171.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 84.9 mt -56.07 -42.98 77.52 Favored 'General case' 0 C--N 1.345 0.371 0 CA-C-N 118.961 0.801 . . . . 0.0 109.609 169.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.97 -33.15 86.47 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 -178.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.2 m -64.33 -41.37 96.82 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 118.18 0.99 . . . . 0.0 110.194 178.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 6.2 mt -68.22 -45.21 83.31 Favored 'Isoleucine or valine' 0 C--N 1.343 0.312 0 CA-C-N 119.198 0.908 . . . . 0.0 108.8 176.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 52.3 ttt-85 -52.95 -47.82 67.83 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 119.236 0.925 . . . . 0.0 110.157 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -64.98 -23.24 67.16 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 123.87 0.868 . . . . 0.0 112.381 -175.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 76.2 mt -86.2 -46.42 16.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 118.844 0.747 . . . . 0.0 109.381 175.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.0 pt -76.47 -26.27 16.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 119.363 0.983 . . . . 0.0 112.811 -169.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -64.06 -50.23 70.08 Favored Pre-proline 0 CA--C 1.547 0.832 0 CA-C-O 117.654 -1.165 . . . . 0.0 111.846 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -54.54 -29.75 61.58 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.858 2.372 . . . . 0.0 114.038 172.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 28.5 mmm180 -88.11 9.85 21.25 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.888 0.875 . . . . 0.0 111.799 -177.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 79.27 12.62 83.73 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-O 118.645 -1.086 . . . . 0.0 114.132 169.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.42 143.33 45.73 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 118.846 1.323 . . . . 0.0 110.287 173.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 48.7 m -93.15 121.11 34.17 Favored 'General case' 0 CA--C 1.528 0.108 0 N-CA-C 104.821 -2.288 . . . . 0.0 104.821 168.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 14.9 mt -102.23 126.06 56.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -168.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 6.1 m -140.98 174.28 7.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 125.928 1.691 . . . . 0.0 108.979 -170.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 74.56 37.11 47.2 Favored Glycine 0 CA--C 1.529 0.934 0 O-C-N 121.479 -0.763 . . . . 0.0 112.228 -175.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -66.56 138.88 57.8 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 173.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 70.9 t-105 -124.61 126.24 25.42 Favored Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 124.782 1.233 . . . . 0.0 108.423 -169.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -68.47 145.02 63.41 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 121.483 1.455 . . . . 0.0 112.358 -169.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 4.1 p -68.86 -34.6 75.72 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 119.234 -0.413 . . . . 0.0 110.674 169.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 50.06 52.98 13.63 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.356 1.462 . . . . 0.0 112.03 176.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 78.68 38.71 23.37 Favored Glycine 0 CA--C 1.531 1.081 0 CA-C-O 120.064 -0.298 . . . . 0.0 112.577 177.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -59.71 136.34 57.96 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.76 0.824 . . . . 0.0 109.205 173.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 42.0 t60 -143.4 16.57 1.86 Allowed 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -170.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -84.22 177.23 8.28 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.288 -0.883 . . . . 0.0 110.614 176.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -50.7 -50.54 54.87 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.02 1.328 . . . . 0.0 113.127 -168.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -151.86 176.8 11.08 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 124.057 0.943 . . . . 0.0 108.912 169.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.1 133.55 18.63 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 169.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -118.96 -11.45 9.69 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -169.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -82.69 10.0 57.64 Favored Glycine 0 CA--C 1.534 1.268 0 CA-C-N 118.773 0.715 . . . . 0.0 112.743 169.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 82.0 mt -64.67 135.73 56.21 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 118.947 1.374 . . . . 0.0 111.162 -178.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -98.21 -31.57 12.01 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.927 1.291 . . . . 0.0 108.318 166.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -149.54 163.15 38.62 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 127.756 2.422 . . . . 0.0 106.797 172.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -55.71 -30.21 60.75 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.182 -0.949 . . . . 0.0 112.088 176.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -88.07 -10.49 50.02 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 10.9 m-70 -150.94 127.58 10.84 Favored 'General case' 0 C--N 1.347 0.476 0 CA-C-N 119.843 1.201 . . . . 0.0 113.684 -169.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -73.0 151.93 41.55 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 164.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 8.0 p -66.12 -19.05 25.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 O-C-N 121.98 -0.45 . . . . 0.0 112.016 176.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -154.77 163.17 31.17 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 123.791 0.71 . . . . 0.0 111.349 -171.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -56.71 127.82 33.4 Favored 'General case' 0 CA--C 1.522 -0.121 0 C-N-CA 124.22 1.008 . . . . 0.0 108.487 177.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -120.4 115.09 22.82 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 176.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 27.7 pt -78.76 169.13 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 169.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.411 ' C ' HE22 ' A' ' 91' ' ' GLN . 26.5 t70 71.73 145.13 0.07 Allowed 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 127.207 2.203 . . . . 0.0 112.938 -169.204 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -132.88 -1.57 3.34 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.702 1.601 . . . . 0.0 111.889 175.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -160.29 -45.8 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 120.058 1.299 . . . . 0.0 113.797 -171.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.03 -55.14 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.697 1.199 . . . . 0.0 108.561 -175.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -132.88 146.9 63.3 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 125.858 1.663 . . . . 0.0 108.256 -177.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -63.88 145.98 91.01 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 123.046 2.497 . . . . 0.0 112.84 -173.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -147.07 162.81 38.06 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 126.4 1.88 . . . . 0.0 107.436 174.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 62.0 mt 53.49 26.18 5.35 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.76 1.224 . . . . 0.0 111.694 -172.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 87.7 m -53.83 -52.43 60.39 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 125.099 1.36 . . . . 0.0 111.012 -169.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -71.44 -32.3 68.2 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 122.178 0.191 . . . . 0.0 110.786 -171.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -67.16 -44.03 80.75 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 122.995 0.518 . . . . 0.0 109.64 173.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 38.5 mtt180 -66.2 -42.83 88.27 Favored 'General case' 0 C--O 1.232 0.184 0 O-C-N 121.606 -0.684 . . . . 0.0 110.964 -177.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 28.3 m -69.09 -35.52 68.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-O 118.148 -0.929 . . . . 0.0 109.809 178.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -60.07 -49.96 75.61 Favored 'General case' 0 C--N 1.342 0.279 0 CA-C-N 120.469 1.486 . . . . 0.0 110.233 174.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 59.6 mttm -57.83 -40.01 79.04 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 118.132 0.424 . . . . 0.0 110.554 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 61.8 t90 -72.09 -45.35 61.02 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 117.872 0.305 . . . . 0.0 110.745 -177.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 75.7 t -63.68 -34.81 70.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 O-C-N 121.489 -0.757 . . . . 0.0 109.716 -179.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -62.75 -34.61 77.56 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 118.455 -0.783 . . . . 0.0 110.714 177.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -62.67 -57.19 11.88 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.992 0.814 . . . . 0.0 110.053 171.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 6.9 pt -65.61 -30.27 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 118.828 0.74 . . . . 0.0 110.369 -171.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 49.4 m -58.74 -29.09 66.46 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 117.711 -1.138 . . . . 0.0 112.151 178.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -96.86 -13.32 22.6 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 120.456 1.48 . . . . 0.0 113.118 175.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -82.82 -39.67 21.39 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 118.972 0.806 . . . . 0.0 110.34 173.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 1.9 mp -90.24 -12.61 37.47 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.556 1.942 . . . . 0.0 110.719 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 57.19 30.52 18.5 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.731 1.612 . . . . 0.0 112.703 -169.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 55.2 mt -68.92 -18.91 64.17 Favored 'General case' 0 N--CA 1.467 0.403 0 O-C-N 121.434 -0.791 . . . . 0.0 110.476 169.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -54.34 -39.48 67.14 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.541 0.736 . . . . 0.0 110.353 173.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -71.76 -4.92 30.42 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 121.575 -0.703 . . . . 0.0 112.442 -178.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 22.6 mt -109.8 -54.66 5.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 125.176 1.39 . . . . 0.0 108.446 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.5 pp -79.16 -24.08 43.51 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.347 0.659 . . . . 0.0 112.179 -173.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -126.0 40.1 3.81 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.591 1.956 . . . . 0.0 108.71 -177.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.22 0 CA-C-O 118.304 -0.855 . . . . 0.0 109.367 174.603 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.5 ptp . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 120.959 0.409 . . . . 0.0 111.691 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -66.34 159.94 25.7 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.495 0.718 . . . . 0.0 110.597 174.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.0 pt -74.51 -29.93 24.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 O-C-N 122.144 -0.347 . . . . 0.0 110.987 178.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.3 m -110.25 136.01 50.12 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 124.637 1.175 . . . . 0.0 109.338 -179.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -108.21 118.96 5.55 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 107.299 -2.32 . . . . 0.0 107.299 168.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 39.8 mt -92.83 127.49 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 104.573 -2.38 . . . . 0.0 104.573 169.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -122.87 128.94 51.03 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 176.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -123.53 127.11 47.87 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 118.979 0.809 . . . . 0.0 112.376 -177.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -87.28 141.54 17.56 Favored Glycine 0 C--N 1.338 0.692 0 N-CA-C 108.35 -1.9 . . . . 0.0 108.35 167.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 37.8 m -153.15 166.44 32.49 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.716 1.758 . . . . 0.0 110.534 176.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -145.76 -51.65 0.25 Allowed 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.283 1.033 . . . . 0.0 109.794 169.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.9 p -80.77 -15.14 57.23 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.815 0.846 . . . . 0.0 112.058 172.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.22 32.09 6.9 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 124.491 1.043 . . . . 0.0 113.058 172.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -82.58 -52.73 6.55 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 118.423 1.112 . . . . 0.0 111.772 176.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -67.58 -23.62 65.42 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 121.588 -0.695 . . . . 0.0 112.441 -167.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -60.67 -35.65 76.77 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.283 0.947 . . . . 0.0 111.032 175.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -70.09 -42.79 72.26 Favored 'General case' 0 C--N 1.34 0.16 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 26.5 mm -61.77 -42.14 93.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 178.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.13 -41.88 93.62 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 121.517 -0.739 . . . . 0.0 111.017 178.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -67.72 -39.26 84.31 Favored 'General case' 0 CA--C 1.53 0.198 0 O-C-N 121.77 -0.581 . . . . 0.0 110.77 176.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 75.2 mtp -64.62 -30.01 71.03 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 119.283 0.947 . . . . 0.0 111.653 177.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 58.9 mt -70.4 -55.99 12.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 170.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -59.13 -32.97 70.33 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 121.323 -0.861 . . . . 0.0 112.386 -173.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -66.65 -34.85 78.78 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 120.039 1.29 . . . . 0.0 111.487 179.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -75.57 -39.65 57.81 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.015 0.526 . . . . 0.0 110.663 175.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -75.26 -39.79 59.44 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.807 0.843 . . . . 0.0 111.383 -174.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.53 141.57 5.87 Favored Glycine 0 CA--C 1.531 1.034 0 N-CA-C 108.818 -1.713 . . . . 0.0 108.818 -167.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 58.3 tttp -62.1 -31.08 71.48 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 121.643 -0.916 . . . . 0.0 111.722 -172.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -65.06 -29.53 70.43 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 123.071 0.548 . . . . 0.0 111.74 178.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.2 t -92.7 -38.24 9.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 123.755 0.822 . . . . 0.0 109.68 -178.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -139.04 125.71 20.72 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 119.411 1.005 . . . . 0.0 112.028 178.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -103.31 159.58 15.43 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.408 0.683 . . . . 0.0 110.191 173.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 51.1 t -121.7 129.35 75.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 124.234 1.013 . . . . 0.0 109.971 -169.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -144.9 172.43 13.04 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.887 1.675 . . . . 0.0 111.736 -173.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -125.88 136.81 53.49 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 175.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.5 tp -60.86 -25.99 37.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 O-C-N 121.435 -0.791 . . . . 0.0 111.633 -174.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -55.03 -36.36 65.44 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.578 1.151 . . . . 0.0 112.05 178.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -105.31 0.78 27.39 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.885 1.274 . . . . 0.0 111.912 -178.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 18.4 m -88.14 175.0 7.91 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.941 0.896 . . . . 0.0 109.654 177.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 70.7 m -153.85 162.4 41.26 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 120.888 -1.132 . . . . 0.0 109.483 179.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -51.0 -47.85 61.52 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.849 1.26 . . . . 0.0 111.178 -176.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -73.67 -24.39 59.97 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.459 -174.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -77.74 -35.58 51.67 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 122.818 0.447 . . . . 0.0 110.513 176.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -64.28 -50.46 67.82 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.498 0.719 . . . . 0.0 110.34 178.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -67.74 -19.27 65.11 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -172.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.51 -29.93 69.47 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.153 0.981 . . . . 0.0 112.667 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -75.25 159.57 31.38 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 123.827 0.851 . . . . 0.0 109.861 175.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -110.21 -22.23 11.86 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.309 0.644 . . . . 0.0 112.218 170.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.0 mp -120.71 132.56 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 175.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 97.4 mt -126.87 125.66 41.99 Favored 'General case' 0 CA--C 1.519 -0.232 0 C-N-CA 124.081 0.953 . . . . 0.0 108.865 -178.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 7.4 mp -114.11 107.92 16.29 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 176.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 66.7 mt -110.54 107.71 17.43 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 -170.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.43 117.94 5.44 Favored Glycine 0 C--N 1.331 0.285 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 17.5 tt -131.61 118.22 16.75 Favored Pre-proline 0 CA--C 1.539 0.523 0 CA-C-N 118.034 0.917 . . . . 0.0 110.408 -177.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -83.33 147.19 12.66 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.754 2.302 . . . . 0.0 108.427 168.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 54.5 m -99.29 143.52 29.45 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 177.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 68.2 m95 -136.13 171.15 14.9 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 125.731 1.612 . . . . 0.0 110.242 -174.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.423 ' CE1' HM73 ' A' ' 201' ' ' FMN . 69.1 m-85 25.83 72.17 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 128.062 2.545 . . . . 0.0 114.394 169.351 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 56.69 54.6 7.13 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.128 0.971 . . . . 0.0 111.81 174.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 82.8 13.3 78.19 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-O 119.388 -0.673 . . . . 0.0 114.326 171.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -74.39 154.08 38.97 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.511 1.156 . . . . 0.0 109.873 169.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.56 165.9 23.18 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 123.508 0.723 . . . . 0.0 110.571 170.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 14.9 tm0? -61.91 145.18 53.62 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 169.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 52.4 m -60.12 -37.2 79.32 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 114.959 1.466 . . . . 0.0 114.959 -167.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -76.09 -38.21 57.25 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 118.632 0.651 . . . . 0.0 109.281 -177.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -62.77 -47.26 84.29 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.185 0.594 . . . . 0.0 109.543 173.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -59.0 -40.36 84.66 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.598 0.759 . . . . 0.0 111.431 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -69.01 -31.76 70.81 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.245 0.618 . . . . 0.0 112.098 176.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -84.84 -21.84 29.68 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 117.889 -1.053 . . . . 0.0 112.647 -177.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 18.2 m-30 -48.37 -44.65 65.06 Favored Pre-proline 0 CA--C 1.544 0.735 0 CA-C-N 121.005 1.729 . . . . 0.0 115.114 -178.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.07 -16.36 54.85 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 CA-C-N 122.731 2.011 . . . . 0.0 113.897 176.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 31.5 m -91.46 -35.14 14.51 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.185 0.994 . . . . 0.0 109.643 169.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.45 ' HA ' HD12 ' A' ' 76' ' ' ILE . 17.0 tp -59.39 -39.17 82.52 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.222 1.009 . . . . 0.0 110.491 -178.339 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -73.66 -7.99 54.19 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -93.51 -1.55 55.46 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 119.619 1.1 . . . . 0.0 111.344 178.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.45 HD12 ' HA ' ' A' ' 73' ' ' LEU . 66.7 mt -92.37 146.03 6.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 -175.427 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -86.13 121.22 28.42 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 172.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -114.08 10.54 17.45 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 118.3 -0.857 . . . . 0.0 111.715 175.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 31.6 m-80 -59.32 117.36 4.71 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 120.269 1.395 . . . . 0.0 109.791 -172.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 72.84 -1.04 41.19 Favored Glycine 0 CA--C 1.534 1.28 0 CA-C-O 118.689 -1.062 . . . . 0.0 114.212 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -72.27 144.96 48.21 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 119.602 1.701 . . . . 0.0 108.024 172.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 35.7 mt -85.17 133.51 34.19 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 177.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.1 t -132.1 135.86 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 176.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -129.35 143.9 51.03 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 175.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 67.1 mt -118.94 148.19 43.22 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -175.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -145.65 153.69 41.3 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 123.205 0.602 . . . . 0.0 110.614 175.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -174.64 164.56 35.5 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-O 121.701 0.612 . . . . 0.0 112.683 179.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 24.9 p -121.27 167.67 12.47 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 125.418 1.487 . . . . 0.0 109.253 175.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -163.74 -160.18 11.45 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 114.271 0.468 . . . . 0.0 114.271 -177.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -143.42 153.67 42.9 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 126.622 1.969 . . . . 0.0 109.991 -175.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -138.28 7.66 2.64 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.865 0.866 . . . . 0.0 112.519 168.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -69.11 -33.28 73.24 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.58 1.082 . . . . 0.0 109.285 173.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -135.22 -36.7 0.8 Allowed 'General case' 0 C--O 1.234 0.285 0 C-N-CA 123.002 0.521 . . . . 0.0 112.17 171.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -89.78 29.98 1.1 Allowed 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 118.562 0.619 . . . . 0.0 112.604 -173.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.32 -31.8 71.66 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.189 0.996 . . . . 0.0 112.801 -174.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -79.92 1.16 28.35 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.266 1.026 . . . . 0.0 112.071 178.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -134.95 19.8 3.48 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.597 1.559 . . . . 0.0 109.896 -176.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -65.59 114.82 5.2 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -171.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 72.6 m 51.27 34.99 12.55 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.54 1.536 . . . . 0.0 113.203 -173.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -50.6 -44.54 57.06 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.672 1.189 . . . . 0.0 111.489 -179.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.84 -12.88 62.01 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 -169.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 90.0 mt -58.55 -39.68 80.93 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 118.893 0.77 . . . . 0.0 109.707 169.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.9 -32.08 83.04 Favored Glycine 0 CA--C 1.528 0.848 0 N-CA-C 111.412 -0.675 . . . . 0.0 111.412 178.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.6 m -65.85 -38.58 89.24 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.358 1.079 . . . . 0.0 110.334 178.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 7.0 mt -71.82 -42.49 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 119.105 0.866 . . . . 0.0 109.004 175.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 47.5 ttt180 -53.46 -45.43 69.55 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 119.408 1.003 . . . . 0.0 110.334 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -63.85 -20.07 65.53 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.026 0.93 . . . . 0.0 112.81 -177.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 96.4 mt -92.09 -48.77 13.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 123.974 0.91 . . . . 0.0 109.661 176.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.5 pt -78.07 -33.85 18.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-N 118.921 0.782 . . . . 0.0 111.979 -168.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -70.76 -43.91 15.43 Favored Pre-proline 0 CA--C 1.544 0.715 0 CA-C-O 117.962 -1.018 . . . . 0.0 111.269 -172.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -64.6 -31.42 59.92 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.032 1.821 . . . . 0.0 113.132 173.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? -75.81 6.51 4.92 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.019 0.928 . . . . 0.0 112.259 172.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 78.52 20.16 72.24 Favored Glycine 0 CA--C 1.527 0.828 0 CA-C-O 118.686 -1.064 . . . . 0.0 114.082 169.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -59.75 142.42 53.25 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 118.725 1.263 . . . . 0.0 109.857 170.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 37.6 m -89.1 116.45 27.37 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 104.461 -2.422 . . . . 0.0 104.461 168.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 38.9 mt -90.92 130.53 39.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 -176.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 3.7 m -137.44 165.86 26.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 126.103 1.761 . . . . 0.0 108.487 -177.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 74.49 31.44 58.87 Favored Glycine 0 CA--C 1.524 0.616 0 CA-C-O 119.141 -0.811 . . . . 0.0 112.293 -175.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 83.9 m-70 -58.48 134.08 56.36 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 169.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 70.8 t-105 -113.38 124.96 30.36 Favored Pre-proline 0 C--O 1.235 0.296 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -169.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -67.95 140.31 49.87 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 121.254 1.303 . . . . 0.0 110.632 -173.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 81.1 p -74.5 -21.24 59.65 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.186 0.594 . . . . 0.0 110.876 176.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 52.52 44.05 30.41 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 126.154 1.781 . . . . 0.0 110.974 -174.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 78.69 77.49 0.88 Allowed Glycine 0 C--N 1.338 0.653 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 -171.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -43.53 131.79 4.95 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.449 1.1 . . . . 0.0 111.222 171.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 42.2 t60 -147.99 32.49 0.84 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.736 0.815 . . . . 0.0 111.175 -175.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -112.14 -178.56 3.45 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.03 1.332 . . . . 0.0 107.856 177.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -83.92 -54.91 4.53 Favored 'General case' 0 C--O 1.236 0.365 0 O-C-N 121.397 -0.815 . . . . 0.0 111.989 -168.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -156.71 140.35 15.97 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 119.131 0.878 . . . . 0.0 111.043 170.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 73.5 m -142.09 111.62 6.61 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 124.953 1.301 . . . . 0.0 107.857 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -77.89 -11.41 59.89 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 122.2 -0.313 . . . . 0.0 110.882 -173.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -78.46 0.19 76.54 Favored Glycine 0 CA--C 1.533 1.164 0 CA-C-O 118.404 -1.22 . . . . 0.0 113.798 169.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 65.0 mt -62.31 125.73 24.89 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 120.869 2.335 . . . . 0.0 108.618 171.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -91.82 -32.55 15.31 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.714 0.806 . . . . 0.0 109.541 170.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -149.78 163.02 39.1 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 127.227 2.211 . . . . 0.0 106.848 172.094 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -55.29 -29.55 58.41 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.392 -0.817 . . . . 0.0 112.243 175.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -90.49 -12.39 37.42 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.216 1.007 . . . . 0.0 113.486 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -147.58 128.23 14.22 Favored 'General case' 0 C--N 1.346 0.434 0 CA-C-N 119.991 1.269 . . . . 0.0 113.399 -170.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -78.45 152.32 32.19 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 166.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 10.7 p -58.15 -28.68 35.13 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 C-N-CA 124.824 1.249 . . . . 0.0 111.49 175.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -157.8 175.83 35.0 Favored Glycine 0 C--N 1.336 0.56 0 C-N-CA 125.048 1.309 . . . . 0.0 110.219 -174.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -56.96 126.6 27.87 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 124.101 0.96 . . . . 0.0 108.611 178.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -136.47 112.52 9.68 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 -179.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 33.3 pt -123.07 128.79 75.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-O 122.272 1.034 . . . . 0.0 113.038 -173.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -166.46 163.0 17.23 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 128.88 2.872 . . . . 0.0 105.821 169.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -130.79 -24.43 2.43 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.929 0.892 . . . . 0.0 112.014 171.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -168.57 -53.48 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.204 1.402 . . . . 0.0 108.244 179.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 21.6 ttm180 -152.14 112.39 4.08 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 105.423 -2.066 . . . . 0.0 105.423 168.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 67.1 149.48 0.12 Allowed Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 126.366 1.866 . . . . 0.0 111.153 -175.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -75.91 158.08 38.73 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 121.838 1.692 . . . . 0.0 113.38 -170.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -135.56 170.12 16.46 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 126.261 1.824 . . . . 0.0 106.527 167.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 23.5 mt 56.19 24.6 8.24 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.192 0.997 . . . . 0.0 111.192 -168.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 99.1 m -53.81 -50.66 65.65 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 125.697 1.599 . . . . 0.0 110.861 -169.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -71.64 -34.52 69.84 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 119.075 -0.488 . . . . 0.0 111.063 -171.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -67.53 -43.96 79.51 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 118.507 0.594 . . . . 0.0 109.687 175.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 52.1 mtt180 -64.61 -43.2 94.53 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 121.933 -0.48 . . . . 0.0 110.633 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 58.1 t -67.82 -40.18 83.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-O 118.247 -0.883 . . . . 0.0 109.8 178.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -60.69 -47.48 86.07 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 120.612 1.551 . . . . 0.0 109.909 176.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 59.3 mttm -57.98 -45.89 86.06 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 118.331 0.514 . . . . 0.0 110.184 178.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 55.1 t90 -65.62 -45.78 81.79 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 118.109 0.413 . . . . 0.0 110.513 -177.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 55.6 t -62.56 -38.64 81.98 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 C-N-CA 123.046 0.538 . . . . 0.0 110.202 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -69.8 -36.05 75.36 Favored 'General case' 0 CA--C 1.532 0.265 0 O-C-N 121.224 -0.923 . . . . 0.0 110.256 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 20.5 mm100 -64.61 -52.09 59.25 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.652 0.66 . . . . 0.0 110.634 174.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 12.3 pt -64.22 -32.69 58.46 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 CA-C-N 119.51 1.05 . . . . 0.0 110.787 -178.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 57.2 m -56.05 -36.07 67.63 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.287 0.949 . . . . 0.0 112.172 176.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -87.62 -27.17 22.67 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.9 1.227 . . . . 0.0 112.24 177.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -68.55 -32.02 71.65 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 119.357 0.981 . . . . 0.0 110.73 173.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 1.8 mp -82.69 -3.68 56.73 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.458 1.903 . . . . 0.0 110.89 174.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 54.8 35.12 23.41 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 126.126 1.771 . . . . 0.0 112.379 -177.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 70.1 mt -63.48 -27.86 69.57 Favored 'General case' 0 N--CA 1.464 0.273 0 O-C-N 121.314 -0.866 . . . . 0.0 111.301 -177.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -59.89 -37.7 80.15 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 118.346 0.521 . . . . 0.0 110.92 177.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -67.74 -21.75 65.26 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.002 0.521 . . . . 0.0 111.498 178.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 14.8 mm -86.81 -50.01 14.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 124.091 0.957 . . . . 0.0 108.428 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.6 pp -75.41 -28.37 59.38 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -172.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -98.45 17.18 19.54 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.562 1.145 . . . . 0.0 111.719 -178.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.351 0 C-N-CA 123.554 0.742 . . . . 0.0 109.569 174.47 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' FMN . . . . . 0.423 HM73 ' CE1' ' A' ' 58' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.1 ttp . . . . . 0 N--CA 1.487 1.421 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -60.83 141.89 56.64 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.184 0.593 . . . . 0.0 111.372 -177.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.5 pt -104.45 -24.84 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 126.051 1.741 . . . . 0.0 110.587 178.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 51.6 m -105.79 125.9 51.54 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.142 1.377 . . . . 0.0 108.547 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -100.36 116.02 5.46 Favored Glycine 0 C--N 1.331 0.295 0 N-CA-C 107.082 -2.407 . . . . 0.0 107.082 168.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 35.0 mt -92.57 122.27 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 104.304 -2.48 . . . . 0.0 104.304 172.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -118.21 128.11 54.39 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 106.633 -1.618 . . . . 0.0 106.633 176.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -123.81 132.66 53.82 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 118.574 0.625 . . . . 0.0 111.247 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -86.36 142.32 18.75 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 108.205 -1.958 . . . . 0.0 108.205 168.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.9 m -160.62 160.41 31.63 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 119.233 1.517 . . . . 0.0 110.815 173.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -137.31 -47.14 0.57 Allowed 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.89 1.276 . . . . 0.0 109.525 169.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.2 p -80.99 -12.58 59.35 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.323 1.049 . . . . 0.0 112.162 170.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.41 10.86 53.21 Favored Glycine 0 C--N 1.343 0.946 0 C-N-CA 124.799 1.19 . . . . 0.0 113.884 170.166 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -66.28 -47.76 72.62 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 118.835 1.318 . . . . 0.0 112.158 -172.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.1 m -74.52 -14.93 60.87 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -168.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -56.15 -43.38 78.24 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.683 0.674 . . . . 0.0 109.755 171.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -68.78 -37.63 79.44 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 121.772 -0.58 . . . . 0.0 109.906 -177.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 29.7 mm -63.83 -43.33 97.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 176.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.36 -38.92 85.39 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.58 -0.7 . . . . 0.0 110.942 177.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -68.28 -40.62 81.75 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 118.177 -0.916 . . . . 0.0 111.342 175.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 63.9 mtt -58.98 -34.26 71.63 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 120.027 1.285 . . . . 0.0 111.051 175.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 55.6 mt -71.45 -53.96 18.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 175.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -61.49 -37.03 82.19 Favored 'General case' 0 N--CA 1.462 0.161 0 O-C-N 121.364 -0.835 . . . . 0.0 111.827 -173.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -63.55 -35.72 81.41 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 119.202 0.91 . . . . 0.0 111.088 -178.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -75.33 -41.79 55.88 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 122.902 0.481 . . . . 0.0 111.05 177.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -72.47 -34.24 67.58 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 122.73 0.412 . . . . 0.0 111.083 -177.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.43 145.07 8.52 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 -169.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -58.78 -33.98 70.93 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 122.015 -0.697 . . . . 0.0 112.078 -175.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -74.64 -11.75 60.27 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.26 -174.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.2 t -106.65 -42.09 6.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 124.337 1.055 . . . . 0.0 109.586 178.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -129.4 140.25 51.4 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 119.473 1.033 . . . . 0.0 111.482 -178.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -122.58 155.29 36.6 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.556 1.142 . . . . 0.0 109.473 177.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 77.6 t -119.7 130.33 74.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 124.234 1.014 . . . . 0.0 110.071 -169.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -146.79 177.61 8.97 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.857 1.663 . . . . 0.0 111.551 -172.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -133.81 130.22 37.64 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 126.884 2.074 . . . . 0.0 105.764 178.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.2 tp -60.56 -21.35 23.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 C-N-CA 123.496 0.719 . . . . 0.0 112.137 -172.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.6 -29.52 68.03 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 118.893 0.77 . . . . 0.0 111.322 177.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -81.08 -26.75 36.04 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.097 0.559 . . . . 0.0 111.438 177.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 62.7 m -71.89 159.48 34.2 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 122.129 0.966 . . . . 0.0 112.427 -168.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 23.5 m -130.07 175.34 8.97 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.849 2.059 . . . . 0.0 107.054 173.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -53.01 -45.63 68.01 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.236 0.615 . . . . 0.0 112.002 -172.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -81.6 -11.8 58.99 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 -175.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -70.8 -32.6 69.74 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 118.98 0.809 . . . . 0.0 111.304 -176.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -69.33 -43.71 73.16 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 123.429 0.692 . . . . 0.0 109.392 173.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 77.9 mt-10 -70.79 -11.66 61.08 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.932 0.893 . . . . 0.0 112.049 -171.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.88 -29.26 69.68 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.08 0.952 . . . . 0.0 111.907 173.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -98.34 153.6 18.43 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.854 1.262 . . . . 0.0 110.348 -178.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -99.54 -27.91 13.48 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.567 174.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.2 mp -113.84 129.79 69.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 174.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -114.15 125.71 54.25 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 107.086 -1.449 . . . . 0.0 107.086 175.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.3 mp -111.89 112.35 23.94 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 173.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.1 mt -112.9 112.28 23.64 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -169.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -100.82 115.15 5.21 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 125.602 1.572 . . . . 0.0 110.126 -178.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 16.2 tt -123.02 118.17 28.2 Favored Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 118.442 1.121 . . . . 0.0 111.71 -173.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -79.63 138.19 13.37 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 121.731 1.621 . . . . 0.0 108.039 167.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 79.7 m -94.39 143.71 26.17 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 174.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 66.2 m95 -134.25 173.74 11.27 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 126.082 1.753 . . . . 0.0 109.414 -177.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 24.4 t80 32.26 64.69 0.23 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 127.902 2.481 . . . . 0.0 114.364 169.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 54.58 53.69 10.33 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.816 0.847 . . . . 0.0 111.738 171.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 82.79 55.78 2.9 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 123.551 0.596 . . . . 0.0 112.085 174.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -128.99 155.87 44.7 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 125.846 1.658 . . . . 0.0 108.355 170.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.13 161.83 27.09 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 123.133 0.573 . . . . 0.0 110.252 172.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 34.1 tp60 -67.33 143.94 56.11 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 169.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 58.4 m -55.62 -35.23 65.65 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.815 0.846 . . . . 0.0 112.51 -172.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -64.76 -41.06 96.17 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.291 0.637 . . . . 0.0 110.444 -178.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -73.31 -46.75 47.72 Favored 'General case' 0 C--N 1.34 0.185 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 177.082 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -58.26 -36.24 72.94 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.582 0.753 . . . . 0.0 112.155 -177.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -69.9 -23.58 63.26 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.736 0.815 . . . . 0.0 112.552 177.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -100.39 -15.64 17.89 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.219 1.007 . . . . 0.0 112.025 -177.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 12.8 m-30 -48.4 -45.94 68.18 Favored Pre-proline 0 CA--C 1.542 0.668 0 CA-C-O 117.09 -1.433 . . . . 0.0 113.119 171.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -65.04 -20.93 63.83 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 CA-C-N 122.577 1.956 . . . . 0.0 113.116 176.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.8 m -82.75 -35.6 26.47 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 119.589 1.086 . . . . 0.0 110.047 174.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 71.8 mt -56.91 -34.0 67.51 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 119.856 1.207 . . . . 0.0 111.205 178.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -82.53 -1.23 49.9 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 178.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -99.95 -29.58 12.49 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.122 0.969 . . . . 0.0 109.629 169.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 92.9 mt -66.4 142.91 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 C-N-CA 125.69 1.596 . . . . 0.0 107.93 177.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -88.14 130.53 35.01 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 123.547 0.739 . . . . 0.0 109.537 173.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -124.37 18.48 8.97 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.513 0.725 . . . . 0.0 111.741 172.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 23.1 m-80 -61.95 116.79 5.18 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 119.95 1.25 . . . . 0.0 109.554 -175.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.0 5.92 66.56 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-O 118.881 -0.955 . . . . 0.0 113.189 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 9.8 mmpt? -76.88 153.13 35.06 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 119.216 1.508 . . . . 0.0 107.26 172.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -95.05 141.02 29.17 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 173.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 15.5 t -134.89 146.38 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 175.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -137.59 146.88 44.55 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 170.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 75.5 mt -116.78 142.36 47.02 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -172.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -138.85 157.3 46.3 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 169.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -162.72 153.41 23.99 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-O 122.455 1.03 . . . . 0.0 112.835 -171.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 51.8 m -126.12 150.93 47.88 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 113.017 -1.592 . . . . 0.0 108.821 -168.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -177.46 175.99 47.84 Favored Glycine 0 CA--C 1.523 0.534 0 C-N-CA 121.035 -0.602 . . . . 0.0 113.544 -172.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -100.54 140.68 34.46 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 125.391 1.476 . . . . 0.0 109.007 171.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -130.15 37.85 3.85 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.219 1.007 . . . . 0.0 109.532 -179.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -113.07 -55.55 2.51 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 124.44 1.096 . . . . 0.0 108.443 172.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -113.75 -33.3 5.85 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.551 1.14 . . . . 0.0 111.198 -175.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -92.02 22.57 4.23 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.703 0.801 . . . . 0.0 112.357 -178.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.61 -33.61 74.2 Favored 'General case' 0 C--N 1.343 0.302 0 CA-C-N 120.023 1.283 . . . . 0.0 113.515 -169.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -65.03 -31.01 72.03 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 119.934 1.243 . . . . 0.0 110.284 175.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -100.18 9.17 43.19 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.745 1.618 . . . . 0.0 111.218 -177.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -65.97 118.76 10.23 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 119.114 0.87 . . . . 0.0 108.884 -169.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 60.6 m 53.24 28.71 7.45 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.967 1.307 . . . . 0.0 112.789 -175.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -53.71 -36.48 62.29 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.73 1.212 . . . . 0.0 111.731 -176.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.72 -11.78 61.15 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -174.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 32.1 mt -54.38 -47.86 72.18 Favored 'General case' 0 C--N 1.344 0.353 0 CA-C-N 119.148 0.885 . . . . 0.0 110.47 173.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.0 -29.23 74.29 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 111.745 -0.542 . . . . 0.0 111.745 -176.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.8 m -63.63 -37.63 88.06 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 117.76 0.78 . . . . 0.0 110.049 177.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 5.8 mt -67.87 -44.17 85.5 Favored 'Isoleucine or valine' 0 C--N 1.344 0.346 0 CA-C-O 117.781 -1.104 . . . . 0.0 108.938 177.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 57.7 ttp85 -56.27 -46.74 79.58 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 120.032 1.287 . . . . 0.0 110.041 177.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -59.82 -28.18 67.24 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -178.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 80.0 mt -84.28 -45.67 18.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 124.38 1.072 . . . . 0.0 110.688 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 10.5 pt -85.83 -28.1 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 119.508 1.049 . . . . 0.0 112.584 -169.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -63.56 -42.12 70.85 Favored Pre-proline 0 CA--C 1.548 0.868 0 CA-C-O 117.814 -1.089 . . . . 0.0 111.434 -174.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -61.54 -20.02 67.01 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 122.727 2.285 . . . . 0.0 114.19 172.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 23.9 mmm180 -86.9 5.01 39.09 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.065 0.946 . . . . 0.0 111.44 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 75.73 17.53 80.06 Favored Glycine 0 CA--C 1.529 0.945 0 CA-C-O 118.51 -1.161 . . . . 0.0 113.03 178.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -59.1 137.76 57.82 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 118.809 1.305 . . . . 0.0 109.482 169.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 36.6 m -94.18 126.57 39.5 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 169.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 57.1 mt -105.22 132.6 51.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -174.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 27.1 m -129.01 176.35 8.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 125.737 1.615 . . . . 0.0 108.523 172.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 80.78 26.58 53.37 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-O 119.043 -0.865 . . . . 0.0 114.023 175.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 65.1 m80 -62.3 130.45 45.38 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 168.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 65.2 t-105 -107.64 124.56 34.59 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-O 118.258 -0.877 . . . . 0.0 108.787 -169.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -71.29 146.86 51.98 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 121.501 1.468 . . . . 0.0 112.144 -172.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 33.2 p -77.37 -39.69 46.47 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.874 0.87 . . . . 0.0 111.242 179.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 50.13 47.7 23.15 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.35 1.46 . . . . 0.0 111.628 -172.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.06 61.76 2.6 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -179.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 80.6 t80 -75.43 -79.28 0.1 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.814 0.845 . . . . 0.0 109.615 178.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 34.7 t60 43.98 45.76 6.67 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.467 1.907 . . . . 0.0 112.826 177.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 30.1 t80 -78.4 -65.41 0.99 Allowed 'General case' 0 C--N 1.342 0.242 0 O-C-N 121.864 -0.522 . . . . 0.0 109.891 -173.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -126.54 -99.21 0.39 Allowed 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 168.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -157.02 42.49 0.34 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 122.66 1.219 . . . . 0.0 110.328 -174.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 8.4 m -58.73 122.69 14.15 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 113.42 -1.718 . . . . 0.0 112.129 -168.12 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.41 -9.81 57.4 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -175.232 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -64.75 -18.73 64.38 Favored Glycine 0 CA--C 1.536 1.404 0 CA-C-N 119.407 1.003 . . . . 0.0 112.295 169.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 91.7 mt -64.44 130.29 43.17 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.809 1.304 . . . . 0.0 109.237 175.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -93.7 -33.44 13.64 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.472 0.709 . . . . 0.0 109.386 168.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -149.87 165.78 31.53 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 126.717 2.007 . . . . 0.0 107.638 177.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -55.67 -26.79 46.54 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 121.717 -0.614 . . . . 0.0 112.108 172.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -90.55 -19.3 23.92 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.891 1.276 . . . . 0.0 114.216 -179.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 24.0 p80 -156.74 147.34 21.56 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 120.481 1.491 . . . . 0.0 114.311 -176.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -82.72 151.17 26.31 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 126.215 1.806 . . . . 0.0 108.607 168.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 5.8 p -69.19 -16.96 21.33 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 122.856 0.462 . . . . 0.0 111.612 179.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -157.45 174.06 34.91 Favored Glycine 0 C--N 1.339 0.742 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 178.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -67.08 105.63 1.73 Allowed 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 123.542 0.737 . . . . 0.0 109.219 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -82.66 131.07 35.21 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 168.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 41.5 pt -63.52 -17.44 20.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -173.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -135.27 163.69 29.42 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.985 1.314 . . . . 0.0 110.651 -174.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -133.96 -14.73 2.37 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.402 1.881 . . . . 0.0 111.906 173.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -154.06 105.04 2.69 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 121.012 1.733 . . . . 0.0 112.332 -169.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 13.9 tpt180 45.95 72.56 0.21 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.721 2.009 . . . . 0.0 113.192 169.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 67.08 148.07 0.11 Allowed Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 127.83 2.452 . . . . 0.0 113.024 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -60.15 130.15 33.09 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 122.598 2.199 . . . . 0.0 114.535 -167.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -154.17 154.04 32.85 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 127.126 2.171 . . . . 0.0 105.24 167.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 47.5 mt 57.19 30.11 17.81 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 119.284 0.947 . . . . 0.0 112.002 -172.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 87.4 m -59.42 -51.35 70.26 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 125.159 1.384 . . . . 0.0 111.118 -176.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -67.53 -31.92 72.35 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 119.398 -0.334 . . . . 0.0 111.01 -169.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 24.8 mp0 -60.81 -43.72 97.83 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.513 1.125 . . . . 0.0 109.813 174.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 68.4 mtt85 -62.8 -42.69 99.82 Favored 'General case' 0 N--CA 1.466 0.347 0 O-C-N 121.573 -0.705 . . . . 0.0 110.506 175.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 58.1 t -66.64 -37.88 80.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-O 118.753 -0.641 . . . . 0.0 109.494 -179.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -62.03 -51.04 69.59 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 120.215 1.37 . . . . 0.0 110.012 175.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 61.1 mttm -58.51 -42.63 88.14 Favored 'General case' 0 CA--C 1.529 0.153 0 O-C-N 122.119 -0.363 . . . . 0.0 110.43 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 58.0 t90 -67.85 -47.51 68.77 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 118.131 0.423 . . . . 0.0 110.641 -177.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 50.9 t -60.64 -37.91 76.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 118.365 0.53 . . . . 0.0 110.104 -178.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 56.0 mttm -64.99 -46.8 79.92 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 121.637 -0.665 . . . . 0.0 109.275 176.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 6.1 mm-40 -59.86 -46.95 87.66 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 118.695 0.679 . . . . 0.0 111.819 179.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 18.5 pt -68.74 -32.11 53.57 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.19 0 CA-C-N 119.329 0.968 . . . . 0.0 110.212 -178.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 36.0 m -61.69 -32.16 72.34 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 119.033 0.833 . . . . 0.0 110.927 172.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -72.12 -44.42 63.2 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.442 1.019 . . . . 0.0 110.192 174.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -66.75 -35.62 80.52 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.168 0.587 . . . . 0.0 111.466 -178.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 86.3 mt -84.28 -3.12 58.03 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.533 1.533 . . . . 0.0 111.452 178.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 54.53 28.24 9.48 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.837 1.655 . . . . 0.0 112.811 -173.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 85.8 mt -78.47 -26.31 46.07 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 123.233 0.613 . . . . 0.0 109.846 170.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -59.04 -39.12 81.01 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 122.901 0.481 . . . . 0.0 110.319 176.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -61.55 -23.51 66.02 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.625 0.77 . . . . 0.0 111.934 177.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 43.4 mt -89.32 -52.7 10.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 124.308 1.043 . . . . 0.0 108.217 -179.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 3.0 pp -76.89 -22.47 53.38 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -170.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -74.8 -26.67 59.9 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 118.642 0.655 . . . . 0.0 112.016 179.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.189 0 C-N-CA 124.196 0.998 . . . . 0.0 110.335 -177.885 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.3 mtt . . . . . 0 N--CA 1.488 1.468 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -60.61 146.73 44.28 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.562 0.745 . . . . 0.0 111.487 -177.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.1 pt -113.45 -18.24 7.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 126.317 1.847 . . . . 0.0 111.045 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 40.9 m -109.92 124.29 51.11 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.565 1.546 . . . . 0.0 108.845 178.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -99.43 120.24 6.79 Favored Glycine 0 CA--C 1.522 0.469 0 N-CA-C 108.437 -1.865 . . . . 0.0 108.437 169.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 55.1 mt -97.67 94.21 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 104.773 -2.306 . . . . 0.0 104.773 177.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -97.1 108.53 21.29 Favored 'General case' 0 CA--C 1.52 -0.177 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 178.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -128.25 118.45 23.31 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 118.961 0.8 . . . . 0.0 109.755 -168.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -83.8 132.98 11.46 Favored Glycine 0 C--N 1.338 0.688 0 N-CA-C 110.376 -1.089 . . . . 0.0 110.376 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.1 m -137.78 161.22 37.14 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.292 1.437 . . . . 0.0 107.959 174.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -136.13 -50.92 0.7 Allowed 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.088 0.555 . . . . 0.0 110.008 169.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -81.74 -6.4 59.01 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.424 0.689 . . . . 0.0 111.778 170.484 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.33 11.65 51.13 Favored Glycine 0 C--N 1.345 1.034 0 C-N-CA 124.615 1.102 . . . . 0.0 115.138 167.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -73.47 -46.22 49.48 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 119.324 1.562 . . . . 0.0 111.822 -177.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.76 -39.08 93.02 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 118.8 0.727 . . . . 0.0 110.601 -168.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -64.13 -27.58 69.18 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.232 -0.918 . . . . 0.0 112.096 -178.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -66.72 -37.04 83.87 Favored 'General case' 0 N--CA 1.465 0.276 0 O-C-N 121.49 -0.756 . . . . 0.0 109.984 174.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.3 mm -67.61 -43.26 87.06 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.153 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 174.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.39 -38.5 71.57 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.912 0.778 . . . . 0.0 111.059 -179.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 68.6 mttt -67.19 -42.34 84.34 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 122.955 0.502 . . . . 0.0 110.833 175.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 77.3 mtm -67.15 -29.78 69.58 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 119.281 0.946 . . . . 0.0 111.883 177.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 70.6 mt -68.73 -53.92 24.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 173.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -59.33 -37.9 78.96 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.765 -0.584 . . . . 0.0 111.193 -176.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -63.44 -39.18 93.8 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 119.116 0.871 . . . . 0.0 110.952 -179.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -71.97 -41.62 67.5 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 122.697 0.399 . . . . 0.0 110.978 177.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.9 mp -73.82 -33.44 64.17 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 118.096 0.407 . . . . 0.0 111.174 -176.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.16 143.34 12.88 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 125.26 1.409 . . . . 0.0 110.58 -171.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -65.37 -29.0 69.67 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.735 -0.862 . . . . 0.0 111.794 -174.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -77.47 -7.57 56.4 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 122.942 0.497 . . . . 0.0 112.006 177.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.0 t -108.04 -41.03 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 C-N-CA 124.421 1.088 . . . . 0.0 109.569 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -132.82 147.53 52.31 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 119.512 1.051 . . . . 0.0 112.144 -175.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.3 t0 -132.71 151.31 52.01 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.515 0.726 . . . . 0.0 110.773 173.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 97.5 t -106.9 137.48 37.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 C-N-CA 124.87 1.268 . . . . 0.0 109.648 -169.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -145.11 164.78 30.22 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.615 1.566 . . . . 0.0 110.598 -171.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -131.02 134.38 46.63 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 175.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.407 ' HB ' ' CH2' ' A' ' 66' ' ' TRP . 1.3 tp -65.72 -26.36 38.69 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-O 118.514 -0.755 . . . . 0.0 113.003 -168.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.99 -29.58 68.64 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 119.287 0.949 . . . . 0.0 110.479 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -84.22 -28.75 27.06 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.417 0.687 . . . . 0.0 111.325 175.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.4 m -77.32 168.4 20.09 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.137 0.975 . . . . 0.0 111.621 -169.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.3 m -131.3 159.67 37.19 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.887 1.275 . . . . 0.0 110.138 -174.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -53.25 -47.58 68.94 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.676 1.19 . . . . 0.0 111.811 -175.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -80.81 -13.42 58.97 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 122.245 -0.284 . . . . 0.0 111.63 -174.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -76.68 -31.16 57.08 Favored 'General case' 0 C--O 1.234 0.267 0 O-C-N 121.534 -0.729 . . . . 0.0 111.566 -172.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.9 mp -66.22 -35.69 81.08 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 175.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -68.83 -13.43 62.41 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.348 0.659 . . . . 0.0 112.38 -174.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.15 -29.12 68.73 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.531 0.732 . . . . 0.0 111.484 174.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -94.22 147.61 23.01 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.162 0.985 . . . . 0.0 110.381 -177.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -91.38 -33.65 15.18 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.895 173.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.2 mp -107.82 134.52 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 176.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 96.8 mt -122.07 124.36 43.76 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 174.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.3 mp -105.79 110.08 22.25 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 104.956 -2.239 . . . . 0.0 104.956 169.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 73.9 mt -109.55 111.15 22.48 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 -173.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -96.25 123.31 7.66 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 -179.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 2.1 tp -137.12 100.87 9.45 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 125.067 1.347 . . . . 0.0 109.32 -171.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.25 142.52 30.51 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.204 1.936 . . . . 0.0 109.091 168.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 59.1 m -91.84 136.84 32.85 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 177.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 24.5 m95 -135.51 168.17 19.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 120.58 1.536 . . . . 0.0 112.605 -169.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 58.66 -61.69 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 130.707 3.603 . . . . 0.0 116.32 169.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -150.98 30.08 0.64 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.448 1.899 . . . . 0.0 110.44 -169.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 73.23 48.39 19.58 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 -171.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -123.98 175.75 6.76 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.58 1.552 . . . . 0.0 108.43 177.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -79.24 158.35 27.62 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.138 -0.976 . . . . 0.0 109.54 169.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -58.95 138.11 57.58 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 172.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 99.5 m -55.78 -40.21 72.34 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -167.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -73.73 -27.1 61.01 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.366 0.667 . . . . 0.0 111.705 -177.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.407 ' CH2' ' HB ' ' A' ' 36' ' ' ILE . 1.0 OUTLIER -77.79 -44.49 27.38 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.172 0.989 . . . . 0.0 109.541 174.194 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -58.65 -42.12 87.63 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.399 1.079 . . . . 0.0 111.06 176.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -61.8 -22.29 65.32 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.16 0.984 . . . . 0.0 112.2 177.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -90.85 -17.12 27.06 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 118.348 -0.834 . . . . 0.0 112.067 178.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 21.2 m-30 -54.98 -40.66 85.83 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-O 116.445 -1.741 . . . . 0.0 114.408 179.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -63.49 -20.27 69.43 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 CA-C-N 122.912 2.076 . . . . 0.0 113.24 173.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.4 m -82.44 -45.16 15.13 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.262 0.937 . . . . 0.0 109.14 170.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 12.9 tp -56.22 -40.16 73.63 Favored 'General case' 0 C--N 1.342 0.241 0 C-N-CA 125.077 1.351 . . . . 0.0 110.523 -175.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -72.39 -1.02 14.02 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -178.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -104.94 -12.0 16.42 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 119.647 1.112 . . . . 0.0 112.124 172.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 80.8 mt -78.23 142.04 14.67 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 -179.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -82.63 130.05 35.05 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 178.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -122.06 13.01 10.46 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 118.682 -0.675 . . . . 0.0 111.849 173.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -62.3 115.79 4.48 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-N 120.035 1.289 . . . . 0.0 108.754 -176.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 74.69 -0.72 55.7 Favored Glycine 0 CA--C 1.535 1.296 0 CA-C-O 118.459 -1.189 . . . . 0.0 114.095 -179.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -69.33 146.47 52.15 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 119.738 1.769 . . . . 0.0 107.288 169.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -90.03 137.34 32.42 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 170.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.0 t -131.97 142.35 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 177.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -131.27 141.45 49.98 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 170.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 73.3 mt -110.66 149.98 29.67 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -176.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.454 ' CE2' HD12 ' A' ' 142' ' ' LEU . 14.4 t80 -141.53 147.49 37.84 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 -179.373 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -164.96 137.58 4.79 Favored Glycine 0 CA--C 1.522 0.5 0 CA-C-N 119.216 0.916 . . . . 0.0 110.936 169.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 4.5 p -95.11 152.81 18.02 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 168.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -145.33 -158.36 7.63 Favored Glycine 0 CA--C 1.525 0.702 0 CA-C-O 121.048 0.249 . . . . 0.0 113.019 -173.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -146.9 145.38 29.8 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 127.504 2.322 . . . . 0.0 107.85 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -133.14 12.39 4.24 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.37 1.468 . . . . 0.0 109.931 177.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -81.9 -47.05 13.24 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 177.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -126.72 -33.2 2.53 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 123.949 0.9 . . . . 0.0 111.126 -175.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -91.33 33.89 0.97 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.211 1.004 . . . . 0.0 111.421 176.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.45 -20.02 62.65 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.278 1.431 . . . . 0.0 113.116 -178.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -97.62 6.6 47.79 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.912 0.885 . . . . 0.0 111.948 176.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -138.53 24.47 2.67 Favored 'General case' 0 C--O 1.237 0.411 0 O-C-N 120.854 -1.154 . . . . 0.0 110.858 -174.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -65.97 118.57 9.95 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -169.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 86.3 m 48.28 35.23 5.3 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.648 1.979 . . . . 0.0 113.636 -175.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -53.38 -41.17 65.62 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.364 0.666 . . . . 0.0 112.342 -178.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.99 -12.06 60.06 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -170.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 53.9 mt -56.22 -42.21 76.88 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 118.719 0.691 . . . . 0.0 109.647 169.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -65.0 -30.66 78.6 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.811 -0.515 . . . . 0.0 111.811 -178.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 4.3 m -64.93 -40.13 94.57 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 117.985 0.893 . . . . 0.0 110.098 179.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.7 mt -73.86 -39.85 52.43 Favored 'Isoleucine or valine' 0 C--N 1.344 0.363 0 CA-C-N 118.908 0.777 . . . . 0.0 109.271 176.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 57.7 ttt-85 -52.67 -46.64 67.29 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 119.583 1.083 . . . . 0.0 110.331 177.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -64.73 -21.59 66.79 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.596 0.758 . . . . 0.0 112.455 -176.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 95.8 mt -87.98 -46.01 15.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 123.454 0.702 . . . . 0.0 109.474 175.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 7.0 pt -77.79 -28.69 15.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-N 118.926 0.785 . . . . 0.0 112.045 -169.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -62.12 -56.86 27.35 Favored Pre-proline 0 CA--C 1.544 0.724 0 CA-C-O 117.568 -1.206 . . . . 0.0 112.167 179.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -66.23 -24.06 51.53 Favored 'Trans proline' 0 C--N 1.353 0.781 0 CA-C-N 121.96 1.736 . . . . 0.0 112.208 -179.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 79.5 mmt-85 -78.28 5.11 11.08 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.856 0.862 . . . . 0.0 112.774 172.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 77.22 20.92 74.52 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-N 119.604 1.093 . . . . 0.0 113.993 169.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.9 148.91 48.31 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 118.56 1.18 . . . . 0.0 110.589 170.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 60.2 m -97.47 124.36 41.65 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 105.01 -2.218 . . . . 0.0 105.01 167.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 48.9 mt -98.43 134.13 38.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 -175.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 29.1 m -133.14 176.63 8.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 125.582 1.553 . . . . 0.0 108.854 172.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 78.04 23.38 66.45 Favored Glycine 0 CA--C 1.529 0.926 0 CA-C-O 119.065 -0.853 . . . . 0.0 113.906 175.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 15.4 p-80 -60.3 140.85 56.87 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 118.327 1.063 . . . . 0.0 108.809 168.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 75.4 t-105 -131.19 136.48 28.84 Favored Pre-proline 0 CA--C 1.536 0.43 0 C-N-CA 124.26 1.024 . . . . 0.0 110.244 -168.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -70.36 152.3 66.13 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.466 2.111 . . . . 0.0 111.912 -176.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 22.2 p -70.82 -22.07 62.38 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.867 0.867 . . . . 0.0 112.613 174.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 53.09 38.7 28.07 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.628 1.571 . . . . 0.0 111.851 -171.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 68.77 50.36 36.49 Favored Glycine 0 C--N 1.341 0.852 0 N-CA-C 111.543 -0.623 . . . . 0.0 111.543 176.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -57.14 149.27 19.9 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 117.317 0.558 . . . . 0.0 110.942 178.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 36.1 t60 -139.63 60.49 1.57 Allowed 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.156 0.982 . . . . 0.0 109.28 -175.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -129.89 176.05 8.36 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.191 1.396 . . . . 0.0 108.942 177.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -61.59 -47.75 84.06 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 118.577 -0.725 . . . . 0.0 111.978 -168.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -163.31 133.93 4.56 Favored 'General case' 0 C--N 1.34 0.192 0 CA-C-N 119.018 0.826 . . . . 0.0 112.11 172.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 58.2 m -97.31 126.73 42.72 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 166.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -115.88 -4.96 12.04 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 -171.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -83.04 8.59 62.88 Favored Glycine 0 CA--C 1.535 1.324 0 CA-C-N 118.619 0.645 . . . . 0.0 112.775 168.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 74.9 mt -62.29 138.77 58.49 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.564 1.145 . . . . 0.0 111.204 -179.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -104.56 -26.22 12.44 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.629 1.572 . . . . 0.0 109.792 168.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -143.66 165.71 26.88 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.01 1.724 . . . . 0.0 107.219 172.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -53.61 -27.2 25.54 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.197 1.399 . . . . 0.0 114.186 -169.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -123.49 9.98 9.1 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.781 1.232 . . . . 0.0 113.58 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -137.91 130.39 29.4 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 119.788 1.176 . . . . 0.0 111.143 -172.187 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -81.39 151.44 27.93 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 124.935 1.294 . . . . 0.0 110.165 173.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 14.5 p -61.89 -29.89 47.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 123.0 0.52 . . . . 0.0 111.528 175.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -141.28 -176.36 15.57 Favored Glycine 0 CA--C 1.521 0.445 0 C-N-CA 125.305 1.431 . . . . 0.0 109.606 -175.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.454 HD12 ' CE2' ' A' ' 86' ' ' PHE . 3.3 tm? -60.9 125.99 25.75 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 169.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -123.3 125.21 44.62 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 171.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 20.9 tt -136.38 122.83 30.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 113.769 1.026 . . . . 0.0 113.769 -171.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -174.11 154.82 2.34 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 127.9 2.48 . . . . 0.0 106.687 167.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -137.65 106.78 6.02 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 168.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 30.8 t70 64.85 -33.38 0.15 Allowed 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 128.895 2.878 . . . . 0.0 116.901 174.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 3.2 tpm_? -149.26 -63.3 0.23 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 119.668 1.122 . . . . 0.0 110.708 -176.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -144.97 148.42 38.63 Favored Pre-proline 0 C--O 1.239 0.504 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 170.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -67.04 149.81 82.56 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.163 1.909 . . . . 0.0 111.495 -177.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -134.41 -26.33 1.44 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.95 1.3 . . . . 0.0 111.57 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 74.3 mt -92.34 33.43 1.1 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.976 1.31 . . . . 0.0 108.873 169.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 97.1 m -51.09 -53.44 34.12 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 126.988 2.115 . . . . 0.0 111.85 -174.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.59 -43.86 95.71 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 119.083 -0.484 . . . . 0.0 111.884 -166.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -67.12 -36.1 81.2 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 118.794 0.725 . . . . 0.0 111.091 -177.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 77.3 mtt85 -67.12 -47.55 70.79 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 118.825 0.738 . . . . 0.0 109.883 -179.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 16.8 m -72.41 -31.67 39.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-O 118.77 -0.633 . . . . 0.0 110.481 -176.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -63.35 -49.63 73.12 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 119.659 1.118 . . . . 0.0 109.948 171.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -58.61 -42.26 87.76 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 118.477 0.58 . . . . 0.0 109.972 178.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 66.8 t90 -64.32 -46.77 82.09 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 118.822 0.737 . . . . 0.0 110.589 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 28.5 t -56.89 -42.71 78.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 118.24 0.473 . . . . 0.0 109.863 176.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 54.7 mttm -69.01 -38.32 79.16 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 118.567 -0.73 . . . . 0.0 109.825 -176.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 19.1 mm100 -59.89 -55.45 34.04 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 118.611 0.641 . . . . 0.0 110.304 172.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 16.1 pt -65.32 -30.53 50.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 118.924 0.784 . . . . 0.0 110.642 -174.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 50.8 m -61.82 -25.74 67.69 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.747 0.703 . . . . 0.0 111.692 177.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -89.33 -28.88 19.54 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 119.599 1.091 . . . . 0.0 111.023 176.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -72.19 -37.82 69.21 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 118.663 0.665 . . . . 0.0 110.67 175.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 76.8 mt -90.83 -9.32 46.84 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.186 1.794 . . . . 0.0 111.848 -177.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 55.57 29.44 13.48 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.534 1.534 . . . . 0.0 112.759 -170.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 86.5 mt -72.08 -20.13 61.7 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.349 -0.845 . . . . 0.0 110.286 169.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -59.88 -35.24 74.39 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.952 0.796 . . . . 0.0 110.238 176.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -66.4 -11.25 50.58 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 121.404 -0.81 . . . . 0.0 112.347 177.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 22.1 mt -104.65 -55.34 5.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 125.252 1.421 . . . . 0.0 108.374 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 3.0 pp -78.88 -21.92 46.76 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.075 0.55 . . . . 0.0 112.473 -172.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -124.62 39.3 4.01 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 127.059 2.144 . . . . 0.0 108.776 -179.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.318 0 C-N-CA 123.606 0.762 . . . . 0.0 109.453 173.765 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.1 ttt . . . . . 0 N--CA 1.488 1.459 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -58.85 142.44 50.5 Favored 'General case' 0 C--N 1.344 0.33 0 C-N-CA 123.325 0.65 . . . . 0.0 111.408 -178.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.1 pt -109.89 -15.96 9.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 125.363 1.465 . . . . 0.0 111.3 178.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 28.9 m -111.77 123.69 50.77 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.201 1.4 . . . . 0.0 108.317 177.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -96.49 119.29 6.26 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 107.434 -2.267 . . . . 0.0 107.434 169.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 56.8 mt -98.07 91.88 2.64 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 105.23 -2.137 . . . . 0.0 105.23 176.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -88.48 129.08 35.53 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 178.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -128.54 133.48 48.41 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 120.011 1.278 . . . . 0.0 111.88 179.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -89.92 145.24 18.12 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 169.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 9.3 m -164.23 158.34 18.85 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.679 1.24 . . . . 0.0 109.743 172.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -125.18 -51.13 1.66 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.614 0.765 . . . . 0.0 109.432 168.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.2 p -86.35 8.11 22.84 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.097 1.359 . . . . 0.0 112.976 173.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 84.19 -9.02 64.99 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 116.963 1.545 . . . . 0.0 116.963 168.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -60.78 -37.45 81.92 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 120.23 2.015 . . . . 0.0 113.825 -169.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.7 m -73.55 -15.09 61.3 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 120.01 1.277 . . . . 0.0 110.799 -175.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -60.19 -41.95 94.04 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 119.643 1.111 . . . . 0.0 109.676 172.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -63.04 -41.29 99.46 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -178.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 25.7 mm -64.8 -45.06 96.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 177.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.88 -40.25 88.09 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.589 0.631 . . . . 0.0 111.04 178.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.2 mtpt -67.47 -42.09 83.56 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 118.022 -0.99 . . . . 0.0 110.72 177.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 63.4 mtt -55.66 -47.62 76.4 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 119.851 1.205 . . . . 0.0 109.721 175.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 62.1 mt -60.37 -52.69 58.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -179.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -61.79 -38.64 88.81 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.958 0.799 . . . . 0.0 111.212 -175.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -65.02 -35.86 82.53 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 118.908 0.776 . . . . 0.0 111.023 -179.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -70.64 -49.38 48.13 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.322 0.51 . . . . 0.0 110.838 175.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 54.5 mt -67.8 -32.6 73.27 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.329 0.513 . . . . 0.0 111.783 -177.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.0 145.09 14.79 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 125.407 1.48 . . . . 0.0 110.792 -173.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 22.8 ptmt -63.72 -29.53 70.74 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 121.728 -0.866 . . . . 0.0 113.184 -172.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -77.68 -11.49 59.88 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.591 179.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 22.4 t -103.57 -39.33 5.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 C-N-CA 124.283 1.033 . . . . 0.0 109.711 177.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -133.24 146.55 51.56 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 119.234 0.924 . . . . 0.0 111.94 -176.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -130.71 139.58 50.3 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.104 0.962 . . . . 0.0 109.853 175.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 98.3 t -90.4 139.27 17.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 123.655 0.782 . . . . 0.0 109.15 -177.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -148.27 172.95 13.54 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.925 1.29 . . . . 0.0 111.133 -168.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -143.79 125.63 15.2 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 125.856 1.662 . . . . 0.0 108.629 -172.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.4 tp -62.35 -28.43 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-O 118.855 -0.593 . . . . 0.0 111.723 -172.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.09 -27.89 69.7 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 118.77 0.714 . . . . 0.0 111.537 -175.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 61.9 pttt -105.45 -3.95 21.93 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.627 1.171 . . . . 0.0 112.359 176.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 50.9 m -79.25 166.85 21.71 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.398 0.679 . . . . 0.0 110.953 -179.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.4 m -134.43 163.58 29.36 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.189 1.396 . . . . 0.0 109.021 179.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 53.5 tttm -52.81 -57.25 10.8 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.024 0.93 . . . . 0.0 110.985 -174.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -75.34 -16.07 60.43 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 122.354 0.262 . . . . 0.0 111.329 -173.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -74.31 -29.29 61.56 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 122.889 0.476 . . . . 0.0 110.928 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.8 mp -71.43 -41.98 68.81 Favored 'General case' 0 C--N 1.344 0.336 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 168.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.3 -15.73 63.46 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.234 0.614 . . . . 0.0 112.264 -174.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.88 -30.06 70.12 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.324 1.05 . . . . 0.0 112.277 174.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -84.58 155.22 22.16 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 123.845 0.858 . . . . 0.0 110.059 178.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -102.45 -26.73 13.15 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.236 0.614 . . . . 0.0 111.129 169.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.9 mp -113.74 123.43 69.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 174.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -109.85 123.14 49.05 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 173.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.1 mp -109.2 120.68 43.24 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 105.43 -2.063 . . . . 0.0 105.43 169.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 59.6 mt -118.38 109.42 16.25 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 -173.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -90.05 121.24 6.09 Favored Glycine 0 N--CA 1.451 -0.323 0 N-CA-C 108.568 -1.813 . . . . 0.0 108.568 176.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 3.0 tp -141.65 103.84 5.88 Favored Pre-proline 0 CA--C 1.541 0.611 0 CA-C-N 117.741 0.771 . . . . 0.0 110.039 -169.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -76.47 147.14 28.31 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.463 2.109 . . . . 0.0 109.564 169.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 33.5 m -95.5 140.93 29.65 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 177.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 38.7 m95 -134.16 171.29 14.43 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 125.208 1.403 . . . . 0.0 111.24 -170.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 51.85 -87.59 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 127.8 2.44 . . . . 0.0 113.114 178.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -150.0 78.23 1.34 Allowed 'General case' 0 C--O 1.234 0.289 0 C-N-CA 126.682 1.993 . . . . 0.0 106.813 179.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 70.99 19.6 77.21 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 123.68 0.657 . . . . 0.0 113.337 179.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -93.12 161.33 14.47 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.582 1.153 . . . . 0.0 109.357 -176.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -79.31 159.41 27.22 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 167.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -58.18 143.88 42.59 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 168.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 60.4 m -51.74 -38.89 57.23 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.566 1.146 . . . . 0.0 113.645 -169.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -70.78 -35.63 72.66 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 118.548 0.613 . . . . 0.0 110.694 -175.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -71.5 -45.51 62.29 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 175.018 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -57.92 -41.29 82.36 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 122.738 0.415 . . . . 0.0 111.379 179.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -68.2 -25.53 65.27 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.729 0.812 . . . . 0.0 112.268 177.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -92.69 -18.65 22.72 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.55 0.74 . . . . 0.0 112.506 -178.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 19.4 m-30 -50.73 -40.61 64.46 Favored Pre-proline 0 CA--C 1.545 0.78 0 CA-C-O 116.469 -1.729 . . . . 0.0 114.633 178.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -63.2 -20.86 71.8 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 CA-C-N 123.033 2.119 . . . . 0.0 113.912 173.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.2 m -85.7 -39.05 17.64 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 119.381 0.991 . . . . 0.0 109.441 169.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 13.6 tp -58.24 -38.05 76.11 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.031 0.932 . . . . 0.0 110.697 -177.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -72.51 -3.98 27.72 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 179.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -103.13 -12.46 17.35 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.134 0.879 . . . . 0.0 111.357 173.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 79.4 mt -77.23 138.39 20.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -176.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -78.18 124.23 27.83 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.592 176.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -122.06 11.03 10.18 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.769 0.827 . . . . 0.0 111.6 172.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -63.08 114.09 3.51 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 120.012 1.278 . . . . 0.0 109.143 -171.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.17 3.65 61.54 Favored Glycine 0 CA--C 1.536 1.392 0 CA-C-O 118.546 -1.141 . . . . 0.0 113.866 -178.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -75.21 152.03 38.4 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 119.544 1.672 . . . . 0.0 108.182 170.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 20.8 mt -91.6 136.59 33.02 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 175.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 18.5 t -133.81 141.69 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -134.32 143.26 47.6 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 171.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 64.7 mt -111.86 144.42 41.2 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -177.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -140.53 154.46 46.55 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 170.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -173.54 155.66 22.65 Favored Glycine 0 N--CA 1.449 -0.476 0 CA-C-O 122.416 1.009 . . . . 0.0 112.705 176.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 64.1 m -101.96 149.87 23.78 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 169.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -145.51 -159.32 8.08 Favored Glycine 0 CA--C 1.521 0.409 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 176.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -144.79 139.51 27.85 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 124.968 1.307 . . . . 0.0 108.546 170.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -109.09 -14.7 14.48 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 123.962 0.905 . . . . 0.0 111.419 177.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -75.11 -43.62 51.79 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 119.843 1.201 . . . . 0.0 110.796 -170.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -112.87 -40.22 4.05 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 123.495 0.718 . . . . 0.0 110.755 179.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -83.89 37.86 0.62 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.533 0.733 . . . . 0.0 111.018 176.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.06 -23.64 63.92 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 126.805 2.042 . . . . 0.0 114.019 -170.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -99.34 0.26 42.52 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.321 1.448 . . . . 0.0 111.918 -179.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -131.98 16.99 4.65 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.258 1.023 . . . . 0.0 111.925 -169.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -65.15 125.88 26.35 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 121.247 -0.908 . . . . 0.0 110.27 -169.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 88.1 m 53.24 29.45 8.48 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.842 1.657 . . . . 0.0 114.349 176.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -61.43 -31.51 71.46 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.755 0.822 . . . . 0.0 111.339 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.56 -33.58 76.25 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 120.754 -1.216 . . . . 0.0 111.687 179.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 7.5 mp -63.29 -43.89 96.6 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-N 119.691 1.132 . . . . 0.0 109.633 175.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.71 -31.99 82.01 Favored Glycine 0 CA--C 1.532 1.114 0 N-CA-C 111.337 -0.705 . . . . 0.0 111.337 174.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 14.7 m -66.56 -41.42 88.65 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 117.76 0.78 . . . . 0.0 110.113 176.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 5.4 mt -65.75 -43.83 93.38 Favored 'Isoleucine or valine' 0 C--N 1.345 0.401 0 CA-C-N 119.425 1.012 . . . . 0.0 109.509 173.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 41.3 ttt180 -52.32 -45.93 65.81 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 119.381 0.991 . . . . 0.0 110.435 -178.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -62.0 -17.98 58.96 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.96 0.904 . . . . 0.0 113.035 -178.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 82.8 mt -95.4 -54.72 6.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 124.397 1.079 . . . . 0.0 109.216 175.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 23.2 pt -71.56 -33.46 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 O-C-N 121.251 -0.906 . . . . 0.0 112.195 -168.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -66.53 -50.37 47.22 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-O 117.694 -1.146 . . . . 0.0 111.486 -174.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -68.36 -24.67 36.83 Favored 'Trans proline' 0 C--N 1.354 0.836 0 CA-C-N 121.731 1.654 . . . . 0.0 112.769 174.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 7.7 mpt_? -74.76 6.76 3.63 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 119.42 1.009 . . . . 0.0 112.523 169.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 81.38 16.66 73.29 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-O 118.435 -1.203 . . . . 0.0 114.007 169.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.13 141.9 55.11 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 118.882 1.341 . . . . 0.0 109.998 170.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 88.1 m -93.13 119.34 32.24 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 104.641 -2.355 . . . . 0.0 104.641 167.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 33.6 mt -96.61 132.79 40.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 -173.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 29.9 m -129.44 172.62 15.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 C-N-CA 124.869 1.268 . . . . 0.0 109.033 175.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 77.35 27.74 59.09 Favored Glycine 0 CA--C 1.526 0.722 0 CA-C-O 119.105 -0.83 . . . . 0.0 113.542 177.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 28.9 p-80 -60.84 139.69 57.88 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 118.815 1.307 . . . . 0.0 108.678 168.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 75.6 t-105 -127.78 137.88 31.7 Favored Pre-proline 0 CA--C 1.533 0.321 0 C-N-CA 124.453 1.101 . . . . 0.0 108.245 -169.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -70.89 144.65 48.6 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 121.762 1.642 . . . . 0.0 112.347 -170.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 63.0 p -76.52 -31.14 57.48 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.471 0.708 . . . . 0.0 110.055 169.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 53.77 41.59 32.02 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.866 2.067 . . . . 0.0 110.846 -170.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 74.34 80.06 0.52 Allowed Glycine 0 CA--C 1.527 0.831 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -173.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -46.0 126.3 7.27 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.616 0.766 . . . . 0.0 109.936 172.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -94.21 -27.91 15.92 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -168.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -90.15 -170.09 2.65 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.573 0.749 . . . . 0.0 111.41 -168.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -66.56 -56.1 12.37 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -167.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -155.66 143.53 19.78 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-N 118.921 0.782 . . . . 0.0 110.873 176.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 2.4 p -123.77 138.47 54.5 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 124.513 1.125 . . . . 0.0 107.965 170.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.02 -4.77 20.12 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 122.875 0.47 . . . . 0.0 112.264 177.575 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -75.76 0.79 60.59 Favored Glycine 0 CA--C 1.535 1.295 0 CA-C-O 119.216 -0.769 . . . . 0.0 112.867 169.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 96.7 mt -64.32 139.19 58.74 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 119.468 1.634 . . . . 0.0 111.083 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -108.53 -31.07 7.93 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.456 1.503 . . . . 0.0 108.778 167.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -145.23 162.54 36.89 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 127.86 2.464 . . . . 0.0 106.181 169.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -55.65 -30.52 61.14 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 121.17 -0.956 . . . . 0.0 112.084 176.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -91.0 -9.41 46.06 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.241 1.016 . . . . 0.0 113.448 -179.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 58.7 m80 -147.36 130.94 16.81 Favored 'General case' 0 C--N 1.348 0.509 0 CA-C-N 119.93 1.241 . . . . 0.0 113.229 -171.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -76.22 155.58 34.31 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.008 0.923 . . . . 0.0 108.767 167.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 14.2 p -60.56 -32.19 50.85 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 124.144 0.978 . . . . 0.0 111.419 176.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -146.41 -177.25 20.9 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 124.905 1.241 . . . . 0.0 110.32 -172.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -62.55 123.39 18.21 Favored 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 171.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -135.05 109.93 8.72 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 -176.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 26.3 pt -122.23 141.23 43.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-O 121.807 0.813 . . . . 0.0 113.034 -172.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -162.23 -37.48 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 127.304 2.242 . . . . 0.0 108.395 168.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 59.2 tt0 65.31 -66.76 0.14 Allowed 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 128.224 2.61 . . . . 0.0 110.36 -177.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -169.98 99.11 0.29 Allowed 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 126.526 1.93 . . . . 0.0 107.104 169.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 16.4 tpp85 51.65 67.83 0.9 Allowed 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.143 1.377 . . . . 0.0 110.625 -176.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . 0.406 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 3.0 mm-40 71.39 139.02 0.06 OUTLIER Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 131.097 3.759 . . . . 0.0 111.665 178.035 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 149' ' ' GLN . 3.0 Cg_exo -77.07 162.15 32.01 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 121.341 1.361 . . . . 0.0 113.767 -167.257 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -110.09 -9.3 14.72 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.065 -0.97 . . . . 0.0 112.386 171.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 90.0 mt -121.56 39.44 3.85 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 125.79 1.636 . . . . 0.0 109.853 175.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 93.9 m -53.66 -58.21 8.02 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.424 1.09 . . . . 0.0 110.614 -175.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -68.91 -32.67 72.46 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 122.278 -0.264 . . . . 0.0 110.517 -169.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 25.3 mp0 -63.97 -48.47 76.33 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.234 1.014 . . . . 0.0 109.292 176.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 74.3 mtt85 -65.53 -37.18 86.0 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 118.912 0.778 . . . . 0.0 110.635 -179.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 96.3 t -64.41 -42.26 94.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-O 118.358 -0.829 . . . . 0.0 109.093 174.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -59.41 -48.71 80.59 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-N 119.832 1.196 . . . . 0.0 110.359 177.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -58.94 -44.62 91.44 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 118.088 0.403 . . . . 0.0 110.094 179.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 68.0 t90 -66.06 -44.44 84.52 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 118.363 0.529 . . . . 0.0 110.02 -175.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 79.1 t -62.77 -39.64 85.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -65.17 -38.67 91.27 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 121.389 -0.819 . . . . 0.0 110.138 178.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 43.4 mm-40 -64.35 -52.19 59.61 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 118.586 0.63 . . . . 0.0 110.964 176.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 21.0 pt -64.59 -31.72 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 119.568 1.077 . . . . 0.0 110.326 -178.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 65.6 m -60.79 -26.14 67.06 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 118.062 -0.97 . . . . 0.0 112.538 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -95.22 -10.39 30.54 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 120.117 1.326 . . . . 0.0 112.699 175.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -88.0 -39.5 14.62 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 118.981 0.809 . . . . 0.0 110.304 171.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 88.0 mt -84.51 -12.32 54.44 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.677 1.991 . . . . 0.0 111.421 178.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 30.4 m80 56.58 30.16 16.82 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.556 1.543 . . . . 0.0 112.885 -170.048 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 67.6 mt -72.35 -20.45 61.46 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.477 -0.764 . . . . 0.0 110.38 169.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -57.0 -38.08 72.58 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.842 0.747 . . . . 0.0 110.304 175.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -68.0 -10.23 51.89 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 121.596 -0.69 . . . . 0.0 112.419 178.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 28.7 mt -106.12 -54.18 6.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 C-N-CA 125.345 1.458 . . . . 0.0 108.567 -178.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.3 pp -78.77 -24.97 44.37 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.319 0.648 . . . . 0.0 112.145 -173.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -125.53 39.41 3.97 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.605 1.962 . . . . 0.0 108.915 -175.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.36 0 C-N-CA 123.632 0.773 . . . . 0.0 109.453 175.119 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.4 ttt . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 110.37 -0.233 . . . . 0.0 110.37 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -66.97 154.77 40.31 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.182 0.593 . . . . 0.0 110.536 177.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.7 pt -86.78 -23.9 6.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 122.269 0.228 . . . . 0.0 111.581 -178.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.9 m -112.01 130.15 55.96 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.825 1.25 . . . . 0.0 108.646 -178.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -103.95 116.35 5.35 Favored Glycine 0 CA--C 1.521 0.417 0 N-CA-C 108.241 -1.944 . . . . 0.0 108.241 169.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 74.6 mt -90.81 126.14 43.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 104.847 -2.279 . . . . 0.0 104.847 171.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -122.38 126.94 49.06 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 174.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -125.28 136.59 53.67 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 118.311 0.505 . . . . 0.0 111.027 178.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -85.93 136.86 14.63 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 108.632 -1.787 . . . . 0.0 108.632 168.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 22.6 m -157.35 158.12 35.39 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 119.395 1.598 . . . . 0.0 110.908 169.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -142.67 -42.79 0.32 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.878 1.271 . . . . 0.0 110.062 170.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.5 p -77.54 -13.28 59.95 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 122.977 0.511 . . . . 0.0 111.506 169.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 88.71 34.58 9.03 Favored Glycine 0 C--N 1.342 0.895 0 C-N-CA 124.079 0.847 . . . . 0.0 112.373 172.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -86.02 -54.12 4.67 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 117.493 0.647 . . . . 0.0 111.759 179.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.4 m -74.74 -16.62 60.73 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 118.511 -0.757 . . . . 0.0 112.21 -168.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -58.19 -35.97 72.41 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 119.605 1.093 . . . . 0.0 110.514 172.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -71.43 -40.85 70.14 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -179.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 34.4 mm -63.55 -43.5 98.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 177.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.03 -42.65 90.7 Favored 'General case' 0 CA--C 1.53 0.184 0 O-C-N 121.661 -0.65 . . . . 0.0 110.628 177.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -66.88 -39.77 87.59 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 118.434 -0.793 . . . . 0.0 111.087 176.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 63.0 mtt -61.77 -33.48 74.16 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 119.948 1.249 . . . . 0.0 111.499 176.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 26.1 mt -74.16 -49.55 32.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 175.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -59.78 -40.14 87.27 Favored 'General case' 0 C--O 1.225 -0.214 0 O-C-N 121.629 -0.669 . . . . 0.0 111.728 -176.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -63.57 -34.01 76.86 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 119.764 1.165 . . . . 0.0 111.171 -178.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -73.68 -41.29 62.85 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 122.722 0.409 . . . . 0.0 110.826 175.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.2 mp -74.75 -36.93 62.61 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 122.915 0.486 . . . . 0.0 111.25 -176.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.0 146.41 18.19 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 125.764 1.65 . . . . 0.0 110.85 -173.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 53.8 tptt -61.04 -31.66 71.3 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.565 1.146 . . . . 0.0 111.819 -175.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -68.0 -27.33 66.47 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.23 0.612 . . . . 0.0 111.192 178.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 39.0 t -96.89 -37.63 7.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 C-N-CA 124.248 1.019 . . . . 0.0 110.003 -175.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -135.55 137.17 41.75 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 119.252 0.933 . . . . 0.0 111.901 -174.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -119.08 158.34 26.05 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.861 0.864 . . . . 0.0 109.849 169.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 51.8 t -120.56 135.62 60.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 124.349 1.06 . . . . 0.0 110.543 -168.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -147.3 172.19 14.26 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.145 1.778 . . . . 0.0 111.456 -171.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -126.68 135.49 51.22 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 126.605 1.962 . . . . 0.0 106.364 170.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.0 tp -61.0 -18.54 18.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 123.759 0.824 . . . . 0.0 112.656 -172.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.99 -29.12 63.01 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 119.014 0.825 . . . . 0.0 111.304 178.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 45.7 mtmt -80.6 -24.15 39.33 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 122.922 0.489 . . . . 0.0 112.209 177.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 46.9 m -77.48 159.59 29.27 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.353 1.061 . . . . 0.0 113.337 -166.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.3 m -132.58 176.17 8.67 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 127.633 2.373 . . . . 0.0 106.632 169.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.5 tttm -50.11 -48.47 53.41 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.942 0.792 . . . . 0.0 111.96 -175.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -78.58 -11.95 59.99 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -173.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -69.96 -34.48 73.45 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.442 -0.786 . . . . 0.0 111.245 -176.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.3 mp -76.22 -35.25 59.12 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-O 119.103 -0.475 . . . . 0.0 110.832 172.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -64.25 -23.75 67.42 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 118.595 0.634 . . . . 0.0 112.175 -177.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.13 -28.87 69.73 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.78 0.832 . . . . 0.0 112.506 178.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -91.8 152.15 20.26 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 124.551 1.141 . . . . 0.0 109.68 176.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -109.92 -15.23 14.12 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.614 0.766 . . . . 0.0 111.8 174.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.4 mp -123.22 134.06 67.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 169.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 91.2 mt -124.3 147.88 47.83 Favored 'General case' 0 CA--C 1.518 -0.281 0 C-N-CA 123.651 0.781 . . . . 0.0 109.702 178.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.8 mt -130.99 107.46 9.11 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 177.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 76.2 mt -112.4 114.14 26.71 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -169.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -106.25 116.38 5.08 Favored Glycine 0 C--N 1.335 0.51 0 C-N-CA 125.475 1.512 . . . . 0.0 110.27 -177.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 16.1 tt -123.74 117.66 27.42 Favored Pre-proline 0 CA--C 1.541 0.609 0 CA-C-N 118.574 1.187 . . . . 0.0 111.749 -172.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -77.35 141.72 20.56 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 121.806 1.671 . . . . 0.0 109.288 168.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 35.3 m -91.03 142.72 27.47 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 172.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 51.0 m95 -132.96 172.66 12.32 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.948 2.099 . . . . 0.0 109.797 -175.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 33.92 53.61 0.51 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 128.918 2.887 . . . . 0.0 115.824 169.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 53.04 62.78 2.51 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.174 0.99 . . . . 0.0 111.28 176.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 87.43 52.12 3.11 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 123.713 0.673 . . . . 0.0 112.386 174.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -135.21 161.38 35.53 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.823 1.649 . . . . 0.0 108.628 171.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.12 165.57 21.47 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 168.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -67.01 147.77 52.79 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 169.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 57.9 m -53.28 -34.78 58.68 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.075 0.95 . . . . 0.0 112.741 -176.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -67.4 -44.26 79.29 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.156 0.582 . . . . 0.0 110.426 -176.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -71.4 -43.46 66.78 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.213 0.605 . . . . 0.0 109.474 176.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -60.21 -39.31 86.13 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.523 0.729 . . . . 0.0 111.737 -178.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -70.77 -24.7 62.65 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.955 0.902 . . . . 0.0 112.104 176.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -88.23 -23.59 23.5 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-O 118.326 -0.845 . . . . 0.0 112.156 178.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -51.11 -43.31 84.65 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-O 116.631 -1.652 . . . . 0.0 114.462 178.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -64.65 -15.39 49.8 Favored 'Trans proline' 0 CA--C 1.543 0.953 0 CA-C-N 122.8 2.036 . . . . 0.0 113.691 175.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.0 m -90.72 -38.84 12.79 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.783 1.233 . . . . 0.0 109.613 170.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 23.6 tp -57.84 -40.36 79.87 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 124.352 1.061 . . . . 0.0 109.946 -179.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -71.87 -7.05 46.13 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -86.15 -15.44 41.05 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 120.185 1.357 . . . . 0.0 110.412 173.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 65.1 mt -90.02 128.47 41.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 -174.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -87.5 139.54 30.44 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 168.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -126.38 20.52 7.36 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.492 1.117 . . . . 0.0 111.315 -175.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -50.55 -34.07 24.14 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 115.777 1.769 . . . . 0.0 115.777 -168.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -110.64 13.6 29.97 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-O 118.385 -1.231 . . . . 0.0 113.556 -178.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -112.33 146.97 37.34 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 119.602 1.701 . . . . 0.0 109.99 -169.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -95.83 141.88 28.75 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 176.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 16.4 t -134.76 143.04 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 173.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -124.61 145.46 49.61 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 169.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 88.9 mt -121.69 139.48 53.51 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -169.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -140.98 164.15 31.05 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 169.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -168.34 156.55 28.12 Favored Glycine 0 N--CA 1.443 -0.838 0 O-C-N 121.059 -1.026 . . . . 0.0 112.132 -178.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 33.5 m -122.32 152.65 39.9 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 -168.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -164.92 -153.38 7.47 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.501 -174.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -152.46 140.31 20.03 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.101 1.36 . . . . 0.0 110.331 -178.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -120.5 13.56 11.78 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.616 1.566 . . . . 0.0 110.816 -179.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -94.27 -43.78 8.27 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.344 1.057 . . . . 0.0 109.541 -178.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -127.82 -31.5 2.42 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.702 1.201 . . . . 0.0 111.789 177.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -90.04 24.8 2.33 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.522 0.729 . . . . 0.0 111.971 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.76 -19.34 64.9 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.212 1.405 . . . . 0.0 114.027 -170.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -99.49 7.71 45.15 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 119.527 1.058 . . . . 0.0 112.343 176.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -133.86 25.01 3.98 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 126.206 1.802 . . . . 0.0 109.494 176.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -65.84 122.56 17.59 Favored 'General case' 0 C--O 1.238 0.481 0 O-C-N 121.767 -0.583 . . . . 0.0 109.65 -168.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 93.5 m 50.61 33.85 8.75 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.669 1.588 . . . . 0.0 112.778 -177.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -52.48 -38.15 58.78 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 121.753 -0.592 . . . . 0.0 112.561 -177.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -73.12 -14.65 61.42 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -171.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -59.67 -39.3 84.02 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.158 -0.964 . . . . 0.0 111.281 -177.048 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -70.41 -23.02 77.81 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 123.239 0.447 . . . . 0.0 112.692 179.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.2 m -65.59 -29.86 70.52 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 118.28 1.04 . . . . 0.0 110.894 -177.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 6.4 mt -71.62 -48.81 50.27 Favored 'Isoleucine or valine' 0 C--N 1.345 0.372 0 CA-C-O 118.51 -0.757 . . . . 0.0 109.056 175.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 18.6 ttm-85 -53.03 -42.95 66.2 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 119.053 0.842 . . . . 0.0 109.806 178.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -59.18 -23.78 62.53 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -176.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 94.8 mt -95.2 -50.49 11.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 124.016 0.926 . . . . 0.0 109.84 175.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 20.0 pt -75.72 -24.48 16.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 119.194 0.906 . . . . 0.0 112.16 -168.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -67.93 -52.86 22.63 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-O 117.394 -1.288 . . . . 0.0 112.101 -179.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -65.77 -25.47 53.44 Favored 'Trans proline' 0 C--N 1.352 0.746 0 CA-C-N 122.137 1.799 . . . . 0.0 111.953 175.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 83.1 mmt-85 -75.82 5.31 6.51 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.03 0.932 . . . . 0.0 112.976 170.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 78.15 14.55 82.14 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-O 117.891 -1.505 . . . . 0.0 114.801 168.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.11 143.04 45.15 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 119.657 1.729 . . . . 0.0 109.19 171.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 69.7 m -88.7 125.91 35.07 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 104.419 -2.437 . . . . 0.0 104.419 167.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 21.5 mt -116.23 130.25 71.29 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 -169.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 29.8 m -130.36 175.28 11.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 124.403 1.081 . . . . 0.0 109.76 177.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 91.55 24.48 25.9 Favored Glycine 0 CA--C 1.528 0.888 0 CA-C-O 119.097 -0.835 . . . . 0.0 114.025 170.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 49.0 p-80 -60.96 150.66 32.69 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 119.262 1.531 . . . . 0.0 109.068 168.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 73.3 t-105 -136.62 133.62 19.15 Favored Pre-proline 0 CA--C 1.535 0.379 0 C-N-CA 123.697 0.799 . . . . 0.0 109.543 -169.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -69.76 146.37 59.99 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.385 2.057 . . . . 0.0 112.048 -176.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 68.4 p -74.57 -23.43 58.76 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.753 1.221 . . . . 0.0 111.814 174.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 52.73 41.87 31.61 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.673 1.589 . . . . 0.0 112.059 -171.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 68.17 52.06 29.65 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 176.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -58.91 151.55 21.52 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 122.83 0.452 . . . . 0.0 111.294 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 57.0 p-80 -119.85 0.79 10.92 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.55 1.14 . . . . 0.0 113.159 -171.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -76.21 169.97 17.2 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.326 0.65 . . . . 0.0 111.035 -177.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -57.18 -57.46 12.48 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.937 0.895 . . . . 0.0 112.602 -168.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -162.8 116.39 1.68 Allowed 'General case' 0 C--O 1.235 0.339 0 CA-C-N 118.779 0.718 . . . . 0.0 111.29 175.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 59.3 m -81.42 127.33 32.67 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 168.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -102.05 -9.85 20.22 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 122.968 0.507 . . . . 0.0 111.45 175.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -74.57 0.57 55.38 Favored Glycine 0 CA--C 1.535 1.285 0 CA-C-N 118.813 0.733 . . . . 0.0 113.207 169.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 77.6 mt -63.05 142.63 58.31 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 119.111 1.456 . . . . 0.0 112.17 177.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -107.01 -27.86 10.39 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 125.932 1.693 . . . . 0.0 109.647 167.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -144.16 159.11 43.21 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 127.251 2.22 . . . . 0.0 106.291 175.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -53.01 -29.55 29.98 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -179.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -101.38 -7.32 23.04 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -137.91 133.25 33.59 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 120.798 1.636 . . . . 0.0 113.035 -170.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -76.25 149.01 37.23 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.436 1.095 . . . . 0.0 108.898 167.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 6.2 p -68.91 -17.61 22.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 124.977 1.311 . . . . 0.0 111.719 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -154.54 178.81 31.11 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 108.172 -1.971 . . . . 0.0 108.172 178.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -66.61 109.62 2.88 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 118.282 1.041 . . . . 0.0 108.21 173.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -88.25 136.69 32.86 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 171.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 10.3 tp -133.72 119.82 34.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -175.63 155.39 1.74 Allowed 'General case' 0 C--O 1.237 0.428 0 C-N-CA 130.585 3.554 . . . . 0.0 105.0 166.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -127.15 -59.79 1.23 Allowed 'General case' 0 C--O 1.234 0.252 0 CA-C-N 119.654 1.116 . . . . 0.0 109.339 178.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -160.83 99.92 1.26 Allowed 'General case' 0 C--O 1.236 0.367 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 171.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 4.3 tpm_? 50.72 80.69 0.07 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.338 1.455 . . . . 0.0 109.997 -171.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 75.39 150.63 0.13 Allowed Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 127.057 2.143 . . . . 0.0 110.489 -168.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -74.94 155.86 43.25 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 122.649 2.232 . . . . 0.0 112.398 -177.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -132.24 -11.27 3.26 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.925 0.89 . . . . 0.0 112.968 172.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 68.6 mt -103.0 27.51 7.05 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.858 1.263 . . . . 0.0 108.959 170.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 8.6 m -49.94 -60.1 3.24 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 126.812 2.045 . . . . 0.0 112.339 -168.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -74.73 -35.37 62.65 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 118.951 -0.547 . . . . 0.0 111.28 -167.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -67.52 -41.11 84.93 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 118.565 0.621 . . . . 0.0 110.517 176.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 64.5 mtp180 -62.02 -41.3 97.93 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 119.32 0.964 . . . . 0.0 110.537 176.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 84.9 t -70.79 -33.78 53.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-O 118.52 -0.752 . . . . 0.0 110.388 179.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -65.03 -49.53 69.78 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 120.916 1.689 . . . . 0.0 109.378 175.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -59.28 -34.84 72.76 Favored 'General case' 0 C--N 1.339 0.136 0 CA-C-O 118.599 -0.715 . . . . 0.0 110.973 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 35.8 t90 -73.03 -52.5 14.15 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 119.007 0.821 . . . . 0.0 110.728 178.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 77.1 t -65.86 -31.9 55.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 O-C-N 121.4 -0.813 . . . . 0.0 110.831 -171.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 55.8 mttm -60.21 -35.53 75.63 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 121.49 -0.756 . . . . 0.0 110.889 174.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 21.8 mm100 -70.85 -50.22 37.63 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 118.59 0.632 . . . . 0.0 110.928 173.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 2.3 pt -63.13 -30.82 50.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 119.221 0.919 . . . . 0.0 110.533 -174.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 50.8 m -61.87 -32.35 72.7 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 119.06 -0.495 . . . . 0.0 111.203 179.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -79.89 -40.89 27.31 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 119.219 0.918 . . . . 0.0 109.837 176.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -66.42 -34.88 78.94 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.455 0.702 . . . . 0.0 111.444 -177.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 95.5 mt -92.24 -1.56 57.04 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.958 1.703 . . . . 0.0 111.552 179.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 30.5 m80 56.73 21.17 5.67 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.166 1.786 . . . . 0.0 113.595 -174.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 72.5 mt -73.13 -21.4 60.73 Favored 'General case' 0 N--CA 1.464 0.228 0 O-C-N 121.399 -0.813 . . . . 0.0 110.442 175.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -55.17 -39.67 69.81 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 123.839 0.856 . . . . 0.0 110.203 173.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -71.53 -6.99 44.71 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.685 -0.634 . . . . 0.0 112.357 -179.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 35.4 mt -105.21 -54.1 6.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 125.275 1.43 . . . . 0.0 108.547 179.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.6 pp -79.43 -23.66 43.03 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.69 0.796 . . . . 0.0 112.057 -173.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -129.13 44.26 3.0 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.697 1.999 . . . . 0.0 108.229 -176.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.248 0 C-N-CA 123.772 0.829 . . . . 0.0 109.657 175.239 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.0 tpt . . . . . 0 N--CA 1.487 1.41 0 N-CA-C 110.359 -0.238 . . . . 0.0 110.359 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -58.74 143.07 48.18 Favored 'General case' 0 C--N 1.344 0.357 0 C-N-CA 123.554 0.741 . . . . 0.0 111.133 179.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.9 pt -106.35 -16.16 8.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 125.239 1.415 . . . . 0.0 110.926 178.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 53.7 m -112.04 124.38 52.29 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.485 1.514 . . . . 0.0 108.426 177.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -98.44 121.64 7.24 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 108.748 -1.741 . . . . 0.0 108.748 169.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 61.9 mt -96.14 96.16 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 103.773 -2.677 . . . . 0.0 103.773 176.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -99.17 119.42 37.84 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -133.5 156.72 47.26 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 123.402 0.681 . . . . 0.0 109.276 -169.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -131.93 144.82 16.57 Favored Glycine 0 C--N 1.336 0.576 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 169.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.0 m -141.14 161.85 36.88 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.208 1.403 . . . . 0.0 108.811 177.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -126.54 -54.16 1.45 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.033 0.533 . . . . 0.0 110.254 171.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.13 -3.06 56.94 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.036 0.934 . . . . 0.0 111.614 170.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 93.4 7.65 61.81 Favored Glycine 0 C--N 1.342 0.875 0 C-N-CA 124.561 1.077 . . . . 0.0 113.254 169.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -71.07 -43.3 68.06 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 118.657 1.228 . . . . 0.0 111.377 -173.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -65.62 -37.76 87.52 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 118.801 0.728 . . . . 0.0 110.037 -172.334 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.3 tp10 -59.79 -35.95 75.71 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.475 1.11 . . . . 0.0 111.342 179.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -64.07 -38.16 90.06 Favored 'General case' 0 CA--C 1.53 0.203 0 O-C-N 121.678 -0.638 . . . . 0.0 110.377 176.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.5 mm -68.97 -41.45 81.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 176.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.7 -39.28 70.81 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.122 0.874 . . . . 0.0 111.041 178.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -66.6 -45.72 78.24 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 118.843 -0.598 . . . . 0.0 110.856 173.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 69.1 mtm -63.86 -27.78 69.4 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 119.713 1.142 . . . . 0.0 112.003 178.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 61.6 mt -70.03 -56.19 12.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 172.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -57.55 -40.09 78.11 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.588 -0.695 . . . . 0.0 111.97 -177.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -62.98 -34.07 76.75 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 119.505 1.048 . . . . 0.0 111.522 -178.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -75.05 -41.48 58.99 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 122.849 0.46 . . . . 0.0 111.172 178.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -77.08 -32.26 56.61 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 118.886 0.766 . . . . 0.0 111.616 -177.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.07 143.54 11.47 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 124.952 1.263 . . . . 0.0 110.165 -169.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -63.58 -31.19 72.28 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.917 0.887 . . . . 0.0 111.947 -172.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -77.6 -7.66 56.71 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 46.4 t -105.28 -47.34 9.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 124.318 1.047 . . . . 0.0 109.157 176.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -131.44 140.32 49.58 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 119.386 0.994 . . . . 0.0 110.965 -176.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -132.86 147.74 52.3 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 176.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 58.0 t -99.75 137.59 26.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 C-N-CA 124.919 1.288 . . . . 0.0 110.48 -169.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -141.06 145.38 35.77 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.373 1.469 . . . . 0.0 109.392 -177.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -88.51 124.1 33.67 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 169.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.4 tp -58.32 -34.93 51.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 119.119 -0.467 . . . . 0.0 111.276 -174.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.84 -33.84 76.76 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 119.126 0.875 . . . . 0.0 112.318 -171.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -92.98 -7.61 45.4 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.125 0.57 . . . . 0.0 112.153 176.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 49.9 m -74.99 165.48 25.19 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.137 0.575 . . . . 0.0 110.096 179.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.3 m -128.72 158.94 37.19 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 124.241 1.017 . . . . 0.0 110.745 -170.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -51.2 -51.72 51.16 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.884 1.274 . . . . 0.0 111.373 -176.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -79.88 -14.27 58.77 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 122.542 0.337 . . . . 0.0 111.439 -173.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -76.67 -34.25 58.24 Favored 'General case' 0 C--N 1.34 0.166 0 O-C-N 121.599 -0.688 . . . . 0.0 111.045 -176.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.6 mp -65.76 -36.88 84.81 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 171.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -67.24 -19.47 65.53 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 123.039 0.536 . . . . 0.0 112.251 -174.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.53 -28.64 68.7 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.645 0.778 . . . . 0.0 112.05 177.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -89.37 152.46 21.5 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 123.93 0.892 . . . . 0.0 110.398 -176.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -92.51 -34.98 13.86 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.462 172.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 20.1 mt -113.78 137.99 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 -179.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 91.8 mt -124.89 134.87 52.52 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.666 0.786 . . . . 0.0 109.012 174.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.0 mp -112.85 116.2 29.67 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 104.821 -2.288 . . . . 0.0 104.821 168.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 66.6 mt -112.04 111.83 23.03 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 -172.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -105.19 106.69 2.71 Favored Glycine 0 C--N 1.338 0.648 0 C-N-CA 124.355 0.979 . . . . 0.0 112.336 -173.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.4 tp -124.62 107.44 29.21 Favored Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 126.114 1.766 . . . . 0.0 109.886 -168.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -76.21 141.74 23.58 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.095 1.863 . . . . 0.0 109.62 169.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 44.9 m -93.47 138.96 31.25 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 174.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 16.2 m95 -131.55 172.06 12.68 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 124.537 1.135 . . . . 0.0 110.606 -177.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 33.88 63.3 0.4 Allowed 'General case' 0 C--O 1.236 0.343 0 C-N-CA 128.22 2.608 . . . . 0.0 113.306 169.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.263 19.9 p90 49.67 58.96 4.86 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.633 1.173 . . . . 0.0 111.992 174.202 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.86 53.71 2.34 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-N 115.031 -0.986 . . . . 0.0 114.108 168.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -137.46 157.58 46.26 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 117.828 0.814 . . . . 0.0 110.283 167.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.84 150.59 32.23 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 168.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -62.59 152.41 35.11 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 169.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 60.9 m -57.96 -30.49 66.03 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.835 0.854 . . . . 0.0 111.83 -175.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -61.06 -39.07 88.46 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.922 0.889 . . . . 0.0 110.773 -179.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -85.09 -42.8 14.47 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 123.605 0.762 . . . . 0.0 110.671 175.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -61.51 -37.39 83.51 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.061 0.391 . . . . 0.0 111.828 -174.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -69.72 -21.96 63.43 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.529 0.732 . . . . 0.0 112.079 175.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -91.86 -23.65 19.59 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.6 0.76 . . . . 0.0 111.759 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -51.73 -41.57 78.89 Favored Pre-proline 0 CA--C 1.545 0.777 0 CA-C-O 116.539 -1.696 . . . . 0.0 114.763 179.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -64.38 -24.41 64.46 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 CA-C-N 122.991 2.104 . . . . 0.0 112.828 174.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.4 m -78.22 -40.57 37.02 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.257 0.935 . . . . 0.0 109.359 170.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 13.3 tp -59.5 -36.85 76.84 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.551 1.141 . . . . 0.0 111.151 -174.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -77.44 -6.65 54.21 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.893 0.877 . . . . 0.0 112.844 178.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 67.2 mt-10 -92.15 -23.28 19.46 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.432 1.014 . . . . 0.0 110.428 169.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 79.2 mt -73.14 147.61 9.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 176.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -116.91 137.74 52.01 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 176.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -124.82 16.11 8.65 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.458 1.103 . . . . 0.0 111.13 -171.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -59.73 126.74 28.8 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 120.062 1.301 . . . . 0.0 109.635 -179.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 72.3 2.79 55.4 Favored Glycine 0 CA--C 1.536 1.352 0 CA-C-O 118.121 -1.377 . . . . 0.0 114.605 -176.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -86.36 149.32 25.11 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 120.176 1.988 . . . . 0.0 108.036 173.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 14.9 mt -95.26 139.79 31.08 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 173.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.5 t -135.54 144.55 33.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 176.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -128.48 142.44 51.08 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 168.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 74.1 mt -105.29 149.7 25.79 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -178.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.433 ' CE2' HD12 ' A' ' 142' ' ' LEU . 15.1 t80 -140.15 146.76 39.21 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 176.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.485 ' HA3' HD11 ' A' ' 102' ' ' LEU . . . -165.31 143.21 8.28 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-N 119.555 1.07 . . . . 0.0 113.002 168.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 6.6 t -88.4 160.06 17.74 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 114.114 -1.043 . . . . 0.0 109.043 170.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -177.91 -174.53 44.32 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 -179.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -133.16 140.45 47.59 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.802 1.641 . . . . 0.0 109.543 174.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 22.0 pt20 -134.46 45.88 2.54 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.398 0.618 . . . . 0.0 110.584 169.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -109.17 -33.66 6.81 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.841 1.256 . . . . 0.0 108.83 168.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -127.84 -34.88 2.13 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 125.046 1.338 . . . . 0.0 111.367 173.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -90.29 26.37 1.95 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.038 0.935 . . . . 0.0 111.971 178.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.59 -14.89 62.08 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.014 -1.054 . . . . 0.0 113.685 -175.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -89.32 2.24 54.65 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 118.986 0.812 . . . . 0.0 111.868 173.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -142.58 11.86 1.89 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.152 1.381 . . . . 0.0 111.546 -173.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -67.8 127.55 33.22 Favored 'General case' 0 C--O 1.236 0.388 0 O-C-N 121.221 -0.924 . . . . 0.0 110.707 -168.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 85.2 m 50.99 31.77 6.71 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.085 1.354 . . . . 0.0 112.42 177.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -60.25 -38.44 83.47 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 121.777 -0.577 . . . . 0.0 111.354 -179.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.6 -21.96 62.6 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -169.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.485 HD11 ' HA3' ' A' ' 87' ' ' GLY . 6.9 mp -59.96 -38.02 81.26 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 119.063 0.847 . . . . 0.0 109.322 172.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.68 -34.48 88.73 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 111.306 -0.718 . . . . 0.0 111.306 175.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 4.7 m -65.68 -38.47 89.35 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.588 1.194 . . . . 0.0 110.364 177.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.1 mt -70.23 -46.1 73.11 Favored 'Isoleucine or valine' 0 C--N 1.343 0.323 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 175.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 37.5 ttt180 -53.42 -45.71 69.5 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 118.807 0.731 . . . . 0.0 110.579 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -61.85 -17.92 58.18 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.408 1.083 . . . . 0.0 112.571 -178.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 94.3 mt -95.69 -57.59 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 C-N-CA 123.997 0.919 . . . . 0.0 108.918 173.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 19.9 pt -69.05 -33.4 58.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 119.369 0.986 . . . . 0.0 112.203 -167.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -66.93 -54.06 23.01 Favored Pre-proline 0 CA--C 1.545 0.783 0 CA-C-O 117.816 -1.088 . . . . 0.0 111.006 -174.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.86 -22.39 36.53 Favored 'Trans proline' 0 C--N 1.353 0.786 0 CA-C-N 121.646 1.624 . . . . 0.0 112.677 175.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 30.4 mmm180 -79.68 11.31 3.24 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 119.015 0.825 . . . . 0.0 112.124 172.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 98.12 -2.57 59.73 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 125.463 1.506 . . . . 0.0 116.82 166.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.95 143.15 57.97 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 120.155 1.978 . . . . 0.0 111.059 -176.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 48.6 m -94.27 123.83 37.92 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 105.138 -2.171 . . . . 0.0 105.138 168.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 42.3 mt -105.86 131.77 54.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 -170.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 33.4 m -132.74 178.33 5.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 125.544 1.537 . . . . 0.0 109.258 177.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 77.35 22.89 69.44 Favored Glycine 0 CA--C 1.525 0.657 0 O-C-N 121.613 -0.679 . . . . 0.0 112.686 174.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 9.1 p-80 -61.5 113.88 2.92 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.313 1.045 . . . . 0.0 108.28 169.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 73.6 t-105 -84.06 140.85 40.02 Favored Pre-proline 0 CA--C 1.536 0.439 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 177.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -66.25 149.06 85.43 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 121.981 1.788 . . . . 0.0 111.296 179.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 81.2 p -80.47 -11.0 59.73 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.267 0.627 . . . . 0.0 111.118 169.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 53.98 42.86 31.5 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.863 1.665 . . . . 0.0 110.968 -169.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 73.2 70.74 1.18 Allowed Glycine 0 C--N 1.339 0.717 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 -178.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -42.06 136.34 2.18 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.403 1.081 . . . . 0.0 112.838 174.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 9.1 p80 -150.63 15.65 0.78 Allowed 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 176.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -88.87 -157.05 0.42 Allowed 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 119.069 0.85 . . . . 0.0 110.428 -179.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -73.4 -82.49 0.05 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.788 0.835 . . . . 0.0 112.862 -168.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -156.64 67.32 0.56 Allowed 'General case' 0 C--N 1.342 0.26 0 CA-C-O 123.13 1.443 . . . . 0.0 110.742 -177.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 19.5 m -70.68 133.87 47.02 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 113.87 -1.514 . . . . 0.0 107.564 171.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 60.0 mttt -112.38 -1.98 14.9 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -168.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -76.88 0.96 64.3 Favored Glycine 0 CA--C 1.532 1.135 0 CA-C-O 118.93 -0.928 . . . . 0.0 113.214 168.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 8.3 mp -63.67 129.92 42.13 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 119.938 1.869 . . . . 0.0 110.277 178.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.06 -38.25 22.79 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.82 1.248 . . . . 0.0 108.058 167.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -153.94 166.68 32.22 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 129.548 3.139 . . . . 0.0 106.105 -174.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -52.67 -35.64 55.59 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.052 -1.03 . . . . 0.0 112.336 175.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -95.92 -7.37 36.85 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -174.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -146.28 141.09 26.98 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.814 1.188 . . . . 0.0 112.207 -172.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -83.93 160.87 20.99 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.003 1.321 . . . . 0.0 108.768 168.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 34.3 m -72.03 -7.16 8.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 O-C-N 120.963 -1.086 . . . . 0.0 112.872 179.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -166.64 -157.63 10.52 Favored Glycine 0 CA--C 1.521 0.42 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.433 HD12 ' CE2' ' A' ' 86' ' ' PHE . 2.8 tm? -76.97 96.24 4.32 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 169.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -84.77 130.13 34.73 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 104.042 -2.577 . . . . 0.0 104.042 165.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 7.9 tp -61.97 -8.75 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 N-CA-C 115.842 1.793 . . . . 0.0 115.842 -168.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.448 ' HA ' ' CZ ' ' A' ' 156' ' ' ARG . 31.7 t70 -149.95 147.58 28.06 Favored 'General case' 0 N--CA 1.452 -0.368 0 O-C-N 120.722 -1.236 . . . . 0.0 113.193 -173.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.48 14.3 2.36 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 126.752 2.021 . . . . 0.0 110.128 169.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -124.99 -54.57 1.61 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.139 1.376 . . . . 0.0 111.609 -173.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -165.23 -47.8 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 124.558 1.143 . . . . 0.0 111.178 170.046 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 -150.18 173.64 4.14 Favored Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 125.137 1.375 . . . . 0.0 110.093 -169.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -64.78 24.76 0.08 OUTLIER 'Trans proline' 0 CA--C 1.547 1.175 0 C-N-CA 124.727 3.618 . . . . 0.0 116.92 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -63.31 -26.91 68.99 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 120.509 -1.369 . . . . 0.0 112.319 -169.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 85.3 mt -109.13 27.77 9.18 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 125.021 1.329 . . . . 0.0 110.684 -175.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 13.5 m -48.23 -55.61 10.07 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 123.946 0.899 . . . . 0.0 110.512 -175.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -61.85 -40.84 96.74 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.481 0.582 . . . . 0.0 111.121 -170.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -66.12 -49.92 65.8 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 177.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.448 ' CZ ' ' HA ' ' A' ' 145' ' ' ASP . 87.4 mtt180 -58.73 -47.49 84.44 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 123.073 0.549 . . . . 0.0 110.219 -175.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 13.0 m -77.51 -33.69 19.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-O 118.611 -0.709 . . . . 0.0 110.729 -171.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -65.97 -47.81 73.35 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 119.841 1.2 . . . . 0.0 109.526 174.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -61.13 -40.37 93.56 Favored 'General case' 0 C--O 1.227 -0.11 0 CA-C-O 119.132 -0.461 . . . . 0.0 110.157 179.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 60.9 t90 -64.08 -47.7 79.06 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 118.71 0.686 . . . . 0.0 110.791 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 40.7 t -57.62 -40.55 75.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 118.265 0.484 . . . . 0.0 109.805 177.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 53.7 mttm -68.83 -36.96 78.82 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 118.353 -0.832 . . . . 0.0 110.227 -178.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -62.59 -55.35 27.97 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 119.106 0.867 . . . . 0.0 110.42 174.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 22.4 pt -68.58 -29.03 42.48 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.369 0 CA-C-O 119.015 -0.517 . . . . 0.0 110.409 -172.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 64.3 m -58.01 -29.67 65.49 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 119.011 0.823 . . . . 0.0 111.593 175.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -79.37 -45.46 19.51 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 119.64 1.109 . . . . 0.0 110.272 175.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -66.37 -35.03 79.3 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.516 0.726 . . . . 0.0 111.236 -175.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 73.6 mt -86.75 -3.59 59.07 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.075 1.75 . . . . 0.0 111.377 179.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 54.12 33.98 19.04 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.56 1.544 . . . . 0.0 112.51 -173.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 95.9 mt -81.36 -26.56 35.43 Favored 'General case' 0 N--CA 1.464 0.265 0 O-C-N 121.549 -0.719 . . . . 0.0 110.359 173.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -57.26 -37.93 73.11 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 118.64 0.654 . . . . 0.0 110.028 174.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -66.97 -10.06 45.3 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.325 0.65 . . . . 0.0 112.682 178.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 64.7 mt -106.21 -55.47 5.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 125.164 1.386 . . . . 0.0 108.126 -179.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.4 pp -78.13 -22.08 49.36 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.166 0.586 . . . . 0.0 112.182 -171.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -127.73 38.32 4.06 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.523 1.929 . . . . 0.0 109.183 -176.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.152 0 C-N-CA 123.865 0.866 . . . . 0.0 109.703 174.897 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.8 ttt . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 118.161 -0.923 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 60.08 -178.1 0.1 Allowed 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.908 1.283 . . . . 0.0 112.42 -170.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 22.4 pt -89.47 -18.96 7.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 O-C-N 121.623 -0.673 . . . . 0.0 112.091 -177.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.2 m -117.46 122.46 43.81 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 124.997 1.319 . . . . 0.0 107.521 178.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -98.45 114.28 4.97 Favored Glycine 0 C--N 1.334 0.472 0 N-CA-C 107.873 -2.091 . . . . 0.0 107.873 171.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 65.4 mt -94.69 106.75 18.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 104.872 -2.27 . . . . 0.0 104.872 174.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 11.7 m-30 -105.08 133.66 49.48 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 177.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -125.69 130.21 51.1 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.515 0.598 . . . . 0.0 112.149 -178.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -86.29 144.92 20.21 Favored Glycine 0 C--N 1.338 0.665 0 N-CA-C 108.738 -1.745 . . . . 0.0 108.738 168.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 11.0 m -158.27 169.76 23.77 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 119.12 1.46 . . . . 0.0 110.321 175.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -141.6 -49.45 0.4 Allowed 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.556 1.142 . . . . 0.0 109.124 168.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.3 p -80.56 -17.22 52.12 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.938 0.895 . . . . 0.0 112.171 170.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 103.95 7.41 41.38 Favored Glycine 0 C--N 1.342 0.885 0 C-N-CA 124.673 1.13 . . . . 0.0 113.99 171.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -65.13 -42.04 94.27 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 118.999 1.4 . . . . 0.0 112.069 -171.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -70.26 -18.41 63.13 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 118.942 0.792 . . . . 0.0 111.751 -170.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -58.81 -43.57 90.62 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 119.432 1.014 . . . . 0.0 110.036 174.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -64.4 -40.44 95.8 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 23.3 mm -66.42 -42.33 90.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 O-C-N 121.804 -0.56 . . . . 0.0 109.507 179.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.71 -40.08 86.76 Favored 'General case' 0 CA--C 1.532 0.253 0 O-C-N 121.721 -0.612 . . . . 0.0 110.579 176.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp -68.39 -39.43 81.72 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 118.336 -0.84 . . . . 0.0 111.145 176.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 64.1 mtt -59.51 -37.39 78.18 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 119.827 1.194 . . . . 0.0 110.976 175.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 51.9 mt -71.31 -51.38 34.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 177.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -62.13 -37.11 83.91 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 121.507 -0.745 . . . . 0.0 111.203 -174.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 59.1 tptt -63.13 -38.28 90.57 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 119.063 0.847 . . . . 0.0 110.812 -178.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -71.76 -41.62 68.2 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.952 0.501 . . . . 0.0 110.753 177.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.1 mp -73.21 -35.73 66.37 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.098 0.408 . . . . 0.0 111.24 -176.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 90.93 147.71 19.8 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 125.089 1.328 . . . . 0.0 110.771 -172.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -66.42 -28.3 68.51 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.694 0.798 . . . . 0.0 112.186 -171.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -69.04 -25.92 64.72 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 122.873 0.469 . . . . 0.0 111.348 176.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 31.6 t -98.52 -36.31 5.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 C-N-CA 124.481 1.112 . . . . 0.0 110.58 -174.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -135.33 144.76 46.86 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 118.777 0.717 . . . . 0.0 112.207 -177.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -129.32 154.65 46.66 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 125.288 1.435 . . . . 0.0 108.212 175.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 69.7 t -117.76 133.96 62.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 124.165 0.986 . . . . 0.0 108.901 -169.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -149.73 -174.78 4.79 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.218 1.007 . . . . 0.0 111.319 -177.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -135.02 141.31 46.14 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 125.224 1.41 . . . . 0.0 107.197 173.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.8 tp -59.49 -24.96 29.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 123.869 0.868 . . . . 0.0 112.906 -169.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.56 -27.81 69.21 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 118.729 0.695 . . . . 0.0 111.165 178.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -96.85 -33.78 11.52 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.751 1.22 . . . . 0.0 110.986 -179.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 19.8 m -60.38 162.11 6.56 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.332 0.653 . . . . 0.0 110.001 169.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.4 m -136.29 157.28 47.17 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.619 0.768 . . . . 0.0 110.449 -171.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -51.69 -51.71 53.86 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.23 1.012 . . . . 0.0 110.884 -179.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -75.24 -16.34 60.47 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 122.693 0.397 . . . . 0.0 111.587 -176.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -78.49 -37.98 41.99 Favored 'General case' 0 CA--C 1.53 0.19 0 O-C-N 121.541 -0.724 . . . . 0.0 110.213 179.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.0 mp -65.24 -35.05 79.86 Favored 'General case' 0 C--N 1.342 0.248 0 O-C-N 121.808 -0.558 . . . . 0.0 110.265 170.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -63.87 -23.85 67.51 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 118.81 0.732 . . . . 0.0 111.493 174.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -86.83 -31.4 20.85 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.941 0.896 . . . . 0.0 112.75 -178.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -67.55 160.17 28.28 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 123.994 0.917 . . . . 0.0 110.688 174.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -109.27 -40.17 5.01 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.493 0.717 . . . . 0.0 111.39 169.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.9 mt -112.47 125.19 69.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 177.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -113.9 132.19 56.01 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 171.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.0 mp -115.28 119.24 35.67 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 172.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 69.2 mt -117.41 109.46 16.81 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -172.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.78 123.07 6.63 Favored Glycine 0 CA--C 1.521 0.463 0 N-CA-C 108.949 -1.661 . . . . 0.0 108.949 176.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 3.4 tp -137.1 115.4 10.11 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-N 118.129 0.965 . . . . 0.0 110.125 -169.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -78.6 -173.22 1.77 Allowed 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 123.207 2.605 . . . . 0.0 109.986 169.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 95.5 m -144.45 145.96 32.19 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 119.99 -1.694 . . . . 0.0 107.592 169.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 75.0 m95 -139.71 169.74 17.17 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 125.144 1.378 . . . . 0.0 110.984 -169.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 55.88 -73.1 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 128.833 2.853 . . . . 0.0 114.642 175.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -161.76 56.25 0.26 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 127.239 2.216 . . . . 0.0 108.379 -174.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 81.72 19.66 65.33 Favored Glycine 0 CA--C 1.534 1.258 0 O-C-N 121.438 -0.789 . . . . 0.0 113.47 -179.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -88.31 154.29 20.53 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.416 1.108 . . . . 0.0 109.489 179.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.85 161.88 24.24 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 168.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.252 0.0 OUTLIER -70.93 159.85 33.94 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 170.413 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 57.7 m -53.71 -37.53 63.38 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 115.567 1.691 . . . . 0.0 115.567 -166.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -76.79 -43.97 34.63 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 119.046 0.839 . . . . 0.0 109.458 -170.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -64.18 -45.75 87.0 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.653 0.781 . . . . 0.0 109.446 173.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -58.76 -39.32 80.67 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 122.583 0.353 . . . . 0.0 111.732 179.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -71.22 -30.64 66.61 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.897 0.879 . . . . 0.0 112.253 176.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -87.34 -21.67 25.56 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 118.618 0.645 . . . . 0.0 112.562 -176.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 16.5 m-30 -50.08 -44.63 80.38 Favored Pre-proline 0 CA--C 1.546 0.799 0 CA-C-O 116.932 -1.509 . . . . 0.0 114.683 178.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -65.98 -16.32 52.1 Favored 'Trans proline' 0 CA--C 1.542 0.913 0 CA-C-N 122.598 1.964 . . . . 0.0 113.798 175.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 14.7 m -85.87 -40.31 16.09 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 119.481 1.037 . . . . 0.0 109.207 169.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.435 ' HA ' HD12 ' A' ' 76' ' ' ILE . 37.3 tp -59.71 -36.9 77.48 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.94 1.296 . . . . 0.0 111.572 -173.189 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -66.85 -15.58 63.72 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 177.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 -91.97 -14.26 29.78 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 119.261 0.937 . . . . 0.0 111.781 179.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.435 HD12 ' HA ' ' A' ' 73' ' ' LEU . 96.7 mt -80.65 138.39 19.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 -173.043 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -80.88 132.0 35.41 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.707 -0.678 . . . . 0.0 109.259 175.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -126.88 16.43 7.39 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 118.187 -0.911 . . . . 0.0 111.42 174.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 23.9 m-80 -59.41 114.31 2.62 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 120.542 1.519 . . . . 0.0 109.377 -175.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.65 4.6 66.26 Favored Glycine 0 CA--C 1.536 1.357 0 CA-C-O 118.69 -1.061 . . . . 0.0 114.123 -178.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -77.39 151.58 34.75 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 119.515 1.658 . . . . 0.0 108.224 171.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 17.8 mt -95.74 137.2 35.13 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 175.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.3 t -132.11 144.29 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 172.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -135.36 149.18 49.63 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 169.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 72.6 mt -120.52 149.13 42.9 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 -174.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -146.59 157.39 43.71 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 123.234 0.614 . . . . 0.0 109.55 172.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -170.2 166.34 39.57 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-O 122.305 0.947 . . . . 0.0 113.208 -175.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 15.2 t -142.64 162.18 36.14 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 126.754 2.021 . . . . 0.0 107.106 179.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -176.0 -170.71 39.07 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -139.42 142.88 37.44 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 127.086 2.154 . . . . 0.0 105.978 176.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.62 21.99 1.99 Allowed 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -172.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -64.5 -46.19 84.02 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 178.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -95.84 -38.18 10.41 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.174 0.59 . . . . 0.0 110.704 169.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -83.22 41.89 0.79 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.408 1.483 . . . . 0.0 111.551 -172.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.18 -21.14 66.45 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.823 1.249 . . . . 0.0 113.72 -169.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -97.36 2.85 51.05 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.716 1.207 . . . . 0.0 111.386 178.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -133.98 18.18 3.8 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.4 1.08 . . . . 0.0 112.481 -169.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -61.86 120.37 10.6 Favored 'General case' 0 CA--C 1.529 0.169 0 O-C-N 121.104 -0.997 . . . . 0.0 109.346 -176.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 80.1 m 45.88 35.76 2.51 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.557 1.543 . . . . 0.0 112.654 -176.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -49.48 -41.1 39.59 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.43 1.092 . . . . 0.0 111.911 -171.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.67 -13.88 62.47 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -171.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 34.1 mt -56.23 -41.84 76.32 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 119.837 1.199 . . . . 0.0 109.793 169.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.97 -36.42 93.05 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 178.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.0 m -62.71 -44.23 96.75 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 117.944 0.872 . . . . 0.0 109.906 177.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.7 mt -66.29 -45.48 89.64 Favored 'Isoleucine or valine' 0 C--N 1.344 0.357 0 CA-C-N 119.613 1.097 . . . . 0.0 108.908 178.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 45.6 ttt180 -54.64 -48.15 72.63 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 119.379 0.99 . . . . 0.0 110.43 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -62.08 -29.8 70.56 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.329 0.652 . . . . 0.0 111.603 -177.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 85.9 mt -81.53 -44.36 20.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-O 117.595 -1.193 . . . . 0.0 110.634 178.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.7 pt -86.88 -33.55 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 120.121 1.328 . . . . 0.0 113.003 -168.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -64.57 -37.85 27.23 Favored Pre-proline 0 CA--C 1.547 0.832 0 CA-C-O 117.946 -1.026 . . . . 0.0 112.008 -171.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -64.38 -17.1 58.5 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 122.417 2.078 . . . . 0.0 114.223 174.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 13.7 mmt180 -90.25 10.2 25.63 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.076 0.95 . . . . 0.0 111.536 -173.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 77.94 10.85 85.93 Favored Glycine 0 CA--C 1.531 1.06 0 CA-C-O 118.432 -1.205 . . . . 0.0 113.391 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -57.66 137.94 55.9 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 118.712 1.256 . . . . 0.0 109.426 171.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 55.8 m -93.96 120.87 34.8 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 168.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 36.9 mt -97.65 128.17 49.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 -176.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 34.6 m -128.79 175.44 10.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 124.983 1.313 . . . . 0.0 108.987 176.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 75.93 28.85 59.96 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-O 119.079 -0.845 . . . . 0.0 112.731 -177.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 81.4 m-70 -60.43 135.17 57.66 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 169.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 74.7 t-105 -129.99 139.7 36.44 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 124.248 1.019 . . . . 0.0 109.385 -169.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -62.08 162.39 22.99 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 121.781 1.654 . . . . 0.0 113.065 -178.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -55.01 -34.25 63.29 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.659 0.784 . . . . 0.0 112.015 174.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 42.42 55.01 4.22 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.738 1.615 . . . . 0.0 112.981 168.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 99.9 -7.92 59.28 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-O 118.656 -1.08 . . . . 0.0 114.658 175.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -59.65 133.47 56.13 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 118.974 1.387 . . . . 0.0 109.264 169.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 8.8 t-80 -154.84 40.98 0.45 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.062 0.945 . . . . 0.0 110.276 176.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -106.34 -176.37 3.06 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.956 0.902 . . . . 0.0 111.307 -170.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 -71.98 -47.02 55.1 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 118.839 -0.6 . . . . 0.0 111.191 -169.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -157.38 149.44 22.53 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 118.749 0.704 . . . . 0.0 111.413 173.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 40.0 t -140.09 126.08 19.66 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 105.444 -2.058 . . . . 0.0 105.444 167.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.63 -10.54 58.9 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.791 -175.366 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -79.08 -4.9 89.05 Favored Glycine 0 C--N 1.341 0.815 0 CA-C-O 118.596 -1.114 . . . . 0.0 113.19 170.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 70.4 mt -68.96 120.09 14.3 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 120.402 2.101 . . . . 0.0 108.156 175.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -87.91 -28.69 21.37 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.635 1.174 . . . . 0.0 110.337 175.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -146.73 168.38 21.5 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.161 1.784 . . . . 0.0 107.403 171.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -57.25 -25.96 60.01 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.742 1.217 . . . . 0.0 113.57 -170.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -121.43 11.34 10.67 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.349 1.46 . . . . 0.0 113.163 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -142.72 127.53 18.22 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-N 119.404 1.002 . . . . 0.0 111.593 -175.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -80.64 152.99 28.21 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 125.061 1.344 . . . . 0.0 109.658 169.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 12.2 p -59.73 -24.95 30.58 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 C-N-CA 124.76 1.224 . . . . 0.0 111.654 171.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -156.72 171.82 34.32 Favored Glycine 0 C--N 1.337 0.629 0 C-N-CA 124.763 1.173 . . . . 0.0 110.53 -169.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -60.24 127.26 30.91 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -117.35 121.05 40.04 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 170.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 1.5 pt -100.75 111.37 30.2 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.098 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 173.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -158.33 153.4 25.38 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 129.46 3.104 . . . . 0.0 106.342 172.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -150.58 -44.84 0.12 Allowed 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 119.736 1.153 . . . . 0.0 111.559 179.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -105.82 -111.48 0.27 Allowed 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 106.046 -1.835 . . . . 0.0 106.046 170.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 16.8 ptm180 -88.09 -16.21 34.15 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 119.777 1.171 . . . . 0.0 110.806 165.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -144.62 166.24 19.4 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 129.215 3.006 . . . . 0.0 105.776 -179.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.13 152.64 45.66 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 122.019 1.813 . . . . 0.0 112.822 179.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -130.77 -5.84 4.05 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.275 1.03 . . . . 0.0 111.88 168.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 66.9 mt -113.38 28.78 8.51 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.522 1.529 . . . . 0.0 110.078 178.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 74.3 m -47.08 -56.98 5.55 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.806 1.643 . . . . 0.0 111.992 -169.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -69.59 -39.37 77.33 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 119.245 -0.407 . . . . 0.0 111.27 -168.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -73.52 -35.04 65.53 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.456 0.571 . . . . 0.0 111.118 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 33.2 mtp180 -64.8 -41.11 96.06 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 119.341 0.973 . . . . 0.0 109.892 174.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 72.4 t -67.89 -41.33 84.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-O 118.592 -0.718 . . . . 0.0 109.634 177.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -59.26 -50.78 72.71 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 120.134 1.334 . . . . 0.0 110.283 176.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 58.1 mttm -57.41 -42.92 83.24 Favored 'General case' 0 CA--C 1.522 -0.115 0 CA-C-O 118.652 -0.69 . . . . 0.0 109.994 -178.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 60.5 t90 -66.43 -48.55 69.64 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 118.546 0.612 . . . . 0.0 110.797 -178.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 53.6 t -60.87 -36.2 70.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 118.107 0.412 . . . . 0.0 109.95 -177.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -65.94 -33.91 76.91 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 118.427 -0.797 . . . . 0.0 110.438 177.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 41.5 mm-40 -65.58 -54.77 23.31 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 119.015 0.825 . . . . 0.0 110.534 171.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 5.7 pt -64.65 -29.91 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-N 118.807 0.731 . . . . 0.0 110.633 -170.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 49.6 m -60.09 -27.01 66.64 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 118.646 -0.692 . . . . 0.0 111.774 178.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -82.41 -38.11 24.55 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 119.644 1.111 . . . . 0.0 110.717 175.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -71.36 -36.78 71.6 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.136 0.574 . . . . 0.0 111.133 -178.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 85.7 mt -85.75 -5.75 59.21 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.749 1.62 . . . . 0.0 111.306 178.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 84.7 m-70 54.63 29.99 12.49 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.81 1.644 . . . . 0.0 112.88 -171.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 80.0 mt -77.59 -20.41 54.02 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 118.668 -0.682 . . . . 0.0 110.723 173.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -56.99 -38.3 72.86 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 119.292 0.951 . . . . 0.0 110.356 174.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -66.95 -12.87 60.97 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 121.637 -0.665 . . . . 0.0 112.522 178.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 44.4 mt -103.9 -55.32 5.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 124.993 1.317 . . . . 0.0 108.566 -179.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.4 pp -79.31 -24.87 42.54 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.567 0.747 . . . . 0.0 112.179 -171.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -121.8 35.48 4.87 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.08 1.752 . . . . 0.0 109.582 -175.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.333 0 C-N-CA 123.695 0.798 . . . . 0.0 109.571 174.184 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_